Citrus Sinensis ID: 028681
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 205 | 2.2.26 [Sep-21-2011] | |||||||
| Q75H77 | 362 | Serine/threonine-protein | yes | no | 0.990 | 0.560 | 0.926 | 1e-110 | |
| Q7Y0B9 | 371 | Serine/threonine-protein | no | no | 0.985 | 0.544 | 0.915 | 1e-108 | |
| Q39193 | 361 | Serine/threonine-protein | yes | no | 0.985 | 0.559 | 0.896 | 1e-107 | |
| Q940H6 | 362 | Serine/threonine-protein | no | no | 0.980 | 0.555 | 0.921 | 1e-107 | |
| Q75V57 | 361 | Serine/threonine-protein | no | no | 0.980 | 0.556 | 0.877 | 1e-103 | |
| Q39192 | 362 | Serine/threonine-protein | no | no | 0.936 | 0.530 | 0.885 | 1e-101 | |
| A2YNT8 | 339 | Serine/threonine-protein | N/A | no | 0.892 | 0.539 | 0.874 | 9e-94 | |
| Q0D4J7 | 339 | Serine/threonine-protein | no | no | 0.892 | 0.539 | 0.868 | 2e-93 | |
| P43291 | 363 | Serine/threonine-protein | no | no | 0.892 | 0.504 | 0.846 | 8e-93 | |
| Q9C958 | 361 | Serine/threonine-protein | no | no | 0.892 | 0.506 | 0.846 | 5e-92 |
| >sp|Q75H77|SAPKA_ORYSJ Serine/threonine-protein kinase SAPK10 OS=Oryza sativa subsp. japonica GN=SAPK10 PE=2 SV=1 | Back alignment and function desciption |
|---|
Score = 397 bits (1019), Expect = e-110, Method: Compositional matrix adjust.
Identities = 188/203 (92%), Positives = 195/203 (96%)
Query: 1 MDRSAMTVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI 60
MDR+A+TVGPGMDMPIMHD DRYELVRDIGSGNFGVARLMR + +LVAVKYIERGDKI
Sbjct: 1 MDRAALTVGPGMDMPIMHDGDRYELVRDIGSGNFGVARLMRSRADGQLVAVKYIERGDKI 60
Query: 61 DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 120
DENVQREIINHRSLRHPNI+RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR
Sbjct: 61 DENVQREIINHRSLRHPNIIRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 120
Query: 121 FFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 180
FFFQQLISGVSYCHSMQVCHRDLKLENTLLDGS APRLKICDFGYSKSSVLHSQPKSTVG
Sbjct: 121 FFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSTAPRLKICDFGYSKSSVLHSQPKSTVG 180
Query: 181 TPAYIAPEVLLKKEYDGKVMCVY 203
TPAYIAPEVLLKKEYDGK+ V+
Sbjct: 181 TPAYIAPEVLLKKEYDGKIADVW 203
|
May play a role in signal transduction of hyperosmotic response. Oryza sativa subsp. japonica (taxid: 39947) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q7Y0B9|SAPK8_ORYSJ Serine/threonine-protein kinase SAPK8 OS=Oryza sativa subsp. japonica GN=SAPK8 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 390 bits (1003), Expect = e-108, Method: Compositional matrix adjust.
Identities = 185/202 (91%), Positives = 195/202 (96%)
Query: 2 DRSAMTVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID 61
DR+A+TVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRD++T ELVAVKYIERG+KID
Sbjct: 12 DRAALTVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDRRTMELVAVKYIERGEKID 71
Query: 62 ENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARF 121
+NVQREIINHRSL+HPNI+RFKEVILTPTHLAIVMEYASGGELFERIC RFSEDEAR+
Sbjct: 72 DNVQREIINHRSLKHPNIIRFKEVILTPTHLAIVMEYASGGELFERICKNVRFSEDEARY 131
Query: 122 FFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGT 181
FFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGT
Sbjct: 132 FFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGT 191
Query: 182 PAYIAPEVLLKKEYDGKVMCVY 203
PAYIAPEVLLKKEYDGK V+
Sbjct: 192 PAYIAPEVLLKKEYDGKTADVW 213
|
May play a role in signal transduction of hyperosmotic response. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q39193|SRK2I_ARATH Serine/threonine-protein kinase SRK2I OS=Arabidopsis thaliana GN=SRK2I PE=1 SV=1 | Back alignment and function description |
|---|
Score = 388 bits (996), Expect = e-107, Method: Compositional matrix adjust.
Identities = 182/203 (89%), Positives = 196/203 (96%), Gaps = 1/203 (0%)
Query: 1 MDRSAMTVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI 60
MDR+ +T GP +DMPIMHDSDRY+ V+DIGSGNFGVARLMRDK T+ELVAVKYIERGDKI
Sbjct: 1 MDRAPVTTGP-LDMPIMHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGDKI 59
Query: 61 DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 120
DENVQREIINHRSLRHPNIVRFKEVILTPTHLAI+MEYASGGEL+ERICNAGRFSEDEAR
Sbjct: 60 DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEAR 119
Query: 121 FFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 180
FFFQQL+SGVSYCHSMQ+CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG
Sbjct: 120 FFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 179
Query: 181 TPAYIAPEVLLKKEYDGKVMCVY 203
TPAYIAPEVLL++EYDGK+ V+
Sbjct: 180 TPAYIAPEVLLRQEYDGKIADVW 202
|
Together with SRK2D, key component and activator of the abscisic acid (ABA) signaling pathway that regulates numerous ABA responses, such as seed germination, Pro accumulation, root growth inhibition, dormancy and seedling growth, and, to a lesser extent, stomatal closure. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q940H6|SRK2E_ARATH Serine/threonine-protein kinase SRK2E OS=Arabidopsis thaliana GN=SRK2E PE=1 SV=1 | Back alignment and function description |
|---|
Score = 387 bits (994), Expect = e-107, Method: Compositional matrix adjust.
Identities = 187/203 (92%), Positives = 197/203 (97%), Gaps = 2/203 (0%)
Query: 1 MDRSAMTVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI 60
MDR A++ GP MD+PIMHDSDRYELV+DIGSGNFGVARLMRDK++ ELVAVKYIERG+KI
Sbjct: 1 MDRPAVS-GP-MDLPIMHDSDRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKI 58
Query: 61 DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 120
DENV+REIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR
Sbjct: 59 DENVKREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 118
Query: 121 FFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 180
FFFQQLISGVSYCH+MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG
Sbjct: 119 FFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 178
Query: 181 TPAYIAPEVLLKKEYDGKVMCVY 203
TPAYIAPEVLLKKEYDGKV V+
Sbjct: 179 TPAYIAPEVLLKKEYDGKVADVW 201
|
Activator of the abscisic acid (ABA) signaling pathway that regulates numerous ABA responses, such as stomata closure in response to drought, plant pathogens, or decreases in atmospheric relative humidity (RH). Involved in the resistance to drought by avoiding water loss. Required for the stomata closure mediated by pathogen-associated molecular pattern (PAMPs) (e.g. flg22 and LPS) of pathogenic bacteria such as P.syringae pv. tomato (Pst) and E.coli O157:H7. As a plant defense process, stomata are closed transiently in order to limit invaders, but actively reopened by bacteria after a few hours; virulent strains (e.g. Pst DC3000) are more efficient than avirulent strains (e.g. Pst DC3000 AvrRpt2) in reopening stomata. Mediates the phosphorylation and activation of the S-type anion efflux channel SLAC1, and thus promotes stomata closure. Essential for stomatal closure in response to reactive oxygen species (ROS). Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q75V57|SAPK9_ORYSJ Serine/threonine-protein kinase SAPK9 OS=Oryza sativa subsp. japonica GN=SAPK9 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 373 bits (957), Expect = e-103, Method: Compositional matrix adjust.
Identities = 179/204 (87%), Positives = 194/204 (95%), Gaps = 3/204 (1%)
Query: 1 MDRSAMTVGP-GMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK 59
M+R+A GP GM+MPIMHD DRYELV++IGSGNFGVARLMR++ + +LVAVKYI+RG+K
Sbjct: 1 MERAA--AGPLGMEMPIMHDGDRYELVKEIGSGNFGVARLMRNRASGDLVAVKYIDRGEK 58
Query: 60 IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEA 119
IDENVQREIINHRSLRHPNI+RFKEVILTPTHLAIVMEYASGGELFERIC+AGRFSEDEA
Sbjct: 59 IDENVQREIINHRSLRHPNIIRFKEVILTPTHLAIVMEYASGGELFERICSAGRFSEDEA 118
Query: 120 RFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV 179
RFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGS APRLKICDFGYSKSSVLHSQPKSTV
Sbjct: 119 RFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSTAPRLKICDFGYSKSSVLHSQPKSTV 178
Query: 180 GTPAYIAPEVLLKKEYDGKVMCVY 203
GTPAYIAPEVLLKKEYDGK+ V+
Sbjct: 179 GTPAYIAPEVLLKKEYDGKIADVW 202
|
May play a role in signal transduction of hyperosmotic response. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q39192|SRK2D_ARATH Serine/threonine-protein kinase SRK2D OS=Arabidopsis thaliana GN=SRK2D PE=1 SV=1 | Back alignment and function description |
|---|
Score = 368 bits (945), Expect = e-101, Method: Compositional matrix adjust.
Identities = 170/192 (88%), Positives = 187/192 (97%)
Query: 12 MDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINH 71
+D+PIMHDSDRY+ V+DIGSGNFGVARLM D+ T+ELVAVKYIERG+KIDENVQREIINH
Sbjct: 12 IDLPIMHDSDRYDFVKDIGSGNFGVARLMTDRVTKELVAVKYIERGEKIDENVQREIINH 71
Query: 72 RSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS 131
RSLRHPNIVRFKEVILTP+HLAIVMEYA+GGEL+ERICNAGRFSEDEARFFFQQLISGVS
Sbjct: 72 RSLRHPNIVRFKEVILTPSHLAIVMEYAAGGELYERICNAGRFSEDEARFFFQQLISGVS 131
Query: 132 YCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL 191
YCH+MQ+CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPE+LL
Sbjct: 132 YCHAMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEILL 191
Query: 192 KKEYDGKVMCVY 203
++EYDGK+ V+
Sbjct: 192 RQEYDGKLADVW 203
|
Together with SRK2I, key component and activator of the abscisic acid (ABA) signaling pathway that regulates numerous ABA responses, such as seed germination, Pro accumulation, root growth inhibition, dormancy and seedling growth, and, to a lesser extent, stomatal closure. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|A2YNT8|SAPK2_ORYSI Serine/threonine-protein kinase SAPK2 OS=Oryza sativa subsp. indica GN=SAPK2 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 342 bits (877), Expect = 9e-94, Method: Compositional matrix adjust.
Identities = 160/183 (87%), Positives = 176/183 (96%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIV 80
+RYE+++DIGSGNFGVA+L+RD +T+EL AVK+IERG KIDENVQREI+NHRSLRHPNIV
Sbjct: 2 ERYEVIKDIGSGNFGVAKLVRDVRTKELFAVKFIERGQKIDENVQREIMNHRSLRHPNIV 61
Query: 81 RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCH 140
RFKEV+LTPTHLAIVMEYA+GGELFERIC+AGRFSEDEARFFFQQLISGVSYCHSMQ+CH
Sbjct: 62 RFKEVVLTPTHLAIVMEYAAGGELFERICSAGRFSEDEARFFFQQLISGVSYCHSMQICH 121
Query: 141 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKVM 200
RDLKLENTLLDGS APRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL +KEYDGKV
Sbjct: 122 RDLKLENTLLDGSIAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLARKEYDGKVA 181
Query: 201 CVY 203
V+
Sbjct: 182 DVW 184
|
May play a role in signal transduction of hyperosmotic response. Oryza sativa subsp. indica (taxid: 39946) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q0D4J7|SAPK2_ORYSJ Serine/threonine-protein kinase SAPK2 OS=Oryza sativa subsp. japonica GN=SAPK2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 341 bits (874), Expect = 2e-93, Method: Compositional matrix adjust.
Identities = 159/183 (86%), Positives = 176/183 (96%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIV 80
+RYE+++DIGSGNFGVA+L+RD +T+EL AVK+IERG KIDENVQREI+NHRSLRHPNIV
Sbjct: 2 ERYEVIKDIGSGNFGVAKLVRDVRTKELFAVKFIERGQKIDENVQREIMNHRSLRHPNIV 61
Query: 81 RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCH 140
RFKEV+LTPTHLAIVMEYA+GGELFERIC+AGRFSEDEARFFFQQLISGVSYCHSMQ+CH
Sbjct: 62 RFKEVVLTPTHLAIVMEYAAGGELFERICSAGRFSEDEARFFFQQLISGVSYCHSMQICH 121
Query: 141 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKVM 200
RDLKLENTLLDGS APRLKICDFGYSKSS+LHSQPKSTVGTPAYIAPEVL +KEYDGKV
Sbjct: 122 RDLKLENTLLDGSIAPRLKICDFGYSKSSLLHSQPKSTVGTPAYIAPEVLARKEYDGKVA 181
Query: 201 CVY 203
V+
Sbjct: 182 DVW 184
|
May play a role in signal transduction of hyperosmotic response. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P43291|SRK2A_ARATH Serine/threonine-protein kinase SRK2A OS=Arabidopsis thaliana GN=SRK2A PE=1 SV=1 | Back alignment and function description |
|---|
Score = 339 bits (869), Expect = 8e-93, Method: Compositional matrix adjust.
Identities = 155/183 (84%), Positives = 175/183 (95%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIV 80
D+YELV+DIG+GNFGVARLM+ K ++ELVA+KYIERG KIDENV REIINHRSLRHPNI+
Sbjct: 2 DKYELVKDIGAGNFGVARLMKVKNSKELVAMKYIERGPKIDENVAREIINHRSLRHPNII 61
Query: 81 RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCH 140
RFKEV+LTPTHLAI MEYA+GGELFERIC+AGRFSEDEAR+FFQQLISGVSYCH+MQ+CH
Sbjct: 62 RFKEVVLTPTHLAIAMEYAAGGELFERICSAGRFSEDEARYFFQQLISGVSYCHAMQICH 121
Query: 141 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKVM 200
RDLKLENTLLDGSPAPRLKICDFGYSKSS+LHS+PKSTVGTPAYIAPEVL ++EYDGK+
Sbjct: 122 RDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKMA 181
Query: 201 CVY 203
V+
Sbjct: 182 DVW 184
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9C958|SRK2B_ARATH Serine/threonine-protein kinase SRK2B OS=Arabidopsis thaliana GN=SRK2B PE=1 SV=1 | Back alignment and function description |
|---|
Score = 337 bits (863), Expect = 5e-92, Method: Compositional matrix adjust.
Identities = 155/183 (84%), Positives = 173/183 (94%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIV 80
D+YELV+DIG+GNFGVARLMR K ++ELVA+KYIERG KIDENV REIINHRSLRHPNI+
Sbjct: 2 DKYELVKDIGAGNFGVARLMRVKNSKELVAMKYIERGPKIDENVAREIINHRSLRHPNII 61
Query: 81 RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCH 140
RFKEV+LTPTH+AI MEYA+GGELFERIC+AGRFSEDEAR+FFQQLISGVSYCH+MQ+CH
Sbjct: 62 RFKEVVLTPTHIAIAMEYAAGGELFERICSAGRFSEDEARYFFQQLISGVSYCHAMQICH 121
Query: 141 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKVM 200
RDLKLENTLLDGSPAPRLKICDFGYSKSS+LHS PKSTVGTPAYIAPEVL + EYDGK+
Sbjct: 122 RDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSMPKSTVGTPAYIAPEVLSRGEYDGKMA 181
Query: 201 CVY 203
V+
Sbjct: 182 DVW 184
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 205 | ||||||
| 356575154 | 364 | PREDICTED: serine/threonine-protein kina | 0.990 | 0.557 | 0.965 | 1e-112 | |
| 356521207 | 364 | PREDICTED: serine/threonine-protein kina | 0.990 | 0.557 | 0.955 | 1e-112 | |
| 356519681 | 369 | PREDICTED: serine/threonine-protein kina | 0.985 | 0.547 | 0.955 | 1e-111 | |
| 255561655 | 363 | Serine/threonine-protein kinase SAPK10, | 0.990 | 0.559 | 0.935 | 1e-111 | |
| 225428695 | 363 | PREDICTED: serine/threonine-protein kina | 0.990 | 0.559 | 0.940 | 1e-110 | |
| 356575156 | 373 | PREDICTED: serine/threonine-protein kina | 0.990 | 0.544 | 0.924 | 1e-110 | |
| 449438438 | 365 | PREDICTED: serine/threonine-protein kina | 0.990 | 0.556 | 0.935 | 1e-110 | |
| 356521209 | 371 | PREDICTED: serine/threonine-protein kina | 0.990 | 0.547 | 0.923 | 1e-110 | |
| 356563656 | 360 | PREDICTED: serine/threonine-protein kina | 0.990 | 0.563 | 0.926 | 1e-110 | |
| 224123434 | 363 | predicted protein [Populus trichocarpa] | 0.990 | 0.559 | 0.935 | 1e-110 |
| >gi|356575154|ref|XP_003555707.1| PREDICTED: serine/threonine-protein kinase SRK2E-like isoform 1 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 411 bits (1056), Expect = e-112, Method: Compositional matrix adjust.
Identities = 196/203 (96%), Positives = 200/203 (98%)
Query: 1 MDRSAMTVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI 60
MDRSAMTVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDK TEELVAVKYIERGDKI
Sbjct: 1 MDRSAMTVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKHTEELVAVKYIERGDKI 60
Query: 61 DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 120
DENV+REIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR
Sbjct: 61 DENVRREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 120
Query: 121 FFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 180
FFFQQLISGVSYCH+MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG
Sbjct: 121 FFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 180
Query: 181 TPAYIAPEVLLKKEYDGKVMCVY 203
TPAYIAPEVLLKKEYDGK+ V+
Sbjct: 181 TPAYIAPEVLLKKEYDGKIADVW 203
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356521207|ref|XP_003529248.1| PREDICTED: serine/threonine-protein kinase SRK2E-like isoform 1 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 409 bits (1052), Expect = e-112, Method: Compositional matrix adjust.
Identities = 194/203 (95%), Positives = 200/203 (98%)
Query: 1 MDRSAMTVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI 60
MDRSAMTVGPGMDMPIMHDSD+YELVRDIGSGNFGVARLMRDK TEELVAVKYIERGDKI
Sbjct: 1 MDRSAMTVGPGMDMPIMHDSDKYELVRDIGSGNFGVARLMRDKHTEELVAVKYIERGDKI 60
Query: 61 DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 120
DENV+REIINHRSLRHPNIVRFKE+ILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR
Sbjct: 61 DENVRREIINHRSLRHPNIVRFKEIILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 120
Query: 121 FFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 180
FFFQQLISGVSYCH+MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG
Sbjct: 121 FFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 180
Query: 181 TPAYIAPEVLLKKEYDGKVMCVY 203
TPAYIAPEVLLKKEYDGK+ V+
Sbjct: 181 TPAYIAPEVLLKKEYDGKIADVW 203
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356519681|ref|XP_003528498.1| PREDICTED: serine/threonine-protein kinase SRK2E-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 406 bits (1044), Expect = e-111, Method: Compositional matrix adjust.
Identities = 193/202 (95%), Positives = 199/202 (98%)
Query: 2 DRSAMTVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID 61
DRSAM+VGPGMD+PIMHDSDRYELVRDIGSGNFGVARLMRDK TEELVAVKYIERG+KID
Sbjct: 13 DRSAMSVGPGMDLPIMHDSDRYELVRDIGSGNFGVARLMRDKHTEELVAVKYIERGEKID 72
Query: 62 ENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARF 121
ENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARF
Sbjct: 73 ENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARF 132
Query: 122 FFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGT 181
FFQQLISGVSYCH+MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGT
Sbjct: 133 FFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGT 192
Query: 182 PAYIAPEVLLKKEYDGKVMCVY 203
PAYIAPEVLLKKEYDGK+ V+
Sbjct: 193 PAYIAPEVLLKKEYDGKIADVW 214
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255561655|ref|XP_002521837.1| Serine/threonine-protein kinase SAPK10, putative [Ricinus communis] gi|223538875|gb|EEF40473.1| Serine/threonine-protein kinase SAPK10, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 406 bits (1043), Expect = e-111, Method: Compositional matrix adjust.
Identities = 190/203 (93%), Positives = 201/203 (99%)
Query: 1 MDRSAMTVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI 60
MDRSA+T+GPGMD+PIMHDSDRYELV+DIG+GNFGVARLMRDK+T+ELVAVKYIERG+KI
Sbjct: 1 MDRSALTIGPGMDLPIMHDSDRYELVKDIGAGNFGVARLMRDKQTDELVAVKYIERGEKI 60
Query: 61 DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 120
DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR
Sbjct: 61 DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 120
Query: 121 FFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 180
FFFQQLISGVSYCH+MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG
Sbjct: 121 FFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 180
Query: 181 TPAYIAPEVLLKKEYDGKVMCVY 203
TPAYIAPEVLLKKEYDGK+ V+
Sbjct: 181 TPAYIAPEVLLKKEYDGKIADVW 203
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225428695|ref|XP_002284959.1| PREDICTED: serine/threonine-protein kinase SAPK10 isoform 1 [Vitis vinifera] gi|297741336|emb|CBI32467.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 404 bits (1038), Expect = e-110, Method: Compositional matrix adjust.
Identities = 191/203 (94%), Positives = 199/203 (98%)
Query: 1 MDRSAMTVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI 60
MDRSA+TVGP MD+PIMHDSDRYELVRDIGSGNFGVARLMRDK+T ELVAVKYIERG+KI
Sbjct: 1 MDRSAITVGPAMDVPIMHDSDRYELVRDIGSGNFGVARLMRDKQTGELVAVKYIERGEKI 60
Query: 61 DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 120
DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR
Sbjct: 61 DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 120
Query: 121 FFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 180
FFFQQL+SGVSYCH+MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG
Sbjct: 121 FFFQQLVSGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 180
Query: 181 TPAYIAPEVLLKKEYDGKVMCVY 203
TPAYIAPEVLLKKEYDGK+ V+
Sbjct: 181 TPAYIAPEVLLKKEYDGKIADVW 203
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356575156|ref|XP_003555708.1| PREDICTED: serine/threonine-protein kinase SRK2E-like isoform 2 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 404 bits (1037), Expect = e-110, Method: Compositional matrix adjust.
Identities = 196/212 (92%), Positives = 200/212 (94%), Gaps = 9/212 (4%)
Query: 1 MDRSAMTVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI 60
MDRSAMTVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDK TEELVAVKYIERGDKI
Sbjct: 1 MDRSAMTVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKHTEELVAVKYIERGDKI 60
Query: 61 DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 120
DENV+REIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR
Sbjct: 61 DENVRREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 120
Query: 121 FFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK---------SSVL 171
FFFQQLISGVSYCH+MQVCHRDLKLENTLLDGSPAPRLKICDFGYSK SSVL
Sbjct: 121 FFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKVHFLRTVISSSVL 180
Query: 172 HSQPKSTVGTPAYIAPEVLLKKEYDGKVMCVY 203
HSQPKSTVGTPAYIAPEVLLKKEYDGK+ V+
Sbjct: 181 HSQPKSTVGTPAYIAPEVLLKKEYDGKIADVW 212
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449438438|ref|XP_004136995.1| PREDICTED: serine/threonine-protein kinase SRK2E-like [Cucumis sativus] gi|449495591|ref|XP_004159888.1| PREDICTED: serine/threonine-protein kinase SRK2E-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 403 bits (1036), Expect = e-110, Method: Compositional matrix adjust.
Identities = 190/203 (93%), Positives = 199/203 (98%)
Query: 1 MDRSAMTVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI 60
MDRSA+TVGPGMD+PIMHDSDRYELVRDIGSGNFG+ARLMRDK+T ELVAVKYIERG+KI
Sbjct: 1 MDRSALTVGPGMDIPIMHDSDRYELVRDIGSGNFGIARLMRDKQTGELVAVKYIERGEKI 60
Query: 61 DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 120
D NV+REIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR
Sbjct: 61 DANVKREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 120
Query: 121 FFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 180
FFFQQLISGVSYCH+MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG
Sbjct: 121 FFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 180
Query: 181 TPAYIAPEVLLKKEYDGKVMCVY 203
TPAYIAPEVLLKKEYDGK+ V+
Sbjct: 181 TPAYIAPEVLLKKEYDGKIADVW 203
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356521209|ref|XP_003529249.1| PREDICTED: serine/threonine-protein kinase SRK2E-like isoform 2 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 402 bits (1034), Expect = e-110, Method: Compositional matrix adjust.
Identities = 194/210 (92%), Positives = 200/210 (95%), Gaps = 7/210 (3%)
Query: 1 MDRSAMTVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI 60
MDRSAMTVGPGMDMPIMHDSD+YELVRDIGSGNFGVARLMRDK TEELVAVKYIERGDKI
Sbjct: 1 MDRSAMTVGPGMDMPIMHDSDKYELVRDIGSGNFGVARLMRDKHTEELVAVKYIERGDKI 60
Query: 61 DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 120
DENV+REIINHRSLRHPNIVRFKE+ILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR
Sbjct: 61 DENVRREIINHRSLRHPNIVRFKEIILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 120
Query: 121 FFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK-------SSVLHS 173
FFFQQLISGVSYCH+MQVCHRDLKLENTLLDGSPAPRLKICDFGYSK SSVLHS
Sbjct: 121 FFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKVYFFLHTSSVLHS 180
Query: 174 QPKSTVGTPAYIAPEVLLKKEYDGKVMCVY 203
QPKSTVGTPAYIAPEVLLKKEYDGK+ V+
Sbjct: 181 QPKSTVGTPAYIAPEVLLKKEYDGKIADVW 210
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356563656|ref|XP_003550077.1| PREDICTED: serine/threonine-protein kinase SRK2I-like isoform 1 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 402 bits (1033), Expect = e-110, Method: Compositional matrix adjust.
Identities = 188/203 (92%), Positives = 201/203 (99%)
Query: 1 MDRSAMTVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI 60
MDR+A+TVGPGMDMPIMHDSDRY+LVRDIGSGNFGVARLM+DK+T+ELVAVKYIERGDKI
Sbjct: 1 MDRAALTVGPGMDMPIMHDSDRYDLVRDIGSGNFGVARLMQDKQTKELVAVKYIERGDKI 60
Query: 61 DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 120
DENV+REIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFE+ICNAGRF+EDEAR
Sbjct: 61 DENVKREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFEKICNAGRFTEDEAR 120
Query: 121 FFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 180
FFFQQLISGVSYCH+MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG
Sbjct: 121 FFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 180
Query: 181 TPAYIAPEVLLKKEYDGKVMCVY 203
TPAYIAPEVLLK+EYDGK+ V+
Sbjct: 181 TPAYIAPEVLLKQEYDGKLADVW 203
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224123434|ref|XP_002330314.1| predicted protein [Populus trichocarpa] gi|222871349|gb|EEF08480.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 402 bits (1033), Expect = e-110, Method: Compositional matrix adjust.
Identities = 190/203 (93%), Positives = 197/203 (97%)
Query: 1 MDRSAMTVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI 60
MDRS MTVGPGMDMPIMHD DRYELVRDIGSGNFGVARLMRDK+ +ELVAVKYIERG+KI
Sbjct: 1 MDRSVMTVGPGMDMPIMHDGDRYELVRDIGSGNFGVARLMRDKQADELVAVKYIERGEKI 60
Query: 61 DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 120
DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICN+GRFSEDEAR
Sbjct: 61 DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNSGRFSEDEAR 120
Query: 121 FFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 180
FFFQQLISGVSYCH+MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP STVG
Sbjct: 121 FFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPTSTVG 180
Query: 181 TPAYIAPEVLLKKEYDGKVMCVY 203
TPAYIAPEVLLKKEYDGK+ V+
Sbjct: 181 TPAYIAPEVLLKKEYDGKIADVW 203
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 205 | ||||||
| TAIR|locus:2174999 | 361 | SNRK2.3 "sucrose nonfermenting | 0.985 | 0.559 | 0.896 | 2e-97 | |
| TAIR|locus:2118929 | 362 | OST1 "OPEN STOMATA 1" [Arabido | 0.980 | 0.555 | 0.921 | 2.5e-97 | |
| TAIR|locus:2206046 | 361 | SNRK2.10 "SNF1-related protein | 0.892 | 0.506 | 0.846 | 3.1e-83 | |
| TAIR|locus:2160559 | 360 | SNRK2.5 "SNF1-related protein | 0.868 | 0.494 | 0.859 | 2.8e-82 | |
| TAIR|locus:2159597 | 353 | SNRK2.1 "SNF1-related protein | 0.868 | 0.504 | 0.837 | 1.1e-80 | |
| TAIR|locus:2032075 | 343 | SNRK2-8 "SNF1-RELATED PROTEIN | 0.892 | 0.533 | 0.814 | 7.6e-80 | |
| TAIR|locus:2140104 | 350 | SNRK2.7 "SNF1-related protein | 0.892 | 0.522 | 0.792 | 3.3e-79 | |
| TAIR|locus:2045319 | 339 | SNRK2.9 "SNF1-related protein | 0.892 | 0.539 | 0.786 | 9e-77 | |
| TAIR|locus:2059279 | 451 | CIPK3 "CBL-interacting protein | 0.848 | 0.385 | 0.453 | 4e-35 | |
| TAIR|locus:2135962 | 445 | CIPK8 "CBL-interacting protein | 0.863 | 0.397 | 0.457 | 5.1e-35 |
| TAIR|locus:2174999 SNRK2.3 "sucrose nonfermenting 1(SNF1)-related protein kinase 2.3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 968 (345.8 bits), Expect = 2.0e-97, P = 2.0e-97
Identities = 182/203 (89%), Positives = 196/203 (96%)
Query: 1 MDRSAMTVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI 60
MDR+ +T GP +DMPIMHDSDRY+ V+DIGSGNFGVARLMRDK T+ELVAVKYIERGDKI
Sbjct: 1 MDRAPVTTGP-LDMPIMHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGDKI 59
Query: 61 DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 120
DENVQREIINHRSLRHPNIVRFKEVILTPTHLAI+MEYASGGEL+ERICNAGRFSEDEAR
Sbjct: 60 DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEAR 119
Query: 121 FFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 180
FFFQQL+SGVSYCHSMQ+CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG
Sbjct: 120 FFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 179
Query: 181 TPAYIAPEVLLKKEYDGKVMCVY 203
TPAYIAPEVLL++EYDGK+ V+
Sbjct: 180 TPAYIAPEVLLRQEYDGKIADVW 202
|
|
| TAIR|locus:2118929 OST1 "OPEN STOMATA 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 967 (345.5 bits), Expect = 2.5e-97, P = 2.5e-97
Identities = 187/203 (92%), Positives = 197/203 (97%)
Query: 1 MDRSAMTVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI 60
MDR A++ GP MD+PIMHDSDRYELV+DIGSGNFGVARLMRDK++ ELVAVKYIERG+KI
Sbjct: 1 MDRPAVS-GP-MDLPIMHDSDRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKI 58
Query: 61 DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 120
DENV+REIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR
Sbjct: 59 DENVKREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 118
Query: 121 FFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 180
FFFQQLISGVSYCH+MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG
Sbjct: 119 FFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 178
Query: 181 TPAYIAPEVLLKKEYDGKVMCVY 203
TPAYIAPEVLLKKEYDGKV V+
Sbjct: 179 TPAYIAPEVLLKKEYDGKVADVW 201
|
|
| TAIR|locus:2206046 SNRK2.10 "SNF1-related protein kinase 2.10" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 834 (298.6 bits), Expect = 3.1e-83, P = 3.1e-83
Identities = 155/183 (84%), Positives = 173/183 (94%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIV 80
D+YELV+DIG+GNFGVARLMR K ++ELVA+KYIERG KIDENV REIINHRSLRHPNI+
Sbjct: 2 DKYELVKDIGAGNFGVARLMRVKNSKELVAMKYIERGPKIDENVAREIINHRSLRHPNII 61
Query: 81 RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCH 140
RFKEV+LTPTH+AI MEYA+GGELFERIC+AGRFSEDEAR+FFQQLISGVSYCH+MQ+CH
Sbjct: 62 RFKEVVLTPTHIAIAMEYAAGGELFERICSAGRFSEDEARYFFQQLISGVSYCHAMQICH 121
Query: 141 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKVM 200
RDLKLENTLLDGSPAPRLKICDFGYSKSS+LHS PKSTVGTPAYIAPEVL + EYDGK+
Sbjct: 122 RDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSMPKSTVGTPAYIAPEVLSRGEYDGKMA 181
Query: 201 CVY 203
V+
Sbjct: 182 DVW 184
|
|
| TAIR|locus:2160559 SNRK2.5 "SNF1-related protein kinase 2.5" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 825 (295.5 bits), Expect = 2.8e-82, P = 2.8e-82
Identities = 153/178 (85%), Positives = 170/178 (95%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIV 80
D+YE+V+D+G+GNFGVARL+R K+T+ELVA+KYIERG KIDENV REIINHRSLRHPNI+
Sbjct: 2 DKYEVVKDLGAGNFGVARLLRHKETKELVAMKYIERGRKIDENVAREIINHRSLRHPNII 61
Query: 81 RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCH 140
RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSE EAR+FFQQLI GV YCHS+Q+CH
Sbjct: 62 RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEAEARYFFQQLICGVDYCHSLQICH 121
Query: 141 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGK 198
RDLKLENTLLDGSPAP LKICDFGYSKSS+LHS+PKSTVGTPAYIAPEVL ++EYDGK
Sbjct: 122 RDLKLENTLLDGSPAPLLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGK 179
|
|
| TAIR|locus:2159597 SNRK2.1 "SNF1-related protein kinase 2.1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 810 (290.2 bits), Expect = 1.1e-80, P = 1.1e-80
Identities = 149/178 (83%), Positives = 168/178 (94%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIV 80
D+Y++V+D+G+GNFGVARL+R K T+ELVA+KYIERG KIDENV REIINHRSL+HPNI+
Sbjct: 2 DKYDVVKDLGAGNFGVARLLRHKDTKELVAMKYIERGRKIDENVAREIINHRSLKHPNII 61
Query: 81 RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCH 140
RFKEVILTPTHLAIVMEYASGGELF+RIC AGRFSE EAR+FFQQLI GV YCHS+Q+CH
Sbjct: 62 RFKEVILTPTHLAIVMEYASGGELFDRICTAGRFSEAEARYFFQQLICGVDYCHSLQICH 121
Query: 141 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGK 198
RDLKLENTLLDGSPAP LKICDFGYSKSS+LHS+PKSTVGTPAYIAPEVL ++EYDGK
Sbjct: 122 RDLKLENTLLDGSPAPLLKICDFGYSKSSILHSRPKSTVGTPAYIAPEVLSRREYDGK 179
|
|
| TAIR|locus:2032075 SNRK2-8 "SNF1-RELATED PROTEIN KINASE 2-8" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 802 (287.4 bits), Expect = 7.6e-80, P = 7.6e-80
Identities = 149/183 (81%), Positives = 171/183 (93%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIV 80
+RYE+V+DIGSGNFGVA+L+RDK ++EL AVK+IERG KIDE+VQREI+NHRSL HPNI+
Sbjct: 2 ERYEIVKDIGSGNFGVAKLVRDKFSKELFAVKFIERGQKIDEHVQREIMNHRSLIHPNII 61
Query: 81 RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCH 140
RFKEV+LT THLA+VMEYA+GGELF RIC+AGRFSEDEARFFFQQLISGV+YCHS+Q+CH
Sbjct: 62 RFKEVLLTATHLALVMEYAAGGELFGRICSAGRFSEDEARFFFQQLISGVNYCHSLQICH 121
Query: 141 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKVM 200
RDLKLENTLLDGS APR+KICDFGYSKS VLHSQPK+TVGTPAYIAPEVL KEYDGK+
Sbjct: 122 RDLKLENTLLDGSEAPRVKICDFGYSKSGVLHSQPKTTVGTPAYIAPEVLSTKEYDGKIA 181
Query: 201 CVY 203
V+
Sbjct: 182 DVW 184
|
|
| TAIR|locus:2140104 SNRK2.7 "SNF1-related protein kinase 2.7" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 796 (285.3 bits), Expect = 3.3e-79, P = 3.3e-79
Identities = 145/183 (79%), Positives = 169/183 (92%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIV 80
+RY+++RD+GSGNFGVA+L+R+K E AVKYIERG KIDE+VQREIINHR L+HPNI+
Sbjct: 2 ERYDILRDLGSGNFGVAKLVREKANGEFYAVKYIERGLKIDEHVQREIINHRDLKHPNII 61
Query: 81 RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCH 140
RFKEV +TPTHLAIVMEYA+GGELFERICNAGRFSEDE R++F+QLISGVSYCH+MQ+CH
Sbjct: 62 RFKEVFVTPTHLAIVMEYAAGGELFERICNAGRFSEDEGRYYFKQLISGVSYCHAMQICH 121
Query: 141 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKVM 200
RDLKLENTLLDGSP+ LKICDFGYSKSSVLHSQPKSTVGTPAY+APEVL +KEY+GK+
Sbjct: 122 RDLKLENTLLDGSPSSHLKICDFGYSKSSVLHSQPKSTVGTPAYVAPEVLSRKEYNGKIA 181
Query: 201 CVY 203
V+
Sbjct: 182 DVW 184
|
|
| TAIR|locus:2045319 SNRK2.9 "SNF1-related protein kinase 2.9" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 773 (277.2 bits), Expect = 9.0e-77, P = 9.0e-77
Identities = 144/183 (78%), Positives = 165/183 (90%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIV 80
++YE+V+D+G GNFG+ARLMR+K+T ELVAVK+I+RG KIDENV REIINHR+L HPNIV
Sbjct: 2 EKYEMVKDLGFGNFGLARLMRNKQTNELVAVKFIDRGYKIDENVAREIINHRALNHPNIV 61
Query: 81 RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCH 140
RFKEV+LTPTHL IVMEYA+GGELFERI + GRFSE EAR+FFQQLI GV Y H++Q+CH
Sbjct: 62 RFKEVVLTPTHLGIVMEYAAGGELFERISSVGRFSEAEARYFFQQLICGVHYLHALQICH 121
Query: 141 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKVM 200
RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS PKSTVGTPAYIAPEV + EYDGK +
Sbjct: 122 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSNPKSTVGTPAYIAPEVFCRSEYDGKSV 181
Query: 201 CVY 203
V+
Sbjct: 182 DVW 184
|
|
| TAIR|locus:2059279 CIPK3 "CBL-interacting protein kinase 3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 380 (138.8 bits), Expect = 4.0e-35, P = 4.0e-35
Identities = 83/183 (45%), Positives = 114/183 (62%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHP 77
+YE+ R IG G F + R+ +T E VA+K +++ K+ E ++REI + ++HP
Sbjct: 23 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIRREIATMKLIKHP 82
Query: 78 NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ 137
N+V+ EV+ + T + I++EY +GGELF++I N GR EDEAR +FQQLI V YCHS
Sbjct: 83 NVVQLYEVMASKTKIFIILEYVTGGELFDKIVNDGRMKEDEARRYFQQLIHAVDYCHSRG 142
Query: 138 VCHRDLKLENTLLDGSPAPRLKICDFGYSK-SSVLHSQP--KSTVGTPAYIAPEVLLKKE 194
V HRDLK EN LLD LKI DFG S S + ++ GTP Y+APEVL +
Sbjct: 143 VYHRDLKPENLLLDSYG--NLKISDFGLSALSQQVRDDGLLHTSCGTPNYVAPEVLNDRG 200
Query: 195 YDG 197
YDG
Sbjct: 201 YDG 203
|
|
| TAIR|locus:2135962 CIPK8 "CBL-interacting protein kinase 8" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 379 (138.5 bits), Expect = 5.1e-35, P = 5.1e-35
Identities = 87/190 (45%), Positives = 116/190 (61%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHP 77
+YEL R IG G F + ++ +T E VA+K ++R K+ + ++REI + +RHP
Sbjct: 8 KYELGRTIGEGTFAKVKFAQNTETGESVAMKIVDRSTIIKRKMVDQIKREISIMKLVRHP 67
Query: 78 NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ 137
+VR EV+ + T + I++EY +GGELF++I GR SE EAR +F QLI GV YCHS
Sbjct: 68 CVVRLYEVLASRTKIYIILEYITGGELFDKIVRNGRLSESEARKYFHQLIDGVDYCHSKG 127
Query: 138 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP----KSTVGTPAYIAPEVLLKK 193
V HRDLK EN LLD LKI DFG S L Q K+T GTP Y+APEVL K
Sbjct: 128 VYHRDLKPENLLLDSQG--NLKISDFGLS---ALPEQGVTILKTTCGTPNYVAPEVLSHK 182
Query: 194 EYDGKVMCVY 203
Y+G V ++
Sbjct: 183 GYNGAVADIW 192
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q39193 | SRK2I_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.8965 | 0.9853 | 0.5595 | yes | no |
| Q75H77 | SAPKA_ORYSJ | 2, ., 7, ., 1, 1, ., 1 | 0.9261 | 0.9902 | 0.5607 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.946 |
| 3rd Layer | 2.7.11 | 0.963 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 205 | |||
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 3e-73 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 1e-63 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 6e-56 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 2e-52 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 7e-46 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 5e-43 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 2e-42 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 3e-39 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 7e-39 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 3e-38 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 5e-37 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 1e-34 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 1e-34 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 3e-34 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 3e-34 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 4e-34 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 9e-34 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 1e-33 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 2e-33 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 3e-33 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 3e-33 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 6e-33 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 9e-33 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 9e-33 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 2e-32 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 2e-32 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 2e-32 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 3e-32 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 2e-31 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 4e-31 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 1e-30 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 2e-30 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 6e-30 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 8e-30 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 2e-29 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 2e-29 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 4e-29 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 7e-29 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 7e-29 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 8e-29 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 1e-28 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 1e-28 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 2e-28 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 3e-28 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 3e-28 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 3e-28 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 5e-28 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 1e-27 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 2e-27 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 2e-27 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 2e-27 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 4e-27 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 6e-27 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 7e-27 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 1e-26 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 2e-26 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 2e-26 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 2e-26 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 3e-26 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 3e-26 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 4e-26 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 6e-26 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 1e-25 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 1e-25 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 2e-25 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 5e-25 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 7e-25 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 8e-25 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 1e-24 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 1e-24 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 1e-24 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 1e-24 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 1e-24 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 2e-24 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 2e-24 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 4e-24 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 6e-24 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 8e-24 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 9e-24 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 1e-23 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 1e-23 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 1e-23 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 2e-23 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 2e-23 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 3e-23 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 4e-23 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 5e-23 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 6e-23 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 6e-23 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 7e-23 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 8e-23 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 8e-23 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 1e-22 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 1e-22 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 2e-22 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 2e-22 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 2e-22 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 4e-22 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 6e-22 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 8e-22 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 9e-22 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 1e-21 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 1e-21 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 2e-21 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 2e-21 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 2e-21 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 2e-21 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 3e-21 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 3e-21 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 3e-21 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 9e-21 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 1e-20 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 1e-20 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 1e-20 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 2e-20 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 3e-20 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 3e-20 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 4e-20 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 4e-20 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 5e-20 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 6e-20 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 6e-20 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 1e-19 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 1e-19 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 1e-19 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 1e-19 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 1e-19 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 2e-19 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 2e-19 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 3e-19 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 5e-19 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 6e-19 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 8e-19 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 9e-19 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 1e-18 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 1e-18 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 2e-18 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 2e-18 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 3e-18 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 3e-18 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 4e-18 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 4e-18 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 7e-18 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 7e-18 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 1e-17 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 1e-17 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 2e-17 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 2e-17 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 3e-17 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 6e-17 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 1e-16 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 1e-16 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 2e-16 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 2e-16 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 2e-16 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 3e-16 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 3e-16 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 5e-16 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 7e-16 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 7e-16 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 8e-16 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 9e-16 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 1e-15 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 2e-15 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 2e-15 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 2e-15 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 2e-15 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 2e-15 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 4e-15 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 5e-15 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 6e-15 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 7e-15 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 7e-15 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 8e-15 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 1e-14 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 1e-14 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 3e-14 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 3e-14 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 3e-14 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 3e-14 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 3e-14 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 5e-14 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 7e-14 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 7e-14 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 8e-14 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 8e-14 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 1e-13 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 1e-13 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 1e-13 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 2e-13 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 3e-13 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 4e-13 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 5e-13 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 5e-13 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 5e-13 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 6e-13 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 7e-13 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 8e-13 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 9e-13 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 1e-12 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 1e-12 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 2e-12 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 3e-12 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 3e-12 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 3e-12 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 6e-12 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 6e-12 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 7e-12 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 7e-12 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 8e-12 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 1e-11 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 2e-11 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 3e-11 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 3e-11 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 4e-11 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 4e-11 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 4e-11 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 6e-11 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 7e-11 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 8e-11 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 2e-10 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 3e-10 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 4e-10 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 5e-10 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 6e-10 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 6e-10 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 1e-09 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 2e-09 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 2e-09 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 2e-09 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 3e-09 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 3e-09 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 4e-09 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 5e-09 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 5e-09 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 7e-09 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 9e-09 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 1e-08 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 2e-08 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 2e-08 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 3e-08 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 4e-08 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 4e-08 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 5e-08 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 8e-08 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 2e-07 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 2e-07 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 3e-07 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 6e-07 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 7e-07 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 9e-07 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 3e-06 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 3e-06 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 3e-06 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 4e-06 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 4e-06 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 6e-06 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 1e-05 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 1e-05 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 1e-05 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 2e-05 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 2e-05 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 3e-05 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 3e-05 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 3e-05 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 3e-05 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 5e-05 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 5e-05 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 6e-05 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 9e-05 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 1e-04 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 2e-04 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 3e-04 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 4e-04 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 4e-04 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 6e-04 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 6e-04 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 0.001 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 0.001 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 0.001 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 0.001 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 0.002 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 0.002 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 0.003 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 0.004 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 221 bits (566), Expect = 3e-73
Identities = 81/179 (45%), Positives = 110/179 (61%), Gaps = 4/179 (2%)
Query: 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYI--ERGDKIDENVQREIINHRSLRHPNIV 80
YE++ +G G+FG L RDKKT +LVA+K I ++ K E + REI + L+HPNIV
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60
Query: 81 RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCH 140
R +V L +VMEY GG+LF+ + GR SEDEARF+ +Q++S + Y HS + H
Sbjct: 61 RLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYLHSKGIVH 120
Query: 141 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKV 199
RDLK EN LLD +K+ DFG ++ + + VGTP Y+APEVLL K Y V
Sbjct: 121 RDLKPENILLDED--GHVKLADFGLARQLDPGEKLTTFVGTPEYMAPEVLLGKGYGKAV 177
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 197 bits (503), Expect = 1e-63
Identities = 79/180 (43%), Positives = 104/180 (57%), Gaps = 6/180 (3%)
Query: 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYI---ERGDKIDENVQREIINHRSLRHPNI 79
YEL+R +GSG+FG + K T ++VAVK + K D+ +REI R L HPNI
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNI 60
Query: 80 VRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVC 139
VR + HL +VMEY GG+LF+ + G SEDEA+ Q++ G+ Y HS +
Sbjct: 61 VRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLHSNGII 120
Query: 140 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKEYDGK 198
HRDLK EN LLD + +KI DFG +K + S +T VGTP Y+APEVLL G
Sbjct: 121 HRDLKPENILLDEN--GVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGGNGYGP 178
|
Length = 260 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 176 bits (448), Expect = 6e-56
Identities = 79/174 (45%), Positives = 102/174 (58%), Gaps = 5/174 (2%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIERGDKID--ENVQREIINHRSLRHPNIVRFKEVI 86
+G G FG L RDKKT + VA+K I++ D E + REI + L HPNIV+ V
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 87 LTPTHLAIVMEYASGGELFERIC-NAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKL 145
HL +VMEY GG L + + N G+ SEDE Q++ G+ Y HS + HRDLK
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKP 120
Query: 146 ENTLLDGSPAPRLKICDFGYSK-SSVLHSQPKSTVGTPAYIAPEVLLKKEYDGK 198
EN LLD S ++K+ DFG SK + S K+ VGTPAY+APEVLL K Y +
Sbjct: 121 ENILLD-SDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSE 173
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 168 bits (428), Expect = 2e-52
Identities = 66/187 (35%), Positives = 102/187 (54%), Gaps = 14/187 (7%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYI---ERGDKIDENVQREIINHRSLRHPN 78
+YE+++ IG G+FG L+R K +L +K I +K E+ E+ + L HPN
Sbjct: 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPN 60
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGR----FSEDEARFFFQQLISGVSYCH 134
I+++ E L IVMEYA GG+L ++I + F E++ +F QL + Y H
Sbjct: 61 IIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLH 120
Query: 135 SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQPKSTVGTPAYIAPEVLL 191
S ++ HRD+K +N L +K+ DFG SK S+V + K+ VGTP Y++PE+
Sbjct: 121 SRKILHRDIKPQNIFLT--SNGLVKLGDFGISKVLSSTVDLA--KTVVGTPYYLSPELCQ 176
Query: 192 KKEYDGK 198
K Y+ K
Sbjct: 177 NKPYNYK 183
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 151 bits (385), Expect = 7e-46
Identities = 65/183 (35%), Positives = 94/183 (51%), Gaps = 10/183 (5%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENV---QREIINHRSLRHPN 78
+ +G G+FG L DK T EL+AVK +E +E + +REI SL+HPN
Sbjct: 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPN 60
Query: 79 IVRFK--EVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
IVR+ E L I +EY SGG L + G+ E R + +Q++ G++Y HS
Sbjct: 61 IVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSN 120
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQPKSTVGTPAYIAPEVLLKK 193
+ HRD+K N L+D +K+ DFG +K S GTP ++APEV+ +
Sbjct: 121 GIVHRDIKGANILVDSD--GVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGE 178
Query: 194 EYD 196
EY
Sbjct: 179 EYG 181
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 144 bits (365), Expect = 5e-43
Identities = 63/181 (34%), Positives = 95/181 (52%), Gaps = 8/181 (4%)
Query: 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYI-ERGDKIDENVQREIINHRSLRHPNIVR 81
+E++ IG G FG R K+T + VA+K I + E + EI + +HPNIV+
Sbjct: 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVK 61
Query: 82 FKEVILTPTHLAIVMEYASGGELFERICNAGR-FSEDEARFFFQQLISGVSYCHSMQVCH 140
+ L L IVME+ SGG L + + + + +E + + ++L+ G+ Y HS + H
Sbjct: 62 YYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIH 121
Query: 141 RDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGK 198
RD+K N LL DG +K+ DFG S + VGTP ++APEV+ K YD K
Sbjct: 122 RDIKAANILLTSDGE----VKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVINGKPYDYK 177
Query: 199 V 199
Sbjct: 178 A 178
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 143 bits (362), Expect = 2e-42
Identities = 67/175 (38%), Positives = 97/175 (55%), Gaps = 11/175 (6%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRS----LRHPNIVRFKE 84
+G G+FG L+R K T +L A+K +++ I + R+ + HP IV+
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60
Query: 85 VILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLK 144
T L +V+EYA GGELF + GRFSE+ ARF+ +++ + Y HS+ + +RDLK
Sbjct: 61 AFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLK 120
Query: 145 LENTLLD--GSPAPRLKICDFGYSKSSVLH-SQPKSTVGTPAYIAPEVLLKKEYD 196
EN LLD G +K+ DFG +K S+ + GTP Y+APEVLL K Y
Sbjct: 121 PENILLDADG----HIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGKGYG 171
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 135 bits (342), Expect = 3e-39
Identities = 70/187 (37%), Positives = 100/187 (53%), Gaps = 17/187 (9%)
Query: 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQ----REIINHRSLRHPN 78
YE + +G G +GV RDKKT E+VA+K I R D +E + REI + L+HPN
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKI-RLDNEEEGIPSTALREISLLKELKHPN 59
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQ 137
IV+ +VI T L +V EY +L + + G S + + QL+ G++YCHS +
Sbjct: 60 IVKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHR 118
Query: 138 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST----VGTPAYIAPEVLLK- 192
+ HRDLK +N L++ LK+ DFG +++ P T V T Y APE+LL
Sbjct: 119 ILHRDLKPQNILINRD--GVLKLADFGLARA---FGIPLRTYTHEVVTLWYRAPEILLGS 173
Query: 193 KEYDGKV 199
K Y V
Sbjct: 174 KHYSTAV 180
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 134 bits (340), Expect = 7e-39
Identities = 69/187 (36%), Positives = 110/187 (58%), Gaps = 22/187 (11%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQRE-IINHR----SLR 75
D +E ++ +G+G+FG L+R K + + A+K + + KI + Q E ++N + S+R
Sbjct: 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSK-AKIVKLKQVEHVLNEKRILQSIR 59
Query: 76 HPNIVR----FKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS 131
HP +V F++ ++L +VMEY GGELF + +GRF E ARF+ Q++ +
Sbjct: 60 HPFLVNLYGSFQD----DSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALE 115
Query: 132 YCHSMQVCHRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEV 189
Y HS+ + +RDLK EN LLD G +KI DFG++K + + + GTP Y+APE+
Sbjct: 116 YLHSLDIVYRDLKPENLLLDSDGY----IKITDFGFAK--RVKGRTYTLCGTPEYLAPEI 169
Query: 190 LLKKEYD 196
+L K Y
Sbjct: 170 ILSKGYG 176
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 133 bits (336), Expect = 3e-38
Identities = 58/185 (31%), Positives = 92/185 (49%), Gaps = 10/185 (5%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYI---ERGDKIDENVQREIINHRSLRHPN 78
RY+++ IG G G+ +D++T E VA+K + I REI ++ +HP
Sbjct: 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPY 60
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGR-FSEDEARFFFQQLISGVSYCHSMQ 137
+V+ +V + +VMEY +L E + + R E + + + + L+ GV+Y H+
Sbjct: 61 VVKLLDVFPHGSGFVLVMEYM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANG 119
Query: 138 VCHRDLKLENTLLDGSPAPRLKICDFGYSK--SSVLHSQPKSTVGTPAYIAPEVLL-KKE 194
+ HRDLK N L+ S LKI DFG ++ S V T Y APE+L ++
Sbjct: 120 IMHRDLKPANLLI--SADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARK 177
Query: 195 YDGKV 199
YD V
Sbjct: 178 YDPGV 182
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 129 bits (327), Expect = 5e-37
Identities = 63/175 (36%), Positives = 98/175 (56%), Gaps = 8/175 (4%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILT 88
IG G G D+ T + VA+K + + E + EI+ + +HPNIV + + L
Sbjct: 27 IGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYDSYLV 86
Query: 89 PTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLEN 147
L +VMEY GG L + I N R +E + + ++++ G+ Y HS V HRD+K +N
Sbjct: 87 GDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDN 146
Query: 148 TLL--DGSPAPRLKICDFGYS-KSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKV 199
LL DGS +K+ DFG++ + + S+ S VGTP ++APEV+ +K+Y KV
Sbjct: 147 ILLSKDGS----VKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVIKRKDYGPKV 197
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 123 bits (310), Expect = 1e-34
Identities = 59/180 (32%), Positives = 92/180 (51%), Gaps = 15/180 (8%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHR----SLRHPNIVRFKE 84
I G +G L + K T ++ A+K I++ D I +N +++ R + P +V+
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYY 60
Query: 85 VILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLK 144
+L +VMEY GG+L + N G ED AR + +++ + Y HS + HRDLK
Sbjct: 61 SFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLK 120
Query: 145 LENTLLDGSPAPRLKICDFGYSK---------SSVLHSQPKSTVGTPAYIAPEVLLKKEY 195
+N L+D + LK+ DFG SK + + K VGTP YIAPEV+L + +
Sbjct: 121 PDNILIDSN--GHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGH 178
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 122 bits (309), Expect = 1e-34
Identities = 64/188 (34%), Positives = 97/188 (51%), Gaps = 14/188 (7%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYI--ERGD-KIDENVQREIINHRSLRHPN 78
R++ IG G FG + T EL+AVK I + D K + + E+ L+HPN
Sbjct: 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPN 60
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEA--RFFFQQLISGVSYCHSM 136
+V++ V + + I MEY SGG L E + GR DE R + QL+ G++Y HS
Sbjct: 61 LVKYYGVEVHREKVYIFMEYCSGGTL-EELLEHGRI-LDEHVIRVYTLQLLEGLAYLHSH 118
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSK-----SSVLHSQPKSTVGTPAYIAPEVLL 191
+ HRD+K N LD + +K+ DFG + ++ + + +S GTPAY+APEV+
Sbjct: 119 GIVHRDIKPANIFLDHNGV--IKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVIT 176
Query: 192 KKEYDGKV 199
+ G
Sbjct: 177 GGKGKGHG 184
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 124 bits (312), Expect = 3e-34
Identities = 69/187 (36%), Positives = 97/187 (51%), Gaps = 19/187 (10%)
Query: 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDEN----VQREIINHRSLRHP- 77
Y ++R +G G+FG L RD+K VA+K + + + REI SL HP
Sbjct: 2 YRILRKLGEGSFGEVYLARDRKL---VALKVLAKKLESKSKEVERFLREIQILASLNHPP 58
Query: 78 NIVRFKEVILTPTHLAIVMEYASGGELFERICN---AGRFSEDEARFFFQQLISGVSYCH 134
NIV+ + L +VMEY GG L + + G SE EA F Q++S + Y H
Sbjct: 59 NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH 118
Query: 135 SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK-------SSVLHSQPKSTVGTPAYIAP 187
S + HRD+K EN LLD +K+ DFG +K +S + + P ++VGTP Y+AP
Sbjct: 119 SKGIIHRDIKPENILLD-RDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAP 177
Query: 188 EVLLKKE 194
EVLL
Sbjct: 178 EVLLGLS 184
|
Length = 384 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 121 bits (306), Expect = 3e-34
Identities = 62/175 (35%), Positives = 92/175 (52%), Gaps = 10/175 (5%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDEN---VQREIINHRSLRHPN 78
Y+L IG G FGV + +T + VA+K I +E + +EI ++L+HPN
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQV 138
IV++ I T L I++EYA G L + I G F E + Q++ G++Y H V
Sbjct: 61 IVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGV 120
Query: 139 CHRDLKLENTLL--DGSPAPRLKICDFGYS-KSSVLHSQPKSTVGTPAYIAPEVL 190
HRD+K N L DG +K+ DFG + K + + S VGTP ++APEV+
Sbjct: 121 IHRDIKAANILTTKDGV----VKLADFGVATKLNDVSKDDASVVGTPYWMAPEVI 171
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 4e-34
Identities = 62/183 (33%), Positives = 99/183 (54%), Gaps = 8/183 (4%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID----ENVQREIINHRSLRH 76
D E ++ +G+G FG L+RD+ +E A+K + + I ++V E + + H
Sbjct: 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSH 60
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
P I+R L ++MEY GGELF + N+GRFS F+ +++ + Y HS
Sbjct: 61 PFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSK 120
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYD 196
++ +RDLK EN LLD +K+ DFG++K L + + GTP Y+APEV+ K ++
Sbjct: 121 EIVYRDLKPENILLDKE--GHIKLTDFGFAKK--LRDRTWTLCGTPEYLAPEVIQSKGHN 176
Query: 197 GKV 199
V
Sbjct: 177 KAV 179
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 120 bits (304), Expect = 9e-34
Identities = 64/192 (33%), Positives = 95/192 (49%), Gaps = 19/192 (9%)
Query: 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINH----RSLRHPN 78
YE++ IG G+FG R +R K +++ K I+ G + E ++++++ R L+HPN
Sbjct: 2 YEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYG-NMTEKEKQQLVSEVNILRELKHPN 60
Query: 79 IVRF--KEVILTPTHLAIVMEYASGGELFERICNA----GRFSEDEARFFFQQLISGVSY 132
IVR+ + + + L IVMEY GG+L + I E+ QL+ +
Sbjct: 61 IVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYE 120
Query: 133 CH-----SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIA 186
CH V HRDLK N LD + +K+ DFG +K S T VGTP Y++
Sbjct: 121 CHNRSDPGNTVLHRDLKPANIFLDANNN--VKLGDFGLAKILGHDSSFAKTYVGTPYYMS 178
Query: 187 PEVLLKKEYDGK 198
PE L YD K
Sbjct: 179 PEQLNHMSYDEK 190
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 122 bits (307), Expect = 1e-33
Identities = 65/177 (36%), Positives = 94/177 (53%), Gaps = 8/177 (4%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRS-----LRHPNIVRFK 83
IG G+FG L + K + AVK +++ + + Q+ I+ R+ ++HP +V
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 84 EVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDL 143
T L V++Y +GGELF + F E ARF+ ++ S + Y HS+ + +RDL
Sbjct: 63 YSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDL 122
Query: 144 KLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKEYDGKV 199
K EN LLD L DFG K + HS+ ST GTP Y+APEVL K+ YD V
Sbjct: 123 KPENILLDSQGHVVLT--DFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRKQPYDRTV 177
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 2e-33
Identities = 61/185 (32%), Positives = 97/185 (52%), Gaps = 12/185 (6%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYI---ERGDKIDENVQREIINHRSLRHP 77
+ + L+ IG G+FG DK+T ++VA+K I E D+I++ +Q+EI R P
Sbjct: 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIED-IQQEIQFLSQCRSP 59
Query: 78 NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ 137
I ++ L + L I+MEY GG + + G+ E F ++++ G+ Y H
Sbjct: 60 YITKYYGSFLKGSKLWIIMEYCGGGSCLDLL-KPGKLDETYIAFILREVLLGLEYLHEEG 118
Query: 138 VCHRDLKLENTLL--DGSPAPRLKICDFGYSKS-SVLHSQPKSTVGTPAYIAPEVLLKKE 194
HRD+K N LL +G +K+ DFG S + S+ + VGTP ++APEV+ +
Sbjct: 119 KIHRDIKAANILLSEEGD----VKLADFGVSGQLTSTMSKRNTFVGTPFWMAPEVIKQSG 174
Query: 195 YDGKV 199
YD K
Sbjct: 175 YDEKA 179
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 120 bits (304), Expect = 3e-33
Identities = 66/177 (37%), Positives = 96/177 (54%), Gaps = 8/177 (4%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIERGDKI-DENVQREIINHRSL----RHPNIVRFK 83
+G G+FG L K T+EL AVK +++ + D++V+ + R L +HP + +
Sbjct: 3 LGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLH 62
Query: 84 EVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDL 143
T L VMEY +GG+L I +GRF E ARF+ +++ G+ + H + +RDL
Sbjct: 63 SCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDL 122
Query: 144 KLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKEYDGKV 199
KL+N LLD +KI DFG K +L ST GTP YIAPE+L + Y V
Sbjct: 123 KLDNVLLDSE--GHIKIADFGMCKEGILGGVTTSTFCGTPDYIAPEILSYQPYGPAV 177
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 119 bits (302), Expect = 3e-33
Identities = 68/188 (36%), Positives = 100/188 (53%), Gaps = 19/188 (10%)
Query: 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG-DKIDENVQ-REIINHRSLR----H 76
Y++++ +G G FG L R+K+T ELVA+K +++ +E + RE+ +SLR H
Sbjct: 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREV---KSLRKLNEH 57
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERIC--NAGRFSEDEARFFFQQLISGVSYCH 134
PNIV+ KEV L V EY G L++ + FSE R Q++ G+++ H
Sbjct: 58 PNIVKLKEVFRENDELYFVFEYME-GNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIH 116
Query: 135 SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVLLK 192
HRDLK EN L+ S +KI DFG ++ + S+P T V T Y APE+LL+
Sbjct: 117 KHGFFHRDLKPENLLV--SGPEVVKIADFGLARE--IRSRPPYTDYVSTRWYRAPEILLR 172
Query: 193 -KEYDGKV 199
Y V
Sbjct: 173 STSYSSPV 180
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 6e-33
Identities = 57/203 (28%), Positives = 94/203 (46%), Gaps = 38/203 (18%)
Query: 23 YELVRDIGSGNFGVARLMRDKKTEELVAVK-----YIERGDKIDE-NVQREIINHRSLRH 76
++ + IG G+F L ++K+T + A+K + + K+ +++E++ R H
Sbjct: 3 FKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVL-TRLNGH 61
Query: 77 PNIVR----FKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 132
P I++ F++ +L V+EYA GEL + I G E RF+ +++ + Y
Sbjct: 62 PGIIKLYYTFQD----EENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEY 117
Query: 133 CHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK---------------------SSVL 171
HS + HRDLK EN LLD +KI DFG +K
Sbjct: 118 LHSKGIIHRDLKPENILLDKD--MHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKN 175
Query: 172 HSQPKSTVGTPAYIAPEVLLKKE 194
+ S VGT Y++PE+L +K
Sbjct: 176 RRRFASFVGTAEYVSPELLNEKP 198
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 118 bits (296), Expect = 9e-33
Identities = 71/182 (39%), Positives = 96/182 (52%), Gaps = 6/182 (3%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYI--ERGDKIDEN-VQREIINHRSLRHPN 78
+YE +R +G G FG+ L R K ++LV +K I E+ K + Q E + L HPN
Sbjct: 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPN 60
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGR--FSEDEARFFFQQLISGVSYCHSM 136
I+ + E L L IVMEYA GG L E I ED FF Q++ + + H+
Sbjct: 61 IIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTK 120
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYD 196
+ HRDLK +N LLD +KI DFG SK S+ + VGTP YI+PE+ K Y+
Sbjct: 121 LILHRDLKTQNILLDKHKMV-VKIGDFGISKILSSKSKAYTVVGTPCYISPELCEGKPYN 179
Query: 197 GK 198
K
Sbjct: 180 QK 181
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 9e-33
Identities = 54/181 (29%), Positives = 97/181 (53%), Gaps = 6/181 (3%)
Query: 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHR----SLRHPN 78
+EL+R IG G FG +++ + T+++ A+KY+ + +++ R ++N R L HP
Sbjct: 2 FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPF 61
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQV 138
+V ++ +V++ GG+L + +FSE++ +F+ +++ + Y HS +
Sbjct: 62 LVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGI 121
Query: 139 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGK 198
HRD+K +N LLD + I DF + + ST GTP Y+APEVL ++ Y
Sbjct: 122 IHRDIKPDNILLDEQ--GHVHITDFNIATKVTPDTLTTSTSGTPGYMAPEVLCRQGYSVA 179
Query: 199 V 199
V
Sbjct: 180 V 180
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 2e-32
Identities = 73/190 (38%), Positives = 102/190 (53%), Gaps = 18/190 (9%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYI--ERGDKIDENVQREIINHRSLRHPN 78
+ YEL++ IGSG +G RD T ELVA+K I E GD + +Q+EI + RHPN
Sbjct: 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEI-IQQEISMLKECRHPN 61
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFERIC-NAGRFSEDEARFFFQQLISGVSYCHSMQ 137
IV + L L IVMEY GG L + G SE + + ++ + G++Y H
Sbjct: 62 IVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETG 121
Query: 138 VCHRDLKLENTLL--DGSPAPRLKICDFGYS---KSSVLHSQPKSTVGTPAYIAPEVL-- 190
HRD+K N LL DG +K+ DFG S +++ ++ KS +GTP ++APEV
Sbjct: 122 KIHRDIKGANILLTEDGD----VKLADFGVSAQLTATI--AKRKSFIGTPYWMAPEVAAV 175
Query: 191 -LKKEYDGKV 199
K YDGK
Sbjct: 176 ERKGGYDGKC 185
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 2e-32
Identities = 67/176 (38%), Positives = 94/176 (53%), Gaps = 15/176 (8%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINH--------RSLRHPNIV 80
+G G FG L+R+K T + A+K I + + I + ++ + H ++ RHP +
Sbjct: 3 LGKGTFGKVILVREKATGKYYAMK-ILKKEVI---IAKDEVAHTLTESRVLQNTRHPFLT 58
Query: 81 RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCH 140
K T L VMEYA+GGELF + FSED ARF+ +++S + Y HS V +
Sbjct: 59 ALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVY 118
Query: 141 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKEY 195
RDLKLEN +LD +KI DFG K + T GTP Y+APEVL +Y
Sbjct: 119 RDLKLENLMLDKD--GHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDY 172
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 117 bits (296), Expect = 2e-32
Identities = 65/181 (35%), Positives = 97/181 (53%), Gaps = 15/181 (8%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKY---IERGDKIDENVQREIINHRSLRHP 77
++YE++ +G G +GV R+K T E+VA+K E + + + RE+ R LRH
Sbjct: 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHE 60
Query: 78 NIVRFKEVILTPTHLAIVMEYASGG--ELFERICNAGRFSEDEARFFFQQLISGVSYCHS 135
NIV KE L +V EY EL E + G D R + QL+ ++YCHS
Sbjct: 61 NIVNLKEAFRRKGRLYLVFEYVERTLLELLEA--SPGGLPPDAVRSYIWQLLQAIAYCHS 118
Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST----VGTPAYIAPEVLL 191
+ HRD+K EN L+ S + LK+CDFG++++ L ++P S V T Y APE+L+
Sbjct: 119 HNIIHRDIKPENILV--SESGVLKLCDFGFARA--LRARPASPLTDYVATRWYRAPELLV 174
Query: 192 K 192
Sbjct: 175 G 175
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 3e-32
Identities = 61/181 (33%), Positives = 93/181 (51%), Gaps = 8/181 (4%)
Query: 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSL----RHPN 78
++++ +G G +G L + K T E+VA+K +++ N R ++ R + +
Sbjct: 3 FQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEW 62
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQV 138
+V+ +L + MEY GG+ + N G SED ARF+ ++ V H +
Sbjct: 63 LVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGY 122
Query: 139 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGK 198
HRDLK EN L+D S +K+ DFG SK V + S VG+P Y+APEVL K YD
Sbjct: 123 IHRDLKPENFLIDAS--GHIKLTDFGLSKGIV--TYANSVVGSPDYMAPEVLRGKGYDFT 178
Query: 199 V 199
V
Sbjct: 179 V 179
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 2e-31
Identities = 64/185 (34%), Positives = 96/185 (51%), Gaps = 13/185 (7%)
Query: 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG---DKIDENVQREIINHRSLRHPNI 79
Y+ + IG G +GV RDK T E+VA+K I+ + I + REI + L HPNI
Sbjct: 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNI 60
Query: 80 VRFKEVILTPTHLAIVMEYASGGELFERICNAGR-FSEDEARFFFQQLISGVSYCHSMQV 138
++ +V L +V E+ +L++ I + R E + + QL+ G+++CHS +
Sbjct: 61 IKLLDVFRHKGDLYLVFEFMDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGI 119
Query: 139 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK---STVGTPAYIAPEVLLK-KE 194
HRDLK EN L++ LK+ DFG ++S S + V T Y APE+LL K
Sbjct: 120 LHRDLKPENLLINTEGV--LKLADFGLARS--FGSPVRPYTHYVVTRWYRAPELLLGDKG 175
Query: 195 YDGKV 199
Y V
Sbjct: 176 YSTPV 180
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 113 bits (286), Expect = 4e-31
Identities = 54/172 (31%), Positives = 89/172 (51%), Gaps = 6/172 (3%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRS----LRHPNIVRFKE 84
+G G FG L++ K A+K +++ ++ Q I + + HP IV+
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 85 VILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLK 144
++ ++MEY GGEL+ + + G F E ARF+ ++ Y H+ + +RDLK
Sbjct: 61 TFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLK 120
Query: 145 LENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYD 196
EN LLD + +K+ DFG++K + + GTP Y+APE++L K YD
Sbjct: 121 PENLLLDSN--GYVKLVDFGFAKKLKSGQKTWTFCGTPEYVAPEIILNKGYD 170
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 1e-30
Identities = 66/190 (34%), Positives = 96/190 (50%), Gaps = 20/190 (10%)
Query: 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDE----NVQREIINHRSLRHPN 78
YE + IG G +G R+KKT ELVA+K I R + E REI + LRHPN
Sbjct: 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKI-RMENEKEGFPITAIREIKLLQKLRHPN 59
Query: 79 IVRFKEVILTPTHLAI--VMEYA----SGGELFERICNAGRFSEDEARFFFQQLISGVSY 132
IVR KE++ + +I V EY +G L + +F+E + + + +QL+ G+ Y
Sbjct: 60 IVRLKEIVTSKGKGSIYMVFEYMDHDLTG--LLDS--PEVKFTESQIKCYMKQLLEGLQY 115
Query: 133 CHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVL 190
HS + HRD+K N L++ LK+ DFG ++ + T V T Y PE+L
Sbjct: 116 LHSNGILHRDIKGSNILINND--GVLKLADFGLARPYTKRNSADYTNRVITLWYRPPELL 173
Query: 191 L-KKEYDGKV 199
L Y +V
Sbjct: 174 LGATRYGPEV 183
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 113 bits (283), Expect = 2e-30
Identities = 64/177 (36%), Positives = 91/177 (51%), Gaps = 8/177 (4%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHR-----SLRHPNIVRFK 83
IG G+FG L + K AVK +++ + + Q I+ R +L+HP +V
Sbjct: 3 IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLH 62
Query: 84 EVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDL 143
T L V++Y +GGELF + F E ARF+ ++ S + Y HS+ + +RDL
Sbjct: 63 YSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDL 122
Query: 144 KLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKEYDGKV 199
K EN LLD + + DFG K V + ST GTP Y+APEVL K+ YD V
Sbjct: 123 KPENILLDSQ--GHVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEVLRKEPYDRTV 177
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 6e-30
Identities = 68/179 (37%), Positives = 95/179 (53%), Gaps = 11/179 (6%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIERGDKID-ENVQREIINHR------SLRHPNIVR 81
+G G+FG L KKT EL A+K +++GD I + V+ + R S RHP +V
Sbjct: 7 LGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVN 66
Query: 82 FKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHR 141
T H+ VMEYA+GG+L I + FSE A F+ ++ G+ Y H ++ +R
Sbjct: 67 LFACFQTEDHVCFVMEYAAGGDLMMHI-HTDVFSEPRAVFYAACVVLGLQYLHENKIVYR 125
Query: 142 DLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKEYDGKV 199
DLKL+N LLD +KI DFG K + ST GTP ++APEVL + Y V
Sbjct: 126 DLKLDNLLLD--TEGFVKIADFGLCKEGMGFGDRTSTFCGTPEFLAPEVLTETSYTRAV 182
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 8e-30
Identities = 61/205 (29%), Positives = 93/205 (45%), Gaps = 38/205 (18%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDEN------VQREIINHRSL 74
++ ++ +G G+ G L+R K T +L A+K +++ + I N ++EI+ +L
Sbjct: 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEIL--ATL 58
Query: 75 RHPNIVRFKEVILTPTHLAIVMEYASGGELFE--RICNAGRFSEDEARFFFQQLISGVSY 132
HP + T T+L +VM+Y GGELF + SE+ ARF+ +++ + Y
Sbjct: 59 DHPFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEY 118
Query: 133 CHSMQVCHRDLKLENTLLDGS-----------------PAPRLKICDFGYSKSSVLHSQP 175
H + + +RDLK EN LL S P P K G +SSV
Sbjct: 119 LHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPS 178
Query: 176 -----------KSTVGTPAYIAPEV 189
S VGT YIAPEV
Sbjct: 179 ETFSEEPSFRSNSFVGTEEYIAPEV 203
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 2e-29
Identities = 61/186 (32%), Positives = 96/186 (51%), Gaps = 14/186 (7%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRS----LRHP 77
Y +R +G G FG A L R + + LV K + + E +R+ +N L+HP
Sbjct: 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTR-LSEKERRDALNEIVILSLLQHP 59
Query: 78 NIVRFKEVILTPTHLAIVMEYASGGELFERIC--NAGRFSEDEARFFFQQLISGVSYCHS 135
NI+ + + L I MEYA+GG L+++I F E+ ++ Q++S VSY H
Sbjct: 60 NIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHK 119
Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQPKSTVGTPAYIAPEVLLK 192
+ HRD+K N L + A +K+ DFG SK S ++ + VGTP Y++PE+
Sbjct: 120 AGILHRDIKTLNIFL--TKAGLIKLGDFGISKILGSEYSMAE--TVVGTPYYMSPELCQG 175
Query: 193 KEYDGK 198
+Y+ K
Sbjct: 176 VKYNFK 181
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 2e-29
Identities = 72/196 (36%), Positives = 99/196 (50%), Gaps = 29/196 (14%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQ-------REIINHRS 73
D YE + I G +GV RDKKT E+VA+K + K+++ + REI
Sbjct: 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKL----KMEKEKEGFPITSLREINILLK 60
Query: 74 LRHPNIVRFKEVIL--TPTHLAIVMEYASGGE-----LFERICNAGRFSEDEARFFFQQL 126
L+HPNIV KEV++ + +VMEY E L E + F + E + QL
Sbjct: 61 LQHPNIVTVKEVVVGSNLDKIYMVMEYV---EHDLKSLMETM--KQPFLQSEVKCLMLQL 115
Query: 127 ISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK--SSVLHSQPKSTVGTPAY 184
+SGV++ H + HRDLK N LL + LKICDFG ++ S L + V T Y
Sbjct: 116 LSGVAHLHDNWILHRDLKTSNLLL--NNRGILKICDFGLAREYGSPLKPYTQLVV-TLWY 172
Query: 185 IAPEVLL-KKEYDGKV 199
APE+LL KEY +
Sbjct: 173 RAPELLLGAKEYSTAI 188
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 110 bits (275), Expect = 4e-29
Identities = 65/172 (37%), Positives = 92/172 (53%), Gaps = 7/172 (4%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIERGDKI-DENVQREIINHRSL---RHPNIVRFKE 84
+G G FG L+R+K T A+K + + I + V + R L RHP + K
Sbjct: 3 LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKY 62
Query: 85 VILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLK 144
T L VMEYA+GGELF + F+E+ ARF+ +++S + Y HS V +RD+K
Sbjct: 63 AFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIK 122
Query: 145 LENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKSTVGTPAYIAPEVLLKKEY 195
LEN +LD +KI DFG K + + K+ GTP Y+APEVL +Y
Sbjct: 123 LENLMLDKD--GHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDY 172
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 7e-29
Identities = 66/178 (37%), Positives = 98/178 (55%), Gaps = 10/178 (5%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIERGDKI--DENVQREIINHRSL----RHPNIVRF 82
+G G+FG L K T E A+K +++ D + D++V+ ++ R L HP +
Sbjct: 3 LGKGSFGKVMLAELKGTNEFFAIKALKK-DVVLEDDDVECTMVERRVLALAWEHPFLTHL 61
Query: 83 KEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRD 142
T HL VMEY +GG+L I ++GRF E ARF+ ++I G+ + H + +RD
Sbjct: 62 FCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRD 121
Query: 143 LKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKEYDGKV 199
LKL+N LLD +KI DFG K ++ ST GTP YIAPE+L ++Y+ V
Sbjct: 122 LKLDNVLLDKD--GHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKGQKYNESV 177
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 7e-29
Identities = 60/186 (32%), Positives = 106/186 (56%), Gaps = 14/186 (7%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYI---ERGDKIDENVQREIINHRSLRHPN 78
+Y V+ IG G+FG A L++ K+ + +K I + K E ++E+ +++HPN
Sbjct: 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPN 60
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGR---FSEDEARFFFQQLISGVSYCHS 135
IV+++E +L IVM+Y GG+L+++I NA R F ED+ +F Q+ + + H
Sbjct: 61 IVQYQESFEENGNLYIVMDYCEGGDLYKKI-NAQRGVLFPEDQILDWFVQICLALKHVHD 119
Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLK 192
++ HRD+K +N L +K+ DFG ++ VL+S ++ +GTP Y++PE+
Sbjct: 120 RKILHRDIKSQNIFLTKDGT--IKLGDFGIAR--VLNSTVELARTCIGTPYYLSPEICEN 175
Query: 193 KEYDGK 198
+ Y+ K
Sbjct: 176 RPYNNK 181
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 8e-29
Identities = 66/217 (30%), Positives = 97/217 (44%), Gaps = 44/217 (20%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSL----RH 76
D +E+++ IG G FG L+RDK T ++ A+K + + D I N + R +
Sbjct: 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADS 60
Query: 77 PNIVR----FKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 132
P IV+ F++ HL +VMEY GG+L + F E+ ARF+ +L+ +
Sbjct: 61 PWIVKLYYSFQDE----EHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDS 116
Query: 133 CHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK------------------------- 167
H + HRD+K +N L+D +K+ DFG K
Sbjct: 117 VHKLGFIHRDIKPDNILIDAD--GHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVL 174
Query: 168 -SSVLHSQPK----STVGTPAYIAPEVLLKKEYDGKV 199
H Q + STVGTP YIAPEVL Y +
Sbjct: 175 VRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLEC 211
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 1e-28
Identities = 51/182 (28%), Positives = 94/182 (51%), Gaps = 7/182 (3%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNI 79
+ ++++ +G G++G K+T ++VA+K + + + + + +EI + P I
Sbjct: 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDL-QEIIKEISILKQCDSPYI 60
Query: 80 VRFKEVILTPTHLAIVMEYASGGELFE--RICNAGRFSEDEARFFFQQLISGVSYCHSMQ 137
V++ T L IVMEY G + + +I N +E+E Q + G+ Y HS +
Sbjct: 61 VKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNK-TLTEEEIAAILYQTLKGLEYLHSNK 119
Query: 138 VCHRDLKLENTLLDGSPAPRLKICDFGYS-KSSVLHSQPKSTVGTPAYIAPEVLLKKEYD 196
HRD+K N LL+ K+ DFG S + + ++ + +GTP ++APEV+ + Y+
Sbjct: 120 KIHRDIKAGNILLNEEGQA--KLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYN 177
Query: 197 GK 198
K
Sbjct: 178 NK 179
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 1e-28
Identities = 58/181 (32%), Positives = 95/181 (52%), Gaps = 8/181 (4%)
Query: 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRS----LRHPN 78
+E+ +G+G+FG R+ + K T E A+K +++ + + + + +S L HP
Sbjct: 20 FEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPF 79
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQV 138
IV + ++E+ GGELF + AGRF D A+F+ +L+ Y HS +
Sbjct: 80 IVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDI 139
Query: 139 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGK 198
+RDLK EN LLD +K+ DFG++K + + + GTP Y+APEV+ K +
Sbjct: 140 IYRDLKPENLLLDNK--GHVKVTDFGFAKK--VPDRTFTLCGTPEYLAPEVIQSKGHGKA 195
Query: 199 V 199
V
Sbjct: 196 V 196
|
Length = 329 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 108 bits (270), Expect = 2e-28
Identities = 64/177 (36%), Positives = 97/177 (54%), Gaps = 8/177 (4%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSL-----RHPNIVRFK 83
IG G+FG L R K E+ AVK +++ + + ++ I++ R++ +HP +V
Sbjct: 3 IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 62
Query: 84 EVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDL 143
T L V++Y +GGELF + F E ARF+ ++ S + Y HS+ + +RDL
Sbjct: 63 FSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDL 122
Query: 144 KLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKEYDGKV 199
K EN LLD + + DFG K ++ H+ ST GTP Y+APEVL K+ YD V
Sbjct: 123 KPENILLDSQ--GHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLHKQPYDRTV 177
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 3e-28
Identities = 54/186 (29%), Positives = 78/186 (41%), Gaps = 20/186 (10%)
Query: 24 ELVRDIGSGNFGVARL----MRDKKTEELVAVKYIERGDKIDENVQ---REIINHRSLRH 76
L + +G G FG + E VAVK + + D ++ ++ RE R L H
Sbjct: 2 TLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTL-KEDASEQQIEEFLREARIMRKLDH 60
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCH 134
PNIV+ V L IVMEY GG+L + R S + F Q+ G+ Y
Sbjct: 61 PNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLE 120
Query: 135 SMQVCHRDLKLENTLLDGSPAPRLKICDFG-----YSKSSVLHSQPKSTVGTPAYIAPEV 189
S HRDL N L+ + +KI DFG Y K + ++APE
Sbjct: 121 SKNFIHRDLAARNCLVGEN--LVVKISDFGLSRDLYDDDYYKVKGGKLPI---RWMAPES 175
Query: 190 LLKKEY 195
L + ++
Sbjct: 176 LKEGKF 181
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 3e-28
Identities = 63/178 (35%), Positives = 97/178 (54%), Gaps = 10/178 (5%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENV------QREIINHRSLRH-PNIVR 81
IG G FG +R K T + A+K + + + + + +R I+ L P IV
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 82 FKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHR 141
K T + L +V +Y SGGELF + GRFSED A+F+ +L+ + + H + +R
Sbjct: 61 LKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYR 120
Query: 142 DLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKEYDGK 198
DLK EN LLD + + +CDFG SK+++ ++ +T GT Y+APEVLL ++ K
Sbjct: 121 DLKPENILLDAT--GHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEKGYTK 176
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 3e-28
Identities = 53/185 (28%), Positives = 80/185 (43%), Gaps = 19/185 (10%)
Query: 24 ELVRDIGSGNFGVARL----MRDKKTEELVAVKYIERGDKIDENVQ---REIINHRSLRH 76
L + +G G FG + K + VAVK + + D ++ ++ RE R L H
Sbjct: 2 TLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTL-KEDASEQQIEEFLREARIMRKLDH 60
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHS 135
PN+V+ V L IVMEY GG+L + N + S + F Q+ G+ Y S
Sbjct: 61 PNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYLES 120
Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFG-----YSKSSVLHSQPKSTVGTPAYIAPEVL 190
HRDL N L+ + +KI DFG Y K + ++APE L
Sbjct: 121 KNFIHRDLAARNCLVGEN--LVVKISDFGLSRDLYDDDYYRKRGGKLPI---RWMAPESL 175
Query: 191 LKKEY 195
+ ++
Sbjct: 176 KEGKF 180
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 5e-28
Identities = 67/197 (34%), Positives = 93/197 (47%), Gaps = 34/197 (17%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER--GDKID-ENVQREIINHRSLRHPN 78
RYEL++ IGSG +GV DK+T VA+K I D ID + + REI R LRH N
Sbjct: 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHEN 60
Query: 79 IVRFKEVILTPT-----HLAIVMEYA---------SGGELFERICNAGRFSEDEARFFFQ 124
I+ +++ P+ + IV E S L ++D ++F
Sbjct: 61 IIGLLDILRPPSPEDFNDVYIVTELMETDLHKVIKSPQPL----------TDDHIQYFLY 110
Query: 125 QLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST----VG 180
Q++ G+ Y HS V HRDLK N L++ + LKICDFG ++ K V
Sbjct: 111 QILRGLKYLHSANVIHRDLKPSNILVNSNCD--LKICDFGLARGVDPDEDEKGFLTEYVV 168
Query: 181 TPAYIAPEVLLK-KEYD 196
T Y APE+LL Y
Sbjct: 169 TRWYRAPELLLSSSRYT 185
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 1e-27
Identities = 62/178 (34%), Positives = 94/178 (52%), Gaps = 10/178 (5%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIERGDKI--DENVQREIINHRSL----RHPNIVRF 82
+G G+FG L K T+E+ A+K +++ D I D++V + R L +HP +
Sbjct: 3 LGKGSFGKVMLAELKGTDEVYAIKVLKK-DVILQDDDVDCTMTEKRILALAAKHPFLTAL 61
Query: 83 KEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRD 142
T L VMEY +GG+L +I + +F E +RF+ ++ + + H V +RD
Sbjct: 62 HCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRD 121
Query: 143 LKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKEYDGKV 199
LKL+N LLD K+ DFG K +L+ +T GTP YIAPE+L + EY V
Sbjct: 122 LKLDNILLDAE--GHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQELEYGPSV 177
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 2e-27
Identities = 63/187 (33%), Positives = 95/187 (50%), Gaps = 19/187 (10%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIE----------RGDKIDENVQREIINHRSLRHPN 78
IGSG+FG L + + EL+AVK +E R + + + REI + L+H N
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQV 138
IV++ L HL I +EY GG + + N G F E R F +Q++ G++Y H+ +
Sbjct: 68 IVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGI 127
Query: 139 CHRDLKLENTLLDGSPAPRLKICDFGYSK-------SSVLHSQPKSTVGTPAYIAPEVLL 191
HRD+K N L+D +KI DFG SK S+ + S G+ ++APEV+
Sbjct: 128 IHRDIKGANILVDNKGG--IKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVK 185
Query: 192 KKEYDGK 198
+ Y K
Sbjct: 186 QTSYTRK 192
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 2e-27
Identities = 54/178 (30%), Positives = 85/178 (47%), Gaps = 10/178 (5%)
Query: 24 ELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQ--REIINHRSLRHPNIVR 81
E V+ +G G+ GV +R K T ++ A+K I + Q RE+ RS P +V+
Sbjct: 4 ERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVK 63
Query: 82 FKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM-QVCH 140
++IV+EY GG L + + G+ E + +Q++ G+ Y H+ + H
Sbjct: 64 CYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIH 123
Query: 141 RDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKEY 195
RD+K N L+ G KI DFG SK +T VGT Y++PE + + Y
Sbjct: 124 RDIKPSNLLINSKGEV----KIADFGISKVLENTLDQCNTFVGTVTYMSPERIQGESY 177
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 2e-27
Identities = 64/172 (37%), Positives = 93/172 (54%), Gaps = 7/172 (4%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIERGDKI-DENVQREIINHRSL---RHPNIVRFKE 84
+G G FG L+R+K + + A+K +++ I + V + R L RHP + K
Sbjct: 3 LGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKY 62
Query: 85 VILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLK 144
T L VMEY +GGELF + FSED RF+ +++S + Y HS ++ +RDLK
Sbjct: 63 SFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLK 122
Query: 145 LENTLLDGSPAPRLKICDFGYSKSSVLHSQP-KSTVGTPAYIAPEVLLKKEY 195
LEN +LD +KI DFG K + + K+ GTP Y+APEVL +Y
Sbjct: 123 LENLMLDKD--GHIKITDFGLCKEGITDAATMKTFCGTPEYLAPEVLEDNDY 172
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 103 bits (257), Expect = 4e-27
Identities = 64/185 (34%), Positives = 102/185 (55%), Gaps = 13/185 (7%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIE--RGDKIDENVQREIINHRSLRHPNI 79
+Y ++R +G G+FG A L++ +++ A+K I + E+ ++E + ++HPNI
Sbjct: 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNI 60
Query: 80 VRFKEVILTPTHLAIVMEYASGGELFERI-CNAGR-FSEDEARFFFQQLISGVSYCHSMQ 137
V FKE HL IVMEY GG+L ++I G+ F ED +F Q+ GV + H +
Sbjct: 61 VAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKR 120
Query: 138 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS----TVGTPAYIAPEVLLKK 193
V HRD+K +N L + ++K+ DFG S+ L + P + VGTP Y+ PE+
Sbjct: 121 VLHRDIKSKNIFL--TQNGKVKLGDFG---SARLLTSPGAYACTYVGTPYYVPPEIWENM 175
Query: 194 EYDGK 198
Y+ K
Sbjct: 176 PYNNK 180
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 6e-27
Identities = 62/178 (34%), Positives = 94/178 (52%), Gaps = 10/178 (5%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIERGDKI--DENVQREIINHRSL----RHPNIVRF 82
+G G+FG L K T+EL A+K I + D I D++V+ ++ R L + P + +
Sbjct: 8 LGKGSFGKVMLAERKGTDELYAIK-ILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQL 66
Query: 83 KEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRD 142
T L VMEY +GG+L I G+F E A F+ ++ G+ + HS + +RD
Sbjct: 67 HSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRD 126
Query: 143 LKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKEYDGKV 199
LKL+N +LD +KI DFG K ++ + T GTP YIAPE++ + Y V
Sbjct: 127 LKLDNVMLDAE--GHIKIADFGMCKENIFGGKTTRTFCGTPDYIAPEIIAYQPYGKSV 182
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 7e-27
Identities = 64/176 (36%), Positives = 95/176 (53%), Gaps = 10/176 (5%)
Query: 27 RDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI--DENVQREIINHRSL----RHPNIV 80
R +G G+FG L R K++ L AVK +++ D I D++V+ + R L HP +
Sbjct: 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKK-DVILQDDDVECTMTEKRILSLARNHPFLT 59
Query: 81 RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCH 140
+ TP L VME+ +GG+L I + RF E ARF+ ++ S + + H + +
Sbjct: 60 QLYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIY 119
Query: 141 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKEY 195
RDLKL+N LLD K+ DFG K + + + ST GTP YIAPE+L + Y
Sbjct: 120 RDLKLDNVLLDHE--GHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQEMLY 173
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 1e-26
Identities = 64/187 (34%), Positives = 92/187 (49%), Gaps = 18/187 (9%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIERGDKIDEN-----------VQREIINHRSLRHP 77
IG G +G L + T E++AVK +E I ++ EI + L H
Sbjct: 9 IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68
Query: 78 NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ 137
NIV++ T +L+I +EY GG + + GRF E RFF +Q++ G++Y HS
Sbjct: 69 NIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKG 128
Query: 138 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSS---VLHSQPKSTVGTPAYIAPEV--LLK 192
+ HRDLK +N L+D KI DFG SK S + Q S G+ ++APEV
Sbjct: 129 ILHRDLKADNLLVDADGI--CKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYS 186
Query: 193 KEYDGKV 199
+ Y KV
Sbjct: 187 QGYSAKV 193
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 2e-26
Identities = 55/171 (32%), Positives = 86/171 (50%), Gaps = 8/171 (4%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVK---YIERGDKIDENVQ---REIINHRSLRHPNIVRF 82
+GSG+FG + + AVK + G E V+ +EI L+HPNIV++
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 83 KEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRD 142
+L I +E GG L + + G F E R + +Q++ G+ Y H HRD
Sbjct: 68 LGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRD 127
Query: 143 LKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKK 193
+K N L+D + +K+ DFG +K V S KS G+P ++APEV+ ++
Sbjct: 128 IKGANILVDTNGV--VKLADFGMAKQVVEFSFAKSFKGSPYWMAPEVIAQQ 176
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 2e-26
Identities = 64/182 (35%), Positives = 94/182 (51%), Gaps = 15/182 (8%)
Query: 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQ----REIINHRSLRHPN 78
++ V IG G +GV R+K T E+VA+K I R D E V REI + L HPN
Sbjct: 2 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKELNHPN 60
Query: 79 IVRFKEVILTPTHLAIVMEYASGG-ELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ 137
IV+ +VI T L +V E+ + F + + QL+ G+++CHS +
Sbjct: 61 IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHR 120
Query: 138 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST----VGTPAYIAPEVLLKK 193
V HRDLK +N L++ A +K+ DFG +++ + P T V T Y APE+LL
Sbjct: 121 VLHRDLKPQNLLINTEGA--IKLADFGLARAFGV---PVRTYTHEVVTLWYRAPEILLGC 175
Query: 194 EY 195
+Y
Sbjct: 176 KY 177
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 2e-26
Identities = 60/177 (33%), Positives = 93/177 (52%), Gaps = 8/177 (4%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSL-----RHPNIVRFK 83
IG G+FG L + K + AVK +++ ++ Q+ I+ R++ +HP +V
Sbjct: 3 IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 84 EVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDL 143
T L V+++ +GGELF + F E ARF+ ++ S + Y HS+ + +RDL
Sbjct: 63 YSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDL 122
Query: 144 KLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKEYDGKV 199
K EN LLD + + DFG K + S +T GTP Y+APEV+ K+ YD V
Sbjct: 123 KPENILLDSQ--GHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRKQPYDNTV 177
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 3e-26
Identities = 61/177 (34%), Positives = 95/177 (53%), Gaps = 8/177 (4%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIERGDKI-DENVQREIINHRSL----RHPNIVRFK 83
+G G+FG L K T + A+K +++ + D++V+ ++ R L HP +
Sbjct: 3 LGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLY 62
Query: 84 EVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDL 143
T +L VMEY +GG+L I + +F A F+ ++I G+ + HS + +RDL
Sbjct: 63 CTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDL 122
Query: 144 KLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKEYDGKV 199
KL+N LLD +KI DFG K ++L T GTP YIAPE+LL ++Y+ V
Sbjct: 123 KLDNILLDTD--GHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLGQKYNTSV 177
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 3e-26
Identities = 61/173 (35%), Positives = 91/173 (52%), Gaps = 8/173 (4%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIERGDK-IDENVQREIINHRSL----RHPNIVRFK 83
+G G+FG L K E AVK +++ ID++V+ ++ R L +P +
Sbjct: 3 LGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLY 62
Query: 84 EVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDL 143
T HL VME+ +GG+L I + GRF A F+ +++ G+ + HS + +RDL
Sbjct: 63 CTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDL 122
Query: 144 KLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKEY 195
KL+N +LD +KI DFG K +V ST GTP YIAPE+L +Y
Sbjct: 123 KLDNVMLDRD--GHIKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQGLKY 173
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 102 bits (254), Expect = 4e-26
Identities = 66/173 (38%), Positives = 94/173 (54%), Gaps = 8/173 (4%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIERGDKI-DENVQREIINHRSL---RHPNIVRFKE 84
+G G FG L+++K T A+K +++ + + V + +R L RHP + K
Sbjct: 3 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKY 62
Query: 85 VILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS-MQVCHRDL 143
T L VMEYA+GGELF + FSED ARF+ +++S + Y HS V +RDL
Sbjct: 63 SFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDL 122
Query: 144 KLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKSTVGTPAYIAPEVLLKKEY 195
KLEN +LD +KI DFG K + + K+ GTP Y+APEVL +Y
Sbjct: 123 KLENLMLDKD--GHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDY 173
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 6e-26
Identities = 67/179 (37%), Positives = 94/179 (52%), Gaps = 16/179 (8%)
Query: 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYI----ERGDKIDENVQREIINHRSLRHPN 78
+E + IG G +G+ RD + E+VA+K + ER D I + REI +LRHPN
Sbjct: 9 FEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNER-DGIPISSLREITLLLNLRHPN 67
Query: 79 IVRFKEVILTPTHLA---IVMEYASG--GELFERICNAGRFSEDEARFFFQQLISGVSYC 133
IV KEV+ HL +VMEY L + + FSE + + QL+ G+ Y
Sbjct: 68 IVELKEVV-VGKHLDSIFLVMEYCEQDLASLLDNMPTP--FSESQVKCLMLQLLRGLQYL 124
Query: 134 HSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS-TVGTPAYIAPEVLL 191
H + HRDLK+ N LL LKI DFG +++ L ++P + V T Y APE+LL
Sbjct: 125 HENFIIHRDLKVSNLLLTDKGC--LKIADFGLARTYGLPAKPMTPKVVTLWYRAPELLL 181
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 99.6 bits (248), Expect = 1e-25
Identities = 66/188 (35%), Positives = 100/188 (53%), Gaps = 17/188 (9%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYI---ERGDKIDENVQREIINHRSLRHPN 78
RYE+++ IG G+FG L + K E +K I + K E ++E+I ++HPN
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPN 60
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGR---FSEDEARFFFQQLISGVSYCHS 135
IV F L IVMEY GG+L +RI N R FSED+ +F Q+ G+ + H
Sbjct: 61 IVTFFASFQENGRLFIVMEYCDGGDLMKRI-NRQRGVLFSEDQILSWFVQISLGLKHIHD 119
Query: 136 MQVCHRDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVL 190
++ HRD+K +N L +G A K+ DFG ++ L+ + VGTP Y++PE+
Sbjct: 120 RKILHRDIKSQNIFLSKNGMVA---KLGDFGIAR--QLNDSMELAYTCVGTPYYLSPEIC 174
Query: 191 LKKEYDGK 198
+ Y+ K
Sbjct: 175 QNRPYNNK 182
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 99.8 bits (249), Expect = 1e-25
Identities = 62/185 (33%), Positives = 94/185 (50%), Gaps = 13/185 (7%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDE--NVQREIINHRSLRH--- 76
R EL IG G +G + T +VA+K I D+ ++QRE+ LR
Sbjct: 5 RLEL---IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQP 61
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
PNI ++ L L I+MEYA GG + + AG +E ++++ + Y H +
Sbjct: 62 PNITKYYGSYLKGPRLWIIMEYAEGGSV-RTLMKAGPIAEKYISVIIREVLVALKYIHKV 120
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLK-KE 194
V HRD+K N L+ + +K+CDFG + +S +ST VGTP ++APEV+ + K
Sbjct: 121 GVIHRDIKAANILV--TNTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITEGKY 178
Query: 195 YDGKV 199
YD K
Sbjct: 179 YDTKA 183
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 99.5 bits (248), Expect = 2e-25
Identities = 65/181 (35%), Positives = 103/181 (56%), Gaps = 16/181 (8%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQ----REIINHRSLRH 76
D+YE V IG G +GV RD+ T E +A+K I R ++ DE V REI + ++H
Sbjct: 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKI-RLEQEDEGVPSTAIREISLLKEMQH 60
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDE--ARFFFQQLISGVSYCH 134
NIVR ++V+ + L +V EY +L + + ++ F+++ + + Q++ G++YCH
Sbjct: 61 GNIVRLQDVVHSEKRLYLVFEYLDL-DLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCH 119
Query: 135 SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST----VGTPAYIAPEVL 190
S +V HRDLK +N L+D LK+ DFG +++ + P T V T Y APE+L
Sbjct: 120 SHRVLHRDLKPQNLLIDRR-TNALKLADFGLARAFGI---PVRTFTHEVVTLWYRAPEIL 175
Query: 191 L 191
L
Sbjct: 176 L 176
|
Length = 294 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 98.7 bits (246), Expect = 5e-25
Identities = 64/187 (34%), Positives = 95/187 (50%), Gaps = 16/187 (8%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINH----RSLRHP 77
+ +R+IG G+FG RD +T E+VA+K + K ++II + LRHP
Sbjct: 16 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHP 75
Query: 78 NIVRFKEVILTPTHLAIVMEY--ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 135
N + +K L +VMEY S ++ E + E E + G++Y HS
Sbjct: 76 NTIEYKGCYLREHTAWLVMEYCLGSASDILE--VHKKPLQEVEIAAICHGALQGLAYLHS 133
Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL---K 192
+ HRD+K N LL + +K+ DFG S+ L S S VGTP ++APEV+L +
Sbjct: 134 HERIHRDIKAGNILL--TEPGTVKLADFG---SASLVSPANSFVGTPYWMAPEVILAMDE 188
Query: 193 KEYDGKV 199
+YDGKV
Sbjct: 189 GQYDGKV 195
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 98.9 bits (246), Expect = 7e-25
Identities = 61/177 (34%), Positives = 95/177 (53%), Gaps = 8/177 (4%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIERGDKI-DENVQREIINHRSL----RHPNIVRFK 83
+G G+FG L K T+EL A+K +++ I D++V+ ++ R L + P + +
Sbjct: 8 LGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLH 67
Query: 84 EVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDL 143
T L VMEY +GG+L +I GRF E A F+ ++ G+ + HS + +RDL
Sbjct: 68 SCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDL 127
Query: 144 KLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKSTVGTPAYIAPEVLLKKEYDGKV 199
KL+N +LD +KI DFG K ++ K+ GTP YIAPE++ + Y V
Sbjct: 128 KLDNVMLDSE--GHIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEIIAYQPYGKSV 182
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 97.7 bits (244), Expect = 8e-25
Identities = 61/200 (30%), Positives = 95/200 (47%), Gaps = 36/200 (18%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLR---- 75
+ +ELV IG G +G R KKT +LVA+K ++ + +E ++ E LR
Sbjct: 5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEY---NILRKYSN 61
Query: 76 HPNIVRFKEVILTPTH------LAIVMEYASGG---ELFERICNAG-RFSEDEARFFFQQ 125
HPNI F + L +VME GG +L + + G R E+ + ++
Sbjct: 62 HPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRE 121
Query: 126 LISGVSYCHSMQVCHRDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQPKST----- 178
+ G++Y H +V HRD+K +N LL + +K+ DFG S +Q ST
Sbjct: 122 TLRGLAYLHENKVIHRDIKGQNILLTKNA----EVKLVDFGVS------AQLDSTLGRRN 171
Query: 179 --VGTPAYIAPEVLLKKEYD 196
+GTP ++APEV+ E
Sbjct: 172 TFIGTPYWMAPEVIACDEQP 191
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 98.1 bits (244), Expect = 1e-24
Identities = 59/177 (33%), Positives = 93/177 (52%), Gaps = 8/177 (4%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIERGDKI-DENVQREIINHRSL----RHPNIVRFK 83
+G G+FG L K T+EL A+K +++ I D++V+ ++ R L + P + +
Sbjct: 8 LGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLH 67
Query: 84 EVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDL 143
T L VMEY +GG+L I G+F E +A F+ ++ G+ + H + +RDL
Sbjct: 68 SCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDL 127
Query: 144 KLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKEYDGKV 199
KL+N +LD +KI DFG K ++ T GTP YIAPE++ + Y V
Sbjct: 128 KLDNVMLDSE--GHIKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEIIAYQPYGKSV 182
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 96.8 bits (241), Expect = 1e-24
Identities = 57/180 (31%), Positives = 89/180 (49%), Gaps = 12/180 (6%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIE--RGDKIDEN----VQREIINHRSLRHPNIVRF 82
+G G FG L D T +AVK + + ++ EI ++L+H IV++
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQY 69
Query: 83 KEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRD 142
+ L+I MEY GG + +++ G +E R + +Q++ GV Y HS + HRD
Sbjct: 70 YGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRD 129
Query: 143 LKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQ---PKSTVGTPAYIAPEVLLKKEYDGK 198
+K N L D A +K+ DFG SK + S KS GTP +++PEV+ + Y K
Sbjct: 130 IKGANILRDS--AGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRK 187
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 97.3 bits (243), Expect = 1e-24
Identities = 62/189 (32%), Positives = 87/189 (46%), Gaps = 22/189 (11%)
Query: 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYI-----ERGDKIDENVQREIINHRSLR-- 75
YE + +IG G +G RD T VA+K + E G I + REI + L
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEG--IPLSTLREIALLKQLESF 58
Query: 76 -HPNIVRFKEVILTP-----THLAIVMEYASGG-ELFERICNAGRFSEDEARFFFQQLIS 128
HPNIVR +V P L +V E+ + C + + +QL+
Sbjct: 59 EHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQLLR 118
Query: 129 GVSYCHSMQVCHRDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIA 186
GV + HS ++ HRDLK +N L+ DG ++KI DFG ++ S V T Y A
Sbjct: 119 GVDFLHSHRIVHRDLKPQNILVTSDG----QVKIADFGLARIYSFEMALTSVVVTLWYRA 174
Query: 187 PEVLLKKEY 195
PEVLL+ Y
Sbjct: 175 PEVLLQSSY 183
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 97.7 bits (243), Expect = 1e-24
Identities = 57/172 (33%), Positives = 87/172 (50%), Gaps = 7/172 (4%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSL----RHPNIVRFKE 84
IG G+FG +R + T+ + A+K I + + + + R++ P IV K
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 85 VILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLK 144
+P L +V+ + +GGELF + GRF ARF+ +L+ + H V +RDLK
Sbjct: 61 SFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLK 120
Query: 145 LENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKEY 195
EN LLD + +CDFG K ++ +T GTP Y+APE+LL Y
Sbjct: 121 PENILLD--YQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHGY 170
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 97.3 bits (243), Expect = 1e-24
Identities = 54/182 (29%), Positives = 88/182 (48%), Gaps = 19/182 (10%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK------IDENVQREIINHRSLR 75
RYE + +G G + V RDK+T +VA+K I+ G++ I+ REI + L+
Sbjct: 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELK 60
Query: 76 HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYC 133
HPNI+ +V +++ +V E+ +L E++ + + + + + G+ Y
Sbjct: 61 HPNIIGLLDVFGHKSNINLVFEFMET-DL-EKVIKDKSIVLTPADIKSYMLMTLRGLEYL 118
Query: 134 HSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK----STVGTPAYIAPEV 189
HS + HRDLK N L+ LK+ DFG ++S P V T Y APE+
Sbjct: 119 HSNWILHRDLKPNNLLIA--SDGVLKLADFGLARS---FGSPNRKMTHQVVTRWYRAPEL 173
Query: 190 LL 191
L
Sbjct: 174 LF 175
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 97.0 bits (242), Expect = 2e-24
Identities = 68/179 (37%), Positives = 96/179 (53%), Gaps = 17/179 (9%)
Query: 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQ----REIINHRSLRHPN 78
Y+ V IG G +GV RDK T E+VA+K I R + DE V REI + L HPN
Sbjct: 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKI-RLETEDEGVPSTAIREISLLKELNHPN 59
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARF--FFQQLISGVSYCHSM 136
IVR +V+ + L +V E+ +L + + ++ D + QL+ G++YCHS
Sbjct: 60 IVRLLDVVHSENKLYLVFEFLDL-DLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSH 118
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST----VGTPAYIAPEVLL 191
+V HRDLK +N L+D A LK+ DFG +++ P T V T Y APE+LL
Sbjct: 119 RVLHRDLKPQNLLIDREGA--LKLADFGLARA---FGVPVRTYTHEVVTLWYRAPEILL 172
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 96.3 bits (239), Expect = 2e-24
Identities = 62/180 (34%), Positives = 94/180 (52%), Gaps = 6/180 (3%)
Query: 13 DMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYI--ERGDKIDENVQREIIN 70
D+ + + +EL++ IGSG +G R+ T EL A+K I E G+ VQ+EII
Sbjct: 1 DLSRRNPQEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAV-VQQEIIM 59
Query: 71 HRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGV 130
+ +H NIV + L L I ME+ GG L + G SE + + ++ + G+
Sbjct: 60 MKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGL 119
Query: 131 SYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKSTVGTPAYIAPEV 189
Y HS HRD+K N LL + +K+ DFG S + ++ KS +GTP ++APEV
Sbjct: 120 YYLHSKGKMHRDIKGANILL--TDNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEV 177
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 96.0 bits (239), Expect = 4e-24
Identities = 60/175 (34%), Positives = 95/175 (54%), Gaps = 9/175 (5%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIE-RGDKIDENVQREIINHRSLRHPNIVRFKEVIL 87
IG G+ G+ + DK T VAVK ++ R + E + E++ R +HPNIV L
Sbjct: 27 IGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYL 86
Query: 88 TPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLEN 147
L +VME+ GG L + I R +E++ ++ +S+ H+ V HRD+K ++
Sbjct: 87 VGDELWVVMEFLEGGALTD-IVTHTRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDS 145
Query: 148 TLL--DGSPAPRLKICDFGY-SKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKV 199
LL DG R+K+ DFG+ ++ S + KS VGTP ++APEV+ + Y +V
Sbjct: 146 ILLTSDG----RVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEVISRLPYGTEV 196
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 95.1 bits (237), Expect = 6e-24
Identities = 56/173 (32%), Positives = 89/173 (51%), Gaps = 15/173 (8%)
Query: 24 ELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREI-----INHRSLRHPN 78
E + ++G+GN GV + + T +++AVK I I+E +Q++I I H+ P
Sbjct: 4 EYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLE--INEAIQKQILRELDILHKC-NSPY 60
Query: 79 IVRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHS- 135
IV F ++I MEY GG L + GR E ++ G++Y H
Sbjct: 61 IVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQ-GRIPERILGKIAVAVLKGLTYLHEK 119
Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPE 188
++ HRD+K N L++ ++K+CDFG S V +S K+ VGT +Y+APE
Sbjct: 120 HKIIHRDVKPSNILVNSR--GQIKLCDFGVSGQLV-NSLAKTFVGTSSYMAPE 169
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 95.2 bits (237), Expect = 8e-24
Identities = 59/183 (32%), Positives = 97/183 (53%), Gaps = 13/183 (7%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQ----REIINHRSLRHP 77
+YE + IG G +G ++++T E+VA+K + R D DE V REI + L+H
Sbjct: 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRV-RLDDDDEGVPSSALREICLLKELKHK 59
Query: 78 NIVRFKEVILTPTHLAIVMEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHS 135
NIVR +V+ + L +V EY + ++ ++ G + + F QL+ G+++CHS
Sbjct: 60 NIVRLYDVLHSDKKLTLVFEYCD--QDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHS 117
Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKSTVGTPAYIAPEVLL-KK 193
V HRDLK +N L++ + LK+ DFG +++ + + V T Y P+VL K
Sbjct: 118 HNVLHRDLKPQNLLINKN--GELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAK 175
Query: 194 EYD 196
Y
Sbjct: 176 LYS 178
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 95.9 bits (239), Expect = 9e-24
Identities = 59/192 (30%), Positives = 91/192 (47%), Gaps = 16/192 (8%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQR---EIINHRSLRHP 77
RY+ + +IGSG +GV D ++ + VA+K I + +R E+ R +H
Sbjct: 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHD 64
Query: 78 NIVRFKEVILTP----THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYC 133
NI+ ++++ P + +VM+ +L I + +E+ R+F QL+ G+ Y
Sbjct: 65 NIIAIRDILRPPGADFKDVYVVMDLM-ESDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYI 123
Query: 134 HSMQVCHRDLKLENTLLDGSPAPRLKICDFG----YSKSSVLHSQ-PKSTVGTPAYIAPE 188
HS V HRDLK N L++ L+I DFG S S H V T Y APE
Sbjct: 124 HSANVIHRDLKPSNLLVNED--CELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPE 181
Query: 189 VLLK-KEYDGKV 199
+LL EY +
Sbjct: 182 LLLSLPEYTTAI 193
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 95.1 bits (236), Expect = 1e-23
Identities = 62/186 (33%), Positives = 96/186 (51%), Gaps = 11/186 (5%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYI---ERGDKIDENVQREIINHRSLRHP 77
+++E++ +G G +GV R K+T+E+VA+K E +++ E RE+ R+L+
Sbjct: 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQE 60
Query: 78 NIVRFKEVILTPTHLAIVMEYASGG--ELFERICNAGRFSEDEARFFFQQLISGVSYCHS 135
NIV KE L +V EY EL E + N ++ R + QLI + +CH
Sbjct: 61 NIVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGV--PPEKVRSYIYQLIKAIHWCHK 118
Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVLLKK 193
+ HRD+K EN L+ S LK+CDFG++++ S T V T Y +PE+LL
Sbjct: 119 NDIVHRDIKPENLLI--SHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGA 176
Query: 194 EYDGKV 199
Y V
Sbjct: 177 PYGKAV 182
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 94.1 bits (234), Expect = 1e-23
Identities = 64/185 (34%), Positives = 91/185 (49%), Gaps = 12/185 (6%)
Query: 22 RYELVRDIGSGNFG-VARLMR--DKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPN 78
+++++ +G G++G V ++ R D + L V K E+ EI S+ HPN
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGR----FSEDEARFFFQQLISGVSYCH 134
I+ +KE L L IVMEYA G+L + I + E E F QL+ G+ H
Sbjct: 61 IISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH 120
Query: 135 SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-PKSTVGTPAYIAPEVLLKK 193
++ HRDLK N LL +KI D G SK VL K+ +GTP Y+APEV +
Sbjct: 121 EQKILHRDLKSANILL--VANDLVKIGDLGISK--VLKKNMAKTQIGTPHYMAPEVWKGR 176
Query: 194 EYDGK 198
Y K
Sbjct: 177 PYSYK 181
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 94.1 bits (235), Expect = 1e-23
Identities = 51/187 (27%), Positives = 75/187 (40%), Gaps = 19/187 (10%)
Query: 29 IGSGNFGV---ARLMRDKKTEELVAVKYIERGDKIDENVQ--REIINHRSLRHPNIVRFK 83
+G G FG +L VAVK ++ +E +E + L HPN+VR
Sbjct: 3 LGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLL 62
Query: 84 EVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLIS-------GVSYCH 134
V L +V+EY GG+L + R S +++ + L+S G+ Y
Sbjct: 63 GVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLA 122
Query: 135 SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI---APEVLL 191
S + HRDL N L+ +KI DFG S+ + G I APE L
Sbjct: 123 SKKFVHRDLAARNCLVGED--LVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPESLK 180
Query: 192 KKEYDGK 198
+ K
Sbjct: 181 DGIFTSK 187
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 94.9 bits (236), Expect = 2e-23
Identities = 62/200 (31%), Positives = 98/200 (49%), Gaps = 27/200 (13%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDEN------VQREIINHRSL 74
+ +E ++ I +G +G L+R K+T + A+K I + + I N V+R+I+
Sbjct: 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAE- 59
Query: 75 RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCH 134
+P +V T HL +VMEY GG+ + N G D AR +F + + + Y H
Sbjct: 60 -NPFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLH 118
Query: 135 SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS----------------QPKST 178
+ + HRDLK +N L+ + +K+ DFG SK ++ K
Sbjct: 119 NYGIVHRDLKPDNLLI--TSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQV 176
Query: 179 VGTPAYIAPEVLLKKEYDGK 198
GTP YIAPEV+L++ Y GK
Sbjct: 177 CGTPEYIAPEVILRQGY-GK 195
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 93.7 bits (233), Expect = 2e-23
Identities = 57/178 (32%), Positives = 93/178 (52%), Gaps = 13/178 (7%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI---DENVQREIINHRSLRHP 77
D +E++ ++G G FG + K+T A K I+ + D V+ +I++ +HP
Sbjct: 5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILS--ECKHP 62
Query: 78 NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR-FSEDEARFFFQQLISGVSYCHSM 136
NIV E L I++E+ GG L + R +E + R+ +Q++ +++ HS
Sbjct: 63 NIVGLYEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSH 122
Query: 137 QVCHRDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLL 191
+V HRDLK N LL DG +K+ DFG S + Q + T +GTP ++APEV+
Sbjct: 123 KVIHRDLKAGNILLTLDGD----VKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVA 176
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 93.5 bits (233), Expect = 3e-23
Identities = 61/195 (31%), Positives = 91/195 (46%), Gaps = 20/195 (10%)
Query: 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKY-IERGDKIDE-NVQREIINHRSLR-HPNI 79
Y+++ IG G F + +KT + A+K + +++ N REI R L HPNI
Sbjct: 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNI 60
Query: 80 VRFKEVILTPTH--LAIVMEYASGGELFERICNAGR-FSEDEARFFFQQLISGVSYCHSM 136
+R EV+ LA+V E L+E I R E + + QL+ + + H
Sbjct: 61 LRLIEVLFDRKTGRLALVFELMDM-NLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRN 119
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVLLKKE 194
+ HRD+K EN L+ LK+ DFG + ++S+P T + T Y APE LL
Sbjct: 120 GIFHRDIKPENILIKDD---ILKLADFGSCRG--IYSKPPYTEYISTRWYRAPECLLTDG 174
Query: 195 YDGKVM------CVY 203
Y G M CV+
Sbjct: 175 YYGPKMDIWAVGCVF 189
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 94.5 bits (235), Expect = 4e-23
Identities = 58/188 (30%), Positives = 99/188 (52%), Gaps = 17/188 (9%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDEN------VQREIINHRS 73
++ +++++ IG G FG +L+R K ++++ A+K + + + I + +R+I+ H +
Sbjct: 42 AEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHAN 101
Query: 74 LRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYC 133
IV+ +L +VMEY GG+L + N E ARF+ +++ +
Sbjct: 102 --SEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSNY-DIPEKWARFYTAEVVLALDAI 158
Query: 134 HSMQVCHRDLKLENTLLDGSPAPRLKICDFG----YSKSSVLHSQPKSTVGTPAYIAPEV 189
HSM HRD+K +N LLD S LK+ DFG + ++ + VGTP YI+PEV
Sbjct: 159 HSMGFIHRDVKPDNMLLDKS--GHLKLADFGTCMKMDANGMVRCD--TAVGTPDYISPEV 214
Query: 190 LLKKEYDG 197
L + DG
Sbjct: 215 LKSQGGDG 222
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 92.6 bits (230), Expect = 5e-23
Identities = 57/181 (31%), Positives = 93/181 (51%), Gaps = 17/181 (9%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIE-------RGDKIDENVQREIINHRSLRHPNIVR 81
+G+G F RD KT L+AVK + +++ E +++EI L HP+I+R
Sbjct: 8 LGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIR 67
Query: 82 FKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHR 141
+H + +E+ +GG + + G F E + +QL+ G+SY H Q+ HR
Sbjct: 68 MLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHR 127
Query: 142 DLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-------VGTPAYIAPEVLLKKE 194
D+K N L+D S RL+I DFG ++ L ++ +GT A++APEVL ++
Sbjct: 128 DVKGANLLID-STGQRLRIADFG--AAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQ 184
Query: 195 Y 195
Y
Sbjct: 185 Y 185
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 92.3 bits (229), Expect = 6e-23
Identities = 65/188 (34%), Positives = 92/188 (48%), Gaps = 14/188 (7%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKT---EELVAVKYIERGD-KIDENVQREIINH--RSLR 75
RY L + +G G+FG L++DKK E L +K I G+ +E VQ L
Sbjct: 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLD 60
Query: 76 HPNIVRFKEVILTPTHLAIVMEYASGGELFERI----CNAGRFSEDEARFFFQQLISGVS 131
HP IV+F L I+ EY G +L ++ SE++ +F QL+ GV
Sbjct: 61 HPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVH 120
Query: 132 YCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVL 190
Y H ++ HRDLK +N L + LKI DFG S+ + +T GTP Y++PE L
Sbjct: 121 YMHQRRILHRDLKAKNIFLKNN---LLKIGDFGVSRLLMGSCDLATTFTGTPYYMSPEAL 177
Query: 191 LKKEYDGK 198
+ YD K
Sbjct: 178 KHQGYDSK 185
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 92.2 bits (229), Expect = 6e-23
Identities = 59/185 (31%), Positives = 94/185 (50%), Gaps = 14/185 (7%)
Query: 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINH----RSLRHPN 78
+E++ IG G+FGV + K + + A+K I+ K++ + E I+ L
Sbjct: 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDL-SKMNRREREEAIDEARVLAKLDSSY 60
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFERI--CNAGRFSEDEARFFFQQLISGVSYCHSM 136
I+R+ E L L IVMEYA G+L + + ED+ FF Q++ G+++ HS
Sbjct: 61 IIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSK 120
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKK 193
++ HRD+K N LD +KI D G +K +L + VGTP Y++PE+ K
Sbjct: 121 KILHRDIKSLNLFLDAY--DNVKIGDLGVAK--LLSDNTNFANTIVGTPYYLSPELCEDK 176
Query: 194 EYDGK 198
Y+ K
Sbjct: 177 PYNEK 181
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 92.4 bits (229), Expect = 7e-23
Identities = 62/170 (36%), Positives = 92/170 (54%), Gaps = 6/170 (3%)
Query: 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYI--ERGDKIDENVQREIINHRSLRHPNIV 80
YEL++ +GSG +G R+ T EL AVK I E GD +Q+EI + +H NIV
Sbjct: 11 YELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSL-IQQEIFMVKECKHCNIV 69
Query: 81 RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCH 140
+ L+ L I MEY GG L + G SE + + ++ + G++Y HS H
Sbjct: 70 AYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMH 129
Query: 141 RDLKLENTLLDGSPAPRLKICDFGY-SKSSVLHSQPKSTVGTPAYIAPEV 189
RD+K N LL + +K+ DFG +K + ++ KS +GTP ++APEV
Sbjct: 130 RDIKGANILL--TDNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEV 177
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 93.3 bits (232), Expect = 8e-23
Identities = 56/189 (29%), Positives = 98/189 (51%), Gaps = 13/189 (6%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENV------QREIINHRSL 74
+++ +G G+FG +++R+K T ++ A+K +++ + + +R+I++ +
Sbjct: 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISN- 59
Query: 75 RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYC 133
P I + + +L +VMEY GG+L + +F ED A+F+ +L+ +
Sbjct: 60 -SPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSV 118
Query: 134 HSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK--SSVLHSQPKSTVGTPAYIAPEVLL 191
H M HRD+K EN L+D + +K+ DFG + ++ K VGTP YIAPEVL
Sbjct: 119 HQMGYVHRDIKPENVLIDRT--GHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLT 176
Query: 192 KKEYDGKVM 200
DGK
Sbjct: 177 TMNGDGKGT 185
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 91.8 bits (229), Expect = 8e-23
Identities = 54/185 (29%), Positives = 78/185 (42%), Gaps = 18/185 (9%)
Query: 24 ELVRDIGSGNFGV---ARL-MRDKKTEELVAVKYIERG--DKIDENVQREIINHRSLRHP 77
EL + +G G FG L + TE VAVK ++ G ++ E E + L HP
Sbjct: 2 ELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHP 61
Query: 78 NIVRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHS 135
NIVR V L IV EY GG+L F R + + + + Q+ G+ Y S
Sbjct: 62 NIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRK-HGEKLTLKDLLQMALQIAKGMEYLES 120
Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI-----APEVL 190
HRDL N L+ + +KI DFG S+ ++ + APE L
Sbjct: 121 KNFVHRDLAARNCLVTEN--LVVKISDFGLSR--DIYEDDYYRKRGGGKLPIKWMAPESL 176
Query: 191 LKKEY 195
++
Sbjct: 177 KDGKF 181
|
Length = 258 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 91.6 bits (228), Expect = 1e-22
Identities = 63/193 (32%), Positives = 87/193 (45%), Gaps = 19/193 (9%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQ---REIINHRSLRHP 77
D YEL+ IG G V E VA+K I+ +K +V +E+ HP
Sbjct: 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDL-EKCQTSVDELRKEVQAMSQCNHP 59
Query: 78 NIVRFKEVILTPTHLAIVMEYASGGELFE---RICNAGRFSEDEARFFFQQLISGVSYCH 134
N+V++ + L +VM Y SGG L + G E ++++ G+ Y H
Sbjct: 60 NVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLH 119
Query: 135 SMQVCHRDLKLENTLL--DGSPAPRLKICDFGYSKS-----SVLHSQPKSTVGTPAYIAP 187
S HRD+K N LL DGS +KI DFG S S K+ VGTP ++AP
Sbjct: 120 SNGQIHRDIKAGNILLGEDGS----VKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAP 175
Query: 188 EVL-LKKEYDGKV 199
EV+ YD K
Sbjct: 176 EVMEQVHGYDFKA 188
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 91.9 bits (228), Expect = 1e-22
Identities = 61/182 (33%), Positives = 91/182 (50%), Gaps = 9/182 (4%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK-IDENVQREIINHRSLRHPNIV 80
+Y IG G G D T + VA+K + + E + EI+ R +HPNIV
Sbjct: 20 KYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIV 79
Query: 81 RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCH 140
+ + L L +VMEY +GG L + + E + ++ + + + HS QV H
Sbjct: 80 NYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQALEFLHSNQVIH 138
Query: 141 RDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKEYDG 197
RD+K +N LL DGS +K+ DFG+ +ST VGTP ++APEV+ +K Y
Sbjct: 139 RDIKSDNILLGMDGS----VKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGP 194
Query: 198 KV 199
KV
Sbjct: 195 KV 196
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 92.2 bits (229), Expect = 2e-22
Identities = 54/177 (30%), Positives = 97/177 (54%), Gaps = 13/177 (7%)
Query: 29 IGSGNFGVARLMRDKKTEE---LVAVKYIERG-----DKIDENVQREIINHRSLRHPNIV 80
+G G+FG L+R + L A+K +++ D++ ++R+I+ + HP IV
Sbjct: 4 LGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAE--VNHPFIV 61
Query: 81 RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCH 140
+ T L +++++ GG+LF R+ F+E++ +F+ +L + + HS+ + +
Sbjct: 62 KLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIY 121
Query: 141 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKSTVGTPAYIAPEVLLKKEYD 196
RDLK EN LLD +K+ DFG SK S+ H + S GT Y+APEV+ ++ +
Sbjct: 122 RDLKPENILLDEE--GHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHT 176
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 92.8 bits (231), Expect = 2e-22
Identities = 60/222 (27%), Positives = 96/222 (43%), Gaps = 53/222 (23%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINH-RSLR---- 75
D +E ++ IG G FG RL++ K T + A+K + + + + ++E + H R+ R
Sbjct: 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEML----EKEQVAHVRAERDILA 56
Query: 76 ---HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 132
+P +V+ +L ++MEY GG++ + F+E+E RF+ + I +
Sbjct: 57 EADNPWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDS 116
Query: 133 CHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK---------------------SSVL 171
H + HRD+K +N LLD +K+ DFG
Sbjct: 117 IHKLGYIHRDIKPDNLLLDAK--GHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDF 174
Query: 172 HSQPK------------------STVGTPAYIAPEVLLKKEY 195
S+P STVGTP YIAPEV L+ Y
Sbjct: 175 ISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGY 216
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 91.7 bits (228), Expect = 2e-22
Identities = 58/206 (28%), Positives = 93/206 (45%), Gaps = 34/206 (16%)
Query: 10 PGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQ---- 65
+ P + +YE + IG G FG R KKT+++VA+K + + EN +
Sbjct: 1 DQYEFPFCDEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKV-----LMENEKEGFP 55
Query: 66 ----REIINHRSLRHPNIVRFKEVILTPT--------HLAIVMEYASGGELFERICNAG- 112
REI + L+H N+V E+ T +V E+ +L + N
Sbjct: 56 ITALREIKILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCE-HDLAGLLSNKNV 114
Query: 113 RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLL--DGSPAPRLKICDFGYSKSSV 170
+F+ E + + L++G+ Y H ++ HRD+K N L+ DG LK+ DFG +++
Sbjct: 115 KFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGI----LKLADFGLARAFS 170
Query: 171 LHSQPKST-----VGTPAYIAPEVLL 191
L K V T Y PE+LL
Sbjct: 171 LSKNSKPNRYTNRVVTLWYRPPELLL 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 91.4 bits (227), Expect = 4e-22
Identities = 57/179 (31%), Positives = 91/179 (50%), Gaps = 8/179 (4%)
Query: 27 RDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDEN----VQREI-INHRSLRHPNIVR 81
R IG G++ L+ KKT + A+K I++ D+ VQ E + + HP +V
Sbjct: 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVG 60
Query: 82 FKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHR 141
T + L V+E+ SGG+L + + E+ ARF+ ++ +++ H + +R
Sbjct: 61 LHSCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYR 120
Query: 142 DLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKEYDGKV 199
DLKL+N LLD +K+ D+G K + ST GTP YIAPE+L ++Y V
Sbjct: 121 DLKLDNVLLDAE--GHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILRGEDYGFSV 177
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 90.1 bits (223), Expect = 6e-22
Identities = 59/174 (33%), Positives = 94/174 (54%), Gaps = 8/174 (4%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIERGDKIDE--NVQREIINHRSLRHPNIVRFKEVI 86
IG G+FG D +T+++VA+K I+ + DE ++Q+EI P + ++
Sbjct: 12 IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 71
Query: 87 LTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLE 146
L T L I+MEY GG + + AG F E + ++++ G+ Y HS + HRD+K
Sbjct: 72 LKGTKLWIIMEYLGGGSALD-LLRAGPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAA 130
Query: 147 NTLLDGSPAPRLKICDFGYSKSSVLHSQPK--STVGTPAYIAPEVLLKKEYDGK 198
N LL S +K+ DFG + + +Q K + VGTP ++APEV+ + YD K
Sbjct: 131 NVLL--SEQGDVKLADFGVA-GQLTDTQIKRNTFVGTPFWMAPEVIQQSAYDSK 181
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 92.1 bits (228), Expect = 8e-22
Identities = 75/223 (33%), Positives = 107/223 (47%), Gaps = 38/223 (17%)
Query: 14 MPIMHDS-----DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIE-RGDKIDENVQR- 66
MP +D + YE+++ IG+G FG L++ K+T+E K I RG K E Q
Sbjct: 1 MPGKYDDGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLV 60
Query: 67 -EIINHRSLRHPNIVRFKEVILTPTH--LAIVMEYASGGELFERICNA----GRFSEDEA 119
E+ R L+H NIVR+ + L + L I+ME+ G+L I G+ E
Sbjct: 61 IEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAI 120
Query: 120 RFFFQQLISGVSYCHSMQ-------VCHRDLKLENTLLDG---------------SPAPR 157
+QL+ ++YCH+++ V HRDLK +N L + P
Sbjct: 121 VDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPI 180
Query: 158 LKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL--KKEYDGK 198
KI DFG SK+ + S S VGTP Y +PE+LL K YD K
Sbjct: 181 AKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDK 223
|
Length = 1021 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.1 bits (221), Expect = 9e-22
Identities = 54/179 (30%), Positives = 89/179 (49%), Gaps = 16/179 (8%)
Query: 26 VRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLR--------HP 77
++ I G FG L + + T + A+K +++ D I +N ++ N ++ R P
Sbjct: 1 LKPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKN---QVTNVKAERAIMMIQGESP 57
Query: 78 NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ 137
+ + + +L +VMEY +GG+ I G ED A+ + +++ GV H
Sbjct: 58 YVAKLYYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRG 117
Query: 138 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYD 196
+ HRD+K EN L+D LK+ DFG S++ + K VGTP Y+APE +L D
Sbjct: 118 IIHRDIKPENLLIDQ--TGHLKLTDFGLSRNGLE---NKKFVGTPDYLAPETILGVGDD 171
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 90.4 bits (224), Expect = 1e-21
Identities = 57/176 (32%), Positives = 92/176 (52%), Gaps = 13/176 (7%)
Query: 23 YELVRDIGSGNFGVARLMRDKKTE-ELVAVKYIERGDKIDEN------VQREIINHRSLR 75
+ +R +G+G+FG L K + VA+K E+ I + +R+I+N+ +
Sbjct: 32 FNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNY--IN 89
Query: 76 HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 135
HP V ++L +V+E+ GGE F + RF D F+ Q++ Y S
Sbjct: 90 HPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQS 149
Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL 191
+ + +RDLK EN LLD +K+ DFG++K V+ ++ + GTP YIAPE+LL
Sbjct: 150 LNIVYRDLKPENLLLDKDGF--IKMTDFGFAK--VVDTRTYTLCGTPEYIAPEILL 201
|
Length = 340 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 89.5 bits (222), Expect = 1e-21
Identities = 53/180 (29%), Positives = 94/180 (52%), Gaps = 15/180 (8%)
Query: 23 YELVRDIGSGNFGVARLMRD---KKTEELVAVKYIERGD-----KIDENV--QREIINHR 72
+EL+R +G+G +G L+R +L A+K +++ K E+ +R+++
Sbjct: 2 FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAV 61
Query: 73 SLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 132
R P +V T T L ++++Y +GGELF + F+E E R + +++ + +
Sbjct: 62 R-RCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDH 120
Query: 133 CHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK--STVGTPAYIAPEVL 190
H + + +RD+KLEN LLD + + DFG SK + + + S GT Y+APEV+
Sbjct: 121 LHQLGIIYRDIKLENILLDSE--GHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVI 178
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 89.4 bits (221), Expect = 2e-21
Identities = 62/183 (33%), Positives = 95/183 (51%), Gaps = 16/183 (8%)
Query: 26 VRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINH----RSLRHPNIVR 81
+R+IG G+FG RD +T E+VA+K + K ++II + ++HPN +
Sbjct: 30 LREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIE 89
Query: 82 FKEVILTPTHLAIVMEY--ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVC 139
+K L +VMEY S +L E + E E + G++Y HS +
Sbjct: 90 YKGCYLREHTAWLVMEYCLGSASDLLE--VHKKPLQEVEIAAITHGALQGLAYLHSHNMI 147
Query: 140 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL---KKEYD 196
HRD+K N LL + ++K+ DFG S+ + S S VGTP ++APEV+L + +YD
Sbjct: 148 HRDIKAGNILL--TEPGQVKLADFG---SASIASPANSFVGTPYWMAPEVILAMDEGQYD 202
Query: 197 GKV 199
GKV
Sbjct: 203 GKV 205
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 89.0 bits (221), Expect = 2e-21
Identities = 57/176 (32%), Positives = 90/176 (51%), Gaps = 10/176 (5%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVK-YIERGDK--IDENVQREIINHRSLRHP 77
++YE + IG G++GV R+++T ++VA+K ++E D I + REI + L+HP
Sbjct: 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHP 60
Query: 78 NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ 137
N+V EV L +V EY L E N E + Q + V++CH
Sbjct: 61 NLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHN 120
Query: 138 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS---TVGTPAYIAPEVL 190
HRD+K EN L+ + ++K+CDFG+++ +L V T Y APE+L
Sbjct: 121 CIHRDVKPENILI--TKQGQIKLCDFGFAR--ILTGPGDDYTDYVATRWYRAPELL 172
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 88.7 bits (220), Expect = 2e-21
Identities = 57/176 (32%), Positives = 82/176 (46%), Gaps = 12/176 (6%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIE------RGDKIDENVQREIINHRSLRHPNIVRF 82
+G G FG + K T ++ A K ++ R + +++I+ S R IV
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRF--IVSL 58
Query: 83 KEVILTPTHLAIVMEYASGGELFERICNAGR--FSEDEARFFFQQLISGVSYCHSMQVCH 140
T L +VM +GG+L I N G F E A F+ Q+I G+ + H ++ +
Sbjct: 59 AYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVY 118
Query: 141 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYD 196
RDLK EN LLD R I D G + + K GTP Y+APEVL + YD
Sbjct: 119 RDLKPENVLLDDHGNVR--ISDLGLAVELKGGKKIKGRAGTPGYMAPEVLQGEVYD 172
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 88.4 bits (219), Expect = 2e-21
Identities = 52/167 (31%), Positives = 86/167 (51%), Gaps = 6/167 (3%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYI-ERGDKIDENVQREIINHRSLRHPNIVRFKEVIL 87
+G G +G+ RD T+ +A+K I ER + + + EI H L+H NIV++
Sbjct: 16 LGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDS 75
Query: 88 TPTHLAIVMEYASGGEL---FERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLK 144
I ME GG L + +E F+ +Q++ G+ Y H Q+ HRD+K
Sbjct: 76 ENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIK 135
Query: 145 LENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKSTVGTPAYIAPEVL 190
+N L++ + + +KI DFG SK + ++ ++ GT Y+APEV+
Sbjct: 136 GDNVLVN-TYSGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPEVI 181
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 89.5 bits (222), Expect = 3e-21
Identities = 60/181 (33%), Positives = 89/181 (49%), Gaps = 13/181 (7%)
Query: 24 ELVRDIGSGNFGVARLMRDKKTEELVAVK--YIERGDKIDENVQREIINHRSLRHPNIVR 81
E V IGSG G + + T L A+K Y D + + REI R + HPN+V+
Sbjct: 77 ERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVK 136
Query: 82 FKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHR 141
++ + +++E+ GG L +F D AR Q++SG++Y H + HR
Sbjct: 137 CHDMFDHNGEIQVLLEFMDGGSLEGTHIADEQFLADVAR----QILSGIAYLHRRHIVHR 192
Query: 142 DLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP-KSTVGTPAYIAPEV----LLKKEYD 196
D+K N L++ A +KI DFG S+ P S+VGT AY++PE L YD
Sbjct: 193 DIKPSNLLINS--AKNVKIADFGVSRILAQTMDPCNSSVGTIAYMSPERINTDLNHGAYD 250
Query: 197 G 197
G
Sbjct: 251 G 251
|
Length = 353 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 89.0 bits (220), Expect = 3e-21
Identities = 61/183 (33%), Positives = 93/183 (50%), Gaps = 16/183 (8%)
Query: 26 VRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINH----RSLRHPNIVR 81
+R+IG G+FG RD + E+VA+K + K ++II + LRHPN ++
Sbjct: 20 LREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQ 79
Query: 82 FKEVILTPTHLAIVMEY--ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVC 139
++ L +VMEY S +L E + E E + G++Y HS +
Sbjct: 80 YRGCYLREHTAWLVMEYCLGSASDLLE--VHKKPLQEVEIAAVTHGALQGLAYLHSHNMI 137
Query: 140 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL---KKEYD 196
HRD+K N LL S +K+ DFG S+ + + VGTP ++APEV+L + +YD
Sbjct: 138 HRDVKAGNILL--SEPGLVKLGDFG---SASIMAPANXFVGTPYWMAPEVILAMDEGQYD 192
Query: 197 GKV 199
GKV
Sbjct: 193 GKV 195
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 88.3 bits (219), Expect = 3e-21
Identities = 55/176 (31%), Positives = 88/176 (50%), Gaps = 11/176 (6%)
Query: 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYI----ERGDKIDENVQREIINHRSLRHPN 78
++ + +G G + R++ T E+VA+K I E G REI + L+H N
Sbjct: 2 FKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTP--STAIREISLMKELKHEN 59
Query: 79 IVRFKEVILTPTHLAIVMEYASGG--ELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
IVR +VI T L +V EY + + G + + F QL+ G+++CH
Sbjct: 60 IVRLHDVIHTENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN 119
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKSTVGTPAYIAPEVLL 191
+V HRDLK +N L++ LK+ DFG +++ + + + V T Y AP+VLL
Sbjct: 120 RVLHRDLKPQNLLINKR--GELKLADFGLARAFGIPVNTFSNEVVTLWYRAPDVLL 173
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 9e-21
Identities = 56/175 (32%), Positives = 92/175 (52%), Gaps = 8/175 (4%)
Query: 27 RDIGSGNFGVARLMRDKKTEELVAVKYIER-----GDKIDENVQREIINHRSLRHPNIVR 81
R IG G++ L+R KKTE + A+K +++ + ID + + ++ HP +V
Sbjct: 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 60
Query: 82 FKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHR 141
T + L V+EY +GG+L + + E+ ARF+ ++ ++Y H + +R
Sbjct: 61 LHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYR 120
Query: 142 DLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKEY 195
DLKL+N LLD +K+ D+G K + ST GTP YIAPE+L ++Y
Sbjct: 121 DLKLDNVLLDSE--GHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDY 173
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 86.7 bits (214), Expect = 1e-20
Identities = 57/174 (32%), Positives = 91/174 (52%), Gaps = 8/174 (4%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIERGDKIDE--NVQREIINHRSLRHPNIVRFKEVI 86
IG G+FG D +T+++VA+K I+ + DE ++Q+EI P + ++
Sbjct: 12 IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 71
Query: 87 LTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLE 146
L T L I+MEY GG + + G E + ++++ G+ Y HS + HRD+K
Sbjct: 72 LKDTKLWIIMEYLGGGSALD-LLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIKAA 130
Query: 147 NTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVLLKKEYDGK 198
N LL S +K+ DFG + + +Q K VGTP ++APEV+ + YD K
Sbjct: 131 NVLL--SEHGEVKLADFGVA-GQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSK 181
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 87.4 bits (216), Expect = 1e-20
Identities = 53/175 (30%), Positives = 93/175 (53%), Gaps = 8/175 (4%)
Query: 27 RDIGSGNFGVARLMRDKKTEELVAVKYIER-----GDKIDENVQREIINHRSLRHPNIVR 81
R IG G++ L+R KK +++ A+K +++ + ID + + ++ +P +V
Sbjct: 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVG 60
Query: 82 FKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHR 141
T + L +V+EY +GG+L + + E+ ARF+ ++ +++ H + +R
Sbjct: 61 LHSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYR 120
Query: 142 DLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKEY 195
DLKL+N LLD +K+ D+G K + ST GTP YIAPE+L +EY
Sbjct: 121 DLKLDNVLLDAD--GHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEY 173
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 86.3 bits (214), Expect = 1e-20
Identities = 58/181 (32%), Positives = 94/181 (51%), Gaps = 20/181 (11%)
Query: 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQ----REIINHRSLRHPN 78
Y + IG G +GV R+KKT ++VA+K I R + +E V REI + L+HPN
Sbjct: 2 YTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKI-RLESEEEGVPSTAIREISLLKELQHPN 60
Query: 79 IVRFKEVILTPTHLAIVMEYASGG--ELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
IV ++V++ + L ++ E+ S + + + + + + Q++ G+ +CHS
Sbjct: 61 IVCLQDVLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSR 120
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKS------SVLHSQPKSTVGTPAYIAPEVL 190
+V HRDLK +N L+D +K+ DFG +++ H V T Y APEVL
Sbjct: 121 RVLHRDLKPQNLLIDNKGV--IKLADFGLARAFGIPVRVYTHE-----VVTLWYRAPEVL 173
Query: 191 L 191
L
Sbjct: 174 L 174
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 86.4 bits (214), Expect = 2e-20
Identities = 57/185 (30%), Positives = 96/185 (51%), Gaps = 11/185 (5%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---IDENVQREIINHRSLRH 76
++RY ++ +G G FG+ RD+ T + VA+K I + + + RE+ + LRH
Sbjct: 9 TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRH 68
Query: 77 PNIVRFKEVILTP-THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 135
NI+ ++ ++P + V E G R+ + + ++F Q++ G+ Y HS
Sbjct: 69 ENIISLSDIFISPLEDIYFVTELL--GTDLHRLLTSRPLEKQFIQYFLYQILRGLKYVHS 126
Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLK-KE 194
V HRDLK N L++ + LKICDFG ++ + Q V T Y APE++L ++
Sbjct: 127 AGVVHRDLKPSNILINEN--CDLKICDFGLAR--IQDPQMTGYVSTRYYRAPEIMLTWQK 182
Query: 195 YDGKV 199
YD +V
Sbjct: 183 YDVEV 187
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 85.9 bits (213), Expect = 3e-20
Identities = 55/184 (29%), Positives = 85/184 (46%), Gaps = 13/184 (7%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER--GDKIDENVQREIINHRSLRHPN 78
++ + +G G G R K T + A+K I + + + RE+ ++S + P
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPY 60
Query: 79 IVRFKEVILTP--THLAIVMEYASGGELFERI-----CNAGRFSEDEARFFFQQLISGVS 131
IV++ L + + I MEY GG L + I GR E + ++ G+S
Sbjct: 61 IVKYYGAFLDESSSSIGIAMEYCEGGSL-DSIYKKVKKRGGRIGEKVLGKIAESVLKGLS 119
Query: 132 YCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL 191
Y HS ++ HRD+K N LL +K+CDFG S V S + GT Y+APE +
Sbjct: 120 YLHSRKIIHRDIKPSNILLTRKGQ--VKLCDFGVSGELVN-SLAGTFTGTSFYMAPERIQ 176
Query: 192 KKEY 195
K Y
Sbjct: 177 GKPY 180
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 3e-20
Identities = 58/190 (30%), Positives = 100/190 (52%), Gaps = 15/190 (7%)
Query: 23 YELVRDIGSGNFGVARLMRD---KKTEELVAVKYIERG-----DKIDENV--QREIINHR 72
+EL++ +G+G +G L+R T +L A+K +++ K E+ +R ++ H
Sbjct: 2 FELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHV 61
Query: 73 SLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 132
+ P +V T L ++++Y SGGE+F + FSEDE RF+ ++I + +
Sbjct: 62 R-QSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEH 120
Query: 133 CHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK--STVGTPAYIAPEVL 190
H + + +RD+KLEN LLD + + DFG SK + + + S GT Y+APE++
Sbjct: 121 LHKLGIVYRDIKLENILLDSE--GHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEII 178
Query: 191 LKKEYDGKVM 200
K GK +
Sbjct: 179 RGKGGHGKAV 188
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 85.5 bits (211), Expect = 4e-20
Identities = 57/175 (32%), Positives = 97/175 (55%), Gaps = 9/175 (5%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIE-RGDKIDENVQREIINHRSLRHPNIVRFKEVIL 87
IG G+ G+ + R+K + VAVK ++ R + E + E++ R +H N+V + L
Sbjct: 29 IGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYL 88
Query: 88 TPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLEN 147
L ++ME+ GG L + I + R +E++ + ++ + Y HS V HRD+K ++
Sbjct: 89 VGEELWVLMEFLQGGALTD-IVSQTRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDS 147
Query: 148 TL--LDGSPAPRLKICDFGY-SKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKV 199
L LDG R+K+ DFG+ ++ S + KS VGTP ++APEV+ + Y +V
Sbjct: 148 ILLTLDG----RVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRTPYGTEV 198
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 85.5 bits (211), Expect = 4e-20
Identities = 62/183 (33%), Positives = 94/183 (51%), Gaps = 16/183 (8%)
Query: 26 VRDIGSGNFGVARLMRDKKTEELVAVKYIE-RGDKIDENVQ---REIINHRSLRHPNIVR 81
+ +IG G+FG + T E+VAVK + G + +E Q +E+ + L+HPN +
Sbjct: 26 LHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIE 85
Query: 82 FKEVILTPTHLAIVMEY--ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVC 139
+K L +VMEY S +L E + E E + G++Y HS +
Sbjct: 86 YKGCYLKEHTAWLVMEYCLGSASDLLE--VHKKPLQEVEIAAITHGALQGLAYLHSHNMI 143
Query: 140 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL---KKEYD 196
HRD+K N LL + ++K+ DFG S+ S S VGTP ++APEV+L + +YD
Sbjct: 144 HRDIKAGNILL--TEPGQVKLADFG---SASKSSPANSFVGTPYWMAPEVILAMDEGQYD 198
Query: 197 GKV 199
GKV
Sbjct: 199 GKV 201
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 5e-20
Identities = 59/173 (34%), Positives = 89/173 (51%), Gaps = 6/173 (3%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIERGDKIDE--NVQREIINHRSLRHPNIVRFKEVI 86
IG G+FG D +T+E+VA+K I+ + DE ++Q+EI P I R+
Sbjct: 12 IGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSY 71
Query: 87 LTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLE 146
L T L I+MEY GG + + G E ++++ G+ Y HS + HRD+K
Sbjct: 72 LKGTKLWIIMEYLGGGSALD-LLKPGPLEETYIATILREILKGLDYLHSERKIHRDIKAA 130
Query: 147 NTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKEYDGK 198
N LL S +K+ DFG + ++T VGTP ++APEV+ + YD K
Sbjct: 131 NVLL--SEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDFK 181
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 85.5 bits (212), Expect = 6e-20
Identities = 63/180 (35%), Positives = 95/180 (52%), Gaps = 14/180 (7%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG--DKID-ENVQREIINHRSLRHPN 78
+Y ++ IG G +G+ ++ +T E VA+K I ++ID + REI R L H N
Sbjct: 6 KYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHEN 65
Query: 79 IVRFKEVILTPTH------LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 132
++ K+ I+ P H + IV E +L + I ++ S+D ++F QL+ G+ Y
Sbjct: 66 VIAIKD-IMPPPHREAFNDVYIVYELMDT-DLHQIIRSSQTLSDDHCQYFLYQLLRGLKY 123
Query: 133 CHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK-SSVLHSQPKSTVGTPAYIAPEVLL 191
HS V HRDLK N LL+ + LKICDFG ++ +S V T Y APE+LL
Sbjct: 124 IHSANVLHRDLKPSNLLLNAN--CDLKICDFGLARTTSEKGDFMTEYVVTRWYRAPELLL 181
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 6e-20
Identities = 60/183 (32%), Positives = 90/183 (49%), Gaps = 21/183 (11%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQ------REIINHRSLR 75
RY++ IG G++GV D T E VA+K I + + E+V REI R LR
Sbjct: 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKI---NDVFEHVSDATRILREIKLLRLLR 57
Query: 76 HPNIVRFKEVILTPTH-----LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGV 130
HP+IV K ++L P+ + +V E +L + I + + +FF QL+ +
Sbjct: 58 HPDIVEIKHIMLPPSRREFKDIYVVFELM-ESDLHQVIKANDDLTPEHHQFFLYQLLRAL 116
Query: 131 SYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK----STVGTPAYIA 186
Y H+ V HRDLK +N L + +LKICDFG ++ + + V T Y A
Sbjct: 117 KYIHTANVFHRDLKPKNILANAD--CKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRA 174
Query: 187 PEV 189
PE+
Sbjct: 175 PEL 177
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 84.4 bits (208), Expect = 1e-19
Identities = 60/182 (32%), Positives = 91/182 (50%), Gaps = 9/182 (4%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIE-RGDKIDENVQREIINHRSLRHPNIV 80
+Y IG G G D T + VA+K + + E + EI+ R ++PNIV
Sbjct: 20 KYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIV 79
Query: 81 RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCH 140
+ + L L +VMEY +GG L + + E + ++ + + + HS QV H
Sbjct: 80 NYLDSYLVGDELWVVMEYLAGGSLTDVVTETC-MDEGQIAAVCRECLQALDFLHSNQVIH 138
Query: 141 RDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKEYDG 197
RD+K +N LL DGS +K+ DFG+ +ST VGTP ++APEV+ +K Y
Sbjct: 139 RDIKSDNILLGMDGS----VKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGP 194
Query: 198 KV 199
KV
Sbjct: 195 KV 196
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 84.1 bits (208), Expect = 1e-19
Identities = 67/194 (34%), Positives = 93/194 (47%), Gaps = 27/194 (13%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQ----REIINHRSLRH 76
D+++++ IG G +G RDK T ELVA+K + R D E REI R L H
Sbjct: 7 DKFDIIGQIGEGTYGQVYKARDKDTGELVALKKV-RLDNEKEGFPITAIREIKILRQLNH 65
Query: 77 PNIVRFKEVILTPTHLA-----------IVMEYASG---GELFERICNAGRFSEDEARFF 122
NIV KE I+T A +V EY G L + + FSED + F
Sbjct: 66 RNIVNLKE-IVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVH---FSEDHIKSF 121
Query: 123 FQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VG 180
+QL+ G++YCH HRD+K N LL+ ++K+ DFG ++ T V
Sbjct: 122 MKQLLEGLNYCHKKNFLHRDIKCSNILLNNK--GQIKLADFGLARLYNSEESRPYTNKVI 179
Query: 181 TPAYIAPEVLLKKE 194
T Y PE+LL +E
Sbjct: 180 TLWYRPPELLLGEE 193
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 1e-19
Identities = 56/186 (30%), Positives = 96/186 (51%), Gaps = 13/186 (6%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSL----R 75
++ Y++V+ IG G FG +L+R K ++++ A+K + + + I + R +
Sbjct: 42 AEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFAN 101
Query: 76 HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 135
P +V+ +L +VMEY GG+L + N E A+F+ +++ + HS
Sbjct: 102 SPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYD-VPEKWAKFYTAEVVLALDAIHS 160
Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFG----YSKSSVLHSQPKSTVGTPAYIAPEVLL 191
M + HRD+K +N LLD LK+ DFG ++ ++ + VGTP YI+PEVL
Sbjct: 161 MGLIHRDVKPDNMLLD--KHGHLKLADFGTCMKMDETGMVRCD--TAVGTPDYISPEVLK 216
Query: 192 KKEYDG 197
+ DG
Sbjct: 217 SQGGDG 222
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 84.0 bits (207), Expect = 1e-19
Identities = 63/184 (34%), Positives = 94/184 (51%), Gaps = 13/184 (7%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIE-RGDKIDENVQREIINHRSLRHPNIV 80
+Y IG G G D T + VA+K I + E + EI+ + L++PNIV
Sbjct: 20 KYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIV 79
Query: 81 RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARF--FFQQLISGVSYCHSMQV 138
F + L L +VMEY +GG L + + DEA+ ++ + + + H+ QV
Sbjct: 80 NFLDSFLVGDELFVVMEYLAGGSLTDVVTET---CMDEAQIAAVCRECLQALEFLHANQV 136
Query: 139 CHRDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKEY 195
HRD+K +N LL DGS +K+ DFG+ +ST VGTP ++APEV+ +K Y
Sbjct: 137 IHRDIKSDNVLLGMDGS----VKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAY 192
Query: 196 DGKV 199
KV
Sbjct: 193 GPKV 196
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 84.5 bits (210), Expect = 1e-19
Identities = 60/195 (30%), Positives = 89/195 (45%), Gaps = 32/195 (16%)
Query: 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI-D--ENVQ------REI 68
H +YE+++ +G G +G+ D++T+E+VA+K KI D N REI
Sbjct: 4 HILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALK------KIFDAFRNATDAQRTFREI 57
Query: 69 INHRSLR-HPNIVRFKEVILTPTHLAIVMEYASGGELFE----RICNAGRFSEDEARFFF 123
+ + L HPNIV+ VI I + + E E + A + R+
Sbjct: 58 MFLQELGDHPNIVKLLNVIKAENDKDIYLVF----EYMETDLHAVIRANILEDVHKRYIM 113
Query: 124 QQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST----- 178
QL+ + Y HS V HRDLK N LL+ R+K+ DFG ++S +
Sbjct: 114 YQLLKALKYIHSGNVIHRDLKPSNILLNS--DCRVKLADFGLARSLSELEENPENPVLTD 171
Query: 179 -VGTPAYIAPEVLLK 192
V T Y APE+LL
Sbjct: 172 YVATRWYRAPEILLG 186
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 83.2 bits (206), Expect = 2e-19
Identities = 59/194 (30%), Positives = 103/194 (53%), Gaps = 16/194 (8%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVK-YIERGDKIDENVQ----REIINHRSLR 75
++YE + +G G++G+ + K+T ++VA+K ++E D D+ V+ REI + LR
Sbjct: 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESED--DKMVKKIAMREIRMLKQLR 58
Query: 76 HPNIVRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYC 133
H N+V EV L +V E+ L E+ N E R + Q++ G+ +C
Sbjct: 59 HENLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNG--LDESRVRKYLFQILRGIEFC 116
Query: 134 HSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVLL 191
HS + HRD+K EN L+ S + +K+CDFG+++ ++ T V T Y APE+L+
Sbjct: 117 HSHNIIHRDIKPENILV--SQSGVVKLCDFGFAR-TLAAPGEVYTDYVATRWYRAPELLV 173
Query: 192 KKEYDGKVMCVYVI 205
G+ + ++ +
Sbjct: 174 GDTKYGRAVDIWAV 187
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 83.2 bits (206), Expect = 2e-19
Identities = 47/152 (30%), Positives = 73/152 (48%), Gaps = 11/152 (7%)
Query: 25 LVRDIGSGNFGVARLMR----DKKTEELVAVKYIER--GDKIDENVQREIINHRSLRHPN 78
++ +G G+FG L R T E VAVK + ++ + +REI R+L H N
Sbjct: 8 FIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHEN 67
Query: 79 IVRFKEVILTPTH--LAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHS 135
IV++K V P L ++MEY G L + + + + + F Q+ G+ Y S
Sbjct: 68 IVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGS 127
Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 167
+ HRDL N L++ +KI DFG +K
Sbjct: 128 QRYIHRDLAARNILVESE--DLVKISDFGLAK 157
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 3e-19
Identities = 61/186 (32%), Positives = 95/186 (51%), Gaps = 13/186 (6%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSL----R 75
++ YE+V+ IG G FG +L+R K T ++ A+K + + + I + R +
Sbjct: 42 AEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFAN 101
Query: 76 HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 135
P +V+ +L +VMEY GG+L + N E ARF+ +++ + HS
Sbjct: 102 SPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYD-VPEKWARFYTAEVVLALDAIHS 160
Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFG----YSKSSVLHSQPKSTVGTPAYIAPEVLL 191
M HRD+K +N LLD S LK+ DFG +K ++ + VGTP YI+PEVL
Sbjct: 161 MGFIHRDVKPDNMLLDKS--GHLKLADFGTCMKMNKEGMVRCD--TAVGTPDYISPEVLK 216
Query: 192 KKEYDG 197
+ DG
Sbjct: 217 SQGGDG 222
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 82.5 bits (203), Expect = 5e-19
Identities = 58/182 (31%), Positives = 94/182 (51%), Gaps = 9/182 (4%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIE-RGDKIDENVQREIINHRSLRHPNIV 80
+Y IG G G D T + VA++ + + E + EI+ R ++PNIV
Sbjct: 21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIV 80
Query: 81 RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCH 140
+ + L L +VMEY +GG L + + E + ++ + + + HS QV H
Sbjct: 81 NYLDSYLVGDELWVVMEYLAGGSLTDVVTETC-MDEGQIAAVCRECLQALEFLHSNQVIH 139
Query: 141 RDLKLENTLL--DGSPAPRLKICDFGY-SKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDG 197
RD+K +N LL DGS +K+ DFG+ ++ + S+ + VGTP ++APEV+ +K Y
Sbjct: 140 RDIKSDNILLGMDGS----VKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGP 195
Query: 198 KV 199
KV
Sbjct: 196 KV 197
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.7 bits (205), Expect = 6e-19
Identities = 57/187 (30%), Positives = 82/187 (43%), Gaps = 14/187 (7%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK--IDENVQREIINHRSLRHP 77
RY+ + IG G +G+ K T VA+K I + + REI R +H
Sbjct: 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHE 63
Query: 78 NIVRFKEVILTPTHLAIVMEYASGGELFE----RICNAGRFSEDEARFFFQQLISGVSYC 133
NI+ + I+ P + EL E ++ S D ++F Q++ G+ Y
Sbjct: 64 NIIGILD-IIRPPSFESFNDVYIVQELMETDLYKLIKTQHLSNDHIQYFLYQILRGLKYI 122
Query: 134 HSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST----VGTPAYIAPEV 189
HS V HRDLK N LL+ LKICDFG ++ + V T Y APE+
Sbjct: 123 HSANVLHRDLKPSNLLLNT--NCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEI 180
Query: 190 LLK-KEY 195
+L K Y
Sbjct: 181 MLNSKGY 187
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 8e-19
Identities = 56/177 (31%), Positives = 94/177 (53%), Gaps = 9/177 (5%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID-ENVQREIINHRSLRHPN 78
++ +E++ ++G G FG ++K+T L A K IE + + E+ EI + HP
Sbjct: 11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPY 70
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGR-FSEDEARFFFQQLISGVSYCHSMQ 137
IV+ L I++E+ GG + + R +E + + +Q++ + Y HSM+
Sbjct: 71 IVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMK 130
Query: 138 VCHRDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQPK-STVGTPAYIAPEVLL 191
+ HRDLK N LL DG +K+ DFG S +V Q + S +GTP ++APEV++
Sbjct: 131 IIHRDLKAGNVLLTLDGD----IKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVM 183
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 9e-19
Identities = 60/194 (30%), Positives = 89/194 (45%), Gaps = 20/194 (10%)
Query: 23 YELVRDIGSGNFG-VARLMRDKKTEELVAVKYI------------ERGDKIDENVQREII 69
Y ++ +GSG FG V ++ + + L+A+K I ER I + V I
Sbjct: 2 YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTI 61
Query: 70 NHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICN----AGRFSEDEARFFFQQ 125
LRHPNIVR+ + L L IVM+ G L E + RF+E+ F Q
Sbjct: 62 IKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQ 121
Query: 126 LISGVSYCH-SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAY 184
++ + Y H ++ HRDL N +L ++ I DFG +K S+ S VGT Y
Sbjct: 122 MVLALRYLHKEKRIVHRDLTPNNIML--GEDDKVTITDFGLAKQKQPESKLTSVVGTILY 179
Query: 185 IAPEVLLKKEYDGK 198
PE++ + Y K
Sbjct: 180 SCPEIVKNEPYGEK 193
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 82.5 bits (204), Expect = 1e-18
Identities = 61/223 (27%), Positives = 91/223 (40%), Gaps = 54/223 (24%)
Query: 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDEN------VQREIINHRSLRH 76
+ ++ IG G FG L+R T L A+K + + D + N +R+I+ +
Sbjct: 3 FVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEAD--N 60
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
+V+ +L VM+Y GG++ + G F ED ARF+ +L + H M
Sbjct: 61 EWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKM 120
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFG-------------YSK---------------S 168
HRD+K +N L+D +K+ DFG Y K S
Sbjct: 121 GFIHRDIKPDNILIDRD--GHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWS 178
Query: 169 SVLHSQPK----------------STVGTPAYIAPEVLLKKEY 195
+ + K S VGTP YIAPEVLL+ Y
Sbjct: 179 EIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGY 221
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 1e-18
Identities = 55/176 (31%), Positives = 95/176 (53%), Gaps = 9/176 (5%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIE-RGDKIDENVQREIINHRSLRHPNI 79
+ +E++ ++G G FG ++K+T L A K I+ + ++ E+ EI S HPNI
Sbjct: 5 EFWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNI 64
Query: 80 VRFKEVILTPTHLAIVMEYASGGELFERICNAGR-FSEDEARFFFQQLISGVSYCHSMQV 138
V+ + +L I++E+ +GG + + R +E + R +Q + ++Y H ++
Sbjct: 65 VKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKI 124
Query: 139 CHRDLKLENTL--LDGSPAPRLKICDFGYSKSSVLHSQPK-STVGTPAYIAPEVLL 191
HRDLK N L LDG +K+ DFG S + Q + S +GTP ++APEV++
Sbjct: 125 IHRDLKAGNILFTLDGD----IKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVM 176
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 2e-18
Identities = 56/189 (29%), Positives = 97/189 (51%), Gaps = 14/189 (7%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSL-RHPN 78
+D +E++ IG G +G + +KK L AVK ++ +DE ++ E +SL HPN
Sbjct: 21 TDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPN 80
Query: 79 IVRFKEVILTPTHLA-----IVMEYASGG---ELFERICNAG-RFSEDEARFFFQQLISG 129
+V+F + L +V+E +GG EL + + G R E + + G
Sbjct: 81 VVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLG 140
Query: 130 VSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKSTVGTPAYIAPE 188
+ + H+ ++ HRD+K N LL +K+ DFG S + + ++VGTP ++APE
Sbjct: 141 LQHLHNNRIIHRDVKGNNILLTTEGG--VKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPE 198
Query: 189 VL-LKKEYD 196
V+ +++YD
Sbjct: 199 VIACEQQYD 207
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 2e-18
Identities = 54/175 (30%), Positives = 86/175 (49%), Gaps = 15/175 (8%)
Query: 29 IGSGNFG---VARLMRDKKTEELVAVKYIERG-------DKIDENVQREIINHRSLRHPN 78
+G G +G R + T ++ A+K +++ D +R I+ +++HP
Sbjct: 4 LGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNIL--EAVKHPF 61
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQV 138
IV T L +++EY SGGELF + G F ED A F+ ++ + + H +
Sbjct: 62 IVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGI 121
Query: 139 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLK 192
+RDLK EN LLD +K+ DFG K S+ T GT Y+APE+L++
Sbjct: 122 IYRDLKPENILLDAQ--GHVKLTDFGLCKESIHEGTVTHTFCGTIEYMAPEILMR 174
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 80.0 bits (197), Expect = 3e-18
Identities = 56/184 (30%), Positives = 89/184 (48%), Gaps = 17/184 (9%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIE-------RGDKIDENVQREIINHRSLRHPNIVR 81
+G G +G +L+AVK +E +K E +Q E+ +SL+H NIV+
Sbjct: 8 LGKGAYGTVYCGL-TNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQ 66
Query: 82 FKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHR 141
+ L ++I ME+ GG + + G E + +Q++ GV+Y H+ V HR
Sbjct: 67 YLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHR 126
Query: 142 DLKLENTLLDGSPAPRLKICDFGYSKS------SVLHSQP-KSTVGTPAYIAPEVLLKKE 194
D+K N +L P +K+ DFG ++ HS KS GTP ++APEV+ +
Sbjct: 127 DIKGNNVML--MPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESG 184
Query: 195 YDGK 198
Y K
Sbjct: 185 YGRK 188
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 3e-18
Identities = 60/182 (32%), Positives = 94/182 (51%), Gaps = 14/182 (7%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYI------ERGDKIDENVQREIINHRSLRHPNIVRF 82
+G G FG L D T +AVK + + K ++ EI ++LRH IV++
Sbjct: 10 LGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQY 69
Query: 83 KEVILTPTH--LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCH 140
+ P L+I +EY GG + +++ G +E+ R + +Q++ GVSY HS + H
Sbjct: 70 YGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVH 129
Query: 141 RDLKLENTLLDGSPAPRLKICDFGYSK--SSVLHSQP--KSTVGTPAYIAPEVLLKKEYD 196
RD+K N L D A +K+ DFG SK ++ S KS GTP +++PEV+ + Y
Sbjct: 130 RDIKGANILRDS--AGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYG 187
Query: 197 GK 198
K
Sbjct: 188 RK 189
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 80.0 bits (197), Expect = 4e-18
Identities = 48/180 (26%), Positives = 94/180 (52%), Gaps = 15/180 (8%)
Query: 23 YELVRDIGSGNFGVARLMRD---KKTEELVAVKYIERGDKIDE-------NVQREIINHR 72
+EL++ +G+G +G L+R + +L A+K +++ + + +R+++ H
Sbjct: 2 FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHI 61
Query: 73 SLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 132
+ P +V T T L ++++Y +GGELF + RF E E + + +++ + +
Sbjct: 62 R-QSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEH 120
Query: 133 CHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK--STVGTPAYIAPEVL 190
H + + +RD+KLEN LLD + + + DFG SK + S GT Y+AP+++
Sbjct: 121 LHKLGIIYRDIKLENILLDSN--GHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIV 178
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 4e-18
Identities = 51/191 (26%), Positives = 91/191 (47%), Gaps = 19/191 (9%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID----ENVQREIINHRSLRH 76
+++ + IG G F V +VA+K ++ + +D ++ +EI + L H
Sbjct: 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDH 61
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR----FSEDEARFFFQQLISGVSY 132
PN++++ + L IV+E A G+L I + + E +F QL S + +
Sbjct: 62 PNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEH 121
Query: 133 CHSMQVCHRDLKLENTLLDGSPAPRLKICDFGY-----SKSSVLHSQPKSTVGTPAYIAP 187
HS ++ HRD+K N + + +K+ D G SK++ HS VGTP Y++P
Sbjct: 122 MHSKRIMHRDIKPANVFITATGV--VKLGDLGLGRFFSSKTTAAHSL----VGTPYYMSP 175
Query: 188 EVLLKKEYDGK 198
E + + Y+ K
Sbjct: 176 ERIHENGYNFK 186
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.6 bits (197), Expect = 7e-18
Identities = 54/190 (28%), Positives = 83/190 (43%), Gaps = 22/190 (11%)
Query: 22 RYELVRDIGSGNFGVARLMRDK--KTEELVAVKYIE----RGDKIDENVQREIINHRSLR 75
+YE+ IG G +G + K K + A+K + + I ++ REI R L+
Sbjct: 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELK 60
Query: 76 HPNIVRFKEVILTPTHLAIVM--EYASGGEL----FERICNAGRFSEDEARFFFQQLISG 129
H N+V EV L ++ + +YA F R + Q+++G
Sbjct: 61 HENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNG 120
Query: 130 VSYCHSMQVCHRDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQPKS------TVGT 181
V Y HS V HRDLK N L+ +G +KI D G ++ + ++ K V T
Sbjct: 121 VHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLAR--LFNAPLKPLADLDPVVVT 178
Query: 182 PAYIAPEVLL 191
Y APE+LL
Sbjct: 179 IWYRAPELLL 188
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 7e-18
Identities = 58/196 (29%), Positives = 97/196 (49%), Gaps = 20/196 (10%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLR-HPN 78
SD +E++ IG G +G + +KK AVK ++ IDE ++ E ++L HPN
Sbjct: 17 SDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPN 76
Query: 79 IVRF-----KEVILTPTHLAIVMEYASGG---ELFERICNAG-RFSEDEARFFFQQLISG 129
+V+F K+ + L +V+E +GG +L + G R E + + + G
Sbjct: 77 VVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMG 136
Query: 130 VSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK--SSVLHSQPKSTVGTPAYIAP 187
+ + H + HRD+K N LL + +K+ DFG S +S + ++VGTP ++AP
Sbjct: 137 LQHLHVNKTIHRDVKGNNILL--TTEGGVKLVDFGVSAQLTSTRLRR-NTSVGTPFWMAP 193
Query: 188 EVL-----LKKEYDGK 198
EV+ L YD +
Sbjct: 194 EVIACEQQLDSTYDAR 209
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 1e-17
Identities = 57/167 (34%), Positives = 87/167 (52%), Gaps = 7/167 (4%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYI--ERGDKIDENVQREIINHRSLRHPNIVRFKEVI 86
+G G + R K TE LVA+K I E + RE+ ++L+H NIV ++I
Sbjct: 13 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDII 72
Query: 87 LTPTHLAIVMEYASGGELFERICNAGRF-SEDEARFFFQQLISGVSYCHSMQVCHRDLKL 145
T L +V EY +L + + N G S + F QL+ G+SYCH ++ HRDLK
Sbjct: 73 HTERCLTLVFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKP 131
Query: 146 ENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLL 191
+N L++ LK+ DFG +++ + ++ S V T Y P+VLL
Sbjct: 132 QNLLINEK--GELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLL 176
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 78.2 bits (192), Expect = 1e-17
Identities = 58/188 (30%), Positives = 95/188 (50%), Gaps = 14/188 (7%)
Query: 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQR------EIINHRSLRH 76
+ L + +G G FG L D T +AVK ++ + E + EI ++L H
Sbjct: 4 WRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLH 63
Query: 77 PNIVRFKEVILTPTH--LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCH 134
IV++ + P L+I ME+ GG + +++ + G +E+ R + +Q++ GVSY H
Sbjct: 64 ERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLH 123
Query: 135 SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS----SVLHSQPKSTVGTPAYIAPEVL 190
S + HRD+K N L D +K+ DFG SK + + KS GTP +++PEV+
Sbjct: 124 SNMIVHRDIKGANILRDS--VGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVI 181
Query: 191 LKKEYDGK 198
+ Y K
Sbjct: 182 SGEGYGRK 189
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 2e-17
Identities = 58/175 (33%), Positives = 94/175 (53%), Gaps = 9/175 (5%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIE-RGDKIDENVQREIINHRSLRHPNIVRFKEVIL 87
IG G+ G+ + +K T + VAVK ++ R + E + E++ R H N+V L
Sbjct: 30 IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYL 89
Query: 88 TPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLEN 147
L +VME+ GG L + I R +E++ ++ +SY H+ V HRD+K ++
Sbjct: 90 VGDELWVVMEFLEGGALTD-IVTHTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDS 148
Query: 148 TLL--DGSPAPRLKICDFGY-SKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKV 199
LL DG R+K+ DFG+ ++ S + KS VGTP ++APEV+ + Y +V
Sbjct: 149 ILLTSDG----RIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISRLPYGTEV 199
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 2e-17
Identities = 62/191 (32%), Positives = 84/191 (43%), Gaps = 22/191 (11%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID-ENVQREIINHRSLRHPN 78
RY +R +G G+ G+ D ++ VAVK I D ++ REI R L H N
Sbjct: 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDN 63
Query: 79 IVRFKEVILT-----------PTHLA---IVMEYASGGELFERICNAGRFSEDEARFFFQ 124
IV+ EV+ T L IV EY + G SE+ AR F
Sbjct: 64 IVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETD--LANVLEQGPLSEEHARLFMY 121
Query: 125 QLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS----TVG 180
QL+ G+ Y HS V HRDLK N ++ + LKI DFG ++ H K +
Sbjct: 122 QLLRGLKYIHSANVLHRDLKPANVFIN-TEDLVLKIGDFGLARIVDPHYSHKGYLSEGLV 180
Query: 181 TPAYIAPEVLL 191
T Y +P +LL
Sbjct: 181 TKWYRSPRLLL 191
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 77.8 bits (192), Expect = 3e-17
Identities = 54/183 (29%), Positives = 84/183 (45%), Gaps = 19/183 (10%)
Query: 24 ELVRDIGSGNFG--VARLMRDKKTEELVAVKYIERGDKIDENV---QREIINHRSLRHPN 78
EL+ IG + L + K T LVAVK I E++ Q+EII R L+HPN
Sbjct: 1 ELLTLIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPN 60
Query: 79 IVRFKEVILTPTHLAIV---MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 135
I+ + + + L +V M Y S +L + G E F + +++ + Y HS
Sbjct: 61 ILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEG-LPELAIAFILKDVLNALDYIHS 119
Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYS--------KSSVLHSQPKSTVGTPAYIAP 187
HR +K + LL G ++ + YS + V+H PKS+V +++P
Sbjct: 120 KGFIHRSVKASHILLSGD--GKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSP 177
Query: 188 EVL 190
EVL
Sbjct: 178 EVL 180
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 76.4 bits (189), Expect = 6e-17
Identities = 36/121 (29%), Positives = 60/121 (49%), Gaps = 4/121 (3%)
Query: 76 HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 135
+PN ++ + T ++M+Y G+LF+ + G+ SE E + +QL+ ++ H
Sbjct: 68 NPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHK 127
Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEY 195
+ H D+KLEN L D + R+ +CD+G K P GT Y +PE + Y
Sbjct: 128 HNIIHNDIKLENVLYDRA-KDRIYLCDYGLCKII---GTPSCYDGTLDYFSPEKIKGHNY 183
Query: 196 D 196
D
Sbjct: 184 D 184
|
Length = 267 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.5 bits (186), Expect = 1e-16
Identities = 60/177 (33%), Positives = 90/177 (50%), Gaps = 11/177 (6%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYI----ERGDKIDENVQREIINHRSLRH 76
+ Y+ + +G G++ R K T +LVA+K I E G RE + L+H
Sbjct: 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPF--TAIREASLLKDLKH 62
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRF-SEDEARFFFQQLISGVSYCHS 135
NIV ++I T L +V EY +L + + + G S R F QL+ G++YCH
Sbjct: 63 ANIVTLHDIIHTKKTLTLVFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQ 121
Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLL 191
+V HRDLK +N L+ S LK+ DFG +++ + S+ S V T Y P+VLL
Sbjct: 122 RRVLHRDLKPQNLLI--SERGELKLADFGLARAKSVPSKTYSNEVVTLWYRPPDVLL 176
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 75.9 bits (186), Expect = 1e-16
Identities = 61/196 (31%), Positives = 90/196 (45%), Gaps = 15/196 (7%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYI----ERGDKIDENVQREIINHRSLR 75
+D YE + +G G++ + K +LVA+K I E G RE + L+
Sbjct: 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPF--TAIREASLLKGLK 61
Query: 76 HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 135
H NIV ++I T L +V EY + G + + F QL+ G+SY H
Sbjct: 62 HANIVLLHDIIHTKETLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQ 121
Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLL-KK 193
+ HRDLK +N L+ S LK+ DFG +++ + S S V T Y P+VLL
Sbjct: 122 RYILHRDLKPQNLLI--SDTGELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVLLGST 179
Query: 194 EYDG-----KVMCVYV 204
EY V C++V
Sbjct: 180 EYSTCLDMWGVGCIFV 195
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 2e-16
Identities = 56/175 (32%), Positives = 94/175 (53%), Gaps = 9/175 (5%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIE-RGDKIDENVQREIINHRSLRHPNIVRFKEVIL 87
IG G+ G+ + K + +LVAVK ++ R + E + E++ R +H N+V L
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87
Query: 88 TPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLEN 147
L +VME+ GG L + I R +E++ ++ +S H+ V HRD+K ++
Sbjct: 88 VGDELWVVMEFLEGGALTD-IVTHTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDS 146
Query: 148 TLL--DGSPAPRLKICDFGY-SKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKV 199
LL DG R+K+ DFG+ ++ S + KS VGTP ++APE++ + Y +V
Sbjct: 147 ILLTHDG----RVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEV 197
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 2e-16
Identities = 55/175 (31%), Positives = 82/175 (46%), Gaps = 18/175 (10%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRH-------PNIVR 81
IG G FG R T ++ A+K +++ + + +N R + P IV
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 82 FKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHR 141
TP L +++ +GG+L + G FSE E RF+ ++I G+ + H+ V +R
Sbjct: 62 MTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYR 121
Query: 142 DLKLENTLLDGSPAPRLK----ICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLK 192
DLK N LLD R+ CDF K P ++VGT Y+APEVL K
Sbjct: 122 DLKPANILLDEHGHVRISDLGLACDFSKKK-------PHASVGTHGYMAPEVLQK 169
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 2e-16
Identities = 57/184 (30%), Positives = 93/184 (50%), Gaps = 8/184 (4%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYI--ERGDKIDENVQREIINHRSLRHPN 78
+ Y + +G G + R K TE LVA+K I E + RE+ + L+H N
Sbjct: 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHAN 65
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGR-FSEDEARFFFQQLISGVSYCHSMQ 137
IV +++ T L +V EY +L + + + G S + F Q++ G++YCH +
Sbjct: 66 IVTLHDIVHTDKSLTLVFEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRK 124
Query: 138 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLL-KKEY 195
V HRDLK +N L++ LK+ DFG +++ + ++ S V T Y P+VLL EY
Sbjct: 125 VLHRDLKPQNLLIN--ERGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSSEY 182
Query: 196 DGKV 199
++
Sbjct: 183 STQI 186
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 76.1 bits (187), Expect = 3e-16
Identities = 45/149 (30%), Positives = 76/149 (51%), Gaps = 6/149 (4%)
Query: 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSL----RHPN 78
+ +V+ I G FG L R K +L AVK +++ D I++N+ ++ R + P
Sbjct: 6 FVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPF 65
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQV 138
IV + + ++ +VMEY GG++ + G F E+ A + ++ + Y H +
Sbjct: 66 IVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGI 125
Query: 139 CHRDLKLENTLLDGSPAPRLKICDFGYSK 167
HRDLK +N L+ S +K+ DFG SK
Sbjct: 126 IHRDLKPDNMLI--SNEGHIKLTDFGLSK 152
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 75.4 bits (186), Expect = 3e-16
Identities = 55/188 (29%), Positives = 83/188 (44%), Gaps = 31/188 (16%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLR----- 75
DRY+ + +GSG +G D KT VA+K K+ Q I R+ R
Sbjct: 15 DRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIK------KLSRPFQSAIHAKRTYRELRLL 68
Query: 76 ----HPNIVRFKEVILTPTHLA------IVMEYASGGELFERICNAGRFSEDEARFFFQQ 125
H N++ +V + L +V G +L I + S+D +F Q
Sbjct: 69 KHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLM-GADL-NNIVKCQKLSDDHIQFLVYQ 126
Query: 126 LISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPA 183
++ G+ Y HS + HRDLK N ++ LKI DFG ++ H+ + T V T
Sbjct: 127 ILRGLKYIHSAGIIHRDLKPSNIAVNED--CELKILDFGLAR----HTDDEMTGYVATRW 180
Query: 184 YIAPEVLL 191
Y APE++L
Sbjct: 181 YRAPEIML 188
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 74.2 bits (182), Expect = 5e-16
Identities = 55/175 (31%), Positives = 83/175 (47%), Gaps = 18/175 (10%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRH-------PNIVR 81
IG G FG R T ++ A+K +++ + + +N R + P IV
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 82 FKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHR 141
TP L+ +++ +GG+L + G FSE E RF+ ++I G+ + H+ V +R
Sbjct: 62 MSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYR 121
Query: 142 DLKLENTLLDGSPAPRLK----ICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLK 192
DLK N LLD R+ CDF K P ++VGT Y+APEVL K
Sbjct: 122 DLKPANILLDEHGHVRISDLGLACDFSKKK-------PHASVGTHGYMAPEVLQK 169
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 7e-16
Identities = 53/216 (24%), Positives = 92/216 (42%), Gaps = 42/216 (19%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPN-- 78
D +E ++ IG G FG RL++ K T + A+K + + D +++ I R +
Sbjct: 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADG 60
Query: 79 --IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
+V+ +L ++ME+ GG++ + SE+ +F+ + + + H +
Sbjct: 61 AWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQL 120
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-----------SVLHSQPK--------- 176
HRD+K +N LLD +K+ DFG ++ H+ P
Sbjct: 121 GFIHRDIKPDNLLLDAK--GHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNS 178
Query: 177 ----------------STVGTPAYIAPEVLLKKEYD 196
STVGTP YIAPEV ++ Y+
Sbjct: 179 KRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYN 214
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 7e-16
Identities = 53/167 (31%), Positives = 86/167 (51%), Gaps = 7/167 (4%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYI--ERGDKIDENVQREIINHRSLRHPNIVRFKEVI 86
+G G + R K T+ LVA+K I E + RE+ + L+H NIV ++I
Sbjct: 14 LGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDII 73
Query: 87 LTPTHLAIVMEYASGGELFERICNAGR-FSEDEARFFFQQLISGVSYCHSMQVCHRDLKL 145
T L +V EY +L + + + G + + F QL+ G++YCH +V HRDLK
Sbjct: 74 HTEKSLTLVFEYLDK-DLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKP 132
Query: 146 ENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLL 191
+N L++ LK+ DFG +++ + ++ S V T Y P++LL
Sbjct: 133 QNLLINER--GELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDILL 177
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 74.0 bits (182), Expect = 8e-16
Identities = 62/195 (31%), Positives = 93/195 (47%), Gaps = 38/195 (19%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKT--EELVAVKYIERGDKIDENVQREIINHRSLR---- 75
RYEL++++G G +G+ R+ +T EE VA+K KI ++I+ R+LR
Sbjct: 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIK------KITNVFSKKILAKRALRELKL 54
Query: 76 ------HPNIVRFKEV-ILTPTHLAIVMEYASGGELFE----RICNAG-RFSEDEARFFF 123
H NI ++ I+ P + + Y EL E +I +G ++ + F
Sbjct: 55 LRHFRGHKNITCLYDMDIVFPGNFNELYLYE---ELMEADLHQIIRSGQPLTDAHFQSFI 111
Query: 124 QQLISGVSYCHSMQVCHRDLKLENTL--LDGSPAPRLKICDFGYSKS-SVLH--SQPKST 178
Q++ G+ Y HS V HRDLK N L D LKICDFG ++ S + T
Sbjct: 112 YQILCGLKYIHSANVLHRDLKPGNLLVNADC----ELKICDFGLARGFSENPGENAGFMT 167
Query: 179 --VGTPAYIAPEVLL 191
V T Y APE++L
Sbjct: 168 EYVATRWYRAPEIML 182
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 73.2 bits (179), Expect = 9e-16
Identities = 56/182 (30%), Positives = 90/182 (49%), Gaps = 14/182 (7%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQR------EIINHRSLRHPNIVRF 82
+G G FG L D T +A K ++ + E + EI ++L+H IV++
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQY 69
Query: 83 KEVILTPTH--LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCH 140
+ L I MEY GG + +++ G +E R + +Q++ G+SY HS + H
Sbjct: 70 YGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVH 129
Query: 141 RDLKLENTLLDGSPAPRLKICDFGYSK--SSVLHSQP--KSTVGTPAYIAPEVLLKKEYD 196
RD+K N L D A +K+ DFG SK ++ S +S GTP +++PEV+ + Y
Sbjct: 130 RDIKGANILRDS--AGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYG 187
Query: 197 GK 198
K
Sbjct: 188 RK 189
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 1e-15
Identities = 55/191 (28%), Positives = 91/191 (47%), Gaps = 24/191 (12%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDE------NVQREIINHRSL 74
D +E+++ IG G FG +++ K TE + A+K + + + + +R ++ +
Sbjct: 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDC 60
Query: 75 RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYC 133
+ I +L +VM+Y GG+L + R ED ARF+ +++ +
Sbjct: 61 QW--ITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSI 118
Query: 134 HSMQVCHRDLKLENTLLDGSPAPR-------LKICDFGYSKSSVLHSQPKSTVGTPAYIA 186
H + HRD+K +N LLD + R LK+ G +SSV VGTP YI+
Sbjct: 119 HQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSV-------AVGTPDYIS 171
Query: 187 PEVLLKKEYDG 197
PE+L E DG
Sbjct: 172 PEILQAME-DG 181
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 2e-15
Identities = 62/187 (33%), Positives = 86/187 (45%), Gaps = 19/187 (10%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQ----REIINHRSLRH 76
D YE + IG G +G RDK T +LVA+K R + +E + REI + L
Sbjct: 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKT-RLEMDEEGIPPTALREISLLQMLSE 59
Query: 77 -PNIVRFKEVILTPTH-----LAIVMEYASGGELFERICNAGR-----FSEDEARFFFQQ 125
IVR +V L +V EY +L + + + GR + F Q
Sbjct: 60 SIYIVRLLDVEHVEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQ 118
Query: 126 LISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKSTVGTPAY 184
L+ GV++CH V HRDLK +N L+D LKI D G ++ S+ + T Y
Sbjct: 119 LLKGVAHCHKHGVMHRDLKPQNLLVDKQKG-LLKIADLGLGRAFSIPVKSYTHEIVTLWY 177
Query: 185 IAPEVLL 191
APEVLL
Sbjct: 178 RAPEVLL 184
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 2e-15
Identities = 54/195 (27%), Positives = 100/195 (51%), Gaps = 13/195 (6%)
Query: 11 GMDMPIMHD-SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREI- 68
+D+ + D + +ELV +G+G +G R KT +L A+K ++ + +E ++ EI
Sbjct: 5 DIDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEIN 64
Query: 69 INHRSLRHPNIVRFKEVILT---PTH---LAIVMEYASGGELFERICN--AGRFSEDEAR 120
+ + H NI + + P H L +VME+ G + + + N ED
Sbjct: 65 MLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIA 124
Query: 121 FFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-V 179
+ ++++ G+++ H+ +V HRD+K +N LL + +K+ DFG S ++T +
Sbjct: 125 YICREILRGLAHLHAHKVIHRDIKGQNVLL--TENAEVKLVDFGVSAQLDRTVGRRNTFI 182
Query: 180 GTPAYIAPEVLLKKE 194
GTP ++APEV+ E
Sbjct: 183 GTPYWMAPEVIACDE 197
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 2e-15
Identities = 58/191 (30%), Positives = 92/191 (48%), Gaps = 22/191 (11%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVK------YIERGDKIDENVQREIINHRSL 74
D +E+++ IG G FG +++ K T ++ A+K ++R + +R+++ +
Sbjct: 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDR 60
Query: 75 RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYC 133
R I +L +VM+Y GG+L + R ED ARF+ +++ +
Sbjct: 61 RW--ITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSV 118
Query: 134 HSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST------VGTPAYIAP 187
H + HRD+K +N LLD + RL DFG S L T VGTP YI+P
Sbjct: 119 HQLGYVHRDIKPDNVLLDKNGHIRL--ADFG----SCLRLLADGTVQSNVAVGTPDYISP 172
Query: 188 EVLLKKEYDGK 198
E+L E DGK
Sbjct: 173 EILQAME-DGK 182
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 2e-15
Identities = 56/189 (29%), Positives = 92/189 (48%), Gaps = 19/189 (10%)
Query: 23 YELVRDIGSGNFG---VARLMRDKKTEELVAVKYIERGD-KIDENVQREIINHRSLRHPN 78
+++ + IG G F A + D+K L V+ E D K ++ +EI + L HPN
Sbjct: 4 FQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPN 63
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGR----FSEDEARFFFQQLISGVSYCH 134
++++ + + L IV+E A G+L + I + E +F QL S V + H
Sbjct: 64 VIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMH 123
Query: 135 SMQVCHRDLKLENTLLDGSPAPRLKICDFGY-----SKSSVLHSQPKSTVGTPAYIAPEV 189
S +V HRD+K N + + +K+ D G SK++ H S VGTP Y++PE
Sbjct: 124 SRRVMHRDIKPANVFITATGV--VKLGDLGLGRFFSSKTTAAH----SLVGTPYYMSPER 177
Query: 190 LLKKEYDGK 198
+ + Y+ K
Sbjct: 178 IHENGYNFK 186
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 2e-15
Identities = 57/180 (31%), Positives = 87/180 (48%), Gaps = 11/180 (6%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIERGD-KIDENVQREIINHRSLRHPN---IVRFKE 84
+G G FG + + T +L A K + + K + + ++ R L + IV
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60
Query: 85 VILTPTHLAIVMEYASGGELFERICNAGR----FSEDEARFFFQQLISGVSYCHSMQVCH 140
T T L +VM +GG+L I N F E A F+ Q+ISG+ + H ++ +
Sbjct: 61 AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIY 120
Query: 141 RDLKLENTLLDGSPAPRLKICDFGYS-KSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKV 199
RDLK EN LLD ++I D G + + S+ K GTP ++APE+L +EYD V
Sbjct: 121 RDLKPENVLLDN--DGNVRISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQGEEYDFSV 178
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 4e-15
Identities = 53/187 (28%), Positives = 86/187 (45%), Gaps = 16/187 (8%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIE---RGDKIDENVQREIINHRSLR--- 75
+YE V +IG G +G RD + VA+K + D + + RE+ + L
Sbjct: 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFD 60
Query: 76 HPNIVRFKEVILT-----PTHLAIVMEYASGG--ELFERICNAGRFSEDEARFFFQQLIS 128
HPNIVR +V T T + +V E+ +++ G + + +Q +
Sbjct: 61 HPNIVRLMDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPG-LPAETIKDLMRQFLR 119
Query: 129 GVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPE 188
G+ + H+ + HRDLK EN L+ + ++K+ DFG ++ V T Y APE
Sbjct: 120 GLDFLHANCIVHRDLKPENILV--TSGGQVKLADFGLARIYSCQMALTPVVVTLWYRAPE 177
Query: 189 VLLKKEY 195
VLL+ Y
Sbjct: 178 VLLQSTY 184
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 5e-15
Identities = 55/196 (28%), Positives = 95/196 (48%), Gaps = 19/196 (9%)
Query: 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIE---RGDKIDENVQREIINHRSLRHPNI 79
Y VR +G G++G L+R + + +K + + + ++E L+HPNI
Sbjct: 2 YCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNI 61
Query: 80 VRFKEVIL-TPTHLAIVMEYASGGELFERIC-NAGRF-SEDEARFFFQQLISGVSYCHSM 136
V ++E L IVM + GG+L+ ++ G+ E++ +F Q+ + Y H
Sbjct: 62 VAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEK 121
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKK 193
+ HRDLK +N L + +K+ D G ++ VL +Q + +GTP Y++PE+ K
Sbjct: 122 HILHRDLKTQNVFLTRTNI--IKVGDLGIAR--VLENQCDMASTLIGTPYYMSPELFSNK 177
Query: 194 EYDGKV------MCVY 203
Y+ K CVY
Sbjct: 178 PYNYKSDVWALGCCVY 193
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 6e-15
Identities = 53/214 (24%), Positives = 92/214 (42%), Gaps = 42/214 (19%)
Query: 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPN---- 78
+E ++ IG G FG RL++ K T + A+K + + D +++ I R +
Sbjct: 3 FESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLW 62
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQV 138
+V+ +L ++ME+ GG++ + +E+E +F+ + + + H +
Sbjct: 63 VVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGF 122
Query: 139 CHRDLKLENTLLDGSPAPRLKICDFGYSKS-----------SVLHSQPK----------- 176
HRD+K +N LLD +K+ DFG ++ HS P
Sbjct: 123 IHRDIKPDNLLLDSK--GHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKR 180
Query: 177 --------------STVGTPAYIAPEVLLKKEYD 196
STVGTP YIAPEV ++ Y+
Sbjct: 181 KAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYN 214
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 7e-15
Identities = 53/167 (31%), Positives = 79/167 (47%), Gaps = 10/167 (5%)
Query: 40 MRDKKTEELVAVKYIERGDKIDENVQR-EIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98
R +E V K++ D+ R E+ + H IV+ + + L ++MEY
Sbjct: 87 TRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEY 146
Query: 99 ASGGELFERICNAGR----FSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSP 154
SGG+L ++I + F E E F Q++ + HS ++ HRDLK N L P
Sbjct: 147 GSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFL--MP 204
Query: 155 APRLKICDFGYSKS---SVLHSQPKSTVGTPAYIAPEVLLKKEYDGK 198
+K+ DFG+SK SV S GTP Y+APE+ +K Y K
Sbjct: 205 TGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKK 251
|
Length = 478 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 70.3 bits (172), Expect = 7e-15
Identities = 54/184 (29%), Positives = 83/184 (45%), Gaps = 20/184 (10%)
Query: 25 LVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKE 84
++++G+G FGV + + + + VA+K I+ G ++ E L H +V+
Sbjct: 8 FLKELGTGQFGVVKYGKWRGQYD-VAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYG 66
Query: 85 VILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLI-------SGVSYCHSMQ 137
V + IV EY S G C E RF QL+ G++Y S Q
Sbjct: 67 VCTKQRPIYIVTEYMSNG------CLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQ 120
Query: 138 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTP---AYIAPEVLLKKE 194
HRDL N L+D +K+ DFG S+ VL + S+VG+ + PEVLL +
Sbjct: 121 FIHRDLAARNCLVDDQGC--VKVSDFGLSR-YVLDDEYTSSVGSKFPVRWSPPEVLLYSK 177
Query: 195 YDGK 198
+ K
Sbjct: 178 FSSK 181
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 70.7 bits (173), Expect = 8e-15
Identities = 52/176 (29%), Positives = 84/176 (47%), Gaps = 14/176 (7%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIER-------GDKIDENVQREIINHRSLRHPNIVR 81
+G G FG ++ K T ++ A K +++ G+K+ +++EI+ + P IV
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKM-ALLEKEIL--EKVNSPFIVN 57
Query: 82 FKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR--FFFQQLISGVSYCHSMQVC 139
+ THL +VM +GG+L I N G + R + Q+ G+ + HSM +
Sbjct: 58 LAYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIV 117
Query: 140 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEY 195
+RD+K EN LLD RL D G + GT Y+APE+L ++ Y
Sbjct: 118 YRDMKPENVLLDDQGNCRLS--DLGLAVELKDGKTITQRAGTNGYMAPEILKEEPY 171
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 1e-14
Identities = 50/178 (28%), Positives = 90/178 (50%), Gaps = 12/178 (6%)
Query: 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREI-INHRSLRHPNIVR 81
+ELV +G+G +G R KT +L A+K ++ +E +++EI + + H NI
Sbjct: 8 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIAT 67
Query: 82 FKEVILTPT------HLAIVMEYASGGELFERICN--AGRFSEDEARFFFQQLISGVSYC 133
+ + L +VME+ G + + I N E+ + ++++ G+S+
Sbjct: 68 YYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHL 127
Query: 134 HSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVL 190
H +V HRD+K +N LL + +K+ DFG S ++T +GTP ++APEV+
Sbjct: 128 HQHKVIHRDIKGQNVLL--TENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVI 183
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 70.3 bits (172), Expect = 1e-14
Identities = 51/156 (32%), Positives = 79/156 (50%), Gaps = 12/156 (7%)
Query: 22 RY-ELVRDIGSGNFGVARLMR----DKKTEELVAVKYIER--GDKIDENVQREIINHRSL 74
RY + +R +G G+FG L + T E+VAVK ++R G + ++EI ++L
Sbjct: 4 RYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTL 63
Query: 75 RHPNIVRFKEVILTP--THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 132
H NIV++K L ++MEY G L + + + + + F QQ+ G++Y
Sbjct: 64 YHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYL-PKHKLNLAQLLLFAQQICEGMAY 122
Query: 133 CHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 168
HS HRDL N LLD +KI DFG +K+
Sbjct: 123 LHSQHYIHRDLAARNVLLDNDRL--VKIGDFGLAKA 156
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 3e-14
Identities = 51/185 (27%), Positives = 92/185 (49%), Gaps = 14/185 (7%)
Query: 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDE------NVQREIINHRSLRH 76
+E+++ IG G FG +++ K +++ A+K + + + + +R+++ + +
Sbjct: 3 FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQW 62
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHS 135
I +L +VM+Y GG+L + R ED ARF+ +++ + H
Sbjct: 63 --ITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQ 120
Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVLLKK 193
+ HRD+K +N L+D + RL DFG + +S+ VGTP YI+PE+L
Sbjct: 121 LHYVHRDIKPDNILMDMNGHIRL--ADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAM 178
Query: 194 EYDGK 198
E DGK
Sbjct: 179 E-DGK 182
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 3e-14
Identities = 53/150 (35%), Positives = 74/150 (49%), Gaps = 9/150 (6%)
Query: 47 ELVAVKYIERGDKIDENVQ----REIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGG 102
+LVA+K I K +E V RE + L+H NIV ++I T L V EY
Sbjct: 31 QLVALKVISM--KTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFEYMHTD 88
Query: 103 ELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICD 162
I + G R F QL+ G++Y H + HRDLK +N L+ S LK+ D
Sbjct: 89 LAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLI--SYLGELKLAD 146
Query: 163 FGYSKSSVLHSQPKST-VGTPAYIAPEVLL 191
FG +++ + SQ S+ V T Y P+VLL
Sbjct: 147 FGLARAKSIPSQTYSSEVVTLWYRPPDVLL 176
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 3e-14
Identities = 53/180 (29%), Positives = 90/180 (50%), Gaps = 10/180 (5%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRH---- 76
D +E + ++G+GN GV ++ K + ++A K I +I ++ +II + H
Sbjct: 5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHL--EIKPAIRNQIIRELQVLHECNS 62
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
P IV F + ++I ME+ GG L + + A R E+ ++ G++Y
Sbjct: 63 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREK 122
Query: 137 -QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEY 195
Q+ HRD+K N L++ +K+CDFG S ++ S S VGT +Y++PE L Y
Sbjct: 123 HQIMHRDVKPSNILVNSR--GEIKLCDFGVS-GQLIDSMANSFVGTRSYMSPERLQGTHY 179
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 3e-14
Identities = 54/183 (29%), Positives = 91/183 (49%), Gaps = 15/183 (8%)
Query: 26 VRDIGSGNFGVARLMR----DKKTEELVAVKYI--ERGDKIDENVQREIINHRSLRHPNI 79
+RD+G G+FG L R T E VAVK + E G ++++EI R+L H NI
Sbjct: 9 IRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENI 68
Query: 80 VRFKEVILTP--THLAIVMEYASGGELFERIC-NAGRFSEDEARFFFQQLISGVSYCHSM 136
V++K + + ++ME+ G L E + N + + + + Q+ G+ Y S
Sbjct: 69 VKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSR 128
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP---KSTVGTPAY-IAPEVLLK 192
Q HRDL N L++ ++KI DFG +K+ + K + +P + APE L++
Sbjct: 129 QYVHRDLAARNVLVESE--HQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQ 186
Query: 193 KEY 195
++
Sbjct: 187 SKF 189
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 3e-14
Identities = 54/180 (30%), Positives = 89/180 (49%), Gaps = 10/180 (5%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRH---- 76
D +E + ++G+GN GV + K + ++A K I +I ++ +II + H
Sbjct: 5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHL--EIKPAIRNQIIRELQVLHECNS 62
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
P IV F + ++I ME+ GG L + + AGR E +I G++Y
Sbjct: 63 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK 122
Query: 137 -QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEY 195
++ HRD+K N L++ +K+CDFG S ++ S S VGT +Y++PE L Y
Sbjct: 123 HKIMHRDVKPSNILVNSR--GEIKLCDFGVS-GQLIDSMANSFVGTRSYMSPERLQGTHY 179
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 68.2 bits (167), Expect = 5e-14
Identities = 53/175 (30%), Positives = 79/175 (45%), Gaps = 14/175 (8%)
Query: 29 IGSGNFGVARL--MRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVI 86
IG G FG L R +K VAVK ++ + E +LRHPN+V+ V+
Sbjct: 14 IGKGEFGDVMLGDYRGQK----VAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVV 69
Query: 87 LTPTHLAIVMEYASGGELFERICNAGR--FSEDEARFFFQQLISGVSYCHSMQVCHRDLK 144
L L IV EY + G L + + + GR + + F + G+ Y HRDL
Sbjct: 70 LQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLA 129
Query: 145 LENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA-YIAPEVLLKKEYDGK 198
N L+ K+ DFG +K + SQ + + P + APE L +K++ K
Sbjct: 130 ARNVLVSEDLVA--KVSDFGLAKEA---SQGQDSGKLPVKWTAPEALREKKFSTK 179
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 7e-14
Identities = 57/229 (24%), Positives = 97/229 (42%), Gaps = 58/229 (25%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD--KIDE----NVQREIINHRSL 74
+ + V+ IG G FG RL++ K T ++ A+K + + + K D+ +R+++
Sbjct: 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESD- 59
Query: 75 RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCH 134
P +V +L ++ME+ GG+L + FSED RF+ + + + H
Sbjct: 60 -SPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVH 118
Query: 135 SMQVCHRDLKLENTLLDGSPAPRLKICDFG-------------YSK-------------- 167
+ HRD+K +N L+D +K+ DFG Y K
Sbjct: 119 KLGFIHRDIKPDNILIDRGG--HIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNR 176
Query: 168 --------SSVLHSQPK-------------STVGTPAYIAPEVLLKKEY 195
+ + S+ + STVGTP YIAPE+ L++ Y
Sbjct: 177 NSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGY 225
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 7e-14
Identities = 58/225 (25%), Positives = 87/225 (38%), Gaps = 54/225 (24%)
Query: 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDEN------VQREIINHRSLRH 76
+ ++ +G G FG L R T+ L A+K + + D + N +R+I+ +
Sbjct: 3 FVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEAD--N 60
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
+VR +L VM+Y GG++ + G F ED ARF+ +L V H M
Sbjct: 61 EWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKM 120
Query: 137 QVCHRDLKLENTLLD--------------------------GSPAPRLKICDFGYS---- 166
HRD+K +N L+D R DF
Sbjct: 121 GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDP 180
Query: 167 --------------KSSVLHSQ--PKSTVGTPAYIAPEVLLKKEY 195
+++ H + S VGTP YIAPEVLL+ Y
Sbjct: 181 ANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGY 225
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 8e-14
Identities = 58/188 (30%), Positives = 88/188 (46%), Gaps = 17/188 (9%)
Query: 22 RYELVRDIGSGNFGVARLMRD-KKTEELVAVKYI-----ERGDKIDENVQREIINH-RSL 74
+YE V +IG G +G RD K VA+K + E G + + ++ H +
Sbjct: 2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETF 61
Query: 75 RHPNIVRFKEVILTP-----THLAIVMEYASGG--ELFERICNAGRFSEDEARFFFQQLI 127
HPN+VR +V T L +V E+ +++ G +E FQ L+
Sbjct: 62 EHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ-LL 120
Query: 128 SGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAP 187
G+ + HS +V HRDLK +N L+ S ++K+ DFG ++ S V T Y AP
Sbjct: 121 RGLDFLHSHRVVHRDLKPQNILVTSS--GQIKLADFGLARIYSFQMALTSVVVTLWYRAP 178
Query: 188 EVLLKKEY 195
EVLL+ Y
Sbjct: 179 EVLLQSSY 186
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 8e-14
Identities = 40/114 (35%), Positives = 65/114 (57%), Gaps = 9/114 (7%)
Query: 92 LAIVMEYASGGELFERICNAGR----FSEDEARFFFQQLISGVSYCHSMQVCHRDLKLEN 147
+A+V++YA+ G+L + I + + F E EA F Q++ V + HS + HRD+K N
Sbjct: 114 IALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSAN 173
Query: 148 TLLDGSPAPRLKICDFGYSK---SSVLHSQPKSTVGTPAYIAPEVLLKKEYDGK 198
LL + +K+ DFG+SK ++V ++ GTP Y+APE+ +K Y K
Sbjct: 174 ILLCSNGL--VKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKK 225
|
Length = 496 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 1e-13
Identities = 49/147 (33%), Positives = 73/147 (49%), Gaps = 10/147 (6%)
Query: 29 IGSGNFGVARLMR----DKKTEELVAVKYIERGDKID-ENVQREIINHRSLRHPNIVRFK 83
+G GNFG L R T E+VAVK ++ + +REI +SL+H NIV++K
Sbjct: 12 LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYK 71
Query: 84 EVILTP--THLAIVMEYASGGELFER-ICNAGRFSEDEARFFFQQLISGVSYCHSMQVCH 140
V + +L +VMEY G L + + R + + Q+ G+ Y S + H
Sbjct: 72 GVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVH 131
Query: 141 RDLKLENTLLDGSPAPRLKICDFGYSK 167
RDL N L++ R+KI DFG +K
Sbjct: 132 RDLATRNILVESE--NRVKIGDFGLTK 156
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 1e-13
Identities = 52/180 (28%), Positives = 86/180 (47%), Gaps = 15/180 (8%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER---GDKIDENVQREIINHRSLRHP 77
DRY ++ +GSG +G D++T VA+K + R + + RE+ + ++H
Sbjct: 15 DRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHE 74
Query: 78 NIVRFKEVILTPTHLA------IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS 131
N++ +V L +VM + G ++ + SED +F Q++ G+
Sbjct: 75 NVIGLLDVFTPDLSLDRFHDFYLVMPFM--GTDLGKLMKHEKLSEDRIQFLVYQMLKGLK 132
Query: 132 YCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL 191
Y H+ + HRDLK N L + LKI DFG ++ + S+ V T Y APEV+L
Sbjct: 133 YIHAAGIIHRDLKPGN--LAVNEDCELKILDFGLARQT--DSEMTGYVVTRWYRAPEVIL 188
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 1e-13
Identities = 60/226 (26%), Positives = 89/226 (39%), Gaps = 62/226 (27%)
Query: 26 VRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDEN------VQREIINHRSLRHPNI 79
++ +G G FG L T L A+K + + D ++ N +R+I+ + +
Sbjct: 6 IKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEAD--NEWV 63
Query: 80 VRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVC 139
V+ +L VM+Y GG++ + F E ARF+ +L + H M
Sbjct: 64 VKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFI 123
Query: 140 HRDLKLENTL--LDGSPAPRLKICDFG-------------YSKSSVLHS---QPK----- 176
HRD+K +N L LDG +K+ DFG Y K S + +P
Sbjct: 124 HRDIKPDNILIDLDG----HIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDD 179
Query: 177 ---------------------------STVGTPAYIAPEVLLKKEY 195
S VGTP YIAPEVLL+K Y
Sbjct: 180 VSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGY 225
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 2e-13
Identities = 45/175 (25%), Positives = 87/175 (49%), Gaps = 10/175 (5%)
Query: 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRH-- 76
++ E + D+G+GN G ++ T ++A K + G K +V+++I+ + H
Sbjct: 3 RNEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAK--SSVRKQILRELQIMHEC 60
Query: 77 --PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCH 134
P IV F L ++ + ME+ G L G + ++ G++Y +
Sbjct: 61 RSPYIVSFYGAFLNENNICMCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLY 120
Query: 135 SM-QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPE 188
++ ++ HRD+K N L++ ++K+CDFG S +++S + VGT Y++PE
Sbjct: 121 NVHRIMHRDIKPSNILVNS--RGQIKLCDFGVS-GELINSIADTFVGTSTYMSPE 172
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 3e-13
Identities = 52/179 (29%), Positives = 86/179 (48%), Gaps = 16/179 (8%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER---GDKIDENVQREIINHRSLRHPN 78
RY ++ +GSG +G DK+T E VA+K + R + + RE+ + ++H N
Sbjct: 16 RYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHEN 75
Query: 79 IVRFKEVILTPTHLA------IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 132
++ +V + +VM Y ++I SED+ ++ Q++ G+ Y
Sbjct: 76 VIGLLDVFTSAVSGDEFQDFYLVMPYMQTD--LQKI-MGHPLSEDKVQYLVYQMLCGLKY 132
Query: 133 CHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL 191
HS + HRDLK N L + LKI DFG ++ + ++ V T Y APEV+L
Sbjct: 133 IHSAGIIHRDLKPGN--LAVNEDCELKILDFGLARHA--DAEMTGYVVTRWYRAPEVIL 187
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 4e-13
Identities = 51/189 (26%), Positives = 86/189 (45%), Gaps = 19/189 (10%)
Query: 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINH----RSLRHPN 78
+ + + IG G F VA+K ++ D +D + + I + L HPN
Sbjct: 4 FRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPN 63
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGR----FSEDEARFFFQQLISGVSYCH 134
++++ + L IV+E A G+L I + + E +F QL S + + H
Sbjct: 64 VIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMH 123
Query: 135 SMQVCHRDLKLENTLLDGSPAPRLKICDFGY-----SKSSVLHSQPKSTVGTPAYIAPEV 189
S +V HRD+K N + + +K+ D G SK++ H S VGTP Y++PE
Sbjct: 124 SRRVMHRDIKPANVFITATGV--VKLGDLGLGRFFSSKTTAAH----SLVGTPYYMSPER 177
Query: 190 LLKKEYDGK 198
+ + Y+ K
Sbjct: 178 IHENGYNFK 186
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 5e-13
Identities = 54/187 (28%), Positives = 86/187 (45%), Gaps = 14/187 (7%)
Query: 19 DSDRYELVRDIGSGNFGVARL---MRDKKTEELVAVKYIERGDKIDENVQREIINHRSLR 75
LV++IGSG FG+ L + +K VA+K I G +E+ E L
Sbjct: 2 HPSELTLVQEIGSGQFGLVWLGYWLEKRK----VAIKTIREGAMSEEDFIEEAQVMMKLS 57
Query: 76 HPNIVRFKEVILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCH 134
HP +V+ V + + +V E+ G L + + G+FS++ + G++Y
Sbjct: 58 HPKLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLE 117
Query: 135 SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTP---AYIAPEVLL 191
S V HRDL N L+ + +K+ DFG ++ VL Q S+ GT + +PEV
Sbjct: 118 SSNVIHRDLAARNCLVGENQV--VKVSDFGMTR-FVLDDQYTSSTGTKFPVKWSSPEVFS 174
Query: 192 KKEYDGK 198
+Y K
Sbjct: 175 FSKYSSK 181
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 5e-13
Identities = 48/151 (31%), Positives = 74/151 (49%), Gaps = 16/151 (10%)
Query: 28 DIGSGNFGVARLMRDKKTEEL-----VAVKYIERGDKIDENVQ---REIINHRSLRHPNI 79
+G G+FGV R R + + VAVK + DK+ + + +E SL H N+
Sbjct: 2 KLGDGSFGVVR--RGEWSTSGGKVIPVAVK-CLKSDKLSDIMDDFLKEAAIMHSLDHENL 58
Query: 80 VRFKEVILTPTHLAIVMEYASGGELFERI-CNA-GRFSEDEARFFFQQLISGVSYCHSMQ 137
+R V+LT L +V E A G L +R+ +A G F + Q+ +G+ Y S +
Sbjct: 59 IRLYGVVLTHP-LMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKR 117
Query: 138 VCHRDLKLENTLLDGSPAPRLKICDFGYSKS 168
HRDL N LL + ++KI DFG ++
Sbjct: 118 FIHRDLAARNILL--ASDDKVKIGDFGLMRA 146
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 5e-13
Identities = 55/188 (29%), Positives = 89/188 (47%), Gaps = 25/188 (13%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNI 79
+ Y+L IG+G+FGV T E VA+K + + + RE++ ++L H NI
Sbjct: 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYK---NRELLIMKNLNHINI 121
Query: 80 VRFKEVILTPT--------HLAIVMEYASGG-----ELFERICNAGRFSEDEARFFFQQL 126
+ K+ T L +VME+ + + R N + + QL
Sbjct: 122 IFLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYAR--NNHALPLFLVKLYSYQL 179
Query: 127 ISGVSYCHSMQVCHRDLKLENTLLDGSPAPR---LKICDFGYSKSSVLHSQPKSTVGTPA 183
++Y HS +CHRDLK +N L+D P LK+CDFG +K+ + + S + +
Sbjct: 180 CRALAYIHSKFICHRDLKPQNLLID----PNTHTLKLCDFGSAKNLLAGQRSVSYICSRF 235
Query: 184 YIAPEVLL 191
Y APE++L
Sbjct: 236 YRAPELML 243
|
Length = 440 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 6e-13
Identities = 48/176 (27%), Positives = 85/176 (48%), Gaps = 13/176 (7%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRH---- 76
D E++ ++G GN+G + + T +A+K I ++DE+ +II + H
Sbjct: 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRL--ELDESKFNQIIMELDILHKAVS 58
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGG---ELFERICNAGRFSEDEARFFFQQLISGVSYC 133
P IV F + + MEY G +L+ ED R ++ G+ +
Sbjct: 59 PYIVDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFL 118
Query: 134 -HSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPE 188
+ HRD+K N L++G+ ++K+CDFG S +++ S K+ +G +Y+APE
Sbjct: 119 KEEHNIIHRDVKPTNVLVNGN--GQVKLCDFGVS-GNLVASLAKTNIGCQSYMAPE 171
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 65.4 bits (160), Expect = 7e-13
Identities = 48/162 (29%), Positives = 74/162 (45%), Gaps = 27/162 (16%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYI----ERGDKIDENVQREIINHRSLRH 76
YE++ +G G FG R KT +VA+K I E+ D REI + L+H
Sbjct: 8 RDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEK-DGFPITALREIKILKKLKH 66
Query: 77 PNIVRFKEVIL--------TPTHLAIVMEYA----SGGELFE--RICNAGRFSEDEARFF 122
PN+V ++ + + +V Y SG L E + + +E + + +
Sbjct: 67 PNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSG--LLENPSV----KLTESQIKCY 120
Query: 123 FQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFG 164
QL+ G++Y H + HRD+K N L+D LKI DFG
Sbjct: 121 MLQLLEGINYLHENHILHRDIKAANILIDNQGI--LKIADFG 160
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 64.7 bits (158), Expect = 8e-13
Identities = 45/149 (30%), Positives = 69/149 (46%), Gaps = 12/149 (8%)
Query: 27 RDIGSGNFGVAR--LMRDKKTEEL-VAVKYIERGDKIDENVQREIINHRS----LRHPNI 79
+++G GNFG + K +E+ VAVK +++ + I ++E + S L HP I
Sbjct: 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQ-EHIAAG-KKEFLREASVMAQLDHPCI 58
Query: 80 VRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVC 139
VR V L +VME A G L + + + + Q+ G++Y S
Sbjct: 59 VRLIGVCKGEP-LMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFV 117
Query: 140 HRDLKLENTLLDGSPAPRLKICDFGYSKS 168
HRDL N LL + KI DFG S++
Sbjct: 118 HRDLAARNVLLVNR--HQAKISDFGMSRA 144
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 9e-13
Identities = 57/190 (30%), Positives = 86/190 (45%), Gaps = 20/190 (10%)
Query: 24 ELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDEN------VQREIINHRSLRHP 77
E R IG G FGV + D + + VA+K + + +N V RE+ +H
Sbjct: 3 EPDRPIGYGAFGVVWSVTDPRDGKRVALKKMP---NVFQNLVSCKRVFRELKMLCFFKHD 59
Query: 78 NIVRFKEVILTPTHLAIVMEYASGGELFER-----ICNAGRFSEDEARFFFQQLISGVSY 132
N++ + IL P H+ E EL + I + S D + F Q++ G+ Y
Sbjct: 60 NVLSALD-ILQPPHIDPFEEIYVVTELMQSDLHKIIVSPQPLSSDHVKVFLYQILRGLKY 118
Query: 133 CHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVL 190
HS + HRD+K N L++ + LKICDFG ++ T V T Y APE+L
Sbjct: 119 LHSAGILHRDIKPGNLLVNSN--CVLKICDFGLARVEEPDESKHMTQEVVTQYYRAPEIL 176
Query: 191 L-KKEYDGKV 199
+ + Y V
Sbjct: 177 MGSRHYTSAV 186
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 1e-12
Identities = 52/180 (28%), Positives = 90/180 (50%), Gaps = 10/180 (5%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRH---- 76
D +E + ++G+GN GV + + + ++A K I +I ++ +II + H
Sbjct: 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHL--EIKPAIRNQIIRELKVLHECNS 58
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS- 135
P IV F + ++I ME+ GG L + + AGR E+ ++ G++Y
Sbjct: 59 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREK 118
Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEY 195
++ HRD+K N L++ +K+CDFG S ++ S S VGT +Y++PE L Y
Sbjct: 119 HKIMHRDVKPSNILVNSRG--EIKLCDFGVS-GQLIDSMANSFVGTRSYMSPERLQGTHY 175
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 1e-12
Identities = 52/181 (28%), Positives = 86/181 (47%), Gaps = 17/181 (9%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI---DENVQREIINHRSLRHP 77
+RY+ + +GSG +G D KT VAVK + R + + RE+ + ++H
Sbjct: 17 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 76
Query: 78 NIVRFKEVILTPTHL-----AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 132
N++ +V L ++ + G +L I + ++D +F Q++ G+ Y
Sbjct: 77 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 135
Query: 133 CHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVL 190
HS + HRDLK N L + LKI DFG ++ H+ + T V T Y APE++
Sbjct: 136 IHSADIIHRDLKPSN--LAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 189
Query: 191 L 191
L
Sbjct: 190 L 190
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 2e-12
Identities = 48/179 (26%), Positives = 82/179 (45%), Gaps = 13/179 (7%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI---DENVQREIINHRSLRHP 77
+RY+ + +GSG +G D + + VAVK + R + RE+ + ++H
Sbjct: 15 ERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHE 74
Query: 78 NIVRFKEVILTPTHLAIVMEY-----ASGGELFERICNAGRFSEDEARFFFQQLISGVSY 132
N++ +V T + E G +L I + S++ +F QL+ G+ Y
Sbjct: 75 NVIGLLDVFTPATSIENFNEVYLVTNLMGADL-NNIVKCQKLSDEHVQFLIYQLLRGLKY 133
Query: 133 CHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL 191
HS + HRDLK N ++ L+I DFG ++ + + V T Y APE++L
Sbjct: 134 IHSAGIIHRDLKPSNVAVNED--CELRILDFGLARQA--DDEMTGYVATRWYRAPEIML 188
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 3e-12
Identities = 57/198 (28%), Positives = 92/198 (46%), Gaps = 25/198 (12%)
Query: 29 IGSGNFGVARLMR--DKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVI 86
+G G +G + D K E+ A+K IE G I + REI R L+HPN++ ++V
Sbjct: 9 VGRGTYGHVYKAKRKDGKDEKEYALKQIE-GTGISMSACREIALLRELKHPNVIALQKVF 67
Query: 87 LTPT--HLAIVMEYASGGEL----FERICNAGR----FSEDEARFFFQQLISGVSYCHSM 136
L+ + + ++ +YA F R A + + Q++ G+ Y H+
Sbjct: 68 LSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN 127
Query: 137 QVCHRDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQP-------KSTVGTPAYIAP 187
V HRDLK N L+ +G R+KI D G+++ L + P V T Y AP
Sbjct: 128 WVLHRDLKPANILVMGEGPERGRVKIADMGFAR---LFNSPLKPLADLDPVVVTFWYRAP 184
Query: 188 EVLLKKEYDGKVMCVYVI 205
E+LL + K + ++ I
Sbjct: 185 ELLLGARHYTKAIDIWAI 202
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 63.1 bits (154), Expect = 3e-12
Identities = 44/149 (29%), Positives = 63/149 (42%), Gaps = 19/149 (12%)
Query: 25 LVRDIGSGNFG-VARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFK 83
L R +G+G FG V + T+ VAVK ++ G E +E + LRH +V+
Sbjct: 10 LERKLGAGQFGEVWMGTWNGTTK--VAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQLY 67
Query: 84 EVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFF-FQQLI-------SGVSYCHS 135
V + IV EY S G L + + E + QL+ G++Y S
Sbjct: 68 AVCSEEEPIYIVTEYMSKGSLLDFL------KSGEGKKLRLPQLVDMAAQIAEGMAYLES 121
Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFG 164
HRDL N L+ + KI DFG
Sbjct: 122 RNYIHRDLAARNILVGENLV--CKIADFG 148
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 3e-12
Identities = 50/175 (28%), Positives = 86/175 (49%), Gaps = 21/175 (12%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRH----PNIVRFKE 84
+G GN G T ++AVK I I +Q++I++ + + P I+ F
Sbjct: 9 LGHGNGGTVYKAYHLLTRRILAVKVIPL--DITVELQKQIMSELEILYKCDSPYIIGFYG 66
Query: 85 VILTPTHLAIVMEYASGGEL--FERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCH 140
++I E+ GG L + +I GR + ++ G++Y S+++ H
Sbjct: 67 AFFVENRISICTEFMDGGSLDVYRKIPEHVLGRIA--------VAVVKGLTYLWSLKILH 118
Query: 141 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEY 195
RD+K N L++ ++K+CDFG S V +S K+ VGT AY+APE + ++Y
Sbjct: 119 RDVKPSNMLVNTRG--QVKLCDFGVSTQLV-NSIAKTYVGTNAYMAPERISGEQY 170
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 6e-12
Identities = 51/177 (28%), Positives = 78/177 (44%), Gaps = 8/177 (4%)
Query: 26 VRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEV 85
++++GSG FGV L + + + VA+K I G +E+ E L HP +V+ V
Sbjct: 9 MKELGSGQFGVVHLGK-WRAQIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGV 67
Query: 86 ILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLK 144
L IV E+ G L + G+ S+D Q + G+ Y HRDL
Sbjct: 68 CTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLA 127
Query: 145 LENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTP---AYIAPEVLLKKEYDGK 198
N L+ S +K+ DFG ++ VL + S+ G + PEV +Y K
Sbjct: 128 ARNCLV--SSTGVVKVSDFGMTR-YVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSK 181
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 6e-12
Identities = 40/178 (22%), Positives = 87/178 (48%), Gaps = 9/178 (5%)
Query: 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRF 82
Y +++ + G+ G + + V +K ++G + E + + +NH P+++R
Sbjct: 68 YTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKGTTLIEAMLLQNVNH-----PSVIRM 122
Query: 83 KEVILTPTHLAIVMEYASGGELFERIC-NAGRFSEDEARFFFQQLISGVSYCHSMQVCHR 141
K+ +++ +V+ + S +L+ + + D+A +Q++ G+ Y H+ ++ HR
Sbjct: 123 KDTLVSGAITCMVLPHYSS-DLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHR 181
Query: 142 DLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKV 199
D+K EN ++ ++ I D G ++ V+ GT APEVL + +Y+ K
Sbjct: 182 DVKTENIFIND--VDQVCIGDLGAAQFPVVAPAFLGLAGTVETNAPEVLARDKYNSKA 237
|
Length = 357 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 7e-12
Identities = 48/178 (26%), Positives = 76/178 (42%), Gaps = 8/178 (4%)
Query: 25 LVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKE 84
++++GSG FGV L + + + VA+K I G +++ E L HPN+V+
Sbjct: 8 FLKELGSGQFGVVHLGKWRGKID-VAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYG 66
Query: 85 VILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDL 143
V + IV EY + G L + G+ + + + Y S HRDL
Sbjct: 67 VCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDL 126
Query: 144 KLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI---APEVLLKKEYDGK 198
N L+ +K+ DFG ++ VL Q S+ GT + PEV + K
Sbjct: 127 AARNCLVGEDNV--VKVSDFGLAR-YVLDDQYTSSQGTKFPVKWAPPEVFDYSRFSSK 181
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 7e-12
Identities = 47/161 (29%), Positives = 65/161 (40%), Gaps = 16/161 (9%)
Query: 45 TEELVAVKYIERGDKIDE-----NVQREIINHRSLRHPNIVRF-KEVILTPTHLAIVMEY 98
T VA+K + R D +E +RE L HPNIV P L V EY
Sbjct: 2 TGHEVAIKLL-RTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEY 60
Query: 99 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSP-APR 157
G L E + G E Q++ ++ H+ + HRDLK +N ++ + P
Sbjct: 61 VPGRTLREVLAADGALPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQTGVRPH 120
Query: 158 LKICDFGYSK-----SSVLHSQPKST---VGTPAYIAPEVL 190
K+ DFG + T +GTP Y APE L
Sbjct: 121 AKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQL 161
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 62.4 bits (152), Expect = 8e-12
Identities = 62/190 (32%), Positives = 91/190 (47%), Gaps = 18/190 (9%)
Query: 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHR--SLRH 76
D + E + +IGSG G MR KKT ++AVK + R +EN +R +++ H
Sbjct: 13 DLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEEN-KRILMDLDVVLKSH 71
Query: 77 --PNIVRFKEVILTPTHLAIVMEYASG--GELFERICNAGRFSEDEARFFFQQLISGVSY 132
P IV+ +T + + I ME S +L +RI G ED ++ + Y
Sbjct: 72 DCPYIVKCYGYFITDSDVFICMELMSTCLDKLLKRI--QGPIPEDILGKMTVAIVKALHY 129
Query: 133 C-HSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS-TVGTPAYIAPEVL 190
V HRD+K N LLD S +K+CDFG S V S+ K+ + G AY+APE +
Sbjct: 130 LKEKHGVIHRDVKPSNILLDAS--GNVKLCDFGISGRLV-DSKAKTRSAGCAAYMAPERI 186
Query: 191 ----LKKEYD 196
+YD
Sbjct: 187 DPPDPNPKYD 196
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 1e-11
Identities = 54/190 (28%), Positives = 84/190 (44%), Gaps = 20/190 (10%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQR---EIINHRSLRHPN 78
RY+ ++ IGSG G+ D E VA+K + R + + +R E++ + + H N
Sbjct: 25 RYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKN 84
Query: 79 IVRFKEVILTPTH-------LAIVMEYASGGELFERICNAGRFSEDEAR--FFFQQLISG 129
I+ V TP + IVME +C + D R + Q++ G
Sbjct: 85 IIGLLNV-FTPQKSLEEFQDVYIVMELMDAN-----LCQVIQMELDHERMSYLLYQMLCG 138
Query: 130 VSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEV 189
+ + HS + HRDLK N ++ LKI DFG ++++ V T Y APEV
Sbjct: 139 IKHLHSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSFMMTPYVVTRYYRAPEV 196
Query: 190 LLKKEYDGKV 199
+L Y V
Sbjct: 197 ILGMGYKENV 206
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 2e-11
Identities = 58/198 (29%), Positives = 92/198 (46%), Gaps = 25/198 (12%)
Query: 29 IGSGNFG-VARLMR-DKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVI 86
+G G +G V + R D K + A+K IE G I + REI R L+HPN++ ++V
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDRDYALKQIE-GTGISMSACREIALLRELKHPNVISLQKVF 67
Query: 87 LTPT--HLAIVMEYASGGEL----FERICNAGR----FSEDEARFFFQQLISGVSYCHSM 136
L+ + ++ +YA F R A + + Q++ G+ Y H+
Sbjct: 68 LSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN 127
Query: 137 QVCHRDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQP-------KSTVGTPAYIAP 187
V HRDLK N L+ +G R+KI D G+++ L + P V T Y AP
Sbjct: 128 WVLHRDLKPANILVMGEGPERGRVKIADMGFAR---LFNSPLKPLADLDPVVVTFWYRAP 184
Query: 188 EVLLKKEYDGKVMCVYVI 205
E+LL + K + ++ I
Sbjct: 185 ELLLGARHYTKAIDIWAI 202
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 3e-11
Identities = 53/190 (27%), Positives = 83/190 (43%), Gaps = 20/190 (10%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQR---EIINHRSLRHPN 78
RY+ ++ IGSG G+ D VAVK + R + + +R E++ + + H N
Sbjct: 22 RYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKN 81
Query: 79 IVRFKEVILTPTH-------LAIVMEYASGGELFERICNAGRFSEDEAR--FFFQQLISG 129
I+ V TP + +VME +C D R + Q++ G
Sbjct: 82 IISLLNV-FTPQKSLEEFQDVYLVMELMDAN-----LCQVIHMELDHERMSYLLYQMLCG 135
Query: 130 VSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEV 189
+ + HS + HRDLK N ++ LKI DFG ++++ + V T Y APEV
Sbjct: 136 IKHLHSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTACTNFMMTPYVVTRYYRAPEV 193
Query: 190 LLKKEYDGKV 199
+L Y V
Sbjct: 194 ILGMGYKENV 203
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 3e-11
Identities = 54/192 (28%), Positives = 90/192 (46%), Gaps = 22/192 (11%)
Query: 19 DSDRYELVRDIGSGNFG---VARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLR 75
D+ ++ + IG+G FG RL K E VA+K ++ G E +R+ ++ S+
Sbjct: 2 DASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAG--YTEKQRRDFLSEASIM 59
Query: 76 ----HPNIVRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISG 129
HPNI+ + V+ + IV EY G L F R + G+F+ + + + SG
Sbjct: 60 GQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRK-HDGQFTVIQLVGMLRGIASG 118
Query: 130 VSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA------ 183
+ Y M HRDL N L++ + K+ DFG S+ VL P++ T
Sbjct: 119 MKYLSDMGYVHRDLAARNILVNSNLV--CKVSDFGLSR--VLEDDPEAAYTTRGGKIPIR 174
Query: 184 YIAPEVLLKKEY 195
+ APE + +++
Sbjct: 175 WTAPEAIAYRKF 186
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 60.3 bits (146), Expect = 4e-11
Identities = 44/148 (29%), Positives = 71/148 (47%), Gaps = 14/148 (9%)
Query: 29 IGSGNFG---VARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSL----RHPNIVR 81
IG+G FG RL K E VA+K ++ G E +R+ ++ S+ HPNI+
Sbjct: 12 IGAGEFGEVCRGRLKLPGKREIFVAIKTLKSG--YTEKQRRDFLSEASIMGQFDHPNIIH 69
Query: 82 FKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHSMQVC 139
+ V+ + I+ E+ G L F R N G+F+ + + + +G+ Y M
Sbjct: 70 LEGVVTKSRPVMIITEFMENGALDSFLRQ-NDGQFTVIQLVGMLRGIAAGMKYLSEMNYV 128
Query: 140 HRDLKLENTLLDGSPAPRLKICDFGYSK 167
HRDL N L++ + K+ DFG S+
Sbjct: 129 HRDLAARNILVNSNLV--CKVSDFGLSR 154
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 60.5 bits (147), Expect = 4e-11
Identities = 55/193 (28%), Positives = 88/193 (45%), Gaps = 26/193 (13%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQ------REIINHRSLR 75
RY+ ++ IGSG G+ D T + VA+K + R +NV RE++ + +
Sbjct: 17 RYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPF---QNVTHAKRAYRELVLMKLVN 73
Query: 76 HPNIVRFKEVILTP-------THLAIVMEY--ASGGELFERICNAGRFSEDEARFFFQQL 126
H NI+ V TP + +VME A+ ++ + + R S + Q+
Sbjct: 74 HKNIIGLLNV-FTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMS-----YLLYQM 127
Query: 127 ISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIA 186
+ G+ + HS + HRDLK N ++ LKI DFG ++++ V T Y A
Sbjct: 128 LCGIKHLHSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSFMMTPYVVTRYYRA 185
Query: 187 PEVLLKKEYDGKV 199
PEV+L Y V
Sbjct: 186 PEVILGMGYKENV 198
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 60.1 bits (146), Expect = 4e-11
Identities = 54/176 (30%), Positives = 79/176 (44%), Gaps = 11/176 (6%)
Query: 21 DRYELVRDIGSGNFGVAR--LMRDKKTEEL-VAVKY--IERGDKIDENVQREIINHRSLR 75
+ L R IG G FG + + E++ VAVK + E +E R
Sbjct: 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFD 65
Query: 76 HPNIVRFKEVILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCH 134
HP+IV+ VI T + IVME A GEL + N + QL + ++Y
Sbjct: 66 HPHIVKLIGVI-TENPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLE 124
Query: 135 SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGT-P-AYIAPE 188
S + HRD+ N L+ SP +K+ DFG S+ S K++ G P ++APE
Sbjct: 125 SKRFVHRDIAARNVLV-SSPDC-VKLGDFGLSRYLEDESYYKASKGKLPIKWMAPE 178
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 59.7 bits (145), Expect = 6e-11
Identities = 48/157 (30%), Positives = 69/157 (43%), Gaps = 24/157 (15%)
Query: 25 LVRDIGSGNFG---VARLMRDKKTEELVAVKYIERG--DKIDENVQREIINHRSLRHPNI 79
+ + IG G FG RL K E VA+K ++ G DK + E HPNI
Sbjct: 8 IEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNI 67
Query: 80 VRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLI-------SGV 130
+R + V+ + I+ EY G L F R E++ +F QL+ SG+
Sbjct: 68 IRLEGVVTKSRPVMIITEYMENGSLDKFLR--------ENDGKFTVGQLVGMLRGIASGM 119
Query: 131 SYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 167
Y M HRDL N L++ + K+ DFG S+
Sbjct: 120 KYLSEMNYVHRDLAARNILVNSN--LVCKVSDFGLSR 154
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 7e-11
Identities = 44/203 (21%), Positives = 81/203 (39%), Gaps = 34/203 (16%)
Query: 20 SDRYELV-RDIGSGNFGVARLMRDKKTEELVAVKYI----------ERGDKIDE-----N 63
S+RY +G G +G D T ++VA+K + + +
Sbjct: 7 SERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFT 66
Query: 64 VQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFF 123
RE+ ++H NI+ +V + + +VM+ + +L + + R +E + +
Sbjct: 67 TLRELKIMNEIKHENIMGLVDVYVEGDFINLVMDIMAS-DLKKVVDRKIRLTESQVKCIL 125
Query: 124 QQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-----------H 172
Q+++G++ H HRDL N ++ KI DFG ++
Sbjct: 126 LQILNGLNVLHKWYFMHRDLSPANIFINSKGI--CKIADFGLARRYGYPPYSDTLSKDET 183
Query: 173 SQPK----STVGTPAYIAPEVLL 191
Q + S V T Y APE+L+
Sbjct: 184 MQRREEMTSKVVTLWYRAPELLM 206
|
Length = 335 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 60.1 bits (145), Expect = 8e-11
Identities = 50/184 (27%), Positives = 82/184 (44%), Gaps = 8/184 (4%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQR---EIINHRSLRHPN 78
RY+ ++ IGSG G+ D + VA+K + R + + +R E++ + + H N
Sbjct: 18 RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKN 77
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFE-RICNAGRFSEDEAR--FFFQQLISGVSYCHS 135
I+ V L + EL + +C + D R + Q++ G+ + HS
Sbjct: 78 IISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHS 137
Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEY 195
+ HRDLK N ++ LKI DFG ++++ V T Y APEV+L Y
Sbjct: 138 AGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGY 195
Query: 196 DGKV 199
V
Sbjct: 196 KENV 199
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 2e-10
Identities = 50/178 (28%), Positives = 83/178 (46%), Gaps = 14/178 (7%)
Query: 27 RDIGSGNFGVARLMRDKKTEELVAVKYIER-------GDKIDENVQREIINHRSLRHPNI 79
R +G G FG + + T ++ A K +E+ G+ + N +++I+ + + +
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALN-EKQILEKVNSQF--V 62
Query: 80 VRFKEVILTPTHLAIVMEYASGGELFERICNAGR--FSEDEARFFFQQLISGVSYCHSMQ 137
V T L +V+ +GG+L I N G F E+ A F+ +++ G+ H
Sbjct: 63 VNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHREN 122
Query: 138 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEY 195
+RDLK EN LLD ++I D G + + VGT Y+APEVL + Y
Sbjct: 123 TVYRDLKPENILLDDY--GHIRISDLGLAVKIPEGESIRGRVGTVGYMAPEVLNNQRY 178
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 3e-10
Identities = 52/180 (28%), Positives = 82/180 (45%), Gaps = 18/180 (10%)
Query: 27 RDIGSGNFGVARLMRDKKTEELVAVKYIER-------GDKIDENVQR--EIINHRSLRHP 77
R +G G FG + + T ++ A K +E+ G+ + N +R E +N R
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRF---- 61
Query: 78 NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR--FSEDEARFFFQQLISGVSYCHS 135
+V T L +V+ +GG+L I N G F E A F+ +L G+
Sbjct: 62 -VVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQR 120
Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEY 195
++ +RDLK EN LLD ++I D G + + VGT Y+APEV+ ++Y
Sbjct: 121 ERIVYRDLKPENILLDDR--GHIRISDLGLAVQIPEGETVRGRVGTVGYMAPEVINNEKY 178
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 57.4 bits (139), Expect = 4e-10
Identities = 46/174 (26%), Positives = 65/174 (37%), Gaps = 31/174 (17%)
Query: 24 ELVRDIGSGNFGV----------------ARLMRDKKTEELVAVKYIERG--DKIDENVQ 65
V +G G FG + LVAVK + D E+
Sbjct: 8 NFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFL 67
Query: 66 REIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL--FER---------ICNAGRF 114
+E+ L PNI R V L ++MEY G+L F + CN+
Sbjct: 68 KEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSL 127
Query: 115 SEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 168
S + Q+ SG+ Y S+ HRDL N L+ +KI DFG S++
Sbjct: 128 SFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVG--KNYTIKIADFGMSRN 179
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 5e-10
Identities = 47/180 (26%), Positives = 81/180 (45%), Gaps = 10/180 (5%)
Query: 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSL----RHPN 78
+ R +G G FG + + T ++ A K +E+ + +N + +
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF 61
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGR--FSEDEARFFFQQLISGVSYCHSM 136
+V T L +V+ +GG+L I N G F E+ A F+ ++ G+ H
Sbjct: 62 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRE 121
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP-KSTVGTPAYIAPEVLLKKEY 195
++ +RDLK EN LLD ++I D G + + + + VGT Y+APEV+ + Y
Sbjct: 122 RIVYRDLKPENILLDDY--GHIRISDLGLA-VEIPEGETIRGRVGTVGYMAPEVVKNERY 178
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 57.0 bits (138), Expect = 6e-10
Identities = 47/185 (25%), Positives = 79/185 (42%), Gaps = 26/185 (14%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINH----RSLRHPNIVRFKE 84
IG G FG M K + ++AVK I R ++ +R +++ RS P IV+F
Sbjct: 12 IGRGAFGTVNKMLHKPSGTIMAVKRI-RSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYG 70
Query: 85 VILTPTHLAIVMEY--ASGGELFERICNAGRFSEDEARFFFQQLISGVSYC--------- 133
+ I ME S + ++ + + ++++ ++
Sbjct: 71 ALFREGDCWICMELMDISLDKFYKYVYEVLK------SVIPEEILGKIAVATVKALNYLK 124
Query: 134 HSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLK 192
+++ HRD+K N LLD + +K+CDFG S V S K+ G Y+APE +
Sbjct: 125 EELKIIHRDVKPSNILLDRNGN--IKLCDFGISGQLV-DSIAKTRDAGCRPYMAPERIDP 181
Query: 193 KEYDG 197
DG
Sbjct: 182 SARDG 186
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 6e-10
Identities = 50/178 (28%), Positives = 83/178 (46%), Gaps = 14/178 (7%)
Query: 27 RDIGSGNFGVARLMRDKKTEELVAVKYIER-------GDKIDENVQREIINHRSLRHPNI 79
R +G G FG + + T ++ A K +E+ G+ + N +++I+ + R +
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALN-EKQILEKVNSRF--V 62
Query: 80 VRFKEVILTPTHLAIVMEYASGGELFERICNAGR--FSEDEARFFFQQLISGVSYCHSMQ 137
V T L +V+ +GG+L I + G F E A F+ ++ G+ H +
Sbjct: 63 VSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQER 122
Query: 138 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEY 195
+ +RDLK EN LLD ++I D G + K VGT Y+APEV+ + Y
Sbjct: 123 IVYRDLKPENILLDDH--GHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERY 178
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 1e-09
Identities = 44/176 (25%), Positives = 79/176 (44%), Gaps = 17/176 (9%)
Query: 27 RDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVI 86
R + S N G + E L+A K ++ G + ++ EI+ L H NI++ +E++
Sbjct: 180 RGVNSTNQGKPK------CERLIA-KRVKAGSRAAIQLENEILALGRLNHENILKIEEIL 232
Query: 87 LTPTHLAIVMEYASGGELFERICNAGRFSED-----EARFFFQQLISGVSYCHSMQVCHR 141
+ + ++ + +L+ + + +D + R +QL+ V Y H ++ HR
Sbjct: 233 RSEANTYMITQKYDF-DLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHR 291
Query: 142 DLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVLLKKEY 195
D+KLEN L+ L DFG + + VGT A +PE+L Y
Sbjct: 292 DIKLENIFLNCDGKIVLG--DFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGY 345
|
Length = 501 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 2e-09
Identities = 56/176 (31%), Positives = 76/176 (43%), Gaps = 18/176 (10%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQ---REIINHRSLRHPNIVRFKEV 85
IG G FG +++ + T + VAVK I K D Q E L H N+VR V
Sbjct: 14 IGEGEFGA--VLQGEYTGQKVAVKNI----KCDVTAQAFLEETAVMTKLHHKNLVRLLGV 67
Query: 86 ILTPTHLAIVMEYASGGELFERICNAGRFSEDEARF--FFQQLISGVSYCHSMQVCHRDL 143
IL L IVME S G L + GR + F + G+ Y S ++ HRDL
Sbjct: 68 ILH-NGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDL 126
Query: 144 KLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA-YIAPEVLLKKEYDGK 198
N L+ S K+ DFG ++ + S P + APE L K++ K
Sbjct: 127 AARNILV--SEDGVAKVSDFGLAR---VGSMGVDNSKLPVKWTAPEALKHKKFSSK 177
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 2e-09
Identities = 57/209 (27%), Positives = 82/209 (39%), Gaps = 46/209 (22%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLR------ 75
RY+++R IG G G L D VA+K I R D + ++ R LR
Sbjct: 3 RYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKI-REDLSEN----PLLKKRFLREAKIAA 57
Query: 76 ---HPNIVRFKEVILTPTHLAIVMEYASG---GELFERICNAGRFSEDEAR------FF- 122
HP IV + + M Y G L + + S++ A F
Sbjct: 58 DLIHPGIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLS 117
Query: 123 -FQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFG----------------Y 165
F ++ + + Y HS V HRDLK +N LL + I D+G
Sbjct: 118 IFHKICATIEYVHSKGVLHRDLKPDNILL--GLFGEVVILDWGAAIFKKLEEEDLLDIDV 175
Query: 166 SKSSVLHSQ---PKSTVGTPAYIAPEVLL 191
+ ++ +S P VGTP Y+APE LL
Sbjct: 176 DERNICYSSMTIPGKIVGTPDYMAPERLL 204
|
Length = 932 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 2e-09
Identities = 50/181 (27%), Positives = 84/181 (46%), Gaps = 20/181 (11%)
Query: 29 IGSGNFG-VAR--LMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLR----HPNIVR 81
IG+G FG V R L + E VA+K ++ G E +++ ++ S+ H NI+R
Sbjct: 13 IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPG--YTEKQRQDFLSEASIMGQFSHHNIIR 70
Query: 82 FKEVILTPTHLAIVMEYASGGELFERIC-NAGRFSEDEARFFFQQLISGVSYCHSMQVCH 140
+ V+ I+ EY G L + + + G FS + + + +G+ Y M H
Sbjct: 71 LEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVH 130
Query: 141 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA------YIAPEVLLKKE 194
RDL N L++ + K+ DFG S+ VL P+ T T + APE + ++
Sbjct: 131 RDLAARNILVNSNLE--CKVSDFGLSR--VLEDDPEGTYTTSGGKIPIRWTAPEAIAYRK 186
Query: 195 Y 195
+
Sbjct: 187 F 187
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 55.1 bits (133), Expect = 3e-09
Identities = 50/179 (27%), Positives = 84/179 (46%), Gaps = 17/179 (9%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREI-----INHRSLR 75
D E++ ++G G +GV MR T ++AVK I E Q+ + I+ RS+
Sbjct: 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQE--QKRLLMDLDISMRSVD 58
Query: 76 HPNIVRFKEVILTPTHLAIVMEY--ASGGELFERICNAGRFSEDE--ARFFFQQLISGVS 131
P V F + + I ME S + ++++ + G ++ + ++ +
Sbjct: 59 CPYTVTFYGALFREGDVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAV-SIVKALE 117
Query: 132 YCHS-MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPE 188
Y HS + V HRD+K N L++ ++K+CDFG S V S K+ G Y+APE
Sbjct: 118 YLHSKLSVIHRDVKPSNVLIN--RNGQVKLCDFGISGYLV-DSVAKTIDAGCKPYMAPE 173
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 3e-09
Identities = 47/147 (31%), Positives = 68/147 (46%), Gaps = 10/147 (6%)
Query: 28 DIGSGNFGVAR--LMRDKKTEELVAVKYIERGDKIDENVQREIINH----RSLRHPNIVR 81
++GSGNFG + + + KK+E+ VAVK I + D D ++ E++ + L +P IVR
Sbjct: 2 ELGSGNFGTVKKGMYKMKKSEKTVAVK-ILKNDNNDPALKDELLREANVMQQLDNPYIVR 60
Query: 82 FKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHR 141
I +VME A G L + + +E Q+ G+ Y HR
Sbjct: 61 MIG-ICEAESWMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHR 119
Query: 142 DLKLENTLLDGSPAPRLKICDFGYSKS 168
DL N LL KI DFG SK+
Sbjct: 120 DLAARNVLL--VTQHYAKISDFGLSKA 144
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 4e-09
Identities = 48/179 (26%), Positives = 73/179 (40%), Gaps = 35/179 (19%)
Query: 21 DRYELVRDIGSGNFGVARL-----MRDKKTEE-----------LVAVKYIERGDKIDENV 64
R +G G FG L M ++ LVAVK + R D ++N
Sbjct: 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKML-REDA-NKNA 62
Query: 65 Q----REIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERIC----------- 109
+ +EI L+ PNI+R V +T L ++ EY G+L + +
Sbjct: 63 RNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKA 122
Query: 110 NAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 168
+ S F Q+ SG+ Y S+ HRDL N L+ + +KI DFG S++
Sbjct: 123 DVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNYT--IKIADFGMSRN 179
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 54.3 bits (131), Expect = 5e-09
Identities = 40/166 (24%), Positives = 71/166 (42%), Gaps = 29/166 (17%)
Query: 21 DRYELVRDIGSGNFG-----VARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRS-- 73
++ L+R++G G+FG +A+ + + E VA+K + + E E +N S
Sbjct: 6 EKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRER--IEFLNEASVM 63
Query: 74 --LRHPNIVRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARF-------- 121
++VR V+ T +VME + G+L + R R +
Sbjct: 64 KEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSR---RPEAENNPGLGPPTLQK 120
Query: 122 FFQ---QLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFG 164
F Q ++ G++Y + + HRDL N ++ +KI DFG
Sbjct: 121 FIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLT--VKIGDFG 164
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 5e-09
Identities = 45/154 (29%), Positives = 63/154 (40%), Gaps = 26/154 (16%)
Query: 27 RDIGSGNFG---VARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSL---RHPNIV 80
IG GNFG L K VAVK R + ++ + L HPNIV
Sbjct: 1 EKIGKGNFGDVYKGVL----KGNTEVAVKTC-RSTLPPDLKRKFLQEAEILKQYDHPNIV 55
Query: 81 RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLI-------SGVSYC 133
+ V + + IVME GG L + + + R ++L+ +G+ Y
Sbjct: 56 KLIGVCVQKQPIYIVMELVPGGSLLTFL------RKKKNRLTVKKLLQMSLDAAAGMEYL 109
Query: 134 HSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 167
S HRDL N L+ + LKI DFG S+
Sbjct: 110 ESKNCIHRDLAARNCLVGENNV--LKISDFGMSR 141
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 7e-09
Identities = 49/179 (27%), Positives = 72/179 (40%), Gaps = 31/179 (17%)
Query: 18 HDSDRYELVRDIGSGNFGV---ARLMRDKKTEE--LVAVKYIERG--DKIDENVQREIIN 70
+ + E VRDIG G FG AR E +VAVK ++ + + QRE
Sbjct: 2 YPRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAAL 61
Query: 71 HRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFE--------------------RICN 110
HPNIV+ V + ++ EY + G+L E R C
Sbjct: 62 MAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCG 121
Query: 111 AGR--FSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 167
S E +Q+ +G++Y + HRDL N L+ + +KI DFG S+
Sbjct: 122 LNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGEN--MVVKIADFGLSR 178
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 9e-09
Identities = 43/144 (29%), Positives = 60/144 (41%), Gaps = 9/144 (6%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINH----RSLRHPNIVRFKE 84
IG GNFG R + VAVK + + +++ + + + HPNIVR
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCR--ETLPPDLKAKFLQEARILKQYSHPNIVRLIG 60
Query: 85 VILTPTHLAIVMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQVCHRDL 143
V + IVME GG+ + G R E + +G+ Y S HRDL
Sbjct: 61 VCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDL 120
Query: 144 KLENTLLDGSPAPRLKICDFGYSK 167
N L+ LKI DFG S+
Sbjct: 121 AARNCLVTEKNV--LKISDFGMSR 142
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 1e-08
Identities = 45/159 (28%), Positives = 65/159 (40%), Gaps = 22/159 (13%)
Query: 29 IGSGNFG------VARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSL----RHPN 78
+GSG FG ++ VAVK + +G E ++E + L HPN
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQE--KKEFLKEAHLMSNFNHPN 60
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLIS-------GVS 131
IV+ V L I+ME GG+L + +A ++L+ G
Sbjct: 61 IVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCV 120
Query: 132 YCHSMQVCHRDLKLENTLLD--GSPAPR-LKICDFGYSK 167
Y M HRDL N L+ G A R +KI DFG ++
Sbjct: 121 YLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLAR 159
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 52.6 bits (126), Expect = 2e-08
Identities = 53/196 (27%), Positives = 82/196 (41%), Gaps = 27/196 (13%)
Query: 24 ELVRDIGSG--NFGVARLMRDKKTEELVAVKYIERGDKIDENV---QREIINHRSLRHPN 78
EL+ IG G + L R K T E V V+ I +E V Q E+ + HPN
Sbjct: 1 ELLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPN 60
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFERICN--AGRFSEDEARFFFQQLISGVSYCHSM 136
IV ++ + L +V + + G + IC SE + Q ++ + Y H M
Sbjct: 61 IVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHM 120
Query: 137 QVCHRDLKLENTL--LDGSPAPRLKICDFGY----------SKSSVLHSQPKSTVGTPAY 184
HR +K + L +DG K+ G + V+H PK +V +
Sbjct: 121 GYVHRSVKASHILISVDG------KVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLPW 174
Query: 185 IAPEVLLK--KEYDGK 198
++PEVL + + YD K
Sbjct: 175 LSPEVLQQNLQGYDAK 190
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 2e-08
Identities = 36/146 (24%), Positives = 60/146 (41%), Gaps = 8/146 (5%)
Query: 23 YELVRDIGSGNFGVARLMRDK-KTEELVAVKYIERGDKID-ENVQREIINHRSLRHPNIV 80
+ L R +GSG FG + K VA+K ++ D + ++ Q+E+ + LRH +++
Sbjct: 8 FTLERKLGSGYFG--EVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLI 65
Query: 81 RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARF--FFQQLISGVSYCHSMQV 138
V + I+ E G L + + A Q+ G++Y
Sbjct: 66 SLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNS 125
Query: 139 CHRDLKLENTLLDGSPAPRLKICDFG 164
HRDL N L+ K+ DFG
Sbjct: 126 IHRDLAARNILVGEDLV--CKVADFG 149
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 3e-08
Identities = 44/164 (26%), Positives = 69/164 (42%), Gaps = 23/164 (14%)
Query: 25 LVRDIGSGNFGVARL-----MRDKKTEELVAVKYIERG--DKIDENVQREIINHRSLRHP 77
L R++G G FG L + + +ELVAVK ++ + ++ +RE + +H
Sbjct: 9 LKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHE 68
Query: 78 NIVRFKEVILTPTHLAIVMEYASGGELFERI--------------CNAGRFSEDEARFFF 123
NIV+F V +V EY G+L + + G + +
Sbjct: 69 NIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIA 128
Query: 124 QQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 167
Q+ SG+ Y S HRDL N L+ +KI DFG S+
Sbjct: 129 VQIASGMVYLASQHFVHRDLATRNCLV--GYDLVVKIGDFGMSR 170
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 4e-08
Identities = 46/164 (28%), Positives = 66/164 (40%), Gaps = 19/164 (11%)
Query: 21 DRYELVRDIGSGNFG-----VARLMRDKKTEELVAVKYI----ERGDKIDENVQREIINH 71
D L+R +G G FG + R E VAVK + D+ D ++ I++
Sbjct: 6 DSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMS- 64
Query: 72 RSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL--FERIC--NAGRFSE---DEARFFFQ 124
H NIVR V I++E +GG+L F R R S + F +
Sbjct: 65 -KFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCAR 123
Query: 125 QLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRL-KICDFGYSK 167
+ G Y HRD+ N LL R+ KI DFG ++
Sbjct: 124 DVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMAR 167
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 4e-08
Identities = 35/141 (24%), Positives = 58/141 (41%), Gaps = 4/141 (2%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILT 88
+G G +G KK VAVK ++ E +E + ++HPN+V+ V
Sbjct: 14 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 73
Query: 89 PTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQ--QLISGVSYCHSMQVCHRDLKLE 146
I+ E+ + G L + + R + + Q+ S + Y HRDL
Sbjct: 74 EPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAAR 133
Query: 147 NTLLDGSPAPRLKICDFGYSK 167
N L+ +K+ DFG S+
Sbjct: 134 NCLV--GENHLVKVADFGLSR 152
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 5e-08
Identities = 47/178 (26%), Positives = 71/178 (39%), Gaps = 34/178 (19%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEE--------------LVAVKYIERGDKIDENVQ- 65
+ L +G G FG L + E LVAVK + R D + + +
Sbjct: 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKML-RAD-VTKTARN 62
Query: 66 ---REIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL------------FERICN 110
+EI L++PNI+R V ++ L ++ EY G+L F N
Sbjct: 63 DFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANN 122
Query: 111 AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 168
S + Q+ SG+ Y S+ HRDL N L+ +KI DFG S++
Sbjct: 123 IPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYT--IKIADFGMSRN 178
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 8e-08
Identities = 41/149 (27%), Positives = 68/149 (45%), Gaps = 5/149 (3%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIV 80
+ +LV+ +G+G FG M VAVK ++ G + E ++L+H +V
Sbjct: 6 ESIKLVKKLGAGQFGEV-WMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLV 64
Query: 81 RFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHSMQV 138
R V+ + I+ EY + G L F + G+ + F Q+ G++Y
Sbjct: 65 RLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNY 124
Query: 139 CHRDLKLENTLLDGSPAPRLKICDFGYSK 167
HRDL+ N L+ S + KI DFG ++
Sbjct: 125 IHRDLRAANVLV--SESLMCKIADFGLAR 151
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 49.7 bits (119), Expect = 2e-07
Identities = 42/157 (26%), Positives = 66/157 (42%), Gaps = 17/157 (10%)
Query: 19 DSDRYELVRDIGSGNFG-VARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHP 77
D +L+R +G+G FG V + + T VAVK ++ G ++ E + LRHP
Sbjct: 4 DRTSIQLLRKLGAGQFGEVWEGLWNNTTP--VAVKTLKPGTMDPKDFLAEAQIMKKLRHP 61
Query: 78 NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLI-------SGV 130
+++ V + IV E G L E + QLI SG+
Sbjct: 62 KLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQG-----GAGRALKLPQLIDMAAQVASGM 116
Query: 131 SYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 167
+Y + HRDL N L+ + K+ DFG ++
Sbjct: 117 AYLEAQNYIHRDLAARNVLVGENNI--CKVADFGLAR 151
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 2e-07
Identities = 40/146 (27%), Positives = 67/146 (45%), Gaps = 6/146 (4%)
Query: 24 ELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFK 83
+LV+ +G+G FG M VA+K +++G E E + L+HP +VR
Sbjct: 9 KLVKKLGAGQFGEV-WMGYYNGHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLY 67
Query: 84 EVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHR 141
V+ T + I+ EY G L F + + + ++ Q+ G+++ HR
Sbjct: 68 AVV-TQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHR 126
Query: 142 DLKLENTLLDGSPAPRLKICDFGYSK 167
DL+ N L+ S KI DFG ++
Sbjct: 127 DLRAANILV--SETLCCKIADFGLAR 150
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 3e-07
Identities = 44/148 (29%), Positives = 69/148 (46%), Gaps = 12/148 (8%)
Query: 28 DIGSGNFGVAR--LMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRH----PNIVR 81
++GSGNFG + + + +K + VA+K ++ + +++V+ E++ + H P IVR
Sbjct: 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN--EKSVRDEMMREAEIMHQLDNPYIVR 59
Query: 82 FKEVILTPTHLAIVMEYASGGELFERIC-NAGRFSEDEARFFFQQLISGVSYCHSMQVCH 140
V L +VME ASGG L + + + Q+ G+ Y H
Sbjct: 60 MIGVC-EAEALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVH 118
Query: 141 RDLKLENTLLDGSPAPRLKICDFGYSKS 168
RDL N LL KI DFG SK+
Sbjct: 119 RDLAARNVLLVNQHYA--KISDFGLSKA 144
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 6e-07
Identities = 48/151 (31%), Positives = 69/151 (45%), Gaps = 24/151 (15%)
Query: 29 IGSGNFG--VARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLR---HPNIVRFK 83
+G GNFG ++DK VAVK + D E + + R L+ HPNIV+
Sbjct: 3 LGKGNFGEVFKGTLKDKTP---VAVKTCKE-DLPQELKIKFLSEARILKQYDHPNIVKLI 58
Query: 84 EVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLI-------SGVSYCHSM 136
V + IVME GG+ + R +DE + +QL+ +G++Y S
Sbjct: 59 GVCTQRQPIYIVMELVPGGDFLSFL----RKKKDELK--TKQLVKFALDAAAGMAYLESK 112
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSK 167
HRDL N L+ + LKI DFG S+
Sbjct: 113 NCIHRDLAARNCLVGENNV--LKISDFGMSR 141
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 7e-07
Identities = 44/153 (28%), Positives = 62/153 (40%), Gaps = 10/153 (6%)
Query: 19 DSDRYELVRDIGSGNFG-VAR--LMRDKKTEELVAVKYIERG--DKIDENVQREIINHRS 73
D+ ++ R +G+G FG + R L K E VA+ + G DK E +
Sbjct: 3 DNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQ 62
Query: 74 LRHPNIVRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVS 131
H NIVR + VI + IV EY S G L F R + G+ + L SG+
Sbjct: 63 FDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRK-HEGQLVAGQLMGMLPGLASGMK 121
Query: 132 YCHSMQVCHRDLKLENTLLDGSPAPRLKICDFG 164
Y M H+ L L++ KI F
Sbjct: 122 YLSEMGYVHKGLAAHKVLVNSDLV--CKISGFR 152
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 47.8 bits (113), Expect = 9e-07
Identities = 45/162 (27%), Positives = 73/162 (45%), Gaps = 21/162 (12%)
Query: 25 LVRDIGSGNFGVARLMR-----DKKTEELVAVKYI-ERGDKIDENVQREIINHRSLRHPN 78
L R++G G FG L ++ + LVAVK + + D ++ RE +L+H +
Sbjct: 9 LKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEH 68
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFERICNAG-------------RFSEDEARFFFQQ 125
IV+F V + L +V EY G+L + + G ++ + QQ
Sbjct: 69 IVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQ 128
Query: 126 LISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 167
+ +G+ Y S HRDL N L+ + +KI DFG S+
Sbjct: 129 IAAGMVYLASQHFVHRDLATRNCLVGENLL--VKIGDFGMSR 168
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 3e-06
Identities = 47/181 (25%), Positives = 77/181 (42%), Gaps = 15/181 (8%)
Query: 24 ELVRDIGSG--NFGVARLMRDKKTEELVAVKYIERGDKIDENV---QREIINHRSLRHPN 78
EL +IG G N L R T LV V+ + + +E++ Q E++ RHPN
Sbjct: 1 ELQVEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPN 60
Query: 79 IVRFKEVILTPTHLAIV---MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 135
I+ V T + L ++ M Y S L + G SE + G++Y H
Sbjct: 61 IMTSWTVFTTGSWLWVISPFMAYGSANSLLKTYFPEG-MSEALIGNILFGALRGLNYLHQ 119
Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYS------KSSVLHSQPKSTVGTPAYIAPEV 189
HR++K + L+ G L YS K+ V++ P+ + +++PE+
Sbjct: 120 NGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPEL 179
Query: 190 L 190
L
Sbjct: 180 L 180
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 3e-06
Identities = 40/147 (27%), Positives = 70/147 (47%), Gaps = 8/147 (5%)
Query: 24 ELVRDIGSGNFG-VARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRF 82
+L + +G+G FG V +K T+ VAVK ++ G E E ++L+H +V+
Sbjct: 9 KLEKKLGAGQFGEVWMATYNKHTK--VAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKL 66
Query: 83 KEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCH 140
V+ T + I+ E+ + G L F + + + F Q+ G+++ H
Sbjct: 67 HAVV-TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIH 125
Query: 141 RDLKLENTLLDGSPAPRLKICDFGYSK 167
RDL+ N L+ S + KI DFG ++
Sbjct: 126 RDLRAANILV--SASLVCKIADFGLAR 150
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 3e-06
Identities = 45/154 (29%), Positives = 74/154 (48%), Gaps = 16/154 (10%)
Query: 21 DRYELVRDIGSGNFG-VARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNI 79
+ +L++ +G+G FG V + T+ VAVK ++ G E+ E + LRH +
Sbjct: 6 ESLQLIKKLGNGQFGEVWMGTWNGNTK--VAVKTLKPGTMSPESFLEEAQIMKKLRHDKL 63
Query: 80 VRFKEVILTPTHLAIVMEYASGGELFERICNA-GRFSE-----DEARFFFQQLISGVSYC 133
V+ V+ + + IV EY S G L + + + GR + D A Q+ +G++Y
Sbjct: 64 VQLYAVV-SEEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMA----AQVAAGMAYI 118
Query: 134 HSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 167
M HRDL+ N L+ KI DFG ++
Sbjct: 119 ERMNYIHRDLRSANILVGDGLV--CKIADFGLAR 150
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 45.9 bits (109), Expect = 4e-06
Identities = 46/194 (23%), Positives = 80/194 (41%), Gaps = 28/194 (14%)
Query: 24 ELVRDIGSGNFG-VAR----LMRDKKTEELVAVKYIERGD--KIDENVQREIINHRSLRH 76
+ ++G G FG V + ++ + VA+K ++ K+ + ++E L+H
Sbjct: 8 RFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQH 67
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFE------RICNAGRFSED-------EARFFF 123
PNIV V ++ EY + G+L E + G S D + F
Sbjct: 68 PNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFL 127
Query: 124 Q---QLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQPKS 177
Q+ +G+ Y S HRDL N L+ +KI DFG S+ S+ +
Sbjct: 128 HIAIQIAAGMEYLSSHHFVHRDLAARNCLV--GEGLTVKISDFGLSRDIYSADYYRVQSK 185
Query: 178 TVGTPAYIAPEVLL 191
++ ++ PE +L
Sbjct: 186 SLLPVRWMPPEAIL 199
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 4e-06
Identities = 57/196 (29%), Positives = 90/196 (45%), Gaps = 29/196 (14%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNI 79
+ R++++ +G G FG D+K +E AVK + K + + EI +R +
Sbjct: 128 TQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADP 187
Query: 80 V-RFKEVILT------PTHLAIVM-EYASGGELFERICNAGRFSEDE-ARFFFQQLISGV 130
RF + + H+ IVM +Y G L + I G FS A+ FQ ++ +
Sbjct: 188 ADRFPLMKIQRYFQNETGHMCIVMPKY--GPCLLDWIMKHGPFSHRHLAQIIFQTGVA-L 244
Query: 131 SYCHS-MQVCHRDLKLENTLLDGS-------------PAP-RLKICDFGYSKSSVLHSQP 175
Y H+ + + H DLK EN L++ S P P R++ICD G HS+
Sbjct: 245 DYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLG-GCCDERHSR- 302
Query: 176 KSTVGTPAYIAPEVLL 191
+ V T Y +PEV+L
Sbjct: 303 TAIVSTRHYRSPEVVL 318
|
Length = 467 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 6e-06
Identities = 44/157 (28%), Positives = 71/157 (45%), Gaps = 14/157 (8%)
Query: 16 IMHDSDRYELVRDIGSGNFG-VARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSL 74
I +S R E+ +G G FG V + T VA+K ++ G E +E + L
Sbjct: 3 IPRESLRLEV--KLGQGCFGEVWMGTWNGTTR--VAIKTLKPGTMSPEAFLQEAQVMKKL 58
Query: 75 RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSE----DEARFFFQQLISGV 130
RH +V+ V+ + + IV EY S G L + + G + + Q+ SG+
Sbjct: 59 RHEKLVQLYAVV-SEEPIYIVTEYMSKGSLLDFL--KGEMGKYLRLPQLVDMAAQIASGM 115
Query: 131 SYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 167
+Y M HRDL+ N L+ + K+ DFG ++
Sbjct: 116 AYVERMNYVHRDLRAANILVGENLV--CKVADFGLAR 150
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 1e-05
Identities = 55/207 (26%), Positives = 93/207 (44%), Gaps = 37/207 (17%)
Query: 21 DRYELVRDIGSGNFGVARLM------RDKKTEEL-VAVKYIERGDKIDENVQREIINHRS 73
D+ L + +G G FG + +DK E + VAVK ++ D E ++++
Sbjct: 15 DKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLK--DDATEKDLSDLVSEME 72
Query: 74 L-----RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR-----FSEDEAR--- 120
+ +H NI+ L +++EYAS G L E + A R +S D AR
Sbjct: 73 MMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYL-RARRPPGMEYSYDIARVPD 131
Query: 121 --FFFQQLIS-------GVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK--SS 169
F+ L+S G+ Y S + HRDL N L+ + +KI DFG ++ ++
Sbjct: 132 EQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTENNV--MKIADFGLARDVNN 189
Query: 170 VLHSQPKSTVGTPA-YIAPEVLLKKEY 195
+ + + + P ++APE L + Y
Sbjct: 190 IDYYKKTTNGRLPVKWMAPEALFDRVY 216
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 1e-05
Identities = 48/165 (29%), Positives = 69/165 (41%), Gaps = 24/165 (14%)
Query: 25 LVRDIGSGNFGVARL-----MRDKKTEELVAVKYIERGD-KIDENVQREIINHRSLRHPN 78
L R++G G FG L + K + LVAVK ++ ++ QRE +L+H +
Sbjct: 9 LKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEH 68
Query: 79 IVRFKEVILTPTHLAIVMEYASGGEL--FER--------------ICNAGRFSEDEARFF 122
IV+F V L +V EY G+L F R G +
Sbjct: 69 IVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHI 128
Query: 123 FQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 167
Q+ SG+ Y S HRDL N L+ + +KI DFG S+
Sbjct: 129 ASQIASGMVYLASQHFVHRDLATRNCLVGANLL--VKIGDFGMSR 171
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 44.1 bits (104), Expect = 1e-05
Identities = 38/151 (25%), Positives = 63/151 (41%), Gaps = 19/151 (12%)
Query: 27 RDIGSGNFG------VARLMRDKKTEELVAVKYIERGDKIDENVQ--REIINHRSLRHPN 78
+IG+G FG R M + V VK + DE + +E+ +R L HPN
Sbjct: 1 DEIGNGWFGKVLLGEAHRGMSKAR----VVVKELRASATPDEQLLFLQEVQPYRELNHPN 56
Query: 79 IVRFKEVILTPTHLAIVMEYASGGEL-----FERICNAGRFSEDEARFFFQQLISGVSYC 133
+++ + +V+E+ G+L R A +D + ++ SG+ +
Sbjct: 57 VLQCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWL 116
Query: 134 HSMQVCHRDLKLENTLLDGSPAPRLKICDFG 164
H H DL L N L + +KI D+G
Sbjct: 117 HQADFIHSDLALRNCQLTADLS--VKIGDYG 145
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 2e-05
Identities = 50/175 (28%), Positives = 73/175 (41%), Gaps = 29/175 (16%)
Query: 29 IGSGNFG-VARLMRDKKTEEL-VAVKYIERGDKIDENVQREIINHRSL-----RHPNIVR 81
IG GNFG V R M K ++ A+K ++ + EN R+ + HPNI+
Sbjct: 10 IGEGNFGQVIRAMIKKDGLKMNAAIKMLK--EFASENDHRDFAGELEVLCKLGHHPNIIN 67
Query: 82 FKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEA---------RFFFQQLI----- 127
+L I +EYA G L + + + D A QQL+
Sbjct: 68 LLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASD 127
Query: 128 --SGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 180
+G+ Y Q HRDL N L+ + A KI DFG S+ ++ K T+G
Sbjct: 128 VATGMQYLSEKQFIHRDLAARNVLVGENLAS--KIADFGLSRGEEVYV--KKTMG 178
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 2e-05
Identities = 47/161 (29%), Positives = 70/161 (43%), Gaps = 23/161 (14%)
Query: 28 DIGSGNFGVARL-----MRDKKTEELVAVKYI-ERGDKIDENVQREIINHRSLRHPNIVR 81
++G G FG L + ++ + LVAVK + E + ++ QRE L+H +IVR
Sbjct: 12 ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVR 71
Query: 82 FKEVILTPTHLAIVMEYASGGEL--FER-------------ICNAGRFSEDEARFFFQQL 126
F V L +V EY G+L F R G+ + + Q+
Sbjct: 72 FYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQI 131
Query: 127 ISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 167
SG+ Y S+ HRDL N L+ +KI DFG S+
Sbjct: 132 ASGMVYLASLHFVHRDLATRNCLVGQGLV--VKIGDFGMSR 170
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 43.2 bits (102), Expect = 3e-05
Identities = 54/209 (25%), Positives = 85/209 (40%), Gaps = 43/209 (20%)
Query: 21 DRYELVRDIGSGNFG-----VARLMRDKKTEELVAVKYI-------ERGDKIDENVQREI 68
DR L + +G G FG A + + VAVK + + D + E ++
Sbjct: 12 DRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKM 71
Query: 69 INHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARF------- 121
I +H NI+ V L +V+EYA+ G L + + A R + A
Sbjct: 72 IG----KHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFL-RARRPPGEYASPDDPRPPE 126
Query: 122 ----------FFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 171
F Q+ G+ + S + HRDL N L+ + +KI DFG ++ +
Sbjct: 127 ETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLV--TEDHVMKIADFGLARD--I 182
Query: 172 HSQP---KSTVG-TPA-YIAPEVLLKKEY 195
H K+T G P ++APE L + Y
Sbjct: 183 HHIDYYRKTTNGRLPVKWMAPEALFDRVY 211
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 3e-05
Identities = 34/151 (22%), Positives = 66/151 (43%), Gaps = 8/151 (5%)
Query: 39 LMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98
L+ D +T++ +K + + + + II H PN+V + I++ + +V+++
Sbjct: 11 LVMDTRTQQTFILKGLRKSSEYSRE-RLTIIPHCV---PNMVCLHKYIVSEDSVFLVLQH 66
Query: 99 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRL 158
A GG+L+ I E+ + + +++ + H + RDL N LLD +L
Sbjct: 67 AEGGKLWSHISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQL 126
Query: 159 KICDFGYSKSSVLHSQPKSTVGTPAYIAPEV 189
+S+ S + Y APEV
Sbjct: 127 TY----FSRWSEVEDSCDGEAVENMYCAPEV 153
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 3e-05
Identities = 43/175 (24%), Positives = 68/175 (38%), Gaps = 29/175 (16%)
Query: 29 IGSGNFG-VARLMRDKKTEEL-VAVKYIERGDKIDENVQREIINHRSL-----RHPNIVR 81
IG GNFG V + K + A+K ++ + ++ R+ + HPNI+
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDAAIKRMK--EYASKDDHRDFAGELEVLCKLGHHPNIIN 60
Query: 82 FKEVILTPTHLAIVMEYASGGELFE-----RIC-----------NAGRFSEDEARFFFQQ 125
+L + +EYA G L + R+ A S + F
Sbjct: 61 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 120
Query: 126 LISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 180
+ G+ Y Q HRDL N L+ + KI DFG S+ ++ K T+G
Sbjct: 121 VARGMDYLSQKQFIHRDLAARNILVGENYVA--KIADFGLSRGQEVYV--KKTMG 171
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 3e-05
Identities = 39/168 (23%), Positives = 66/168 (39%), Gaps = 34/168 (20%)
Query: 25 LVRDIGSGNFGV---ARLMRDKKTEELVAVKYIERGDKIDENVQREI-------INHRSL 74
L + +G G FG +L +D ++ VAVK + K+D + EI +
Sbjct: 3 LGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTM----KLDIHTYSEIEEFLSEAACMKDF 58
Query: 75 RHPNIVRFKEVILTPTHLA------IVMEYASGGELFERICNAGRFSEDEARFFFQQLI- 127
HPN+++ V + L +++ + G+L + R + Q L+
Sbjct: 59 DHPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLL-YSRLGGLPEKLPLQTLLK 117
Query: 128 ------SGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKIC--DFGYSK 167
G+ Y + HRDL N +L + +C DFG SK
Sbjct: 118 FMVDIALGMEYLSNRNFIHRDLAARNCMLRED----MTVCVADFGLSK 161
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 5e-05
Identities = 41/148 (27%), Positives = 66/148 (44%), Gaps = 9/148 (6%)
Query: 27 RDIGSGNFGV---ARLMRDKKTEELVAVKYIERGDKIDENVQ--REIINHRSLRHPNIVR 81
R IG G+FG L+ + AVK + R ++E Q +E I + HPN++
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLS 60
Query: 82 FKEVILTPTHLA-IVMEYASGGELFERICNAGRF-SEDEARFFFQQLISGVSYCHSMQVC 139
+ L +V+ Y G+L I + + + F Q+ G+ Y S +
Sbjct: 61 LLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFV 120
Query: 140 HRDLKLENTLLDGSPAPRLKICDFGYSK 167
HRDL N +LD S +K+ DFG ++
Sbjct: 121 HRDLAARNCMLDESFT--VKVADFGLAR 146
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 42.4 bits (100), Expect = 5e-05
Identities = 36/155 (23%), Positives = 71/155 (45%), Gaps = 14/155 (9%)
Query: 22 RYELVRDIGSGNFGV---ARLMRDKKTEEL-VAVKYIERGDKIDENVQREIINH----RS 73
E ++ +GSG FG + + + ++ VA+K + ++ +EI++ S
Sbjct: 8 ELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLR--EETSPKANKEILDEAYVMAS 65
Query: 74 LRHPNIVRFKEVILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSY 132
+ HP++VR + L+ ++ + G L + + + + Q+ G+SY
Sbjct: 66 VDHPHVVRLLGICLSSQV-QLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSY 124
Query: 133 CHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 167
++ HRDL N L+ +P +KI DFG +K
Sbjct: 125 LEEKRLVHRDLAARNVLVK-TPQ-HVKITDFGLAK 157
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 6e-05
Identities = 30/158 (18%), Positives = 59/158 (37%), Gaps = 18/158 (11%)
Query: 41 RDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYAS 100
E V +K + + L H ++V+ V + ++ +V EY
Sbjct: 25 VGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKHLVKLYGVCVRDENI-MVEEYVK 83
Query: 101 GGEL-----FERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLL----- 150
G L E+ + + D A +QL S + Y ++ H ++ +N L+
Sbjct: 84 FGPLDVFLHREKNNVSLHWKLDVA----KQLASALHYLEDKKLVHGNVCGKNILVARYGL 139
Query: 151 DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPE 188
+ P +K+ D G + + + + +IAPE
Sbjct: 140 NEGYVPFIKLSDPGIPITVLSREERVERI---PWIAPE 174
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 9e-05
Identities = 44/193 (22%), Positives = 74/193 (38%), Gaps = 30/193 (15%)
Query: 29 IGSGNFGVARLMRDKKTEE-----LVAVKYIERGDKIDENVQ----REIINHRSLRHPNI 79
+G G FG L + K EE LV VK +++ DEN+Q RE+ R L H N+
Sbjct: 13 LGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK--DENLQSEFRRELDMFRKLSHKNV 70
Query: 80 VRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLIS-------GV 130
VR + +++EY G+L F R + +Q ++ G+
Sbjct: 71 VRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGM 130
Query: 131 SYCHSMQVCHRDLKLENTLLDGS-----PAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI 185
+ + + HRDL N L+ L Y+ + ++
Sbjct: 131 DHLSNARFVHRDLAARNCLVSSQREVKVSLLSL--SKDVYNSEYYKLRNALIPL---RWL 185
Query: 186 APEVLLKKEYDGK 198
APE + + ++ K
Sbjct: 186 APEAVQEDDFSTK 198
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 1e-04
Identities = 30/80 (37%), Positives = 38/80 (47%), Gaps = 15/80 (18%)
Query: 124 QQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKIC--DFGY------SKSSVLHSQP 175
+QL+S + Y H + HRD+K EN L++G IC DFG S S+ H
Sbjct: 267 RQLLSAIDYIHGEGIIHRDIKTENVLVNGPE----DICLGDFGAACFARGSWSTPFHYGI 322
Query: 176 KSTVGTPAYIAPEVLLKKEY 195
TV T APEVL Y
Sbjct: 323 AGTVDTN---APEVLAGDPY 339
|
Length = 461 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 2e-04
Identities = 41/149 (27%), Positives = 71/149 (47%), Gaps = 10/149 (6%)
Query: 26 VRDIGSGNFGVAR---LMRDKKTEEL-VAVKYIER--GDKIDENVQREIINHRSLRHPNI 79
V+ +GSG FG + + +T ++ VA+K + G K + E + S+ HP++
Sbjct: 12 VKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHL 71
Query: 80 VRFKEVILTPTHLAIVMEYASGGELFERIC-NAGRFSEDEARFFFQQLISGVSYCHSMQV 138
VR V L+PT + +V + G L + + + + Q+ G+ Y ++
Sbjct: 72 VRLLGVCLSPT-IQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRL 130
Query: 139 CHRDLKLENTLLDGSPAPRLKICDFGYSK 167
HRDL N L+ SP +KI DFG ++
Sbjct: 131 VHRDLAARNVLVK-SPN-HVKITDFGLAR 157
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 3e-04
Identities = 32/124 (25%), Positives = 55/124 (44%), Gaps = 22/124 (17%)
Query: 47 ELVAVKYIERGDKID----ENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGG 102
+ VA+K ++ DK + E + E + L+HPNIV V+ L+++ Y S
Sbjct: 36 QAVAIKTLK--DKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHS 93
Query: 103 ELFERIC------NAGRFSEDE--------ARFF--FQQLISGVSYCHSMQVCHRDLKLE 146
+L E + + G +D+ A F Q+ +G+ + S V H+DL
Sbjct: 94 DLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATR 153
Query: 147 NTLL 150
N L+
Sbjct: 154 NVLV 157
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 39.9 bits (93), Expect = 4e-04
Identities = 39/149 (26%), Positives = 64/149 (42%), Gaps = 11/149 (7%)
Query: 27 RDIGSGNFGVARL--MRDKKTEELVAVKYIERGDKIDENVQ--REIINHRSLRHPNIVRF 82
++IG+G FG L + T V VK + + E ++ E +RSL+H N+++
Sbjct: 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQC 60
Query: 83 KEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQ---QLISGVSYCHSMQ 137
T +VME+ G+L + R C + + ++ G+ + H
Sbjct: 61 LGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN 120
Query: 138 VCHRDLKLENTLLDGSPAPRLKICDFGYS 166
H DL L N LL +KI D+G S
Sbjct: 121 FIHSDLALRNCLLTADLT--VKIGDYGLS 147
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 4e-04
Identities = 46/175 (26%), Positives = 70/175 (40%), Gaps = 29/175 (16%)
Query: 29 IGSGNFGV---ARLMRDKKTEELVAVK----YIERGDKIDENVQREIINHRSLRHPNIVR 81
IG GNFG AR+ +D + A+K Y + D D + E++ + HPNI+
Sbjct: 15 IGEGNFGQVLKARIKKDGLRMD-AAIKRMKEYASKDDHRDFAGELEVLC-KLGHHPNIIN 72
Query: 82 FKEVILTPTHLAIVMEYASGGELFERI----------------CNAGRFSEDEARFFFQQ 125
+L + +EYA G L + + A S + F
Sbjct: 73 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 132
Query: 126 LISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 180
+ G+ Y Q HRDL N L+ + KI DFG S+ ++ K T+G
Sbjct: 133 VARGMDYLSQKQFIHRDLAARNILVGENYVA--KIADFGLSRGQEVYV--KKTMG 183
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 39.8 bits (93), Expect = 6e-04
Identities = 44/177 (24%), Positives = 73/177 (41%), Gaps = 23/177 (12%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILT 88
I G G + + K VK I + I + EI + L+HPNIV+ + +
Sbjct: 698 ISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSS---EIADMGKLQHPNIVKLIGLCRS 754
Query: 89 PTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS------YCH-SMQVCHR 141
++ EY G L E + N E R +++ G++ +C S V
Sbjct: 755 EKGAYLIHEYIEGKNLSEVLRNLSW----ERR---RKIAIGIAKALRFLHCRCSPAVVVG 807
Query: 142 DLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGK 198
+L E ++DG P L++ S +L + K + + AY+APE K+ K
Sbjct: 808 NLSPEKIIIDGKDEPHLRL-----SLPGLLCTDTKCFISS-AYVAPETRETKDITEK 858
|
Length = 968 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 6e-04
Identities = 56/206 (27%), Positives = 93/206 (45%), Gaps = 37/206 (17%)
Query: 22 RYELVRDIGSGNFGVARLM------RDKKTEEL-VAVKYIERGDKIDENVQREIINHRSL 74
R L + +G G FG + +DK + + VAVK + + D D+++ ++++ +
Sbjct: 13 RLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKML-KDDATDKDLS-DLVSEMEM 70
Query: 75 -----RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR-----FSED-----EA 119
+H NI+ L +++EYAS G L E + A R +S D E
Sbjct: 71 MKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYL-RARRPPGMDYSFDTCKLPEE 129
Query: 120 RFFFQQLIS-------GVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVL 171
+ F+ L+S G+ Y S + HRDL N L+ +KI DFG ++ +
Sbjct: 130 QLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDNV--MKIADFGLARDVHNI 187
Query: 172 HSQPKSTVGT-PA-YIAPEVLLKKEY 195
K+T G P ++APE L + Y
Sbjct: 188 DYYKKTTNGRLPVKWMAPEALFDRVY 213
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 38.8 bits (90), Expect = 0.001
Identities = 38/145 (26%), Positives = 61/145 (42%), Gaps = 29/145 (20%)
Query: 48 LVAVKYIERGDKIDENVQREIINH----RSLRHPNIVRFKEVILTPTHLAIVMEYASGGE 103
LVAVK I R D ++N + + + L+ PNI+R V + L ++ EY G+
Sbjct: 48 LVAVK-ILRPDA-NKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGD 105
Query: 104 LFERICNAGRFSEDEAR--------------------FFFQQLISGVSYCHSMQVCHRDL 143
L + ++ + E Q+ SG+ Y S+ HRDL
Sbjct: 106 L-NQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDL 164
Query: 144 KLENTLLDGSPAPRLKICDFGYSKS 168
N L+ + +KI DFG S++
Sbjct: 165 ATRNCLVGENLT--IKIADFGMSRN 187
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 38.8 bits (90), Expect = 0.001
Identities = 49/207 (23%), Positives = 82/207 (39%), Gaps = 42/207 (20%)
Query: 29 IGSGNFG-----VARLMRDKKTEELVAVKYIERGDKIDE--NVQREIINHRSLRHPNIVR 81
+G G FG A ++ + VAVK ++ E ++ E + + HP++++
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIK 67
Query: 82 FKEVILTPTHLAIVMEYASGGEL--FERIC---------------NAGRFSEDEARFFFQ 124
L +++EYA G L F R ++ + DE
Sbjct: 68 LYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMG 127
Query: 125 QLIS-------GVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK------SSVL 171
LIS G+ Y M++ HRDL N L+ + ++KI DFG S+ S V
Sbjct: 128 DLISFAWQISRGMQYLAEMKLVHRDLAARNVLV--AEGRKMKISDFGLSRDVYEEDSYVK 185
Query: 172 HSQPKSTVGTPAYIAPEVLLKKEYDGK 198
S+ + V ++A E L Y +
Sbjct: 186 RSKGRIPV---KWMAIESLFDHIYTTQ 209
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 38.4 bits (89), Expect = 0.001
Identities = 57/207 (27%), Positives = 93/207 (44%), Gaps = 37/207 (17%)
Query: 21 DRYELVRDIGSGNFG-VARLMR---DKKTEE---LVAVKYIERGDKIDENVQREIINHRS 73
DR L + +G G FG V R DK + VAVK + + + D+++ ++I+
Sbjct: 12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKML-KDNATDKDLA-DLISEME 69
Query: 74 L-----RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR-----FSED-----E 118
L +H NI+ V L +++EYA+ G L E + A R ++ D E
Sbjct: 70 LMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFL-RARRPPGPDYTFDITKVPE 128
Query: 119 ARFFFQQLIS-------GVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS--S 169
+ F+ L+S G+ Y S + HRDL N L+ +KI DFG ++
Sbjct: 129 EQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTEDNV--MKIADFGLARGVHD 186
Query: 170 VLHSQPKSTVGTPA-YIAPEVLLKKEY 195
+ + + S P ++APE L + Y
Sbjct: 187 IDYYKKTSNGRLPVKWMAPEALFDRVY 213
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 38.1 bits (88), Expect = 0.001
Identities = 37/141 (26%), Positives = 62/141 (43%), Gaps = 6/141 (4%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILT 88
+G G FG + T + VA+K ++ G + E +E + LRH +V V+ +
Sbjct: 14 LGQGCFGEVWMGTWNGTTK-VAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVV-S 71
Query: 89 PTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLE 146
+ IV E+ G L F + + + Q+ G++Y M HRDL+
Sbjct: 72 EEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAA 131
Query: 147 NTLLDGSPAPRLKICDFGYSK 167
N L+ + KI DFG ++
Sbjct: 132 NILVGDNLV--CKIADFGLAR 150
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 37.7 bits (87), Expect = 0.002
Identities = 35/152 (23%), Positives = 71/152 (46%), Gaps = 10/152 (6%)
Query: 23 YELVRDIGSGNFG-VARLMRDKKTEEL---VAVKYIERGD--KIDENVQREIINHRSLRH 76
++ ++ +GSG FG V + + + E++ VA+K + K ++ + E S+ +
Sbjct: 9 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 68
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERIC-NAGRFSEDEARFFFQQLISGVSYCHS 135
P++ R + LT T + ++ + G L + + + + Q+ G++Y
Sbjct: 69 PHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEE 127
Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 167
++ HRDL N L+ +KI DFG +K
Sbjct: 128 RRLVHRDLAARNVLVKT--PQHVKITDFGLAK 157
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 37.4 bits (87), Expect = 0.002
Identities = 27/107 (25%), Positives = 40/107 (37%), Gaps = 25/107 (23%)
Query: 72 RSLRHPNIVRFKEVILTPTHLAI--------VMEYASGGEL--FERIC------NAGRFS 115
L H NI L H+ I + Y + G L F + C N S
Sbjct: 63 YGLSHQNI-------LPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALS 115
Query: 116 EDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICD 162
+ Q+ G+SY H V H+D+ N ++D ++KI D
Sbjct: 116 TQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEE--LQVKITD 160
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 37.2 bits (86), Expect = 0.003
Identities = 44/166 (26%), Positives = 69/166 (41%), Gaps = 26/166 (15%)
Query: 23 YELVRDIGSGNFGVAR---LMRDKKTEELVAVKYIERGDKIDENVQ---REIINHRSLRH 76
+ L R +G G FG R L + + + VAVK ++ +++ RE + H
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60
Query: 77 PNIVRFKEVIL---TPTHLAIVM---EYASGGELFERICNAGRFSEDEARFFFQQLI--- 127
PN+++ V L L I M + G+L + R E+ Q L+
Sbjct: 61 PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLL-MSRIGEEPFTLPLQTLVRFM 119
Query: 128 ----SGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKIC--DFGYSK 167
SG+ Y S HRDL N +L+ + + +C DFG SK
Sbjct: 120 IDIASGMEYLSSKNFIHRDLAARNCMLNEN----MTVCVADFGLSK 161
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 36.9 bits (85), Expect = 0.004
Identities = 40/159 (25%), Positives = 71/159 (44%), Gaps = 16/159 (10%)
Query: 42 DKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM-EYAS 100
D KT E V +K +RG E I+ R++ HP+I++ K +++ Y +
Sbjct: 113 DNKTCEHVVIKAGQRGGTATE---AHIL--RAINHPSIIQLKGTFTYNKFTCLILPRYKT 167
Query: 101 GGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKI 160
+L+ + + + + ++ + Y H ++ HRD+K EN ++ P +
Sbjct: 168 --DLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFIN-HPG---DV 221
Query: 161 C--DFGYSKSSVLHSQPK--STVGTPAYIAPEVLLKKEY 195
C DFG + V + K GT A APE+L + Y
Sbjct: 222 CLGDFGAACFPVDINANKYYGWAGTIATNAPELLARDPY 260
|
Length = 391 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 205 | |||
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.98 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 99.98 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 99.98 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 99.98 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.98 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.98 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 99.98 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 99.98 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 99.98 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 99.98 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 99.98 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 99.98 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 99.98 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 99.98 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.98 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.98 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.98 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 99.98 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 99.98 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 99.98 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 99.98 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 99.98 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 99.98 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.97 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 99.97 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 99.97 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 99.97 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.97 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.97 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.97 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 99.97 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 99.97 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 99.97 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 99.97 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.97 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 99.97 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.97 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 99.97 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.97 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.97 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.97 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.97 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 99.97 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 99.97 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 99.97 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.97 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.97 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.97 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 99.97 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 99.97 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.97 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.97 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.97 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.97 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 99.97 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.97 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.97 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.97 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 99.97 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.96 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.96 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.96 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 99.96 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.96 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.96 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.96 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.96 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.96 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.96 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.96 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.96 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.95 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.95 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.95 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.95 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 99.95 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.95 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.95 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.95 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.94 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.94 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.93 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.93 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.93 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.93 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.93 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.92 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.92 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.9 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.89 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.88 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.88 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.88 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.87 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.86 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.86 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.85 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.85 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.84 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.83 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.82 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.81 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.77 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.77 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.77 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.74 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.73 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.72 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.71 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.68 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.64 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.62 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.61 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.61 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.59 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.55 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.54 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.5 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.5 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.48 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.42 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.41 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.41 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.37 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.33 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.3 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.26 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.23 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 99.19 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.15 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 99.12 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 99.07 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 99.0 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 99.0 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.83 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.77 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.77 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.69 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.68 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.64 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.59 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 98.51 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.49 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.47 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.47 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.46 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 98.44 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.43 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 98.4 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 98.28 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.26 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 98.12 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 98.11 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 98.05 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 98.01 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 98.0 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.95 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.9 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.73 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 97.63 | |
| PLN02236 | 344 | choline kinase | 97.63 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 97.58 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.56 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.55 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 97.55 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 97.5 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 97.44 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 97.35 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 97.34 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 97.33 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 97.32 | |
| PTZ00384 | 383 | choline kinase; Provisional | 97.25 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 97.17 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 97.05 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 97.02 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 96.94 | |
| PTZ00296 | 442 | choline kinase; Provisional | 96.67 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 96.26 | |
| KOG2269 | 531 | consensus Serine/threonine protein kinase [Signal | 96.24 | |
| smart00587 | 196 | CHK ZnF_C4 abd HLH domain containing kinases domai | 95.93 | |
| COG3231 | 266 | Aph Aminoglycoside phosphotransferase [Translation | 95.84 |
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-47 Score=280.91 Aligned_cols=186 Identities=40% Similarity=0.640 Sum_probs=173.6
Q ss_pred cCCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCc---cchHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEE
Q 028681 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV 95 (205)
Q Consensus 19 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 95 (205)
..++|.+.+.||.|+|++||.++++.++..||||.+.+.. ...+.+..|+.+|+.++||||+.+++.+..++++|+|
T Consensus 8 ~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lV 87 (429)
T KOG0595|consen 8 VVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLV 87 (429)
T ss_pred ccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEE
Confidence 4689999999999999999999999999999999997653 3456788999999999999999999999999999999
Q ss_pred EEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCC-CC---CcEEEeeecccccccC
Q 028681 96 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGS-PA---PRLKICDFGYSKSSVL 171 (205)
Q Consensus 96 ~~~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~-~~---~~~~l~df~~~~~~~~ 171 (205)
||||.+|+|.+++++.+.+++..++.++.|++.|+++||+++|+||||||.|||++.+ .. ..+||+|||+|+...+
T Consensus 88 MEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~~ 167 (429)
T KOG0595|consen 88 MEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQP 167 (429)
T ss_pred EEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhhCCc
Confidence 9999999999999999999999999999999999999999999999999999999875 22 4599999999999999
Q ss_pred CCCCCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 172 HSQPKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 172 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
.....+.+|++.|||||++..+.|+.| +|+||+
T Consensus 168 ~~~a~tlcGSplYMAPEV~~~~~YdAK-ADLWSi 200 (429)
T KOG0595|consen 168 GSMAETLCGSPLYMAPEVIMSQQYDAK-ADLWSI 200 (429)
T ss_pred hhHHHHhhCCccccCHHHHHhccccch-hhHHHH
Confidence 999999999999999999999999977 999985
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-46 Score=275.22 Aligned_cols=186 Identities=39% Similarity=0.622 Sum_probs=169.0
Q ss_pred CCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCccch--------HHHHHHHHHHHhcCCCCeeEEEEEEEeCCe
Q 028681 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID--------ENVQREIINHRSLRHPNIVRFKEVILTPTH 91 (205)
Q Consensus 20 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~--------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 91 (205)
.+.|.+.+.||+|+||.|-+|..+.+++.||+|++++..... ....+|+++|++|+||||+++.++|..+.+
T Consensus 171 ~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds 250 (475)
T KOG0615|consen 171 NDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDS 250 (475)
T ss_pred cceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCc
Confidence 577899999999999999999999999999999998753221 235799999999999999999999999999
Q ss_pred EEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCC-CCCcEEEeeeccccccc
Q 028681 92 LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGS-PAPRLKICDFGYSKSSV 170 (205)
Q Consensus 92 ~~lv~~~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~-~~~~~~l~df~~~~~~~ 170 (205)
.|+|+||+.+|.|.+.+..++.+.+...+.+++|++.|+.|||++||+||||||+|||+..+ ....+||+|||+|+...
T Consensus 251 ~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK~~g 330 (475)
T KOG0615|consen 251 SYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLAKVSG 330 (475)
T ss_pred eEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchhhccc
Confidence 99999999999999999999999999999999999999999999999999999999999866 23359999999999999
Q ss_pred CCCCCCCCCCCCCccCCceeccCcC--CCeeeEEEeC
Q 028681 171 LHSQPKSTVGTPAYIAPEVLLKKEY--DGKVMCVYVI 205 (205)
Q Consensus 171 ~~~~~~~~~~~~~~~aPE~~~~~~~--~~~~~Dvwsl 205 (205)
......+.+||+.|.|||++.++.+ +.++.|+|||
T Consensus 331 ~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSl 367 (475)
T KOG0615|consen 331 EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSL 367 (475)
T ss_pred cceehhhhcCCccccChhheecCCeecccchheeeec
Confidence 8899999999999999999987654 4556899997
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-44 Score=280.37 Aligned_cols=182 Identities=38% Similarity=0.589 Sum_probs=171.6
Q ss_pred CCeEEEeeeccccceeEEEEEecCCCcEEEEEEeec----CccchHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEE
Q 028681 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER----GDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (205)
Q Consensus 21 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 96 (205)
.+|+..+.||+|+|..+|.+++..+|..||+|++.+ .....+.+.+|++++++|+|||||+++++|++.+++|+|.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 679999999999999999999999999999999987 4566788999999999999999999999999999999999
Q ss_pred EecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCC-CCC
Q 028681 97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQP 175 (205)
Q Consensus 97 ~~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~-~~~ 175 (205)
|.|..++|.+++++.+++++.+++.+++||+.|+.|||+++|+|||||..|+|++++.+ |||+|||+|...... ...
T Consensus 98 ELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~--VKIgDFGLAt~le~~~Erk 175 (592)
T KOG0575|consen 98 ELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMN--VKIGDFGLATQLEYDGERK 175 (592)
T ss_pred EecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCc--EEecccceeeeecCccccc
Confidence 99999999999998889999999999999999999999999999999999999998887 999999999887644 777
Q ss_pred CCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 176 KSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 176 ~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
.+.+||+.|+|||++.+..++-. +||||+
T Consensus 176 ~TlCGTPNYIAPEVl~k~gHsfE-vDiWSl 204 (592)
T KOG0575|consen 176 KTLCGTPNYIAPEVLNKSGHSFE-VDIWSL 204 (592)
T ss_pred ceecCCCcccChhHhccCCCCCc-hhhhhh
Confidence 88899999999999999888877 999996
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-45 Score=267.77 Aligned_cols=186 Identities=35% Similarity=0.584 Sum_probs=170.4
Q ss_pred eecCCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCcc----chHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeE
Q 028681 17 MHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK----IDENVQREIINHRSLRHPNIVRFKEVILTPTHL 92 (205)
Q Consensus 17 ~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 92 (205)
....++|++++.||+|+||+||+|+.+.+++.+|+|++++... .......|..+|..++||+|+++...|++...+
T Consensus 21 ~~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kL 100 (357)
T KOG0598|consen 21 MVGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKL 100 (357)
T ss_pred cCChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeE
Confidence 3457999999999999999999999999999999999987542 345678899999999999999999999999999
Q ss_pred EEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccc-cC
Q 028681 93 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS-VL 171 (205)
Q Consensus 93 ~lv~~~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~-~~ 171 (205)
|+|+||+.||.|...+++++.+++..++.++.+|+.||.|||+.||+|||+||+|||++..++ ++|+|||+|+.. ..
T Consensus 101 ylVld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GH--i~LtDFgL~k~~~~~ 178 (357)
T KOG0598|consen 101 YLVLDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGH--IKLTDFGLCKEDLKD 178 (357)
T ss_pred EEEEeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCc--EEEeccccchhcccC
Confidence 999999999999999999999999999999999999999999999999999999999999888 999999999854 44
Q ss_pred CCCCCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 172 HSQPKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 172 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
+....+.+||+.|+|||++.+..|+.. +|+|||
T Consensus 179 ~~~t~tfcGT~eYmAPEil~~~gy~~~-vDWWsL 211 (357)
T KOG0598|consen 179 GDATRTFCGTPEYMAPEILLGKGYDKA-VDWWSL 211 (357)
T ss_pred CCccccccCCccccChHHHhcCCCCcc-cchHhH
Confidence 455666799999999999999999855 999997
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-45 Score=266.86 Aligned_cols=184 Identities=31% Similarity=0.463 Sum_probs=168.7
Q ss_pred ecCCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeec--CccchHHHHHHHHHHHhcCCCCeeEEEEEEEeCCe-EEE
Q 028681 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER--GDKIDENVQREIINHRSLRHPNIVRFKEVILTPTH-LAI 94 (205)
Q Consensus 18 ~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-~~l 94 (205)
...++.+.+..||+|..|+||++.++.+++.+|+|++.. +.....++..|+.+++..+||+|+.+||.|.++.. ..+
T Consensus 76 i~~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI 155 (364)
T KOG0581|consen 76 ISLSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISI 155 (364)
T ss_pred cCHHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEe
Confidence 334588999999999999999999999999999999944 34456788999999999999999999999999994 999
Q ss_pred EEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-cCcEeecCCCCCeEecCCCCCcEEEeeecccccccCCC
Q 028681 95 VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS-MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 173 (205)
Q Consensus 95 v~~~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~-~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~~ 173 (205)
+||||++|||..++...+.+++..+..++.++++||.|||+ ++|+||||||+|||++..+. |||+|||.+......
T Consensus 156 ~mEYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGe--VKicDFGVS~~lvnS- 232 (364)
T KOG0581|consen 156 CMEYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGE--VKICDFGVSGILVNS- 232 (364)
T ss_pred ehhhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCC--EEeccccccHHhhhh-
Confidence 99999999999999888889999999999999999999995 99999999999999988887 999999999876555
Q ss_pred CCCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 174 QPKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 174 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
...+..||..|||||-+.+..|+.+ +|||||
T Consensus 233 ~a~tfvGT~~YMsPERi~g~~Ys~~-sDIWSL 263 (364)
T KOG0581|consen 233 IANTFVGTSAYMSPERISGESYSVK-SDIWSL 263 (364)
T ss_pred hcccccccccccChhhhcCCcCCcc-cceecc
Confidence 6678889999999999999999988 999997
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-43 Score=252.16 Aligned_cols=183 Identities=33% Similarity=0.595 Sum_probs=170.4
Q ss_pred ecCCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCcc----chHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEE
Q 028681 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK----IDENVQREIINHRSLRHPNIVRFKEVILTPTHLA 93 (205)
Q Consensus 18 ~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 93 (205)
...++|+.++.||.|+||.|.+++++.++.-+|+|++++++. ..+...+|..+|+.+.||+++++++.|.+.++++
T Consensus 41 ~~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~ly 120 (355)
T KOG0616|consen 41 YSLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLY 120 (355)
T ss_pred cchhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEE
Confidence 457899999999999999999999999999999999988653 3466889999999999999999999999999999
Q ss_pred EEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCCC
Q 028681 94 IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 173 (205)
Q Consensus 94 lv~~~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~~ 173 (205)
+||||.++|.|-..+++.+++++..++.++.|++.|++|||+++|++||+||+|||++.++. +||+|||.|+....
T Consensus 121 mvmeyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~--iKitDFGFAK~v~~-- 196 (355)
T KOG0616|consen 121 MVMEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGH--IKITDFGFAKRVSG-- 196 (355)
T ss_pred EEEeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCc--EEEEeccceEEecC--
Confidence 99999999999999999999999999999999999999999999999999999999999998 99999999986653
Q ss_pred CCCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 174 QPKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 174 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
.+.+.+||+.|+|||++..+++... +|+|||
T Consensus 197 rT~TlCGTPeYLAPEii~sk~ynka-vDWWal 227 (355)
T KOG0616|consen 197 RTWTLCGTPEYLAPEIIQSKGYNKA-VDWWAL 227 (355)
T ss_pred cEEEecCCccccChHHhhcCCCCcc-hhHHHH
Confidence 3788999999999999999999755 999986
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=260.46 Aligned_cols=186 Identities=53% Similarity=0.815 Sum_probs=170.6
Q ss_pred ecCCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecC----c--cchHHHHHHHHHHHhcC-CCCeeEEEEEEEeCC
Q 028681 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG----D--KIDENVQREIINHRSLR-HPNIVRFKEVILTPT 90 (205)
Q Consensus 18 ~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~----~--~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~ 90 (205)
...++|.+.+.||+|+||+|+.+.+..++..||+|++.+. . ...+.+.+|+.+++.++ ||||+++++++....
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 4467999999999999999999999999999999987664 1 23456778999999999 999999999999999
Q ss_pred eEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCC-CCCcEEEeeecccccc
Q 028681 91 HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGS-PAPRLKICDFGYSKSS 169 (205)
Q Consensus 91 ~~~lv~~~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~-~~~~~~l~df~~~~~~ 169 (205)
.+++||||+.+|.|.+.+...+++.+..++.+++|++.|++|+|++||+||||||+||+++.+ ++ +||+|||++...
T Consensus 94 ~~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~--~Kl~DFG~s~~~ 171 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGN--LKLSDFGLSAIS 171 (370)
T ss_pred eEEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCC--EEEecccccccc
Confidence 999999999999999999988899999999999999999999999999999999999999988 65 999999999887
Q ss_pred -cCCCCCCCCCCCCCccCCceeccCc-CCCeeeEEEeC
Q 028681 170 -VLHSQPKSTVGTPAYIAPEVLLKKE-YDGKVMCVYVI 205 (205)
Q Consensus 170 -~~~~~~~~~~~~~~~~aPE~~~~~~-~~~~~~Dvwsl 205 (205)
..+....+.+|++.|+|||++.+.. |+.+++||||+
T Consensus 172 ~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~ 209 (370)
T KOG0583|consen 172 PGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSL 209 (370)
T ss_pred CCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhh
Confidence 5667778889999999999999988 99899999996
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-41 Score=254.88 Aligned_cols=196 Identities=30% Similarity=0.491 Sum_probs=168.7
Q ss_pred ccCCCcccCceecCCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCcc---chHHHHHHHHHHHhcCCCCeeEEE
Q 028681 7 TVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFK 83 (205)
Q Consensus 7 ~~~~~~~~~~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~ 83 (205)
.+++....+.....+.|+.+++||+|.||.||++++..+|+.||+|.+..... ...-..+|+.+|++|.||||+++.
T Consensus 103 ~~ge~~~~w~~r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~ 182 (560)
T KOG0600|consen 103 VAGEALHGWGPRRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLE 182 (560)
T ss_pred ccccccccccccchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCccccee
Confidence 34555556777788999999999999999999999999999999999976542 234578899999999999999999
Q ss_pred EEEEeC--CeEEEEEEecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEE
Q 028681 84 EVILTP--THLAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKI 160 (205)
Q Consensus 84 ~~~~~~--~~~~lv~~~~~~~sl~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l 160 (205)
+...+. +.+|+|||||+. +|..++... -.|++.+++.++.|++.||+|+|.+|+.|||||.+||||+.++. +||
T Consensus 183 eivt~~~~~siYlVFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~--LKi 259 (560)
T KOG0600|consen 183 EIVTSKLSGSIYLVFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGV--LKI 259 (560)
T ss_pred eEEEecCCceEEEEEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCC--EEe
Confidence 998877 689999999965 788888663 36999999999999999999999999999999999999998888 999
Q ss_pred eeecccccccCCCC--CCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 161 CDFGYSKSSVLHSQ--PKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 161 ~df~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
+|||+|+.+.+... .....-|+.|.|||.+.+..-.....|+||.
T Consensus 260 aDFGLAr~y~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~ 306 (560)
T KOG0600|consen 260 ADFGLARFYTPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSV 306 (560)
T ss_pred ccccceeeccCCCCcccccceEEeeccChHHhcCCcccccceeehhh
Confidence 99999997766653 3455679999999999987654455999984
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=252.69 Aligned_cols=187 Identities=35% Similarity=0.454 Sum_probs=164.0
Q ss_pred cCceecCCCeEEEeeeccccceeEEEEEecCCCcE-EEEEEeecCccc---hHHHHHHHHHHHhcCCCCeeEEEEEEEeC
Q 028681 14 MPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEEL-VAVKYIERGDKI---DENVQREIINHRSLRHPNIVRFKEVILTP 89 (205)
Q Consensus 14 ~~~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~-v~iK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 89 (205)
.....+.+...+.+.||.|+||+||.+.... .. ||+|++...... .+.+..|+.++.+++||||++++|++.++
T Consensus 34 ~~~~i~~~~l~~~~~iG~G~~g~V~~~~~~g--~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~ 111 (362)
T KOG0192|consen 34 PEEEIDPDELPIEEVLGSGSFGTVYKGKWRG--TDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSP 111 (362)
T ss_pred cceecChHHhhhhhhcccCCceeEEEEEeCC--ceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence 4455667888888899999999999998874 44 999999876533 45899999999999999999999999998
Q ss_pred C-eEEEEEEecCCCchHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhcC-cEeecCCCCCeEecCCC-CCcEEEeeec
Q 028681 90 T-HLAIVMEYASGGELFERICN--AGRFSEDEARFFFQQLISGVSYCHSMQ-VCHRDLKLENTLLDGSP-APRLKICDFG 164 (205)
Q Consensus 90 ~-~~~lv~~~~~~~sl~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lh~~~-i~H~di~p~nili~~~~-~~~~~l~df~ 164 (205)
. ..++||||+++|+|.+++.. ...++...+..++.+|+.|++|||+++ |||+||||+|||++.+. . +||+|||
T Consensus 112 ~~~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~--~KI~DFG 189 (362)
T KOG0192|consen 112 PGSLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKT--LKIADFG 189 (362)
T ss_pred CCceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCE--EEECCCc
Confidence 7 79999999999999999987 578999999999999999999999999 99999999999999886 5 9999999
Q ss_pred ccccccCC-CCCCCCCCCCCccCCceec--cCcCCCeeeEEEeC
Q 028681 165 YSKSSVLH-SQPKSTVGTPAYIAPEVLL--KKEYDGKVMCVYVI 205 (205)
Q Consensus 165 ~~~~~~~~-~~~~~~~~~~~~~aPE~~~--~~~~~~~~~Dvwsl 205 (205)
+++..... .......||+.|||||++. ...++.+ +|||||
T Consensus 190 lsr~~~~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K-~DvySF 232 (362)
T KOG0192|consen 190 LSREKVISKTSMTSVAGTYRWMAPEVLRGEKSPYTEK-SDVYSF 232 (362)
T ss_pred cceeeccccccccCCCCCccccChhhhcCCCCcCCcc-chhhhH
Confidence 99766654 3444468999999999999 5688766 999997
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=254.79 Aligned_cols=184 Identities=34% Similarity=0.550 Sum_probs=162.8
Q ss_pred cCCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCccc----hHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEE
Q 028681 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI----DENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 94 (205)
Q Consensus 19 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 94 (205)
..++|++++.||+|+||.||+|+-+.+|..+|+|++++.... .+.+..|-.+|....++.||+++..|++..++||
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL 218 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL 218 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence 468999999999999999999999999999999999986533 3557888999999999999999999999999999
Q ss_pred EEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccC---
Q 028681 95 VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL--- 171 (205)
Q Consensus 95 v~~~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~--- 171 (205)
||||++||.+..++.+.+.+++..++.++.+++.|++.||+.|+||+||||+|+||+..|+ +||.|||+|.....
T Consensus 219 iMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GH--iKLSDFGLs~gl~~~~~ 296 (550)
T KOG0605|consen 219 IMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGH--IKLSDFGLSTGLDKKHR 296 (550)
T ss_pred EEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCC--Eeeccccccchhhhhhh
Confidence 9999999999999999999999999999999999999999999999999999999999998 99999999842110
Q ss_pred -------------------CCCC------C--------------------CCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 172 -------------------HSQP------K--------------------STVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 172 -------------------~~~~------~--------------------~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
.... . +..|||.|+|||++.++.|+-. +|+|||
T Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~-cDwWSL 374 (550)
T KOG0605|consen 297 IESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKE-CDWWSL 374 (550)
T ss_pred hhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCcc-ccHHHH
Confidence 0000 0 0138999999999999998755 999997
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=244.76 Aligned_cols=182 Identities=28% Similarity=0.524 Sum_probs=159.7
Q ss_pred CCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCcc---chHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEE
Q 028681 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (205)
Q Consensus 21 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~ 97 (205)
++|+.+.++|+|++|+|+.++++.+|+.||||.+...+. ..+...+|+.+|+++.|+|+|.+.++|......++|||
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 578999999999999999999999999999999976543 23567899999999999999999999999999999999
Q ss_pred ecCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeeccccccc-CCCCC
Q 028681 98 YASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV-LHSQP 175 (205)
Q Consensus 98 ~~~~~sl~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~-~~~~~ 175 (205)
|++. ++.+.+.. ...++.+.+..+++|++.|+.|+|+++++||||+|+||+++.++. +||+|||+|+... ++..-
T Consensus 82 ~~dh-TvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gv--vKLCDFGFAR~L~~pgd~Y 158 (396)
T KOG0593|consen 82 YCDH-TVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGV--VKLCDFGFARTLSAPGDNY 158 (396)
T ss_pred ecch-HHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCc--EEeccchhhHhhcCCcchh
Confidence 9976 45555544 445999999999999999999999999999999999999998888 9999999999876 55655
Q ss_pred CCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 176 KSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 176 ~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
.-...|..|.|||.+.+.....++.||||+
T Consensus 159 TDYVATRWYRaPELLvGDtqYG~pVDiWAi 188 (396)
T KOG0593|consen 159 TDYVATRWYRAPELLVGDTQYGKPVDIWAI 188 (396)
T ss_pred hhhhhhhhccChhhhcccCcCCCcccchhh
Confidence 666789999999999985544566999985
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-41 Score=256.38 Aligned_cols=186 Identities=31% Similarity=0.487 Sum_probs=164.9
Q ss_pred eecCCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCccc----hHHHHHHHHHHHhc-CCCCeeEEEEEEEeCCe
Q 028681 17 MHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI----DENVQREIINHRSL-RHPNIVRFKEVILTPTH 91 (205)
Q Consensus 17 ~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~----~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~ 91 (205)
....++|.+.+.||.|+|++|++|+++.+++.||+|++.+.-.. .+-+..|-..|.+| .||.|++++-.|.++..
T Consensus 69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s 148 (604)
T KOG0592|consen 69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES 148 (604)
T ss_pred cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence 45578999999999999999999999999999999999865322 23356677778888 79999999999999999
Q ss_pred EEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccC
Q 028681 92 LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 171 (205)
Q Consensus 92 ~~lv~~~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~ 171 (205)
+|+|++|.++|.|.+++++-+.+++...+.++.+|+.||+|||++|||||||||+|||+++|++ ++|+|||.|+..++
T Consensus 149 LYFvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmh--ikITDFGsAK~l~~ 226 (604)
T KOG0592|consen 149 LYFVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGH--IKITDFGSAKILSP 226 (604)
T ss_pred eEEEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCc--EEEeeccccccCCh
Confidence 9999999999999999999999999999999999999999999999999999999999999998 99999999987654
Q ss_pred CCCC--------------CCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 172 HSQP--------------KSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 172 ~~~~--------------~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
.... .+-.||-.|++||++.....+.. +|+|+|
T Consensus 227 ~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~-sDiWAl 273 (604)
T KOG0592|consen 227 SQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPS-SDLWAL 273 (604)
T ss_pred hhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcc-cchHHH
Confidence 4332 22358999999999998888756 999986
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-43 Score=248.75 Aligned_cols=187 Identities=30% Similarity=0.481 Sum_probs=162.7
Q ss_pred ceecCCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCc---cchHHHHHHHHHHHhcCCCCeeEEEE-EEEeCCe
Q 028681 16 IMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKE-VILTPTH 91 (205)
Q Consensus 16 ~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~-~~~~~~~ 91 (205)
.-....+|+++++||.|.||.||++.+..+|..+|.|.++-+. ...+....|+.+|++|+||||+++++ .|..++.
T Consensus 14 ~~~~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~e 93 (375)
T KOG0591|consen 14 PQKTLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNE 93 (375)
T ss_pred CcccHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccch
Confidence 3444678999999999999999999999999999999987443 33466889999999999999999988 4444444
Q ss_pred -EEEEEEecCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh--cC--cEeecCCCCCeEecCCCCCcEEEee
Q 028681 92 -LAIVMEYASGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHS--MQ--VCHRDLKLENTLLDGSPAPRLKICD 162 (205)
Q Consensus 92 -~~lv~~~~~~~sl~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lh~--~~--i~H~di~p~nili~~~~~~~~~l~d 162 (205)
++++||+++.|.|..+++. ++.++++.++.++.|++.||+.+|. .+ ++||||||.||+++.++. |||+|
T Consensus 94 vlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gv--vKLGD 171 (375)
T KOG0591|consen 94 VLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGV--VKLGD 171 (375)
T ss_pred hhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCc--eeecc
Confidence 8899999999999998853 4569999999999999999999998 45 899999999999998887 99999
Q ss_pred ecccccccCCCC-CCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 163 FGYSKSSVLHSQ-PKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 163 f~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
||+++....... ..+..||+.||+||.+...+|+.+ ||||||
T Consensus 172 fGL~r~l~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~k-SDiWsl 214 (375)
T KOG0591|consen 172 FGLGRFLSSKTTFAHSLVGTPYYMSPERIHESGYNFK-SDIWSL 214 (375)
T ss_pred chhHhHhcchhHHHHhhcCCCcccCHHHHhcCCCCcc-hhHHHH
Confidence 999988766544 355679999999999999999977 999996
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=256.08 Aligned_cols=185 Identities=30% Similarity=0.527 Sum_probs=168.9
Q ss_pred eecCCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCccch-HHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEE
Q 028681 17 MHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID-ENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV 95 (205)
Q Consensus 17 ~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~-~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 95 (205)
.+....|...++||+|+.|.||.+....+++.||+|.+....... +-+.+|+.+++..+|+||+.+++.|...+.+|+|
T Consensus 269 ~dP~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVV 348 (550)
T KOG0578|consen 269 GDPRSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVV 348 (550)
T ss_pred CChhhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEE
Confidence 345678899999999999999999999999999999998766544 5578999999999999999999999999999999
Q ss_pred EEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCCC-C
Q 028681 96 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-Q 174 (205)
Q Consensus 96 ~~~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~~-~ 174 (205)
|||+++++|.+.... ..+++.+++.|+++++.||+|||.+||+|+||+.+||++..++. +||+|||+|..+.... .
T Consensus 349 MEym~ggsLTDvVt~-~~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~--vKltDFGFcaqi~~~~~K 425 (550)
T KOG0578|consen 349 MEYMEGGSLTDVVTK-TRMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGS--VKLTDFGFCAQISEEQSK 425 (550)
T ss_pred EeecCCCchhhhhhc-ccccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCc--EEEeeeeeeeccccccCc
Confidence 999999999998844 55999999999999999999999999999999999999999988 9999999998776665 5
Q ss_pred CCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 175 PKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 175 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
..+..||+.|||||++..+.|+.+ .|||||
T Consensus 426 R~TmVGTPYWMAPEVvtrk~YG~K-VDIWSL 455 (550)
T KOG0578|consen 426 RSTMVGTPYWMAPEVVTRKPYGPK-VDIWSL 455 (550)
T ss_pred cccccCCCCccchhhhhhcccCcc-ccchhh
Confidence 666789999999999999999988 999997
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-42 Score=257.99 Aligned_cols=184 Identities=35% Similarity=0.536 Sum_probs=164.6
Q ss_pred cCCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCccchHH--HHHHHHHHHhcC-CCCeeEEEEEEEeCC-eEEE
Q 028681 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDEN--VQREIINHRSLR-HPNIVRFKEVILTPT-HLAI 94 (205)
Q Consensus 19 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~--~~~e~~~l~~l~-h~~i~~~~~~~~~~~-~~~l 94 (205)
..++|+++++||.|+||.||+++...++..||||.+++.-..-++ -.+|+..|+++. ||||+++.+++.+.. .+++
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~f 87 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYF 87 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEee
Confidence 358999999999999999999999999999999999876443333 357899999998 999999999999887 8999
Q ss_pred EEEecCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCCC
Q 028681 95 VMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 173 (205)
Q Consensus 95 v~~~~~~~sl~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~~ 173 (205)
|||||+. +|.++++. ++.|++..++.|++||++||+|+|++|+.|||+||+|||+..... +||+|||+|+......
T Consensus 88 VfE~Md~-NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~--iKiaDFGLARev~Skp 164 (538)
T KOG0661|consen 88 VFEFMDC-NLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDV--IKIADFGLAREVRSKP 164 (538)
T ss_pred eHHhhhh-hHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccce--eEecccccccccccCC
Confidence 9999965 89999975 446999999999999999999999999999999999999986555 9999999999888888
Q ss_pred CCCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 174 QPKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 174 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
.-.....|..|.|||++....+.+++.|+||+
T Consensus 165 PYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~ 196 (538)
T KOG0661|consen 165 PYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAV 196 (538)
T ss_pred CcchhhhcccccchHHhhhccccCCchHHHHH
Confidence 88888899999999999988777777999985
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=248.26 Aligned_cols=181 Identities=27% Similarity=0.365 Sum_probs=159.7
Q ss_pred CCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCccc-hHHHHHHHHHHHhcCCCCeeEEEEEEEeCC-eEEEEEEe
Q 028681 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI-DENVQREIINHRSLRHPNIVRFKEVILTPT-HLAIVMEY 98 (205)
Q Consensus 21 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~lv~~~ 98 (205)
++|.-...||+|+||.||++....+ ..||||++...... ..+|.+|+.++.+++|||+++++|+|.+.+ ..++|+||
T Consensus 75 ~~Fs~~~~ig~Ggfg~VYkG~l~~~-~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~~~LVYEy 153 (361)
T KOG1187|consen 75 NNFSESNLIGEGGFGTVYKGVLSDG-TVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYCLEGGEHRLLVYEY 153 (361)
T ss_pred hCCchhcceecCCCeEEEEEEECCC-CEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEEecCCceEEEEEEc
Confidence 5777788999999999999988764 88999988776554 566999999999999999999999999998 49999999
Q ss_pred cCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhc---CcEeecCCCCCeEecCCCCCcEEEeeecccccccC-C
Q 028681 99 ASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSM---QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-H 172 (205)
Q Consensus 99 ~~~~sl~~~~~~~~--~~~~~~~~~i~~~i~~~l~~lh~~---~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~-~ 172 (205)
+++|+|.+.+.... +++|.....|+.+++.||+|||.. .|+||||||+|||+|++.. .||+|||+|+..+. .
T Consensus 154 m~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~--aKlsDFGLa~~~~~~~ 231 (361)
T KOG1187|consen 154 MPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFN--AKLSDFGLAKLGPEGD 231 (361)
T ss_pred cCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCC--EEccCccCcccCCccc
Confidence 99999999997654 899999999999999999999974 4999999999999998888 99999999976665 4
Q ss_pred CCCCCC-CCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 173 SQPKST-VGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 173 ~~~~~~-~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
...... .||..|+|||+...+..+.+ +|||||
T Consensus 232 ~~~~~~~~gt~gY~~PEy~~~g~lt~K-sDVySF 264 (361)
T KOG1187|consen 232 TSVSTTVMGTFGYLAPEYASTGKLTEK-SDVYSF 264 (361)
T ss_pred cceeeecCCCCccCChhhhccCCcCcc-cccccc
Confidence 443334 89999999999999888767 999997
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-39 Score=238.84 Aligned_cols=184 Identities=35% Similarity=0.528 Sum_probs=158.2
Q ss_pred CCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCcc-chHHHHHHHHHHHhcCCCCeeEEEEEEEeCC--eEEEEE
Q 028681 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK-IDENVQREIINHRSLRHPNIVRFKEVILTPT--HLAIVM 96 (205)
Q Consensus 20 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~lv~ 96 (205)
..++...+.||+|+||.||.+.+..+|..+|+|.+..... ..+.+..|+.+|.+++|||||+++|...... .+++.|
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~m 95 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFM 95 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeee
Confidence 5779999999999999999999999999999999876522 1466899999999999999999999744333 688999
Q ss_pred EecCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecC-CCCCcEEEeeecccccccC---
Q 028681 97 EYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVL--- 171 (205)
Q Consensus 97 ~~~~~~sl~~~~~~~~-~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~-~~~~~~~l~df~~~~~~~~--- 171 (205)
||+++|+|.+++.+.+ .+++..++.+.+|++.||+|||++||+||||||+|||++. ++. +||+|||+++....
T Consensus 96 Ey~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~--~KlaDFG~a~~~~~~~~ 173 (313)
T KOG0198|consen 96 EYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGD--VKLADFGLAKKLESKGT 173 (313)
T ss_pred eccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCe--EEeccCccccccccccc
Confidence 9999999999998866 7999999999999999999999999999999999999998 566 99999999876653
Q ss_pred -CCCCCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 172 -HSQPKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 172 -~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
........||+.|||||++.+.....+++|||||
T Consensus 174 ~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSl 208 (313)
T KOG0198|consen 174 KSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSL 208 (313)
T ss_pred cccccccccCCccccCchhhcCCCcCCccchhhhc
Confidence 1223345699999999999974444446999997
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-39 Score=241.13 Aligned_cols=190 Identities=29% Similarity=0.460 Sum_probs=165.1
Q ss_pred ccCceecCCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCccc--hHHHHHHHHHHHhcCCCCeeEEEEEEEeCC
Q 028681 13 DMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI--DENVQREIINHRSLRHPNIVRFKEVILTPT 90 (205)
Q Consensus 13 ~~~~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 90 (205)
...++...++|++.+.||.|..++||+++...++..||||+++..+.. -+.+..|+..++.+.||||++++..|..+.
T Consensus 18 ~~~~p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~ 97 (516)
T KOG0582|consen 18 EKEFPLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDS 97 (516)
T ss_pred cccCCCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecc
Confidence 345666789999999999999999999999999999999999876543 367899999999999999999999999999
Q ss_pred eEEEEEEecCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeeccccc
Q 028681 91 HLAIVMEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 168 (205)
Q Consensus 91 ~~~lv~~~~~~~sl~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~ 168 (205)
.+|+||.+|.+||+.+++... ..+++..+..|++++++||.|||++|.||||+|+.|||++.++. |+|+|||.+..
T Consensus 98 ~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~--VkLadFgvsa~ 175 (516)
T KOG0582|consen 98 ELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGT--VKLADFGVSAS 175 (516)
T ss_pred eeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCc--EEEcCceeeee
Confidence 999999999999999999763 34999999999999999999999999999999999999999998 99999997643
Q ss_pred ccC-CCCC----CCCCCCCCccCCceec--cCcCCCeeeEEEeC
Q 028681 169 SVL-HSQP----KSTVGTPAYIAPEVLL--KKEYDGKVMCVYVI 205 (205)
Q Consensus 169 ~~~-~~~~----~~~~~~~~~~aPE~~~--~~~~~~~~~Dvwsl 205 (205)
... +... ++..|++.|||||++. -..|+.| +|||||
T Consensus 176 l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfK-aDIwSf 218 (516)
T KOG0582|consen 176 LFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFK-ADIWSF 218 (516)
T ss_pred ecccCceeeEeeccccCcccccChHHhhhcccCccch-hhhhhh
Confidence 322 2222 3336999999999964 3567766 999997
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=247.44 Aligned_cols=182 Identities=27% Similarity=0.474 Sum_probs=159.8
Q ss_pred CCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCc----cchHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEE
Q 028681 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (205)
Q Consensus 21 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 96 (205)
++|++.+.||+|++|+||++.+..+++.||+|++.+.. .....+..|+.++..++|+|++++++.+.++..++++|
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 47999999999999999999999999999999997642 22345778999999999999999999999999999999
Q ss_pred EecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCCCC--
Q 028681 97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-- 174 (205)
Q Consensus 97 ~~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~-- 174 (205)
||+++++|.+.+...+.+++..++.++.|++.||+|||++||+||||+|+||+++.++. ++|+|||+++.......
T Consensus 81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~--vkL~DFGla~~~~~~~~~~ 158 (363)
T cd05628 81 EFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGH--VKLSDFGLCTGLKKAHRTE 158 (363)
T ss_pred cCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCC--EEEeeccCccccccccccc
Confidence 99999999999988888999999999999999999999999999999999999988877 99999999864322110
Q ss_pred ----------------------------------CCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 175 ----------------------------------PKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 175 ----------------------------------~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
.....||+.|+|||++.+..++.+ +|||||
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~-~DvwSl 222 (363)
T cd05628 159 FYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKL-CDWWSL 222 (363)
T ss_pred ccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCc-hhhhhh
Confidence 123368999999999998888765 999996
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=247.42 Aligned_cols=189 Identities=29% Similarity=0.377 Sum_probs=165.8
Q ss_pred ccCceecCCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCccchHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeE
Q 028681 13 DMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHL 92 (205)
Q Consensus 13 ~~~~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 92 (205)
..++......+++.+.||+|.||.|+.+....+ ..|++|.++.+....+.+.+|+.++++|+|++|++++++|..+..+
T Consensus 198 ~d~wei~r~~l~l~~~LG~G~FG~V~~g~~~~~-~~vavk~ik~~~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~pi 276 (468)
T KOG0197|consen 198 RDPWEIPREELKLIRELGSGQFGEVWLGKWNGS-TKVAVKTIKEGSMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPI 276 (468)
T ss_pred cCCeeecHHHHHHHHHhcCCccceEEEEEEcCC-CcccceEEeccccChhHHHHHHHHHHhCcccCeEEEEEEEecCCce
Confidence 445566677788899999999999999998864 4589999999888889999999999999999999999999999999
Q ss_pred EEEEEecCCCchHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeeccccccc
Q 028681 93 AIVMEYASGGELFERICN--AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 170 (205)
Q Consensus 93 ~lv~~~~~~~sl~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~ 170 (205)
++||||++.|+|.++++. +..++..+...++.|||.|++||+++++|||||..+|||++++.. +||+|||+|+...
T Consensus 277 yIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~--vKIsDFGLAr~~~ 354 (468)
T KOG0197|consen 277 YIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLV--VKISDFGLARLIG 354 (468)
T ss_pred EEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCce--EEEcccccccccC
Confidence 999999999999999986 456999999999999999999999999999999999999998887 9999999998433
Q ss_pred CCCCCCC--CCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 171 LHSQPKS--TVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 171 ~~~~~~~--~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
.+.-... ..-+..|.|||++....++.+ ||||||
T Consensus 355 d~~Y~~~~~~kfPIkWtAPEa~~~~~FS~k-SDVWSF 390 (468)
T KOG0197|consen 355 DDEYTASEGGKFPIKWTAPEALNYGKFSSK-SDVWSF 390 (468)
T ss_pred CCceeecCCCCCCceecCHHHHhhCCcccc-cceeeh
Confidence 2222221 224577999999999999877 999997
|
|
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=248.84 Aligned_cols=181 Identities=34% Similarity=0.464 Sum_probs=164.6
Q ss_pred CCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCccchHHHHHHHHHHHhcC-C-----CCeeEEEEEEEeCCeEEE
Q 028681 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLR-H-----PNIVRFKEVILTPTHLAI 94 (205)
Q Consensus 21 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~-h-----~~i~~~~~~~~~~~~~~l 94 (205)
.+|++.+.||+|+||+|.+|.+..+++.||||++++.+....+...|+.+|..|+ | -|+++++++|...+++|+
T Consensus 186 ~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlci 265 (586)
T KOG0667|consen 186 YRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCI 265 (586)
T ss_pred EEEEEEEEecccccceeEEEEecCCCcEEEEEeeccChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceee
Confidence 4889999999999999999999999999999999998888888899999999996 3 579999999999999999
Q ss_pred EEEecCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCC
Q 028681 95 VMEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 172 (205)
Q Consensus 95 v~~~~~~~sl~~~~~~~~--~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~ 172 (205)
|+|.+. .+|.++++.+. .++...++.++.||+.||..||+.+||||||||+|||+..-....|||+|||+|+.....
T Consensus 266 VfELL~-~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~~q~ 344 (586)
T KOG0667|consen 266 VFELLS-TNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFESQR 344 (586)
T ss_pred eehhhh-hhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEecccccccCCc
Confidence 999984 58999998755 588999999999999999999999999999999999997766667999999999766544
Q ss_pred CCCCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 173 SQPKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 173 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
.- +...+..|.|||++.+.+|+.+ .|+|||
T Consensus 345 vy--tYiQSRfYRAPEVILGlpY~~~-IDmWSL 374 (586)
T KOG0667|consen 345 VY--TYIQSRFYRAPEVILGLPYDTA-IDMWSL 374 (586)
T ss_pred ce--eeeeccccccchhhccCCCCCc-cceeeh
Confidence 33 6788999999999999999987 999997
|
|
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=245.09 Aligned_cols=182 Identities=31% Similarity=0.534 Sum_probs=159.6
Q ss_pred CCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCc----cchHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEE
Q 028681 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (205)
Q Consensus 21 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 96 (205)
++|++.+.||+|+||.||++.+..+++.||+|++.... .....+..|+.++..++|+||+++++++.+++..+++|
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 57999999999999999999999999999999997642 22345778999999999999999999999999999999
Q ss_pred EecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCCCC--
Q 028681 97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-- 174 (205)
Q Consensus 97 ~~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~-- 174 (205)
||+++++|.+.+.....+++..++.++.|++.||+|||++|++||||+|+||+++.++. ++|+|||++........
T Consensus 81 E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~--~kl~Dfg~~~~~~~~~~~~ 158 (364)
T cd05599 81 EYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGH--IKLSDFGLCTGLKKSHRTE 158 (364)
T ss_pred CCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCC--EEEeecccceecccccccc
Confidence 99999999999988888999999999999999999999999999999999999998887 99999998864322110
Q ss_pred -------------------------------------CCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 175 -------------------------------------PKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 175 -------------------------------------~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
.....||+.|+|||++.+..++.+ +|||||
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwSl 225 (364)
T cd05599 159 FYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKE-CDWWSL 225 (364)
T ss_pred ccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCe-eeeecc
Confidence 112358999999999998888766 999997
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=228.34 Aligned_cols=182 Identities=31% Similarity=0.508 Sum_probs=160.4
Q ss_pred CCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCccc---hHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEE
Q 028681 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI---DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (205)
Q Consensus 21 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~ 97 (205)
++|...+.||+|.||.||++++..+|+.||+|.++.+... .-...+|+..|+.++|+||+.+.++|.+.+.+.+|+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 5788999999999999999999999999999999876543 4678899999999999999999999999999999999
Q ss_pred ecCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCCCCCC
Q 028681 98 YASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK 176 (205)
Q Consensus 98 ~~~~~sl~~~~~~~~-~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~~~ 176 (205)
|++. +|+..++.+. .+++.+++.++.++++|++|+|++.|+||||||.|++++.++. +||+|||+|+.+.+.....
T Consensus 82 fm~t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~--lKiADFGLAr~f~~p~~~~ 158 (318)
T KOG0659|consen 82 FMPT-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQ--LKIADFGLARFFGSPNRIQ 158 (318)
T ss_pred eccc-cHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCc--EEeecccchhccCCCCccc
Confidence 9965 7888887644 6999999999999999999999999999999999999999998 9999999999876554443
Q ss_pred C-CCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 177 S-TVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 177 ~-~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
+ ..-|..|.|||.+.+........|+||.
T Consensus 159 ~~~V~TRWYRAPELLfGsr~Yg~~VDmWav 188 (318)
T KOG0659|consen 159 THQVVTRWYRAPELLFGSRQYGTGVDMWAV 188 (318)
T ss_pred ccceeeeeccChHHhccchhcCCcchhhhH
Confidence 3 3678889999999875543444999983
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=242.17 Aligned_cols=182 Identities=32% Similarity=0.546 Sum_probs=162.6
Q ss_pred cCCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCc----cchHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEE
Q 028681 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 94 (205)
Q Consensus 19 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 94 (205)
..++|++.+.||+|++|.||++.+..+++.|++|.+.... ...+.+..|+.+++.++||||+++++++.+++..++
T Consensus 16 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 95 (329)
T PTZ00263 16 KLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYF 95 (329)
T ss_pred CchheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEE
Confidence 4689999999999999999999999999999999987643 223567889999999999999999999999999999
Q ss_pred EEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCCCC
Q 028681 95 VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 174 (205)
Q Consensus 95 v~~~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~ 174 (205)
+|||+.+++|.+.+.....+++..+..++.|++.||.|||++|++|+||+|+||+++.++. ++|+|||++......
T Consensus 96 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~--~kl~Dfg~~~~~~~~-- 171 (329)
T PTZ00263 96 LLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGH--VKVTDFGFAKKVPDR-- 171 (329)
T ss_pred EEcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCC--EEEeeccCceEcCCC--
Confidence 9999999999999988888999999999999999999999999999999999999998877 999999998755332
Q ss_pred CCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 175 PKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 175 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
.....|++.|+|||++.+..++.+ +|||||
T Consensus 172 ~~~~~gt~~y~aPE~~~~~~~~~~-~Diwsl 201 (329)
T PTZ00263 172 TFTLCGTPEYLAPEVIQSKGHGKA-VDWWTM 201 (329)
T ss_pred cceecCChhhcCHHHHcCCCCCCc-ceeech
Confidence 233568999999999998888755 999997
|
|
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-38 Score=244.77 Aligned_cols=182 Identities=30% Similarity=0.495 Sum_probs=158.1
Q ss_pred CCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCcc----chHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEE
Q 028681 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK----IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (205)
Q Consensus 21 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 96 (205)
++|++.+.||.|+||.||++.+..+++.||+|.+.+... ..+.+..|+.+++.+.||||+++++++.++...++||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 479999999999999999999999999999999875321 2355778999999999999999999999999999999
Q ss_pred EecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCCC---
Q 028681 97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS--- 173 (205)
Q Consensus 97 ~~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~~--- 173 (205)
||+++++|.+.+.....+++..++.++.|++.||+|||++||+||||+|+||+++.++. ++|+|||+++......
T Consensus 81 E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~--~kl~DfGla~~~~~~~~~~ 158 (377)
T cd05629 81 EFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGH--IKLSDFGLSTGFHKQHDSA 158 (377)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCC--EEEeecccccccccccccc
Confidence 99999999999988788999999999999999999999999999999999999988777 9999999885321100
Q ss_pred ---------------------------------------------CCCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 174 ---------------------------------------------QPKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 174 ---------------------------------------------~~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
......|++.|+|||++.+..++.+ +|||||
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwSl 234 (377)
T cd05629 159 YYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQE-CDWWSL 234 (377)
T ss_pred cccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCc-eeeEec
Confidence 0012358999999999998888766 999997
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-38 Score=240.71 Aligned_cols=180 Identities=33% Similarity=0.514 Sum_probs=161.1
Q ss_pred CCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCc----cchHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEE
Q 028681 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (205)
Q Consensus 21 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 96 (205)
++|++.+.||+|++|.||++.+..++..||+|++.... .....+..|+.++..++|+||+++++++..++..+++|
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 47999999999999999999999999999999997642 22345778999999999999999999999999999999
Q ss_pred EecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCCCCCC
Q 028681 97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK 176 (205)
Q Consensus 97 ~~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~~~ 176 (205)
||+++++|.+++.....+++..++.++.|++.||.+||++|++|+||+|+||+++.++. ++|+|||++..... ...
T Consensus 81 e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~--~kL~Dfg~a~~~~~--~~~ 156 (333)
T cd05600 81 EYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGH--IKLTDFGLSKGIVT--YAN 156 (333)
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCC--EEEEeCcCCccccc--ccC
Confidence 99999999999988888999999999999999999999999999999999999988877 99999999875433 334
Q ss_pred CCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 177 STVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 177 ~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
...|++.|+|||++.+..++.+ +|||||
T Consensus 157 ~~~gt~~y~aPE~~~~~~~~~~-~Dvwsl 184 (333)
T cd05600 157 SVVGSPDYMAPEVLRGKGYDFT-VDYWSL 184 (333)
T ss_pred CcccCccccChhHhcCCCCCCc-cceecc
Confidence 4568999999999998888766 999997
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-38 Score=243.44 Aligned_cols=182 Identities=31% Similarity=0.496 Sum_probs=158.5
Q ss_pred CCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCc----cchHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEE
Q 028681 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (205)
Q Consensus 21 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 96 (205)
++|++.+.||+|++|.||++.+..+++.||+|.+.+.. .....+..|+.+++.++|+||+++++.+.+++.++++|
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 57999999999999999999999999999999987532 22355778999999999999999999999999999999
Q ss_pred EecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCC----
Q 028681 97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH---- 172 (205)
Q Consensus 97 ~~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~---- 172 (205)
||+++++|.+.+...+.+++..++.++.|++.||+|||++||+||||+|+||+++.++. ++|+|||+|......
T Consensus 81 E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~--ikL~DFG~a~~~~~~~~~~ 158 (376)
T cd05598 81 DYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGH--IKLTDFGLCTGFRWTHDSK 158 (376)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCC--EEEEeCCCCcccccccccc
Confidence 99999999999988888999999999999999999999999999999999999998877 999999987422100
Q ss_pred ----------------------------------------CCCCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 173 ----------------------------------------SQPKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 173 ----------------------------------------~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
.......|++.|+|||++.+..++.+ +|||||
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwSl 230 (376)
T cd05598 159 YYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQL-CDWWSV 230 (376)
T ss_pred ccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcc-eeeeec
Confidence 00112358999999999998888765 999997
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-39 Score=249.89 Aligned_cols=182 Identities=38% Similarity=0.715 Sum_probs=172.4
Q ss_pred CCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCcc----chHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEE
Q 028681 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK----IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (205)
Q Consensus 21 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 96 (205)
+-|++.+.||.|+-|.|.+|++..+|+.+|||++.+... ....+..|+.+++.+.|||++.++++|+++.++|+|.
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl 91 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL 91 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence 568999999999999999999999999999999987522 2356889999999999999999999999999999999
Q ss_pred EecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCCCCCC
Q 028681 97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK 176 (205)
Q Consensus 97 ~~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~~~ 176 (205)
||+++|.|.+++..++++++.+++.+++||+.|+.|+|..+|+|+|++|+|++++..++ +||+|||.|..-.++..-.
T Consensus 92 Eyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~n--IKIADFGMAsLe~~gklLe 169 (786)
T KOG0588|consen 92 EYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNN--IKIADFGMASLEVPGKLLE 169 (786)
T ss_pred EecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccC--EeeeccceeecccCCcccc
Confidence 99999999999999999999999999999999999999999999999999999998887 9999999999999999999
Q ss_pred CCCCCCCccCCceeccCcCCCeeeEEEe
Q 028681 177 STVGTPAYIAPEVLLKKEYDGKVMCVYV 204 (205)
Q Consensus 177 ~~~~~~~~~aPE~~~~~~~~~~~~Dvws 204 (205)
+.+|++-|+|||++.+.+|+..++||||
T Consensus 170 TSCGSPHYA~PEIV~G~pYdG~~sDVWS 197 (786)
T KOG0588|consen 170 TSCGSPHYAAPEIVSGRPYDGRPSDVWS 197 (786)
T ss_pred ccCCCcccCCchhhcCCCCCCCccccch
Confidence 9999999999999999999989999998
|
|
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=243.36 Aligned_cols=182 Identities=29% Similarity=0.434 Sum_probs=158.5
Q ss_pred CCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCcc----chHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEE
Q 028681 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK----IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (205)
Q Consensus 21 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 96 (205)
+.|++.+.||+|+||+||++.+..++..||+|.+..... ..+.+..|+.+++.++|+||+++++++.+++..+++|
T Consensus 1 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~ 80 (381)
T cd05626 1 SMFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (381)
T ss_pred CCceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEE
Confidence 479999999999999999999999999999999976432 2345788999999999999999999999999999999
Q ss_pred EecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCC----
Q 028681 97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH---- 172 (205)
Q Consensus 97 ~~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~---- 172 (205)
||+++++|.+.+.....+++..++.++.|++.||.|||+.||+||||+|+||+++.++. ++|+|||++......
T Consensus 81 E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~--~kL~DFGl~~~~~~~~~~~ 158 (381)
T cd05626 81 DYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGH--IKLTDFGLCTGFRWTHNSK 158 (381)
T ss_pred ecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCC--EEEeeCcCCcccccccccc
Confidence 99999999999988888999999999999999999999999999999999999988776 999999987532100
Q ss_pred --------------------------------------------CCCCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 173 --------------------------------------------SQPKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 173 --------------------------------------------~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
.......||+.|+|||++.+..++.+ +|||||
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~-~DiwSl 234 (381)
T cd05626 159 YYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQL-CDWWSV 234 (381)
T ss_pred cccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCc-cceeeh
Confidence 00122358999999999998888765 999997
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=242.78 Aligned_cols=182 Identities=31% Similarity=0.483 Sum_probs=158.3
Q ss_pred CCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCcc----chHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEE
Q 028681 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK----IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (205)
Q Consensus 21 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 96 (205)
++|++++.||+|+||.||++.+..++..||+|.+..... ..+.+..|+.+++.+.|+||+++++.+.+++..++||
T Consensus 1 ~~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (382)
T cd05625 1 SMFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM 80 (382)
T ss_pred CCcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEE
Confidence 469999999999999999999999999999999876432 2356788999999999999999999999999999999
Q ss_pred EecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCC----
Q 028681 97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH---- 172 (205)
Q Consensus 97 ~~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~---- 172 (205)
||+++++|.+.+...+.+++..++.++.|++.||.|||+++|+||||+|+||+++.++. ++|+|||++......
T Consensus 81 E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~--~kL~DFGla~~~~~~~~~~ 158 (382)
T cd05625 81 DYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGH--IKLTDFGLCTGFRWTHDSK 158 (382)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCC--EEEeECCCCcccccccccc
Confidence 99999999999988778999999999999999999999999999999999999998887 999999987422100
Q ss_pred --------------------------------------------CCCCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 173 --------------------------------------------SQPKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 173 --------------------------------------------~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
.......|++.|+|||++.+..++.+ +|||||
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~-~DiwSl 234 (382)
T cd05625 159 YYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQL-CDWWSV 234 (382)
T ss_pred ccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCe-eeEEec
Confidence 00112358999999999998888866 999997
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=239.64 Aligned_cols=187 Identities=29% Similarity=0.452 Sum_probs=162.6
Q ss_pred cCceecCCCeEEEeeeccccceeEEEEEecCCC-cEEEEEEeecCc----cchHHHHHHHHHHHhcCCCCeeEEEEEEEe
Q 028681 14 MPIMHDSDRYELVRDIGSGNFGVARLMRDKKTE-ELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILT 88 (205)
Q Consensus 14 ~~~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~-~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 88 (205)
.......++|++.+.||+|++|.||.+.+..++ ..|++|.+.... ...+.+..|+.+++.++||||+++++++.+
T Consensus 23 ~~~~~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~ 102 (340)
T PTZ00426 23 RKNKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKD 102 (340)
T ss_pred cCCCCChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEe
Confidence 334456789999999999999999999876554 689999886532 233567789999999999999999999999
Q ss_pred CCeEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeeccccc
Q 028681 89 PTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 168 (205)
Q Consensus 89 ~~~~~lv~~~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~ 168 (205)
++..+++|||+++++|.+.+.....+++..+..++.|++.||.|||+.|++||||+|+||+++.++. ++|+|||++..
T Consensus 103 ~~~~~lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~--ikL~DFG~a~~ 180 (340)
T PTZ00426 103 ESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGF--IKMTDFGFAKV 180 (340)
T ss_pred CCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCC--EEEecCCCCee
Confidence 9999999999999999999988888999999999999999999999999999999999999988877 99999999875
Q ss_pred ccCCCCCCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 169 SVLHSQPKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 169 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
... ......|++.|+|||++.+..++.+ +|||||
T Consensus 181 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwSl 214 (340)
T PTZ00426 181 VDT--RTYTLCGTPEYIAPEILLNVGHGKA-ADWWTL 214 (340)
T ss_pred cCC--CcceecCChhhcCHHHHhCCCCCcc-ccccch
Confidence 432 2234568999999999998888755 999997
|
|
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=240.25 Aligned_cols=182 Identities=27% Similarity=0.477 Sum_probs=159.2
Q ss_pred CCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCc----cchHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEE
Q 028681 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (205)
Q Consensus 21 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 96 (205)
++|++.+.||+|++|.||.+.+..+++.||+|.+.... .....+..|+.++..++|++++++++.+.+++..++||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 47999999999999999999999999999999987532 22355778999999999999999999999999999999
Q ss_pred EecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCCC---
Q 028681 97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS--- 173 (205)
Q Consensus 97 ~~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~~--- 173 (205)
||+++++|.+.+...+.+++..++.++.|++.||.|||++||+||||+|+||+++.++. ++|+|||++.......
T Consensus 81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~--vkL~DfG~~~~~~~~~~~~ 158 (360)
T cd05627 81 EFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGH--VKLSDFGLCTGLKKAHRTE 158 (360)
T ss_pred eCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCC--EEEeeccCCcccccccccc
Confidence 99999999999988888999999999999999999999999999999999999988777 9999999886432110
Q ss_pred ---------------------------------CCCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 174 ---------------------------------QPKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 174 ---------------------------------~~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
......|++.|+|||++.+..++.+ +|||||
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~-~DiwSl 222 (360)
T cd05627 159 FYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKL-CDWWSL 222 (360)
T ss_pred cccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCc-ceeccc
Confidence 0112358999999999999888866 999997
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=239.75 Aligned_cols=180 Identities=33% Similarity=0.572 Sum_probs=160.0
Q ss_pred CCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCc----cchHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEE
Q 028681 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (205)
Q Consensus 21 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 96 (205)
++|++.+.||+|++|.||++.+..+++.|++|.+.... ...+.+.+|+.+++.++||||+++++++.+++..+++|
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 47999999999999999999999999999999987543 22356788999999999999999999999999999999
Q ss_pred EecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCCCCCC
Q 028681 97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK 176 (205)
Q Consensus 97 ~~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~~~ 176 (205)
||+++++|.+.+...+.+++..+..++.|++.||.|||++|++|+||+|+||+++.++. ++|+|||++..... ...
T Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~--~kl~Dfg~~~~~~~--~~~ 156 (291)
T cd05612 81 EYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGH--IKLTDFGFAKKLRD--RTW 156 (291)
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCC--EEEEecCcchhccC--Ccc
Confidence 99999999999988888999999999999999999999999999999999999988777 99999999875432 223
Q ss_pred CCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 177 STVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 177 ~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
...|++.|+|||++.+..++.+ +|||||
T Consensus 157 ~~~gt~~y~aPE~~~~~~~~~~-~DiwSl 184 (291)
T cd05612 157 TLCGTPEYLAPEVIQSKGHNKA-VDWWAL 184 (291)
T ss_pred cccCChhhcCHHHHcCCCCCch-hhHHHH
Confidence 4568999999999998888755 999996
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=250.32 Aligned_cols=181 Identities=36% Similarity=0.629 Sum_probs=166.6
Q ss_pred CCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCccch---HHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEE
Q 028681 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID---ENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (205)
Q Consensus 21 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~---~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~ 97 (205)
++|.+.+.||+|+||.||+++.+.+.+.||+|.+.+..+.. ..+.+|+++++.++||||+.++++|+....+|+|+|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 68999999999999999999999999999999998865544 457789999999999999999999999999999999
Q ss_pred ecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCCCCCC-
Q 028681 98 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK- 176 (205)
Q Consensus 98 ~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~~~- 176 (205)
|+.+ +|..++...+.++++.++.++.+++.||.|||+.+|.|||++|.||++..++. +|++|||+|+....+....
T Consensus 82 ~a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~--~KlcdFg~Ar~m~~~t~vlt 158 (808)
T KOG0597|consen 82 YAVG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGT--LKLCDFGLARAMSTNTSVLT 158 (808)
T ss_pred hhhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCc--eeechhhhhhhcccCceeee
Confidence 9976 99999999999999999999999999999999999999999999999998888 9999999998877665443
Q ss_pred CCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 177 STVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 177 ~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
...||+.|||||.+..++|+.. +|.|||
T Consensus 159 sikGtPlYmAPElv~e~pyd~~-sDlWsl 186 (808)
T KOG0597|consen 159 SIKGTPLYMAPELVEEQPYDHT-SDLWSL 186 (808)
T ss_pred eccCcccccCHHHHcCCCccch-hhHHHH
Confidence 3469999999999999999877 999996
|
|
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=240.73 Aligned_cols=182 Identities=34% Similarity=0.555 Sum_probs=161.9
Q ss_pred CCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCc----cchHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEE
Q 028681 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (205)
Q Consensus 21 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 96 (205)
++|++.+.||+|++|.||++.+..+++.||+|++.... .....+..|+.++..++|+|++++++++.+++..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 47999999999999999999999999999999997642 23356788999999999999999999999999999999
Q ss_pred EecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCCC---
Q 028681 97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS--- 173 (205)
Q Consensus 97 ~~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~~--- 173 (205)
||+++++|.+.+.....+++..++.++.|++.||.|||+.|++|+||+|+||+++.++. ++|+|||++.......
T Consensus 81 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~--~kL~Dfg~~~~~~~~~~~~ 158 (350)
T cd05573 81 EYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGH--IKLADFGLCKKMNKAKDRE 158 (350)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCC--EEeecCCCCccCcccCccc
Confidence 99999999999988788999999999999999999999999999999999999998887 9999999987554333
Q ss_pred ---------------------------CCCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 174 ---------------------------QPKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 174 ---------------------------~~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
......|++.|+|||++.+..++.+ +|||||
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwSl 216 (350)
T cd05573 159 YYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLE-CDWWSL 216 (350)
T ss_pred ccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCc-eeeEec
Confidence 2233468999999999999888766 999997
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=240.64 Aligned_cols=188 Identities=36% Similarity=0.570 Sum_probs=160.2
Q ss_pred ceecCCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCcc---------------chHHHHHHHHHHHhcCCCCee
Q 028681 16 IMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---------------IDENVQREIINHRSLRHPNIV 80 (205)
Q Consensus 16 ~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~---------------~~~~~~~e~~~l~~l~h~~i~ 80 (205)
-....++|++.+.||+|.+|.|.++.+..+++.||+|++.+.+. ..+....|+.+++++.|+|||
T Consensus 92 ~~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV 171 (576)
T KOG0585|consen 92 DRKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVV 171 (576)
T ss_pred cceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCee
Confidence 34457899999999999999999999999999999999975321 125788999999999999999
Q ss_pred EEEEEEEeC--CeEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcE
Q 028681 81 RFKEVILTP--THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRL 158 (205)
Q Consensus 81 ~~~~~~~~~--~~~~lv~~~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~ 158 (205)
+++++..++ +.+|+|+||+..|.+.+.-.....+++.+++.+++.++.||+|||.+||+||||||+|+|+++++. |
T Consensus 172 ~LiEvLDDP~s~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g~--V 249 (576)
T KOG0585|consen 172 KLIEVLDDPESDKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDGT--V 249 (576)
T ss_pred EEEEeecCcccCceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCCc--E
Confidence 999998766 579999999998887766544444999999999999999999999999999999999999998887 9
Q ss_pred EEeeecccccccCCC------CCCCCCCCCCccCCceecc---CcCCCeeeEEEeC
Q 028681 159 KICDFGYSKSSVLHS------QPKSTVGTPAYIAPEVLLK---KEYDGKVMCVYVI 205 (205)
Q Consensus 159 ~l~df~~~~~~~~~~------~~~~~~~~~~~~aPE~~~~---~~~~~~~~Dvwsl 205 (205)
||+|||.+-..+... ......||+.|+|||.... ..++..+.|||||
T Consensus 250 KIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWal 305 (576)
T KOG0585|consen 250 KISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWAL 305 (576)
T ss_pred EeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhh
Confidence 999999886553331 1223469999999999987 5577788999996
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=231.77 Aligned_cols=181 Identities=25% Similarity=0.339 Sum_probs=158.1
Q ss_pred CeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCcc----chHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEE
Q 028681 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK----IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (205)
Q Consensus 22 ~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~ 97 (205)
.|++.+.||+|+||.||++.+..+++.||+|.+..... ....+.+|+.+++.++|++++++.+++.+++..++++|
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 48899999999999999999999999999999875432 22356789999999999999999999999999999999
Q ss_pred ecCCCchHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCCCCC
Q 028681 98 YASGGELFERICN--AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 175 (205)
Q Consensus 98 ~~~~~sl~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~~ 175 (205)
|+++++|.+.+.. ...+++..+..++.|++.||+|||+.+++|+||+|+||+++.++. ++|+|||++.........
T Consensus 81 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~--~kl~Dfg~~~~~~~~~~~ 158 (285)
T cd05631 81 IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGH--IRISDLGLAVQIPEGETV 158 (285)
T ss_pred ecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCC--EEEeeCCCcEEcCCCCee
Confidence 9999999877754 335899999999999999999999999999999999999988777 999999999765444444
Q ss_pred CCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 176 KSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 176 ~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
....|+..|+|||++.+..++.+ +|||||
T Consensus 159 ~~~~g~~~y~aPE~~~~~~~~~~-~Dvwsl 187 (285)
T cd05631 159 RGRVGTVGYMAPEVINNEKYTFS-PDWWGL 187 (285)
T ss_pred cCCCCCCCccCHhhhcCCCCCcc-cCchhH
Confidence 45578999999999999888866 999996
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=237.10 Aligned_cols=176 Identities=37% Similarity=0.566 Sum_probs=154.4
Q ss_pred eeeccccceeEEEEEecCCCcEEEEEEeecCc----cchHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEEecCCC
Q 028681 27 RDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGG 102 (205)
Q Consensus 27 ~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~~~~~ 102 (205)
+.||+|+||.||++.+..+++.||+|++.... .....+..|+.+++.++|||++++.+++..++..+++|||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 46899999999999999999999999987642 12245678999999999999999999999999999999999999
Q ss_pred chHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccC-CCCCCCCCCC
Q 028681 103 ELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQPKSTVGT 181 (205)
Q Consensus 103 sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~-~~~~~~~~~~ 181 (205)
+|.+.+...+.+++..+..++.|++.||+|||++||+||||+|+||+++.++. ++|+|||+++.... ........|+
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~--~kl~DfG~a~~~~~~~~~~~~~~gt 158 (323)
T cd05571 81 ELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGH--IKITDFGLCKEGISDGATMKTFCGT 158 (323)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCC--EEEeeCCCCcccccCCCcccceecC
Confidence 99999988888999999999999999999999999999999999999988777 99999999865322 2223345689
Q ss_pred CCccCCceeccCcCCCeeeEEEeC
Q 028681 182 PAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 182 ~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
+.|+|||++.+..++.+ +|||||
T Consensus 159 ~~y~aPE~~~~~~~~~~-~DiwSl 181 (323)
T cd05571 159 PEYLAPEVLEDNDYGRA-VDWWGL 181 (323)
T ss_pred ccccChhhhcCCCCCcc-ccCccc
Confidence 99999999998888766 999997
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=243.48 Aligned_cols=183 Identities=34% Similarity=0.549 Sum_probs=168.8
Q ss_pred CCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCc---cchHHHHHHHHHHHhcCCCCeeEEEEEEEeCCe-EEEE
Q 028681 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTH-LAIV 95 (205)
Q Consensus 20 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-~~lv 95 (205)
.++|.+++++|+|+||.++.++++..+..+++|.+.... ..++....|+.++++++||||+.+.+.|..++. .+++
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Iv 82 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIV 82 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEE
Confidence 578999999999999999999999999999999997643 344568899999999999999999999999887 9999
Q ss_pred EEecCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCCC
Q 028681 96 MEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 173 (205)
Q Consensus 96 ~~~~~~~sl~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~~ 173 (205)
|+|++||++.+.+... ..++++.+..|+.|++.|+.|||+..|.||||++.|||+..++. |+|+|||+|+...+..
T Consensus 83 m~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~--VkLgDfGlaK~l~~~~ 160 (426)
T KOG0589|consen 83 MEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKK--VKLGDFGLAKILNPED 160 (426)
T ss_pred EeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCc--eeecchhhhhhcCCch
Confidence 9999999999999654 46999999999999999999999999999999999999999988 9999999999988887
Q ss_pred -CCCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 174 -QPKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 174 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
...+..||+.|++||.+.+.+|..+ +|||||
T Consensus 161 ~~a~tvvGTp~YmcPEil~d~pYn~K-SDiWsL 192 (426)
T KOG0589|consen 161 SLASTVVGTPYYMCPEILSDIPYNEK-SDIWSL 192 (426)
T ss_pred hhhheecCCCcccCHHHhCCCCCCcc-Ccchhh
Confidence 6777889999999999999999877 999997
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-38 Score=246.26 Aligned_cols=185 Identities=34% Similarity=0.521 Sum_probs=165.5
Q ss_pred eecCCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCcc----chHHHHHHHHHHHhc-CCCCeeEEEEEEEeCCe
Q 028681 17 MHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK----IDENVQREIINHRSL-RHPNIVRFKEVILTPTH 91 (205)
Q Consensus 17 ~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~ 91 (205)
....++|.+++.||+|+||+|+++..+.+++.+|||.++++.. ..+....|.+++... +||.++.++..|+...+
T Consensus 364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~ 443 (694)
T KOG0694|consen 364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEH 443 (694)
T ss_pred cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCe
Confidence 4457899999999999999999999999999999999998753 346678888888776 59999999999999999
Q ss_pred EEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeeccccccc-
Q 028681 92 LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV- 170 (205)
Q Consensus 92 ~~lv~~~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~- 170 (205)
+++||||..||++ ..++....+++..++.++..++.||.|||++|||+||||.+||++|.+++ +||+|||+++..-
T Consensus 444 l~fvmey~~Ggdm-~~~~~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh--~kiADFGlcKe~m~ 520 (694)
T KOG0694|consen 444 LFFVMEYVAGGDL-MHHIHTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGH--VKIADFGLCKEGMG 520 (694)
T ss_pred EEEEEEecCCCcE-EEEEecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCc--EEecccccccccCC
Confidence 9999999999883 33345567999999999999999999999999999999999999999998 9999999998654
Q ss_pred CCCCCCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 171 LHSQPKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 171 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
.+..+.+.+||+.|+|||++....|+.. .|+|||
T Consensus 521 ~g~~TsTfCGTpey~aPEil~e~~Yt~a-VDWW~l 554 (694)
T KOG0694|consen 521 QGDRTSTFCGTPEFLAPEVLTEQSYTRA-VDWWGL 554 (694)
T ss_pred CCCccccccCChhhcChhhhccCcccch-hhHHHH
Confidence 6677788899999999999999999866 999996
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-39 Score=239.37 Aligned_cols=184 Identities=41% Similarity=0.693 Sum_probs=171.2
Q ss_pred CCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCccchH----HHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEE
Q 028681 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDE----NVQREIINHRSLRHPNIVRFKEVILTPTHLAIV 95 (205)
Q Consensus 20 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~----~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 95 (205)
-.+|++.+.||.|.+|+|-++.....|+.||+|.+.++....+ .+..|++++..|.||||+.++++|++.+...+|
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv 131 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV 131 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence 3579999999999999999999999999999999988764433 367899999999999999999999999999999
Q ss_pred EEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCCCCC
Q 028681 96 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 175 (205)
Q Consensus 96 ~~~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~~ 175 (205)
|||..+|.|.+++...+.+++.+.+.+++||..|+.|+|+++++|+|++.+||+++.+++ +||+|||++-.+..+...
T Consensus 132 MEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~N--iKIADFGLSNly~~~kfL 209 (668)
T KOG0611|consen 132 MEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNN--IKIADFGLSNLYADKKFL 209 (668)
T ss_pred EEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCC--eeeeccchhhhhccccHH
Confidence 999999999999999999999999999999999999999999999999999999998888 999999999777767777
Q ss_pred CCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 176 KSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 176 ~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
.+.+|++.|.+||++.+.+|.....|.|||
T Consensus 210 qTFCGSPLYASPEIvNG~PY~GPEVDsWsL 239 (668)
T KOG0611|consen 210 QTFCGSPLYASPEIVNGTPYKGPEVDSWSL 239 (668)
T ss_pred HHhcCCcccCCccccCCCCCCCCccchhhH
Confidence 788999999999999999998888999997
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=225.22 Aligned_cols=184 Identities=34% Similarity=0.591 Sum_probs=168.5
Q ss_pred ecCCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCc----cchHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEE
Q 028681 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLA 93 (205)
Q Consensus 18 ~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 93 (205)
...++|++.+.||.|.||.||+++.+.++..||+|++.+.. ....++.+|+++...|+||||++++++|.++...|
T Consensus 19 ~~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riy 98 (281)
T KOG0580|consen 19 WTLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIY 98 (281)
T ss_pred cchhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeE
Confidence 34689999999999999999999999999999999998754 23467888999999999999999999999999999
Q ss_pred EEEEecCCCchHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccC
Q 028681 94 IVMEYASGGELFERIC--NAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 171 (205)
Q Consensus 94 lv~~~~~~~sl~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~ 171 (205)
+++||.+.+++...+. ....+++.....+..|++.|+.|+|..+++||||+|+|++++..+. +|++|||.+...+
T Consensus 99 LilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~--lkiAdfGwsV~~p- 175 (281)
T KOG0580|consen 99 LILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGE--LKIADFGWSVHAP- 175 (281)
T ss_pred EEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCC--eeccCCCceeecC-
Confidence 9999999999999998 4557999999999999999999999999999999999999988887 9999999997666
Q ss_pred CCCCCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 172 HSQPKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 172 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
.....+.+||+.|.+||...+..++.. .|+|++
T Consensus 176 ~~kR~tlcgt~dyl~pEmv~~~~hd~~-Vd~w~l 208 (281)
T KOG0580|consen 176 SNKRKTLCGTLDYLPPEMVEGRGHDKF-VDLWSL 208 (281)
T ss_pred CCCceeeecccccCCHhhcCCCCccch-hhHHHH
Confidence 677788899999999999999999866 999985
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-38 Score=229.18 Aligned_cols=182 Identities=32% Similarity=0.475 Sum_probs=158.5
Q ss_pred CCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCcc---chHHHHHHHHHHHhcCCCC-eeEEEEEEEeCC-----
Q 028681 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---IDENVQREIINHRSLRHPN-IVRFKEVILTPT----- 90 (205)
Q Consensus 20 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~h~~-i~~~~~~~~~~~----- 90 (205)
...|+.+++||+|++|+||.++.+.+|+.||+|.+..... .......|+.+++.++|+| ++.+++++...+
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~ 89 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI 89 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence 5678889999999999999999999999999999986543 3466789999999999999 999999999877
Q ss_pred -eEEEEEEecCCCchHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecc
Q 028681 91 -HLAIVMEYASGGELFERICNAG----RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGY 165 (205)
Q Consensus 91 -~~~lv~~~~~~~sl~~~~~~~~----~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~ 165 (205)
.+++|+|+++. .|...+...+ .++...++.+++||+.|++|||+++|+||||||.||++++++. +||+|||+
T Consensus 90 ~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~--lKlaDFGl 166 (323)
T KOG0594|consen 90 GKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGV--LKLADFGL 166 (323)
T ss_pred ceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCc--Eeeeccch
Confidence 78899999954 7888876543 4777899999999999999999999999999999999999887 99999999
Q ss_pred ccccc-CCCCCCCCCCCCCccCCceeccC-cCCCeeeEEEeC
Q 028681 166 SKSSV-LHSQPKSTVGTPAYIAPEVLLKK-EYDGKVMCVYVI 205 (205)
Q Consensus 166 ~~~~~-~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~~Dvwsl 205 (205)
|+... +.....+...|..|.|||++.+. .|++. .||||+
T Consensus 167 Ara~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~-vDiWs~ 207 (323)
T KOG0594|consen 167 ARAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTS-VDIWSL 207 (323)
T ss_pred HHHhcCCcccccccEEEeeccCHHHhcCCCcCCCC-cchHhH
Confidence 98766 34445666789999999999987 45555 999995
|
|
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-37 Score=237.07 Aligned_cols=184 Identities=29% Similarity=0.447 Sum_probs=158.2
Q ss_pred ecCCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCc----cchHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEE
Q 028681 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLA 93 (205)
Q Consensus 18 ~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 93 (205)
...++|++.+.||+|+||.||++.+..+++.+|+|.+.+.. .....+.+|+.+++.+.|||++++++.+.++...+
T Consensus 40 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~ 119 (370)
T cd05621 40 MKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLY 119 (370)
T ss_pred CCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEE
Confidence 34578999999999999999999999999999999987532 12345778999999999999999999999999999
Q ss_pred EEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCCC
Q 028681 94 IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 173 (205)
Q Consensus 94 lv~~~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~~ 173 (205)
+||||+++++|.+.+.. ..+++..+..++.|++.||+|||+++|+||||+|+||+++.++. ++|+|||++.......
T Consensus 120 lv~Ey~~gg~L~~~l~~-~~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~--~kL~DFG~a~~~~~~~ 196 (370)
T cd05621 120 MVMEYMPGGDLVNLMSN-YDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGH--LKLADFGTCMKMDETG 196 (370)
T ss_pred EEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCC--EEEEecccceecccCC
Confidence 99999999999998855 45899999999999999999999999999999999999988877 9999999987654322
Q ss_pred C--CCCCCCCCCccCCceeccCc----CCCeeeEEEeC
Q 028681 174 Q--PKSTVGTPAYIAPEVLLKKE----YDGKVMCVYVI 205 (205)
Q Consensus 174 ~--~~~~~~~~~~~aPE~~~~~~----~~~~~~Dvwsl 205 (205)
. .....|++.|+|||++.+.. ++ .++|||||
T Consensus 197 ~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~-~~~DiwSl 233 (370)
T cd05621 197 MVRCDTAVGTPDYISPEVLKSQGGDGYYG-RECDWWSV 233 (370)
T ss_pred ceecccCCCCcccCCHHHHhccCCCCCCC-cccCEEee
Confidence 2 23456999999999997653 44 45999996
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=234.80 Aligned_cols=176 Identities=35% Similarity=0.560 Sum_probs=153.7
Q ss_pred eeeccccceeEEEEEecCCCcEEEEEEeecCc----cchHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEEecCCC
Q 028681 27 RDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGG 102 (205)
Q Consensus 27 ~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~~~~~ 102 (205)
+.||+|+||.||.+.+..++..||+|.+.... .....+..|+.+++.++|||++++++.+..++..++||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 46899999999999999999999999987642 12245667899999999999999999999999999999999999
Q ss_pred chHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCC-CCCCCCCCC
Q 028681 103 ELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKSTVGT 181 (205)
Q Consensus 103 sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~-~~~~~~~~~ 181 (205)
+|...+.....+++..++.++.|++.||.|||++|++|+||+|+||+++.++. ++|+|||++...... .......|+
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~--~kL~Dfg~~~~~~~~~~~~~~~~gt 158 (323)
T cd05595 81 ELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGH--IKITDFGLCKEGISDGATMKTFCGT 158 (323)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCC--EEecccHHhccccCCCCccccccCC
Confidence 99988888888999999999999999999999999999999999999988877 999999998653222 222345689
Q ss_pred CCccCCceeccCcCCCeeeEEEeC
Q 028681 182 PAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 182 ~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
+.|+|||.+.+..++.+ +|||||
T Consensus 159 ~~y~aPE~~~~~~~~~~-~DiwSl 181 (323)
T cd05595 159 PEYLAPEVLEDNDYGRA-VDWWGL 181 (323)
T ss_pred cCcCCcccccCCCCCch-hchhhh
Confidence 99999999998888755 999996
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-37 Score=233.77 Aligned_cols=182 Identities=30% Similarity=0.486 Sum_probs=157.8
Q ss_pred CCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCcc----chHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEE
Q 028681 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK----IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (205)
Q Consensus 21 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 96 (205)
++|++.+.||+|++|.||++.+..+++.||+|.+..... ..+.+..|+.+++.+.|+|++++++++.+++..+++|
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 479999999999999999999999999999999986432 3355788899999999999999999999999999999
Q ss_pred EecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCCCCC
Q 028681 97 EYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 175 (205)
Q Consensus 97 ~~~~~~sl~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~~ 175 (205)
||+++++|.+++... ..+++..+..++.|++.||.+||+.+|+||||+|+||+++.++. ++|+|||++.........
T Consensus 81 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~--~kL~Dfg~a~~~~~~~~~ 158 (330)
T cd05601 81 EYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGH--IKLADFGSAARLTANKMV 158 (330)
T ss_pred CCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCC--EEeccCCCCeECCCCCce
Confidence 999999999999775 67999999999999999999999999999999999999988877 999999998765433222
Q ss_pred --CCCCCCCCccCCceec------cCcCCCeeeEEEeC
Q 028681 176 --KSTVGTPAYIAPEVLL------KKEYDGKVMCVYVI 205 (205)
Q Consensus 176 --~~~~~~~~~~aPE~~~------~~~~~~~~~Dvwsl 205 (205)
....+++.|+|||++. +..++.+ +|||||
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~-~Diwsl 195 (330)
T cd05601 159 NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVE-CDWWSL 195 (330)
T ss_pred eeecccCCccccCHHHhccccccccCCCCCc-ceeecc
Confidence 2346899999999997 3445544 999997
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-37 Score=233.55 Aligned_cols=176 Identities=35% Similarity=0.561 Sum_probs=153.9
Q ss_pred eeeccccceeEEEEEecCCCcEEEEEEeecCc----cchHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEEecCCC
Q 028681 27 RDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGG 102 (205)
Q Consensus 27 ~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~~~~~ 102 (205)
+.||+|+||.||.+.+..++..||+|.+.+.. .....+..|+.+++.++|||++++.+++..++..++||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 46899999999999999999999999997642 22345778899999999999999999999999999999999999
Q ss_pred chHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCC-CCCCCCCCC
Q 028681 103 ELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKSTVGT 181 (205)
Q Consensus 103 sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~-~~~~~~~~~ 181 (205)
+|...+.....+++.++..++.|++.||.|||++||+|+||+|+||+++.++. ++|+|||+++..... .......|+
T Consensus 81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~--~kL~DfG~~~~~~~~~~~~~~~~gt 158 (328)
T cd05593 81 ELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGH--IKITDFGLCKEGITDAATMKTFCGT 158 (328)
T ss_pred CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCc--EEEecCcCCccCCCcccccccccCC
Confidence 99988888788999999999999999999999999999999999999988777 999999998653222 222344689
Q ss_pred CCccCCceeccCcCCCeeeEEEeC
Q 028681 182 PAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 182 ~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
+.|+|||++.+..++.+ +|||||
T Consensus 159 ~~y~aPE~~~~~~~~~~-~Diwsl 181 (328)
T cd05593 159 PEYLAPEVLEDNDYGRA-VDWWGL 181 (328)
T ss_pred cCccChhhhcCCCCCcc-CCcccc
Confidence 99999999998888755 999997
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=231.37 Aligned_cols=174 Identities=32% Similarity=0.553 Sum_probs=153.0
Q ss_pred eccccceeEEEEEecCCCcEEEEEEeecCc----cchHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEEecCCCch
Q 028681 29 IGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL 104 (205)
Q Consensus 29 l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~~~~~sl 104 (205)
||+|+||.||++.+..+++.||+|.+.... .....+..|+.+++.++||||+++++++..++..++++||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 689999999999999999999999987532 2234567899999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCC-CCCCCCCCCCC
Q 028681 105 FERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKSTVGTPA 183 (205)
Q Consensus 105 ~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~-~~~~~~~~~~~ 183 (205)
.+.+.....+++..+..++.|++.||.|||++|++||||+|+||+++.++. ++|+|||+++..... .......|++.
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~gt~~ 158 (312)
T cd05585 81 FHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGH--IALCDFGLCKLNMKDDDKTNTFCGTPE 158 (312)
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCc--EEEEECcccccCccCCCccccccCCcc
Confidence 999988888999999999999999999999999999999999999988877 999999998753322 22334568999
Q ss_pred ccCCceeccCcCCCeeeEEEeC
Q 028681 184 YIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 184 ~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
|+|||++.+..++.+ +|||||
T Consensus 159 y~aPE~~~~~~~~~~-~Dvwsl 179 (312)
T cd05585 159 YLAPELLLGHGYTKA-VDWWTL 179 (312)
T ss_pred cCCHHHHcCCCCCCc-cceech
Confidence 999999998888766 999996
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=235.44 Aligned_cols=185 Identities=31% Similarity=0.451 Sum_probs=158.4
Q ss_pred eecCCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCc----cchHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeE
Q 028681 17 MHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHL 92 (205)
Q Consensus 17 ~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 92 (205)
....++|++.+.||+|+||.||++.+..+++.+|+|.+.+.. .....+.+|..+++.++|||++++++.+..++..
T Consensus 39 ~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~ 118 (371)
T cd05622 39 RMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYL 118 (371)
T ss_pred CcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEE
Confidence 334689999999999999999999999999999999987532 1224467889999999999999999999999999
Q ss_pred EEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCC
Q 028681 93 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 172 (205)
Q Consensus 93 ~lv~~~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~ 172 (205)
+++|||+++++|.+++.. ..+++..+..++.|++.||.|||++||+||||+|+||+++.++. ++|+|||++......
T Consensus 119 ~lv~Ey~~gg~L~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~--ikL~DfG~a~~~~~~ 195 (371)
T cd05622 119 YMVMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGH--LKLADFGTCMKMNKE 195 (371)
T ss_pred EEEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCC--EEEEeCCceeEcCcC
Confidence 999999999999998855 45899999999999999999999999999999999999988877 999999998765433
Q ss_pred CC--CCCCCCCCCccCCceeccCc----CCCeeeEEEeC
Q 028681 173 SQ--PKSTVGTPAYIAPEVLLKKE----YDGKVMCVYVI 205 (205)
Q Consensus 173 ~~--~~~~~~~~~~~aPE~~~~~~----~~~~~~Dvwsl 205 (205)
.. .....|++.|+|||++.+.. ++ .++|||||
T Consensus 196 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~-~~~DiwSl 233 (371)
T cd05622 196 GMVRCDTAVGTPDYISPEVLKSQGGDGYYG-RECDWWSV 233 (371)
T ss_pred CcccccCcccCccccCHHHHhccCCCccCC-Cccceeeh
Confidence 22 23456999999999997643 44 45999997
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=231.31 Aligned_cols=182 Identities=27% Similarity=0.463 Sum_probs=156.6
Q ss_pred CCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCc----cchHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEE
Q 028681 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (205)
Q Consensus 21 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 96 (205)
++|++.+.||+|+||.||++.+..+++.||+|.+.+.. .....+.+|..++..+.|++++++++++.+++..+++|
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 57999999999999999999999999999999987532 12344678888899999999999999999999999999
Q ss_pred EecCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCCCCC
Q 028681 97 EYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 175 (205)
Q Consensus 97 ~~~~~~sl~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~~ 175 (205)
||+++++|.+.+.. ...+++..+..++.|++.||+|||+++|+|+||+|+||+++.++. ++|+|||++.........
T Consensus 81 Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~--~kl~DfG~a~~~~~~~~~ 158 (331)
T cd05624 81 DYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGH--IRLADFGSCLKMNQDGTV 158 (331)
T ss_pred eCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCC--EEEEeccceeeccCCCce
Confidence 99999999999976 457999999999999999999999999999999999999988777 999999998765433222
Q ss_pred --CCCCCCCCccCCceecc-----CcCCCeeeEEEeC
Q 028681 176 --KSTVGTPAYIAPEVLLK-----KEYDGKVMCVYVI 205 (205)
Q Consensus 176 --~~~~~~~~~~aPE~~~~-----~~~~~~~~Dvwsl 205 (205)
....|++.|+|||++.+ ..++.+ +|||||
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~-~DiwSl 194 (331)
T cd05624 159 QSSVAVGTPDYISPEILQAMEDGMGKYGPE-CDWWSL 194 (331)
T ss_pred eeccccCCcccCCHHHHhccccCCCCCCCc-ccEEee
Confidence 23468999999999875 345544 999996
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=231.26 Aligned_cols=181 Identities=30% Similarity=0.496 Sum_probs=156.4
Q ss_pred CeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCc----cchHHHHHHHHHHHhcCC-CCeeEEEEEEEeCCeEEEEE
Q 028681 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRH-PNIVRFKEVILTPTHLAIVM 96 (205)
Q Consensus 22 ~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~ 96 (205)
+|++.+.||+|++|.||++.+..+++.||+|++.+.. ...+.+..|..++..+.| ++++++++++...+..+++|
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 5899999999999999999999999999999987642 223556778888888876 56888999999999999999
Q ss_pred EecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeeccccccc-CCCCC
Q 028681 97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV-LHSQP 175 (205)
Q Consensus 97 ~~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~-~~~~~ 175 (205)
||+++++|.+.+.....+++..+..++.|++.||.|||++||+|+||+|+||+++.++. ++|+|||++.... .....
T Consensus 81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~--~kL~Dfg~~~~~~~~~~~~ 158 (324)
T cd05587 81 EYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGH--IKIADFGMCKENIFGGKTT 158 (324)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCC--EEEeecCcceecCCCCCce
Confidence 99999999999988888999999999999999999999999999999999999988877 9999999886432 22223
Q ss_pred CCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 176 KSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 176 ~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
....|++.|+|||++.+..++.+ +|||||
T Consensus 159 ~~~~gt~~y~aPE~~~~~~~~~~-~Diwsl 187 (324)
T cd05587 159 RTFCGTPDYIAPEIIAYQPYGKS-VDWWAF 187 (324)
T ss_pred eeecCCccccChhhhcCCCCCcc-cchhhh
Confidence 34468999999999999888765 999996
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=233.91 Aligned_cols=187 Identities=41% Similarity=0.642 Sum_probs=169.1
Q ss_pred eecCCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCcc----chHHHHHHHHHHHhcC-CCCeeEEEEEEEeCCe
Q 028681 17 MHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK----IDENVQREIINHRSLR-HPNIVRFKEVILTPTH 91 (205)
Q Consensus 17 ~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~ 91 (205)
......|++.+.||.|.||.||.++...+|+.+|+|.+.+... ..+.+..|+.++++++ |||++.+.++|++...
T Consensus 31 ~~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~ 110 (382)
T KOG0032|consen 31 EDIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDS 110 (382)
T ss_pred ccccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCe
Confidence 3446689999999999999999999999999999999987654 2367999999999998 9999999999999999
Q ss_pred EEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCC--CcEEEeeecccccc
Q 028681 92 LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPA--PRLKICDFGYSKSS 169 (205)
Q Consensus 92 ~~lv~~~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~--~~~~l~df~~~~~~ 169 (205)
+++|||++.++.|.+.+... .+++..+..++.|++.++.|||+.|++|+|++|+|+++..... ..++++|||++...
T Consensus 111 ~~lvmEL~~GGeLfd~i~~~-~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~ 189 (382)
T KOG0032|consen 111 VYLVMELCEGGELFDRIVKK-HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFI 189 (382)
T ss_pred EEEEEEecCCchHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEc
Confidence 99999999999999999776 5999999999999999999999999999999999999965432 35999999999988
Q ss_pred cCCCCCCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 170 VLHSQPKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 170 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
..........||+.|+|||++....|+.. +||||+
T Consensus 190 ~~~~~~~~~~Gtp~y~APEvl~~~~y~~~-~DiWS~ 224 (382)
T KOG0032|consen 190 KPGERLHTIVGTPEYVAPEVLGGRPYGDE-VDVWSI 224 (382)
T ss_pred cCCceEeeecCCccccCchhhcCCCCCcc-cchhHH
Confidence 88667777899999999999998888866 999985
|
|
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=231.28 Aligned_cols=176 Identities=36% Similarity=0.556 Sum_probs=153.2
Q ss_pred eeeccccceeEEEEEecCCCcEEEEEEeecCc----cchHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEEecCCC
Q 028681 27 RDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGG 102 (205)
Q Consensus 27 ~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~~~~~ 102 (205)
+.||+|+||.||.+.+..++..|++|.+.+.. .....+..|+.+++.++|+||+++.+++..++..++||||++++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 46899999999999999999999999997642 12345677889999999999999999999999999999999999
Q ss_pred chHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-cCcEeecCCCCCeEecCCCCCcEEEeeecccccccC-CCCCCCCCC
Q 028681 103 ELFERICNAGRFSEDEARFFFQQLISGVSYCHS-MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQPKSTVG 180 (205)
Q Consensus 103 sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~-~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~-~~~~~~~~~ 180 (205)
+|...+.....+++..+..++.|++.||.|||+ .|++|+||+|+||+++.++. ++|+|||++..... ........|
T Consensus 81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~--~kL~Dfg~~~~~~~~~~~~~~~~g 158 (325)
T cd05594 81 ELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGH--IKITDFGLCKEGIKDGATMKTFCG 158 (325)
T ss_pred cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCC--EEEecCCCCeecCCCCcccccccC
Confidence 999988888889999999999999999999997 79999999999999988877 99999999864322 222334568
Q ss_pred CCCccCCceeccCcCCCeeeEEEeC
Q 028681 181 TPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 181 ~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
++.|+|||++.+..++.+ +|||||
T Consensus 159 t~~y~aPE~~~~~~~~~~-~Diwsl 182 (325)
T cd05594 159 TPEYLAPEVLEDNDYGRA-VDWWGL 182 (325)
T ss_pred CcccCCHHHHccCCCCCc-cccccc
Confidence 999999999998888765 999997
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=228.72 Aligned_cols=179 Identities=36% Similarity=0.532 Sum_probs=154.5
Q ss_pred CeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCccchHHHHHHHHHHHhcCCCCeeEEEEEEEeCC-----eEEEEE
Q 028681 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPT-----HLAIVM 96 (205)
Q Consensus 22 ~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~lv~ 96 (205)
.|+-.+.+|.|+||.||.+...+++..||||.+-.++. -...|+.+++.+.||||+++.-+|.... +..+||
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r---~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVl 101 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR---YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVL 101 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC---cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHH
Confidence 57889999999999999999999999999998876543 2346888999999999999988877432 456899
Q ss_pred EecCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCC
Q 028681 97 EYASGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 172 (205)
Q Consensus 97 ~~~~~~sl~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~ 172 (205)
||++. +|.+.++. +..++...++-+.+||+.||.|||+.||+||||||.|+++|.+.. .+||+|||.|+....+
T Consensus 102 eymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg-~LKicDFGSAK~L~~~ 179 (364)
T KOG0658|consen 102 EYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTG-VLKICDFGSAKVLVKG 179 (364)
T ss_pred HhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCC-eEEeccCCcceeeccC
Confidence 99965 78888863 567889999999999999999999999999999999999987643 3999999999999888
Q ss_pred CCCCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 173 SQPKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 173 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
....+...+..|.|||.+.+....+.+.||||.
T Consensus 180 epniSYicSRyYRaPELifga~~Yt~~IDiWSa 212 (364)
T KOG0658|consen 180 EPNISYICSRYYRAPELIFGATEYTTSIDIWSA 212 (364)
T ss_pred CCceeEEEeccccCHHHHcCccccCceeEEhhh
Confidence 888888999999999999986654455999983
|
|
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=234.35 Aligned_cols=184 Identities=29% Similarity=0.453 Sum_probs=157.6
Q ss_pred ecCCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCc----cchHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEE
Q 028681 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLA 93 (205)
Q Consensus 18 ~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 93 (205)
...++|++.+.||+|++|.||++.+..++..||+|.+.+.. .....+..|+.+++.++|||++++++++.+++..+
T Consensus 40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~ 119 (370)
T cd05596 40 MKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLY 119 (370)
T ss_pred CCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence 34679999999999999999999999999999999987532 12244678999999999999999999999999999
Q ss_pred EEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCCC
Q 028681 94 IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 173 (205)
Q Consensus 94 lv~~~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~~ 173 (205)
+||||+++++|.+.+.. ..+++..+..++.|++.||+|||+.||+||||+|+||+++.++. ++|+|||++.......
T Consensus 120 lv~Ey~~gg~L~~~l~~-~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~--~kL~DfG~~~~~~~~~ 196 (370)
T cd05596 120 MVMEYMPGGDLVNLMSN-YDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGH--LKLADFGTCMKMDANG 196 (370)
T ss_pred EEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCC--EEEEeccceeeccCCC
Confidence 99999999999988854 46889999999999999999999999999999999999998887 9999999987654332
Q ss_pred C--CCCCCCCCCccCCceeccCc----CCCeeeEEEeC
Q 028681 174 Q--PKSTVGTPAYIAPEVLLKKE----YDGKVMCVYVI 205 (205)
Q Consensus 174 ~--~~~~~~~~~~~aPE~~~~~~----~~~~~~Dvwsl 205 (205)
. .....|++.|+|||++.+.. ++ .++|||||
T Consensus 197 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~-~~~DiwSl 233 (370)
T cd05596 197 MVRCDTAVGTPDYISPEVLKSQGGDGYYG-RECDWWSV 233 (370)
T ss_pred cccCCCCCCCcCeECHHHhccCCCCCCCC-Cceeeeeh
Confidence 2 23456899999999997643 44 44999997
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=230.40 Aligned_cols=182 Identities=26% Similarity=0.469 Sum_probs=155.8
Q ss_pred CCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCc----cchHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEE
Q 028681 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (205)
Q Consensus 21 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 96 (205)
++|++.+.||+|++|.||++.+..+++.||+|.+.+.. ...+.+.+|..++..+.|+|++++++++.+++..++|+
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 57999999999999999999999999999999987532 12345778899999999999999999999999999999
Q ss_pred EecCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCCCCC
Q 028681 97 EYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 175 (205)
Q Consensus 97 ~~~~~~sl~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~~ 175 (205)
||+++++|.+.+.. ...+++..++.++.|++.||.|||+++++|+||+|+||+++.++. ++|+|||++.........
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~--~kl~Dfg~~~~~~~~~~~ 158 (331)
T cd05597 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGH--IRLADFGSCLRLLADGTV 158 (331)
T ss_pred ecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCC--EEEEECCceeecCCCCCc
Confidence 99999999999875 456999999999999999999999999999999999999988877 999999998654433222
Q ss_pred --CCCCCCCCccCCceecc-----CcCCCeeeEEEeC
Q 028681 176 --KSTVGTPAYIAPEVLLK-----KEYDGKVMCVYVI 205 (205)
Q Consensus 176 --~~~~~~~~~~aPE~~~~-----~~~~~~~~Dvwsl 205 (205)
....|++.|+|||++.. ..++ .++|||||
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~-~~~Diwsl 194 (331)
T cd05597 159 QSNVAVGTPDYISPEILQAMEDGKGRYG-PECDWWSL 194 (331)
T ss_pred cccceeccccccCHHHHhhccccccCCC-Ccceeehh
Confidence 22358999999999973 3344 44999996
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=230.53 Aligned_cols=182 Identities=31% Similarity=0.533 Sum_probs=154.9
Q ss_pred CeEEEeeeccccceeEEEEEec---CCCcEEEEEEeecCc-----cchHHHHHHHHHHHhc-CCCCeeEEEEEEEeCCeE
Q 028681 22 RYELVRDIGSGNFGVARLMRDK---KTEELVAVKYIERGD-----KIDENVQREIINHRSL-RHPNIVRFKEVILTPTHL 92 (205)
Q Consensus 22 ~y~~~~~l~~g~~g~v~~~~~~---~~~~~v~iK~~~~~~-----~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~ 92 (205)
+|++.+.||+|++|.||++... .++..|++|++.+.. ...+.+..|+.+++.+ .|++++++++++..++..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 5899999999999999998864 468899999987532 2234577889999999 589999999999999999
Q ss_pred EEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCC
Q 028681 93 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 172 (205)
Q Consensus 93 ~lv~~~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~ 172 (205)
+++|||+++++|.+.+.....+++..+..++.|++.||.|||++|++||||+|+||+++.++. ++|+|||+++.....
T Consensus 81 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~--~kl~DfG~~~~~~~~ 158 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGH--VVLTDFGLSKEFLSE 158 (332)
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCC--EEEeeCcCCcccccc
Confidence 999999999999999988788999999999999999999999999999999999999988877 999999998754332
Q ss_pred CC--CCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 173 SQ--PKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 173 ~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
.. .....|++.|+|||++.+....+.++|||||
T Consensus 159 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Diwsl 193 (332)
T cd05614 159 EKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSL 193 (332)
T ss_pred CCCccccccCCccccCHHHhcCCCCCCCccccccc
Confidence 22 2234689999999999876533345999997
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=231.25 Aligned_cols=176 Identities=30% Similarity=0.477 Sum_probs=153.4
Q ss_pred eeeccccceeEEEEEecCCCcEEEEEEeecCcc----chHHHHHHHHHHHhc-CCCCeeEEEEEEEeCCeEEEEEEecCC
Q 028681 27 RDIGSGNFGVARLMRDKKTEELVAVKYIERGDK----IDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIVMEYASG 101 (205)
Q Consensus 27 ~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~~~~~~ 101 (205)
+.||+|++|.||.+.+..++..||+|++++... ..+.+..|..++..+ +||||+++++++..++.++++|||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 468999999999999999999999999986422 224567888888888 699999999999999999999999999
Q ss_pred CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccc-cCCCCCCCCCC
Q 028681 102 GELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS-VLHSQPKSTVG 180 (205)
Q Consensus 102 ~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~-~~~~~~~~~~~ 180 (205)
++|...+...+.+++..++.++.|++.||.|||++|++|+||+|+||+++.++. ++|+|||+++.. ..........|
T Consensus 81 g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~--~kL~Dfg~~~~~~~~~~~~~~~~g 158 (329)
T cd05588 81 GDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGH--IKLTDYGMCKEGIRPGDTTSTFCG 158 (329)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCC--EEECcCccccccccCCCccccccC
Confidence 999988888788999999999999999999999999999999999999988877 999999998642 22333344568
Q ss_pred CCCccCCceeccCcCCCeeeEEEeC
Q 028681 181 TPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 181 ~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
++.|+|||++.+..++.+ +|||||
T Consensus 159 t~~y~aPE~~~~~~~~~~-~Diwsl 182 (329)
T cd05588 159 TPNYIAPEILRGEDYGFS-VDWWAL 182 (329)
T ss_pred CccccCHHHHcCCCCCCc-cceech
Confidence 999999999998888766 999996
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=228.10 Aligned_cols=182 Identities=30% Similarity=0.519 Sum_probs=157.2
Q ss_pred CCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCc---cchHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEE
Q 028681 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (205)
Q Consensus 21 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~ 97 (205)
++|++.+.||+|++|.||++.+..++..|++|.+.... ...+.+..|+.+++.++|+|++++++++..++..+++||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 47999999999999999999999999999999987643 224567889999999999999999999999999999999
Q ss_pred ecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCCCC--C
Q 028681 98 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ--P 175 (205)
Q Consensus 98 ~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~--~ 175 (205)
|++++.+.........+++..++.++.|++.||.|||+.+++|+||+|+||+++.++. ++|+|||++........ .
T Consensus 81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~--~kl~Dfg~~~~~~~~~~~~~ 158 (287)
T cd07848 81 YVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDV--LKLCDFGFARNLSEGSNANY 158 (287)
T ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCc--EEEeeccCcccccccccccc
Confidence 9988776655544557999999999999999999999999999999999999988877 99999999876543322 2
Q ss_pred CCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 176 KSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 176 ~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
....+++.|+|||++.+..++.+ +|||||
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~-~Diwsl 187 (287)
T cd07848 159 TEYVATRWYRSPELLLGAPYGKA-VDMWSV 187 (287)
T ss_pred cccccccccCCcHHHcCCCCCCc-hhHHhH
Confidence 23468899999999998888755 999996
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=230.00 Aligned_cols=184 Identities=28% Similarity=0.466 Sum_probs=154.3
Q ss_pred cCCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCcc--chHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEE
Q 028681 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (205)
Q Consensus 19 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 96 (205)
..++|++.+.||+|++|.||.+.+..+++.||+|.+..... ....+.+|+.+++.++|+|++++++++.++...+++|
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 82 (303)
T cd07869 3 KADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVF 82 (303)
T ss_pred ccccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEE
Confidence 45889999999999999999999999999999999875432 2345778999999999999999999999999999999
Q ss_pred EecCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCC-CC
Q 028681 97 EYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQ 174 (205)
Q Consensus 97 ~~~~~~sl~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~-~~ 174 (205)
||+++ +|.+.+.. ...+++..++.++.|++.||.|||+.|++|+||+|+||+++.++. ++|+|||++...... ..
T Consensus 83 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~--~kl~Dfg~~~~~~~~~~~ 159 (303)
T cd07869 83 EYVHT-DLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGE--LKLADFGLARAKSVPSHT 159 (303)
T ss_pred ECCCc-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCC--EEECCCCcceeccCCCcc
Confidence 99964 67666654 456899999999999999999999999999999999999988777 999999998643322 22
Q ss_pred CCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 175 PKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 175 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
.....+++.|+|||++.+......++|||||
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~Diwsl 190 (303)
T cd07869 160 YSNEVVTLWYRPPDVLLGSTEYSTCLDMWGV 190 (303)
T ss_pred CCCCcccCCCCChHHHcCCCCCCcHHHHHHH
Confidence 2344678999999998765433344999996
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=229.16 Aligned_cols=181 Identities=31% Similarity=0.508 Sum_probs=155.6
Q ss_pred CeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCcc----chHHHHHHHHHHHhc-CCCCeeEEEEEEEeCCeEEEEE
Q 028681 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK----IDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIVM 96 (205)
Q Consensus 22 ~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~ 96 (205)
+|++.+.||+|+||.||++.+..++..|++|.+.+... ..+....|..++..+ .|++++++++++...+..++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 58999999999999999999999999999999886432 123345566666666 5799999999999999999999
Q ss_pred EecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCC-CCC
Q 028681 97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQP 175 (205)
Q Consensus 97 ~~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~-~~~ 175 (205)
||+++++|.+.+.....+++..+..++.|++.||+|||++||+|+||+|+||+++.++. ++|+|||++...... ...
T Consensus 81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~--~kL~DfG~~~~~~~~~~~~ 158 (323)
T cd05616 81 EYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGH--IKIADFGMCKENMWDGVTT 158 (323)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCc--EEEccCCCceecCCCCCcc
Confidence 99999999999988788999999999999999999999999999999999999998887 999999998754322 223
Q ss_pred CCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 176 KSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 176 ~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
....|++.|+|||++.+..++.+ +|||||
T Consensus 159 ~~~~gt~~y~aPE~~~~~~~~~~-~DiwSl 187 (323)
T cd05616 159 KTFCGTPDYIAPEIIAYQPYGKS-VDWWAF 187 (323)
T ss_pred ccCCCChhhcCHHHhcCCCCCCc-cchhch
Confidence 34568999999999999888766 999996
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=230.08 Aligned_cols=176 Identities=31% Similarity=0.507 Sum_probs=152.6
Q ss_pred eeeccccceeEEEEEecCCCcEEEEEEeecCc----cchHHHHHHHHHHHhc-CCCCeeEEEEEEEeCCeEEEEEEecCC
Q 028681 27 RDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIVMEYASG 101 (205)
Q Consensus 27 ~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~~~~~~ 101 (205)
+.||+|+||.||.+.+..+++.|++|.+.+.. ...+.+..|..++.++ +||||+++++++..++..+++|||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 46999999999999999999999999998642 2234566788777766 799999999999999999999999999
Q ss_pred CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeeccccccc-CCCCCCCCCC
Q 028681 102 GELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV-LHSQPKSTVG 180 (205)
Q Consensus 102 ~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~-~~~~~~~~~~ 180 (205)
++|...+.....+++..++.++.|++.||.|||+++++||||+|+||+++.++. ++|+|||+++... .........|
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~--~kL~DfG~~~~~~~~~~~~~~~~g 158 (329)
T cd05618 81 GDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGH--IKLTDYGMCKEGLRPGDTTSTFCG 158 (329)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCC--EEEeeCCccccccCCCCccccccC
Confidence 999988888788999999999999999999999999999999999999998887 9999999986532 2223334568
Q ss_pred CCCccCCceeccCcCCCeeeEEEeC
Q 028681 181 TPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 181 ~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
+..|+|||++.+..++.+ +|||||
T Consensus 159 t~~y~aPE~~~~~~~~~~-~Diwsl 182 (329)
T cd05618 159 TPNYIAPEILRGEDYGFS-VDWWAL 182 (329)
T ss_pred CccccCHHHHcCCCCCCc-cceecc
Confidence 999999999998888766 999997
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=228.24 Aligned_cols=182 Identities=25% Similarity=0.471 Sum_probs=155.2
Q ss_pred CCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCc----cchHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEE
Q 028681 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (205)
Q Consensus 21 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 96 (205)
++|++.+.||+|+||.||.+....+++.+++|.+.+.. .....+..|..++..++|++++++++.+.+++..++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 47999999999999999999999999999999986532 12234778888899999999999999999999999999
Q ss_pred EecCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCCCC-
Q 028681 97 EYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ- 174 (205)
Q Consensus 97 ~~~~~~sl~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~- 174 (205)
||+++++|.+.+.. ...+++..++.++.|++.|+.+||+++++||||+|+||+++.++. ++|+|||++........
T Consensus 81 ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~--~kL~DfG~a~~~~~~~~~ 158 (332)
T cd05623 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGH--IRLADFGSCLKLMEDGTV 158 (332)
T ss_pred eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCC--EEEeecchheecccCCcc
Confidence 99999999999976 457899999999999999999999999999999999999987777 99999999865433222
Q ss_pred -CCCCCCCCCccCCceecc-----CcCCCeeeEEEeC
Q 028681 175 -PKSTVGTPAYIAPEVLLK-----KEYDGKVMCVYVI 205 (205)
Q Consensus 175 -~~~~~~~~~~~aPE~~~~-----~~~~~~~~Dvwsl 205 (205)
.....|++.|+|||++.. ..++.+ +|||||
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~-~DvwSl 194 (332)
T cd05623 159 QSSVAVGTPDYISPEILQAMEDGKGKYGPE-CDWWSL 194 (332)
T ss_pred eecccccCccccCHHHHhccccCCCCCCCc-CCEEee
Confidence 223468999999999862 345544 999996
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=224.88 Aligned_cols=188 Identities=31% Similarity=0.407 Sum_probs=160.6
Q ss_pred CceecCCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCccc---hHHHHHHHHHHHhcCCCCeeEEEEEEEeC--
Q 028681 15 PIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI---DENVQREIINHRSLRHPNIVRFKEVILTP-- 89 (205)
Q Consensus 15 ~~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-- 89 (205)
.-+..-+.|+.+..|++|+||.||+++++.++..||+|+++..... .-...+|+.+|.+.+||||+.+-.+..-.
T Consensus 70 ~gCrsv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~ 149 (419)
T KOG0663|consen 70 GGCRSVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNM 149 (419)
T ss_pred cCcccHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEecccc
Confidence 3455678899999999999999999999999999999999875422 23467899999999999999998887744
Q ss_pred CeEEEEEEecCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeeccccc
Q 028681 90 THLAIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 168 (205)
Q Consensus 90 ~~~~lv~~~~~~~sl~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~ 168 (205)
+.+|+||||+.. .|..++.. ..++.+.+++.++.|++.|++|||.+.|+|||+||+|++++..+. +||+|||+|+.
T Consensus 150 d~iy~VMe~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~--lKiaDFGLAR~ 226 (419)
T KOG0663|consen 150 DKIYIVMEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGI--LKIADFGLARE 226 (419)
T ss_pred ceeeeeHHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCc--EEecccchhhh
Confidence 579999999964 67777755 457999999999999999999999999999999999999998888 99999999998
Q ss_pred ccCCCC-CCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 169 SVLHSQ-PKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 169 ~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
+..... .....-|+.|.|||.+.+.+..+.+.|+||+
T Consensus 227 ygsp~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSv 264 (419)
T KOG0663|consen 227 YGSPLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSV 264 (419)
T ss_pred hcCCcccCcceEEEeeecCHHHhcCCcccCcchhhhhH
Confidence 766533 4445689999999999986654455999995
|
|
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=229.36 Aligned_cols=176 Identities=32% Similarity=0.561 Sum_probs=149.7
Q ss_pred eeeccccceeEEEEEecCCCcEEEEEEeecCcc----chHHHHHHH-HHHHhcCCCCeeEEEEEEEeCCeEEEEEEecCC
Q 028681 27 RDIGSGNFGVARLMRDKKTEELVAVKYIERGDK----IDENVQREI-INHRSLRHPNIVRFKEVILTPTHLAIVMEYASG 101 (205)
Q Consensus 27 ~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~----~~~~~~~e~-~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~~~~ 101 (205)
+.||+|++|+||++.+..+++.|++|.+.+... ....+..|. .+++.++||||+++++.+..++..+++|||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 468999999999999999999999999875421 122333343 356788999999999999999999999999999
Q ss_pred CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccC-CCCCCCCCC
Q 028681 102 GELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQPKSTVG 180 (205)
Q Consensus 102 ~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~-~~~~~~~~~ 180 (205)
++|...+.....+++..+..++.|++.||.|||++|++|+||+|+||+++.++. ++|+|||++..... ........|
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~g 158 (323)
T cd05575 81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGH--VVLTDFGLCKEGIEHSKTTSTFCG 158 (323)
T ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCc--EEEeccCCCcccccCCCccccccC
Confidence 999999988888999999999999999999999999999999999999988877 99999999865322 222334468
Q ss_pred CCCccCCceeccCcCCCeeeEEEeC
Q 028681 181 TPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 181 ~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
++.|+|||++.+..++.+ +|||||
T Consensus 159 t~~y~aPE~~~~~~~~~~-~Dvwsl 182 (323)
T cd05575 159 TPEYLAPEVLRKQPYDRT-VDWWCL 182 (323)
T ss_pred ChhhcChhhhcCCCCCcc-cccccc
Confidence 999999999998888765 999997
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=237.69 Aligned_cols=184 Identities=32% Similarity=0.496 Sum_probs=168.1
Q ss_pred cCCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCcc--chHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEE
Q 028681 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (205)
Q Consensus 19 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 96 (205)
....|+..+.||+|+||.||++.+..+++.||+|++..... ..+.++.|+.++.++.++||.++++.+..+..+|++|
T Consensus 11 ~~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiM 90 (467)
T KOG0201|consen 11 PELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIM 90 (467)
T ss_pred cccccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHH
Confidence 35678888999999999999999999999999999987643 3467899999999999999999999999999999999
Q ss_pred EecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCCCCC-
Q 028681 97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP- 175 (205)
Q Consensus 97 ~~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~~- 175 (205)
||+.+|++.+.++.+..+.+..+..++++++.|+.|||..+.+|+||++.||++..++. ++|+|||.+.........
T Consensus 91 ey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~--vkl~DfgVa~ql~~~~~rr 168 (467)
T KOG0201|consen 91 EYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGD--VKLADFGVAGQLTNTVKRR 168 (467)
T ss_pred HHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCc--EEEEecceeeeeechhhcc
Confidence 99999999999988887899999999999999999999999999999999999998877 999999999776655444
Q ss_pred CCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 176 KSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 176 ~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
.+..||+.|||||++....|+.+ +|||||
T Consensus 169 ~tfvGTPfwMAPEVI~~~~Y~~K-ADIWSL 197 (467)
T KOG0201|consen 169 KTFVGTPFWMAPEVIKQSGYDTK-ADIWSL 197 (467)
T ss_pred ccccccccccchhhhccccccch-hhhhhh
Confidence 66689999999999998899888 999997
|
|
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-36 Score=227.66 Aligned_cols=177 Identities=29% Similarity=0.481 Sum_probs=152.4
Q ss_pred EeeeccccceeEEEEEec---CCCcEEEEEEeecCc-----cchHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEE
Q 028681 26 VRDIGSGNFGVARLMRDK---KTEELVAVKYIERGD-----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (205)
Q Consensus 26 ~~~l~~g~~g~v~~~~~~---~~~~~v~iK~~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~ 97 (205)
++.||+|+||.||++... .+++.||+|.+.... .....+..|+.+++.++||||+++++++..++..+++||
T Consensus 1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e 80 (323)
T cd05584 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILE 80 (323)
T ss_pred CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEe
Confidence 368999999999999864 467899999987532 122456789999999999999999999999999999999
Q ss_pred ecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCC-CCCC
Q 028681 98 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPK 176 (205)
Q Consensus 98 ~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~-~~~~ 176 (205)
|+++++|.+.+...+.+++..+..++.|++.||.|||+.|++|+||+|+||+++.++. ++|+|||++...... ....
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~~~ 158 (323)
T cd05584 81 YLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGH--VKLTDFGLCKESIHEGTVTH 158 (323)
T ss_pred CCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCC--EEEeeCcCCeecccCCCccc
Confidence 9999999999988888999999999999999999999999999999999999988877 999999998643322 2233
Q ss_pred CCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 177 STVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 177 ~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
...|++.|+|||++.+..++.+ +|||||
T Consensus 159 ~~~gt~~y~aPE~~~~~~~~~~-~Diwsl 186 (323)
T cd05584 159 TFCGTIEYMAPEILMRSGHGKA-VDWWSL 186 (323)
T ss_pred ccCCCccccChhhccCCCCCCc-ceeccc
Confidence 4568999999999998887755 999997
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=229.38 Aligned_cols=176 Identities=31% Similarity=0.544 Sum_probs=149.9
Q ss_pred eeeccccceeEEEEEecCCCcEEEEEEeecCcc----chHHHHHHH-HHHHhcCCCCeeEEEEEEEeCCeEEEEEEecCC
Q 028681 27 RDIGSGNFGVARLMRDKKTEELVAVKYIERGDK----IDENVQREI-INHRSLRHPNIVRFKEVILTPTHLAIVMEYASG 101 (205)
Q Consensus 27 ~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~----~~~~~~~e~-~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~~~~ 101 (205)
+.||+|+||.||.+.+..++..+++|++.+... ....+..|. .+++.++||||+++++++..++..+++|||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 468999999999999999999999999875421 223334444 356778999999999999999999999999999
Q ss_pred CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccC-CCCCCCCCC
Q 028681 102 GELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQPKSTVG 180 (205)
Q Consensus 102 ~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~-~~~~~~~~~ 180 (205)
++|...+.....+++..+..++.|++.||.|||+.|++|+||+|+||+++.++. ++|+|||++..... ........|
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~--~kL~DfG~~~~~~~~~~~~~~~~g 158 (325)
T cd05604 81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGH--VVLTDFGLCKEGIAQSDTTTTFCG 158 (325)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCC--EEEeecCCcccCCCCCCCcccccC
Confidence 999988888888999999999999999999999999999999999999998887 99999999865322 222334468
Q ss_pred CCCccCCceeccCcCCCeeeEEEeC
Q 028681 181 TPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 181 ~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
++.|+|||++.+..++.+ +|||||
T Consensus 159 t~~y~aPE~~~~~~~~~~-~Dvwsl 182 (325)
T cd05604 159 TPEYLAPEVIRKQPYDNT-VDWWCL 182 (325)
T ss_pred ChhhCCHHHHcCCCCCCc-Cccccc
Confidence 999999999998888765 999997
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-36 Score=228.08 Aligned_cols=176 Identities=31% Similarity=0.494 Sum_probs=151.7
Q ss_pred eeeccccceeEEEEEecCCCcEEEEEEeecCc----cchHHHHHHHHHHHhc-CCCCeeEEEEEEEeCCeEEEEEEecCC
Q 028681 27 RDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIVMEYASG 101 (205)
Q Consensus 27 ~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~~~~~~ 101 (205)
+.||+|+||.||++.+..++..|++|.+.... ...+.+..|..++..+ +||||+++++++..++..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 46899999999999999999999999987642 2224456777777765 799999999999999999999999999
Q ss_pred CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccC-CCCCCCCCC
Q 028681 102 GELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQPKSTVG 180 (205)
Q Consensus 102 ~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~-~~~~~~~~~ 180 (205)
++|...+.....+++..+..++.|++.||.|||++|++|+||+|+||+++.++. ++|+|||++..... ........|
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~--~kL~Dfg~~~~~~~~~~~~~~~~g 158 (321)
T cd05591 81 GDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGH--CKLADFGMCKEGILNGVTTTTFCG 158 (321)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCC--EEEeecccceecccCCcccccccc
Confidence 999999988888999999999999999999999999999999999999988877 99999999865332 222334468
Q ss_pred CCCccCCceeccCcCCCeeeEEEeC
Q 028681 181 TPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 181 ~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
+..|+|||++.+..++.+ +|||||
T Consensus 159 t~~y~aPE~~~~~~~~~~-~Dvwsl 182 (321)
T cd05591 159 TPDYIAPEILQELEYGPS-VDWWAL 182 (321)
T ss_pred CccccCHHHHcCCCCCCc-cceech
Confidence 999999999998888766 999996
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-36 Score=228.78 Aligned_cols=176 Identities=34% Similarity=0.575 Sum_probs=149.2
Q ss_pred eeeccccceeEEEEEecCCCcEEEEEEeecCcc----chHHHHHH-HHHHHhcCCCCeeEEEEEEEeCCeEEEEEEecCC
Q 028681 27 RDIGSGNFGVARLMRDKKTEELVAVKYIERGDK----IDENVQRE-IINHRSLRHPNIVRFKEVILTPTHLAIVMEYASG 101 (205)
Q Consensus 27 ~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~----~~~~~~~e-~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~~~~ 101 (205)
+.||+|+||.||++.+..++..|++|++..... ....+..| ..+++.++|+||+++++++..++..+++|||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 468999999999999999999999999875321 11223333 3456778999999999999999999999999999
Q ss_pred CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccC-CCCCCCCCC
Q 028681 102 GELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQPKSTVG 180 (205)
Q Consensus 102 ~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~-~~~~~~~~~ 180 (205)
++|.+.+.....+++..++.++.|++.||.|||+.|++||||+|+||+++.++. ++|+|||++..... ........|
T Consensus 81 ~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~--~kl~DfG~a~~~~~~~~~~~~~~g 158 (325)
T cd05602 81 GELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGH--IVLTDFGLCKENIEHNGTTSTFCG 158 (325)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCC--EEEccCCCCcccccCCCCcccccC
Confidence 999999988888999999999999999999999999999999999999988777 99999999864322 223334568
Q ss_pred CCCccCCceeccCcCCCeeeEEEeC
Q 028681 181 TPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 181 ~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
++.|+|||++.+..++.+ +|||||
T Consensus 159 t~~y~aPE~~~~~~~~~~-~Diwsl 182 (325)
T cd05602 159 TPEYLAPEVLHKQPYDRT-VDWWCL 182 (325)
T ss_pred CccccCHHHHcCCCCCCc-cccccc
Confidence 999999999998888765 999997
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-36 Score=227.93 Aligned_cols=181 Identities=30% Similarity=0.498 Sum_probs=155.4
Q ss_pred CeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCc----cchHHHHHHHHHHHhcC-CCCeeEEEEEEEeCCeEEEEE
Q 028681 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLR-HPNIVRFKEVILTPTHLAIVM 96 (205)
Q Consensus 22 ~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~ 96 (205)
+|+..+.||+|++|.||++.+..+++.||+|++.+.. ...+.+..|..+++.+. |++++++.+.+...+..++||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 5789999999999999999999999999999987542 22244667777777775 577888999999999999999
Q ss_pred EecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCC-CCC
Q 028681 97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQP 175 (205)
Q Consensus 97 ~~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~-~~~ 175 (205)
||+++++|.+.+.....+++.++..++.|++.||.|||++|++|+||+|+||+++.++. ++|+|||++...... ...
T Consensus 81 Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~--ikL~Dfg~~~~~~~~~~~~ 158 (323)
T cd05615 81 EYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGH--IKIADFGMCKEHMVDGVTT 158 (323)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCC--EEEeccccccccCCCCccc
Confidence 99999999999988788999999999999999999999999999999999999998877 999999998754322 223
Q ss_pred CCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 176 KSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 176 ~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
....|++.|+|||++.+..++.+ +|||||
T Consensus 159 ~~~~gt~~y~aPE~~~~~~~~~~-~Diwsl 187 (323)
T cd05615 159 RTFCGTPDYIAPEIIAYQPYGKS-VDWWAY 187 (323)
T ss_pred cCccCCccccCHHHHcCCCCCCc-cchhhh
Confidence 34468999999999998888755 999996
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=223.22 Aligned_cols=181 Identities=25% Similarity=0.345 Sum_probs=157.3
Q ss_pred CeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCcc----chHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEE
Q 028681 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK----IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (205)
Q Consensus 22 ~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~ 97 (205)
+|++.+.||+|++|.||.+.+..+++.||+|.+..... ....+.+|+.+++.++|+|++++++.+..++..+++||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 58999999999999999999999999999999875422 12346789999999999999999999999999999999
Q ss_pred ecCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCCCCC
Q 028681 98 YASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 175 (205)
Q Consensus 98 ~~~~~sl~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~~ 175 (205)
|+++++|.+.+... ..+++..+..++.|++.|+.|||+.+++|+||+|+||++++++. ++|+|||++.........
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~--~~l~Dfg~~~~~~~~~~~ 158 (285)
T cd05605 81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGH--IRISDLGLAVEIPEGETI 158 (285)
T ss_pred ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCC--EEEeeCCCceecCCCCcc
Confidence 99999998877543 45899999999999999999999999999999999999988777 999999998765444443
Q ss_pred CCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 176 KSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 176 ~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
....++..|+|||++.+..++.+ +|||||
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~-~Diws~ 187 (285)
T cd05605 159 RGRVGTVGYMAPEVVKNERYTFS-PDWWGL 187 (285)
T ss_pred ccccCCCCccCcHHhcCCCCCcc-ccchhH
Confidence 44578999999999988888766 999996
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-36 Score=228.55 Aligned_cols=183 Identities=28% Similarity=0.444 Sum_probs=162.0
Q ss_pred cCCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCc--cchHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEE
Q 028681 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (205)
Q Consensus 19 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 96 (205)
..++|++.+.||+|++|.||++.+..++..+++|.+.... ...+.+..|+.+++.++|+|++++++++..++..+++|
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 82 (331)
T cd06649 3 KDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 82 (331)
T ss_pred CcccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEe
Confidence 3689999999999999999999999999999999987642 23466889999999999999999999999999999999
Q ss_pred EecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhc-CcEeecCCCCCeEecCCCCCcEEEeeecccccccCCCCC
Q 028681 97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM-QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 175 (205)
Q Consensus 97 ~~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~-~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~~ 175 (205)
||+++++|.+.+.....+++..+..++.|++.|+.|||+. +++|+||+|+||+++.++. ++|+|||++..... ...
T Consensus 83 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~-~~~ 159 (331)
T cd06649 83 EHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGE--IKLCDFGVSGQLID-SMA 159 (331)
T ss_pred ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCc--EEEccCcccccccc-ccc
Confidence 9999999999998878899999999999999999999985 6999999999999988877 99999999865432 223
Q ss_pred CCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 176 KSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 176 ~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
....++..|+|||++.+..++.+ +|||||
T Consensus 160 ~~~~g~~~y~aPE~~~~~~~~~~-~Diwsl 188 (331)
T cd06649 160 NSFVGTRSYMSPERLQGTHYSVQ-SDIWSM 188 (331)
T ss_pred ccCCCCcCcCCHhHhcCCCCCch-HhHHHH
Confidence 44568999999999998888765 999996
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=225.93 Aligned_cols=183 Identities=31% Similarity=0.503 Sum_probs=155.3
Q ss_pred cCCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCcc--chHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEE
Q 028681 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (205)
Q Consensus 19 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 96 (205)
+.++|++.+.||.|++|.||++.+..++..|++|.+..... ....+.+|+.+++.++|+|++++++++..++..++++
T Consensus 3 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 82 (288)
T cd07871 3 KLETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVF 82 (288)
T ss_pred ccccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEE
Confidence 46789999999999999999999999999999999875432 2356778999999999999999999999999999999
Q ss_pred EecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCCC-C
Q 028681 97 EYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-Q 174 (205)
Q Consensus 97 ~~~~~~sl~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~~-~ 174 (205)
|++++ +|.+.+... ..++...+..++.|++.||.|||++||+|+||+|+||+++.++. ++|+|||++....... .
T Consensus 83 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~--~kl~DfG~~~~~~~~~~~ 159 (288)
T cd07871 83 EYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGE--LKLADFGLARAKSVPTKT 159 (288)
T ss_pred eCCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCC--EEECcCcceeeccCCCcc
Confidence 99975 788877654 35789999999999999999999999999999999999988877 9999999986543222 2
Q ss_pred CCCCCCCCCccCCceeccC-cCCCeeeEEEeC
Q 028681 175 PKSTVGTPAYIAPEVLLKK-EYDGKVMCVYVI 205 (205)
Q Consensus 175 ~~~~~~~~~~~aPE~~~~~-~~~~~~~Dvwsl 205 (205)
.....+++.|+|||.+.+. .++. ++|||||
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~-~~Diwsl 190 (288)
T cd07871 160 YSNEVVTLWYRPPDVLLGSTEYST-PIDMWGV 190 (288)
T ss_pred ccCceecccccChHHhcCCcccCc-HHHHHHH
Confidence 2334678999999998764 4554 4999986
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=234.36 Aligned_cols=178 Identities=20% Similarity=0.289 Sum_probs=155.2
Q ss_pred cCCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCccchHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEEe
Q 028681 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (205)
Q Consensus 19 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~ 98 (205)
...+|++.+.||+|++|.||.+.+..+++.||+|... ...+.+|+.+++.++||||+++++++..+...++++++
T Consensus 90 ~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~-----~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~ 164 (391)
T PHA03212 90 EKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ-----RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPR 164 (391)
T ss_pred ccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh-----hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEec
Confidence 3468999999999999999999999999999999643 24567899999999999999999999999999999999
Q ss_pred cCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCC--CCCC
Q 028681 99 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH--SQPK 176 (205)
Q Consensus 99 ~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~--~~~~ 176 (205)
+. ++|...+.....+++..++.++.|++.||.|||++||+|+||+|+||+++.++. ++|+|||++...... ....
T Consensus 165 ~~-~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~--vkL~DFG~a~~~~~~~~~~~~ 241 (391)
T PHA03212 165 YK-TDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGD--VCLGDFGAACFPVDINANKYY 241 (391)
T ss_pred CC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCC--EEEEeCCcccccccccccccc
Confidence 85 578888877778999999999999999999999999999999999999988777 999999998643221 1223
Q ss_pred CCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 177 STVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 177 ~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
...||+.|+|||++.+..++.+ +|||||
T Consensus 242 ~~~gt~~y~aPE~~~~~~~~~~-~DiwSl 269 (391)
T PHA03212 242 GWAGTIATNAPELLARDPYGPA-VDIWSA 269 (391)
T ss_pred cccCccCCCChhhhcCCCCCcH-HHHHHH
Confidence 3468999999999998888765 999996
|
|
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-36 Score=228.22 Aligned_cols=179 Identities=36% Similarity=0.553 Sum_probs=152.2
Q ss_pred eEEEeeeccccceeEEEEEecCCCcEEEEEEeecCc----cchHHHHHHHHHH---HhcCCCCeeEEEEEEEeCCeEEEE
Q 028681 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINH---RSLRHPNIVRFKEVILTPTHLAIV 95 (205)
Q Consensus 23 y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~e~~~l---~~l~h~~i~~~~~~~~~~~~~~lv 95 (205)
|++.+.||+|++|.||.+.+..+++.|++|.+.+.. ...+.+..|..++ +.++||||+++++++..++..++|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 788999999999999999999999999999997542 1234455665554 466799999999999999999999
Q ss_pred EEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccC-CCC
Q 028681 96 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQ 174 (205)
Q Consensus 96 ~~~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~-~~~ 174 (205)
|||+++++|...+.. ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++. ++|+|||++..... ...
T Consensus 81 ~E~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~--~kL~Dfg~~~~~~~~~~~ 157 (324)
T cd05589 81 MEYAAGGDLMMHIHT-DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGF--VKIADFGLCKEGMGFGDR 157 (324)
T ss_pred EcCCCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCc--EEeCcccCCccCCCCCCc
Confidence 999999999877744 56999999999999999999999999999999999999998887 99999998865332 233
Q ss_pred CCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 175 PKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 175 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
.....|++.|+|||.+.+..++.+ +|||||
T Consensus 158 ~~~~~g~~~y~aPE~~~~~~~~~~-~Diwsl 187 (324)
T cd05589 158 TSTFCGTPEFLAPEVLTETSYTRA-VDWWGL 187 (324)
T ss_pred ccccccCccccCHhHhcCCCCCcc-cchhhH
Confidence 344568999999999998888755 999996
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-36 Score=227.96 Aligned_cols=176 Identities=33% Similarity=0.509 Sum_probs=151.7
Q ss_pred eeeccccceeEEEEEecCCCcEEEEEEeecCc----cchHHHHHHHHHHHhc-CCCCeeEEEEEEEeCCeEEEEEEecCC
Q 028681 27 RDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIVMEYASG 101 (205)
Q Consensus 27 ~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~~~~~~ 101 (205)
+.||+|++|.||++.+..+++.||+|.+.+.. ...+.+..|..++..+ +|||++++++++...+..+++|||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 46899999999999999999999999987532 2234556777777766 699999999999999999999999999
Q ss_pred CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccC-CCCCCCCCC
Q 028681 102 GELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQPKSTVG 180 (205)
Q Consensus 102 ~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~-~~~~~~~~~ 180 (205)
++|.+.+.....+++..+..++.|++.||.|||+.+++||||+|+||+++.++. ++|+|||++..... ........|
T Consensus 81 g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~--~kL~DfG~~~~~~~~~~~~~~~~g 158 (320)
T cd05590 81 GDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGH--CKLADFGMCKEGIFNGKTTSTFCG 158 (320)
T ss_pred chHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCc--EEEeeCCCCeecCcCCCccccccc
Confidence 999998888888999999999999999999999999999999999999988877 99999999865322 223334568
Q ss_pred CCCccCCceeccCcCCCeeeEEEeC
Q 028681 181 TPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 181 ~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
++.|+|||.+.+..++.+ +|||||
T Consensus 159 t~~y~aPE~~~~~~~~~~-~Diwsl 182 (320)
T cd05590 159 TPDYIAPEILQEMLYGPS-VDWWAM 182 (320)
T ss_pred CccccCHHHHcCCCCCCc-cchhhh
Confidence 999999999998888765 999996
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-36 Score=227.59 Aligned_cols=176 Identities=34% Similarity=0.557 Sum_probs=149.6
Q ss_pred eeeccccceeEEEEEecCCCcEEEEEEeecCcc----chHHHHHHH-HHHHhcCCCCeeEEEEEEEeCCeEEEEEEecCC
Q 028681 27 RDIGSGNFGVARLMRDKKTEELVAVKYIERGDK----IDENVQREI-INHRSLRHPNIVRFKEVILTPTHLAIVMEYASG 101 (205)
Q Consensus 27 ~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~----~~~~~~~e~-~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~~~~ 101 (205)
+.||+|++|.||++.+..++..|++|.+.+... ....+..|. .+++.++|+||+++++++.+.+..+++|||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 468999999999999999999999999875321 122334443 457888999999999999999999999999999
Q ss_pred CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeeccccccc-CCCCCCCCCC
Q 028681 102 GELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV-LHSQPKSTVG 180 (205)
Q Consensus 102 ~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~-~~~~~~~~~~ 180 (205)
++|...+.....+++..+..++.|++.||.|||+.|++|+||+|+||+++.++. ++|+|||+++... .........|
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~g 158 (321)
T cd05603 81 GELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGH--VVLTDFGLCKEGVEPEETTSTFCG 158 (321)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCC--EEEccCCCCccCCCCCCccccccC
Confidence 999988887788999999999999999999999999999999999999988877 9999999986432 2223334468
Q ss_pred CCCccCCceeccCcCCCeeeEEEeC
Q 028681 181 TPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 181 ~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
++.|+|||.+.+..++.+ +|||||
T Consensus 159 t~~y~aPE~~~~~~~~~~-~Diwsl 182 (321)
T cd05603 159 TPEYLAPEVLRKEPYDRT-VDWWCL 182 (321)
T ss_pred CcccCCHHHhcCCCCCCc-Cccccc
Confidence 999999999998888766 999997
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=227.18 Aligned_cols=176 Identities=30% Similarity=0.493 Sum_probs=153.3
Q ss_pred eeeccccceeEEEEEecCCCcEEEEEEeecCcc----chHHHHHHHHHHHhc-CCCCeeEEEEEEEeCCeEEEEEEecCC
Q 028681 27 RDIGSGNFGVARLMRDKKTEELVAVKYIERGDK----IDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIVMEYASG 101 (205)
Q Consensus 27 ~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~~~~~~ 101 (205)
+.||+|++|.||++.+..+++.|++|++.+... ..+.+..|..++.++ .|++++++++.+...+.+++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 479999999999999999999999999986432 234567888888887 699999999999999999999999999
Q ss_pred CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeeccccccc-CCCCCCCCCC
Q 028681 102 GELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV-LHSQPKSTVG 180 (205)
Q Consensus 102 ~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~-~~~~~~~~~~ 180 (205)
++|...+...+.+++..++.++.|++.|+.|||++|++|+||+|+||+++.++. ++|+|||++.... .........|
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~g 158 (327)
T cd05617 81 GDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGH--IKLTDYGMCKEGLGPGDTTSTFCG 158 (327)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCC--EEEeccccceeccCCCCceecccC
Confidence 999988887788999999999999999999999999999999999999988887 9999999986432 2233344568
Q ss_pred CCCccCCceeccCcCCCeeeEEEeC
Q 028681 181 TPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 181 ~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
++.|+|||++.+..++.+ +|||||
T Consensus 159 t~~y~aPE~~~~~~~~~~-~Diwsl 182 (327)
T cd05617 159 TPNYIAPEILRGEEYGFS-VDWWAL 182 (327)
T ss_pred CcccCCHHHHCCCCCCch-heeehh
Confidence 999999999998888765 999997
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=226.80 Aligned_cols=176 Identities=34% Similarity=0.536 Sum_probs=149.5
Q ss_pred eeeccccceeEEEEEecCCCcEEEEEEeecCc----cchHHHHHHHHHHHh-cCCCCeeEEEEEEEeCCeEEEEEEecCC
Q 028681 27 RDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRS-LRHPNIVRFKEVILTPTHLAIVMEYASG 101 (205)
Q Consensus 27 ~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~-l~h~~i~~~~~~~~~~~~~~lv~~~~~~ 101 (205)
+.||+|+||.||++.+..+++.||+|.++... ...+....|..++.. .+||||+++++++..++..+++|||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46899999999999999999999999987642 122334455555554 4899999999999999999999999999
Q ss_pred CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCC-CCCCCCCC
Q 028681 102 GELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKSTVG 180 (205)
Q Consensus 102 ~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~-~~~~~~~~ 180 (205)
++|...+.....+++..+..++.|++.||.|||+++|+|+||+|+||+++.++. ++|+|||++...... .......|
T Consensus 81 g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~--~kL~Dfg~a~~~~~~~~~~~~~~g 158 (316)
T cd05592 81 GDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGH--IKIADFGMCKENMNGEGKASTFCG 158 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCC--EEEccCcCCeECCCCCCccccccC
Confidence 999999988788999999999999999999999999999999999999988877 999999998754322 22334468
Q ss_pred CCCccCCceeccCcCCCeeeEEEeC
Q 028681 181 TPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 181 ~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
++.|+|||.+.+..++.+ +|||||
T Consensus 159 t~~y~aPE~~~~~~~~~~-~Dvwsl 182 (316)
T cd05592 159 TPDYIAPEILKGQKYNES-VDWWSF 182 (316)
T ss_pred CccccCHHHHcCCCCCCc-ccchhH
Confidence 999999999998888766 999996
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=226.47 Aligned_cols=176 Identities=30% Similarity=0.486 Sum_probs=152.4
Q ss_pred eeeccccceeEEEEEec---CCCcEEEEEEeecCcc---chHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEEecC
Q 028681 27 RDIGSGNFGVARLMRDK---KTEELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYAS 100 (205)
Q Consensus 27 ~~l~~g~~g~v~~~~~~---~~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~~~ 100 (205)
+.||+|++|.||.+.+. .+++.|++|++..... ....+..|+.++++++|+||+++++++..++..++++||+.
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 67999999999998763 5688999999976432 23456778999999999999999999999999999999999
Q ss_pred CCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCC-CCCCCCC
Q 028681 101 GGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKSTV 179 (205)
Q Consensus 101 ~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~-~~~~~~~ 179 (205)
+++|.+.+.+...+++..+..++.|++.||.|||+++++|+||+|+||+++.++. ++|+|||++...... .......
T Consensus 82 ~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~--~kL~Dfg~~~~~~~~~~~~~~~~ 159 (318)
T cd05582 82 GGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGH--IKLTDFGLSKESIDHEKKAYSFC 159 (318)
T ss_pred CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCc--EEEeeccCCcccCCCCCceeccc
Confidence 9999999988778999999999999999999999999999999999999988877 999999998754433 2233456
Q ss_pred CCCCccCCceeccCcCCCeeeEEEeC
Q 028681 180 GTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 180 ~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
|++.|+|||.+.+..++.+ +|||||
T Consensus 160 g~~~y~aPE~~~~~~~~~~-~Diwsl 184 (318)
T cd05582 160 GTVEYMAPEVVNRRGHTQS-ADWWSF 184 (318)
T ss_pred CChhhcCHHHHcCCCCCCc-cceecc
Confidence 8999999999988887755 999997
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=230.27 Aligned_cols=185 Identities=24% Similarity=0.369 Sum_probs=151.6
Q ss_pred ecCCCeEEEeeeccccceeEEEEEec-----CCCcEEEEEEeecCcc--chHHHHHHHHHHHhc-CCCCeeEEEEEEEeC
Q 028681 18 HDSDRYELVRDIGSGNFGVARLMRDK-----KTEELVAVKYIERGDK--IDENVQREIINHRSL-RHPNIVRFKEVILTP 89 (205)
Q Consensus 18 ~~~~~y~~~~~l~~g~~g~v~~~~~~-----~~~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~ 89 (205)
...++|++.+.||+|+||.||.+.+. .++..||+|.+..... ..+.+..|+.++..+ +||||+++++++...
T Consensus 4 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~ 83 (338)
T cd05102 4 FPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKP 83 (338)
T ss_pred cchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCC
Confidence 34578999999999999999999752 3456799999875432 235688899999999 899999999988765
Q ss_pred C-eEEEEEEecCCCchHHHHHhc---------------------------------------------------------
Q 028681 90 T-HLAIVMEYASGGELFERICNA--------------------------------------------------------- 111 (205)
Q Consensus 90 ~-~~~lv~~~~~~~sl~~~~~~~--------------------------------------------------------- 111 (205)
+ .++++|||+++++|.+++...
T Consensus 84 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (338)
T cd05102 84 NGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQET 163 (338)
T ss_pred CCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhc
Confidence 4 588999999999999888642
Q ss_pred -----CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCCCC---CCCCCCCCC
Q 028681 112 -----GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPA 183 (205)
Q Consensus 112 -----~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~ 183 (205)
.+++...+..++.|++.||+|||+.||+|+||+|+||+++.++. ++|+|||+++....... .....++..
T Consensus 164 ~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~--~kl~DfG~a~~~~~~~~~~~~~~~~~~~~ 241 (338)
T cd05102 164 DDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNV--VKICDFGLARDIYKDPDYVRKGSARLPLK 241 (338)
T ss_pred cccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCc--EEEeecccccccccCcchhcccCCCCCcc
Confidence 24777888999999999999999999999999999999988776 99999999875432211 122345678
Q ss_pred ccCCceeccCcCCCeeeEEEeC
Q 028681 184 YIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 184 ~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
|+|||++.+..++.+ +|||||
T Consensus 242 y~aPE~~~~~~~~~~-sDiwsl 262 (338)
T cd05102 242 WMAPESIFDKVYTTQ-SDVWSF 262 (338)
T ss_pred ccCcHHhhcCCCCcc-cCHHHH
Confidence 999999998888766 999996
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=225.97 Aligned_cols=176 Identities=32% Similarity=0.482 Sum_probs=150.5
Q ss_pred eeeccccceeEEEEEecCCCcEEEEEEeecCc----cchHHHHHHHHHHHh-cCCCCeeEEEEEEEeCCeEEEEEEecCC
Q 028681 27 RDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRS-LRHPNIVRFKEVILTPTHLAIVMEYASG 101 (205)
Q Consensus 27 ~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~-l~h~~i~~~~~~~~~~~~~~lv~~~~~~ 101 (205)
+.||+|+||.||++.+..++..||+|.+.... ...+....|..++.. ..|++++++++++.+++..++||||+.+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 46999999999999999999999999997642 223445566666664 4899999999999999999999999999
Q ss_pred CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCC-CCCCCCCC
Q 028681 102 GELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKSTVG 180 (205)
Q Consensus 102 ~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~-~~~~~~~~ 180 (205)
++|...+.....+++..+..++.|++.||+|||++|++|+||+|+||+++.++. ++|+|||++...... .......|
T Consensus 81 g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~g 158 (316)
T cd05620 81 GDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGH--IKIADFGMCKENVFGDNRASTFCG 158 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCC--EEeCccCCCeecccCCCceeccCC
Confidence 999999988788999999999999999999999999999999999999988877 999999988643222 22334568
Q ss_pred CCCccCCceeccCcCCCeeeEEEeC
Q 028681 181 TPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 181 ~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
++.|+|||++.+..++.+ +|||||
T Consensus 159 t~~y~aPE~~~~~~~~~~-~Diwsl 182 (316)
T cd05620 159 TPDYIAPEILQGLKYTFS-VDWWSF 182 (316)
T ss_pred CcCccCHHHHcCCCCCcc-cchhhh
Confidence 999999999998888766 999996
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=227.77 Aligned_cols=183 Identities=29% Similarity=0.447 Sum_probs=160.7
Q ss_pred cCCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCc--cchHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEE
Q 028681 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (205)
Q Consensus 19 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 96 (205)
..++|++.+.||+|++|.||.+.+..++..+++|.+.... ...+.+..|+.+++.++|+||+++++++..++..+++|
T Consensus 3 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 82 (333)
T cd06650 3 KDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 82 (333)
T ss_pred chhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEE
Confidence 3589999999999999999999999999999999887542 23456889999999999999999999999999999999
Q ss_pred EecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-cCcEeecCCCCCeEecCCCCCcEEEeeecccccccCCCCC
Q 028681 97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS-MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 175 (205)
Q Consensus 97 ~~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~-~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~~ 175 (205)
||+++++|.+.+...+.+++..+..++.|++.|+.|||+ .+++|+||+|+||+++.++. ++|+|||++..... ...
T Consensus 83 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~--~kL~Dfg~~~~~~~-~~~ 159 (333)
T cd06650 83 EHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGE--IKLCDFGVSGQLID-SMA 159 (333)
T ss_pred ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCC--EEEeeCCcchhhhh-hcc
Confidence 999999999999887889999999999999999999997 47999999999999988777 99999999865432 222
Q ss_pred CCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 176 KSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 176 ~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
....++..|+|||++.+..++.+ +|||||
T Consensus 160 ~~~~~~~~y~aPE~~~~~~~~~~-~Dvwsl 188 (333)
T cd06650 160 NSFVGTRSYMSPERLQGTHYSVQ-SDIWSM 188 (333)
T ss_pred ccCCCCccccCHHHhcCCCCCcH-HHHHHH
Confidence 34468899999999988877765 999996
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=234.92 Aligned_cols=183 Identities=28% Similarity=0.406 Sum_probs=156.7
Q ss_pred CCCeEEEeeeccccceeEEEEEecCC-CcEEEEEEeecCccc-hHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEE
Q 028681 20 SDRYELVRDIGSGNFGVARLMRDKKT-EELVAVKYIERGDKI-DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (205)
Q Consensus 20 ~~~y~~~~~l~~g~~g~v~~~~~~~~-~~~v~iK~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~ 97 (205)
...|.+.+.||+|++|.||.+....+ +..|++|.+...... ...+..|+.+++.++||||+++++++..++..++|||
T Consensus 66 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E 145 (478)
T PTZ00267 66 EHMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIME 145 (478)
T ss_pred ceeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEE
Confidence 45599999999999999999998877 778888877554332 3457789999999999999999999999999999999
Q ss_pred ecCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCCC
Q 028681 98 YASGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 173 (205)
Q Consensus 98 ~~~~~sl~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~~ 173 (205)
|+++++|.+.+.. ..++++..+..++.|++.||.|||+++|+||||+|+||+++.++. ++|+|||+++......
T Consensus 146 ~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~--~kL~DFgla~~~~~~~ 223 (478)
T PTZ00267 146 YGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGI--IKLGDFGFSKQYSDSV 223 (478)
T ss_pred CCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCc--EEEEeCcCceecCCcc
Confidence 9999999887643 446899999999999999999999999999999999999988777 9999999997654322
Q ss_pred C---CCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 174 Q---PKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 174 ~---~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
. .....|++.|+|||++.+..++.+ +|||||
T Consensus 224 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~Dv~sl 257 (478)
T PTZ00267 224 SLDVASSFCGTPYYLAPELWERKRYSKK-ADMWSL 257 (478)
T ss_pred ccccccccCCCccccCHhHhCCCCCCcH-HhHHHH
Confidence 2 233468999999999998888765 999996
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=224.07 Aligned_cols=183 Identities=25% Similarity=0.361 Sum_probs=152.5
Q ss_pred CCCeEEEeeeccccceeEEEEEecC----------------CCcEEEEEEeecCcc--chHHHHHHHHHHHhcCCCCeeE
Q 028681 20 SDRYELVRDIGSGNFGVARLMRDKK----------------TEELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVR 81 (205)
Q Consensus 20 ~~~y~~~~~l~~g~~g~v~~~~~~~----------------~~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~ 81 (205)
.++|++.+.||+|+||.||++.+.. ++..|++|.+..... ....+.+|+.++.+++|+||++
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 83 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR 83 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence 5789999999999999999997532 345799998876432 2356889999999999999999
Q ss_pred EEEEEEeCCeEEEEEEecCCCchHHHHHhc-------------------CCCCHHHHHHHHHHHHHHHHHHHhcCcEeec
Q 028681 82 FKEVILTPTHLAIVMEYASGGELFERICNA-------------------GRFSEDEARFFFQQLISGVSYCHSMQVCHRD 142 (205)
Q Consensus 82 ~~~~~~~~~~~~lv~~~~~~~sl~~~~~~~-------------------~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~d 142 (205)
+++++.+.+..++++||+++++|.+.+... ..+++..+..++.|++.||.|||+.|++|+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~ivH~d 163 (304)
T cd05096 84 LLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRD 163 (304)
T ss_pred EEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCccccC
Confidence 999999999999999999999999888542 1367788999999999999999999999999
Q ss_pred CCCCCeEecCCCCCcEEEeeecccccccCCC---CCCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 143 LKLENTLLDGSPAPRLKICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 143 i~p~nili~~~~~~~~~l~df~~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
|+|+||+++.++. ++|+|||+++...... ......++..|+|||++....++.+ +|||||
T Consensus 164 lkp~Nill~~~~~--~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~sl 226 (304)
T cd05096 164 LATRNCLVGENLT--IKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTA-SDVWAF 226 (304)
T ss_pred cchhheEEcCCcc--EEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCch-hhhHHH
Confidence 9999999998777 9999999986543222 1122345788999999988888766 999996
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=225.19 Aligned_cols=176 Identities=32% Similarity=0.506 Sum_probs=150.2
Q ss_pred eeeccccceeEEEEEecCCCcEEEEEEeecCc----cchHHHHHHHHHHHh-cCCCCeeEEEEEEEeCCeEEEEEEecCC
Q 028681 27 RDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRS-LRHPNIVRFKEVILTPTHLAIVMEYASG 101 (205)
Q Consensus 27 ~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~-l~h~~i~~~~~~~~~~~~~~lv~~~~~~ 101 (205)
+.||+|+||.||++.+..++..||+|.+.... ...+....|..++.. +.||||+++++++.+++.++++|||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 46899999999999999999999999987642 222345556666665 4899999999999999999999999999
Q ss_pred CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCC-CCCCCCCC
Q 028681 102 GELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKSTVG 180 (205)
Q Consensus 102 ~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~-~~~~~~~~ 180 (205)
++|...+.....+++.++..++.|++.||.|||++|++|+||+|+||+++.++. ++|+|||++...... .......|
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~g 158 (316)
T cd05619 81 GDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGH--IKIADFGMCKENMLGDAKTCTFCG 158 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCC--EEEccCCcceECCCCCCceeeecC
Confidence 999999987778999999999999999999999999999999999999988877 999999998643222 22334468
Q ss_pred CCCccCCceeccCcCCCeeeEEEeC
Q 028681 181 TPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 181 ~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
+..|+|||++.+..++.+ +|||||
T Consensus 159 t~~y~aPE~~~~~~~~~~-~Dvwsl 182 (316)
T cd05619 159 TPDYIAPEILLGQKYNTS-VDWWSF 182 (316)
T ss_pred CccccCHHHHcCCCCCch-hhhhhH
Confidence 999999999998888766 999996
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=229.50 Aligned_cols=187 Identities=41% Similarity=0.659 Sum_probs=174.4
Q ss_pred eecCCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCcc---chHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEE
Q 028681 17 MHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTPTHLA 93 (205)
Q Consensus 17 ~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 93 (205)
...-..|.+.+.||.|.|++|.++.+.-++..||+|.+.+... ....+..|+.++..+.||||++++.+...+..++
T Consensus 52 ~~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~ly 131 (596)
T KOG0586|consen 52 SNSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLY 131 (596)
T ss_pred cccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeE
Confidence 3445789999999999999999999999999999999987533 2355789999999999999999999999999999
Q ss_pred EEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCCC
Q 028681 94 IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 173 (205)
Q Consensus 94 lv~~~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~~ 173 (205)
+||||..++.+.+.+.+.+...+..++.++.|+..|++|+|+..|+|+||+.+||+++.+.+ +||+|||++..+....
T Consensus 132 lV~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mn--ikIaDfgfS~~~~~~~ 209 (596)
T KOG0586|consen 132 LVMEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMN--IKIADFGFSTFFDYGL 209 (596)
T ss_pred EEEEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccc--eeeeccccceeecccc
Confidence 99999999999999999999999999999999999999999999999999999999998888 9999999999998888
Q ss_pred CCCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 174 QPKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 174 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
...+.+|++.|+|||++.+..|+...+|+|||
T Consensus 210 ~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wsl 241 (596)
T KOG0586|consen 210 MLQTFCGSPPYAAPELFNGKKYDGPEVDIWSL 241 (596)
T ss_pred cccccCCCCCccChHhhcCcccCCcceehhhh
Confidence 88999999999999999999999999999996
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=229.96 Aligned_cols=188 Identities=28% Similarity=0.339 Sum_probs=160.6
Q ss_pred CceecCCCeEEEeeeccccceeEEEEEecCCCc---E-EEEEEeecC----ccchHHHHHHHHHHHhcCCCCeeEEEEEE
Q 028681 15 PIMHDSDRYELVRDIGSGNFGVARLMRDKKTEE---L-VAVKYIERG----DKIDENVQREIINHRSLRHPNIVRFKEVI 86 (205)
Q Consensus 15 ~~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~---~-v~iK~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 86 (205)
.+....++-.+.++||+|+||.||.+.....+. . ||+|..+.. .....++..|.+++++++||||++++|+.
T Consensus 151 ~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa 230 (474)
T KOG0194|consen 151 KWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVA 230 (474)
T ss_pred ccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence 445556777788999999999999999876432 3 899988752 23346788999999999999999999999
Q ss_pred EeCCeEEEEEEecCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecc
Q 028681 87 LTPTHLAIVMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGY 165 (205)
Q Consensus 87 ~~~~~~~lv~~~~~~~sl~~~~~~~~-~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~ 165 (205)
.....+++|||++++|+|.+.+++.+ .++..+...++.+.+.||+|||+.+++||||-.+|+|++.+.. +||+|||+
T Consensus 231 ~~~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~--vKISDFGL 308 (474)
T KOG0194|consen 231 VLEEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGV--VKISDFGL 308 (474)
T ss_pred cCCCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCe--EEeCcccc
Confidence 99999999999999999999998877 4999999999999999999999999999999999999988776 89999999
Q ss_pred cccccCCCCCC-CCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 166 SKSSVLHSQPK-STVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 166 ~~~~~~~~~~~-~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
++......... ...-+..|+|||.+....++.+ +|||||
T Consensus 309 s~~~~~~~~~~~~~klPirWLAPEtl~~~~~s~k-TDV~sf 348 (474)
T KOG0194|consen 309 SRAGSQYVMKKFLKKLPIRWLAPETLNTGIFSFK-TDVWSF 348 (474)
T ss_pred ccCCcceeeccccccCcceecChhhhccCccccc-cchhhe
Confidence 87665222222 2235688999999999988877 999997
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=227.69 Aligned_cols=180 Identities=33% Similarity=0.521 Sum_probs=151.7
Q ss_pred CeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCc---cchHHHHHHHHHHHhcCCCCeeEEEEEEEeC-----CeEE
Q 028681 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTP-----THLA 93 (205)
Q Consensus 22 ~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~ 93 (205)
+|++.+.||+|++|.||.+.+..++..|++|.+.... .....+..|+.+++.++|||++++++++... ...+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 5899999999999999999999999999999887432 2234578899999999999999999988643 2579
Q ss_pred EEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCCC
Q 028681 94 IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 173 (205)
Q Consensus 94 lv~~~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~~ 173 (205)
++|||+. ++|.+.+.....+++..+..++.|++.||.|||++|++|+||+|+||+++.++. ++|+|||+++......
T Consensus 81 lv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~--~kL~Dfg~~~~~~~~~ 157 (338)
T cd07859 81 VVFELME-SDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCK--LKICDFGLARVAFNDT 157 (338)
T ss_pred EEEecCC-CCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCc--EEEccCcccccccccc
Confidence 9999995 588888887778999999999999999999999999999999999999988877 9999999987543222
Q ss_pred C----CCCCCCCCCccCCceecc--CcCCCeeeEEEeC
Q 028681 174 Q----PKSTVGTPAYIAPEVLLK--KEYDGKVMCVYVI 205 (205)
Q Consensus 174 ~----~~~~~~~~~~~aPE~~~~--~~~~~~~~Dvwsl 205 (205)
. .....++..|+|||++.+ ..++.+ +|||||
T Consensus 158 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~-~DvwSl 194 (338)
T cd07859 158 PTAIFWTDYVATRWYRAPELCGSFFSKYTPA-IDIWSI 194 (338)
T ss_pred CccccccCCCCCCCcCCHHHHhccccccCch-hHHHHH
Confidence 1 123468999999999876 455544 999996
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=223.53 Aligned_cols=186 Identities=27% Similarity=0.406 Sum_probs=160.3
Q ss_pred eecCCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCccc----hHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeE
Q 028681 17 MHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI----DENVQREIINHRSLRHPNIVRFKEVILTPTHL 92 (205)
Q Consensus 17 ~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 92 (205)
....+.|++++.||.|..|+||++....++..+|+|++.+.... ..+++.|-++|..+.||.++.+|..|+.+.+.
T Consensus 73 ~l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~ 152 (459)
T KOG0610|consen 73 SLGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYS 152 (459)
T ss_pred ccCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeecccee
Confidence 33467899999999999999999999999999999999876433 24578899999999999999999999999999
Q ss_pred EEEEEecCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeeccccccc
Q 028681 93 AIVMEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 170 (205)
Q Consensus 93 ~lv~~~~~~~sl~~~~~~~~--~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~ 170 (205)
|++||||+||.|-.++++.+ .+++..++.++.+++.||+|||..|||.|||||+|||+.++++ ++|.||.++....
T Consensus 153 cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGH--IMLsDFDLS~~~~ 230 (459)
T KOG0610|consen 153 CLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGH--IMLSDFDLSLRCP 230 (459)
T ss_pred EEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCc--EEeeeccccccCC
Confidence 99999999999988887643 5999999999999999999999999999999999999999999 9999999874211
Q ss_pred C---------------------------------CCC------------------------CCCCCCCCCccCCceeccC
Q 028681 171 L---------------------------------HSQ------------------------PKSTVGTPAYIAPEVLLKK 193 (205)
Q Consensus 171 ~---------------------------------~~~------------------------~~~~~~~~~~~aPE~~~~~ 193 (205)
. ... ..+-.||-+|+|||++.+.
T Consensus 231 ~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~ 310 (459)
T KOG0610|consen 231 VSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGE 310 (459)
T ss_pred CCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecC
Confidence 0 000 0111378899999999999
Q ss_pred cCCCeeeEEEeC
Q 028681 194 EYDGKVMCVYVI 205 (205)
Q Consensus 194 ~~~~~~~Dvwsl 205 (205)
..+.. .|||+|
T Consensus 311 GHgsA-VDWWtf 321 (459)
T KOG0610|consen 311 GHGSA-VDWWTF 321 (459)
T ss_pred CCCch-hhHHHH
Confidence 99866 999986
|
|
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=220.31 Aligned_cols=180 Identities=39% Similarity=0.588 Sum_probs=158.3
Q ss_pred eEEEeeeccccceeEEEEEecCCCcEEEEEEeecCccchHH---HHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEEec
Q 028681 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDEN---VQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA 99 (205)
Q Consensus 23 y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~---~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~~ 99 (205)
|++.+.||+|++|+||++.+..++..+|+|.+......... ...|+..++.++|+||+++.+++.+....+++|+++
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 88999999999999999999999999999999887544333 345899999999999999999999999999999999
Q ss_pred CCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccc-cCCCCCCCC
Q 028681 100 SGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS-VLHSQPKST 178 (205)
Q Consensus 100 ~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~-~~~~~~~~~ 178 (205)
++++|.+.+...+.++...+..++.|++.||++||+.+++|+||+|+||+++.++. ++|+|||.+... .........
T Consensus 81 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~--~~l~Dfg~~~~~~~~~~~~~~~ 158 (260)
T PF00069_consen 81 PGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGE--VKLIDFGSSVKLSENNENFNPF 158 (260)
T ss_dssp TTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSE--EEESSGTTTEESTSTTSEBSSS
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccc--cccccccccccccccccccccc
Confidence 99999999987888999999999999999999999999999999999999997777 999999998753 233344455
Q ss_pred CCCCCccCCceec-cCcCCCeeeEEEeC
Q 028681 179 VGTPAYIAPEVLL-KKEYDGKVMCVYVI 205 (205)
Q Consensus 179 ~~~~~~~aPE~~~-~~~~~~~~~Dvwsl 205 (205)
.++..|.|||++. +...+.+ +|||||
T Consensus 159 ~~~~~y~aPE~~~~~~~~~~~-~Di~sl 185 (260)
T PF00069_consen 159 VGTPEYMAPEVLQQGKKYTRK-SDIWSL 185 (260)
T ss_dssp SSSGGGSCHHHHTTTSSBSTH-HHHHHH
T ss_pred ccccccccccccccccccccc-cccccc
Confidence 6889999999998 5666655 999985
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=218.12 Aligned_cols=181 Identities=26% Similarity=0.353 Sum_probs=157.0
Q ss_pred CeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCcc----chHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEE
Q 028681 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK----IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (205)
Q Consensus 22 ~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~ 97 (205)
.|+..+.||+|+||+||.+.+..+++.+++|.+..... ....+.+|+.+++.++|++++++.+.+..++..++++|
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEE
Confidence 47889999999999999999999999999999875432 22346789999999999999999999999999999999
Q ss_pred ecCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCCCCC
Q 028681 98 YASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 175 (205)
Q Consensus 98 ~~~~~sl~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~~ 175 (205)
|+++++|.+.+... .++++..+..++.|++.||.|||+.||+|+||+|+||+++.++. ++|+|||++.........
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~--~kl~Dfg~~~~~~~~~~~ 158 (285)
T cd05632 81 IMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGH--IRISDLGLAVKIPEGESI 158 (285)
T ss_pred eccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCC--EEEecCCcceecCCCCcc
Confidence 99999998777543 36999999999999999999999999999999999999988776 999999988665443333
Q ss_pred CCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 176 KSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 176 ~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
....++..|+|||++.+..++.+ +|+|||
T Consensus 159 ~~~~g~~~~~aPE~~~~~~~~~~-~Di~sl 187 (285)
T cd05632 159 RGRVGTVGYMAPEVLNNQRYTLS-PDYWGL 187 (285)
T ss_pred cCCCCCcCccChHHhcCCCCCcc-cchHHH
Confidence 44578999999999998888766 999996
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=226.59 Aligned_cols=181 Identities=27% Similarity=0.404 Sum_probs=154.1
Q ss_pred cCCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCc---cchHHHHHHHHHHHhcCCCCeeEEEEEEEeCC-----
Q 028681 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPT----- 90 (205)
Q Consensus 19 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----- 90 (205)
..++|++.+.||+|+||.||.+.+..++..|++|.+.... .....+.+|+.+++.++|||++++++++....
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 3689999999999999999999999999999999986532 22356778999999999999999999987543
Q ss_pred -eEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccc
Q 028681 91 -HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 169 (205)
Q Consensus 91 -~~~lv~~~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~ 169 (205)
..+++|||+++ ++.+.+.. .++...+..++.|++.||.|||++||+||||+|+||+++.++. ++|+|||+++..
T Consensus 99 ~~~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~--~kl~Dfg~a~~~ 173 (359)
T cd07876 99 QDVYLVMELMDA-NLCQVIHM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTA 173 (359)
T ss_pred ceeEEEEeCCCc-CHHHHHhc--cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCC--EEEecCCCcccc
Confidence 47899999975 56555533 4889999999999999999999999999999999999998877 999999999765
Q ss_pred cCCCCCCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 170 VLHSQPKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 170 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
..........+++.|+|||.+.+..++.+ +|||||
T Consensus 174 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~-~DiwSl 208 (359)
T cd07876 174 CTNFMMTPYVVTRYYRAPEVILGMGYKEN-VDIWSV 208 (359)
T ss_pred ccCccCCCCcccCCCCCchhccCCCCCcc-hhhHHH
Confidence 44444455578999999999999888766 999996
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=218.03 Aligned_cols=181 Identities=25% Similarity=0.355 Sum_probs=157.0
Q ss_pred CeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCccc----hHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEE
Q 028681 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI----DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (205)
Q Consensus 22 ~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~ 97 (205)
.|+..+.||+|+||.||.+.+..+++.+++|.+...... ...+..|+.+++.++|++++++.+.+.+++..++++|
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence 478899999999999999999999999999998754321 2346779999999999999999999999999999999
Q ss_pred ecCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCCCCC
Q 028681 98 YASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 175 (205)
Q Consensus 98 ~~~~~sl~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~~ 175 (205)
|+++++|.+.+... ..+++..+..++.|++.||.|||+.+++|+||+|+||+++.++. ++|+|||++.........
T Consensus 81 ~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~--~~l~Dfg~~~~~~~~~~~ 158 (285)
T cd05630 81 LMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGH--IRISDLGLAVHVPEGQTI 158 (285)
T ss_pred ecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCC--EEEeeccceeecCCCccc
Confidence 99999998887543 35899999999999999999999999999999999999988777 999999998655444433
Q ss_pred CCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 176 KSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 176 ~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
....|+..|+|||++.+..++.+ +|||||
T Consensus 159 ~~~~g~~~y~aPE~~~~~~~~~~-~Diwsl 187 (285)
T cd05630 159 KGRVGTVGYMAPEVVKNERYTFS-PDWWAL 187 (285)
T ss_pred cCCCCCccccChHHHcCCCCCCc-cccHHH
Confidence 44578999999999998888766 999996
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=226.51 Aligned_cols=178 Identities=37% Similarity=0.610 Sum_probs=159.8
Q ss_pred EeeeccccceeEEEEEecCCCcEEEEEEeecC---ccchHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEEecCCC
Q 028681 26 VRDIGSGNFGVARLMRDKKTEELVAVKYIERG---DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGG 102 (205)
Q Consensus 26 ~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~~~~~ 102 (205)
.+.||+|-||+||-+++..+|+.||+|++.+. +...+.+.+|+.+|+++.||.|+.+...|+..+.+++|||-+.+
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~G- 647 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHG- 647 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcc-
Confidence 57899999999999999999999999999764 34457789999999999999999999999999999999999966
Q ss_pred chHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecC-CCCCcEEEeeecccccccCCCCCCCCC
Q 028681 103 ELFERIC--NAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVLHSQPKSTV 179 (205)
Q Consensus 103 sl~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~-~~~~~~~l~df~~~~~~~~~~~~~~~~ 179 (205)
...+++. ..+.+++.....+..||+-||.|||..+|+|||+||+||++.. +.-+++||+|||.|++++...-..+..
T Consensus 648 DMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksFRrsVV 727 (888)
T KOG4236|consen 648 DMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSFRRSVV 727 (888)
T ss_pred hHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecchhhhhhhhc
Confidence 4445553 3567999999999999999999999999999999999999964 344579999999999999999989999
Q ss_pred CCCCccCCceeccCcCCCeeeEEEeC
Q 028681 180 GTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 180 ~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
||+.|+|||++.++.|..+ -|+||.
T Consensus 728 GTPAYLaPEVLrnkGyNrS-LDMWSV 752 (888)
T KOG4236|consen 728 GTPAYLAPEVLRNKGYNRS-LDMWSV 752 (888)
T ss_pred CCccccCHHHHhhcccccc-ccceee
Confidence 9999999999999999877 899984
|
|
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=224.30 Aligned_cols=176 Identities=35% Similarity=0.555 Sum_probs=151.7
Q ss_pred eeeccccceeEEEEEecCCCcEEEEEEeecCc----cchHHHHHHHHHHHhc-CCCCeeEEEEEEEeCCeEEEEEEecCC
Q 028681 27 RDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIVMEYASG 101 (205)
Q Consensus 27 ~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~~~~~~ 101 (205)
+.||+|+||.||++.+..++..||+|.+.+.. ...+.+..|..+++.+ +|||++++++++...+..+++|||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999999999999999998642 2234456777777777 699999999999999999999999999
Q ss_pred CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccC-CCCCCCCCC
Q 028681 102 GELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQPKSTVG 180 (205)
Q Consensus 102 ~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~-~~~~~~~~~ 180 (205)
++|...+.....+++..+..++.|++.||.|||+++++|+||+|+||+++.++. ++|+|||++..... ........+
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~g 158 (318)
T cd05570 81 GDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGH--IKIADFGMCKEGILGGVTTSTFCG 158 (318)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCc--EEecccCCCeecCcCCCcccceec
Confidence 999999888778999999999999999999999999999999999999998877 99999998864322 222233458
Q ss_pred CCCccCCceeccCcCCCeeeEEEeC
Q 028681 181 TPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 181 ~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
+..|+|||++.+..++.+ +|||||
T Consensus 159 ~~~y~aPE~~~~~~~~~~-~Diwsl 182 (318)
T cd05570 159 TPDYIAPEILSYQPYGPA-VDWWAL 182 (318)
T ss_pred CccccCHHHhcCCCCCcc-hhhhhH
Confidence 999999999998888765 999996
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=218.54 Aligned_cols=180 Identities=37% Similarity=0.637 Sum_probs=160.3
Q ss_pred CCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCc----cchHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEE
Q 028681 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (205)
Q Consensus 21 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 96 (205)
++|++.+.||+|++|.||.+.+..+++.+++|.+.... ...+.+..|+.+++.++|+|++++++++.+++..++++
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 57999999999999999999999999999999987543 22356788999999999999999999999999999999
Q ss_pred EecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCCCCCC
Q 028681 97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK 176 (205)
Q Consensus 97 ~~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~~~ 176 (205)
||+++++|.+.+.....+++..+..++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||++...... ..
T Consensus 81 e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~--~kl~dfg~~~~~~~~--~~ 156 (290)
T cd05580 81 EYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGY--IKITDFGFAKRVKGR--TY 156 (290)
T ss_pred ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCC--EEEeeCCCccccCCC--CC
Confidence 99999999999988888999999999999999999999999999999999999988877 999999998765433 33
Q ss_pred CCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 177 STVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 177 ~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
...+++.|+|||.+.+...+.+ +|+|||
T Consensus 157 ~~~~~~~y~aPE~~~~~~~~~~-~Di~sl 184 (290)
T cd05580 157 TLCGTPEYLAPEIILSKGYGKA-VDWWAL 184 (290)
T ss_pred CCCCCccccChhhhcCCCCCcc-ccHHHH
Confidence 4468899999999988877655 999996
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-35 Score=223.16 Aligned_cols=174 Identities=35% Similarity=0.575 Sum_probs=145.5
Q ss_pred eccccceeEEEEEecCCCcEEEEEEeecCccc----hHHHHHHHHHHHhc---CCCCeeEEEEEEEeCCeEEEEEEecCC
Q 028681 29 IGSGNFGVARLMRDKKTEELVAVKYIERGDKI----DENVQREIINHRSL---RHPNIVRFKEVILTPTHLAIVMEYASG 101 (205)
Q Consensus 29 l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~----~~~~~~e~~~l~~l---~h~~i~~~~~~~~~~~~~~lv~~~~~~ 101 (205)
||+|+||+||++.+..++..||+|++.+.... ......|..++... .|||++++++++..++..+++|||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 68999999999999999999999998753221 12233455555444 699999999999999999999999999
Q ss_pred CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCC-CCCCCCCC
Q 028681 102 GELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKSTVG 180 (205)
Q Consensus 102 ~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~-~~~~~~~~ 180 (205)
++|.+.+.....+++..++.++.|++.||.|||++||+|+||+|+||+++.++. ++|+|||++...... .......|
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~--~kl~Dfg~a~~~~~~~~~~~~~~g 158 (330)
T cd05586 81 GELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGH--IALCDFGLSKANLTDNKTTNTFCG 158 (330)
T ss_pred ChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCC--EEEecCCcCcCCCCCCCCccCccC
Confidence 999999988888999999999999999999999999999999999999988877 999999998654322 23344568
Q ss_pred CCCccCCceeccCc-CCCeeeEEEeC
Q 028681 181 TPAYIAPEVLLKKE-YDGKVMCVYVI 205 (205)
Q Consensus 181 ~~~~~aPE~~~~~~-~~~~~~Dvwsl 205 (205)
+..|+|||++.+.. ++ .++|||||
T Consensus 159 t~~y~aPE~~~~~~~~~-~~~Dvwsl 183 (330)
T cd05586 159 TTEYLAPEVLLDEKGYT-KHVDFWSL 183 (330)
T ss_pred CccccCHHHHcCCCCCC-Cccceecc
Confidence 99999999997654 45 45999997
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=227.71 Aligned_cols=185 Identities=29% Similarity=0.439 Sum_probs=154.4
Q ss_pred CceecCCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCcc--chHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeE
Q 028681 15 PIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHL 92 (205)
Q Consensus 15 ~~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 92 (205)
......++|+..+.||+|++|.||.+.+..+++.|++|.+..... ..+.+.+|+.+++.++|+||+++++++..++.+
T Consensus 68 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 147 (353)
T PLN00034 68 SAAKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEI 147 (353)
T ss_pred CCCCCHHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeE
Confidence 344456889999999999999999999999999999999865432 246688999999999999999999999999999
Q ss_pred EEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCC
Q 028681 93 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 172 (205)
Q Consensus 93 ~lv~~~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~ 172 (205)
++++||+.+++|.+. ...++..+..++.|++.||.|||++|++|+||+|+||+++.++. ++|+|||++......
T Consensus 148 ~lv~e~~~~~~L~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~--~kL~DfG~~~~~~~~ 221 (353)
T PLN00034 148 QVLLEFMDGGSLEGT----HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKN--VKIADFGVSRILAQT 221 (353)
T ss_pred EEEEecCCCCccccc----ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCC--EEEcccccceecccc
Confidence 999999999887542 33567888899999999999999999999999999999988877 999999998765432
Q ss_pred C-CCCCCCCCCCccCCceeccC----cCCCeeeEEEeC
Q 028681 173 S-QPKSTVGTPAYIAPEVLLKK----EYDGKVMCVYVI 205 (205)
Q Consensus 173 ~-~~~~~~~~~~~~aPE~~~~~----~~~~~~~Dvwsl 205 (205)
. ......|+..|+|||.+... .+...++|||||
T Consensus 222 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~Dvwsl 259 (353)
T PLN00034 222 MDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSL 259 (353)
T ss_pred cccccccccCccccCccccccccccCcCCCcchhHHHH
Confidence 2 22345689999999998532 333346999996
|
|
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=213.99 Aligned_cols=182 Identities=31% Similarity=0.464 Sum_probs=158.7
Q ss_pred CCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCcc------chHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEE
Q 028681 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK------IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 94 (205)
Q Consensus 21 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 94 (205)
++|++.+.||+|++|.||.+.+..++..+++|.+..... ....+.+|+.++++++|+|++++++++..+...++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 679999999999999999999999999999998875422 12457889999999999999999999999999999
Q ss_pred EEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCCCC
Q 028681 95 VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 174 (205)
Q Consensus 95 v~~~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~ 174 (205)
++|++++++|.+.+...+.+++..+..++.|++.|+.+||+.|++|+||+|+||+++.++. ++|+|||.+........
T Consensus 82 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~--~~l~dfg~~~~~~~~~~ 159 (263)
T cd06625 82 FMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGN--VKLGDFGASKRLQTICS 159 (263)
T ss_pred EEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCC--EEEeecccceecccccc
Confidence 9999999999999988788999999999999999999999999999999999999988777 99999999875543322
Q ss_pred C----CCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 175 P----KSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 175 ~----~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
. ....++..|+|||.+.+..++.+ +|||||
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~sl 193 (263)
T cd06625 160 SGTGMKSVTGTPYWMSPEVISGEGYGRK-ADVWSV 193 (263)
T ss_pred ccccccCCCcCccccCcceeccCCCCch-hhhHHH
Confidence 2 22357788999999998887655 999986
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=217.99 Aligned_cols=181 Identities=31% Similarity=0.471 Sum_probs=148.8
Q ss_pred CCeEEEeeeccccceeEEEEEecC-CCcEEEEEEeecCcc---chHHHHHHHHHHHhc---CCCCeeEEEEEEEe-----
Q 028681 21 DRYELVRDIGSGNFGVARLMRDKK-TEELVAVKYIERGDK---IDENVQREIINHRSL---RHPNIVRFKEVILT----- 88 (205)
Q Consensus 21 ~~y~~~~~l~~g~~g~v~~~~~~~-~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l---~h~~i~~~~~~~~~----- 88 (205)
.+|++.+.||+|++|.||++.+.. ++..||+|.+..... ....+..|+..++.+ .||||+++++++..
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 479999999999999999999854 467899998875422 223455666666655 69999999998863
Q ss_pred CCeEEEEEEecCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeeccc
Q 028681 89 PTHLAIVMEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYS 166 (205)
Q Consensus 89 ~~~~~lv~~~~~~~sl~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~ 166 (205)
....++++|+++ ++|.+.+... ..+++..+..++.|++.||.|||++|++|+||+|+||+++.++. ++|+|||++
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~--~kl~Dfg~~ 157 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQ--IKLADFGLA 157 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCC--EEEccccce
Confidence 356899999996 5788887653 35899999999999999999999999999999999999988877 999999999
Q ss_pred ccccCCCCCCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 167 KSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 167 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
.............+++.|+|||.+.+..++.+ +|||||
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Diwsl 195 (290)
T cd07862 158 RIYSFQMALTSVVVTLWYRAPEVLLQSSYATP-VDLWSV 195 (290)
T ss_pred EeccCCcccccccccccccChHHHhCCCCCCc-cchHHH
Confidence 76655444455578999999999988888765 999996
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-35 Score=225.72 Aligned_cols=177 Identities=23% Similarity=0.397 Sum_probs=152.6
Q ss_pred CCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCccchHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEEec
Q 028681 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA 99 (205)
Q Consensus 20 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~~ 99 (205)
..+|++.+.||+|++|.||++.+..++..|++|..... ....|+.+++.++|+||+++++++......+++++++
T Consensus 65 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~-----~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 139 (357)
T PHA03209 65 SLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG-----TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHY 139 (357)
T ss_pred hcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc-----ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEcc
Confidence 45799999999999999999999999999999975433 2346888999999999999999999999999999999
Q ss_pred CCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCCCCCCCC
Q 028681 100 SGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST 178 (205)
Q Consensus 100 ~~~sl~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~~~~~ 178 (205)
.+ +|.+.+.. ..++++..+..++.|++.||.|||++||+||||+|+||+++.++. ++|+|||+++...........
T Consensus 140 ~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~--~kl~DfG~a~~~~~~~~~~~~ 216 (357)
T PHA03209 140 SS-DLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQ--VCIGDLGAAQFPVVAPAFLGL 216 (357)
T ss_pred CC-cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCC--EEEecCccccccccCcccccc
Confidence 64 67776644 557999999999999999999999999999999999999988777 999999998754333333445
Q ss_pred CCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 179 VGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 179 ~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
.|+..|+|||++.+..++.+ +|||||
T Consensus 217 ~gt~~y~aPE~~~~~~~~~~-~DiwSl 242 (357)
T PHA03209 217 AGTVETNAPEVLARDKYNSK-ADIWSA 242 (357)
T ss_pred cccccccCCeecCCCCCCch-hhHHHH
Confidence 68999999999998888766 999996
|
|
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-35 Score=218.04 Aligned_cols=174 Identities=31% Similarity=0.425 Sum_probs=149.2
Q ss_pred eccccceeEEEEEecCCCcEEEEEEeecCccc----hHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEEecCCCch
Q 028681 29 IGSGNFGVARLMRDKKTEELVAVKYIERGDKI----DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL 104 (205)
Q Consensus 29 l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~~~~~sl 104 (205)
||+|+||+||.+.+..+++.|++|.+...... .+.+..|+.+++.++|+|++++.+++..+...+++|||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 68999999999999999999999998754321 24567899999999999999999999999999999999999999
Q ss_pred HHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCCCC-CCCCC
Q 028681 105 FERICN----AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-PKSTV 179 (205)
Q Consensus 105 ~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~-~~~~~ 179 (205)
...+.. ...+++..+..++.|++.||.|||+++++|+||+|+||+++.++. ++|+|||++........ .....
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~--~~l~dfg~~~~~~~~~~~~~~~~ 158 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGN--VRISDLGLAVELKDGQSKTKGYA 158 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCC--EEEeeCccceecCCCCccccccC
Confidence 877632 346899999999999999999999999999999999999987776 99999999875543322 23346
Q ss_pred CCCCccCCceeccCcCCCeeeEEEeC
Q 028681 180 GTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 180 ~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
+++.|+|||++.+..++.+ +|||||
T Consensus 159 g~~~y~aPE~~~~~~~~~~-~Dvwsl 183 (280)
T cd05608 159 GTPGFMAPELLQGEEYDFS-VDYFAL 183 (280)
T ss_pred CCcCccCHHHhcCCCCCcc-ccHHHH
Confidence 8899999999998888765 999996
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=215.73 Aligned_cols=174 Identities=26% Similarity=0.391 Sum_probs=149.8
Q ss_pred eccccceeEEEEEecCCCcEEEEEEeecCcc----chHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEEecCCCch
Q 028681 29 IGSGNFGVARLMRDKKTEELVAVKYIERGDK----IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL 104 (205)
Q Consensus 29 l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~~~~~sl 104 (205)
||+|+||.||++....+++.|++|.+..... ....+..|+.+++.++|||++++.+.+..+...+++|||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 6899999999999999999999999865321 123455689999999999999999999999999999999999999
Q ss_pred HHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCCCCCCCCCCCC
Q 028681 105 FERICNAG--RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTP 182 (205)
Q Consensus 105 ~~~~~~~~--~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~ 182 (205)
.+.+.... .+++..+..++.|++.|+++||+.|++|+||+|+||+++.++. ++|+|||++.............++.
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~--~~l~Dfg~~~~~~~~~~~~~~~~~~ 158 (277)
T cd05607 81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGN--CRLSDLGLAVELKDGKTITQRAGTN 158 (277)
T ss_pred HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCC--EEEeeceeeeecCCCceeeccCCCC
Confidence 88775433 5888999999999999999999999999999999999988777 9999999987665444434456899
Q ss_pred CccCCceeccCcCCCeeeEEEeC
Q 028681 183 AYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 183 ~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
.|+|||++.+..++.+ +|||||
T Consensus 159 ~y~aPE~~~~~~~~~~-~Dvwsl 180 (277)
T cd05607 159 GYMAPEILKEEPYSYP-VDWFAM 180 (277)
T ss_pred CccCHHHHccCCCCCc-hhHHHH
Confidence 9999999998887755 999996
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=230.74 Aligned_cols=180 Identities=28% Similarity=0.411 Sum_probs=155.2
Q ss_pred cCCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCccc---hHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEE
Q 028681 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI---DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV 95 (205)
Q Consensus 19 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 95 (205)
..+...+.+.||+|.||+||++.+.++ ||||.++..... .+.|++|+..+++-+|.||+-+.|++..+.. .+|
T Consensus 390 p~~ev~l~~rIGsGsFGtV~Rg~whGd---VAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AIi 465 (678)
T KOG0193|consen 390 PPEEVLLGERIGSGSFGTVYRGRWHGD---VAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AII 465 (678)
T ss_pred CHHHhhccceeccccccceeecccccc---eEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-eee
Confidence 356778899999999999999999865 999999876544 4679999999999999999999999998887 999
Q ss_pred EEecCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeeccccc---ccC
Q 028681 96 MEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS---SVL 171 (205)
Q Consensus 96 ~~~~~~~sl~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~---~~~ 171 (205)
+.+|.+.+|...+.. ...|..-+.+.|++|+++|+.|||.++|||+||+..|||+.++.. |||+|||++.. ...
T Consensus 466 TqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~k--VkIgDFGLatvk~~w~g 543 (678)
T KOG0193|consen 466 TQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLK--VKIGDFGLATVKTRWSG 543 (678)
T ss_pred ehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCc--EEEecccceeeeeeecc
Confidence 999999999988864 345888899999999999999999999999999999999998877 99999999843 334
Q ss_pred CCCCCCCCCCCCccCCceecc---CcCCCeeeEEEeC
Q 028681 172 HSQPKSTVGTPAYIAPEVLLK---KEYDGKVMCVYVI 205 (205)
Q Consensus 172 ~~~~~~~~~~~~~~aPE~~~~---~~~~~~~~Dvwsl 205 (205)
........|...|||||+++- .+|+ .++|||||
T Consensus 544 ~~q~~qp~gsilwmAPEvIRmqd~nPfS-~qSDVYaF 579 (678)
T KOG0193|consen 544 EQQLEQPHGSLLWMAPEVIRMQDDNPFS-FQSDVYAF 579 (678)
T ss_pred ccccCCCccchhhhcHHHHhhcccCCCC-cccchhhh
Confidence 444555678999999999984 3555 55999997
|
|
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=219.84 Aligned_cols=183 Identities=29% Similarity=0.491 Sum_probs=153.9
Q ss_pred cCCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCcc--chHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEE
Q 028681 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (205)
Q Consensus 19 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 96 (205)
+.++|++.+.||+|++|.||++.+..++..|++|.+..... ....+..|+.+++.++|+|++++++++..++..+++|
T Consensus 4 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 83 (309)
T cd07872 4 KMETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVF 83 (309)
T ss_pred CCCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEE
Confidence 45789999999999999999999999999999999875432 2345778999999999999999999999999999999
Q ss_pred EecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCCC-C
Q 028681 97 EYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-Q 174 (205)
Q Consensus 97 ~~~~~~sl~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~~-~ 174 (205)
||+++ +|.+.+... ..++...+..++.|++.||.|||++|++||||+|+||+++.++. ++|+|||++....... .
T Consensus 84 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~--~kl~Dfg~~~~~~~~~~~ 160 (309)
T cd07872 84 EYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGE--LKLADFGLARAKSVPTKT 160 (309)
T ss_pred eCCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCC--EEECccccceecCCCccc
Confidence 99975 777766543 45889999999999999999999999999999999999988777 9999999986543322 2
Q ss_pred CCCCCCCCCccCCceeccCc-CCCeeeEEEeC
Q 028681 175 PKSTVGTPAYIAPEVLLKKE-YDGKVMCVYVI 205 (205)
Q Consensus 175 ~~~~~~~~~~~aPE~~~~~~-~~~~~~Dvwsl 205 (205)
.....++..|+|||.+.+.. ++ .++|||||
T Consensus 161 ~~~~~~~~~y~aPE~~~~~~~~~-~~~Diwsl 191 (309)
T cd07872 161 YSNEVVTLWYRPPDVLLGSSEYS-TQIDMWGV 191 (309)
T ss_pred cccccccccccCCHHHhCCCCCC-cHHHHHHH
Confidence 23345788999999987644 45 44999986
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=231.36 Aligned_cols=188 Identities=29% Similarity=0.427 Sum_probs=158.1
Q ss_pred CceecCCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCcc---chHHHHHHHHHHHhcCCCCeeEEEEEEEeCC-
Q 028681 15 PIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTPT- 90 (205)
Q Consensus 15 ~~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~- 90 (205)
......++|++.+.||+|+||+||.+.+..+++.||+|.+..... ....+..|+..+..++|+|++++.+.+....
T Consensus 26 ~~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~ 105 (496)
T PTZ00283 26 TAKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDP 105 (496)
T ss_pred cccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccc
Confidence 344456899999999999999999999999999999999876432 2345778999999999999999988775432
Q ss_pred -------eEEEEEEecCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEE
Q 028681 91 -------HLAIVMEYASGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLK 159 (205)
Q Consensus 91 -------~~~lv~~~~~~~sl~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~ 159 (205)
.+++++||+++++|.+.+.. ...+++..+..++.|++.||.|||+.+|+|+||+|+||+++.++. ++
T Consensus 106 ~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~--vk 183 (496)
T PTZ00283 106 RNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGL--VK 183 (496)
T ss_pred cCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCC--EE
Confidence 36799999999999988854 346899999999999999999999999999999999999988877 99
Q ss_pred EeeecccccccCC---CCCCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 160 ICDFGYSKSSVLH---SQPKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 160 l~df~~~~~~~~~---~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
|+|||+++..... .......|++.|+|||++.+..++.+ +|||||
T Consensus 184 L~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k-~DVwSl 231 (496)
T PTZ00283 184 LGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKK-ADMFSL 231 (496)
T ss_pred EEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcH-HHHHHH
Confidence 9999998765432 22234568999999999998888766 999996
|
|
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=239.27 Aligned_cols=182 Identities=30% Similarity=0.388 Sum_probs=155.0
Q ss_pred CCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCc----cchHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEE
Q 028681 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (205)
Q Consensus 21 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 96 (205)
++|++.+.||+|++|.||++.+..+++.||+|.+.... ...+++.+|+.+++.++|||++++++++.+++..+++|
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 68999999999999999999999999999999987532 22456888999999999999999999999999999999
Q ss_pred EecCCCchHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecc
Q 028681 97 EYASGGELFERICNA-----------GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGY 165 (205)
Q Consensus 97 ~~~~~~sl~~~~~~~-----------~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~ 165 (205)
||+++++|.+.+... ...+...+..++.|++.||.|||+.||+||||+|+||+++.++. ++|+|||+
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~--vKLiDFGL 159 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGE--VVILDWGA 159 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCC--EEEEecCc
Confidence 999999999888531 23556778899999999999999999999999999999988877 99999999
Q ss_pred cccccCCC-------------------CCCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 166 SKSSVLHS-------------------QPKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 166 ~~~~~~~~-------------------~~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
++...... ......|++.|+|||.+.+..++.+ +|||||
T Consensus 160 Ak~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~k-SDIWSL 217 (932)
T PRK13184 160 AIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASES-TDIYAL 217 (932)
T ss_pred ceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcH-hHHHHH
Confidence 87542110 0112358999999999998888765 999996
|
|
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=215.49 Aligned_cols=180 Identities=29% Similarity=0.465 Sum_probs=149.3
Q ss_pred CeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCcc---chHHHHHHHHHHHhc---CCCCeeEEEEEEEeC-----C
Q 028681 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---IDENVQREIINHRSL---RHPNIVRFKEVILTP-----T 90 (205)
Q Consensus 22 ~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l---~h~~i~~~~~~~~~~-----~ 90 (205)
+|++.+.||+|++|.||++.+..+++.|++|.+..... .......|+.+++.+ .|+|++++++++... .
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 58999999999999999999999999999998875322 223455666666655 699999999988643 4
Q ss_pred eEEEEEEecCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeeccccc
Q 028681 91 HLAIVMEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 168 (205)
Q Consensus 91 ~~~lv~~~~~~~sl~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~ 168 (205)
..++++|++++ +|.+.+... ..+++..++.++.|++.||.|||+.|++|+||+|+||+++.++. ++|+|||++..
T Consensus 81 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~--~kl~dfg~~~~ 157 (288)
T cd07863 81 KVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQ--VKLADFGLARI 157 (288)
T ss_pred eEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCC--EEECccCcccc
Confidence 57899999975 787777553 34899999999999999999999999999999999999988877 99999999876
Q ss_pred ccCCCCCCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 169 SVLHSQPKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 169 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
...........++..|+|||++.+..++.+ +|||||
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Diwsl 193 (288)
T cd07863 158 YSCQMALTPVVVTLWYRAPEVLLQSTYATP-VDMWSV 193 (288)
T ss_pred ccCcccCCCccccccccCchHhhCCCCCCc-chhhhH
Confidence 654444444568899999999988888766 999996
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=225.85 Aligned_cols=188 Identities=23% Similarity=0.308 Sum_probs=154.5
Q ss_pred CceecCCCeEEEeeeccccceeEEEEEe-----cCCCcEEEEEEeecCcc--chHHHHHHHHHHHhc-CCCCeeEEEEEE
Q 028681 15 PIMHDSDRYELVRDIGSGNFGVARLMRD-----KKTEELVAVKYIERGDK--IDENVQREIINHRSL-RHPNIVRFKEVI 86 (205)
Q Consensus 15 ~~~~~~~~y~~~~~l~~g~~g~v~~~~~-----~~~~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l-~h~~i~~~~~~~ 86 (205)
......++|++.+.||+|+||.||.+.. ..++..||+|+++.... ..+.+.+|+.+++.+ +||||+++++++
T Consensus 29 ~~~~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~ 108 (375)
T cd05104 29 KWEFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGAC 108 (375)
T ss_pred ccccchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeee
Confidence 3344466899999999999999999974 34566899999875432 235678899999999 899999999999
Q ss_pred EeCCeEEEEEEecCCCchHHHHHhcC------------------------------------------------------
Q 028681 87 LTPTHLAIVMEYASGGELFERICNAG------------------------------------------------------ 112 (205)
Q Consensus 87 ~~~~~~~lv~~~~~~~sl~~~~~~~~------------------------------------------------------ 112 (205)
...+..+++|||+++++|.+.+....
T Consensus 109 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 188 (375)
T cd05104 109 TVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRS 188 (375)
T ss_pred ccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccc
Confidence 99999999999999999988885421
Q ss_pred ---------------------CCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccC
Q 028681 113 ---------------------RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 171 (205)
Q Consensus 113 ---------------------~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~ 171 (205)
.+++..+..++.|++.||.|||+.+++|+||+|+||+++.+.. ++|+|||++.....
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~--~kl~DfG~a~~~~~ 266 (375)
T cd05104 189 VRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRI--TKICDFGLARDIRN 266 (375)
T ss_pred cccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCc--EEEecCccceeccC
Confidence 3678889999999999999999999999999999999987776 99999999875543
Q ss_pred CCCC---CCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 172 HSQP---KSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 172 ~~~~---~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
.... ....++..|+|||.+.+..++.+ +|||||
T Consensus 267 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-sDi~sl 302 (375)
T cd05104 267 DSNYVVKGNARLPVKWMAPESIFNCVYTFE-SDVWSY 302 (375)
T ss_pred cccccccCCCCCCcceeChhHhcCCCCCCC-CCHHHH
Confidence 2221 11234567999999998888766 999996
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=229.40 Aligned_cols=180 Identities=30% Similarity=0.471 Sum_probs=148.8
Q ss_pred CCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCccchHHHHHHHHHHHhcCCCCeeEEEEEEEeC--------Ce
Q 028681 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTP--------TH 91 (205)
Q Consensus 20 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--------~~ 91 (205)
..+|++.+.||+|+||.||.+.+..++..||+|.+.... .....|+.+++.++|+|++++.+++... ..
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~---~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~ 141 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP---QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIF 141 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc---chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceE
Confidence 457999999999999999999999999999999886533 2345689999999999999998877532 24
Q ss_pred EEEEEEecCCCchHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccc
Q 028681 92 LAIVMEYASGGELFERIC----NAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 167 (205)
Q Consensus 92 ~~lv~~~~~~~sl~~~~~----~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~ 167 (205)
++++|||+++ ++.+.+. ....+++..++.++.|++.||.|||+.+|+||||+|+||+++.++. .+||+|||+|+
T Consensus 142 l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~-~vkL~DFGla~ 219 (440)
T PTZ00036 142 LNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTH-TLKLCDFGSAK 219 (440)
T ss_pred EEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCC-ceeeeccccch
Confidence 6789999975 6655553 3456999999999999999999999999999999999999985542 29999999998
Q ss_pred cccCCCCCCCCCCCCCccCCceeccC-cCCCeeeEEEeC
Q 028681 168 SSVLHSQPKSTVGTPAYIAPEVLLKK-EYDGKVMCVYVI 205 (205)
Q Consensus 168 ~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~~Dvwsl 205 (205)
............+++.|+|||++.+. .++.+ +|||||
T Consensus 220 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~-~DiwSl 257 (440)
T PTZ00036 220 NLLAGQRSVSYICSRFYRAPELMLGATNYTTH-IDLWSL 257 (440)
T ss_pred hccCCCCcccCCCCcCccCHHHhcCCCCCCcH-HHHHHH
Confidence 76655555556789999999998765 45544 999996
|
|
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=228.50 Aligned_cols=178 Identities=21% Similarity=0.255 Sum_probs=152.6
Q ss_pred cCCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCccchHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEEe
Q 028681 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (205)
Q Consensus 19 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~ 98 (205)
....|.+.+.||+|++|.||++.+..++..|++|... ...+..|+.++++++|+||+++++++..++..++++++
T Consensus 167 ~~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~-----~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~ 241 (461)
T PHA03211 167 AGLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW-----YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK 241 (461)
T ss_pred ccCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc-----ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 3568999999999999999999999999999999532 23456899999999999999999999999999999999
Q ss_pred cCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCCCC---
Q 028681 99 ASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ--- 174 (205)
Q Consensus 99 ~~~~sl~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~--- 174 (205)
+. ++|.+.+.. ...+++.++..++.|++.||.|||+.||+|+||||+||+++.++. ++|+|||+++.......
T Consensus 242 ~~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~--vkL~DFGla~~~~~~~~~~~ 318 (461)
T PHA03211 242 YR-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPED--ICLGDFGAACFARGSWSTPF 318 (461)
T ss_pred cC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCC--EEEcccCCceeccccccccc
Confidence 85 577777654 346999999999999999999999999999999999999987777 99999999875433222
Q ss_pred CCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 175 PKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 175 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
.....|++.|+|||++.+..++.+ +|||||
T Consensus 319 ~~~~~GT~~Y~APE~~~~~~~~~~-sDvwSl 348 (461)
T PHA03211 319 HYGIAGTVDTNAPEVLAGDPYTPS-VDIWSA 348 (461)
T ss_pred ccccCCCcCCcCHHHHcCCCCCch-HHHHHH
Confidence 123458999999999999888766 999996
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=215.99 Aligned_cols=184 Identities=24% Similarity=0.309 Sum_probs=154.5
Q ss_pred cCCCeEEEeeeccccceeEEEEEec---CCCcEEEEEEeecCcc--chHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEE
Q 028681 19 DSDRYELVRDIGSGNFGVARLMRDK---KTEELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLA 93 (205)
Q Consensus 19 ~~~~y~~~~~l~~g~~g~v~~~~~~---~~~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 93 (205)
+.++|++.+.||+|+||.||.+... ..+..|++|.++.... ....+..|+..++.++|||++++++++..++..+
T Consensus 3 ~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 82 (266)
T cd05064 3 DNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMM 82 (266)
T ss_pred chHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcE
Confidence 4578999999999999999999765 4467899998876532 2356788999999999999999999999999999
Q ss_pred EEEEecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCC
Q 028681 94 IVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 172 (205)
Q Consensus 94 lv~~~~~~~sl~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~ 172 (205)
++|||+++++|.+++... ..+++..++.++.|++.|++|||+++++|+||+|+||+++.++. ++++|||.+......
T Consensus 83 lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~--~~l~dfg~~~~~~~~ 160 (266)
T cd05064 83 IVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLV--CKISGFRRLQEDKSE 160 (266)
T ss_pred EEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCc--EEECCCccccccccc
Confidence 999999999999988663 46899999999999999999999999999999999999988776 999999976543222
Q ss_pred CCCC--CCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 173 SQPK--STVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 173 ~~~~--~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
.... ...++..|+|||.+.+..++.+ +|||||
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~sl 194 (266)
T cd05064 161 AIYTTMSGKSPVLWAAPEAIQYHHFSSA-SDVWSF 194 (266)
T ss_pred chhcccCCCCceeecCHHHHhhCCccch-hHHHHH
Confidence 1111 2234578999999988888765 999996
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-35 Score=226.14 Aligned_cols=185 Identities=23% Similarity=0.324 Sum_probs=152.9
Q ss_pred ecCCCeEEEeeeccccceeEEEEEecCC-----CcEEEEEEeecCcc--chHHHHHHHHHHHhc-CCCCeeEEEEEEEeC
Q 028681 18 HDSDRYELVRDIGSGNFGVARLMRDKKT-----EELVAVKYIERGDK--IDENVQREIINHRSL-RHPNIVRFKEVILTP 89 (205)
Q Consensus 18 ~~~~~y~~~~~l~~g~~g~v~~~~~~~~-----~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~ 89 (205)
...++|++.+.||+|+||.||.+.+... +..|++|.+..... ..+.+..|+.+++.+ +|+||+++++++...
T Consensus 35 ~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~ 114 (374)
T cd05106 35 FPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHG 114 (374)
T ss_pred ccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCC
Confidence 4466899999999999999999986433 35799999875432 235678899999999 899999999999999
Q ss_pred CeEEEEEEecCCCchHHHHHhc----------------------------------------------------------
Q 028681 90 THLAIVMEYASGGELFERICNA---------------------------------------------------------- 111 (205)
Q Consensus 90 ~~~~lv~~~~~~~sl~~~~~~~---------------------------------------------------------- 111 (205)
+..+++|||+++++|.+.+...
T Consensus 115 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (374)
T cd05106 115 GPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQS 194 (374)
T ss_pred CCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccc
Confidence 9999999999999999887532
Q ss_pred ------------CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCCCC---CC
Q 028681 112 ------------GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PK 176 (205)
Q Consensus 112 ------------~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~---~~ 176 (205)
.++++..+..++.|++.||.|||++|++||||+|+||+++.+.. ++|+|||+++....... ..
T Consensus 195 ~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~--~kL~DfGla~~~~~~~~~~~~~ 272 (374)
T cd05106 195 SDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRV--AKICDFGLARDIMNDSNYVVKG 272 (374)
T ss_pred ccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCe--EEEeeceeeeeccCCcceeecc
Confidence 13678889999999999999999999999999999999987776 99999999875433221 11
Q ss_pred CCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 177 STVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 177 ~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
...++..|+|||++.+..++.+ +|||||
T Consensus 273 ~~~~~~~y~aPE~~~~~~~~~~-~DvwSl 300 (374)
T cd05106 273 NARLPVKWMAPESIFDCVYTVQ-SDVWSY 300 (374)
T ss_pred CCCCccceeCHHHhcCCCCCcc-ccHHHH
Confidence 2234567999999988888766 999996
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=224.32 Aligned_cols=181 Identities=27% Similarity=0.408 Sum_probs=154.6
Q ss_pred cCCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCcc---chHHHHHHHHHHHhcCCCCeeEEEEEEEeCC-----
Q 028681 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTPT----- 90 (205)
Q Consensus 19 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----- 90 (205)
..++|++.+.||+|+||.||.+.+..+++.|++|.+..... ....+.+|+.+++.++|+|++++++++....
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 36899999999999999999999999999999999875422 2356778999999999999999999887543
Q ss_pred -eEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccc
Q 028681 91 -HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 169 (205)
Q Consensus 91 -~~~lv~~~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~ 169 (205)
..+++||++++ ++.+.+.. .++...+..++.|++.||.|||++|++||||+|+||+++.++. ++|+|||+++..
T Consensus 95 ~~~~lv~e~~~~-~l~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~--~kl~Dfg~~~~~ 169 (355)
T cd07874 95 QDVYLVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTA 169 (355)
T ss_pred ceeEEEhhhhcc-cHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCC--EEEeeCcccccC
Confidence 57899999965 56665543 4889999999999999999999999999999999999988877 999999999766
Q ss_pred cCCCCCCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 170 VLHSQPKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 170 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
..........++..|+|||++.+..++.+ +|||||
T Consensus 170 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~-~Diwsl 204 (355)
T cd07874 170 GTSFMMTPYVVTRYYRAPEVILGMGYKEN-VDIWSV 204 (355)
T ss_pred CCccccCCccccCCccCHHHHcCCCCCch-hhHHHH
Confidence 55544555678999999999998888766 999996
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=215.35 Aligned_cols=185 Identities=33% Similarity=0.501 Sum_probs=159.4
Q ss_pred ecCCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCcc-chHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEE
Q 028681 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (205)
Q Consensus 18 ~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 96 (205)
...++|++.+.||+|++|.||.+.+..+++.|++|.+..... ....+.+|+.+++.++|||++++++.+..++..++++
T Consensus 6 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~ 85 (267)
T cd06645 6 NPQEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICM 85 (267)
T ss_pred CcHHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEE
Confidence 345789999999999999999999999999999999876532 2345778999999999999999999999999999999
Q ss_pred EecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCC-CCC
Q 028681 97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQP 175 (205)
Q Consensus 97 ~~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~-~~~ 175 (205)
||+++++|.+.+...+.+++.++..++.|++.|+.+||+.|++|+||+|+||+++.++. ++|+|||++...... ...
T Consensus 86 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~--~~l~dfg~~~~~~~~~~~~ 163 (267)
T cd06645 86 EFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGH--VKLADFGVSAQITATIAKR 163 (267)
T ss_pred eccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCC--EEECcceeeeEccCccccc
Confidence 99999999999988888999999999999999999999999999999999999987777 999999988654332 222
Q ss_pred CCCCCCCCccCCceec---cCcCCCeeeEEEeC
Q 028681 176 KSTVGTPAYIAPEVLL---KKEYDGKVMCVYVI 205 (205)
Q Consensus 176 ~~~~~~~~~~aPE~~~---~~~~~~~~~Dvwsl 205 (205)
....++..|+|||.+. +..++. ++|+|||
T Consensus 164 ~~~~~~~~y~aPE~~~~~~~~~~~~-~~DvwSl 195 (267)
T cd06645 164 KSFIGTPYWMAPEVAAVERKGGYNQ-LCDIWAV 195 (267)
T ss_pred ccccCcccccChhhhccccCCCCCc-hhhhHHH
Confidence 3346889999999985 344554 4999996
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-34 Score=217.17 Aligned_cols=181 Identities=28% Similarity=0.450 Sum_probs=158.5
Q ss_pred CCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCcc--chHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEEe
Q 028681 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (205)
Q Consensus 21 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~ 98 (205)
++|++.+.||+|++|.||++.+..++..+++|.+..... ....+..|+.++++++|||++++++.+..++..++++||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 479999999999999999999999999999998875422 235678899999999999999999999999999999999
Q ss_pred cCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-cCcEeecCCCCCeEecCCCCCcEEEeeecccccccCCCCCCC
Q 028681 99 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS-MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS 177 (205)
Q Consensus 99 ~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~-~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~~~~ 177 (205)
+++++|.+.+.....+++..+..++.|++.||.|||+ ++++|+||+|+||+++.++. ++|+|||.+...... ....
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~--~~l~dfg~~~~~~~~-~~~~ 157 (308)
T cd06615 81 MDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGE--IKLCDFGVSGQLIDS-MANS 157 (308)
T ss_pred cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCc--EEEccCCCccccccc-cccc
Confidence 9999999999888889999999999999999999997 69999999999999988777 999999988644322 2234
Q ss_pred CCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 178 TVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 178 ~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
..++..|+|||.+.+..++.+ +|+|||
T Consensus 158 ~~~~~~~~aPE~~~~~~~~~~-~Diwsl 184 (308)
T cd06615 158 FVGTRSYMSPERLQGTHYTVQ-SDIWSL 184 (308)
T ss_pred CCCCcCccChhHhcCCCCCcc-chHHHH
Confidence 568899999999988777655 999986
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=215.87 Aligned_cols=186 Identities=33% Similarity=0.497 Sum_probs=158.8
Q ss_pred eecCCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecC---ccchHHHHHHHHHHHhcCCCCeeEEEEEEEeC----
Q 028681 17 MHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG---DKIDENVQREIINHRSLRHPNIVRFKEVILTP---- 89 (205)
Q Consensus 17 ~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---- 89 (205)
......|...+.||.|++|.|+.+.+..+|..||+|.+... ....++..+|+.+|+.++|+||+.+.+++..+
T Consensus 18 ~~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~ 97 (359)
T KOG0660|consen 18 FEIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDK 97 (359)
T ss_pred EeccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccc
Confidence 34456777789999999999999999999999999998742 33457788999999999999999999998762
Q ss_pred -CeEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeeccccc
Q 028681 90 -THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 168 (205)
Q Consensus 90 -~~~~lv~~~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~ 168 (205)
+.+|+|+|+| ...|...++.++.++...+..+++|++.||.|+|+.+++|||+||+|++++.+.. +||+|||+|+.
T Consensus 98 f~DvYiV~elM-etDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~--lKI~DFGLAR~ 174 (359)
T KOG0660|consen 98 FNDVYLVFELM-ETDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCD--LKICDFGLARY 174 (359)
T ss_pred cceeEEehhHH-hhHHHHHHHcCccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCC--EEeccccceee
Confidence 4689999999 4578888887777999999999999999999999999999999999999987777 99999999987
Q ss_pred ccCC---CCCCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 169 SVLH---SQPKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 169 ~~~~---~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
.... ........|..|.|||++.+....++..||||.
T Consensus 175 ~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSv 214 (359)
T KOG0660|consen 175 LDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSV 214 (359)
T ss_pred ccccCcccchhcceeeeeecCHHHHhccccccchhhhhhh
Confidence 7643 333445678999999999876555566999994
|
|
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=214.12 Aligned_cols=181 Identities=29% Similarity=0.519 Sum_probs=161.9
Q ss_pred CeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCc----cchHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEE
Q 028681 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (205)
Q Consensus 22 ~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~ 97 (205)
+|++.+.||.|++|.||.+.+..++..+++|.+.... ...+.+.+|+..+++++|||++++++.+..+...++++|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 5899999999999999999999899999999997643 234678889999999999999999999999999999999
Q ss_pred ecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCCCCCCC
Q 028681 98 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS 177 (205)
Q Consensus 98 ~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~~~~ 177 (205)
|+.+++|.+.+....++++..+..++.|++.|+.+||+++++|+||+|+||++++++. ++|+|||.+...........
T Consensus 81 ~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~--~~l~d~~~~~~~~~~~~~~~ 158 (258)
T cd05578 81 LLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGH--VHITDFNIATKVTPDTLTTS 158 (258)
T ss_pred CCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCC--EEEeecccccccCCCccccc
Confidence 9999999999977778999999999999999999999999999999999999998877 99999999876655544455
Q ss_pred CCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 178 TVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 178 ~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
..++..|+|||.+.+..++.+ +|+|||
T Consensus 159 ~~~~~~y~~PE~~~~~~~~~~-~Di~sl 185 (258)
T cd05578 159 TSGTPGYMAPEVLCRQGYSVA-VDWWSL 185 (258)
T ss_pred cCCChhhcCHHHHcccCCCCc-ccchhh
Confidence 668889999999988887655 999996
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=223.26 Aligned_cols=181 Identities=28% Similarity=0.406 Sum_probs=154.8
Q ss_pred cCCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCc---cchHHHHHHHHHHHhcCCCCeeEEEEEEEeC------
Q 028681 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTP------ 89 (205)
Q Consensus 19 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------ 89 (205)
..++|++.+.||+|++|.||.+.+..+++.|++|.+.... .....+.+|+.+++.++|+|++++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 4689999999999999999999999999999999987532 2235677899999999999999999987643
Q ss_pred CeEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccc
Q 028681 90 THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 169 (205)
Q Consensus 90 ~~~~lv~~~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~ 169 (205)
...++||||+++ +|.+.+.. .++...+..++.|++.||.+||++||+||||+|+||+++.++. ++|+|||+++..
T Consensus 102 ~~~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~--~kL~DfG~a~~~ 176 (364)
T cd07875 102 QDVYIVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTA 176 (364)
T ss_pred CeEEEEEeCCCC-CHHHHHHh--cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCc--EEEEeCCCcccc
Confidence 357999999965 66666643 4888999999999999999999999999999999999988877 999999999766
Q ss_pred cCCCCCCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 170 VLHSQPKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 170 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
..........++..|+|||++.+..++.+ +|||||
T Consensus 177 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~-~DiwSl 211 (364)
T cd07875 177 GTSFMMTPYVVTRYYRAPEVILGMGYKEN-VDIWSV 211 (364)
T ss_pred CCCCcccCCcccCCcCCHHHHhCCCCCch-hhHHhH
Confidence 55444455678999999999998888766 999996
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-34 Score=216.69 Aligned_cols=184 Identities=24% Similarity=0.301 Sum_probs=151.8
Q ss_pred cCCCeEEEeeeccccceeEEEEEecCCCc--EEEEEEeecCc--cchHHHHHHHHHHHhc-CCCCeeEEEEEEEeCCeEE
Q 028681 19 DSDRYELVRDIGSGNFGVARLMRDKKTEE--LVAVKYIERGD--KIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLA 93 (205)
Q Consensus 19 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~--~v~iK~~~~~~--~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~ 93 (205)
..++|++.+.||+|+||.||++.+..++. .+++|.+.... .....+..|+.++.++ +|+|++++++++..++..+
T Consensus 5 ~~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~ 84 (303)
T cd05088 5 EWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLY 84 (303)
T ss_pred chhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCce
Confidence 35799999999999999999999877665 45666655422 2235677899999999 8999999999999999999
Q ss_pred EEEEecCCCchHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCc
Q 028681 94 IVMEYASGGELFERICNAG----------------RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPR 157 (205)
Q Consensus 94 lv~~~~~~~sl~~~~~~~~----------------~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~ 157 (205)
+++||+++++|.+++.... .+++.++..++.|++.|++|||++|++|+||+|+||+++.++.
T Consensus 85 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~~~-- 162 (303)
T cd05088 85 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYV-- 162 (303)
T ss_pred EEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCCCc--
Confidence 9999999999999886432 4788999999999999999999999999999999999988777
Q ss_pred EEEeeecccccccCCCCCCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 158 LKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 158 ~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
++|+|||++..............+..|+|||.+.+..++.+ +|||||
T Consensus 163 ~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~sl 209 (303)
T cd05088 163 AKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTN-SDVWSY 209 (303)
T ss_pred EEeCccccCcccchhhhcccCCCcccccCHHHHhccCCccc-ccchhh
Confidence 99999998864332222222334677999999988777655 999996
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=225.53 Aligned_cols=181 Identities=28% Similarity=0.424 Sum_probs=152.7
Q ss_pred CeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCc---cchHHHHHHHHHHHhcCCCCeeEEEEEEEeCC-----eEE
Q 028681 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPT-----HLA 93 (205)
Q Consensus 22 ~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~ 93 (205)
+|++.+.||+|++|.||.+.+..+++.||+|.+.... .....+..|+.+++.++|+|++++++++.... ..+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 4789999999999999999999999999999886532 22356788999999999999999999998776 789
Q ss_pred EEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCCC
Q 028681 94 IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 173 (205)
Q Consensus 94 lv~~~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~~ 173 (205)
+++||+. ++|.+.+.....+++..+..++.|++.||.|||+.|++|+||+|+||+++.++. ++|+|||++.......
T Consensus 81 lv~e~~~-~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~--~kL~Dfg~a~~~~~~~ 157 (372)
T cd07853 81 VVTELMQ-SDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCV--LKICDFGLARVEEPDE 157 (372)
T ss_pred EEeeccc-cCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCC--EEeccccceeecccCc
Confidence 9999986 478787777778999999999999999999999999999999999999988877 9999999987543322
Q ss_pred --CCCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 174 --QPKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 174 --~~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
......++..|+|||.+.+......++|||||
T Consensus 158 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Diwsl 191 (372)
T cd07853 158 SKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSV 191 (372)
T ss_pred cccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhH
Confidence 22234578899999999875433345999996
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-34 Score=211.70 Aligned_cols=183 Identities=26% Similarity=0.403 Sum_probs=156.0
Q ss_pred cCCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCccchHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEEe
Q 028681 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (205)
Q Consensus 19 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~ 98 (205)
+.++|++.+.||+|++|.||++.... +..+++|.+.......+.+..|+.+++.++|||++++++++...+..+++|||
T Consensus 2 ~~~~~~~~~~lg~G~~~~vy~~~~~~-~~~~a~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~ 80 (256)
T cd05114 2 NPSELTFMKELGSGQFGVVHLGKWRA-QIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEF 80 (256)
T ss_pred CHHHcEEeeEecCCcCceEEEEEecc-CceEEEEecccCCccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEc
Confidence 35789999999999999999998765 45799998876665667788999999999999999999999999999999999
Q ss_pred cCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCCCCC--
Q 028681 99 ASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP-- 175 (205)
Q Consensus 99 ~~~~sl~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~~-- 175 (205)
+++++|.+.+... ..+++..+..++.|++.||+|||+.+++|+||+|+||+++.++. ++|+|||.+.........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~--~kl~d~g~~~~~~~~~~~~~ 158 (256)
T cd05114 81 MENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGV--VKVSDFGMTRYVLDDEYTSS 158 (256)
T ss_pred CCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCe--EEECCCCCccccCCCceecc
Confidence 9999999988653 45899999999999999999999999999999999999987776 999999988654322211
Q ss_pred CCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 176 KSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 176 ~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
....++..|+|||.+.+..++.+ +|||||
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~-~Di~s~ 187 (256)
T cd05114 159 SGAKFPVKWSPPEVFNFSKYSSK-SDVWSF 187 (256)
T ss_pred CCCCCchhhCChhhcccCccchh-hhhHHH
Confidence 12235568999999988887765 999996
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=212.97 Aligned_cols=184 Identities=22% Similarity=0.301 Sum_probs=159.0
Q ss_pred cCCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCccchHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEEe
Q 028681 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (205)
Q Consensus 19 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~ 98 (205)
...+|++.+.||+|++|.||++.....+..|++|.+.........+..|+..++.++|+|++++++++..++..++++||
T Consensus 4 ~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (263)
T cd05052 4 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 83 (263)
T ss_pred chHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCchHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEe
Confidence 45789999999999999999999999899999999886655556788999999999999999999999999999999999
Q ss_pred cCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCCCCCC
Q 028681 99 ASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK 176 (205)
Q Consensus 99 ~~~~sl~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~~~ 176 (205)
+++++|.+.+... ..+++..+..++.|++.|+++||+.|++|+||+|+||++++++. ++|+|||.+..........
T Consensus 84 ~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~--~kl~df~~~~~~~~~~~~~ 161 (263)
T cd05052 84 MTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHL--VKVADFGLSRLMTGDTYTA 161 (263)
T ss_pred CCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCc--EEeCCCccccccccceeec
Confidence 9999999988653 35889999999999999999999999999999999999988777 9999999987554332211
Q ss_pred --CCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 177 --STVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 177 --~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
....+..|+|||.+.+..++.+ +|||||
T Consensus 162 ~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~sl 191 (263)
T cd05052 162 HAGAKFPIKWTAPESLAYNKFSIK-SDVWAF 191 (263)
T ss_pred cCCCCCccccCCHHHhccCCCCch-hHHHHH
Confidence 1224567999999988888766 999996
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-34 Score=212.24 Aligned_cols=184 Identities=32% Similarity=0.483 Sum_probs=158.6
Q ss_pred cCCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCcc-chHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEE
Q 028681 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (205)
Q Consensus 19 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~ 97 (205)
..++|++.+.||+|++|.||.+.+..++..|++|.+..... ....+..|+.+++.++|+|++++++++..+...++++|
T Consensus 7 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e 86 (267)
T cd06646 7 PQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICME 86 (267)
T ss_pred chhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEe
Confidence 35689999999999999999999999999999999875432 33557789999999999999999999999999999999
Q ss_pred ecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCCC-CCC
Q 028681 98 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPK 176 (205)
Q Consensus 98 ~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~~-~~~ 176 (205)
|+++++|.+.+....++++..+..++.|++.|+.+||+.+++|+|++|+||+++.++. ++|+|||++....... ...
T Consensus 87 ~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~--~~l~dfg~~~~~~~~~~~~~ 164 (267)
T cd06646 87 YCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGD--VKLADFGVAAKITATIAKRK 164 (267)
T ss_pred CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCC--EEECcCccceeecccccccC
Confidence 9999999999887778999999999999999999999999999999999999987777 9999999987654332 233
Q ss_pred CCCCCCCccCCceecc---CcCCCeeeEEEeC
Q 028681 177 STVGTPAYIAPEVLLK---KEYDGKVMCVYVI 205 (205)
Q Consensus 177 ~~~~~~~~~aPE~~~~---~~~~~~~~Dvwsl 205 (205)
...+++.|+|||.+.. ..++ .++|+|||
T Consensus 165 ~~~~~~~y~~PE~~~~~~~~~~~-~~~Dvws~ 195 (267)
T cd06646 165 SFIGTPYWMAPEVAAVEKNGGYN-QLCDIWAV 195 (267)
T ss_pred ccccCccccCHhHcccccCCCCc-chhhHHHH
Confidence 4468889999999853 3344 45999985
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=209.26 Aligned_cols=183 Identities=37% Similarity=0.543 Sum_probs=160.7
Q ss_pred CCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCcc-chHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEEe
Q 028681 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (205)
Q Consensus 20 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~ 98 (205)
.++|++.+.||.|++|.||.+.+..++..+++|.+..... ..+.+..|+.+++.++|+|++++++.+...+.++++||+
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~ 81 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEY 81 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeC
Confidence 4789999999999999999999998889999999886543 346788999999999999999999999999999999999
Q ss_pred cCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCCC-CCC
Q 028681 99 ASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPK 176 (205)
Q Consensus 99 ~~~~sl~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~~-~~~ 176 (205)
+++++|.+.+... .++++.++..++.|++.|+.+||+.+++|+||+|+||+++.++. ++|+|||.+....... ...
T Consensus 82 ~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~--~~l~d~g~~~~~~~~~~~~~ 159 (262)
T cd06613 82 CGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGD--VKLADFGVSAQLTATIAKRK 159 (262)
T ss_pred CCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCC--EEECccccchhhhhhhhccc
Confidence 9999999988775 67999999999999999999999999999999999999998777 9999999887654432 223
Q ss_pred CCCCCCCccCCceeccC---cCCCeeeEEEeC
Q 028681 177 STVGTPAYIAPEVLLKK---EYDGKVMCVYVI 205 (205)
Q Consensus 177 ~~~~~~~~~aPE~~~~~---~~~~~~~Dvwsl 205 (205)
...++..|+|||.+.+. .++.+ +|+|||
T Consensus 160 ~~~~~~~y~~Pe~~~~~~~~~~~~~-~Di~sl 190 (262)
T cd06613 160 SFIGTPYWMAPEVAAVERKGGYDGK-CDIWAL 190 (262)
T ss_pred cccCCccccCchhhcccccCCcCch-hhhHHH
Confidence 34678889999999876 66655 999996
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=221.73 Aligned_cols=180 Identities=24% Similarity=0.452 Sum_probs=162.0
Q ss_pred CeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCccchHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEEecCC
Q 028681 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASG 101 (205)
Q Consensus 22 ~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~~~~ 101 (205)
-|.++++||+|++|.||.+.++.+|..+|+|.+.... ..+++..|+.+++++..++++++||.+.....+|+|||||..
T Consensus 34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~s-DLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGA 112 (502)
T KOG0574|consen 34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDT-DLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGA 112 (502)
T ss_pred HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccc-hHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCC
Confidence 3667899999999999999999999999999887644 346678899999999999999999999999999999999999
Q ss_pred CchHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeeccccccc-CCCCCCCCC
Q 028681 102 GELFERIC-NAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV-LHSQPKSTV 179 (205)
Q Consensus 102 ~sl~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~-~~~~~~~~~ 179 (205)
|+..++++ ++.++++.++..+++..+++|+|||...-+||||+..||+++.++. .||+|||.|.... .....++..
T Consensus 113 GSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~--AKLADFGVAGQLTDTMAKRNTVI 190 (502)
T KOG0574|consen 113 GSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGI--AKLADFGVAGQLTDTMAKRNTVI 190 (502)
T ss_pred CcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccch--hhhhhccccchhhhhHHhhCccc
Confidence 99999986 4568999999999999999999999999999999999999988888 9999999886443 335557778
Q ss_pred CCCCccCCceeccCcCCCeeeEEEeC
Q 028681 180 GTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 180 ~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
||+.|||||++..-.|+.+ +|||||
T Consensus 191 GTPFWMAPEVI~EIGY~~~-ADIWSL 215 (502)
T KOG0574|consen 191 GTPFWMAPEVIEEIGYDTK-ADIWSL 215 (502)
T ss_pred cCcccccHHHHHHhccchh-hhHhhh
Confidence 9999999999999999888 999997
|
|
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=212.73 Aligned_cols=183 Identities=31% Similarity=0.492 Sum_probs=156.3
Q ss_pred CCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCcc---chHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEE
Q 028681 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (205)
Q Consensus 21 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~ 97 (205)
++|++.+.||+|++|.||++.+..+++.|++|.+..... ..+.+.+|+.+++.++|+|++++++++..+...++++|
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 579999999999999999999998899999998865432 23567889999999999999999999999999999999
Q ss_pred ecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCCC-CCC
Q 028681 98 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPK 176 (205)
Q Consensus 98 ~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~~-~~~ 176 (205)
|+++++|.........+++..+..++.|++.+|.+||+.|++|+||+|+||+++.++. ++|+|||++....... ...
T Consensus 81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~--~~l~dfg~~~~~~~~~~~~~ 158 (286)
T cd07847 81 YCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQ--IKLCDFGFARILTGPGDDYT 158 (286)
T ss_pred ccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCc--EEECccccceecCCCccccc
Confidence 9998888777766667999999999999999999999999999999999999988776 9999999987654433 223
Q ss_pred CCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 177 STVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 177 ~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
...++..|+|||.+.+....+.++|||||
T Consensus 159 ~~~~~~~~~aPE~~~~~~~~~~~~Di~sl 187 (286)
T cd07847 159 DYVATRWYRAPELLVGDTQYGPPVDVWAI 187 (286)
T ss_pred CcccccccCCHHHHhCCCCcCchhhhHHH
Confidence 34577889999998764432345999986
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=207.82 Aligned_cols=181 Identities=33% Similarity=0.541 Sum_probs=156.6
Q ss_pred CeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCc--cchHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEEec
Q 028681 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA 99 (205)
Q Consensus 22 ~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~~ 99 (205)
+|++.+.||.|++|.||.+.+..++..+++|.+.... ...+.+..|+.+++.++|+|++++.+.+..++..++++||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 5899999999999999999999999999999886532 23466788999999999999999999999999999999999
Q ss_pred CCCchHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCCC-CCC
Q 028681 100 SGGELFERICN--AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPK 176 (205)
Q Consensus 100 ~~~sl~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~~-~~~ 176 (205)
++++|.+.+.. ...+++..+..++.|++.|+.+||++|++|+||+|+||+++.++. ++++|||.+....... ...
T Consensus 81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~--~~l~dfg~~~~~~~~~~~~~ 158 (255)
T cd08219 81 DGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGK--VKLGDFGSARLLTSPGAYAC 158 (255)
T ss_pred CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCc--EEEcccCcceeecccccccc
Confidence 99999888754 345899999999999999999999999999999999999988777 9999999986554322 223
Q ss_pred CCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 177 STVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 177 ~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
...+++.|+|||++.+..++.+ +|+|||
T Consensus 159 ~~~~~~~~~aPE~~~~~~~~~~-~Dv~sl 186 (255)
T cd08219 159 TYVGTPYYVPPEIWENMPYNNK-SDIWSL 186 (255)
T ss_pred cccCCccccCHHHHccCCcCch-hhhhhh
Confidence 3458889999999988877655 999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-37 Score=214.88 Aligned_cols=184 Identities=35% Similarity=0.558 Sum_probs=160.3
Q ss_pred CCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCc---cchHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEE
Q 028681 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (205)
Q Consensus 20 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 96 (205)
.+.|++.+.||+|+|+.|+++.+..+|+.+++|+++... ...+++.+|+++-+.|+||||+++.+...+....++|+
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF 89 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 89 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence 578999999999999999999999999999999987543 34578899999999999999999999999999999999
Q ss_pred EecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecC-CCCCcEEEeeecccccccCCCCC
Q 028681 97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVLHSQP 175 (205)
Q Consensus 97 ~~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~-~~~~~~~l~df~~~~~~~~~~~~ 175 (205)
|++.++.|-.-+...-.+++..+..+++||+.||.|+|.++|+|||++|.|+++-. +...-+||+|||+|.........
T Consensus 90 e~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~g~~~ 169 (355)
T KOG0033|consen 90 DLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVNDGEAW 169 (355)
T ss_pred ecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeCCcccc
Confidence 99999988666655566889999999999999999999999999999999999943 22234999999999877744444
Q ss_pred CCCCCCCCccCCceeccCcCCCeeeEEEe
Q 028681 176 KSTVGTPAYIAPEVLLKKEYDGKVMCVYV 204 (205)
Q Consensus 176 ~~~~~~~~~~aPE~~~~~~~~~~~~Dvws 204 (205)
....|++.|+|||++.+.+|+.+ +|||+
T Consensus 170 ~G~~GtP~fmaPEvvrkdpy~kp-vDiW~ 197 (355)
T KOG0033|consen 170 HGFAGTPGYLSPEVLKKDPYSKP-VDIWA 197 (355)
T ss_pred ccccCCCcccCHHHhhcCCCCCc-chhhh
Confidence 45579999999999999999755 99997
|
|
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-34 Score=212.42 Aligned_cols=177 Identities=26% Similarity=0.391 Sum_probs=153.5
Q ss_pred CCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCc--cchHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEEe
Q 028681 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (205)
Q Consensus 21 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~ 98 (205)
++|++.+.||+|++|.||.+.+..++..|++|.+.... ....++.+|+.+++++.|||++++++.+..++..++++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 80 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF 80 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence 46889999999999999999999999999999987542 2235688899999999999999999999999999999999
Q ss_pred cCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCCCCCCCC
Q 028681 99 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST 178 (205)
Q Consensus 99 ~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~~~~~ 178 (205)
+++++|... ..+++..+..++.|++.|+.|||+.|++|+||+|+||+++.++. ++|+|||++...... .....
T Consensus 81 ~~~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~--~~l~dfg~~~~~~~~-~~~~~ 153 (279)
T cd06619 81 MDGGSLDVY----RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQ--VKLCDFGVSTQLVNS-IAKTY 153 (279)
T ss_pred CCCCChHHh----hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCC--EEEeeCCcceecccc-cccCC
Confidence 999888543 34788899999999999999999999999999999999998887 999999998654322 23345
Q ss_pred CCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 179 VGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 179 ~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
.++..|+|||.+.+..++.+ +|+|||
T Consensus 154 ~~~~~y~aPE~~~~~~~~~~-~Dvwsl 179 (279)
T cd06619 154 VGTNAYMAPERISGEQYGIH-SDVWSL 179 (279)
T ss_pred CCChhhcCceeecCCCCCCc-chHHHH
Confidence 68899999999998888765 999986
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=246.93 Aligned_cols=184 Identities=31% Similarity=0.488 Sum_probs=160.5
Q ss_pred cCCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCc---cc-hHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEE
Q 028681 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KI-DENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 94 (205)
Q Consensus 19 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~---~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 94 (205)
..++|.+++.||+|+||.|.+++++.+++.||+|++++-. .. ..-|.+|-.++..-..+=|+.++-+|.++.++|+
T Consensus 73 ~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYl 152 (1317)
T KOG0612|consen 73 KAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLYL 152 (1317)
T ss_pred CHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEE
Confidence 4589999999999999999999999999999999998732 22 2347777777777778889999999999999999
Q ss_pred EEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCCCC
Q 028681 95 VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 174 (205)
Q Consensus 95 v~~~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~ 174 (205)
|||||+||.|..++.+-.++++..++.++..|+.||..||+.|+|||||||+|||++..|+ ++|+|||.|-....+..
T Consensus 153 VMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GH--ikLADFGsClkm~~dG~ 230 (1317)
T KOG0612|consen 153 VMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGH--IKLADFGSCLKMDADGT 230 (1317)
T ss_pred EEecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCc--EeeccchhHHhcCCCCc
Confidence 9999999999999988778999999999999999999999999999999999999999998 99999999876654433
Q ss_pred --CCCCCCCCCccCCceecc-----CcCCCeeeEEEeC
Q 028681 175 --PKSTVGTPAYIAPEVLLK-----KEYDGKVMCVYVI 205 (205)
Q Consensus 175 --~~~~~~~~~~~aPE~~~~-----~~~~~~~~Dvwsl 205 (205)
.....|||.|++||++.. +.|+.. +|+|||
T Consensus 231 V~s~~aVGTPDYISPEvLqs~~~~~g~yG~e-cDwWSl 267 (1317)
T KOG0612|consen 231 VRSSVAVGTPDYISPEVLQSQGDGKGEYGRE-CDWWSL 267 (1317)
T ss_pred EEeccccCCCCccCHHHHHhhcCCccccCCc-cchhhh
Confidence 344579999999999973 455555 999996
|
|
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=209.09 Aligned_cols=181 Identities=32% Similarity=0.491 Sum_probs=158.4
Q ss_pred CeEEEeeeccccceeEEEEEecCCCcEEEEEEeecC---ccchHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEEe
Q 028681 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG---DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (205)
Q Consensus 22 ~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~ 98 (205)
+|++.+.|++|++|.+|++.+..++..|++|.+... ....+.+..|+.+++.++|+|++++++.+..++..++++||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 588999999999999999999999999999998753 23446688899999999999999999999999999999999
Q ss_pred cCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCCCC-C
Q 028681 99 ASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-P 175 (205)
Q Consensus 99 ~~~~sl~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~-~ 175 (205)
+++++|.+.+... ..+++..+..++.+++.|+.+||+.|++|+||+|+||+++.++. ++|+|||++........ .
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~--~~l~df~~~~~~~~~~~~~ 158 (256)
T cd08529 81 AENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDN--VKIGDLGVAKLLSDNTNFA 158 (256)
T ss_pred CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCC--EEEcccccceeccCccchh
Confidence 9999999988663 56899999999999999999999999999999999999998777 99999998876544322 2
Q ss_pred CCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 176 KSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 176 ~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
....+++.|+|||++.+..++.+ +|+|||
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~-~Di~sl 187 (256)
T cd08529 159 NTIVGTPYYLSPELCEDKPYNEK-SDVWAL 187 (256)
T ss_pred hccccCccccCHHHhcCCCCCCc-cchHHH
Confidence 33457889999999998887755 999996
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=208.39 Aligned_cols=181 Identities=33% Similarity=0.537 Sum_probs=159.0
Q ss_pred CeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCc---cchHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEEe
Q 028681 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (205)
Q Consensus 22 ~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~ 98 (205)
+|++.+.||.|++|.++.+.+..++..+++|.+.... ....++.+|+.++++++|+|++++++++.+.+..++++||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 5899999999999999999999999999999887542 3345688999999999999999999999999999999999
Q ss_pred cCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCCC-CC
Q 028681 99 ASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QP 175 (205)
Q Consensus 99 ~~~~sl~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~~-~~ 175 (205)
+++++|.+.+... ..+++..+..++.|++.++.+||+.|++|+||+|+||+++.++. ++|+|||.+....... ..
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~--~kl~d~~~~~~~~~~~~~~ 158 (256)
T cd08221 81 ANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGL--IKLGDFGISKILGSEYSMA 158 (256)
T ss_pred cCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCC--EEECcCcceEEcccccccc
Confidence 9999999998764 46899999999999999999999999999999999999988777 9999999987654433 33
Q ss_pred CCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 176 KSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 176 ~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
....+++.|.|||.+.+..++.+ +|||||
T Consensus 159 ~~~~~~~~y~ape~~~~~~~~~~-~Dv~sl 187 (256)
T cd08221 159 ETVVGTPYYMSPELCQGVKYNFK-SDIWAL 187 (256)
T ss_pred cccCCCccccCHhhcCCCCCCCc-chhHHH
Confidence 44568899999999988877655 999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-34 Score=210.35 Aligned_cols=184 Identities=24% Similarity=0.334 Sum_probs=157.4
Q ss_pred ecCCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCccchHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEE
Q 028681 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (205)
Q Consensus 18 ~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~ 97 (205)
...++|++.++||+|++|.||++.... +..|++|.+.......+.+..|+.+++.++|+|++++++.+...+..++++|
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~-~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (261)
T cd05072 3 IPRESIKLVKKLGAGQFGEVWMGYYNN-STKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITE 81 (261)
T ss_pred CchHHeEEeeecCCcCCceEEEEEecC-CceEEEEEccCCchhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEe
Confidence 456899999999999999999998654 5679999887666566788999999999999999999999999999999999
Q ss_pred ecCCCchHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCCCC-
Q 028681 98 YASGGELFERICN--AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ- 174 (205)
Q Consensus 98 ~~~~~sl~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~- 174 (205)
++++++|.+.+.. ...++...+..++.|++.|+.|||+.+++|+||+|+||+++.++. ++|+|||++........
T Consensus 82 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~--~~l~dfg~~~~~~~~~~~ 159 (261)
T cd05072 82 YMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLM--CKIADFGLARVIEDNEYT 159 (261)
T ss_pred cCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCc--EEECCCccceecCCCcee
Confidence 9999999998865 345888999999999999999999999999999999999988877 99999999875533221
Q ss_pred -CCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 175 -PKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 175 -~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
.....++..|+|||.+....++.+ +|||||
T Consensus 160 ~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~sl 190 (261)
T cd05072 160 AREGAKFPIKWTAPEAINFGSFTIK-SDVWSF 190 (261)
T ss_pred ccCCCccceecCCHHHhccCCCChh-hhhhhh
Confidence 122345678999999988877755 999996
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-34 Score=221.88 Aligned_cols=193 Identities=25% Similarity=0.302 Sum_probs=158.0
Q ss_pred CCcccCceecCCCeEEEeeeccccceeEEEEEecCC-----CcEEEEEEeecCcc--chHHHHHHHHHHHhcC-CCCeeE
Q 028681 10 PGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKT-----EELVAVKYIERGDK--IDENVQREIINHRSLR-HPNIVR 81 (205)
Q Consensus 10 ~~~~~~~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~-----~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~-h~~i~~ 81 (205)
.+.+.....+.++|++.+.||+|+||.||.+.+... +..||+|.+..... ..+.+..|+.+++.+. ||||++
T Consensus 26 ~~~~~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~ 105 (400)
T cd05105 26 LPYDSRWEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVN 105 (400)
T ss_pred CCCCCceeccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeee
Confidence 344445666788999999999999999999987432 34699999875432 2456889999999996 999999
Q ss_pred EEEEEEeCCeEEEEEEecCCCchHHHHHhc--------------------------------------------------
Q 028681 82 FKEVILTPTHLAIVMEYASGGELFERICNA-------------------------------------------------- 111 (205)
Q Consensus 82 ~~~~~~~~~~~~lv~~~~~~~sl~~~~~~~-------------------------------------------------- 111 (205)
+++++......+++|||+++++|.+.+...
T Consensus 106 l~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 185 (400)
T cd05105 106 LLGACTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADT 185 (400)
T ss_pred EEEEEccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccc
Confidence 999999999999999999999998877532
Q ss_pred ----------------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCC
Q 028681 112 ----------------------------------------------GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKL 145 (205)
Q Consensus 112 ----------------------------------------------~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p 145 (205)
..+++..+..++.|++.|+.|||+.+++|+||+|
T Consensus 186 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp 265 (400)
T cd05105 186 TQYVPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAA 265 (400)
T ss_pred cccchhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCh
Confidence 1367788889999999999999999999999999
Q ss_pred CCeEecCCCCCcEEEeeecccccccCCCC---CCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 146 ENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 146 ~nili~~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
+||+++.++. ++|+|||+++....... .....++..|+|||.+.+..++.+ +|||||
T Consensus 266 ~Nill~~~~~--~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~DiwSl 325 (400)
T cd05105 266 RNVLLAQGKI--VKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTL-SDVWSY 325 (400)
T ss_pred HhEEEeCCCE--EEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCch-hhHHHH
Confidence 9999988776 99999999875433222 222346778999999988888765 999996
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-34 Score=236.81 Aligned_cols=190 Identities=35% Similarity=0.573 Sum_probs=157.8
Q ss_pred CceecCCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCc---cchHHHHHHHHHHHhcCCCCeeEEEEEEEeC--
Q 028681 15 PIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTP-- 89 (205)
Q Consensus 15 ~~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-- 89 (205)
+.....++|++.+.||.|+||.||++.+..++..+++|.+.... .....+..|+.+++.++||||++++++|...
T Consensus 7 ~ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~ 86 (1021)
T PTZ00266 7 DGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKAN 86 (1021)
T ss_pred CCccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCC
Confidence 33445689999999999999999999999999999999987542 2345688899999999999999999998654
Q ss_pred CeEEEEEEecCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhc-------CcEeecCCCCCeEecCC-----
Q 028681 90 THLAIVMEYASGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHSM-------QVCHRDLKLENTLLDGS----- 153 (205)
Q Consensus 90 ~~~~lv~~~~~~~sl~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lh~~-------~i~H~di~p~nili~~~----- 153 (205)
..+++||||+++++|.+.+.. ...+++..++.|+.||+.||.|||+. +|+|+||+|+|||++.+
T Consensus 87 ~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg 166 (1021)
T PTZ00266 87 QKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIG 166 (1021)
T ss_pred CEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccc
Confidence 578999999999999988864 34699999999999999999999985 49999999999999642
Q ss_pred ----------CCCcEEEeeecccccccCCCCCCCCCCCCCccCCceecc--CcCCCeeeEEEeC
Q 028681 154 ----------PAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLK--KEYDGKVMCVYVI 205 (205)
Q Consensus 154 ----------~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~--~~~~~~~~Dvwsl 205 (205)
+...++|+|||++.............+++.|+|||++.. ..++.+ +|||||
T Consensus 167 ~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~K-SDVWSL 229 (1021)
T PTZ00266 167 KITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDK-SDMWAL 229 (1021)
T ss_pred cccccccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCch-hHHHHH
Confidence 223489999999976654444455679999999999864 345544 999996
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-35 Score=234.02 Aligned_cols=187 Identities=27% Similarity=0.381 Sum_probs=162.9
Q ss_pred ceecCCCeEEEeeeccccceeEEEEEec-----CCCcEEEEEEeecCccc--hHHHHHHHHHHHhcCCCCeeEEEEEEEe
Q 028681 16 IMHDSDRYELVRDIGSGNFGVARLMRDK-----KTEELVAVKYIERGDKI--DENVQREIINHRSLRHPNIVRFKEVILT 88 (205)
Q Consensus 16 ~~~~~~~y~~~~~l~~g~~g~v~~~~~~-----~~~~~v~iK~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 88 (205)
......+-++.+.||+|+||+||++... +....||||.++..... ..+|++|++++..++|||||+++|+|..
T Consensus 481 ~~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~ 560 (774)
T KOG1026|consen 481 LEIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCRE 560 (774)
T ss_pred eEechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEcc
Confidence 3445677888999999999999999865 34578999999876543 5789999999999999999999999999
Q ss_pred CCeEEEEEEecCCCchHHHHHhc--------------CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCC
Q 028681 89 PTHLAIVMEYASGGELFERICNA--------------GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSP 154 (205)
Q Consensus 89 ~~~~~lv~~~~~~~sl~~~~~~~--------------~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~ 154 (205)
++..++|+|||..|+|.+++... ++++..+...|+.||+.|++||-++.++||||-.+|.++.++-
T Consensus 561 ~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVge~l 640 (774)
T KOG1026|consen 561 GDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVGENL 640 (774)
T ss_pred CCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceeccce
Confidence 99999999999999999999642 1388999999999999999999999999999999999998777
Q ss_pred CCcEEEeeecccccccCCCCCCCC---CCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 155 APRLKICDFGYSKSSVLHSQPKST---VGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 155 ~~~~~l~df~~~~~~~~~~~~~~~---~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
. |||+|||+++......-.... .-.++|||||.+..++++++ ||||||
T Consensus 641 ~--VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTte-SDVWs~ 691 (774)
T KOG1026|consen 641 V--VKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTE-SDVWSF 691 (774)
T ss_pred E--EEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccch-hhhhhh
Confidence 7 999999999876655443333 35689999999999999988 999996
|
|
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=209.73 Aligned_cols=183 Identities=31% Similarity=0.474 Sum_probs=155.4
Q ss_pred CCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCcc------chHHHHHHHHHHHhcCCCCeeEEEEEEEeC--Ce
Q 028681 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK------IDENVQREIINHRSLRHPNIVRFKEVILTP--TH 91 (205)
Q Consensus 20 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~ 91 (205)
+++|++.+.||+|++|.||.+.+..++..|++|.+..... ..+.+.+|+.+++.+.|+|++++++.+.+. ..
T Consensus 1 ~~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 80 (265)
T cd06652 1 PTNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERT 80 (265)
T ss_pred CCcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCce
Confidence 3689999999999999999999999999999998864321 124677899999999999999999988764 46
Q ss_pred EEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccC
Q 028681 92 LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 171 (205)
Q Consensus 92 ~~lv~~~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~ 171 (205)
+++++|++++++|.+.+.....+++..+..++.|++.||++||+++++|+||+|+||+++.++. ++|+|||.+.....
T Consensus 81 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~--~~l~Dfg~~~~~~~ 158 (265)
T cd06652 81 LSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGN--VKLGDFGASKRLQT 158 (265)
T ss_pred EEEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCC--EEECcCcccccccc
Confidence 7899999999999999877777899999999999999999999999999999999999988777 99999998865432
Q ss_pred C----CCCCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 172 H----SQPKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 172 ~----~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
. .......++..|+|||.+.+..++.+ +|||||
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~sl 195 (265)
T cd06652 159 ICLSGTGMKSVTGTPYWMSPEVISGEGYGRK-ADIWSV 195 (265)
T ss_pred ccccccccccCCCCccccChhhhcCCCCCcc-hhHHHH
Confidence 1 11223357889999999988877655 999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=211.05 Aligned_cols=184 Identities=32% Similarity=0.484 Sum_probs=164.5
Q ss_pred CCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCc---------cchHHHHHHHHHHHhc-CCCCeeEEEEEEEeC
Q 028681 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---------KIDENVQREIINHRSL-RHPNIVRFKEVILTP 89 (205)
Q Consensus 20 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~---------~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~ 89 (205)
..+|.-.+.||.|..+.|.++.++.++..+++|++.... ...++...|+.+|+++ .||+|+++.++++.+
T Consensus 16 y~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~ 95 (411)
T KOG0599|consen 16 YAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESD 95 (411)
T ss_pred HhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCc
Confidence 567888999999999999999999999999999986421 1235567899999998 599999999999999
Q ss_pred CeEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccc
Q 028681 90 THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 169 (205)
Q Consensus 90 ~~~~lv~~~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~ 169 (205)
..+++|+|.++.|.|-+.+.....++++..+.|++|++.+++|||.++|+|+|+||+||+++++.+ ++|.|||+++..
T Consensus 96 sF~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~--i~isDFGFa~~l 173 (411)
T KOG0599|consen 96 AFVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMN--IKISDFGFACQL 173 (411)
T ss_pred chhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccc--eEEeccceeecc
Confidence 999999999999999999998889999999999999999999999999999999999999998887 999999999999
Q ss_pred cCCCCCCCCCCCCCccCCceeccCcC-----CCeeeEEEeC
Q 028681 170 VLHSQPKSTVGTPAYIAPEVLLKKEY-----DGKVMCVYVI 205 (205)
Q Consensus 170 ~~~~~~~~~~~~~~~~aPE~~~~~~~-----~~~~~Dvwsl 205 (205)
.++......+||+.|+|||.+....+ .++..|.||.
T Consensus 174 ~~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~ 214 (411)
T KOG0599|consen 174 EPGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWAC 214 (411)
T ss_pred CCchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHH
Confidence 99999899999999999999974322 2456899973
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-35 Score=229.76 Aligned_cols=184 Identities=31% Similarity=0.407 Sum_probs=160.9
Q ss_pred CCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecC--ccchHHHHHHHHHHHhcCCCCeeEEEEEEEeCC------eE
Q 028681 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG--DKIDENVQREIINHRSLRHPNIVRFKEVILTPT------HL 92 (205)
Q Consensus 21 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~------~~ 92 (205)
..+...+.||+|+||.||+++++.+|+.||+|.+++. ....+.--.|+++++++.|+|||+++++=+... ..
T Consensus 13 y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~ 92 (732)
T KOG4250|consen 13 YLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLP 92 (732)
T ss_pred cceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccc
Confidence 6678899999999999999999999999999999874 344567778999999999999999988765433 46
Q ss_pred EEEEEecCCCchHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecC--CCCCcEEEeeecccc
Q 028681 93 AIVMEYASGGELFERICNAG---RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDG--SPAPRLKICDFGYSK 167 (205)
Q Consensus 93 ~lv~~~~~~~sl~~~~~~~~---~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~--~~~~~~~l~df~~~~ 167 (205)
.++||||++|+|...+.+.. .+++.+++.++..+..|+.|||++||+||||||.||++.. ++...-||+|||.|+
T Consensus 93 vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Ar 172 (732)
T KOG4250|consen 93 VLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAAR 172 (732)
T ss_pred eEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeecccccc
Confidence 79999999999999997643 4999999999999999999999999999999999999854 345568999999999
Q ss_pred cccCCCCCCCCCCCCCccCCceecc-CcCCCeeeEEEeC
Q 028681 168 SSVLHSQPKSTVGTPAYIAPEVLLK-KEYDGKVMCVYVI 205 (205)
Q Consensus 168 ~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~~Dvwsl 205 (205)
....+....+..||..|.+||.+.+ +.|+ ...|.|||
T Consensus 173 el~d~s~~~S~vGT~~YLhPel~E~q~~y~-~tVDLWS~ 210 (732)
T KOG4250|consen 173 ELDDNSLFTSLVGTEEYLHPELYERQKKYT-ATVDLWSF 210 (732)
T ss_pred cCCCCCeeeeecCchhhcChHHHhhccCcC-ceeehhhh
Confidence 8888888888899999999999997 5555 55999997
|
|
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=209.66 Aligned_cols=183 Identities=24% Similarity=0.305 Sum_probs=156.9
Q ss_pred cCCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCccchHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEEe
Q 028681 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (205)
Q Consensus 19 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~ 98 (205)
..++|++.+.||+|++|.||.+.... +..|++|.+.......+.+.+|+.++++++|+|++++++++...+..++++|+
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~~-~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 82 (261)
T cd05068 4 DRTSIQLLRKLGAGQFGEVWEGLWNN-TTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTEL 82 (261)
T ss_pred chhheeeEEEecccCCccEEEEEecC-CeEEEEEeeCCCcccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeec
Confidence 45789999999999999999998765 56799999887665567788999999999999999999999999999999999
Q ss_pred cCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCCCCCC
Q 028681 99 ASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK 176 (205)
Q Consensus 99 ~~~~sl~~~~~~~~--~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~~~ 176 (205)
+++++|.+.+.... .+++..+..++.|++.|+.+||+.|++|+||+|+||+++.++. ++|+|||++..........
T Consensus 83 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~--~~l~dfg~~~~~~~~~~~~ 160 (261)
T cd05068 83 MKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNI--CKVADFGLARVIKEDIYEA 160 (261)
T ss_pred ccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCC--EEECCcceEEEccCCcccc
Confidence 99999999986643 6899999999999999999999999999999999999998877 9999999987654322211
Q ss_pred C--CCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 177 S--TVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 177 ~--~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
. ...+..|+|||.+.+..++.+ +|||||
T Consensus 161 ~~~~~~~~~y~aPE~~~~~~~~~~-~Di~sl 190 (261)
T cd05068 161 REGAKFPIKWTAPEAALYNRFSIK-SDVWSF 190 (261)
T ss_pred cCCCcCceeccCccccccCCCCch-hhHHHH
Confidence 1 123457999999988888766 999996
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=212.94 Aligned_cols=188 Identities=28% Similarity=0.474 Sum_probs=162.9
Q ss_pred cCceecCCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCcc-chHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeE
Q 028681 14 MPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK-IDENVQREIINHRSLRHPNIVRFKEVILTPTHL 92 (205)
Q Consensus 14 ~~~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 92 (205)
+.+.....+|++.+.||+|++|.||++.+..++..+++|.+..... ..+.+..|+.+++.+.|+|++++.+.+..+...
T Consensus 13 ~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~ 92 (296)
T cd06654 13 VSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDEL 92 (296)
T ss_pred cccCCcccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEE
Confidence 4556667899999999999999999999998999999998876443 346678899999999999999999999999999
Q ss_pred EEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCC
Q 028681 93 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 172 (205)
Q Consensus 93 ~lv~~~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~ 172 (205)
++++||+++++|.+++.. ..+++.++..++.|++.|+.+||+.|++|+||+|+||+++.++. ++|+|||++......
T Consensus 93 ~lv~e~~~~~~L~~~~~~-~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~--~kl~dfg~~~~~~~~ 169 (296)
T cd06654 93 WVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGS--VKLTDFGFCAQITPE 169 (296)
T ss_pred EEeecccCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCC--EEECccccchhcccc
Confidence 999999999999998854 46899999999999999999999999999999999999988776 999999988755433
Q ss_pred CC-CCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 173 SQ-PKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 173 ~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
.. .....+++.|+|||.+.+..++.+ +|||||
T Consensus 170 ~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~s~ 202 (296)
T cd06654 170 QSKRSTMVGTPYWMAPEVVTRKAYGPK-VDIWSL 202 (296)
T ss_pred ccccCcccCCccccCHHHHcCCCCCcc-chHHHH
Confidence 22 233468889999999988877755 999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=214.42 Aligned_cols=184 Identities=28% Similarity=0.468 Sum_probs=155.1
Q ss_pred cCCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCcc--chHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEE
Q 028681 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (205)
Q Consensus 19 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 96 (205)
..++|++.+.||.|++|.||.+.+..++..|++|.+..... ....+..|+.+++.++|+||+++++++..++..++++
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~ 83 (301)
T cd07873 4 KLETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVF 83 (301)
T ss_pred cccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEE
Confidence 46889999999999999999999999999999999875432 2346778999999999999999999999999999999
Q ss_pred EecCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCCC-C
Q 028681 97 EYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-Q 174 (205)
Q Consensus 97 ~~~~~~sl~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~~-~ 174 (205)
||+++ +|.+.+.. ...+++..+..++.|++.||.+||+.+++|+||+|+||+++.++. ++|+|||++....... .
T Consensus 84 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~--~kl~dfg~~~~~~~~~~~ 160 (301)
T cd07873 84 EYLDK-DLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGE--LKLADFGLARAKSIPTKT 160 (301)
T ss_pred ecccc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCc--EEECcCcchhccCCCCCc
Confidence 99974 78777755 446899999999999999999999999999999999999988877 9999999986543222 2
Q ss_pred CCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 175 PKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 175 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
.....++..|+|||.+.+....+.++|||||
T Consensus 161 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~sl 191 (301)
T cd07873 161 YSNEVVTLWYRPPDILLGSTDYSTQIDMWGV 191 (301)
T ss_pred ccccceeecccCcHHHhCCCCCccHHHHHHH
Confidence 2234568899999998765433345999986
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=230.39 Aligned_cols=186 Identities=28% Similarity=0.437 Sum_probs=153.9
Q ss_pred eecCCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecC-ccchHHHHHHHHHHHhcC-CCCeeEEEEEEEe----C-
Q 028681 17 MHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG-DKIDENVQREIINHRSLR-HPNIVRFKEVILT----P- 89 (205)
Q Consensus 17 ~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~-~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~----~- 89 (205)
..-..++++.+.|.+|||+.||+|.+...+..||+|++... +...+.+.+|+.+++.|+ |+|||.+++.... +
T Consensus 33 ~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~ 112 (738)
T KOG1989|consen 33 TVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNN 112 (738)
T ss_pred EECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCC
Confidence 33467889999999999999999999998899999987654 344578899999999997 9999999994321 1
Q ss_pred --CeEEEEEEecCCCchHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhcC--cEeecCCCCCeEecCCCCCcEEEeee
Q 028681 90 --THLAIVMEYASGGELFERICN--AGRFSEDEARFFFQQLISGVSYCHSMQ--VCHRDLKLENTLLDGSPAPRLKICDF 163 (205)
Q Consensus 90 --~~~~lv~~~~~~~sl~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lh~~~--i~H~di~p~nili~~~~~~~~~l~df 163 (205)
-.++++||||.+++|.+++.+ ...|++.+++.|+++++.|+.+||.++ |||||||-+|||++.++. .|||||
T Consensus 113 ~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~--~KLCDF 190 (738)
T KOG1989|consen 113 GVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGN--YKLCDF 190 (738)
T ss_pred ceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCC--EEeCcc
Confidence 247799999999999999974 345999999999999999999999887 999999999999998887 999999
Q ss_pred cccccccCCCCCCC----------CCCCCCccCCceec---cCcCCCeeeEEEeC
Q 028681 164 GYSKSSVLHSQPKS----------TVGTPAYIAPEVLL---KKEYDGKVMCVYVI 205 (205)
Q Consensus 164 ~~~~~~~~~~~~~~----------~~~~~~~~aPE~~~---~~~~~~~~~Dvwsl 205 (205)
|.++..-....... ...|+.|.|||.+. +.+.+.| +|||+|
T Consensus 191 GSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eK-sDIWAL 244 (738)
T KOG1989|consen 191 GSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEK-SDIWAL 244 (738)
T ss_pred cccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcch-hHHHHH
Confidence 99864433321111 13799999999985 5566766 999986
|
|
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=210.30 Aligned_cols=182 Identities=27% Similarity=0.429 Sum_probs=156.4
Q ss_pred CCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCc----cchHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEE
Q 028681 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (205)
Q Consensus 21 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 96 (205)
++|++.+.||+|++|.||.+.+..++..|++|.+.... .....+.+|+.+++.++|||++++++++...+..++++
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 68999999999999999999999999999999876432 22345788999999999999999999999999999999
Q ss_pred EecCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCC
Q 028681 97 EYASGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 172 (205)
Q Consensus 97 ~~~~~~sl~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~ 172 (205)
|++++++|.+++.. ...+++..+..++.|++.|+.|||+++++|+||+|+||+++.++. ++|+|||.+......
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~--~~l~d~g~~~~~~~~ 159 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGV--VKLGDLGLGRFFSSK 159 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCC--EEECccccceeccch
Confidence 99999999887753 345889999999999999999999999999999999999988777 999999988765433
Q ss_pred CC-CCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 173 SQ-PKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 173 ~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
.. .....++..|+|||.+.+..++.+ +|+|||
T Consensus 160 ~~~~~~~~~~~~~~aPE~~~~~~~~~~-~Di~sl 192 (267)
T cd08228 160 TTAAHSLVGTPYYMSPERIHENGYNFK-SDIWSL 192 (267)
T ss_pred hHHHhcCCCCccccChhhhccCCCCch-hhHHHH
Confidence 22 223457889999999988877755 999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-34 Score=210.70 Aligned_cols=182 Identities=24% Similarity=0.375 Sum_probs=155.1
Q ss_pred CCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCccchHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEEec
Q 028681 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA 99 (205)
Q Consensus 20 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~~ 99 (205)
..+|++.+.||+|++|.||.+.+.. +..+++|.+.......+.+..|+.+++.++|+|++++++++...+..++++|++
T Consensus 3 ~~~~~~~~~lg~G~~~~v~~~~~~~-~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (256)
T cd05059 3 PSELTFLKELGSGQFGVVHLGKWRG-KIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYM 81 (256)
T ss_pred hHHcchhhhhccCCCceEEEeEecC-CccEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecC
Confidence 4679999999999999999998764 567999988766555677888999999999999999999999999999999999
Q ss_pred CCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCCCCC--C
Q 028681 100 SGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP--K 176 (205)
Q Consensus 100 ~~~sl~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~~--~ 176 (205)
++++|.+.+.. ...+++..+..++.|++.|+.+||+.|++|+||+|+||+++.++. ++|+|||.++........ .
T Consensus 82 ~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~--~kl~dfg~~~~~~~~~~~~~~ 159 (256)
T cd05059 82 ANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNV--VKVSDFGLARYVLDDQYTSSQ 159 (256)
T ss_pred CCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCc--EEECCcccceecccccccccC
Confidence 99999998865 346899999999999999999999999999999999999998877 999999988654322111 1
Q ss_pred CCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 177 STVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 177 ~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
...++..|+|||.+.+..++.+ +|||||
T Consensus 160 ~~~~~~~y~~Pe~~~~~~~~~~-~Di~sl 187 (256)
T cd05059 160 GTKFPVKWAPPEVFDYSRFSSK-SDVWSF 187 (256)
T ss_pred CCCCCccccCHHHhccCCCCch-hhHHHH
Confidence 1123467999999998888765 999986
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=209.42 Aligned_cols=183 Identities=26% Similarity=0.410 Sum_probs=155.8
Q ss_pred cCCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCccchHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEEe
Q 028681 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (205)
Q Consensus 19 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~ 98 (205)
+.++|++.+.||+|++|.||.+.... +..+++|.+.......+.+.+|+.+++.++|||++++++++......+++|||
T Consensus 2 ~~~~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd05113 2 DPKDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEY 80 (256)
T ss_pred ChHHeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCcccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEc
Confidence 45789999999999999999998764 44699998886655567789999999999999999999999998999999999
Q ss_pred cCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCCCCC--
Q 028681 99 ASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP-- 175 (205)
Q Consensus 99 ~~~~sl~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~~-- 175 (205)
+.+++|.+.+... ..+++..+..++.|++.|+.+||+.|++|+||+|+||+++.++. ++|+|||.+.........
T Consensus 81 ~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~--~kl~d~g~~~~~~~~~~~~~ 158 (256)
T cd05113 81 MSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGC--VKVSDFGLSRYVLDDEYTSS 158 (256)
T ss_pred CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCC--EEECCCccceecCCCceeec
Confidence 9999999988663 46899999999999999999999999999999999999988776 999999988654322211
Q ss_pred CCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 176 KSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 176 ~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
....++..|+|||.+.+..++.+ +|||||
T Consensus 159 ~~~~~~~~y~~pe~~~~~~~~~~-~Di~sl 187 (256)
T cd05113 159 VGSKFPVRWSPPEVLLYSKFSSK-SDVWAF 187 (256)
T ss_pred CCCccChhhCCHHHHhcCcccch-hHHHHH
Confidence 12235677999999988887765 999996
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-34 Score=213.51 Aligned_cols=183 Identities=21% Similarity=0.356 Sum_probs=154.9
Q ss_pred CCCeEEEeeeccccceeEEEEEecCCC-----cEEEEEEeecCcc--chHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeE
Q 028681 20 SDRYELVRDIGSGNFGVARLMRDKKTE-----ELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHL 92 (205)
Q Consensus 20 ~~~y~~~~~l~~g~~g~v~~~~~~~~~-----~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 92 (205)
.++|++.+.||+|++|.||.+.....+ ..+++|.+..... ....+.+|+..++.++|+|++++++++......
T Consensus 4 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T cd05048 4 LSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPT 83 (283)
T ss_pred hHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCce
Confidence 468999999999999999999876554 6799998865432 235688999999999999999999999999999
Q ss_pred EEEEEecCCCchHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCC
Q 028681 93 AIVMEYASGGELFERICNA----------------GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAP 156 (205)
Q Consensus 93 ~lv~~~~~~~sl~~~~~~~----------------~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~ 156 (205)
++++||+++++|.+.+... ..++...+..++.|++.||.+||+.+++|+||+|+||++++++.
T Consensus 84 ~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~~~~- 162 (283)
T cd05048 84 CMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLT- 162 (283)
T ss_pred EEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcCCCc-
Confidence 9999999999999988654 34788899999999999999999999999999999999988776
Q ss_pred cEEEeeecccccccCCC---CCCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 157 RLKICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 157 ~~~l~df~~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
++|+|||++....... ......+++.|+|||.+.+..++.+ +|||||
T Consensus 163 -~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-sDv~sl 212 (283)
T cd05048 163 -VKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTE-SDIWSF 212 (283)
T ss_pred -EEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchh-hhHHHH
Confidence 9999999987543322 1223346788999999988888766 999996
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-34 Score=216.05 Aligned_cols=183 Identities=21% Similarity=0.309 Sum_probs=152.5
Q ss_pred cCCCeEEEeeeccccceeEEEEEecCCCc----EEEEEEeecCc--cchHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeE
Q 028681 19 DSDRYELVRDIGSGNFGVARLMRDKKTEE----LVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHL 92 (205)
Q Consensus 19 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~----~v~iK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 92 (205)
...+|++.+.||+|+||.||++.+..++. .|++|.+.... ...+.+..|+.+++.++|+|++++++++..+ ..
T Consensus 5 ~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~ 83 (316)
T cd05108 5 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TV 83 (316)
T ss_pred chhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cc
Confidence 35789999999999999999998765554 48999886532 2346788899999999999999999998765 56
Q ss_pred EEEEEecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccC
Q 028681 93 AIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 171 (205)
Q Consensus 93 ~lv~~~~~~~sl~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~ 171 (205)
+++++++++++|.+.+... ..++...+..++.|++.||+|||+++++|+||+|+||+++.++. ++|+|||+++....
T Consensus 84 ~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~--~kl~DfG~a~~~~~ 161 (316)
T cd05108 84 QLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQH--VKITDFGLAKLLGA 161 (316)
T ss_pred eeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCc--EEEccccccccccC
Confidence 7899999999999988764 35889999999999999999999999999999999999988777 99999999976544
Q ss_pred CCCCC---CCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 172 HSQPK---STVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 172 ~~~~~---~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
..... ....+..|+|||.+.+..++.+ +|||||
T Consensus 162 ~~~~~~~~~~~~~~~y~apE~~~~~~~~~~-~Di~sl 197 (316)
T cd05108 162 DEKEYHAEGGKVPIKWMALESILHRIYTHQ-SDVWSY 197 (316)
T ss_pred CCcceeccCCccceeecChHHhccCCCCch-hhhHHH
Confidence 33221 1234568999999998888766 999996
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=213.76 Aligned_cols=183 Identities=25% Similarity=0.299 Sum_probs=151.1
Q ss_pred CCCeEEEeeeccccceeEEEEEecCCCc--EEEEEEeecCc--cchHHHHHHHHHHHhc-CCCCeeEEEEEEEeCCeEEE
Q 028681 20 SDRYELVRDIGSGNFGVARLMRDKKTEE--LVAVKYIERGD--KIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAI 94 (205)
Q Consensus 20 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~--~v~iK~~~~~~--~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~l 94 (205)
.++|++.+.||+|++|.||.+....++. .+++|.++... ...+.+..|+..++++ +|||++++++++...+..++
T Consensus 1 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l 80 (297)
T cd05089 1 WEDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYI 80 (297)
T ss_pred CccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceE
Confidence 3789999999999999999999877654 46888776422 2235688899999999 79999999999999999999
Q ss_pred EEEecCCCchHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcE
Q 028681 95 VMEYASGGELFERICNAG----------------RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRL 158 (205)
Q Consensus 95 v~~~~~~~sl~~~~~~~~----------------~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~ 158 (205)
++||+++++|.+.+.... .+++..+..++.|++.|+++||++|++|+||+|+||+++.+.. +
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~--~ 158 (297)
T cd05089 81 AIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLA--S 158 (297)
T ss_pred EEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCCe--E
Confidence 999999999999986532 4788999999999999999999999999999999999988776 9
Q ss_pred EEeeecccccccCCCCCCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 159 KICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 159 ~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
+|+|||++..............+..|+|||.+.+..++.+ +|||||
T Consensus 159 kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~DvwSl 204 (297)
T cd05089 159 KIADFGLSRGEEVYVKKTMGRLPVRWMAIESLNYSVYTTK-SDVWSF 204 (297)
T ss_pred EECCcCCCccccceeccCCCCcCccccCchhhccCCCCch-hhHHHH
Confidence 9999998864322222222234567999999988888765 999996
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=210.70 Aligned_cols=183 Identities=28% Similarity=0.435 Sum_probs=151.9
Q ss_pred cCCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCccc--hHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEE
Q 028681 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI--DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (205)
Q Consensus 19 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 96 (205)
..++|++.+.||+|++|.||.+.+..++..|++|.+...... ...+.+|+..++.++|+|++++.+++..+...++++
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 357899999999999999999999998999999998754322 245678999999999999999999999999999999
Q ss_pred EecCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCCC-C
Q 028681 97 EYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-Q 174 (205)
Q Consensus 97 ~~~~~~sl~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~~-~ 174 (205)
|++. +++.+.+.. ...+++..+..++.|++.||.+||+.+++|+||+|+||+++.++. ++|+|||+++...... .
T Consensus 83 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~--~~l~Dfg~~~~~~~~~~~ 159 (291)
T cd07870 83 EYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGE--LKLADFGLARAKSIPSQT 159 (291)
T ss_pred eccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCc--EEEeccccccccCCCCCC
Confidence 9996 466655543 446888999999999999999999999999999999999988777 9999999886543222 2
Q ss_pred CCCCCCCCCccCCceeccCc-CCCeeeEEEeC
Q 028681 175 PKSTVGTPAYIAPEVLLKKE-YDGKVMCVYVI 205 (205)
Q Consensus 175 ~~~~~~~~~~~aPE~~~~~~-~~~~~~Dvwsl 205 (205)
.....+++.|+|||.+.+.. ++. ++|||||
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~-~~Dv~sl 190 (291)
T cd07870 160 YSSEVVTLWYRPPDVLLGATDYSS-ALDIWGA 190 (291)
T ss_pred CCCccccccccCCceeecCCCCCc-HHHHHHH
Confidence 23335788999999997654 454 4999996
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=212.29 Aligned_cols=184 Identities=26% Similarity=0.377 Sum_probs=156.0
Q ss_pred cCCCeEEEeeeccccceeEEEEEecCCC----------------cEEEEEEeecCc--cchHHHHHHHHHHHhcCCCCee
Q 028681 19 DSDRYELVRDIGSGNFGVARLMRDKKTE----------------ELVAVKYIERGD--KIDENVQREIINHRSLRHPNIV 80 (205)
Q Consensus 19 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~----------------~~v~iK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~ 80 (205)
..++|++.+.||+|+||.||.+.+...+ ..|++|.+.... ...+.+..|+.+++.++|+|++
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~ 82 (296)
T cd05051 3 PRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIA 82 (296)
T ss_pred chhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEe
Confidence 3578999999999999999998876533 568999887643 2346688899999999999999
Q ss_pred EEEEEEEeCCeEEEEEEecCCCchHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeE
Q 028681 81 RFKEVILTPTHLAIVMEYASGGELFERICNAG-----------RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTL 149 (205)
Q Consensus 81 ~~~~~~~~~~~~~lv~~~~~~~sl~~~~~~~~-----------~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nil 149 (205)
++++++..+...++++|++++++|.+.+.... .+++..+..++.|++.||.+||+.+++|+||+|+||+
T Consensus 83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~Nil 162 (296)
T cd05051 83 RLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCL 162 (296)
T ss_pred EEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhcee
Confidence 99999999999999999999999999987655 6899999999999999999999999999999999999
Q ss_pred ecCCCCCcEEEeeecccccccCCCC---CCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 150 LDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 150 i~~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
++.++. ++|+|||.+........ .....+++.|+|||.+.+..++.+ +|||||
T Consensus 163 i~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~sl 218 (296)
T cd05051 163 VGKNYT--IKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTK-SDVWAF 218 (296)
T ss_pred ecCCCc--eEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCcc-chhhhh
Confidence 988876 99999999865433221 223346778999999988777755 999996
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-35 Score=226.30 Aligned_cols=188 Identities=27% Similarity=0.421 Sum_probs=160.1
Q ss_pred cCceecCCCe-EEEeeeccccceeEEEEEecCCCcEEEEEEeec-----CccchHHHHHHHHHHHhcCCCCeeEEEEEEE
Q 028681 14 MPIMHDSDRY-ELVRDIGSGNFGVARLMRDKKTEELVAVKYIER-----GDKIDENVQREIINHRSLRHPNIVRFKEVIL 87 (205)
Q Consensus 14 ~~~~~~~~~y-~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~-----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 87 (205)
.-.....++| +....||+|+|.+||++.+..+|..||.--++. .+...+++.+|+.+|+.|+|+||++++.+|.
T Consensus 32 ~ve~~p~gRy~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~ 111 (632)
T KOG0584|consen 32 FVEKDPTGRYLKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWV 111 (632)
T ss_pred ccccCCCCceeehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeehee
Confidence 3344455667 678999999999999999999998888655543 2334478999999999999999999999999
Q ss_pred eCCe--EEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhc--CcEeecCCCCCeEecCCCCCcEEEeee
Q 028681 88 TPTH--LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM--QVCHRDLKLENTLLDGSPAPRLKICDF 163 (205)
Q Consensus 88 ~~~~--~~lv~~~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~--~i~H~di~p~nili~~~~~~~~~l~df 163 (205)
+... ..+|+|.+.+|+|..++++.+..+.+.++.|++||++||.|||.+ .|+|||||.+||||+.+. +.|||+|+
T Consensus 112 d~~n~~in~iTEL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~-G~VKIGDL 190 (632)
T KOG0584|consen 112 DTDNKTINFITELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNL-GEVKIGDL 190 (632)
T ss_pred cCCCceeeeeeecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCc-Cceeecch
Confidence 8754 889999999999999999999999999999999999999999987 699999999999997543 35999999
Q ss_pred cccccccCCCCCCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 164 GYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
|+|+....... .+..||+.|||||.+. ..|+.. +|||||
T Consensus 191 GLAtl~r~s~a-ksvIGTPEFMAPEmYE-E~YnE~-VDVYaF 229 (632)
T KOG0584|consen 191 GLATLLRKSHA-KSVIGTPEFMAPEMYE-ENYNEL-VDVYAF 229 (632)
T ss_pred hHHHHhhcccc-ceeccCccccChHHHh-hhcchh-hhhhhh
Confidence 99976543333 3378999999999997 777767 999997
|
|
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=210.94 Aligned_cols=184 Identities=20% Similarity=0.304 Sum_probs=153.0
Q ss_pred cCCCeEEEeeeccccceeEEEEEe----cCCCcEEEEEEeecCccc--hHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeE
Q 028681 19 DSDRYELVRDIGSGNFGVARLMRD----KKTEELVAVKYIERGDKI--DENVQREIINHRSLRHPNIVRFKEVILTPTHL 92 (205)
Q Consensus 19 ~~~~y~~~~~l~~g~~g~v~~~~~----~~~~~~v~iK~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 92 (205)
+.++|++.+.||+|+||.||++.. ...+..+++|.+...... ...+..|+.+++.++|+|++++++++..+...
T Consensus 3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 82 (283)
T cd05090 3 PLSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPV 82 (283)
T ss_pred ChhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCce
Confidence 357899999999999999999985 345678999988753322 25678899999999999999999999999999
Q ss_pred EEEEEecCCCchHHHHHhc-----------------CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCC
Q 028681 93 AIVMEYASGGELFERICNA-----------------GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPA 155 (205)
Q Consensus 93 ~lv~~~~~~~sl~~~~~~~-----------------~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~ 155 (205)
+++|||+++++|.+++... ..+++..+..++.|++.|+.|||+++++|+||+|+||+++.++.
T Consensus 83 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~~~~ 162 (283)
T cd05090 83 CMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLH 162 (283)
T ss_pred EEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcCCCc
Confidence 9999999999999988532 23778889999999999999999999999999999999988776
Q ss_pred CcEEEeeecccccccCCCC---CCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 156 PRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 156 ~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
++|+|||+++....... .....++..|+|||++.+..++.+ +|||||
T Consensus 163 --~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~sl 212 (283)
T cd05090 163 --VKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSD-SDIWSF 212 (283)
T ss_pred --EEeccccccccccCCcceecccCCCccceecChHHhccCCCCch-hhhHHH
Confidence 99999999875433221 222335677999999988877755 999996
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=212.80 Aligned_cols=188 Identities=29% Similarity=0.474 Sum_probs=162.9
Q ss_pred cCceecCCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCcc-chHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeE
Q 028681 14 MPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK-IDENVQREIINHRSLRHPNIVRFKEVILTPTHL 92 (205)
Q Consensus 14 ~~~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 92 (205)
+.......+|++.+.||+|++|.||++.+..++..|++|.+..... ..+.+..|+.+++.+.|+|++++++.+..++..
T Consensus 12 ~~~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~ 91 (297)
T cd06656 12 VSVGDPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDEL 91 (297)
T ss_pred cccCChhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEE
Confidence 3456667999999999999999999999998999999999876443 345678899999999999999999999999999
Q ss_pred EEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCC
Q 028681 93 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 172 (205)
Q Consensus 93 ~lv~~~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~ 172 (205)
++++||+++++|.+.+.. ..+++..+..++.|++.|+.+||+.|++|+||+|+||+++.++. ++|+|||++......
T Consensus 92 ~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~--~~l~Dfg~~~~~~~~ 168 (297)
T cd06656 92 WVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGS--VKLTDFGFCAQITPE 168 (297)
T ss_pred EEeecccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCC--EEECcCccceEccCC
Confidence 999999999999998854 56899999999999999999999999999999999999988777 999999988765443
Q ss_pred CC-CCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 173 SQ-PKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 173 ~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
.. .....+++.|+|||.+.+..++.+ +|+|||
T Consensus 169 ~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~sl 201 (297)
T cd06656 169 QSKRSTMVGTPYWMAPEVVTRKAYGPK-VDIWSL 201 (297)
T ss_pred ccCcCcccCCccccCHHHHcCCCCCcH-HHHHHH
Confidence 32 233467889999999998888755 999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=225.45 Aligned_cols=182 Identities=26% Similarity=0.403 Sum_probs=150.3
Q ss_pred CCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCccchHHHHHHHHHHHhcCC------CCeeEEEEEEEeC-CeE
Q 028681 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRH------PNIVRFKEVILTP-THL 92 (205)
Q Consensus 20 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h------~~i~~~~~~~~~~-~~~ 92 (205)
.++|++.+.||+|+||+||++.+..++..||+|++............|+.+++.++| .+++++++++..+ ..+
T Consensus 128 ~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~~ 207 (467)
T PTZ00284 128 TQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGHM 207 (467)
T ss_pred CCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCceE
Confidence 478999999999999999999999999999999997654444556667777777654 4588898888765 478
Q ss_pred EEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-cCcEeecCCCCCeEecCCCC--------------Cc
Q 028681 93 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS-MQVCHRDLKLENTLLDGSPA--------------PR 157 (205)
Q Consensus 93 ~lv~~~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~-~~i~H~di~p~nili~~~~~--------------~~ 157 (205)
+++++++ +++|.+.+.+.+.+++..+..++.|++.||.|||+ .||+||||||+||+++.++. ..
T Consensus 208 ~iv~~~~-g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~~~~~ 286 (467)
T PTZ00284 208 CIVMPKY-GPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCR 286 (467)
T ss_pred EEEEecc-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccccCCCCce
Confidence 8999987 56888888777889999999999999999999997 69999999999999976542 14
Q ss_pred EEEeeecccccccCCCCCCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 158 LKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 158 ~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
+||+|||.+.... .......|++.|+|||++.+..++.+ +|||||
T Consensus 287 vkl~DfG~~~~~~--~~~~~~~gt~~Y~APE~~~~~~~~~~-~DiwSl 331 (467)
T PTZ00284 287 VRICDLGGCCDER--HSRTAIVSTRHYRSPEVVLGLGWMYS-TDMWSM 331 (467)
T ss_pred EEECCCCccccCc--cccccccCCccccCcHHhhcCCCCcH-HHHHHH
Confidence 8999999875322 22334578999999999999888866 999996
|
|
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-33 Score=210.86 Aligned_cols=187 Identities=30% Similarity=0.488 Sum_probs=161.7
Q ss_pred CceecCCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCcc-chHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEE
Q 028681 15 PIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLA 93 (205)
Q Consensus 15 ~~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 93 (205)
..+....+|++.+.||.|++|.||.+.+..+++.|++|.+..... ..+.+.+|+..++.++|+|++++++.+..+...+
T Consensus 13 ~~~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 92 (296)
T cd06655 13 SIGDPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELF 92 (296)
T ss_pred hcCCCcceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEE
Confidence 344456789999999999999999999999999999998875433 3466788999999999999999999999999999
Q ss_pred EEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCCC
Q 028681 94 IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 173 (205)
Q Consensus 94 lv~~~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~~ 173 (205)
+++||+++++|.+.+.. ..+++.++..++.|++.|+++||+.|++|+||+|+||+++.++. ++|+|||++.......
T Consensus 93 lv~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~--~kl~dfg~~~~~~~~~ 169 (296)
T cd06655 93 VVMEYLAGGSLTDVVTE-TCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGS--VKLTDFGFCAQITPEQ 169 (296)
T ss_pred EEEEecCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCC--EEEccCccchhccccc
Confidence 99999999999988854 46899999999999999999999999999999999999988777 9999999887654433
Q ss_pred C-CCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 174 Q-PKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 174 ~-~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
. .....++..|+|||.+.+..++.+ +|||||
T Consensus 170 ~~~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~sl 201 (296)
T cd06655 170 SKRSTMVGTPYWMAPEVVTRKAYGPK-VDIWSL 201 (296)
T ss_pred ccCCCcCCCccccCcchhcCCCCCch-hhHHHH
Confidence 2 233468889999999988887765 999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-33 Score=211.27 Aligned_cols=182 Identities=31% Similarity=0.504 Sum_probs=156.9
Q ss_pred CCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCcc----chHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEE
Q 028681 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK----IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (205)
Q Consensus 21 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 96 (205)
++|++.+.|++|++|.||++.+..+++.|++|.+..... ..+.+..|+.+++.++|+|++++++.+..++..++++
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 479999999999999999999999999999999876532 2345778999999999999999999999999999999
Q ss_pred EecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCCC---
Q 028681 97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS--- 173 (205)
Q Consensus 97 ~~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~~--- 173 (205)
|++++++|.+.+...+.+++..+..++.|++.|+.|||+.+++|+||+|+||+++.++. ++|+|||+++......
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~--~~l~dfg~~~~~~~~~~~~ 158 (305)
T cd05609 81 EYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGH--IKLTDFGLSKIGLMSLTTN 158 (305)
T ss_pred ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCC--EEEeeCCCccccCcCcccc
Confidence 99999999999988788999999999999999999999999999999999999988777 9999999886321110
Q ss_pred -------------CCCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 174 -------------QPKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 174 -------------~~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
......++..|+|||.+.+..++.+ +|+|||
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~sl 202 (305)
T cd05609 159 LYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKP-VDWWAM 202 (305)
T ss_pred ccccccccchhhccccCCccCccccCchhccCCCCCch-hhHHHH
Confidence 0112246778999999988887755 999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-34 Score=219.26 Aligned_cols=181 Identities=25% Similarity=0.428 Sum_probs=150.9
Q ss_pred cCCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCcc---chHHHHHHHHHHHhcCCCCeeEEEEEEEeC------
Q 028681 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTP------ 89 (205)
Q Consensus 19 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------ 89 (205)
..++|++.+.||.|+||.||.+.+..++..||+|.+..... ..+.+..|+.+++.++|+||+++++++...
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07878 13 VPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENF 92 (343)
T ss_pred hhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccccc
Confidence 46899999999999999999999999999999999875422 235577899999999999999999987643
Q ss_pred CeEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccc
Q 028681 90 THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 169 (205)
Q Consensus 90 ~~~~lv~~~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~ 169 (205)
...+++++++ +++|.+.+. ...+++..+..++.|++.||.|||+.||+|+||+|+||+++.++. ++|+|||++...
T Consensus 93 ~~~~~~~~~~-~~~l~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~--~kl~Dfg~~~~~ 168 (343)
T cd07878 93 NEVYLVTNLM-GADLNNIVK-CQKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCE--LRILDFGLARQA 168 (343)
T ss_pred CcEEEEeecC-CCCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCC--EEEcCCccceec
Confidence 3468888887 668877664 456999999999999999999999999999999999999998877 999999998754
Q ss_pred cCCCCCCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 170 VLHSQPKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 170 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
.. ......++..|+|||++.+....+.++|||||
T Consensus 169 ~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~Diwsl 202 (343)
T cd07878 169 DD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSV 202 (343)
T ss_pred CC--CcCCccccccccCchHhcCCccCCchhhhHhH
Confidence 33 23345689999999999874333345999996
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=220.12 Aligned_cols=178 Identities=22% Similarity=0.320 Sum_probs=152.2
Q ss_pred CCCeEEEeeeccccceeEEEEEec--CCCcEEEEEEeecCccchHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEE
Q 028681 20 SDRYELVRDIGSGNFGVARLMRDK--KTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (205)
Q Consensus 20 ~~~y~~~~~l~~g~~g~v~~~~~~--~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~ 97 (205)
..+|++.+.||+|++|.||++... ..+..|++|.+... .....|+.+++.++|+||+++++++......+++|+
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~e 166 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMP 166 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEeh
Confidence 457999999999999999999764 34678999987653 235679999999999999999999999999999999
Q ss_pred ecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCCCC---
Q 028681 98 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ--- 174 (205)
Q Consensus 98 ~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~--- 174 (205)
++. ++|.+.+.....+++..+..++.|++.||.|||++||+|+||+|+||+++.++. ++|+|||++........
T Consensus 167 ~~~-~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~--~~l~DfG~a~~~~~~~~~~~ 243 (392)
T PHA03207 167 KYK-CDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPEN--AVLGDFGAACKLDAHPDTPQ 243 (392)
T ss_pred hcC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCC--EEEccCccccccCccccccc
Confidence 986 578788877778999999999999999999999999999999999999988877 99999999865443322
Q ss_pred CCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 175 PKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 175 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
.....|++.|+|||++....++.+ +|||||
T Consensus 244 ~~~~~gt~~y~aPE~~~~~~~~~~-~Dvwsl 273 (392)
T PHA03207 244 CYGWSGTLETNSPELLALDPYCAK-TDIWSA 273 (392)
T ss_pred ccccccccCccCHhHhcCCCCCch-hhHHHH
Confidence 123468999999999998888766 999996
|
|
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-33 Score=209.01 Aligned_cols=188 Identities=29% Similarity=0.490 Sum_probs=156.7
Q ss_pred CceecCCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCccchHHHHHHHHHHHhc-CCCCeeEEEEEEE-----e
Q 028681 15 PIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSL-RHPNIVRFKEVIL-----T 88 (205)
Q Consensus 15 ~~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~-----~ 88 (205)
.+....++|++.+.||+|++|.||++.+..++..+++|.+.......+.+..|+.+++.+ +|+|++++++++. .
T Consensus 12 ~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~ 91 (286)
T cd06638 12 SFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKN 91 (286)
T ss_pred cCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccchHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCC
Confidence 344567899999999999999999999999999999998876544456788899999999 6999999999874 3
Q ss_pred CCeEEEEEEecCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeec
Q 028681 89 PTHLAIVMEYASGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFG 164 (205)
Q Consensus 89 ~~~~~lv~~~~~~~sl~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~ 164 (205)
++..+++|||+++++|.+.+.. ...+++..+..++.|++.|+.+||+.+++|+||+|+||+++.++. ++|+|||
T Consensus 92 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~--~kl~dfg 169 (286)
T cd06638 92 GDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGG--VKLVDFG 169 (286)
T ss_pred CCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCC--EEEccCC
Confidence 4578999999999999887642 346888999999999999999999999999999999999988877 9999999
Q ss_pred ccccccCCC-CCCCCCCCCCccCCceecc-----CcCCCeeeEEEeC
Q 028681 165 YSKSSVLHS-QPKSTVGTPAYIAPEVLLK-----KEYDGKVMCVYVI 205 (205)
Q Consensus 165 ~~~~~~~~~-~~~~~~~~~~~~aPE~~~~-----~~~~~~~~Dvwsl 205 (205)
++....... ......+++.|+|||++.. ..++.+ +|||||
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~-~Dv~sl 215 (286)
T cd06638 170 VSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDAR-CDVWSL 215 (286)
T ss_pred ceeecccCCCccccccCCCcccChhhhchhhhccccccch-hhhhhH
Confidence 987554332 2234468899999999863 334544 999996
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-33 Score=208.96 Aligned_cols=181 Identities=30% Similarity=0.432 Sum_probs=149.7
Q ss_pred CCe-EEEeeeccccceeEEEEE----ecCCCcEEEEEEeecCcc--chHHHHHHHHHHHhcCCCCeeEEEEEEEeC--Ce
Q 028681 21 DRY-ELVRDIGSGNFGVARLMR----DKKTEELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTP--TH 91 (205)
Q Consensus 21 ~~y-~~~~~l~~g~~g~v~~~~----~~~~~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~ 91 (205)
++| ++.+.||+|++|+||++. ...++..|++|.+..... ....+.+|+..++.++|+|++++++++... ..
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (283)
T cd05080 3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKG 82 (283)
T ss_pred hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCce
Confidence 455 999999999999998765 335678899999876432 346678899999999999999999987754 46
Q ss_pred EEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccC
Q 028681 92 LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 171 (205)
Q Consensus 92 ~~lv~~~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~ 171 (205)
.+++||++++++|.+.+.. ..+++.++..++.|++.|+.+||+.+++|+||+|+||+++.++. ++|+|||++.....
T Consensus 83 ~~lv~e~~~~~~l~~~~~~-~~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~--~~l~dfg~~~~~~~ 159 (283)
T cd05080 83 LQLIMEYVPLGSLRDYLPK-HKLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRL--VKIGDFGLAKAVPE 159 (283)
T ss_pred EEEEecCCCCCCHHHHHHH-cCCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCc--EEEeecccccccCC
Confidence 8899999999999998865 45999999999999999999999999999999999999988776 99999999876543
Q ss_pred CCC----CCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 172 HSQ----PKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 172 ~~~----~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
... .....++..|+|||.+.+..++.+ +|||||
T Consensus 160 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~-~Di~sl 196 (283)
T cd05080 160 GHEYYRVREDGDSPVFWYAVECLKENKFSYA-SDVWSF 196 (283)
T ss_pred cchhhccCCCCCCCceeeCHhHhcccCCCcc-cccHHH
Confidence 322 112235567999999988877755 999996
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-33 Score=206.01 Aligned_cols=182 Identities=38% Similarity=0.565 Sum_probs=158.3
Q ss_pred CeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCc---cchHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEEe
Q 028681 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (205)
Q Consensus 22 ~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~ 98 (205)
+|++.+.||+|++|.+|.+.+..++..+++|.+.... .....+.+|+.+++.++|+|++++++.+..++..++++|+
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 5899999999999999999999999999999987543 2345688899999999999999999999999999999999
Q ss_pred cCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCCCCCC
Q 028681 99 ASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK 176 (205)
Q Consensus 99 ~~~~sl~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~~~ 176 (205)
+++++|.+.+... ..+++..+..++.+++.++.+||+++++|+||+|+||+++.++. .++|+|||.+..........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~-~~~l~d~~~~~~~~~~~~~~ 159 (256)
T cd08220 81 APGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKM-VVKIGDFGISKILSSKSKAY 159 (256)
T ss_pred CCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCC-EEEEccCCCceecCCCcccc
Confidence 9999999998763 35899999999999999999999999999999999999975543 37999999997665554444
Q ss_pred CCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 177 STVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 177 ~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
...++..|+|||.+....++.+ +|||||
T Consensus 160 ~~~~~~~y~aPE~~~~~~~~~~-~Dv~sl 187 (256)
T cd08220 160 TVVGTPCYISPELCEGKPYNQK-SDIWAL 187 (256)
T ss_pred ccccCCcccCchhccCCCCCcc-cchHHH
Confidence 5568899999999988777655 999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=223.59 Aligned_cols=174 Identities=32% Similarity=0.450 Sum_probs=156.0
Q ss_pred CCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCccchHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEEecC
Q 028681 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYAS 100 (205)
Q Consensus 21 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~~~ 100 (205)
+.-.-++=||.|+.|.||+++.. ++.||||.++ +....++.-|++|+|+||+.+.|+|.....+|++||||+
T Consensus 124 e~IsELeWlGSGaQGAVF~Grl~--netVAVKKV~------elkETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa 195 (904)
T KOG4721|consen 124 EEISELEWLGSGAQGAVFLGRLH--NETVAVKKVR------ELKETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCA 195 (904)
T ss_pred HHhhhhhhhccCcccceeeeecc--CceehhHHHh------hhhhhhHHHHHhccCcceeeEeeeecCCceeEEeeeccc
Confidence 33444778999999999999876 5679999766 334578899999999999999999999999999999999
Q ss_pred CCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCCCCCCCCCC
Q 028681 101 GGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 180 (205)
Q Consensus 101 ~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~~~~~~~ 180 (205)
.|.|...++.+++++......|..+|+.|+.|||.+.|||||||.-||||+-+.. |||+|||-++-...........|
T Consensus 196 ~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~--VKIsDFGTS~e~~~~STkMSFaG 273 (904)
T KOG4721|consen 196 QGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDV--VKISDFGTSKELSDKSTKMSFAG 273 (904)
T ss_pred cccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccce--EEeccccchHhhhhhhhhhhhhh
Confidence 9999999999999999999999999999999999999999999999999987777 99999999876666655566689
Q ss_pred CCCccCCceeccCcCCCeeeEEEeC
Q 028681 181 TPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 181 ~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
|..|||||++.+.+-+.| .|||||
T Consensus 274 TVaWMAPEvIrnePcsEK-VDIwSf 297 (904)
T KOG4721|consen 274 TVAWMAPEVIRNEPCSEK-VDIWSF 297 (904)
T ss_pred hHhhhCHHHhhcCCcccc-cceehh
Confidence 999999999999999877 999997
|
|
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=212.90 Aligned_cols=182 Identities=32% Similarity=0.478 Sum_probs=156.5
Q ss_pred CCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCccc----hHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEE
Q 028681 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI----DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (205)
Q Consensus 21 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 96 (205)
++|++.+.||+|++|.||.+.+..++..+++|.+...... .+.+..|+..++.++|+|++++++.+......++++
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 4799999999999999999999999999999999865432 345788999999999999999999999999999999
Q ss_pred EecCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCCCC
Q 028681 97 EYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 174 (205)
Q Consensus 97 ~~~~~~sl~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~ 174 (205)
|++.+++|.+.+... ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++. ++|+|||++........
T Consensus 81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~--~~l~dfg~~~~~~~~~~ 158 (316)
T cd05574 81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGH--IMLSDFDLSKQSDVEPP 158 (316)
T ss_pred EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCC--EEEeecchhhccccccc
Confidence 999999999988653 46899999999999999999999999999999999999988777 99999998864432211
Q ss_pred ------------------------------CCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 175 ------------------------------PKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 175 ------------------------------~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
.....|+..|+|||++.+..++.+ +|||||
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~-~Di~sl 218 (316)
T cd05574 159 PVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSA-VDWWTL 218 (316)
T ss_pred ccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCch-HHHHHH
Confidence 112246788999999988877655 999986
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-33 Score=206.86 Aligned_cols=182 Identities=30% Similarity=0.449 Sum_probs=155.5
Q ss_pred CCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCcc------chHHHHHHHHHHHhcCCCCeeEEEEEEEeC--CeE
Q 028681 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK------IDENVQREIINHRSLRHPNIVRFKEVILTP--THL 92 (205)
Q Consensus 21 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~ 92 (205)
.+|+..+.||+|++|.||++.+..++..|++|.+..... ..+.+.+|+.+++.++|+|++++++.+... ...
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 589999999999999999999999999999998865321 224578899999999999999999988763 578
Q ss_pred EEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCC
Q 028681 93 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 172 (205)
Q Consensus 93 ~lv~~~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~ 172 (205)
++++|++++++|.+.+.....+++.....++.|++.|+++||+++++|+||+|+||+++.++. ++|+|||++......
T Consensus 82 ~l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~--~~l~dfg~~~~~~~~ 159 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGN--VKLGDFGASKRLQTI 159 (266)
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCC--EEEccCCCccccccc
Confidence 899999999999999987778999999999999999999999999999999999999987776 999999988654321
Q ss_pred ----CCCCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 173 ----SQPKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 173 ----~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
.......++..|+|||.+.+..++.+ +|||||
T Consensus 160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~sl 195 (266)
T cd06651 160 CMSGTGIRSVTGTPYWMSPEVISGEGYGRK-ADVWSL 195 (266)
T ss_pred cccCCccccCCccccccCHHHhCCCCCCch-hhhHHH
Confidence 11122357889999999988887766 999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-34 Score=213.42 Aligned_cols=181 Identities=30% Similarity=0.524 Sum_probs=152.7
Q ss_pred CeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCcc---chHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEEe
Q 028681 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (205)
Q Consensus 22 ~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~ 98 (205)
+|++.+.||+|++|.||++.+..+|..+++|.+..... ....+..|+.+++.++|+|++++++++.+....++++||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 58999999999999999999999999999999875422 234577899999999999999999999999999999999
Q ss_pred cCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCCCC-CC
Q 028681 99 ASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-PK 176 (205)
Q Consensus 99 ~~~~sl~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~-~~ 176 (205)
+++ +|.+.+.. ...+++..++.++.|++.||.+||+++++|+||+|+||+++.++. ++|+|||++........ ..
T Consensus 81 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~--~~l~dfg~~~~~~~~~~~~~ 157 (284)
T cd07839 81 CDQ-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGE--LKLADFGLARAFGIPVRCYS 157 (284)
T ss_pred CCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCc--EEECccchhhccCCCCCCcC
Confidence 975 67766654 557999999999999999999999999999999999999988777 99999999875543322 22
Q ss_pred CCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 177 STVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 177 ~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
...++..|+|||.+.+....+.++|||||
T Consensus 158 ~~~~~~~y~aPE~~~~~~~~~~~~Diwsl 186 (284)
T cd07839 158 AEVVTLWYRPPDVLFGAKLYSTSIDMWSA 186 (284)
T ss_pred CCccccCCcChHHHhCCcccCcHHHHHHH
Confidence 34578899999998775543345999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=222.18 Aligned_cols=185 Identities=28% Similarity=0.416 Sum_probs=161.0
Q ss_pred ecCCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCccch---------HHHHHHHHHHHhcC---CCCeeEEEEE
Q 028681 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID---------ENVQREIINHRSLR---HPNIVRFKEV 85 (205)
Q Consensus 18 ~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~---------~~~~~e~~~l~~l~---h~~i~~~~~~ 85 (205)
....+|+.++.+|.|+||.|+++.++++...|++|.+.+..... -.+-.|+.+|..+. |+||++++++
T Consensus 558 ~k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdf 637 (772)
T KOG1152|consen 558 KKFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDF 637 (772)
T ss_pred cccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhhe
Confidence 45677999999999999999999999999999999998753211 12456888888886 9999999999
Q ss_pred EEeCCeEEEEEEec-CCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeec
Q 028681 86 ILTPTHLAIVMEYA-SGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFG 164 (205)
Q Consensus 86 ~~~~~~~~lv~~~~-~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~ 164 (205)
|+++++++++||.- ++-.|-+++.-++.+++.++..|+.|+..|+++||++||+|||||-+|++++.++- +||+|||
T Consensus 638 FEddd~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~--~klidfg 715 (772)
T KOG1152|consen 638 FEDDDYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGF--VKLIDFG 715 (772)
T ss_pred eecCCeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCe--EEEeecc
Confidence 99999999999875 35578888888889999999999999999999999999999999999999998888 9999999
Q ss_pred ccccccCCCCCCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 165 YSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 165 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
.|..... .......||..|.|||++.+.+|-.++-|||+|
T Consensus 716 saa~~ks-gpfd~f~gtv~~aapevl~g~~y~gk~qdiwal 755 (772)
T KOG1152|consen 716 SAAYTKS-GPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWAL 755 (772)
T ss_pred chhhhcC-CCcceeeeeccccchhhhCCCccCCCcchhhhh
Confidence 8854332 333455799999999999999998889999986
|
|
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-33 Score=204.95 Aligned_cols=181 Identities=27% Similarity=0.501 Sum_probs=154.4
Q ss_pred CeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCcc---chHHHHHHHHHHHhcCCCCeeEEEEEEEe-CCeEEEEEE
Q 028681 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILT-PTHLAIVME 97 (205)
Q Consensus 22 ~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~~ 97 (205)
+|++.+.||.|++|.||.+.+..+++.+++|.+..... ..+.+..|+..++.++|+|++++.+.+.. +...++++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 58999999999999999999999899999999875432 23567889999999999999999998764 446889999
Q ss_pred ecCCCchHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCC-CC
Q 028681 98 YASGGELFERICN--AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQ 174 (205)
Q Consensus 98 ~~~~~sl~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~-~~ 174 (205)
++++++|.+.+.. ...+++.++..++.+++.++.+||+.|++|+||+|+||+++.++. ++|+|||++...... ..
T Consensus 81 ~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~--~~l~df~~~~~~~~~~~~ 158 (257)
T cd08223 81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNI--IKVGDLGIARVLENQCDM 158 (257)
T ss_pred ccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCc--EEEecccceEEecccCCc
Confidence 9999999988865 345899999999999999999999999999999999999988777 999999998655332 22
Q ss_pred CCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 175 PKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 175 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
.....+++.|+|||.+.+..++.+ +|||||
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~sl 188 (257)
T cd08223 159 ASTLIGTPYYMSPELFSNKPYNYK-SDVWAL 188 (257)
T ss_pred cccccCCcCccChhHhcCCCCCch-hhhHHH
Confidence 233457889999999998888766 999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=210.27 Aligned_cols=181 Identities=31% Similarity=0.500 Sum_probs=151.8
Q ss_pred CeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCcc---chHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEEe
Q 028681 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (205)
Q Consensus 22 ~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~ 98 (205)
+|++.+.||+|++|.||++.+..++..|++|.+..... ..+.+.+|+.+++.++|+|++++++++.+++..++++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 58999999999999999999999999999998865422 235678899999999999999999999999999999999
Q ss_pred cCCCchHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCCC-C
Q 028681 99 ASGGELFERICNA---GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-Q 174 (205)
Q Consensus 99 ~~~~sl~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~~-~ 174 (205)
+. ++|.+.+... ..+++..++.++.|++.||.|||+.+++|+||+|+||+++.++. ++|+|||++....... .
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~--~~l~dfg~~~~~~~~~~~ 157 (285)
T cd07861 81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGV--IKLADFGLARAFGIPVRV 157 (285)
T ss_pred CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCc--EEECcccceeecCCCccc
Confidence 97 4777776542 45899999999999999999999999999999999999988887 9999999986543322 2
Q ss_pred CCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 175 PKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 175 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
.....+++.|+|||.+.+....+.++|||||
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~sl 188 (285)
T cd07861 158 YTHEVVTLWYRAPEVLLGSPRYSTPVDIWSI 188 (285)
T ss_pred ccCCcccccccChHHhcCCCCcCcHHHHHHH
Confidence 2333568889999998765432344999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-33 Score=207.20 Aligned_cols=184 Identities=25% Similarity=0.364 Sum_probs=154.9
Q ss_pred cCCCeEEEeeeccccceeEEEEEecCC---CcEEEEEEeecCcc--chHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEE
Q 028681 19 DSDRYELVRDIGSGNFGVARLMRDKKT---EELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLA 93 (205)
Q Consensus 19 ~~~~y~~~~~l~~g~~g~v~~~~~~~~---~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 93 (205)
..++|++.+.||+|+||.||.+..... ...|++|.+..... ....+..|+..++.++|+|++++++.+...+..+
T Consensus 2 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 81 (266)
T cd05033 2 DPSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVM 81 (266)
T ss_pred ChHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceE
Confidence 357899999999999999999988643 45799998875432 2356788999999999999999999999999999
Q ss_pred EEEEecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCC
Q 028681 94 IVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 172 (205)
Q Consensus 94 lv~~~~~~~sl~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~ 172 (205)
+++|++++++|.+.+... ..+++..+..++.|++.|+.+||+++++|+||+|+||+++.++. ++|+|||++......
T Consensus 82 iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~--~~l~dfg~~~~~~~~ 159 (266)
T cd05033 82 IITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLV--CKVSDFGLSRRLEDS 159 (266)
T ss_pred EEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCC--EEECccchhhccccc
Confidence 999999999999998653 46899999999999999999999999999999999999988777 999999998766421
Q ss_pred -CCCC--CCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 173 -SQPK--STVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 173 -~~~~--~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
.... ...++..|+|||.+.+..++.+ +|||||
T Consensus 160 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~-~Dv~sl 194 (266)
T cd05033 160 EATYTTKGGKIPIRWTAPEAIAYRKFTSA-SDVWSF 194 (266)
T ss_pred ccceeccCCCCCccccChhhhccCCCccc-cchHHH
Confidence 1111 1234578999999988888755 999986
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=219.02 Aligned_cols=190 Identities=35% Similarity=0.572 Sum_probs=172.0
Q ss_pred cCceecCCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCcc---chHHHHHHHHHHHhcCCCCeeEEEEEEEeCC
Q 028681 14 MPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTPT 90 (205)
Q Consensus 14 ~~~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 90 (205)
+.-.....-|.+.+.||+|.|..|-++++.-+|.+||+|++.+.+. ....+..|++.++.++||||+++|++...+.
T Consensus 11 i~DgkIAGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQT 90 (864)
T KOG4717|consen 11 IYDGKIAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQT 90 (864)
T ss_pred ccccceeeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccc
Confidence 3445556789999999999999999999999999999999987543 3456889999999999999999999999999
Q ss_pred eEEEEEEecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecC-CCCCcEEEeeeccccc
Q 028681 91 HLAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDG-SPAPRLKICDFGYSKS 168 (205)
Q Consensus 91 ~~~lv~~~~~~~sl~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~-~~~~~~~l~df~~~~~ 168 (205)
.+|+++|.=++|.|.+++-+. ..+++.....++.||+.|+.|+|+.-++|+|++|+|+.+.+ -+. |||.|||++-.
T Consensus 91 KlyLiLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGl--VKLTDFGFSNk 168 (864)
T KOG4717|consen 91 KLYLILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGL--VKLTDFGFSNK 168 (864)
T ss_pred eEEEEEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCc--eEeeecccccc
Confidence 999999998888999988664 45999999999999999999999999999999999998764 444 99999999999
Q ss_pred ccCCCCCCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 169 SVLHSQPKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 169 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
+.++....+.+|++.|-|||++.+..|+.++.|||||
T Consensus 169 f~PG~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSL 205 (864)
T KOG4717|consen 169 FQPGKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSL 205 (864)
T ss_pred CCCcchhhcccchhhccCchhhhcCccCCcchhhhHH
Confidence 9999999999999999999999999999999999997
|
|
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=201.32 Aligned_cols=190 Identities=25% Similarity=0.383 Sum_probs=160.3
Q ss_pred ccCceecCCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCc-cchHHHHHHHHHHHhcCCCCeeEEEEEEEeCC-
Q 028681 13 DMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKEVILTPT- 90 (205)
Q Consensus 13 ~~~~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~- 90 (205)
...+....++|++.+.||+|||+-|++++...++..+|+|.+.-.. ...+....|++..++++|||++++++....+.
T Consensus 13 ~~tv~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~ 92 (302)
T KOG2345|consen 13 RGTVIINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEK 92 (302)
T ss_pred CCcEEEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhc
Confidence 3445667899999999999999999999999999999999987655 45677899999999999999999987765433
Q ss_pred ----eEEEEEEecCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhcC--cEeecCCCCCeEecCCCCCcEEE
Q 028681 91 ----HLAIVMEYASGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHSMQ--VCHRDLKLENTLLDGSPAPRLKI 160 (205)
Q Consensus 91 ----~~~lv~~~~~~~sl~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lh~~~--i~H~di~p~nili~~~~~~~~~l 160 (205)
..|++++|+..|||.+.+.. +..+++.++..|+.+++.||++||+.. +.|+||||.||++++.+. ++|
T Consensus 93 D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~--~vl 170 (302)
T KOG2345|consen 93 DGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGL--PVL 170 (302)
T ss_pred cCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCc--eEE
Confidence 48999999999999888854 336999999999999999999999988 999999999999998777 999
Q ss_pred eeecccccccCCCCCCCC----------CCCCCccCCceeccC---cCCCeeeEEEeC
Q 028681 161 CDFGYSKSSVLHSQPKST----------VGTPAYIAPEVLLKK---EYDGKVMCVYVI 205 (205)
Q Consensus 161 ~df~~~~~~~~~~~~~~~----------~~~~~~~aPE~~~~~---~~~~~~~Dvwsl 205 (205)
.|||.++..+........ ..|..|.|||.+.-+ ..+++ +|||||
T Consensus 171 ~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~er-tDIWSL 227 (302)
T KOG2345|consen 171 MDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITER-TDIWSL 227 (302)
T ss_pred EeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccc-cchhhh
Confidence 999998765544333322 378999999999744 34555 999997
|
|
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-33 Score=209.50 Aligned_cols=182 Identities=34% Similarity=0.571 Sum_probs=157.0
Q ss_pred CCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCc---cchHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEE
Q 028681 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (205)
Q Consensus 21 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~ 97 (205)
++|++.+.||+|++|.||++.+..+++.|++|.++... ...+.+..|+.+++.++|+|++++.+.+..++..++++|
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 47999999999999999999999999999999887532 234678899999999999999999999999999999999
Q ss_pred ecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCCC--CC
Q 028681 98 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS--QP 175 (205)
Q Consensus 98 ~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~~--~~ 175 (205)
|++++.+..+......+++..+..++.|++.|+.+||+.+++|+|++|+||+++.++. ++|+|||.+....... ..
T Consensus 81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~--~kl~d~g~~~~~~~~~~~~~ 158 (288)
T cd07833 81 YVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGV--LKLCDFGFARALRARPASPL 158 (288)
T ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCC--EEEEeeecccccCCCccccc
Confidence 9988766666656667999999999999999999999999999999999999998777 9999999987655443 22
Q ss_pred CCCCCCCCccCCceeccC-cCCCeeeEEEeC
Q 028681 176 KSTVGTPAYIAPEVLLKK-EYDGKVMCVYVI 205 (205)
Q Consensus 176 ~~~~~~~~~~aPE~~~~~-~~~~~~~Dvwsl 205 (205)
....++..|+|||++.+. .++. ++|||||
T Consensus 159 ~~~~~~~~~~~PE~~~~~~~~~~-~~Dv~sl 188 (288)
T cd07833 159 TDYVATRWYRAPELLVGDTNYGK-PVDVWAI 188 (288)
T ss_pred cCcccccCCcCCchhcCCCCcCc-hhhHHHH
Confidence 334578889999999887 5554 5999996
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-33 Score=207.62 Aligned_cols=181 Identities=34% Similarity=0.513 Sum_probs=156.1
Q ss_pred CeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCccc----------hHHHHHHHHHHHhcCCCCeeEEEEEEEeCCe
Q 028681 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI----------DENVQREIINHRSLRHPNIVRFKEVILTPTH 91 (205)
Q Consensus 22 ~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~----------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 91 (205)
+|.+.+.||+|++|.||.+.+..++..+++|.+...... .+.+..|+.+++.++|+|++++++++.....
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 478889999999999999999988999999988654221 1457789999999999999999999999999
Q ss_pred EEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccC
Q 028681 92 LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 171 (205)
Q Consensus 92 ~~lv~~~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~ 171 (205)
.++++||+++++|.+.+.....+++..+..++.|++.|+.+||+.|++|+||+|+||+++.++. ++|+|||.++....
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~--~~l~dfg~~~~~~~ 158 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGG--IKISDFGISKKLEA 158 (267)
T ss_pred cEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCC--EEecccCCCccccc
Confidence 9999999999999999988788999999999999999999999999999999999999987777 99999998875542
Q ss_pred CCC-------CCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 172 HSQ-------PKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 172 ~~~-------~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
... .....++..|+|||.+.+..++.+ +|+|||
T Consensus 159 ~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~-~Dv~sl 198 (267)
T cd06628 159 NSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRK-ADIWSL 198 (267)
T ss_pred ccccCCccccccccCCCcCccChhHhccCCCCch-hhhHHH
Confidence 211 112347889999999988887755 999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-33 Score=208.76 Aligned_cols=182 Identities=27% Similarity=0.414 Sum_probs=153.0
Q ss_pred CCeEEEeeeccccceeEEEEEe----cCCCcEEEEEEeecCc--cchHHHHHHHHHHHhcCCCCeeEEEEEEEeC--CeE
Q 028681 21 DRYELVRDIGSGNFGVARLMRD----KKTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTP--THL 92 (205)
Q Consensus 21 ~~y~~~~~l~~g~~g~v~~~~~----~~~~~~v~iK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~ 92 (205)
..|++.+.||+|++|.||.+.. ..++..|++|.+.... ...+.+..|+.+++.++|+|++++.+++... ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 4579999999999999999974 4567889999987542 2345788999999999999999999998875 568
Q ss_pred EEEEEecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccC
Q 028681 93 AIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 171 (205)
Q Consensus 93 ~lv~~~~~~~sl~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~ 171 (205)
++++||+++++|.+++... ..+++..+..++.|++.||.+||++|++|+||+|+||+++.++. ++|+|||++.....
T Consensus 84 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~--~~l~dfg~~~~~~~ 161 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQ--VKIGDFGLTKAIET 161 (284)
T ss_pred EEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCC--EEECCCcccccccc
Confidence 8999999999999998654 35899999999999999999999999999999999999988777 99999999876543
Q ss_pred CCC----CCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 172 HSQ----PKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 172 ~~~----~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
... .....++..|+|||++.+..++.+ +|||||
T Consensus 162 ~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~-~Di~sl 198 (284)
T cd05079 162 DKEYYTVKDDLDSPVFWYAPECLIQSKFYIA-SDVWSF 198 (284)
T ss_pred CccceeecCCCCCCccccCHHHhccCCCCcc-ccchhh
Confidence 322 123346678999999988877765 999996
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=207.50 Aligned_cols=182 Identities=27% Similarity=0.467 Sum_probs=161.1
Q ss_pred CCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCccchHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEEec
Q 028681 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA 99 (205)
Q Consensus 20 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~~ 99 (205)
.++|++.+.|++|++|.+|.+....++..+++|.+..... .+.+.+|+.+++.++|+|++++++.+..+...++++|++
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~ 80 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED-LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYC 80 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH-HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecC
Confidence 4789999999999999999999998889999999876543 678899999999999999999999999999999999999
Q ss_pred CCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCCC-CCCC
Q 028681 100 SGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKS 177 (205)
Q Consensus 100 ~~~sl~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~~-~~~~ 177 (205)
++++|.+.+.. ...+++..+..++.|++.|+.+||+.+++|+||+|+||+++.++. ++|+|||++....... ....
T Consensus 81 ~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~--~~l~dfg~~~~~~~~~~~~~~ 158 (256)
T cd06612 81 GAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQ--AKLADFGVSGQLTDTMAKRNT 158 (256)
T ss_pred CCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCc--EEEcccccchhcccCcccccc
Confidence 99999999865 456899999999999999999999999999999999999998877 9999999987654433 2333
Q ss_pred CCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 178 TVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 178 ~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
..++..|+|||.+.+..++.+ +|||||
T Consensus 159 ~~~~~~y~~PE~~~~~~~~~~-~Di~s~ 185 (256)
T cd06612 159 VIGTPFWMAPEVIQEIGYNNK-ADIWSL 185 (256)
T ss_pred ccCCccccCHHHHhcCCCCch-hhHHHH
Confidence 457889999999988887755 999986
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=212.38 Aligned_cols=179 Identities=34% Similarity=0.478 Sum_probs=149.6
Q ss_pred EEEeeeccccceeEEEEEec----CCCcEEEEEEeecCcc--chHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEE
Q 028681 24 ELVRDIGSGNFGVARLMRDK----KTEELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (205)
Q Consensus 24 ~~~~~l~~g~~g~v~~~~~~----~~~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~ 97 (205)
++.+.||.|+||.||++... ..+..|++|.++.... ..+.+.+|+..+++++||||++++|++...+..++++|
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e 81 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVME 81 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccccccccc
Confidence 57899999999999999998 4467899999965432 25778999999999999999999999998888999999
Q ss_pred ecCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCCCC-
Q 028681 98 YASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ- 174 (205)
Q Consensus 98 ~~~~~sl~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~- 174 (205)
|++.++|.+.+... ..+++.....++.|++.||.|||+.+++|+||+++||+++.++. +||+|||++........
T Consensus 82 ~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~--~Kl~~f~~~~~~~~~~~~ 159 (259)
T PF07714_consen 82 YCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQ--VKLSDFGLSRPISEKSKY 159 (259)
T ss_dssp --TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTE--EEEESTTTGEETTTSSSE
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc--cccccccccccccccccc
Confidence 99999999999876 67999999999999999999999999999999999999998776 99999999876632211
Q ss_pred --CCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 175 --PKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 175 --~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
.........|+|||.+....++.+ +|||||
T Consensus 160 ~~~~~~~~~~~~~aPE~~~~~~~~~k-sDVysf 191 (259)
T PF07714_consen 160 KNDSSQQLPLRYLAPEVLKDGEYTKK-SDVYSF 191 (259)
T ss_dssp EESTTSESGGGGS-HHHHHHSEESHH-HHHHHH
T ss_pred cccccccccccccccccccccccccc-cccccc
Confidence 223346788999999998887756 999996
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=210.88 Aligned_cols=184 Identities=26% Similarity=0.408 Sum_probs=154.5
Q ss_pred cCCCeEEEeeeccccceeEEEEEe-----cCCCcEEEEEEeecCcc-chHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeE
Q 028681 19 DSDRYELVRDIGSGNFGVARLMRD-----KKTEELVAVKYIERGDK-IDENVQREIINHRSLRHPNIVRFKEVILTPTHL 92 (205)
Q Consensus 19 ~~~~y~~~~~l~~g~~g~v~~~~~-----~~~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 92 (205)
..++|.+.+.||+|++|.||.+.. ..++..+++|.+..... ..+.+..|+.++++++|+|++++++++...+..
T Consensus 3 ~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 82 (288)
T cd05093 3 KRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPL 82 (288)
T ss_pred chHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCcc
Confidence 357899999999999999999985 33456789998875432 345688999999999999999999999999999
Q ss_pred EEEEEecCCCchHHHHHhcC-------------CCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEE
Q 028681 93 AIVMEYASGGELFERICNAG-------------RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLK 159 (205)
Q Consensus 93 ~lv~~~~~~~sl~~~~~~~~-------------~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~ 159 (205)
++++||+++++|.+++...+ .+++..+..++.|++.||++||++|++|+||+|+||+++.++. ++
T Consensus 83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~--~k 160 (288)
T cd05093 83 IMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLL--VK 160 (288)
T ss_pred EEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCc--EE
Confidence 99999999999999886433 3899999999999999999999999999999999999988777 99
Q ss_pred EeeecccccccCCCC---CCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 160 ICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 160 l~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
|+|||++........ .....++..|+|||.+.+..++.+ +|||||
T Consensus 161 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-sDiwsl 208 (288)
T cd05093 161 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTE-SDVWSL 208 (288)
T ss_pred eccCCccccccCCceeecCCCCCccccccCHHHhccCCCCch-hhHHHH
Confidence 999999875432221 122235678999999988877765 999996
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=209.25 Aligned_cols=181 Identities=31% Similarity=0.531 Sum_probs=159.3
Q ss_pred CCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCc--cchHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEEe
Q 028681 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (205)
Q Consensus 21 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~ 98 (205)
++|++.+.||.|++|.||++.+..++..+++|.+.... .....+..|+.+++.++|+|++++.+.+..+...++++|+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 47899999999999999999999999999999987543 2235678899999999999999999999999999999999
Q ss_pred cCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCC-CCCCC
Q 028681 99 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKS 177 (205)
Q Consensus 99 ~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~-~~~~~ 177 (205)
+++++|.+.+... ++++..+..++.|++.|+.+||+.+++|+||+|+||+++.++. ++|+|||.++..... .....
T Consensus 81 ~~~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~--~~l~d~g~~~~~~~~~~~~~~ 157 (274)
T cd06609 81 CGGGSCLDLLKPG-KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGD--VKLADFGVSGQLTSTMSKRNT 157 (274)
T ss_pred eCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCC--EEEcccccceeeccccccccc
Confidence 9999999988654 7999999999999999999999999999999999999998877 999999998766544 23334
Q ss_pred CCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 178 TVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 178 ~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
..++..|+|||.+.+..++.+ +|||||
T Consensus 158 ~~~~~~y~~PE~~~~~~~~~~-sDv~sl 184 (274)
T cd06609 158 FVGTPFWMAPEVIKQSGYDEK-ADIWSL 184 (274)
T ss_pred ccCCccccChhhhccCCCCch-hhHHHH
Confidence 467888999999998887755 999996
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=207.99 Aligned_cols=187 Identities=24% Similarity=0.335 Sum_probs=155.0
Q ss_pred ceecCCCeEEEeeeccccceeEEEEEecCC-----CcEEEEEEeecCcc--chHHHHHHHHHHHhc-CCCCeeEEEEEEE
Q 028681 16 IMHDSDRYELVRDIGSGNFGVARLMRDKKT-----EELVAVKYIERGDK--IDENVQREIINHRSL-RHPNIVRFKEVIL 87 (205)
Q Consensus 16 ~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~-----~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l-~h~~i~~~~~~~~ 87 (205)
.....++|++.+.||+|++|.||.+..... ...+++|.+..... ....+..|+.+++.+ +|+|++++++++.
T Consensus 7 ~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 86 (293)
T cd05053 7 WELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCT 86 (293)
T ss_pred cccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEc
Confidence 344568999999999999999999987643 36799998875432 234577899999999 7999999999999
Q ss_pred eCCeEEEEEEecCCCchHHHHHh----------------cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEec
Q 028681 88 TPTHLAIVMEYASGGELFERICN----------------AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLD 151 (205)
Q Consensus 88 ~~~~~~lv~~~~~~~sl~~~~~~----------------~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~ 151 (205)
.++..+++|||+++++|.+.+.. ...+++..+..++.|++.|+.|||+.+++|+||+|+||+++
T Consensus 87 ~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil~~ 166 (293)
T cd05053 87 QEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVT 166 (293)
T ss_pred CCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEEEc
Confidence 99999999999999999998854 23588999999999999999999999999999999999998
Q ss_pred CCCCCcEEEeeecccccccCCCC---CCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 152 GSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 152 ~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
.++. ++|+|||.+........ .....++..|+|||++.+..++.+ +|||||
T Consensus 167 ~~~~--~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~sl 220 (293)
T cd05053 167 EDHV--MKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQ-SDVWSF 220 (293)
T ss_pred CCCe--EEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcc-cceeeh
Confidence 8776 99999999875443221 112234577999999988888766 999997
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=207.06 Aligned_cols=181 Identities=30% Similarity=0.482 Sum_probs=158.8
Q ss_pred CeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCcc------chHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEE
Q 028681 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK------IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV 95 (205)
Q Consensus 22 ~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 95 (205)
+|+..+.||+|++|.||.+....++..|++|.+..... ..+.+..|+.+++.++|+|++++++++..+...+++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 47888999999999999999998899999999875431 335688899999999999999999999999999999
Q ss_pred EEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCCCCC
Q 028681 96 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 175 (205)
Q Consensus 96 ~~~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~~ 175 (205)
+||+++++|.+.+....++++..+..++.|++.|+.+||+.|++|+||+|+||+++.++. ++|+|||.+.........
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~--~kl~d~~~~~~~~~~~~~ 158 (258)
T cd06632 81 LELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGV--VKLADFGMAKQVVEFSFA 158 (258)
T ss_pred EEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCC--EEEccCccceeccccccc
Confidence 999999999999988778999999999999999999999999999999999999988777 999999988765544434
Q ss_pred CCCCCCCCccCCceeccCc-CCCeeeEEEeC
Q 028681 176 KSTVGTPAYIAPEVLLKKE-YDGKVMCVYVI 205 (205)
Q Consensus 176 ~~~~~~~~~~aPE~~~~~~-~~~~~~Dvwsl 205 (205)
....++..|+|||.+.+.. ++.+ +|+|||
T Consensus 159 ~~~~~~~~y~~pe~~~~~~~~~~~-~D~~sl 188 (258)
T cd06632 159 KSFKGSPYWMAPEVIAQQGGYGLA-ADIWSL 188 (258)
T ss_pred cccCCCcceeCHHHhcCCCCCCch-hhhHHH
Confidence 5556889999999998776 6545 999985
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=206.98 Aligned_cols=180 Identities=28% Similarity=0.403 Sum_probs=156.5
Q ss_pred cCCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCccchHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEEe
Q 028681 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (205)
Q Consensus 19 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~ 98 (205)
..++|++.+.||.|++|.||.+... ++.|++|.+.......+++.+|+.+++.++|+|++++++++......++++|+
T Consensus 4 ~~~~~~~~~~ig~g~~g~v~~~~~~--~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 81 (256)
T cd05039 4 NSKELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEY 81 (256)
T ss_pred ChhhccceeeeecCCCceEEEEEec--CcEEEEEEeccchhHHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEe
Confidence 4678999999999999999999875 67899999876655457788999999999999999999999998999999999
Q ss_pred cCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCCCCCC
Q 028681 99 ASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK 176 (205)
Q Consensus 99 ~~~~sl~~~~~~~~--~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~~~ 176 (205)
+++++|.+.+.... .+++..+..++.|++.|+.+||+.+++|+||+|+||+++.++. ++|+|||.+........
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~--~~l~d~g~~~~~~~~~~-- 157 (256)
T cd05039 82 MAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLV--AKVSDFGLAKEASQGQD-- 157 (256)
T ss_pred cCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCC--EEEcccccccccccccc--
Confidence 99999999987655 6999999999999999999999999999999999999988777 99999999876532222
Q ss_pred CCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 177 STVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 177 ~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
....+..|+|||.+....++.+ +|||||
T Consensus 158 ~~~~~~~~~ape~~~~~~~~~~-~Di~sl 185 (256)
T cd05039 158 SGKLPVKWTAPEALREKKFSTK-SDVWSF 185 (256)
T ss_pred cCCCcccccCchhhcCCcCCcH-HHHHHH
Confidence 3345677999999988777655 999986
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=212.38 Aligned_cols=181 Identities=29% Similarity=0.455 Sum_probs=154.7
Q ss_pred CeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCccc------hHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEE
Q 028681 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI------DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV 95 (205)
Q Consensus 22 ~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 95 (205)
+|++.+.||+|++|.||++.+..++..|++|.+...... ...+..|+.+++.++|+|++++++++.+++..++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 588999999999999999999988999999999765432 34567899999999999999999999999999999
Q ss_pred EEecCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCCC-
Q 028681 96 MEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS- 173 (205)
Q Consensus 96 ~~~~~~~sl~~~~~~~~-~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~~- 173 (205)
+|++ +++|.+.+.... .+++..+..++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||++.......
T Consensus 81 ~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~--~~l~dfg~~~~~~~~~~ 157 (298)
T cd07841 81 FEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGV--LKLADFGLARSFGSPNR 157 (298)
T ss_pred Eccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCC--EEEccceeeeeccCCCc
Confidence 9999 889999987765 7999999999999999999999999999999999999998777 9999999987654432
Q ss_pred CCCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 174 QPKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 174 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
......++..|.|||.+.+....+.++|||||
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~sl 189 (298)
T cd07841 158 KMTHQVVTRWYRAPELLFGARHYGVGVDMWSV 189 (298)
T ss_pred cccccccceeeeCHHHHhCCCCCCcHHHHHHH
Confidence 22333567889999998654433445999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-35 Score=225.82 Aligned_cols=177 Identities=33% Similarity=0.539 Sum_probs=153.4
Q ss_pred CeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCccch----HHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEE
Q 028681 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID----ENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (205)
Q Consensus 22 ~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~ 97 (205)
.|.-++.||-|+||.||.+.+..+...||||.+.-..... ..+..|+..|+++.|||.+.+-|.|..+.-.|+|||
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME 106 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME 106 (948)
T ss_pred HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence 4667899999999999999999999999999986543322 347789999999999999999999999999999999
Q ss_pred ecCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCCCCCC
Q 028681 98 YASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK 176 (205)
Q Consensus 98 ~~~~~sl~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~~~ 176 (205)
||- ||-.+++.- ..++.+-.+..|..+.+.||+|||+.+.||+||+..||++++.+. |||+|||.|....| .+
T Consensus 107 YCl-GSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~--VKLaDFGSAsi~~P---An 180 (948)
T KOG0577|consen 107 YCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGL--VKLADFGSASIMAP---AN 180 (948)
T ss_pred HHh-ccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCe--eeeccccchhhcCc---hh
Confidence 994 466666643 457999999999999999999999999999999999999998888 99999999875543 45
Q ss_pred CCCCCCCccCCceecc---CcCCCeeeEEEeC
Q 028681 177 STVGTPAYIAPEVLLK---KEYDGKVMCVYVI 205 (205)
Q Consensus 177 ~~~~~~~~~aPE~~~~---~~~~~~~~Dvwsl 205 (205)
+..||+.|||||++.. +.|+.+ +|||||
T Consensus 181 sFvGTPywMAPEVILAMDEGqYdgk-vDvWSL 211 (948)
T KOG0577|consen 181 SFVGTPYWMAPEVILAMDEGQYDGK-VDVWSL 211 (948)
T ss_pred cccCCccccchhHheeccccccCCc-cceeec
Confidence 5789999999999974 567767 999997
|
|
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-33 Score=207.21 Aligned_cols=183 Identities=23% Similarity=0.354 Sum_probs=153.5
Q ss_pred CCCeEEEeeeccccceeEEEEEecCCCc---EEEEEEeecCc--cchHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEE
Q 028681 20 SDRYELVRDIGSGNFGVARLMRDKKTEE---LVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 94 (205)
Q Consensus 20 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~---~v~iK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 94 (205)
.++|++.+.||+|++|.||.+....++. .|++|.+.... .....+..|+.+++.++|||++++.+++..+...++
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l 82 (269)
T cd05065 3 VSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMI 82 (269)
T ss_pred hHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEE
Confidence 4679999999999999999999876554 69999887542 234678899999999999999999999999999999
Q ss_pred EEEecCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCCC
Q 028681 95 VMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 173 (205)
Q Consensus 95 v~~~~~~~sl~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~~ 173 (205)
++||+++++|.+++.. .+.+++.+++.++.|++.|+++||++|++|+||+|+||+++.+.. ++|+|||++.......
T Consensus 83 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~--~kl~dfg~~~~~~~~~ 160 (269)
T cd05065 83 ITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLV--CKVSDFGLSRFLEDDT 160 (269)
T ss_pred EEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCc--EEECCCccccccccCc
Confidence 9999999999988865 346899999999999999999999999999999999999987776 9999999886543322
Q ss_pred CCCC---CC---CCCCccCCceeccCcCCCeeeEEEeC
Q 028681 174 QPKS---TV---GTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 174 ~~~~---~~---~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
.... .. .+..|+|||.+.+..++.+ +|||||
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~-~Dvwsl 197 (269)
T cd05065 161 SDPTYTSSLGGKIPIRWTAPEAIAYRKFTSA-SDVWSY 197 (269)
T ss_pred cccccccccCCCcceeecCHhHhccCcccch-hhhhhh
Confidence 2111 11 1357999999998888765 999996
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=207.87 Aligned_cols=182 Identities=25% Similarity=0.324 Sum_probs=153.5
Q ss_pred cCCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCccchHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEEe
Q 028681 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (205)
Q Consensus 19 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~ 98 (205)
..++|++.+.||+|++|.||++.+..+ ..|++|.+.......+.+..|+.+++.++|+|++++++.+. ....++++|+
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~ 81 (262)
T cd05071 4 PRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEY 81 (262)
T ss_pred ChHHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCccCHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEc
Confidence 357899999999999999999988765 45999998875555677899999999999999999999874 4567899999
Q ss_pred cCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCCCCC-
Q 028681 99 ASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP- 175 (205)
Q Consensus 99 ~~~~sl~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~~- 175 (205)
+++++|.+.+... ..+++..+..++.|++.||.+||+.+++|+||+|+||+++.++. ++|+|||.+.........
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~--~~L~dfg~~~~~~~~~~~~ 159 (262)
T cd05071 82 MSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLV--CKVADFGLARLIEDNEYTA 159 (262)
T ss_pred CCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCc--EEeccCCceeecccccccc
Confidence 9999999998653 35889999999999999999999999999999999999988777 999999998655432221
Q ss_pred -CCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 176 -KSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 176 -~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
....++..|+|||...+..++.+ +|||||
T Consensus 160 ~~~~~~~~~y~~PE~~~~~~~~~~-~Dvwsl 189 (262)
T cd05071 160 RQGAKFPIKWTAPEAALYGRFTIK-SDVWSF 189 (262)
T ss_pred ccCCcccceecCHhHhccCCCCch-hhHHHH
Confidence 22345678999999988888766 999996
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-33 Score=208.69 Aligned_cols=183 Identities=30% Similarity=0.489 Sum_probs=155.8
Q ss_pred CCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCcc-chHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEEe
Q 028681 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (205)
Q Consensus 20 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~ 98 (205)
.+.|++.+.||.|++|.||++.+..++..+++|.+..... ..+.+..|+.+++.++|+|++++++.+..++..+++|||
T Consensus 11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 90 (292)
T cd06644 11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEF 90 (292)
T ss_pred chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEec
Confidence 4779999999999999999999999999999999876543 346678899999999999999999999999999999999
Q ss_pred cCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCC-CCCC
Q 028681 99 ASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPK 176 (205)
Q Consensus 99 ~~~~sl~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~-~~~~ 176 (205)
+++++|...+.. ...+++..+..++.|++.++.+||+.+++|+||+|+||+++.++. ++|+|||.+...... ....
T Consensus 91 ~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~--~kl~dfg~~~~~~~~~~~~~ 168 (292)
T cd06644 91 CPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGD--IKLADFGVSAKNVKTLQRRD 168 (292)
T ss_pred CCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCC--EEEccCccceeccccccccc
Confidence 999999887754 456899999999999999999999999999999999999987776 999999987654322 2223
Q ss_pred CCCCCCCccCCceecc-----CcCCCeeeEEEeC
Q 028681 177 STVGTPAYIAPEVLLK-----KEYDGKVMCVYVI 205 (205)
Q Consensus 177 ~~~~~~~~~aPE~~~~-----~~~~~~~~Dvwsl 205 (205)
...+++.|+|||++.. ..++.+ +|||||
T Consensus 169 ~~~~~~~y~aPE~~~~~~~~~~~~~~~-~Dv~sl 201 (292)
T cd06644 169 SFIGTPYWMAPEVVMCETMKDTPYDYK-ADIWSL 201 (292)
T ss_pred eecCCccccCceeeccccccCCCCCch-hhhHhH
Confidence 4467889999999853 334444 999996
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-33 Score=205.62 Aligned_cols=182 Identities=26% Similarity=0.431 Sum_probs=157.4
Q ss_pred CCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCc----cchHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEE
Q 028681 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (205)
Q Consensus 21 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 96 (205)
++|++.+.||+|++|.||.+.+..++..|++|.++... ...+.+..|+.+++.++|++++++++.+..++..++++
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 68999999999999999999999899999999886432 22456889999999999999999999999999999999
Q ss_pred EecCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCC
Q 028681 97 EYASGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 172 (205)
Q Consensus 97 ~~~~~~sl~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~ 172 (205)
||+++++|.+.+.. ...+++.++..++.+++.|+.+||+.|++|+||+|+||+++.++. ++|+|||.+......
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~--~~l~d~~~~~~~~~~ 159 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGV--VKLGDLGLGRFFSSK 159 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCc--EEEeccceeeeccCC
Confidence 99999999988854 345899999999999999999999999999999999999988777 999999988654433
Q ss_pred CC-CCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 173 SQ-PKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 173 ~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
.. .....++..|.|||.+.+..++.+ +|+|||
T Consensus 160 ~~~~~~~~~~~~y~apE~~~~~~~~~~-~Di~sl 192 (267)
T cd08224 160 TTAAHSLVGTPYYMSPERIHENGYNFK-SDIWSL 192 (267)
T ss_pred CcccceecCCccccCHHHhccCCCCch-hcHHHH
Confidence 22 233457889999999988888755 999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-33 Score=207.63 Aligned_cols=185 Identities=21% Similarity=0.296 Sum_probs=154.8
Q ss_pred ecCCCeEEEeeeccccceeEEEEEecCC-----CcEEEEEEeecCcc--chHHHHHHHHHHHhcCCCCeeEEEEEEEeCC
Q 028681 18 HDSDRYELVRDIGSGNFGVARLMRDKKT-----EELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPT 90 (205)
Q Consensus 18 ~~~~~y~~~~~l~~g~~g~v~~~~~~~~-----~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 90 (205)
...++|++.+.||+|++|.||.+..... +..|++|.+..... ....+.+|+.+++.++|+|++++++++..+.
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~ 82 (277)
T cd05032 3 LPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQ 82 (277)
T ss_pred cchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCC
Confidence 3568999999999999999999988643 37899999875432 2346778999999999999999999999999
Q ss_pred eEEEEEEecCCCchHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEE
Q 028681 91 HLAIVMEYASGGELFERICNAG----------RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKI 160 (205)
Q Consensus 91 ~~~lv~~~~~~~sl~~~~~~~~----------~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l 160 (205)
..++++||+++++|.+.+.... .+++..+..++.|++.|+.|||+.+++|+||+|+||+++.++. ++|
T Consensus 83 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~--~kl 160 (277)
T cd05032 83 PTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLT--VKI 160 (277)
T ss_pred CcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCC--EEE
Confidence 9999999999999999886422 3677889999999999999999999999999999999998887 999
Q ss_pred eeecccccccCCC---CCCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 161 CDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 161 ~df~~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
+|||+++...... ......++..|+|||.+.+..++.+ +|||||
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~sl 207 (277)
T cd05032 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTK-SDVWSF 207 (277)
T ss_pred CCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcc-cchHHH
Confidence 9999986543322 1223346788999999988877755 999996
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=211.82 Aligned_cols=183 Identities=28% Similarity=0.508 Sum_probs=155.7
Q ss_pred CCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCcc---chHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEE
Q 028681 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (205)
Q Consensus 21 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~ 97 (205)
++|++.+.||+|++|.||++.+..+++.|++|.+..... ..+.+.+|+.+++.++|+|++++++++..++..++++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 479999999999999999999998899999998865432 23567889999999999999999999999999999999
Q ss_pred ecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCCC-CCC
Q 028681 98 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPK 176 (205)
Q Consensus 98 ~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~~-~~~ 176 (205)
|++++++.........+++..+..++.|++.|+.|||+.+++|+||+|+||++++++. ++|+|||++....... ...
T Consensus 81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~--~~l~dfg~~~~~~~~~~~~~ 158 (286)
T cd07846 81 FVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGV--VKLCDFGFARTLAAPGEVYT 158 (286)
T ss_pred cCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCc--EEEEeeeeeeeccCCccccC
Confidence 9998888877766667999999999999999999999999999999999999988877 9999999987543332 222
Q ss_pred CCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 177 STVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 177 ~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
...++..|+|||.+.+....+.++|||||
T Consensus 159 ~~~~~~~y~aPE~~~~~~~~~~~~Dv~sl 187 (286)
T cd07846 159 DYVATRWYRAPELLVGDTKYGRAVDIWAV 187 (286)
T ss_pred cccceeeccCcHHhccccccCchHhHHHH
Confidence 34578889999998764433345999986
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-33 Score=206.05 Aligned_cols=176 Identities=27% Similarity=0.399 Sum_probs=154.4
Q ss_pred eeeccccceeEEEEEecCC---CcEEEEEEeecCccc--hHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEEecCC
Q 028681 27 RDIGSGNFGVARLMRDKKT---EELVAVKYIERGDKI--DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASG 101 (205)
Q Consensus 27 ~~l~~g~~g~v~~~~~~~~---~~~v~iK~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~~~~ 101 (205)
+.||+|++|.||.+..... +..+++|.+...... .+.+..|+..++.++|+|++++++++......++++||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 4689999999999999876 889999998865443 46788999999999999999999999999999999999999
Q ss_pred CchHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCC
Q 028681 102 GELFERICNA---------GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 172 (205)
Q Consensus 102 ~sl~~~~~~~---------~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~ 172 (205)
++|.+.+... ..+++..+..++.|++.|+.+||+.+++|+||+|+||+++.++. ++|+|||.+......
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~--~~l~dfg~~~~~~~~ 158 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLV--VKISDFGLSRDVYDD 158 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCc--EEEcccccccccccc
Confidence 9999999775 67999999999999999999999999999999999999998877 999999998766543
Q ss_pred C---CCCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 173 S---QPKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 173 ~---~~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
. ......++..|+|||.+....++.+ +|||||
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~sl 193 (262)
T cd00192 159 DYYRKKTGGKLPIRWMAPESLKDGIFTSK-SDVWSF 193 (262)
T ss_pred cccccccCCCcCccccCHHHhccCCcchh-hccHHH
Confidence 2 2233457889999999988877655 999986
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-33 Score=207.97 Aligned_cols=182 Identities=31% Similarity=0.493 Sum_probs=156.8
Q ss_pred CeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCcc-------chHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEE
Q 028681 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK-------IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 94 (205)
Q Consensus 22 ~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~-------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 94 (205)
+|+..+.||+|++|.||.+.+..++..+++|.+..... ..+.+..|+..++.++|+|++++++++.+++..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 57888999999999999999999999999999875321 23568889999999999999999999999999999
Q ss_pred EEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCCCC
Q 028681 95 VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 174 (205)
Q Consensus 95 v~~~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~ 174 (205)
+++++.+++|.+.+...+++++..+..++.|++.|+.+||++|++|+||+|+||+++.++. .++|+|||.+........
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~-~~~l~dfg~~~~~~~~~~ 159 (268)
T cd06630 81 FVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQ-RLRIADFGAAARLAAKGT 159 (268)
T ss_pred EEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCC-EEEEcccccccccccccc
Confidence 9999999999999988788999999999999999999999999999999999999976543 389999999866543321
Q ss_pred C-----CCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 175 P-----KSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 175 ~-----~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
. ....++..|+|||.+.+..++.+ +|+|||
T Consensus 160 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~-~Dv~sl 194 (268)
T cd06630 160 GAGEFQGQLLGTIAFMAPEVLRGEQYGRS-CDVWSV 194 (268)
T ss_pred cCCccccccccccceeCHhHhccCCCCcc-cchHHH
Confidence 1 22357889999999988877755 999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-33 Score=205.31 Aligned_cols=174 Identities=31% Similarity=0.522 Sum_probs=153.9
Q ss_pred eccccceeEEEEEecCCCcEEEEEEeecCc----cchHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEEecCCCch
Q 028681 29 IGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL 104 (205)
Q Consensus 29 l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~~~~~sl 104 (205)
||.|++|.||.+.+..+++.+++|.+.... ...+.+..|+.+++.++|+|++++++.+.++...++++||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 689999999999999989999999987643 2335688899999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCCCCCCCCCCCCCc
Q 028681 105 FERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAY 184 (205)
Q Consensus 105 ~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~ 184 (205)
.+.+.+...+++..+..++.|++.||.+||+++++|+||+|+||+++.++. ++|+|||++.............++..|
T Consensus 81 ~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~--~~l~df~~~~~~~~~~~~~~~~~~~~~ 158 (262)
T cd05572 81 WTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGY--VKLVDFGFAKKLKSGQKTWTFCGTPEY 158 (262)
T ss_pred HHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCC--EEEeeCCcccccCcccccccccCCcCc
Confidence 999988778999999999999999999999999999999999999988877 999999998766544333445678899
Q ss_pred cCCceeccCcCCCeeeEEEeC
Q 028681 185 IAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 185 ~aPE~~~~~~~~~~~~Dvwsl 205 (205)
+|||.+.+..++.+ +|+|||
T Consensus 159 ~~PE~~~~~~~~~~-~Di~sl 178 (262)
T cd05572 159 VAPEIILNKGYDFS-VDYWSL 178 (262)
T ss_pred cChhHhcCCCCCCh-hhhhhh
Confidence 99999988877766 999996
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=211.61 Aligned_cols=183 Identities=26% Similarity=0.388 Sum_probs=151.9
Q ss_pred CCCeEEEeeeccccceeEEEEEecCC--------------CcEEEEEEeecCc--cchHHHHHHHHHHHhcCCCCeeEEE
Q 028681 20 SDRYELVRDIGSGNFGVARLMRDKKT--------------EELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFK 83 (205)
Q Consensus 20 ~~~y~~~~~l~~g~~g~v~~~~~~~~--------------~~~v~iK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~ 83 (205)
.++|++.+.||+|+||.||.+.+... ...|++|.+.... ...+.+.+|+..++.++|+|+++++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~ 83 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL 83 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence 46899999999999999999987543 2358999887542 2235688899999999999999999
Q ss_pred EEEEeCCeEEEEEEecCCCchHHHHHhcC------------CCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEec
Q 028681 84 EVILTPTHLAIVMEYASGGELFERICNAG------------RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLD 151 (205)
Q Consensus 84 ~~~~~~~~~~lv~~~~~~~sl~~~~~~~~------------~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~ 151 (205)
+++...+..+++|||+++++|.+.+.... .+++..+..++.|++.|+.|||+.+++|+||+|+||+++
T Consensus 84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nill~ 163 (295)
T cd05097 84 GVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVG 163 (295)
T ss_pred EEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhEEEc
Confidence 99999999999999999999998885431 367888999999999999999999999999999999998
Q ss_pred CCCCCcEEEeeecccccccCCCC---CCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 152 GSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 152 ~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
.++. ++|+|||++........ .....++..|+|||.+.+..++.+ +|||||
T Consensus 164 ~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~DvwSl 217 (295)
T cd05097 164 NHYT--IKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTA-SDVWAF 217 (295)
T ss_pred CCCc--EEecccccccccccCcceeccCcCcCceeecChhhhccCCcCch-hhHHHH
Confidence 7776 99999999865433221 122234678999999988888755 999996
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=204.92 Aligned_cols=182 Identities=33% Similarity=0.500 Sum_probs=155.0
Q ss_pred CCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCc------cchHHHHHHHHHHHhcCCCCeeEEEEEEEeC--CeE
Q 028681 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD------KIDENVQREIINHRSLRHPNIVRFKEVILTP--THL 92 (205)
Q Consensus 21 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~ 92 (205)
.+|++.+.||+|++|.||.+.+..++..|++|.+.... .....+.+|+.+++.++|+|++++++.+.+. ..+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 68999999999999999999999999999999875421 1224678899999999999999999998764 468
Q ss_pred EEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCC
Q 028681 93 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 172 (205)
Q Consensus 93 ~lv~~~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~ 172 (205)
++++|++++++|.+.+....++++..+..++.|++.|+.+||+++++|+||+|+||+++.++. ++|+|||.+......
T Consensus 82 ~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~--~~l~dfg~~~~~~~~ 159 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGN--VKLGDFGASKRIQTI 159 (264)
T ss_pred EEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCC--EEECccccccccccc
Confidence 899999999999999887777999999999999999999999999999999999999987776 999999998754321
Q ss_pred ----CCCCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 173 ----SQPKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 173 ----~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
.......++..|+|||.+.+..++.+ +|+|||
T Consensus 160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~sl 195 (264)
T cd06653 160 CMSGTGIKSVTGTPYWMSPEVISGEGYGRK-ADVWSV 195 (264)
T ss_pred cccCccccccCCcccccCHhhhcCCCCCcc-ccHHHH
Confidence 11123457889999999998877655 999986
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=204.69 Aligned_cols=181 Identities=33% Similarity=0.496 Sum_probs=158.3
Q ss_pred CeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCcc---chHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEEe
Q 028681 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (205)
Q Consensus 22 ~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~ 98 (205)
+|++.+.||+|++|.+|.+.+..++..+++|.+..... ....+..|+.+++.++|+|++++++.+...+..++++||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 58999999999999999999998899999999886544 346788999999999999999999999999999999999
Q ss_pred cCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCCCCCC--
Q 028681 99 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK-- 176 (205)
Q Consensus 99 ~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~~~-- 176 (205)
+++++|.+.+..+..+++..+..++.+++.|+.+||+.|++|+||+|+||+++.++. ++|+|||.+..........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~--~kl~d~g~~~~~~~~~~~~~~ 158 (264)
T cd06626 81 CSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGV--IKLGDFGCAVKLKNNTTTMGE 158 (264)
T ss_pred CCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCC--EEEcccccccccCCCCCcccc
Confidence 999999999988777899999999999999999999999999999999999998777 9999999987654332221
Q ss_pred ---CCCCCCCccCCceeccCc---CCCeeeEEEeC
Q 028681 177 ---STVGTPAYIAPEVLLKKE---YDGKVMCVYVI 205 (205)
Q Consensus 177 ---~~~~~~~~~aPE~~~~~~---~~~~~~Dvwsl 205 (205)
...++..|+|||++.... .+. ++|||||
T Consensus 159 ~~~~~~~~~~~~~PE~~~~~~~~~~~~-~~Dv~s~ 192 (264)
T cd06626 159 EVQSLAGTPAYMAPEVITGGKGKGHGR-AADIWSL 192 (264)
T ss_pred cccCCcCCcCccChhhccCCCCCCCCc-ccchHHH
Confidence 235788999999998765 554 4999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-33 Score=205.41 Aligned_cols=182 Identities=28% Similarity=0.470 Sum_probs=162.2
Q ss_pred CCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCcc--chHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEEe
Q 028681 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (205)
Q Consensus 21 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~ 98 (205)
++|++.+.||.|++|.+|.+.+..++..|++|.+..... ..+.+..|+..+..++|+|++++++.+..++..++++||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 479999999999999999999999999999999876543 356788999999999999999999999999999999999
Q ss_pred cCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-cCcEeecCCCCCeEecCCCCCcEEEeeecccccccCCCCCC-
Q 028681 99 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS-MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK- 176 (205)
Q Consensus 99 ~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~-~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~~~- 176 (205)
+++++|.+.+....++++..+..++.|++.|+.+||+ .+++|+||+|+||+++.++. ++|+|||.+..........
T Consensus 81 ~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~--~~l~df~~~~~~~~~~~~~~ 158 (264)
T cd06623 81 MDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGE--VKIADFGISKVLENTLDQCN 158 (264)
T ss_pred cCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCC--EEEccCccceecccCCCccc
Confidence 9999999999887889999999999999999999999 99999999999999988777 9999999887665443332
Q ss_pred CCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 177 STVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 177 ~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
...++..|+|||.+.+..++.+ +|+|||
T Consensus 159 ~~~~~~~y~~pE~~~~~~~~~~-~Dv~sl 186 (264)
T cd06623 159 TFVGTVTYMSPERIQGESYSYA-ADIWSL 186 (264)
T ss_pred ceeecccccCHhhhCCCCCCch-hhHHHH
Confidence 4457889999999988877655 999986
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-33 Score=207.97 Aligned_cols=181 Identities=29% Similarity=0.458 Sum_probs=156.2
Q ss_pred CeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCcc---chHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEEe
Q 028681 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (205)
Q Consensus 22 ~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~ 98 (205)
+|++.+.||+|++|.||.+.+..++..|++|.+..... ..+.+..|+.+++.++|+|++++++++..+...++++|+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 58999999999999999999998899999999876432 245688999999999999999999999999999999999
Q ss_pred cCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCCCC--C
Q 028681 99 ASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ--P 175 (205)
Q Consensus 99 ~~~~sl~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~--~ 175 (205)
+ +++|.+.+.. ..++++.+++.++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||.+........ .
T Consensus 81 ~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~--~~l~dfg~~~~~~~~~~~~~ 157 (286)
T cd07832 81 M-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGV--LKIADFGLARLFSEEEPRLY 157 (286)
T ss_pred c-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCc--EEEeeeeecccccCCCCCcc
Confidence 9 8899988854 456999999999999999999999999999999999999988776 99999998876544332 2
Q ss_pred CCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 176 KSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 176 ~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
....++..|+|||.+.+......++|||||
T Consensus 158 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~sl 187 (286)
T cd07832 158 SHQVATRWYRAPELLYGARKYDPGVDLWAV 187 (286)
T ss_pred ccccCcccccCceeeeccccCCchhHHHHH
Confidence 334688899999999765543455999985
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=210.65 Aligned_cols=183 Identities=27% Similarity=0.369 Sum_probs=155.0
Q ss_pred CCCeEEEeeeccccceeEEEEEecC-----CCcEEEEEEeecCccc--hHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeE
Q 028681 20 SDRYELVRDIGSGNFGVARLMRDKK-----TEELVAVKYIERGDKI--DENVQREIINHRSLRHPNIVRFKEVILTPTHL 92 (205)
Q Consensus 20 ~~~y~~~~~l~~g~~g~v~~~~~~~-----~~~~v~iK~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 92 (205)
..+|++.+.||+|++|.||.+.... ++..|++|.+...... .+.+..|+.+++.++|+|++++++++......
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 83 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP 83 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence 4679999999999999999998753 3578999998765433 46788999999999999999999999999999
Q ss_pred EEEEEecCCCchHHHHHhcC--------------CCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcE
Q 028681 93 AIVMEYASGGELFERICNAG--------------RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRL 158 (205)
Q Consensus 93 ~lv~~~~~~~sl~~~~~~~~--------------~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~ 158 (205)
+++|||+++++|.+.+...+ .+++..+..++.|++.|+.+||+.|++|+||+|+||+++.++. +
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~--~ 161 (280)
T cd05049 84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLV--V 161 (280)
T ss_pred EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCCe--E
Confidence 99999999999999986532 3788899999999999999999999999999999999988877 9
Q ss_pred EEeeecccccccCCCC---CCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 159 KICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 159 ~l~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
+|+|||.+........ .....+++.|+|||++.+..++.+ +|||||
T Consensus 162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~sl 210 (280)
T cd05049 162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTE-SDVWSF 210 (280)
T ss_pred EECCcccceecccCcceecCCCCcccceecChhhhccCCcchh-hhHHHH
Confidence 9999999865432221 122345678999999998888766 999996
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-32 Score=205.81 Aligned_cols=187 Identities=29% Similarity=0.509 Sum_probs=156.6
Q ss_pred ceecCCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCccchHHHHHHHHHHHhc-CCCCeeEEEEEEEeC-----
Q 028681 16 IMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSL-RHPNIVRFKEVILTP----- 89 (205)
Q Consensus 16 ~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~----- 89 (205)
+....++|++.+.||+|++|.||.+.+..+++.+++|.+.......+.+..|+.+++++ .|+|++++++++...
T Consensus 17 ~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 96 (291)
T cd06639 17 LGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVG 96 (291)
T ss_pred CCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCC
Confidence 33457889999999999999999999999999999999876555556778899999988 799999999998754
Q ss_pred CeEEEEEEecCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecc
Q 028681 90 THLAIVMEYASGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGY 165 (205)
Q Consensus 90 ~~~~lv~~~~~~~sl~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~ 165 (205)
+..++++||+++++|.+.+.. ...+++..++.++.|++.|+.+||+.+++|+||+|+||+++.++. ++|+|||+
T Consensus 97 ~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~--~kl~dfg~ 174 (291)
T cd06639 97 GQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGG--VKLVDFGV 174 (291)
T ss_pred CeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCC--EEEeeccc
Confidence 358999999999999887752 456899999999999999999999999999999999999988777 99999999
Q ss_pred cccccCCC-CCCCCCCCCCccCCceeccCc-----CCCeeeEEEeC
Q 028681 166 SKSSVLHS-QPKSTVGTPAYIAPEVLLKKE-----YDGKVMCVYVI 205 (205)
Q Consensus 166 ~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~-----~~~~~~Dvwsl 205 (205)
+....... ......++..|+|||.+.... ++ .++|||||
T Consensus 175 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~-~~~Di~sl 219 (291)
T cd06639 175 SAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYD-ARCDVWSL 219 (291)
T ss_pred chhcccccccccCccCCccccChhhhcCCCCcccccC-CccchHHH
Confidence 87554332 223345788999999986543 34 44999996
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=206.50 Aligned_cols=176 Identities=28% Similarity=0.352 Sum_probs=148.5
Q ss_pred eeeccccceeEEEEEecCCCcEEEEEEeecCc--cchHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEEecCCCch
Q 028681 27 RDIGSGNFGVARLMRDKKTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL 104 (205)
Q Consensus 27 ~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~~~~~sl 104 (205)
+.||+|++|.||.+.+..+++.+++|.+.... .....+.+|+.+++.++|+|++++++++......++++||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 46899999999999999899999999876432 2345688999999999999999999999999999999999999999
Q ss_pred HHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCCCCCC---CCCC
Q 028681 105 FERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK---STVG 180 (205)
Q Consensus 105 ~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~~~---~~~~ 180 (205)
.+.+... ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++. ++|+|||.+.......... ....
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~~ 158 (252)
T cd05084 81 LTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNV--LKISDFGMSREEEDGVYASTGGMKQI 158 (252)
T ss_pred HHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCc--EEECccccCcccccccccccCCCCCC
Confidence 9988654 45899999999999999999999999999999999999988776 9999999886543221111 1123
Q ss_pred CCCccCCceeccCcCCCeeeEEEeC
Q 028681 181 TPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 181 ~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
+..|+|||.+.+..++.+ +|||||
T Consensus 159 ~~~y~aPE~~~~~~~~~~-~Dv~sl 182 (252)
T cd05084 159 PVKWTAPEALNYGRYSSE-SDVWSF 182 (252)
T ss_pred ceeecCchhhcCCCCChH-HHHHHH
Confidence 457999999988888766 999996
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-33 Score=208.72 Aligned_cols=184 Identities=19% Similarity=0.271 Sum_probs=151.8
Q ss_pred cCCCeEEEeeeccccceeEEEEEecC-----CCcEEEEEEeecCcc--chHHHHHHHHHHHhcCCCCeeEEEEEEEeCCe
Q 028681 19 DSDRYELVRDIGSGNFGVARLMRDKK-----TEELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTH 91 (205)
Q Consensus 19 ~~~~y~~~~~l~~g~~g~v~~~~~~~-----~~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 91 (205)
..++|++.+.||+|++|.||.+.+.. .+..|++|.+..... ...++.+|+.+++.++|+|++++++++.....
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 83 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 83 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 45789999999999999999988642 356799998865332 23457889999999999999999999999999
Q ss_pred EEEEEEecCCCchHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEe
Q 028681 92 LAIVMEYASGGELFERICNAG----------RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKIC 161 (205)
Q Consensus 92 ~~lv~~~~~~~sl~~~~~~~~----------~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~ 161 (205)
.++++||+++++|.+.+.... .++...+..++.|++.|+.|||+.+++|+||+|+||++++++. ++|+
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~--~~l~ 161 (277)
T cd05062 84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFT--VKIG 161 (277)
T ss_pred eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCC--EEEC
Confidence 999999999999999886522 3577889999999999999999999999999999999998777 9999
Q ss_pred eecccccccCCCC---CCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 162 DFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 162 df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
|||++........ .....++..|+|||.+.+..++.+ +|||||
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~sl 207 (277)
T cd05062 162 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTY-SDVWSF 207 (277)
T ss_pred CCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCch-hHHHHH
Confidence 9998865432221 112235678999999988887755 999996
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-33 Score=208.66 Aligned_cols=179 Identities=20% Similarity=0.161 Sum_probs=150.3
Q ss_pred CCCeEEE--eeeccccceeEEEEEecCCCcEEEEEEeecCccch----HHHHHHHHHHHhcCCCCeeEEEEEEEe----C
Q 028681 20 SDRYELV--RDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID----ENVQREIINHRSLRHPNIVRFKEVILT----P 89 (205)
Q Consensus 20 ~~~y~~~--~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~----~ 89 (205)
.++++.. ..|++|+++.||.+.. +++.||+|.+....... +.+.+|+.++++++||||+++++++.+ .
T Consensus 17 ~~~i~~~~~~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~ 94 (283)
T PHA02988 17 SDDIDKYTSVLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDL 94 (283)
T ss_pred HHHcCCCCCeEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCC
Confidence 3444444 6789999999999987 47889999997654333 567799999999999999999999877 3
Q ss_pred CeEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-cCcEeecCCCCCeEecCCCCCcEEEeeeccccc
Q 028681 90 THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS-MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 168 (205)
Q Consensus 90 ~~~~lv~~~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~-~~i~H~di~p~nili~~~~~~~~~l~df~~~~~ 168 (205)
...++++||+++++|.+.+...+.+++.....++.+++.|+.+||+ .+++|+||+|+||+++.++. ++|+|||++..
T Consensus 95 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~--~kl~dfg~~~~ 172 (283)
T PHA02988 95 PRLSLILEYCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYK--LKIICHGLEKI 172 (283)
T ss_pred CceEEEEEeCCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCc--EEEcccchHhh
Confidence 5789999999999999999888889999999999999999999998 59999999999999998877 99999999875
Q ss_pred ccCCCCCCCCCCCCCccCCceecc--CcCCCeeeEEEeC
Q 028681 169 SVLHSQPKSTVGTPAYIAPEVLLK--KEYDGKVMCVYVI 205 (205)
Q Consensus 169 ~~~~~~~~~~~~~~~~~aPE~~~~--~~~~~~~~Dvwsl 205 (205)
.... .....++..|+|||++.+ ..++.+ +|||||
T Consensus 173 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~k-~Di~Sl 208 (283)
T PHA02988 173 LSSP--PFKNVNFMVYFSYKMLNDIFSEYTIK-DDIYSL 208 (283)
T ss_pred hccc--cccccCcccccCHHHhhhccccccch-hhhhHH
Confidence 4322 233467899999999976 566655 999996
|
|
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-33 Score=206.28 Aligned_cols=184 Identities=24% Similarity=0.299 Sum_probs=157.8
Q ss_pred ecCCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCccchHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEE
Q 028681 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (205)
Q Consensus 18 ~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~ 97 (205)
...++|++.+.||.|++|.||.+.... +..+++|.+.......+.+.+|+.+++.++|+|++++++++......++++|
T Consensus 3 ~~~~~~~i~~~ig~g~~~~v~~~~~~~-~~~~~vK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 81 (261)
T cd05034 3 IPRESLKLERKLGAGQFGEVWMGTWNG-TTKVAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTE 81 (261)
T ss_pred cchhheeeeeeeccCcceEEEEEEEcC-CceEEEEEecCCccCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEe
Confidence 457899999999999999999998764 5779999988766667789999999999999999999999998899999999
Q ss_pred ecCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCCCC-
Q 028681 98 YASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ- 174 (205)
Q Consensus 98 ~~~~~sl~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~- 174 (205)
++++++|.+.+... ..++...+..++.+++.|+.+||+++++|+||+|+||+++.++. ++|+|||.+........
T Consensus 82 ~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~--~~l~d~g~~~~~~~~~~~ 159 (261)
T cd05034 82 YMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLV--CKIADFGLARLIEDDEYT 159 (261)
T ss_pred ccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCC--EEECccccceeccchhhh
Confidence 99999999998654 36899999999999999999999999999999999999988877 99999998865543211
Q ss_pred -CCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 175 -PKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 175 -~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
......+..|+|||.+.+..++.+ +|+|||
T Consensus 160 ~~~~~~~~~~y~~PE~~~~~~~~~~-~Di~sl 190 (261)
T cd05034 160 AREGAKFPIKWTAPEAANYGRFTIK-SDVWSF 190 (261)
T ss_pred hhhccCCCccccCHHHhccCCcCch-hHHHHH
Confidence 112234567999999988777655 999986
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=206.43 Aligned_cols=181 Identities=29% Similarity=0.477 Sum_probs=153.4
Q ss_pred CeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCcc-chHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEEecC
Q 028681 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYAS 100 (205)
Q Consensus 22 ~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~~~ 100 (205)
-|++.+.||+|++|.||++.+..++..+++|.+..... ..+.+..|+.+++.+.|+|++++++.+..++..++++||++
T Consensus 6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~ 85 (282)
T cd06643 6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCA 85 (282)
T ss_pred HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecC
Confidence 36888999999999999999999999999998875432 34567889999999999999999999999999999999999
Q ss_pred CCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCC-CCCCCC
Q 028681 101 GGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKST 178 (205)
Q Consensus 101 ~~sl~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~-~~~~~~ 178 (205)
+++|...+.. ..++++..+..++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||++...... ......
T Consensus 86 ~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~--~kl~dfg~~~~~~~~~~~~~~~ 163 (282)
T cd06643 86 GGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGD--IKLADFGVSAKNTRTIQRRDSF 163 (282)
T ss_pred CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCC--EEEccccccccccccccccccc
Confidence 9999887754 457999999999999999999999999999999999999988777 999999988654322 222334
Q ss_pred CCCCCccCCceec-----cCcCCCeeeEEEeC
Q 028681 179 VGTPAYIAPEVLL-----KKEYDGKVMCVYVI 205 (205)
Q Consensus 179 ~~~~~~~aPE~~~-----~~~~~~~~~Dvwsl 205 (205)
.++..|+|||++. +..++. ++|||||
T Consensus 164 ~~~~~y~aPE~~~~~~~~~~~~~~-~~Dv~sl 194 (282)
T cd06643 164 IGTPYWMAPEVVMCETSKDRPYDY-KADVWSL 194 (282)
T ss_pred cccccccCHhhccccCCCCCCCCc-cchhhhH
Confidence 5888999999985 334544 4999996
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-33 Score=206.26 Aligned_cols=182 Identities=25% Similarity=0.345 Sum_probs=153.2
Q ss_pred cCCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCccchHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEEe
Q 028681 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (205)
Q Consensus 19 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~ 98 (205)
..++|++.+.||+|++|.||.+.... +..+++|.+.......+.+.+|+.+++.++|++++++++++. ....+++|++
T Consensus 4 ~~~~~~~~~~ig~g~~~~v~~~~~~~-~~~~~~k~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~ 81 (260)
T cd05070 4 PRESLQLIKKLGNGQFGEVWMGTWNG-NTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEY 81 (260)
T ss_pred chHHhhhhheeccccCceEEEEEecC-CceeEEEEecCCCCCHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEe
Confidence 45789999999999999999998764 566999998876666678899999999999999999999875 4567899999
Q ss_pred cCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCCCCC-
Q 028681 99 ASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP- 175 (205)
Q Consensus 99 ~~~~sl~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~~- 175 (205)
+++++|.+.+... ..+++..+..++.+++.|+.|||+.+++|+||+|+||+++.++. ++|+|||.+.........
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~--~~l~dfg~~~~~~~~~~~~ 159 (260)
T cd05070 82 MSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLV--CKIADFGLARLIEDNEYTA 159 (260)
T ss_pred cCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCce--EEeCCceeeeeccCccccc
Confidence 9999999988653 35899999999999999999999999999999999999988776 999999998654332211
Q ss_pred -CCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 176 -KSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 176 -~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
....++..|+|||.+.+..++.+ +|+|||
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~-~Di~sl 189 (260)
T cd05070 160 RQGAKFPIKWTAPEAALYGRFTIK-SDVWSF 189 (260)
T ss_pred ccCCCCCccccChHHHhcCCCcch-hhhHHH
Confidence 12235567999999988877755 999996
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=203.45 Aligned_cols=181 Identities=30% Similarity=0.558 Sum_probs=156.5
Q ss_pred CeEEEeeeccccceeEEEEEecCCCcEEEEEEeecC---ccchHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEEe
Q 028681 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG---DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (205)
Q Consensus 22 ~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~ 98 (205)
+|++.+.||+|++|.+|.+.+..+++.|++|.+... ....+++..|+..++.++|+|++++.+.+...+..++++|+
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 589999999999999999999999999999998753 22345788899999999999999999999999999999999
Q ss_pred cCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCCCCC-
Q 028681 99 ASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP- 175 (205)
Q Consensus 99 ~~~~sl~~~~~~~~--~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~~- 175 (205)
+++++|.+.+.... .+++.++..++.|++.|+.+||+++++|+||+|+||+++.++. ++|+|||.+.........
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~--~~l~d~~~~~~~~~~~~~~ 158 (256)
T cd08218 81 CEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGT--IKLGDFGIARVLNSTVELA 158 (256)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCC--EEEeeccceeecCcchhhh
Confidence 99999998886533 5789999999999999999999999999999999999988777 999999988655433222
Q ss_pred CCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 176 KSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 176 ~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
....+++.|+|||++.+...+.+ +|+|||
T Consensus 159 ~~~~~~~~~~~pe~~~~~~~~~~-~Dv~sl 187 (256)
T cd08218 159 RTCIGTPYYLSPEICENRPYNNK-SDIWAL 187 (256)
T ss_pred hhccCCccccCHHHhCCCCCCCc-cchhHH
Confidence 22357888999999988887765 999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-33 Score=207.69 Aligned_cols=183 Identities=29% Similarity=0.448 Sum_probs=151.9
Q ss_pred CCCeEEEeeeccccceeEEEEEe----cCCCcEEEEEEeecCccc-hHHHHHHHHHHHhcCCCCeeEEEEEEEeC--CeE
Q 028681 20 SDRYELVRDIGSGNFGVARLMRD----KKTEELVAVKYIERGDKI-DENVQREIINHRSLRHPNIVRFKEVILTP--THL 92 (205)
Q Consensus 20 ~~~y~~~~~l~~g~~g~v~~~~~----~~~~~~v~iK~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~ 92 (205)
..+|++.+.||+|++|.||.+.. ..++..|++|.+...... .+.+..|+.+++.++|+|++++.+++... ...
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 82 (284)
T cd05081 3 ERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 82 (284)
T ss_pred cccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCce
Confidence 46899999999999999999873 456789999998765432 45688999999999999999999987543 468
Q ss_pred EEEEEecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccC
Q 028681 93 AIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 171 (205)
Q Consensus 93 ~lv~~~~~~~sl~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~ 171 (205)
++++||+++++|.+.+... ..+++..+..++.|++.||.+||++|++|+||+|+||+++.++. ++|+|||++.....
T Consensus 83 ~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~--~~l~dfg~~~~~~~ 160 (284)
T cd05081 83 RLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENR--VKIGDFGLTKVLPQ 160 (284)
T ss_pred EEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCe--EEECCCcccccccC
Confidence 8999999999999998654 45899999999999999999999999999999999999988777 99999999876543
Q ss_pred CCCC----CCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 172 HSQP----KSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 172 ~~~~----~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
.... ....++..|+|||.+.+..++.+ +|||||
T Consensus 161 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~sl 197 (284)
T cd05081 161 DKEYYKVREPGESPIFWYAPESLTESKFSVA-SDVWSF 197 (284)
T ss_pred CCcceeecCCCCCceEeeCHHHhccCCcChH-HHHHHH
Confidence 3221 11123456999999988877755 999996
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=208.59 Aligned_cols=182 Identities=27% Similarity=0.415 Sum_probs=156.7
Q ss_pred CCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCc----cchHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEE
Q 028681 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (205)
Q Consensus 21 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 96 (205)
++|++.+.||+|++|.||++.+..++..+++|.+.... ...+.+.+|+.+++.++|+|++++++.+..++..++++
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 67999999999999999999999899999999886532 22356788999999999999999999999999999999
Q ss_pred EecCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCC
Q 028681 97 EYASGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 172 (205)
Q Consensus 97 ~~~~~~sl~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~ 172 (205)
+++++++|.+.+.. ...+++..+..++.|++.|+.+||++|++|+||+|+||+++.++. ++|+|||.+......
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~--~~l~dfg~~~~~~~~ 159 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGV--VKLGDLGLGRFFSSK 159 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCC--EEECcchhhhccccC
Confidence 99999999988753 345899999999999999999999999999999999999988777 999999988655433
Q ss_pred CC-CCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 173 SQ-PKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 173 ~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
.. .....++..|+|||.+.+..++.+ +|+|||
T Consensus 160 ~~~~~~~~~~~~~~ape~~~~~~~~~~-~Dv~sl 192 (267)
T cd08229 160 TTAAHSLVGTPYYMSPERIHENGYNFK-SDIWSL 192 (267)
T ss_pred CcccccccCCcCccCHHHhcCCCccch-hhHHHH
Confidence 22 223458889999999988877755 999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=209.53 Aligned_cols=183 Identities=30% Similarity=0.474 Sum_probs=156.4
Q ss_pred CCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCcc-chHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEEe
Q 028681 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (205)
Q Consensus 20 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~ 98 (205)
.++|++.+.||.|++|.||.+.+..++..+++|.+..... ..+.+..|+.++++++|+|++++++.+..+...+++|||
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF 83 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence 4679999999999999999999988899999999876533 335688899999999999999999999999999999999
Q ss_pred cCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCCC-CCC
Q 028681 99 ASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPK 176 (205)
Q Consensus 99 ~~~~sl~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~~-~~~ 176 (205)
+++++|.+.+.. ...+++..++.++.|++.|+.|||+.+++|+||+|+||+++.++. ++|+|||.+....... ...
T Consensus 84 ~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~--~~l~d~g~~~~~~~~~~~~~ 161 (280)
T cd06611 84 CDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGD--VKLADFGVSAKNKSTLQKRD 161 (280)
T ss_pred cCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCC--EEEccCccchhhcccccccc
Confidence 999999998866 356999999999999999999999999999999999999988777 9999999876543322 223
Q ss_pred CCCCCCCccCCceecc-----CcCCCeeeEEEeC
Q 028681 177 STVGTPAYIAPEVLLK-----KEYDGKVMCVYVI 205 (205)
Q Consensus 177 ~~~~~~~~~aPE~~~~-----~~~~~~~~Dvwsl 205 (205)
...++..|+|||.+.. ..++.+ +|+|||
T Consensus 162 ~~~~~~~y~~PE~~~~~~~~~~~~~~~-sDi~sl 194 (280)
T cd06611 162 TFIGTPYWMAPEVVACETFKDNPYDYK-ADIWSL 194 (280)
T ss_pred eeecchhhcCHHHHhhcccCCCCCCcc-ccHHHH
Confidence 3458889999999853 334444 999986
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=207.17 Aligned_cols=183 Identities=31% Similarity=0.506 Sum_probs=153.3
Q ss_pred cCCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCcc--chHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEE
Q 028681 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (205)
Q Consensus 19 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 96 (205)
..++|++.+.||+|++|.||++.+..++..|++|.+..... ....+.+|+.+++.++|+|++++.+++..++..++|+
T Consensus 3 ~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 82 (291)
T cd07844 3 KLETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVF 82 (291)
T ss_pred CccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEE
Confidence 35889999999999999999999998899999999875432 2345678999999999999999999999999999999
Q ss_pred EecCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCCCC-
Q 028681 97 EYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ- 174 (205)
Q Consensus 97 ~~~~~~sl~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~- 174 (205)
||+++ +|.+.+.. ...+++..++.++.|++.||.|||+.+++|+||+|+||+++.++. ++|+|||++........
T Consensus 83 e~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~--~kl~dfg~~~~~~~~~~~ 159 (291)
T cd07844 83 EYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGE--LKLADFGLARAKSVPSKT 159 (291)
T ss_pred ecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCC--EEECccccccccCCCCcc
Confidence 99975 88887765 346899999999999999999999999999999999999988877 99999998865432211
Q ss_pred CCCCCCCCCccCCceeccCc-CCCeeeEEEeC
Q 028681 175 PKSTVGTPAYIAPEVLLKKE-YDGKVMCVYVI 205 (205)
Q Consensus 175 ~~~~~~~~~~~aPE~~~~~~-~~~~~~Dvwsl 205 (205)
.....++..|+|||.+.+.. ++. ++|||||
T Consensus 160 ~~~~~~~~~~~aPE~~~~~~~~~~-~~Dv~sl 190 (291)
T cd07844 160 YSNEVVTLWYRPPDVLLGSTEYST-SLDMWGV 190 (291)
T ss_pred ccccccccccCCcHHhhcCcccCc-HHHHHHH
Confidence 12234678899999987644 554 4999996
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=215.24 Aligned_cols=184 Identities=24% Similarity=0.364 Sum_probs=151.0
Q ss_pred cCCCeEEEeeeccccceeEEEEEecC-----CCcEEEEEEeecCcc--chHHHHHHHHHHHhc-CCCCeeEEEEEEEeC-
Q 028681 19 DSDRYELVRDIGSGNFGVARLMRDKK-----TEELVAVKYIERGDK--IDENVQREIINHRSL-RHPNIVRFKEVILTP- 89 (205)
Q Consensus 19 ~~~~y~~~~~l~~g~~g~v~~~~~~~-----~~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~- 89 (205)
..++|++.+.||+|+||.||.+.... +++.|++|.+..... ..+.+..|+.++.++ +|+||+++++++...
T Consensus 5 ~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~ 84 (337)
T cd05054 5 PRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPG 84 (337)
T ss_pred CHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCC
Confidence 45789999999999999999997543 357899998875322 234577899999999 799999999988754
Q ss_pred CeEEEEEEecCCCchHHHHHhc----------------------------------------------------------
Q 028681 90 THLAIVMEYASGGELFERICNA---------------------------------------------------------- 111 (205)
Q Consensus 90 ~~~~lv~~~~~~~sl~~~~~~~---------------------------------------------------------- 111 (205)
..++++++|+++++|.+.+...
T Consensus 85 ~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (337)
T cd05054 85 GPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDE 164 (337)
T ss_pred CCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhH
Confidence 5688999999999998887532
Q ss_pred ---CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCCCC---CCCCCCCCCcc
Q 028681 112 ---GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYI 185 (205)
Q Consensus 112 ---~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~ 185 (205)
.++++..+..++.|++.||+|||+++|+|+||+|+||+++.++. ++|+|||++........ .....++..|+
T Consensus 165 ~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~--vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~ 242 (337)
T cd05054 165 LYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNV--VKICDFGLARDIYKDPDYVRKGDARLPLKWM 242 (337)
T ss_pred HhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCc--EEEeccccchhcccCcchhhccCCCCCcccc
Confidence 25788999999999999999999999999999999999998776 99999999876433221 22234567899
Q ss_pred CCceeccCcCCCeeeEEEeC
Q 028681 186 APEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 186 aPE~~~~~~~~~~~~Dvwsl 205 (205)
|||++.+..++.+ +|||||
T Consensus 243 aPE~~~~~~~~~~-~Di~Sl 261 (337)
T cd05054 243 APESIFDKVYTTQ-SDVWSF 261 (337)
T ss_pred CcHHhcCCCCCcc-ccHHHH
Confidence 9999999888877 999996
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-33 Score=209.70 Aligned_cols=185 Identities=25% Similarity=0.331 Sum_probs=152.4
Q ss_pred ecCCCeEEEeeeccccceeEEEEEecC-------CCcEEEEEEeecCc--cchHHHHHHHHHHHhc-CCCCeeEEEEEEE
Q 028681 18 HDSDRYELVRDIGSGNFGVARLMRDKK-------TEELVAVKYIERGD--KIDENVQREIINHRSL-RHPNIVRFKEVIL 87 (205)
Q Consensus 18 ~~~~~y~~~~~l~~g~~g~v~~~~~~~-------~~~~v~iK~~~~~~--~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~ 87 (205)
...++|.+.+.||+|+||.||.+.+.. ....+++|.+.... .....+..|+.+++.+ +|+|++++++++.
T Consensus 15 ~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 94 (307)
T cd05098 15 VPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT 94 (307)
T ss_pred eehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEe
Confidence 335899999999999999999998643 23469999887542 2235677899999999 7999999999999
Q ss_pred eCCeEEEEEEecCCCchHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEec
Q 028681 88 TPTHLAIVMEYASGGELFERICNAG----------------RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLD 151 (205)
Q Consensus 88 ~~~~~~lv~~~~~~~sl~~~~~~~~----------------~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~ 151 (205)
..+..++++||+++++|.+.+.... .++..++..++.|++.||.+||++|++|+||+|+||+++
T Consensus 95 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~ 174 (307)
T cd05098 95 QDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT 174 (307)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHheEEc
Confidence 9999999999999999999986532 378889999999999999999999999999999999998
Q ss_pred CCCCCcEEEeeecccccccCCCC---CCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 152 GSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 152 ~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
.++. ++|+|||.+........ .....+++.|+|||++.+..++.+ +|||||
T Consensus 175 ~~~~--~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Dvwsl 228 (307)
T cd05098 175 EDNV--MKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQ-SDVWSF 228 (307)
T ss_pred CCCc--EEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcH-HHHHHH
Confidence 8876 99999999865432211 111234568999999988887755 999996
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-33 Score=206.67 Aligned_cols=184 Identities=25% Similarity=0.351 Sum_probs=153.8
Q ss_pred cCCCeEEEeeeccccceeEEEEEecCCC---cEEEEEEeecCc--cchHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEE
Q 028681 19 DSDRYELVRDIGSGNFGVARLMRDKKTE---ELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLA 93 (205)
Q Consensus 19 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~---~~v~iK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 93 (205)
+..+|++.+.||+|++|.||.+.+..++ ..+++|.+.... ...+.+..|+..++.++|||++++++++..++..+
T Consensus 2 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 81 (267)
T cd05066 2 DASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVM 81 (267)
T ss_pred CHHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence 3578999999999999999999876443 378999886542 23457888999999999999999999999999999
Q ss_pred EEEEecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCC
Q 028681 94 IVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 172 (205)
Q Consensus 94 lv~~~~~~~sl~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~ 172 (205)
++||++++++|.+.+... ..++..++..++.|++.|+.+||+.+++|+||+|+||+++.++. ++|+|||++......
T Consensus 82 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~--~~l~dfg~~~~~~~~ 159 (267)
T cd05066 82 IVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLV--CKVSDFGLSRVLEDD 159 (267)
T ss_pred EEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCe--EEeCCCCcccccccc
Confidence 999999999999998664 46899999999999999999999999999999999999987776 999999998765432
Q ss_pred CCCC----CCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 173 SQPK----STVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 173 ~~~~----~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
.... ....+..|+|||.+.+..++.+ +|+|||
T Consensus 160 ~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~-~Dv~sl 195 (267)
T cd05066 160 PEAAYTTRGGKIPIRWTAPEAIAYRKFTSA-SDVWSY 195 (267)
T ss_pred cceeeecCCCccceeecCHhHhccCccCch-hhhHHH
Confidence 2211 1123467999999998888766 999986
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=210.37 Aligned_cols=182 Identities=26% Similarity=0.440 Sum_probs=159.6
Q ss_pred CCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCc--cchHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEE
Q 028681 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (205)
Q Consensus 20 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~ 97 (205)
.++|++.+.||+|++|+||++.+..++..|++|.+.... ...+.+.+|+.+++.++|+|++++++.+...+..++++|
T Consensus 4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (284)
T cd06620 4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCME 83 (284)
T ss_pred HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEe
Confidence 478999999999999999999999999999999887543 234678899999999999999999999999999999999
Q ss_pred ecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-cCcEeecCCCCCeEecCCCCCcEEEeeecccccccCCCCCC
Q 028681 98 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS-MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK 176 (205)
Q Consensus 98 ~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~-~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~~~ 176 (205)
|+++++|.+.+...+++++..+..++.+++.++.|||+ .+++|+||+|+||+++.++. ++|+|||++..... ....
T Consensus 84 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~--~~l~d~gl~~~~~~-~~~~ 160 (284)
T cd06620 84 FMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQ--IKLCDFGVSGELIN-SIAD 160 (284)
T ss_pred cCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCc--EEEccCCcccchhh-hccC
Confidence 99999999988877789999999999999999999996 69999999999999988776 99999998764322 2223
Q ss_pred CCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 177 STVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 177 ~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
...++..|+|||++.+..++.+ +|||||
T Consensus 161 ~~~~~~~~~aPE~~~~~~~~~~-~Di~sl 188 (284)
T cd06620 161 TFVGTSTYMSPERIQGGKYTVK-SDVWSL 188 (284)
T ss_pred ccccCcccCCHHHHccCCCCcc-chHHHH
Confidence 4568999999999988877766 999986
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-33 Score=206.75 Aligned_cols=184 Identities=28% Similarity=0.473 Sum_probs=155.9
Q ss_pred cCCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCccchHHHHHHHHHHHhc-CCCCeeEEEEEEEeC------Ce
Q 028681 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSL-RHPNIVRFKEVILTP------TH 91 (205)
Q Consensus 19 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~------~~ 91 (205)
..+.|++.+.||+|++|.||.+....++..+++|.+.........+..|+.+++.+ +|+|++++.+++... ..
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~ 83 (272)
T cd06637 4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQ 83 (272)
T ss_pred hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcE
Confidence 35679999999999999999999999999999999987665667788899999988 699999999998753 46
Q ss_pred EEEEEEecCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccc
Q 028681 92 LAIVMEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 169 (205)
Q Consensus 92 ~~lv~~~~~~~sl~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~ 169 (205)
.++++||+++++|.+.+... ..+++..+..++.|++.|+.|||+++++|+||+|+||+++.++. ++|+|||++...
T Consensus 84 ~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~--~~l~Dfg~~~~~ 161 (272)
T cd06637 84 LWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAE--VKLVDFGVSAQL 161 (272)
T ss_pred EEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCC--EEEccCCCceec
Confidence 88999999999999988753 35899999999999999999999999999999999999998877 999999998754
Q ss_pred cCC-CCCCCCCCCCCccCCceecc-----CcCCCeeeEEEeC
Q 028681 170 VLH-SQPKSTVGTPAYIAPEVLLK-----KEYDGKVMCVYVI 205 (205)
Q Consensus 170 ~~~-~~~~~~~~~~~~~aPE~~~~-----~~~~~~~~Dvwsl 205 (205)
... .......++..|+|||++.. ..++.+ +|||||
T Consensus 162 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~-~Dv~sl 202 (272)
T cd06637 162 DRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFK-SDLWSL 202 (272)
T ss_pred ccccccCCcccccccccCHhHhccccCcCCCCCch-hhHHHH
Confidence 332 22234468899999999863 345544 999996
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=203.80 Aligned_cols=182 Identities=23% Similarity=0.339 Sum_probs=154.2
Q ss_pred cCCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCccchHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEEe
Q 028681 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (205)
Q Consensus 19 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~ 98 (205)
..++|++.+.||+|++|.||++.... +..+++|.+.......+.+.+|+.+++.++|+|++++++++. .+..++++|+
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~-~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~ 81 (260)
T cd05067 4 PRETLKLVKKLGAGQFGEVWMGYYNG-HTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEY 81 (260)
T ss_pred chHHceeeeeeccCccceEEeeecCC-CceEEEEEecCCCCcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEc
Confidence 46789999999999999999998654 678999999876666678899999999999999999999864 4578999999
Q ss_pred cCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCCCC--
Q 028681 99 ASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-- 174 (205)
Q Consensus 99 ~~~~sl~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~-- 174 (205)
+.+++|.+.+... ..++..++..++.|++.||++||+.|++|+||+|+||+++.++. ++|+|||.+........
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~--~~l~dfg~~~~~~~~~~~~ 159 (260)
T cd05067 82 MENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLC--CKIADFGLARLIEDNEYTA 159 (260)
T ss_pred CCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCC--EEEccCcceeecCCCCccc
Confidence 9999999988653 35889999999999999999999999999999999999998877 99999998865542221
Q ss_pred CCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 175 PKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 175 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
.....++..|+|||++....++.+ +|||||
T Consensus 160 ~~~~~~~~~y~~pe~~~~~~~~~~-~Di~sl 189 (260)
T cd05067 160 REGAKFPIKWTAPEAINYGTFTIK-SDVWSF 189 (260)
T ss_pred ccCCcccccccCHHHhccCCcCcc-cchHHH
Confidence 122345678999999988877655 999996
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-32 Score=202.34 Aligned_cols=182 Identities=31% Similarity=0.475 Sum_probs=157.2
Q ss_pred CCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCcc--chHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEEe
Q 028681 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (205)
Q Consensus 21 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~ 98 (205)
++|++.+.||.|++|+||.+....++..+++|.+..... ....+.+|+..++.++|+|++++++.+..++..++++++
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 579999999999999999999988899999999875432 346788999999999999999999999999999999999
Q ss_pred cCCCchHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCCCCC
Q 028681 99 ASGGELFERICNA---GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 175 (205)
Q Consensus 99 ~~~~sl~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~~ 175 (205)
+++++|.+.+... ..+++..+..++.|++.|+++||+.|++|+||+|+||++++++. ++|+|||.+.........
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~--~~l~df~~~~~~~~~~~~ 158 (267)
T cd06610 81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGS--VKIADFGVSASLADGGDR 158 (267)
T ss_pred cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCC--EEEcccchHHHhccCccc
Confidence 9999999998764 35899999999999999999999999999999999999998776 999999988655443322
Q ss_pred -----CCCCCCCCccCCceeccC-cCCCeeeEEEeC
Q 028681 176 -----KSTVGTPAYIAPEVLLKK-EYDGKVMCVYVI 205 (205)
Q Consensus 176 -----~~~~~~~~~~aPE~~~~~-~~~~~~~Dvwsl 205 (205)
....++..|+|||.+... .++. ++|+|||
T Consensus 159 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~-~~Dv~sl 193 (267)
T cd06610 159 TRKVRKTFVGTPCWMAPEVMEQVHGYDF-KADIWSF 193 (267)
T ss_pred cccccccccCChhhcChHHHccccCcCc-ccchHhH
Confidence 223578899999999877 4554 4999996
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=209.04 Aligned_cols=185 Identities=24% Similarity=0.322 Sum_probs=152.0
Q ss_pred ecCCCeEEEeeeccccceeEEEEEecC-------CCcEEEEEEeecCcc--chHHHHHHHHHHHhc-CCCCeeEEEEEEE
Q 028681 18 HDSDRYELVRDIGSGNFGVARLMRDKK-------TEELVAVKYIERGDK--IDENVQREIINHRSL-RHPNIVRFKEVIL 87 (205)
Q Consensus 18 ~~~~~y~~~~~l~~g~~g~v~~~~~~~-------~~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l-~h~~i~~~~~~~~ 87 (205)
...++|++.+.||+|++|.||.+.+.. ....+++|.+..... ....+..|+.+++.+ +|+|++++++++.
T Consensus 9 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 88 (314)
T cd05099 9 FPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCT 88 (314)
T ss_pred ccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEc
Confidence 345799999999999999999998632 345689998875322 235677899999999 6999999999999
Q ss_pred eCCeEEEEEEecCCCchHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEec
Q 028681 88 TPTHLAIVMEYASGGELFERICNA----------------GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLD 151 (205)
Q Consensus 88 ~~~~~~lv~~~~~~~sl~~~~~~~----------------~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~ 151 (205)
..+..++++||+++++|.+++... ..++..++..++.|++.||.|||++|++|+||+|+||+++
T Consensus 89 ~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~ 168 (314)
T cd05099 89 QEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVT 168 (314)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeEEEc
Confidence 999999999999999999988653 2378889999999999999999999999999999999998
Q ss_pred CCCCCcEEEeeecccccccCCCC---CCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 152 GSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 152 ~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
.++. ++|+|||.++....... .....++..|+|||.+.+..++.+ +|||||
T Consensus 169 ~~~~--~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Diwsl 222 (314)
T cd05099 169 EDNV--MKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQ-SDVWSF 222 (314)
T ss_pred CCCc--EEEccccccccccccccccccccCCCCccccCHHHHccCCcCcc-chhhHH
Confidence 8776 99999999875532211 112234567999999988887765 999996
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-33 Score=209.35 Aligned_cols=184 Identities=35% Similarity=0.474 Sum_probs=154.6
Q ss_pred cCCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCccc---hHHHHHHHHHHHhcCCCCeeEEEEEEEeC--CeEE
Q 028681 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI---DENVQREIINHRSLRHPNIVRFKEVILTP--THLA 93 (205)
Q Consensus 19 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~ 93 (205)
..++|++.+.||+|++|.||.+.+..+++.+++|.++..... ...+.+|+.++++++|||++++.+++..+ +..+
T Consensus 3 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~ 82 (293)
T cd07843 3 SVDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIY 82 (293)
T ss_pred chhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEE
Confidence 346899999999999999999999999999999999754322 23456799999999999999999999887 8899
Q ss_pred EEEEecCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCC
Q 028681 94 IVMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 172 (205)
Q Consensus 94 lv~~~~~~~sl~~~~~~~~-~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~ 172 (205)
+++||+++ +|.+.+.... .+++..++.++.|++.||.|||+.+++|+||+|+||+++.++. ++|+|||++......
T Consensus 83 lv~e~~~~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~--~~l~d~g~~~~~~~~ 159 (293)
T cd07843 83 MVMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGI--LKICDFGLAREYGSP 159 (293)
T ss_pred EEehhcCc-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCc--EEEeecCceeeccCC
Confidence 99999975 8888876543 5899999999999999999999999999999999999988877 999999988765443
Q ss_pred -CCCCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 173 -SQPKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 173 -~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
.......++..|+|||.+.+....+.++|+|||
T Consensus 160 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~sl 193 (293)
T cd07843 160 LKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSV 193 (293)
T ss_pred ccccccccccccccCchhhcCCccccchhhHHHH
Confidence 222334578889999998765543345999985
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=206.23 Aligned_cols=174 Identities=30% Similarity=0.426 Sum_probs=150.7
Q ss_pred eccccceeEEEEEecCCCcEEEEEEeecCcc----chHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEEecCCCch
Q 028681 29 IGSGNFGVARLMRDKKTEELVAVKYIERGDK----IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL 104 (205)
Q Consensus 29 l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~~~~~sl 104 (205)
||+|++|+||.+.+..+++.+++|.+..... ....+..|+.+++.++|+|++++.+++...+..++++||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 6899999999999999999999999875321 233456899999999999999999999999999999999999999
Q ss_pred HHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCCCCCCCCCCCC
Q 028681 105 FERICNAG--RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTP 182 (205)
Q Consensus 105 ~~~~~~~~--~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~ 182 (205)
.+.+.... .+++..+..++.|++.|+.+||+.|++|+||+|+||+++.++. ++|+|||.+.............++.
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~ 158 (277)
T cd05577 81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGN--VRISDLGLAVELKGGKKIKGRAGTP 158 (277)
T ss_pred HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCC--EEEccCcchhhhccCCccccccCCC
Confidence 99887655 6999999999999999999999999999999999999988877 9999999887654443344456788
Q ss_pred CccCCceeccCcCCCeeeEEEeC
Q 028681 183 AYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 183 ~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
.|+|||.+.+..++.+ +|+|||
T Consensus 159 ~y~~PE~~~~~~~~~~-~Di~sl 180 (277)
T cd05577 159 GYMAPEVLQGEVYDFS-VDWFAL 180 (277)
T ss_pred CcCCHHHhcCCCCCch-hhhHHH
Confidence 9999999988777655 999986
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=212.76 Aligned_cols=181 Identities=27% Similarity=0.402 Sum_probs=154.4
Q ss_pred cCCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCc---cchHHHHHHHHHHHhcCCCCeeEEEEEEEeC------
Q 028681 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTP------ 89 (205)
Q Consensus 19 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------ 89 (205)
..++|++.+.||+|++|.||.+.+..++..|++|.+.... .....+..|+.+++.++|+|++++++++...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 3688999999999999999999999999999999986432 2235567899999999999999999988654
Q ss_pred CeEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccc
Q 028681 90 THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 169 (205)
Q Consensus 90 ~~~~lv~~~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~ 169 (205)
...++++|++.+ +|.+.+... ++...+..++.|++.||++||++|++|+||+|+||+++.++. ++|+|||++...
T Consensus 94 ~~~~lv~e~~~~-~l~~~~~~~--l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~--~kL~Dfg~~~~~ 168 (353)
T cd07850 94 QDVYLVMELMDA-NLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTA 168 (353)
T ss_pred CcEEEEEeccCC-CHHHHHhhc--CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCC--EEEccCccceeC
Confidence 357899999965 777776544 899999999999999999999999999999999999998877 999999999766
Q ss_pred cCCCCCCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 170 VLHSQPKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 170 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
..........++..|+|||.+.+..++.+ +|||||
T Consensus 169 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Dvwsl 203 (353)
T cd07850 169 GTSFMMTPYVVTRYYRAPEVILGMGYKEN-VDIWSV 203 (353)
T ss_pred CCCCCCCCCcccccccCHHHHhCCCCCCc-hhhHhH
Confidence 55444444567889999999998888766 999996
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-34 Score=214.54 Aligned_cols=185 Identities=28% Similarity=0.407 Sum_probs=165.1
Q ss_pred ecCCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCc----cchHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEE
Q 028681 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLA 93 (205)
Q Consensus 18 ~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 93 (205)
...+.|..-+.||.|+||.|+-++-..+|+.+|+|.+.+.. ....-..+|-.+|.+++.+.||.+--+|+.++.++
T Consensus 182 vt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LC 261 (591)
T KOG0986|consen 182 VTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALC 261 (591)
T ss_pred ccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceE
Confidence 34678999999999999999999999999999999886531 12234678899999999999999999999999999
Q ss_pred EEEEecCCCchHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccC
Q 028681 94 IVMEYASGGELFERICN--AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 171 (205)
Q Consensus 94 lv~~~~~~~sl~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~ 171 (205)
+|+..|.||.|.--+-+ ++.+++..++.++.+|+-||++||+.+|+.||+||+|||+|+.++ ++|.|+|+|+.++.
T Consensus 262 lVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~Gh--vRISDLGLAvei~~ 339 (591)
T KOG0986|consen 262 LVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGH--VRISDLGLAVEIPE 339 (591)
T ss_pred EEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCC--eEeeccceEEecCC
Confidence 99999999988544433 236999999999999999999999999999999999999999988 99999999999998
Q ss_pred CCCCCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 172 HSQPKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 172 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
+.......||..|||||++.+..|+.+ .|+|||
T Consensus 340 g~~~~~rvGT~GYMAPEvl~ne~Y~~s-~Dwf~l 372 (591)
T KOG0986|consen 340 GKPIRGRVGTVGYMAPEVLQNEVYDFS-PDWFSL 372 (591)
T ss_pred CCccccccCcccccCHHHHcCCcccCC-ccHHHH
Confidence 888888899999999999999999877 899986
|
|
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-33 Score=209.60 Aligned_cols=189 Identities=22% Similarity=0.313 Sum_probs=156.8
Q ss_pred cCceecCCCeEEEeeeccccceeEEEEEec-----CCCcEEEEEEeecCcc--chHHHHHHHHHHHhc-CCCCeeEEEEE
Q 028681 14 MPIMHDSDRYELVRDIGSGNFGVARLMRDK-----KTEELVAVKYIERGDK--IDENVQREIINHRSL-RHPNIVRFKEV 85 (205)
Q Consensus 14 ~~~~~~~~~y~~~~~l~~g~~g~v~~~~~~-----~~~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l-~h~~i~~~~~~ 85 (205)
.......++|++.+.||+|++|.||.+.+. ..+..+++|.+..... ..+.+.+|+.+++++ +|+|++++++.
T Consensus 28 ~~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~ 107 (302)
T cd05055 28 LKWEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGA 107 (302)
T ss_pred ccccccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEE
Confidence 344556789999999999999999999753 3455799998875432 235688899999999 79999999999
Q ss_pred EEeCCeEEEEEEecCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeee
Q 028681 86 ILTPTHLAIVMEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDF 163 (205)
Q Consensus 86 ~~~~~~~~lv~~~~~~~sl~~~~~~~~--~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df 163 (205)
+...+..++++||+++++|.+.+.... .+++.++..++.|++.|+.|||+.+++|+||+|+||+++.++. ++|+||
T Consensus 108 ~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~--~~l~df 185 (302)
T cd05055 108 CTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKI--VKICDF 185 (302)
T ss_pred EecCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCe--EEECCC
Confidence 999999999999999999999986543 3899999999999999999999999999999999999987776 999999
Q ss_pred cccccccCCCC---CCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 164 GYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 164 ~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
|++........ .....++..|+|||.+....++.+ +|||||
T Consensus 186 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Diwsl 229 (302)
T cd05055 186 GLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFE-SDVWSY 229 (302)
T ss_pred cccccccCCCceeecCCCCcccccCCHhhhccCCCCcH-hHHHHH
Confidence 99875433221 122345678999999988888765 999986
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-32 Score=202.29 Aligned_cols=183 Identities=22% Similarity=0.325 Sum_probs=153.8
Q ss_pred ecCCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCccchHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEE
Q 028681 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (205)
Q Consensus 18 ~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~ 97 (205)
...++|++.+.||+|++|.||++.... +..+++|.+.......+.+.+|+.+++.++|+|++++.+.+.. ...++++|
T Consensus 3 ~~~~~~~~~~~lg~g~~~~vy~~~~~~-~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e 80 (260)
T cd05073 3 IPRESLKLEKKLGAGQFGEVWMATYNK-HTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITE 80 (260)
T ss_pred ccccceeEEeEecCccceEEEEEEecC-CccEEEEecCCChhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEE
Confidence 346899999999999999999998654 5569999888765556778899999999999999999999887 77899999
Q ss_pred ecCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCCCC-
Q 028681 98 YASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ- 174 (205)
Q Consensus 98 ~~~~~sl~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~- 174 (205)
|+++++|.+.+... ..++...+..++.|++.|+.+||+.|++|+||+|+||+++.++. ++|+|||.+........
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~--~~l~d~~~~~~~~~~~~~ 158 (260)
T cd05073 81 FMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLV--CKIADFGLARVIEDNEYT 158 (260)
T ss_pred eCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCc--EEECCCcceeeccCCCcc
Confidence 99999999998653 35788889999999999999999999999999999999988776 99999998865433221
Q ss_pred -CCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 175 -PKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 175 -~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
.....++..|+|||++....++.+ +|+|||
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~-~Di~sl 189 (260)
T cd05073 159 AREGAKFPIKWTAPEAINFGSFTIK-SDVWSF 189 (260)
T ss_pred cccCCcccccccCHhHhccCCcCcc-ccchHH
Confidence 122345677999999988777655 999996
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=208.61 Aligned_cols=182 Identities=22% Similarity=0.290 Sum_probs=157.4
Q ss_pred CCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCcc-chHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEEe
Q 028681 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (205)
Q Consensus 20 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~ 98 (205)
..+|++.+.||.|++|.||.+.+.. +..+++|.+..... ....+..|+..++.++|+|++++++++......++++||
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 83 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITEL 83 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEee
Confidence 4679999999999999999999988 78899999876554 456788999999999999999999999999999999999
Q ss_pred cCCCchHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCCCC-C
Q 028681 99 ASGGELFERICN--AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-P 175 (205)
Q Consensus 99 ~~~~sl~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~-~ 175 (205)
+++++|.+.+.. ...++...+..++.|++.|+.+||+.|++|+||+|+||+++.++. ++|+|||.+........ .
T Consensus 84 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~--~kl~d~g~~~~~~~~~~~~ 161 (261)
T cd05148 84 MEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLV--CKVADFGLARLIKEDVYLS 161 (261)
T ss_pred cccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCce--EEEccccchhhcCCccccc
Confidence 999999999975 335899999999999999999999999999999999999988877 99999999876543222 1
Q ss_pred CCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 176 KSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 176 ~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
....++..|+|||.+.+..++.+ +|||||
T Consensus 162 ~~~~~~~~~~~PE~~~~~~~~~~-~Diwsl 190 (261)
T cd05148 162 SDKKIPYKWTAPEAASHGTFSTK-SDVWSF 190 (261)
T ss_pred cCCCCceEecCHHHHccCCCCch-hhHHHH
Confidence 22345678999999988888766 999986
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=204.84 Aligned_cols=185 Identities=31% Similarity=0.520 Sum_probs=157.1
Q ss_pred ecCCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCccchHHHHHHHHHHHhc-CCCCeeEEEEEEEeCC------
Q 028681 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSL-RHPNIVRFKEVILTPT------ 90 (205)
Q Consensus 18 ~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~------ 90 (205)
...++|++.+.||+|++|.+|.+.+..++..+++|.+.......+.+..|+.+++++ .|+|++++++.+....
T Consensus 3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (275)
T cd06608 3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDD 82 (275)
T ss_pred CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCchhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcce
Confidence 345899999999999999999999998899999999887766667889999999999 6999999999997644
Q ss_pred eEEEEEEecCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeeccc
Q 028681 91 HLAIVMEYASGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYS 166 (205)
Q Consensus 91 ~~~lv~~~~~~~sl~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~ 166 (205)
..++++||+++++|.+.+.. +..+++..+..++.|++.|+.+||+.+++|+||+|+||+++.++. ++|+|||.+
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~--~~l~d~~~~ 160 (275)
T cd06608 83 QLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAE--VKLVDFGVS 160 (275)
T ss_pred EEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCe--EEECCCccc
Confidence 48999999999999888764 347999999999999999999999999999999999999988776 999999988
Q ss_pred ccccCC-CCCCCCCCCCCccCCceeccC-----cCCCeeeEEEeC
Q 028681 167 KSSVLH-SQPKSTVGTPAYIAPEVLLKK-----EYDGKVMCVYVI 205 (205)
Q Consensus 167 ~~~~~~-~~~~~~~~~~~~~aPE~~~~~-----~~~~~~~Dvwsl 205 (205)
...... .......++..|+|||.+... .++. ++|||||
T Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~-~~Dv~sl 204 (275)
T cd06608 161 AQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDA-RSDVWSL 204 (275)
T ss_pred eecccchhhhcCccccccccCHhHhcccccccCCccc-cccHHHh
Confidence 654332 223345688899999998642 3444 4999996
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=204.28 Aligned_cols=180 Identities=29% Similarity=0.448 Sum_probs=153.8
Q ss_pred CeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCcc-------chHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEE
Q 028681 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK-------IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 94 (205)
Q Consensus 22 ~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~-------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 94 (205)
+|++.+.||+|++|.||.+... ++..+++|.+..... ....+.+|+..++.++|+|++++.+++.+.+..++
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~-~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 79 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTN-QGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISI 79 (265)
T ss_pred CccccceEeccCCeEEEEEEEc-CCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEE
Confidence 5888999999999999999864 678899998865321 12457889999999999999999999999999999
Q ss_pred EEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCC--
Q 028681 95 VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-- 172 (205)
Q Consensus 95 v~~~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~-- 172 (205)
++||+++++|.+.+....++++..+..++.|++.|+++||+.+++|+||+|+||+++.++. ++|+|||.+......
T Consensus 80 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~--~~l~dfg~~~~~~~~~~ 157 (265)
T cd06631 80 FMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGI--IKLIDFGCARRLAWVGL 157 (265)
T ss_pred EEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCe--EEeccchhhHhhhhccc
Confidence 9999999999999988778999999999999999999999999999999999999988777 999999988654211
Q ss_pred -----CCCCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 173 -----SQPKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 173 -----~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
.......++..|+|||.+.+..++.+ +|+|||
T Consensus 158 ~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~-~Dv~sl 194 (265)
T cd06631 158 HGTHSNMLKSMHGTPYWMAPEVINESGYGRK-SDIWSI 194 (265)
T ss_pred cccccccccccCCCccccChhhhcCCCCcch-hhHHHH
Confidence 11123357889999999988887766 999986
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=209.07 Aligned_cols=181 Identities=30% Similarity=0.482 Sum_probs=158.6
Q ss_pred CCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCc--cchHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEEe
Q 028681 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (205)
Q Consensus 21 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~ 98 (205)
++|+..+.||.|++|.||++.+..+++.+++|.+.... ...+++.+|+.+++.++|+|++++++.+..++..++++|+
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY 80 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence 46888999999999999999999999999999987653 2345678899999999999999999999999999999999
Q ss_pred cCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh-cCcEeecCCCCCeEecCCCCCcEEEeeecccccccCCCCCC
Q 028681 99 ASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHS-MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK 176 (205)
Q Consensus 99 ~~~~sl~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~-~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~~~ 176 (205)
+++++|.+.+... .++++..+..++.|++.|+.+||+ .+++|+||+|+||+++.++. ++|+|||.+.........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~--~~l~d~g~~~~~~~~~~~- 157 (265)
T cd06605 81 MDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQ--IKLCDFGVSGQLVNSLAK- 157 (265)
T ss_pred cCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCC--EEEeecccchhhHHHHhh-
Confidence 9989999999765 679999999999999999999999 99999999999999998776 999999988654332222
Q ss_pred CCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 177 STVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 177 ~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
...++..|+|||.+.+..++.+ +|||||
T Consensus 158 ~~~~~~~y~~PE~~~~~~~~~~-~Dv~sl 185 (265)
T cd06605 158 TFVGTSSYMAPERIQGNDYSVK-SDIWSL 185 (265)
T ss_pred cccCChhccCHHHHcCCCCCch-hhHHHH
Confidence 2668889999999988877766 999986
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=207.44 Aligned_cols=183 Identities=27% Similarity=0.373 Sum_probs=153.8
Q ss_pred CCCeEEEeeeccccceeEEEEEec-----CCCcEEEEEEeecCccc-hHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEE
Q 028681 20 SDRYELVRDIGSGNFGVARLMRDK-----KTEELVAVKYIERGDKI-DENVQREIINHRSLRHPNIVRFKEVILTPTHLA 93 (205)
Q Consensus 20 ~~~y~~~~~l~~g~~g~v~~~~~~-----~~~~~v~iK~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 93 (205)
..+|.+.+.||+|++|.||.+.+. .++..+++|.+...... .+.+.+|+..++.++|+|++++++++......+
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (291)
T cd05094 4 RRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLI 83 (291)
T ss_pred hHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceE
Confidence 467999999999999999999854 34556888887654433 356889999999999999999999999999999
Q ss_pred EEEEecCCCchHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCc
Q 028681 94 IVMEYASGGELFERICNAG----------------RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPR 157 (205)
Q Consensus 94 lv~~~~~~~sl~~~~~~~~----------------~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~ 157 (205)
++|||+++++|.+.+.... .+++..++.++.|++.|+++||+++++|+||+|+||+++.++.
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~~~-- 161 (291)
T cd05094 84 MVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLL-- 161 (291)
T ss_pred EEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCc--
Confidence 9999999999999986532 3788999999999999999999999999999999999988776
Q ss_pred EEEeeecccccccCCCC---CCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 158 LKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 158 ~~l~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
++|+|||.+........ .....++..|+|||.+.+..++.+ +|||||
T Consensus 162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~sl 211 (291)
T cd05094 162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTE-SDVWSF 211 (291)
T ss_pred EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCch-hhHHHH
Confidence 99999999865433221 122346788999999988888765 999996
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=206.47 Aligned_cols=183 Identities=21% Similarity=0.327 Sum_probs=152.0
Q ss_pred cCCCeEEEeeeccccceeEEEEEecCCCc----EEEEEEeecCcc--chHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeE
Q 028681 19 DSDRYELVRDIGSGNFGVARLMRDKKTEE----LVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHL 92 (205)
Q Consensus 19 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~----~v~iK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 92 (205)
..++|++.+.||+|++|.||++.+..++. .|++|.+..... ....+..|+.++..+.|+|++++++++... ..
T Consensus 5 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~ 83 (279)
T cd05109 5 KETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TV 83 (279)
T ss_pred chhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-Cc
Confidence 35789999999999999999999776665 478998865432 345678899999999999999999988754 56
Q ss_pred EEEEEecCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccC
Q 028681 93 AIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 171 (205)
Q Consensus 93 ~lv~~~~~~~sl~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~ 171 (205)
+++++++++++|.+.+.. ...+++..+..++.|++.||.|||+++++|+||+|+||+++.++. ++|+|||+++....
T Consensus 84 ~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~--~kL~dfG~~~~~~~ 161 (279)
T cd05109 84 QLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNH--VKITDFGLARLLDI 161 (279)
T ss_pred EEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCc--EEECCCCceeeccc
Confidence 789999999999999876 346899999999999999999999999999999999999987776 99999999876543
Q ss_pred CCCC---CCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 172 HSQP---KSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 172 ~~~~---~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
.... ....++..|+|||...+..++.+ +|||||
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~-~Di~sl 197 (279)
T cd05109 162 DETEYHADGGKVPIKWMALESILHRRFTHQ-SDVWSY 197 (279)
T ss_pred ccceeecCCCccchhhCCHHHhccCCCCch-hHHHHH
Confidence 3221 12234678999999988888766 999996
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=207.68 Aligned_cols=183 Identities=26% Similarity=0.408 Sum_probs=151.2
Q ss_pred CCCeEEEeeeccccceeEEEEEecC----------------CCcEEEEEEeecCcc--chHHHHHHHHHHHhcCCCCeeE
Q 028681 20 SDRYELVRDIGSGNFGVARLMRDKK----------------TEELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVR 81 (205)
Q Consensus 20 ~~~y~~~~~l~~g~~g~v~~~~~~~----------------~~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~ 81 (205)
.++|++.+.||+|++|.||.+.+.. ++..+++|.+..... ....+..|+.+++.++|+|+++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~ 83 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIR 83 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcce
Confidence 4679999999999999999985432 345789998875432 2356889999999999999999
Q ss_pred EEEEEEeCCeEEEEEEecCCCchHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEe
Q 028681 82 FKEVILTPTHLAIVMEYASGGELFERICNAG-----------RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLL 150 (205)
Q Consensus 82 ~~~~~~~~~~~~lv~~~~~~~sl~~~~~~~~-----------~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili 150 (205)
+++++..++..++++|++++++|.+.+.... .+++.++..++.|++.|+++||+.|++|+||+|+||++
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~Nili 163 (296)
T cd05095 84 LLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLV 163 (296)
T ss_pred EEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChheEEE
Confidence 9999999999999999999999998886532 26677899999999999999999999999999999999
Q ss_pred cCCCCCcEEEeeecccccccCCCC---CCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 151 DGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 151 ~~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
+.++. ++|+|||++........ .....++..|++||...+..++.+ +|||||
T Consensus 164 ~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~-~DiwSl 218 (296)
T cd05095 164 GKNYT--IKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTA-SDVWAF 218 (296)
T ss_pred cCCCC--EEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccch-hhhhHH
Confidence 87776 99999999875433221 112234678999999888888765 999996
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-32 Score=202.46 Aligned_cols=183 Identities=27% Similarity=0.402 Sum_probs=156.2
Q ss_pred cCCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCccchHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEEe
Q 028681 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (205)
Q Consensus 19 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~ 98 (205)
+.++|++.+.||+|++|.||++.+.. +..+++|.+.........+..|+.+++.++|++++++++++......+++++|
T Consensus 2 ~~~~~~~~~~ig~g~~g~v~~~~~~~-~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd05112 2 HPSELTLVQEIGSGQFGLVWLGYWLE-KRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEF 80 (256)
T ss_pred ChhHeEEEeeecCcccceEEEEEEeC-CCeEEEEECCCCCCCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEc
Confidence 35789999999999999999998764 56799998887666667889999999999999999999999999999999999
Q ss_pred cCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCCCC--C
Q 028681 99 ASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ--P 175 (205)
Q Consensus 99 ~~~~sl~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~--~ 175 (205)
+++++|.+.+... .++++..+..++.|++.++++||+.+++|+||+|+||+++.++. ++|+|||.+........ .
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~--~~l~d~g~~~~~~~~~~~~~ 158 (256)
T cd05112 81 MEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQV--VKVSDFGMTRFVLDDQYTSS 158 (256)
T ss_pred CCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCe--EEECCCcceeecccCccccc
Confidence 9999999888653 46899999999999999999999999999999999999987776 99999998865433221 1
Q ss_pred CCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 176 KSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 176 ~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
....++..|+|||.+.+..++.+ +|||||
T Consensus 159 ~~~~~~~~~~aPe~~~~~~~~~~-~Dv~sl 187 (256)
T cd05112 159 TGTKFPVKWSSPEVFSFSKYSSK-SDVWSF 187 (256)
T ss_pred CCCccchhhcCHhHhccCCcChH-HHHHHH
Confidence 12234578999999988877755 999996
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-33 Score=207.03 Aligned_cols=184 Identities=27% Similarity=0.386 Sum_probs=153.5
Q ss_pred cCCCeEEEeeeccccceeEEEEEec-----CCCcEEEEEEeecCcc-chHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeE
Q 028681 19 DSDRYELVRDIGSGNFGVARLMRDK-----KTEELVAVKYIERGDK-IDENVQREIINHRSLRHPNIVRFKEVILTPTHL 92 (205)
Q Consensus 19 ~~~~y~~~~~l~~g~~g~v~~~~~~-----~~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 92 (205)
...+|++.++||+|++|.||.+... .++..+++|.+..... ..+.+..|+..++.++|+|++++++++..+...
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 82 (280)
T cd05092 3 KRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPL 82 (280)
T ss_pred ChHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCce
Confidence 3578999999999999999999642 3466788998765432 346788999999999999999999999999999
Q ss_pred EEEEEecCCCchHHHHHhcC---------------CCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCc
Q 028681 93 AIVMEYASGGELFERICNAG---------------RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPR 157 (205)
Q Consensus 93 ~lv~~~~~~~sl~~~~~~~~---------------~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~ 157 (205)
++++||+++++|.+.+.... .+++..+..++.|++.|+.|||++|++|+||+|+||++++++.
T Consensus 83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~~~-- 160 (280)
T cd05092 83 LMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGLV-- 160 (280)
T ss_pred EEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCCCC--
Confidence 99999999999999886543 3788999999999999999999999999999999999988776
Q ss_pred EEEeeecccccccCCCC---CCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 158 LKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 158 ~~l~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
++|+|||++........ .....+++.|+|||.+.+..++.+ +|||||
T Consensus 161 ~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~sl 210 (280)
T cd05092 161 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTE-SDIWSF 210 (280)
T ss_pred EEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCch-hhHHHH
Confidence 99999998865433221 112234678999999998888766 999996
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-33 Score=205.88 Aligned_cols=174 Identities=17% Similarity=0.138 Sum_probs=146.4
Q ss_pred eeeccccceeEEEEEecCCC----------cEEEEEEeecCccchHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEE
Q 028681 27 RDIGSGNFGVARLMRDKKTE----------ELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (205)
Q Consensus 27 ~~l~~g~~g~v~~~~~~~~~----------~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 96 (205)
+.||+|++|.||.+.+..++ ..+++|.+.........+.+|+.+++.++|+|++++++++.. ...++++
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~ 79 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMVE 79 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhhHHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEEE
Confidence 46899999999999998766 357888776554446778899999999999999999999988 7789999
Q ss_pred EecCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCC-----cEEEeeeccccccc
Q 028681 97 EYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAP-----RLKICDFGYSKSSV 170 (205)
Q Consensus 97 ~~~~~~sl~~~~~~~~-~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~-----~~~l~df~~~~~~~ 170 (205)
||+++++|.+++...+ .++...+..++.|++.||.|||+++++|+||+|+||+++.++.. .++|+|||++....
T Consensus 80 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a~~~~ 159 (259)
T cd05037 80 EYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVL 159 (259)
T ss_pred EcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCcccccc
Confidence 9999999999997755 68999999999999999999999999999999999999876621 49999999887543
Q ss_pred CCCCCCCCCCCCCccCCceeccC--cCCCeeeEEEeC
Q 028681 171 LHSQPKSTVGTPAYIAPEVLLKK--EYDGKVMCVYVI 205 (205)
Q Consensus 171 ~~~~~~~~~~~~~~~aPE~~~~~--~~~~~~~Dvwsl 205 (205)
. .....++..|+|||++... .++.+ +|||||
T Consensus 160 ~---~~~~~~~~~y~aPE~~~~~~~~~~~~-~Di~sl 192 (259)
T cd05037 160 S---REERVERIPWIAPECIRNGQASLTIA-ADKWSF 192 (259)
T ss_pred c---ccccccCCCccChhhhcCCCCCcchh-hHHHHH
Confidence 3 2234467789999999876 55545 999986
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=204.42 Aligned_cols=181 Identities=34% Similarity=0.498 Sum_probs=154.5
Q ss_pred CeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCcc-----------chHHHHHHHHHHHhcCCCCeeEEEEEEEeCC
Q 028681 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK-----------IDENVQREIINHRSLRHPNIVRFKEVILTPT 90 (205)
Q Consensus 22 ~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~-----------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 90 (205)
+|.+.+.||+|++|.||.+.+..++..+++|.+..... ..+.+..|+.+++.++|+|++++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 58899999999999999999998899999998864211 1235778999999999999999999999999
Q ss_pred eEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeeccccccc
Q 028681 91 HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 170 (205)
Q Consensus 91 ~~~lv~~~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~ 170 (205)
..++++||+++++|.+.+.....+++..+..++.|++.|+.+||+.+++|+||+|+||+++.++. ++|+|||++....
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~--~~l~d~~~~~~~~ 159 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGI--CKISDFGISKKSD 159 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCe--EEEeecccccccc
Confidence 99999999999999999988778999999999999999999999999999999999999988777 9999999886543
Q ss_pred CCC---CCCCCCCCCCccCCceeccCc--CCCeeeEEEeC
Q 028681 171 LHS---QPKSTVGTPAYIAPEVLLKKE--YDGKVMCVYVI 205 (205)
Q Consensus 171 ~~~---~~~~~~~~~~~~aPE~~~~~~--~~~~~~Dvwsl 205 (205)
... ......++..|+|||.+.... ++. ++|+|||
T Consensus 160 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~-~~Dv~sl 198 (272)
T cd06629 160 DIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSA-KVDIWSL 198 (272)
T ss_pred ccccccccccccCCccccCHHHhccccCCCCc-cchhHHH
Confidence 221 122335788999999998755 554 4999985
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-33 Score=215.81 Aligned_cols=193 Identities=25% Similarity=0.329 Sum_probs=158.4
Q ss_pred CCcccCceecCCCeEEEeeeccccceeEEEEEec-----CCCcEEEEEEeecCccc--hHHHHHHHHHHHhcC-CCCeeE
Q 028681 10 PGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDK-----KTEELVAVKYIERGDKI--DENVQREIINHRSLR-HPNIVR 81 (205)
Q Consensus 10 ~~~~~~~~~~~~~y~~~~~l~~g~~g~v~~~~~~-----~~~~~v~iK~~~~~~~~--~~~~~~e~~~l~~l~-h~~i~~ 81 (205)
.+.+..+....++|.+.+.||+|+||.||.+.+. ..+..|++|.++..... .+.+..|+.++..+. |+||++
T Consensus 26 ~~~~~~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~ 105 (401)
T cd05107 26 LPYDSAWEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVN 105 (401)
T ss_pred CCCCCcceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEE
Confidence 4455566777889999999999999999999864 34568999999764322 346888999999997 999999
Q ss_pred EEEEEEeCCeEEEEEEecCCCchHHHHHhcC-------------------------------------------------
Q 028681 82 FKEVILTPTHLAIVMEYASGGELFERICNAG------------------------------------------------- 112 (205)
Q Consensus 82 ~~~~~~~~~~~~lv~~~~~~~sl~~~~~~~~------------------------------------------------- 112 (205)
+++++...+..++++||+++++|.+.+...+
T Consensus 106 ~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 185 (401)
T cd05107 106 LLGACTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDE 185 (401)
T ss_pred EEEEEccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCcc
Confidence 9999999999999999999999998885421
Q ss_pred -------------------------------------------------CCCHHHHHHHHHHHHHHHHHHHhcCcEeecC
Q 028681 113 -------------------------------------------------RFSEDEARFFFQQLISGVSYCHSMQVCHRDL 143 (205)
Q Consensus 113 -------------------------------------------------~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di 143 (205)
.++...+..++.|++.||.|||+.+++|+||
T Consensus 186 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdl 265 (401)
T cd05107 186 SADYVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDL 265 (401)
T ss_pred ccCccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccC
Confidence 2566778889999999999999999999999
Q ss_pred CCCCeEecCCCCCcEEEeeecccccccCCCC---CCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 144 KLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 144 ~p~nili~~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
+|+||+++.++. ++|+|||+++....... .....++..|+|||.+.+..++.+ +|||||
T Consensus 266 kp~NiLl~~~~~--~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Dvwsl 327 (401)
T cd05107 266 AARNVLICEGKL--VKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTL-SDVWSF 327 (401)
T ss_pred CcceEEEeCCCE--EEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcH-hHHHHH
Confidence 999999987766 99999999875432221 122346788999999998888766 999985
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=205.78 Aligned_cols=182 Identities=29% Similarity=0.483 Sum_probs=155.1
Q ss_pred CCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCc--cchHHHHHHHHHHHhcC---CCCeeEEEEEEEeCCeEEEE
Q 028681 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD--KIDENVQREIINHRSLR---HPNIVRFKEVILTPTHLAIV 95 (205)
Q Consensus 21 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~~~~~~lv 95 (205)
+.|+..+.||+|++|.||.+.+..++..+++|.+.... ...+.+..|+.+++.++ |+|++++++++..+...+++
T Consensus 1 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv 80 (277)
T cd06917 1 SLYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWII 80 (277)
T ss_pred ChhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEE
Confidence 35888999999999999999999999999999887542 23456788899998886 99999999999999999999
Q ss_pred EEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCCCC-
Q 028681 96 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ- 174 (205)
Q Consensus 96 ~~~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~- 174 (205)
+||+++++|.+.+.. ..+++..+..++.|++.|+.+||+.|++|+||+|+||+++.++. ++|+|||.+........
T Consensus 81 ~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~--~~l~dfg~~~~~~~~~~~ 157 (277)
T cd06917 81 MEYAEGGSVRTLMKA-GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGN--VKLCDFGVAALLNQNSSK 157 (277)
T ss_pred EecCCCCcHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCC--EEEccCCceeecCCCccc
Confidence 999999999988855 47999999999999999999999999999999999999998776 99999999876654432
Q ss_pred CCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 175 PKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 175 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
.....++..|+|||.+.+....+.++|+|||
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~sl 188 (277)
T cd06917 158 RSTFVGTPYWMAPEVITEGKYYDTKADIWSL 188 (277)
T ss_pred cccccCCcceeCHHHhccCCccccchhHHHH
Confidence 2334688899999998765443345999986
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-32 Score=204.76 Aligned_cols=183 Identities=23% Similarity=0.335 Sum_probs=153.2
Q ss_pred cCCCeEEEeeeccccceeEEEEEecCCCc----EEEEEEeecCcc--chHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeE
Q 028681 19 DSDRYELVRDIGSGNFGVARLMRDKKTEE----LVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHL 92 (205)
Q Consensus 19 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~----~v~iK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 92 (205)
...+|++.+.||+|+||.||++....++. .+++|....... ...++.+|+..++.++|+|++++++++.. ...
T Consensus 5 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~ 83 (279)
T cd05057 5 KETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQV 83 (279)
T ss_pred CHHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-Cce
Confidence 45789999999999999999999866554 588898765432 23568889999999999999999999887 788
Q ss_pred EEEEEecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccC
Q 028681 93 AIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 171 (205)
Q Consensus 93 ~lv~~~~~~~sl~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~ 171 (205)
++++|++++++|.+.+... ..+++..+..++.|++.|++|||+++++|+||+|+||+++.++. ++|+|||.++....
T Consensus 84 ~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~--~kL~dfg~~~~~~~ 161 (279)
T cd05057 84 QLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQH--VKITDFGLAKLLDV 161 (279)
T ss_pred EEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCe--EEECCCcccccccC
Confidence 9999999999999988763 46899999999999999999999999999999999999987776 99999999876543
Q ss_pred CCCCCC---CCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 172 HSQPKS---TVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 172 ~~~~~~---~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
...... ..++..|+|||.+....++.+ +|+|||
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~-~Di~sl 197 (279)
T cd05057 162 DEKEYHAEGGKVPIKWMALESILHRIYTHK-SDVWSY 197 (279)
T ss_pred cccceecCCCcccccccCHHHhhcCCcCch-hhHHHH
Confidence 322211 123567999999988887755 999996
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=203.48 Aligned_cols=180 Identities=31% Similarity=0.384 Sum_probs=154.9
Q ss_pred eEEEeeeccccceeEEEEEecCCC----cEEEEEEeecCcc--chHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEE
Q 028681 23 YELVRDIGSGNFGVARLMRDKKTE----ELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (205)
Q Consensus 23 y~~~~~l~~g~~g~v~~~~~~~~~----~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 96 (205)
+++.+.||.|++|.||.+.+...+ ..+++|.+..... ..+.+..|+..++.++|+|++++++.+.+.+..++++
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 467889999999999999998766 8899999976544 3567889999999999999999999999999999999
Q ss_pred EecCCCchHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCCCC
Q 028681 97 EYASGGELFERICNAGR--FSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 174 (205)
Q Consensus 97 ~~~~~~sl~~~~~~~~~--~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~ 174 (205)
+++++++|.+.+..... +++..+..++.|++.|+.+||+.+++|+||+|+||+++.++. ++|+|||.+........
T Consensus 81 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~--~~l~dfg~~~~~~~~~~ 158 (258)
T smart00219 81 EYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLV--VKISDFGLSRDLYDDDY 158 (258)
T ss_pred eccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCe--EEEcccCCceecccccc
Confidence 99999999999876554 999999999999999999999999999999999999988876 99999999876554422
Q ss_pred CCC--CCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 175 PKS--TVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 175 ~~~--~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
... ..++..|+|||.+.+..++.+ +|+|||
T Consensus 159 ~~~~~~~~~~~y~~Pe~~~~~~~~~~-~Di~sl 190 (258)
T smart00219 159 YKKKGGKLPIRWMAPESLKDGKFTSK-SDVWSF 190 (258)
T ss_pred cccccCCCcccccChHHhccCCCCcc-hhHHHH
Confidence 221 236788999999977777655 999985
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-32 Score=203.14 Aligned_cols=181 Identities=28% Similarity=0.392 Sum_probs=148.0
Q ss_pred CCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCccc--hHHHHHHHHH-HHhcCCCCeeEEEEEEEeCCeEEEEEE
Q 028681 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI--DENVQREIIN-HRSLRHPNIVRFKEVILTPTHLAIVME 97 (205)
Q Consensus 21 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~--~~~~~~e~~~-l~~l~h~~i~~~~~~~~~~~~~~lv~~ 97 (205)
++|++.+.||+|+||.||++.+..++..||+|.+...... ...+..|+.. ++.+.|+|++++++++..++..++++|
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 5799999999999999999999999999999998765322 2334445443 566789999999999999999999999
Q ss_pred ecCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhc-CcEeecCCCCCeEecCCCCCcEEEeeecccccccCC
Q 028681 98 YASGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHSM-QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 172 (205)
Q Consensus 98 ~~~~~sl~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lh~~-~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~ 172 (205)
|++ ++|.+.+.. ...+++..+..++.|++.|+.|||++ +++|+||+|+||+++.++. ++|+|||.+......
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~--~kl~dfg~~~~~~~~ 157 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQ--VKLCDFGISGYLVDS 157 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCC--EEEeecccccccccc
Confidence 996 577776643 34689999999999999999999987 9999999999999988777 999999998765433
Q ss_pred CCCCCCCCCCCccCCceecc----CcCCCeeeEEEeC
Q 028681 173 SQPKSTVGTPAYIAPEVLLK----KEYDGKVMCVYVI 205 (205)
Q Consensus 173 ~~~~~~~~~~~~~aPE~~~~----~~~~~~~~Dvwsl 205 (205)
.......++..|+|||.+.+ ..++.+ +|+|||
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~-~Di~sl 193 (283)
T cd06617 158 VAKTIDAGCKPYMAPERINPELNQKGYDVK-SDVWSL 193 (283)
T ss_pred cccccccCCccccChhhcCCcccccccCcc-ccchhh
Confidence 33333567889999999865 334544 999996
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-32 Score=207.68 Aligned_cols=190 Identities=28% Similarity=0.455 Sum_probs=154.7
Q ss_pred ccCceecCCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCcc---chHHHHHHHHHHHhcCCCCeeEEEEEEEeC
Q 028681 13 DMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTP 89 (205)
Q Consensus 13 ~~~~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 89 (205)
++++....++|++.+.||+|++|.||.+.+..++..|++|.+..... ....+.+|+.+++.++|||++++++++...
T Consensus 4 ~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 83 (310)
T cd07865 4 EFPFCDEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTK 83 (310)
T ss_pred cCcccchhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecc
Confidence 45677788999999999999999999999999999999998865322 223456799999999999999999988765
Q ss_pred C--------eEEEEEEecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEE
Q 028681 90 T--------HLAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKI 160 (205)
Q Consensus 90 ~--------~~~lv~~~~~~~sl~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l 160 (205)
. ..++++||+.+ +|.+.+... ..+++.++..++.|++.|+.+||+.|++|+||+|+||+++.++. ++|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~--~kl 160 (310)
T cd07865 84 ATPYNRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGI--LKL 160 (310)
T ss_pred cccccCCCceEEEEEcCCCc-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCc--EEE
Confidence 3 45999999965 777776543 36899999999999999999999999999999999999988877 999
Q ss_pred eeecccccccCCCCC-----CCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 161 CDFGYSKSSVLHSQP-----KSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 161 ~df~~~~~~~~~~~~-----~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
+|||++......... ....++..|+|||.+.+......++|||||
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~sl 210 (310)
T cd07865 161 ADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGA 210 (310)
T ss_pred CcCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHH
Confidence 999998654332221 223467889999998765432345999996
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-33 Score=207.52 Aligned_cols=182 Identities=25% Similarity=0.375 Sum_probs=153.7
Q ss_pred CCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCc--cchHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEEe
Q 028681 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (205)
Q Consensus 21 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~ 98 (205)
++|++.+.||+|++|.||.+.+..++..+++|.+.... .....+..|+.++++++|+|++++++.+..++..++++||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY 80 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence 47899999999999999999999899999999886532 2235678899999999999999999999999999999999
Q ss_pred cCCCchHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHh-cCcEeecCCCCCeEecCCCCCcEEEeeecccccccCCCC
Q 028681 99 ASGGELFERICNA---GRFSEDEARFFFQQLISGVSYCHS-MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 174 (205)
Q Consensus 99 ~~~~sl~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lh~-~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~ 174 (205)
+++++|.+++... ..+++..+..++.|++.|+.|||+ ++++|+||+|+||+++.++. ++|+|||.+..... ..
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~--~~l~dfg~~~~~~~-~~ 157 (286)
T cd06622 81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQ--VKLCDFGVSGNLVA-SL 157 (286)
T ss_pred cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCC--EEEeecCCcccccC-Cc
Confidence 9999998888653 369999999999999999999996 69999999999999988776 99999998865432 22
Q ss_pred CCCCCCCCCccCCceeccCcC-----CCeeeEEEeC
Q 028681 175 PKSTVGTPAYIAPEVLLKKEY-----DGKVMCVYVI 205 (205)
Q Consensus 175 ~~~~~~~~~~~aPE~~~~~~~-----~~~~~Dvwsl 205 (205)
.....++..|+|||.+.+... .+.++|+|||
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Diwsl 193 (286)
T cd06622 158 AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSL 193 (286)
T ss_pred cccCCCccCccCcchhcCCCCCccCCCCcccchHhH
Confidence 334457889999999865432 1345999996
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-32 Score=200.79 Aligned_cols=181 Identities=35% Similarity=0.521 Sum_probs=161.4
Q ss_pred CeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCc---cchHHHHHHHHHHHhcCCCCeeEEEEEEEeC--CeEEEEE
Q 028681 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTP--THLAIVM 96 (205)
Q Consensus 22 ~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~ 96 (205)
+|+..+.|++|++|.||.+.+..++..+++|.+.... ...+.+.+|+..+++++|+|++++++.+... ...++++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 5889999999999999999999899999999987654 3356788999999999999999999999988 8899999
Q ss_pred EecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCCCC--
Q 028681 97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-- 174 (205)
Q Consensus 97 ~~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~-- 174 (205)
|++++++|.+.+.....+++..+..++.|++.++.+||+.+++|+|++|+||+++.++. ++|+|||.+........
T Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~--~~l~d~~~~~~~~~~~~~~ 158 (260)
T cd06606 81 EYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGV--VKLADFGCAKRLGDIETGE 158 (260)
T ss_pred EecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCC--EEEcccccEEecccccccc
Confidence 99999999999988778999999999999999999999999999999999999998776 99999999876665543
Q ss_pred -CCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 175 -PKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 175 -~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
.....++..|.|||.+.....+.+ +|||||
T Consensus 159 ~~~~~~~~~~y~~pE~~~~~~~~~~-~Dv~sl 189 (260)
T cd06606 159 GTGSVRGTPYWMAPEVIRGEEYGRA-ADIWSL 189 (260)
T ss_pred cccCCCCCccccCHhhhcCCCCCch-hhHHHH
Confidence 445568899999999988877655 999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-32 Score=206.02 Aligned_cols=186 Identities=30% Similarity=0.480 Sum_probs=159.8
Q ss_pred ceecCCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCc-cchHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEE
Q 028681 16 IMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 94 (205)
Q Consensus 16 ~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 94 (205)
++...++|++.+.||+|++|.||++.+..++..+++|.+.... ...+.+.+|+.+++.++|||++++++.+..++..++
T Consensus 14 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~l 93 (293)
T cd06647 14 VGDPKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWV 93 (293)
T ss_pred ccCchhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEE
Confidence 4455689999999999999999999998889999999986533 334667889999999999999999999999999999
Q ss_pred EEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCCCC
Q 028681 95 VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 174 (205)
Q Consensus 95 v~~~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~ 174 (205)
++||+++++|.+.+.. ..+++..+..++.|++.|+.+||+.|++|+||+|+||+++.++. ++|+|||++........
T Consensus 94 v~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~--~kL~dfg~~~~~~~~~~ 170 (293)
T cd06647 94 VMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGS--VKLTDFGFCAQITPEQS 170 (293)
T ss_pred EEecCCCCcHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCC--EEEccCcceeccccccc
Confidence 9999999999988854 45889999999999999999999999999999999999988776 99999998765443322
Q ss_pred -CCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 175 -PKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 175 -~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
.....+++.|+|||.+.+..++.+ +|+|||
T Consensus 171 ~~~~~~~~~~y~~PE~~~~~~~~~~-~Dv~sl 201 (293)
T cd06647 171 KRSTMVGTPYWMAPEVVTRKAYGPK-VDIWSL 201 (293)
T ss_pred ccccccCChhhcCchhhccCCCCch-hhHHHH
Confidence 233457888999999988877655 999996
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-32 Score=199.58 Aligned_cols=181 Identities=34% Similarity=0.552 Sum_probs=160.9
Q ss_pred CeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCcc-chHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEEecC
Q 028681 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYAS 100 (205)
Q Consensus 22 ~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~~~ 100 (205)
+|++.+.||+|++|.+|.+.+..++..+++|.+..... ....+.+|+..++.++|++++++.+.+..+...++++++++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 58899999999999999999998899999999877554 45678899999999999999999999999999999999999
Q ss_pred CCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCCCCCCCCC
Q 028681 101 GGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV 179 (205)
Q Consensus 101 ~~sl~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~~~~~~ 179 (205)
+++|.+.+... ..+++..+..++.|++.|+.+||+.+++|+||+|+||+++.++. ++|+|||.+.............
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~--~~l~d~~~~~~~~~~~~~~~~~ 158 (253)
T cd05122 81 GGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGE--VKLIDFGLSAQLSDTKARNTMV 158 (253)
T ss_pred CCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCe--EEEeecccccccccccccccee
Confidence 99999998775 57999999999999999999999999999999999999988776 9999999987766554344556
Q ss_pred CCCCccCCceeccCcCCCeeeEEEeC
Q 028681 180 GTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 180 ~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
++..|+|||.+.....+.+ +|+|||
T Consensus 159 ~~~~~~~PE~~~~~~~~~~-~Dv~sl 183 (253)
T cd05122 159 GTPYWMAPEVINGKPYDYK-ADIWSL 183 (253)
T ss_pred cCCcccCHHHHcCCCCCcc-ccHHHH
Confidence 8899999999988776655 999985
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=206.46 Aligned_cols=185 Identities=20% Similarity=0.299 Sum_probs=151.7
Q ss_pred ecCCCeEEEeeeccccceeEEEEEecC-----CCcEEEEEEeecCccc--hHHHHHHHHHHHhcCCCCeeEEEEEEEeCC
Q 028681 18 HDSDRYELVRDIGSGNFGVARLMRDKK-----TEELVAVKYIERGDKI--DENVQREIINHRSLRHPNIVRFKEVILTPT 90 (205)
Q Consensus 18 ~~~~~y~~~~~l~~g~~g~v~~~~~~~-----~~~~v~iK~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 90 (205)
...++|++.+.||+|++|.||++.... .+..|++|.+...... ...+.+|+..++.++|+|++++++++..+.
T Consensus 3 ~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 82 (288)
T cd05061 3 VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQ 82 (288)
T ss_pred ccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence 356899999999999999999987542 3457999987654322 245678999999999999999999999999
Q ss_pred eEEEEEEecCCCchHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEE
Q 028681 91 HLAIVMEYASGGELFERICNA----------GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKI 160 (205)
Q Consensus 91 ~~~lv~~~~~~~sl~~~~~~~----------~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l 160 (205)
..+++|||+++++|.+.+... ...+...+..++.|++.||.|||+++++|+||+|+||+++.++. ++|
T Consensus 83 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~--~~L 160 (288)
T cd05061 83 PTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFT--VKI 160 (288)
T ss_pred CcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCc--EEE
Confidence 999999999999999999642 23466788999999999999999999999999999999988776 999
Q ss_pred eeecccccccCCCC---CCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 161 CDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 161 ~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
+|||+++....... .....++..|+|||.+.+..++.+ +|+|||
T Consensus 161 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~-~Dvwsl 207 (288)
T cd05061 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTS-SDMWSF 207 (288)
T ss_pred CcCCccccccccccccccCCCcccccccCHHHhccCCCChH-hHHHHH
Confidence 99999875432221 112235678999999988888765 999996
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=208.36 Aligned_cols=186 Identities=24% Similarity=0.342 Sum_probs=153.9
Q ss_pred eecCCCeEEEeeeccccceeEEEEEec-------CCCcEEEEEEeecCc--cchHHHHHHHHHHHhc-CCCCeeEEEEEE
Q 028681 17 MHDSDRYELVRDIGSGNFGVARLMRDK-------KTEELVAVKYIERGD--KIDENVQREIINHRSL-RHPNIVRFKEVI 86 (205)
Q Consensus 17 ~~~~~~y~~~~~l~~g~~g~v~~~~~~-------~~~~~v~iK~~~~~~--~~~~~~~~e~~~l~~l-~h~~i~~~~~~~ 86 (205)
....++|++.+.||+|++|.||.+... ..+..+++|.+.... ...+.+..|+.+++.+ +|+|++++++.+
T Consensus 11 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~ 90 (304)
T cd05101 11 EFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC 90 (304)
T ss_pred cccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEE
Confidence 345789999999999999999999753 234578999886532 2335688999999999 899999999999
Q ss_pred EeCCeEEEEEEecCCCchHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEe
Q 028681 87 LTPTHLAIVMEYASGGELFERICNA----------------GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLL 150 (205)
Q Consensus 87 ~~~~~~~lv~~~~~~~sl~~~~~~~----------------~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili 150 (205)
......+++|||+++++|.+++... ..++..++..++.|++.||.|||+.|++|+||+|+||++
T Consensus 91 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nili 170 (304)
T cd05101 91 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLV 170 (304)
T ss_pred ecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccceEEE
Confidence 9999999999999999999998653 236778899999999999999999999999999999999
Q ss_pred cCCCCCcEEEeeecccccccCCCC---CCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 151 DGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 151 ~~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
+.++. ++|+|||.++....... .....++..|+|||++.+..++.+ +|||||
T Consensus 171 ~~~~~--~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~sl 225 (304)
T cd05101 171 TENNV--MKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQ-SDVWSF 225 (304)
T ss_pred cCCCc--EEECCCccceecccccccccccCCCCCceeeCchhhccCCCCch-hhHHHH
Confidence 87776 99999999876543222 122235678999999988888766 999996
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=205.72 Aligned_cols=185 Identities=24% Similarity=0.317 Sum_probs=153.9
Q ss_pred CCCeEEEeeeccccceeEEEEEecC-----CCcEEEEEEeecCcc--chHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeE
Q 028681 20 SDRYELVRDIGSGNFGVARLMRDKK-----TEELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHL 92 (205)
Q Consensus 20 ~~~y~~~~~l~~g~~g~v~~~~~~~-----~~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 92 (205)
.++|++.+.||+|++|.||.+.+.. .+..|++|.+..... ....+..|+..++.++|+|++++++++.+....
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPR 84 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCc
Confidence 4789999999999999999999987 678899998865432 234578899999999999999999999999999
Q ss_pred EEEEEecCCCchHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCC-CcEEEeeec
Q 028681 93 AIVMEYASGGELFERICNAG-------RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPA-PRLKICDFG 164 (205)
Q Consensus 93 ~lv~~~~~~~sl~~~~~~~~-------~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~-~~~~l~df~ 164 (205)
++++|++++++|.+.+...+ .+++..+..++.|++.|+.|||+.+++|+||+|+||+++.++. ..++|+|||
T Consensus 85 ~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~dfg 164 (277)
T cd05036 85 FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFG 164 (277)
T ss_pred EEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEeccCc
Confidence 99999999999999886543 4889999999999999999999999999999999999976542 248999999
Q ss_pred ccccccCCCC---CCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 165 YSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 165 ~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
+++....... ......+..|+|||++.+..++.+ +|||||
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Diwsl 207 (277)
T cd05036 165 MARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSK-TDVWSF 207 (277)
T ss_pred cccccCCccceecCCCCCccHhhCCHHHHhcCCcCch-hHHHHH
Confidence 9875532211 112233567999999988888766 999986
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-32 Score=203.11 Aligned_cols=180 Identities=21% Similarity=0.301 Sum_probs=148.1
Q ss_pred eEEEeeeccccceeEEEEEecCC---CcEEEEEEeecCccc---hHHHHHHHHHHHhcCCCCeeEEEEEEEeCCe-----
Q 028681 23 YELVRDIGSGNFGVARLMRDKKT---EELVAVKYIERGDKI---DENVQREIINHRSLRHPNIVRFKEVILTPTH----- 91 (205)
Q Consensus 23 y~~~~~l~~g~~g~v~~~~~~~~---~~~v~iK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~----- 91 (205)
|++.+.||+|++|.||.+....+ +..|++|.+...... .+.+..|+..++.++|+|++++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 67889999999999999987653 478999998754322 3567889999999999999999998876543
Q ss_pred -EEEEEEecCCCchHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeec
Q 028681 92 -LAIVMEYASGGELFERICNA------GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFG 164 (205)
Q Consensus 92 -~~lv~~~~~~~sl~~~~~~~------~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~ 164 (205)
.+++++|+++++|...+... ..+++..+..++.|++.||.|||+.+++|+||+|+||++++++. ++|+|||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~--~kl~dfg 158 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMT--VCVADFG 158 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCe--EEECCcc
Confidence 78999999999998887432 25899999999999999999999999999999999999988776 9999999
Q ss_pred ccccccCCCCC---CCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 165 YSKSSVLHSQP---KSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 165 ~~~~~~~~~~~---~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
+++........ .....+..|+|||.+.+..++.+ +|||||
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~-~Dv~Sl 201 (273)
T cd05035 159 LSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSK-SDVWAF 201 (273)
T ss_pred ceeeccccccccccccccCCccccCHhhcccCCCCcc-cchHHH
Confidence 98755433211 11234678999999988888766 999996
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=205.38 Aligned_cols=182 Identities=20% Similarity=0.292 Sum_probs=149.4
Q ss_pred CCCeEEEeeeccccceeEEEEEecCCCc----EEEEEEeecCcc--chHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEE
Q 028681 20 SDRYELVRDIGSGNFGVARLMRDKKTEE----LVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLA 93 (205)
Q Consensus 20 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~----~v~iK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 93 (205)
.++|++.+.||+|++|.||.+....++. .+++|.+..... ...++..|+..++.+.|+|++++++++. ....+
T Consensus 6 ~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~ 84 (279)
T cd05111 6 ETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQ 84 (279)
T ss_pred HhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccE
Confidence 4789999999999999999999876665 477777654321 2245677788888999999999999875 45577
Q ss_pred EEEEecCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCC
Q 028681 94 IVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 172 (205)
Q Consensus 94 lv~~~~~~~sl~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~ 172 (205)
++++++++++|.+.+.. ...+++..+..++.|++.|+.|||+.+++|+||+|+||+++.++. ++|+|||.++.....
T Consensus 85 ~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~--~kl~Dfg~~~~~~~~ 162 (279)
T cd05111 85 LVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSI--VQIADFGVADLLYPD 162 (279)
T ss_pred EEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCc--EEEcCCccceeccCC
Confidence 89999999999999975 456899999999999999999999999999999999999987776 999999998765433
Q ss_pred CCC---CCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 173 SQP---KSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 173 ~~~---~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
... ....++..|+|||.+.+..++.+ +|||||
T Consensus 163 ~~~~~~~~~~~~~~y~~pE~~~~~~~~~~-~Dv~sl 197 (279)
T cd05111 163 DKKYFYSEHKTPIKWMALESILFGRYTHQ-SDVWSY 197 (279)
T ss_pred CcccccCCCCCcccccCHHHhccCCcCch-hhHHHH
Confidence 221 22346678999999988888755 999996
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=210.39 Aligned_cols=178 Identities=26% Similarity=0.425 Sum_probs=147.2
Q ss_pred EEeeeccc--cceeEEEEEecCCCcEEEEEEeecCcc---chHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEEec
Q 028681 25 LVRDIGSG--NFGVARLMRDKKTEELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA 99 (205)
Q Consensus 25 ~~~~l~~g--~~g~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~~ 99 (205)
+.+.||+| ++++||++.+..+++.||+|.+..... ..+.+.+|+.+++.++||||+++++++..++..++++||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 56789999 788999999999999999999876432 2356778999999999999999999999999999999999
Q ss_pred CCCchHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCC-C---
Q 028681 100 SGGELFERICN--AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-S--- 173 (205)
Q Consensus 100 ~~~sl~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~-~--- 173 (205)
++++|.+++.. ...+++..++.++.|++.||.|||+++++|+||+|+||+++.++. +++.||+.+...... .
T Consensus 82 ~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~--~~l~~~~~~~~~~~~~~~~~ 159 (327)
T cd08227 82 AYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGK--VYLSGLRSNLSMINHGQRLR 159 (327)
T ss_pred CCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCc--EEEcccchhhcccccccccc
Confidence 99999998865 345899999999999999999999999999999999999988776 999999754322111 1
Q ss_pred ----CCCCCCCCCCccCCceeccC--cCCCeeeEEEeC
Q 028681 174 ----QPKSTVGTPAYIAPEVLLKK--EYDGKVMCVYVI 205 (205)
Q Consensus 174 ----~~~~~~~~~~~~aPE~~~~~--~~~~~~~Dvwsl 205 (205)
......++..|+|||++.+. .++.+ +|||||
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~-~Diwsl 196 (327)
T cd08227 160 VVHDFPKYSVKVLPWLSPEVLQQNLQGYDAK-SDIYSV 196 (327)
T ss_pred ccccccccccceecccChHHhhcccCCCCch-hhHHHH
Confidence 01122456779999999763 46555 999996
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=208.94 Aligned_cols=178 Identities=29% Similarity=0.428 Sum_probs=140.8
Q ss_pred EeeeccccceeEEEEEec--CCCcEEEEEEeecCccchHHHHHHHHHHHhcCCCCeeEEEEEEEe--CCeEEEEEEecCC
Q 028681 26 VRDIGSGNFGVARLMRDK--KTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILT--PTHLAIVMEYASG 101 (205)
Q Consensus 26 ~~~l~~g~~g~v~~~~~~--~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~~~~~~ 101 (205)
.++||+|+||.||++.+. .++..+++|.+.... ....+..|+.+++.++||||+++++++.. +...+++++++.+
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~ 84 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG-ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEH 84 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC-CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccCC
Confidence 468999999999999965 456889999886543 34557789999999999999999999865 4568899999854
Q ss_pred CchHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCC--CCCcEEEeeeccccccc
Q 028681 102 GELFERICNA---------GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGS--PAPRLKICDFGYSKSSV 170 (205)
Q Consensus 102 ~sl~~~~~~~---------~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~--~~~~~~l~df~~~~~~~ 170 (205)
+|.+.+... ..+++..++.++.|++.||.|||+.||+|+||+|+||++..+ ....++|+|||+++...
T Consensus 85 -~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~ 163 (317)
T cd07868 85 -DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFN 163 (317)
T ss_pred -CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCceeccC
Confidence 777766421 248899999999999999999999999999999999999532 22249999999997654
Q ss_pred CCC----CCCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 171 LHS----QPKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 171 ~~~----~~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
... ......+++.|+|||++.+....+.++|||||
T Consensus 164 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diwsl 202 (317)
T cd07868 164 SPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAI 202 (317)
T ss_pred CCCccccccCCccccccccCCHHHcCCCCcCchhhHHHH
Confidence 322 12334678999999999875533345999996
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-32 Score=201.72 Aligned_cols=180 Identities=27% Similarity=0.383 Sum_probs=150.9
Q ss_pred ecCCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCccchHHHHHHHHHHHhcCCCCeeEEEEEEE-eCCeEEEEE
Q 028681 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVIL-TPTHLAIVM 96 (205)
Q Consensus 18 ~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~~lv~ 96 (205)
.+..+|++.+.||+|++|.||++... +..+++|.+.... ..+.+..|+.+++.++|+|++++++++. .++..++++
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~~--~~~~~~k~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~ 79 (256)
T cd05082 3 LNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT 79 (256)
T ss_pred ccHHhCeeeeeecccCCCeEEEEEEc--CCcEEEEEeCCCc-hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEE
Confidence 35679999999999999999999765 6778999886543 3567889999999999999999999765 446789999
Q ss_pred EecCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCCCC
Q 028681 97 EYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 174 (205)
Q Consensus 97 ~~~~~~sl~~~~~~~~--~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~ 174 (205)
||+++++|.+.+.... .+++..+..++.|++.||.+||++|++|+||+|+||+++.++. ++|+|||++.......
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~--~kl~dfg~~~~~~~~~- 156 (256)
T cd05082 80 EYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNV--AKVSDFGLTKEASSTQ- 156 (256)
T ss_pred ECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCc--EEecCCccceeccccC-
Confidence 9999999999886543 4888999999999999999999999999999999999988877 9999999886443222
Q ss_pred CCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 175 PKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 175 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
.....+..|+|||++.+..++.+ +|||||
T Consensus 157 -~~~~~~~~y~aPE~~~~~~~~~~-~Dv~sl 185 (256)
T cd05082 157 -DTGKLPVKWTAPEALREKKFSTK-SDVWSF 185 (256)
T ss_pred -CCCccceeecCHHHHccCCCCch-hhhHHH
Confidence 23345678999999988877755 999996
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-32 Score=203.85 Aligned_cols=176 Identities=26% Similarity=0.311 Sum_probs=144.8
Q ss_pred eeeccccceeEEEEEecCCCc--EEEEEEeecCc--cchHHHHHHHHHHHhc-CCCCeeEEEEEEEeCCeEEEEEEecCC
Q 028681 27 RDIGSGNFGVARLMRDKKTEE--LVAVKYIERGD--KIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIVMEYASG 101 (205)
Q Consensus 27 ~~l~~g~~g~v~~~~~~~~~~--~v~iK~~~~~~--~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~~~~~~ 101 (205)
+.||+|++|.||.+....++. .+++|.+.... ...+.+..|+..+.++ .|||++++++++...+..+++|||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 368999999999999987765 46888776432 2345688899999999 799999999999999999999999999
Q ss_pred CchHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecc
Q 028681 102 GELFERICNAG----------------RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGY 165 (205)
Q Consensus 102 ~sl~~~~~~~~----------------~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~ 165 (205)
++|.+++.... .+++.++..++.|++.|++|||+.|++|+||+|+||+++.++. ++|+|||+
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~--~kl~dfgl 158 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYV--AKIADFGL 158 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCe--EEECCCCC
Confidence 99999986532 3788999999999999999999999999999999999988777 99999998
Q ss_pred cccccCCCCCCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 166 SKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 166 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
+..............+..|+|||++....++.+ +|||||
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~-~Di~sl 197 (270)
T cd05047 159 SRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTN-SDVWSY 197 (270)
T ss_pred ccccchhhhccCCCCccccCChHHHccCCCCch-hhHHHH
Confidence 853322222222234567999999988877755 999996
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-32 Score=209.10 Aligned_cols=185 Identities=24% Similarity=0.327 Sum_probs=151.8
Q ss_pred ecCCCeEEEeeeccccceeEEEEEecCC-------CcEEEEEEeecCc--cchHHHHHHHHHHHhc-CCCCeeEEEEEEE
Q 028681 18 HDSDRYELVRDIGSGNFGVARLMRDKKT-------EELVAVKYIERGD--KIDENVQREIINHRSL-RHPNIVRFKEVIL 87 (205)
Q Consensus 18 ~~~~~y~~~~~l~~g~~g~v~~~~~~~~-------~~~v~iK~~~~~~--~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~ 87 (205)
....+|++.+.||+|+||.||.+.+... +..+++|.+.... ...+.+..|+.+++++ +|+||+++++++.
T Consensus 9 ~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 88 (334)
T cd05100 9 LSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACT 88 (334)
T ss_pred cCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEc
Confidence 3456899999999999999999986432 2368999877532 2345688899999999 7999999999999
Q ss_pred eCCeEEEEEEecCCCchHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEec
Q 028681 88 TPTHLAIVMEYASGGELFERICNAG----------------RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLD 151 (205)
Q Consensus 88 ~~~~~~lv~~~~~~~sl~~~~~~~~----------------~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~ 151 (205)
.++..++++||+++++|.+.+.... .++..++..++.|++.||.|||++|++|+||+|+||+++
T Consensus 89 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nill~ 168 (334)
T cd05100 89 QDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVT 168 (334)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEc
Confidence 9999999999999999999886532 377788899999999999999999999999999999998
Q ss_pred CCCCCcEEEeeecccccccCCCC---CCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 152 GSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 152 ~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
.++. ++|+|||+++....... .....++..|+|||++.+..++.+ +|||||
T Consensus 169 ~~~~--~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~sl 222 (334)
T cd05100 169 EDNV--MKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQ-SDVWSF 222 (334)
T ss_pred CCCc--EEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCch-hhhHHH
Confidence 8776 99999999875433221 122234567999999998888766 999996
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-32 Score=203.65 Aligned_cols=186 Identities=27% Similarity=0.470 Sum_probs=155.8
Q ss_pred eecCCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCccchHHHHHHHHHHHhc-CCCCeeEEEEEEEe------C
Q 028681 17 MHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSL-RHPNIVRFKEVILT------P 89 (205)
Q Consensus 17 ~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~------~ 89 (205)
....+.|++.+.||.|++|.||.+.+..++..+++|.+.........+..|+.+++.+ .|+|++++++++.. .
T Consensus 12 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 91 (282)
T cd06636 12 RDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHD 91 (282)
T ss_pred cChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCC
Confidence 3456899999999999999999999999999999999877655556788889988888 69999999999853 4
Q ss_pred CeEEEEEEecCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccc
Q 028681 90 THLAIVMEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 167 (205)
Q Consensus 90 ~~~~lv~~~~~~~sl~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~ 167 (205)
...+++|||+++++|.+++... ..+++..+..++.|++.|+.|||+.+++|+||+|+||+++.++. ++|+|||.+.
T Consensus 92 ~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~--~~l~dfg~~~ 169 (282)
T cd06636 92 DQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAE--VKLVDFGVSA 169 (282)
T ss_pred CEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCC--EEEeeCcchh
Confidence 5789999999999999988653 35888889999999999999999999999999999999988777 9999999886
Q ss_pred cccCC-CCCCCCCCCCCccCCceecc-----CcCCCeeeEEEeC
Q 028681 168 SSVLH-SQPKSTVGTPAYIAPEVLLK-----KEYDGKVMCVYVI 205 (205)
Q Consensus 168 ~~~~~-~~~~~~~~~~~~~aPE~~~~-----~~~~~~~~Dvwsl 205 (205)
..... .......++..|+|||.+.. ..++.+ +|||||
T Consensus 170 ~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~-~Dvwsl 212 (282)
T cd06636 170 QLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYR-SDIWSL 212 (282)
T ss_pred hhhccccCCCcccccccccCHhhcCcccCcCcCCCcc-cchhHH
Confidence 54322 22234468889999999863 345545 999996
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-32 Score=203.45 Aligned_cols=179 Identities=31% Similarity=0.480 Sum_probs=147.5
Q ss_pred eEEEeeeccccceeEEEEEecCCCcEEEEEEeecCcc--chHHHHHHHHHHHhcC-CCCeeEEEEEEEeC--CeEEEEEE
Q 028681 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK--IDENVQREIINHRSLR-HPNIVRFKEVILTP--THLAIVME 97 (205)
Q Consensus 23 y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~--~~~~lv~~ 97 (205)
|++.+.||+|++|.||++.+..++..+++|.+..... .......|+..++++. |+|++++++++.++ +..++++|
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 6889999999999999999999999999998875422 2223446788888885 99999999999987 88999999
Q ss_pred ecCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCCCCCC
Q 028681 98 YASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK 176 (205)
Q Consensus 98 ~~~~~sl~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~~~ 176 (205)
|+++ ++.+.+.. ...+++.++..++.|++.||++||+.+++|+||+|+||+++. +. ++|+|||++..........
T Consensus 81 ~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~--~kl~dfg~~~~~~~~~~~~ 156 (282)
T cd07831 81 LMDM-NLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DI--LKLADFGSCRGIYSKPPYT 156 (282)
T ss_pred cCCc-cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CC--eEEEecccccccccCCCcC
Confidence 9975 77777755 456899999999999999999999999999999999999987 55 9999999987654444334
Q ss_pred CCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 177 STVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 177 ~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
...++..|+|||.+......+.++|||||
T Consensus 157 ~~~~~~~y~aPE~~~~~~~~~~~~Di~sl 185 (282)
T cd07831 157 EYISTRWYRAPECLLTDGYYGPKMDIWAV 185 (282)
T ss_pred CCCCCcccCChhHhhcCCCCCcchhHHHH
Confidence 45678899999987654443455999986
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-32 Score=201.81 Aligned_cols=182 Identities=24% Similarity=0.315 Sum_probs=152.5
Q ss_pred cCCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCccchHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEEe
Q 028681 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (205)
Q Consensus 19 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~ 98 (205)
..++|++.+.||.|++|.||.+.+..+. .+++|.+.......+.+.+|+.+++.+.|+|++++++++. .+..+++||+
T Consensus 4 ~~~~~~~~~~ig~g~~~~v~~~~~~~~~-~~~lK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~ 81 (260)
T cd05069 4 PRESLRLDVKLGQGCFGEVWMGTWNGTT-KVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEF 81 (260)
T ss_pred ChHHeeeeeeecCcCCCeEEEEEEcCCc-eEEEEEcccCCccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEc
Confidence 3478999999999999999999887654 5899988766656677889999999999999999998875 4567899999
Q ss_pred cCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCCCCC-
Q 028681 99 ASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP- 175 (205)
Q Consensus 99 ~~~~sl~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~~- 175 (205)
+++++|.+.+... ..+++..+..++.|++.||.|||+.|++|+||+|+||++++++. ++|+|||.+.........
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~--~~l~dfg~~~~~~~~~~~~ 159 (260)
T cd05069 82 MGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLV--CKIADFGLARLIEDNEYTA 159 (260)
T ss_pred CCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCe--EEECCCccceEccCCcccc
Confidence 9999999988653 34789999999999999999999999999999999999988777 999999998654332211
Q ss_pred -CCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 176 -KSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 176 -~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
....++..|+|||...+...+.+ +|||||
T Consensus 160 ~~~~~~~~~y~~Pe~~~~~~~~~~-~Di~sl 189 (260)
T cd05069 160 RQGAKFPIKWTAPEAALYGRFTIK-SDVWSF 189 (260)
T ss_pred cCCCccchhhCCHHHhccCCcChH-HHHHHH
Confidence 12245678999999988877755 999996
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-32 Score=203.73 Aligned_cols=186 Identities=31% Similarity=0.534 Sum_probs=163.0
Q ss_pred eecCCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCccchHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEE
Q 028681 17 MHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (205)
Q Consensus 17 ~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 96 (205)
....+.|+..+.|++|++|.||.+.+..++..+++|.+.......+.+..|+..++.++|+|++++++.+..+...++++
T Consensus 15 ~~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 94 (286)
T cd06614 15 GDPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVM 94 (286)
T ss_pred CCccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCchhHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEE
Confidence 34567899999999999999999999988999999999876554567889999999999999999999999999999999
Q ss_pred EecCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCCC-C
Q 028681 97 EYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-Q 174 (205)
Q Consensus 97 ~~~~~~sl~~~~~~~~-~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~~-~ 174 (205)
||+++++|.+.+.... .++...+..++.|++.|+.+||+.|++|+||+|+||+++.++. ++|+|||.+....... .
T Consensus 95 e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~--~~l~d~~~~~~~~~~~~~ 172 (286)
T cd06614 95 EYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGS--VKLADFGFAAQLTKEKSK 172 (286)
T ss_pred eccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCC--EEECccchhhhhccchhh
Confidence 9999999999998766 7999999999999999999999999999999999999988777 9999999876544322 2
Q ss_pred CCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 175 PKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 175 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
.....++..|+|||.+.+..++.+ +|+|||
T Consensus 173 ~~~~~~~~~y~~PE~~~~~~~~~~-~Dv~sl 202 (286)
T cd06614 173 RNSVVGTPYWMAPEVIKRKDYGPK-VDIWSL 202 (286)
T ss_pred hccccCCcccCCHhHhcCCCCCCc-cccHHH
Confidence 233457788999999988888766 999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=205.00 Aligned_cols=182 Identities=30% Similarity=0.508 Sum_probs=157.5
Q ss_pred CCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCc--cchHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEE
Q 028681 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (205)
Q Consensus 20 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~ 97 (205)
...|+..+.||.|++|.||.+.+..++..|++|.+.... ...+.+.+|+.+++.+.|+|++++++.+.++...++++|
T Consensus 3 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (277)
T cd06640 3 EELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIME 82 (277)
T ss_pred HHhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEe
Confidence 356888999999999999999999889999999887543 234568889999999999999999999999999999999
Q ss_pred ecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCCCC-CC
Q 028681 98 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-PK 176 (205)
Q Consensus 98 ~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~-~~ 176 (205)
|+++++|.+.+.. .++++.++..++.|++.|+++||+.+++|+||+|+||+++.++. ++|+|||.+........ ..
T Consensus 83 ~~~~~~L~~~i~~-~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~--~~l~dfg~~~~~~~~~~~~~ 159 (277)
T cd06640 83 YLGGGSALDLLRA-GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGD--VKLADFGVAGQLTDTQIKRN 159 (277)
T ss_pred cCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCC--EEEcccccceeccCCccccc
Confidence 9999999988854 56899999999999999999999999999999999999988777 99999999865543332 22
Q ss_pred CCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 177 STVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 177 ~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
...++..|+|||++.+...+.+ +|+|||
T Consensus 160 ~~~~~~~y~apE~~~~~~~~~~-~Dv~sl 187 (277)
T cd06640 160 TFVGTPFWMAPEVIQQSAYDSK-ADIWSL 187 (277)
T ss_pred cccCcccccCHhHhccCCCccH-HHHHHH
Confidence 3357888999999988877755 999986
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-33 Score=228.70 Aligned_cols=185 Identities=26% Similarity=0.371 Sum_probs=158.5
Q ss_pred ecCCCeEEEeeeccccceeEEEEEecCCCc-----EEEEEEeecCcc--chHHHHHHHHHHHhcCCCCeeEEEEEEEeCC
Q 028681 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEE-----LVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPT 90 (205)
Q Consensus 18 ~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~-----~v~iK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 90 (205)
....+.++.+.||+|+||.||.+....... .|++|.+.+... ...+|..|..+++.+.||||++++|++.+..
T Consensus 689 v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~ 768 (1025)
T KOG1095|consen 689 VPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSG 768 (1025)
T ss_pred CChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCC
Confidence 457888999999999999999999875443 499999887643 3467999999999999999999999999999
Q ss_pred eEEEEEEecCCCchHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeee
Q 028681 91 HLAIVMEYASGGELFERICNA-------GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDF 163 (205)
Q Consensus 91 ~~~lv~~~~~~~sl~~~~~~~-------~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df 163 (205)
..++++|||.+|+|..+++.. ..++..++..++.++++|..||+++.+|||||..+|+|++.... |||+||
T Consensus 769 ~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~--VKIaDF 846 (1025)
T KOG1095|consen 769 PPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRV--VKIADF 846 (1025)
T ss_pred CcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCc--EEEccc
Confidence 999999999999999999875 24899999999999999999999999999999999999988865 999999
Q ss_pred cccccccCCCC-CCC--CCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 164 GYSKSSVLHSQ-PKS--TVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 164 ~~~~~~~~~~~-~~~--~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
|+|+.+..... ... ..-...|||||++..+.++++ ||||||
T Consensus 847 GlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtsk-SDvWsF 890 (1025)
T KOG1095|consen 847 GLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSK-SDVWSF 890 (1025)
T ss_pred chhHhhhhchheeccCccccceecCCHHHHhhcccccc-cchhhh
Confidence 99984322211 111 124568999999999999877 999997
|
|
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-32 Score=200.73 Aligned_cols=175 Identities=27% Similarity=0.319 Sum_probs=147.2
Q ss_pred eeeccccceeEEEEEecCCC---cEEEEEEeecCcc--chHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEEecCC
Q 028681 27 RDIGSGNFGVARLMRDKKTE---ELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASG 101 (205)
Q Consensus 27 ~~l~~g~~g~v~~~~~~~~~---~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~~~~ 101 (205)
+.||+|++|.||++.....+ ..+++|.+..... ..+.+..|+.+++.+.|+|++++++++. .+..+++++++++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 47899999999999876544 7899999876554 3466888999999999999999999876 4567999999999
Q ss_pred CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCCCCC----CC
Q 028681 102 GELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP----KS 177 (205)
Q Consensus 102 ~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~~----~~ 177 (205)
++|.+.+.....+++..+..++.|++.|+.+||+.+++|+||+|+||+++.++. ++|+|||.+......... ..
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~--~kl~df~~~~~~~~~~~~~~~~~~ 157 (257)
T cd05060 80 GPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQ--AKISDFGMSRALGAGSDYYRATTA 157 (257)
T ss_pred CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCc--EEeccccccceeecCCcccccccC
Confidence 999999988778999999999999999999999999999999999999988777 999999998755433221 11
Q ss_pred CCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 178 TVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 178 ~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
..++..|+|||.+.+..++.+ +|||||
T Consensus 158 ~~~~~~y~aPE~~~~~~~~~~-~Di~sl 184 (257)
T cd05060 158 GRWPLKWYAPECINYGKFSSK-SDVWSY 184 (257)
T ss_pred ccccccccCHHHhcCCCCCcc-chHHHH
Confidence 123467999999988887765 999996
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-33 Score=223.25 Aligned_cols=182 Identities=23% Similarity=0.368 Sum_probs=142.6
Q ss_pred CCCeEEEeeeccccceeEEEEEecCCCc-EE------------------EEEEeecCccchHHHHHHHHHHHhcCCCCee
Q 028681 20 SDRYELVRDIGSGNFGVARLMRDKKTEE-LV------------------AVKYIERGDKIDENVQREIINHRSLRHPNIV 80 (205)
Q Consensus 20 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~-~v------------------~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~ 80 (205)
.++|++.+.||+|+||+||++....... .. +.|.+.........+..|+.+++.++|+||+
T Consensus 147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv 226 (501)
T PHA03210 147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENIL 226 (501)
T ss_pred hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcC
Confidence 3689999999999999999987643221 11 1122222223345678899999999999999
Q ss_pred EEEEEEEeCCeEEEEEEecCCCchHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCC
Q 028681 81 RFKEVILTPTHLAIVMEYASGGELFERICNA-----GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPA 155 (205)
Q Consensus 81 ~~~~~~~~~~~~~lv~~~~~~~sl~~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~ 155 (205)
++++++...+..+++++++.. ++.+.+... .......++.++.|++.||.|||++||+|+||+|+||+++.++.
T Consensus 227 ~l~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~~~~ 305 (501)
T PHA03210 227 KIEEILRSEANTYMITQKYDF-DLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGK 305 (501)
T ss_pred cEeEEEEECCeeEEEEecccc-CHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCC
Confidence 999999999999999999854 566655332 12446678889999999999999999999999999999988877
Q ss_pred CcEEEeeecccccccCCCC--CCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 156 PRLKICDFGYSKSSVLHSQ--PKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 156 ~~~~l~df~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
++|+|||++........ .....|+..|+|||++.+..++.+ +|||||
T Consensus 306 --vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwSl 354 (501)
T PHA03210 306 --IVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEI-TDIWSC 354 (501)
T ss_pred --EEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcH-HHHHHH
Confidence 99999999976543322 223468999999999999888766 999996
|
|
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-32 Score=201.55 Aligned_cols=181 Identities=36% Similarity=0.567 Sum_probs=155.4
Q ss_pred CeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCcc---chHHHHHHHHHHHhcCCCCeeEEEEEEEe--CCeEEEEE
Q 028681 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILT--PTHLAIVM 96 (205)
Q Consensus 22 ~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~ 96 (205)
+|++.+.||.|++|.||++.+..++..+++|.+..... ..+.+..|+..++.++|+|++++++.+.. ....++++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 58999999999999999999999999999998875432 23567889999999999999999998764 35688999
Q ss_pred EecCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH-----hcCcEeecCCCCCeEecCCCCCcEEEeeecccc
Q 028681 97 EYASGGELFERICN----AGRFSEDEARFFFQQLISGVSYCH-----SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 167 (205)
Q Consensus 97 ~~~~~~sl~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lh-----~~~i~H~di~p~nili~~~~~~~~~l~df~~~~ 167 (205)
||+++++|.+.+.. ..++++..++.++.|++.|+.+|| +.+++|+||+|+||+++.++. ++|+|||.+.
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~--~kl~d~g~~~ 158 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNN--VKLGDFGLAK 158 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCC--EEEecccccc
Confidence 99999999988865 356899999999999999999999 899999999999999988777 9999999987
Q ss_pred cccCCCC-CCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 168 SSVLHSQ-PKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 168 ~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
....... .....++..|+|||.+.+..++.+ +|+|||
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~-~Dv~sl 196 (265)
T cd08217 159 ILGHDSSFAKTYVGTPYYMSPEQLNHMSYDEK-SDIWSL 196 (265)
T ss_pred cccCCcccccccccCCCccChhhhcCCCCCch-hHHHHH
Confidence 6654443 334568899999999988877655 999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-32 Score=205.73 Aligned_cols=181 Identities=22% Similarity=0.318 Sum_probs=149.8
Q ss_pred CeEEEeeeccccceeEEEEEecC-----CCcEEEEEEeecCcc--chHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEE
Q 028681 22 RYELVRDIGSGNFGVARLMRDKK-----TEELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 94 (205)
Q Consensus 22 ~y~~~~~l~~g~~g~v~~~~~~~-----~~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 94 (205)
+|++.+.||+|+||.||++.... ....+++|.+..... ..+.+..|+..++.++||||+++++.+..++..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 58899999999999999998753 235688888765432 23568889999999999999999999999999999
Q ss_pred EEEecCCCchHHHHHhc------------------------CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEe
Q 028681 95 VMEYASGGELFERICNA------------------------GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLL 150 (205)
Q Consensus 95 v~~~~~~~sl~~~~~~~------------------------~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili 150 (205)
++||+.+++|.+.+... .++++..+..++.|++.||.+||+.+++|+||+|+||++
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~nill 160 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLV 160 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhheEEE
Confidence 99999999999887532 247888999999999999999999999999999999999
Q ss_pred cCCCCCcEEEeeecccccccCCCC---CCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 151 DGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 151 ~~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
++++. ++|+|||+++....... .....++..|+|||.+.+..++.+ +|||||
T Consensus 161 ~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~-~Di~sl 215 (290)
T cd05045 161 AEGRK--MKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQ-SDVWSF 215 (290)
T ss_pred cCCCc--EEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchH-hHHHHH
Confidence 88776 99999999865432221 122235678999999988887755 999996
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-32 Score=203.81 Aligned_cols=183 Identities=22% Similarity=0.339 Sum_probs=154.3
Q ss_pred CCCeEEEeeeccccceeEEEEEecC-----CCcEEEEEEeecCccc--hHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeE
Q 028681 20 SDRYELVRDIGSGNFGVARLMRDKK-----TEELVAVKYIERGDKI--DENVQREIINHRSLRHPNIVRFKEVILTPTHL 92 (205)
Q Consensus 20 ~~~y~~~~~l~~g~~g~v~~~~~~~-----~~~~v~iK~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 92 (205)
.++|+..+.||.|++|.||.+.... ....+++|.+...... .+.+..|+.++++++|+|++++++++.+....
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 83 (275)
T cd05046 4 RSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPH 83 (275)
T ss_pred hHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcc
Confidence 4789999999999999999999753 3467899988654332 46788999999999999999999999998999
Q ss_pred EEEEEecCCCchHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeee
Q 028681 93 AIVMEYASGGELFERICNAG---------RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDF 163 (205)
Q Consensus 93 ~lv~~~~~~~sl~~~~~~~~---------~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df 163 (205)
++++|++++++|.+.+.... .+++..+..++.|++.||.|||+.+++|+||+|+||+++.++. ++++||
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~--~~l~~~ 161 (275)
T cd05046 84 YMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQRE--VKVSLL 161 (275)
T ss_pred eEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCc--EEEccc
Confidence 99999999999999987655 6899999999999999999999999999999999999988777 999999
Q ss_pred cccccccCC--CCCCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 164 GYSKSSVLH--SQPKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 164 ~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
|.+...... .......++..|+|||.+.+..++.+ +|||||
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~-~Di~sl 204 (275)
T cd05046 162 SLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTK-SDVWSF 204 (275)
T ss_pred ccccccCcccccccCCceeEEeecChhhhccCCCCch-hhHHHH
Confidence 987543221 12223345677999999988777655 999996
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-33 Score=207.67 Aligned_cols=183 Identities=19% Similarity=0.322 Sum_probs=152.1
Q ss_pred CCCeEEEeeeccccceeEEEEEecC-----CCcEEEEEEeecCcc--chHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeE
Q 028681 20 SDRYELVRDIGSGNFGVARLMRDKK-----TEELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHL 92 (205)
Q Consensus 20 ~~~y~~~~~l~~g~~g~v~~~~~~~-----~~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 92 (205)
.++|++.+.||.|++|.||.+.... .+..|++|.+..... ..+.+..|+.++..++|+||+++++++......
T Consensus 4 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~ 83 (283)
T cd05091 4 LSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPL 83 (283)
T ss_pred HHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCce
Confidence 4678899999999999999998754 357899999875432 235678899999999999999999999999999
Q ss_pred EEEEEecCCCchHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCC
Q 028681 93 AIVMEYASGGELFERICNA----------------GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAP 156 (205)
Q Consensus 93 ~lv~~~~~~~sl~~~~~~~----------------~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~ 156 (205)
+++++|+++++|.+++... ..+++..+..++.|++.||.|||++|++|+||+|+||++++++.
T Consensus 84 ~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~~~- 162 (283)
T cd05091 84 SMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLN- 162 (283)
T ss_pred EEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecCCCc-
Confidence 9999999999998888532 24788889999999999999999999999999999999987777
Q ss_pred cEEEeeecccccccCCCC---CCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 157 RLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 157 ~~~l~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
++|+|||+++....... .....+++.|+|||.+.+..++.+ +|||||
T Consensus 163 -~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~sl 212 (283)
T cd05091 163 -VKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSID-SDIWSY 212 (283)
T ss_pred -eEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcc-hhHHHH
Confidence 99999998865432221 122345678999999988887765 999996
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-32 Score=202.51 Aligned_cols=183 Identities=23% Similarity=0.325 Sum_probs=153.4
Q ss_pred CCCeEEEeeeccccceeEEEEEecCCCc---EEEEEEeecCc--cchHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEE
Q 028681 20 SDRYELVRDIGSGNFGVARLMRDKKTEE---LVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 94 (205)
Q Consensus 20 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~---~v~iK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 94 (205)
.++|+..+.||+|++|.||.+....++. .+++|.+.... ...+.+..|+.+++.++|+|++++.+++...+..++
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI 83 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence 4689999999999999999999876544 78999886542 234568889999999999999999999999999999
Q ss_pred EEEecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCCC
Q 028681 95 VMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 173 (205)
Q Consensus 95 v~~~~~~~sl~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~~ 173 (205)
+||++++++|.+.+... +.+++.++..++.|++.|+.+||+.+++|+||+|+||+++.++. ++|+|||++.......
T Consensus 84 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~--~kl~dfg~~~~~~~~~ 161 (268)
T cd05063 84 ITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLE--CKVSDFGLSRVLEDDP 161 (268)
T ss_pred EEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCc--EEECCCccceeccccc
Confidence 99999999999988653 56899999999999999999999999999999999999987776 9999999886543222
Q ss_pred CCC----CCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 174 QPK----STVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 174 ~~~----~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
... ....+..|+|||++.+..++.+ +|||||
T Consensus 162 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~-~Dv~sl 196 (268)
T cd05063 162 EGTYTTSGGKIPIRWTAPEAIAYRKFTSA-SDVWSF 196 (268)
T ss_pred ccceeccCCCcCceecCHHHhhcCCcChH-hHHHHH
Confidence 111 1123457999999988887766 999986
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-32 Score=202.65 Aligned_cols=181 Identities=30% Similarity=0.492 Sum_probs=152.4
Q ss_pred CeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCcc--chHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEEec
Q 028681 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA 99 (205)
Q Consensus 22 ~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~~ 99 (205)
+|++.+.||.|++|.||++.+..++..|++|.+..... ..+.+..|+.+++.++|+|++++++.+.+.+..++++||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 58999999999999999999999999999999876532 2456778999999999999999999999999999999999
Q ss_pred CCCchHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCCCC-C
Q 028681 100 SGGELFERICNA---GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-P 175 (205)
Q Consensus 100 ~~~sl~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~-~ 175 (205)
++ +|.+.+... ..+++..+..++.|++.|+.+||+.|++|+||+|+||++++++. ++|+|||++........ .
T Consensus 81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~--~~l~d~g~~~~~~~~~~~~ 157 (284)
T cd07836 81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGE--LKLADFGLARAFGIPVNTF 157 (284)
T ss_pred Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCc--EEEeecchhhhhcCCcccc
Confidence 75 787777543 35899999999999999999999999999999999999988877 99999998865433222 2
Q ss_pred CCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 176 KSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 176 ~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
....++..|++||.+.+......++|||||
T Consensus 158 ~~~~~~~~y~~PE~~~~~~~~~~~~Dv~sl 187 (284)
T cd07836 158 SNEVVTLWYRAPDVLLGSRTYSTSIDIWSV 187 (284)
T ss_pred ccccccccccChHHhcCCCCCCcHHHHHHH
Confidence 234567889999998765433345999986
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-31 Score=197.68 Aligned_cols=181 Identities=33% Similarity=0.474 Sum_probs=159.6
Q ss_pred CeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCcc---chHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEEe
Q 028681 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (205)
Q Consensus 22 ~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~ 98 (205)
+|++.+.||+|++|.+|.+.+..++..+++|.+..... ..+.+.+|+.+++.++|+|++++.+++.+++..++++++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 58999999999999999999998899999999977643 346788999999999999999999999999999999999
Q ss_pred cCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCCCC-CCC
Q 028681 99 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-PKS 177 (205)
Q Consensus 99 ~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~-~~~ 177 (205)
+++++|.+.+.....+++..+..++.|++.++.+||+.|++|+||+|+||+++.++. ++|+|||.+........ ...
T Consensus 81 ~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~--~~l~d~~~~~~~~~~~~~~~~ 158 (254)
T cd06627 81 AENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGV--VKLADFGVATKLNDVSKDDAS 158 (254)
T ss_pred CCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCC--EEEeccccceecCCCcccccc
Confidence 999999999988788999999999999999999999999999999999999988776 99999999876654433 233
Q ss_pred CCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 178 TVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 178 ~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
..++..|+|||...+..++.+ +|||||
T Consensus 159 ~~~~~~y~~pe~~~~~~~~~~-~Dv~~l 185 (254)
T cd06627 159 VVGTPYWMAPEVIEMSGASTA-SDIWSL 185 (254)
T ss_pred cccchhhcCHhhhcCCCCCcc-hhHHHH
Confidence 457889999999987776655 999985
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-32 Score=199.17 Aligned_cols=181 Identities=35% Similarity=0.590 Sum_probs=158.6
Q ss_pred CeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCc---cchHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEEe
Q 028681 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (205)
Q Consensus 22 ~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~ 98 (205)
+|++.+.||.|++|.||.+.+..++..+++|.+.... .....+..|+..++.++|+|++++.+.+......++++|+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 5899999999999999999999999999999987653 2346688899999999999999999999999999999999
Q ss_pred cCCCchHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCCC-
Q 028681 99 ASGGELFERICNA----GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS- 173 (205)
Q Consensus 99 ~~~~sl~~~~~~~----~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~~- 173 (205)
+++++|.+.+... ..+++..+..++.+++.|+.+||+.|++|+||+|+||+++.++. ++|+|||.+.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~--~~l~d~~~~~~~~~~~~ 158 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGL--VKLGDFGISKVLSSTVD 158 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCc--EEECCccceeecccCcc
Confidence 9999999988763 67999999999999999999999999999999999999988776 9999999886554433
Q ss_pred CCCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 174 QPKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 174 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
......+++.|+|||.+.+..++.+ +|+|||
T Consensus 159 ~~~~~~~~~~y~~pe~~~~~~~~~~-~Dv~sl 189 (258)
T cd08215 159 LAKTVVGTPYYLSPELCQNKPYNYK-SDIWSL 189 (258)
T ss_pred eecceeeeecccChhHhccCCCCcc-ccHHHH
Confidence 3333467889999999988887655 999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-32 Score=201.17 Aligned_cols=174 Identities=28% Similarity=0.371 Sum_probs=145.0
Q ss_pred eeccccceeEEEEEe--cCCCcEEEEEEeecCcc---chHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEEecCCC
Q 028681 28 DIGSGNFGVARLMRD--KKTEELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGG 102 (205)
Q Consensus 28 ~l~~g~~g~v~~~~~--~~~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~~~~~ 102 (205)
.||+|++|.||++.. ..++..+++|++..... ..+.+..|+.+++.+.|+|++++++++. ....++++|+++++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 589999999999864 45678899998865432 2456888999999999999999999875 45678999999999
Q ss_pred chHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCCCCC----CCC
Q 028681 103 ELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP----KST 178 (205)
Q Consensus 103 sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~~----~~~ 178 (205)
+|.+.+.....+++..+..++.|++.|+++||++|++|+||+|+||+++.++. ++|+|||.+......... ...
T Consensus 81 ~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~~~ 158 (257)
T cd05116 81 PLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHY--AKISDFGLSKALGADENYYKAKTHG 158 (257)
T ss_pred cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCe--EEECCCccccccCCCCCeeeecCCC
Confidence 99999987778999999999999999999999999999999999999988776 999999998755433221 122
Q ss_pred CCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 179 VGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 179 ~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
.+++.|+|||.+.+..++.+ +|+|||
T Consensus 159 ~~~~~y~aPE~~~~~~~~~~-~Di~sl 184 (257)
T cd05116 159 KWPVKWYAPECMNYYKFSSK-SDVWSF 184 (257)
T ss_pred CCCccccCHhHhccCCcCch-hHHHHH
Confidence 34578999999987777655 999996
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-32 Score=204.25 Aligned_cols=181 Identities=32% Similarity=0.502 Sum_probs=152.5
Q ss_pred CeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCcc---chHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEEe
Q 028681 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (205)
Q Consensus 22 ~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~ 98 (205)
+|+..+.||.|++|.||++.+..++..|++|.+..... ....+.+|+..+++++|+|++++++++.+++..++++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 58999999999999999999999999999998875432 235688899999999999999999999999999999999
Q ss_pred cCCCchHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCCCC-C
Q 028681 99 ASGGELFERICN--AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-P 175 (205)
Q Consensus 99 ~~~~sl~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~-~ 175 (205)
+. ++|.+.+.. ...+++..+..++.|++.|++|||+.+++|+||+|+||+++.++. ++|+|||++........ .
T Consensus 81 ~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~--~~l~dfg~~~~~~~~~~~~ 157 (284)
T cd07860 81 LH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTY 157 (284)
T ss_pred cc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCC--EEEeeccchhhcccCcccc
Confidence 96 578777754 346899999999999999999999999999999999999998887 99999998865543322 2
Q ss_pred CCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 176 KSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 176 ~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
....++..|+|||.+.+....+.++|||||
T Consensus 158 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~sl 187 (284)
T cd07860 158 THEVVTLWYRAPEILLGCKYYSTAVDIWSL 187 (284)
T ss_pred ccccccccccCCeEEecCCCCCcHHHHHHH
Confidence 233567889999998765543455999986
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-32 Score=199.57 Aligned_cols=174 Identities=28% Similarity=0.383 Sum_probs=142.9
Q ss_pred eeccccceeEEEEEec--CCCcEEEEEEeecCcc--chHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEEecCCCc
Q 028681 28 DIGSGNFGVARLMRDK--KTEELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGE 103 (205)
Q Consensus 28 ~l~~g~~g~v~~~~~~--~~~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~~~~~s 103 (205)
.||+|++|.||.+... ..+..|++|.+..... ..+.+..|+.+++.++|+|++++++++. ....++++||+++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence 4899999999998765 3455799998876432 2356889999999999999999999875 457899999999999
Q ss_pred hHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCCCCC----CCC
Q 028681 104 LFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP----KST 178 (205)
Q Consensus 104 l~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~~----~~~ 178 (205)
|.+.+.. ...+++..+..++.|++.|+.+||++|++|+||+|+||+++.++. ++|+|||++......... ...
T Consensus 81 L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~ 158 (257)
T cd05115 81 LNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHY--AKISDFGLSKALGADDSYYKARSAG 158 (257)
T ss_pred HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCc--EEeccCCccccccCCccceeccCCC
Confidence 9998864 446899999999999999999999999999999999999988777 999999998654332221 111
Q ss_pred CCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 179 VGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 179 ~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
.++..|+|||.+.+..++.+ +|||||
T Consensus 159 ~~~~~y~aPE~~~~~~~~~~-~Di~sl 184 (257)
T cd05115 159 KWPLKWYAPECINFRKFSSR-SDVWSY 184 (257)
T ss_pred CCCcccCCHHHHccCCCCch-hhHHHH
Confidence 23578999999988877755 999996
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-32 Score=210.45 Aligned_cols=185 Identities=23% Similarity=0.359 Sum_probs=149.7
Q ss_pred ecCCCeEEEeeeccccceeEEEEEec-----CCCcEEEEEEeecCcc--chHHHHHHHHHHHhc-CCCCeeEEEEEEEeC
Q 028681 18 HDSDRYELVRDIGSGNFGVARLMRDK-----KTEELVAVKYIERGDK--IDENVQREIINHRSL-RHPNIVRFKEVILTP 89 (205)
Q Consensus 18 ~~~~~y~~~~~l~~g~~g~v~~~~~~-----~~~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~ 89 (205)
...++|++.+.||+|+||.||.+.+. .+++.||+|.+..... ....+..|+.++..+ +|+|++++++++...
T Consensus 4 ~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~ 83 (343)
T cd05103 4 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP 83 (343)
T ss_pred cchhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecC
Confidence 34679999999999999999999853 4567899999875432 234577899999999 689999999988654
Q ss_pred -CeEEEEEEecCCCchHHHHHhc---------------------------------------------------------
Q 028681 90 -THLAIVMEYASGGELFERICNA--------------------------------------------------------- 111 (205)
Q Consensus 90 -~~~~lv~~~~~~~sl~~~~~~~--------------------------------------------------------- 111 (205)
...++++||+++++|.+.+...
T Consensus 84 ~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (343)
T cd05103 84 GGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEE 163 (343)
T ss_pred CCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchh
Confidence 4678999999999999888542
Q ss_pred ----------CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCCCC---CCCC
Q 028681 112 ----------GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKST 178 (205)
Q Consensus 112 ----------~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~---~~~~ 178 (205)
..++...+..++.|++.||+|||+++++|+||+|+||+++.++. ++|+|||++........ ....
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~ 241 (343)
T cd05103 164 EEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNV--VKICDFGLARDIYKDPDYVRKGDA 241 (343)
T ss_pred hhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCc--EEEEecccccccccCcchhhcCCC
Confidence 13577788889999999999999999999999999999987776 99999999865432211 1122
Q ss_pred CCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 179 VGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 179 ~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
.++..|+|||.+.+..++.+ +|||||
T Consensus 242 ~~~~~y~aPE~~~~~~~~~~-~Di~sl 267 (343)
T cd05103 242 RLPLKWMAPETIFDRVYTIQ-SDVWSF 267 (343)
T ss_pred CCCcceECcHHhcCCCCCch-hhHHHH
Confidence 35677999999988888766 999986
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-32 Score=202.59 Aligned_cols=180 Identities=33% Similarity=0.525 Sum_probs=152.4
Q ss_pred eEEEeeeccccceeEEEEEecCCCcEEEEEEeecCc---cchHHHHHHHHHHHhcCCCCeeEEEEEEEeC--CeEEEEEE
Q 028681 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTP--THLAIVME 97 (205)
Q Consensus 23 y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~~ 97 (205)
|++.+.||.|++|.||++.+..++..+++|.+.... .....+..|+.+++.+.|+|++++.+++... +..+++++
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 788999999999999999999989999999998753 2335678899999999999999999999988 88999999
Q ss_pred ecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCCCC--
Q 028681 98 YASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-- 174 (205)
Q Consensus 98 ~~~~~sl~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~-- 174 (205)
|+++ +|.+.+... ..+++..+..++.|++.|+++||+.+++|+||+|+||++++++. ++|+|||.+........
T Consensus 81 ~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~--~~l~d~g~~~~~~~~~~~~ 157 (287)
T cd07840 81 YMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGV--LKLADFGLARPYTKRNSAD 157 (287)
T ss_pred cccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCC--EEEccccceeeccCCCccc
Confidence 9975 788887654 57999999999999999999999999999999999999998877 99999999876544331
Q ss_pred CCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 175 PKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 175 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
.....++..|+|||.+.+....+.++|||||
T Consensus 158 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~sl 188 (287)
T cd07840 158 YTNRVITLWYRPPELLLGATRYGPEVDMWSV 188 (287)
T ss_pred ccccccccccCCceeeEccccCChHHHHHHH
Confidence 2334567889999988754333345999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-31 Score=202.52 Aligned_cols=183 Identities=32% Similarity=0.508 Sum_probs=150.1
Q ss_pred CCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCcc---chHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEE
Q 028681 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (205)
Q Consensus 21 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~ 97 (205)
++|++.+.||+|++|.||++.+..+++.|++|.+..... ..+.+..|+..++.++|+|++++++++..+...++++|
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 689999999999999999999999999999998865432 23567889999999999999999999999999999999
Q ss_pred ecCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCCCC-
Q 028681 98 YASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ- 174 (205)
Q Consensus 98 ~~~~~sl~~~~~~~~--~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~- 174 (205)
|+++ ++.+.+.... .+++..+..++.|++.||.+||+++++|+||+|+||+++.++. .++|+|||++........
T Consensus 82 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~-~~kl~dfg~~~~~~~~~~~ 159 (294)
T PLN00009 82 YLDL-DLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTN-ALKLADFGLARAFGIPVRT 159 (294)
T ss_pred cccc-cHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCC-EEEEcccccccccCCCccc
Confidence 9964 6776665433 3578888999999999999999999999999999999975432 389999999865543322
Q ss_pred CCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 175 PKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 175 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
.....+++.|+|||++.+......++|||||
T Consensus 160 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~sl 190 (294)
T PLN00009 160 FTHEVVTLWYRAPEILLGSRHYSTPVDIWSV 190 (294)
T ss_pred cccCceeecccCHHHHhCCCCCCcHHHHHHH
Confidence 2233567899999998765433344999996
|
|
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-32 Score=201.66 Aligned_cols=174 Identities=32% Similarity=0.479 Sum_probs=142.8
Q ss_pred eeccccceeEEEEEecCCCcEEEEEEeecCccc----hHHHHHHHHHHH---hcCCCCeeEEEEEEEeCCeEEEEEEecC
Q 028681 28 DIGSGNFGVARLMRDKKTEELVAVKYIERGDKI----DENVQREIINHR---SLRHPNIVRFKEVILTPTHLAIVMEYAS 100 (205)
Q Consensus 28 ~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~----~~~~~~e~~~l~---~l~h~~i~~~~~~~~~~~~~~lv~~~~~ 100 (205)
.||+|++|.||.+.+..++..+++|.+.+.... .....++..+++ ...|++++.+.+.+..++..+++|||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 479999999999999999999999988754321 122334443333 3478999999999999999999999999
Q ss_pred CCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCCCCCCCCCC
Q 028681 101 GGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 180 (205)
Q Consensus 101 ~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~~~~~~~ 180 (205)
+++|.+.+.....+++..+..++.|++.|+.+||+.+++|+||+|+||+++.++. ++|+|||++...... ......+
T Consensus 81 ~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~--~~l~dfg~~~~~~~~-~~~~~~~ 157 (279)
T cd05633 81 GGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGH--VRISDLGLACDFSKK-KPHASVG 157 (279)
T ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCC--EEEccCCcceecccc-CccCcCC
Confidence 9999998888788999999999999999999999999999999999999988777 999999988644322 2233468
Q ss_pred CCCccCCceecc-CcCCCeeeEEEeC
Q 028681 181 TPAYIAPEVLLK-KEYDGKVMCVYVI 205 (205)
Q Consensus 181 ~~~~~aPE~~~~-~~~~~~~~Dvwsl 205 (205)
+..|+|||.+.+ ..++.+ +|||||
T Consensus 158 ~~~y~aPE~~~~~~~~~~~-~Di~sl 182 (279)
T cd05633 158 THGYMAPEVLQKGTAYDSS-ADWFSL 182 (279)
T ss_pred CcCccCHHHhcCCCCCCch-hhhHHH
Confidence 999999999875 445544 999985
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-31 Score=201.16 Aligned_cols=181 Identities=30% Similarity=0.460 Sum_probs=154.3
Q ss_pred CCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCcc--chHHHHHHHHHHHhcCCCCeeEEEEEEEeC--CeEEEEE
Q 028681 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTP--THLAIVM 96 (205)
Q Consensus 21 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~ 96 (205)
++|+..+.||.|++|.||.+.+..++..+++|.+..... ....+.+|+.+++.++|+||+++++++... +.++++|
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 479999999999999999999999999999999876433 346688999999999999999999988654 4789999
Q ss_pred EecCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCC
Q 028681 97 EYASGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 172 (205)
Q Consensus 97 ~~~~~~sl~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~ 172 (205)
||+++++|.+.+.. ...+++..+..++.|++.||.|||+.+++|+||+|+||+++.++. ++|+|||++......
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~--~~l~dfg~~~~~~~~ 158 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQ--VKLCDFGVSGELVNS 158 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCe--EEEeecccccccccc
Confidence 99999999887643 345899999999999999999999999999999999999987776 999999988654332
Q ss_pred CCCCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 173 SQPKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 173 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
.. ....++..|+|||.+.+..++.+ +|||||
T Consensus 159 ~~-~~~~~~~~y~~pE~~~~~~~~~~-~Dv~sl 189 (287)
T cd06621 159 LA-GTFTGTSFYMAPERIQGKPYSIT-SDVWSL 189 (287)
T ss_pred cc-ccccCCccccCHHHhcCCCCCch-hhHHHH
Confidence 22 23457788999999988888766 999985
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-32 Score=202.48 Aligned_cols=185 Identities=23% Similarity=0.231 Sum_probs=153.9
Q ss_pred ecCCCeEEEeeeccccceeEEEEEecC----CCcEEEEEEeecCcc--chHHHHHHHHHHHhcCCCCeeEEEEEEEe-CC
Q 028681 18 HDSDRYELVRDIGSGNFGVARLMRDKK----TEELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILT-PT 90 (205)
Q Consensus 18 ~~~~~y~~~~~l~~g~~g~v~~~~~~~----~~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~ 90 (205)
...++|++.+.||+|++|.||.+.+.. ++..|++|.+..... ..+.+..|+..++.++|+|++++++++.. +.
T Consensus 3 ~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~ 82 (280)
T cd05043 3 ISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGE 82 (280)
T ss_pred cchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCC
Confidence 356899999999999999999999876 357889998865432 24567889999999999999999998776 46
Q ss_pred eEEEEEEecCCCchHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEee
Q 028681 91 HLAIVMEYASGGELFERICNA--------GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICD 162 (205)
Q Consensus 91 ~~~lv~~~~~~~sl~~~~~~~--------~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~d 162 (205)
..+++++++++++|.+.+... ..+++..+..++.|++.||+|||+.+++|+||+|+||+++.++. ++|+|
T Consensus 83 ~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~--~kl~d 160 (280)
T cd05043 83 PPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQ--VKITD 160 (280)
T ss_pred CCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCc--EEECC
Confidence 788999999999999988653 45889999999999999999999999999999999999987776 99999
Q ss_pred ecccccccCCCCC---CCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 163 FGYSKSSVLHSQP---KSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 163 f~~~~~~~~~~~~---~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
||+++...+.... ....++..|+|||++.+..++.+ +|||||
T Consensus 161 ~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~-~Di~sl 205 (280)
T cd05043 161 NALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSA-SDVWSF 205 (280)
T ss_pred CCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCch-hhHHHh
Confidence 9999755433211 22345678999999988888766 999996
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-32 Score=200.71 Aligned_cols=183 Identities=26% Similarity=0.307 Sum_probs=151.3
Q ss_pred cCCCeEEEeeeccccceeEEEEEecCC---CcEEEEEEeecCc--cchHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEE
Q 028681 19 DSDRYELVRDIGSGNFGVARLMRDKKT---EELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLA 93 (205)
Q Consensus 19 ~~~~y~~~~~l~~g~~g~v~~~~~~~~---~~~v~iK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 93 (205)
..++|++.+.||+|++|.||++.+... ...+++|...... ...+.+.+|+.+++.++|+|++++++++.+ ...+
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~ 82 (270)
T cd05056 4 QREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVW 82 (270)
T ss_pred chhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcE
Confidence 457899999999999999999987543 4568999887543 234678899999999999999999998875 4577
Q ss_pred EEEEecCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCC
Q 028681 94 IVMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 172 (205)
Q Consensus 94 lv~~~~~~~sl~~~~~~~~-~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~ 172 (205)
+++|++++++|.+++.... .+++..+..++.+++.|+.+||+.+++|+||+|+||+++.++. ++|+|||++......
T Consensus 83 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~--~~l~d~g~~~~~~~~ 160 (270)
T cd05056 83 IVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDC--VKLGDFGLSRYLEDE 160 (270)
T ss_pred EEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCC--eEEccCceeeecccc
Confidence 9999999999999997644 5899999999999999999999999999999999999988776 999999988654333
Q ss_pred CCC--CCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 173 SQP--KSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 173 ~~~--~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
... ....++..|+|||.+....++.+ +|||||
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~sl 194 (270)
T cd05056 161 SYYKASKGKLPIKWMAPESINFRRFTSA-SDVWMF 194 (270)
T ss_pred cceecCCCCccccccChhhhccCCCCch-hhhHHH
Confidence 211 12234567999999988877755 999996
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-31 Score=202.36 Aligned_cols=182 Identities=32% Similarity=0.424 Sum_probs=148.4
Q ss_pred CCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCcc---chHHHHHHHHHHHhcC-CCCeeEEEEEEEeCCe-----
Q 028681 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---IDENVQREIINHRSLR-HPNIVRFKEVILTPTH----- 91 (205)
Q Consensus 21 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~----- 91 (205)
++|++.+.||+|++|.||++.+..+++.|++|.+..... ....+..|+.+++.++ |+|++++++++.....
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 479999999999999999999999999999998765432 2356788999999995 6999999999887655
Q ss_pred EEEEEEecCCCchHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecC-CCCCcEEEeeecc
Q 028681 92 LAIVMEYASGGELFERICNA-----GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDG-SPAPRLKICDFGY 165 (205)
Q Consensus 92 ~~lv~~~~~~~sl~~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~-~~~~~~~l~df~~ 165 (205)
.++++||+++ +|.+.+... ..+++..++.++.|++.||.|||+.+++|+||+|+||+++. ++. ++|+|||+
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~--~kl~dfg~ 157 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGL--LKIADLGL 157 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCe--EEEeeccc
Confidence 8999999976 777776542 35799999999999999999999999999999999999987 555 99999999
Q ss_pred cccccCC-CCCCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 166 SKSSVLH-SQPKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 166 ~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
+...... .......+++.|+|||.+.+....+.++|||||
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~sl 198 (295)
T cd07837 158 GRAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSV 198 (295)
T ss_pred ceecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHH
Confidence 8754332 222233567889999998764433345999986
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-31 Score=201.93 Aligned_cols=181 Identities=28% Similarity=0.502 Sum_probs=153.1
Q ss_pred CeEEEeeeccccceeEEEEEec---CCCcEEEEEEeecCc-----cchHHHHHHHHHHHhc-CCCCeeEEEEEEEeCCeE
Q 028681 22 RYELVRDIGSGNFGVARLMRDK---KTEELVAVKYIERGD-----KIDENVQREIINHRSL-RHPNIVRFKEVILTPTHL 92 (205)
Q Consensus 22 ~y~~~~~l~~g~~g~v~~~~~~---~~~~~v~iK~~~~~~-----~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~ 92 (205)
+|++.+.||+|++|.||.+.+. .++..|++|++.... ...+.+..|+.+++.+ +|++|+++++.+..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 5899999999999999999875 468899999987532 2235678899999999 589999999999999999
Q ss_pred EEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCC
Q 028681 93 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 172 (205)
Q Consensus 93 ~lv~~~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~ 172 (205)
++++|++++++|.+.+....++++..+..++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||++......
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~--~kl~dfg~~~~~~~~ 158 (290)
T cd05613 81 HLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGH--VVLTDFGLSKEFHED 158 (290)
T ss_pred EEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCC--EEEeeCccceecccc
Confidence 999999999999999988788999999999999999999999999999999999999988776 999999988754332
Q ss_pred CC--CCCCCCCCCccCCceeccCc--CCCeeeEEEeC
Q 028681 173 SQ--PKSTVGTPAYIAPEVLLKKE--YDGKVMCVYVI 205 (205)
Q Consensus 173 ~~--~~~~~~~~~~~aPE~~~~~~--~~~~~~Dvwsl 205 (205)
.. .....++..|+|||.+.... ++ .++|||||
T Consensus 159 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~~~Dv~sl 194 (290)
T cd05613 159 EVERAYSFCGTIEYMAPDIVRGGDGGHD-KAVDWWSM 194 (290)
T ss_pred cccccccccCCcccCChhhccCCCCCCC-ccccHHHH
Confidence 21 12345788999999997542 34 44999986
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-31 Score=201.36 Aligned_cols=183 Identities=28% Similarity=0.431 Sum_probs=154.6
Q ss_pred CCCeEEEeeeccccceeEEEEEec----CCCcEEEEEEeecCccc--hHHHHHHHHHHHhcCCCCeeEEEEEEEe--CCe
Q 028681 20 SDRYELVRDIGSGNFGVARLMRDK----KTEELVAVKYIERGDKI--DENVQREIINHRSLRHPNIVRFKEVILT--PTH 91 (205)
Q Consensus 20 ~~~y~~~~~l~~g~~g~v~~~~~~----~~~~~v~iK~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~ 91 (205)
..+|++.+.||+|++|.||.+... .++..+++|.+...... .+.+..|+..++.++|+|++++++++.. ...
T Consensus 3 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~ 82 (284)
T cd05038 3 KRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRS 82 (284)
T ss_pred hhhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCc
Confidence 467889999999999999999864 34788999998866543 5678999999999999999999999887 557
Q ss_pred EEEEEEecCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeeccccccc
Q 028681 92 LAIVMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 170 (205)
Q Consensus 92 ~~lv~~~~~~~sl~~~~~~~~-~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~ 170 (205)
.++++||+++++|.+.+.... .++...+..++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||.+....
T Consensus 83 ~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~--~~l~dfg~~~~~~ 160 (284)
T cd05038 83 LRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDL--VKISDFGLAKVLP 160 (284)
T ss_pred eEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCC--EEEcccccccccc
Confidence 899999999999999996644 5899999999999999999999999999999999999988876 9999999987655
Q ss_pred CCCCC----CCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 171 LHSQP----KSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 171 ~~~~~----~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
..... ....++..|+|||.+.+..++.+ +|||||
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~-~Di~sl 198 (284)
T cd05038 161 EDKDYYYVKEPGESPIFWYAPECLRTSKFSSA-SDVWSF 198 (284)
T ss_pred cCCcceeccCCCCCcccccCcHHHccCCCCcc-cchHHH
Confidence 32221 12234567999999988877755 999996
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-33 Score=200.72 Aligned_cols=181 Identities=35% Similarity=0.522 Sum_probs=156.4
Q ss_pred CCCeEE-EeeeccccceeEEEEEecCCCcEEEEEEeecCccchHHHHHHHHHHHhc-CCCCeeEEEEEEEeC----CeEE
Q 028681 20 SDRYEL-VRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSL-RHPNIVRFKEVILTP----THLA 93 (205)
Q Consensus 20 ~~~y~~-~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~----~~~~ 93 (205)
-++|++ -+.||-|-.|.|..+.++.++..+|+|++... ....+|++++-.. .|+|||.+++++++. .++.
T Consensus 60 tedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLL 135 (400)
T KOG0604|consen 60 TEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLL 135 (400)
T ss_pred hhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeE
Confidence 466765 46789999999999999999999999987743 4456778777666 599999999998753 5788
Q ss_pred EEEEecCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCC-CCcEEEeeeccccccc
Q 028681 94 IVMEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSP-APRLKICDFGYSKSSV 170 (205)
Q Consensus 94 lv~~~~~~~sl~~~~~~~~--~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~-~~~~~l~df~~~~~~~ 170 (205)
+|||.+.||.|.+.++..+ .+++.++..|+.||+.|+.|||+.+|.|||+||+|+|+.... +..+||+|||+|+...
T Consensus 136 iVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~ 215 (400)
T KOG0604|consen 136 IVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQ 215 (400)
T ss_pred eeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEecccccccccC
Confidence 9999999999999998765 499999999999999999999999999999999999996533 3359999999998877
Q ss_pred CCCCCCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 171 LHSQPKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 171 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
......+.+-|+.|.|||++...+|+.+ .|+|||
T Consensus 216 ~~~~L~TPc~TPyYvaPevlg~eKydks-cdmwSl 249 (400)
T KOG0604|consen 216 EPGDLMTPCFTPYYVAPEVLGPEKYDKS-CDMWSL 249 (400)
T ss_pred CCccccCCcccccccCHHHhCchhcCCC-CCccch
Confidence 7777788889999999999999999855 999996
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-33 Score=215.67 Aligned_cols=184 Identities=27% Similarity=0.381 Sum_probs=160.9
Q ss_pred ecCCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCcc--chHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEE
Q 028681 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV 95 (205)
Q Consensus 18 ~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 95 (205)
...+...++++||+|.||.|.++.-.. +..||+|.++.... .+.+|..|+.+|.+++||||+.++|+|..++.++++
T Consensus 535 fPRs~L~~~ekiGeGqFGEVhLCeveg-~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI 613 (807)
T KOG1094|consen 535 FPRSRLRFKEKIGEGQFGEVHLCEVEG-PLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMI 613 (807)
T ss_pred cchhheehhhhhcCcccceeEEEEecC-ceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHH
Confidence 446788899999999999999998765 78999999987643 357899999999999999999999999999999999
Q ss_pred EEecCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCCC
Q 028681 96 MEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 173 (205)
Q Consensus 96 ~~~~~~~sl~~~~~~~~--~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~~ 173 (205)
+||+.+|.|.+++..+. .........|+.||+.|++||.+.+++|||+.+.|+|++.+.+ +||+|||.++......
T Consensus 614 ~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~--iKiadfgmsR~lysg~ 691 (807)
T KOG1094|consen 614 TEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFT--IKIADFGMSRNLYSGD 691 (807)
T ss_pred HHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCccc--EEecCcccccccccCC
Confidence 99999999999998763 3456667789999999999999999999999999999998888 9999999998765554
Q ss_pred CCCCC---CCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 174 QPKST---VGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 174 ~~~~~---~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
..... .-.++|+|||.+..++++++ ||+|+|
T Consensus 692 yy~vqgr~vlpiRwmawEsillgkFtta-SDvWaf 725 (807)
T KOG1094|consen 692 YYRVQGRAVLPIRWMAWESILLGKFTTA-SDVWAF 725 (807)
T ss_pred ceeeecceeeeeeehhHHHHHhccccch-hhhhhh
Confidence 43322 35789999999999999877 999986
|
|
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-32 Score=207.80 Aligned_cols=182 Identities=34% Similarity=0.548 Sum_probs=153.2
Q ss_pred CCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecC---ccchHHHHHHHHHHHhcCCCCeeEEEEEEEeC-----Ce
Q 028681 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG---DKIDENVQREIINHRSLRHPNIVRFKEVILTP-----TH 91 (205)
Q Consensus 20 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~ 91 (205)
..+|++.+.||+|++|.||.+.+..++..|++|.+... ......+..|+.+++.++|+|++++++++... ..
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 46899999999999999999999999999999988653 22234567899999999999999999987654 34
Q ss_pred EEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccC
Q 028681 92 LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 171 (205)
Q Consensus 92 ~~lv~~~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~ 171 (205)
.+++++|+. ++|.+.+...+.+++..+..++.|++.||.+||+.+++|+||+|+||+++.++. ++|+|||++.....
T Consensus 84 ~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~--~kL~Dfg~~~~~~~ 160 (337)
T cd07858 84 VYIVYELMD-TDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCD--LKICDFGLARTTSE 160 (337)
T ss_pred EEEEEeCCC-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCC--EEECcCccccccCC
Confidence 799999996 578888877778999999999999999999999999999999999999988777 99999999876543
Q ss_pred C-CCCCCCCCCCCccCCceeccC-cCCCeeeEEEeC
Q 028681 172 H-SQPKSTVGTPAYIAPEVLLKK-EYDGKVMCVYVI 205 (205)
Q Consensus 172 ~-~~~~~~~~~~~~~aPE~~~~~-~~~~~~~Dvwsl 205 (205)
. .......++..|+|||.+.+. .++ .++|||||
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~~Diwsl 195 (337)
T cd07858 161 KGDFMTEYVVTRWYRAPELLLNCSEYT-TAIDVWSV 195 (337)
T ss_pred CcccccccccccCccChHHHhcCCCCC-CcccHHHH
Confidence 3 223344578899999998764 454 45999996
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-32 Score=204.61 Aligned_cols=184 Identities=33% Similarity=0.503 Sum_probs=151.8
Q ss_pred cCCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCccc---hHHHHHHHHHHHhcCCCCeeEEEEEEEeC--CeEE
Q 028681 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI---DENVQREIINHRSLRHPNIVRFKEVILTP--THLA 93 (205)
Q Consensus 19 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~ 93 (205)
..++|++.+.||+|++|.||.+.+..++..|++|.+...... .....+|+.++++++|+|++++++++... +..+
T Consensus 5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (309)
T cd07845 5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIF 84 (309)
T ss_pred cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEE
Confidence 468999999999999999999999999999999998754322 23456799999999999999999998765 5689
Q ss_pred EEEEecCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCC
Q 028681 94 IVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 172 (205)
Q Consensus 94 lv~~~~~~~sl~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~ 172 (205)
+++|++.+ +|.+.+.. ...+++.++..++.|++.|+.+||+.|++|+||+|+||+++.++. ++|+|||.+......
T Consensus 85 lv~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~--~kL~dfg~~~~~~~~ 161 (309)
T cd07845 85 LVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGC--LKIADFGLARTYGLP 161 (309)
T ss_pred EEEecCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCC--EEECccceeeecCCc
Confidence 99999965 77777754 356899999999999999999999999999999999999988777 999999998765443
Q ss_pred C-CCCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 173 S-QPKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 173 ~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
. ......++..|+|||.+.+....+.++|||||
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dvwsl 195 (309)
T cd07845 162 AKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAV 195 (309)
T ss_pred cCCCCcccccccccChhhhcCCCCcCchHHHHHH
Confidence 2 22223457789999998764433345999986
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-31 Score=199.99 Aligned_cols=176 Identities=26% Similarity=0.471 Sum_probs=147.4
Q ss_pred CCCeEEEeee--ccccceeEEEEEecCCCcEEEEEEeecCccchHHHHHHHHHHHhc-CCCCeeEEEEEEEeCCeEEEEE
Q 028681 20 SDRYELVRDI--GSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIVM 96 (205)
Q Consensus 20 ~~~y~~~~~l--~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~ 96 (205)
.++|++.+.+ |+|+||.||.+.+..++..+++|.+........ |......+ .|+|++++++.+..++..+++|
T Consensus 13 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~----e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv~ 88 (267)
T PHA03390 13 LKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI----EPMVHQLMKDNPNFIKLYYSVTTLKGHVLIM 88 (267)
T ss_pred HHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh----hHHHHHHhhcCCCEEEEEEEEecCCeeEEEE
Confidence 4577777776 999999999999999999999999875432211 12222222 6999999999999999999999
Q ss_pred EecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCC-CCcEEEeeecccccccCCCCC
Q 028681 97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSP-APRLKICDFGYSKSSVLHSQP 175 (205)
Q Consensus 97 ~~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~-~~~~~l~df~~~~~~~~~~~~ 175 (205)
||+++++|.+++.....+++.++..++.|++.|+.+||+.|++|+||+|+||+++.++ . ++|+|||.+......
T Consensus 89 e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~--~~l~dfg~~~~~~~~--- 163 (267)
T PHA03390 89 DYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDR--IYLCDYGLCKIIGTP--- 163 (267)
T ss_pred EcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCe--EEEecCccceecCCC---
Confidence 9999999999998877899999999999999999999999999999999999998777 5 999999988654322
Q ss_pred CCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 176 KSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 176 ~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
....++..|+|||++.+..++.+ +|||||
T Consensus 164 ~~~~~~~~y~aPE~~~~~~~~~~-~Dvwsl 192 (267)
T PHA03390 164 SCYDGTLDYFSPEKIKGHNYDVS-FDWWAV 192 (267)
T ss_pred ccCCCCCcccChhhhcCCCCCch-hhHHHH
Confidence 23467889999999998888755 999985
|
|
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-32 Score=204.69 Aligned_cols=184 Identities=27% Similarity=0.406 Sum_probs=153.5
Q ss_pred cCCCeEEEeeeccccceeEEEEEecC-----CCcEEEEEEeecCcc--chHHHHHHHHHHHhcCCCCeeEEEEEEEeCCe
Q 028681 19 DSDRYELVRDIGSGNFGVARLMRDKK-----TEELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTH 91 (205)
Q Consensus 19 ~~~~y~~~~~l~~g~~g~v~~~~~~~-----~~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 91 (205)
..++|++.+.||+|++|.||++.+.. ++..+++|.+..... ....+..|+..++.+.|+|++++++++..+..
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~ 82 (288)
T cd05050 3 PRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKP 82 (288)
T ss_pred ChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCc
Confidence 35789999999999999999998753 567899998875432 23567889999999999999999999999999
Q ss_pred EEEEEEecCCCchHHHHHhcC----------------------CCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeE
Q 028681 92 LAIVMEYASGGELFERICNAG----------------------RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTL 149 (205)
Q Consensus 92 ~~lv~~~~~~~sl~~~~~~~~----------------------~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nil 149 (205)
.++++|++++++|.+.+.... .+++..+..++.|++.||.+||+.+++|+||+|+||+
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~nil 162 (288)
T cd05050 83 MCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCL 162 (288)
T ss_pred cEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhheE
Confidence 999999999999999986432 3678888999999999999999999999999999999
Q ss_pred ecCCCCCcEEEeeecccccccCCCC---CCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 150 LDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 150 i~~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
++.++. ++|+|||.+........ ......++.|+|||.+.+..++.+ +|||||
T Consensus 163 ~~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~sl 218 (288)
T cd05050 163 VGENMV--VKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTE-SDVWAY 218 (288)
T ss_pred ecCCCc--eEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCch-hHHHHH
Confidence 988777 99999998865433221 122234667999999988888765 999996
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-31 Score=199.62 Aligned_cols=174 Identities=32% Similarity=0.474 Sum_probs=143.4
Q ss_pred eeccccceeEEEEEecCCCcEEEEEEeecCccc----hHHHHHHHH---HHHhcCCCCeeEEEEEEEeCCeEEEEEEecC
Q 028681 28 DIGSGNFGVARLMRDKKTEELVAVKYIERGDKI----DENVQREII---NHRSLRHPNIVRFKEVILTPTHLAIVMEYAS 100 (205)
Q Consensus 28 ~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~----~~~~~~e~~---~l~~l~h~~i~~~~~~~~~~~~~~lv~~~~~ 100 (205)
.||+|++|.||.+.+..+++.|++|.+.+.... ......|.. .++...|++++++.+.+..++..++++||+.
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 479999999999999999999999998754211 112333333 3344579999999999999999999999999
Q ss_pred CCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCCCCCCCCCC
Q 028681 101 GGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 180 (205)
Q Consensus 101 ~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~~~~~~~ 180 (205)
+++|...+.....+++..++.++.|++.|+.|||+.+++|+||+|+||+++.++. ++|+|||++...... ......+
T Consensus 81 g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~--~kl~dfg~~~~~~~~-~~~~~~~ 157 (278)
T cd05606 81 GGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGH--VRISDLGLACDFSKK-KPHASVG 157 (278)
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCC--EEEccCcCccccCcc-CCcCcCC
Confidence 9999988877778999999999999999999999999999999999999988777 999999988654322 2234468
Q ss_pred CCCccCCceeccC-cCCCeeeEEEeC
Q 028681 181 TPAYIAPEVLLKK-EYDGKVMCVYVI 205 (205)
Q Consensus 181 ~~~~~aPE~~~~~-~~~~~~~Dvwsl 205 (205)
+..|+|||.+.+. .++.+ +|||||
T Consensus 158 ~~~y~aPE~~~~~~~~~~~-~Di~s~ 182 (278)
T cd05606 158 THGYMAPEVLQKGVAYDSS-ADWFSL 182 (278)
T ss_pred CcCCcCcHHhcCCCCCCcc-cchHhH
Confidence 9999999999865 45645 999996
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=208.12 Aligned_cols=183 Identities=28% Similarity=0.472 Sum_probs=156.3
Q ss_pred cCCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCcc-chHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEE
Q 028681 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (205)
Q Consensus 19 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~ 97 (205)
..+.|.....||+|++|.||.+.+..++..|++|.+..... ..+.+..|+..++.++|+|++++++.+..++..++++|
T Consensus 20 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e 99 (292)
T cd06658 20 PREYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVME 99 (292)
T ss_pred hHHHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEe
Confidence 34566778889999999999999998899999998875432 34567889999999999999999999999999999999
Q ss_pred ecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCCCC-CC
Q 028681 98 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-PK 176 (205)
Q Consensus 98 ~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~-~~ 176 (205)
++++++|.+.+.. ..+++..+..++.|++.|+.+||+.+++|+||+|+||+++.++. ++|+|||++........ ..
T Consensus 100 ~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~--~kL~dfg~~~~~~~~~~~~~ 176 (292)
T cd06658 100 FLEGGALTDIVTH-TRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGR--IKLSDFGFCAQVSKEVPKRK 176 (292)
T ss_pred CCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCC--EEEccCcchhhcccccccCc
Confidence 9999999887743 46899999999999999999999999999999999999988776 99999998865433222 23
Q ss_pred CCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 177 STVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 177 ~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
...++..|+|||.+.+..++.+ +|||||
T Consensus 177 ~~~~~~~y~aPE~~~~~~~~~~-~Dv~sl 204 (292)
T cd06658 177 SLVGTPYWMAPEVISRLPYGTE-VDIWSL 204 (292)
T ss_pred eeecCccccCHHHHccCCCCch-hhHHHH
Confidence 3458889999999988887765 999996
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-32 Score=199.74 Aligned_cols=180 Identities=33% Similarity=0.529 Sum_probs=157.2
Q ss_pred CeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCc---cchHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEEe
Q 028681 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (205)
Q Consensus 22 ~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~ 98 (205)
+|++.+.|++|++|.+|++.+..++..+++|.+.... ....++..|+..++.++|+|++++.+++......++++|+
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 5899999999999999999999999999999987643 2235677899999999999999999999999999999999
Q ss_pred cCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCCCC
Q 028681 99 ASGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 174 (205)
Q Consensus 99 ~~~~sl~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~ 174 (205)
+++++|.+.+.. ...+++..+..++.|++.|+.+||+.|++|+||+|+||+++.++. ++|+|||++...... .
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~--~kl~d~g~~~~~~~~-~ 157 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDL--VKIGDLGISKVLKKN-M 157 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCc--EEEeeccchhhhccC-C
Confidence 999999888765 356899999999999999999999999999999999999988766 999999998766554 3
Q ss_pred CCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 175 PKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 175 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
.....++..|+|||.+.+..++.+ +|+|||
T Consensus 158 ~~~~~~~~~~~~Pe~~~~~~~~~~-~D~~sl 187 (256)
T cd08530 158 AKTQIGTPHYMAPEVWKGRPYSYK-SDIWSL 187 (256)
T ss_pred cccccCCccccCHHHHCCCCCCch-hhHHHH
Confidence 334567889999999988887755 999986
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-31 Score=198.19 Aligned_cols=186 Identities=30% Similarity=0.442 Sum_probs=153.1
Q ss_pred ecCCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCcc-chHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEE
Q 028681 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (205)
Q Consensus 18 ~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 96 (205)
...+++.....||+|++|.||.+.+..++..|++|.+..... ..+.+.+|+.+++.++|+|++++++++..++..++++
T Consensus 5 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 84 (268)
T cd06624 5 YEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFM 84 (268)
T ss_pred cccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEE
Confidence 344566666789999999999999998899999998875533 3456889999999999999999999999999999999
Q ss_pred EecCCCchHHHHHhc-CCC--CHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCCC
Q 028681 97 EYASGGELFERICNA-GRF--SEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 173 (205)
Q Consensus 97 ~~~~~~sl~~~~~~~-~~~--~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~~ 173 (205)
|++++++|.+.+... .++ +...+..++.|++.|+++||+.|++|+||+|+||+++.+.. .++|+|||.+.......
T Consensus 85 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~-~~~l~dfg~~~~~~~~~ 163 (268)
T cd06624 85 EQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSG-VVKISDFGTSKRLAGIN 163 (268)
T ss_pred ecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCC-eEEEecchhheecccCC
Confidence 999999999988754 445 88889999999999999999999999999999999976332 39999999886543322
Q ss_pred C-CCCCCCCCCccCCceeccCc--CCCeeeEEEeC
Q 028681 174 Q-PKSTVGTPAYIAPEVLLKKE--YDGKVMCVYVI 205 (205)
Q Consensus 174 ~-~~~~~~~~~~~aPE~~~~~~--~~~~~~Dvwsl 205 (205)
. .....++..|+|||.+.+.. ++ .++|||||
T Consensus 164 ~~~~~~~~~~~~~aPE~~~~~~~~~~-~~~Dv~sl 197 (268)
T cd06624 164 PCTETFTGTLQYMAPEVIDKGPRGYG-APADIWSL 197 (268)
T ss_pred CccccCCCCccccChhhhccccccCC-chhhhHHH
Confidence 2 22335788999999987643 44 45999986
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.2e-31 Score=213.11 Aligned_cols=187 Identities=27% Similarity=0.507 Sum_probs=165.4
Q ss_pred ceecCCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCccchHHHHHHHHHHHhc-CCCCeeEEEEEEEe-----C
Q 028681 16 IMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSL-RHPNIVRFKEVILT-----P 89 (205)
Q Consensus 16 ~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~-----~ 89 (205)
..+..+.|++.+.||.|.+|.||++++..+++..|+|+........++.+.|..+++.. .|||++.++|++.. +
T Consensus 14 lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~ 93 (953)
T KOG0587|consen 14 LPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNG 93 (953)
T ss_pred CCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCC
Confidence 34567889999999999999999999999999999999998888889999999999988 58999999999874 3
Q ss_pred CeEEEEEEecCCCchHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccc
Q 028681 90 THLAIVMEYASGGELFERICN--AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 167 (205)
Q Consensus 90 ~~~~lv~~~~~~~sl~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~ 167 (205)
+.+|+|||||.+||..++.+. +..+.+..+..|++.++.|+.+||+..++|+||+=.||+++.++. |||.|||.+.
T Consensus 94 DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~--VKLvDFGvSa 171 (953)
T KOG0587|consen 94 DQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAE--VKLVDFGVSA 171 (953)
T ss_pred CeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCc--EEEeeeeeee
Confidence 689999999999999999965 456999999999999999999999999999999999999998888 9999999876
Q ss_pred cccCC-CCCCCCCCCCCccCCceeccC-----cCCCeeeEEEeC
Q 028681 168 SSVLH-SQPKSTVGTPAYIAPEVLLKK-----EYDGKVMCVYVI 205 (205)
Q Consensus 168 ~~~~~-~~~~~~~~~~~~~aPE~~~~~-----~~~~~~~Dvwsl 205 (205)
..... ....+..||+.|||||++... .|+.. +|+|||
T Consensus 172 QldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R-~D~WsL 214 (953)
T KOG0587|consen 172 QLDSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYR-SDLWSL 214 (953)
T ss_pred eeecccccccCcCCCcccccceeeecccCCCCCcccc-cchhhc
Confidence 54433 555667899999999999843 45555 999997
|
|
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.6e-31 Score=201.82 Aligned_cols=179 Identities=33% Similarity=0.527 Sum_probs=150.7
Q ss_pred CCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCcc----chHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEE
Q 028681 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK----IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV 95 (205)
Q Consensus 20 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 95 (205)
...|+..+.||+|++|.||.+....++..|++|.+..... ..+.+..|+.+++.++|||++++.+++..++..+++
T Consensus 14 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv 93 (307)
T cd06607 14 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLV 93 (307)
T ss_pred chhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEE
Confidence 3669999999999999999999998899999998864322 224577899999999999999999999999999999
Q ss_pred EEecCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCCCC
Q 028681 96 MEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 174 (205)
Q Consensus 96 ~~~~~~~sl~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~ 174 (205)
+||+.+ ++.+.+.. ..++++..+..++.|++.|+.|||+.+++|+||+|+||+++.++. ++|+|||++....+.
T Consensus 94 ~e~~~g-~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~--~kL~dfg~~~~~~~~-- 168 (307)
T cd06607 94 MEYCLG-SASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGT--VKLADFGSASLVSPA-- 168 (307)
T ss_pred HHhhCC-CHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCC--EEEeecCcceecCCC--
Confidence 999974 66666543 456999999999999999999999999999999999999988877 999999988654332
Q ss_pred CCCCCCCCCccCCceec---cCcCCCeeeEEEeC
Q 028681 175 PKSTVGTPAYIAPEVLL---KKEYDGKVMCVYVI 205 (205)
Q Consensus 175 ~~~~~~~~~~~aPE~~~---~~~~~~~~~Dvwsl 205 (205)
....++..|+|||.+. ...++.+ +|||||
T Consensus 169 -~~~~~~~~y~aPE~~~~~~~~~~~~~-sDv~s~ 200 (307)
T cd06607 169 -NSFVGTPYWMAPEVILAMDEGQYDGK-VDVWSL 200 (307)
T ss_pred -CCccCCccccCceeeeccCCCCCCcc-cchHHH
Confidence 2345788899999985 3445544 999996
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.4e-32 Score=205.04 Aligned_cols=181 Identities=30% Similarity=0.409 Sum_probs=149.2
Q ss_pred CeEEEeeeccccceeEEEEEecC--CCcEEEEEEeecCc----cchHHHHHHHHHHHhcCCCCeeEEEEEEEeC--CeEE
Q 028681 22 RYELVRDIGSGNFGVARLMRDKK--TEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTP--THLA 93 (205)
Q Consensus 22 ~y~~~~~l~~g~~g~v~~~~~~~--~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~ 93 (205)
+|++.+.||+|++|.||.+.+.. .+..|++|.+.... ...+.+..|+.+++.++|||++++++++.+. ...+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 58999999999999999999988 78999999988633 2346678899999999999999999999988 7899
Q ss_pred EEEEecCCCchHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecC----CCCCcEEEeeec
Q 028681 94 IVMEYASGGELFERICN-----AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDG----SPAPRLKICDFG 164 (205)
Q Consensus 94 lv~~~~~~~sl~~~~~~-----~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~----~~~~~~~l~df~ 164 (205)
+|+|++++ ++.+.+.. ...+++..+..++.|++.|+.|||+.+++|+||+|+||+++. ++. ++|+|||
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~--~kl~Dfg 157 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGV--VKIGDLG 157 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccce--EEECCCc
Confidence 99999965 66666542 126899999999999999999999999999999999999987 555 9999999
Q ss_pred ccccccCCCC----CCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 165 YSKSSVLHSQ----PKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 165 ~~~~~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
++........ .....++..|+|||.+.+......++|||||
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~sl 202 (316)
T cd07842 158 LARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAI 202 (316)
T ss_pred cccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHH
Confidence 9875433222 2233578889999998765433345999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.7e-33 Score=206.95 Aligned_cols=181 Identities=31% Similarity=0.499 Sum_probs=156.0
Q ss_pred CCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCc--cchHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEEe
Q 028681 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (205)
Q Consensus 21 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~ 98 (205)
..|+..+.||+|++|.||.+.+..++..|++|.+.... ...+.+.+|+.+++.++|+|++++++.+..++..++++||
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEc
Confidence 45778889999999999999999889999999887443 2345688999999999999999999999999999999999
Q ss_pred cCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCCCC-CCC
Q 028681 99 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-PKS 177 (205)
Q Consensus 99 ~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~-~~~ 177 (205)
+++++|.+.+. ..++++..+..++.|++.|+.+||+.+++|+||+|+||+++.++. ++|+|||++........ ...
T Consensus 84 ~~~~~L~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~--~~l~dfg~~~~~~~~~~~~~~ 160 (277)
T cd06642 84 LGGGSALDLLK-PGPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGD--VKLADFGVAGQLTDTQIKRNT 160 (277)
T ss_pred cCCCcHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCC--EEEccccccccccCcchhhhc
Confidence 99999988875 456899999999999999999999999999999999999988777 99999999865543322 223
Q ss_pred CCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 178 TVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 178 ~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
..++..|+|||.+.+..++.+ +|+|||
T Consensus 161 ~~~~~~y~aPE~~~~~~~~~~-~Dv~sl 187 (277)
T cd06642 161 FVGTPFWMAPEVIKQSAYDFK-ADIWSL 187 (277)
T ss_pred ccCcccccCHHHhCcCCCchh-hhHHHH
Confidence 357888999999998887755 999986
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.1e-32 Score=203.96 Aligned_cols=182 Identities=32% Similarity=0.495 Sum_probs=158.1
Q ss_pred CCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCc----cchHHHHHHHHHHHhcC-CCCeeEEEEEEEeCCeEEEE
Q 028681 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLR-HPNIVRFKEVILTPTHLAIV 95 (205)
Q Consensus 21 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv 95 (205)
++|++.+.||+|++|.||.+....++..|++|++.+.. ...+.+..|..++++++ |+|++++++++..++..+++
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 57999999999999999999999999999999987632 22356778899999998 99999999999999999999
Q ss_pred EEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCCCC-
Q 028681 96 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ- 174 (205)
Q Consensus 96 ~~~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~- 174 (205)
|+++.+++|.+.+...+.+++..+..++.|++.|+.+||+.|++|+||+|+||+++.++. ++|+|||++........
T Consensus 81 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~--~~l~df~~~~~~~~~~~~ 158 (280)
T cd05581 81 LEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMH--IKITDFGTAKVLDPNSSP 158 (280)
T ss_pred EcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCC--EEecCCccccccCCcccc
Confidence 999999999999988878999999999999999999999999999999999999988777 99999999875543321
Q ss_pred --------------------CCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 175 --------------------PKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 175 --------------------~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
.....++..|+|||.+....++.+ +|+|||
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~-~Di~sl 208 (280)
T cd05581 159 ESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKS-SDLWAL 208 (280)
T ss_pred ccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChh-hhHHHH
Confidence 112246788999999988777655 999985
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.8e-35 Score=222.66 Aligned_cols=185 Identities=29% Similarity=0.445 Sum_probs=171.4
Q ss_pred ecCCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecC----ccchHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEE
Q 028681 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG----DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLA 93 (205)
Q Consensus 18 ~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 93 (205)
...++++.+..||-|+||.|-++..+.....+|+|++++. ....+.+.+|-.++...+.+.|+++|..|.+++++|
T Consensus 417 v~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvY 496 (732)
T KOG0614|consen 417 VKLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVY 496 (732)
T ss_pred cchhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhh
Confidence 3457888999999999999999998877666889988764 344566888999999999999999999999999999
Q ss_pred EEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCCC
Q 028681 94 IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 173 (205)
Q Consensus 94 lv~~~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~~ 173 (205)
++||.|-||.++..+...+.+...+.+.++..++.|++|||+.|||.||+||+|.+++.++. +||.|||+|+....+.
T Consensus 497 mLmEaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy--~KLVDFGFAKki~~g~ 574 (732)
T KOG0614|consen 497 MLMEACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGY--LKLVDFGFAKKIGSGR 574 (732)
T ss_pred hhHHhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCc--eEEeehhhHHHhccCC
Confidence 99999999999999999999999999999999999999999999999999999999999998 9999999999999999
Q ss_pred CCCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 174 QPKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 174 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
.+++.+||++|.|||++.++..+.+ +|.|||
T Consensus 575 KTwTFcGTpEYVAPEIILnKGHD~a-vDyWaL 605 (732)
T KOG0614|consen 575 KTWTFCGTPEYVAPEIILNKGHDRA-VDYWAL 605 (732)
T ss_pred ceeeecCCcccccchhhhccCcchh-hHHHHH
Confidence 9999999999999999999999977 999986
|
|
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.9e-34 Score=224.02 Aligned_cols=182 Identities=29% Similarity=0.471 Sum_probs=159.3
Q ss_pred CCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecC-ccchHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEEec
Q 028681 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG-DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA 99 (205)
Q Consensus 21 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~~ 99 (205)
+.|++...||.|+||.||.+..+.++...|.|++... ....+.+.-|+.+|..+.||+++++++.|..++.+|++.|||
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC 111 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFC 111 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeec
Confidence 4567888999999999999999998888888888643 344577888999999999999999999999999999999999
Q ss_pred CCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccc-cCCCCCCC
Q 028681 100 SGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS-VLHSQPKS 177 (205)
Q Consensus 100 ~~~sl~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~-~~~~~~~~ 177 (205)
+||....++.. +.++++.++..+++|++.||.|||+..|||+||+..||++..++. ++|+|||.+... ..-....+
T Consensus 112 ~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGd--irLADFGVSAKn~~t~qkRDs 189 (1187)
T KOG0579|consen 112 GGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGD--IRLADFGVSAKNKSTRQKRDS 189 (1187)
T ss_pred CCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCc--EeeecccccccchhHHhhhcc
Confidence 99998887755 667999999999999999999999999999999999999999998 999999976443 33355566
Q ss_pred CCCCCCccCCceecc-----CcCCCeeeEEEeC
Q 028681 178 TVGTPAYIAPEVLLK-----KEYDGKVMCVYVI 205 (205)
Q Consensus 178 ~~~~~~~~aPE~~~~-----~~~~~~~~Dvwsl 205 (205)
..||+.|||||+... .+|+.+ +|||||
T Consensus 190 FIGTPYWMAPEVvmCET~KD~PYDyk-aDiWSl 221 (1187)
T KOG0579|consen 190 FIGTPYWMAPEVVMCETFKDQPYDYK-ADIWSL 221 (1187)
T ss_pred ccCCcccccchheeeccccCCCchhh-hhHHhh
Confidence 789999999999873 567766 999997
|
|
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.8e-31 Score=199.81 Aligned_cols=181 Identities=29% Similarity=0.511 Sum_probs=155.2
Q ss_pred CCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCcc--chHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEEe
Q 028681 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (205)
Q Consensus 21 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~ 98 (205)
+-|++.+.||.|++|.||.+.+..++..+++|.+..... ....+.+|+..++.++|+|++++++.+..+...++++||
T Consensus 4 ~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06641 4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY 83 (277)
T ss_pred HhhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEe
Confidence 457889999999999999999998899999998765432 235678899999999999999999999999999999999
Q ss_pred cCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCCC-CCCC
Q 028681 99 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKS 177 (205)
Q Consensus 99 ~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~~-~~~~ 177 (205)
+++++|.+.+.. .++++..+..++.|++.++.+||+.|++|+||+|+||+++.++. ++|+|||++....... ....
T Consensus 84 ~~~~~l~~~i~~-~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~--~~l~dfg~~~~~~~~~~~~~~ 160 (277)
T cd06641 84 LGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGE--VKLADFGVAGQLTDTQIKRNT 160 (277)
T ss_pred CCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCC--EEEeecccceecccchhhhcc
Confidence 999999888754 56899999999999999999999999999999999999988777 9999999886543322 1223
Q ss_pred CCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 178 TVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 178 ~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
..++..|+|||.+.+...+.+ +|+|||
T Consensus 161 ~~~~~~y~~PE~~~~~~~~~~-~Dv~sl 187 (277)
T cd06641 161 FVGTPFWMAPEVIKQSAYDSK-ADIWSL 187 (277)
T ss_pred ccCCccccChhhhccCCCCch-hhHHHH
Confidence 457888999999988777755 999985
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.5e-31 Score=198.51 Aligned_cols=173 Identities=31% Similarity=0.478 Sum_probs=145.1
Q ss_pred eeeccccceeEEEEEecCCCcEEEEEEeecCccch----HHHHHHHH-HHHhcCCCCeeEEEEEEEeCCeEEEEEEecCC
Q 028681 27 RDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID----ENVQREII-NHRSLRHPNIVRFKEVILTPTHLAIVMEYASG 101 (205)
Q Consensus 27 ~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~----~~~~~e~~-~l~~l~h~~i~~~~~~~~~~~~~~lv~~~~~~ 101 (205)
+.||+|++|.||++.+..+++.|++|.+.+..... ..+..|.. +.....|+|++++++++..++..++++||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 57899999999999999999999999987543211 22333333 33455899999999999999999999999999
Q ss_pred CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCCCCCCCCCCC
Q 028681 102 GELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGT 181 (205)
Q Consensus 102 ~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~ 181 (205)
++|.+++....++++..+..++.|++.||.+||+.+++|+||+|+||+++.++. ++|+|||++..... .....++
T Consensus 82 ~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~--~~l~dfg~~~~~~~---~~~~~~~ 156 (260)
T cd05611 82 GDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGH--LKLTDFGLSRNGLE---NKKFVGT 156 (260)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCc--EEEeecccceeccc---cccCCCC
Confidence 999999988788999999999999999999999999999999999999988776 99999998864332 2334578
Q ss_pred CCccCCceeccCcCCCeeeEEEeC
Q 028681 182 PAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 182 ~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
..|+|||.+.+..++.+ +|||||
T Consensus 157 ~~y~~pe~~~~~~~~~~-~Dv~sl 179 (260)
T cd05611 157 PDYLAPETILGVGDDKM-SDWWSL 179 (260)
T ss_pred cCccChhhhcCCCCcch-hhhHHH
Confidence 89999999988876655 999985
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=99.98 E-value=6e-32 Score=207.53 Aligned_cols=183 Identities=29% Similarity=0.478 Sum_probs=152.9
Q ss_pred CCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCc---cchHHHHHHHHHHHhcCCCCeeEEEEEEEe----CCeE
Q 028681 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILT----PTHL 92 (205)
Q Consensus 20 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~ 92 (205)
.++|++.+.||+|++|.||++.+..++..|++|.+.... .....+..|+.+++.++|+|++++.+++.. ....
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 478999999999999999999999999999999987542 233567789999999999999999988763 3568
Q ss_pred EEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCC
Q 028681 93 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 172 (205)
Q Consensus 93 ~lv~~~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~ 172 (205)
++++||+. ++|.+.+.....+++..+..++.|++.||.+||+.+++|+||+|+||+++.++. ++|+|||.+......
T Consensus 84 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~--~kl~dfg~~~~~~~~ 160 (334)
T cd07855 84 YVVMDLME-SDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCE--LRIGDFGMARGLSSS 160 (334)
T ss_pred EEEEehhh-hhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCc--EEecccccceeeccc
Confidence 99999996 588888877777999999999999999999999999999999999999998887 999999998654332
Q ss_pred CCC-----CCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 173 SQP-----KSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 173 ~~~-----~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
... ....++..|+|||.+.+......++|||||
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~sl 198 (334)
T cd07855 161 PTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSV 198 (334)
T ss_pred CcCCCcccccccccccccChHHhcCCcccccccchHHH
Confidence 221 233578899999998764333355999996
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-31 Score=204.11 Aligned_cols=178 Identities=29% Similarity=0.429 Sum_probs=139.9
Q ss_pred EeeeccccceeEEEEEecC--CCcEEEEEEeecCccchHHHHHHHHHHHhcCCCCeeEEEEEEEe--CCeEEEEEEecCC
Q 028681 26 VRDIGSGNFGVARLMRDKK--TEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILT--PTHLAIVMEYASG 101 (205)
Q Consensus 26 ~~~l~~g~~g~v~~~~~~~--~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~~~~~~ 101 (205)
..+||+|+||.||++.... ++..|++|.+.... ....+..|+.+++.++|||++++++++.. +...+++++|+.+
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~ 84 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG-ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH 84 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC-CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCC
Confidence 3679999999999999654 56789999886543 34567789999999999999999998864 4678999999865
Q ss_pred CchHHHHHh---------cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCC--CCcEEEeeeccccccc
Q 028681 102 GELFERICN---------AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSP--APRLKICDFGYSKSSV 170 (205)
Q Consensus 102 ~sl~~~~~~---------~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~--~~~~~l~df~~~~~~~ 170 (205)
+|.+.+.. ...+++..+..++.|++.||.|||+.+++|+||+|+||++..++ ...++|+|||+++...
T Consensus 85 -~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~ 163 (317)
T cd07867 85 -DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFN 163 (317)
T ss_pred -cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccceeccC
Confidence 67666642 12488899999999999999999999999999999999994321 2249999999997654
Q ss_pred CCCC----CCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 171 LHSQ----PKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 171 ~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
.... .....+++.|+|||.+.+....+.++|||||
T Consensus 164 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSl 202 (317)
T cd07867 164 SPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAI 202 (317)
T ss_pred CCcccccccCcceecccccCcHHhcCCCccCcHHHHHhH
Confidence 3322 2234578999999999875433345999996
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.9e-33 Score=203.94 Aligned_cols=184 Identities=36% Similarity=0.579 Sum_probs=164.5
Q ss_pred cCCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCccch----HHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEE
Q 028681 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID----ENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 94 (205)
Q Consensus 19 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 94 (205)
-.++|..++.||+|.||+|-+++.+.+++.+|+|++++.-... .....|-+.|+..+||.+..+--.|+.++.+|+
T Consensus 166 Tm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCF 245 (516)
T KOG0690|consen 166 TMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCF 245 (516)
T ss_pred ccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEE
Confidence 3578999999999999999999999999999999998764332 234578889999999999999889999999999
Q ss_pred EEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccc-cCCC
Q 028681 95 VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS-VLHS 173 (205)
Q Consensus 95 v~~~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~-~~~~ 173 (205)
||||..+|.|.--+.+.+.+++...+.+...|+.||.|||+++|+.||++.+|.+++.+++ +||+|||+|+.. .-+.
T Consensus 246 VMeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGH--IKitDFGLCKE~I~~g~ 323 (516)
T KOG0690|consen 246 VMEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGH--IKITDFGLCKEEIKYGD 323 (516)
T ss_pred EEEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCc--eEeeecccchhcccccc
Confidence 9999999999877777888999999999999999999999999999999999999999999 999999999753 4456
Q ss_pred CCCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 174 QPKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 174 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
...+.+||+.|+|||++....|... .|+|.+
T Consensus 324 t~kTFCGTPEYLAPEVleDnDYgra-VDWWG~ 354 (516)
T KOG0690|consen 324 TTKTFCGTPEYLAPEVLEDNDYGRA-VDWWGV 354 (516)
T ss_pred eeccccCChhhcCchhhccccccce-eehhhh
Confidence 6677899999999999999999866 999964
|
|
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.7e-32 Score=206.81 Aligned_cols=181 Identities=33% Similarity=0.533 Sum_probs=149.1
Q ss_pred CCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCc--cchHHHHHHHHHHHhcCCCCeeEEEEEEEeCC-----eE
Q 028681 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPT-----HL 92 (205)
Q Consensus 20 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~ 92 (205)
.++|++.+.||+|++|.||.+.+..++..|++|.+.... .....+..|+.+++.++|+|++++++++.... ..
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 478999999999999999999999999999999986432 23456778999999999999999998876543 57
Q ss_pred EEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCC
Q 028681 93 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 172 (205)
Q Consensus 93 ~lv~~~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~ 172 (205)
+++++++.+ ++.+.+ ....+++..+..++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||++......
T Consensus 84 ~lv~e~~~~-~l~~~~-~~~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~--~kl~dfg~~~~~~~~ 159 (336)
T cd07849 84 YIVQELMET-DLYKLI-KTQHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCD--LKICDFGLARIADPE 159 (336)
T ss_pred EEEehhccc-CHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCC--EEECcccceeecccc
Confidence 899999965 677666 4456999999999999999999999999999999999999988877 999999998654332
Q ss_pred CCC----CCCCCCCCccCCceeccC-cCCCeeeEEEeC
Q 028681 173 SQP----KSTVGTPAYIAPEVLLKK-EYDGKVMCVYVI 205 (205)
Q Consensus 173 ~~~----~~~~~~~~~~aPE~~~~~-~~~~~~~Dvwsl 205 (205)
... ....++..|+|||.+.+. .++ .++|||||
T Consensus 160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~~Dvwsl 196 (336)
T cd07849 160 HDHTGFLTEYVATRWYRAPEIMLNSKGYT-KAIDIWSV 196 (336)
T ss_pred ccccCCcCCcCcCCCccChHHhhCCCCCC-cHHHHHHH
Confidence 211 223578899999987654 455 44999996
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.1e-31 Score=200.30 Aligned_cols=184 Identities=29% Similarity=0.481 Sum_probs=157.4
Q ss_pred ecCCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCcc-chHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEE
Q 028681 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (205)
Q Consensus 18 ~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 96 (205)
+....|...+.||+|++|.||.+.+..++..+++|.+..... ..+.+.+|+.+++.+.|+|++++++++..++..++++
T Consensus 16 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~ 95 (285)
T cd06648 16 DPRSYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVM 95 (285)
T ss_pred cchHhhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEE
Confidence 334567778899999999999999988899999998865433 2355788999999999999999999999999999999
Q ss_pred EecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCCC-CC
Q 028681 97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QP 175 (205)
Q Consensus 97 ~~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~~-~~ 175 (205)
+++++++|.+.+.. .+++...+..++.|++.|+++||++|++|+||+|+||+++.++. ++|+|||.+....... ..
T Consensus 96 e~~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~--~~l~d~g~~~~~~~~~~~~ 172 (285)
T cd06648 96 EFLEGGALTDIVTH-TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGR--VKLSDFGFCAQVSKEVPRR 172 (285)
T ss_pred eccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCc--EEEcccccchhhccCCccc
Confidence 99999999998866 66899999999999999999999999999999999999988777 9999999876543322 22
Q ss_pred CCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 176 KSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 176 ~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
....+++.|+|||.+.+..++.+ +|||||
T Consensus 173 ~~~~~~~~y~aPE~~~~~~~~~~-~Dv~sl 201 (285)
T cd06648 173 KSLVGTPYWMAPEVISRLPYGTE-VDIWSL 201 (285)
T ss_pred ccccCCccccCHHHhcCCCCCCc-ccHHHH
Confidence 23458889999999988887766 999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.5e-31 Score=197.26 Aligned_cols=175 Identities=26% Similarity=0.316 Sum_probs=146.1
Q ss_pred eeeccccceeEEEEEecCCCcEEEEEEeecCcc--chHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEEecCCCch
Q 028681 27 RDIGSGNFGVARLMRDKKTEELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL 104 (205)
Q Consensus 27 ~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~~~~~sl 104 (205)
+.||+|++|.||++... ++..+++|.+..... ....+.+|+.+++.++|+|++++++++...+..++++||+++++|
T Consensus 1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 79 (250)
T cd05085 1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDF 79 (250)
T ss_pred CccCCCCCceEEEEEec-CCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcH
Confidence 46899999999999865 578899998875432 234678899999999999999999999999999999999999999
Q ss_pred HHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCCCCCC--CCCCC
Q 028681 105 FERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK--STVGT 181 (205)
Q Consensus 105 ~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~~~--~~~~~ 181 (205)
.+.+... ..+++..+..++.+++.++.+||+.|++|+||+|+||+++.++. ++|+|||++.......... ...++
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~--~~l~d~g~~~~~~~~~~~~~~~~~~~ 157 (250)
T cd05085 80 LSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNV--LKISDFGMSRQEDDGIYSSSGLKQIP 157 (250)
T ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCe--EEECCCccceeccccccccCCCCCCc
Confidence 9988653 45889999999999999999999999999999999999988776 9999999886543322211 12345
Q ss_pred CCccCCceeccCcCCCeeeEEEeC
Q 028681 182 PAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 182 ~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
+.|+|||++.+..++.+ +|||||
T Consensus 158 ~~y~aPE~~~~~~~~~~-~Di~sl 180 (250)
T cd05085 158 IKWTAPEALNYGRYSSE-SDVWSY 180 (250)
T ss_pred ccccCHHHhccCCCCch-hHHHHH
Confidence 67999999988877755 999996
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.7e-33 Score=201.69 Aligned_cols=179 Identities=28% Similarity=0.436 Sum_probs=153.2
Q ss_pred EeeeccccceeEEEEEecCCCcEEEEEEeecCc-cchHHHHHHHHHHHhcC-CCCeeEEEEEEEeCCeEEEEEEecCCCc
Q 028681 26 VRDIGSGNFGVARLMRDKKTEELVAVKYIERGD-KIDENVQREIINHRSLR-HPNIVRFKEVILTPTHLAIVMEYASGGE 103 (205)
Q Consensus 26 ~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~~~~~~~s 103 (205)
.+.||+|+++.|..++...++..||+|++.+.+ ..+.++.+|++++...+ |+||+.++++|+++..+|+|||-|.+|+
T Consensus 83 ~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGp 162 (463)
T KOG0607|consen 83 SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGP 162 (463)
T ss_pred HHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCch
Confidence 578999999999999999999999999998875 34677899999999986 9999999999999999999999999999
Q ss_pred hHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecC-CCCCcEEEeeecccccccCC--------CC
Q 028681 104 LFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVLH--------SQ 174 (205)
Q Consensus 104 l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~-~~~~~~~l~df~~~~~~~~~--------~~ 174 (205)
|...+++...+++.++..+...|+.||.+||++||.|||+||+||++.. +.-.-|||+||.+....... ..
T Consensus 163 lLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spastP~ 242 (463)
T KOG0607|consen 163 LLSHIQKRKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSPASTPE 242 (463)
T ss_pred HHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccCCCCCCCCCcc
Confidence 9999999999999999999999999999999999999999999999954 33345999999987432211 11
Q ss_pred CCCCCCCCCccCCceecc-----CcCCCeeeEEEeC
Q 028681 175 PKSTVGTPAYIAPEVLLK-----KEYDGKVMCVYVI 205 (205)
Q Consensus 175 ~~~~~~~~~~~aPE~~~~-----~~~~~~~~Dvwsl 205 (205)
..+..|+-+|||||+..- ..|+ |..|.|||
T Consensus 243 L~tPvGSAEfMAPEVVd~fv~qA~~YD-KrCDlwSL 277 (463)
T KOG0607|consen 243 LLTPVGSAEFMAPEVVDVFVDQATFYD-KRCDLWSL 277 (463)
T ss_pred ccCcccchhhcchhHHhhhcccccccc-ccccHHHH
Confidence 123458889999999862 3344 66999997
|
|
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.5e-32 Score=205.65 Aligned_cols=182 Identities=28% Similarity=0.477 Sum_probs=155.5
Q ss_pred CCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCcc-chHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEEe
Q 028681 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (205)
Q Consensus 20 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~ 98 (205)
..-|.....||+|++|.||.+.+..++..|++|.+..... ..+.+.+|+..++.+.|||++++++.+..++..++++||
T Consensus 20 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~ 99 (297)
T cd06659 20 RSLLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEF 99 (297)
T ss_pred hhhHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEec
Confidence 3556667789999999999999998899999999865432 345678899999999999999999999999999999999
Q ss_pred cCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCCCC-CCC
Q 028681 99 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-PKS 177 (205)
Q Consensus 99 ~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~-~~~ 177 (205)
+++++|...+.. ..+++..+..++.|++.|+.+||+.+++|+||+|+||+++.++. ++|+|||++........ ...
T Consensus 100 ~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~--~kL~dfg~~~~~~~~~~~~~~ 176 (297)
T cd06659 100 LQGGALTDIVSQ-TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGR--VKLSDFGFCAQISKDVPKRKS 176 (297)
T ss_pred CCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCc--EEEeechhHhhcccccccccc
Confidence 999999887644 56899999999999999999999999999999999999988877 99999999865443322 233
Q ss_pred CCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 178 TVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 178 ~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
..++..|+|||.+.+..++.+ +|||||
T Consensus 177 ~~~~~~y~aPE~~~~~~~~~~-~Dv~sl 203 (297)
T cd06659 177 LVGTPYWMAPEVISRTPYGTE-VDIWSL 203 (297)
T ss_pred eecCccccCHHHHccCCCCch-hhHHHH
Confidence 458899999999988877655 999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.5e-31 Score=200.77 Aligned_cols=180 Identities=34% Similarity=0.532 Sum_probs=151.9
Q ss_pred eEEEeeeccccceeEEEEEecCCCcEEEEEEeecCcc--chHHHHHHHHHHHhcC-CCCeeEEEEEEEeCCeEEEEEEec
Q 028681 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK--IDENVQREIINHRSLR-HPNIVRFKEVILTPTHLAIVMEYA 99 (205)
Q Consensus 23 y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~~~~ 99 (205)
|++.+.||+|++|.||.+....+++.|++|.+..... .......|+..++.++ |+|++++++++..++..++++|++
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 6889999999999999999998899999998875432 2223456888899998 999999999999999999999999
Q ss_pred CCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCCCCCCC
Q 028681 100 SGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS 177 (205)
Q Consensus 100 ~~~sl~~~~~~~~--~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~~~~ 177 (205)
+++|.+.+.... .+++..+..++.|++.++.+||+++++|+||+|+||+++.++. ++|+|||.+...........
T Consensus 81 -~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~--~~l~d~~~~~~~~~~~~~~~ 157 (283)
T cd07830 81 -EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEV--VKIADFGLAREIRSRPPYTD 157 (283)
T ss_pred -CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCC--EEEeecccceeccCCCCcCC
Confidence 678888886654 6899999999999999999999999999999999999998777 99999999876554444444
Q ss_pred CCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 178 TVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 178 ~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
..++..|+|||.+......+.++|+|||
T Consensus 158 ~~~~~~~~aPE~~~~~~~~~~~~Di~s~ 185 (283)
T cd07830 158 YVSTRWYRAPEILLRSTSYSSPVDIWAL 185 (283)
T ss_pred CCCcccccCceeeecCcCcCCccchhhH
Confidence 5678899999998654433345999996
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.7e-32 Score=204.35 Aligned_cols=183 Identities=21% Similarity=0.312 Sum_probs=150.8
Q ss_pred cCCCeEEEeeeccccceeEEEEEecCCCc----EEEEEEeecCcc--chHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeE
Q 028681 19 DSDRYELVRDIGSGNFGVARLMRDKKTEE----LVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHL 92 (205)
Q Consensus 19 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~----~v~iK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 92 (205)
..++|+..+.||+|++|.||.+.+..++. .+++|.+..... ...++.+|+.+++.++|+|++++++.+..+ ..
T Consensus 5 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~ 83 (303)
T cd05110 5 KETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TI 83 (303)
T ss_pred chhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cc
Confidence 35788999999999999999999876665 468887765432 234678899999999999999999988754 46
Q ss_pred EEEEEecCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccC
Q 028681 93 AIVMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 171 (205)
Q Consensus 93 ~lv~~~~~~~sl~~~~~~~~-~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~ 171 (205)
+++++++++++|.+.+.... .+++..+..++.|++.||.|||+++++|+||+|+||+++.++. ++|+|||+++....
T Consensus 84 ~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~--~kL~Dfg~~~~~~~ 161 (303)
T cd05110 84 QLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNH--VKITDFGLARLLEG 161 (303)
T ss_pred eeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCc--eEEccccccccccC
Confidence 78899999999999886643 5899999999999999999999999999999999999987776 99999999976543
Q ss_pred CCCC---CCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 172 HSQP---KSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 172 ~~~~---~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
.... ....++..|+|||.+.+..++.+ +|||||
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~-~Diwsl 197 (303)
T cd05110 162 DEKEYNADGGKMPIKWMALECIHYRKFTHQ-SDVWSY 197 (303)
T ss_pred cccccccCCCccccccCCHHHhccCCCChH-HHHHHH
Confidence 3221 22335678999999988888766 999996
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.3e-32 Score=200.75 Aligned_cols=180 Identities=23% Similarity=0.331 Sum_probs=146.2
Q ss_pred eEEEeeeccccceeEEEEEecCCCc--EEEEEEeecCc---cchHHHHHHHHHHHhcCCCCeeEEEEEEEeC------Ce
Q 028681 23 YELVRDIGSGNFGVARLMRDKKTEE--LVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTP------TH 91 (205)
Q Consensus 23 y~~~~~l~~g~~g~v~~~~~~~~~~--~v~iK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------~~ 91 (205)
|.+.+.||+|++|.||.+....++. .+++|.++... ...+.+..|+..++.++|+|++++++.+... ..
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 3567899999999999999877664 68999887542 2235678899999999999999999987532 24
Q ss_pred EEEEEEecCCCchHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecc
Q 028681 92 LAIVMEYASGGELFERICN------AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGY 165 (205)
Q Consensus 92 ~~lv~~~~~~~sl~~~~~~------~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~ 165 (205)
.+++++|+++++|.+.+.. ...+++..+..++.|++.|+.|||+++++|+||+|+||+++.++. ++|+|||+
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~--~kl~Dfg~ 158 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMN--VCVADFGL 158 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCC--EEECCCCc
Confidence 6899999999999887742 234889999999999999999999999999999999999988777 99999999
Q ss_pred cccccCCCC---CCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 166 SKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 166 ~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
+........ .....++..|+|||.+.+..++.+ +|||||
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~-~Di~sl 200 (272)
T cd05075 159 SKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTK-SDVWSF 200 (272)
T ss_pred ccccCcccceecCCcccCCcccCCHHHccCCCcChH-HHHHHH
Confidence 876543221 122345678999999998888765 999996
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.5e-30 Score=215.07 Aligned_cols=184 Identities=26% Similarity=0.392 Sum_probs=158.4
Q ss_pred CCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCccc----hHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEE
Q 028681 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI----DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV 95 (205)
Q Consensus 20 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 95 (205)
.++|++.+.||+|+||.||++.+..++..||+|++...... ...+..|+.+++.++|+||+++++++......++|
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV 82 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV 82 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence 57899999999999999999999999999999998764322 35678889999999999999999999999999999
Q ss_pred EEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCCC-C
Q 028681 96 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-Q 174 (205)
Q Consensus 96 ~~~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~~-~ 174 (205)
|||+.+++|.+++.....+++..++.++.|++.||.|||.++|+|+||+|+||+++.++. ++|+|||+++...... .
T Consensus 83 mEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~--vkL~DFGls~~~~~~~~~ 160 (669)
T cd05610 83 MEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGH--IKLTDFGLSKVTLNRELN 160 (669)
T ss_pred EeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCC--EEEEeCCCCccccCCccc
Confidence 999999999999987778999999999999999999999999999999999999988776 9999999997654332 2
Q ss_pred CCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 175 PKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 175 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
.....+++.|.+||.........-.+++|++
T Consensus 161 ~~~~~~t~~~~~pe~~~~~~~~~~~s~~~s~ 191 (669)
T cd05610 161 MMDILTTPSMAKPKNDYSRTPGQVLSLISSL 191 (669)
T ss_pred ccccccCccccCccccccCCCCceeeeeeec
Confidence 2334688999999987665554455777764
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-31 Score=201.16 Aligned_cols=179 Identities=35% Similarity=0.543 Sum_probs=151.5
Q ss_pred eEEEeeeccccceeEEEEEecCCCcEEEEEEeecCcc---chHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEEec
Q 028681 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA 99 (205)
Q Consensus 23 y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~~ 99 (205)
|++.+.||.|++|.||++.+..++..|++|.+..... ..+.+.+|+..++.++|+|++++++++.+++..+++++|+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 6788999999999999999999999999999875432 2356788999999999999999999999999999999999
Q ss_pred CCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCCC-CCC
Q 028681 100 SGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPK 176 (205)
Q Consensus 100 ~~~sl~~~~~~~~--~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~~-~~~ 176 (205)
+ ++|.+.+.... .+++..+..++.|++.||.+||+.+++|+||+|+||+++.++. ++|+|||++....... ...
T Consensus 81 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~--~~l~df~~~~~~~~~~~~~~ 157 (283)
T cd07835 81 D-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGA--LKLADFGLARAFGVPVRTYT 157 (283)
T ss_pred C-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCc--EEEeecccccccCCCccccC
Confidence 5 58888886655 6899999999999999999999999999999999999998776 9999999986543322 222
Q ss_pred CCCCCCCccCCceeccCc-CCCeeeEEEeC
Q 028681 177 STVGTPAYIAPEVLLKKE-YDGKVMCVYVI 205 (205)
Q Consensus 177 ~~~~~~~~~aPE~~~~~~-~~~~~~Dvwsl 205 (205)
...++..|+|||++.+.. ++. ++|+|||
T Consensus 158 ~~~~~~~~~aPE~~~~~~~~~~-~~Di~sl 186 (283)
T cd07835 158 HEVVTLWYRAPEILLGSRQYST-PVDIWSI 186 (283)
T ss_pred ccccccCCCCCceeecCcccCc-HHHHHHH
Confidence 335688899999887654 444 4999996
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-31 Score=200.74 Aligned_cols=174 Identities=20% Similarity=0.197 Sum_probs=140.4
Q ss_pred eeccccceeEEEEEecC------------------------CCcEEEEEEeecCcc-chHHHHHHHHHHHhcCCCCeeEE
Q 028681 28 DIGSGNFGVARLMRDKK------------------------TEELVAVKYIERGDK-IDENVQREIINHRSLRHPNIVRF 82 (205)
Q Consensus 28 ~l~~g~~g~v~~~~~~~------------------------~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~ 82 (205)
.||+|+||.||++.... ....|++|.+..... ...++.+|+.+++.++|+||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 58999999999987432 224688888865433 23567788899999999999999
Q ss_pred EEEEEeCCeEEEEEEecCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCC-----C
Q 028681 83 KEVILTPTHLAIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPA-----P 156 (205)
Q Consensus 83 ~~~~~~~~~~~lv~~~~~~~sl~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~-----~ 156 (205)
++++..+...++||||+++++|..++.. .+.+++..+..++.|++.||+|||+.+++|+||+|+||+++.++. .
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~~~~~ 161 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEGTSP 161 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCcccCccc
Confidence 9999999999999999999999888865 456899999999999999999999999999999999999975432 2
Q ss_pred cEEEeeecccccccCCCCCCCCCCCCCccCCceeccC-cCCCeeeEEEeC
Q 028681 157 RLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKK-EYDGKVMCVYVI 205 (205)
Q Consensus 157 ~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~~Dvwsl 205 (205)
.+++.|||.+...... ....++..|+|||.+.+. .++ .++|||||
T Consensus 162 ~~kl~d~g~~~~~~~~---~~~~~~~~~~aPe~~~~~~~~~-~~~Dv~sl 207 (274)
T cd05076 162 FIKLSDPGVSFTALSR---EERVERIPWIAPECVPGGNSLS-TAADKWSF 207 (274)
T ss_pred eeeecCCccccccccc---cccccCCcccCchhhcCCCCCC-cHHHHHHH
Confidence 3799999987543221 223567889999999764 445 44999986
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.3e-31 Score=197.61 Aligned_cols=176 Identities=24% Similarity=0.286 Sum_probs=141.3
Q ss_pred eeeccccceeEEEEEecC--CCcEEEEEEeecCcc--chHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEEecCCC
Q 028681 27 RDIGSGNFGVARLMRDKK--TEELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGG 102 (205)
Q Consensus 27 ~~l~~g~~g~v~~~~~~~--~~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~~~~~ 102 (205)
+.||+|+||.||.+.... ++..+++|.+..... ....+.+|+.+++.++|+|++++++.+.+....+++|||++++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 468999999999997653 456789998765432 2346788999999999999999999999999999999999999
Q ss_pred chHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCCCC---
Q 028681 103 ELFERICNAG-----RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ--- 174 (205)
Q Consensus 103 sl~~~~~~~~-----~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~--- 174 (205)
+|.+.+.... ..++..+..++.|++.|++|||+.+++|+||+|+||+++.++. ++|+|||.+........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~--~kL~dfg~~~~~~~~~~~~~ 158 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLT--VKIGDYGLSHNKYKEDYYVT 158 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCc--EEECCccccccccCcceeec
Confidence 9999886422 3566778889999999999999999999999999999988776 99999998864332211
Q ss_pred CCCCCCCCCccCCceeccCc-------CCCeeeEEEeC
Q 028681 175 PKSTVGTPAYIAPEVLLKKE-------YDGKVMCVYVI 205 (205)
Q Consensus 175 ~~~~~~~~~~~aPE~~~~~~-------~~~~~~Dvwsl 205 (205)
.....++..|+|||++.+.. ++ .++|+|||
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~-~~~Diwsl 195 (269)
T cd05087 159 PDQLWVPLRWIAPELVDEVHGNLLVVDQT-KESNVWSL 195 (269)
T ss_pred CCCcCCcccccCHhHhccccccccccCCC-ccchhHHH
Confidence 12234678899999986432 33 45999996
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-31 Score=199.14 Aligned_cols=174 Identities=33% Similarity=0.536 Sum_probs=151.0
Q ss_pred eccccceeEEEEEecCCCcEEEEEEeecCcc----chHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEEecCCCch
Q 028681 29 IGSGNFGVARLMRDKKTEELVAVKYIERGDK----IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL 104 (205)
Q Consensus 29 l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~~~~~sl 104 (205)
||.|++|.||.+.+..++..+++|.+..... ..+.+..|+.+++.++|+|++++++.+..+...+++++++++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 5889999999999999899999999876533 345678889999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCCC---------CC
Q 028681 105 FERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS---------QP 175 (205)
Q Consensus 105 ~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~~---------~~ 175 (205)
.+.+...+.+++..+..++.|++.||.+||+.+++|+||+|+||+++.++. ++|+|||++....... ..
T Consensus 81 ~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~~~ 158 (265)
T cd05579 81 ASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGH--LKLTDFGLSKVGLVRRQINLNDDEKED 158 (265)
T ss_pred HHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCC--EEEEecccchhcccCcccccccccccc
Confidence 999987778999999999999999999999999999999999999998887 9999999886543332 12
Q ss_pred CCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 176 KSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 176 ~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
....++..|+|||...+...+.+ +|||||
T Consensus 159 ~~~~~~~~~~~Pe~~~~~~~~~~-~Dv~sl 187 (265)
T cd05579 159 KRIVGTPDYIAPEVILGQGHSKT-VDWWSL 187 (265)
T ss_pred cCcccCccccCHHHhcCCCCCcc-hhhHHH
Confidence 23357788999999988776655 999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.3e-31 Score=195.59 Aligned_cols=175 Identities=27% Similarity=0.321 Sum_probs=148.0
Q ss_pred eeeccccceeEEEEEecCCCcEEEEEEeecCcc--chHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEEecCCCch
Q 028681 27 RDIGSGNFGVARLMRDKKTEELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL 104 (205)
Q Consensus 27 ~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~~~~~sl 104 (205)
+.||+|++|.||.+.+.. ++.|++|.+..... ..+.+..|+.+++++.|+|++++++++......++++|++++++|
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l 79 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSL 79 (251)
T ss_pred CccccCCCceEEEEEEeC-CCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcH
Confidence 468999999999999888 88999998876543 345788999999999999999999999999999999999999999
Q ss_pred HHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCCCCC---CCCCC
Q 028681 105 FERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP---KSTVG 180 (205)
Q Consensus 105 ~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~~---~~~~~ 180 (205)
.+.+.. ...++...+..++.+++.++.+||+++++|+||+|+||+++.++. ++|+|||.+......... .....
T Consensus 80 ~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~--~~l~d~g~~~~~~~~~~~~~~~~~~~ 157 (251)
T cd05041 80 LTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNV--LKISDFGMSREEEGGIYTVSDGLKQI 157 (251)
T ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCc--EEEeeccccccccCCcceeccccCcc
Confidence 998865 346889999999999999999999999999999999999988777 999999988654321111 11223
Q ss_pred CCCccCCceeccCcCCCeeeEEEeC
Q 028681 181 TPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 181 ~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
+..|+|||.+.+..++.+ +|+|||
T Consensus 158 ~~~y~~PE~~~~~~~~~~-~Di~sl 181 (251)
T cd05041 158 PIKWTAPEALNYGRYTSE-SDVWSY 181 (251)
T ss_pred eeccCChHhhccCCCCcc-hhHHHH
Confidence 567999999988877755 999996
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.3e-31 Score=196.85 Aligned_cols=178 Identities=29% Similarity=0.368 Sum_probs=149.3
Q ss_pred cCCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCccchHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEEe
Q 028681 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (205)
Q Consensus 19 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~ 98 (205)
..++|++.+.||+|++|.||.+.. ++..+++|.+... ...+.+.+|+.+++.++|+|++++.+++..+ ..++++||
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~--~~~~~~iK~~~~~-~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~ 79 (254)
T cd05083 4 NLQKLTLGEIIGEGEFGAVLQGEY--TGQKVAVKNIKCD-VTAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMEL 79 (254)
T ss_pred cHHHceeeeeeccCCCCceEeccc--CCCceEEEeecCc-chHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEEC
Confidence 357899999999999999998864 5678999988653 3456788999999999999999999998765 47899999
Q ss_pred cCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCCCCCC
Q 028681 99 ASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK 176 (205)
Q Consensus 99 ~~~~sl~~~~~~~~--~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~~~ 176 (205)
+++++|.+.+.... .+++..+..++.|++.|+.+||+.|++|+||+|+||+++.++. ++|+|||++...... ..
T Consensus 80 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~--~kl~Dfg~~~~~~~~--~~ 155 (254)
T cd05083 80 MSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGV--AKVSDFGLARVGSMG--VD 155 (254)
T ss_pred CCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCc--EEECCCccceecccc--CC
Confidence 99999999987543 4789999999999999999999999999999999999988776 999999988654322 12
Q ss_pred CCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 177 STVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 177 ~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
....+..|+|||.+.+..++.+ +|+|||
T Consensus 156 ~~~~~~~y~~pe~~~~~~~~~~-~Dv~sl 183 (254)
T cd05083 156 NSKLPVKWTAPEALKHKKFSSK-SDVWSY 183 (254)
T ss_pred CCCCCceecCHHHhccCCcCch-hhHHHH
Confidence 2334567999999988887755 999996
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.6e-31 Score=197.88 Aligned_cols=182 Identities=34% Similarity=0.561 Sum_probs=156.0
Q ss_pred CeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCc---cchHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEEe
Q 028681 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (205)
Q Consensus 22 ~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~ 98 (205)
+|++.+.||+|++|.||++....++..+++|.+.... ...+.+.+|+.+++.++|+|++++++.+..+...++++||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 5899999999999999999999999999999987542 2345678899999999999999999999999999999999
Q ss_pred cCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCCCCC-
Q 028681 99 ASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP- 175 (205)
Q Consensus 99 ~~~~sl~~~~~~~~--~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~~- 175 (205)
+++++|.+.+.... .+++..+..++.|++.|+.+||+.+++|+||+|+||++++++. .++|+|||.+.........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~-~~~l~d~~~~~~~~~~~~~~ 159 (257)
T cd08225 81 CDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGM-VAKLGDFGIARQLNDSMELA 159 (257)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCC-eEEecccccchhccCCcccc
Confidence 99999999886533 4789999999999999999999999999999999999987654 2799999988765433222
Q ss_pred CCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 176 KSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 176 ~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
....+++.|+|||.+.+..++.+ +|+|||
T Consensus 160 ~~~~~~~~~~ape~~~~~~~~~~-~Dv~sl 188 (257)
T cd08225 160 YTCVGTPYYLSPEICQNRPYNNK-TDIWSL 188 (257)
T ss_pred cccCCCccccCHHHHcCCCCCch-hhHHHH
Confidence 23358889999999988877755 999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.4e-32 Score=213.79 Aligned_cols=179 Identities=31% Similarity=0.486 Sum_probs=154.8
Q ss_pred EeeeccccceeEEEEEecCCCcEEEEEEeecCc-cchHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEEecCCCch
Q 028681 26 VRDIGSGNFGVARLMRDKKTEELVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL 104 (205)
Q Consensus 26 ~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~~~~~sl 104 (205)
.=.||.|.+|+||-+++..+...+|+|-+.... ...+-+.+|+.+++.++|+||+++.|.+..++++-+.||-.+||||
T Consensus 580 rvVLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSL 659 (1226)
T KOG4279|consen 580 RVVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSL 659 (1226)
T ss_pred eEEeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcH
Confidence 447899999999999999999999999887543 3346689999999999999999999999999999999999999999
Q ss_pred HHHHHh-cCCC--CHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccc-cCCCCCCCCCC
Q 028681 105 FERICN-AGRF--SEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS-VLHSQPKSTVG 180 (205)
Q Consensus 105 ~~~~~~-~~~~--~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~-~~~~~~~~~~~ 180 (205)
.+++.. .+|+ ++.++..+..||+.||.|||++.|+|||||-+|++++.-. +.+||.|||-++.. +.+..+.+..|
T Consensus 660 SsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTyS-GvlKISDFGTsKRLAginP~TETFTG 738 (1226)
T KOG4279|consen 660 SSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYS-GVLKISDFGTSKRLAGINPCTETFTG 738 (1226)
T ss_pred HHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeecc-ceEEecccccchhhccCCcccccccc
Confidence 999964 4666 8999999999999999999999999999999999997433 24999999988654 55666777789
Q ss_pred CCCccCCceeccCcC-CCeeeEEEeC
Q 028681 181 TPAYIAPEVLLKKEY-DGKVMCVYVI 205 (205)
Q Consensus 181 ~~~~~aPE~~~~~~~-~~~~~Dvwsl 205 (205)
|+.|||||++..++- ..+++|||||
T Consensus 739 TLQYMAPEvIDqG~RGYG~aADIWS~ 764 (1226)
T KOG4279|consen 739 TLQYMAPEVIDQGPRGYGKAADIWSF 764 (1226)
T ss_pred chhhhChHhhccCCcCCCchhhhhhc
Confidence 999999999975432 3466999997
|
|
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.7e-31 Score=196.82 Aligned_cols=179 Identities=32% Similarity=0.480 Sum_probs=150.2
Q ss_pred eEEEeeeccccceeEEEEEecCCCcEEEEEEeecCccc---hHHHHHHHHHHHhc---CCCCeeEEEEEEEeCCe-----
Q 028681 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI---DENVQREIINHRSL---RHPNIVRFKEVILTPTH----- 91 (205)
Q Consensus 23 y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~---~~~~~~e~~~l~~l---~h~~i~~~~~~~~~~~~----- 91 (205)
|++.+.||+|++|.||++.+..++..+++|.+...... ...+..|+.+++.+ .|+|++++.+.+.....
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 78899999999999999999988999999998754222 23455677777666 59999999999998776
Q ss_pred EEEEEEecCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccc
Q 028681 92 LAIVMEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 169 (205)
Q Consensus 92 ~~lv~~~~~~~sl~~~~~~~~--~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~ 169 (205)
.++++|++.+ +|.+.+.... .+++..+..++.|++.||.+||+.+++|+||+|+||+++.++. ++|+|||++...
T Consensus 81 ~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~--~~l~dfg~~~~~ 157 (287)
T cd07838 81 LTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQ--VKIADFGLARIY 157 (287)
T ss_pred eEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCC--EEEeccCcceec
Confidence 8999999975 7887776533 4899999999999999999999999999999999999998876 999999998766
Q ss_pred cCCCCCCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 170 VLHSQPKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 170 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
..........++..|+|||.+.+..++.+ +|+|||
T Consensus 158 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~-~Di~s~ 192 (287)
T cd07838 158 SFEMALTSVVVTLWYRAPEVLLQSSYATP-VDMWSV 192 (287)
T ss_pred cCCcccccccccccccChHHhccCCCCCc-chhhhH
Confidence 54444444457888999999998887766 999996
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-31 Score=197.08 Aligned_cols=175 Identities=19% Similarity=0.167 Sum_probs=141.3
Q ss_pred eeeccccceeEEEEEecC------------CCcEEEEEEeecCcc-chHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEE
Q 028681 27 RDIGSGNFGVARLMRDKK------------TEELVAVKYIERGDK-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLA 93 (205)
Q Consensus 27 ~~l~~g~~g~v~~~~~~~------------~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 93 (205)
+.||+|++|.||.+.... ....+++|.+..... ....+.+|+.+++.++||||+++++++..+...+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 468999999999998542 234688888765433 2346778889999999999999999999999999
Q ss_pred EEEEecCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCC-----cEEEeeecccc
Q 028681 94 IVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAP-----RLKICDFGYSK 167 (205)
Q Consensus 94 lv~~~~~~~sl~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~-----~~~l~df~~~~ 167 (205)
+++||+++++|..++.. ...+++..+..++.|++.|+.|||+.+++|+||+|+||+++.++.. .++++|||.+.
T Consensus 81 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g~~~ 160 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPI 160 (262)
T ss_pred EEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCCCCCc
Confidence 99999999999888765 4568999999999999999999999999999999999999755421 38999999875
Q ss_pred cccCCCCCCCCCCCCCccCCceecc-CcCCCeeeEEEeC
Q 028681 168 SSVLHSQPKSTVGTPAYIAPEVLLK-KEYDGKVMCVYVI 205 (205)
Q Consensus 168 ~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~~Dvwsl 205 (205)
.... .....++..|+|||.+.+ ..++ .++|||||
T Consensus 161 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~-~~~Diwsl 195 (262)
T cd05077 161 TVLS---RQECVERIPWIAPECVEDSKNLS-IAADKWSF 195 (262)
T ss_pred cccC---cccccccccccChhhhcCCCCCC-chhHHHHH
Confidence 4422 223457788999999874 4455 44999996
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=205.72 Aligned_cols=180 Identities=35% Similarity=0.543 Sum_probs=155.1
Q ss_pred CeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCc---cchHHHHHHHHHHHhcCCCCeeEEEEEEEeCC-----eEE
Q 028681 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPT-----HLA 93 (205)
Q Consensus 22 ~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~ 93 (205)
+|++.+.||+|++|.||++.+..++..+++|.+.... ...+.+..|+..++.++|+|++++.+++.... ..+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 5899999999999999999999889999999887643 23467888999999999999999999988775 789
Q ss_pred EEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCCC
Q 028681 94 IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 173 (205)
Q Consensus 94 lv~~~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~~ 173 (205)
+++++++ ++|.+.+....++++..+..++.|++.||++||+.|++|+||+|+||+++.++. ++|+|||.+.......
T Consensus 81 lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~--~~L~dfg~~~~~~~~~ 157 (330)
T cd07834 81 IVTELME-TDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCD--LKICDFGLARGVDPDE 157 (330)
T ss_pred EEecchh-hhHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCC--EEEcccCceEeecccc
Confidence 9999997 478888877778999999999999999999999999999999999999998876 9999999987655443
Q ss_pred ----CCCCCCCCCCccCCceeccC-cCCCeeeEEEeC
Q 028681 174 ----QPKSTVGTPAYIAPEVLLKK-EYDGKVMCVYVI 205 (205)
Q Consensus 174 ----~~~~~~~~~~~~aPE~~~~~-~~~~~~~Dvwsl 205 (205)
......++..|+|||.+.+. .++.+ +|+|||
T Consensus 158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~-sDi~sl 193 (330)
T cd07834 158 DEKGFLTEYVVTRWYRAPELLLSSSRYTKA-IDIWSV 193 (330)
T ss_pred cccccccccccccCcCCceeeecccCCCcc-hhHHHH
Confidence 12334578889999999887 55544 999986
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-31 Score=201.67 Aligned_cols=184 Identities=33% Similarity=0.531 Sum_probs=151.2
Q ss_pred cCCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCc---cchHHHHHHHHHHHhcCCCCeeEEEEEEEeCC-----
Q 028681 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPT----- 90 (205)
Q Consensus 19 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----- 90 (205)
..++|++.+.||.|++|.||++.+..++..|++|.+.... .....+..|+.+++.++|||++++++++.+..
T Consensus 5 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~ 84 (302)
T cd07864 5 CVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDF 84 (302)
T ss_pred hhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhc
Confidence 3578999999999999999999999999999999987543 22345678999999999999999999987654
Q ss_pred -----eEEEEEEecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeec
Q 028681 91 -----HLAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFG 164 (205)
Q Consensus 91 -----~~~lv~~~~~~~sl~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~ 164 (205)
.+++++||+++ ++...+... ..+++..+..++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||
T Consensus 85 ~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~--~kl~dfg 161 (302)
T cd07864 85 KKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQ--IKLADFG 161 (302)
T ss_pred cccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCc--EEeCccc
Confidence 78999999976 666666543 46999999999999999999999999999999999999988877 9999999
Q ss_pred ccccccCCCCC--CCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 165 YSKSSVLHSQP--KSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 165 ~~~~~~~~~~~--~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
.+......... ....++..|+|||.+.+....+.++|||||
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~sl 204 (302)
T cd07864 162 LARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSC 204 (302)
T ss_pred ccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHH
Confidence 98765433321 222457789999988754432345999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-31 Score=203.03 Aligned_cols=185 Identities=29% Similarity=0.460 Sum_probs=149.3
Q ss_pred eecCCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCcc---chHHHHHHHHHHHhcCCCCeeEEEEEEEeC----
Q 028681 17 MHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTP---- 89 (205)
Q Consensus 17 ~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---- 89 (205)
+...++|++.+.||+|++|.||++.+..++..+++|.+..... ....+.+|+.+++.++|+|++++++.+...
T Consensus 4 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (311)
T cd07866 4 CSKLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKS 83 (311)
T ss_pred CcccccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheecccccc
Confidence 3446899999999999999999999999999999998865432 234567899999999999999999887543
Q ss_pred ----CeEEEEEEecCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeec
Q 028681 90 ----THLAIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFG 164 (205)
Q Consensus 90 ----~~~~lv~~~~~~~sl~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~ 164 (205)
..++++++|+.. ++...+.. ...+++..+..++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||
T Consensus 84 ~~~~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~--~~l~dfg 160 (311)
T cd07866 84 KRKRGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGI--LKIADFG 160 (311)
T ss_pred cccCceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCC--EEECcCc
Confidence 346899999865 56665544 457999999999999999999999999999999999999998887 9999999
Q ss_pred ccccccCCCCC------------CCCCCCCCccCCceeccCc-CCCeeeEEEeC
Q 028681 165 YSKSSVLHSQP------------KSTVGTPAYIAPEVLLKKE-YDGKVMCVYVI 205 (205)
Q Consensus 165 ~~~~~~~~~~~------------~~~~~~~~~~aPE~~~~~~-~~~~~~Dvwsl 205 (205)
++......... ....+++.|+|||.+.+.. ++ .++|||||
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~~Dv~sl 213 (311)
T cd07866 161 LARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYT-TAVDIWGI 213 (311)
T ss_pred cchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccC-chhHhHHH
Confidence 88654332211 1123577899999987654 44 44999996
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-31 Score=197.12 Aligned_cols=175 Identities=29% Similarity=0.397 Sum_probs=148.1
Q ss_pred eeeccccceeEEEEEecC-CC--cEEEEEEeecCcc--chHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEEecCC
Q 028681 27 RDIGSGNFGVARLMRDKK-TE--ELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASG 101 (205)
Q Consensus 27 ~~l~~g~~g~v~~~~~~~-~~--~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~~~~ 101 (205)
+.||+|++|.||++.+.. .+ ..+++|.+..... ..+.+..|+..+++++|+|++++++.+.. ...++++|++++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 468999999999999865 33 3689998876544 34678899999999999999999999988 889999999999
Q ss_pred CchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCCCC----C
Q 028681 102 GELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ----P 175 (205)
Q Consensus 102 ~sl~~~~~~~~--~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~----~ 175 (205)
++|.+.+.... .+++..+..++.|++.||.+||+.+++|+||+|+||+++.++. ++|+|||.+........ .
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~--~kl~dfg~~~~~~~~~~~~~~~ 157 (257)
T cd05040 80 GSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDK--VKIGDFGLMRALPQNEDHYVME 157 (257)
T ss_pred CcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCE--EEeccccccccccccccceecc
Confidence 99999987654 6899999999999999999999999999999999999988876 99999999876544221 1
Q ss_pred CCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 176 KSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 176 ~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
....++..|+|||.+.+..++.+ +|||||
T Consensus 158 ~~~~~~~~y~~pE~~~~~~~~~~-~Di~sl 186 (257)
T cd05040 158 EHLKVPFAWCAPESLRTRTFSHA-SDVWMF 186 (257)
T ss_pred cCCCCCceecCHHHhcccCcCch-hhhHHH
Confidence 22346778999999988888766 999996
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-31 Score=205.09 Aligned_cols=183 Identities=24% Similarity=0.358 Sum_probs=152.0
Q ss_pred CCCeE-EEeeeccccceeEEEEEecCCCcEEEEEEeecCccch---------------HHHHHHHHHHHhcCCCCeeEEE
Q 028681 20 SDRYE-LVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID---------------ENVQREIINHRSLRHPNIVRFK 83 (205)
Q Consensus 20 ~~~y~-~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~---------------~~~~~e~~~l~~l~h~~i~~~~ 83 (205)
.++|. +.+.||+|++|.||++.+..++..|++|.+....... ..+.+|+.+++.++|+|+++++
T Consensus 7 ~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~ 86 (335)
T PTZ00024 7 SERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLV 86 (335)
T ss_pred ccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeee
Confidence 56775 4677999999999999999999999999986543221 2467899999999999999999
Q ss_pred EEEEeCCeEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeee
Q 028681 84 EVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDF 163 (205)
Q Consensus 84 ~~~~~~~~~~lv~~~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df 163 (205)
+++..++..++++|++. ++|.+.+.....+++..+..++.|++.|+.+||+.|++|+||+|+||+++.++. ++|+||
T Consensus 87 ~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~--~kl~df 163 (335)
T PTZ00024 87 DVYVEGDFINLVMDIMA-SDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGI--CKIADF 163 (335)
T ss_pred EEEecCCcEEEEEeccc-cCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCC--EEECCc
Confidence 99999999999999996 588888877778999999999999999999999999999999999999988877 999999
Q ss_pred cccccccCCC---------------CCCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 164 GYSKSSVLHS---------------QPKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 164 ~~~~~~~~~~---------------~~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
|.+....... ......++..|+|||.+.+....+.++|||||
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~sl 220 (335)
T PTZ00024 164 GLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSV 220 (335)
T ss_pred cceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHH
Confidence 9886544111 11122357789999999765443345999986
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.3e-32 Score=211.39 Aligned_cols=182 Identities=31% Similarity=0.486 Sum_probs=158.5
Q ss_pred CCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCccch----HHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEE
Q 028681 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID----ENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (205)
Q Consensus 21 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 96 (205)
+-|..++.||-|+||.|.++.-..+...||+|.+.+.+... ..++.|-.+|..-..+-||+++-.|.+++++|+||
T Consensus 629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVM 708 (1034)
T KOG0608|consen 629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM 708 (1034)
T ss_pred cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEE
Confidence 56888999999999999999999999999999998755332 34778899999999999999999999999999999
Q ss_pred EecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeeccccccc------
Q 028681 97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV------ 170 (205)
Q Consensus 97 ~~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~------ 170 (205)
+|++||.+..++-+-+-|.+..++.++.++.-|+++.|+.|+|||||||+|||||.+++ +||+|||+|+.+.
T Consensus 709 dYIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGH--IKLTDFGLCTGfRWTHdsk 786 (1034)
T KOG0608|consen 709 DYIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGH--IKLTDFGLCTGFRWTHDSK 786 (1034)
T ss_pred eccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCc--eeeeeccccccceeccccc
Confidence 99999999999988888999999999999999999999999999999999999999998 9999999985210
Q ss_pred ---CCC----------------------------------CCCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 171 ---LHS----------------------------------QPKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 171 ---~~~----------------------------------~~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
.+. ......||..|+|||++.+..++-. +|+||.
T Consensus 787 YYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~-cdwws~ 857 (1034)
T KOG0608|consen 787 YYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQL-CDWWSV 857 (1034)
T ss_pred cccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCcccc-chhhHh
Confidence 000 0011238999999999999999866 999983
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-32 Score=186.82 Aligned_cols=186 Identities=25% Similarity=0.350 Sum_probs=153.5
Q ss_pred ceecCCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecC--ccchHHHHHHHHHHHhc-CCCCeeEEEEEEEeCCeE
Q 028681 16 IMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG--DKIDENVQREIINHRSL-RHPNIVRFKEVILTPTHL 92 (205)
Q Consensus 16 ~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~ 92 (205)
+....++......||+|++|.|-+.++..+|...|+|.+... .....++..|+.+..+. .+|+.++++|........
T Consensus 41 ~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdv 120 (282)
T KOG0984|consen 41 FEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDV 120 (282)
T ss_pred cccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccE
Confidence 334456666688999999999999999999999999998754 33345566777666544 689999999999999999
Q ss_pred EEEEEecCCCchHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHh-cCcEeecCCCCCeEecCCCCCcEEEeeecccc
Q 028681 93 AIVMEYASGGELFERI----CNAGRFSEDEARFFFQQLISGVSYCHS-MQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 167 (205)
Q Consensus 93 ~lv~~~~~~~sl~~~~----~~~~~~~~~~~~~i~~~i~~~l~~lh~-~~i~H~di~p~nili~~~~~~~~~l~df~~~~ 167 (205)
|+.||.|+. ||..+. .+++.+++..+-.|+..++.|+.+||+ ..++|||+||+|||++.++. ||++|||++-
T Consensus 121 wIcME~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~Gq--VKiCDFGIsG 197 (282)
T KOG0984|consen 121 WICMELMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQ--VKICDFGISG 197 (282)
T ss_pred EEeHHHhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCc--EEEcccccce
Confidence 999999954 676555 346679999999999999999999995 59999999999999988887 9999999997
Q ss_pred cccCCCCCCCCCCCCCccCCceecc----CcCCCeeeEEEeC
Q 028681 168 SSVLHSQPKSTVGTPAYIAPEVLLK----KEYDGKVMCVYVI 205 (205)
Q Consensus 168 ~~~~~~~~~~~~~~~~~~aPE~~~~----~~~~~~~~Dvwsl 205 (205)
....+.......|...|+|||.+.. ..|+.+ ||||||
T Consensus 198 ~L~dSiAkt~daGCkpYmaPEri~~e~n~~gY~vk-sDvWSL 238 (282)
T KOG0984|consen 198 YLVDSIAKTMDAGCKPYMAPERINPELNQKGYSVK-SDVWSL 238 (282)
T ss_pred eehhhhHHHHhcCCCccCChhhcCcccCcccceee-hhhhhh
Confidence 6655555455789999999999974 367766 999997
|
|
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-31 Score=204.34 Aligned_cols=185 Identities=28% Similarity=0.428 Sum_probs=152.5
Q ss_pred CceecCCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCc---cchHHHHHHHHHHHhcCCCCeeEEEEEEEeCC-
Q 028681 15 PIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPT- 90 (205)
Q Consensus 15 ~~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~- 90 (205)
.++...++|++.+.||+|++|.||.+.+..++..|++|.+.... ...+.+..|+.+++.++|+||+++.+++..+.
T Consensus 9 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 88 (343)
T cd07880 9 TIWEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLS 88 (343)
T ss_pred hhhccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcc
Confidence 44445788999999999999999999999999999999886432 22356788999999999999999999987653
Q ss_pred -----eEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecc
Q 028681 91 -----HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGY 165 (205)
Q Consensus 91 -----~~~lv~~~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~ 165 (205)
.++++++++ +++|.+.+. ...+++..+..++.|++.|+.+||+.|++|+||+|+||+++.++. ++|+|||.
T Consensus 89 ~~~~~~~~lv~e~~-~~~l~~~~~-~~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~--~kl~dfg~ 164 (343)
T cd07880 89 LDRFHDFYLVMPFM-GTDLGKLMK-HEKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCE--LKILDFGL 164 (343)
T ss_pred ccccceEEEEEecC-CCCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCC--EEEeeccc
Confidence 458999998 668877775 456999999999999999999999999999999999999987776 99999999
Q ss_pred cccccCCCCCCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 166 SKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 166 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
+..... ......++..|+|||.+.+....+.++|+|||
T Consensus 165 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~sl 202 (343)
T cd07880 165 ARQTDS--EMTGYVVTRWYRAPEVILNWMHYTQTVDIWSV 202 (343)
T ss_pred cccccc--CccccccCCcccCHHHHhCCCCCCcHHHHHHH
Confidence 875432 22234568889999999764333345999985
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-31 Score=197.36 Aligned_cols=181 Identities=33% Similarity=0.532 Sum_probs=151.4
Q ss_pred CeEEEeeeccccceeEEEEEecC-CCcEEEEEEeecCc-----------cchHHHHHHHHHHHh-cCCCCeeEEEEEEEe
Q 028681 22 RYELVRDIGSGNFGVARLMRDKK-TEELVAVKYIERGD-----------KIDENVQREIINHRS-LRHPNIVRFKEVILT 88 (205)
Q Consensus 22 ~y~~~~~l~~g~~g~v~~~~~~~-~~~~v~iK~~~~~~-----------~~~~~~~~e~~~l~~-l~h~~i~~~~~~~~~ 88 (205)
+|++.+.||+|++|.||.+.+.. .+..+++|.+.... ....++..|+.++.+ ++|+|++++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 48889999999999999999987 67889999875321 112345667776654 689999999999999
Q ss_pred CCeEEEEEEecCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-cCcEeecCCCCCeEecCCCCCcEEEeee
Q 028681 89 PTHLAIVMEYASGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHS-MQVCHRDLKLENTLLDGSPAPRLKICDF 163 (205)
Q Consensus 89 ~~~~~lv~~~~~~~sl~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lh~-~~i~H~di~p~nili~~~~~~~~~l~df 163 (205)
++..++++||+++++|.+.+.. ...+++..++.++.|++.++.+||+ .+++|+||+|+||+++.++. ++|+||
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~--~~l~df 158 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDK--VTITDF 158 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCc--EEEecc
Confidence 9999999999999999887743 3468999999999999999999995 78999999999999988777 999999
Q ss_pred cccccccCCCCCCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 164 GYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
|.+.............++..|+|||.+.+..++.+ +|+|||
T Consensus 159 g~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~-~Dv~sl 199 (269)
T cd08528 159 GLAKQKQPESKLTSVVGTILYSCPEIVKNEPYGEK-ADVWAF 199 (269)
T ss_pred cceeecccccccccccCcccCcChhhhcCCCCchH-HHHHHH
Confidence 99876554444445568899999999998877655 999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.2e-32 Score=200.06 Aligned_cols=175 Identities=15% Similarity=0.157 Sum_probs=143.6
Q ss_pred eeeccccceeEEEEEecCCCc-------EEEEEEeecCcc-chHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEEe
Q 028681 27 RDIGSGNFGVARLMRDKKTEE-------LVAVKYIERGDK-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (205)
Q Consensus 27 ~~l~~g~~g~v~~~~~~~~~~-------~v~iK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~ 98 (205)
+.||.|+||.||++.....+. .+++|.+..... ..+.+.+|..+++.++|+|++++++++..+...+++|||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 468999999999998865443 488887765432 245678899999999999999999999999999999999
Q ss_pred cCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCC------cEEEeeecccccccC
Q 028681 99 ASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAP------RLKICDFGYSKSSVL 171 (205)
Q Consensus 99 ~~~~sl~~~~~~~~-~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~------~~~l~df~~~~~~~~ 171 (205)
+++++|.+++...+ .+++..+..++.|++.|++|||+.+++|+||+|+||+++.++.. .++++|||.+....+
T Consensus 81 ~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~~~~ 160 (258)
T cd05078 81 VKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLP 160 (258)
T ss_pred CCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEecccccccccCC
Confidence 99999999987644 58999999999999999999999999999999999999876542 379999998754432
Q ss_pred CCCCCCCCCCCCccCCceeccCc-CCCeeeEEEeC
Q 028681 172 HSQPKSTVGTPAYIAPEVLLKKE-YDGKVMCVYVI 205 (205)
Q Consensus 172 ~~~~~~~~~~~~~~aPE~~~~~~-~~~~~~Dvwsl 205 (205)
.....++..|+|||++.+.. ++ .++|||||
T Consensus 161 ---~~~~~~~~~y~aPE~~~~~~~~~-~~~Diwsl 191 (258)
T cd05078 161 ---KEILLERIPWVPPECIENPQNLS-LAADKWSF 191 (258)
T ss_pred ---chhccccCCccCchhccCCCCCC-chhhHHHH
Confidence 22345778899999998744 45 44999996
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-31 Score=197.48 Aligned_cols=176 Identities=22% Similarity=0.316 Sum_probs=139.8
Q ss_pred eeeccccceeEEEEEecC--CCcEEEEEEeecCcc--chHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEEecCCC
Q 028681 27 RDIGSGNFGVARLMRDKK--TEELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGG 102 (205)
Q Consensus 27 ~~l~~g~~g~v~~~~~~~--~~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~~~~~ 102 (205)
+.||+|+||.||.+.... ....+++|.+..... ....+.+|+..++.++|+||+++++.+......+++|||++++
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG 80 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence 368999999999986543 345788887764322 2345778999999999999999999999999999999999999
Q ss_pred chHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCCCC---
Q 028681 103 ELFERICNAG-----RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ--- 174 (205)
Q Consensus 103 sl~~~~~~~~-----~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~--- 174 (205)
+|.+++.... ..++.....++.|++.|+.|||+++++|+||+|+||+++.++. ++|+|||++........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~--~kl~dfg~~~~~~~~~~~~~ 158 (269)
T cd05042 81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLS--VKIGDYGLALEQYPEDYYIT 158 (269)
T ss_pred cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCc--EEEeccccccccccchheec
Confidence 9999986643 2457788899999999999999999999999999999998877 99999998864332211
Q ss_pred CCCCCCCCCccCCceecc-------CcCCCeeeEEEeC
Q 028681 175 PKSTVGTPAYIAPEVLLK-------KEYDGKVMCVYVI 205 (205)
Q Consensus 175 ~~~~~~~~~~~aPE~~~~-------~~~~~~~~Dvwsl 205 (205)
.....++..|+|||++.. ..++ .++|||||
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~-~~~Diwsl 195 (269)
T cd05042 159 KDCHAVPLRWLAPELVEIRGQDLLPKDQT-KKSNIWSL 195 (269)
T ss_pred cCCCCCcccccCHHHHhhccccccccccc-hhhHHHHH
Confidence 122345677999999753 2334 45999986
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-32 Score=194.36 Aligned_cols=183 Identities=28% Similarity=0.365 Sum_probs=153.1
Q ss_pred cCCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCc--cchHHHHHHHHHHHhc-CCCCeeEEEEEEEeCCeEEEE
Q 028681 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD--KIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIV 95 (205)
Q Consensus 19 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv 95 (205)
+.++.+.+..||.|+.|+|+.++...+|..+|+|.+.... ...+++..++.++..- .+|+|++++|+|..+..+++.
T Consensus 90 dindl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~Ic 169 (391)
T KOG0983|consen 90 DINDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFIC 169 (391)
T ss_pred ChHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHH
Confidence 3566777899999999999999999999999999997643 3345566667666554 489999999999999999999
Q ss_pred EEecCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH-hcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCCC
Q 028681 96 MEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCH-SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 173 (205)
Q Consensus 96 ~~~~~~~sl~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lh-~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~~ 173 (205)
||.|.. -+..++.. .+++++.-+-.+...+++||.||- ++|++|||+||+||++++.++ +||+|||++.+.....
T Consensus 170 MelMs~-C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~Gn--iKlCDFGIsGrlvdSk 246 (391)
T KOG0983|consen 170 MELMST-CAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGN--IKLCDFGISGRLVDSK 246 (391)
T ss_pred HHHHHH-HHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCC--EEeecccccceeeccc
Confidence 998842 44444433 557999999999999999999997 579999999999999999988 9999999998777777
Q ss_pred CCCCCCCCCCccCCceeccC---cCCCeeeEEEeC
Q 028681 174 QPKSTVGTPAYIAPEVLLKK---EYDGKVMCVYVI 205 (205)
Q Consensus 174 ~~~~~~~~~~~~aPE~~~~~---~~~~~~~Dvwsl 205 (205)
......|...|||||-+... .|+.. +|||||
T Consensus 247 AhtrsAGC~~YMaPERidp~~~~kYDiR-aDVWSl 280 (391)
T KOG0983|consen 247 AHTRSAGCAAYMAPERIDPPDKPKYDIR-ADVWSL 280 (391)
T ss_pred ccccccCCccccCccccCCCCCCccchh-hhhhhh
Confidence 77777899999999999743 56766 999997
|
|
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.2e-31 Score=199.00 Aligned_cols=183 Identities=16% Similarity=0.181 Sum_probs=138.4
Q ss_pred cCCCeEEEeeeccccceeEEEEEecCC---CcEEEEEEeecCccc--hH----------HHHHHHHHHHhcCCCCeeEEE
Q 028681 19 DSDRYELVRDIGSGNFGVARLMRDKKT---EELVAVKYIERGDKI--DE----------NVQREIINHRSLRHPNIVRFK 83 (205)
Q Consensus 19 ~~~~y~~~~~l~~g~~g~v~~~~~~~~---~~~v~iK~~~~~~~~--~~----------~~~~e~~~l~~l~h~~i~~~~ 83 (205)
..++|++.+.||+|+||.||.+....+ +..+++|........ .+ ....+...+..+.|+++++++
T Consensus 10 ~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~ 89 (294)
T PHA02882 10 TGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYY 89 (294)
T ss_pred CCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEE
Confidence 347899999999999999999998877 667777764332211 11 111223344566899999999
Q ss_pred EEEEeCC----eEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEE
Q 028681 84 EVILTPT----HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLK 159 (205)
Q Consensus 84 ~~~~~~~----~~~lv~~~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~ 159 (205)
+.+.... ..+++++.+. .++.+.+......++..+..++.|++.|+.|||+.+++||||+|+||+++.++. ++
T Consensus 90 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~--~~ 166 (294)
T PHA02882 90 GCGSFKRCRMYYRFILLEKLV-ENTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNR--GY 166 (294)
T ss_pred EeeeEecCCceEEEEEEehhc-cCHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCc--EE
Confidence 8766543 3466777663 366666666555788899999999999999999999999999999999987766 99
Q ss_pred EeeecccccccCCC--------CCCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 160 ICDFGYSKSSVLHS--------QPKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 160 l~df~~~~~~~~~~--------~~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
|+|||+|+...... ......||+.|+|||++.+..++.+ +|||||
T Consensus 167 l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~-~DiwSl 219 (294)
T PHA02882 167 IIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRR-GDLESL 219 (294)
T ss_pred EEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcH-HHHHHH
Confidence 99999987553221 1122358999999999998888755 999996
|
|
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-31 Score=199.49 Aligned_cols=182 Identities=25% Similarity=0.333 Sum_probs=150.5
Q ss_pred CCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCc--cchHHHHHHHHHHHhcC-CCCeeEEEEEEEeCCeEEEEE
Q 028681 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD--KIDENVQREIINHRSLR-HPNIVRFKEVILTPTHLAIVM 96 (205)
Q Consensus 20 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~ 96 (205)
.++|+..+.||+|++|.||.+.+..++..+++|.+.... .....+..|+..+.++. |+|++++++++..++..++++
T Consensus 3 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~ 82 (288)
T cd06616 3 AEDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICM 82 (288)
T ss_pred HHHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEE
Confidence 357788899999999999999999999999999987543 23356778888888886 999999999999999999999
Q ss_pred EecCCCchHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHh-cCcEeecCCCCCeEecCCCCCcEEEeeeccccccc
Q 028681 97 EYASGGELFERIC-----NAGRFSEDEARFFFQQLISGVSYCHS-MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 170 (205)
Q Consensus 97 ~~~~~~sl~~~~~-----~~~~~~~~~~~~i~~~i~~~l~~lh~-~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~ 170 (205)
+++.. ++.++.. ....+++..+..++.|++.|++|||+ .+++|+||+|+||+++.++. ++|+|||++....
T Consensus 83 e~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~--~kl~dfg~~~~~~ 159 (288)
T cd06616 83 ELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGN--IKLCDFGISGQLV 159 (288)
T ss_pred ecccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCc--EEEeecchhHHhc
Confidence 99854 5544332 23569999999999999999999997 59999999999999988776 9999999987654
Q ss_pred CCCCCCCCCCCCCccCCceeccC---cCCCeeeEEEeC
Q 028681 171 LHSQPKSTVGTPAYIAPEVLLKK---EYDGKVMCVYVI 205 (205)
Q Consensus 171 ~~~~~~~~~~~~~~~aPE~~~~~---~~~~~~~Dvwsl 205 (205)
.........++..|+|||.+.+. .++.+ +|||||
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~-~Di~sl 196 (288)
T cd06616 160 DSIAKTRDAGCRPYMAPERIDPSARDGYDVR-SDVWSL 196 (288)
T ss_pred cCCccccccCccCccCHHHhccccccCCcch-hhhhHH
Confidence 44444445688899999999876 45544 999986
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-31 Score=199.48 Aligned_cols=179 Identities=33% Similarity=0.518 Sum_probs=153.1
Q ss_pred eEEEeeeccccceeEEEEEecCCCcEEEEEEeecCccc---hHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEEec
Q 028681 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI---DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA 99 (205)
Q Consensus 23 y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~~ 99 (205)
|++.+.||+|++|.||++.+..++..+++|.+...... ...+..|+..++.++|+|++++++++..++..++++||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 67889999999999999999989999999998764332 456788999999999999999999999999999999999
Q ss_pred CCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCCC-CCCC
Q 028681 100 SGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKS 177 (205)
Q Consensus 100 ~~~sl~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~~-~~~~ 177 (205)
++ ++.+.+.. ..++++..+..++.|++.|+.+||+.+++|+||+|+||+++.++. ++|+|||.+....... ....
T Consensus 81 ~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~--~~l~df~~~~~~~~~~~~~~~ 157 (283)
T cd05118 81 DT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGV--LKLADFGLARSFGSPVRPYTH 157 (283)
T ss_pred CC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCc--EEEeeeeeeEecCCCcccccC
Confidence 75 77777765 457999999999999999999999999999999999999988777 9999999987665443 2233
Q ss_pred CCCCCCccCCceeccC-cCCCeeeEEEeC
Q 028681 178 TVGTPAYIAPEVLLKK-EYDGKVMCVYVI 205 (205)
Q Consensus 178 ~~~~~~~~aPE~~~~~-~~~~~~~Dvwsl 205 (205)
..++..|+|||.+.+. .++ .++|+|||
T Consensus 158 ~~~~~~~~~PE~~~~~~~~~-~~~Di~sl 185 (283)
T cd05118 158 YVVTRWYRAPELLLGDKGYS-TPVDIWSV 185 (283)
T ss_pred ccCcccccCcHHHhcCCCCC-chhHHHHH
Confidence 4577889999999877 444 55999986
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-31 Score=203.80 Aligned_cols=182 Identities=31% Similarity=0.479 Sum_probs=150.5
Q ss_pred CCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecC---ccchHHHHHHHHHHHhc-CCCCeeEEEEEEEeC--CeEE
Q 028681 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG---DKIDENVQREIINHRSL-RHPNIVRFKEVILTP--THLA 93 (205)
Q Consensus 20 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~---~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~--~~~~ 93 (205)
.++|++.+.||+|++|.||++.+..++..+++|.+... ......+..|+.+++++ +|+|++++++++... ...+
T Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~ 85 (337)
T cd07852 6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIY 85 (337)
T ss_pred hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEE
Confidence 57899999999999999999999988999999988542 22234567899999999 999999999998754 3689
Q ss_pred EEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCCC
Q 028681 94 IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 173 (205)
Q Consensus 94 lv~~~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~~ 173 (205)
+++|++++ +|...+..+ .+++.....++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||.+.......
T Consensus 86 lv~e~~~~-~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~--~kl~d~g~~~~~~~~~ 161 (337)
T cd07852 86 LVFEYMET-DLHAVIRAN-ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCR--VKLADFGLARSLSELE 161 (337)
T ss_pred EEeccccc-CHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCc--EEEeeccchhcccccc
Confidence 99999974 888877654 7889999999999999999999999999999999999998887 9999999987554332
Q ss_pred C------CCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 174 Q------PKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 174 ~------~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
. .....++..|+|||.+.+......++|||||
T Consensus 162 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~sl 199 (337)
T cd07852 162 ENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSV 199 (337)
T ss_pred ccccCcchhcccccccccCceeeeccccccccchHHHH
Confidence 1 1223578889999998765443455999996
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.7e-32 Score=182.32 Aligned_cols=181 Identities=30% Similarity=0.535 Sum_probs=155.4
Q ss_pred CCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCcc---chHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEE
Q 028681 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (205)
Q Consensus 21 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~ 97 (205)
.+|..+++||+|.+|+||.+++..++..|++|++..++. ......+|+.+++.+.|+||++++++..+++.+-+|+|
T Consensus 2 ~~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe 81 (292)
T KOG0662|consen 2 QKYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_pred cchHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHH
Confidence 467788999999999999999999999999999986543 24678899999999999999999999999999999999
Q ss_pred ecCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCCCC-C
Q 028681 98 YASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-P 175 (205)
Q Consensus 98 ~~~~~sl~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~-~ 175 (205)
++.- .|..+... ++.+..+.++.++.|++.++.++|++.+.|+|++|.|.+|+.++. +|++|||+++.++.... .
T Consensus 82 ~cdq-dlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~nge--lkladfglarafgipvrcy 158 (292)
T KOG0662|consen 82 FCDQ-DLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGE--LKLADFGLARAFGIPVRCY 158 (292)
T ss_pred HhhH-HHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCc--EEecccchhhhcCCceEee
Confidence 9953 56555533 567999999999999999999999999999999999999998888 99999999987665442 2
Q ss_pred CCCCCCCCccCCceeccCcCCCeeeEEEe
Q 028681 176 KSTVGTPAYIAPEVLLKKEYDGKVMCVYV 204 (205)
Q Consensus 176 ~~~~~~~~~~aPE~~~~~~~~~~~~Dvws 204 (205)
....-|+.|.+|.++.+....+.+.|+||
T Consensus 159 saevvtlwyrppdvlfgakly~tsidmws 187 (292)
T KOG0662|consen 159 SAEVVTLWYRPPDVLFGAKLYSTSIDMWS 187 (292)
T ss_pred eceeeeeeccCcceeeeeehhccchHhhh
Confidence 33457889999999988665444499998
|
|
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-31 Score=206.04 Aligned_cols=186 Identities=24% Similarity=0.322 Sum_probs=151.6
Q ss_pred CceecCCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecC---ccchHHHHHHHHHHHhcC-CCCeeEEEEEEEeCC
Q 028681 15 PIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG---DKIDENVQREIINHRSLR-HPNIVRFKEVILTPT 90 (205)
Q Consensus 15 ~~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~---~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~ 90 (205)
-+......|+++++||.||.+.||++.....+ .+++|++... ....+.+..|+.+|.+|+ |.+|+.++++=..++
T Consensus 355 ~i~Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~-iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~ 433 (677)
T KOG0596|consen 355 IIKVKGREYEILKQIGSGGSSKVFKVLNSDKQ-IYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDG 433 (677)
T ss_pred eEEECcchhhHHHhhcCCCcceeeeeecCCCc-chhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCc
Confidence 45567788999999999999999999987654 4666655432 233467899999999995 899999999999999
Q ss_pred eEEEEEEecCCCchHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccc
Q 028681 91 HLAIVMEYASGGELFERICNAGR-FSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 169 (205)
Q Consensus 91 ~~~lv~~~~~~~sl~~~~~~~~~-~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~ 169 (205)
++|+|||+ ....|..++++... .+...++.+..|++.|+.++|+.||||.||||.|+++..+. +||+|||+|...
T Consensus 434 ~lYmvmE~-Gd~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlVkG~---LKLIDFGIA~aI 509 (677)
T KOG0596|consen 434 YLYMVMEC-GDIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLVKGR---LKLIDFGIANAI 509 (677)
T ss_pred eEEEEeec-ccccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEEeee---EEeeeechhccc
Confidence 99999996 45689998876553 55568999999999999999999999999999999996443 899999999776
Q ss_pred cCC---CCCCCCCCCCCccCCceeccCcCC----------CeeeEEEeC
Q 028681 170 VLH---SQPKSTVGTPAYIAPEVLLKKEYD----------GKVMCVYVI 205 (205)
Q Consensus 170 ~~~---~~~~~~~~~~~~~aPE~~~~~~~~----------~~~~Dvwsl 205 (205)
.++ ....+..||+.||+||++....++ ..++|||||
T Consensus 510 ~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSL 558 (677)
T KOG0596|consen 510 QPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSL 558 (677)
T ss_pred CccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhh
Confidence 654 334556899999999999743322 345999997
|
|
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=199.22 Aligned_cols=180 Identities=31% Similarity=0.509 Sum_probs=149.9
Q ss_pred cCCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecC---ccchHHHHHHHHHHHhcCCCCeeEEEEEEEe-CCeEEE
Q 028681 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG---DKIDENVQREIINHRSLRHPNIVRFKEVILT-PTHLAI 94 (205)
Q Consensus 19 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~l 94 (205)
..++|++.+.||.|++|.||++.+..++..|++|.+.+. ....+.+..|+.+++.++|||++++.+++.. ....++
T Consensus 8 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~l 87 (328)
T cd07856 8 ITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYF 87 (328)
T ss_pred cccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEE
Confidence 468899999999999999999999999999999987643 2234567789999999999999999999876 457889
Q ss_pred EEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCCCC
Q 028681 95 VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 174 (205)
Q Consensus 95 v~~~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~ 174 (205)
+++++ +++|.+.+. ..++++..+..++.|++.||.+||+.+++|+||+|+||+++.++. ++|+|||.+..... .
T Consensus 88 v~e~~-~~~L~~~~~-~~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~--~~l~dfg~~~~~~~--~ 161 (328)
T cd07856 88 VTELL-GTDLHRLLT-SRPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCD--LKICDFGLARIQDP--Q 161 (328)
T ss_pred Eeehh-ccCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCC--EEeCccccccccCC--C
Confidence 99998 457877774 346888899999999999999999999999999999999988776 99999998864332 2
Q ss_pred CCCCCCCCCccCCceeccC-cCCCeeeEEEeC
Q 028681 175 PKSTVGTPAYIAPEVLLKK-EYDGKVMCVYVI 205 (205)
Q Consensus 175 ~~~~~~~~~~~aPE~~~~~-~~~~~~~Dvwsl 205 (205)
.....++..|+|||.+.+. .++ .++|||||
T Consensus 162 ~~~~~~~~~y~aPE~~~~~~~~~-~~~Dv~sl 192 (328)
T cd07856 162 MTGYVSTRYYRAPEIMLTWQKYD-VEVDIWSA 192 (328)
T ss_pred cCCCcccccccCceeeeccCCcC-cHHHHHHH
Confidence 2334567889999998763 455 45999985
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-30 Score=197.63 Aligned_cols=179 Identities=32% Similarity=0.527 Sum_probs=150.2
Q ss_pred CCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCccc----hHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEE
Q 028681 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI----DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV 95 (205)
Q Consensus 20 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 95 (205)
...|+..+.||+|++|.||++.+..++..+++|.+...... ...+..|+..++.++|+|++++.+++..+...+++
T Consensus 24 ~~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 103 (317)
T cd06635 24 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLV 103 (317)
T ss_pred hhhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEE
Confidence 35588999999999999999999988999999998754222 24577899999999999999999999999999999
Q ss_pred EEecCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCCCC
Q 028681 96 MEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 174 (205)
Q Consensus 96 ~~~~~~~sl~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~ 174 (205)
+||+.+ ++.+.+.. ..++++.++..++.+++.|+.+||+.+++|+||+|+||+++.++. ++|+|||++.....
T Consensus 104 ~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~--~kl~dfg~~~~~~~--- 177 (317)
T cd06635 104 MEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQ--VKLADFGSASIASP--- 177 (317)
T ss_pred EeCCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCC--EEEecCCCccccCC---
Confidence 999975 66666643 556999999999999999999999999999999999999988776 99999998764332
Q ss_pred CCCCCCCCCccCCceec---cCcCCCeeeEEEeC
Q 028681 175 PKSTVGTPAYIAPEVLL---KKEYDGKVMCVYVI 205 (205)
Q Consensus 175 ~~~~~~~~~~~aPE~~~---~~~~~~~~~Dvwsl 205 (205)
.....++..|+|||.+. .+.++.+ +|||||
T Consensus 178 ~~~~~~~~~y~aPE~~~~~~~~~~~~~-~Dv~sl 210 (317)
T cd06635 178 ANSFVGTPYWMAPEVILAMDEGQYDGK-VDVWSL 210 (317)
T ss_pred cccccCCccccChhhhhcCCCCCCCcc-ccHHHH
Confidence 23346788999999984 3445544 999986
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.1e-31 Score=198.13 Aligned_cols=179 Identities=36% Similarity=0.571 Sum_probs=153.6
Q ss_pred eEEEeeeccccceeEEEEEecCCCcEEEEEEeecCc---cchHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEEec
Q 028681 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA 99 (205)
Q Consensus 23 y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~~ 99 (205)
|++.+.||+|++|.||.+....+++.+++|.+.... ...+.+..|+..++.++|+|++++.+++.+.+..++++|++
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 678899999999999999999999999999988643 23466788999999999999999999999999999999999
Q ss_pred CCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCCC-CCCC
Q 028681 100 SGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKS 177 (205)
Q Consensus 100 ~~~sl~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~~-~~~~ 177 (205)
+ ++|.+.+... ..+++..+..++.|++.|+.+||+.|++|+||+|+||+++.++. ++|+|||.+....... ....
T Consensus 81 ~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~--~~l~d~g~~~~~~~~~~~~~~ 157 (282)
T cd07829 81 D-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGV--LKLADFGLARAFGIPLRTYTH 157 (282)
T ss_pred C-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCC--EEEecCCcccccCCCccccCc
Confidence 7 4899888775 57999999999999999999999999999999999999988777 9999999887654332 2233
Q ss_pred CCCCCCccCCceeccC-cCCCeeeEEEeC
Q 028681 178 TVGTPAYIAPEVLLKK-EYDGKVMCVYVI 205 (205)
Q Consensus 178 ~~~~~~~~aPE~~~~~-~~~~~~~Dvwsl 205 (205)
...+..|+|||.+.+. .++. ++|+|||
T Consensus 158 ~~~~~~~~aPE~~~~~~~~~~-~~Dv~sl 185 (282)
T cd07829 158 EVVTLWYRAPEILLGSKHYST-AVDIWSV 185 (282)
T ss_pred cccCcCcCChHHhcCCcCCCc-cccHHHH
Confidence 3467789999999876 5554 4999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-30 Score=200.40 Aligned_cols=180 Identities=27% Similarity=0.452 Sum_probs=148.8
Q ss_pred cCCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCcc---chHHHHHHHHHHHhcCCCCeeEEEEEEEeC------
Q 028681 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTP------ 89 (205)
Q Consensus 19 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------ 89 (205)
..++|++.+.||+|++|.||.+.+..++..|++|.+..... ..+.+.+|+.++++++|+||+++.+++...
T Consensus 15 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~ 94 (345)
T cd07877 15 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 94 (345)
T ss_pred ccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeeccccccc
Confidence 45899999999999999999999998999999998875322 235677899999999999999999988643
Q ss_pred CeEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccc
Q 028681 90 THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 169 (205)
Q Consensus 90 ~~~~lv~~~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~ 169 (205)
...+++++++ +++|.+.+.. ..+++..+..++.|++.|+.|||+.|++|+||+|+||+++.++. ++|+|||++...
T Consensus 95 ~~~~lv~~~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~--~kl~dfg~~~~~ 170 (345)
T cd07877 95 NDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCE--LKILDFGLARHT 170 (345)
T ss_pred ccEEEEehhc-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCC--EEEecccccccc
Confidence 3467777776 6688777644 46999999999999999999999999999999999999998877 999999988654
Q ss_pred cCCCCCCCCCCCCCccCCceeccC-cCCCeeeEEEeC
Q 028681 170 VLHSQPKSTVGTPAYIAPEVLLKK-EYDGKVMCVYVI 205 (205)
Q Consensus 170 ~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~~Dvwsl 205 (205)
.. ......++..|+|||.+.+. .++.+ +|||||
T Consensus 171 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~-~Dvwsl 204 (345)
T cd07877 171 DD--EMTGYVATRWYRAPEIMLNWMHYNQT-VDIWSV 204 (345)
T ss_pred cc--cccccccCCCccCHHHHhCccCCCch-hhHHHH
Confidence 32 22334678899999998763 45544 999996
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.5e-31 Score=193.19 Aligned_cols=174 Identities=38% Similarity=0.619 Sum_probs=152.6
Q ss_pred eccccceeEEEEEecCCCcEEEEEEeecCcc----chHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEEecCCCch
Q 028681 29 IGSGNFGVARLMRDKKTEELVAVKYIERGDK----IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL 104 (205)
Q Consensus 29 l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~~~~~sl 104 (205)
||+|++|.+|.+.+..++..+++|.+..... ..+.+..|+.+++.++|+|++++++.+..++..+++|+++++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 6899999999999998899999999876533 235688899999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCC-CCCCCCCCCCC
Q 028681 105 FERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKSTVGTPA 183 (205)
Q Consensus 105 ~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~-~~~~~~~~~~~ 183 (205)
.+.+.....+++..+..++.|++.|+.+||+++++|+||+|+||+++.++. ++|+|||.+...... .......++..
T Consensus 81 ~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~--~~l~d~~~~~~~~~~~~~~~~~~~~~~ 158 (250)
T cd05123 81 FSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGH--IKLTDFGLAKELSSEGSRTNTFCGTPE 158 (250)
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCc--EEEeecCcceecccCCCcccCCcCCcc
Confidence 999988778999999999999999999999999999999999999988776 999999988665443 23344568889
Q ss_pred ccCCceeccCcCCCeeeEEEeC
Q 028681 184 YIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 184 ~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
|+|||.+.+...+.+ +|+|||
T Consensus 159 ~~~Pe~~~~~~~~~~-~D~~sl 179 (250)
T cd05123 159 YLAPEVLLGKGYGKA-VDWWSL 179 (250)
T ss_pred ccChHHhCCCCCCch-hhHHHH
Confidence 999999988776655 999986
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.6e-31 Score=195.14 Aligned_cols=176 Identities=25% Similarity=0.314 Sum_probs=142.0
Q ss_pred eeeccccceeEEEEEecC---CCcEEEEEEeecCc--cchHHHHHHHHHHHhcCCCCeeEEEEEEE-eCCeEEEEEEecC
Q 028681 27 RDIGSGNFGVARLMRDKK---TEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVIL-TPTHLAIVMEYAS 100 (205)
Q Consensus 27 ~~l~~g~~g~v~~~~~~~---~~~~v~iK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~~lv~~~~~ 100 (205)
+.||+|++|.||.+.... ....+++|.+.... ...+.+..|+.+++.++|||++++++++. .++..+++++|+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 468999999999998643 34679999876432 22356778999999999999999999776 4556889999999
Q ss_pred CCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCCC-----C
Q 028681 101 GGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-----Q 174 (205)
Q Consensus 101 ~~sl~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~~-----~ 174 (205)
+++|.+++... ...+...+..++.|++.|+.|||+.+++|+||+|+||+++.++. ++|+|||++....... .
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~--~kl~dfg~~~~~~~~~~~~~~~ 158 (262)
T cd05058 81 HGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFT--VKVADFGLARDIYDKEYYSVHN 158 (262)
T ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCc--EEECCccccccccCCcceeecc
Confidence 99999998653 34677888899999999999999999999999999999988777 9999999986443211 1
Q ss_pred CCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 175 PKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 175 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
.....++..|+|||.+.+..++.+ +|||||
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~-~Di~sl 188 (262)
T cd05058 159 HTGAKLPVKWMALESLQTQKFTTK-SDVWSF 188 (262)
T ss_pred cccCcCCccccChhHhccCccchH-HHHHHH
Confidence 122345678999999988888766 999996
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.9e-31 Score=197.07 Aligned_cols=178 Identities=26% Similarity=0.347 Sum_probs=145.6
Q ss_pred eeeccccceeEEEEEecCCC------cEEEEEEeecCc--cchHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEEe
Q 028681 27 RDIGSGNFGVARLMRDKKTE------ELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (205)
Q Consensus 27 ~~l~~g~~g~v~~~~~~~~~------~~v~iK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~ 98 (205)
+.||+|++|.||.+...... ..+++|.+.... .....+.+|+..++.++|+||+++++++..+...++++|+
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 36899999999999876433 678999876543 2345688899999999999999999999999999999999
Q ss_pred cCCCchHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCC---CCcEEEeeeccccc
Q 028681 99 ASGGELFERICNA-------GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSP---APRLKICDFGYSKS 168 (205)
Q Consensus 99 ~~~~sl~~~~~~~-------~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~---~~~~~l~df~~~~~ 168 (205)
+++++|.+.+... ..+++.++..++.|++.|+.|||+.+++|+||+|+||+++.++ ...++|+|||++..
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~~~ 160 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARD 160 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCcccccc
Confidence 9999999888642 2378899999999999999999999999999999999998766 11399999999865
Q ss_pred ccCCCC---CCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 169 SVLHSQ---PKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 169 ~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
...... .....++..|+|||.+.+..++.+ +|||||
T Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~sl 199 (269)
T cd05044 161 IYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQ-SDVWSF 199 (269)
T ss_pred cccccccccCcccCCCccccCHHHHccCCcccc-hhHHHH
Confidence 432211 112235678999999988888655 999996
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.7e-31 Score=195.62 Aligned_cols=180 Identities=24% Similarity=0.332 Sum_probs=145.1
Q ss_pred eEEEeeeccccceeEEEEEec---CCCcEEEEEEeecCc---cchHHHHHHHHHHHhcCCCCeeEEEEEEEeCC------
Q 028681 23 YELVRDIGSGNFGVARLMRDK---KTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPT------ 90 (205)
Q Consensus 23 y~~~~~l~~g~~g~v~~~~~~---~~~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~------ 90 (205)
|++.+.||+|++|.||.+... .++..+++|.+.... ...+++..|+..++.++|||++++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 678889999999999999864 356889999887542 22356778999999999999999999887542
Q ss_pred eEEEEEEecCCCchHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeec
Q 028681 91 HLAIVMEYASGGELFERICNA------GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFG 164 (205)
Q Consensus 91 ~~~lv~~~~~~~sl~~~~~~~------~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~ 164 (205)
..+++++|+.+++|.+.+... ..++...+..++.|++.|++|||+.+++|+||+|+||+++.++. ++|+|||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~--~kl~dfg 158 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMT--VCVADFG 158 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCC--EEECccc
Confidence 246788999999998776432 14788999999999999999999999999999999999987777 9999999
Q ss_pred ccccccCCC---CCCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 165 YSKSSVLHS---QPKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 165 ~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
+++...... ......++..|++||.+.+..++.+ +|||||
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~-sDi~sl 201 (273)
T cd05074 159 LSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTH-SDVWAF 201 (273)
T ss_pred ccccccCCcceecCCCccCchhhcCHhHHhcCccchh-hhhHHH
Confidence 987553322 1122235678999999988888765 999996
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-31 Score=213.11 Aligned_cols=187 Identities=26% Similarity=0.373 Sum_probs=160.8
Q ss_pred ceecCCCeEEEeeeccccceeEEEEEecCC---CcEEEEEEeecCc--cchHHHHHHHHHHHhcCCCCeeEEEEEEEeCC
Q 028681 16 IMHDSDRYELVRDIGSGNFGVARLMRDKKT---EELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPT 90 (205)
Q Consensus 16 ~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~---~~~v~iK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 90 (205)
-..+.+..++.+.||.|.||.|+.+..+.. ...||||.++.+. +.+.+|..|..++.+++||||+++.|+....+
T Consensus 624 kEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~ 703 (996)
T KOG0196|consen 624 KEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSK 703 (996)
T ss_pred hhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCc
Confidence 345667788999999999999999998754 4689999999874 44567999999999999999999999999999
Q ss_pred eEEEEEEecCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccc
Q 028681 91 HLAIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 169 (205)
Q Consensus 91 ~~~lv~~~~~~~sl~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~ 169 (205)
.+++++|||++++|..+++. .+.++..++..+++.|+.|+.||-+++++||||..+|||++.+-- +|+.|||+++..
T Consensus 704 PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLv--CKVsDFGLSRvl 781 (996)
T KOG0196|consen 704 PVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLV--CKVSDFGLSRVL 781 (996)
T ss_pred eeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceE--EEeccccceeec
Confidence 99999999999999999976 346999999999999999999999999999999999999976665 999999999865
Q ss_pred cCCCCC--CCCCC--CCCccCCceeccCcCCCeeeEEEeC
Q 028681 170 VLHSQP--KSTVG--TPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 170 ~~~~~~--~~~~~--~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
..+... .+.-| ..+|.|||++...++++. |||||+
T Consensus 782 edd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsA-SDVWSy 820 (996)
T KOG0196|consen 782 EDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSA-SDVWSY 820 (996)
T ss_pred ccCCCccccccCCccceeecChhHhhhcccCch-hhcccc
Confidence 433321 12222 478999999999999866 999996
|
|
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=196.94 Aligned_cols=185 Identities=30% Similarity=0.386 Sum_probs=150.7
Q ss_pred eecCCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCcc--chHHHHHHHHHHHhc-CCCCeeEEEEEEEeCCeEE
Q 028681 17 MHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK--IDENVQREIINHRSL-RHPNIVRFKEVILTPTHLA 93 (205)
Q Consensus 17 ~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~ 93 (205)
....++|++.+.||+|++|.||++.+..++..|++|.+..... ...++..|+..+... .|+|++++++++..+...+
T Consensus 11 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~ 90 (296)
T cd06618 11 PADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVF 90 (296)
T ss_pred cCCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEE
Confidence 3456899999999999999999999998899999999876432 234455566656555 4999999999999999999
Q ss_pred EEEEecCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHh-cCcEeecCCCCCeEecCCCCCcEEEeeecccccccC
Q 028681 94 IVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHS-MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 171 (205)
Q Consensus 94 lv~~~~~~~sl~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lh~-~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~ 171 (205)
+++|++.+ ++.+.+.. ..++++..+..++.|++.|+.|||+ .+++|+||+|+||+++.++. ++|+|||.+.....
T Consensus 91 ~v~e~~~~-~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~--~kL~dfg~~~~~~~ 167 (296)
T cd06618 91 ICMELMST-CLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGN--VKLCDFGISGRLVD 167 (296)
T ss_pred EEeeccCc-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCC--EEECccccchhccC
Confidence 99999854 66666644 4578999999999999999999997 69999999999999987776 99999999865543
Q ss_pred CCCCCCCCCCCCccCCceeccCc----CCCeeeEEEeC
Q 028681 172 HSQPKSTVGTPAYIAPEVLLKKE----YDGKVMCVYVI 205 (205)
Q Consensus 172 ~~~~~~~~~~~~~~aPE~~~~~~----~~~~~~Dvwsl 205 (205)
........++..|+|||.+.+.. ++.+ +|||||
T Consensus 168 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~-~Di~sl 204 (296)
T cd06618 168 SKAKTRSAGCAAYMAPERIDPPDPNPKYDIR-ADVWSL 204 (296)
T ss_pred CCcccCCCCCccccCHhhcCCCCCccccccc-hhHHHH
Confidence 33333445778899999997654 5544 999986
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=199.72 Aligned_cols=180 Identities=31% Similarity=0.481 Sum_probs=147.5
Q ss_pred CeEEEeeeccccceeEEEEEecCC--CcEEEEEEeecCc---cchHHHHHHHHHHHhc-CCCCeeEEEEEEEeC----Ce
Q 028681 22 RYELVRDIGSGNFGVARLMRDKKT--EELVAVKYIERGD---KIDENVQREIINHRSL-RHPNIVRFKEVILTP----TH 91 (205)
Q Consensus 22 ~y~~~~~l~~g~~g~v~~~~~~~~--~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~----~~ 91 (205)
+|++.+.||+|++|.||.+.+... +..|++|.+.... ...+.+..|+.+++.+ .|+|++++++.+... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 589999999999999999999887 8899999886432 2235677899999998 599999999875432 35
Q ss_pred EEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccC
Q 028681 92 LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 171 (205)
Q Consensus 92 ~~lv~~~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~ 171 (205)
.+++++++. ++|.+.+.....+++..++.++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||.+.....
T Consensus 81 ~~~~~e~~~-~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~--~kl~Dfg~a~~~~~ 157 (332)
T cd07857 81 LYLYEELME-ADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCE--LKICDFGLARGFSE 157 (332)
T ss_pred EEEEEeccc-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCC--EEeCcCCCceeccc
Confidence 678888875 588888877778999999999999999999999999999999999999988877 99999999875443
Q ss_pred CCC-----CCCCCCCCCccCCceeccC-cCCCeeeEEEeC
Q 028681 172 HSQ-----PKSTVGTPAYIAPEVLLKK-EYDGKVMCVYVI 205 (205)
Q Consensus 172 ~~~-----~~~~~~~~~~~aPE~~~~~-~~~~~~~Dvwsl 205 (205)
... .....++..|+|||.+.+. .++.+ +|||||
T Consensus 158 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~-~Di~sl 196 (332)
T cd07857 158 NPGENAGFMTEYVATRWYRAPEIMLSFQSYTKA-IDVWSV 196 (332)
T ss_pred ccccccccccCcccCccccCcHHHhCCCCCCcH-HHHHHH
Confidence 221 1223578899999988664 45544 999986
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-31 Score=196.32 Aligned_cols=182 Identities=32% Similarity=0.466 Sum_probs=157.4
Q ss_pred CCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCccchHHHHHHHHHHHhcCC--CC----eeEEEEEEEeCCeEE
Q 028681 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRH--PN----IVRFKEVILTPTHLA 93 (205)
Q Consensus 20 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h--~~----i~~~~~~~~~~~~~~ 93 (205)
.++|+++..+|+|.||.|-.+.+..++..||+|+++.-+.-.++...|+..|.++.+ |+ ++...++|...+..|
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghiC 167 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHIC 167 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCceE
Confidence 688999999999999999999999999999999999888888999999999999932 22 677778899999999
Q ss_pred EEEEecCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCC-----------------
Q 028681 94 IVMEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSP----------------- 154 (205)
Q Consensus 94 lv~~~~~~~sl~~~~~~~~--~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~----------------- 154 (205)
+|+|.+ |.|+.+++..+. +++...++.+++|++.++++||+.+++|.|+||+||++.+..
T Consensus 168 ivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~~~~~r~~ 246 (415)
T KOG0671|consen 168 IVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKKVCFIRPL 246 (415)
T ss_pred EEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCccceeccC
Confidence 999998 558999997755 599999999999999999999999999999999999984211
Q ss_pred -CCcEEEeeecccccccCCCCCCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 155 -APRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 155 -~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
...++++|||.|+...... .+...|.-|.|||++.+-.++.+ +||||+
T Consensus 247 ks~~I~vIDFGsAtf~~e~h--s~iVsTRHYRAPEViLgLGwS~p-CDvWSi 295 (415)
T KOG0671|consen 247 KSTAIKVIDFGSATFDHEHH--STIVSTRHYRAPEVILGLGWSQP-CDVWSI 295 (415)
T ss_pred CCcceEEEecCCcceeccCc--ceeeeccccCCchheeccCcCCc-cCceee
Confidence 1148999999997654333 45568899999999999999877 999996
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-32 Score=197.74 Aligned_cols=186 Identities=32% Similarity=0.434 Sum_probs=154.8
Q ss_pred cCCCeEEEeeeccccceeEEEEEecCCC----cEEEEEEeecCc---cchHHHHHHHHHHHhcCCCCeeEEEEEEEe-CC
Q 028681 19 DSDRYELVRDIGSGNFGVARLMRDKKTE----ELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILT-PT 90 (205)
Q Consensus 19 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~----~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~ 90 (205)
....|+....||+|.+|.||++....++ +.+|+|.++..+ -.....-+|+.+++.++|+|++.+..+|.. +.
T Consensus 22 ~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~ 101 (438)
T KOG0666|consen 22 DLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDK 101 (438)
T ss_pred HHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCc
Confidence 4678999999999999999999765443 368999887542 335678899999999999999999999987 78
Q ss_pred eEEEEEEecCCCchHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCC--CcEEEeee
Q 028681 91 HLAIVMEYASGGELFERICN-----AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPA--PRLKICDF 163 (205)
Q Consensus 91 ~~~lv~~~~~~~sl~~~~~~-----~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~--~~~~l~df 163 (205)
.+++++||.+. .|++++.- ...++...++.|++||+.|+.|||++=++|||+||.||++..++. ++|||+||
T Consensus 102 ~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaDl 180 (438)
T KOG0666|consen 102 KVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIADL 180 (438)
T ss_pred eEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeecc
Confidence 99999999865 78888853 335999999999999999999999999999999999999987732 35999999
Q ss_pred cccccccCCCCC----CCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 164 GYSKSSVLHSQP----KSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 164 ~~~~~~~~~~~~----~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
|+++.+...... ....-|..|.|||.+.+....+++.||||+
T Consensus 181 GlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAi 226 (438)
T KOG0666|consen 181 GLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAI 226 (438)
T ss_pred cHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHH
Confidence 999877544332 222468899999999998877888999984
|
|
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-32 Score=226.62 Aligned_cols=183 Identities=32% Similarity=0.451 Sum_probs=159.4
Q ss_pred CCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCccc---hHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEE
Q 028681 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI---DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (205)
Q Consensus 21 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~ 97 (205)
-+++....||+|.||.||.+.+..+|...|+|-+..++.. .....+|+.++..+.|||+++++|+=.+....++.||
T Consensus 1235 ~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFME 1314 (1509)
T KOG4645|consen 1235 FRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFME 1314 (1509)
T ss_pred eeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHH
Confidence 3567788999999999999999999999999988765433 3557889999999999999999999999899999999
Q ss_pred ecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCCCCC--
Q 028681 98 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP-- 175 (205)
Q Consensus 98 ~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~~-- 175 (205)
||.+|+|.+.++.++...+.....+..|++.|++|||+.||+||||||.||+++.++. +|++|||.|+...+....
T Consensus 1315 yC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~--iK~~DFGsa~ki~~~~~~~~ 1392 (1509)
T KOG4645|consen 1315 YCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGL--IKYGDFGSAVKIKNNAQTMP 1392 (1509)
T ss_pred HhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCc--EEeecccceeEecCchhcCC
Confidence 9999999999988888888889999999999999999999999999999999998887 999999999876655322
Q ss_pred ---CCCCCCCCccCCceeccCcC--CCeeeEEEeC
Q 028681 176 ---KSTVGTPAYIAPEVLLKKEY--DGKVMCVYVI 205 (205)
Q Consensus 176 ---~~~~~~~~~~aPE~~~~~~~--~~~~~Dvwsl 205 (205)
+...||+.|||||++.+..- ...++|||||
T Consensus 1393 ~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWsl 1427 (1509)
T KOG4645|consen 1393 GELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSL 1427 (1509)
T ss_pred HHHHhhcCCchhcCchhhcccccCCCCcchhhhcc
Confidence 23459999999999986442 2346999997
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-31 Score=195.39 Aligned_cols=192 Identities=29% Similarity=0.488 Sum_probs=170.1
Q ss_pred CcccCceecCCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecC----ccchHHHHHHHHHHHhc-CCCCeeEEEEE
Q 028681 11 GMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG----DKIDENVQREIINHRSL-RHPNIVRFKEV 85 (205)
Q Consensus 11 ~~~~~~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~----~~~~~~~~~e~~~l~~l-~h~~i~~~~~~ 85 (205)
+.........++|.+++.||+|++.+|.++..+.+.+.+|+|++++. +...+..+.|-....+. .||.++-+.-.
T Consensus 240 g~~~~~~l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhsc 319 (593)
T KOG0695|consen 240 GIKISQGLGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSC 319 (593)
T ss_pred ccccccccccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhh
Confidence 33455666789999999999999999999999999999999998764 33446677777766655 58999999999
Q ss_pred EEeCCeEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecc
Q 028681 86 ILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGY 165 (205)
Q Consensus 86 ~~~~~~~~lv~~~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~ 165 (205)
|..+..+++|.||.+++.|.=-+++.+.++++.++.+...|+.||.|||++||+.+|++.+|++++..++ +||+|+|.
T Consensus 320 fqtesrlffvieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaegh--ikltdygm 397 (593)
T KOG0695|consen 320 FQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGH--IKLTDYGM 397 (593)
T ss_pred hcccceEEEEEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCc--eeecccch
Confidence 9999999999999999999877788888999999999999999999999999999999999999998888 99999999
Q ss_pred ccc-ccCCCCCCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 166 SKS-SVLHSQPKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 166 ~~~-~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
++. ..++..+.+.+||+.|.|||++.+..|..+ .|+|+|
T Consensus 398 cke~l~~gd~tstfcgtpnyiapeilrgeeygfs-vdwwal 437 (593)
T KOG0695|consen 398 CKEGLGPGDTTSTFCGTPNYIAPEILRGEEYGFS-VDWWAL 437 (593)
T ss_pred hhcCCCCCcccccccCCCcccchhhhcccccCce-ehHHHH
Confidence 864 466677788899999999999999999877 899986
|
|
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-30 Score=193.04 Aligned_cols=176 Identities=23% Similarity=0.283 Sum_probs=139.2
Q ss_pred eeeccccceeEEEEEecCC--CcEEEEEEeecCc--cchHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEEecCCC
Q 028681 27 RDIGSGNFGVARLMRDKKT--EELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGG 102 (205)
Q Consensus 27 ~~l~~g~~g~v~~~~~~~~--~~~v~iK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~~~~~ 102 (205)
+.||+|+||.||++..... ...+++|.+.... ...+.+.+|+..++.++|||++++++.+......+++|||++++
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 80 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG 80 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence 3689999999999875433 3456677666543 23467888999999999999999999999999999999999999
Q ss_pred chHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCC---CCC
Q 028681 103 ELFERICNA----GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH---SQP 175 (205)
Q Consensus 103 sl~~~~~~~----~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~---~~~ 175 (205)
+|.+.+... ...+...+..++.|++.||.|||+.+++|+||+|+||+++.++. ++|+|||++...... ...
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~--~~l~Dfg~~~~~~~~~~~~~~ 158 (268)
T cd05086 81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLT--VKVGDYGIGPSRYKEDYIETE 158 (268)
T ss_pred cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCcc--EEecccccccccCcchhhhcc
Confidence 999988653 23566778899999999999999999999999999999988777 999999987542221 112
Q ss_pred CCCCCCCCccCCceeccC-------cCCCeeeEEEeC
Q 028681 176 KSTVGTPAYIAPEVLLKK-------EYDGKVMCVYVI 205 (205)
Q Consensus 176 ~~~~~~~~~~aPE~~~~~-------~~~~~~~Dvwsl 205 (205)
....++..|+|||++... .++ .++|||||
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~-~~~Diwsl 194 (268)
T cd05086 159 DDKCVPLRWLAPELVGEFHGGLITAEQT-KPSNVWAL 194 (268)
T ss_pred cCCcCcccccCchhcccccCccccCCCC-CcchhHHH
Confidence 234578899999998532 233 34999996
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-30 Score=195.26 Aligned_cols=181 Identities=30% Similarity=0.529 Sum_probs=152.1
Q ss_pred CeEEEeeeccccceeEEEEEec---CCCcEEEEEEeecCc-----cchHHHHHHHHHHHhc-CCCCeeEEEEEEEeCCeE
Q 028681 22 RYELVRDIGSGNFGVARLMRDK---KTEELVAVKYIERGD-----KIDENVQREIINHRSL-RHPNIVRFKEVILTPTHL 92 (205)
Q Consensus 22 ~y~~~~~l~~g~~g~v~~~~~~---~~~~~v~iK~~~~~~-----~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~ 92 (205)
+|++.+.||+|++|.||.+... .++..+++|.+.... ...+.+..|+.++..+ +|++++++.+.+..+...
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 4899999999999999998864 456889999887532 2235577899999999 599999999999999999
Q ss_pred EEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCC
Q 028681 93 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 172 (205)
Q Consensus 93 ~lv~~~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~ 172 (205)
++++||+++++|.+.+.....+++..+..++.|++.+|.+||+.+++|+||+|+||+++.++. ++|+|||++......
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~--~~l~dfg~~~~~~~~ 158 (288)
T cd05583 81 HLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGH--VVLTDFGLSKEFLAE 158 (288)
T ss_pred EEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCC--EEEEECccccccccc
Confidence 999999999999998877778999999999999999999999999999999999999988776 999999988654433
Q ss_pred CCC--CCCCCCCCccCCceeccCc--CCCeeeEEEeC
Q 028681 173 SQP--KSTVGTPAYIAPEVLLKKE--YDGKVMCVYVI 205 (205)
Q Consensus 173 ~~~--~~~~~~~~~~aPE~~~~~~--~~~~~~Dvwsl 205 (205)
... ....++..|+|||.+.+.. .+ .++|||||
T Consensus 159 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~~~Dv~sl 194 (288)
T cd05583 159 EEERAYSFCGTIEYMAPEVIRGGSGGHD-KAVDWWSL 194 (288)
T ss_pred cccccccccCCccccCHHHhcCCCCCCc-chhhhHHH
Confidence 221 2235788999999987654 44 45999986
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.6e-31 Score=197.64 Aligned_cols=180 Identities=27% Similarity=0.449 Sum_probs=152.7
Q ss_pred CeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCcc-chHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEEecC
Q 028681 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYAS 100 (205)
Q Consensus 22 ~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~~~ 100 (205)
.|.....||+|++|.||.+....++..|++|.+..... ..+.+.+|+..++.++|+|++++++.+..++..++++||++
T Consensus 21 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 100 (292)
T cd06657 21 YLDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLE 100 (292)
T ss_pred HhhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCC
Confidence 34445789999999999999999999999998865432 34568889999999999999999999999999999999999
Q ss_pred CCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCCC-CCCCCC
Q 028681 101 GGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKSTV 179 (205)
Q Consensus 101 ~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~~-~~~~~~ 179 (205)
+++|.+.+. ...+++..+..++.|++.++++||+.|++|+||+|+||+++.++. ++|+|||.+....... ......
T Consensus 101 ~~~L~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~--~~l~dfg~~~~~~~~~~~~~~~~ 177 (292)
T cd06657 101 GGALTDIVT-HTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGR--VKLSDFGFCAQVSKEVPRRKSLV 177 (292)
T ss_pred CCcHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCC--EEEcccccceecccccccccccc
Confidence 999988764 456899999999999999999999999999999999999998877 9999999876544332 123345
Q ss_pred CCCCccCCceeccCcCCCeeeEEEeC
Q 028681 180 GTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 180 ~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
++..|+|||.+.+..++.+ +|+|||
T Consensus 178 ~~~~y~~pE~~~~~~~~~~-~Dv~sl 202 (292)
T cd06657 178 GTPYWMAPELISRLPYGPE-VDIWSL 202 (292)
T ss_pred cCccccCHHHhcCCCCCch-hhHHHH
Confidence 7889999999988777655 999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.5e-30 Score=195.02 Aligned_cols=178 Identities=31% Similarity=0.513 Sum_probs=148.9
Q ss_pred CCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCcc----chHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEE
Q 028681 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK----IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (205)
Q Consensus 21 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 96 (205)
+-|...+.||+|++|.||.+.+..++..+++|.+..... ....+..|+.+++.++|+|++++.+++.+....++++
T Consensus 21 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 100 (313)
T cd06633 21 EIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVM 100 (313)
T ss_pred HHhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEE
Confidence 346778889999999999999999999999999875432 2245778999999999999999999999999999999
Q ss_pred EecCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCCCCC
Q 028681 97 EYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 175 (205)
Q Consensus 97 ~~~~~~sl~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~~ 175 (205)
||+.+ ++.+.+.. ..++++.++..++.|++.|+.|||+.|++|+||+|+||+++.++. ++|+|||++.... ..
T Consensus 101 e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~--~kL~dfg~~~~~~---~~ 174 (313)
T cd06633 101 EYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQ--VKLADFGSASKSS---PA 174 (313)
T ss_pred ecCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCC--EEEeecCCCcccC---CC
Confidence 99965 66666654 456899999999999999999999999999999999999988777 9999999875432 22
Q ss_pred CCCCCCCCccCCceec---cCcCCCeeeEEEeC
Q 028681 176 KSTVGTPAYIAPEVLL---KKEYDGKVMCVYVI 205 (205)
Q Consensus 176 ~~~~~~~~~~aPE~~~---~~~~~~~~~Dvwsl 205 (205)
....++..|+|||.+. +..++. ++|||||
T Consensus 175 ~~~~~~~~y~aPE~~~~~~~~~~~~-~sDv~sl 206 (313)
T cd06633 175 NSFVGTPYWMAPEVILAMDEGQYDG-KVDVWSL 206 (313)
T ss_pred CCccccccccChhhccccCCCCCCc-hhhHHHH
Confidence 3456888999999985 344554 4999996
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=200.99 Aligned_cols=183 Identities=33% Similarity=0.442 Sum_probs=148.0
Q ss_pred CCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCcc-chHHHHHHHHHHHhcCCCCeeEEEEEEEeC---------
Q 028681 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK-IDENVQREIINHRSLRHPNIVRFKEVILTP--------- 89 (205)
Q Consensus 20 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--------- 89 (205)
..+|++.+.||.|++|.||++.+..++..|++|.+..... ..+.+.+|+.+++.++|+|++++++++...
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG 83 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence 5899999999999999999999999999999999876543 345688899999999999999998776543
Q ss_pred -----CeEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeec
Q 028681 90 -----THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFG 164 (205)
Q Consensus 90 -----~~~~lv~~~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~ 164 (205)
...++++||++ ++|.+.+. ...+++..++.++.|++.|+.+||+.|++|+||+|+||+++.++. .++|+|||
T Consensus 84 ~~~~~~~~~lv~e~~~-~~L~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~-~~kl~dfg 160 (342)
T cd07854 84 SLTELNSVYIVQEYME-TDLANVLE-QGPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDL-VLKIGDFG 160 (342)
T ss_pred cccccceEEEEeeccc-ccHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCc-eEEECCcc
Confidence 35789999996 47877764 346899999999999999999999999999999999999975432 28999999
Q ss_pred ccccccCCCCC----CCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 165 YSKSSVLHSQP----KSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 165 ~~~~~~~~~~~----~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
.+......... ....++..|+|||.+........++|||||
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSl 205 (342)
T cd07854 161 LARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAA 205 (342)
T ss_pred cceecCCccccccccccccccccccCHHHHhCccccCchhhHHHH
Confidence 98654322211 223467889999987654333355999996
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=221.40 Aligned_cols=186 Identities=32% Similarity=0.474 Sum_probs=148.8
Q ss_pred eecCCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecC--ccchHHHHHHHHHHHhcCCCCeeEEEEEEEeC-----
Q 028681 17 MHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG--DKIDENVQREIINHRSLRHPNIVRFKEVILTP----- 89 (205)
Q Consensus 17 ~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~----- 89 (205)
+.-.++|+.++.||+||||.||+|+++-+|..||+|++... .........|+..+.+|+|||+++++..|.+.
T Consensus 475 SRY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~ 554 (1351)
T KOG1035|consen 475 SRYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELT 554 (1351)
T ss_pred hhHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccc
Confidence 34567889999999999999999999999999999999876 33446688899999999999999998765210
Q ss_pred --------------------------------------------------------------------------------
Q 028681 90 -------------------------------------------------------------------------------- 89 (205)
Q Consensus 90 -------------------------------------------------------------------------------- 89 (205)
T Consensus 555 ~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS 634 (1351)
T KOG1035|consen 555 VLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTS 634 (1351)
T ss_pred cccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccc
Confidence
Q ss_pred ----------------------------------CeEEEEEEecCCCchHHHHHhcCCC-CHHHHHHHHHHHHHHHHHHH
Q 028681 90 ----------------------------------THLAIVMEYASGGELFERICNAGRF-SEDEARFFFQQLISGVSYCH 134 (205)
Q Consensus 90 ----------------------------------~~~~lv~~~~~~~sl~~~~~~~~~~-~~~~~~~i~~~i~~~l~~lh 134 (205)
..+|+-||||+..++.+++..+... .....+.++++|+.||.|+|
T Consensus 635 ~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH 714 (1351)
T KOG1035|consen 635 DSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIH 714 (1351)
T ss_pred ccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHH
Confidence 1245667787776666666554433 36778899999999999999
Q ss_pred hcCcEeecCCCCCeEecCCCCCcEEEeeeccccccc-------------------CCCCCCCCCCCCCccCCceeccCc-
Q 028681 135 SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV-------------------LHSQPKSTVGTPAYIAPEVLLKKE- 194 (205)
Q Consensus 135 ~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~-------------------~~~~~~~~~~~~~~~aPE~~~~~~- 194 (205)
++|||||||||.|||+++++. |||+|||+|+... .........||-.|+|||++.+..
T Consensus 715 ~~giIHRDLKP~NIFLd~~~~--VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~ 792 (1351)
T KOG1035|consen 715 DQGIIHRDLKPRNIFLDSRNS--VKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSS 792 (1351)
T ss_pred hCceeeccCCcceeEEcCCCC--eeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccccc
Confidence 999999999999999998877 9999999997511 111223346999999999998765
Q ss_pred --CCCeeeEEEeC
Q 028681 195 --YDGKVMCVYVI 205 (205)
Q Consensus 195 --~~~~~~Dvwsl 205 (205)
|+.| +|+|||
T Consensus 793 ~~Yn~K-iDmYSL 804 (1351)
T KOG1035|consen 793 NKYNSK-IDMYSL 804 (1351)
T ss_pred ccccch-hhhHHH
Confidence 6655 999996
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-30 Score=189.10 Aligned_cols=165 Identities=20% Similarity=0.256 Sum_probs=139.6
Q ss_pred ccceeEEEEEecCCCcEEEEEEeecCccchHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEEecCCCchHHHHHhc
Q 028681 32 GNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNA 111 (205)
Q Consensus 32 g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~~~~~sl~~~~~~~ 111 (205)
|.+|.||++.+..+++.+++|.+..... ...+...+....|||++++++.+..+...+++|||+++++|.+.+...
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~~----~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~ 79 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSSE----YSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKF 79 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchhh----hhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHHh
Confidence 8899999999999999999999876432 223344445567999999999999999999999999999999998877
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCCCCCCCCCCCCCccCCceec
Q 028681 112 GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL 191 (205)
Q Consensus 112 ~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~ 191 (205)
.++++..+..++.|++.|+.+||+.|++|+||+|+||+++.++. ++++|||.+...... .....++..|+|||.+.
T Consensus 80 ~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~--~~l~df~~~~~~~~~--~~~~~~~~~y~aPE~~~ 155 (237)
T cd05576 80 LNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGH--IQLTYFSRWSEVEDS--CDGEAVENMYCAPEVGG 155 (237)
T ss_pred cCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCC--EEEecccchhccccc--cccCCcCccccCCcccC
Confidence 78999999999999999999999999999999999999998877 999999977544322 22334567799999998
Q ss_pred cCcCCCeeeEEEeC
Q 028681 192 KKEYDGKVMCVYVI 205 (205)
Q Consensus 192 ~~~~~~~~~Dvwsl 205 (205)
+..++.+ +|+|||
T Consensus 156 ~~~~~~~-~Dvwsl 168 (237)
T cd05576 156 ISEETEA-CDWWSL 168 (237)
T ss_pred CCCCCch-hhHHHH
Confidence 8777755 999985
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.5e-30 Score=195.10 Aligned_cols=179 Identities=31% Similarity=0.518 Sum_probs=149.4
Q ss_pred CCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCcc----chHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEE
Q 028681 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK----IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV 95 (205)
Q Consensus 20 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 95 (205)
...|+..+.||+|++|.||.+.+..++..+++|.+..... ...++.+|+.+++.++|+|++++.+++..+...+++
T Consensus 14 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 93 (308)
T cd06634 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 93 (308)
T ss_pred HHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEE
Confidence 3558888999999999999999999999999998864321 224577899999999999999999999999999999
Q ss_pred EEecCCCchHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCCCC
Q 028681 96 MEYASGGELFERIC-NAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 174 (205)
Q Consensus 96 ~~~~~~~sl~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~ 174 (205)
+||+. +++.+.+. ...++++..+..++.|++.|+.+||+.+++|+||+|+||+++.++. ++|+|||++....+.
T Consensus 94 ~e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~--~kl~dfg~~~~~~~~-- 168 (308)
T cd06634 94 MEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGL--VKLGDFGSASIMAPA-- 168 (308)
T ss_pred EEccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCc--EEECCcccceeecCc--
Confidence 99996 46766664 3456899999999999999999999999999999999999988776 999999988654332
Q ss_pred CCCCCCCCCccCCceecc---CcCCCeeeEEEeC
Q 028681 175 PKSTVGTPAYIAPEVLLK---KEYDGKVMCVYVI 205 (205)
Q Consensus 175 ~~~~~~~~~~~aPE~~~~---~~~~~~~~Dvwsl 205 (205)
....++..|+|||.+.+ ..++.+ +|||||
T Consensus 169 -~~~~~~~~y~aPE~~~~~~~~~~~~~-~Di~sl 200 (308)
T cd06634 169 -NXFVGTPYWMAPEVILAMDEGQYDGK-VDVWSL 200 (308)
T ss_pred -ccccCCccccCHHHHhhcccCCCCcc-cchHHH
Confidence 33457889999999853 344444 999996
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-30 Score=197.13 Aligned_cols=176 Identities=22% Similarity=0.319 Sum_probs=142.8
Q ss_pred eeeccc--cceeEEEEEecCCCcEEEEEEeecCccc---hHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEEecCC
Q 028681 27 RDIGSG--NFGVARLMRDKKTEELVAVKYIERGDKI---DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASG 101 (205)
Q Consensus 27 ~~l~~g--~~g~v~~~~~~~~~~~v~iK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~~~~ 101 (205)
..||.| ++|+||.+.+..+++.|++|.+...... .+.+.+|+.+++.++|+||+++++++..++..+++++++.+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 456666 8899999999999999999998754322 35678899999999999999999999999999999999999
Q ss_pred CchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCCCCC----
Q 028681 102 GELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP---- 175 (205)
Q Consensus 102 ~sl~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~~---- 175 (205)
+++.+.+... ..+++..+..++.|++.||+|||+++++|+||+|+||+++.++. +++.||+.+.........
T Consensus 84 ~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 161 (328)
T cd08226 84 GSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGL--VSLSGLSHLYSLVRNGQKAKVV 161 (328)
T ss_pred CCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCc--EEEechHHHhhhhccCcccccc
Confidence 9999888753 34889999999999999999999999999999999999988776 999999765322111111
Q ss_pred ----CCCCCCCCccCCceeccC--cCCCeeeEEEeC
Q 028681 176 ----KSTVGTPAYIAPEVLLKK--EYDGKVMCVYVI 205 (205)
Q Consensus 176 ----~~~~~~~~~~aPE~~~~~--~~~~~~~Dvwsl 205 (205)
....++..|+|||++.+. .++ .++|||||
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~-~~~Diwsl 196 (328)
T cd08226 162 YDFPQFSTSVLPWLSPELLRQDLYGYN-VKSDIYSV 196 (328)
T ss_pred ccccccccCccCccChhhhcCCCCCCC-chhhHHHH
Confidence 111245679999999764 344 45999996
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-30 Score=200.15 Aligned_cols=183 Identities=27% Similarity=0.406 Sum_probs=151.8
Q ss_pred eecCCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCc---cchHHHHHHHHHHHhcCCCCeeEEEEEEEeCCe--
Q 028681 17 MHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTH-- 91 (205)
Q Consensus 17 ~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-- 91 (205)
....++|++.+.||+|++|.||.+.+..++..|++|.+.... ...+.+..|+.+++.+.|+|++++.+++...+.
T Consensus 11 ~~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 90 (343)
T cd07851 11 WEVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLE 90 (343)
T ss_pred ecccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccc
Confidence 344789999999999999999999999999999999886532 223556779999999999999999888776554
Q ss_pred ----EEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccc
Q 028681 92 ----LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 167 (205)
Q Consensus 92 ----~~lv~~~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~ 167 (205)
.+++++++ +++|.+.+.. .++++..+..++.|++.|+.+||+.|++|+||+|+||+++.++. ++|+|||++.
T Consensus 91 ~~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~--~kL~dfg~~~ 166 (343)
T cd07851 91 DFQDVYLVTHLM-GADLNNIVKC-QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCE--LKILDFGLAR 166 (343)
T ss_pred ccccEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCC--EEEccccccc
Confidence 89999998 5688887754 56999999999999999999999999999999999999988777 9999999987
Q ss_pred cccCCCCCCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 168 SSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 168 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
..... .....++..|+|||.+.+....+.++|||||
T Consensus 167 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dvwsl 202 (343)
T cd07851 167 HTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSV 202 (343)
T ss_pred ccccc--ccCCcccccccCHHHHhCCCCCCchHhHHHH
Confidence 55332 2334578889999998764333345999986
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.4e-30 Score=197.30 Aligned_cols=179 Identities=28% Similarity=0.460 Sum_probs=146.7
Q ss_pred CCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCc---cchHHHHHHHHHHHhcCCCCeeEEEEEEEeCC------
Q 028681 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPT------ 90 (205)
Q Consensus 20 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~------ 90 (205)
.++|.+.+.||+|++|.||.+.+..++..|++|.+.... .....+..|+.+++.++|+|++++.+++....
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 578999999999999999999999889999999886532 22345778999999999999999999987543
Q ss_pred eEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeeccccccc
Q 028681 91 HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 170 (205)
Q Consensus 91 ~~~lv~~~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~ 170 (205)
.++++++++.. ++.... ...+++..+..++.|++.|+.+||+.+++|+||+|+||+++.++. ++|+|||++....
T Consensus 94 ~~~lv~e~~~~-~l~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~--~kL~dfg~~~~~~ 168 (342)
T cd07879 94 DFYLVMPYMQT-DLQKIM--GHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCE--LKILDFGLARHAD 168 (342)
T ss_pred eEEEEeccccc-CHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCC--EEEeeCCCCcCCC
Confidence 46899999854 565544 335899999999999999999999999999999999999988877 9999999986543
Q ss_pred CCCCCCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 171 LHSQPKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 171 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
. ......++..|+|||.+.+....+.++|||||
T Consensus 169 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~sl 201 (342)
T cd07879 169 A--EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSV 201 (342)
T ss_pred C--CCCCceeeecccChhhhcCccccCchHHHHHH
Confidence 2 22234567889999998764333345999996
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-30 Score=192.51 Aligned_cols=180 Identities=32% Similarity=0.517 Sum_probs=148.6
Q ss_pred CeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCc------cchHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEE
Q 028681 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD------KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV 95 (205)
Q Consensus 22 ~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 95 (205)
+|++.+.||+|++|.||++.+...+..+++|.++... .....+..|+.+++.++|||++++++.+.+....+++
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 5899999999999999999998776666666655321 1223466788899999999999999999999999999
Q ss_pred EEecCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccC
Q 028681 96 MEYASGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 171 (205)
Q Consensus 96 ~~~~~~~sl~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~ 171 (205)
+||+++++|.+.+.. ...+++..+..++.|++.|+.+||+.|++|+||+|+||+++. +. ++|+|||.+.....
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~~--~~l~d~g~~~~~~~ 157 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NL--LKIGDFGVSRLLMG 157 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-CC--EeecccCceeecCC
Confidence 999999999887753 346899999999999999999999999999999999999974 33 99999998865533
Q ss_pred CC-CCCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 172 HS-QPKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 172 ~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
.. ......++..|+|||.+.+..++.+ +|+|||
T Consensus 158 ~~~~~~~~~~~~~~~~pe~~~~~~~~~~-~Dv~sl 191 (260)
T cd08222 158 SCDLATTFTGTPYYMSPEALKHQGYDSK-SDIWSL 191 (260)
T ss_pred CcccccCCCCCcCccCHHHHccCCCCch-hhHHHH
Confidence 32 2233457889999999988777766 999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-32 Score=193.23 Aligned_cols=184 Identities=27% Similarity=0.382 Sum_probs=152.8
Q ss_pred ecCCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecC--ccchHHHHHHHHHHHhc-CCCCeeEEEEEEEeCCeEEE
Q 028681 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG--DKIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAI 94 (205)
Q Consensus 18 ~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~l 94 (205)
...++.+-+..||.|+||+|++..++.+|+.+|+|++.-. .....++..|.....+- .+|||++++|++..++..|+
T Consensus 61 F~~~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWi 140 (361)
T KOG1006|consen 61 FTSDNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWI 140 (361)
T ss_pred cccchHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceee
Confidence 3455666688999999999999999999999999998653 34456677777655444 68999999999999999999
Q ss_pred EEEecCCCchHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHH-hcCcEeecCCCCCeEecCCCCCcEEEeeeccccc
Q 028681 95 VMEYASGGELFERIC-----NAGRFSEDEARFFFQQLISGVSYCH-SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 168 (205)
Q Consensus 95 v~~~~~~~sl~~~~~-----~~~~~~~~~~~~i~~~i~~~l~~lh-~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~ 168 (205)
.||.|+ .|+..+.. +...+++.-+..|.-..+.||.||- +..|+|||+||+||+++..+. +||+|||++..
T Consensus 141 CMELMd-~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~--vKLCDFGIcGq 217 (361)
T KOG1006|consen 141 CMELMD-ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGD--VKLCDFGICGQ 217 (361)
T ss_pred eHHHHh-hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCC--EeeecccchHh
Confidence 999995 46665553 3456999988999999999999997 569999999999999988888 99999999976
Q ss_pred ccCCCCCCCCCCCCCccCCceeccC--cCCCeeeEEEeC
Q 028681 169 SVLHSQPKSTVGTPAYIAPEVLLKK--EYDGKVMCVYVI 205 (205)
Q Consensus 169 ~~~~~~~~~~~~~~~~~aPE~~~~~--~~~~~~~Dvwsl 205 (205)
...+.......|...|+|||-+.+. .|+.+ ||||||
T Consensus 218 Lv~SiAkT~daGCrpYmAPERi~p~~~gyDiR-SDvWSL 255 (361)
T KOG1006|consen 218 LVDSIAKTVDAGCRPYMAPERIDPSDKGYDIR-SDVWSL 255 (361)
T ss_pred HHHHHHhhhccCCccccChhccCCccCCcchh-hhhhhh
Confidence 6666666677899999999999753 47777 999997
|
|
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.7e-30 Score=194.23 Aligned_cols=170 Identities=28% Similarity=0.459 Sum_probs=140.5
Q ss_pred cceeEEEEEecCCCcEEEEEEeecCc---cchHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEEecCCCchHHHHH
Q 028681 33 NFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERIC 109 (205)
Q Consensus 33 ~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~~~~~sl~~~~~ 109 (205)
+.+.++.+....++..||+|.+.... ...+.+..|+..++.++|+||+++++++..++..++++||+++++|.+.+.
T Consensus 12 ~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~ 91 (314)
T cd08216 12 DLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLK 91 (314)
T ss_pred CCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHHHHH
Confidence 44667777777789999999987652 233578899999999999999999999999999999999999999999886
Q ss_pred hc--CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCCCC--------CCCCC
Q 028681 110 NA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ--------PKSTV 179 (205)
Q Consensus 110 ~~--~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~--------~~~~~ 179 (205)
.. ..+++..+..++.|++.||.|||+.+|+|+||+|+||+++.++. ++|.||+.+........ .....
T Consensus 92 ~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~--~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~ 169 (314)
T cd08216 92 THFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGK--VVLSGLRYSVSMIKHGKRQRVVHDFPKSSV 169 (314)
T ss_pred HhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCc--eEEecCccceeecccccccccccccccccc
Confidence 53 45889999999999999999999999999999999999988777 99999998764432211 22334
Q ss_pred CCCCccCCceeccC--cCCCeeeEEEeC
Q 028681 180 GTPAYIAPEVLLKK--EYDGKVMCVYVI 205 (205)
Q Consensus 180 ~~~~~~aPE~~~~~--~~~~~~~Dvwsl 205 (205)
++..|+|||++... .++.+ +|+|||
T Consensus 170 ~~~~y~aPE~~~~~~~~~~~~-~Diws~ 196 (314)
T cd08216 170 KNLPWLSPEVLQQNLQGYNEK-SDIYSV 196 (314)
T ss_pred ccccccCHHHhcCCCCCCCcc-hhHHHH
Confidence 67789999999764 45545 999985
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-31 Score=198.37 Aligned_cols=186 Identities=31% Similarity=0.494 Sum_probs=159.1
Q ss_pred eecCCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCccch----HHHHHHHHHHHhc-CCCCeeEEEEEEEeCCe
Q 028681 17 MHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID----ENVQREIINHRSL-RHPNIVRFKEVILTPTH 91 (205)
Q Consensus 17 ~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~----~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~ 91 (205)
.....+|..+..||.|+||+|-++..+.+...+|+|+++++-..+ +-...|-++|... +.|.++++.-.|+.-+.
T Consensus 345 ~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDR 424 (683)
T KOG0696|consen 345 RIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDR 424 (683)
T ss_pred ceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhh
Confidence 345688999999999999999999999999999999998764322 2223344444433 46888898888888899
Q ss_pred EEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccc-c
Q 028681 92 LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS-V 170 (205)
Q Consensus 92 ~~lv~~~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~-~ 170 (205)
+|+||||+.+|.|..-+++-+.+.+..+..++.+|+-||.+||++||+.|||+.+||+++.+++ +||+|||.++.. -
T Consensus 425 LyFVMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGH--iKi~DFGmcKEni~ 502 (683)
T KOG0696|consen 425 LYFVMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGH--IKIADFGMCKENIF 502 (683)
T ss_pred eeeEEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCc--eEeeeccccccccc
Confidence 9999999999999998888888999999999999999999999999999999999999999888 999999999753 3
Q ss_pred CCCCCCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 171 LHSQPKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 171 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
....+.+.+||+.|+|||++..++|..+ +|+||+
T Consensus 503 ~~~TTkTFCGTPdYiAPEIi~YqPYgks-vDWWa~ 536 (683)
T KOG0696|consen 503 DGVTTKTFCGTPDYIAPEIIAYQPYGKS-VDWWAF 536 (683)
T ss_pred CCcceeeecCCCcccccceEEecccccc-hhHHHH
Confidence 4455566789999999999999999855 999985
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=204.00 Aligned_cols=184 Identities=22% Similarity=0.295 Sum_probs=164.0
Q ss_pred cCCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCccchHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEEe
Q 028681 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (205)
Q Consensus 19 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~ 98 (205)
...+-++..+||.|-+|.||.+.++.-.--||+|.++.+....++|..|..+++.+.|||+++++|+|..+..+|+|+||
T Consensus 265 eRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEf 344 (1157)
T KOG4278|consen 265 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEF 344 (1157)
T ss_pred cchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcchhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEec
Confidence 34566788999999999999999998888899999999998899999999999999999999999999999999999999
Q ss_pred cCCCchHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCCCCCC
Q 028681 99 ASGGELFERICN--AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK 176 (205)
Q Consensus 99 ~~~~sl~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~~~ 176 (205)
|..|+|.+++.. ...++.-.+..++.||..|++||.+..+|||||...|.|+.++.. ||++|||+++....+.-+.
T Consensus 345 M~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhi--VKvADFGLsRlMtgDTYTA 422 (1157)
T KOG4278|consen 345 MCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHI--VKVADFGLSRLMTGDTYTA 422 (1157)
T ss_pred ccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccce--EEeeccchhhhhcCCceec
Confidence 999999999965 334777788899999999999999999999999999999988877 9999999998765554433
Q ss_pred CC--CCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 177 ST--VGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 177 ~~--~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
.. .-.+-|.|||.+....++.+ +|||+|
T Consensus 423 HAGAKFPIKWTAPEsLAyNtFSiK-SDVWAF 452 (1157)
T KOG4278|consen 423 HAGAKFPIKWTAPESLAYNTFSIK-SDVWAF 452 (1157)
T ss_pred ccCccCcccccCcccccccccccc-hhhHHH
Confidence 32 24577999999999999877 999987
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.6e-31 Score=183.51 Aligned_cols=182 Identities=23% Similarity=0.478 Sum_probs=159.8
Q ss_pred eecCCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCccchHHHHHHHHHHHhcC-CCCeeEEEEEEEeCC--eEE
Q 028681 17 MHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLR-HPNIVRFKEVILTPT--HLA 93 (205)
Q Consensus 17 ~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~--~~~ 93 (205)
+...++|++.+++|+|.++.||.+....++..+++|++++- ....+.+|+.+|..|+ +|||++++++..++. -..
T Consensus 34 wg~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV--kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Sktpa 111 (338)
T KOG0668|consen 34 WGNQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV--KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPS 111 (338)
T ss_pred ccccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH--HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCch
Confidence 34678999999999999999999999999999999999854 3477899999999997 999999999988764 467
Q ss_pred EEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCCC
Q 028681 94 IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 173 (205)
Q Consensus 94 lv~~~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~~ 173 (205)
+++|+..+..+..+... ++...++.++++++.||.|+|++||+|||++|.|++|+.... +++|+|+|+|.++.++.
T Consensus 112 LiFE~v~n~Dfk~ly~t---l~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~r-kLrlIDWGLAEFYHp~~ 187 (338)
T KOG0668|consen 112 LIFEYVNNTDFKQLYPT---LTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELR-KLRLIDWGLAEFYHPGK 187 (338)
T ss_pred hHhhhhccccHHHHhhh---hchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhc-eeeeeecchHhhcCCCc
Confidence 99999988777666644 899999999999999999999999999999999999986544 59999999999999999
Q ss_pred CCCCCCCCCCccCCceeccC-cCCCeeeEEEeC
Q 028681 174 QPKSTVGTPAYIAPEVLLKK-EYDGKVMCVYVI 205 (205)
Q Consensus 174 ~~~~~~~~~~~~aPE~~~~~-~~~~~~~Dvwsl 205 (205)
.-+....+..|-.||.+-.. .|+-+ -|+|||
T Consensus 188 eYnVRVASRyfKGPELLVdy~~YDYS-LD~WS~ 219 (338)
T KOG0668|consen 188 EYNVRVASRYFKGPELLVDYQMYDYS-LDMWSL 219 (338)
T ss_pred eeeeeeehhhcCCchheeechhcccc-HHHHHH
Confidence 88888899999999999754 45545 899996
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-29 Score=190.24 Aligned_cols=181 Identities=29% Similarity=0.360 Sum_probs=146.3
Q ss_pred CCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCccchHHHHHHHHHHHhcCCCCeeEEEEEEEeC----CeEEEE
Q 028681 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTP----THLAIV 95 (205)
Q Consensus 20 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~----~~~~lv 95 (205)
..+-++.+.||+|.||.||++.+. |..||||++...++...-.+.|+..-..|+|+||+.+++.-..+ ..+|+|
T Consensus 210 arqI~L~e~IGkGRyGEVwrG~wr--Ge~VAVKiF~srdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwLv 287 (513)
T KOG2052|consen 210 ARQIVLQEIIGKGRFGEVWRGRWR--GEDVAVKIFSSRDERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWLV 287 (513)
T ss_pred hheeEEEEEecCccccceeecccc--CCceEEEEecccchhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEEe
Confidence 457789999999999999999877 67799999986544333333444444566999999998765433 268999
Q ss_pred EEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhc--------CcEeecCCCCCeEecCCCCCcEEEeeecccc
Q 028681 96 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM--------QVCHRDLKLENTLLDGSPAPRLKICDFGYSK 167 (205)
Q Consensus 96 ~~~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~--------~i~H~di~p~nili~~~~~~~~~l~df~~~~ 167 (205)
++|-+.|||.+++.. ..++......++..++.||++||.. .|.|||||..||++.+++. +-|+|+|+|.
T Consensus 288 TdYHe~GSL~DyL~r-~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~--C~IADLGLAv 364 (513)
T KOG2052|consen 288 TDYHEHGSLYDYLNR-NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGT--CCIADLGLAV 364 (513)
T ss_pred eecccCCcHHHHHhh-ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCc--EEEeeceeeE
Confidence 999999999999977 6799999999999999999999953 5999999999999999998 9999999997
Q ss_pred cccCC-----CCCCCCCCCCCccCCceeccCc----C-CCeeeEEEeC
Q 028681 168 SSVLH-----SQPKSTVGTPAYIAPEVLLKKE----Y-DGKVMCVYVI 205 (205)
Q Consensus 168 ~~~~~-----~~~~~~~~~~~~~aPE~~~~~~----~-~~~~~Dvwsl 205 (205)
..... ...+...||.+|||||++.... + +.+-+|||||
T Consensus 365 ~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYaf 412 (513)
T KOG2052|consen 365 RHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAF 412 (513)
T ss_pred EecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHH
Confidence 65544 3345567999999999997532 1 3456899986
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.3e-30 Score=196.10 Aligned_cols=182 Identities=27% Similarity=0.352 Sum_probs=148.5
Q ss_pred cCCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCccchHHHHHHHHHHHhcCCCCeeEEEEEEEeCC----eEEE
Q 028681 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPT----HLAI 94 (205)
Q Consensus 19 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----~~~l 94 (205)
.....++.+.||+|.||.||++... ++.||||++.........-+.++--+-.+.|+||++++++-.... .+++
T Consensus 208 ~l~pl~l~eli~~Grfg~V~KaqL~--~~~VAVKifp~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywL 285 (534)
T KOG3653|consen 208 ELDPLQLLELIGRGRFGCVWKAQLD--NRLVAVKIFPEQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWL 285 (534)
T ss_pred cCCchhhHHHhhcCccceeehhhcc--CceeEEEecCHHHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeE
Confidence 3677889999999999999999876 478999999865554433444444455778999999988766554 7999
Q ss_pred EEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhc---------CcEeecCCCCCeEecCCCCCcEEEeeecc
Q 028681 95 VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM---------QVCHRDLKLENTLLDGSPAPRLKICDFGY 165 (205)
Q Consensus 95 v~~~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---------~i~H~di~p~nili~~~~~~~~~l~df~~ 165 (205)
|++|.+.|+|.+++.. ..+++.....++..+++||+|||+. .|+|||||..|||+..|.. .-|+|||+
T Consensus 286 Vt~fh~kGsL~dyL~~-ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlT--ccIaDFGL 362 (534)
T KOG3653|consen 286 VTEFHPKGSLCDYLKA-NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLT--CCIADFGL 362 (534)
T ss_pred EeeeccCCcHHHHHHh-ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCc--EEeeccce
Confidence 9999999999999954 4699999999999999999999952 5999999999999998988 99999999
Q ss_pred cccccCCCCCC---CCCCCCCccCCceeccCcC-----CCeeeEEEeC
Q 028681 166 SKSSVLHSQPK---STVGTPAYIAPEVLLKKEY-----DGKVMCVYVI 205 (205)
Q Consensus 166 ~~~~~~~~~~~---~~~~~~~~~aPE~~~~~~~-----~~~~~Dvwsl 205 (205)
|.+..++.... ...||.+|||||++.+..- .-+++||||+
T Consensus 363 Al~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYam 410 (534)
T KOG3653|consen 363 ALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAM 410 (534)
T ss_pred eEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHH
Confidence 98776654432 2469999999999986432 2356888874
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-29 Score=197.15 Aligned_cols=183 Identities=25% Similarity=0.307 Sum_probs=153.2
Q ss_pred cCCCeEEEeeeccccceeEEEEEec----CCCcEEEEEEeecCc--cchHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeE
Q 028681 19 DSDRYELVRDIGSGNFGVARLMRDK----KTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHL 92 (205)
Q Consensus 19 ~~~~y~~~~~l~~g~~g~v~~~~~~----~~~~~v~iK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 92 (205)
....-++.++||.|-||.||.+... .....||+|+++.+. ...+.|..|..+++.+.||||++++|+|.+ ...
T Consensus 387 ~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P~ 465 (974)
T KOG4257|consen 387 RRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QPM 465 (974)
T ss_pred ehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-cce
Confidence 3444556889999999999999864 334679999998742 335789999999999999999999999886 578
Q ss_pred EEEEEecCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccC
Q 028681 93 AIVMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 171 (205)
Q Consensus 93 ~lv~~~~~~~sl~~~~~~~~-~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~ 171 (205)
|+|||.++.|.|.++++.++ .++...+..+++||+.|+.|||+.+++||||..+||++....= |||+|||+++....
T Consensus 466 WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~C--VKLaDFGLSR~~ed 543 (974)
T KOG4257|consen 466 WIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQC--VKLADFGLSRYLED 543 (974)
T ss_pred eEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcce--eeecccchhhhccc
Confidence 99999999999999998755 5888999999999999999999999999999999999987666 99999999986544
Q ss_pred CCCCCC--CCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 172 HSQPKS--TVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 172 ~~~~~~--~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
...... -.-..-|||||.+.-..+++. ||||-|
T Consensus 544 ~~yYkaS~~kLPIKWmaPESINfRrFTtA-SDVWMF 578 (974)
T KOG4257|consen 544 DAYYKASRGKLPIKWMAPESINFRRFTTA-SDVWMF 578 (974)
T ss_pred cchhhccccccceeecCccccchhcccch-hhHHHH
Confidence 332222 234677999999999999866 999965
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-28 Score=211.36 Aligned_cols=172 Identities=23% Similarity=0.273 Sum_probs=142.2
Q ss_pred CCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCccchHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEEecC
Q 028681 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYAS 100 (205)
Q Consensus 21 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~~~ 100 (205)
..++..+.||+|++|.||++....++..||+|.+...... ...|+..+++++||||+++++++.+++..++||||++
T Consensus 690 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~ 766 (968)
T PLN00113 690 SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI---PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIE 766 (968)
T ss_pred hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc---cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCC
Confidence 4466678899999999999999888999999988754322 2345788899999999999999999999999999999
Q ss_pred CCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCCCCCCC
Q 028681 101 GGELFERICNAGRFSEDEARFFFQQLISGVSYCH---SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS 177 (205)
Q Consensus 101 ~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh---~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~~~~ 177 (205)
+++|.+.+.. +++.....++.|++.|++||| +.+++||||+|+||+++.+.. .++. |+...... ....
T Consensus 767 ~g~L~~~l~~---l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~--~~~~-~~~~~~~~---~~~~ 837 (968)
T PLN00113 767 GKNLSEVLRN---LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDE--PHLR-LSLPGLLC---TDTK 837 (968)
T ss_pred CCcHHHHHhc---CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCc--eEEE-eccccccc---cCCC
Confidence 9999999854 889999999999999999999 669999999999999987776 4443 44332221 1122
Q ss_pred CCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 178 TVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 178 ~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
..++..|+|||++.+..++.+ +|||||
T Consensus 838 ~~~t~~y~aPE~~~~~~~~~~-sDv~S~ 864 (968)
T PLN00113 838 CFISSAYVAPETRETKDITEK-SDIYGF 864 (968)
T ss_pred ccccccccCcccccCCCCCcc-cchhhH
Confidence 367899999999998888766 999996
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.7e-32 Score=190.23 Aligned_cols=193 Identities=28% Similarity=0.410 Sum_probs=158.7
Q ss_pred CCCcccCceecCCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecC---ccchHHHHHHHHHHHhcCCCCeeEEEEE
Q 028681 9 GPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG---DKIDENVQREIINHRSLRHPNIVRFKEV 85 (205)
Q Consensus 9 ~~~~~~~~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~ 85 (205)
...+..|++...+.|+.+.+||+|.||.||+++...+++.|++|.+--. .-.......|+.+|..+.|+|++.+++.
T Consensus 5 ~~s~~~P~~~~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEi 84 (376)
T KOG0669|consen 5 KDSMYEPFCDEVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 84 (376)
T ss_pred hhcccCCceecchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHH
Confidence 3456678899999999999999999999999999999999998875331 2224667889999999999999998887
Q ss_pred EEeC--------CeEEEEEEecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCC
Q 028681 86 ILTP--------THLAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAP 156 (205)
Q Consensus 86 ~~~~--------~~~~lv~~~~~~~sl~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~ 156 (205)
|... ..+++||++|.. .|..++... ..++..++..++.++..||.|+|+..|+|||+++.|++|+.++.
T Consensus 85 c~tk~Tp~~r~r~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgi- 162 (376)
T KOG0669|consen 85 CRTKATPTNRDRATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGI- 162 (376)
T ss_pred HhhccCCcccccceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCce-
Confidence 7542 248999999965 677777543 56999999999999999999999999999999999999999888
Q ss_pred cEEEeeecccccccCCCCC-----CCCCCCCCccCCceeccCcCCCeeeEEEe
Q 028681 157 RLKICDFGYSKSSVLHSQP-----KSTVGTPAYIAPEVLLKKEYDGKVMCVYV 204 (205)
Q Consensus 157 ~~~l~df~~~~~~~~~~~~-----~~~~~~~~~~aPE~~~~~~~~~~~~Dvws 204 (205)
++|+|||+++........ ....-|+.|.+||.+.+..-..++.|||.
T Consensus 163 -lklADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWg 214 (376)
T KOG0669|consen 163 -LKLADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWG 214 (376)
T ss_pred -EEeeccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHh
Confidence 999999999655433221 12235889999999998776666799995
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.1e-28 Score=176.51 Aligned_cols=180 Identities=42% Similarity=0.677 Sum_probs=156.8
Q ss_pred eEEEeeeccccceeEEEEEecCCCcEEEEEEeecCcc--chHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEEecC
Q 028681 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYAS 100 (205)
Q Consensus 23 y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~~~ 100 (205)
|.+.+.|++|++|.+|.+....++..+++|.+..... ..+.+..|+..++.++|+|++++++.+......++++++++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 5788999999999999999998889999999987544 35678889999999999999999999999899999999999
Q ss_pred CCchHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCCC--CCCC
Q 028681 101 GGELFERICNAGR-FSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS--QPKS 177 (205)
Q Consensus 101 ~~sl~~~~~~~~~-~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~~--~~~~ 177 (205)
+++|.+.+..... +++..+..++.+++.++.+||+++++|+|++|+||+++.++. ++|+|||.+....... ....
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~--~~l~d~g~~~~~~~~~~~~~~~ 158 (225)
T smart00221 81 GGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGL--VKLADFGLARFIHRDLAALLKT 158 (225)
T ss_pred CCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCC--EEEeeCceeeEecCcccccccc
Confidence 9899999977666 899999999999999999999999999999999999988766 9999999887665443 3344
Q ss_pred CCCCCCccCCcee-ccCcCCCeeeEEEeC
Q 028681 178 TVGTPAYIAPEVL-LKKEYDGKVMCVYVI 205 (205)
Q Consensus 178 ~~~~~~~~aPE~~-~~~~~~~~~~Dvwsl 205 (205)
..++..|++||.+ ....++. ++|+|||
T Consensus 159 ~~~~~~~~~pe~~~~~~~~~~-~~Dv~~l 186 (225)
T smart00221 159 VKGTPFYLAPEVLLGGKGYGE-AVDIWSL 186 (225)
T ss_pred eeccCCcCCHhHhcCCCCCCc-hhhHHHH
Confidence 5678889999999 5566665 5999985
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.5e-29 Score=195.81 Aligned_cols=178 Identities=33% Similarity=0.469 Sum_probs=151.2
Q ss_pred cCCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCccchHHHHHHHHH-HHhcCCCCeeEEEEEEEeCCeEEEEEE
Q 028681 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIIN-HRSLRHPNIVRFKEVILTPTHLAIVME 97 (205)
Q Consensus 19 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~-l~~l~h~~i~~~~~~~~~~~~~~lv~~ 97 (205)
....|++...+|.|+|+.+..+.+..++...++|++.+... ...+|+.+ +..-+|+|++++.+++.++...|+|||
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~---~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e 396 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRAD---DNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVME 396 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheecccccc---ccccccchhhhhcCCCcceeecceecCCceeeeeeh
Confidence 36789999999999999999999999999999999987622 23344433 345579999999999999999999999
Q ss_pred ecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEec-CCCCCcEEEeeecccccccCCCCCC
Q 028681 98 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLD-GSPAPRLKICDFGYSKSSVLHSQPK 176 (205)
Q Consensus 98 ~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~-~~~~~~~~l~df~~~~~~~~~~~~~ 176 (205)
.+.++-+.+.+...+.+. .++..|+.+|+.|+.|||++|++|||++|+|||+. ..++ ++|+|||.++..... ..
T Consensus 397 ~l~g~ell~ri~~~~~~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~--lrltyFG~a~~~~~~--~~ 471 (612)
T KOG0603|consen 397 LLDGGELLRRIRSKPEFC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGH--LRLTYFGFWSELERS--CD 471 (612)
T ss_pred hccccHHHHHHHhcchhH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCc--EEEEEechhhhCchh--hc
Confidence 999988888886665555 78888999999999999999999999999999994 5555 999999998765554 44
Q ss_pred CCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 177 STVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 177 ~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
+.+-|..|.|||++....|+.. +|||||
T Consensus 472 tp~~t~~y~APEvl~~~~yt~a-cD~WSL 499 (612)
T KOG0603|consen 472 TPALTLQYVAPEVLAIQEYTEA-CDWWSL 499 (612)
T ss_pred ccchhhcccChhhhccCCCCcc-hhhHHH
Confidence 5667899999999998889866 999997
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.6e-29 Score=190.99 Aligned_cols=183 Identities=26% Similarity=0.341 Sum_probs=159.0
Q ss_pred cCCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCccchHHHHHHHHHHHhcC------CCCeeEEEEEEEeCCeE
Q 028681 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLR------HPNIVRFKEVILTPTHL 92 (205)
Q Consensus 19 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~------h~~i~~~~~~~~~~~~~ 92 (205)
..++|.+....|+|-|++|..+.+...+..||||++.+.+.....=..|+++|++|. -.|+++++..|...+++
T Consensus 430 LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknHL 509 (752)
T KOG0670|consen 430 LDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNHL 509 (752)
T ss_pred hcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhccee
Confidence 357899999999999999999999999999999999998888888889999999995 35789999999999999
Q ss_pred EEEEEecCCCchHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccc
Q 028681 93 AIVMEYASGGELFERICNAG---RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 169 (205)
Q Consensus 93 ~lv~~~~~~~sl~~~~~~~~---~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~ 169 (205)
|+|||.+. .+|.+.+++-+ .+....++.+++|++.||..|-++|++|+||+|+|||++++.+ .+||||||.|...
T Consensus 510 ClVFE~Ls-lNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~-iLKLCDfGSA~~~ 587 (752)
T KOG0670|consen 510 CLVFEPLS-LNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKN-ILKLCDFGSASFA 587 (752)
T ss_pred EEEehhhh-chHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcc-eeeeccCcccccc
Confidence 99999884 58999997633 4888999999999999999999999999999999999987665 4999999998765
Q ss_pred cCCCCCCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 170 VLHSQPKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 170 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
..+..+ ...-+..|.|||++.+-+|+.. .|+||.
T Consensus 588 ~eneit-PYLVSRFYRaPEIiLG~~yd~~-iD~WSv 621 (752)
T KOG0670|consen 588 SENEIT-PYLVSRFYRAPEIILGLPYDYP-IDTWSV 621 (752)
T ss_pred cccccc-HHHHHHhccCcceeecCcccCC-ccceee
Confidence 544433 3344677999999999999877 999994
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.5e-28 Score=183.75 Aligned_cols=167 Identities=17% Similarity=0.129 Sum_probs=129.4
Q ss_pred CceecCCCeEEEeeeccccceeEEEEEecC-CCcEEEEEEeecC------ccchHHHHHHHHHHHhcCCCCeeE-EEEEE
Q 028681 15 PIMHDSDRYELVRDIGSGNFGVARLMRDKK-TEELVAVKYIERG------DKIDENVQREIINHRSLRHPNIVR-FKEVI 86 (205)
Q Consensus 15 ~~~~~~~~y~~~~~l~~g~~g~v~~~~~~~-~~~~v~iK~~~~~------~~~~~~~~~e~~~l~~l~h~~i~~-~~~~~ 86 (205)
+.....++|++.+.||+|+||+||++.+.. ++..+++|..... +...+.+..|+.+++.++|+|+++ +++
T Consensus 12 ~~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~-- 89 (365)
T PRK09188 12 QIPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA-- 89 (365)
T ss_pred ccccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE--
Confidence 445567889999999999999999998876 6777899986532 112456899999999999999885 443
Q ss_pred EeCCeEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecC-CCCCeEecCCCCCcEEEeeecc
Q 028681 87 LTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDL-KLENTLLDGSPAPRLKICDFGY 165 (205)
Q Consensus 87 ~~~~~~~lv~~~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di-~p~nili~~~~~~~~~l~df~~ 165 (205)
.+..+++|||+++++|.. ... .. ...++.+++.+|.+||+.||+|||| ||+||+++.++. ++|+|||+
T Consensus 90 --~~~~~LVmE~~~G~~L~~-~~~---~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~--ikLiDFGl 158 (365)
T PRK09188 90 --TGKDGLVRGWTEGVPLHL-ARP---HG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGE--AAVIDFQL 158 (365)
T ss_pred --cCCcEEEEEccCCCCHHH-hCc---cc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCC--EEEEECcc
Confidence 245799999999988863 211 11 2467899999999999999999999 999999987766 99999999
Q ss_pred cccccCCCCC---------CCCCCCCCccCCceeccCc
Q 028681 166 SKSSVLHSQP---------KSTVGTPAYIAPEVLLKKE 194 (205)
Q Consensus 166 ~~~~~~~~~~---------~~~~~~~~~~aPE~~~~~~ 194 (205)
|+........ ....+++.|+|||.+....
T Consensus 159 A~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~ 196 (365)
T PRK09188 159 ASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPRE 196 (365)
T ss_pred ceecccCcchhhhhhhhhhhhhhccCccCCcccCChhh
Confidence 9765433211 1234678899999998543
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.9e-31 Score=188.40 Aligned_cols=182 Identities=27% Similarity=0.427 Sum_probs=149.5
Q ss_pred CCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCc---cchHHHHHHHHHHHhcCCCCeeEEEEEEEeCC-----eE
Q 028681 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPT-----HL 92 (205)
Q Consensus 21 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~ 92 (205)
.+.+-.+.||-|+||.||.+++..+|+.|++|.+.+-. ...+.+..|+.+|..++|.|++...++..-.. ..
T Consensus 53 ~Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEi 132 (449)
T KOG0664|consen 53 QDIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQEL 132 (449)
T ss_pred ccCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHH
Confidence 34455688999999999999999999999999887532 23467889999999999999999988776543 35
Q ss_pred EEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCC
Q 028681 93 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 172 (205)
Q Consensus 93 ~lv~~~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~ 172 (205)
|+++|.+.. .|-.++.....++...++-+++||+.||.|||+.+|.||||||.|.+++.|-. +||+|||+++.....
T Consensus 133 YV~TELmQS-DLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCv--LKICDFGLARvee~d 209 (449)
T KOG0664|consen 133 YVLTELMQS-DLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCI--LKICDFGLARTWDQR 209 (449)
T ss_pred HHHHHHHHh-hhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCce--EEecccccccccchh
Confidence 677777743 56666666778999999999999999999999999999999999999976665 999999999876655
Q ss_pred CCCCC--CCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 173 SQPKS--TVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 173 ~~~~~--~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
..... ..-|..|.|||.+.+....+...||||.
T Consensus 210 ~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSV 244 (449)
T KOG0664|consen 210 DRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSV 244 (449)
T ss_pred hhhhhHHHHHHHHhccHHHhhcchhhcCccceehh
Confidence 44333 2467889999999987766677999984
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.1e-28 Score=177.58 Aligned_cols=170 Identities=45% Similarity=0.699 Sum_probs=151.0
Q ss_pred cceeEEEEEecCCCcEEEEEEeecCccc--hHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEEecCCCchHHHHHh
Q 028681 33 NFGVARLMRDKKTEELVAVKYIERGDKI--DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICN 110 (205)
Q Consensus 33 ~~g~v~~~~~~~~~~~v~iK~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~~~~~sl~~~~~~ 110 (205)
++|.||.+....++..+++|.+...... .+.+..|+..++.++|+|++++.+.+......++++|++++++|.+.+..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 5789999999988999999998765433 47889999999999999999999999999999999999999899999877
Q ss_pred cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCCCCCCCCCCCCCccCCcee
Q 028681 111 AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL 190 (205)
Q Consensus 111 ~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~ 190 (205)
...++...+..++.+++.++.+||+.+++|+||+|+||+++.++. ++|+|||.+.............++..|++||.+
T Consensus 81 ~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~--~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pE~~ 158 (244)
T smart00220 81 RGRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGH--VKLADFGLARQLDPGGLLTTFVGTPEYMAPEVL 158 (244)
T ss_pred ccCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCc--EEEccccceeeeccccccccccCCcCCCCHHHH
Confidence 666899999999999999999999999999999999999988766 999999999876665555566788999999999
Q ss_pred ccCcCCCeeeEEEeC
Q 028681 191 LKKEYDGKVMCVYVI 205 (205)
Q Consensus 191 ~~~~~~~~~~Dvwsl 205 (205)
.+..++. ++|||||
T Consensus 159 ~~~~~~~-~~Di~sl 172 (244)
T smart00220 159 LGKGYGK-AVDVWSL 172 (244)
T ss_pred ccCCCCc-hhhHHHH
Confidence 8877776 4999985
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.2e-27 Score=187.68 Aligned_cols=172 Identities=21% Similarity=0.279 Sum_probs=128.4
Q ss_pred cCCCeEEEeeeccccceeEEEEEec----------------CCCcEEEEEEeecCccc-h--------------HHHHHH
Q 028681 19 DSDRYELVRDIGSGNFGVARLMRDK----------------KTEELVAVKYIERGDKI-D--------------ENVQRE 67 (205)
Q Consensus 19 ~~~~y~~~~~l~~g~~g~v~~~~~~----------------~~~~~v~iK~~~~~~~~-~--------------~~~~~e 67 (205)
..++|++.++||+|+||.||++... ..++.|++|.+...... . +....|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 5789999999999999999998642 34567999998653211 1 122335
Q ss_pred HHHHHhcCCCCe-----eEEEEEEEe--------CCeEEEEEEecCCCchHHHHHhcC----------------------
Q 028681 68 IINHRSLRHPNI-----VRFKEVILT--------PTHLAIVMEYASGGELFERICNAG---------------------- 112 (205)
Q Consensus 68 ~~~l~~l~h~~i-----~~~~~~~~~--------~~~~~lv~~~~~~~sl~~~~~~~~---------------------- 112 (205)
+.++.+++|.++ +++.++|.. .+..++|+||+++++|.+.+....
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 666667766554 556666653 356899999999999988875321
Q ss_pred --CCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCCCCCCCC--CCCCCccCCc
Q 028681 113 --RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPE 188 (205)
Q Consensus 113 --~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~~~~~--~~~~~~~aPE 188 (205)
.+++..++.++.|++.++.|||+.+++|+||+|+||+++.++. ++|+|||++............ .+++.|+|||
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~--~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE 380 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQ--VKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPE 380 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCc--EEEEeCcCccccccCCccCccccCCCcceeChh
Confidence 1355678889999999999999999999999999999988776 999999998654433222222 3478999999
Q ss_pred eecc
Q 028681 189 VLLK 192 (205)
Q Consensus 189 ~~~~ 192 (205)
.+..
T Consensus 381 ~l~~ 384 (507)
T PLN03224 381 ELVM 384 (507)
T ss_pred hhcC
Confidence 9864
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-29 Score=199.39 Aligned_cols=185 Identities=35% Similarity=0.531 Sum_probs=164.2
Q ss_pred ecCCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCccc-hHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEE
Q 028681 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI-DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (205)
Q Consensus 18 ~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 96 (205)
...++|+++..+|.|.+|.||+++++.++...++|.++..... ..-++.|+.+++..+|+||+.++|.+......|+.|
T Consensus 12 nP~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicM 91 (829)
T KOG0576|consen 12 NPQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICM 91 (829)
T ss_pred CCccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEE
Confidence 3468999999999999999999999999999999999876543 355778899999999999999999999999999999
Q ss_pred EecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCC-CCC
Q 028681 97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQP 175 (205)
Q Consensus 97 ~~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~-~~~ 175 (205)
||+.+++|.+...-.+++++.++...++..+++++|||..|-+||||+=.||++++.+. +++.|||.+..+... ...
T Consensus 92 EycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gD--vklaDfgvsaqitati~Kr 169 (829)
T KOG0576|consen 92 EYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGD--VKLADFGVSAQITATIAKR 169 (829)
T ss_pred EecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCc--eeecccCchhhhhhhhhhh
Confidence 99999999999999999999999999999999999999999999999999999998888 999999987655443 444
Q ss_pred CCCCCCCCccCCceec---cCcCCCeeeEEEeC
Q 028681 176 KSTVGTPAYIAPEVLL---KKEYDGKVMCVYVI 205 (205)
Q Consensus 176 ~~~~~~~~~~aPE~~~---~~~~~~~~~Dvwsl 205 (205)
....||+.|||||+-. +..|.. .+|||++
T Consensus 170 ksfiGtpywmapEvaaverkggynq-lcdiwa~ 201 (829)
T KOG0576|consen 170 KSFIGTPYWMAPEVAAVERKGGYNQ-LCDIWAL 201 (829)
T ss_pred hcccCCccccchhHHHHHhcccccc-ccccccc
Confidence 5567999999999985 445554 4999985
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.7e-28 Score=184.60 Aligned_cols=186 Identities=29% Similarity=0.388 Sum_probs=153.3
Q ss_pred CCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCccchHH--------HHHHHHHHHhcCCCCeeEEEEEEEeC-C
Q 028681 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDEN--------VQREIINHRSLRHPNIVRFKEVILTP-T 90 (205)
Q Consensus 20 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~--------~~~e~~~l~~l~h~~i~~~~~~~~~~-~ 90 (205)
-++|-++..||.|+|+.||.+-+....+-||+|+-...+.+.++ .-.|..+.+.|.||.||++|++|.-+ .
T Consensus 462 n~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtd 541 (775)
T KOG1151|consen 462 NDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTD 541 (775)
T ss_pred HHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccc
Confidence 36788899999999999999999988999999987665555433 44688999999999999999999854 6
Q ss_pred eEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhc--CcEeecCCCCCeEecCCCC-CcEEEeeecccc
Q 028681 91 HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM--QVCHRDLKLENTLLDGSPA-PRLKICDFGYSK 167 (205)
Q Consensus 91 ~~~lv~~~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~--~i~H~di~p~nili~~~~~-~~~~l~df~~~~ 167 (205)
.+|-|+||+++..|.=+++.++.+++++++.|+.||+.||.||.+. .|||=||+|.||++..+.. +.+||+|||+++
T Consensus 542 sFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFGLSK 621 (775)
T KOG1151|consen 542 SFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFGLSK 621 (775)
T ss_pred cceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecchhh
Confidence 7899999999999988888888999999999999999999999964 7999999999999865433 359999999998
Q ss_pred cccCCCCC--------CCCCCCCCccCCceeccC--cC-CCeeeEEEeC
Q 028681 168 SSVLHSQP--------KSTVGTPAYIAPEVLLKK--EY-DGKVMCVYVI 205 (205)
Q Consensus 168 ~~~~~~~~--------~~~~~~~~~~aPE~~~~~--~~-~~~~~Dvwsl 205 (205)
+....... ..-.||+.|++||.+--. +. -+.+.||||+
T Consensus 622 IMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSv 670 (775)
T KOG1151|consen 622 IMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSV 670 (775)
T ss_pred hccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEee
Confidence 75433222 233589999999999743 21 2335999995
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-27 Score=193.78 Aligned_cols=169 Identities=21% Similarity=0.247 Sum_probs=120.4
Q ss_pred ecCCCeEEEeeeccccceeEEEEEecCC----CcEEEEEEeecCccchHHHHHHHHHHHhcCCCCeeEEEEE------EE
Q 028681 18 HDSDRYELVRDIGSGNFGVARLMRDKKT----EELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEV------IL 87 (205)
Q Consensus 18 ~~~~~y~~~~~l~~g~~g~v~~~~~~~~----~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~------~~ 87 (205)
...++|++.+.||+|+||.||++.+..+ +..|++|.+...... +....+ .++...+.++..+... ..
T Consensus 129 ~~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~-e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~ 205 (566)
T PLN03225 129 FKKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV-EIWMNE--RVRRACPNSCADFVYGFLEPVSSK 205 (566)
T ss_pred CccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh-HHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence 3568999999999999999999999988 899999987643221 111111 1111111111111111 24
Q ss_pred eCCeEEEEEEecCCCchHHHHHhcCC--------------------CCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCC
Q 028681 88 TPTHLAIVMEYASGGELFERICNAGR--------------------FSEDEARFFFQQLISGVSYCHSMQVCHRDLKLEN 147 (205)
Q Consensus 88 ~~~~~~lv~~~~~~~sl~~~~~~~~~--------------------~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~n 147 (205)
.+...+++++|+++++|.+.+..... .....+..++.|++.||.|||+.+|+||||||+|
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLKP~N 285 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQN 285 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCCHHH
Confidence 45678999999999999888864321 1233466799999999999999999999999999
Q ss_pred eEecCC-CCCcEEEeeecccccccCC--CCCCCCCCCCCccCCceec
Q 028681 148 TLLDGS-PAPRLKICDFGYSKSSVLH--SQPKSTVGTPAYIAPEVLL 191 (205)
Q Consensus 148 ili~~~-~~~~~~l~df~~~~~~~~~--~~~~~~~~~~~~~aPE~~~ 191 (205)
|+++.+ +. +||+|||+++..... .......+++.|+|||.+.
T Consensus 286 ILl~~~~~~--~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~ 330 (566)
T PLN03225 286 IIFSEGSGS--FKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYI 330 (566)
T ss_pred EEEeCCCCc--EEEEeCCCccccccccccCCcccccCCCccChHHhh
Confidence 999853 44 999999999754322 2234456889999999764
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.9e-28 Score=192.62 Aligned_cols=182 Identities=25% Similarity=0.373 Sum_probs=155.2
Q ss_pred CCCeEEEeeeccccceeEEEEEecC---CCcEEEEEEeecCccc--hHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEE
Q 028681 20 SDRYELVRDIGSGNFGVARLMRDKK---TEELVAVKYIERGDKI--DENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 94 (205)
Q Consensus 20 ~~~y~~~~~l~~g~~g~v~~~~~~~---~~~~v~iK~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 94 (205)
-.+.++.+.||+|.||.|+++.+.. +...||||.+..+... .+.|..|+..+.+|+|+|++++||+..+ ....+
T Consensus 109 ee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mM 187 (1039)
T KOG0199|consen 109 EEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMM 187 (1039)
T ss_pred HHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhH
Confidence 3567788999999999999999874 3357999999876544 4789999999999999999999999887 67889
Q ss_pred EEEecCCCchHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCC
Q 028681 95 VMEYASGGELFERICN--AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 172 (205)
Q Consensus 95 v~~~~~~~sl~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~ 172 (205)
|+|.++.|||.+.+.+ ...|-...+..++.||+.|+.||..+++||||+-..|+++..-.. |||+|||+.+..+.+
T Consensus 188 V~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprt--VKI~DFGLmRaLg~n 265 (1039)
T KOG0199|consen 188 VFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRT--VKICDFGLMRALGEN 265 (1039)
T ss_pred HhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccce--eeeecccceeccCCC
Confidence 9999999999999977 335888899999999999999999999999999999999976555 999999999876655
Q ss_pred CCC----CCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 173 SQP----KSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 173 ~~~----~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
... ....-.+.|.|||.+....++.+ +|||++
T Consensus 266 ed~Yvm~p~rkvPfAWCaPEsLrh~kFSha-SDvWmy 301 (1039)
T KOG0199|consen 266 EDMYVMAPQRKVPFAWCAPESLRHRKFSHA-SDVWMY 301 (1039)
T ss_pred CcceEecCCCcCcccccCHhHhcccccccc-chhhhh
Confidence 432 22235678999999999999866 999986
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.8e-27 Score=193.34 Aligned_cols=188 Identities=24% Similarity=0.367 Sum_probs=158.1
Q ss_pred CceecCCCeEEEeeeccccceeEEEEEecC-------CCcEEEEEEeecCccc--hHHHHHHHHHHHhc-CCCCeeEEEE
Q 028681 15 PIMHDSDRYELVRDIGSGNFGVARLMRDKK-------TEELVAVKYIERGDKI--DENVQREIINHRSL-RHPNIVRFKE 84 (205)
Q Consensus 15 ~~~~~~~~y~~~~~l~~g~~g~v~~~~~~~-------~~~~v~iK~~~~~~~~--~~~~~~e~~~l~~l-~h~~i~~~~~ 84 (205)
.+..+.++.++.+.||+|.||.|+.+.... ....||+|.++..... .+.+..|+.+++.+ .|+|++.+.|
T Consensus 290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG 369 (609)
T KOG0200|consen 290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLG 369 (609)
T ss_pred ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhhee
Confidence 566677778888999999999999998542 1457999988765433 46788999999988 5999999999
Q ss_pred EEEeCCeEEEEEEecCCCchHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCe
Q 028681 85 VILTPTHLAIVMEYASGGELFERICNAG----------------RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENT 148 (205)
Q Consensus 85 ~~~~~~~~~lv~~~~~~~sl~~~~~~~~----------------~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~ni 148 (205)
++...+..+++.||+..|+|.+++...+ .++...+..+++||+.|++||++..++|||+-.+||
T Consensus 370 ~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNV 449 (609)
T KOG0200|consen 370 ACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNV 449 (609)
T ss_pred eeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhE
Confidence 9999999999999999999999997765 388899999999999999999999999999999999
Q ss_pred EecCCCCCcEEEeeecccccccCCCCCC--CCC--CCCCccCCceeccCcCCCeeeEEEeC
Q 028681 149 LLDGSPAPRLKICDFGYSKSSVLHSQPK--STV--GTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 149 li~~~~~~~~~l~df~~~~~~~~~~~~~--~~~--~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
++..+.. +||+|||+|+......... ... -...|||||.+....++.+ ||||||
T Consensus 450 Li~~~~~--~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~k-SDVWSf 507 (609)
T KOG0200|consen 450 LITKNKV--IKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSK-SDVWSF 507 (609)
T ss_pred EecCCCE--EEEccccceeccCCCCceEecCCCCccceeecCHHHhccCccccc-chhhHH
Confidence 9998876 9999999998544332221 122 3456999999999888877 899996
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.7e-26 Score=165.32 Aligned_cols=174 Identities=44% Similarity=0.656 Sum_probs=149.9
Q ss_pred eccccceeEEEEEecCCCcEEEEEEeecCccc--hHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEEecCCCchHH
Q 028681 29 IGSGNFGVARLMRDKKTEELVAVKYIERGDKI--DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFE 106 (205)
Q Consensus 29 l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~~~~~sl~~ 106 (205)
||+|.+|.+|.+....++..+++|.+...... .+.+..|+..++.++|++++++++++......+++++++++.+|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 68899999999999988999999998876542 4678899999999999999999999999999999999999899999
Q ss_pred HHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecC-CCCCcEEEeeecccccccCCC-CCCCCCCCCC
Q 028681 107 RICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVLHS-QPKSTVGTPA 183 (205)
Q Consensus 107 ~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~-~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~ 183 (205)
.+... ..++...+..++.+++.++.+||+.|++|+||+|.||+++. ++. ++|+||+.+....... ......+...
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~--~~l~d~~~~~~~~~~~~~~~~~~~~~~ 158 (215)
T cd00180 81 LLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGK--VKLADFGLSKLLTSDKSLLKTIVGTPA 158 (215)
T ss_pred HHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCc--EEEecCCceEEccCCcchhhcccCCCC
Confidence 98765 46899999999999999999999999999999999999987 555 9999999887554432 2333457888
Q ss_pred ccCCceeccC-cCCCeeeEEEeC
Q 028681 184 YIAPEVLLKK-EYDGKVMCVYVI 205 (205)
Q Consensus 184 ~~aPE~~~~~-~~~~~~~Dvwsl 205 (205)
|.+||.+... ..+ ..+|+|+|
T Consensus 159 ~~~pe~~~~~~~~~-~~~D~~~l 180 (215)
T cd00180 159 YMAPEVLLGKGYYS-EKSDIWSL 180 (215)
T ss_pred ccChhHhcccCCCC-chhhhHHH
Confidence 9999999876 554 44999985
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.7e-28 Score=194.23 Aligned_cols=182 Identities=23% Similarity=0.299 Sum_probs=155.0
Q ss_pred CCCeEEEeeeccccceeEEEEEecCCC----cEEEEEEeecCc--cchHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEE
Q 028681 20 SDRYELVRDIGSGNFGVARLMRDKKTE----ELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLA 93 (205)
Q Consensus 20 ~~~y~~~~~l~~g~~g~v~~~~~~~~~----~~v~iK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 93 (205)
-...+..++||+|+||+||++.+...+ .+|++|++.... ....++.+|+..+.++.|||++++++++.... ..
T Consensus 695 Etelkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~q 773 (1177)
T KOG1025|consen 695 ETELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQ 773 (1177)
T ss_pred hhhhhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HH
Confidence 344556889999999999999987554 578888876543 34688999999999999999999999998765 77
Q ss_pred EEEEecCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCC
Q 028681 94 IVMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 172 (205)
Q Consensus 94 lv~~~~~~~sl~~~~~~~~-~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~ 172 (205)
+|++|++.|+|.+..+.++ ++..+....|..||++|+.|||+++++||||-.+|+|+..-.. +|+.|||+++...++
T Consensus 774 lvtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~h--vkitdfgla~ll~~d 851 (1177)
T KOG1025|consen 774 LVTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNH--VKITDFGLAKLLAPD 851 (1177)
T ss_pred HHHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCe--EEEEecchhhccCcc
Confidence 8999999999999997644 6999999999999999999999999999999999999987666 999999999887766
Q ss_pred CCCCCCC---CCCCccCCceeccCcCCCeeeEEEeC
Q 028681 173 SQPKSTV---GTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 173 ~~~~~~~---~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
...-... -.+-|+|-|.+....++.. +|||||
T Consensus 852 ~~ey~~~~gK~pikwmale~i~~~~~thq-SDVWsf 886 (1177)
T KOG1025|consen 852 EKEYSAPGGKVPIKWMALESIRIRKYTHQ-SDVWSF 886 (1177)
T ss_pred cccccccccccCcHHHHHHHhhccCCCch-hhhhhh
Confidence 5443332 3567999999999999755 999996
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.1e-26 Score=174.00 Aligned_cols=184 Identities=24% Similarity=0.387 Sum_probs=154.0
Q ss_pred ceecCCCeEEEeeeccccceeEEEEEecC---CCcEEEEEEeecCccchHHHHHHHHHHHhc-CCCCeeEEEEEEEeCCe
Q 028681 16 IMHDSDRYELVRDIGSGNFGVARLMRDKK---TEELVAVKYIERGDKIDENVQREIINHRSL-RHPNIVRFKEVILTPTH 91 (205)
Q Consensus 16 ~~~~~~~y~~~~~l~~g~~g~v~~~~~~~---~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~ 91 (205)
+....+.|.+..+||.|+|++||.+.+.. .++.|++|.+..- .....+.+|+++|..+ .+.|++++.+.+..++.
T Consensus 31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~t-s~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~ 109 (418)
T KOG1167|consen 31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRT-SSPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQ 109 (418)
T ss_pred hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccc-cCchHHHHHHHHHHHhccchhhhcchhhhccCCe
Confidence 44457889999999999999999999887 7889999988753 2346688999999988 48999999999999999
Q ss_pred EEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeeccccc---
Q 028681 92 LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS--- 168 (205)
Q Consensus 92 ~~lv~~~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~--- 168 (205)
..+|++|++.....++... ++...++.+++.++.||.++|..||+||||||+|++++.... +-.|.|||+|..
T Consensus 110 v~ivlp~~~H~~f~~l~~~---l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~-rg~LvDFgLA~~~d~ 185 (418)
T KOG1167|consen 110 VAIVLPYFEHDRFRDLYRS---LSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQ-RGVLVDFGLAQRYDG 185 (418)
T ss_pred eEEEecccCccCHHHHHhc---CCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccC-CceEEechhHHHHHh
Confidence 9999999999888888865 789999999999999999999999999999999999986544 478999999851
Q ss_pred --------------ccC-----------------CC-----------CCCCCCCCCCccCCceeccCcCCCeeeEEEe
Q 028681 169 --------------SVL-----------------HS-----------QPKSTVGTPAYIAPEVLLKKEYDGKVMCVYV 204 (205)
Q Consensus 169 --------------~~~-----------------~~-----------~~~~~~~~~~~~aPE~~~~~~~~~~~~Dvws 204 (205)
..+ .. ......||++|.|||++.+.+-.+.++||||
T Consensus 186 ~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws 263 (418)
T KOG1167|consen 186 YQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWS 263 (418)
T ss_pred hhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceee
Confidence 011 00 0011238999999999998887666799998
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.4e-27 Score=167.73 Aligned_cols=190 Identities=25% Similarity=0.390 Sum_probs=150.7
Q ss_pred ccCceecCCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCccchHHHHHHHHHHHhc-CCCCeeEEEEE-EEeCC
Q 028681 13 DMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSL-RHPNIVRFKEV-ILTPT 90 (205)
Q Consensus 13 ~~~~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~-~~~~~ 90 (205)
+++-..--+.|.+.+.||+|.||.+-++.+++++..+++|.+........+|..|..---.| .|.||+.-|++ |+..+
T Consensus 16 el~kv~l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d 95 (378)
T KOG1345|consen 16 ELKKVDLEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSD 95 (378)
T ss_pred cccccchhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhhHHHHHHHhccceeeccchhhhHHHHHHhhcCc
Confidence 33444456889999999999999999999999999999999988777778888888665555 48898886654 66677
Q ss_pred eEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeeccccccc
Q 028681 91 HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 170 (205)
Q Consensus 91 ~~~lv~~~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~ 170 (205)
.+++++||++.++|.+-+.. ..+.+.....++.|+++|+.|||+.+++||||+.+||||.....-+|||+|||.++..+
T Consensus 96 ~YvF~qE~aP~gdL~snv~~-~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g 174 (378)
T KOG1345|consen 96 AYVFVQEFAPRGDLRSNVEA-AGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVG 174 (378)
T ss_pred eEEEeeccCccchhhhhcCc-ccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeecccccccC
Confidence 88899999999999877744 44888889999999999999999999999999999999965444479999999886443
Q ss_pred CCCCCCCCCCCCCccCCceeccC---cC-CCeeeEEEeC
Q 028681 171 LHSQPKSTVGTPAYIAPEVLLKK---EY-DGKVMCVYVI 205 (205)
Q Consensus 171 ~~~~~~~~~~~~~~~aPE~~~~~---~~-~~~~~Dvwsl 205 (205)
... ...-....|-+||..... .+ ..+.+|+|.|
T Consensus 175 ~tV--~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~Wqf 211 (378)
T KOG1345|consen 175 TTV--KYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQF 211 (378)
T ss_pred cee--hhhhhhcccCCcHHHhhccccceEecccccchhe
Confidence 222 222345678889887632 22 2345999986
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.2e-26 Score=168.54 Aligned_cols=180 Identities=26% Similarity=0.392 Sum_probs=153.9
Q ss_pred cCCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecC---ccchHHHHHHHHHHHhcCCCCeeEEEEEEEeCC-----
Q 028681 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG---DKIDENVQREIINHRSLRHPNIVRFKEVILTPT----- 90 (205)
Q Consensus 19 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----- 90 (205)
...+|.-++.++.|.- .|..+-+.-.+++|++|..... .....+...|..++..+.|+|+++++.+|.-..
T Consensus 15 v~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~ 93 (369)
T KOG0665|consen 15 VPKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEF 93 (369)
T ss_pred eeeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHH
Confidence 3578888999999988 7778888888999999987643 223467788999999999999999999987543
Q ss_pred -eEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccc
Q 028681 91 -HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 169 (205)
Q Consensus 91 -~~~lv~~~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~ 169 (205)
.+|+|||++.. +|-..++. .++=+.+..+++|++-|+.+||+.||+||||+|+||++..+.. +||.|||+|+..
T Consensus 94 ~e~y~v~e~m~~-nl~~vi~~--elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~--lKi~dfg~ar~e 168 (369)
T KOG0665|consen 94 QEVYLVMELMDA-NLCQVILM--ELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCT--LKILDFGLARTE 168 (369)
T ss_pred HhHHHHHHhhhh-HHHHHHHH--hcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhh--eeeccchhhccc
Confidence 57899999954 77777663 3777889999999999999999999999999999999987777 999999999988
Q ss_pred cCCCCCCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 170 VLHSQPKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 170 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
...........+..|.|||++.+..+..+ +||||+
T Consensus 169 ~~~~~mtpyVvtRyyrapevil~~~~ke~-vdiwSv 203 (369)
T KOG0665|consen 169 DTDFMMTPYVVTRYYRAPEVILGMGYKEN-VDIWSV 203 (369)
T ss_pred CcccccCchhheeeccCchheeccCCccc-chhhhh
Confidence 88877777789999999999999888766 999995
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.5e-25 Score=169.83 Aligned_cols=182 Identities=26% Similarity=0.269 Sum_probs=148.5
Q ss_pred CeEEEeeeccccceeEEEEEecCCC-cEEEEEEeecCccc-hHHHHHHHHHHHhcC----CCCeeEEEEEE-EeCCeEEE
Q 028681 22 RYELVRDIGSGNFGVARLMRDKKTE-ELVAVKYIERGDKI-DENVQREIINHRSLR----HPNIVRFKEVI-LTPTHLAI 94 (205)
Q Consensus 22 ~y~~~~~l~~g~~g~v~~~~~~~~~-~~v~iK~~~~~~~~-~~~~~~e~~~l~~l~----h~~i~~~~~~~-~~~~~~~l 94 (205)
+|++.+.||+|+||.||.+.+...+ ..+|+|........ ...+..|..++..++ .+++..+.+.. ..+.+.++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 8999999999999999999998764 67888887764322 237888888888886 36889999888 57788999
Q ss_pred EEEecCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCC-C--CcEEEeeecccc--
Q 028681 95 VMEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSP-A--PRLKICDFGYSK-- 167 (205)
Q Consensus 95 v~~~~~~~sl~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~-~--~~~~l~df~~~~-- 167 (205)
||+.+ +.+|.++.... +.++..++..++.|++.+|++||+.|++||||+|+|+.+.... . ..+.|.|||+++
T Consensus 99 VM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar~~ 177 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLARRF 177 (322)
T ss_pred EEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCCccc
Confidence 99987 67999988543 4699999999999999999999999999999999999997653 1 359999999998
Q ss_pred cccCCCC---------CCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 168 SSVLHSQ---------PKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 168 ~~~~~~~---------~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
....... .....||..|.++.++.+...+.. .|+||+
T Consensus 178 ~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~-DDles~ 223 (322)
T KOG1164|consen 178 KYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRR-DDLESL 223 (322)
T ss_pred cccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCc-hhhhhH
Confidence 3211110 112349999999999999999866 999985
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.4e-26 Score=183.01 Aligned_cols=175 Identities=28% Similarity=0.325 Sum_probs=139.5
Q ss_pred EEeeeccccce-eEEEEEecCCCcEEEEEEeecCccchHHHHHHHHHHHhc-CCCCeeEEEEEEEeCCeEEEEEEecCCC
Q 028681 25 LVRDIGSGNFG-VARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIVMEYASGG 102 (205)
Q Consensus 25 ~~~~l~~g~~g-~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~~~~~~~ 102 (205)
-.+.+|.|+.| .||++... ++.||||++-.. ..+-+.+|+.+|+.- .||||+++++.=.+....|+..|.|..
T Consensus 513 ~~eilG~Gs~Gt~Vf~G~ye--~R~VAVKrll~e--~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~~- 587 (903)
T KOG1027|consen 513 PKEILGYGSNGTVVFRGVYE--GREVAVKRLLEE--FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCAC- 587 (903)
T ss_pred cHHHcccCCCCcEEEEEeeC--CceehHHHHhhH--hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhhh-
Confidence 35667788887 56777765 678999987643 234567899998877 599999999988888899999999965
Q ss_pred chHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecC---CCCCcEEEeeecccccccCCCCC
Q 028681 103 ELFERICNAGR----FSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDG---SPAPRLKICDFGYSKSSVLHSQP 175 (205)
Q Consensus 103 sl~~~~~~~~~----~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~---~~~~~~~l~df~~~~~~~~~~~~ 175 (205)
+|.+++..... ......+.++.|++.|+++||+.+|+||||+|.||+|+. ++..+++|.|||+++..+.+...
T Consensus 588 sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~sS 667 (903)
T KOG1027|consen 588 SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGKSS 667 (903)
T ss_pred hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccccCCCcch
Confidence 89999876421 111445789999999999999999999999999999976 45557999999999887665443
Q ss_pred ----CCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 176 ----KSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 176 ----~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
....||-.|+|||.+....... ++||+||
T Consensus 668 ~~r~s~~sGt~GW~APE~L~~~~~~~-avDiFsl 700 (903)
T KOG1027|consen 668 FSRLSGGSGTSGWQAPEQLREDRKTQ-AVDIFSL 700 (903)
T ss_pred hhcccCCCCcccccCHHHHhccccCc-ccchhhc
Confidence 3335999999999999877764 5999986
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.1e-25 Score=156.12 Aligned_cols=138 Identities=21% Similarity=0.196 Sum_probs=107.7
Q ss_pred EeeeccccceeEEEEEecCCCcEEEEEEeecCccc--h-------------------------HHHHHHHHHHHhcCCCC
Q 028681 26 VRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI--D-------------------------ENVQREIINHRSLRHPN 78 (205)
Q Consensus 26 ~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~--~-------------------------~~~~~e~~~l~~l~h~~ 78 (205)
...||+|++|.||.+.+. +|+.||+|+++..... . .....|+.++..+.+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05147 2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG 80 (190)
T ss_pred CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence 467999999999999987 7999999999764211 0 12235888999998776
Q ss_pred eeEEEEEEEeCCeEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHH-HhcCcEeecCCCCCeEecCCCCCc
Q 028681 79 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYC-HSMQVCHRDLKLENTLLDGSPAPR 157 (205)
Q Consensus 79 i~~~~~~~~~~~~~~lv~~~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~l-h~~~i~H~di~p~nili~~~~~~~ 157 (205)
+......... ..++||||++++++........+++...+..++.|++.+|.++ |+.|++|+||+|+||++++ +.
T Consensus 81 v~~p~~~~~~--~~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~~-~~-- 155 (190)
T cd05147 81 IPCPEPILLK--SHVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYHD-GK-- 155 (190)
T ss_pred CCCCcEEEec--CCEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEEC-Cc--
Confidence 5433322222 2379999998877665544556799999999999999999999 7999999999999999973 33
Q ss_pred EEEeeecccccc
Q 028681 158 LKICDFGYSKSS 169 (205)
Q Consensus 158 ~~l~df~~~~~~ 169 (205)
++|+|||+|...
T Consensus 156 v~LiDFG~a~~~ 167 (190)
T cd05147 156 LYIIDVSQSVEH 167 (190)
T ss_pred EEEEEccccccC
Confidence 999999998643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.1e-24 Score=152.97 Aligned_cols=139 Identities=18% Similarity=0.132 Sum_probs=110.0
Q ss_pred EeeeccccceeEEEEEecCCCcEEEEEEeecCccc---------------------------hHHHHHHHHHHHhcCCCC
Q 028681 26 VRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI---------------------------DENVQREIINHRSLRHPN 78 (205)
Q Consensus 26 ~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~---------------------------~~~~~~e~~~l~~l~h~~ 78 (205)
.+.||+|++|.||++.+. +|+.||+|+++..... ...+..|...+.++.+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05145 2 NGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG 80 (190)
T ss_pred CceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence 468999999999999987 7999999999865211 122357888899998888
Q ss_pred eeEEEEEEEeCCeEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-cCcEeecCCCCCeEecCCCCCc
Q 028681 79 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS-MQVCHRDLKLENTLLDGSPAPR 157 (205)
Q Consensus 79 i~~~~~~~~~~~~~~lv~~~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~-~~i~H~di~p~nili~~~~~~~ 157 (205)
+.....+.... .+++|||++++++.........++......++.|++.++.++|. .|++|+||+|+||+++ ++.
T Consensus 81 i~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~~~-- 155 (190)
T cd05145 81 VPVPEPILLKK--NVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-DGK-- 155 (190)
T ss_pred CCCceEEEecC--CEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-CCC--
Confidence 75444433332 47999999887554443344568889999999999999999999 9999999999999998 554
Q ss_pred EEEeeeccccccc
Q 028681 158 LKICDFGYSKSSV 170 (205)
Q Consensus 158 ~~l~df~~~~~~~ 170 (205)
++|+|||++....
T Consensus 156 ~~liDFG~a~~~~ 168 (190)
T cd05145 156 PYIIDVSQAVELD 168 (190)
T ss_pred EEEEEcccceecC
Confidence 9999999987544
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.2e-24 Score=153.08 Aligned_cols=179 Identities=25% Similarity=0.286 Sum_probs=143.1
Q ss_pred ceecCCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCccchHHHHHHHHHHHhcCC-CCeeEEEEEEEeCCeEEE
Q 028681 16 IMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRH-PNIVRFKEVILTPTHLAI 94 (205)
Q Consensus 16 ~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~l 94 (205)
.....++|.++++||.|+||.+|.+....+|..||+|.-... .....+.-|..+.+.+++ ..|..+.-++.+..+..+
T Consensus 10 ~~iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~-a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvl 88 (341)
T KOG1163|consen 10 ELIVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSK-AKHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVL 88 (341)
T ss_pred hheeccceEEEEeecCCchhheeeeeeccCCceEEEEeeccc-CCCcchhHHHHHHHHhccCCCCchhhhhcccccccee
Confidence 344568999999999999999999999999999999966543 334566778888888875 567777777888889999
Q ss_pred EEEecCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCC-cEEEeeecccccccCC
Q 028681 95 VMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAP-RLKICDFGYSKSSVLH 172 (205)
Q Consensus 95 v~~~~~~~sl~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~-~~~l~df~~~~~~~~~ 172 (205)
||+.+ +.||+++..- .+.++.+++.-.+-|++.-++|+|.++++|+||+|+|++..-+.+. ++.|+|||+|+.+...
T Consensus 89 VMdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~ 167 (341)
T KOG1163|consen 89 VMDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDI 167 (341)
T ss_pred eeecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhhhccc
Confidence 99998 6689888753 5569999999999999999999999999999999999998654433 5999999999765432
Q ss_pred CC--------CCCCCCCCCccCCceeccCcCC
Q 028681 173 SQ--------PKSTVGTPAYIAPEVLLKKEYD 196 (205)
Q Consensus 173 ~~--------~~~~~~~~~~~aPE~~~~~~~~ 196 (205)
.. .....||-+|++--++.+..-+
T Consensus 168 ~t~~HIpyre~r~ltGTaRYASinAh~g~eqS 199 (341)
T KOG1163|consen 168 RTRQHIPYREDRNLTGTARYASINAHLGIEQS 199 (341)
T ss_pred cccccCccccCCccceeeeehhhhhhhhhhhh
Confidence 22 2233588889887777655443
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.4e-24 Score=153.57 Aligned_cols=161 Identities=15% Similarity=0.156 Sum_probs=123.1
Q ss_pred CCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCccchHH----------HHHHHHHHHhcCCCCeeEEEEEEEeC
Q 028681 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDEN----------VQREIINHRSLRHPNIVRFKEVILTP 89 (205)
Q Consensus 20 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~----------~~~e~~~l~~l~h~~i~~~~~~~~~~ 89 (205)
.++|++.+.++.|+||.||.+.. ++..+++|.+.+.....+. +.+|+..+.++.|+++..+.+++...
T Consensus 30 ~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~ 107 (232)
T PRK10359 30 SYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA 107 (232)
T ss_pred hCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence 68999999999999999999766 3667999999765433332 57888899999999999998886643
Q ss_pred --------CeEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEe
Q 028681 90 --------THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKIC 161 (205)
Q Consensus 90 --------~~~~lv~~~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~ 161 (205)
+..+++|||++|.+|.+... +++ ....+++.++..+|+.|++|||++|+||+++.++ ++|+
T Consensus 108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~~----~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g---i~li 176 (232)
T PRK10359 108 ERKTLRYAHTYIMLIEYIEGVELNDMPE----ISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG---LRII 176 (232)
T ss_pred ccccccccCCeEEEEEEECCccHHHhhh----ccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC---EEEE
Confidence 35789999999999977632 333 2456899999999999999999999999998765 8999
Q ss_pred eecccccccCCCCCCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 162 DFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 162 df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
|||........... ..++....+..+ +|+|||
T Consensus 177 Dfg~~~~~~e~~a~-----------d~~vler~y~~~-~di~~l 208 (232)
T PRK10359 177 DLSGKRCTAQRKAK-----------DRIDLERHYGIK-NEIKDL 208 (232)
T ss_pred ECCCcccccchhhH-----------HHHHHHhHhccc-ccccce
Confidence 99977544211111 113444556644 899997
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.3e-22 Score=154.96 Aligned_cols=131 Identities=26% Similarity=0.422 Sum_probs=115.7
Q ss_pred CCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCccchHHHHHHHHHHHhcC-----C---CCeeEEEEEEEeC--
Q 028681 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLR-----H---PNIVRFKEVILTP-- 89 (205)
Q Consensus 20 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~-----h---~~i~~~~~~~~~~-- 89 (205)
..+|.+.++||.|.|++||++.+.++.+.||+|+.+--..-.+....|+.+|++++ + .+|+++++.|...
T Consensus 77 ~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGp 156 (590)
T KOG1290|consen 77 GGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGP 156 (590)
T ss_pred CceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCC
Confidence 35999999999999999999999999999999988876667788999999999884 2 5699999999854
Q ss_pred --CeEEEEEEecCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH-hcCcEeecCCCCCeEec
Q 028681 90 --THLAIVMEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCH-SMQVCHRDLKLENTLLD 151 (205)
Q Consensus 90 --~~~~lv~~~~~~~sl~~~~~~~~--~~~~~~~~~i~~~i~~~l~~lh-~~~i~H~di~p~nili~ 151 (205)
.++++|+|++ |.+|..++.... .++...++.|++|++.||.||| ++||||.||||+|||+.
T Consensus 157 NG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~ 222 (590)
T KOG1290|consen 157 NGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLC 222 (590)
T ss_pred CCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeee
Confidence 4799999999 568888886643 4999999999999999999999 57999999999999984
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=8.1e-23 Score=149.77 Aligned_cols=181 Identities=23% Similarity=0.293 Sum_probs=148.0
Q ss_pred cCCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCccchHHHHHHHHHHHhcC-CCCeeEEEEEEEeCCeEEEEEE
Q 028681 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLR-HPNIVRFKEVILTPTHLAIVME 97 (205)
Q Consensus 19 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~~ 97 (205)
-.-+|++.++||+|+||.++.+.+.-++..||||.-. .+....++..|.+..+.|. .++|..++-+...+.+..+|+|
T Consensus 26 VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEP-rkS~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVid 104 (449)
T KOG1165|consen 26 VGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEP-RKSEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVID 104 (449)
T ss_pred ecccceeccccccCcceeeecccccccCceEEEEecc-ccCCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhh
Confidence 3568999999999999999999999999999999554 3445667888888888884 6999999888888889999999
Q ss_pred ecCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCC---CcEEEeeeccccccc---
Q 028681 98 YASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPA---PRLKICDFGYSKSSV--- 170 (205)
Q Consensus 98 ~~~~~sl~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~---~~~~l~df~~~~~~~--- 170 (205)
.+ +.||+++..- ++.|+.+++..++.|++.-++++|++.+|.|||||+|+||..-+. ..+.++|||+|+.+-
T Consensus 105 LL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp~ 183 (449)
T KOG1165|consen 105 LL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDPK 183 (449)
T ss_pred hh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhhhcCcc
Confidence 88 6799998865 567999999999999999999999999999999999999964322 248999999997542
Q ss_pred -----CCCCCCCCCCCCCccCCceeccCcCCCeeeEE
Q 028681 171 -----LHSQPKSTVGTPAYIAPEVLLKKEYDGKVMCV 202 (205)
Q Consensus 171 -----~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv 202 (205)
+-....+..||-+||+-.-+.++.-+.. .|.
T Consensus 184 TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRR-DDL 219 (449)
T KOG1165|consen 184 TKQHIPYREHKSLSGTARYMSINTHLGREQSRR-DDL 219 (449)
T ss_pred ccccCccccccccccceeeeEeeccccchhhhh-hhH
Confidence 2223344559999999877777665544 443
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.88 E-value=5.1e-22 Score=144.82 Aligned_cols=145 Identities=17% Similarity=0.076 Sum_probs=113.5
Q ss_pred cCCCeEEEeeeccccceeEEEEE-ecCCCcEEEEEEeecCccc-------------------------hHHHHHHHHHHH
Q 028681 19 DSDRYELVRDIGSGNFGVARLMR-DKKTEELVAVKYIERGDKI-------------------------DENVQREIINHR 72 (205)
Q Consensus 19 ~~~~y~~~~~l~~g~~g~v~~~~-~~~~~~~v~iK~~~~~~~~-------------------------~~~~~~e~~~l~ 72 (205)
..-.|++.+.||+|++|.||.+. +..+|..|++|++...... ...+..|+.++.
T Consensus 26 ~~~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~ 105 (237)
T smart00090 26 RGILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQ 105 (237)
T ss_pred cCchHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHH
Confidence 34468899999999999999998 6678999999998754210 122467899999
Q ss_pred hcCCC--CeeEEEEEEEeCCeEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcC-cEeecCCCCCeE
Q 028681 73 SLRHP--NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ-VCHRDLKLENTL 149 (205)
Q Consensus 73 ~l~h~--~i~~~~~~~~~~~~~~lv~~~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~-i~H~di~p~nil 149 (205)
.+.+. .+.++++. ...++|||++++.++.........+....+..++.|++.++.+||+.| ++|+||+|+||+
T Consensus 106 ~L~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIl 181 (237)
T smart00090 106 RLYEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNIL 181 (237)
T ss_pred HHHhcCCCCCeeeEe----cCceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEE
Confidence 88753 34444442 234799999998887665544555667778899999999999999999 999999999999
Q ss_pred ecCCCCCcEEEeeeccccccc
Q 028681 150 LDGSPAPRLKICDFGYSKSSV 170 (205)
Q Consensus 150 i~~~~~~~~~l~df~~~~~~~ 170 (205)
++ ++. ++|+|||.+....
T Consensus 182 i~-~~~--i~LiDFg~a~~~~ 199 (237)
T smart00090 182 VH-DGK--VVIIDVSQSVELD 199 (237)
T ss_pred EE-CCC--EEEEEChhhhccC
Confidence 98 444 9999999886443
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.3e-21 Score=138.33 Aligned_cols=138 Identities=19% Similarity=0.264 Sum_probs=107.0
Q ss_pred EEEeeeccccceeEEEEEecCCCcEEEEEEeecCcc-chHHHHHHHHHHHhc-----CCCCeeEEEEEEEeCC---eEE-
Q 028681 24 ELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK-IDENVQREIINHRSL-----RHPNIVRFKEVILTPT---HLA- 93 (205)
Q Consensus 24 ~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l-----~h~~i~~~~~~~~~~~---~~~- 93 (205)
.-.+.||+|++|.||. +..++.. ++|+...... ..+.+.+|+..++.+ .||||++++|+++++. ..+
T Consensus 5 ~~~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~ 81 (210)
T PRK10345 5 SEQSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYD 81 (210)
T ss_pred CCcceecCCCceEEEE--CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEE
Confidence 3457899999999995 6666655 6888776432 346789999999999 5799999999999874 433
Q ss_pred EEEEe--cCCCchHHHHHhcCCCCHHHHHHHHHHHHHHH-HHHHhcCcEeecCCCCCeEecCC--CCCcEEEee-ecccc
Q 028681 94 IVMEY--ASGGELFERICNAGRFSEDEARFFFQQLISGV-SYCHSMQVCHRDLKLENTLLDGS--PAPRLKICD-FGYSK 167 (205)
Q Consensus 94 lv~~~--~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l-~~lh~~~i~H~di~p~nili~~~--~~~~~~l~d-f~~~~ 167 (205)
+|+|| ..+++|.+++++. .+++. ..++.+++.++ +|||+++|+|+||+|+||+++.. +..+++|+| ||...
T Consensus 82 ~I~e~~G~~~~tL~~~l~~~-~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~~~ 158 (210)
T PRK10345 82 VIADFDGKPSITLTEFAEQC-RYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIGEST 158 (210)
T ss_pred EEecCCCCcchhHHHHHHcc-cccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCCCcc
Confidence 78999 4478999999664 45555 35678888777 89999999999999999999753 233599999 55443
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.4e-22 Score=168.46 Aligned_cols=185 Identities=21% Similarity=0.265 Sum_probs=144.0
Q ss_pred eecCCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCccchHHHHHHHHHHHhcC---CCCeeEEEEEEEeCCeEE
Q 028681 17 MHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLR---HPNIVRFKEVILTPTHLA 93 (205)
Q Consensus 17 ~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~~~~~~ 93 (205)
......|.+.+.||+|++|+||+|.+.. ++.||+|+-++...+.-- --..++.+|. -+.|.++...+...+.-+
T Consensus 694 ~~~~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WEfY--I~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~ 770 (974)
T KOG1166|consen 694 EVGGEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWEFY--ICLQVMERLKPQMLPSIMHISSAHVFQNASV 770 (974)
T ss_pred eecceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCceeee--ehHHHHHhhchhhhcchHHHHHHHccCCcce
Confidence 3447899999999999999999999888 999999988765544311 1111222222 234555566666677788
Q ss_pred EEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecC-----CCCCcEEEeeeccccc
Q 028681 94 IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDG-----SPAPRLKICDFGYSKS 168 (205)
Q Consensus 94 lv~~~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~-----~~~~~~~l~df~~~~~ 168 (205)
++++|.+.|+|.++++..+.+++..++.++.|++..++.||+++||||||||+|+++.. .+..-++|+|||.+.-
T Consensus 771 lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~siD 850 (974)
T KOG1166|consen 771 LVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSID 850 (974)
T ss_pred eeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEeccccee
Confidence 99999999999999998888999999999999999999999999999999999999842 1122499999998743
Q ss_pred ---ccCCCCCCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 169 ---SVLHSQPKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 169 ---~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
.+........+++-.|-++|...+++|+.. +|.|.|
T Consensus 851 m~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq-~DyfGl 889 (974)
T KOG1166|consen 851 MKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQ-IDYFGL 889 (974)
T ss_pred eeEcCCCcEEeeeeccccchhHHHhcCCCCchh-hhhHHH
Confidence 333334445568899999999999999755 887753
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.87 E-value=4.9e-21 Score=145.72 Aligned_cols=179 Identities=39% Similarity=0.618 Sum_probs=149.6
Q ss_pred eEEEeeeccccceeEEEEEecCCCcEEEEEEeecCcc----chHHHHHHHHHHHhcCCC-CeeEEEEEEEeCCeEEEEEE
Q 028681 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK----IDENVQREIINHRSLRHP-NIVRFKEVILTPTHLAIVME 97 (205)
Q Consensus 23 y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~h~-~i~~~~~~~~~~~~~~lv~~ 97 (205)
|++.+.||.|+++.||.+.+. ..+++|.+..... ....+..|...++.+.|+ +++++.+.+......+++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 78 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVME 78 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEe
Confidence 789999999999999999988 6689998876543 245688899999999988 79999999987777899999
Q ss_pred ecCCCchHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCCC-
Q 028681 98 YASGGELFERICNAG---RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS- 173 (205)
Q Consensus 98 ~~~~~sl~~~~~~~~---~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~~- 173 (205)
++.++++.+.+.... .+.......++.|++.++.++|+.+++|+|++|+||+++.... .++++|||.+.......
T Consensus 79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~-~~~l~dfg~~~~~~~~~~ 157 (384)
T COG0515 79 YVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGR-VVKLIDFGLAKLLPDPGS 157 (384)
T ss_pred cCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCC-eEEEeccCcceecCCCCc
Confidence 999999997776654 7999999999999999999999999999999999999987662 28999999987544433
Q ss_pred ------CCCCCCCCCCccCCceeccC--cCCCeeeEEEeC
Q 028681 174 ------QPKSTVGTPAYIAPEVLLKK--EYDGKVMCVYVI 205 (205)
Q Consensus 174 ------~~~~~~~~~~~~aPE~~~~~--~~~~~~~Dvwsl 205 (205)
......++..|++||.+... .......|+||+
T Consensus 158 ~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~ 197 (384)
T COG0515 158 TSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSL 197 (384)
T ss_pred cccccccccccccccccCCHHHhcCCCCCCCCchHhHHHH
Confidence 23555799999999999874 333455899964
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.8e-22 Score=150.88 Aligned_cols=183 Identities=17% Similarity=0.163 Sum_probs=145.8
Q ss_pred CCCeEEEeeeccccceeEEEEEecCC-----CcEEEEEEeecCcc--chHHHHHHHHHHHhcCCCCeeEEEEEEEeC-Ce
Q 028681 20 SDRYELVRDIGSGNFGVARLMRDKKT-----EELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTP-TH 91 (205)
Q Consensus 20 ~~~y~~~~~l~~g~~g~v~~~~~~~~-----~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~ 91 (205)
..++++...+.+|.||.+|.+.+.+. .+.|.+|.++.... ....+..|--++....|||++++.+++.++ ..
T Consensus 283 r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~~ 362 (563)
T KOG1024|consen 283 RCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYAT 362 (563)
T ss_pred hhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccCc
Confidence 45678888889999999999976543 23456666654332 234577788888888999999999988765 46
Q ss_pred EEEEEEecCCCchHHHHHh--------cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeee
Q 028681 92 LAIVMEYASGGELFERICN--------AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDF 163 (205)
Q Consensus 92 ~~lv~~~~~~~sl~~~~~~--------~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df 163 (205)
.++++.++..++|..++.. .+.++..++..++.|+..|++|||+.|++|.||..+|.+|++.- +|||+|-
T Consensus 363 P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~L--qVkltDs 440 (563)
T KOG1024|consen 363 PFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQL--QVKLTDS 440 (563)
T ss_pred ceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhhe--eEEeccc
Confidence 7888899999999999972 23488888999999999999999999999999999999997554 4999999
Q ss_pred cccccccCCCCC---CCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 164 GYSKSSVLHSQP---KSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 164 ~~~~~~~~~~~~---~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
.+++...|..-. .....+..||+||.+.+..|++. +|+|||
T Consensus 441 aLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssa-sDvWsf 484 (563)
T KOG1024|consen 441 ALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSA-SDVWSF 484 (563)
T ss_pred hhccccCcccccccCCCCCCcccccCHHHHhhhhhcch-hhhHHH
Confidence 999866555432 22334678999999999999866 999996
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=2e-20 Score=134.85 Aligned_cols=135 Identities=23% Similarity=0.208 Sum_probs=110.5
Q ss_pred eeeccccceeEEEEEecCCCcEEEEEEeecCcc---------chHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEE
Q 028681 27 RDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---------IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (205)
Q Consensus 27 ~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~---------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~ 97 (205)
+.||+|++|.||.+.. .+..+++|....... ....+..|+.++..+.|+++.....++......+++||
T Consensus 2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e 79 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVME 79 (211)
T ss_pred cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEE
Confidence 5789999999999987 456788897653221 12356788999999999988777777777778899999
Q ss_pred ecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeeccccccc
Q 028681 98 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 170 (205)
Q Consensus 98 ~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~ 170 (205)
|+++.+|.+.+..... ....++.+++.++.++|+.+++|+|++|.||+++ ++. ++|+|||.+....
T Consensus 80 ~~~G~~L~~~~~~~~~----~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~--~~liDf~~a~~~~ 145 (211)
T PRK14879 80 YIEGEPLKDLINSNGM----EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGK--IYLIDFGLAEFSK 145 (211)
T ss_pred EeCCcCHHHHHHhccH----HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCC--EEEEECCcccCCC
Confidence 9999999988865322 7888999999999999999999999999999998 444 9999999886543
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=5.9e-20 Score=129.36 Aligned_cols=134 Identities=19% Similarity=0.210 Sum_probs=105.8
Q ss_pred eEEEeeeccccceeEEEEEecCCCcEEEEEEeecCccchH-----HHHHHHHHHHhcC-CCCeeEEEEEEEeCCeEEEEE
Q 028681 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDE-----NVQREIINHRSLR-HPNIVRFKEVILTPTHLAIVM 96 (205)
Q Consensus 23 y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~-----~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~ 96 (205)
+.+...|++|+||+|+.+.. .+.+++.+.+.......+ .+..|+.+++++. ++++++++++ +..+++|
T Consensus 4 ~~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvm 77 (218)
T PRK12274 4 PAVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDR 77 (218)
T ss_pred cccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEE
Confidence 34678899999999997765 567788777776554333 4788999999995 4778888875 4468999
Q ss_pred EecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecC-CCCCeEecCCCCCcEEEeeecccccccC
Q 028681 97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDL-KLENTLLDGSPAPRLKICDFGYSKSSVL 171 (205)
Q Consensus 97 ~~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di-~p~nili~~~~~~~~~l~df~~~~~~~~ 171 (205)
+|+.+.+|...... ....++.|++.++.++|++|++|+|| +|+||+++.++. ++|+|||++.....
T Consensus 78 eyI~G~~L~~~~~~-------~~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~--i~LIDFG~A~~~~~ 144 (218)
T PRK12274 78 SYLAGAAMYQRPPR-------GDLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGS--PAVIDFQLAVRGNP 144 (218)
T ss_pred eeecCccHHhhhhh-------hhHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCC--EEEEECCCceecCC
Confidence 99998888643311 12357789999999999999999999 799999987776 99999999975543
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=4.3e-22 Score=168.27 Aligned_cols=131 Identities=17% Similarity=0.155 Sum_probs=95.5
Q ss_pred hcCC-CCeeEEEEEE-------EeCCeEEEEEEecCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecC
Q 028681 73 SLRH-PNIVRFKEVI-------LTPTHLAIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDL 143 (205)
Q Consensus 73 ~l~h-~~i~~~~~~~-------~~~~~~~lv~~~~~~~sl~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di 143 (205)
.++| .||..+.++| .....+++++|++ +.+|.+.+.. ...+++..++.++.||+.||.|||++||+||||
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDl 106 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNV 106 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccC
Confidence 3444 4666666666 2334677788887 5589998865 446999999999999999999999999999999
Q ss_pred CCCCeEecCCCC-----------------CcEEEeeecccccccCCC-----------------CCCCCCCCCCccCCce
Q 028681 144 KLENTLLDGSPA-----------------PRLKICDFGYSKSSVLHS-----------------QPKSTVGTPAYIAPEV 189 (205)
Q Consensus 144 ~p~nili~~~~~-----------------~~~~l~df~~~~~~~~~~-----------------~~~~~~~~~~~~aPE~ 189 (205)
||+|||++..+. ..+|++|||+++...... ......+|+.|+|||+
T Consensus 107 KP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~ 186 (793)
T PLN00181 107 RPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEE 186 (793)
T ss_pred CchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhh
Confidence 999999964322 236677777664321100 0011247888999999
Q ss_pred eccCcCCCeeeEEEeC
Q 028681 190 LLKKEYDGKVMCVYVI 205 (205)
Q Consensus 190 ~~~~~~~~~~~Dvwsl 205 (205)
+.+..++.+ +|||||
T Consensus 187 ~~~~~~~~~-sDVwSl 201 (793)
T PLN00181 187 DNGSSSNCA-SDVYRL 201 (793)
T ss_pred hccCCCCch-hhhhhH
Confidence 998888765 999996
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.84 E-value=7.1e-20 Score=130.76 Aligned_cols=131 Identities=21% Similarity=0.174 Sum_probs=103.8
Q ss_pred eeccccceeEEEEEecCCCcEEEEEEeecCcc---------chHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEEe
Q 028681 28 DIGSGNFGVARLMRDKKTEELVAVKYIERGDK---------IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (205)
Q Consensus 28 ~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~---------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~ 98 (205)
.||+|++|.||.+.. ++..+++|....... ..+++..|+.+++.++++++.....++......+++||+
T Consensus 1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 78 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEY 78 (199)
T ss_pred CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEE
Confidence 379999999999984 467789998654221 124567899999999888765555555666777899999
Q ss_pred cCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeeccccccc
Q 028681 99 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 170 (205)
Q Consensus 99 ~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~ 170 (205)
+++.+|.+.+..... .++.+++.++.+||+.|++|+|++|.||+++ ++. ++++|||++....
T Consensus 79 ~~g~~l~~~~~~~~~-------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~--~~liDfg~a~~~~ 140 (199)
T TIGR03724 79 IEGKPLKDVIEEGND-------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDK--LYLIDFGLGKYSD 140 (199)
T ss_pred ECCccHHHHHhhcHH-------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCc--EEEEECCCCcCCC
Confidence 999999887754321 7899999999999999999999999999998 444 9999999886543
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.2e-19 Score=129.43 Aligned_cols=135 Identities=22% Similarity=0.255 Sum_probs=104.9
Q ss_pred CeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCcc-----------------------chHHHHHHHHHHHhcCCC-
Q 028681 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK-----------------------IDENVQREIINHRSLRHP- 77 (205)
Q Consensus 22 ~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~-----------------------~~~~~~~e~~~l~~l~h~- 77 (205)
.|.+.+.|++|++|.||.+... ++..|++|++..... .......|..++..+.++
T Consensus 16 ~~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 94 (198)
T cd05144 16 VESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEG 94 (198)
T ss_pred hhhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcC
Confidence 4788899999999999999875 688999998764321 012356678888888776
Q ss_pred -CeeEEEEEEEeCCeEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCC
Q 028681 78 -NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAP 156 (205)
Q Consensus 78 -~i~~~~~~~~~~~~~~lv~~~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~ 156 (205)
.++..++ ....+++|||+++.+|...... .....++.+++.++.++|+.|++|+||+|+||+++.++.
T Consensus 95 i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~------~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~~- 163 (198)
T cd05144 95 FPVPKPID----WNRHAVVMEYIDGVELYRVRVL------EDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDEK- 163 (198)
T ss_pred CCCCceee----cCCceEEEEEeCCcchhhcccc------ccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCCc-
Confidence 3444443 2445899999999888654321 345678899999999999999999999999999987766
Q ss_pred cEEEeeecccccc
Q 028681 157 RLKICDFGYSKSS 169 (205)
Q Consensus 157 ~~~l~df~~~~~~ 169 (205)
++|+|||.+...
T Consensus 164 -~~liDfg~~~~~ 175 (198)
T cd05144 164 -IYIIDWPQMVST 175 (198)
T ss_pred -EEEEECCccccC
Confidence 999999988544
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.82 E-value=2.7e-19 Score=145.16 Aligned_cols=136 Identities=21% Similarity=0.180 Sum_probs=108.4
Q ss_pred CeEEEeeeccccceeEEEEEecCCCcEEEEEEe-ecCc--------cchHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeE
Q 028681 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYI-ERGD--------KIDENVQREIINHRSLRHPNIVRFKEVILTPTHL 92 (205)
Q Consensus 22 ~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~-~~~~--------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 92 (205)
.|...+.||+|++|.||++.....+ +++|.. .+.. ...+++..|+.+++.++|++++....++......
T Consensus 334 ~~~~~~~iG~G~~g~Vy~~~~~~~~--~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~ 411 (535)
T PRK09605 334 RKIPDHLIGKGAEADIKKGEYLGRD--AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEK 411 (535)
T ss_pred ccCccceeccCCcEEEEEEeecCcc--ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCC
Confidence 3456789999999999998876543 333332 2111 1124578899999999999998887777777788
Q ss_pred EEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeeccccccc
Q 028681 93 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 170 (205)
Q Consensus 93 ~lv~~~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~ 170 (205)
+++|||+++++|.+.+. ....++.+++.++.+||+.+++|+|++|+||+++ ++. ++|+|||+++...
T Consensus 412 ~lv~E~~~g~~L~~~l~--------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl~-~~~--~~liDFGla~~~~ 478 (535)
T PRK09605 412 TIVMEYIGGKDLKDVLE--------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIVR-DDR--LYLIDFGLGKYSD 478 (535)
T ss_pred EEEEEecCCCcHHHHHH--------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEEE-CCc--EEEEeCcccccCC
Confidence 99999999999988774 3567899999999999999999999999999993 444 9999999997644
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.7e-20 Score=152.32 Aligned_cols=182 Identities=34% Similarity=0.541 Sum_probs=141.8
Q ss_pred CCe-EEEeeeccccceeEEEEEecCCCcEEEEEEee----cCccc---hHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeE
Q 028681 21 DRY-ELVRDIGSGNFGVARLMRDKKTEELVAVKYIE----RGDKI---DENVQREIINHRSLRHPNIVRFKEVILTPTHL 92 (205)
Q Consensus 21 ~~y-~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~----~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 92 (205)
..| .....+|.|++|.++.+...........|.+. ..... ...+..|+.+-..+.|+|++.....+.+....
T Consensus 317 ~~y~~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~ 396 (601)
T KOG0590|consen 317 EKYGKPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGI 396 (601)
T ss_pred cccCCccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccc
Confidence 335 56788899999988777776555545555433 11111 12255677777788999998877776666555
Q ss_pred EEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCC
Q 028681 93 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 172 (205)
Q Consensus 93 ~lv~~~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~ 172 (205)
.-.|||+++ .|..++.....++..++..++.|++.|+.|||..|+.|+|++|+|+++..++. +||+|||.+......
T Consensus 397 ~~~mE~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~--lki~Dfg~~~vf~~~ 473 (601)
T KOG0590|consen 397 LQSMEYCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGI--LKIIDFGAASVFRYP 473 (601)
T ss_pred hhhhhcccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCc--eEEeecCcceeeccC
Confidence 555999998 89888877778999999999999999999999999999999999999999887 999999988654433
Q ss_pred CC-----CCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 173 SQ-----PKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 173 ~~-----~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
.. .....|+..|+|||++.+..|+....||||.
T Consensus 474 ~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~ 511 (601)
T KOG0590|consen 474 WEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSC 511 (601)
T ss_pred cchhhhhhcCcccCCcCcCcccccccccCcchhhhhhc
Confidence 33 2334689999999999999999999999983
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.7e-18 Score=122.45 Aligned_cols=135 Identities=21% Similarity=0.231 Sum_probs=94.6
Q ss_pred EeeeccccceeEEEEEecCCCcEEEEEEeecCccchHH-------------------------HHHHHHHHHhcCCC--C
Q 028681 26 VRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDEN-------------------------VQREIINHRSLRHP--N 78 (205)
Q Consensus 26 ~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~-------------------------~~~e~~~l~~l~h~--~ 78 (205)
.+.||+|++|.||.+.+. ++..|++|++......... ...|...+..+.+. .
T Consensus 2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~ 80 (187)
T cd05119 2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP 80 (187)
T ss_pred CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence 467999999999999987 7889999998764321111 12445555555433 2
Q ss_pred eeEEEEEEEeCCeEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-cCcEeecCCCCCeEecCCCCCc
Q 028681 79 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS-MQVCHRDLKLENTLLDGSPAPR 157 (205)
Q Consensus 79 i~~~~~~~~~~~~~~lv~~~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~-~~i~H~di~p~nili~~~~~~~ 157 (205)
+.++++. ...+++|||++++.+........... .....++.+++.++.++|. .+++|+||+|+||+++ ++.
T Consensus 81 ~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~~~-~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~~~-- 152 (187)
T cd05119 81 VPKPIDL----NRHVLVMEFIGGDGIPAPRLKDVRLL-EDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-DGK-- 152 (187)
T ss_pred CCceEec----CCCEEEEEEeCCCCccChhhhhhhhc-ccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-CCc--
Confidence 4444443 23589999998843321111111011 6678899999999999999 9999999999999998 555
Q ss_pred EEEeeecccccc
Q 028681 158 LKICDFGYSKSS 169 (205)
Q Consensus 158 ~~l~df~~~~~~ 169 (205)
++|+|||.+...
T Consensus 153 ~~liDfg~a~~~ 164 (187)
T cd05119 153 VYIIDVPQAVEI 164 (187)
T ss_pred EEEEECcccccc
Confidence 999999988533
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.77 E-value=2.1e-17 Score=120.85 Aligned_cols=135 Identities=19% Similarity=0.212 Sum_probs=101.4
Q ss_pred eeec-cccceeEEEEEecCCCcEEEEEEeecCc--------------cchHHHHHHHHHHHhcCCCCe--eEEEEEEEeC
Q 028681 27 RDIG-SGNFGVARLMRDKKTEELVAVKYIERGD--------------KIDENVQREIINHRSLRHPNI--VRFKEVILTP 89 (205)
Q Consensus 27 ~~l~-~g~~g~v~~~~~~~~~~~v~iK~~~~~~--------------~~~~~~~~e~~~l~~l~h~~i--~~~~~~~~~~ 89 (205)
..|| .|+.|++|.+... +..+++|.+..+. .....+..|+.++..+.|+++ +..+++....
T Consensus 37 ~~lg~~~g~gtv~~v~~~--~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTP--GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred ceeecCCCCccEEEEEeC--CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 4565 7888888888765 5678999885421 112457789999999988774 5666654432
Q ss_pred C-e---EEEEEEecCC-CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeec
Q 028681 90 T-H---LAIVMEYASG-GELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFG 164 (205)
Q Consensus 90 ~-~---~~lv~~~~~~-~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~ 164 (205)
. . .+++++++++ .+|.+++.. .+++.. .+.+++.++.+||+.||+|+||+|.||+++.++. ++|+|||
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~-~~l~~~----~~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~--v~LIDfg 187 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQE-APLSEE----QWQAIGQLIARFHDAGVYHADLNAHNILLDPDGK--FWLIDFD 187 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhc-CCCCHH----HHHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCC--EEEEECC
Confidence 2 2 3599999986 688887754 345554 3568999999999999999999999999987765 9999999
Q ss_pred cccccc
Q 028681 165 YSKSSV 170 (205)
Q Consensus 165 ~~~~~~ 170 (205)
.+....
T Consensus 188 ~~~~~~ 193 (239)
T PRK01723 188 RGELRT 193 (239)
T ss_pred CcccCC
Confidence 887544
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.1e-17 Score=113.99 Aligned_cols=133 Identities=23% Similarity=0.268 Sum_probs=110.4
Q ss_pred EEeeeccccceeEEEEEecCCCcEEEEEEeecCccchHHHHHHHHHHHhcCC--CCeeEEEEEEEeCCeEEEEEEecCCC
Q 028681 25 LVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRH--PNIVRFKEVILTPTHLAIVMEYASGG 102 (205)
Q Consensus 25 ~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h--~~i~~~~~~~~~~~~~~lv~~~~~~~ 102 (205)
+++.|++|.++.||.+.... ..+++|....... ...+..|...++.+++ .++++++.+...++..+++++++++.
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~--~~~~iK~~~~~~~-~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~ 78 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD--EDYVLKINPSREK-GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE 78 (155)
T ss_pred cceecccccccceEEEEecC--CeEEEEecCCCCc-hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence 46789999999999999865 6789998876543 5678889999999976 58889988888778899999999887
Q ss_pred chHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhc---CcEeecCCCCCeEecCCCCCcEEEeeecccccc
Q 028681 103 ELFERICNAGRFSEDEARFFFQQLISGVSYCHSM---QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 169 (205)
Q Consensus 103 sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~i~H~di~p~nili~~~~~~~~~l~df~~~~~~ 169 (205)
.+... +......++.+++.++..+|.. +++|+|++|+||++++++. +++.||+.+...
T Consensus 79 ~~~~~-------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~--~~l~Df~~~~~~ 139 (155)
T cd05120 79 TLDEV-------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKI--LGIIDWEYAGYG 139 (155)
T ss_pred ecccC-------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcE--EEEEecccccCC
Confidence 66543 5566777889999999999984 7999999999999987555 999999988643
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.6e-19 Score=129.68 Aligned_cols=180 Identities=21% Similarity=0.342 Sum_probs=144.7
Q ss_pred ecCCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCc---cchHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEE
Q 028681 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 94 (205)
Q Consensus 18 ~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 94 (205)
.+.+...+..+|.+...|..|+++++.+ .++.|+++..+ .....|.+|.-.|+-+.||||++++|.|.++....+
T Consensus 187 id~~~lnl~tkl~e~hsgelwrgrwqgn--divakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~ 264 (448)
T KOG0195|consen 187 IDVSSLNLITKLAESHSGELWRGRWQGN--DIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVI 264 (448)
T ss_pred cchhhhhhhhhhccCCCcccccccccCc--chhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceE
Confidence 3456677888999999999999988754 46778776543 345679999999999999999999999999999999
Q ss_pred EEEecCCCchHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhc-CcEee-cCCCCCeEecCCCCCcEEEeeeccccccc
Q 028681 95 VMEYASGGELFERICNAGR--FSEDEARFFFQQLISGVSYCHSM-QVCHR-DLKLENTLLDGSPAPRLKICDFGYSKSSV 170 (205)
Q Consensus 95 v~~~~~~~sl~~~~~~~~~--~~~~~~~~i~~~i~~~l~~lh~~-~i~H~-di~p~nili~~~~~~~~~l~df~~~~~~~ 170 (205)
+..|++.+||...+..... ....++..++..++.+++|||+. .++.+ -++...++++++-..++..+|--++
T Consensus 265 isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kfs---- 340 (448)
T KOG0195|consen 265 ISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFS---- 340 (448)
T ss_pred eeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceee----
Confidence 9999999999999977553 77788999999999999999986 44444 6888999999888766666664332
Q ss_pred CCCCCCCCCCCCCccCCceeccCcCC--CeeeEEEeC
Q 028681 171 LHSQPKSTVGTPAYIAPEVLLKKEYD--GKVMCVYVI 205 (205)
Q Consensus 171 ~~~~~~~~~~~~~~~aPE~~~~~~~~--~~~~Dvwsl 205 (205)
.+.....-++.|++||.+.+++.+ ..++|+|||
T Consensus 341 --fqe~gr~y~pawmspealqrkped~n~raadmwsf 375 (448)
T KOG0195|consen 341 --FQEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSF 375 (448)
T ss_pred --eeccccccCcccCCHHHHhcCchhcchhhhhHHHH
Confidence 233444567899999999987653 446999996
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.73 E-value=2.8e-19 Score=140.75 Aligned_cols=169 Identities=27% Similarity=0.434 Sum_probs=138.2
Q ss_pred eccccceeEEEEEec---CCCcEEEEEEeecCccc---hHHHHHHHHHHHhcC-CCCeeEEEEEEEeCCeEEEEEEecCC
Q 028681 29 IGSGNFGVARLMRDK---KTEELVAVKYIERGDKI---DENVQREIINHRSLR-HPNIVRFKEVILTPTHLAIVMEYASG 101 (205)
Q Consensus 29 l~~g~~g~v~~~~~~---~~~~~v~iK~~~~~~~~---~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~~~~~~ 101 (205)
+|+|.+|.|+++.-. ..+..+++|..++.... ......|..++...+ |+.++++...++.+...+++.+++.+
T Consensus 2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~rg 81 (612)
T KOG0603|consen 2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLRG 81 (612)
T ss_pred CCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhccc
Confidence 688999999877643 34677888877653211 124455666777776 99999999999999999999999998
Q ss_pred CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCCCCCCCCCCC
Q 028681 102 GELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGT 181 (205)
Q Consensus 102 ~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~ 181 (205)
+.+-..+.....+.+.....+...++.+++++|+.+++++|+|++||+++.++. +++.|||.++........ +|+
T Consensus 82 g~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Gh--i~~tdfglske~v~~~~~---cgt 156 (612)
T KOG0603|consen 82 GDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGH--IKLTDFGLSKEAVKEKIA---CGT 156 (612)
T ss_pred chhhhccccCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCc--cccCCchhhhHhHhhhhc---ccc
Confidence 888777777777889999999999999999999999999999999999999988 999999998765443333 899
Q ss_pred CCccCCceeccCcCCCeeeEEEeC
Q 028681 182 PAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 182 ~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
..|+|||++. ... +.+|+|||
T Consensus 157 ~eymApEI~~--gh~-~a~D~ws~ 177 (612)
T KOG0603|consen 157 YEYRAPEIIN--GHL-SAADWWSF 177 (612)
T ss_pred hhhhhhHhhh--ccC-Ccccchhh
Confidence 9999999998 333 34899996
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.72 E-value=3.7e-19 Score=147.56 Aligned_cols=176 Identities=26% Similarity=0.385 Sum_probs=133.8
Q ss_pred CcccCceecCCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCccc--hHHHH---HHHHHHHhcCCCCeeEEEEE
Q 028681 11 GMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI--DENVQ---REIINHRSLRHPNIVRFKEV 85 (205)
Q Consensus 11 ~~~~~~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~--~~~~~---~e~~~l~~l~h~~i~~~~~~ 85 (205)
+.+.-+.+....+...+.||++.|=++.++++.+ |. |++|++-+.+.. -+.+. .++. ...+++||++++..+
T Consensus 13 ~~e~yfsd~~~e~~~~~~LGstRFlKv~r~k~~e-G~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~ 89 (1431)
T KOG1240|consen 13 PVEVYFSDLSVECHYVENLGSTRFLKVARAKDRE-GL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKV 89 (1431)
T ss_pred hHHHHhhcCccceeeecccCchhhhhhhhccCCC-ce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHH
Confidence 3344455555689999999999999999998775 33 889988765432 23333 3333 456689999999888
Q ss_pred EEeCCeEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecc
Q 028681 86 ILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGY 165 (205)
Q Consensus 86 ~~~~~~~~lv~~~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~ 165 (205)
-+.++..|+|-+|. ..+|.+++...+-+..-+.+.|++|++.|+..+|+.||+|||||.+|||+..=+. +.|+||..
T Consensus 90 ~~t~kAAylvRqyv-khnLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW--~~LtDFAs 166 (1431)
T KOG1240|consen 90 LVTDKAAYLVRQYV-KHNLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNW--LYLTDFAS 166 (1431)
T ss_pred HHhhHHHHHHHHHH-hhhhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeech--hhhhcccc
Confidence 77777788888887 4589999987777888999999999999999999999999999999999976666 99999987
Q ss_pred cccccCCCCCCC--------CCCCCCccCCceecc
Q 028681 166 SKSSVLHSQPKS--------TVGTPAYIAPEVLLK 192 (205)
Q Consensus 166 ~~~~~~~~~~~~--------~~~~~~~~aPE~~~~ 192 (205)
.+.......... .....+|.|||-+..
T Consensus 167 FKPtYLPeDNPadf~fFFDTSrRRtCYiAPERFv~ 201 (1431)
T KOG1240|consen 167 FKPTYLPEDNPADFTFFFDTSRRRTCYIAPERFVS 201 (1431)
T ss_pred cCCccCCCCCcccceEEEecCCceeeecChHhhhc
Confidence 654322211111 123357999999975
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.71 E-value=1.3e-17 Score=116.66 Aligned_cols=89 Identities=22% Similarity=0.241 Sum_probs=75.4
Q ss_pred CchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCCCCCCCCCC
Q 028681 102 GELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 180 (205)
Q Consensus 102 ~sl~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~~~~~~~ 180 (205)
|+|.+.+.. +.++++.+++.++.|++.||.|||+.+ +|+||+++.++. +++ ||.+....... ..+
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~--~~~--fG~~~~~~~~~----~~g 66 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGL--LKL--DGSVAFKTPEQ----SRV 66 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccc--eee--ccceEeecccc----CCC
Confidence 578888876 456999999999999999999999998 999999988776 777 99886554322 258
Q ss_pred CCCccCCceeccCcCCCeeeEEEeC
Q 028681 181 TPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 181 ~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
++.|+|||++.+..++.+ +|||||
T Consensus 67 ~~~y~aPE~~~~~~~~~~-~DiwSl 90 (176)
T smart00750 67 DPYFMAPEVIQGQSYTEK-ADIYSL 90 (176)
T ss_pred cccccChHHhcCCCCcch-hhHHHH
Confidence 899999999999888765 999996
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.68 E-value=3.7e-17 Score=120.83 Aligned_cols=179 Identities=21% Similarity=0.191 Sum_probs=109.3
Q ss_pred CCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCcc----chHHHHHHHHHHHhcC----------CCCeeEEEEEE
Q 028681 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK----IDENVQREIINHRSLR----------HPNIVRFKEVI 86 (205)
Q Consensus 21 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~----------h~~i~~~~~~~ 86 (205)
-.+...+.||.|+++.||.+++.+++..+++|.+.-... ..+++++|......+. |-.++-..+..
T Consensus 12 r~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~ 91 (288)
T PF14531_consen 12 RTLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLL 91 (288)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEE
T ss_pred eEEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEE
Confidence 456789999999999999999999999999999864332 2244555554444432 21233333333
Q ss_pred EeC------------C-----eEEEEEEecCCCchHHHHH---hcCCC----CHHHHHHHHHHHHHHHHHHHhcCcEeec
Q 028681 87 LTP------------T-----HLAIVMEYASGGELFERIC---NAGRF----SEDEARFFFQQLISGVSYCHSMQVCHRD 142 (205)
Q Consensus 87 ~~~------------~-----~~~lv~~~~~~~sl~~~~~---~~~~~----~~~~~~~i~~~i~~~l~~lh~~~i~H~d 142 (205)
.-. . +.+++|+.+. .+|..++. ..... .......+..|+++.+++||..|++|+|
T Consensus 92 ~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~-~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgd 170 (288)
T PF14531_consen 92 RIPGKPPFFERGPGQSIYWVLNRFLLMPRAQ-GDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGD 170 (288)
T ss_dssp EETTS-SEEEECETTEEEEEESEEEEEE--S-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST
T ss_pred EEcCCCcceecCCCCccceeehhhhccchhh-hcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEecc
Confidence 211 1 2356677664 46766653 22222 1222334558999999999999999999
Q ss_pred CCCCCeEecCCCCCcEEEeeecccccccCCCCCCCCCCCCCccCCceeccC--------cCCCeeeEEEeC
Q 028681 143 LKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKK--------EYDGKVMCVYVI 205 (205)
Q Consensus 143 i~p~nili~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~--------~~~~~~~Dvwsl 205 (205)
|+|+|++++.++. +.|+||+.....+..... ...+..|.+||..... .++. +.|.|+|
T Consensus 171 i~~~nfll~~~G~--v~Lg~F~~~~r~g~~~~~--~~~~~~~~PPe~~~~~~~~~~~~~~~t~-~~DaW~L 236 (288)
T PF14531_consen 171 IKPENFLLDQDGG--VFLGDFSSLVRAGTRYRC--SEFPVAFTPPELESCAGQFGQNNAPYTF-ATDAWQL 236 (288)
T ss_dssp -SGGGEEE-TTS---EEE--GGGEEETTEEEEG--GGS-TTTS-HHHHHHHTSCHHSEEEE-H-HHHHHHH
T ss_pred cceeeEEEcCCCC--EEEcChHHHeecCceeec--cCCCcccCChhhhhhhcccCcccceeee-ccCHHHH
Confidence 9999999999988 999999987655443332 2344778899977542 2333 3677764
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.64 E-value=5e-15 Score=104.20 Aligned_cols=136 Identities=15% Similarity=0.159 Sum_probs=98.4
Q ss_pred eeeccccceeEEEEEecC------CCcEEEEEEeecC-------------cc----------chH----HHHHHHHHHHh
Q 028681 27 RDIGSGNFGVARLMRDKK------TEELVAVKYIERG-------------DK----------IDE----NVQREIINHRS 73 (205)
Q Consensus 27 ~~l~~g~~g~v~~~~~~~------~~~~v~iK~~~~~-------------~~----------~~~----~~~~e~~~l~~ 73 (205)
..|+.|..+.||.+.... .+..+|+|+++.. +. ... +...|+..|++
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 578999999999998654 3578999998531 10 011 23478888888
Q ss_pred cCC--CCeeEEEEEEEeCCeEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHH-HhcCcEeecCCCCCeEe
Q 028681 74 LRH--PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYC-HSMQVCHRDLKLENTLL 150 (205)
Q Consensus 74 l~h--~~i~~~~~~~~~~~~~~lv~~~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~l-h~~~i~H~di~p~nili 150 (205)
+.. -+++.++++ ...+++||++.+..+.....+...++..+...+..+++.++..| |+.|++|||+++.||++
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~NIL~ 158 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYNMLW 158 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE
Confidence 854 345556553 45678999997643322222333466667788889999999988 89999999999999999
Q ss_pred cCCCCCcEEEeeecccccc
Q 028681 151 DGSPAPRLKICDFGYSKSS 169 (205)
Q Consensus 151 ~~~~~~~~~l~df~~~~~~ 169 (205)
.+ +. +.|+||+.+...
T Consensus 159 ~~-~~--v~iIDF~qav~~ 174 (197)
T cd05146 159 HD-GK--VWFIDVSQSVEP 174 (197)
T ss_pred EC-Cc--EEEEECCCceeC
Confidence 74 33 999999988543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.62 E-value=1.5e-15 Score=114.53 Aligned_cols=128 Identities=29% Similarity=0.404 Sum_probs=96.5
Q ss_pred CCCCeeEEEEEEEeC---------------------------CeEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHH
Q 028681 75 RHPNIVRFKEVILTP---------------------------THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLI 127 (205)
Q Consensus 75 ~h~~i~~~~~~~~~~---------------------------~~~~lv~~~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~ 127 (205)
+||||+.+.++|.+. ..+|+||..++. +|.+++-. +..+....+-++.|++
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~-~~~s~r~~~~~laQlL 351 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWT-RHRSYRTGRVILAQLL 351 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhc-CCCchHHHHHHHHHHH
Confidence 499999999887642 247889988854 78877743 4578888899999999
Q ss_pred HHHHHHHhcCcEeecCCCCCeEe--cCCCCCcEEEeeecccccccC-------CCCCCCCCCCCCccCCceeccCc----
Q 028681 128 SGVSYCHSMQVCHRDLKLENTLL--DGSPAPRLKICDFGYSKSSVL-------HSQPKSTVGTPAYIAPEVLLKKE---- 194 (205)
Q Consensus 128 ~~l~~lh~~~i~H~di~p~nili--~~~~~~~~~l~df~~~~~~~~-------~~~~~~~~~~~~~~aPE~~~~~~---- 194 (205)
.|+.|||++|+.|+|+|.+||++ ++|..+.+.+.|||++-.... .+.....-|.-.-+|||+....+
T Consensus 352 Eav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~a 431 (598)
T KOG4158|consen 352 EAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNA 431 (598)
T ss_pred HHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCCCce
Confidence 99999999999999999999998 566667799999998743221 11122234666789999997432
Q ss_pred -CCCeeeEEEe
Q 028681 195 -YDGKVMCVYV 204 (205)
Q Consensus 195 -~~~~~~Dvws 204 (205)
.+..++|.|+
T Consensus 432 vvny~kAD~WA 442 (598)
T KOG4158|consen 432 VVNYEKADTWA 442 (598)
T ss_pred eeccchhhhhh
Confidence 2334589996
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.61 E-value=9.7e-15 Score=101.56 Aligned_cols=129 Identities=19% Similarity=0.246 Sum_probs=94.7
Q ss_pred EeeeccccceeEEEEEecCCCcEEEEEEeecCccchHHHHHHHHHHHhcCCCCe-eEEEEEEEeCCeEEEEEEecCCCch
Q 028681 26 VRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNI-VRFKEVILTPTHLAIVMEYASGGEL 104 (205)
Q Consensus 26 ~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i-~~~~~~~~~~~~~~lv~~~~~~~sl 104 (205)
.+.|+.|..+.+|.+... +..+++|...........+..|+..++.+.+.++ .+++... ....+++||++++.++
T Consensus 3 ~~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l 78 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTELLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSEL 78 (170)
T ss_pred eeecCCcccCceEEEEEC--CeEEEEEeCCCCcccccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCcc
Confidence 467888999999999865 6679999876554333446788888888865443 3454433 3335799999999877
Q ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCc-----EeecCCCCCeEecCCCCCcEEEeeecccccc
Q 028681 105 FERICNAGRFSEDEARFFFQQLISGVSYCHSMQV-----CHRDLKLENTLLDGSPAPRLKICDFGYSKSS 169 (205)
Q Consensus 105 ~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i-----~H~di~p~nili~~~~~~~~~l~df~~~~~~ 169 (205)
.+. ......++.+++.++..||+.++ +|+|++|.||+++ ++. ++++||+.+...
T Consensus 79 ~~~--------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~--~~liDf~~a~~~ 137 (170)
T cd05151 79 LTE--------DFSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGR--LWLIDWEYAGMN 137 (170)
T ss_pred ccc--------cccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCe--EEEEecccccCC
Confidence 543 01123456789999999999885 9999999999998 444 899999988643
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.61 E-value=4e-16 Score=129.38 Aligned_cols=147 Identities=33% Similarity=0.554 Sum_probs=102.9
Q ss_pred CCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCccchHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEEec
Q 028681 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA 99 (205)
Q Consensus 20 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~~ 99 (205)
.++|...+.|..|++|.||.++++.+.+.+++| ++++...... ++.....|.+ |
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~lilRn------ilt~a~npfv---------------v---- 135 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQNLILRN------ILTFAGNPFV---------------V---- 135 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhhc-ccccchhhhc------cccccCCcce---------------e----
Confidence 588999999999999999999999999999995 5543321100 1111122222 2
Q ss_pred CCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCC-------
Q 028681 100 SGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH------- 172 (205)
Q Consensus 100 ~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~------- 172 (205)
+.=...++..++++.. ++.+++|||..||+|+|++|+|.+|..-++ +|++|||+++.....
T Consensus 136 --gDc~tllk~~g~lPvd--------mvla~Eylh~ygivhrdlkpdnllIT~mGh--iKlTDfgLsk~GLms~atnl~e 203 (1205)
T KOG0606|consen 136 --GDCATLLKNIGPLPVD--------MVLAVEYLHSYGIVHRDLKPDNLLITSMGH--IKLTDFGLSKKGLMSLATNLKE 203 (1205)
T ss_pred --chhhhhcccCCCCcch--------hhHHhHhhccCCeecCCCCCCcceeeeccc--ccccchhhhhhhhhhccchhhh
Confidence 1112223332333322 288999999999999999999999987777 999999998643211
Q ss_pred ---------CCCCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 173 ---------SQPKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 173 ---------~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
......+||+.|.|||++..+.|. |+.|||++
T Consensus 204 g~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgyg-kpvdwwam 244 (1205)
T KOG0606|consen 204 GHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYG-KPVDWWAM 244 (1205)
T ss_pred cchHHHHHHhhhccccCCccccChhhhhhhccC-CCccHHHH
Confidence 112233689999999999999997 55999984
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.59 E-value=2.7e-14 Score=112.94 Aligned_cols=138 Identities=17% Similarity=0.162 Sum_probs=92.6
Q ss_pred eeeccccceeEEEEEecCCCcEEEEEEeecCccch-------------------------------H----------HHH
Q 028681 27 RDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID-------------------------------E----------NVQ 65 (205)
Q Consensus 27 ~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~-------------------------------~----------~~~ 65 (205)
+.|+.|++|+||+++.. +|+.||||+..++-... + .+.
T Consensus 123 ~plasaSigQVh~A~l~-~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 123 KPLAAASIAQVHRARLV-DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred cceeeeehhheEEEEec-CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 67999999999999876 57899999986541100 0 122
Q ss_pred HHHHHHHhcC-----CCCeeEEEEEEEeCCeEEEEEEecCCCchHHHHHhc-CCCCHHHHHHHHHHHHH-HHHHHHhcCc
Q 028681 66 REIINHRSLR-----HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLIS-GVSYCHSMQV 138 (205)
Q Consensus 66 ~e~~~l~~l~-----h~~i~~~~~~~~~~~~~~lv~~~~~~~sl~~~~~~~-~~~~~~~~~~i~~~i~~-~l~~lh~~~i 138 (205)
.|...+..+. ++++.-..-++......+++|||+++.++.+..... .... ...++.+++. .+..+|..|+
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~~l~ql~~~g~ 278 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARSFLNQVLRDGF 278 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHHHHHHHHhCCc
Confidence 2333343332 233221111222234578999999999998776432 1222 2345555555 4678899999
Q ss_pred EeecCCCCCeEecCCCCCcEEEeeeccccccc
Q 028681 139 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 170 (205)
Q Consensus 139 ~H~di~p~nili~~~~~~~~~l~df~~~~~~~ 170 (205)
+|+|++|.||++..++. ++++|||++....
T Consensus 279 ~H~D~hPgNilv~~~g~--i~liDfG~~~~l~ 308 (437)
T TIGR01982 279 FHADLHPGNIFVLKDGK--IIALDFGIVGRLS 308 (437)
T ss_pred eeCCCCcccEEECCCCc--EEEEeCCCeeECC
Confidence 99999999999987776 9999999986554
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.55 E-value=9.2e-16 Score=125.02 Aligned_cols=186 Identities=34% Similarity=0.511 Sum_probs=147.7
Q ss_pred cCCCeEEEeeeccccceeEEEEEecCC-CcEEEEEEeecCc---cchHHHHHHHHHHHhcC-CCCeeEEEEEEEeCCeEE
Q 028681 19 DSDRYELVRDIGSGNFGVARLMRDKKT-EELVAVKYIERGD---KIDENVQREIINHRSLR-HPNIVRFKEVILTPTHLA 93 (205)
Q Consensus 19 ~~~~y~~~~~l~~g~~g~v~~~~~~~~-~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~ 93 (205)
....|.+.+.||+|+++.+..+....+ ...++.|.+.... ...+....|..+...+. |.|++..++...+....+
T Consensus 18 ~~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~ 97 (601)
T KOG0590|consen 18 PNSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYL 97 (601)
T ss_pred ccccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccc
Confidence 367899999999999999888776543 3455666555433 22344555777777776 999999999999999999
Q ss_pred EEEEecCCCchHHHH-HhcC-CCCHHHHHHHHHHHHHHHHHHH-hcCcEeecCCCCCeEecCCCCCcEEEeeeccccccc
Q 028681 94 IVMEYASGGELFERI-CNAG-RFSEDEARFFFQQLISGVSYCH-SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 170 (205)
Q Consensus 94 lv~~~~~~~sl~~~~-~~~~-~~~~~~~~~i~~~i~~~l~~lh-~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~ 170 (205)
+.+++..++++-+.+ .... ..+......++.|+..++.|+| ..++.|+||+|+|.+++..+. .+++.|||+|..+.
T Consensus 98 ~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~-~l~~~df~~At~~~ 176 (601)
T KOG0590|consen 98 LSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGS-ALKIADFGLATAYR 176 (601)
T ss_pred cccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCC-cccCCCchhhcccc
Confidence 999998888887777 4444 5777888999999999999999 999999999999999988872 28999999997665
Q ss_pred C-CCC---CCCCCC-CCCccCCceeccCcCCCeeeEEEeC
Q 028681 171 L-HSQ---PKSTVG-TPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 171 ~-~~~---~~~~~~-~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
. ... .....| ++.|+|||.+.+..+..+..|+||.
T Consensus 177 ~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~ 216 (601)
T KOG0590|consen 177 NKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSL 216 (601)
T ss_pred ccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccc
Confidence 5 222 223357 9999999999997777777999984
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.54 E-value=4.5e-15 Score=119.00 Aligned_cols=147 Identities=23% Similarity=0.279 Sum_probs=94.4
Q ss_pred eecCCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCccc-----------------------------------h
Q 028681 17 MHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI-----------------------------------D 61 (205)
Q Consensus 17 ~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~-----------------------------------~ 61 (205)
...+..|.. +.|++|++|+||.++...+|+.||+|+..++-.. .
T Consensus 116 ~~~F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~ 194 (537)
T PRK04750 116 EEWFDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFE 194 (537)
T ss_pred HHHHHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHH
Confidence 334566776 8999999999999999888999999999754100 0
Q ss_pred HH------HHHHHHHHHhcC----CCCeeEEEEEE-EeCCeEEEEEEecCCCchHHHH--HhcC----CCCHHHHHHHHH
Q 028681 62 EN------VQREIINHRSLR----HPNIVRFKEVI-LTPTHLAIVMEYASGGELFERI--CNAG----RFSEDEARFFFQ 124 (205)
Q Consensus 62 ~~------~~~e~~~l~~l~----h~~i~~~~~~~-~~~~~~~lv~~~~~~~sl~~~~--~~~~----~~~~~~~~~i~~ 124 (205)
+. +..|...+.++. +...+.+=.++ ......+++|||+.|..+.+.. ...+ .+....+..++.
T Consensus 195 ~~l~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~ 274 (537)
T PRK04750 195 KTLHDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFT 274 (537)
T ss_pred HHHHHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHH
Confidence 11 222333333332 22222222222 2245678999999999887643 2222 133333334444
Q ss_pred HHHHHHHHHHhcCcEeecCCCCCeEecCCC--CCcEEEeeecccccccC
Q 028681 125 QLISGVSYCHSMQVCHRDLKLENTLLDGSP--APRLKICDFGYSKSSVL 171 (205)
Q Consensus 125 ~i~~~l~~lh~~~i~H~di~p~nili~~~~--~~~~~l~df~~~~~~~~ 171 (205)
|+ ...|++|+|++|.||+++.++ .++++++|||++...+.
T Consensus 275 Qi-------f~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 275 QV-------FRDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred HH-------HhCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 44 468999999999999998776 12499999999865543
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.50 E-value=1.1e-12 Score=89.73 Aligned_cols=141 Identities=16% Similarity=0.101 Sum_probs=104.6
Q ss_pred EEeeeccccceeEEEEEecCCCcEEEEEEeecC---------ccchHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEE
Q 028681 25 LVRDIGSGNFGVARLMRDKKTEELVAVKYIERG---------DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV 95 (205)
Q Consensus 25 ~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~---------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 95 (205)
.+..+.||+.+.|+.+... |+.+++|.-... .....+...|...+.++.--.|.-..-++.+...-.+.
T Consensus 11 ~l~likQGAEArv~~~~~~--Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ 88 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFS--GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIY 88 (229)
T ss_pred cceeeeccceeeEeeeccC--CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEE
Confidence 5678889999998888765 666777754321 12235677889999888655555555566777777899
Q ss_pred EEecCC-CchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCC-cEEEeeecccc
Q 028681 96 MEYASG-GELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAP-RLKICDFGYSK 167 (205)
Q Consensus 96 ~~~~~~-~sl~~~~~~~~--~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~-~~~l~df~~~~ 167 (205)
|||+++ .++.+++.... +...+....+++++-..+.-||..+|+||||..+||++..++.. .+.++|||++.
T Consensus 89 ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~ 164 (229)
T KOG3087|consen 89 MEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSS 164 (229)
T ss_pred EEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchh
Confidence 999976 46777775532 23344447899999999999999999999999999999766654 35899999875
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.50 E-value=6.9e-13 Score=90.93 Aligned_cols=130 Identities=22% Similarity=0.172 Sum_probs=97.2
Q ss_pred eeeccccceeEEEEEecCCCcEEEEEEeecCc---------cchHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEE
Q 028681 27 RDIGSGNFGVARLMRDKKTEELVAVKYIERGD---------KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (205)
Q Consensus 27 ~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~---------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~ 97 (205)
..+++|+...++.+... |..+++|.-.+.. ...++...|..++..+.-..+....=+..++....++||
T Consensus 2 ~~i~~GAEa~i~~~~~~--g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me 79 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL--GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVME 79 (204)
T ss_pred chhhCCcceeEEeeecc--CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEE
Confidence 45789999999888654 4446666532211 112456778899988876666555556677778889999
Q ss_pred ecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeeccccc
Q 028681 98 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 168 (205)
Q Consensus 98 ~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~ 168 (205)
|+++..|.+.+... ...++..+-.-+.-||..||+|||+.++||++..++ +.++|||++..
T Consensus 80 ~I~G~~lkd~l~~~-------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~---i~~IDfGLg~~ 140 (204)
T COG3642 80 YIEGELLKDALEEA-------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGR---IYFIDFGLGEF 140 (204)
T ss_pred EeCChhHHHHHHhc-------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCc---EEEEECCcccc
Confidence 99998888888664 144666666677789999999999999999997555 89999999864
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.48 E-value=4.7e-14 Score=110.87 Aligned_cols=133 Identities=23% Similarity=0.318 Sum_probs=108.8
Q ss_pred HHhcCCCCeeEEEEEEEeCCeEEEEEEecCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCc-EeecCCCCCe
Q 028681 71 HRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQV-CHRDLKLENT 148 (205)
Q Consensus 71 l~~l~h~~i~~~~~~~~~~~~~~lv~~~~~~~sl~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~i-~H~di~p~ni 148 (205)
++.+.|.|+.+++|.+.++...+.+.+++..++|.+.+.. ...++......+.+.++.|+.|||...| .|+.+++.|.
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nC 80 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNC 80 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccc
Confidence 3578899999999999999999999999999999999977 4468888999999999999999998765 8999999999
Q ss_pred EecCCCCCcEEEeeecccccccCC---CCCCCCCCCCCccCCceeccCcC------CCeeeEEEeC
Q 028681 149 LLDGSPAPRLKICDFGYSKSSVLH---SQPKSTVGTPAYIAPEVLLKKEY------DGKVMCVYVI 205 (205)
Q Consensus 149 li~~~~~~~~~l~df~~~~~~~~~---~~~~~~~~~~~~~aPE~~~~~~~------~~~~~Dvwsl 205 (205)
+++.... +||.|||+....... ..........-|.|||.+..... .++++|+|||
T Consensus 81 lvd~~w~--lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~ 144 (484)
T KOG1023|consen 81 LVDSRWV--LKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSF 144 (484)
T ss_pred eeeeeEE--EEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehH
Confidence 9987777 999999987655321 11111224567999999987421 2456999986
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.42 E-value=3.8e-12 Score=92.22 Aligned_cols=141 Identities=20% Similarity=0.268 Sum_probs=99.1
Q ss_pred eeeccccceeEEEEEecCCCcEEEEEEeecCcc--chHHHHHHHHHHHhcCCCC--eeEEEEEEEeCC---eEEEEEEec
Q 028681 27 RDIGSGNFGVARLMRDKKTEELVAVKYIERGDK--IDENVQREIINHRSLRHPN--IVRFKEVILTPT---HLAIVMEYA 99 (205)
Q Consensus 27 ~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~h~~--i~~~~~~~~~~~---~~~lv~~~~ 99 (205)
+.|+.|..+.+|++.... |..+++|....... ....+..|...++.+.+.+ +.+++.+..... ..+++|+++
T Consensus 4 ~~l~~G~~n~~~~v~~~~-g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i 82 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGG-GRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERV 82 (223)
T ss_pred eecCCCccceEEEEEecC-CcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEe
Confidence 568899999999998754 57899998766443 3567888999999887633 566666665532 568999999
Q ss_pred CCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh--------------------------------------------
Q 028681 100 SGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS-------------------------------------------- 135 (205)
Q Consensus 100 ~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~-------------------------------------------- 135 (205)
++.++.+.+.. ..+++.....++.+++.++..||+
T Consensus 83 ~G~~l~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (223)
T cd05154 83 DGRVLRDRLLR-PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERLL 161 (223)
T ss_pred CCEecCCCCCC-CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHHH
Confidence 88777654421 235555555555555555555552
Q ss_pred ------------cCcEeecCCCCCeEecCCCCCcEEEeeecccccc
Q 028681 136 ------------MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 169 (205)
Q Consensus 136 ------------~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~ 169 (205)
..++|+|++|.||+++.+....+.|+||+.+...
T Consensus 162 ~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~g 207 (223)
T cd05154 162 RWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATLG 207 (223)
T ss_pred HHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccccC
Confidence 3578999999999998732223789999977543
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.41 E-value=1.8e-12 Score=103.73 Aligned_cols=146 Identities=18% Similarity=0.239 Sum_probs=112.1
Q ss_pred EEecCCCcEEEEEEeecCcc-chHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEEecCCCchHHHHHhcCCCCHHH
Q 028681 40 MRDKKTEELVAVKYIERGDK-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDE 118 (205)
Q Consensus 40 ~~~~~~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~~~~~sl~~~~~~~~~~~~~~ 118 (205)
+..+.++.+|.+..++.... ..+...+-+..++.++||||++++..++.++..|+|+|.+. .|...+.. ++...
T Consensus 31 ~t~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~---l~~~~ 105 (690)
T KOG1243|consen 31 GTRKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE---LGKEE 105 (690)
T ss_pred cceeccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH---hHHHH
Confidence 45566788888888876554 23556778889999999999999999999999999999874 46666655 44778
Q ss_pred HHHHHHHHHHHHHHHH-hcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCCC-CCCCCCCCCCccCCceecc
Q 028681 119 ARFFFQQLISGVSYCH-SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKSTVGTPAYIAPEVLLK 192 (205)
Q Consensus 119 ~~~i~~~i~~~l~~lh-~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~ 192 (205)
+...++||+.||.+|| +++++|+|++.+-|+++..+. .+|++|..+....... .......-..|..|+.+..
T Consensus 106 v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~Ge--WkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~~~~ 179 (690)
T KOG1243|consen 106 VCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGE--WKLGGLELVSKASGFNAPAKSLYLIESFDDPEEIDP 179 (690)
T ss_pred HHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCc--EEEeeeEEEeccccCCcccccchhhhcccChhhcCc
Confidence 8889999999999997 789999999999999999888 9999999875433222 1222233344566665443
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.41 E-value=1.7e-14 Score=112.05 Aligned_cols=109 Identities=28% Similarity=0.386 Sum_probs=91.6
Q ss_pred eEEEEEEecCCCchHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccc
Q 028681 91 HLAIVMEYASGGELFERICNAG---RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 167 (205)
Q Consensus 91 ~~~lv~~~~~~~sl~~~~~~~~---~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~ 167 (205)
++++.|+++.-.+|.+.+.... ..+......++.|+..+++| ++.+|+|++|.||++..+.. ++|+|||+..
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q--~kIgDFgl~t 404 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQ--LKIGDFGLVT 404 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchh--hhhhhhhhee
Confidence 5788899999999999996543 36667788899999999999 99999999999999987776 9999999875
Q ss_pred cccCCC-------CCCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 168 SSVLHS-------QPKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 168 ~~~~~~-------~~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
...... .+....||..||+||.+.++.|+.+ +|||||
T Consensus 405 s~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~k-vdIyaL 448 (516)
T KOG1033|consen 405 SQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEK-VDIYAL 448 (516)
T ss_pred ecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhh-cchhhH
Confidence 443333 4455679999999999999999877 999986
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.37 E-value=6.2e-11 Score=87.89 Aligned_cols=130 Identities=13% Similarity=0.049 Sum_probs=91.2
Q ss_pred EEEEEecCCCcEEEEEEeecCcc------------chHHHHHHHHHHHhcCCCCe--eEEEEEEEe-----CCeEEEEEE
Q 028681 37 ARLMRDKKTEELVAVKYIERGDK------------IDENVQREIINHRSLRHPNI--VRFKEVILT-----PTHLAIVME 97 (205)
Q Consensus 37 v~~~~~~~~~~~v~iK~~~~~~~------------~~~~~~~e~~~l~~l~h~~i--~~~~~~~~~-----~~~~~lv~~ 97 (205)
|+.+.. .|+.+.+|....... ....+..|...+..+...+| +.+.++.+. ....++|+|
T Consensus 38 vvr~~~--~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVte 115 (268)
T PRK15123 38 TLRFEL--AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIITE 115 (268)
T ss_pred EEEEEE--CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEEe
Confidence 444433 356788886643220 01146788888888854333 233444432 234779999
Q ss_pred ecCCC-chHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecC-----CCCCcEEEeeeccccc
Q 028681 98 YASGG-ELFERICN--AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDG-----SPAPRLKICDFGYSKS 168 (205)
Q Consensus 98 ~~~~~-sl~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~-----~~~~~~~l~df~~~~~ 168 (205)
++++. +|.+++.. ..+.+......++.++...+.-||+.|++|+|++++||+++. ++...+.|+||+-+..
T Consensus 116 ~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~~ 194 (268)
T PRK15123 116 DLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQI 194 (268)
T ss_pred eCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCcccc
Confidence 99875 78888753 345667778899999999999999999999999999999975 2334599999997753
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.33 E-value=1.4e-11 Score=86.47 Aligned_cols=123 Identities=27% Similarity=0.308 Sum_probs=79.2
Q ss_pred EEEEEecCCCcEEEEEEeecC--------------cc-------------chHHHHHHHHHHHhcCCC--CeeEEEEEEE
Q 028681 37 ARLMRDKKTEELVAVKYIERG--------------DK-------------IDENVQREIINHRSLRHP--NIVRFKEVIL 87 (205)
Q Consensus 37 v~~~~~~~~~~~v~iK~~~~~--------------~~-------------~~~~~~~e~~~l~~l~h~--~i~~~~~~~~ 87 (205)
||.+...+ +..+|+|+...+ .. ...+...|...|..+... ++++++++.
T Consensus 2 Vy~~~~~~-~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 2 VYHAIDPD-GEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEECT-TEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred EEEEECCC-CCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 77777643 668999987532 00 113567899999999765 455665432
Q ss_pred eCCeEEEEEEecC--CCchHHHHHhcCCCCHHHHHHHHHHHHHHHHH-HHhcCcEeecCCCCCeEecCCCCCcEEEeeec
Q 028681 88 TPTHLAIVMEYAS--GGELFERICNAGRFSEDEARFFFQQLISGVSY-CHSMQVCHRDLKLENTLLDGSPAPRLKICDFG 164 (205)
Q Consensus 88 ~~~~~~lv~~~~~--~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~-lh~~~i~H~di~p~nili~~~~~~~~~l~df~ 164 (205)
...+||||++ +..+..+.... ++......++.+++..+.. +|+.|++|||+++.||+++++ . +.++|||
T Consensus 80 ---~~~ivME~I~~~G~~~~~l~~~~--~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~-~--~~iIDf~ 151 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPRLKDVD--LSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG-K--VYIIDFG 151 (188)
T ss_dssp ---TTEEEEE--EETTEEGGCHHHCG--GGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT-C--EEE--GT
T ss_pred ---CCEEEEEecCCCccchhhHHhcc--ccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc-e--EEEEecC
Confidence 3469999998 65554433222 2245567788888885554 689999999999999999876 4 9999999
Q ss_pred ccccc
Q 028681 165 YSKSS 169 (205)
Q Consensus 165 ~~~~~ 169 (205)
.+...
T Consensus 152 qav~~ 156 (188)
T PF01163_consen 152 QAVDS 156 (188)
T ss_dssp TEEET
T ss_pred cceec
Confidence 88643
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.30 E-value=3.2e-12 Score=100.96 Aligned_cols=186 Identities=20% Similarity=0.180 Sum_probs=136.1
Q ss_pred ceecCCCeEEEeeeccccceeEEEEEec-CCCcEEEEEEeecCccc--hHH-HHHHHHHHHhc-CCCCeeEEEEEEEeCC
Q 028681 16 IMHDSDRYELVRDIGSGNFGVARLMRDK-KTEELVAVKYIERGDKI--DEN-VQREIINHRSL-RHPNIVRFKEVILTPT 90 (205)
Q Consensus 16 ~~~~~~~y~~~~~l~~g~~g~v~~~~~~-~~~~~v~iK~~~~~~~~--~~~-~~~e~~~l~~l-~h~~i~~~~~~~~~~~ 90 (205)
......+|.++..|+.+.++.++.+... .++..|++|...++-.. .+. -..|+.+...+ .|.+.+.++..|....
T Consensus 260 ~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r 339 (524)
T KOG0601|consen 260 TSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLR 339 (524)
T ss_pred ceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccc
Confidence 5567889999999999999999887755 66778888877665322 111 23455555555 5888888888888888
Q ss_pred eEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeeccccccc
Q 028681 91 HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 170 (205)
Q Consensus 91 ~~~lv~~~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~ 170 (205)
..++-.||+.++++.........+.+...+....|++.++.++|+..++|.|++|+||++..++ ...++.||++.+.
T Consensus 340 ~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~-~~~~~~~~~~~t~-- 416 (524)
T KOG0601|consen 340 QGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDG-FFSKLGDFGCWTR-- 416 (524)
T ss_pred cccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccch-hhhhccccccccc--
Confidence 8888889998888776665556688888999999999999999999999999999999998753 2278999998764
Q ss_pred CCCCCCCCC-CCCCc-cCCceeccCcCCCeeeEEEeC
Q 028681 171 LHSQPKSTV-GTPAY-IAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 171 ~~~~~~~~~-~~~~~-~aPE~~~~~~~~~~~~Dvwsl 205 (205)
......... .+..| .+|+......+. +++|++||
T Consensus 417 ~~~~~~~~~~~~r~~p~~~~~~e~~~~~-~~~~~~sl 452 (524)
T KOG0601|consen 417 LAFSSGVFHHIDRLYPIAEILLEDYPHL-SKADIFSL 452 (524)
T ss_pred cceecccccccccccccchhhccccccc-cccccccc
Confidence 222222222 33334 244444445554 55899886
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.26 E-value=4.1e-12 Score=94.08 Aligned_cols=135 Identities=20% Similarity=0.310 Sum_probs=100.1
Q ss_pred HHHHHhcCCCCeeEEEEEEEeCC-----eEEEEEEecCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhc--
Q 028681 68 IINHRSLRHPNIVRFKEVILTPT-----HLAIVMEYASGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHSM-- 136 (205)
Q Consensus 68 ~~~l~~l~h~~i~~~~~~~~~~~-----~~~lv~~~~~~~sl~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lh~~-- 136 (205)
...+.++-|.|+++++.+|.+.+ ...++++|+..+++..++++ ...++.....+|+.||+.||.|||++
T Consensus 118 FdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~P 197 (458)
T KOG1266|consen 118 FDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDP 197 (458)
T ss_pred HHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCC
Confidence 34455667999999999998664 47889999999999999975 33588999999999999999999987
Q ss_pred CcEeecCCCCCeEecCCCCCcEEEeeecccccccC-----CCCCCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-----HSQPKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 137 ~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~-----~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
-|+|+++..+.|++..++. +|+.--......+. ........+-+.|.+||.=.....+.. +|||+|
T Consensus 198 piihgnlTc~tifiq~ngL--Ikig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a-~dIy~f 268 (458)
T KOG1266|consen 198 PIIHGNLTCDTIFIQHNGL--IKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGA-SDIYKF 268 (458)
T ss_pred ccccCCcchhheeecCCce--EEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccc-hhhhhh
Confidence 5999999999999997776 66653221111111 111222345678889988765555544 899875
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.23 E-value=6.8e-12 Score=99.15 Aligned_cols=182 Identities=21% Similarity=0.184 Sum_probs=139.3
Q ss_pred cCCCeEEEeeecc--ccceeEEEEEe--cCCCcEEEEEEeecCc---cchHHHHHHHHHHHhc-CCCCeeEEEEEEEeCC
Q 028681 19 DSDRYELVRDIGS--GNFGVARLMRD--KKTEELVAVKYIERGD---KIDENVQREIINHRSL-RHPNIVRFKEVILTPT 90 (205)
Q Consensus 19 ~~~~y~~~~~l~~--g~~g~v~~~~~--~~~~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~ 90 (205)
....+...+.+|. |.+|.+|.... ..++..+++|.-+... .....-.+++.....+ .|++.++.+..+...+
T Consensus 112 ~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~ 191 (524)
T KOG0601|consen 112 FDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSG 191 (524)
T ss_pred hhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCC
Confidence 3456778889999 99999999998 7888889998744321 2223344555555555 5899999999999999
Q ss_pred eEEEEEEecCCCchHHHHHhcCC-CCHHHHHHHHHHHHH----HHHHHHhcCcEeecCCCCCeEecCC-CCCcEEEeeec
Q 028681 91 HLAIVMEYASGGELFERICNAGR-FSEDEARFFFQQLIS----GVSYCHSMQVCHRDLKLENTLLDGS-PAPRLKICDFG 164 (205)
Q Consensus 91 ~~~lv~~~~~~~sl~~~~~~~~~-~~~~~~~~i~~~i~~----~l~~lh~~~i~H~di~p~nili~~~-~~~~~~l~df~ 164 (205)
..++-+|.+. .++......... ++...++..+.+... |+.++|...++|-|++|.||+...+ .. .+++||+
T Consensus 192 ~lfiqtE~~~-~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s--~~~~df~ 268 (524)
T KOG0601|consen 192 ILFIQTELCG-ESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTS--CKLTDFG 268 (524)
T ss_pred cceeeecccc-chhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccce--eecCCcc
Confidence 9999999885 567666655444 788888889998888 9999999999999999999999888 44 8999999
Q ss_pred ccccccCCC-CCCC-----CCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 165 YSKSSVLHS-QPKS-----TVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 165 ~~~~~~~~~-~~~~-----~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
+...+.... .... ..+...|++||...+-.- ..+|++||
T Consensus 269 ~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~--~~~di~sl 313 (524)
T KOG0601|consen 269 LVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLAT--FASDIFSL 313 (524)
T ss_pred eeEEccCCccccceeeeecCCCCceEeChhhhccccc--hHhhhcch
Confidence 887655443 2222 257788999999865443 33788875
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.19 E-value=2.7e-10 Score=82.87 Aligned_cols=132 Identities=20% Similarity=0.231 Sum_probs=99.5
Q ss_pred EEEeeeccccceeEEEEEecCCCcEEEEEEeecC-----------------------ccchHHHHHHHHHHHhcCCC--C
Q 028681 24 ELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG-----------------------DKIDENVQREIINHRSLRHP--N 78 (205)
Q Consensus 24 ~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~-----------------------~~~~~~~~~e~~~l~~l~h~--~ 78 (205)
.+...||.|..+.||.+.+. .|.++++|+=..+ .......+.|...|..|... .
T Consensus 94 ~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 94 AIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred hhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 45789999999999999987 4788999964321 01123467788888888755 5
Q ss_pred eeEEEEEEEeCCeEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcE
Q 028681 79 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRL 158 (205)
Q Consensus 79 i~~~~~~~~~~~~~~lv~~~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~ 158 (205)
+++.+++ +.-.++||++.+..|...- ++.+....++..|+.-+...-..|++|||+++-||++++|+. +
T Consensus 173 VP~P~~~----nRHaVvMe~ieG~eL~~~r-----~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg~--~ 241 (304)
T COG0478 173 VPKPIAW----NRHAVVMEYIEGVELYRLR-----LDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDGD--I 241 (304)
T ss_pred CCCcccc----ccceeeeehcccceeeccc-----CcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCCC--E
Confidence 6666543 6678999999885553222 345666677777887777777999999999999999999887 9
Q ss_pred EEeeecccc
Q 028681 159 KICDFGYSK 167 (205)
Q Consensus 159 ~l~df~~~~ 167 (205)
.++||-.+.
T Consensus 242 ~vIDwPQ~v 250 (304)
T COG0478 242 VVIDWPQAV 250 (304)
T ss_pred EEEeCcccc
Confidence 999997664
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.15 E-value=9.7e-10 Score=86.26 Aligned_cols=135 Identities=19% Similarity=0.244 Sum_probs=104.1
Q ss_pred ceeEEEEEecCCCcEEEEEEeecCccc-hHHHHHHHHHHHhcCCCCeeEEEEEEE----eCCeEEEEEEecCC-CchHHH
Q 028681 34 FGVARLMRDKKTEELVAVKYIERGDKI-DENVQREIINHRSLRHPNIVRFKEVIL----TPTHLAIVMEYASG-GELFER 107 (205)
Q Consensus 34 ~g~v~~~~~~~~~~~v~iK~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~----~~~~~~lv~~~~~~-~sl~~~ 107 (205)
..+.|++....+|..|++|+++-.... ....-.-++..+++.|.|++++.++|. .+..+++|++|+++ .+|.+.
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~ 368 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL 368 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence 468899999999999999999432211 122334577789999999999999887 34578999999874 566666
Q ss_pred HHh---------------cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeeccccccc
Q 028681 108 ICN---------------AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 170 (205)
Q Consensus 108 ~~~---------------~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~ 170 (205)
.-. +...++..++.++.|+..||.++|+.|+...-+.|.+|+++.+. +++|..-|+.....
T Consensus 369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~--RIriS~C~i~Dvl~ 444 (655)
T KOG3741|consen 369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKM--RIRISGCGIMDVLQ 444 (655)
T ss_pred HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcc--eEEEecccceeeec
Confidence 532 12367899999999999999999999999999999999997554 48877666554433
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.12 E-value=7.6e-10 Score=79.40 Aligned_cols=110 Identities=17% Similarity=0.169 Sum_probs=84.8
Q ss_pred hHHHHHHHHHHHhcCCCC--eeEEEEEEEeC----CeEEEEEEecCC-CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHH
Q 028681 61 DENVQREIINHRSLRHPN--IVRFKEVILTP----THLAIVMEYASG-GELFERICNAGRFSEDEARFFFQQLISGVSYC 133 (205)
Q Consensus 61 ~~~~~~e~~~l~~l~h~~--i~~~~~~~~~~----~~~~lv~~~~~~-~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~l 133 (205)
......|...+..+...+ .++++++.+.. ...+++++++++ .+|.+.+......+......++.++...+.-|
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~l 134 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIAKL 134 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHHHH
Confidence 356778888888775433 34455555542 245789999976 47888887755577788899999999999999
Q ss_pred HhcCcEeecCCCCCeEecCCC-CCcEEEeeeccccccc
Q 028681 134 HSMQVCHRDLKLENTLLDGSP-APRLKICDFGYSKSSV 170 (205)
Q Consensus 134 h~~~i~H~di~p~nili~~~~-~~~~~l~df~~~~~~~ 170 (205)
|+.|++|+|+++.|||++.+. ..++.++||+-+....
T Consensus 135 H~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~~ 172 (206)
T PF06293_consen 135 HDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFRP 172 (206)
T ss_pred HHCcCCCCCCCcccEEEeCCCCceeEEEEcchhceeCC
Confidence 999999999999999998775 3359999999776543
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=99.07 E-value=8.9e-09 Score=73.37 Aligned_cols=135 Identities=16% Similarity=0.193 Sum_probs=87.2
Q ss_pred CCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCccchHH----------HHHHHHHHHhcCC---CCeeEEEEEE
Q 028681 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDEN----------VQREIINHRSLRH---PNIVRFKEVI 86 (205)
Q Consensus 20 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~----------~~~e~~~l~~l~h---~~i~~~~~~~ 86 (205)
.++|+..+.+......-|.+. .-+++.+++|.........++ ..+.+.....++. .....++-+.
T Consensus 30 ~~~~~~~kv~k~~~r~~ValI--ei~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ 107 (229)
T PF06176_consen 30 DNNYKIIKVFKNTKRNYVALI--EIDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA 107 (229)
T ss_pred hCCceEEEeecCCCccEEEEE--EECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence 567888888887766655544 444678999977654332222 1223333333332 2233322222
Q ss_pred E-----eCCeEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEe
Q 028681 87 L-----TPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKIC 161 (205)
Q Consensus 87 ~-----~~~~~~lv~~~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~ 161 (205)
+ .....++++||++|..|.+... +++ .+...+..++.-||+.|+.|||++|.|+++++++ ++++
T Consensus 108 ekk~~~~~~~~~ll~EYIeG~~l~d~~~----i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~~---i~iI 176 (229)
T PF06176_consen 108 EKKIFRYTSSYVLLMEYIEGVELNDIED----IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNNG---IRII 176 (229)
T ss_pred eeeeccceeEEEEEEEEecCeecccchh----cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEECCc---EEEE
Confidence 2 2245678999999987765542 222 2445677788999999999999999999998555 8999
Q ss_pred eecccc
Q 028681 162 DFGYSK 167 (205)
Q Consensus 162 df~~~~ 167 (205)
||+..+
T Consensus 177 D~~~k~ 182 (229)
T PF06176_consen 177 DTQGKR 182 (229)
T ss_pred ECcccc
Confidence 997553
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.00 E-value=2.5e-08 Score=70.82 Aligned_cols=136 Identities=11% Similarity=0.125 Sum_probs=96.3
Q ss_pred cccceeEEEEEecCCCcEEEEEEeecC-------ccchHHHHHHHHHHHhcCCCC--eeEEE--EEEEeCC--eEEEEEE
Q 028681 31 SGNFGVARLMRDKKTEELVAVKYIERG-------DKIDENVQREIINHRSLRHPN--IVRFK--EVILTPT--HLAIVME 97 (205)
Q Consensus 31 ~g~~g~v~~~~~~~~~~~v~iK~~~~~-------~~~~~~~~~e~~~l~~l~h~~--i~~~~--~~~~~~~--~~~lv~~ 97 (205)
.||.+.|+.....+. .+-+|.-.+- +.....+..|+..+..+...+ ++++. +.-..+. ..++|++
T Consensus 28 rgG~SgV~r~~~~g~--~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVTe 105 (216)
T PRK09902 28 RNGMSGVQCVERNGK--KLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVTE 105 (216)
T ss_pred CCCcceEEEEEeCCc--EEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEEE
Confidence 377888888765533 5777765411 234577999999999885422 33333 1111221 3678999
Q ss_pred ecCC-CchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeeccccc
Q 028681 98 YASG-GELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 168 (205)
Q Consensus 98 ~~~~-~sl~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~ 168 (205)
.+++ .+|.+.+... .+.+......++.++..++.-||+.|+.|+|+.+.||+++.++...+.++||.-++.
T Consensus 106 ~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 106 DMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred eCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 7753 5777777553 246778888999999999999999999999999999999855544599999986643
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.00 E-value=1.7e-08 Score=72.89 Aligned_cols=138 Identities=17% Similarity=0.123 Sum_probs=93.5
Q ss_pred EEeeeccccceeEEEEEecCCCcEEEEEEeecCccc-------------------------hHHHHHHHHHHHhcCCC--
Q 028681 25 LVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI-------------------------DENVQREIINHRSLRHP-- 77 (205)
Q Consensus 25 ~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~-------------------------~~~~~~e~~~l~~l~h~-- 77 (205)
+.-.|+.|....||.+.. .++..+|+|++...... ..+...|+..|+++...
T Consensus 52 ~~g~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGV 130 (268)
T COG1718 52 LVGCISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGV 130 (268)
T ss_pred eEeeecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCC
Confidence 345778899999999876 44778999998643110 12345678888777433
Q ss_pred CeeEEEEEEEeCCeEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-cCcEeecCCCCCeEecCCCCC
Q 028681 78 NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS-MQVCHRDLKLENTLLDGSPAP 156 (205)
Q Consensus 78 ~i~~~~~~~~~~~~~~lv~~~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~-~~i~H~di~p~nili~~~~~~ 156 (205)
.+.+.+++ ....++||+++....-.-..+..++.......+..+++..+.-|-. .+++|+||+.=|||+. ++.
T Consensus 131 rvP~Pi~~----~~nVLvMEfIg~~g~pAP~LkDv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~-~~~- 204 (268)
T COG1718 131 RVPEPIAF----RNNVLVMEFIGDDGLPAPRLKDVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH-DGE- 204 (268)
T ss_pred CCCCceee----cCCeEEEEeccCCCCCCCCcccCCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE-CCe-
Confidence 33444443 2456899998653211111122234444677888889999888876 9999999999999998 444
Q ss_pred cEEEeeeccccccc
Q 028681 157 RLKICDFGYSKSSV 170 (205)
Q Consensus 157 ~~~l~df~~~~~~~ 170 (205)
+.++||+.|....
T Consensus 205 -p~iID~~QaV~~~ 217 (268)
T COG1718 205 -PYIIDVSQAVTID 217 (268)
T ss_pred -EEEEECccccccC
Confidence 8999999886443
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.83 E-value=2.6e-07 Score=67.25 Aligned_cols=136 Identities=13% Similarity=0.120 Sum_probs=83.3
Q ss_pred eeeccccceeEEEEEecCCCcEEEEEEeecCccchHHHHHHHHHHHhcCCCC--eeEEEEEEEeCCeEEEEEEecCCCc-
Q 028681 27 RDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPN--IVRFKEVILTPTHLAIVMEYASGGE- 103 (205)
Q Consensus 27 ~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~--i~~~~~~~~~~~~~~lv~~~~~~~s- 103 (205)
..|++|..+.+|... +..+++|...... .......|...++.+.... +.+++.+....+...++|++++|..
T Consensus 7 ~~i~~G~t~~~y~~~----~~~~VlR~~~~~~-~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~ 81 (226)
T TIGR02172 7 TQTGEGGNGESYTHK----TGKWMLKLYNPGF-DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRS 81 (226)
T ss_pred eeecCCCCcceeEec----CCCEEEEeCCCCC-CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccc
Confidence 678999999999742 4457888776533 4456788999998886443 4667777777777889999998853
Q ss_pred h--------------HHHHHh-----c----CCCCHHHH-HHHHHH----------HHH-HHHHHH----hcCcEeecCC
Q 028681 104 L--------------FERICN-----A----GRFSEDEA-RFFFQQ----------LIS-GVSYCH----SMQVCHRDLK 144 (205)
Q Consensus 104 l--------------~~~~~~-----~----~~~~~~~~-~~i~~~----------i~~-~l~~lh----~~~i~H~di~ 144 (205)
+ ...+.. + ...+.... ..+..+ +.. ...+|. ...++|+|++
T Consensus 82 ~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~~ 161 (226)
T TIGR02172 82 FSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDFQ 161 (226)
T ss_pred hhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCCC
Confidence 1 111111 0 01111111 111100 111 112222 2357899999
Q ss_pred CCCeEecCCCCCcEEEeeeccccccc
Q 028681 145 LENTLLDGSPAPRLKICDFGYSKSSV 170 (205)
Q Consensus 145 p~nili~~~~~~~~~l~df~~~~~~~ 170 (205)
|.||++++++ +.++||+.+....
T Consensus 162 ~~Nii~~~~~---~~iIDwe~a~~Gd 184 (226)
T TIGR02172 162 IGNLITSGKG---TYWIDLGDFGYGN 184 (226)
T ss_pred CCcEEEcCCC---cEEEechhcCcCC
Confidence 9999997655 7899999875443
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.77 E-value=7.1e-07 Score=63.33 Aligned_cols=134 Identities=21% Similarity=0.218 Sum_probs=91.4
Q ss_pred EeeeccccceeEEEEEecCCCcEEEEEEeecCc-----------------cchHHHHHHHHHHHhcC------CCCeeEE
Q 028681 26 VRDIGSGNFGVARLMRDKKTEELVAVKYIERGD-----------------KIDENVQREIINHRSLR------HPNIVRF 82 (205)
Q Consensus 26 ~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~-----------------~~~~~~~~e~~~l~~l~------h~~i~~~ 82 (205)
...|++|+.-.+|.--+.. ..+||+..... ....+...|+.-...+. +.++.++
T Consensus 6 ~~~i~~G~~R~cy~HP~dp---~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~ 82 (199)
T PF10707_consen 6 SDLIAQGGERDCYQHPDDP---NLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF 82 (199)
T ss_pred CcccccCCCceEEECCCCC---CeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence 3567888888877654433 36788876554 12344555655555554 7889999
Q ss_pred EEEEEeCCeEEEEEEecC------CCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCC
Q 028681 83 KEVILTPTHLAIVMEYAS------GGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAP 156 (205)
Q Consensus 83 ~~~~~~~~~~~lv~~~~~------~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~ 156 (205)
+|+.+.+....+|+|.+. ..+|.+++..+ .+++ . +...+-.-..+|-+..|+.+|++|.||++......
T Consensus 83 ~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~-~~~~-~---~~~~L~~f~~~l~~~~Iv~~dl~~~NIv~~~~~~~ 157 (199)
T PF10707_consen 83 YGFVETNLGLGLVVELIRDADGNISPTLEDYLKEG-GLTE-E---LRQALDEFKRYLLDHHIVIRDLNPHNIVVQRRDSG 157 (199)
T ss_pred eEEEecCCceEEEEEEEECCCCCcCccHHHHHHcC-CccH-H---HHHHHHHHHHHHHHcCCeecCCCcccEEEEecCCC
Confidence 999999988999998763 34678877443 3555 3 33333344567789999999999999999754433
Q ss_pred --cEEEee-ecccc
Q 028681 157 --RLKICD-FGYSK 167 (205)
Q Consensus 157 --~~~l~d-f~~~~ 167 (205)
++.|+| ||...
T Consensus 158 ~~~lvlIDG~G~~~ 171 (199)
T PF10707_consen 158 EFRLVLIDGLGEKE 171 (199)
T ss_pred ceEEEEEeCCCCcc
Confidence 478888 56443
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.77 E-value=1.3e-07 Score=76.15 Aligned_cols=140 Identities=19% Similarity=0.166 Sum_probs=91.0
Q ss_pred eeeccccceeEEEEEecCCCcEEEEEEeecCccc-----------------------------------hHHHH------
Q 028681 27 RDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI-----------------------------------DENVQ------ 65 (205)
Q Consensus 27 ~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~-----------------------------------~~~~~------ 65 (205)
+.|+.++-|+||.|+... |+.||||+..++-.. .+.+.
T Consensus 131 ~PiAsASIaQVH~A~L~s-G~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~ 209 (517)
T COG0661 131 EPIASASIAQVHRAVLKS-GEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR 209 (517)
T ss_pred CchhhhhHhhheeEEecC-CCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence 678899999999999887 889999998643100 01111
Q ss_pred HHHHHHHhc-----CCCCeeEEEEEEEeCCeEEEEEEecCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCcE
Q 028681 66 REIINHRSL-----RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVC 139 (205)
Q Consensus 66 ~e~~~l~~l-----~h~~i~~~~~~~~~~~~~~lv~~~~~~~sl~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~i~ 139 (205)
.|...+.++ ..+++.-..=+++..+.-.++|||++|..+.+.... ....+.+.+.....+++ +..+-..|+.
T Consensus 210 ~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~ia~~~~~~f--~~q~~~dgff 287 (517)
T COG0661 210 REAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAGIDRKELAELLVRAF--LRQLLRDGFF 287 (517)
T ss_pred HHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhcCCCHHHHHHHHHHHH--HHHHHhcCcc
Confidence 222333333 124333223344455677899999999888777532 23455444443333322 2334458999
Q ss_pred eecCCCCCeEecCCCCCcEEEeeecccccccC
Q 028681 140 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 171 (205)
Q Consensus 140 H~di~p~nili~~~~~~~~~l~df~~~~~~~~ 171 (205)
|+|.+|.||++..++. +.+.|||+....++
T Consensus 288 HaDpHpGNi~v~~~g~--i~~lDfGi~g~l~~ 317 (517)
T COG0661 288 HADPHPGNILVRSDGR--IVLLDFGIVGRLDP 317 (517)
T ss_pred ccCCCccceEEecCCc--EEEEcCcceecCCH
Confidence 9999999999998877 99999998865543
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.69 E-value=1.2e-06 Score=63.79 Aligned_cols=78 Identities=18% Similarity=0.199 Sum_probs=54.7
Q ss_pred EeeeccccceeEEEEEecCCCcEEEEEEeecCccchHHHHHHHHHHHhcCCCC--eeEEEEEEE---eCCeEEEEEEecC
Q 028681 26 VRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPN--IVRFKEVIL---TPTHLAIVMEYAS 100 (205)
Q Consensus 26 ~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~--i~~~~~~~~---~~~~~~lv~~~~~ 100 (205)
++.++.|..+.+|.+.... ..+++|..... .....+..|..+++.+.... +.+++.... .....++++++++
T Consensus 2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~-~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~ 78 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPP-DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIP 78 (239)
T ss_dssp EEEEEESSSSEEEEEEETT--SEEEEEEESSH-HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEES
T ss_pred CccCCCCCeeeEEEEEECC--cEEEEEEeCCC-CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEec
Confidence 4678889999999998876 37899987654 44567778888888775332 445555333 3345789999998
Q ss_pred CCchHH
Q 028681 101 GGELFE 106 (205)
Q Consensus 101 ~~sl~~ 106 (205)
+.++..
T Consensus 79 g~~~~~ 84 (239)
T PF01636_consen 79 GRPLDD 84 (239)
T ss_dssp SEEHHH
T ss_pred cccccc
Confidence 877666
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.68 E-value=8.6e-07 Score=76.09 Aligned_cols=146 Identities=16% Similarity=0.268 Sum_probs=91.0
Q ss_pred EEeeeccccceeEEEEEecCCC--cEEEEEEeecCc--cchHHHHHHHHHHHhcC-CCCe--eEEEEEEEeC---CeEEE
Q 028681 25 LVRDIGSGNFGVARLMRDKKTE--ELVAVKYIERGD--KIDENVQREIINHRSLR-HPNI--VRFKEVILTP---THLAI 94 (205)
Q Consensus 25 ~~~~l~~g~~g~v~~~~~~~~~--~~v~iK~~~~~~--~~~~~~~~e~~~l~~l~-h~~i--~~~~~~~~~~---~~~~l 94 (205)
.+++++.|.+..+|.+.....+ ..+++|+..... .....+..|..+++.+. |.++ .+++.++.+. +..++
T Consensus 42 ~v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~fl 121 (822)
T PLN02876 42 KVSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFY 121 (822)
T ss_pred eEEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceE
Confidence 3677888989999998765432 467888765443 23356889999999885 5554 7777777654 45789
Q ss_pred EEEecCCCchHH--------------------HHHh-cC-------------C--CCHHHHHHHHHH-------------
Q 028681 95 VMEYASGGELFE--------------------RICN-AG-------------R--FSEDEARFFFQQ------------- 125 (205)
Q Consensus 95 v~~~~~~~sl~~--------------------~~~~-~~-------------~--~~~~~~~~i~~~------------- 125 (205)
|||++++..+.+ .+.. +. + ....++..+..+
T Consensus 122 VME~v~G~~~~~~~~~~~~~~~r~~l~~~l~~~La~LH~vd~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~~~~~~~ 201 (822)
T PLN02876 122 IMEYLEGRIFVDPKLPGVAPERRRAIYRATAKVLAALHSADVDAIGLGKYGRRDNYCKRQVERWAKQYLASTGEGKPPRN 201 (822)
T ss_pred EEEecCCcccCCccCCCCCHHHHHHHHHHHHHHHHHHhCCCchhcChhhcCCCCchHHHHHHHHHHHHHHhhcccCCCCC
Confidence 999998754321 1110 00 0 011223222221
Q ss_pred --HHHHHHHHHh-----------cCcEeecCCCCCeEecCCCCCcEEEeeeccccccc
Q 028681 126 --LISGVSYCHS-----------MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 170 (205)
Q Consensus 126 --i~~~l~~lh~-----------~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~ 170 (205)
+...+.+|.. ..++|+|+++.|++++.+.....-|.||..+....
T Consensus 202 ~~~~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~Gd 259 (822)
T PLN02876 202 PKMLELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPTEDRVIGILDWELSTLGN 259 (822)
T ss_pred hhHHHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCCCCeEEEEEeeeccccCC
Confidence 2223455632 24999999999999985433235799999886543
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.64 E-value=1.2e-06 Score=64.54 Aligned_cols=76 Identities=12% Similarity=0.051 Sum_probs=51.6
Q ss_pred eeeccccc-eeEEEEEecCCCcEEEEEEeecCccchHHHHHHHHHHHhcC-CCCeeEEEEEEEeCCeEEEEEEecCCCch
Q 028681 27 RDIGSGNF-GVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLR-HPNIVRFKEVILTPTHLAIVMEYASGGEL 104 (205)
Q Consensus 27 ~~l~~g~~-g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~~~~~~~sl 104 (205)
+.|..|.. ..||.+... +..+++|+..... ...+..|+..++.+. +--+.++++....++..+++|++++|.++
T Consensus 4 ~~~~~g~~~~~v~~~~~~--~~~~~vk~~~~~~--~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l 79 (244)
T cd05150 4 ERVTEGQSGATVYRLDGK--NPGLYLKIAPSGP--TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPA 79 (244)
T ss_pred eecCCCCCcCeEEEEcCC--CCcEEEEecCCCc--ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccH
Confidence 34555655 678888654 3568888776543 345677888887774 33456677777766678899999988766
Q ss_pred HH
Q 028681 105 FE 106 (205)
Q Consensus 105 ~~ 106 (205)
..
T Consensus 80 ~~ 81 (244)
T cd05150 80 AA 81 (244)
T ss_pred hH
Confidence 53
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.59 E-value=8.8e-09 Score=82.94 Aligned_cols=181 Identities=20% Similarity=0.232 Sum_probs=126.9
Q ss_pred cccCceecCCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCccchHHHHHHHHHHHhcCCCC-eeEEEEEEEeCC
Q 028681 12 MDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPN-IVRFKEVILTPT 90 (205)
Q Consensus 12 ~~~~~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~-i~~~~~~~~~~~ 90 (205)
.+....++..-+...+-.+.++.+++++.+...+.... .+++... ....-++++|.+++||| .+...+-+..+.
T Consensus 233 qpp~lkDk~kws~~fh~fvK~altknpKkRptaeklL~-h~fvs~~----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~ 307 (829)
T KOG0576|consen 233 QPPTLKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT----LSRRLAIELLDKVNNPNPVVRYLEDYDGED 307 (829)
T ss_pred CCCcccCCccchHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc----hhhHHHHHHHHHccCCCCcccccccCCccc
Confidence 33334444455566677778899998888776654333 5544432 44556788999999999 666666666677
Q ss_pred eEEEEEEecCCC--chHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeeccccc
Q 028681 91 HLAIVMEYASGG--ELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 168 (205)
Q Consensus 91 ~~~lv~~~~~~~--sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~ 168 (205)
+.++.++++..+ +....-...-.+.+.+...+.+.-...++++|+..-+|+| ||+..++. .+..+|+....
T Consensus 308 ~~~i~~~i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~~~---~~~~~~~v~~~ 380 (829)
T KOG0576|consen 308 YLWIPMRICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSEEE---VKLLDFAVPPQ 380 (829)
T ss_pred ccchhhhhhcCCccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----cccccccc---cccccccCCcc
Confidence 889999988765 2222111222255555666677777888999988767887 77776543 79999998877
Q ss_pred ccCCCCCCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 169 SVLHSQPKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 169 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
........+..+++.|+|||+.....+... -|.|++
T Consensus 381 L~~~~~~~t~~~~~~~~~pev~~~~~~~~~-p~~~~~ 416 (829)
T KOG0576|consen 381 LTRTMKPRTAIGTPEPLAPEVIQENTIDGC-PDSGSL 416 (829)
T ss_pred cCcccccccCCCCCCCCCchhhcccccccC-CCccCC
Confidence 777767777889999999999988888766 688874
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.51 E-value=1.2e-06 Score=66.96 Aligned_cols=138 Identities=20% Similarity=0.220 Sum_probs=96.9
Q ss_pred EEEeeeccccceeEEEEEecCCCcEEEEEEeecC---------------------------ccchHHHHHHHHHHHhcCC
Q 028681 24 ELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG---------------------------DKIDENVQREIINHRSLRH 76 (205)
Q Consensus 24 ~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~---------------------------~~~~~~~~~e~~~l~~l~h 76 (205)
.+..+|+.|....||.+.... |..+|||+++.+ +...-+...|++.|.++..
T Consensus 147 ~inGCiSTGKEANVYHat~~d-G~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~ 225 (520)
T KOG2270|consen 147 EINGCISTGKEANVYHATEED-GSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNN 225 (520)
T ss_pred ecccccccCccceeEeeecCC-CceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHh
Confidence 456788899999999998654 667999998521 0111346678899988865
Q ss_pred CCeeEEEEEEEeCCeEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHH-HhcCcEeecCCCCCeEecCCCC
Q 028681 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYC-HSMQVCHRDLKLENTLLDGSPA 155 (205)
Q Consensus 77 ~~i~~~~~~~~~~~~~~lv~~~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~l-h~~~i~H~di~p~nili~~~~~ 155 (205)
..|.-.--... ..-.|||+++..........+.-+++...+..+-.+++..+.-| +.++++|.||+--|+|+.++.
T Consensus 226 aGIP~PePIlL--k~hVLVM~FlGrdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~LyhdG~- 302 (520)
T KOG2270|consen 226 AGIPCPEPILL--KNHVLVMEFLGRDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLYHDGK- 302 (520)
T ss_pred cCCCCCCceee--ecceEeeeeccCCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheEECCE-
Confidence 55322111111 24568999996443333333445688888888888888887776 578999999999999997443
Q ss_pred CcEEEeeecccc
Q 028681 156 PRLKICDFGYSK 167 (205)
Q Consensus 156 ~~~~l~df~~~~ 167 (205)
+.++|.+.+.
T Consensus 303 --lyiIDVSQSV 312 (520)
T KOG2270|consen 303 --LYIIDVSQSV 312 (520)
T ss_pred --EEEEEccccc
Confidence 8999998774
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.49 E-value=1.7e-06 Score=69.72 Aligned_cols=140 Identities=17% Similarity=0.168 Sum_probs=88.6
Q ss_pred EeeeccccceeEEEEEecCCCcEEEEEEeecCccc--------------------------------hHH------HHHH
Q 028681 26 VRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI--------------------------------DEN------VQRE 67 (205)
Q Consensus 26 ~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~--------------------------------~~~------~~~e 67 (205)
-+.|+..+.++|++++.+. |..||+|+-+++-.. .+. +..|
T Consensus 166 ~~piaaASlaQVhrA~L~~-G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~E 244 (538)
T KOG1235|consen 166 EEPIAAASLAQVHRARLKN-GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKE 244 (538)
T ss_pred cchhhhcchhheEEEEecC-CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHH
Confidence 3678899999999999887 899999986543100 001 1122
Q ss_pred HHHHH----hcCCCC------eeEEEEEEEeCCeEEEEEEecCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHH-HHHHh
Q 028681 68 IINHR----SLRHPN------IVRFKEVILTPTHLAIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGV-SYCHS 135 (205)
Q Consensus 68 ~~~l~----~l~h~~------i~~~~~~~~~~~~~~lv~~~~~~~sl~~~~~~-~~~~~~~~~~~i~~~i~~~l-~~lh~ 135 (205)
..... .+.|-. +.+++ +.......++|||++|..+.+.-.- ...++... ++..+..+. +.|-.
T Consensus 245 A~Nae~~~~~f~~~~~~~~V~VP~Vy--~~~st~RVLtME~~~G~~i~Dl~~i~~~gi~~~~---i~~~l~~~~~~qIf~ 319 (538)
T KOG1235|consen 245 AKNAERFRENFKDFSLLTYVLVPKVY--WDLSTKRVLTMEYVDGIKINDLDAIDKRGISPHD---ILNKLVEAYLEQIFK 319 (538)
T ss_pred HHhHHHHHHHHHhcccccceeCCeeh--hhcCcceEEEEEecCCccCCCHHHHHHcCCCHHH---HHHHHHHHHHHHHHh
Confidence 22222 222333 34442 2233567899999998777655432 23466664 444444432 33557
Q ss_pred cCcEeecCCCCCeEecCC--CCCcEEEeeecccccccC
Q 028681 136 MQVCHRDLKLENTLLDGS--PAPRLKICDFGYSKSSVL 171 (205)
Q Consensus 136 ~~i~H~di~p~nili~~~--~~~~~~l~df~~~~~~~~ 171 (205)
.|++|+|-+|.||++..+ +...+.+.|||+......
T Consensus 320 ~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 320 TGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH 357 (538)
T ss_pred cCCccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence 789999999999999854 344599999998865443
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.47 E-value=2e-06 Score=66.79 Aligned_cols=159 Identities=13% Similarity=0.116 Sum_probs=107.5
Q ss_pred EEeeeccccceeEEEEEecCCCcEEEEEEeecCccchHHHHHHHHHHHhc-CCCCeeEEEEEEE-------e-CCeEEEE
Q 028681 25 LVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSL-RHPNIVRFKEVIL-------T-PTHLAIV 95 (205)
Q Consensus 25 ~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~-------~-~~~~~lv 95 (205)
..+.||+|+.+.+|..-...+ .+.|++...+...+.-+ +..|... .||-+ .+--+|. + .....++
T Consensus 15 ~gr~LgqGgea~ly~l~e~~d---~VAKIYh~Pppa~~aqk--~a~la~~p~~p~~-~~rvaWPqa~L~G~~~~~~iGfl 88 (637)
T COG4248 15 PGRPLGQGGEADLYTLGEVRD---QVAKIYHAPPPAAQAQK--VAELAATPDAPLL-NYRVAWPQATLHGGRRGKVIGFL 88 (637)
T ss_pred CCccccCCccceeeecchhhc---hhheeecCCCchHHHHH--HHHhccCCCCcch-hhhhcccHHHhhCCCccceeEEe
Confidence 467899999999987765543 45688876554332211 2222233 23322 1111222 1 1236677
Q ss_pred EEecCCCchHHHHHh-------cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeeccccc
Q 028681 96 MEYASGGELFERICN-------AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 168 (205)
Q Consensus 96 ~~~~~~~sl~~~~~~-------~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~ 168 (205)
|..+++..-...+-+ -+..++..+...++.++.+.+.||+.|.+-||.+++|+++++++. |.|.|-.....
T Consensus 89 mP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~--V~LVdsDsfqi 166 (637)
T COG4248 89 MPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSK--VVLVDSDSFQI 166 (637)
T ss_pred cccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCce--EEEEcccceee
Confidence 777765432222211 123888999999999999999999999999999999999998888 99998765555
Q ss_pred ccCCCCCCCCCCCCCccCCceec
Q 028681 169 SVLHSQPKSTVGTPAYIAPEVLL 191 (205)
Q Consensus 169 ~~~~~~~~~~~~~~~~~aPE~~~ 191 (205)
...+.......|...|.+||...
T Consensus 167 ~~ng~~~~cpVg~~eftPPElQ~ 189 (637)
T COG4248 167 NANGTLHLCPVGVSEFTPPELQT 189 (637)
T ss_pred ccCCceEecccCccccCCHHHhc
Confidence 55556666677999999999886
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.47 E-value=2.5e-06 Score=58.73 Aligned_cols=131 Identities=18% Similarity=0.128 Sum_probs=89.2
Q ss_pred CCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCccchHHHHHHHHHHHhcCCCCeeE-EEEEEEeCCeEEEEEEec
Q 028681 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVR-FKEVILTPTHLAIVMEYA 99 (205)
Q Consensus 21 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~-~~~~~~~~~~~~lv~~~~ 99 (205)
...++.+.|+.|..|.||++... +..+++|+- ..+.....+..|..+|..+.-.++.+ ++.+.. .++.|+|+
T Consensus 22 ~~~~v~~~L~KG~~s~Vyl~~~~--~~~~a~Kvr-r~ds~r~~l~kEakiLeil~g~~~~p~vy~yg~----~~i~me~i 94 (201)
T COG2112 22 YELRVEKELAKGTTSVVYLGEWR--GGEVALKVR-RRDSPRRNLEKEAKILEILAGEGVTPEVYFYGE----DFIRMEYI 94 (201)
T ss_pred hhhhhhhhhhcccccEEEEeecc--CceEEEEEe-cCCcchhhHHHHHHHHHHhhhcCCCceEEEech----hhhhhhhh
Confidence 33456788999999999999776 557899944 44556778899999999887655544 444432 23449999
Q ss_pred CCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCC-CCCeEecCCCCCcEEEeeecccc
Q 028681 100 SGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLK-LENTLLDGSPAPRLKICDFGYSK 167 (205)
Q Consensus 100 ~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~-p~nili~~~~~~~~~l~df~~~~ 167 (205)
.|.+|.+.-... ..+.+. .++.+-.-|-..||-|+.|+ |...++.++.. +.|+||..|+
T Consensus 95 ~G~~L~~~~~~~---~rk~l~----~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~~--~~iIDFd~At 154 (201)
T COG2112 95 DGRPLGKLEIGG---DRKHLL----RVLEKAYKLDRLGIEHGELSRPWKNVLVNDRD--VYIIDFDSAT 154 (201)
T ss_pred cCcchhhhhhcc---cHHHHH----HHHHHHHHHHHhccchhhhcCCceeEEecCCc--EEEEEccchh
Confidence 887886655331 233333 34444445778899999875 44455544444 9999999886
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.46 E-value=2.3e-08 Score=84.42 Aligned_cols=185 Identities=24% Similarity=0.293 Sum_probs=128.1
Q ss_pred ecCCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCccc----hHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEE
Q 028681 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI----DENVQREIINHRSLRHPNIVRFKEVILTPTHLA 93 (205)
Q Consensus 18 ~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 93 (205)
...+.+.+.+-+.+++++.++.+.-...+.....|.....+.. .+....+-.++-...+|-++...-.+......+
T Consensus 801 sS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~ 880 (1205)
T KOG0606|consen 801 SSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLP 880 (1205)
T ss_pred CCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcc
Confidence 3467788888899999999988887776644444433322111 111111111111223455555444444456788
Q ss_pred EEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCC-
Q 028681 94 IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH- 172 (205)
Q Consensus 94 lv~~~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~- 172 (205)
++++++.++.|...++..+..+..-.+.....+..+.++||...+.|+|++|.|+++..++. .++.+|+.....+..
T Consensus 881 L~~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh--~~l~~~~t~~~vg~~~ 958 (1205)
T KOG0606|consen 881 LVGHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGH--RPLTDFGTLSKVGLIP 958 (1205)
T ss_pred hhhHHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccchhhcccccccchhhcccCC--cccCcccccccccccc
Confidence 99999999999999988887888888888889999999999999999999999999987777 788888733211100
Q ss_pred -------------------------------CCCCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 173 -------------------------------SQPKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 173 -------------------------------~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
.......++..|.+||.+.+...... +|+|++
T Consensus 959 p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~-ad~~~~ 1021 (1205)
T KOG0606|consen 959 PTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSA-ADWWSS 1021 (1205)
T ss_pred CcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCc-chhhhh
Confidence 00111237899999999999888755 899974
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=98.44 E-value=2e-05 Score=55.75 Aligned_cols=135 Identities=19% Similarity=0.269 Sum_probs=92.0
Q ss_pred CCcccCceecCCCeEEEeeeccccc-eeEEEEEecCCCcEEEEEEeec---C-c------------------cchHHHHH
Q 028681 10 PGMDMPIMHDSDRYELVRDIGSGNF-GVARLMRDKKTEELVAVKYIER---G-D------------------KIDENVQR 66 (205)
Q Consensus 10 ~~~~~~~~~~~~~y~~~~~l~~g~~-g~v~~~~~~~~~~~v~iK~~~~---~-~------------------~~~~~~~~ 66 (205)
++..-++.....+++.++.||.|.. |.||++... |..+|+|.+.. . . ...+-|.+
T Consensus 26 gPKL~~F~~h~~~I~flefLg~g~~~~~V~kv~I~--g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ 103 (207)
T PF13095_consen 26 GPKLEPFTHHGDDIEFLEFLGHGSHDGYVFKVEID--GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNC 103 (207)
T ss_pred CCCcCCcCCCCCcEeeeeecCCCCceeEEEEEEEC--CeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHH
Confidence 3334455555589999999999999 999999876 56899998321 0 0 11134677
Q ss_pred HHHHHHhcC---CCCe--eEEEEEEEeC------------------CeEEEEEEecCCCchHHHHHhcCCCCHHHHHHHH
Q 028681 67 EIINHRSLR---HPNI--VRFKEVILTP------------------THLAIVMEYASGGELFERICNAGRFSEDEARFFF 123 (205)
Q Consensus 67 e~~~l~~l~---h~~i--~~~~~~~~~~------------------~~~~lv~~~~~~~sl~~~~~~~~~~~~~~~~~i~ 123 (205)
|.+...+|+ +.++ ++|+|+..-. ....+|.|+.+... .++... +
T Consensus 104 ECRAfgRLke~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~---------~~~~~~----~ 170 (207)
T PF13095_consen 104 ECRAFGRLKEAGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP---------PLQIRD----I 170 (207)
T ss_pred HHHhhHHHHhccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc---------ccchhH----H
Confidence 777777775 4455 8999987422 11346667665432 233333 4
Q ss_pred HHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeeccc
Q 028681 124 QQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYS 166 (205)
Q Consensus 124 ~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~ 166 (205)
.+|+.-+..+|+.||+-+|+++.|.. + -+|+|||.+
T Consensus 171 ~~~~~dl~~~~k~gI~~~Dv~~~ny~---~----G~lvDfs~~ 206 (207)
T PF13095_consen 171 PQMLRDLKILHKLGIVPRDVKPRNYR---G----GKLVDFSSS 206 (207)
T ss_pred HHHHHHHHHHHHCCeeeccCcccccc---C----CEEEecccC
Confidence 45666677899999999999999986 2 389999854
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.43 E-value=2.3e-07 Score=75.39 Aligned_cols=78 Identities=17% Similarity=0.318 Sum_probs=59.3
Q ss_pred HHHHHHHHHHh-cCcEeecCCCCCeEecCCCCCcEEEeeecccccccCCCCCCC----------CCCCCCccCCceeccC
Q 028681 125 QLISGVSYCHS-MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS----------TVGTPAYIAPEVLLKK 193 (205)
Q Consensus 125 ~i~~~l~~lh~-~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~~~~----------~~~~~~~~aPE~~~~~ 193 (205)
+...|+.++|. .+++|++|.|++|.++.++. .||++|+.+....+...-.. ..-...|.|||++...
T Consensus 107 ~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~--wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~ 184 (700)
T KOG2137|consen 107 NVADGLAFLHRSAKVVHGNIQPEAIVVNANGD--WKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGT 184 (700)
T ss_pred cccchhhhhccCcceeecccchhheeeccCcc--eeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhccc
Confidence 34489999995 59999999999999988887 99999998876554222111 1245789999999885
Q ss_pred cCCCeeeEEEeC
Q 028681 194 EYDGKVMCVYVI 205 (205)
Q Consensus 194 ~~~~~~~Dvwsl 205 (205)
.-+ ..+|++||
T Consensus 185 ~~~-~~sd~fSl 195 (700)
T KOG2137|consen 185 TNT-PASDVFSL 195 (700)
T ss_pred ccc-ccccceee
Confidence 554 44999986
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=98.40 E-value=3.7e-06 Score=61.65 Aligned_cols=72 Identities=11% Similarity=-0.011 Sum_probs=43.6
Q ss_pred eeeccccce-eEEEEEecCCCcEEEEEEeecCccchHHHHHHHHHHHhcCCC---CeeEEEEEEEeC---CeEEEEEEec
Q 028681 27 RDIGSGNFG-VARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHP---NIVRFKEVILTP---THLAIVMEYA 99 (205)
Q Consensus 27 ~~l~~g~~g-~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~---~i~~~~~~~~~~---~~~~lv~~~~ 99 (205)
+.|+.|+.. .||.+. ..+++|.... ......+..|...++.+... .+..+++..... ...+++|+++
T Consensus 3 ~~~~~gG~~n~vy~~~-----~~~VlR~~~~-~~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i 76 (235)
T cd05155 3 EPVDSGGTDNATFRLG-----DDMSVRLPSA-AGYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWL 76 (235)
T ss_pred eeccCCCcccceEEcC-----CceEEEcCCc-cchHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEee
Confidence 456666555 588762 2477786554 33345788899888877532 234444433322 2357889999
Q ss_pred CCCch
Q 028681 100 SGGEL 104 (205)
Q Consensus 100 ~~~sl 104 (205)
+|.++
T Consensus 77 ~G~~l 81 (235)
T cd05155 77 EGETA 81 (235)
T ss_pred cCCCC
Confidence 87655
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=98.28 E-value=4.7e-05 Score=55.72 Aligned_cols=75 Identities=15% Similarity=0.257 Sum_probs=46.6
Q ss_pred EeeeccccceeEEEEEecC-CCcEEEEEEeecCccchHHHHHHHHHHHhcCCCCe-eEEEEEEEeCCeEEEEEEecCCCc
Q 028681 26 VRDIGSGNFGVARLMRDKK-TEELVAVKYIERGDKIDENVQREIINHRSLRHPNI-VRFKEVILTPTHLAIVMEYASGGE 103 (205)
Q Consensus 26 ~~~l~~g~~g~v~~~~~~~-~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i-~~~~~~~~~~~~~~lv~~~~~~~s 103 (205)
.+.|..|-...+|++.... .+..+++|+........-....|+.+++.+...++ +++++.+. + .+++||+++.+
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~~~d~~~E~~~~~~l~~~gl~P~v~~~~~--~--~~l~e~i~G~~ 78 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTELIIDRERELRIHKLLSKHGLAPKLYATFQ--N--GLIYEFIPGRT 78 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCccceecHHHHHHHHHHHHhCCCCCeEEEEeC--C--cEEEEeeCCCc
Confidence 4566667777899887543 35678899776543322334567888887754333 34443322 2 37999998765
Q ss_pred h
Q 028681 104 L 104 (205)
Q Consensus 104 l 104 (205)
+
T Consensus 79 l 79 (235)
T cd05157 79 L 79 (235)
T ss_pred C
Confidence 4
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.26 E-value=7.1e-06 Score=57.93 Aligned_cols=97 Identities=14% Similarity=0.074 Sum_probs=75.5
Q ss_pred HHHHHHHHhcCC-CCeeEEEEEEEeCCeEEEEEEecCCCchHHH---HHhcCCCCHHHHHHHHHHHHHHHHHHHh---cC
Q 028681 65 QREIINHRSLRH-PNIVRFKEVILTPTHLAIVMEYASGGELFER---ICNAGRFSEDEARFFFQQLISGVSYCHS---MQ 137 (205)
Q Consensus 65 ~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~~~~~~~sl~~~---~~~~~~~~~~~~~~i~~~i~~~l~~lh~---~~ 137 (205)
..|..+++.+++ +++++++|+| ..+++.|+.+.+++.+. +..-...++.....|+.+++..+++++. ..
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~C----G~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSC----GRFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeEC----CCEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 457888888876 6999999998 33568888876655421 1111236889999999999999999986 35
Q ss_pred cEeecCCCCCeEecCCCCCcEEEeeecccc
Q 028681 138 VCHRDLKLENTLLDGSPAPRLKICDFGYSK 167 (205)
Q Consensus 138 i~H~di~p~nili~~~~~~~~~l~df~~~~ 167 (205)
+.-+|++|+|+-++.++. ++++|.+.+.
T Consensus 83 ~~lcDv~~~nfgv~~~~~--lk~iDld~v~ 110 (188)
T PF12260_consen 83 FYLCDVSPDNFGVNDDGR--LKLIDLDDVF 110 (188)
T ss_pred EEEeecchHHeEEeCCCc--EEEEechhcc
Confidence 667899999999997777 9999998664
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=98.12 E-value=3.1e-05 Score=57.51 Aligned_cols=133 Identities=14% Similarity=0.088 Sum_probs=74.1
Q ss_pred eccccceeEEEEEecCCCcEEEEEEeecCccch-HHHHHHHHHHHhcCCCCe-eEEEEEEEeCCeEEEEEEecCCCchHH
Q 028681 29 IGSGNFGVARLMRDKKTEELVAVKYIERGDKID-ENVQREIINHRSLRHPNI-VRFKEVILTPTHLAIVMEYASGGELFE 106 (205)
Q Consensus 29 l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~-~~~~~e~~~l~~l~h~~i-~~~~~~~~~~~~~~lv~~~~~~~sl~~ 106 (205)
+..|-...+|++. .++..+++|......... -....|..+++.+....+ .+++... . -+++++|++|.++..
T Consensus 4 ~~~G~tn~~y~~~--~~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~--~--~~~v~e~i~G~~~~~ 77 (256)
T TIGR02721 4 LSGGLTNRSWRIE--HPGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVN--E--HWLLVEWLEGEVITL 77 (256)
T ss_pred CCCcCcCCeEEEE--eCCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEe--C--CEEEEEeccCccccc
Confidence 4556667888876 335678888765433221 235778888888864333 3343332 2 368999998755421
Q ss_pred --------------HHHh---c----CCCCHH-HHHHHHHHH---------HHHHHHHHh--------cCcEeecCCCCC
Q 028681 107 --------------RICN---A----GRFSED-EARFFFQQL---------ISGVSYCHS--------MQVCHRDLKLEN 147 (205)
Q Consensus 107 --------------~~~~---~----~~~~~~-~~~~i~~~i---------~~~l~~lh~--------~~i~H~di~p~n 147 (205)
.+.+ . .+++.. .+..+..++ ...+..+-+ ..++|+|+.|.|
T Consensus 78 ~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~N 157 (256)
T TIGR02721 78 DQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYN 157 (256)
T ss_pred ccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCc
Confidence 1111 0 112221 112222111 111222211 258999999999
Q ss_pred eEecCCCCCcEEEeeeccccccc
Q 028681 148 TLLDGSPAPRLKICDFGYSKSSV 170 (205)
Q Consensus 148 ili~~~~~~~~~l~df~~~~~~~ 170 (205)
|++++++ +.|+||..+....
T Consensus 158 il~~~~~---~~lIDwE~a~~gd 177 (256)
T TIGR02721 158 LVVTPQG---LKLIDWEYASDGD 177 (256)
T ss_pred EEEeCCC---CEEEeccccCcCC
Confidence 9998655 6899999875433
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=98.11 E-value=0.00034 Score=55.06 Aligned_cols=75 Identities=19% Similarity=0.106 Sum_probs=51.7
Q ss_pred EeeeccccceeEEEEEecCCCcEEEEEEeecC--------ccchHHHHHHHHHHHhcC---CCCeeEEEEEEEeCCeEEE
Q 028681 26 VRDIGSGNFGVARLMRDKKTEELVAVKYIERG--------DKIDENVQREIINHRSLR---HPNIVRFKEVILTPTHLAI 94 (205)
Q Consensus 26 ~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~--------~~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~~~~~~l 94 (205)
.+.|+.|....||++....+++.+++|.-.+- +...++...|...|+.+. ..++++++.+ ++...++
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~l 108 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVT 108 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEE
Confidence 46789999999999998754457999974311 123456667777777653 3456777655 4456789
Q ss_pred EEEecCCC
Q 028681 95 VMEYASGG 102 (205)
Q Consensus 95 v~~~~~~~ 102 (205)
+||++++.
T Consensus 109 VME~L~~~ 116 (401)
T PRK09550 109 VMEDLSDH 116 (401)
T ss_pred EEecCCCc
Confidence 99998753
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=98.05 E-value=0.00012 Score=55.55 Aligned_cols=138 Identities=17% Similarity=0.142 Sum_probs=79.3
Q ss_pred EEeeeccccceeEEEEEecCCCcEEEEEEeecCccchHHHHHHHHHHHhcCCCC--eeEEEE------EEEeCCeEEEEE
Q 028681 25 LVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPN--IVRFKE------VILTPTHLAIVM 96 (205)
Q Consensus 25 ~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~--i~~~~~------~~~~~~~~~lv~ 96 (205)
-.+.+..|....+|.+... +..+++|+... ...+.+..|+.++..+...+ +.+++. +...++..++++
T Consensus 18 ~i~~i~~G~~n~~y~v~~~--~~~~vLr~~~~--~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~ 93 (296)
T cd05153 18 SFEGISAGIENTNYFVTTD--SGRYVLTLFEK--VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALV 93 (296)
T ss_pred heecccCccccceEEEEeC--CCcEEEEEcCC--CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEE
Confidence 3566777777788888654 34588898764 33456677787777775332 333332 112345668999
Q ss_pred EecCCCchHH-----------HHH---h-cCCC----------CHHHH--H--------HHHHHHHHHHHHHHh------
Q 028681 97 EYASGGELFE-----------RIC---N-AGRF----------SEDEA--R--------FFFQQLISGVSYCHS------ 135 (205)
Q Consensus 97 ~~~~~~sl~~-----------~~~---~-~~~~----------~~~~~--~--------~i~~~i~~~l~~lh~------ 135 (205)
++++|..+.. .+. . ...+ .+... . .....+..++.++.+
T Consensus 94 ~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~ 173 (296)
T cd05153 94 EFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDL 173 (296)
T ss_pred EeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcC
Confidence 9998755321 110 0 0000 00000 0 011112233334332
Q ss_pred -cCcEeecCCCCCeEecCCCCCcEEEeeeccccc
Q 028681 136 -MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 168 (205)
Q Consensus 136 -~~i~H~di~p~nili~~~~~~~~~l~df~~~~~ 168 (205)
.+++|+|++|.||+++++.. +.|+||+.+..
T Consensus 174 ~~~l~HgD~~~~Nil~~~~~~--~~iIDfe~a~~ 205 (296)
T cd05153 174 PRGVIHADLFRDNVLFDGDEL--SGVIDFYFACT 205 (296)
T ss_pred CCcCCccCcCcccEEEeCCce--EEEeehhhhcC
Confidence 47999999999999987654 68999988753
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.01 E-value=1.3e-06 Score=68.37 Aligned_cols=46 Identities=30% Similarity=0.414 Sum_probs=37.4
Q ss_pred cEEEeeecccccccCCCCCCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 157 RLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 157 ~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
+|||+|||.|+... ........|..|.|||++.+..|+++ +||||+
T Consensus 392 ~vKIaDlGNACW~~--khFT~DIQTRQYRapEVllGsgY~~~-ADiWS~ 437 (590)
T KOG1290|consen 392 RVKIADLGNACWVH--KHFTEDIQTRQYRAPEVLLGSGYSTS-ADIWST 437 (590)
T ss_pred eEEEeeccchhhhh--hhhchhhhhhhccCcceeecCCCCCc-hhHHHH
Confidence 69999999986532 22234568999999999999999988 999995
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=98.00 E-value=0.00027 Score=53.81 Aligned_cols=74 Identities=12% Similarity=0.152 Sum_probs=46.1
Q ss_pred eeeccccceeEEEEEecC------CCcEEEEEEeecCccchHHHHHHHHHHHhcCCCCe-eEEEEEEEeCCeEEEEEEec
Q 028681 27 RDIGSGNFGVARLMRDKK------TEELVAVKYIERGDKIDENVQREIINHRSLRHPNI-VRFKEVILTPTHLAIVMEYA 99 (205)
Q Consensus 27 ~~l~~g~~g~v~~~~~~~------~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i-~~~~~~~~~~~~~~lv~~~~ 99 (205)
+.+..|-...+|++.... .+..+++|+.............|..++..+...++ .++++.+. + ..+++|+
T Consensus 4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~-~---~~v~e~i 79 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVELLIDRERELVVFARLSERNLGPKLYGIFP-N---GRIEEFI 79 (302)
T ss_pred EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCcceechHHHHHHHHHHHhCCCCCceEEEeC-C---Cchhhee
Confidence 445556666888887543 25789999877654444556778888887754333 34454443 2 3578887
Q ss_pred CCCch
Q 028681 100 SGGEL 104 (205)
Q Consensus 100 ~~~sl 104 (205)
+|.++
T Consensus 80 ~G~~l 84 (302)
T cd05156 80 PSRTL 84 (302)
T ss_pred CCCcC
Confidence 76554
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.95 E-value=0.00053 Score=52.62 Aligned_cols=74 Identities=9% Similarity=0.025 Sum_probs=42.8
Q ss_pred EeeeccccceeEEEEEecCCCcEEEEEEeecCccchHHHHHHHHHHHhcCCCC--eeEEEE------EEEeCCeEEEEEE
Q 028681 26 VRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPN--IVRFKE------VILTPTHLAIVME 97 (205)
Q Consensus 26 ~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~--i~~~~~------~~~~~~~~~lv~~ 97 (205)
.+.+..|....+|.+.... | .+++|++. ....+.+..+...+..+...+ +.+++. +....+..+++++
T Consensus 27 ~~~l~~G~~n~~y~v~t~~-g-~~vLK~~~--~~~~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~ 102 (319)
T PRK05231 27 LKGIAEGIENSNFFLTTTQ-G-EYVLTLFE--RLTAEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVT 102 (319)
T ss_pred cchhccccccceEEEEeCC-C-cEEEEEec--cCChHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEE
Confidence 4556667777889887543 3 58889775 222344455566666553222 223221 1123456789999
Q ss_pred ecCCCc
Q 028681 98 YASGGE 103 (205)
Q Consensus 98 ~~~~~s 103 (205)
+++|..
T Consensus 103 ~l~G~~ 108 (319)
T PRK05231 103 FLEGKW 108 (319)
T ss_pred ecCCCC
Confidence 998753
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.90 E-value=0.00046 Score=52.71 Aligned_cols=141 Identities=16% Similarity=0.156 Sum_probs=79.0
Q ss_pred eEEEeeeccccceeEEEEEecCCCcEEEEEEeecCccchHHHHHHHHHHHhcCCCC--eeEEEEEE------EeCCeEEE
Q 028681 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPN--IVRFKEVI------LTPTHLAI 94 (205)
Q Consensus 23 y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~--i~~~~~~~------~~~~~~~l 94 (205)
....+.++.|....+|.+... +..+++|..... ...+.+..+..++..|.... +++++... ...+..++
T Consensus 24 ~~~i~~~~~G~~n~~y~v~t~--~~~~vLK~~~~~-~~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~ 100 (307)
T TIGR00938 24 LLSLKGIAEGVENSNYLLTTD--VGRYILTLYEKR-VKAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPAC 100 (307)
T ss_pred ceeccccCCccccceEEEEeC--CCcEEEEEecCC-CCHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEE
Confidence 444666777777788988653 335788876542 12345556677777664322 33333211 12356789
Q ss_pred EEEecCCCchH-----------HHHH---h-cCCC--------CHHHHH---------------HHHHHHHHHHHHHH--
Q 028681 95 VMEYASGGELF-----------ERIC---N-AGRF--------SEDEAR---------------FFFQQLISGVSYCH-- 134 (205)
Q Consensus 95 v~~~~~~~sl~-----------~~~~---~-~~~~--------~~~~~~---------------~i~~~i~~~l~~lh-- 134 (205)
++++++|..+. ..+. . ...+ ...... .....+...++++.
T Consensus 101 l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~ 180 (307)
T TIGR00938 101 LVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKF 180 (307)
T ss_pred EEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhh
Confidence 99998774321 1111 0 0101 001000 00111223444443
Q ss_pred -----hcCcEeecCCCCCeEecCCCCCcEEEeeeccccc
Q 028681 135 -----SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 168 (205)
Q Consensus 135 -----~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~ 168 (205)
..+++|+|+++.|++++.++. +.|+||+.+..
T Consensus 181 ~~~~~~~~l~HgD~~~~Nvl~~~~~~--~~vIDfd~~~~ 217 (307)
T TIGR00938 181 WPRDLPRGVIHADLFPDNVLFDGDSV--KGVIDFYFACT 217 (307)
T ss_pred hhhcCCCccCCCCCCcCcEEEECCce--EEEeecccccC
Confidence 368999999999999987654 68999998753
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.73 E-value=3e-05 Score=58.72 Aligned_cols=132 Identities=14% Similarity=0.142 Sum_probs=86.1
Q ss_pred CeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCc-------------------cc----hHHHHHHHHHHHhcCCC-
Q 028681 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD-------------------KI----DENVQREIINHRSLRHP- 77 (205)
Q Consensus 22 ~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~-------------------~~----~~~~~~e~~~l~~l~h~- 77 (205)
-+.+..+||-|..+.+|.+.+.. |++.++|.=..+. .+ +-+...|+..++.|...
T Consensus 93 v~svGnqIGVGKESDIY~v~d~~-G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~g 171 (465)
T KOG2268|consen 93 VESVGNQIGVGKESDIYVVADEE-GNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERG 171 (465)
T ss_pred hhhhccccccccccceEEEecCC-CCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcC
Confidence 34568899999999999998765 6677888532110 01 11234566666666432
Q ss_pred C-eeEEEEEEEeCCeEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCC
Q 028681 78 N-IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAP 156 (205)
Q Consensus 78 ~-i~~~~~~~~~~~~~~lv~~~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~ 156 (205)
. +++.++ .+.-++||+++.+-.|.....- .+.. .+...+..-+--|...|+||||.+-=||++.++..
T Consensus 172 fpVPkpiD----~~RH~Vvmelv~g~Pl~~v~~v---~d~~---~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~dd~~- 240 (465)
T KOG2268|consen 172 FPVPKPID----HNRHCVVMELVDGYPLRQVRHV---EDPP---TLYDDLMGLIVRLANHGLIHGDFNEFNIMVKDDDK- 240 (465)
T ss_pred CCCCCccc----ccceeeHHHhhcccceeeeeec---CChH---HHHHHHHHHHHHHHHcCceecccchheeEEecCCC-
Confidence 1 333333 3566789998877666443321 2223 34444555556688999999999999999987776
Q ss_pred cEEEeeeccc
Q 028681 157 RLKICDFGYS 166 (205)
Q Consensus 157 ~~~l~df~~~ 166 (205)
++++||-.+
T Consensus 241 -i~vIDFPQm 249 (465)
T KOG2268|consen 241 -IVVIDFPQM 249 (465)
T ss_pred -EEEeechHh
Confidence 999999755
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=97.63 E-value=0.0019 Score=50.12 Aligned_cols=72 Identities=19% Similarity=0.182 Sum_probs=45.5
Q ss_pred eeccccceeEEEEEecCCCcEEEEEEeec-----C---ccchHHHHHHHHHHHhcC--CC-CeeEEEEEEEeCCeEEEEE
Q 028681 28 DIGSGNFGVARLMRDKKTEELVAVKYIER-----G---DKIDENVQREIINHRSLR--HP-NIVRFKEVILTPTHLAIVM 96 (205)
Q Consensus 28 ~l~~g~~g~v~~~~~~~~~~~v~iK~~~~-----~---~~~~~~~~~e~~~l~~l~--h~-~i~~~~~~~~~~~~~~lv~ 96 (205)
.||.|...-||++.....++.++||.-.+ + +...++..-|...|+... .| .++++ ++.++....++|
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~v--y~~D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRI--FHFDTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeE--EEEccccceehH
Confidence 46888889999999764446789987431 1 222345556666665542 23 45555 344556667899
Q ss_pred EecCC
Q 028681 97 EYASG 101 (205)
Q Consensus 97 ~~~~~ 101 (205)
|+++.
T Consensus 80 EdL~~ 84 (370)
T TIGR01767 80 EDLSH 84 (370)
T ss_pred hhCcc
Confidence 98854
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=97.63 E-value=0.0018 Score=50.37 Aligned_cols=143 Identities=15% Similarity=0.195 Sum_probs=79.5
Q ss_pred CCeEEEeeeccccceeEEEEEecC----CCcEEEEEEeecCccchHHHHHHHHHHHhcCCCCee-EEEEEEEeCCeEEEE
Q 028681 21 DRYELVRDIGSGNFGVARLMRDKK----TEELVAVKYIERGDKIDENVQREIINHRSLRHPNIV-RFKEVILTPTHLAIV 95 (205)
Q Consensus 21 ~~y~~~~~l~~g~~g~v~~~~~~~----~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~-~~~~~~~~~~~~~lv 95 (205)
+...+. .+..|-.-.+|++.... .++.+++|+........-....|..+++.+...++. ++++.+.. + .+
T Consensus 37 ~~~~i~-~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~idR~~E~~~~~~l~~~gl~P~~~~~~~~-g---~v 111 (344)
T PLN02236 37 EALQVI-PLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFDRDDEIRTFECMSRHGQGPRLLGRFPN-G---RV 111 (344)
T ss_pred CcEEEE-EcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeechHHHHHHHHHHHHcCCCCceEEEECC-c---eE
Confidence 334444 45446667888886432 246799998876543332346788888888654443 45555432 2 47
Q ss_pred EEecCCCchHHH----------H----H---h-cCC-----CCHHHHHHHHHHH-----------------HHHHHHH--
Q 028681 96 MEYASGGELFER----------I----C---N-AGR-----FSEDEARFFFQQL-----------------ISGVSYC-- 133 (205)
Q Consensus 96 ~~~~~~~sl~~~----------~----~---~-~~~-----~~~~~~~~i~~~i-----------------~~~l~~l-- 133 (205)
.+|+++.++... + + . ..+ .....+..+..++ ...+..|
T Consensus 112 ~efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~ 191 (344)
T PLN02236 112 EEFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEK 191 (344)
T ss_pred EEeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHH
Confidence 888876554211 1 0 0 001 1122232332211 1111122
Q ss_pred ------HhcCcEeecCCCCCeEecCCCCCcEEEeeecccccc
Q 028681 134 ------HSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 169 (205)
Q Consensus 134 ------h~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~ 169 (205)
+...++|+|+++.||+++++. ..+.++||..+...
T Consensus 192 ~~~~~~~~~~~cH~Dl~~~Nil~~~~~-~~~~lID~Eya~~~ 232 (344)
T PLN02236 192 ELSGDDQEIGFCHNDLQYGNIMIDEET-RAITIIDYEYASYN 232 (344)
T ss_pred HhcccCCCceEEeCCCCcCcEEEeCCC-CcEEEEeehhcccc
Confidence 123689999999999997532 23999999988543
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=97.58 E-value=0.0025 Score=49.23 Aligned_cols=79 Identities=15% Similarity=0.170 Sum_probs=46.5
Q ss_pred CCeEEEeeeccccceeEEEEEecCC---CcEEEEEEeecCccchHHHHHHHHHHHhcCCCCee-EEEEEEEeCCeEEEEE
Q 028681 21 DRYELVRDIGSGNFGVARLMRDKKT---EELVAVKYIERGDKIDENVQREIINHRSLRHPNIV-RFKEVILTPTHLAIVM 96 (205)
Q Consensus 21 ~~y~~~~~l~~g~~g~v~~~~~~~~---~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~-~~~~~~~~~~~~~lv~ 96 (205)
+..++....| |=.-.+|++..... +..|++|+........-....|..+++.+...++. ++++++. ++ ++.
T Consensus 15 ~~i~i~~l~g-GlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~~IdR~~E~~il~~l~~~gl~P~~l~~~~-~G---~i~ 89 (330)
T PLN02421 15 SDFSVERISG-GITNLLLKVSVKEENGNEVSVTVRLFGPNTDYVIDRERELQAIKYLSAAGFGAKLLGVFG-NG---MIQ 89 (330)
T ss_pred CceEEEEeCC-cccceEEEEEecCCCCCCceEEEEEecCCcCeEechHHHHHHHHHHHhcCCCCceeEEeC-Cc---Eee
Confidence 4555555544 55556787764432 34789998876544333346778888888655543 4555442 22 477
Q ss_pred EecCCCch
Q 028681 97 EYASGGEL 104 (205)
Q Consensus 97 ~~~~~~sl 104 (205)
+|+++.++
T Consensus 90 ~fi~g~~l 97 (330)
T PLN02421 90 SFINARTL 97 (330)
T ss_pred hhhcCCCC
Confidence 88766543
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.56 E-value=0.00028 Score=61.45 Aligned_cols=141 Identities=21% Similarity=0.241 Sum_probs=101.7
Q ss_pred HHHHHHHHHHhcCCCCeeEEEEEEEeCCeEE----EEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCc
Q 028681 63 NVQREIINHRSLRHPNIVRFKEVILTPTHLA----IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQV 138 (205)
Q Consensus 63 ~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~----lv~~~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i 138 (205)
....|...+.+..|+|+..++.+........ +..+++...++.+.++.-...+..+.+.+..+...++.++|+...
T Consensus 228 ~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h~~~l 307 (1351)
T KOG1035|consen 228 TTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLHSLSL 307 (1351)
T ss_pred HHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHHHhcc
Confidence 3456677778889999999988877654332 334667777888888777889999999999999999999999866
Q ss_pred EeecCCCC---CeEecCCCCCcEEEe--eecccccccCCCCCCCCCCCCCccCCceeccCcCCCe-eeEEEeC
Q 028681 139 CHRDLKLE---NTLLDGSPAPRLKIC--DFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGK-VMCVYVI 205 (205)
Q Consensus 139 ~H~di~p~---nili~~~~~~~~~l~--df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~-~~Dvwsl 205 (205)
.|.-+..+ +.-.+.++. +.+. ||+.++..+..........+..+.+||.........+ ..|+|.+
T Consensus 308 ~~v~L~~s~~~~~~~~~e~~--~~~sl~~~~ss~~l~d~~~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~l 378 (1351)
T KOG1035|consen 308 EHVVLSASSSKESTVDGEGV--VAISLSDFDSSKPLPDNEKSFSDLLAEIRNADEDLKENTAKKSRLTDLWCL 378 (1351)
T ss_pred ceeEEecccccccccCccce--eecchhhhcccccCCCcccchhhcCccccccccccccccchhhhhhHHHHH
Confidence 66655555 333344444 4444 8888877766666666667778888998877665422 2577753
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.55 E-value=0.0023 Score=48.73 Aligned_cols=105 Identities=11% Similarity=0.040 Sum_probs=67.5
Q ss_pred eEEEeeeccccceeEEEEEecCCCcEEEEEEeecCccchHHHHHHHHHHHhcCC---CCeeEEEEEEEeC---CeEEEEE
Q 028681 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRH---PNIVRFKEVILTP---THLAIVM 96 (205)
Q Consensus 23 y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h---~~i~~~~~~~~~~---~~~~lv~ 96 (205)
-.-.+.|+.|..+.+|...... + .+++|..+ .......+..|...++.+.. -.+.++++++... +..++||
T Consensus 16 ~~~~~~i~~G~~~~vy~~~~~~-~-~~~~k~~~-~~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVm 92 (297)
T PRK10593 16 LSRVECISEQPYAALWALYDSQ-G-NPMPLMAR-SFSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLL 92 (297)
T ss_pred hheeeecCCccceeEEEEEcCC-C-CEEEEEec-ccccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEE
Confidence 3456789999999999996543 3 36777643 32234678899999988853 3577888877543 6689999
Q ss_pred EecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh
Q 028681 97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 135 (205)
Q Consensus 97 ~~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~ 135 (205)
|++++.++.+. ..+......+..+++.++..||+
T Consensus 93 E~i~G~~~~~~-----~~~~~~~~~l~~~l~~~La~LH~ 126 (297)
T PRK10593 93 ERLRGVSVEAP-----ARTPERWEQLKDQIVEGLLAWHR 126 (297)
T ss_pred eccCCEecCCC-----CCCHHHHHHHHHHHHHHHHHHhC
Confidence 99988766431 11222333344444455555554
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=97.55 E-value=0.001 Score=50.04 Aligned_cols=34 Identities=21% Similarity=0.230 Sum_probs=26.4
Q ss_pred CcEeecCCCCCeEecCCCCCcEEEeeecccccccC
Q 028681 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 171 (205)
Q Consensus 137 ~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~ 171 (205)
.++|+|++|.||++++++. ..-|+||+.+....+
T Consensus 186 ~lvHGD~~~~Nilv~~~~~-~~gviDWe~a~iGDP 219 (276)
T cd05152 186 VLVHGDLHPGHILIDEDAR-VTGLIDWTEAKVGDP 219 (276)
T ss_pred eeEeCCCCCCcEEEeCCCC-EEEEECcHhcccCCH
Confidence 5899999999999986432 256999998865443
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.50 E-value=0.0026 Score=48.58 Aligned_cols=146 Identities=12% Similarity=0.083 Sum_probs=82.9
Q ss_pred CCeEEEeeeccccceeEEEEEecCCCcEEEEEEeec---CccchHHHHHHHHHHHhcCCC--CeeEEEEEEEeCC--eEE
Q 028681 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER---GDKIDENVQREIINHRSLRHP--NIVRFKEVILTPT--HLA 93 (205)
Q Consensus 21 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~---~~~~~~~~~~e~~~l~~l~h~--~i~~~~~~~~~~~--~~~ 93 (205)
....+.+.+..|-.-.+|..... ++.++++ ... ..........|+..++.+.-- -+...++.|..+. ..+
T Consensus 25 ~~~~~v~~~~~G~sn~t~~~~~~--~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf 101 (321)
T COG3173 25 AGLLIVEEISGGWSNDTFRLGDT--GQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPF 101 (321)
T ss_pred CCCceeeeccCCcccceEEEecC--CceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCce
Confidence 34455566655544455555544 6678888 332 123345677888888877432 2333455555544 568
Q ss_pred EEEEecCCC------------------chHHHHHh-------cC-------CCCHHHHHHHHHHH--------------H
Q 028681 94 IVMEYASGG------------------ELFERICN-------AG-------RFSEDEARFFFQQL--------------I 127 (205)
Q Consensus 94 lv~~~~~~~------------------sl~~~~~~-------~~-------~~~~~~~~~i~~~i--------------~ 127 (205)
.+|++..+. .+.+.+.. +. .....++..+..+. .
T Consensus 102 ~v~~~veGe~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~ 181 (321)
T COG3173 102 YVMEWVEGEVVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLAD 181 (321)
T ss_pred EEEEEecceeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHH
Confidence 899988661 12222211 00 01222222222222 1
Q ss_pred HHHHHHHhc--------CcEeecCCCCCeEecCCCCCcEEEeeecccccccC
Q 028681 128 SGVSYCHSM--------QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 171 (205)
Q Consensus 128 ~~l~~lh~~--------~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~ 171 (205)
....+++.. .++|||+++.|++++++.. +-++||+.+....|
T Consensus 182 ~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~--~gVlDwe~~~lGDP 231 (321)
T COG3173 182 RLIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRP--TGVLDWELATLGDP 231 (321)
T ss_pred HHHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCe--eEEEeccccccCCc
Confidence 223344432 5899999999999998777 89999998865544
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.44 E-value=0.014 Score=45.02 Aligned_cols=70 Identities=14% Similarity=0.079 Sum_probs=42.0
Q ss_pred ccceeEEEEEecCCCcEEEEEEeecCccchHHHHHHHHHHHhcCCCCe--eE---EEE--EEEeCCeEEEEEEecCCC
Q 028681 32 GNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNI--VR---FKE--VILTPTHLAIVMEYASGG 102 (205)
Q Consensus 32 g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i--~~---~~~--~~~~~~~~~lv~~~~~~~ 102 (205)
+....||.+.... +..+++|+...+......+..|...+..+....+ +. .-| ....++..+.++++++|.
T Consensus 36 s~eN~vy~v~~~~-~~~~vlKv~r~~~~~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~G~ 112 (325)
T PRK11768 36 SYENRVYQFGDED-GRRVVAKFYRPERWSDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRGGR 112 (325)
T ss_pred cccceEEEEecCC-CCEEEEEEcCcccCCHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeCCC
Confidence 3445678886543 5568999876554456677788888776642211 11 111 122345677888888764
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.35 E-value=0.0047 Score=48.58 Aligned_cols=78 Identities=17% Similarity=0.134 Sum_probs=49.4
Q ss_pred CCeEEEeeeccccceeEEEEEecCCCcEEEEEEeec----C---ccchHHHHHHHHHHHhcC---CCCeeEEEEEEEeCC
Q 028681 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER----G---DKIDENVQREIINHRSLR---HPNIVRFKEVILTPT 90 (205)
Q Consensus 21 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~----~---~~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~~~ 90 (205)
+.++ .+.||.|...-||++.+...++.|+||.-.+ + +...++..-|...|+... ..++++++ +.++.
T Consensus 30 ~~~~-~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy--~~D~e 106 (409)
T PRK12396 30 KGLQ-CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVY--LFDSV 106 (409)
T ss_pred ccce-eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEE--EECcH
Confidence 3344 6778999999999999854356688886421 1 223456666777776553 23556663 34555
Q ss_pred eEEEEEEecCC
Q 028681 91 HLAIVMEYASG 101 (205)
Q Consensus 91 ~~~lv~~~~~~ 101 (205)
...++||+++.
T Consensus 107 ~~~~vMEdL~~ 117 (409)
T PRK12396 107 MNCCVMEDLSD 117 (409)
T ss_pred HhhHHHHhCcc
Confidence 66678887753
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=97.34 E-value=0.00098 Score=47.98 Aligned_cols=54 Identities=15% Similarity=0.079 Sum_probs=33.1
Q ss_pred CcEEEEEEeecCccchHHHHHHHHHHHhcCCCCe-eEEEEEEEeCCeEEEEEEecCCCc
Q 028681 46 EELVAVKYIERGDKIDENVQREIINHRSLRHPNI-VRFKEVILTPTHLAIVMEYASGGE 103 (205)
Q Consensus 46 ~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i-~~~~~~~~~~~~~~lv~~~~~~~s 103 (205)
++.|++|+...+....-....|...++.+...++ .++++.+. +. .+.+|+.+.+
T Consensus 2 ~~~~~~Ri~g~~t~~~idr~~E~~~~~~l~~~g~~p~~~~~~~--~g--~v~e~i~g~~ 56 (211)
T PF01633_consen 2 PEKYLVRIPGEGTENFIDRENENEALKLLSEAGLGPKIIYFFE--NG--RVEEFIEGRT 56 (211)
T ss_dssp TSEEEEEEEESCGCSHHHHHHHHHHHHHHHHTTSSS-EEEEET--TE--EEEE--SSEE
T ss_pred CCEEEEEeCCCCcccccCHHHHHHHHHHHHHcCCCCeEEEEcC--CC--cEEEEecccc
Confidence 4678999998876666667788888888865444 44555432 22 4557775544
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=97.33 E-value=0.013 Score=44.91 Aligned_cols=32 Identities=19% Similarity=0.213 Sum_probs=27.6
Q ss_pred CcEeecCCCCCeEecCCCCCcEEEeeeccccccc
Q 028681 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 170 (205)
Q Consensus 137 ~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~ 170 (205)
++||+|+.+.|+++++++. +.++||..+....
T Consensus 197 ~lcHgD~~~~Nvl~~~~~~--~~iIDfd~~~~d~ 228 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDETRG--GYFINFEKASFAS 228 (309)
T ss_pred eeeCCCCcHHhEEEcCCCC--EEEEEhhhcccCC
Confidence 7999999999999987776 8999999886543
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=97.32 E-value=4.2e-05 Score=64.49 Aligned_cols=63 Identities=21% Similarity=0.230 Sum_probs=43.4
Q ss_pred eecCCCC-CeEecCCCCCcEEEeeecccccccCCCC---CCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 140 HRDLKLE-NTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 140 H~di~p~-nili~~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
+++..|. |+++..++. .++.||+.++....... .....||+.|+|||++.+..++.+ +|||||
T Consensus 500 ~~~~~p~~~~~~~p~~~--~~~~~~~~~~~~~~g~~~~~~~~~vGT~~Y~APE~l~~~~~~~~-~DiwSl 566 (669)
T cd05610 500 TQKPRPHGNLYQTPKQV--KIGTPYRTPKSVRRGAAPVEGERILGTPDYLAPELLLGKPHGPA-VDWWAL 566 (669)
T ss_pred CCCCCCCCceeECCccc--cccccCCCchhhhcccccccCCceeeCccccCHHHcCCCCCCcH-HHHHHH
Confidence 3455555 455555554 67888998765433222 233468999999999999888766 999996
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.25 E-value=0.0089 Score=47.12 Aligned_cols=79 Identities=10% Similarity=0.035 Sum_probs=45.4
Q ss_pred CCeEEEeeeccccceeEEEEEecCCC------cEEEEEEeecCccchHHHHHHHHHHHhcCCCCee-EEEEEEEeCCeEE
Q 028681 21 DRYELVRDIGSGNFGVARLMRDKKTE------ELVAVKYIERGDKIDENVQREIINHRSLRHPNIV-RFKEVILTPTHLA 93 (205)
Q Consensus 21 ~~y~~~~~l~~g~~g~v~~~~~~~~~------~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~-~~~~~~~~~~~~~ 93 (205)
+..++. .|..|=...+|.+...... +.|+++.........-....|+.+++.+...++. ++++.+. .+
T Consensus 51 ~~i~i~-~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~----~g 125 (383)
T PTZ00384 51 EFIEIK-KMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTYNSLVIDNDLQYNIAKLLGDNNFGPKIIGRFG----DF 125 (383)
T ss_pred ccEEEE-EeCCcccceEEEEEecCCCCCccccceEEEEeccCCCceEeccHHHHHHHHHHHhCCCCCeEEEecC----CE
Confidence 344444 4544777788888654321 1255554433322222346678888888765554 4555553 25
Q ss_pred EEEEecCCCch
Q 028681 94 IVMEYASGGEL 104 (205)
Q Consensus 94 lv~~~~~~~sl 104 (205)
++.+|+++.++
T Consensus 126 ~l~efIeGr~l 136 (383)
T PTZ00384 126 TIQEWVEGNTM 136 (383)
T ss_pred EEEEEeccccC
Confidence 88899987654
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=97.17 E-value=0.023 Score=45.02 Aligned_cols=73 Identities=16% Similarity=0.186 Sum_probs=47.8
Q ss_pred EEeeeccccceeEEEEEecCCCcEEEEEEeec-----Cc---cchHHHHHHHHHHHhcC---CCCeeEEEEEEEeCCeEE
Q 028681 25 LVRDIGSGNFGVARLMRDKKTEELVAVKYIER-----GD---KIDENVQREIINHRSLR---HPNIVRFKEVILTPTHLA 93 (205)
Q Consensus 25 ~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~-----~~---~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~~~~~~ 93 (205)
..+.||.|....||++.+. +..+++|.-.. +. ...++...|...|+.+. ..++++++.++. +..+
T Consensus 36 ~~~eiggGn~N~VyrV~~~--~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~v 111 (418)
T PLN02756 36 KIKEVGDGNLNFVYIVVSS--SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMAL 111 (418)
T ss_pred eEEEcCCCceeeEEEEEcC--CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCE
Confidence 4778898999999999874 34588987652 22 12334444555555543 357778877766 4456
Q ss_pred EEEEecCC
Q 028681 94 IVMEYASG 101 (205)
Q Consensus 94 lv~~~~~~ 101 (205)
++||++++
T Consensus 112 lvME~L~~ 119 (418)
T PLN02756 112 IGMRYLEP 119 (418)
T ss_pred EEEeecCC
Confidence 78999865
|
|
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.05 E-value=0.018 Score=44.45 Aligned_cols=137 Identities=17% Similarity=0.184 Sum_probs=79.1
Q ss_pred EeeeccccceeEEEEEecCCCcEEEEEEeecCccchHHHHHHHHHHHhcCCCC------eeEEEEEEE--eCC--eEEEE
Q 028681 26 VRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPN------IVRFKEVIL--TPT--HLAIV 95 (205)
Q Consensus 26 ~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~------i~~~~~~~~--~~~--~~~lv 95 (205)
...|.+ ....+|.+.....+ +++|+.... ....++..|...+..+.... +...-|-.. -.. +.+-+
T Consensus 31 ~~~l~s-~eN~~f~~~~~~g~--~iLki~~~~-~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~l 106 (331)
T COG2334 31 LRGLNS-EENSNFRVQTEDGR--YILKIYRPG-WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAAL 106 (331)
T ss_pred cccccc-ccCceEEEEecCCC--eEEEEecCC-CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEE
Confidence 334444 45577888766533 499988887 67788888888888773211 222222111 123 77788
Q ss_pred EEecCCCchHH------------HHH---h-cCC-----------CCHH----HHH---------HHHHHHHHHHHHHH-
Q 028681 96 MEYASGGELFE------------RIC---N-AGR-----------FSED----EAR---------FFFQQLISGVSYCH- 134 (205)
Q Consensus 96 ~~~~~~~sl~~------------~~~---~-~~~-----------~~~~----~~~---------~i~~~i~~~l~~lh- 134 (205)
++|++|..+.. ++. . ... ..+. ... ....++...+..+.
T Consensus 107 f~~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~ 186 (331)
T COG2334 107 FEYLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLA 186 (331)
T ss_pred EEecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHh
Confidence 89998766551 110 0 000 1111 000 01122223333332
Q ss_pred -------hcC--cEeecCCCCCeEecCCCCCcEEEeeecccc
Q 028681 135 -------SMQ--VCHRDLKLENTLLDGSPAPRLKICDFGYSK 167 (205)
Q Consensus 135 -------~~~--i~H~di~p~nili~~~~~~~~~l~df~~~~ 167 (205)
..+ +||+|+.|.||+++.+.. .+.++||+.+.
T Consensus 187 ~~~~~lp~~~~~iIH~D~~~~NVl~d~~~~-~~g~iDFdDa~ 227 (331)
T COG2334 187 RLPAHLPALGDQIIHGDLHPDNVLFDDDTD-VSGFIDFDDAG 227 (331)
T ss_pred hchhhCCcccceeeecCCCccceeEcCCCC-eeeEEEccccc
Confidence 234 999999999999987763 37899999875
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.02 E-value=0.0041 Score=48.18 Aligned_cols=72 Identities=26% Similarity=0.316 Sum_probs=54.4
Q ss_pred CeEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-cCcEeecCCCCCeEecCCCCCcEEEeeeccccc
Q 028681 90 THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS-MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 168 (205)
Q Consensus 90 ~~~~lv~~~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~-~~i~H~di~p~nili~~~~~~~~~l~df~~~~~ 168 (205)
.+.|++|++- ++++ ..+. ....+++..++.+++..+.-+.. ...-|+|+...||+|+ +++ |.|+||-+++.
T Consensus 299 ~y~yl~~kdh-gt~i-s~ik---~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~Gn--vtLIDfklsRl 370 (488)
T COG5072 299 LYLYLHFKDH-GTPI-SIIK---ADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-EGN--VTLIDFKLSRL 370 (488)
T ss_pred eEEEEEEecC-Ccee-eeee---cccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-cCc--eEEEEeeeeec
Confidence 4566777753 4343 2332 25678889999999988888874 5889999999999999 666 99999999974
Q ss_pred c
Q 028681 169 S 169 (205)
Q Consensus 169 ~ 169 (205)
.
T Consensus 371 ~ 371 (488)
T COG5072 371 S 371 (488)
T ss_pred c
Confidence 3
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=96.94 E-value=0.014 Score=44.17 Aligned_cols=76 Identities=11% Similarity=0.069 Sum_probs=48.0
Q ss_pred eEEEeeeccccceeEEEEEecCCCcEEEEEEeecCccchHHHHHHHHHHHhcC---CCCeeEEEEEEEeCCeEEEEEEec
Q 028681 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLR---HPNIVRFKEVILTPTHLAIVMEYA 99 (205)
Q Consensus 23 y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~~~~~~lv~~~~ 99 (205)
-+-.+.++.|....+|.+. .+++.+.+|.-. ......+..|..-|+.|. .-.+++++++...++..++++||+
T Consensus 19 i~~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~--~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l 94 (288)
T PF03881_consen 19 ITSIEPVSGGDINEAYRLD--TDGGSYFVKVNS--ESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFL 94 (288)
T ss_dssp --EEEEE--SSSSEEEEEE--TTS-EEEEEEEE--GGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE--
T ss_pred eeeeEecCCCChhheEEEE--CCCccEEEEecC--hhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEee
Confidence 3456778888889998887 557789999766 334466788888888773 445778888888777779999998
Q ss_pred CCC
Q 028681 100 SGG 102 (205)
Q Consensus 100 ~~~ 102 (205)
+.+
T Consensus 95 ~~~ 97 (288)
T PF03881_consen 95 EMG 97 (288)
T ss_dssp ---
T ss_pred cCC
Confidence 654
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >PTZ00296 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.67 E-value=0.067 Score=43.09 Aligned_cols=78 Identities=15% Similarity=0.035 Sum_probs=46.3
Q ss_pred CCeEEEeeeccccceeEEEEEecCC--------CcEEEEEEeecCccchHHHHHHHHHHHhcCCCCee-EEEEEEEeCCe
Q 028681 21 DRYELVRDIGSGNFGVARLMRDKKT--------EELVAVKYIERGDKIDENVQREIINHRSLRHPNIV-RFKEVILTPTH 91 (205)
Q Consensus 21 ~~y~~~~~l~~g~~g~v~~~~~~~~--------~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~-~~~~~~~~~~~ 91 (205)
++. -.+.|..|=.-.+|++..... ++.|++++...+...--....|...++.+...++. ++++.+.
T Consensus 106 ~~I-~i~~l~gGlTN~~f~v~~~~~~~~~~~~~~~~~lvRiyG~~te~lIdR~~E~~v~~~ls~~gi~P~l~~~f~---- 180 (442)
T PTZ00296 106 DDV-RVNQILSGLTNQLFEVSLKEETANNYPSIRRRVLFRIYGKDVDELYNPISEFEVYKTMSKYRIAPQLLNTFS---- 180 (442)
T ss_pred ccE-EEEEecCcccCceEEEEecCCCCccccCcCceEEEEecCCCccceeCHHHHHHHHHHHHHCCCCCceEEEeC----
Confidence 344 455555565557777764421 46799998877654433456677777777654443 3445442
Q ss_pred EEEEEEecCCCc
Q 028681 92 LAIVMEYASGGE 103 (205)
Q Consensus 92 ~~lv~~~~~~~s 103 (205)
-+.+.+|+++.+
T Consensus 181 gg~I~efi~g~~ 192 (442)
T PTZ00296 181 GGRIEEWLYGDP 192 (442)
T ss_pred CCEEEEeeCCcc
Confidence 235678887653
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=96.26 E-value=0.013 Score=44.68 Aligned_cols=29 Identities=31% Similarity=0.615 Sum_probs=24.6
Q ss_pred cCcEeecCCCCCeEecCCCCCcEEEeeecccc
Q 028681 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 167 (205)
Q Consensus 136 ~~i~H~di~p~nili~~~~~~~~~l~df~~~~ 167 (205)
.+++|||+++.||+++. +. +.|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~-~~--i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NE--VYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEeC-Cc--EEEEECcccc
Confidence 57899999999999976 33 8999999664
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >KOG2269 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=96.24 E-value=0.035 Score=42.66 Aligned_cols=133 Identities=18% Similarity=0.214 Sum_probs=88.7
Q ss_pred EEeeeccccceeEEEEEe-------cC---CCcEEEEEEeecC-------------------------cc--chHHHHHH
Q 028681 25 LVRDIGSGNFGVARLMRD-------KK---TEELVAVKYIERG-------------------------DK--IDENVQRE 67 (205)
Q Consensus 25 ~~~~l~~g~~g~v~~~~~-------~~---~~~~v~iK~~~~~-------------------------~~--~~~~~~~e 67 (205)
+..+|..|..+.|+.+-. +. ....+|||+++.. .. ..-....|
T Consensus 256 i~GiIsTGKEsvvlHAY~GS~E~~~qd~ql~ptecAIKvfKTTLnEFKnRd~YiKDDfRFKDRFSK~NpR~i~~mWAEkE 335 (531)
T KOG2269|consen 256 IDGIISTGKESVVLHAYAGSNEHGHQDPQLSPTECAIKVFKTTLNEFKNRDEYIKDDFRFKDRFSKQNPRGILKMWAEKE 335 (531)
T ss_pred hhhhhhcCcceEEEEeccCcccccccCcccCchHHHHHHHHHHHHHHhhhhhhhccchhhhhhhcccCcHHHHHHHHHHH
Confidence 455677888888887732 11 2356788876410 00 01123456
Q ss_pred HHHHHhcC-----CCCeeEEEEEEEeCCeEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHH-HhcCcEee
Q 028681 68 IINHRSLR-----HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYC-HSMQVCHR 141 (205)
Q Consensus 68 ~~~l~~l~-----h~~i~~~~~~~~~~~~~~lv~~~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~l-h~~~i~H~ 141 (205)
+..|.+++ +|.++.+ ..-.+||.|+...-+..--.+...++..+....-.|+..++.-| |.+-++|.
T Consensus 336 mhNL~RMq~~GlpcP~vV~l-------kkhvLVMsFiGd~~~aAPkLK~v~l~d~E~~~aY~q~~~~M~~lY~Ec~LVHA 408 (531)
T KOG2269|consen 336 MHNLSRMQKHGLPCPQVVKL-------KKHVLVMSFIGDQGLAAPKLKNVELTDDERRNAYDQVQSIMCRLYKECLLVHA 408 (531)
T ss_pred HHHHHHHHhcCCCCCceeee-------ecceEEEEeecCCCCCCccccccccChHHHHHHHHHHHHHHHHHHHhhheeec
Confidence 66666664 5667666 34568898885543332222444588888888888988888766 57899999
Q ss_pred cCCCCCeEecCCCCCcEEEeeecccc
Q 028681 142 DLKLENTLLDGSPAPRLKICDFGYSK 167 (205)
Q Consensus 142 di~p~nili~~~~~~~~~l~df~~~~ 167 (205)
|++--|+++..+ . +.++|...+.
T Consensus 409 DlSEyN~Lw~~g-K--vw~IDVsQsv 431 (531)
T KOG2269|consen 409 DLSEYNLLWTPG-K--VWVIDVSQSV 431 (531)
T ss_pred chhhhhheecCC-c--eEEEechhcc
Confidence 999999999765 3 9999987663
|
|
| >smart00587 CHK ZnF_C4 abd HLH domain containing kinases domain | Back alignment and domain information |
|---|
Probab=95.93 E-value=0.027 Score=40.11 Aligned_cols=37 Identities=19% Similarity=0.161 Sum_probs=28.4
Q ss_pred hcCcEeecCCCCCeEecCCCCC---cEEEeeecccccccC
Q 028681 135 SMQVCHRDLKLENTLLDGSPAP---RLKICDFGYSKSSVL 171 (205)
Q Consensus 135 ~~~i~H~di~p~nili~~~~~~---~~~l~df~~~~~~~~ 171 (205)
...++|||+.+.|+++..++.+ .+.++||..+...++
T Consensus 119 ~~vl~HgD~~~~N~~~~~~~~~~~~~~~liDfq~~~~g~p 158 (196)
T smart00587 119 FNVLNHGDLWANNIMFKYDDEGKPEDVALIDFQLSHYGSP 158 (196)
T ss_pred ceEEeeCCCCccceeeccCCCCCccceEEEecccCCcCCh
Confidence 3478999999999999754421 489999998865543
|
subfamily of choline kinases |
| >COG3231 Aph Aminoglycoside phosphotransferase [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=95.84 E-value=0.29 Score=35.63 Aligned_cols=72 Identities=13% Similarity=0.052 Sum_probs=40.4
Q ss_pred cccc-eeEEEEEecCCCcEEEEEEeecCccchHHHHHHHHHHHhcCCC--CeeEEEEEEEeCCeEEEEEEecCCCchH
Q 028681 31 SGNF-GVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHP--NIVRFKEVILTPTHLAIVMEYASGGELF 105 (205)
Q Consensus 31 ~g~~-g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~--~i~~~~~~~~~~~~~~lv~~~~~~~sl~ 105 (205)
.|.. +.||+........ +.+|+.... ....+..|...++=+.-. .+..+.++-.+.+.-|++|+.++|.++.
T Consensus 28 ~geS~~~v~rl~a~~r~g-~~~k~~~~~--~~a~L~~Ea~RlrWla~~~l~~P~V~~~~~~~~~~wLl~salpG~~~s 102 (266)
T COG3231 28 EGESGAGVFRLFADSRPG-LYLKIASSG--PAAELEGEAARLRWLAGQGLGCPRVLGLEDDADQAWLLMSALPGEDAS 102 (266)
T ss_pred ccCCCCeEEEEeccCCCc-eEEEEecCc--chhhhhhHHHHHHHhcccCCCCCceEeeccCcchhHHhhhhcCCCccc
Confidence 3433 3566655444333 455544322 235677777777655322 2334455555677888999888776543
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 205 | ||||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 1e-107 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 1e-107 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 1e-107 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 1e-107 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 1e-106 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 1e-104 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 9e-35 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 1e-34 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-34 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-34 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-34 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 3e-34 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 5e-34 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 6e-34 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 7e-34 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-33 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 5e-33 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 4e-32 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 4e-32 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 7e-32 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 3e-30 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 3e-30 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 3e-30 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 3e-30 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 5e-29 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 5e-29 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 6e-29 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 1e-28 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 5e-28 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 5e-28 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 5e-28 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 6e-28 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 6e-28 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 6e-28 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 6e-28 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 6e-28 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 6e-28 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 6e-28 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 7e-28 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 1e-27 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 1e-27 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-27 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 2e-27 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 3e-27 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-27 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-27 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-27 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 4e-27 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 8e-27 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 1e-26 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 1e-26 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-26 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 2e-26 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-26 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 2e-26 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 3e-26 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 5e-26 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 5e-26 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 6e-26 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 6e-26 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 6e-26 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 6e-26 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 7e-26 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 7e-26 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 7e-26 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 8e-26 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-25 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-25 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 2e-25 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-25 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-25 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-25 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 2e-25 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 2e-25 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 2e-25 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-25 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 2e-25 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 2e-25 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 2e-25 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 4e-25 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 5e-25 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 5e-25 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 6e-25 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 6e-25 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 6e-25 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 6e-25 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-25 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 2e-24 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 4e-24 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 5e-24 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 5e-24 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 5e-24 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 5e-24 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 6e-24 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 6e-24 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 6e-24 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 7e-24 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 7e-24 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 7e-24 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 7e-24 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 7e-24 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 8e-24 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 8e-24 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 8e-24 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 8e-24 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 9e-24 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 9e-24 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 1e-23 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 1e-23 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 1e-23 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 1e-23 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 1e-23 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 1e-23 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 2e-23 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 2e-23 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 2e-23 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 2e-23 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 2e-23 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 2e-23 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 2e-23 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 2e-23 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 2e-23 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 2e-23 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 2e-23 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 2e-23 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 2e-23 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 2e-23 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 2e-23 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-23 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 3e-23 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 3e-23 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-23 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 3e-23 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 3e-23 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 3e-23 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 3e-23 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 3e-23 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 3e-23 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 3e-23 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 3e-23 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 3e-23 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 4e-23 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 4e-23 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 4e-23 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 4e-23 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 5e-23 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 6e-23 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 8e-23 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 8e-23 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 8e-23 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 9e-23 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 9e-23 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 9e-23 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 9e-23 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 9e-23 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 9e-23 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 1e-22 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 1e-22 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 1e-22 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 1e-22 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 1e-22 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 1e-22 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 1e-22 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 1e-22 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 1e-22 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 1e-22 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-22 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 1e-22 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 1e-22 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 1e-22 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 1e-22 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 1e-22 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 1e-22 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 1e-22 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-22 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 1e-22 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 2e-22 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-22 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-22 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 2e-22 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 2e-22 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-22 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 2e-22 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 2e-22 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 2e-22 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 2e-22 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 2e-22 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 3e-22 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 3e-22 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 3e-22 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 3e-22 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 5e-22 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 5e-22 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 5e-22 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 5e-22 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 8e-22 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 9e-22 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 9e-22 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 9e-22 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 9e-22 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 9e-22 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 1e-21 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 1e-21 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 2e-21 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-21 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 2e-21 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 3e-21 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-21 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 3e-21 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 4e-21 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 5e-21 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-21 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 5e-21 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 6e-21 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 6e-21 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 8e-21 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 9e-21 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 9e-21 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 9e-21 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 1e-20 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 2e-20 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 2e-20 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 3e-20 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 3e-20 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 4e-20 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 4e-20 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 4e-20 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 1e-19 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 1e-19 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 2e-19 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 2e-19 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 2e-19 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 3e-19 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 3e-19 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 4e-19 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 4e-19 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 4e-19 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 4e-19 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 5e-19 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 5e-19 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 5e-19 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 5e-19 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 5e-19 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 5e-19 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 7e-19 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 1e-18 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 3e-18 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 3e-18 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 4e-18 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 5e-18 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 5e-18 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 5e-18 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 5e-18 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 6e-18 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 6e-18 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 6e-18 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 6e-18 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 7e-18 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 1e-17 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 1e-17 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-17 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-17 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-17 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 2e-17 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 2e-17 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 3e-17 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 3e-17 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 3e-17 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 3e-17 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 3e-17 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 3e-17 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 4e-17 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 4e-17 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 4e-17 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 4e-17 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 4e-17 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 4e-17 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 4e-17 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 4e-17 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 4e-17 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 4e-17 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 5e-17 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 5e-17 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 5e-17 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 5e-17 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 6e-17 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 6e-17 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 6e-17 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 6e-17 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 6e-17 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 6e-17 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 6e-17 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 6e-17 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 6e-17 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 7e-17 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 7e-17 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 7e-17 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 7e-17 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 7e-17 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 8e-17 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 8e-17 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 8e-17 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 8e-17 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 8e-17 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 8e-17 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 8e-17 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 8e-17 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 8e-17 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 8e-17 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 8e-17 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 8e-17 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 8e-17 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 8e-17 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 8e-17 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 8e-17 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 9e-17 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 9e-17 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 9e-17 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 9e-17 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 9e-17 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 9e-17 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 9e-17 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 9e-17 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 1e-16 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 1e-16 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 1e-16 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 1e-16 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 1e-16 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 1e-16 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 1e-16 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 1e-16 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-16 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 2e-16 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 2e-16 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 2e-16 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 2e-16 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 2e-16 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 2e-16 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 2e-16 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-16 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 3e-16 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 3e-16 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 3e-16 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 3e-16 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 3e-16 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 4e-16 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 4e-16 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 4e-16 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 4e-16 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 4e-16 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 4e-16 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 5e-16 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 5e-16 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 6e-16 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 8e-16 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 1e-15 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 1e-15 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 1e-15 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 1e-15 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 1e-15 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 1e-15 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 2e-15 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 2e-15 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 2e-15 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 4e-15 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 4e-15 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 4e-15 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 4e-15 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 5e-15 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 5e-15 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 5e-15 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 5e-15 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 8e-15 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 8e-15 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 9e-15 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 1e-14 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 1e-14 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 1e-14 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-14 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-14 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 2e-14 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-14 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 2e-14 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 2e-14 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 2e-14 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 2e-14 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 3e-14 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 3e-14 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 4e-14 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 4e-14 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 4e-14 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 4e-14 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 4e-14 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 4e-14 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 4e-14 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 5e-14 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 5e-14 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 5e-14 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 5e-14 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 5e-14 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 6e-14 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 6e-14 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 8e-14 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 9e-14 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 9e-14 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-13 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 1e-13 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 1e-13 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 1e-13 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 1e-13 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 1e-13 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 1e-13 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 1e-13 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 1e-13 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 1e-13 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 1e-13 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 2e-13 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 2e-13 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 2e-13 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 2e-13 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 2e-13 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 2e-13 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 2e-13 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 3e-13 | ||
| 3kga_A | 299 | Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe | 4e-13 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 4e-13 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 4e-13 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-13 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 5e-13 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 5e-13 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-13 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 5e-13 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 5e-13 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 5e-13 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 5e-13 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 5e-13 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 5e-13 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 6e-13 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 7e-13 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 7e-13 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 8e-13 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 8e-13 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 9e-13 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 9e-13 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 1e-12 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 1e-12 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-12 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 1e-12 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 1e-12 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 1e-12 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 3e-12 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 4e-12 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 5e-12 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 5e-12 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 5e-12 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 7e-12 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 8e-12 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 8e-12 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 8e-12 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 8e-12 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 8e-12 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 8e-12 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 8e-12 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 8e-12 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 9e-12 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 9e-12 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 9e-12 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 9e-12 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 9e-12 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 9e-12 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 1e-11 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 1e-11 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-11 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-11 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 1e-11 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 1e-11 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 1e-11 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 1e-11 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 1e-11 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 1e-11 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 1e-11 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 1e-11 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 2e-11 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 2e-11 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 2e-11 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 2e-11 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 2e-11 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 2e-11 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 2e-11 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 2e-11 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-11 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 2e-11 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 2e-11 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 2e-11 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 2e-11 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 2e-11 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 2e-11 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 2e-11 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 2e-11 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 2e-11 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-11 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 2e-11 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-11 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 2e-11 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 2e-11 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 2e-11 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 2e-11 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 2e-11 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 2e-11 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-11 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 2e-11 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 2e-11 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 2e-11 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 2e-11 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-11 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 2e-11 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 2e-11 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 2e-11 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 2e-11 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 2e-11 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 2e-11 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 2e-11 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 2e-11 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 2e-11 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 2e-11 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 2e-11 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-11 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 2e-11 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 2e-11 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 2e-11 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 2e-11 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 2e-11 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 2e-11 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 2e-11 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 2e-11 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 2e-11 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-11 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 2e-11 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-11 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 2e-11 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 2e-11 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 2e-11 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 3e-11 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 3e-11 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 3e-11 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 3e-11 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 3e-11 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 3e-11 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 3e-11 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 3e-11 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 3e-11 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 3e-11 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 3e-11 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-11 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 3e-11 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 3e-11 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 3e-11 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 3e-11 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 4e-11 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 4e-11 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 4e-11 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 4e-11 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 4e-11 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 4e-11 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 4e-11 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 4e-11 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-11 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 5e-11 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 5e-11 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 5e-11 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 5e-11 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 5e-11 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 6e-11 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 6e-11 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 6e-11 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 6e-11 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 7e-11 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 7e-11 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 9e-11 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 1e-10 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 1e-10 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-10 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-10 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 1e-10 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 1e-10 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-10 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 1e-10 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-10 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 1e-10 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 1e-10 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 1e-10 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 1e-10 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 1e-10 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 2e-10 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 2e-10 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 2e-10 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 2e-10 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 2e-10 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 2e-10 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 2e-10 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 2e-10 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 2e-10 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-10 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 2e-10 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 2e-10 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 2e-10 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-10 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 2e-10 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 2e-10 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 2e-10 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 2e-10 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-10 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 3e-10 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 3e-10 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-10 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 3e-10 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 3e-10 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 3e-10 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 3e-10 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 3e-10 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 3e-10 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 3e-10 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 3e-10 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 3e-10 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 3e-10 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 3e-10 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 3e-10 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 3e-10 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 3e-10 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 3e-10 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 3e-10 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 3e-10 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 4e-10 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 4e-10 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 4e-10 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 4e-10 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 4e-10 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 4e-10 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 4e-10 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 4e-10 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 4e-10 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 4e-10 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 4e-10 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 4e-10 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 4e-10 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 4e-10 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 4e-10 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 5e-10 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 5e-10 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 5e-10 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 5e-10 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 6e-10 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 6e-10 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 6e-10 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 6e-10 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 6e-10 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 6e-10 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 6e-10 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 7e-10 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 7e-10 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 7e-10 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 7e-10 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 7e-10 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 8e-10 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 8e-10 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 8e-10 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 8e-10 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 8e-10 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 8e-10 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 9e-10 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 9e-10 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 9e-10 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 9e-10 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-09 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 1e-09 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-09 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 1e-09 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 1e-09 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 1e-09 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 1e-09 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 1e-09 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 1e-09 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 1e-09 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 1e-09 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 1e-09 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 1e-09 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 1e-09 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 1e-09 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-09 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 1e-09 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 2e-09 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-09 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-09 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 2e-09 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 3e-09 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 3e-09 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 3e-09 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 3e-09 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 4e-09 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-09 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 4e-09 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-09 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 4e-09 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 5e-09 | ||
| 3gni_B | 389 | Structure Of Strad And Mo25 Length = 389 | 5e-09 | ||
| 2wtk_B | 373 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 6e-09 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 6e-09 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 7e-09 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 7e-09 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 7e-09 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 8e-09 | ||
| 1z57_A | 339 | Crystal Structure Of Human Clk1 In Complex With 10z | 8e-09 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 8e-09 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 9e-09 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 9e-09 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 9e-09 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 9e-09 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 9e-09 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 9e-09 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 1e-08 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-08 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 1e-08 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 1e-08 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 1e-08 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 2e-08 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-08 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 2e-08 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 3e-08 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 3e-08 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 3e-08 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 3e-08 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 4e-08 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 4e-08 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 4e-08 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 4e-08 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 4e-08 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 4e-08 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 5e-08 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 5e-08 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 5e-08 | ||
| 2vag_A | 339 | Crystal Structure Of Di-Phosphorylated Human Clk1 I | 6e-08 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 6e-08 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 7e-08 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 7e-08 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 8e-08 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 9e-08 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-07 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 1e-07 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 1e-07 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 1e-07 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 1e-07 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 1e-07 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 1e-07 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-07 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 1e-07 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-07 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 1e-07 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 1e-07 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 1e-07 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 1e-07 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 1e-07 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 1e-07 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-07 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 2e-07 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 2e-07 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 2e-07 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 2e-07 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 2e-07 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 3e-07 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 3e-07 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 3e-07 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 3e-07 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 3e-07 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 3e-07 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 3e-07 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 3e-07 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 3e-07 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-07 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 3e-07 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 3e-07 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 3e-07 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 4e-07 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 4e-07 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 4e-07 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 4e-07 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 4e-07 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 4e-07 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 4e-07 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 4e-07 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 4e-07 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 4e-07 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 4e-07 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 4e-07 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 4e-07 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 5e-07 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 5e-07 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 5e-07 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 5e-07 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-07 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 6e-07 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 6e-07 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 6e-07 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 7e-07 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 7e-07 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 7e-07 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 7e-07 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 7e-07 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 8e-07 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 9e-07 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 9e-07 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-06 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 1e-06 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 1e-06 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 2e-06 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 2e-06 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-06 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 2e-06 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-06 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 2e-06 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 2e-06 | ||
| 3nr9_A | 368 | Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length | 3e-06 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 3e-06 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 3e-06 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 3e-06 | ||
| 3llt_A | 360 | Crystal Structure Of Pf14_0431, Kinase Domain Lengt | 3e-06 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-06 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-06 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-06 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 5e-06 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 5e-06 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 5e-06 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-06 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 6e-06 | ||
| 4hgl_A | 330 | Crystal Structure Of Ck1g3 With Compound 1 Length = | 6e-06 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 7e-06 | ||
| 3beg_A | 381 | Crystal Structure Of Sr Protein Kinase 1 Complexed | 7e-06 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 7e-06 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-06 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 7e-06 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 8e-06 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 8e-06 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 9e-06 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 9e-06 | ||
| 1wbp_A | 397 | Srpk1 Bound To 9mer Docking Motif Peptide Length = | 9e-06 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 1e-05 | ||
| 4dgm_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 1e-05 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 1e-05 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 1e-05 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 1e-05 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-05 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 2e-05 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 2e-05 | ||
| 4dgn_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 2e-05 | ||
| 3kxg_A | 327 | Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun | 2e-05 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 2e-05 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 2e-05 | ||
| 2qc6_A | 332 | Protein Kinase Ck2 In Complex With Dbc Length = 332 | 2e-05 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 2e-05 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 2e-05 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 2e-05 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 2e-05 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 2e-05 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 2e-05 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-05 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 2e-05 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 2e-05 | ||
| 1m2p_A | 325 | Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra | 2e-05 | ||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 2e-05 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 2e-05 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 2e-05 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 2e-05 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 2e-05 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 2e-05 | ||
| 1daw_A | 327 | Crystal Structure Of A Binary Complex Of Protein Ki | 2e-05 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 2e-05 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 2e-05 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 2e-05 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 2e-05 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 2e-05 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 2e-05 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 2e-05 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 2e-05 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 2e-05 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 2e-05 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 2e-05 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 2e-05 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 3e-05 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 3e-05 | ||
| 2wu6_A | 381 | Crystal Structure Of The Human Clk3 In Complex With | 3e-05 | ||
| 2chl_A | 351 | Structure Of Casein Kinase 1 Gamma 3 Length = 351 | 3e-05 | ||
| 2izr_A | 330 | Structure Of Casein Kinase Gamma 3 In Complex With | 3e-05 | ||
| 2exe_A | 357 | Crystal Structure Of The Phosphorylated Clk3 Length | 3e-05 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 3e-05 | ||
| 2eu9_A | 355 | Crystal Structure Of Clk3 Length = 355 | 3e-05 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 3e-05 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 3e-05 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 3e-05 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 4e-05 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 4e-05 | ||
| 2c47_A | 313 | Structure Of Casein Kinase 1 Gamma 2 Length = 313 | 4e-05 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 4e-05 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 4e-05 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 4e-05 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 5e-05 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 5e-05 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 6e-05 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 7e-05 | ||
| 3sv0_A | 483 | Crystal Structure Of Casein Kinase-1 Like Protein I | 9e-05 | ||
| 2pzi_A | 681 | Crystal Structure Of Protein Kinase Pkng From Mycob | 1e-04 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 1e-04 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 1e-04 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 1e-04 | ||
| 3uys_A | 296 | Crystal Structure Of Apo Human Ck1d Length = 296 | 1e-04 | ||
| 2cmw_A | 310 | Structure Of Human Casein Kinase 1 Gamma-1 In Compl | 1e-04 | ||
| 1ckj_A | 317 | Casein Kinase I Delta Truncation Mutant Containing | 2e-04 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 2e-04 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 2e-04 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 2e-04 | ||
| 2x7g_A | 389 | Structure Of Human Serine-Arginine-Rich Protein-Spe | 2e-04 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 2e-04 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 3e-04 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 3e-04 | ||
| 4hni_A | 296 | Crystal Structure Of Ck1e In Complex With Pf4800567 | 3e-04 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 4e-04 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 6e-04 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 6e-04 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 7e-04 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 7e-04 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 7e-04 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 7e-04 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 7e-04 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 7e-04 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 7e-04 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 8e-04 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 8e-04 |
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389 | Back alignment and structure |
|
| >pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|4HGL|A Chain A, Crystal Structure Of Ck1g3 With Compound 1 Length = 330 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3BEG|A Chain A, Crystal Structure Of Sr Protein Kinase 1 Complexed To Its Substrate AsfSF2 Length = 381 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|1WBP|A Chain A, Srpk1 Bound To 9mer Docking Motif Peptide Length = 397 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326 | Back alignment and structure |
|
| >pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
| >pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325 | Back alignment and structure |
|
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381 | Back alignment and structure |
|
| >pdb|2CHL|A Chain A, Structure Of Casein Kinase 1 Gamma 3 Length = 351 | Back alignment and structure |
|
| >pdb|2IZR|A Chain A, Structure Of Casein Kinase Gamma 3 In Complex With Inhibitor Length = 330 | Back alignment and structure |
|
| >pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|2C47|A Chain A, Structure Of Casein Kinase 1 Gamma 2 Length = 313 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3SV0|A Chain A, Crystal Structure Of Casein Kinase-1 Like Protein In Plant Length = 483 | Back alignment and structure |
|
| >pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3UYS|A Chain A, Crystal Structure Of Apo Human Ck1d Length = 296 | Back alignment and structure |
|
| >pdb|2CMW|A Chain A, Structure Of Human Casein Kinase 1 Gamma-1 In Complex With 2-(2-Hydroxyethylamino)-6-(3-Chloroanilino)-9- Isopropylpurine (Casp Target) Length = 310 | Back alignment and structure |
|
| >pdb|1CKJ|A Chain A, Casein Kinase I Delta Truncation Mutant Containing Residues 1-317 Complex With Bound Tungstate Length = 317 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|2X7G|A Chain A, Structure Of Human Serine-Arginine-Rich Protein-Specific Kinase 2 (Srpk2) Bound To Purvalanol B Length = 389 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|4HNI|A Chain A, Crystal Structure Of Ck1e In Complex With Pf4800567 Length = 296 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 357 bits (917), Expect = e-125
Identities = 179/198 (90%), Positives = 191/198 (96%), Gaps = 1/198 (0%)
Query: 1 MDRSAMTVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI 60
MDR+ +T GP +DMPIMHDSDRY+ V+DIGSGNFGVARLMRDK T+ELVAVKYIERG I
Sbjct: 1 MDRAPVTTGP-LDMPIMHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAI 59
Query: 61 DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 120
DENVQREIINHRSLRHPNIVRFKEVILTPTHLAI+MEYASGGEL+ERICNAGRFSEDEAR
Sbjct: 60 DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEAR 119
Query: 121 FFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 180
FFFQQL+SGVSYCHSMQ+CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG
Sbjct: 120 FFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 179
Query: 181 TPAYIAPEVLLKKEYDGK 198
TPAYIAPEVLL++EYDGK
Sbjct: 180 TPAYIAPEVLLRQEYDGK 197
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 293 bits (752), Expect = e-101
Identities = 68/192 (35%), Positives = 109/192 (56%), Gaps = 10/192 (5%)
Query: 12 MDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID--ENVQREII 69
M +P + + ++LV+ +G G +G +L ++ TEE VAVK ++ +D EN+++EI
Sbjct: 1 MAVPFV---EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIC 57
Query: 70 NHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISG 129
++ L H N+V+F + +EY SGGELF+RI E +A+ FF QL++G
Sbjct: 58 INKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAG 117
Query: 130 VSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP---KSTVGTPAYIA 186
V Y H + + HRD+K EN LLD LKI DFG + +++ GT Y+A
Sbjct: 118 VVYLHGIGITHRDIKPENLLLDER--DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVA 175
Query: 187 PEVLLKKEYDGK 198
PE+L ++E+ +
Sbjct: 176 PELLKRREFHAE 187
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 289 bits (742), Expect = e-100
Identities = 68/192 (35%), Positives = 109/192 (56%), Gaps = 10/192 (5%)
Query: 12 MDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID--ENVQREII 69
M +P + + ++LV+ +G G +G +L ++ TEE VAVK ++ +D EN+++EI
Sbjct: 1 MAVPFV---EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIC 57
Query: 70 NHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISG 129
++ L H N+V+F + +EY SGGELF+RI E +A+ FF QL++G
Sbjct: 58 INKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAG 117
Query: 130 VSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP---KSTVGTPAYIA 186
V Y H + + HRD+K EN LLD LKI DFG + +++ GT Y+A
Sbjct: 118 VVYLHGIGITHRDIKPENLLLDER--DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVA 175
Query: 187 PEVLLKKEYDGK 198
PE+L ++E+ +
Sbjct: 176 PELLKRREFHAE 187
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 228 bits (584), Expect = 9e-76
Identities = 61/184 (33%), Positives = 87/184 (47%), Gaps = 7/184 (3%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG----DKIDENVQREIINHRSLRH 76
RY R +G G F + D T+E+ A K + + E + EI HRSL H
Sbjct: 15 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAH 74
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
++V F + +V+E L E +E EAR++ +Q++ G Y H
Sbjct: 75 QHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRN 134
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV-GTPAYIAPEVLLKKEY 195
+V HRDLKL N L+ +KI DFG + + K + GTP YIAPEVL KK +
Sbjct: 135 RVIHRDLKLGNLFLNED--LEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGH 192
Query: 196 DGKV 199
+V
Sbjct: 193 SFEV 196
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 226 bits (579), Expect = 4e-75
Identities = 79/181 (43%), Positives = 101/181 (55%), Gaps = 8/181 (4%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID-----ENVQREIINHRSLRH 76
Y L +G G FG ++ + T VAVK + R KI ++REI N + RH
Sbjct: 12 HYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNR-QKIRSLDVVGKIKREIQNLKLFRH 70
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
P+I++ +VI TPT +VMEY SGGELF+ IC GR E EAR FQQ++S V YCH
Sbjct: 71 PHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRH 130
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYD 196
V HRDLK EN LLD KI DFG S +++ G+P Y APEV+ + Y
Sbjct: 131 MVVHRDLKPENVLLDAH--MNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYA 188
Query: 197 G 197
G
Sbjct: 189 G 189
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 227 bits (581), Expect = 9e-75
Identities = 61/184 (33%), Positives = 87/184 (47%), Gaps = 7/184 (3%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG----DKIDENVQREIINHRSLRH 76
RY R +G G F + D T+E+ A K + + E + EI HRSL H
Sbjct: 41 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAH 100
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
++V F + +V+E L E +E EAR++ +Q++ G Y H
Sbjct: 101 QHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRN 160
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV-GTPAYIAPEVLLKKEY 195
+V HRDLKL N L+ +KI DFG + + K + GTP YIAPEVL KK +
Sbjct: 161 RVIHRDLKLGNLFLNED--LEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGH 218
Query: 196 DGKV 199
+V
Sbjct: 219 SFEV 222
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 222 bits (569), Expect = 5e-73
Identities = 75/181 (41%), Positives = 106/181 (58%), Gaps = 7/181 (3%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID----ENVQREIINHRSLRHP 77
Y L++ IG GNF +L R T VA+K I++ +++ + + RE+ + L HP
Sbjct: 16 NYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDK-TQLNPTSLQKLFREVRIMKILNHP 74
Query: 78 NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ 137
NIV+ EVI T L ++MEYASGGE+F+ + GR E EAR F+Q++S V YCH +
Sbjct: 75 NIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKR 134
Query: 138 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDG 197
+ HRDLK EN LLD +KI DFG+S + + + G P Y APE+ K+YDG
Sbjct: 135 IVHRDLKAENLLLDAD--MNIKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQGKKYDG 192
Query: 198 K 198
Sbjct: 193 P 193
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 226 bits (577), Expect = 2e-72
Identities = 78/181 (43%), Positives = 104/181 (57%), Gaps = 8/181 (4%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID-----ENVQREIINHRSLRH 76
Y L +G G FG ++ + + T VAVK + R KI ++REI N + RH
Sbjct: 17 HYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNR-QKIRSLDVVGKIRREIQNLKLFRH 75
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
P+I++ +VI TP+ + +VMEY SGGELF+ IC GR E E+R FQQ++SGV YCH
Sbjct: 76 PHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRH 135
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYD 196
V HRDLK EN LLD KI DFG S +++ G+P Y APEV+ + Y
Sbjct: 136 MVVHRDLKPENVLLDAH--MNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYA 193
Query: 197 G 197
G
Sbjct: 194 G 194
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 217 bits (554), Expect = 2e-71
Identities = 55/185 (29%), Positives = 92/185 (49%), Gaps = 8/185 (4%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG----DKIDENVQREIINHRSLRH 76
+ +++ +G G+F T VA+K I++ + + VQ E+ H L+H
Sbjct: 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKH 70
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHS 135
P+I+ ++ +V+E GE+ + N FSE+EAR F Q+I+G+ Y HS
Sbjct: 71 PSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHS 130
Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV-GTPAYIAPEVLLKKE 194
+ HRDL L N LL + +KI DFG + + + T+ GTP YI+PE+ +
Sbjct: 131 HGILHRDLTLSNLLLTRN--MNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIATRSA 188
Query: 195 YDGKV 199
+ +
Sbjct: 189 HGLES 193
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 218 bits (558), Expect = 3e-71
Identities = 77/181 (42%), Positives = 108/181 (59%), Gaps = 9/181 (4%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID-----ENVQREIINHRSLRH 76
Y + +G G+FG +L KT++ VA+K+I R + V+REI + LRH
Sbjct: 10 PYIIRETLGEGSFGKVKLATHYKTQQKVALKFISR-QLLKKSDMHMRVEREISYLKLLRH 68
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
P+I++ +VI TPT + +V+EYA GGELF+ I R +EDE R FFQQ+I + YCH
Sbjct: 69 PHIIKLYDVITTPTDIVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRH 127
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYD 196
++ HRDLK EN LLD + +KI DFG S + K++ G+P Y APEV+ K Y
Sbjct: 128 KIVHRDLKPENLLLDDN--LNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVINGKLYA 185
Query: 197 G 197
G
Sbjct: 186 G 186
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 213 bits (546), Expect = 4e-70
Identities = 59/183 (32%), Positives = 100/183 (54%), Gaps = 7/183 (3%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRH 76
D +++ R +G G FG L R+K+ + ++A+K + + ++ ++REI LRH
Sbjct: 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 73
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
PNI+R + +++E+A GEL++ + GRF E + F ++L + YCH
Sbjct: 74 PNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHER 133
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYD 196
+V HRD+K EN L+ LKI DFG+S + + ++ GT Y+ PE++ K +D
Sbjct: 134 KVIHRDIKPENLLMGYK--GELKIADFGWSVHAP-SLRRRTMCGTLDYLPPEMIEGKTHD 190
Query: 197 GKV 199
KV
Sbjct: 191 EKV 193
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 212 bits (543), Expect = 1e-69
Identities = 58/183 (31%), Positives = 99/183 (54%), Gaps = 7/183 (3%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRH 76
+ +E+ R +G G FG L R+K+++ ++A+K + + ++ ++RE+ LRH
Sbjct: 9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 68
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
PNI+R T + +++EYA G ++ + +F E + +L + +SYCHS
Sbjct: 69 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK 128
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYD 196
+V HRD+K EN LL + LKI DFG+S S+ GT Y+ PE++ + +D
Sbjct: 129 RVIHRDIKPENLLLGSA--GELKIADFGWSV-HAPSSRRTDLCGTLDYLPPEMIEGRMHD 185
Query: 197 GKV 199
KV
Sbjct: 186 EKV 188
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 212 bits (541), Expect = 5e-69
Identities = 53/190 (27%), Positives = 95/190 (50%), Gaps = 18/190 (9%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI------DENVQREIINHRSLR 75
+Y + +G G++G + + D +T AVK +++ K+ + NV++EI R LR
Sbjct: 6 KYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKK-KKLRRIPNGEANVKKEIQLLRRLR 64
Query: 76 HPNIVRFKEVIL--TPTHLAIVMEYASGG--ELFERICNAGRFSEDEARFFFQQLISGVS 131
H N+++ +V+ + +VMEY G E+ + + RF +A +F QLI G+
Sbjct: 65 HKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPE-KRFPVCQAHGYFCQLIDGLE 123
Query: 132 YCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP---KSTVGTPAYIAPE 188
Y HS + H+D+K N LL LKI G +++ + +++ G+PA+ PE
Sbjct: 124 YLHSQGIVHKDIKPGNLLLTTG--GTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPE 181
Query: 189 VLL-KKEYDG 197
+ + G
Sbjct: 182 IANGLDTFSG 191
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 212 bits (542), Expect = 7e-69
Identities = 56/187 (29%), Positives = 84/187 (44%), Gaps = 12/187 (6%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER---------GDKIDENVQREIINHR 72
+Y + +GSG FG DK+ + V VK+I++ D V EI
Sbjct: 25 KYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILS 84
Query: 73 SLRHPNIVRFKEVILTPTHLAIVME-YASGGELFERICNAGRFSEDEARFFFQQLISGVS 131
+ H NI++ ++ +VME + SG +LF I R E A + F+QL+S V
Sbjct: 85 RVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVG 144
Query: 132 YCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL 191
Y + HRD+K EN ++ +K+ DFG + + GT Y APEVL+
Sbjct: 145 YLRLKDIIHRDIKDENIVIAED--FTIKLIDFGSAAYLERGKLFYTFCGTIEYCAPEVLM 202
Query: 192 KKEYDGK 198
Y G
Sbjct: 203 GNPYRGP 209
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 208 bits (533), Expect = 5e-68
Identities = 64/184 (34%), Positives = 92/184 (50%), Gaps = 4/184 (2%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER---GDKIDENVQREIINHRSLRH 76
SD Y++ ++G G F V R K T A K I + + ++RE R L+H
Sbjct: 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
PNIVR + I + +V + +GGELFE I +SE +A QQ++ ++YCHS
Sbjct: 65 PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSN 124
Query: 137 QVCHRDLKLENTLL-DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEY 195
+ HR+LK EN LL + +K+ DFG + GTP Y++PEVL K Y
Sbjct: 125 GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPY 184
Query: 196 DGKV 199
V
Sbjct: 185 SKPV 188
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 208 bits (533), Expect = 7e-68
Identities = 63/183 (34%), Positives = 100/183 (54%), Gaps = 5/183 (2%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDE-NVQREIINHRSLRHPN 78
+ + +GSG F L++ + T +L A+K I++ + +++ EI + ++H N
Sbjct: 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHEN 67
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQV 138
IV +++ + TH +VM+ SGGELF+RI G ++E +A QQ++S V Y H +
Sbjct: 68 IVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGI 127
Query: 139 CHRDLKLENTLL-DGSPAPRLKICDFGYSKSSVLHSQP-KSTVGTPAYIAPEVLLKKEYD 196
HRDLK EN L ++ I DFG SK + + + GTP Y+APEVL +K Y
Sbjct: 128 VHRDLKPENLLYLTPEENSKIMITDFGLSK--MEQNGIMSTACGTPGYVAPEVLAQKPYS 185
Query: 197 GKV 199
V
Sbjct: 186 KAV 188
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 209 bits (534), Expect = 9e-68
Identities = 53/192 (27%), Positives = 87/192 (45%), Gaps = 20/192 (10%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDEN--------VQREIINHR 72
+Y++ +GSG FG VA+K++E+ D+I + V E++ +
Sbjct: 43 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEK-DRISDWGELPNGTRVPMEVVLLK 101
Query: 73 SLRH--PNIVRFKEVILTPTHLAIVMEYASG-GELFERICNAGRFSEDEARFFFQQLISG 129
+ ++R + P +++E +LF+ I G E+ AR FF Q++
Sbjct: 102 KVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEA 161
Query: 130 VSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYS---KSSVLHSQPKSTVGTPAYIA 186
V +CH+ V HRD+K EN L+D + LK+ DFG K +V GT Y
Sbjct: 162 VRHCHNCGVLHRDIKDENILIDLNRG-ELKLIDFGSGALLKDTVYT----DFDGTRVYSP 216
Query: 187 PEVLLKKEYDGK 198
PE + Y G+
Sbjct: 217 PEWIRYHRYHGR 228
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 207 bits (530), Expect = 1e-67
Identities = 65/183 (35%), Positives = 98/183 (53%), Gaps = 5/183 (2%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID--ENVQREIINHRSLRHP 77
+ Y L IG G++G ++ K T A K I + ++ + ++EI +SL HP
Sbjct: 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPK-YFVEDVDRFKQEIEIMKSLDHP 66
Query: 78 NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ 137
NI+R E T + +VME +GGELFER+ + F E +A + ++S V+YCH +
Sbjct: 67 NIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLN 126
Query: 138 VCHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYD 196
V HRDLK EN L SP LK+ DFG + ++ VGTP Y++P+V L+ Y
Sbjct: 127 VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQV-LEGLYG 185
Query: 197 GKV 199
+
Sbjct: 186 PEC 188
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 207 bits (530), Expect = 2e-67
Identities = 49/194 (25%), Positives = 75/194 (38%), Gaps = 22/194 (11%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDE--------NVQREIINHR 72
Y L +G G FG VA+K I R +++ E+
Sbjct: 31 AEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPR-NRVLGWSPLSDSVTCPLEVALLW 89
Query: 73 SLR----HPNIVRFKEVILTPTHLAIVMEYA-SGGELFERICNAGRFSEDEARFFFQQLI 127
+ HP ++R + T +V+E +LF+ I G E +R FF Q++
Sbjct: 90 KVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVV 149
Query: 128 SGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYS---KSSVLHSQPKSTVGTPAY 184
+ + +CHS V HRD+K EN L+D K+ DFG GT Y
Sbjct: 150 AAIQHCHSRGVVHRDIKDENILIDLRRG-CAKLIDFGSGALLHDEPYT----DFDGTRVY 204
Query: 185 IAPEVLLKKEYDGK 198
PE + + +Y
Sbjct: 205 SPPEWISRHQYHAL 218
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 216 bits (552), Expect = 4e-67
Identities = 61/191 (31%), Positives = 85/191 (44%), Gaps = 12/191 (6%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER--GDKIDENVQREIINHRSLRHPN 78
+E+ +G+G FG + T E VA+K + K E EI + L HPN
Sbjct: 14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPN 73
Query: 79 IVRFKEVILTPTHLA------IVMEYASGGELFERIC---NAGRFSEDEARFFFQQLISG 129
+V +EV LA + MEY GG+L + + N E R + S
Sbjct: 74 VVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSA 133
Query: 130 VSYCHSMQVCHRDLKLENTLLD-GSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPE 188
+ Y H ++ HRDLK EN +L G KI D GY+K VGT Y+APE
Sbjct: 134 LRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAPE 193
Query: 189 VLLKKEYDGKV 199
+L +K+Y V
Sbjct: 194 LLEQKKYTVTV 204
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 207 bits (530), Expect = 6e-67
Identities = 64/184 (34%), Positives = 89/184 (48%), Gaps = 7/184 (3%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREI-INHRSLRHPN 78
+D YE+ DIG G++ V + K T AVK I DK + EI I R +HPN
Sbjct: 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKII---DKSKRDPTEEIEILLRYGQHPN 77
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQV 138
I+ K+V ++ +V E GGEL ++I FSE EA + V Y H+ V
Sbjct: 78 IITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGV 137
Query: 139 CHRDLKLENTLLDGSP--APRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKEY 195
HRDLK N L ++ICDFG++K + T T ++APEVL ++ Y
Sbjct: 138 VHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLERQGY 197
Query: 196 DGKV 199
D
Sbjct: 198 DAAC 201
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 205 bits (525), Expect = 2e-66
Identities = 64/188 (34%), Positives = 93/188 (49%), Gaps = 11/188 (5%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER---------GDKIDENVQREIIN 70
D Y + + +GSG G +L ++KT + VA+K I + NV+ EI
Sbjct: 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEI 68
Query: 71 HRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGV 130
+ L HP I++ K + IV+E GGELF+++ R E + +F Q++ V
Sbjct: 69 LKKLNHPCIIKIKNFFDAEDYY-IVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAV 127
Query: 131 SYCHSMQVCHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEV 189
Y H + HRDLK EN LL +KI DFG+SK S ++ GTP Y+APEV
Sbjct: 128 QYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEV 187
Query: 190 LLKKEYDG 197
L+ G
Sbjct: 188 LVSVGTAG 195
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 205 bits (524), Expect = 2e-66
Identities = 45/197 (22%), Positives = 79/197 (40%), Gaps = 17/197 (8%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG--DKIDENVQREIINHRSLRHP 77
+ + L +G G R KKT +L A+K + + RE + L H
Sbjct: 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHK 67
Query: 78 NIVRFKEVI--LTPTHLAIVMEYASGGELFERIC---NAGRFSEDEARFFFQQLISGVSY 132
NIV+ + T H ++ME+ G L+ + NA E E + ++ G+++
Sbjct: 68 NIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNH 127
Query: 133 CHSMQVCHRDLKLENTLLDGSPAPR--LKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL 190
+ HR++K N + + K+ DFG ++ Q S GT Y+ P++
Sbjct: 128 LRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMY 187
Query: 191 --------LKKEYDGKV 199
+K+Y V
Sbjct: 188 ERAVLRKDHQKKYGATV 204
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 204 bits (521), Expect = 3e-66
Identities = 64/189 (33%), Positives = 102/189 (53%), Gaps = 9/189 (4%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYI-------ERGDKIDENVQREIINHR 72
D YE+ ++GSG F + R R K T + A K+I R E ++RE+ R
Sbjct: 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILR 63
Query: 73 SLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 132
+RHPNI+ ++ T + +++E SGGELF+ + +EDEA F +Q++ GV Y
Sbjct: 64 EIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHY 123
Query: 133 CHSMQVCHRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL 190
HS ++ H DLK EN +L P PR+K+ DFG + ++ K+ GTP ++APE++
Sbjct: 124 LHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIV 183
Query: 191 LKKEYDGKV 199
+ +
Sbjct: 184 NYEPLGLEA 192
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 204 bits (522), Expect = 3e-66
Identities = 67/213 (31%), Positives = 101/213 (47%), Gaps = 43/213 (20%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER------------------------- 56
+Y L +IG G++GV +L ++ A+K + +
Sbjct: 14 QYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGC 73
Query: 57 --GDKIDENVQREIINHRSLRHPNIVRFKEVILTPT--HLAIVMEYASGGELFERICNAG 112
E V +EI + L HPN+V+ EV+ P HL +V E + G + E +
Sbjct: 74 IQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVME-VPTLK 132
Query: 113 RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYS-----K 167
SED+ARF+FQ LI G+ Y H ++ HRD+K N L+ +KI DFG S
Sbjct: 133 PLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGED--GHIKIADFGVSNEFKGS 190
Query: 168 SSVLHSQPKSTVGTPAYIAPEVL--LKKEYDGK 198
++L +TVGTPA++APE L +K + GK
Sbjct: 191 DALLS----NTVGTPAFMAPESLSETRKIFSGK 219
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 206 bits (526), Expect = 8e-66
Identities = 45/197 (22%), Positives = 79/197 (40%), Gaps = 17/197 (8%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG--DKIDENVQREIINHRSLRHP 77
+ + L +G G R KKT +L A+K + + RE + L H
Sbjct: 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHK 67
Query: 78 NIVRFKEVI--LTPTHLAIVMEYASGGELFERIC---NAGRFSEDEARFFFQQLISGVSY 132
NIV+ + T H ++ME+ G L+ + NA E E + ++ G+++
Sbjct: 68 NIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNH 127
Query: 133 CHSMQVCHRDLKLENTLLDGSPAPR--LKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL 190
+ HR++K N + + K+ DFG ++ Q S GT Y+ P++
Sbjct: 128 LRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMY 187
Query: 191 --------LKKEYDGKV 199
+K+Y V
Sbjct: 188 ERAVLRKDHQKKYGATV 204
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 202 bits (517), Expect = 1e-65
Identities = 69/184 (37%), Positives = 103/184 (55%), Gaps = 5/184 (2%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER---GDKIDENVQREIINHRSLRH 76
++RY +V +G G+FG +D+ T++ AVK I + +K + RE+ + L H
Sbjct: 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
PNI++ E++ + IV E +GGELF+ I RFSE +A +Q+ SG++Y H
Sbjct: 81 PNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKH 140
Query: 137 QVCHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEY 195
+ HRDLK EN LL+ +KI DFG S +++ K +GT YIAPEV L+ Y
Sbjct: 141 NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEV-LRGTY 199
Query: 196 DGKV 199
D K
Sbjct: 200 DEKC 203
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 204 bits (521), Expect = 2e-65
Identities = 67/181 (37%), Positives = 101/181 (55%), Gaps = 2/181 (1%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNI 79
SD +E+ ++G G + + K T++ A+K +++ + V+ EI L HPNI
Sbjct: 52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDK-KIVRTEIGVLLRLSHPNI 110
Query: 80 VRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVC 139
++ KE+ TPT +++V+E +GGELF+RI G +SE +A +Q++ V+Y H +
Sbjct: 111 IKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIV 170
Query: 140 HRDLKLENTLL-DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGK 198
HRDLK EN L +P LKI DFG SK K+ GTP Y APE+L Y +
Sbjct: 171 HRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEILRGCAYGPE 230
Query: 199 V 199
V
Sbjct: 231 V 231
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 206 bits (525), Expect = 2e-65
Identities = 64/193 (33%), Positives = 94/193 (48%), Gaps = 14/193 (7%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER---------GDKIDENVQREIIN 70
D Y + + +GSG G +L ++KT + VA++ I + NV+ EI
Sbjct: 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEI 193
Query: 71 HRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGV 130
+ L HP I++ K + IV+E GGELF+++ R E + +F Q++ V
Sbjct: 194 LKKLNHPCIIKIKNFFDAEDYY-IVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAV 252
Query: 131 SYCHSMQVCHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEV 189
Y H + HRDLK EN LL +KI DFG+SK S ++ GTP Y+APEV
Sbjct: 253 QYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEV 312
Query: 190 L---LKKEYDGKV 199
L Y+ V
Sbjct: 313 LVSVGTAGYNRAV 325
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 203 bits (519), Expect = 4e-65
Identities = 65/184 (35%), Positives = 93/184 (50%), Gaps = 4/184 (2%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIE--RGDKID-ENVQREIINHRSLRH 76
SD Y++ ++G G F V R K T A K I + D + ++RE R L+H
Sbjct: 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 87
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
PNIVR + I + +V + +GGELFE I +SE +A QQ++ ++YCHS
Sbjct: 88 PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSN 147
Query: 137 QVCHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEY 195
+ HR+LK EN LL + +K+ DFG + GTP Y++PEVL K Y
Sbjct: 148 GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPY 207
Query: 196 DGKV 199
V
Sbjct: 208 SKPV 211
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 201 bits (513), Expect = 5e-65
Identities = 62/187 (33%), Positives = 92/187 (49%), Gaps = 8/187 (4%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIE-RGDKID-ENVQREIINHRSLRHP 77
D + R +GSG FG L+ ++ + +K I ++ E ++ EI +SL HP
Sbjct: 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHP 80
Query: 78 NIVRFKEVILTPTHLAIVMEYASGGELFERIC----NAGRFSEDEARFFFQQLISGVSYC 133
NI++ EV ++ IVME GGEL ERI SE +Q+++ ++Y
Sbjct: 81 NIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYF 140
Query: 134 HSMQVCHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLK 192
HS V H+DLK EN L SP +KI DFG ++ + GT Y+APEV K
Sbjct: 141 HSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPEV-FK 199
Query: 193 KEYDGKV 199
++ K
Sbjct: 200 RDVTFKC 206
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 200 bits (512), Expect = 2e-64
Identities = 62/189 (32%), Positives = 104/189 (55%), Gaps = 9/189 (4%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYI-------ERGDKIDENVQREIINHR 72
D Y+ ++GSG F V + R+K T A K+I R E+++RE+ +
Sbjct: 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69
Query: 73 SLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 132
++HPN++ EV T + +++E +GGELF+ + +E+EA F +Q+++GV Y
Sbjct: 70 EIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYY 129
Query: 133 CHSMQVCHRDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL 190
HS+Q+ H DLK EN +L P PR+KI DFG + ++ K+ GTP ++APE++
Sbjct: 130 LHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIV 189
Query: 191 LKKEYDGKV 199
+ +
Sbjct: 190 NYEPLGLEA 198
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 200 bits (511), Expect = 2e-64
Identities = 71/186 (38%), Positives = 101/186 (54%), Gaps = 8/186 (4%)
Query: 20 SDRYEL---VRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREI-INHRSLR 75
Y+L + +G G+F + R KK+ + AVK I + +++ N Q+EI
Sbjct: 7 YQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISK--RMEANTQKEITALKLCEG 64
Query: 76 HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 135
HPNIV+ EV H +VME +GGELFERI FSE EA + ++L+S VS+ H
Sbjct: 65 HPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHD 124
Query: 136 MQVCHRDLKLENTLL-DGSPAPRLKICDFGYSKSSVLHSQP-KSTVGTPAYIAPEVLLKK 193
+ V HRDLK EN L D + +KI DFG+++ +QP K+ T Y APE+L +
Sbjct: 125 VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLNQN 184
Query: 194 EYDGKV 199
YD
Sbjct: 185 GYDESC 190
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 199 bits (507), Expect = 5e-64
Identities = 57/190 (30%), Positives = 86/190 (45%), Gaps = 13/190 (6%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYI----------ERGDKIDENVQREI- 68
+ YE +G G V R K T + AVK I E ++ E +E+
Sbjct: 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVD 75
Query: 69 INHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLIS 128
I + HPNI++ K+ T T +V + GELF+ + SE E R + L+
Sbjct: 76 ILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLE 135
Query: 129 GVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPE 188
+ H + + HRDLK EN LLD +K+ DFG+S + + GTP+Y+APE
Sbjct: 136 VICALHKLNIVHRDLKPENILLDDD--MNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPE 193
Query: 189 VLLKKEYDGK 198
++ D
Sbjct: 194 IIECSMNDNH 203
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 201 bits (512), Expect = 6e-64
Identities = 53/189 (28%), Positives = 87/189 (46%), Gaps = 12/189 (6%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER---------GDKIDENVQREI-I 69
+Y+ IG G V R + T AVK +E +++ E +RE I
Sbjct: 93 YQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHI 152
Query: 70 NHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISG 129
+ HP+I+ + + + + +V + GELF+ + SE E R + L+
Sbjct: 153 LRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEA 212
Query: 130 VSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEV 189
VS+ H+ + HRDLK EN LLD + +++ DFG+S + + GTP Y+APE+
Sbjct: 213 VSFLHANNIVHRDLKPENILLDDN-MQ-IRLSDFGFSCHLEPGEKLRELCGTPGYLAPEI 270
Query: 190 LLKKEYDGK 198
L +
Sbjct: 271 LKCSMDETH 279
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 199 bits (508), Expect = 6e-64
Identities = 58/189 (30%), Positives = 99/189 (52%), Gaps = 9/189 (4%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYI-------ERGDKIDENVQREIINHR 72
D Y++ ++GSG F + + R+K T A K+I R E ++RE+ R
Sbjct: 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILR 70
Query: 73 SLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 132
+ H N++ +V T + +++E SGGELF+ + SE+EA F +Q++ GV+Y
Sbjct: 71 QVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNY 130
Query: 133 CHSMQVCHRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL 190
H+ ++ H DLK EN +L P P +K+ DFG + + K+ GTP ++APE++
Sbjct: 131 LHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIV 190
Query: 191 LKKEYDGKV 199
+ +
Sbjct: 191 NYEPLGLEA 199
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 200 bits (510), Expect = 9e-64
Identities = 60/189 (31%), Positives = 100/189 (52%), Gaps = 9/189 (4%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYI-------ERGDKIDENVQREIINHR 72
D Y++ ++GSG F + + R+K T A K+I R E ++RE+ R
Sbjct: 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILR 70
Query: 73 SLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 132
+ HPNI+ +V T + +++E SGGELF+ + SE+EA F +Q++ GV+Y
Sbjct: 71 QVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNY 130
Query: 133 CHSMQVCHRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL 190
H+ ++ H DLK EN +L P P +K+ DFG + + K+ GTP ++APE++
Sbjct: 131 LHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIV 190
Query: 191 LKKEYDGKV 199
+ +
Sbjct: 191 NYEPLGLEA 199
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 198 bits (505), Expect = 2e-63
Identities = 42/181 (23%), Positives = 79/181 (43%), Gaps = 1/181 (0%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNI 79
++Y + D+G G FG+ + +++ K+++ V++EI RH NI
Sbjct: 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNI 63
Query: 80 VRFKEVILTPTHLAIVMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQV 138
+ E + L ++ E+ SG ++FERI + +E E + Q+ + + HS +
Sbjct: 64 LHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNI 123
Query: 139 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGK 198
H D++ EN + + +KI +FG ++ + P Y APEV
Sbjct: 124 GHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVVSTA 183
Query: 199 V 199
Sbjct: 184 T 184
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 200 bits (512), Expect = 4e-63
Identities = 64/188 (34%), Positives = 91/188 (48%), Gaps = 11/188 (5%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER--GDKID-ENVQREIINHRSLRH 76
++ Y+L ++G G F V R + A I D + ++RE R L+H
Sbjct: 10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKH 69
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
PNIVR + I H ++ + +GGELFE I +SE +A QQ++ V +CH M
Sbjct: 70 PNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQM 129
Query: 137 QVCHRDLKLENTLL----DGSPAPRLKICDFGYSKSSVLHSQP-KSTVGTPAYIAPEVLL 191
V HR+LK EN LL G+ +K+ DFG + Q GTP Y++PEVL
Sbjct: 130 GVVHRNLKPENLLLASKLKGAA---VKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLR 186
Query: 192 KKEYDGKV 199
K Y V
Sbjct: 187 KDPYGKPV 194
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 201 bits (513), Expect = 8e-63
Identities = 69/184 (37%), Positives = 103/184 (55%), Gaps = 5/184 (2%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER---GDKIDENVQREIINHRSLRH 76
++RY +V +G G+FG +D+ T++ AVK I + +K + RE+ + L H
Sbjct: 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
PNI++ E++ + IV E +GGELF+ I RFSE +A +Q+ SG++Y H
Sbjct: 81 PNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKH 140
Query: 137 QVCHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEY 195
+ HRDLK EN LL+ +KI DFG S +++ K +GT YIAPEV L+ Y
Sbjct: 141 NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEV-LRGTY 199
Query: 196 DGKV 199
D K
Sbjct: 200 DEKC 203
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 200 bits (510), Expect = 2e-62
Identities = 77/204 (37%), Positives = 108/204 (52%), Gaps = 8/204 (3%)
Query: 3 RSAMTVGPGM--DMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER---G 57
+ PGM SDRY+ R +G G+FG L +DK T + AVK I +
Sbjct: 6 MDHLHATPGMFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVK 65
Query: 58 DKID-ENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSE 116
K D E++ RE+ + L HPNI++ E + +V E +GGELF+ I + RFSE
Sbjct: 66 QKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSE 125
Query: 117 DEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVLHSQP 175
+A +Q++SG++Y H ++ HRDLK EN LL+ S ++I DFG S +
Sbjct: 126 VDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKM 185
Query: 176 KSTVGTPAYIAPEVLLKKEYDGKV 199
K +GT YIAPEV L YD K
Sbjct: 186 KDKIGTAYYIAPEV-LHGTYDEKC 208
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 200 bits (510), Expect = 2e-62
Identities = 68/184 (36%), Positives = 99/184 (53%), Gaps = 5/184 (2%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER---GDKIDENVQREIINHRSLRH 76
S+ Y+ V+ +GSG +G L RDK T A+K I + + + E+ + L H
Sbjct: 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDH 95
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
PNI++ + + +VME GGELF+ I + +F+E +A +Q++SGV+Y H
Sbjct: 96 PNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKH 155
Query: 137 QVCHRDLKLENTLL-DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEY 195
+ HRDLK EN LL +KI DFG S + K +GT YIAPEV L+K+Y
Sbjct: 156 NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEV-LRKKY 214
Query: 196 DGKV 199
D K
Sbjct: 215 DEKC 218
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 197 bits (502), Expect = 3e-62
Identities = 51/182 (28%), Positives = 86/182 (47%), Gaps = 2/182 (1%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID-ENVQREIINHRSLRHPN 78
D Y+++ ++GSG FGV +K T + K+I +D V+ EI L HP
Sbjct: 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPK 109
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQ 137
++ + + +++E+ SGGELF+RI + SE E + +Q G+ + H
Sbjct: 110 LINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS 169
Query: 138 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDG 197
+ H D+K EN + + A +KI DFG + K T T + APE++ ++
Sbjct: 170 IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPVGF 229
Query: 198 KV 199
Sbjct: 230 YT 231
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 194 bits (494), Expect = 5e-62
Identities = 56/210 (26%), Positives = 86/210 (40%), Gaps = 32/210 (15%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNI 79
+ +E + +G G FG R+ A+K I ++ + E++ SL H +
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYV 64
Query: 80 VRFKEVIL-------------TPTHLAIVMEYASGGELFERICNAGRF-SEDEARFFFQQ 125
VR+ L + L I MEY G L++ I + DE F+Q
Sbjct: 65 VRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQ 124
Query: 126 LISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS---------------SV 170
++ +SY HS + HRDLK N +D S +KI DFG +K+
Sbjct: 125 ILEALSYIHSQGIIHRDLKPMNIFIDES--RNVKIGDFGLAKNVHRSLDILKLDSQNLPG 182
Query: 171 LHSQPKSTVGTPAYIAPEVLLKK-EYDGKV 199
S +GT Y+A EVL Y+ K+
Sbjct: 183 SSDNLTSAIGTAMYVATEVLDGTGHYNEKI 212
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 199 bits (507), Expect = 8e-62
Identities = 68/195 (34%), Positives = 102/195 (52%), Gaps = 16/195 (8%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER--------------GDKIDENVQ 65
+ Y VR +GSG +G L ++K A+K I++ +K E +
Sbjct: 35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIY 94
Query: 66 REIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQ 125
EI +SL HPNI++ +V + +V E+ GGELFE+I N +F E +A +Q
Sbjct: 95 NEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQ 154
Query: 126 LISGVSYCHSMQVCHRDLKLENTLL-DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAY 184
++SG+ Y H + HRD+K EN LL + + +KI DFG S + + +GT Y
Sbjct: 155 ILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYY 214
Query: 185 IAPEVLLKKEYDGKV 199
IAPEV LKK+Y+ K
Sbjct: 215 IAPEV-LKKKYNEKC 228
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 192 bits (491), Expect = 3e-61
Identities = 55/188 (29%), Positives = 90/188 (47%), Gaps = 8/188 (4%)
Query: 20 SDRYELV-RDIGSGNFGVARLMRDKKTEELVAVKYIE---RGDKIDENVQREI-INHRSL 74
++ Y L +++G G F V R K T + A K+++ RG + EI + +
Sbjct: 27 NNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAK 86
Query: 75 RHPNIVRFKEVILTPTHLAIVMEYASGGELFERIC--NAGRFSEDEARFFFQQLISGVSY 132
P ++ EV + + +++EYA+GGE+F A SE++ +Q++ GV Y
Sbjct: 87 SCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYY 146
Query: 133 CHSMQVCHRDLKLENTLL-DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL 191
H + H DLK +N LL P +KI DFG S+ + + +GTP Y+APE+L
Sbjct: 147 LHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAPEILN 206
Query: 192 KKEYDGKV 199
Sbjct: 207 YDPITTAT 214
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 194 bits (494), Expect = 6e-61
Identities = 65/206 (31%), Positives = 103/206 (50%), Gaps = 13/206 (6%)
Query: 3 RSAMTVGPGMDMPIMHDSDRYELV-RDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID 61
V G+ + D Y++ + +G G G + +K+T+E A+K ++
Sbjct: 43 FPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD----C 98
Query: 62 ENVQREI-INHRSLRHPNIVRFKEV----ILTPTHLAIVMEYASGGELFERICNAG--RF 114
+RE+ ++ R+ + P+IVR +V L IVME GGELF RI + G F
Sbjct: 99 PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAF 158
Query: 115 SEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLL-DGSPAPRLKICDFGYSKSSVLHS 173
+E EA + + + Y HS+ + HRD+K EN L P LK+ DFG++K + H+
Sbjct: 159 TEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN 218
Query: 174 QPKSTVGTPAYIAPEVLLKKEYDGKV 199
+ TP Y+APEVL ++YD
Sbjct: 219 SLTTPCYTPYYVAPEVLGPEKYDKSC 244
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 192 bits (490), Expect = 7e-61
Identities = 37/209 (17%), Positives = 77/209 (36%), Gaps = 39/209 (18%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER------------------GDKIDE 62
+ Y ++R + G F L K + A+K E+ +
Sbjct: 31 NDYRIIRTLNQGKFNKIILCE--KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYD 88
Query: 63 NVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAG--------RF 114
+ + E+ +++ + + +I + I+ EY + +
Sbjct: 89 DFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFI 148
Query: 115 SEDEARFFFQQLISGVSYCHS-MQVCHRDLKLENTLLDGSPAPRLKICDFGYSK---SSV 170
+ + +++ SY H+ +CHRD+K N L+D + R+K+ DFG S+
Sbjct: 149 PIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKN--GRVKLSDFGESEYMVDKK 206
Query: 171 LHSQPKSTVGTPAYIAPEVLL-KKEYDGK 198
+ + GT ++ PE + Y+G
Sbjct: 207 IK----GSRGTYEFMPPEFFSNESSYNGA 231
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 198 bits (504), Expect = 9e-61
Identities = 56/182 (30%), Positives = 89/182 (48%), Gaps = 2/182 (1%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID-ENVQREIINHRSLRHPN 78
D Y++ ++G+G FGV + ++ T A K++ + D E V++EI LRHP
Sbjct: 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPT 215
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQ 137
+V + + ++ E+ SGGELFE++ + + SEDEA + +Q+ G+ + H
Sbjct: 216 LVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN 275
Query: 138 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDG 197
H DLK EN + + LK+ DFG + K T GT + APEV K
Sbjct: 276 YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGY 335
Query: 198 KV 199
Sbjct: 336 YT 337
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 191 bits (488), Expect = 1e-60
Identities = 55/192 (28%), Positives = 87/192 (45%), Gaps = 12/192 (6%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIE------RGDKIDENVQREIINHRS 73
D YEL IG G F V R +++T + AVK ++ E+++RE
Sbjct: 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHM 82
Query: 74 LRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR----FSEDEARFFFQQLISG 129
L+HP+IV E + L +V E+ G +L I +SE A + +Q++
Sbjct: 83 LKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEA 142
Query: 130 VSYCHSMQVCHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVLHSQP-KSTVGTPAYIAP 187
+ YCH + HRD+K LL + +K+ FG + VGTP ++AP
Sbjct: 143 LRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAP 202
Query: 188 EVLLKKEYDGKV 199
EV+ ++ Y V
Sbjct: 203 EVVKREPYGKPV 214
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 192 bits (489), Expect = 2e-60
Identities = 57/184 (30%), Positives = 89/184 (48%), Gaps = 4/184 (2%)
Query: 20 SDRYELVR--DIGSGNFGVARLMRDKKTEELVAVKYIE-RGDKIDENVQREIINHRSLRH 76
+ Y + + +G G FG + T +A K I+ RG K E V+ EI L H
Sbjct: 86 NSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDH 145
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHS 135
N+++ + + + +VMEY GGELF+RI + +E + F +Q+ G+ + H
Sbjct: 146 ANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQ 205
Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEY 195
M + H DLK EN L A ++KI DFG ++ + K GTP ++APEV+
Sbjct: 206 MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFGTPEFLAPEVVNYDFV 265
Query: 196 DGKV 199
Sbjct: 266 SFPT 269
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 190 bits (484), Expect = 2e-60
Identities = 54/198 (27%), Positives = 84/198 (42%), Gaps = 19/198 (9%)
Query: 20 SDRYELVRD-IGSGNFGVARLMRDKKTEELVAVKYIE-RGDKIDENVQREI-INHRSLRH 76
D Y+L D +G G + + T + AVK IE + I V RE+ + ++ H
Sbjct: 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGH 70
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
N++ E +V E GG + I F+E EA Q + S + + H+
Sbjct: 71 RNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNK 130
Query: 137 QVCHRDLKLENTLLD--GSPAPRLKICDFGYSK--------SSVLHSQPKSTVGTPAYIA 186
+ HRDLK EN L + +P +KICDF S + + + G+ Y+A
Sbjct: 131 GIAHRDLKPENILCEHPNQVSP-VKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMA 189
Query: 187 PEVLLK-----KEYDGKV 199
PEV+ YD +
Sbjct: 190 PEVVEAFSEEASIYDKRC 207
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 188 bits (480), Expect = 4e-60
Identities = 49/197 (24%), Positives = 82/197 (41%), Gaps = 23/197 (11%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIV 80
++ + IGSG FG + + + +K + +E +RE+ L H NIV
Sbjct: 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRV---KYNNEKAEREVKALAKLDHVNIV 67
Query: 81 RFKEVILTPTH----------------LAIVMEYASGGELFERI--CNAGRFSEDEARFF 122
+ + L I ME+ G L + I + + A
Sbjct: 68 HYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALEL 127
Query: 123 FQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTP 182
F+Q+ GV Y HS ++ +RDLK N L + ++KI DFG S + + GT
Sbjct: 128 FEQITKGVDYIHSKKLINRDLKPSNIFLVDT--KQVKIGDFGLVTSLKNDGKRTRSKGTL 185
Query: 183 AYIAPEVLLKKEYDGKV 199
Y++PE + ++Y +V
Sbjct: 186 RYMSPEQISSQDYGKEV 202
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 187 bits (478), Expect = 2e-59
Identities = 40/183 (21%), Positives = 77/183 (42%), Gaps = 13/183 (7%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID---ENVQREIINHRSLRHPN 78
Y +++ IGSG + ++K + + A+KY+ + + ++ + EI L+ +
Sbjct: 29 IYSILKQIGSGGSSKVFQVLNEKKQ-IYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 87
Query: 79 --IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
I+R + +T ++ +VME +L + E + +++ ++ V H
Sbjct: 88 DKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH 146
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQPKSTVGTPAYIAPEVLLKK 193
+ H DLK N L+ LK+ DFG + S VGT Y+ PE +
Sbjct: 147 GIVHSDLKPANFLIVDG---MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDM 203
Query: 194 EYD 196
Sbjct: 204 SSS 206
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 188 bits (480), Expect = 2e-59
Identities = 57/233 (24%), Positives = 93/233 (39%), Gaps = 53/233 (22%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER-----GDKID-ENVQREIINHRS 73
+Y L IG G++GV R+ + +T + A+K + + + D E ++ E+ +
Sbjct: 25 QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKK 84
Query: 74 LRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR-------------------- 113
L HPNI R EV ++ +VME GG L +++
Sbjct: 85 LHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPE 144
Query: 114 --------------------FSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGS 153
E +Q+ S + Y H+ +CHRD+K EN L +
Sbjct: 145 CNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTN 204
Query: 154 PAPRLKICDFGYSKSSVLHSQP-----KSTVGTPAYIAPEVL--LKKEYDGKV 199
+ +K+ DFG SK + + GTP ++APEVL + Y K
Sbjct: 205 KSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKC 257
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 187 bits (476), Expect = 9e-59
Identities = 54/184 (29%), Positives = 96/184 (52%), Gaps = 8/184 (4%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID---ENVQREIINHRSLRHP 77
++Y ++ IG G+FG A L++ + +K I E +RE+ +++HP
Sbjct: 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHP 83
Query: 78 NIVRFKEVILTPTHLAIVMEYASGGELFERI--CNAGRFSEDEARFFFQQLISGVSYCHS 135
NIV+++E L IVM+Y GG+LF+RI F ED+ +F Q+ + + H
Sbjct: 84 NIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHD 143
Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKSTVGTPAYIAPEVLLKKE 194
++ HRD+K +N L +++ DFG ++ + ++ +GTP Y++PE+ K
Sbjct: 144 RKILHRDIKSQNIFLTKD--GTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICENKP 201
Query: 195 YDGK 198
Y+ K
Sbjct: 202 YNNK 205
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 186 bits (475), Expect = 1e-58
Identities = 40/183 (21%), Positives = 77/183 (42%), Gaps = 13/183 (7%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID---ENVQREIINHRSLRHPN 78
Y +++ IGSG + ++K + + A+KY+ + + ++ + EI L+ +
Sbjct: 10 IYSILKQIGSGGSSKVFQVLNEKKQ-IYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 68
Query: 79 --IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
I+R + +T ++ +VME +L + E + +++ ++ V H
Sbjct: 69 DKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH 127
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQPKSTVGTPAYIAPEVLLKK 193
+ H DLK N L+ LK+ DFG + S VGT Y+ PE +
Sbjct: 128 GIVHSDLKPANFLIVDG---MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDM 184
Query: 194 EYD 196
Sbjct: 185 SSS 187
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 186 bits (474), Expect = 1e-58
Identities = 55/190 (28%), Positives = 89/190 (46%), Gaps = 16/190 (8%)
Query: 20 SDRYELVRD-IGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREI-INHRSLRHP 77
+D Y+L + +G G G ++T + A+K + ++E+ + ++ P
Sbjct: 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYD----SPKARQEVDHHWQASGGP 82
Query: 78 NIVRFKEVILTPTHLA----IVMEYASGGELFERICNAG--RFSEDEARFFFQQLISGVS 131
+IV +V H I+ME GGELF RI G F+E EA + + + +
Sbjct: 83 HIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQ 142
Query: 132 YCHSMQVCHRDLKLENTLL-DGSPAPRLKICDFGYSKSSVLHSQP-KSTVGTPAYIAPEV 189
+ HS + HRD+K EN L LK+ DFG++K ++ TP Y+APEV
Sbjct: 143 FLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAK--ETTQNALQTPCYTPYYVAPEV 200
Query: 190 LLKKEYDGKV 199
L ++YD
Sbjct: 201 LGPEKYDKSC 210
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 185 bits (472), Expect = 8e-58
Identities = 38/183 (20%), Positives = 77/183 (42%), Gaps = 13/183 (7%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID---ENVQREIINHRSLRHPN 78
Y +++ IGSG + ++ +++ A+KY+ + + ++ + EI L+ +
Sbjct: 57 IYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 115
Query: 79 --IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
I+R + +T ++ +VME +L + E + +++ ++ V H
Sbjct: 116 DKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH 174
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP---KSTVGTPAYIAPEVLLKK 193
+ H DLK N L+ LK+ DFG + + S VG Y+ PE +
Sbjct: 175 GIVHSDLKPANFLIVDG---MLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDM 231
Query: 194 EYD 196
Sbjct: 232 SSS 234
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 180 bits (459), Expect = 4e-57
Identities = 61/194 (31%), Positives = 97/194 (50%), Gaps = 17/194 (8%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID---ENVQREIINHRSLRHP 77
+ YE++ IG+G++G + +R K +++ K ++ G + + + E+ R L+HP
Sbjct: 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65
Query: 78 NIVRFKEVILTPT--HLAIVMEYASGGELFERICNAGR----FSEDEARFFFQQLISGVS 131
NIVR+ + I+ T L IVMEY GG+L I + E+ QL +
Sbjct: 66 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 125
Query: 132 YCHSM-----QVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKSTVGTPAYI 185
CH V HRDLK N LDG +K+ DFG ++ + S K+ VGTP Y+
Sbjct: 126 ECHRRSDGGHTVLHRDLKPANVFLDGK--QNVKLGDFGLARILNHDTSFAKTFVGTPYYM 183
Query: 186 APEVLLKKEYDGKV 199
+PE + + Y+ K
Sbjct: 184 SPEQMNRMSYNEKS 197
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 179 bits (456), Expect = 3e-56
Identities = 50/188 (26%), Positives = 85/188 (45%), Gaps = 11/188 (5%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID----ENVQREIINHRSLRH 76
+ + + IG G F VA+K ++ D +D + +EI + L H
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR----FSEDEARFFFQQLISGVSY 132
PN++++ + L IV+E A G+L I + + E +F QL S + +
Sbjct: 92 PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEH 151
Query: 133 CHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKSTVGTPAYIAPEVLL 191
HS +V HRD+K N + + +K+ D G + S + S VGTP Y++PE +
Sbjct: 152 MHSRRVMHRDIKPANVFITAT--GVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIH 209
Query: 192 KKEYDGKV 199
+ Y+ K
Sbjct: 210 ENGYNFKS 217
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 177 bits (450), Expect = 3e-55
Identities = 45/184 (24%), Positives = 75/184 (40%), Gaps = 9/184 (4%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYI---ERGDKIDENVQREIINHRSL-RH 76
++ + +G G++G +R K+ L AVK RG K E+ +H + +H
Sbjct: 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQH 116
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHS 135
P VR ++ L + E G L + G E + + + + +++ HS
Sbjct: 117 PCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHS 175
Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEY 195
+ H D+K N L P R K+ DFG + G P Y+APE+ L+ Y
Sbjct: 176 QGLVHLDVKPANIFLG--PRGRCKLGDFGLLVELGTAGAGEVQEGDPRYMAPEL-LQGSY 232
Query: 196 DGKV 199
Sbjct: 233 GTAA 236
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 172 bits (438), Expect = 2e-53
Identities = 45/197 (22%), Positives = 74/197 (37%), Gaps = 21/197 (10%)
Query: 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID-ENVQREIINHRSLRHP 77
D+ Y ++ +G G F L+ A+K I ++ D E QRE HR HP
Sbjct: 27 DNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHP 86
Query: 78 NIVRFKEVILTPT----HLAIVMEYASGGELFERI----CNAGRFSEDEARFFFQQLISG 129
NI+R L +++ + G L+ I +ED+ + + G
Sbjct: 87 NILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRG 146
Query: 130 VSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST----------V 179
+ H+ HRDLK N LL + + D G + +H +
Sbjct: 147 LEAIHAKGYAHRDLKPTNILLGDE--GQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQR 204
Query: 180 GTPAYIAPEVLLKKEYD 196
T +Y APE+ + +
Sbjct: 205 CTISYRAPELFSVQSHC 221
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 171 bits (435), Expect = 3e-53
Identities = 50/209 (23%), Positives = 76/209 (36%), Gaps = 32/209 (15%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYI--ERGDKIDENVQREIINHRSLRHPN 78
+E ++ +G G FGV ++K + A+K I + E V RE+ L HP
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64
Query: 79 IVRFKEVILT------------PTHLAIVMEYASGGELFERI---CNAGRFSEDEARFFF 123
IVR+ L +L I M+ L + + C F
Sbjct: 65 IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIF 124
Query: 124 QQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK-------------SSV 170
Q+ V + HS + HRDLK N +K+ DFG
Sbjct: 125 LQIAEAVEFLHSKGLMHRDLKPSNIFFTMD--DVVKVGDFGLVTAMDQDEEEQTVLTPMP 182
Query: 171 LHSQPKSTVGTPAYIAPEVLLKKEYDGKV 199
+++ VGT Y++PE + Y KV
Sbjct: 183 AYARHTGQVGTKLYMSPEQIHGNSYSHKV 211
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 166 bits (423), Expect = 2e-51
Identities = 54/188 (28%), Positives = 82/188 (43%), Gaps = 33/188 (17%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREI-INHRSLRHPN 78
D + +G G G + +K+T+E A+K ++ +RE+ ++ R+ + P+
Sbjct: 17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD----CPKARREVELHWRASQCPH 72
Query: 79 IVRFKEV----ILTPTHLAIVMEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSY 132
IVR +V L IVME GGELF RI + G F+E EA + + + Y
Sbjct: 73 IVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQY 132
Query: 133 CHSMQVCHRDLKLENTLL-DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL 191
HS+ + HRD+K EN L P LK+ DFG A E
Sbjct: 133 LHSINIAHRDVKPENLLYTSKRPNAILKLTDFG--------------------FAKET-T 171
Query: 192 KKEYDGKV 199
++YD
Sbjct: 172 GEKYDKSC 179
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 162 bits (412), Expect = 4e-49
Identities = 33/206 (16%), Positives = 70/206 (33%), Gaps = 27/206 (13%)
Query: 19 DSDRYELVRDIGSGNFGVARL-----MRDKKTEELVAVKYIERGDKIDENVQREIIN-HR 72
S + +G G F + D K ++ +K + + + + +++ +
Sbjct: 63 GSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLK 122
Query: 73 SLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERIC-----NAGRFSEDEARFFFQQLI 127
++F L +V E S G L I + F +++
Sbjct: 123 PSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRML 182
Query: 128 SGVSYCHSMQVCHRDLKLENTLLDGSPAPR---------LKICDFGYSKSSVLHSQPKST 178
+ H ++ H D+K +N +L + L + D G S + PK T
Sbjct: 183 YMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSID--MKLFPKGT 240
Query: 179 V-----GTPAYIAPEVLLKKEYDGKV 199
+ T + E+L K ++ ++
Sbjct: 241 IFTAKCETSGFQCVEMLSNKPWNYQI 266
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 163 bits (413), Expect = 1e-48
Identities = 47/198 (23%), Positives = 78/198 (39%), Gaps = 28/198 (14%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREI-INHRSLRHPNI 79
+ + +G G+ G + VAVK + + EI + S HPN+
Sbjct: 15 NLVVSEKILGYGSSGTVVF-QGSFQGRPVAVKRMLIDF--CDIALMEIKLLTESDDHPNV 71
Query: 80 VRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSED-------EARFFFQQLISGVSY 132
+R+ T L I +E L + + + E+ +Q+ SGV++
Sbjct: 72 IRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAH 130
Query: 133 CHSMQVCHRDLKLENTLLDGSPAP-----------RLKICDFGYSK-----SSVLHSQPK 176
HS+++ HRDLK +N L+ S R+ I DFG K S +
Sbjct: 131 LHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLN 190
Query: 177 STVGTPAYIAPEVLLKKE 194
+ GT + APE+L +
Sbjct: 191 NPSGTSGWRAPELLEESN 208
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 8e-48
Identities = 52/206 (25%), Positives = 80/206 (38%), Gaps = 29/206 (14%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIE---RGDKIDENVQREIINHRSL-R 75
+ + + IGSG FG + + A+K + G ++N RE+ H L +
Sbjct: 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69
Query: 76 HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR----FSEDEARFFFQQLISGVS 131
H ++VR+ H+ I EY +GG L + I R F E E + Q+ G+
Sbjct: 70 HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLR 129
Query: 132 YCHSMQVCHRDLKLENTLLD-----------------GSPAPRLKICDFGYSKSSVLHSQ 174
Y HSM + H D+K N + S KI D G+ S
Sbjct: 130 YIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTR---ISS 186
Query: 175 PKSTVGTPAYIAPEVLL-KKEYDGKV 199
P+ G ++A EVL + K
Sbjct: 187 PQVEEGDSRFLANEVLQENYTHLPKA 212
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 4e-47
Identities = 48/208 (23%), Positives = 78/208 (37%), Gaps = 32/208 (15%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDEN-VQREIINHRSLR-HPNI 79
R + R + G F +D + A+K + ++ + +E+ + L HPNI
Sbjct: 29 RLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNI 88
Query: 80 VRF-------KEVILTPTHLAIVMEYASGGELFERICNA---GRFSEDEARFFFQQLISG 129
V+F KE T +++ G+L E + G S D F Q
Sbjct: 89 VQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRA 148
Query: 130 VSYCHSMQ--VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--------- 178
V + H + + HRDLK+EN LL +K+CDFG + + + +
Sbjct: 149 VQHMHRQKPPIIHRDLKVENLLLSNQ--GTIKLCDFGSATTISHYPDYSWSAQRRALVEE 206
Query: 179 ----VGTPAYIAPEVL---LKKEYDGKV 199
TP Y PE++ K
Sbjct: 207 EITRNTTPMYRTPEIIDLYSNFPIGEKQ 234
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 7e-47
Identities = 49/190 (25%), Positives = 71/190 (37%), Gaps = 16/190 (8%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREI-INHRSLRHPNIV 80
+ +G G G R VAVK I + RE+ + S HPN++
Sbjct: 25 SFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILP--ECFSFADREVQLLRESDEHPNVI 81
Query: 81 RFKEVILTPTHLAIVMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQVC 139
R+ I +E L E + E QQ SG+++ HS+ +
Sbjct: 82 RYFCTEKDRQFQYIAIELC-AATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIV 140
Query: 140 HRDLKLENTLL---DGSPAPRLKICDFGYSK----SSVLHSQPKSTVGTPAYIAPEVL-- 190
HRDLK N L+ + + I DFG K S+ GT +IAPE+L
Sbjct: 141 HRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSE 200
Query: 191 -LKKEYDGKV 199
K+ V
Sbjct: 201 DCKENPTYTV 210
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 1e-46
Identities = 53/183 (28%), Positives = 87/183 (47%), Gaps = 13/183 (7%)
Query: 23 YELVRDIGSGNFGVARLMRDKKTEELVAVK-----YIERGDKIDE-NVQREIINHRSLRH 76
++ + +G G+F L R+ T A+K +I + +K+ +R++++ L H
Sbjct: 32 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMS--RLDH 89
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
P V+ L + YA GEL + I G F E RF+ +++S + Y H
Sbjct: 90 PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 149
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST---VGTPAYIAPEVLLKK 193
+ HRDLK EN LL+ ++I DFG +K S+ VGT Y++PE+L +K
Sbjct: 150 GIIHRDLKPENILLNED--MHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEK 207
Query: 194 EYD 196
Sbjct: 208 SAC 210
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 3e-46
Identities = 52/187 (27%), Positives = 81/187 (43%), Gaps = 11/187 (5%)
Query: 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPN 78
+ +G G+FG M+DK+T AVK + ++ E++ L P
Sbjct: 56 EVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVR----LEVFRVEELVACAGLSSPR 111
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQV 138
IV + + I ME GG L + I G ED A ++ Q + G+ Y H+ ++
Sbjct: 112 IVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRI 171
Query: 139 CHRDLKLENTLLDGSPAPRLKICDFGYSK------SSVLHSQPKSTVGTPAYIAPEVLLK 192
H D+K +N LL R +CDFG++ GT ++APEV++
Sbjct: 172 LHGDVKADNVLLSSD-GSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMG 230
Query: 193 KEYDGKV 199
K D KV
Sbjct: 231 KPCDAKV 237
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 146 bits (372), Expect = 2e-43
Identities = 52/189 (27%), Positives = 97/189 (51%), Gaps = 15/189 (7%)
Query: 21 DRYELVRDIGSGNFG---VARLMRDKKTEELVAVKYIERGDKIDENVQREIINHR----S 73
++EL++ +G G+FG + + + +L A+K + + + + R
Sbjct: 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVL-KKATLKVRDRVRTKMERDILVE 82
Query: 74 LRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYC 133
+ HP IV+ T L +++++ GG+LF R+ F+E++ +F+ +L + +
Sbjct: 83 VNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHL 142
Query: 134 HSMQVCHRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQPKSTV-GTPAYIAPEVL 190
HS+ + +RDLK EN LLD G +K+ DFG SK S+ H + + GT Y+APEV+
Sbjct: 143 HSLGIIYRDLKPENILLDEEG----HIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVV 198
Query: 191 LKKEYDGKV 199
++ +
Sbjct: 199 NRRGHTQSA 207
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 9e-43
Identities = 56/185 (30%), Positives = 105/185 (56%), Gaps = 12/185 (6%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHR----SLRH 76
D+++ ++ +G+G+FG L++ K++ A+K +++ + +N + ++
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
P +V+ + ++L +VMEY +GGE+F + GRFSE ARF+ Q++ Y HS+
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL 160
Query: 137 QVCHRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKE 194
+ +RDLK EN L+D G +++ DFG++K + + + GTP +APE++L K
Sbjct: 161 DLIYRDLKPENLLIDQQG----YIQVTDFGFAK--RVKGRTWTLCGTPEALAPEIILSKG 214
Query: 195 YDGKV 199
Y+ V
Sbjct: 215 YNKAV 219
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 144 bits (367), Expect = 1e-42
Identities = 57/184 (30%), Positives = 94/184 (51%), Gaps = 20/184 (10%)
Query: 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINH--------RSL 74
++++R +G+G+FG L+R + A+K + K + V+ + + H +
Sbjct: 8 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVL----KKEIVVRLKQVEHTNDERLMLSIV 63
Query: 75 RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCH 134
HP I+R + ++M+Y GGELF + + RF A+F+ ++ + Y H
Sbjct: 64 THPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLH 123
Query: 135 SMQVCHRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLK 192
S + +RDLK EN LLD G +KI DFG++K + + GTP YIAPEV+
Sbjct: 124 SKDIIYRDLKPENILLDKNG----HIKITDFGFAK--YVPDVTYTLCGTPDYIAPEVVST 177
Query: 193 KEYD 196
K Y+
Sbjct: 178 KPYN 181
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 1e-42
Identities = 65/191 (34%), Positives = 98/191 (51%), Gaps = 20/191 (10%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINH--------- 71
+ ++ IG G+FG L R K E AVK + + I ++++ H
Sbjct: 38 SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVL-QKKAI---LKKKEEKHIMSERNVLL 93
Query: 72 RSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS 131
++++HP +V T L V++Y +GGELF + F E ARF+ ++ S +
Sbjct: 94 KNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALG 153
Query: 132 YCHSMQVCHRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQPKSTV-GTPAYIAPE 188
Y HS+ + +RDLK EN LLD G + + DFG K ++ H+ ST GTP Y+APE
Sbjct: 154 YLHSLNIVYRDLKPENILLDSQG----HIVLTDFGLCKENIEHNSTTSTFCGTPEYLAPE 209
Query: 189 VLLKKEYDGKV 199
VL K+ YD V
Sbjct: 210 VLHKQPYDRTV 220
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 2e-42
Identities = 66/190 (34%), Positives = 100/190 (52%), Gaps = 19/190 (10%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINH--------R 72
+ ++ ++ +G G FG L+R+K T A+K + R + I + ++ + H +
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKIL-RKEVI---IAKDEVAHTVTESRVLQ 60
Query: 73 SLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 132
+ RHP + K T L VMEYA+GGELF + F+E+ ARF+ +++S + Y
Sbjct: 61 NTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEY 120
Query: 133 CHSMQVCHRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQPKSTV-GTPAYIAPEV 189
HS V +RD+KLEN +LD G +KI DFG K + T GTP Y+APEV
Sbjct: 121 LHSRDVVYRDIKLENLMLDKDG----HIKITDFGLCKEGISDGATMKTFCGTPEYLAPEV 176
Query: 190 LLKKEYDGKV 199
L +Y V
Sbjct: 177 LEDNDYGRAV 186
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 3e-42
Identities = 64/186 (34%), Positives = 96/186 (51%), Gaps = 16/186 (8%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINH--------- 71
D +E +R +G G+FG L R K+T +L AVK + + D I +Q + +
Sbjct: 23 DNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVL-KKDVI---LQDDDVECTMTEKRILS 78
Query: 72 RSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS 131
+ HP + + TP L VME+ +GG+L I + RF E ARF+ ++IS +
Sbjct: 79 LARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALM 138
Query: 132 YCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVL 190
+ H + +RDLKL+N LLD K+ DFG K + + +T GTP YIAPE+L
Sbjct: 139 FLHDKGIIYRDLKLDNVLLDHE--GHCKLADFGMCKEGICNGVTTATFCGTPDYIAPEIL 196
Query: 191 LKKEYD 196
+ Y
Sbjct: 197 QEMLYG 202
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 3e-42
Identities = 58/191 (30%), Positives = 97/191 (50%), Gaps = 20/191 (10%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINH--------- 71
++L+R IG G++ L+R KKT+ + A+K + + + + E I+
Sbjct: 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVV-KKELV---NDDEDIDWVQTEKHVFE 64
Query: 72 RSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS 131
++ HP +V T + L V+EY +GG+L + + E+ ARF+ ++ ++
Sbjct: 65 QASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALN 124
Query: 132 YCHSMQVCHRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQPKSTV-GTPAYIAPE 188
Y H + +RDLKL+N LLD G +K+ D+G K + ST GTP YIAPE
Sbjct: 125 YLHERGIIYRDLKLDNVLLDSEG----HIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPE 180
Query: 189 VLLKKEYDGKV 199
+L ++Y V
Sbjct: 181 ILRGEDYGFSV 191
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 3e-42
Identities = 62/191 (32%), Positives = 96/191 (50%), Gaps = 20/191 (10%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINH--------- 71
+ + L + +G G+FG L KKT + A+K + K D + + +
Sbjct: 17 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKAL----KKDVVLMDDDVECTMVEKRVLS 72
Query: 72 RSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS 131
+ HP + T +L VMEY +GG+L I + +F A F+ ++I G+
Sbjct: 73 LAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQ 132
Query: 132 YCHSMQVCHRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQPKSTV-GTPAYIAPE 188
+ HS + +RDLKL+N LLD G +KI DFG K ++L +T GTP YIAPE
Sbjct: 133 FLHSKGIVYRDLKLDNILLDKDG----HIKIADFGMCKENMLGDAKTNTFCGTPDYIAPE 188
Query: 189 VLLKKEYDGKV 199
+LL ++Y+ V
Sbjct: 189 ILLGQKYNHSV 199
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 6e-42
Identities = 46/180 (25%), Positives = 86/180 (47%), Gaps = 10/180 (5%)
Query: 24 ELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHR----SLRHPNI 79
E++R IG G+FG +++ T+++ A+KY+ + ++ N R + L HP +
Sbjct: 18 EILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFL 77
Query: 80 VRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVC 139
V + +V++ GG+L + F E+ + F +L+ + Y + ++
Sbjct: 78 VNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRII 137
Query: 140 HRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDG 197
HRD+K +N LLD G + I DF + +Q + GT Y+APE+ ++ G
Sbjct: 138 HRDMKPDNILLDEHG----HVHITDFNIAAMLPRETQITTMAGTKPYMAPEMFSSRKGAG 193
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 8e-42
Identities = 55/190 (28%), Positives = 93/190 (48%), Gaps = 15/190 (7%)
Query: 21 DRYELVRDIGSGNFG---VARLMRDKKTEELVAVKYIERGDKIDENVQRE-IINHR---- 72
+ +EL+R +G G +G R + T ++ A+K +++ + R
Sbjct: 17 ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILE 76
Query: 73 SLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 132
++HP IV T L +++EY SGGELF ++ G F ED A F+ ++ + +
Sbjct: 77 EVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGH 136
Query: 133 CHSMQVCHRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQPKSTV-GTPAYIAPEV 189
H + +RDLK EN +L+ G +K+ DFG K S+ T GT Y+APE+
Sbjct: 137 LHQKGIIYRDLKPENIMLNHQG----HVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEI 192
Query: 190 LLKKEYDGKV 199
L++ ++ V
Sbjct: 193 LMRSGHNRAV 202
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 1e-41
Identities = 56/188 (29%), Positives = 96/188 (51%), Gaps = 20/188 (10%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINH--------- 71
++L+R IG G++ L+R KKT+ + A++ + + + + E I+
Sbjct: 52 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVV-KKELV---NDDEDIDWVQTEKHVFE 107
Query: 72 RSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS 131
++ HP +V T + L V+EY +GG+L + + E+ ARF+ ++ ++
Sbjct: 108 QASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALN 167
Query: 132 YCHSMQVCHRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQPKSTV-GTPAYIAPE 188
Y H + +RDLKL+N LLD G +K+ D+G K + ST GTP YIAPE
Sbjct: 168 YLHERGIIYRDLKLDNVLLDSEG----HIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPE 223
Query: 189 VLLKKEYD 196
+L ++Y
Sbjct: 224 ILRGEDYG 231
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 2e-41
Identities = 59/191 (30%), Positives = 90/191 (47%), Gaps = 20/191 (10%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINH--------- 71
+ + +G G+FG L K T+EL AVK + + D + +Q + +
Sbjct: 20 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKIL-KKDVV---IQDDDVECTMVEKRVLA 75
Query: 72 RSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS 131
+ P + + T L VMEY +GG+L I GRF E A F+ ++ G+
Sbjct: 76 LPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLF 135
Query: 132 YCHSMQVCHRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQPKSTV-GTPAYIAPE 188
+ S + +RDLKL+N +LD G +KI DFG K ++ T GTP YIAPE
Sbjct: 136 FLQSKGIIYRDLKLDNVMLDSEG----HIKIADFGMCKENIWDGVTTKTFCGTPDYIAPE 191
Query: 189 VLLKKEYDGKV 199
++ + Y V
Sbjct: 192 IIAYQPYGKSV 202
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 2e-41
Identities = 50/184 (27%), Positives = 92/184 (50%), Gaps = 9/184 (4%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNI 79
+ ++++ +G G++G K+T ++VA+K + + E + +EI + P++
Sbjct: 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQE-IIKEISIMQQCDSPHV 86
Query: 80 VRFKEVILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHSMQV 138
V++ T L IVMEY G + + I +EDE Q + G+ Y H M+
Sbjct: 87 VKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRK 146
Query: 139 CHRDLKLENTLL--DGSPAPRLKICDFGYS-KSSVLHSQPKSTVGTPAYIAPEVLLKKEY 195
HRD+K N LL +G K+ DFG + + + ++ + +GTP ++APEV+ + Y
Sbjct: 147 IHRDIKAGNILLNTEG----HAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGY 202
Query: 196 DGKV 199
+
Sbjct: 203 NCVA 206
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 4e-41
Identities = 58/201 (28%), Positives = 95/201 (47%), Gaps = 6/201 (2%)
Query: 2 DRSAMTVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYI--ERGDK 59
+ PGM + + + IG G+FG D +T+++VA+K I E +
Sbjct: 3 HSPVQSGLPGMQNLKADPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAED 62
Query: 60 IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEA 119
E++Q+EI P + ++ L T L I+MEY GG + + G E +
Sbjct: 63 EIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALD-LLEPGPLDETQI 121
Query: 120 RFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST- 178
++++ G+ Y HS + HRD+K N LL +K+ DFG + ++T
Sbjct: 122 ATILREILKGLDYLHSEKKIHRDIKAANVLLSEH--GEVKLADFGVAGQLTDTQIKRNTF 179
Query: 179 VGTPAYIAPEVLLKKEYDGKV 199
VGTP ++APEV+ + YD K
Sbjct: 180 VGTPFWMAPEVIKQSAYDSKA 200
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 6e-41
Identities = 52/178 (29%), Positives = 87/178 (48%), Gaps = 8/178 (4%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIERGDKID-ENVQREIINHRSLRHPNIVRFKEVIL 87
+G G +G+ RD + +A+K I D + + EI H+ L+H NIV++
Sbjct: 30 LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 89
Query: 88 TPTHLAIVMEYASGG---ELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLK 144
+ I ME GG L + +E F+ +Q++ G+ Y H Q+ HRD+K
Sbjct: 90 ENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIK 149
Query: 145 LENTLLDGSPAPRLKICDFGYSK-SSVLHSQPKSTVGTPAYIAPEVLLKKE--YDGKV 199
+N L++ + + LKI DFG SK + ++ ++ GT Y+APE++ K Y
Sbjct: 150 GDNVLIN-TYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKAA 206
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 2e-40
Identities = 57/185 (30%), Positives = 94/185 (50%), Gaps = 11/185 (5%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYI--ERGDKIDENVQREIINHRSLRHP 77
+Y IG G G D T + VA++ + ++ K + + EI+ R ++P
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKEL-IINEILVMRENKNP 77
Query: 78 NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ 137
NIV + + L L +VMEY +GG L + + E + ++ + + + HS Q
Sbjct: 78 NIVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQALEFLHSNQ 136
Query: 138 VCHRDLKLENTLL--DGSPAPRLKICDFGYS-KSSVLHSQPKSTVGTPAYIAPEVLLKKE 194
V HRD+K +N LL DG +K+ DFG+ + + S+ + VGTP ++APEV+ +K
Sbjct: 137 VIHRDIKSDNILLGMDG----SVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKA 192
Query: 195 YDGKV 199
Y KV
Sbjct: 193 YGPKV 197
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 2e-40
Identities = 65/185 (35%), Positives = 97/185 (52%), Gaps = 8/185 (4%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHR----SLRH 76
+ +E ++ +G G FG L+++K T A+K +++ + ++ + + RH
Sbjct: 148 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH 207
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
P + K T L VMEYA+GGELF + FSED ARF+ +++S + Y HS
Sbjct: 208 PFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSE 267
Query: 137 Q-VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV-GTPAYIAPEVLLKKE 194
+ V +RDLKLEN +LD +KI DFG K + T GTP Y+APEVL +
Sbjct: 268 KNVVYRDLKLENLMLDKD--GHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDND 325
Query: 195 YDGKV 199
Y V
Sbjct: 326 YGRAV 330
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 4e-40
Identities = 57/184 (30%), Positives = 98/184 (53%), Gaps = 9/184 (4%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIE-RGDKIDENVQREIINHRSLRHPN 78
+ IG G+ G+ L R+K + VAVK ++ R + E + E++ R +H N
Sbjct: 44 RLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFN 103
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQV 138
+V + L L ++ME+ GG L + I + R +E++ + ++ ++Y H+ V
Sbjct: 104 VVEMYKSYLVGEELWVLMEFLQGGALTD-IVSQVRLNEEQIATVCEAVLQALAYLHAQGV 162
Query: 139 CHRDLKLENTLL--DGSPAPRLKICDFGYS-KSSVLHSQPKSTVGTPAYIAPEVLLKKEY 195
HRD+K ++ LL DG R+K+ DFG+ + S + KS VGTP ++APEV+ + Y
Sbjct: 163 IHRDIKSDSILLTLDG----RVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRSLY 218
Query: 196 DGKV 199
+V
Sbjct: 219 ATEV 222
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 7e-40
Identities = 59/186 (31%), Positives = 87/186 (46%), Gaps = 17/186 (9%)
Query: 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINH--------RSL 74
YE+V+ IG G FG +L+R K T ++ A+K + E ++R
Sbjct: 71 YEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLL----SKFEMIKRSDSAFFWEERDIMAFA 126
Query: 75 RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCH 134
P +V+ +L +VMEY GG+L + + E ARF+ +++ + H
Sbjct: 127 NSPWVVQLFYAFQDDRYLYMVMEYMPGGDLV-NLMSNYDVPEKWARFYTAEVVLALDAIH 185
Query: 135 SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVLLK 192
SM HRD+K +N LLD S LK+ DFG + VGTP YI+PEVL
Sbjct: 186 SMGFIHRDVKPDNMLLDKS--GHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKS 243
Query: 193 KEYDGK 198
+ DG
Sbjct: 244 QGGDGY 249
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 142 bits (358), Expect = 2e-39
Identities = 58/186 (31%), Positives = 92/186 (49%), Gaps = 10/186 (5%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDEN------VQREIINHRSL 74
+ + +G G+FG L K T+EL AVK +++ I ++ V++ ++
Sbjct: 341 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLA-LPG 399
Query: 75 RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCH 134
+ P + + T L VMEY +GG+L I GRF E A F+ ++ G+ +
Sbjct: 400 KPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQ 459
Query: 135 SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV-GTPAYIAPEVLLKK 193
S + +RDLKL+N +LD +KI DFG K ++ T GTP YIAPE++ +
Sbjct: 460 SKGIIYRDLKLDNVMLD--SEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQ 517
Query: 194 EYDGKV 199
Y V
Sbjct: 518 PYGKSV 523
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 7e-39
Identities = 52/189 (27%), Positives = 92/189 (48%), Gaps = 25/189 (13%)
Query: 24 ELVRDIGSGNFG---VARLMRDKKTEELVAVK-----YIERGDKIDENVQRE-----IIN 70
EL++ +G+G +G + R + T +L A+K I + K E+ + E I
Sbjct: 57 ELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIR 116
Query: 71 HRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGV 130
P +V T T L ++++Y +GGELF + RF+E E + + +++ +
Sbjct: 117 Q----SPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLAL 172
Query: 131 SYCHSMQVCHRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIA 186
+ H + + +RD+KLEN LLD G + + DFG SK V ++ GT Y+A
Sbjct: 173 EHLHKLGIIYRDIKLENILLDSNG----HVVLTDFGLSKEFVADETERAYDFCGTIEYMA 228
Query: 187 PEVLLKKEY 195
P+++ +
Sbjct: 229 PDIVRGGDS 237
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 1e-38
Identities = 60/187 (32%), Positives = 85/187 (45%), Gaps = 14/187 (7%)
Query: 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPN 78
D E+ +G G FGV + + K + VA+K I + + E+ + HPN
Sbjct: 6 DYKEIEVEEVVGRGAFGV--VCKAKWRAKDVAIKQI-ESESERKAFIVELRQLSRVNHPN 62
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLI---SGVSYCHS 135
IV+ L P + +VMEYA GG L+ + A A + GV+Y HS
Sbjct: 63 IVKLYGACLNP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHS 120
Query: 136 MQ---VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLK 192
MQ + HRDLK N LL LKICDFG + + + + G+ A++APEV
Sbjct: 121 MQPKALIHRDLKPPNLLLVAG-GTVLKICDFGTAC--DIQTHMTNNKGSAAWMAPEVFEG 177
Query: 193 KEYDGKV 199
Y K
Sbjct: 178 SNYSEKC 184
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 1e-38
Identities = 46/185 (24%), Positives = 85/185 (45%), Gaps = 17/185 (9%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINH--------R 72
D +E+++ IG G F +++ K+T ++ A+K + + ++R ++
Sbjct: 61 DDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIM----NKWDMLKRGEVSCFREERDVLV 116
Query: 73 SLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVS 131
+ I + +L +VMEY GG+L + G R + ARF+ +++ +
Sbjct: 117 NGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAID 176
Query: 132 YCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEV 189
H + HRD+K +N LLD +++ DFG +S VGTP Y++PE+
Sbjct: 177 SVHRLGYVHRDIKPDNILLDRC--GHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEI 234
Query: 190 LLKKE 194
L
Sbjct: 235 LQAVG 239
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 5e-38
Identities = 51/191 (26%), Positives = 96/191 (50%), Gaps = 16/191 (8%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYI--ERGDKIDENVQREIINHRSLRHP 77
++ +E+V ++G G FG ++K+T L A K I + +++++ EI + HP
Sbjct: 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELED-YIVEIEILATCDHP 76
Query: 78 NIVRFKEVILTPTHLAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSM 136
IV+ L I++E+ GG + + +E + + +Q++ +++ HS
Sbjct: 77 YIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSK 136
Query: 137 QVCHRDLKLENTLL--DGSPAPRLKICDFGYS-KSSVLHSQPKSTVGTPAYIAPEVLL-- 191
++ HRDLK N L+ +G +++ DFG S K+ + S +GTP ++APEV++
Sbjct: 137 RIIHRDLKAGNVLMTLEGD----IRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCE 192
Query: 192 ---KKEYDGKV 199
YD K
Sbjct: 193 TMKDTPYDYKA 203
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 6e-38
Identities = 46/183 (25%), Positives = 85/183 (46%), Gaps = 17/183 (9%)
Query: 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINH--------RSL 74
+E+++ IG G FG +++ K +++ A+K + E ++R +
Sbjct: 76 FEILKVIGRGAFGEVAVVKLKNADKVFAMKIL----NKWEMLKRAETACFREERDVLVNG 131
Query: 75 RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYC 133
I +L +VM+Y GG+L + R E+ ARF+ +++ +
Sbjct: 132 DSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSV 191
Query: 134 HSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVLL 191
H + HRD+K +N L+D + +++ DFG + +S+ VGTP YI+PE+L
Sbjct: 192 HQLHYVHRDIKPDNILMDMN--GHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQ 249
Query: 192 KKE 194
E
Sbjct: 250 AME 252
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 7e-38
Identities = 55/184 (29%), Positives = 88/184 (47%), Gaps = 11/184 (5%)
Query: 24 ELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHR-------SLRH 76
+ R IG G FG R T ++ A+K +++ + + +N R +
Sbjct: 192 SVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDC 251
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
P IV TP L+ +++ +GG+L + G FSE + RF+ ++I G+ + H+
Sbjct: 252 PFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNR 311
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKE-Y 195
V +RDLK N LLD ++I D G + +P ++VGT Y+APEVL K Y
Sbjct: 312 FVVYRDLKPANILLDEH--GHVRISDLGLAC-DFSKKKPHASVGTHGYMAPEVLQKGVAY 368
Query: 196 DGKV 199
D
Sbjct: 369 DSSA 372
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 2e-37
Identities = 54/184 (29%), Positives = 87/184 (47%), Gaps = 8/184 (4%)
Query: 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDEN--VQREI-INHRSLR 75
D +E + ++G+GN GV + K + ++A K I K + RE+ + H
Sbjct: 31 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHEC-N 89
Query: 76 HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 135
P IV F + ++I ME+ GG L + + AGR E +I G++Y
Sbjct: 90 SPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLRE 149
Query: 136 -MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKE 194
++ HRD+K N L++ +K+CDFG S + S S VGT +Y++PE L
Sbjct: 150 KHKIMHRDVKPSNILVNSR--GEIKLCDFGVSGQLI-DSMANSFVGTRSYMSPERLQGTH 206
Query: 195 YDGK 198
Y +
Sbjct: 207 YSVQ 210
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 3e-37
Identities = 57/198 (28%), Positives = 88/198 (44%), Gaps = 19/198 (9%)
Query: 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYI--ERGDKIDENVQREIINHRSLRH 76
+ D YEL IGSG V + +E VA+K I E+ + + +EI H
Sbjct: 13 NRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHH 72
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELF--------ERICNAGRFSEDEARFFFQQLIS 128
PNIV + + L +VM+ SGG + + +G E ++++
Sbjct: 73 PNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLE 132
Query: 129 GVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYS------KSSVLHSQPKSTVGTP 182
G+ Y H HRD+K N LL + ++I DFG S + K+ VGTP
Sbjct: 133 GLEYLHKNGQIHRDVKAGNILLGEDGS--VQIADFGVSAFLATGGDITRNKVRKTFVGTP 190
Query: 183 AYIAPEVLLK-KEYDGKV 199
++APEV+ + + YD K
Sbjct: 191 CWMAPEVMEQVRGYDFKA 208
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 4e-37
Identities = 55/190 (28%), Positives = 83/190 (43%), Gaps = 15/190 (7%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHR----SLRH 76
D + R +G G FG + K T +L A K + + + + + +
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHS 244
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERICN----AGRFSEDEARFFFQQLISGVSY 132
IV T T L +VM +GG++ I N F E A F+ Q++SG+ +
Sbjct: 245 RFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEH 304
Query: 133 CHSMQVCHRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEV 189
H + +RDLK EN LLD G ++I D G + GTP ++APE+
Sbjct: 305 LHQRNIIYRDLKPENVLLDDDG----NVRISDLGLAVELKAGQTKTKGYAGTPGFMAPEL 360
Query: 190 LLKKEYDGKV 199
LL +EYD V
Sbjct: 361 LLGEEYDFSV 370
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 4e-37
Identities = 58/190 (30%), Positives = 93/190 (48%), Gaps = 18/190 (9%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYI-----ERGDKIDENVQREIINHRSL 74
+ +R+IG G+FG RD + E+VA+K + + +K + + +E+ + L
Sbjct: 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQD-IIKEVRFLQKL 111
Query: 75 RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCH 134
RHPN ++++ L +VMEY G + E E + G++Y H
Sbjct: 112 RHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH 171
Query: 135 SMQVCHRDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL- 191
S + HRD+K N LL G +K+ DFG + + S VGTP ++APEV+L
Sbjct: 172 SHNMIHRDVKAGNILLSEPG----LVKLGDFGSASI---MAPANSFVGTPYWMAPEVILA 224
Query: 192 --KKEYDGKV 199
+ +YDGKV
Sbjct: 225 MDEGQYDGKV 234
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 5e-37
Identities = 47/185 (25%), Positives = 80/185 (43%), Gaps = 8/185 (4%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRS----LRH 76
+ + R +G G FG + + T ++ A K +E+ + +N + +
Sbjct: 184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNS 243
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR--FSEDEARFFFQQLISGVSYCH 134
+V T L +V+ +GG+L I + G+ F E A F+ ++ G+ H
Sbjct: 244 RFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLH 303
Query: 135 SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKE 194
++ +RDLK EN LLD ++I D G + K VGT Y+APEV+ +
Sbjct: 304 RERIVYRDLKPENILLDDH--GHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNER 361
Query: 195 YDGKV 199
Y
Sbjct: 362 YTFSP 366
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 7e-37
Identities = 62/187 (33%), Positives = 91/187 (48%), Gaps = 17/187 (9%)
Query: 24 ELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQ---REIINHRSLRHPNIV 80
+ IG+G+FG + R + VAVK + D E V RE+ + LRHPNIV
Sbjct: 40 NIKEKIGAGSFG--TVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIV 97
Query: 81 RFKEVILTPTHLAIVMEYASGGELFERICNAGR---FSEDEARFFFQQLISGVSYCHSM- 136
F + P +L+IV EY S G L+ + +G E + G++Y H+
Sbjct: 98 LFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRN 157
Query: 137 -QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP---KSTVGTPAYIAPEVLLK 192
+ HR+LK N L+D +K+CDFG S+ + S KS GTP ++APEVL
Sbjct: 158 PPIVHRNLKSPNLLVDKK--YTVKVCDFGLSR--LKASTFLSSKSAAGTPEWMAPEVLRD 213
Query: 193 KEYDGKV 199
+ + K
Sbjct: 214 EPSNEKS 220
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 9e-37
Identities = 25/213 (11%), Positives = 55/213 (25%), Gaps = 42/213 (19%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID----ENVQREIINHRSLR-- 75
+G + D++T E V ++ + ++ E++ R LR
Sbjct: 74 TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGI 133
Query: 76 -----------------------HPNIVRFKEVILTPTHLAIVMEY--------ASGGEL 104
++R + L+ Y G L
Sbjct: 134 KNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVL 193
Query: 105 FERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFG 164
Q+I ++ H + H L+ + +LD + + F
Sbjct: 194 LSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQR--GGVFLTGFE 251
Query: 165 YSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDG 197
V + + + PE+ ++
Sbjct: 252 ---HLVRDGARVVSSVSRGFEPPELEARRATIS 281
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 9e-37
Identities = 47/198 (23%), Positives = 82/198 (41%), Gaps = 19/198 (9%)
Query: 19 DSDRYELVRDIGSG--NFGVARLMRDKKTEELVAVKYI---ERGDKIDENVQREIINHRS 73
+ YEL+ IG G + L R K T E V V+ I +++ +Q E+ +
Sbjct: 23 EGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKL 82
Query: 74 LRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNA--GRFSEDEARFFFQQLISGVS 131
HPNIV ++ + L +V + + G + IC +E + Q ++ +
Sbjct: 83 FNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALD 142
Query: 132 YCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYS--------KSSVLHSQPKSTVGTPA 183
Y H M HR +K + L+ + + + + V+H PK +V
Sbjct: 143 YIHHMGYVHRSVKASHILISVDGK--VYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLP 200
Query: 184 YIAPEVL--LKKEYDGKV 199
+++PEVL + YD K
Sbjct: 201 WLSPEVLQQNLQGYDAKS 218
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 1e-36
Identities = 64/188 (34%), Positives = 94/188 (50%), Gaps = 11/188 (5%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQ----REIINHRSLRH 76
DRY + +G G +G D T E VA+K I R + +E V RE+ + L+H
Sbjct: 34 DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRI-RLEHEEEGVPGTAIREVSLLKELQH 92
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
NI+ K VI L ++ EYA +L + + S + F QLI+GV++CHS
Sbjct: 93 RNIIELKSVIHHNHRLHLIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSR 151
Query: 137 QVCHRDLKLENTLLDGSPAPR---LKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLL- 191
+ HRDLK +N LL S A LKI DFG +++ + + + + T Y PE+LL
Sbjct: 152 RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLWYRPPEILLG 211
Query: 192 KKEYDGKV 199
+ Y V
Sbjct: 212 SRHYSTSV 219
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 5e-36
Identities = 57/190 (30%), Positives = 82/190 (43%), Gaps = 18/190 (9%)
Query: 24 ELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID-----ENVQREIINHRSLRHPN 78
L IG G FG ++ R + VAVK D ENV++E L+HPN
Sbjct: 10 TLEEIIGIGGFG--KVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPN 67
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM-- 136
I+ + V L +L +VME+A GG L + R D + Q+ G++Y H
Sbjct: 68 IIALRGVCLKEPNLCLVMEFARGGPLNRVLSGK-RIPPDILVNWAVQIARGMNYLHDEAI 126
Query: 137 -QVCHRDLKLENTLLDGSPAPR------LKICDFGYSKSSVLHSQPKSTVGTPAYIAPEV 189
+ HRDLK N L+ LKI DFG ++ + S G A++APEV
Sbjct: 127 VPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR-EWHRTTKMSAAGAYAWMAPEV 185
Query: 190 LLKKEYDGKV 199
+ +
Sbjct: 186 IRASMFSKGS 195
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 6e-36
Identities = 46/184 (25%), Positives = 78/184 (42%), Gaps = 6/184 (3%)
Query: 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYI--ERGDKIDENVQREI-INHRSLR 75
+ + E + ++GSG G MR +KT ++AVK + + ++ + ++ + +S
Sbjct: 23 EINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHD 82
Query: 76 HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 135
P IV+ +T T + I ME + G E ++ + Y
Sbjct: 83 CPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKE 142
Query: 136 -MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKE 194
V HRD+K N LLD ++K+CDFG S V + G AY+APE + +
Sbjct: 143 KHGVIHRDVKPSNILLDER--GQIKLCDFGISGRLVDDKAKDRSAGCAAYMAPERIDPPD 200
Query: 195 YDGK 198
Sbjct: 201 PTKP 204
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 1e-35
Identities = 53/197 (26%), Positives = 93/197 (47%), Gaps = 21/197 (10%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSL-RHPN 78
+ +ELV +G+G +G R KT +L A+K ++ +E +++EI + H N
Sbjct: 23 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRN 82
Query: 79 IVRF------KEVILTPTHLAIVMEYASGGELFE--RICNAGRFSEDEARFFFQQLISGV 130
I + K L +VME+ G + + + E+ + ++++ G+
Sbjct: 83 IATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGL 142
Query: 131 SYCHSMQVCHRDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAP 187
S+ H +V HRD+K +N LL + +K+ DFG S ++T +GTP ++AP
Sbjct: 143 SHLHQHKVIHRDIKGQNVLLTENA----EVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAP 198
Query: 188 EVLLKKE-----YDGKV 199
EV+ E YD K
Sbjct: 199 EVIACDENPDATYDFKS 215
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 1e-35
Identities = 31/217 (14%), Positives = 54/217 (24%), Gaps = 44/217 (20%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID----ENVQREIINHRSLRHP 77
+ +LV + G+ V L+RD + E A+K G + E + L
Sbjct: 63 KLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGE 122
Query: 78 NIVRFKEVI--------------------------LTPTHLAIVMEYASG------GELF 105
+ ++ + ++M AS L
Sbjct: 123 SPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLD 182
Query: 106 ERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGY 165
G QLI + S + H +N + RL + D
Sbjct: 183 FVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPD--GRLMLGDVS- 239
Query: 166 SKSSVLHSQPKSTVGTPAYIAPEVLLKKE---YDGKV 199
+ P AP L + +
Sbjct: 240 --ALWKVGTRGPASSVPVTYAPREFLNASTATFTHAL 274
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 3e-35
Identities = 60/205 (29%), Positives = 91/205 (44%), Gaps = 21/205 (10%)
Query: 7 TVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQR 66
T G G D P Y + IG+G+FGV + + ELVA+K + DK +N R
Sbjct: 43 TPGQGPDRPQ---EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKRFKN--R 96
Query: 67 EIINHRSLRHPNIVRFKEVILTPT------HLAIVMEYASG---GELFERICNAGRFSED 117
E+ R L H NIVR + + +L +V++Y
Sbjct: 97 ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI 156
Query: 118 EARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS 177
+ + QL ++Y HS +CHRD+K +N LLD A LK+CDFG +K L +
Sbjct: 157 YVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTA-VLKLCDFGSAK--QLVRGEPN 213
Query: 178 T--VGTPAYIAPEVLLK-KEYDGKV 199
+ + Y APE++ +Y +
Sbjct: 214 VSYICSRYYRAPELIFGATDYTSSI 238
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 4e-35
Identities = 52/189 (27%), Positives = 85/189 (44%), Gaps = 18/189 (9%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQR---EIINHRSLRHPNIVRF--- 82
IG G+F D +T VA ++ QR E + L+HPNIVRF
Sbjct: 34 IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDS 93
Query: 83 -KEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ--VC 139
+ + + +V E + G L + R + +Q++ G+ + H+ +
Sbjct: 94 WESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPII 153
Query: 140 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKV 199
HRDLK +N + G P +KI D G + S K+ +GTP ++APE+ +++YD V
Sbjct: 154 HRDLKCDNIFITG-PTGSVKIGDLGLATLKR-ASFAKAVIGTPEFMAPEM-YEEKYDESV 210
Query: 200 ------MCV 202
MC+
Sbjct: 211 DVYAFGMCM 219
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 5e-35
Identities = 55/196 (28%), Positives = 91/196 (46%), Gaps = 12/196 (6%)
Query: 3 RSAMTVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDE 62
+ V G + ++YE + +G G++G+ R+K T +VA+K D+
Sbjct: 7 HHSSGVDLGTENLYFQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKF-LESDDDK 65
Query: 63 NV----QREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASG--GELFERICNAGRFSE 116
V REI + LRH N+V EV +V E+ + E N
Sbjct: 66 MVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNG--LDY 123
Query: 117 DEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK 176
+ + Q+I+G+ +CHS + HRD+K EN L+ S +K+CDFG++++ +
Sbjct: 124 QVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQS--GVVKLCDFGFARTLAAPGEVY 181
Query: 177 ST-VGTPAYIAPEVLL 191
V T Y APE+L+
Sbjct: 182 DDEVATRWYRAPELLV 197
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 7e-35
Identities = 49/192 (25%), Positives = 80/192 (41%), Gaps = 20/192 (10%)
Query: 24 ELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENV--------QREIINHRSLR 75
E + IG G FG+ R K + +VA+K + GD E QRE+ +L
Sbjct: 22 EYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLN 81
Query: 76 HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR-FSEDEARFFFQQLISGVSYCH 134
HPNIV+ ++ P +VME+ G+L+ R+ + + G+ Y
Sbjct: 82 HPNIVKLYGLMHNP--PRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQ 139
Query: 135 SM--QVCHRDLKLENTLLDG---SPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEV 189
+ + HRDL+ N L + K+ DFG S+ +G ++APE
Sbjct: 140 NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ--QSVHSVSGLLGNFQWMAPET 197
Query: 190 LL--KKEYDGKV 199
+ ++ Y K
Sbjct: 198 IGAEEESYTEKA 209
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 7e-35
Identities = 48/192 (25%), Positives = 85/192 (44%), Gaps = 15/192 (7%)
Query: 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDEN--VQREI-INHRSLR 75
+D E + ++G G +GV MR + +++AVK I E + ++ I+ R++
Sbjct: 5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVD 64
Query: 76 HPNIVRFKEVILTPTHLAIVMEYASGG--ELFERICN-AGRFSEDEARFFFQQLISGVSY 132
P V F + + I ME + ++++ + ED ++ + +
Sbjct: 65 CPFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEH 124
Query: 133 CHS-MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVL 190
HS + V HRD+K N L++ ++K+CDFG S V K G Y+APE +
Sbjct: 125 LHSKLSVIHRDVKPSNVLINAL--GQVKMCDFGISGYLV-DDVAKDIDAGCKPYMAPERI 181
Query: 191 L----KKEYDGK 198
+K Y K
Sbjct: 182 NPELNQKGYSVK 193
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 8e-35
Identities = 51/192 (26%), Positives = 92/192 (47%), Gaps = 11/192 (5%)
Query: 17 MHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYI--ERGDKIDENVQREIINHRSL 74
M S +++ + +G+G + +K T VA+K + + + REI + L
Sbjct: 1 MSSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKEL 60
Query: 75 RHPNIVRFKEVILTPTHLAIVMEY-----ASGGELFERICNAGRFSEDEARFFFQQLISG 129
+H NIVR +VI T L +V E+ + + ++F QL+ G
Sbjct: 61 KHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQG 120
Query: 130 VSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPE 188
+++CH ++ HRDLK +N L++ +LK+ DFG +++ + S+ V T Y AP+
Sbjct: 121 LAFCHENKILHRDLKPQNLLINKR--GQLKLGDFGLARAFGIPVNTFSSEVVTLWYRAPD 178
Query: 189 VLL-KKEYDGKV 199
VL+ + Y +
Sbjct: 179 VLMGSRTYSTSI 190
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 8e-35
Identities = 52/180 (28%), Positives = 84/180 (46%), Gaps = 16/180 (8%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQ----REIINHRSLRH 76
++YE + IG G++GV R++ T ++VA+K + D ++ REI + L+H
Sbjct: 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKF-LESEDDPVIKKIALREIRMLKQLKH 61
Query: 77 PNIVRFKEVILTPTHLAIVMEYASG--GELFERICNAGRFSEDEARFFFQQLISGVSYCH 134
PN+V EV L +V EY +R E + Q + V++CH
Sbjct: 62 PNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDR--YQRGVPEHLVKSITWQTLQAVNFCH 119
Query: 135 SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS-T--VGTPAYIAPEVLL 191
HRD+K EN L+ +K+CDFG+++ L V T Y +PE+L+
Sbjct: 120 KHNCIHRDVKPENILITKH--SVIKLCDFGFARL--LTGPSDYYDDEVATRWYRSPELLV 175
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 1e-34
Identities = 59/187 (31%), Positives = 96/187 (51%), Gaps = 13/187 (6%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQ----REIINHRSLRH 76
+YE + IG G +G ++++T E+VA+K + R D DE V REI + L+H
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRV-RLDDDDEGVPSSALREICLLKELKH 60
Query: 77 PNIVRFKEVILTPTHLAIVMEYASG--GELFERICNAGRFSEDEARFFFQQLISGVSYCH 134
NIVR +V+ + L +V E+ + F+ G + + F QL+ G+ +CH
Sbjct: 61 KNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDS--CNGDLDPEIVKSFLFQLLKGLGFCH 118
Query: 135 SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLL-K 192
S V HRDLK +N L++ + LK+ +FG +++ + + S V T Y P+VL
Sbjct: 119 SRNVLHRDLKPQNLLINRN--GELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGA 176
Query: 193 KEYDGKV 199
K Y +
Sbjct: 177 KLYSTSI 183
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 2e-34
Identities = 46/205 (22%), Positives = 87/205 (42%), Gaps = 16/205 (7%)
Query: 6 MTVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYI--ERGDKIDEN 63
+ + P ++ + + +IG G +G M K + +++AVK I +K +
Sbjct: 9 LKISPEQHWDF--TAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQ 66
Query: 64 VQREI-INHRSLRHPNIVRFKEVILTPTHLAIVMEYASGG--ELFERICNA--GRFSEDE 118
+ ++ + RS P IV+F + I ME S + ++ + + E+
Sbjct: 67 LLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEI 126
Query: 119 ARFFFQQLISGVSYCHS-MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS 177
+ +++ +++ HRD+K N LLD S +K+CDFG S V
Sbjct: 127 LGKITLATVKALNHLKENLKIIHRDIKPSNILLDRS--GNIKLCDFGISGQLVDSIAKTR 184
Query: 178 TVGTPAYIAPEVL----LKKEYDGK 198
G Y+APE + ++ YD +
Sbjct: 185 DAGCRPYMAPERIDPSASRQGYDVR 209
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 6e-34
Identities = 45/180 (25%), Positives = 83/180 (46%), Gaps = 22/180 (12%)
Query: 24 ELVRDIGSGNFGV---ARLMRDKKTEELVAVKYIERGDKIDENVQ---REIINHRSLRHP 77
E+ IG G FG R + VA++ I+ ++ ++ RE++ +R RH
Sbjct: 36 EIGELIGKGRFGQVYHGRWHGE------VAIRLIDIERDNEDQLKAFKREVMAYRQTRHE 89
Query: 78 NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR-FSEDEARFFFQQLISGVSYCHSM 136
N+V F ++P HLAI+ G L+ + +A ++ R Q+++ G+ Y H+
Sbjct: 90 NVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAK 149
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSK------SSVLHSQPKSTVGTPAYIAPEVL 190
+ H+DLK +N D ++ I DFG + + + G ++APE++
Sbjct: 150 GILHKDLKSKNVFYDNG---KVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEII 206
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 7e-34
Identities = 55/201 (27%), Positives = 90/201 (44%), Gaps = 20/201 (9%)
Query: 12 MDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQ------ 65
M + + + RYE + +G G F RDK T ++VA+K I + E
Sbjct: 1 MALDVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKI-KLGHRSEAKDGINRTA 59
Query: 66 -REIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASG--GELFERICNAGRFSEDEARFF 122
REI + L HPNI+ + +++++V ++ + + N+ + + +
Sbjct: 60 LREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKD--NSLVLTPSHIKAY 117
Query: 123 FQQLISGVSYCHSMQVCHRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQPKST-V 179
+ G+ Y H + HRDLK N LLD G LK+ DFG +KS ++ + V
Sbjct: 118 MLMTLQGLEYLHQHWILHRDLKPNNLLLDENG----VLKLADFGLAKSFGSPNRAYTHQV 173
Query: 180 GTPAYIAPEVLL-KKEYDGKV 199
T Y APE+L + Y V
Sbjct: 174 VTRWYRAPELLFGARMYGVGV 194
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 1e-33
Identities = 33/182 (18%), Positives = 69/182 (37%), Gaps = 17/182 (9%)
Query: 24 ELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIV 80
+ + + G R + + + VK ++ D + + E R HPN++
Sbjct: 13 NFLTKLNENHSGELWKGRWQGND--IVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVL 70
Query: 81 RFKEVILTP--THLAIVMEYASGGELFERICNAGRFSEDEARF--FFQQLISGVSYCHSM 136
+P H ++ + G L+ + F D+++ F + G+++ H++
Sbjct: 71 PVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTL 130
Query: 137 Q--VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKE 194
+ + L + ++D +I S Q + PA++APE L KK
Sbjct: 131 EPLIPRHALNSRSVMIDEDM--TARISMADVKFSF----QSPGRMYAPAWVAPEALQKKP 184
Query: 195 YD 196
D
Sbjct: 185 ED 186
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 2e-33
Identities = 60/187 (32%), Positives = 97/187 (51%), Gaps = 14/187 (7%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQ----REIINHRSLRH 76
++Y + IG G +GV ++ E A+K I R +K DE + REI + L+H
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKI-RLEKEDEGIPSTTIREISILKELKH 59
Query: 77 PNIVRFKEVILTPTHLAIVMEYASG--GELFERICNAGRFSEDEARFFFQQLISGVSYCH 134
NIV+ +VI T L +V E+ +L + G A+ F QL++G++YCH
Sbjct: 60 SNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDV--CEGGLESVTAKSFLLQLLNGIAYCH 117
Query: 135 SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLL-K 192
+V HRDLK +N L++ LKI DFG +++ + + + + T Y AP+VL+
Sbjct: 118 DRRVLHRDLKPQNLLINRE--GELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGS 175
Query: 193 KEYDGKV 199
K+Y +
Sbjct: 176 KKYSTTI 182
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 3e-33
Identities = 51/185 (27%), Positives = 88/185 (47%), Gaps = 10/185 (5%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYI--ERGDKIDENVQREIINHRSLRHPN 78
+ Y + +G G + + K T+ LVA+K I E + RE+ + L+H N
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHAN 61
Query: 79 IVRFKEVILTPTHLAIVMEYASG--GELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
IV ++I T L +V EY + + + + F QL+ G++YCH
Sbjct: 62 IVTLHDIIHTEKSLTLVFEYLDKDLKQYLDD--CGNIINMHNVKLFLFQLLRGLAYCHRQ 119
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLL-KKE 194
+V HRDLK +N L++ LK+ DFG +++ + ++ V T Y P++LL +
Sbjct: 120 KVLHRDLKPQNLLINERGE--LKLADFGLARAKSIPTKTYDNEVVTLWYRPPDILLGSTD 177
Query: 195 YDGKV 199
Y ++
Sbjct: 178 YSTQI 182
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 5e-33
Identities = 52/192 (27%), Positives = 88/192 (45%), Gaps = 19/192 (9%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNI 79
Y + IG+G+FGV + +++E VA+K + DK +N RE+ R ++HPN+
Sbjct: 39 EIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKV-LQDKRFKN--RELQIMRIVKHPNV 94
Query: 80 VRFKEVILTPTH------LAIVMEYASG---GELFERICNAGRFSEDEARFFFQQLISGV 130
V K + L +V+EY + + QL+ +
Sbjct: 95 VDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSL 154
Query: 131 SYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPE 188
+Y HS+ +CHRD+K +N LLD LK+ DFG +K +L + + + + Y APE
Sbjct: 155 AYIHSIGICHRDIKPQNLLLDPPSG-VLKLIDFGSAK--ILIAGEPNVSYICSRYYRAPE 211
Query: 189 VLLK-KEYDGKV 199
++ Y +
Sbjct: 212 LIFGATNYTTNI 223
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 1e-32
Identities = 58/207 (28%), Positives = 100/207 (48%), Gaps = 14/207 (6%)
Query: 1 MDRSAMTVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI 60
M ++ ++Y+ + +G G +GV +D +VA+K I R D
Sbjct: 1 MHHHHHHSSGRENLYFQGLMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRI-RLDAE 58
Query: 61 DENVQ----REIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASG--GELFERICNAGRF 114
DE + REI + L HPNIV +VI + L +V E+ ++ + N
Sbjct: 59 DEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDE--NKTGL 116
Query: 115 SEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 174
+ + + + QL+ GV++CH ++ HRDLK +N L++ LK+ DFG +++ + +
Sbjct: 117 QDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSD--GALKLADFGLARAFGIPVR 174
Query: 175 PKST-VGTPAYIAPEVLL-KKEYDGKV 199
+ V T Y AP+VL+ K+Y V
Sbjct: 175 SYTHEVVTLWYRAPDVLMGSKKYSTSV 201
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 3e-32
Identities = 53/210 (25%), Positives = 90/210 (42%), Gaps = 25/210 (11%)
Query: 10 PGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENV----Q 65
++ P + +YE + IG G FG R +KT + VA+K + + E
Sbjct: 6 DSVECPFCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKV-LMENEKEGFPITAL 64
Query: 66 REIINHRSLRHPNIVRFKEVILTPTHLA--------IVMEYASG--GELFERICNAGRFS 115
REI + L+H N+V E+ T +V ++ L + +F+
Sbjct: 65 REIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNV--LVKFT 122
Query: 116 EDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFG----YSKSSVL 171
E + Q L++G+ Y H ++ HRD+K N L+ LK+ DFG +S +
Sbjct: 123 LSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRD--GVLKLADFGLARAFSLAKNS 180
Query: 172 HSQP-KSTVGTPAYIAPEVLL-KKEYDGKV 199
+ V T Y PE+LL +++Y +
Sbjct: 181 QPNRYTNRVVTLWYRPPELLLGERDYGPPI 210
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 3e-32
Identities = 51/191 (26%), Positives = 82/191 (42%), Gaps = 22/191 (11%)
Query: 21 DRYELVRD-IGSGNFGV---ARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRH 76
D +E +G G +G A+ +D K ++ A+K IE I + REI R L+H
Sbjct: 20 DLFEYEGCKVGRGTYGHVYKAK-RKDGKDDKDYALKQIEG-TGISMSACREIALLRELKH 77
Query: 77 PNIVRFKEVILTPTHLAI--VMEYAS--------GGELFERICNAGRFSEDEARFFFQQL 126
PN++ ++V L+ + + +YA + + + Q+
Sbjct: 78 PNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQI 137
Query: 127 ISGVSYCHSMQVCHRDLKLENTLLDGSPAPR--LKICDFG----YSKSSVLHSQPKSTVG 180
+ G+ Y H+ V HRDLK N L+ G R +KI D G ++ + V
Sbjct: 138 LDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV 197
Query: 181 TPAYIAPEVLL 191
T Y APE+LL
Sbjct: 198 TFWYRAPELLL 208
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 119 bits (298), Expect = 4e-32
Identities = 27/218 (12%), Positives = 58/218 (26%), Gaps = 41/218 (18%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID----ENVQREIINHRSLR-- 75
+G + D++T E V ++ + ++ E++ R LR
Sbjct: 79 TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGI 138
Query: 76 --------------------HPNIVRFKEVILTPTHLAIVMEYAS-----------GGEL 104
P + V L + ++ + G L
Sbjct: 139 KNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVL 198
Query: 105 FERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFG 164
Q+I ++ H + H L+ + +LD + + F
Sbjct: 199 LSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLD--QRGGVFLTGFE 256
Query: 165 YSKS--SVLHSQPKSTVGTPAYIAPEVLLKKEYDGKVM 200
+ + S P A +L ++ +M
Sbjct: 257 HLVRDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLM 294
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 6e-32
Identities = 32/158 (20%), Positives = 52/158 (32%), Gaps = 18/158 (11%)
Query: 58 DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERI---CNAGRF 114
+ +I N V + +L I M+ L + + C+
Sbjct: 102 PSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDR 161
Query: 115 SEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 174
F Q+ V + HS + HRDLK N +K+ DFG + +
Sbjct: 162 EHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMD--DVVKVGDFGLVTAMDQDEE 219
Query: 175 PKST-------------VGTPAYIAPEVLLKKEYDGKV 199
++ VGT Y++PE + Y KV
Sbjct: 220 EQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKV 257
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 56.8 bits (137), Expect = 5e-10
Identities = 20/66 (30%), Positives = 32/66 (48%), Gaps = 2/66 (3%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID--ENVQREIINHRSLRHPN 78
+E ++ +G G FGV ++K + A+K I ++ E V RE+ L HP
Sbjct: 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 65
Query: 79 IVRFKE 84
IVR+
Sbjct: 66 IVRYFN 71
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 1e-31
Identities = 50/188 (26%), Positives = 80/188 (42%), Gaps = 20/188 (10%)
Query: 24 ELVRDIGSGNFG-VAR-LMRDKKTEELVAVKYIERGDKIDENVQ---REIINHRSLRHPN 78
+ + IGSG+FG V + VAVK + + +Q E+ R RH N
Sbjct: 27 TVGQRIGSGSFGTVYKGKWHGD-----VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN 81
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHSMQ 137
I+ F T LAIV ++ G L+ + + +F + +Q G+ Y H+
Sbjct: 82 ILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKS 140
Query: 138 VCHRDLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQPKSTVGTPAYIAPEVLLKKE 194
+ HRDLK N L +KI DFG + Q + G+ ++APEV+ ++
Sbjct: 141 IIHRDLKSNNIFLHED--NTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQD 198
Query: 195 ---YDGKV 199
Y +
Sbjct: 199 SNPYSFQS 206
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 2e-31
Identities = 50/188 (26%), Positives = 88/188 (46%), Gaps = 19/188 (10%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIER-GDKIDENVQREIINHRSLRHPNIVRFKEVIL 87
+G G FG A + ++T E++ +K + R ++ +E+ R L HPN+++F V+
Sbjct: 18 LGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLY 77
Query: 88 TPTHLAIVMEYASGGELFERICNAGR-FSEDEARFFFQQLISGVSYCHSMQVCHRDLKLE 146
L + EY GG L I + + + F + + SG++Y HSM + HRDL
Sbjct: 78 KDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSH 137
Query: 147 NTLLDGSPAPRLKICDFGYSK---------------SSVLHSQPKSTVGTPAYIAPEVLL 191
N L+ + + + DFG ++ + + VG P ++APE++
Sbjct: 138 NCLVREN--KNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMIN 195
Query: 192 KKEYDGKV 199
+ YD KV
Sbjct: 196 GRSYDEKV 203
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 2e-31
Identities = 47/183 (25%), Positives = 90/183 (49%), Gaps = 14/183 (7%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLR-HPN 78
D Y+LVR +G G + + E V VK ++ K + ++REI +LR PN
Sbjct: 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKK--KKIKREIKILENLRGGPN 92
Query: 79 IVRFKEVILTPTH--LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
I+ +++ P A+V E+ + + + ++ + RF+ +++ + YCHSM
Sbjct: 93 IITLADIVKDPVSRTPALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSM 149
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVLLK-K 193
+ HRD+K N ++D +L++ D+G ++ H + V + + PE+L+ +
Sbjct: 150 GIMHRDVKPHNVMIDHEHR-KLRLIDWGLAEFY--HPGQEYNVRVASRYFKGPELLVDYQ 206
Query: 194 EYD 196
YD
Sbjct: 207 MYD 209
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 4e-31
Identities = 54/199 (27%), Positives = 82/199 (41%), Gaps = 27/199 (13%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQ-------REIINHRS 73
RYE V +IG G +G RD + VA+K + R RE+ R
Sbjct: 9 SRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSV-RVPNGGGGGGGLPISTVREVALLRR 67
Query: 74 LR---HPNIVRFKEVILTPTH-----LAIVMEYASG--GELFERICNAGRFSEDEARFFF 123
L HPN+VR +V T + +V E+ ++ + +
Sbjct: 68 LEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDK-APPPGLPAETIKDLM 126
Query: 124 QQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK---STVG 180
+Q + G+ + H+ + HRDLK EN L+ +K+ DFG ++ +S V
Sbjct: 127 RQFLRGLDFLHANCIVHRDLKPENILVTSG--GTVKLADFGLARI---YSYQMALTPVVV 181
Query: 181 TPAYIAPEVLLKKEYDGKV 199
T Y APEVLL+ Y V
Sbjct: 182 TLWYRAPEVLLQSTYATPV 200
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 1e-30
Identities = 58/212 (27%), Positives = 90/212 (42%), Gaps = 18/212 (8%)
Query: 3 RSAMTVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDE 62
++ D + DR+++ R G G FG +L ++K T VA+K + D
Sbjct: 5 MMSLNAAAAADERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKV-IQDPRFR 63
Query: 63 N-VQREIINHRSLRHPNIVRFKEVILTPTH-------LAIVMEYASGGELFERICNAGR- 113
N + + + L HPNIV+ + T L +VMEY L N R
Sbjct: 64 NRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYV-PDTLHRCCRNYYRR 122
Query: 114 ---FSEDEARFFFQQLISGVSYCH--SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 168
+ F QLI + H S+ VCHRD+K N L++ + LK+CDFG +K
Sbjct: 123 QVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADG-TLKLCDFGSAKK 181
Query: 169 SVLHSQPKSTVGTPAYIAPEVLLK-KEYDGKV 199
+ + + Y APE++ + Y V
Sbjct: 182 LSPSEPNVAYICSRYYRAPELIFGNQHYTTAV 213
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 2e-30
Identities = 47/184 (25%), Positives = 74/184 (40%), Gaps = 22/184 (11%)
Query: 24 ELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRF- 82
L+ +G G +G + R E VAVK D+ + E+ N LRH NI+ F
Sbjct: 11 TLLECVGKGRYG--EVWRGSWQGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFI 68
Query: 83 ---KEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ-- 137
+ T L ++ Y G L++ + + SG+++ H
Sbjct: 69 ASDMTSRHSSTQLWLITHYHEMGSLYDYL-QLTTLDTVSCLRIVLSIASGLAHLHIEIFG 127
Query: 138 ------VCHRDLKLENTLLDGSPAPRLKICDFGYSK-----SSVLHSQPKSTVGTPAYIA 186
+ HRDLK +N L+ + + I D G + ++ L VGT Y+A
Sbjct: 128 TQGKPAIAHRDLKSKNILVKKN--GQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMA 185
Query: 187 PEVL 190
PEVL
Sbjct: 186 PEVL 189
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 3e-30
Identities = 48/204 (23%), Positives = 87/204 (42%), Gaps = 25/204 (12%)
Query: 7 TVGPGMDMPIMH---DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDEN 63
+ G G +P++ + + ++V+ IG G +G + K E VAVK ++
Sbjct: 20 SSGSGSGLPLLVQRTIAKQIQMVKQIGKGRYG--EVWMGKWRGEKVAVKVFFTTEEASWF 77
Query: 64 VQREIINHRSLRHPNIVRF----KEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEA 119
+ EI +RH NI+ F + + T L ++ +Y G L++ + +
Sbjct: 78 RETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKST-TLDAKSM 136
Query: 120 RFFFQQLISGVSYCHSMQ--------VCHRDLKLENTLLDGSPAPRLKICDFGYSK---- 167
+SG+ + H+ + HRDLK +N L+ + I D G +
Sbjct: 137 LKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKN--GTCCIADLGLAVKFIS 194
Query: 168 -SSVLHSQPKSTVGTPAYIAPEVL 190
++ + P + VGT Y+ PEVL
Sbjct: 195 DTNEVDIPPNTRVGTKRYMPPEVL 218
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 8e-30
Identities = 57/204 (27%), Positives = 84/204 (41%), Gaps = 25/204 (12%)
Query: 7 TVGPGMDMPIMH---DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDEN 63
T G G +P++ + L IG G FG + R K E VAVK ++
Sbjct: 25 TSGSGSGLPLLVQRTIARTIVLQESIGKGRFG--EVWRGKWRGEEVAVKIFSSREERSWF 82
Query: 64 VQREIINHRSLRHPNIVRF----KEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEA 119
+ EI LRH NI+ F + T T L +V +Y G LF+ + N + +
Sbjct: 83 REAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL-NRYTVTVEGM 141
Query: 120 RFFFQQLISGVSYCHS--------MQVCHRDLKLENTLLDGSPAPRLKICDFGYSK---- 167
SG+++ H + HRDLK +N L+ + I D G +
Sbjct: 142 IKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKN--GTCCIADLGLAVRHDS 199
Query: 168 -SSVLHSQPKSTVGTPAYIAPEVL 190
+ + P VGT Y+APEVL
Sbjct: 200 ATDTIDIAPNHRVGTKRYMAPEVL 223
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 2e-29
Identities = 55/198 (27%), Positives = 81/198 (40%), Gaps = 19/198 (9%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID-ENVQREIINHRSLRHPN 78
RY ++ +G G G+ D ++ VA+K I D ++ REI R L H N
Sbjct: 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDN 69
Query: 79 IVRFKEVILTPTHLAIVMEYASGG--------ELFE----RICNAGRFSEDEARFFFQQL 126
IV+ E++ + E E + G E+ AR F QL
Sbjct: 70 IVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHARLFMYQL 129
Query: 127 ISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST----VGTP 182
+ G+ Y HS V HRDLK N ++ + LKI DFG ++ H K + T
Sbjct: 130 LRGLKYIHSANVLHRDLKPANLFIN-TEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTK 188
Query: 183 AYIAPEVLLK-KEYDGKV 199
Y +P +LL Y +
Sbjct: 189 WYRSPRLLLSPNNYTKAI 206
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 2e-28
Identities = 58/196 (29%), Positives = 88/196 (44%), Gaps = 23/196 (11%)
Query: 21 DRYELVRDIGSGNFGVARLMRD-KKTEELVAVKYIERGDKIDENVQ----REI---INHR 72
+YE V +IG G +G RD K VA+K + R +E + RE+ +
Sbjct: 11 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRV-RVQTGEEGMPLSTIREVAVLRHLE 69
Query: 73 SLRHPNIVRFKEVILTP-----THLAIVMEYASG--GELFERICNAGRFSEDEARFFFQQ 125
+ HPN+VR +V T L +V E+ ++ + + Q
Sbjct: 70 TFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDK-VPEPGVPTETIKDMMFQ 128
Query: 126 LISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPA 183
L+ G+ + HS +V HRDLK +N L+ S ++K+ DFG ++ Q T V T
Sbjct: 129 LLRGLDFLHSHRVVHRDLKPQNILVTSS--GQIKLADFGLARI--YSFQMALTSVVVTLW 184
Query: 184 YIAPEVLLKKEYDGKV 199
Y APEVLL+ Y V
Sbjct: 185 YRAPEVLLQSSYATPV 200
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 108 bits (270), Expect = 2e-28
Identities = 48/195 (24%), Positives = 73/195 (37%), Gaps = 28/195 (14%)
Query: 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPN 78
D D +L+ IG G +G + + E VAVK ++ + ++ I + H N
Sbjct: 11 DLDNLKLLELIGRGRYG--AVYKGSLDERPVAVKVFSFANRQNFINEKNIYRVPLMEHDN 68
Query: 79 IVRF-----KEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYC 133
I RF + +VMEY G L + + + + + G++Y
Sbjct: 69 IARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYL-SLHTSDWVSSCRLAHSVTRGLAYL 127
Query: 134 HSM---------QVCHRDLKLENTLLDGSPAPRLKICDFGYSK---------SSVLHSQP 175
H+ + HRDL N L+ I DFG S +
Sbjct: 128 HTELPRGDHYKPAISHRDLNSRNVLVKND--GTCVISDFGLSMRLTGNRLVRPGEEDNAA 185
Query: 176 KSTVGTPAYIAPEVL 190
S VGT Y+APEVL
Sbjct: 186 ISEVGTIRYMAPEVL 200
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 2e-27
Identities = 54/192 (28%), Positives = 87/192 (45%), Gaps = 20/192 (10%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER--GDKID-ENVQREIINHRSLRH 76
+RY+ + +GSG +G D KT VAVK + R I + RE+ + ++H
Sbjct: 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 87
Query: 77 PNIVRFKEVILTPTHLA------IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGV 130
N++ +V L +V G +L I + ++D +F Q++ G+
Sbjct: 88 ENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-NNIVKCQKLTDDHVQFLIYQILRGL 145
Query: 131 SYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPE 188
Y HS + HRDLK N ++ LKI DFG ++ + + T V T Y APE
Sbjct: 146 KYIHSADIIHRDLKPSNLAVNED--CELKILDFGLARH----TADEMTGYVATRWYRAPE 199
Query: 189 VLLK-KEYDGKV 199
++L Y+ V
Sbjct: 200 IMLNWMHYNQTV 211
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 3e-27
Identities = 59/175 (33%), Positives = 84/175 (48%), Gaps = 8/175 (4%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENV----QREIINHRSLR 75
++RY++V +G G L D VA+K I + E +RE+ N L
Sbjct: 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLS 69
Query: 76 HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 135
H NIV +V +VMEY G L E I + G S D A F Q++ G+ + H
Sbjct: 70 HQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHD 129
Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSK--SSVLHSQPKSTVGTPAYIAPE 188
M++ HRD+K +N L+D LKI DFG +K S +Q +GT Y +PE
Sbjct: 130 MRIVHRDIKPQNILID--SNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPE 182
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 3e-27
Identities = 52/192 (27%), Positives = 87/192 (45%), Gaps = 20/192 (10%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER--GDKID-ENVQREIINHRSLRH 76
Y ++ +GSG +G D +T VA+K + R ++ + RE+ + +RH
Sbjct: 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRH 83
Query: 77 PNIVRFKEVILTPTHLA------IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGV 130
N++ +V L +VM + G +L ++ + ED +F Q++ G+
Sbjct: 84 ENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDL-GKLMKHEKLGEDRIQFLVYQMLKGL 141
Query: 131 SYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPE 188
Y H+ + HRDLK N ++ LKI DFG ++ + + T V T Y APE
Sbjct: 142 RYIHAAGIIHRDLKPGNLAVNED--CELKILDFGLARQ----ADSEMTGYVVTRWYRAPE 195
Query: 189 VLLK-KEYDGKV 199
V+L Y V
Sbjct: 196 VILNWMRYTQTV 207
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 3e-27
Identities = 54/192 (28%), Positives = 92/192 (47%), Gaps = 21/192 (10%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER--GDKID-ENVQREIINHRSLRH 76
Y +GSG +G DK++ E VA+K + R +I + RE++ + ++H
Sbjct: 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQH 82
Query: 77 PNIVRFKEVILTPTHLA------IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGV 130
N++ +V + L +VM + +L + + +FSE++ ++ Q++ G+
Sbjct: 83 ENVIGLLDVFTPASSLRNFYDFYLVMPFM-QTDLQKIM--GLKFSEEKIQYLVYQMLKGL 139
Query: 131 SYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPE 188
Y HS V HRDLK N ++ LKI DFG ++ + + T V T Y APE
Sbjct: 140 KYIHSAGVVHRDLKPGNLAVNED--CELKILDFGLARH----ADAEMTGYVVTRWYRAPE 193
Query: 189 VLLK-KEYDGKV 199
V+L Y+ V
Sbjct: 194 VILSWMHYNQTV 205
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 3e-27
Identities = 51/189 (26%), Positives = 81/189 (42%), Gaps = 14/189 (7%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER--GDKID-ENVQREIINHRSLRH 76
RY+ ++ IGSG G+ D E VA+K + R ++ + RE++ + + H
Sbjct: 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 83
Query: 77 PNIVRFKEVILTPTHLA------IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGV 130
NI+ V L IVME L ++ + + Q++ G+
Sbjct: 84 KNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANL-CQVIQM-ELDHERMSYLLYQMLCGI 140
Query: 131 SYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL 190
+ HS + HRDLK N ++ LKI DFG ++++ V T Y APEV+
Sbjct: 141 KHLHSAGIIHRDLKPSNIVVKSD--CTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 198
Query: 191 LKKEYDGKV 199
L Y V
Sbjct: 199 LGMGYKENV 207
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 4e-27
Identities = 59/198 (29%), Positives = 85/198 (42%), Gaps = 28/198 (14%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID--ENVQ------REIINH 71
RY + IG G +G+ D + VA+K KI E+ REI
Sbjct: 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIK------KISPFEHQTYCQRTLREIKIL 79
Query: 72 RSLRHPNIVRFKEVILTPTH-----LAIVMEYASGGELFERICNAGRFSEDEARFFFQQL 126
RH NI+ ++I PT + IV + +L ++ S D +F Q+
Sbjct: 80 LRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM-ETDL-YKLLKTQHLSNDHICYFLYQI 137
Query: 127 ISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST----VGTP 182
+ G+ Y HS V HRDLK N LL+ + LKICDFG ++ + V T
Sbjct: 138 LRGLKYIHSANVLHRDLKPSNLLLNTT--CDLKICDFGLARVADPDHDHTGFLTEYVATR 195
Query: 183 AYIAPEVLLK-KEYDGKV 199
Y APE++L K Y +
Sbjct: 196 WYRAPEIMLNSKGYTKSI 213
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 106 bits (265), Expect = 4e-27
Identities = 51/191 (26%), Positives = 82/191 (42%), Gaps = 18/191 (9%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER--GDKID-ENVQREIINHRSLRH 76
RY+ ++ IGSG G+ D + VA+K + R ++ + RE++ + + H
Sbjct: 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 120
Query: 77 PNIVRFKEVILTPTHLA------IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGV 130
NI+ V L +VME L + I + + Q++ G+
Sbjct: 121 KNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVI--QMELDHERMSYLLYQMLCGI 177
Query: 131 SYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPE 188
+ HS + HRDLK N ++ LKI DFG +++ + T V T Y APE
Sbjct: 178 KHLHSAGIIHRDLKPSNIVVKSD--CTLKILDFGLART--AGTSFMMTPYVVTRYYRAPE 233
Query: 189 VLLKKEYDGKV 199
V+L Y V
Sbjct: 234 VILGMGYKENV 244
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 5e-27
Identities = 47/222 (21%), Positives = 84/222 (37%), Gaps = 46/222 (20%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNI 79
S +Y L + +G+G+FG+ + D ++ + A+K + + D +N RE+ + L H NI
Sbjct: 6 SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQ-DPRYKN--RELDIMKVLDHVNI 62
Query: 80 VRFKEVILTPTHLAIVMEYASGGELFERICNAG--------------------------- 112
++ + T N G
Sbjct: 63 IKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD 122
Query: 113 --------------RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRL 158
+ + QL V + HS+ +CHRD+K +N L++ L
Sbjct: 123 TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDN-TL 181
Query: 159 KICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLK-KEYDGKV 199
K+CDFG +K + + + + Y APE++L EY +
Sbjct: 182 KLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSI 223
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 6e-27
Identities = 56/207 (27%), Positives = 89/207 (42%), Gaps = 35/207 (16%)
Query: 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID--ENVQ------REII 69
+ S ++L +G G +GV K T E+VA+K KI+ + REI
Sbjct: 8 NISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIK------KIEPFDKPLFALRTLREIK 61
Query: 70 NHRSLRHPNIVRFKEVILTPTHLA-----IVMEYASGGELFERICNAGRFSEDEARFFFQ 124
+ +H NI+ + + I+ E +L R+ + S+D ++F
Sbjct: 62 ILKHFKHENIITIFNIQRPDSFENFNEVYIIQELM-QTDL-HRVISTQMLSDDHIQYFIY 119
Query: 125 QLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFG----YSKSSVLHSQPKST-- 178
Q + V H V HRDLK N L++ + LK+CDFG +S+ +S+P
Sbjct: 120 QTLRAVKVLHGSNVIHRDLKPSNLLINSN--CDLKVCDFGLARIIDESAADNSEPTGQQS 177
Query: 179 -----VGTPAYIAPEVLLK-KEYDGKV 199
V T Y APEV+L +Y +
Sbjct: 178 GMVEFVATRWYRAPEVMLTSAKYSRAM 204
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 2e-26
Identities = 47/155 (30%), Positives = 75/155 (48%), Gaps = 11/155 (7%)
Query: 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER--GDKID-ENVQREIINHRSL 74
DRYE+ IG+G++G DK + +VA+K I R D ID + + REI L
Sbjct: 50 QIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRL 109
Query: 75 RHPNIVRFKEVILTPT-----HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISG 129
H ++V+ ++++ L +V+E A + + +E + L+ G
Sbjct: 110 NHDHVVKVLDIVIPKDVEKFDELYVVLEIA-DSDFKKLFRTPVYLTELHIKTLLYNLLVG 168
Query: 130 VSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFG 164
V Y HS + HRDLK N L++ +K+CDFG
Sbjct: 169 VKYVHSAGILHRDLKPANCLVNQD--CSVKVCDFG 201
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 3e-26
Identities = 46/201 (22%), Positives = 75/201 (37%), Gaps = 23/201 (11%)
Query: 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQ------------ 65
Y + R I SG++G D + VA+K + V
Sbjct: 19 AMQSPYTVQRFISSGSYGAVCAGVDSEGIP-VAIKRVFNTVSDGRTVNILSDSFLCKRVL 77
Query: 66 REIINHRSLRHPNIVRFKEVILTPTH-----LAIVMEYASGGELFERI-CNAGRFSEDEA 119
REI HPNI+ +++ + L +V E +L + I S
Sbjct: 78 REIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELM-RTDLAQVIHDQRIVISPQHI 136
Query: 120 RFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV 179
++F ++ G+ H V HRDL N LL + + ICDF ++ + V
Sbjct: 137 QYFMYHILLGLHVLHEAGVVHRDLHPGNILLADN--NDITICDFNLAREDTADANKTHYV 194
Query: 180 GTPAYIAPEVLLK-KEYDGKV 199
Y APE++++ K + V
Sbjct: 195 THRWYRAPELVMQFKGFTKLV 215
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 1e-25
Identities = 49/200 (24%), Positives = 79/200 (39%), Gaps = 23/200 (11%)
Query: 9 GPGMDMP-IMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQRE 67
G + + S +L+ G FG + + + E VAVK DK + E
Sbjct: 11 GVDLGTENLYFQSMPLQLLEVKARGRFGC--VWKAQLLNEYVAVKIFPIQDKQSWQNEYE 68
Query: 68 IINHRSLRHPNIVRF----KEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFF 123
+ + ++H NI++F K L ++ + G L + + A S +E
Sbjct: 69 VYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL-KANVVSWNELCHIA 127
Query: 124 QQLISGVSYCHSMQ----------VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 173
+ + G++Y H + HRD+K +N LL + I DFG +
Sbjct: 128 ETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTA--CIADFGLALKFEAGK 185
Query: 174 QPKST---VGTPAYIAPEVL 190
T VGT Y+APEVL
Sbjct: 186 SAGDTHGQVGTRRYMAPEVL 205
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 2e-25
Identities = 45/180 (25%), Positives = 70/180 (38%), Gaps = 20/180 (11%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEE-LVAVKYIERGDKIDENVQ----REIINHRSL 74
+ +YE+ I G G L D+ V +K + D Q E +
Sbjct: 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSG--DAEAQAMAMAERQFLAEV 136
Query: 75 RHPNIVRFKEVILTPTHLA-----IVMEYASGGELFERICNAGRFSEDEARFFFQQLISG 129
HP+IV+ + IVMEY G L + EA + +++
Sbjct: 137 VHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSK--GQKLPVAEAIAYLLEILPA 194
Query: 130 VSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEV 189
+SY HS+ + + DLK EN +L +LK+ D G + GTP + APE+
Sbjct: 195 LSYLHSIGLVYNDLKPENIMLTEE---QLKLIDLGAVSR---INSFGYLYGTPGFQAPEI 248
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 99.2 bits (248), Expect = 2e-25
Identities = 53/192 (27%), Positives = 78/192 (40%), Gaps = 15/192 (7%)
Query: 9 GPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENV---- 64
G M P DRYEL +G G L RD + VAVK + D +
Sbjct: 1 GSHMTTPSHLS-DRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRF 59
Query: 65 QREIINHRSLRHPNIVRF----KEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 120
+RE N +L HP IV + IVMEY G L + + G + A
Sbjct: 60 RREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAI 119
Query: 121 FFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFG----YSKSSVLHSQPK 176
+++ H + HRD+K N ++ S +K+ DFG + S +Q
Sbjct: 120 EVIADACQALNFSHQNGIIHRDVKPANIMI--SATNAVKVMDFGIARAIADSGNSVTQTA 177
Query: 177 STVGTPAYIAPE 188
+ +GT Y++PE
Sbjct: 178 AVIGTAQYLSPE 189
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 2e-25
Identities = 52/193 (26%), Positives = 89/193 (46%), Gaps = 13/193 (6%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER--GDKID-ENVQREIINHRSLRH 76
D Y + IG G++G L DK TE+ VA+K + R D ID + + REI L+
Sbjct: 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKS 84
Query: 77 PNIVRFKEVILTPTHLA-----IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS 131
I+R ++I+ L IV+E A +L + +E+ + L+ G +
Sbjct: 85 DYIIRLYDLIIPDDLLKFDELYIVLEIA-DSDLKKLFKTPIFLTEEHIKTILYNLLLGEN 143
Query: 132 YCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL 191
+ H + HRDLK N LL+ +K+CDFG +++ ++S+ + + E
Sbjct: 144 FIHESGIIHRDLKPANCLLNQD--CSVKVCDFGLART--INSEKDTNIVNDLEENEEPGP 199
Query: 192 KKEYDGKVMCVYV 204
+ K + +V
Sbjct: 200 HNKNLKKQLTSHV 212
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 1e-24
Identities = 47/173 (27%), Positives = 72/173 (41%), Gaps = 8/173 (4%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENV----QREIINHRSLRHP 77
Y L R +G G G D E +VA+K + D QRE L+ P
Sbjct: 35 PYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEP 94
Query: 78 NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ 137
++V + L + M +G +L + G + A +Q+ S + H+
Sbjct: 95 HVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAG 154
Query: 138 VCHRDLKLENTLLDGSPAPRLKICDFG--YSKSSVLHSQPKSTVGTPAYIAPE 188
HRD+K EN L+ S + DFG + + +Q +TVGT Y+APE
Sbjct: 155 ATHRDVKPENILV--SADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPE 205
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 3e-24
Identities = 58/209 (27%), Positives = 89/209 (42%), Gaps = 33/209 (15%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER--GDKID-ENVQREIINHRSLR- 75
+YELV+ +G G +G+ D++T E+VAVK I + D + REI+ L
Sbjct: 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSG 67
Query: 76 HPNIVRFKEVILTPT--HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYC 133
H NIV V+ + +V +Y +L + A ++ QLI + Y
Sbjct: 68 HENIVNLLNVLRADNDRDVYLVFDYM-ETDL-HAVIRANILEPVHKQYVVYQLIKVIKYL 125
Query: 134 HSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--------------- 178
HS + HRD+K N LL+ +K+ DFG S+S V + +
Sbjct: 126 HSGGLLHRDMKPSNILLNAE--CHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDD 183
Query: 179 -------VGTPAYIAPEVLLK-KEYDGKV 199
V T Y APE+LL +Y +
Sbjct: 184 QPILTDYVATRWYRAPEILLGSTKYTKGI 212
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 93.2 bits (232), Expect = 8e-23
Identities = 46/201 (22%), Positives = 77/201 (38%), Gaps = 25/201 (12%)
Query: 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREI-----INHR 72
+ RY LVR +G G+F L +D VA+K + E + EI +N
Sbjct: 16 YKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDA 75
Query: 73 SLRHP------NIVRFKEV----ILTPTHLAIVMEYASGGELFE--RICNAGRFSEDEAR 120
+I++ + H+ +V E G L + +
Sbjct: 76 DNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFE-VLGENLLALIKKYEHRGIPLIYVK 134
Query: 121 FFFQQLISGVSYCHSM-QVCHRDLKLENTLLDGSPAPR----LKICDFGYSKSSVLHSQP 175
+QL+ G+ Y H + H D+K EN L++ +P +KI D G +
Sbjct: 135 QISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLG--NACWYDEHY 192
Query: 176 KSTVGTPAYIAPEVLLKKEYD 196
+++ T Y +PEVLL +
Sbjct: 193 TNSIQTREYRSPEVLLGAPWG 213
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 93.3 bits (232), Expect = 1e-22
Identities = 56/192 (29%), Positives = 81/192 (42%), Gaps = 21/192 (10%)
Query: 18 HDSDRYELVRDIGSGNFG-VARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRH 76
H + RYE+++ IG G+FG V + D K + VA+K + + EI R L H
Sbjct: 94 HVAYRYEVLKVIGKGSFGQVVK-AYDHKVHQHVALKMVRNEKRFHRQAAEEI---RILEH 149
Query: 77 ---------PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAG--RFSEDEARFFFQQ 125
N++ E H+ + E S L+E I FS R F
Sbjct: 150 LRKQDKDNTMNVIHMLENFTFRNHICMTFELLSM-NLYELIKKNKFQGFSLPLVRKFAHS 208
Query: 126 LISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAY 184
++ + H ++ H DLK EN LL +K+ DFG SS Q T + + Y
Sbjct: 209 ILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFG---SSCYEHQRVYTYIQSRFY 265
Query: 185 IAPEVLLKKEYD 196
APEV+L Y
Sbjct: 266 RAPEVILGARYG 277
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 89.8 bits (223), Expect = 1e-21
Identities = 56/187 (29%), Positives = 81/187 (43%), Gaps = 15/187 (8%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHP--- 77
DRYE+ IG G+FG D+ +E VA+K I+ Q E+ +
Sbjct: 54 DRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTE 113
Query: 78 ---NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR--FSEDEARFFFQQLISGVSY 132
IV K + HL +V E S L++ + N S + R F QQ+ + + +
Sbjct: 114 MKYYIVHLKRHFMFRNHLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLF 172
Query: 133 CHS--MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEV 189
+ + + H DLK EN LL +KI DFG SS Q + + Y +PEV
Sbjct: 173 LATPELSIIHCDLKPENILLCNPKRSAIKIVDFG---SSCQLGQRIYQYIQSRFYRSPEV 229
Query: 190 LLKKEYD 196
LL YD
Sbjct: 230 LLGMPYD 236
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 8e-21
Identities = 51/186 (27%), Positives = 85/186 (45%), Gaps = 16/186 (8%)
Query: 19 DSDRYELVRDIGSGNFGVARL----MRDKKTEELVAVKYI-ERGDKIDENVQREIINHRS 73
+ + ++ +G GNFG + T E+VAVK + ++ + +REI +S
Sbjct: 39 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKS 98
Query: 74 LRHPNIVRFKEVILTPTH--LAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGV 130
L+H NIV++K V + L ++MEY G L + + + R + + Q+ G+
Sbjct: 99 LQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGM 158
Query: 131 SYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI----- 185
Y + + HRDL N L+ + R+KI DFG +K + + V P
Sbjct: 159 EYLGTKRYIHRDLATRNILV-ENEN-RVKIGDFGLTK-VLPQDKEYYKVKEPGESPIFWY 215
Query: 186 APEVLL 191
APE L
Sbjct: 216 APESLT 221
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 1e-20
Identities = 51/186 (27%), Positives = 85/186 (45%), Gaps = 16/186 (8%)
Query: 19 DSDRYELVRDIGSGNFGVARL----MRDKKTEELVAVKYI-ERGDKIDENVQREIINHRS 73
+ + ++ +G GNFG + T E+VAVK + ++ + +REI +S
Sbjct: 8 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKS 67
Query: 74 LRHPNIVRFKEVILTPTH--LAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGV 130
L+H NIV++K V + L ++MEY G L + + + R + + Q+ G+
Sbjct: 68 LQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGM 127
Query: 131 SYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI----- 185
Y + + HRDL N L+ + R+KI DFG +K + + V P
Sbjct: 128 EYLGTKRYIHRDLATRNILV-ENEN-RVKIGDFGLTK-VLPQDKEFFKVKEPGESPIFWY 184
Query: 186 APEVLL 191
APE L
Sbjct: 185 APESLT 190
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 1e-20
Identities = 51/180 (28%), Positives = 64/180 (35%), Gaps = 12/180 (6%)
Query: 24 ELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQ--REIINHRSLRHPNIVR 81
L IG GNFG R + LVAVK D + +E + HPNIVR
Sbjct: 117 VLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVR 176
Query: 82 FKEVILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHSMQVCH 140
V + IVME GG+ + R +G+ Y S H
Sbjct: 177 LIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIH 236
Query: 141 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI-----APEVLLKKEY 195
RDL N L+ LKI DFG S+ + G + APE L Y
Sbjct: 237 RDLAARNCLVTEKNV--LKISDFGMSR--EEADGVYAASGGLRQVPVKWTAPEALNYGRY 292
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 6e-20
Identities = 48/158 (30%), Positives = 77/158 (48%), Gaps = 11/158 (6%)
Query: 19 DSDRYELVRDIGSGNFGV---ARL-MRDKKTEELVAVKYI--ERGDKIDENVQREIINHR 72
+ + +RD+G G+FG R T E VAVK + E G ++++EI R
Sbjct: 19 EKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILR 78
Query: 73 SLRHPNIVRFKEVILTPTH--LAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISG 129
+L H NIV++K + + ++ME+ G L E + N + + + + Q+ G
Sbjct: 79 NLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKG 138
Query: 130 VSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 167
+ Y S Q HRDL N L+ S ++KI DFG +K
Sbjct: 139 MDYLGSRQYVHRDLAARNVLV-ESEH-QVKIGDFGLTK 174
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 8e-20
Identities = 48/157 (30%), Positives = 70/157 (44%), Gaps = 10/157 (6%)
Query: 19 DSDRYELVRDIGSGNFGVARL----MRDKKTEELVAVKYI-ERGDKIDENVQREIINHRS 73
+ + + +G GNFG L T LVAVK + G + QREI ++
Sbjct: 21 EERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKA 80
Query: 74 LRHPNIVRFKEVILTPTH--LAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGV 130
L IV+++ V P L +VMEY G L + + + R + Q+ G+
Sbjct: 81 LHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGM 140
Query: 131 SYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 167
Y S + HRDL N L+ S A +KI DFG +K
Sbjct: 141 EYLGSRRCVHRDLAARNILV-ESEA-HVKIADFGLAK 175
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 83.3 bits (206), Expect = 1e-19
Identities = 24/149 (16%), Positives = 44/149 (29%), Gaps = 8/149 (5%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDEN----VQREIINHRSLRH 76
RY L+ G D + VA+ +++ + ++ + +
Sbjct: 31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDK 90
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
P + R +V+ T +V E+ GG L E S A Q L + H
Sbjct: 91 PGVARVLDVVHTRAGGLVVAEWIRGGSLQEVA--DTSPSPVGAIRAMQSLAAAADAAHRA 148
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGY 165
V + S + +
Sbjct: 149 GVALSIDHPSRVRV--SIDGDVVLAYPAT 175
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 84.1 bits (208), Expect = 2e-19
Identities = 42/184 (22%), Positives = 70/184 (38%), Gaps = 6/184 (3%)
Query: 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPN 78
+ + +G G +G KK VAVK ++ E +E + ++HPN
Sbjct: 218 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPN 277
Query: 79 IVRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
+V+ V I+ E+ + G L + R CN S + Q+ S + Y
Sbjct: 278 LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK 337
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAY--IAPEVLLKKE 194
HR+L N L+ + +K+ DFG S+ + APE L +
Sbjct: 338 NFIHRNLAARNCLVGENHL--VKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNK 395
Query: 195 YDGK 198
+ K
Sbjct: 396 FSIK 399
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 3e-19
Identities = 44/152 (28%), Positives = 65/152 (42%), Gaps = 11/152 (7%)
Query: 24 ELVRDIGSGNFGV---ARLMRDKKTEELVAVKYIERGDKIDENVQREIINH----RSLRH 76
L+ +G G+FGV VAVK ++ + I SL H
Sbjct: 21 RLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDH 80
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHS 135
N++R V+LTP + +V E A G L +R+ + G F + Q+ G+ Y S
Sbjct: 81 RNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLES 139
Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 167
+ HRDL N LL + +KI DFG +
Sbjct: 140 KRFIHRDLAARNLLL-ATRD-LVKIGDFGLMR 169
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 8e-19
Identities = 46/208 (22%), Positives = 84/208 (40%), Gaps = 37/208 (17%)
Query: 21 DRYELVRDIGSGNFG-VARLMRDKKTEELVAVKYIERGDKIDENVQREI-----INHRSL 74
+ + ++R +G G FG V + ++ AVK + K + + E I + +
Sbjct: 35 NAFLVIRKMGDGTFGRVLL-CQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDI 93
Query: 75 RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR--FSEDEARFFFQQLISGVSY 132
+ NIV++ + H+ ++ E G L+E I F ++ + + +++ ++Y
Sbjct: 94 NNNNIVKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNY 152
Query: 133 CHSMQVCHRDLKLENTLLDGSPA-----------------------PRLKICDFGYSKSS 169
M + H DLK EN LLD +K+ DFG +
Sbjct: 153 LRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFG---CA 209
Query: 170 VLHSQPKST-VGTPAYIAPEVLLKKEYD 196
S + + T Y APEV+L +D
Sbjct: 210 TFKSDYHGSIINTRQYRAPEVILNLGWD 237
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 1e-18
Identities = 49/203 (24%), Positives = 77/203 (37%), Gaps = 31/203 (15%)
Query: 21 DRYELVRDIGSGNFG-VARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHP-- 77
+RYE+V ++G G FG V + + + VA+K I K E + EI + ++
Sbjct: 19 ERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDK 78
Query: 78 ----NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR--FSEDEARFFFQQLISGVS 131
V + H+ I E G FE + + R QL +
Sbjct: 79 ENKFLCVLMSDWFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALR 137
Query: 132 YCHSMQVCHRDLKLENTLLDGSPA-----------------PRLKICDFGYSKSSVLHSQ 174
+ H Q+ H DLK EN L S +++ DFG S+ +
Sbjct: 138 FLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFG---SATFDHE 194
Query: 175 PKST-VGTPAYIAPEVLLKKEYD 196
+T V T Y PEV+L+ +
Sbjct: 195 HHTTIVATRHYRPPEVILELGWA 217
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 1e-18
Identities = 47/155 (30%), Positives = 74/155 (47%), Gaps = 11/155 (7%)
Query: 21 DRYELVRDIGSGNFGVARL----MRDKKTEELVAVKYI--ERGDKIDENVQREIINHRSL 74
+ +RD+G G+FG L + T E+VAVK + + G + ++EI R+L
Sbjct: 31 RYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTL 90
Query: 75 RHPNIVRFKEVILTPTH--LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 132
H +I+++K L +VMEY G L + + + F QQ+ G++Y
Sbjct: 91 YHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYL-PRHSIGLAQLLLFAQQICEGMAY 149
Query: 133 CHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 167
H+ HRDL N LL + +KI DFG +K
Sbjct: 150 LHAQHYIHRDLAARNVLL-DNDR-LVKIGDFGLAK 182
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 3e-18
Identities = 38/151 (25%), Positives = 62/151 (41%), Gaps = 4/151 (2%)
Query: 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPN 78
+ + +G G +G KK VAVK ++ E +E + ++HPN
Sbjct: 11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPN 70
Query: 79 IVRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
+V+ V I+ E+ + G L + R CN S + Q+ S + Y
Sbjct: 71 LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK 130
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSK 167
HRDL N L+ + +K+ DFG S+
Sbjct: 131 NFIHRDLAARNCLVGENHL--VKVADFGLSR 159
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 78.0 bits (193), Expect = 1e-17
Identities = 34/153 (22%), Positives = 70/153 (45%), Gaps = 14/153 (9%)
Query: 24 ELVRDIGSGNFGV---ARLMRDKKTEEL-VAVKYIERGDKIDENVQREIINH----RSLR 75
+ ++ +GSG FG + + + ++ VA+K + +EI++ S+
Sbjct: 18 KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVD 75
Query: 76 HPNIVRFKEVILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCH 134
+P++ R + LT T + ++ + G L + + + + Q+ G++Y
Sbjct: 76 NPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 134
Query: 135 SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 167
++ HRDL N L+ +P +KI DFG +K
Sbjct: 135 DRRLVHRDLAARNVLV-KTPQ-HVKITDFGLAK 165
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 2e-17
Identities = 59/204 (28%), Positives = 83/204 (40%), Gaps = 33/204 (16%)
Query: 21 DRYELVRDIGSGNFG-VARLMRDKKTEELVAVKYIERGDKIDENVQREI-----INHR-- 72
RYE+V +G G FG V + K VAVK ++ D+ E + EI +N
Sbjct: 14 ARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDP 73
Query: 73 SLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR--FSEDEARFFFQQLISGV 130
+ V+ E H+ IV E G ++ I G F D R Q+ V
Sbjct: 74 NSTF-RCVQMLEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSV 131
Query: 131 SYCHSMQVCHRDLKLENTLLDGSPA-----------------PRLKICDFGYSKSSVLHS 173
++ HS ++ H DLK EN L S P +K+ DFG S+
Sbjct: 132 NFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFG---SATYDD 188
Query: 174 QPKST-VGTPAYIAPEVLLKKEYD 196
+ ST V T Y APEV+L +
Sbjct: 189 EHHSTLVSTRHYRAPEVILALGWS 212
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 78.3 bits (193), Expect = 3e-17
Identities = 40/151 (26%), Positives = 64/151 (42%), Gaps = 6/151 (3%)
Query: 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPN 78
+ L +G G FG + T VA+K ++ G E +E + LRH
Sbjct: 182 PRESLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLRHEK 240
Query: 79 IVRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
+V+ V+ + + IV EY S G L F + + Q+ SG++Y M
Sbjct: 241 LVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM 299
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSK 167
HRDL+ N L+ + K+ DFG ++
Sbjct: 300 NYVHRDLRAANILVGENLV--CKVADFGLAR 328
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 78.0 bits (192), Expect = 3e-17
Identities = 40/151 (26%), Positives = 64/151 (42%), Gaps = 6/151 (3%)
Query: 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPN 78
+ L +G G FG + T VA+K ++ G E +E + LRH
Sbjct: 265 PRESLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLRHEK 323
Query: 79 IVRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
+V+ V+ + + IV EY S G L F + + Q+ SG++Y M
Sbjct: 324 LVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM 382
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSK 167
HRDL+ N L+ + K+ DFG ++
Sbjct: 383 NYVHRDLRAANILVGENLV--CKVADFGLAR 411
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 76.5 bits (188), Expect = 9e-17
Identities = 47/241 (19%), Positives = 84/241 (34%), Gaps = 65/241 (26%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREI-----INHRSLR 75
RY ++R +G G+F L D + ++ VA+K ++ + E EI + +
Sbjct: 37 GRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPN 96
Query: 76 HPN---IVR----FKEVILTPTHLAIVMEYA--SGGELFERICNAGRFSEDEARFFFQQL 126
PN +V+ FK + TH+ +V E + + N + QQ+
Sbjct: 97 DPNREMVVQLLDDFKISGVNGTHICMVFEVLGHHLLKWIIK-SNYQGLPLPCVKKIIQQV 155
Query: 127 ISGVSYCHS-MQVCHRDLKLENTLLD---------------------------------- 151
+ G+ Y H+ ++ H D+K EN LL
Sbjct: 156 LQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPA 215
Query: 152 -------------GSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGK 198
+ ++KI D G + +H + T Y + EVL+ Y+
Sbjct: 216 TAGNFLVNPLEPKNAEKLKVKIADLG--NACWVHKHFTEDIQTRQYRSLEVLIGSGYNTP 273
Query: 199 V 199
Sbjct: 274 A 274
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 1e-16
Identities = 43/156 (27%), Positives = 72/156 (46%), Gaps = 10/156 (6%)
Query: 19 DSDRYELVRDIGSGNFGV---ARLMRDKKTEELVAVKYIERG--DKIDENVQREIINHRS 73
++ R + + IGSG+ G RL + + VA+K ++ G ++ + E
Sbjct: 47 EASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQ 106
Query: 74 LRHPNIVRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVS 131
HPNI+R + V+ IV EY G L F R + G+F+ + + + +G+
Sbjct: 107 FDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLR-THDGQFTIMQLVGMLRGVGAGMR 165
Query: 132 YCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 167
Y + HRDL N L+D + K+ DFG S+
Sbjct: 166 YLSDLGYVHRDLAARNVLVDSNLV--CKVSDFGLSR 199
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 74.9 bits (185), Expect = 1e-16
Identities = 42/151 (27%), Positives = 67/151 (44%), Gaps = 6/151 (3%)
Query: 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPN 78
D V++IGSG FG+ L ++ VA+K I G +E+ E L HP
Sbjct: 6 DPSELTFVQEIGSGQFGLVHLGYWLNKDK-VAIKTIREGAMSEEDFIEEAEVMMKLSHPK 64
Query: 79 IVRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
+V+ V L + +V E+ G L + R G F+ + + G++Y
Sbjct: 65 LVQLYGVCLEQAPICLVTEFMEHGCLSDYLR-TQRGLFAAETLLGMCLDVCEGMAYLEEA 123
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSK 167
V HRDL N L+ + +K+ DFG ++
Sbjct: 124 CVIHRDLAARNCLVGENQV--IKVSDFGMTR 152
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 76.3 bits (188), Expect = 1e-16
Identities = 38/151 (25%), Positives = 68/151 (45%), Gaps = 6/151 (3%)
Query: 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPN 78
+ +L + +G+G FG + K + VAVK ++ G E E ++L+H
Sbjct: 186 PRESLKLEKKLGAGQFGEVWMATYNKHTK-VAVKTMKPGSMSVEAFLAEANVMKTLQHDK 244
Query: 79 IVRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
+V+ V+ T + I+ E+ + G L F + + + F Q+ G+++
Sbjct: 245 LVKLHAVV-TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR 303
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSK 167
HRDL+ N L+ S KI DFG ++
Sbjct: 304 NYIHRDLRAANILVSASLV--CKIADFGLAR 332
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 2e-16
Identities = 47/161 (29%), Positives = 63/161 (39%), Gaps = 18/161 (11%)
Query: 21 DRYELVRD--------IGSGNFGV---ARLMRDKKTEELVAVKYIERG--DKIDENVQRE 67
+ L RD +G GNFG KK + VA+K +++G E + RE
Sbjct: 2 KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQID-VAIKVLKQGTEKADTEEMMRE 60
Query: 68 IINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQL 126
L +P IVR V + +VME A GG L + + Q+
Sbjct: 61 AQIMHQLDNPYIVRLIGVCQAEALM-LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQV 119
Query: 127 ISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 167
G+ Y HRDL N LL + KI DFG SK
Sbjct: 120 SMGMKYLEEKNFVHRDLAARNVLL-VNRH-YAKISDFGLSK 158
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 2e-16
Identities = 34/151 (22%), Positives = 70/151 (46%), Gaps = 10/151 (6%)
Query: 24 ELVRDIGSGNFGV---ARLMRDKKTEEL-VAVKYIERG--DKIDENVQREIINHRSLRHP 77
+ ++ +GSG FG + + + ++ VA+K + K ++ + E S+ +P
Sbjct: 18 KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNP 77
Query: 78 NIVRFKEVILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHSM 136
++ R + LT T + ++ + G L + + + + Q+ G++Y
Sbjct: 78 HVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR 136
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSK 167
++ HRDL N L+ +P +KI DFG +K
Sbjct: 137 RLVHRDLAARNVLV-KTPQ-HVKITDFGLAK 165
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 74.7 bits (183), Expect = 5e-16
Identities = 50/176 (28%), Positives = 80/176 (45%), Gaps = 15/176 (8%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLR-HPNI 79
+++ L R IGSG+FG L + +T E VA+K E + E +R L+ I
Sbjct: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL-ENVKTKHPQLLYESKIYRILQGGTGI 65
Query: 80 VRFKEVILTPTHLAIVMEY--ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ 137
+ + + +VM+ S +LF C+ + S Q+I+ V + HS
Sbjct: 66 PNVRWFGVEGDYNVLVMDLLGPSLEDLF-NFCS-RKLSLKTVLMLADQMINRVEFVHSKS 123
Query: 138 VCHRDLKLENTLLD-GSPAPRLKICDFGYSK-----SSVLH---SQPKSTVGTPAY 184
HRD+K +N L+ G A ++ I DFG +K S+ H + K+ GT Y
Sbjct: 124 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARY 179
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 5e-16
Identities = 44/156 (28%), Positives = 70/156 (44%), Gaps = 10/156 (6%)
Query: 19 DSDRYELVRDIGSGNFGV---ARLMRDKKTEELVAVKYIERG--DKIDENVQREIINHRS 73
D+ + + +G+G FG RL K E VA+K ++ G +K + E
Sbjct: 43 DATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQ 102
Query: 74 LRHPNIVRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVS 131
HPNI+R + V+ + IV EY G L F R + +F+ + + + SG+
Sbjct: 103 FDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLR-KHDAQFTVIQLVGMLRGIASGMK 161
Query: 132 YCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 167
Y M HRDL N L++ + K+ DFG +
Sbjct: 162 YLSDMGYVHRDLAARNILINSNLV--CKVSDFGLGR 195
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 73.4 bits (181), Expect = 5e-16
Identities = 37/151 (24%), Positives = 69/151 (45%), Gaps = 6/151 (3%)
Query: 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPN 78
+ +LV +G+G FG + + VAVK +++G + E + L+H
Sbjct: 11 PRETLKLVERLGAGQFGEVWMGYYNGHTK-VAVKSLKQGSMSPDAFLAEANLMKQLQHQR 69
Query: 79 IVRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
+VR V+ T + I+ EY G L F + + + + ++ Q+ G+++
Sbjct: 70 LVRLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER 128
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSK 167
HRDL+ N L+ + + KI DFG ++
Sbjct: 129 NYIHRDLRAANILVSDTLS--CKIADFGLAR 157
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 7e-16
Identities = 45/156 (28%), Positives = 70/156 (44%), Gaps = 13/156 (8%)
Query: 21 DRYELV---RDIGSGNFGVAR--LMRDKKTEELVAVKYIERGDKIDENVQREIINH---- 71
DR L +++GSGNFG + + KK + VAVK + + + D ++ E++
Sbjct: 14 DRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKIL-KNEANDPALKDELLAEANVM 72
Query: 72 RSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS 131
+ L +P IVR + + + +VME A G L + + + Q+ G+
Sbjct: 73 QQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMK 131
Query: 132 YCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 167
Y HRDL N LL + KI DFG SK
Sbjct: 132 YLEESNFVHRDLAARNVLL-VTQH-YAKISDFGLSK 165
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 72.6 bits (179), Expect = 8e-16
Identities = 40/161 (24%), Positives = 64/161 (39%), Gaps = 16/161 (9%)
Query: 20 SDRYE-------LVRDIGSGNFGV---ARLMRDKKTEELVAVKYIERG--DKIDENVQRE 67
+Y L R +G G FG K + VAVK ++ E E
Sbjct: 4 GPQYGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSE 63
Query: 68 IINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQL 126
+ ++L HP+IV+ +I I+ME GEL + N + Q+
Sbjct: 64 AVIMKNLDHPHIVKLIGIIEEEPTW-IIMELYPYGELGHYLERNKNSLKVLTLVLYSLQI 122
Query: 127 ISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 167
++Y S+ HRD+ + N L+ +K+ DFG S+
Sbjct: 123 CKAMAYLESINCVHRDIAVRNILVASPEC--VKLGDFGLSR 161
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 74.2 bits (182), Expect = 9e-16
Identities = 43/145 (29%), Positives = 59/145 (40%), Gaps = 10/145 (6%)
Query: 29 IGSGNFGV---ARLMRDKKTEELVAVKYIERG--DKIDENVQREIINHRSLRHPNIVRFK 83
+G GNFG KK + VA+K +++G E + RE L +P IVR
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQID-VAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 402
Query: 84 EVILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRD 142
V + +VME A GG L + + Q+ G+ Y HR+
Sbjct: 403 GVCQAEALM-LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRN 461
Query: 143 LKLENTLLDGSPAPRLKICDFGYSK 167
L N LL + KI DFG SK
Sbjct: 462 LAARNVLL-VNRH-YAKISDFGLSK 484
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 9e-16
Identities = 43/152 (28%), Positives = 61/152 (40%), Gaps = 8/152 (5%)
Query: 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPN 78
+ +L++ IG G FG L + + VAVK I + D + E LRH N
Sbjct: 191 NMKELKLLQTIGKGEFGDVMLGDYRGNK--VAVKCI-KNDATAQAFLAEASVMTQLRHSN 247
Query: 79 IVRFKEVILT-PTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHS 135
+V+ VI+ L IV EY + G L + R D F + + Y
Sbjct: 248 LVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG 307
Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 167
HRDL N L+ K+ DFG +K
Sbjct: 308 NNFVHRDLAARNVLVSEDNV--AKVSDFGLTK 337
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 1e-15
Identities = 36/156 (23%), Positives = 70/156 (44%), Gaps = 10/156 (6%)
Query: 19 DSDRYELVRDIGSGNFGV---ARLMRDKKTEEL-VAVKYI--ERGDKIDENVQREIINHR 72
++ +GSG FG + + ++ ++ V +K I + G + + V ++
Sbjct: 11 KETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIG 70
Query: 73 SLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVS 131
SL H +IVR + + L +V +Y G L + + + G + Q+ G+
Sbjct: 71 SLDHAHIVRLLGLCPGSS-LQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMY 129
Query: 132 YCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 167
Y + HR+L N LL SP+ ++++ DFG +
Sbjct: 130 YLEEHGMVHRNLAARNVLL-KSPS-QVQVADFGVAD 163
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 1e-15
Identities = 40/178 (22%), Positives = 72/178 (40%), Gaps = 17/178 (9%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRH-PNI 79
Y++ R IG G+FGV + + VA+K+ E ++ E ++ L I
Sbjct: 10 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKF-EPRRSDAPQLRDEYRTYKLLAGCTGI 68
Query: 80 VRFKEVILTPTHLAIVMEY--ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ 137
H +V++ S +L +C +FS +Q+++ V H
Sbjct: 69 PNVYYFGQEGLHNVLVIDLLGPSLEDLL-DLCG-RKFSVKTVAMAAKQMLARVQSIHEKS 126
Query: 138 VCHRDLKLENTLL---DGSPAPRLKICDFGYSK-----SSVLH---SQPKSTVGTPAY 184
+ +RD+K +N L+ + A + + DFG K + H + K+ GT Y
Sbjct: 127 LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARY 184
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 1e-15
Identities = 44/156 (28%), Positives = 67/156 (42%), Gaps = 11/156 (7%)
Query: 19 DSDRYELVRDIGSGNFGV---ARLMRDKKTEELVAVKYIERG--DKIDENVQREIINHRS 73
+R EL R IG G FG M + VA+K + D + E +E + R
Sbjct: 13 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQ 72
Query: 74 LRHPNIVRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVS 131
HP+IV+ VI I+ME + GEL F + + QL + ++
Sbjct: 73 FDHPHIVKLIGVITENPVW-IIMELCTLGELRSFLQ-VRKYSLDLASLILYAYQLSTALA 130
Query: 132 YCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 167
Y S + HRD+ N L+ + +K+ DFG S+
Sbjct: 131 YLESKRFVHRDIAARNVLVSSNDC--VKLGDFGLSR 164
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 2e-15
Identities = 43/163 (26%), Positives = 66/163 (40%), Gaps = 11/163 (6%)
Query: 13 DMPIMHDSDRYELVRDIGSGNFGV---ARLMRDKKTEELVAVKYIERGDKIDENVQ--RE 67
+ I S IG G+FG L+ + + AVK + R I E Q E
Sbjct: 17 HVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTE 76
Query: 68 IINHRSLRHPNIVRFKEVILTPTH-LAIVMEYASGGEL--FERICNAGRFSEDEARFFFQ 124
I + HPN++ + L +V+ Y G+L F R + + F
Sbjct: 77 GIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIR-NETHNPTVKDLIGFGL 135
Query: 125 QLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 167
Q+ G+ Y S + HRDL N +LD +K+ DFG ++
Sbjct: 136 QVAKGMKYLASKKFVHRDLAARNCMLDEKFT--VKVADFGLAR 176
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 2e-15
Identities = 38/154 (24%), Positives = 66/154 (42%), Gaps = 12/154 (7%)
Query: 19 DSDRYELVRDIGSGNFGV---ARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLR 75
D ++++G+G FGV + + + VA+K I+ G ++ E +L
Sbjct: 22 DPKDLTFLKELGTGQFGVVKYGKW----RGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLS 77
Query: 76 HPNIVRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYC 133
H +V+ V + I+ EY + G L + R RF + + + + Y
Sbjct: 78 HEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLR-EMRHRFQTQQLLEMCKDVCEAMEYL 136
Query: 134 HSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 167
S Q HRDL N L++ +K+ DFG S+
Sbjct: 137 ESKQFLHRDLAARNCLVNDQGV--VKVSDFGLSR 168
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 73.0 bits (179), Expect = 2e-15
Identities = 42/150 (28%), Positives = 64/150 (42%), Gaps = 9/150 (6%)
Query: 24 ELVRDIGSGNFGV---ARLMRDKKTEELVAVKYIERG--DKIDENVQREIINHRSLRHPN 78
EL R IG G FG M + VA+K + D + E +E + R HP+
Sbjct: 393 ELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPH 452
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHSMQ 137
IV+ VI I+ME + GEL + + QL + ++Y S +
Sbjct: 453 IVKLIGVITENPVW-IIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKR 511
Query: 138 VCHRDLKLENTLLDGSPAPRLKICDFGYSK 167
HRD+ N L+ + +K+ DFG S+
Sbjct: 512 FVHRDIAARNVLVSSNDC--VKLGDFGLSR 539
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 2e-15
Identities = 37/170 (21%), Positives = 65/170 (38%), Gaps = 26/170 (15%)
Query: 19 DSDRYELVRDIGSGNFGV---ARLMRDKKTEELVAVKYIERGDKIDENVQ---REIINHR 72
++ L R +G G FG A+L ++ + VAVK ++ +++ RE +
Sbjct: 21 PEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMK 80
Query: 73 SLRHPNIVRF------KEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQ 124
HP++ + +++ + G+L F A R E+ Q
Sbjct: 81 EFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLL---ASRIGENPFNLPLQ 137
Query: 125 QLI-------SGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 167
L+ G+ Y S HRDL N +L + + DFG S+
Sbjct: 138 TLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMT--VCVADFGLSR 185
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 2e-15
Identities = 48/177 (27%), Positives = 75/177 (42%), Gaps = 17/177 (9%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRH-PNIV 80
+ + + IG GNFG RL ++ T E VA+K +E + E ++ L I
Sbjct: 10 NFRVGKKIGCGNFGELRLGKNLYTNEYVAIK-LEPMKSRAPQLHLEYRFYKQLGSGDGIP 68
Query: 81 RFKEVILTPTHLAIVMEY--ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQV 138
+ + A+V+E S +LF +C+ FS QLIS + Y HS +
Sbjct: 69 QVYYFGPCGKYNAMVLELLGPSLEDLF-DLCD-RTFSLKTVLMIAIQLISRMEYVHSKNL 126
Query: 139 CHRDLKLENTLLDGSPAPRLKIC---DFGYSK-----SSVLH---SQPKSTVGTPAY 184
+RD+K EN L+ ++ DF +K + H + KS GT Y
Sbjct: 127 IYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARY 183
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 3e-15
Identities = 44/152 (28%), Positives = 62/152 (40%), Gaps = 8/152 (5%)
Query: 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPN 78
+ +L++ IG G FG L + + VAVK I + D + E LRH N
Sbjct: 19 NMKELKLLQTIGKGEFGDVMLGDYRGNK--VAVKCI-KNDATAQAFLAEASVMTQLRHSN 75
Query: 79 IVRFKEVILTPT-HLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHS 135
+V+ VI+ L IV EY + G L + R D F + + Y
Sbjct: 76 LVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG 135
Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 167
HRDL N L+ S K+ DFG +K
Sbjct: 136 NNFVHRDLAARNVLV--SEDNVAKVSDFGLTK 165
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 4e-15
Identities = 51/176 (28%), Positives = 75/176 (42%), Gaps = 15/176 (8%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRH-PNI 79
+RY L R IGSG+FG L D E VA+K E + E ++ ++ I
Sbjct: 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKL-ECVKTKHPQLHIESKIYKMMQGGVGI 67
Query: 80 VRFKEVILTPTHLAIVMEY--ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ 137
+ + +VME S +LF C+ +FS Q+IS + Y HS
Sbjct: 68 PTIRWCGAEGDYNVMVMELLGPSLEDLF-NFCS-RKFSLKTVLLLADQMISRIEYIHSKN 125
Query: 138 VCHRDLKLENTLL-DGSPAPRLKICDFGYSK-----SSVLH---SQPKSTVGTPAY 184
HRD+K +N L+ G + I DFG +K + H + K+ GT Y
Sbjct: 126 FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARY 181
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 70.7 bits (174), Expect = 4e-15
Identities = 55/185 (29%), Positives = 84/185 (45%), Gaps = 16/185 (8%)
Query: 19 DSDRYELVRDIGSGNFGV---ARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLR 75
+ L++++GSG FGV + K + VAVK I+ G ++ +E L
Sbjct: 6 KREEITLLKELGSGQFGVVKLGKW----KGQYDVAVKMIKEGSMSEDEFFQEAQTMMKLS 61
Query: 76 HPNIVRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYC 133
HP +V+F V + IV EY S G L + R + + + G+++
Sbjct: 62 HPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLR-SHGKGLEPSQLLEMCYDVCEGMAFL 120
Query: 134 HSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI---APEVL 190
S Q HRDL N L+D +K+ DFG ++ VL Q S+VGT + APEV
Sbjct: 121 ESHQFIHRDLAARNCLVDRDLC--VKVSDFGMTR-YVLDDQYVSSVGTKFPVKWSAPEVF 177
Query: 191 LKKEY 195
+Y
Sbjct: 178 HYFKY 182
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 5e-15
Identities = 40/162 (24%), Positives = 58/162 (35%), Gaps = 15/162 (9%)
Query: 21 DRYELVRDIGSGNFG-----VARLMRDKKTEELVAVKYIERGDKIDENV--QREIINHRS 73
L+R +G G FG M + + VAVK + + + E +
Sbjct: 30 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 89
Query: 74 LRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLI------ 127
H NIVR V L I+ME +GG+L + + L+
Sbjct: 90 FNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 149
Query: 128 -SGVSYCHSMQVCHRDLKLENTLLDGSPAPRL-KICDFGYSK 167
G Y HRD+ N LL R+ KI DFG ++
Sbjct: 150 ACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 191
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 7e-15
Identities = 35/185 (18%), Positives = 63/185 (34%), Gaps = 32/185 (17%)
Query: 10 PGMDMPIMHDSDRYE-------LVRDIGSGNFGV---ARLMRDKKTEELVAVKYIERGDK 59
P + + + L + +G G FG L ++ T VAVK ++ +
Sbjct: 16 PRGSEELQNKLEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNS 75
Query: 60 IDENVQ---REIINHRSLRHPNIVR-----FKEVILTPTHLAIVMEYASGGEL--FERIC 109
++ E + HPN++R + +++ + G+L +
Sbjct: 76 SQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYS 135
Query: 110 NAGRFSEDEARFFFQQLI-------SGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICD 162
R Q L+ G+ Y + HRDL N +L + + D
Sbjct: 136 ---RLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMT--VCVAD 190
Query: 163 FGYSK 167
FG SK
Sbjct: 191 FGLSK 195
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 9e-15
Identities = 26/160 (16%), Positives = 51/160 (31%), Gaps = 17/160 (10%)
Query: 24 ELVRDIGSGNFGV-------ARLMRDKKTEELVAVKYIERGD-KIDENVQREIINHRSLR 75
+G G F + E V +K +++ E+ L
Sbjct: 11 IFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLS 70
Query: 76 HPNIVRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYC 133
H ++V V + +V E+ G L + + N + +QL + + +
Sbjct: 71 HKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLK-KNKNCINILWKLEVAKQLAAAMHFL 129
Query: 134 HSMQVCHRDLKLENTLLDGSPAPRL------KICDFGYSK 167
+ H ++ +N LL + K+ D G S
Sbjct: 130 EENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISI 169
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 1e-14
Identities = 43/157 (27%), Positives = 67/157 (42%), Gaps = 11/157 (7%)
Query: 19 DSDRYELVRDIGSGNFGV---ARLMRDKKTEEL-VAVKYIERG--DKIDENVQREIINHR 72
+ IG+G FG L +E+ VA+K ++ G +K + E
Sbjct: 42 HPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMG 101
Query: 73 SLRHPNIVRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGV 130
H NI+R + VI + I+ EY G L F R G FS + + + +G+
Sbjct: 102 QFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLR-EKDGEFSVLQLVGMLRGIAAGM 160
Query: 131 SYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 167
Y +M HRDL N L++ + K+ DFG S+
Sbjct: 161 KYLANMNYVHRDLAARNILVNSNLV--CKVSDFGLSR 195
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 1e-14
Identities = 39/162 (24%), Positives = 58/162 (35%), Gaps = 15/162 (9%)
Query: 21 DRYELVRDIGSGNFG-----VARLMRDKKTEELVAVKYIERGDKIDENV--QREIINHRS 73
L+R +G G FG M + + VAVK + + + E +
Sbjct: 71 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 130
Query: 74 LRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLI------ 127
H NIVR V L I++E +GG+L + + L+
Sbjct: 131 FNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 190
Query: 128 -SGVSYCHSMQVCHRDLKLENTLLDGSPAPRL-KICDFGYSK 167
G Y HRD+ N LL R+ KI DFG ++
Sbjct: 191 ACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 232
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 70.2 bits (172), Expect = 1e-14
Identities = 42/163 (25%), Positives = 66/163 (40%), Gaps = 11/163 (6%)
Query: 13 DMPIMHDSDRYELVRDIGSGNFGV---ARLMRDKKTEELVAVKYIERGDKIDENVQ--RE 67
+ I S IG G+FG L+ + + AVK + R I E Q E
Sbjct: 81 HVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTE 140
Query: 68 IINHRSLRHPNIVRFKEVILTPTH-LAIVMEYASGGEL--FERICNAGRFSEDEARFFFQ 124
I + HPN++ + L +V+ Y G+L F R + + F
Sbjct: 141 GIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIR-NETHNPTVKDLIGFGL 199
Query: 125 QLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 167
Q+ G+ + S + HRDL N +LD +K+ DFG ++
Sbjct: 200 QVAKGMKFLASKKFVHRDLAARNCMLDEKFT--VKVADFGLAR 240
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 68.8 bits (169), Expect = 2e-14
Identities = 51/198 (25%), Positives = 78/198 (39%), Gaps = 31/198 (15%)
Query: 21 DRYELVRDIGSGNFG-----VARLMRDKKTEELVAVKYIERGDKIDEN-VQREIINHRSL 74
L R++G G FG + K + LVAVK ++ QRE +L
Sbjct: 15 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNL 74
Query: 75 RHPNIVRFKEVILTPTHLAIVMEYASGGELFE---------RICNAGRFSEDEARFFFQQ 125
+H +IV+F V L +V EY G+L + I G+ + + Q
Sbjct: 75 QHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQ 134
Query: 126 LI-------SGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST 178
++ SG+ Y S HRDL N L+ +KI DFG S+ ++S
Sbjct: 135 MLHIASQIASGMVYLASQHFVHRDLATRNCLV--GANLLVKIGDFGMSR--DVYSTDYYR 190
Query: 179 VGTPAYI-----APEVLL 191
VG + PE ++
Sbjct: 191 VGGHTMLPIRWMPPESIM 208
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 68.4 bits (168), Expect = 3e-14
Identities = 42/164 (25%), Positives = 71/164 (43%), Gaps = 13/164 (7%)
Query: 13 DMPIMHDSDRYELVRDIGSGNFGV---ARLMRDKKTEELVAVKYIERGDKIDENVQ--RE 67
D+ I H+ R IG G+FGV + + A+K + R ++ + RE
Sbjct: 13 DVLIPHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLRE 72
Query: 68 IINHRSLRHPNIVRFKEVILT--PTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFF 123
+ R L HPN++ ++L +++ Y G+L F R + + F
Sbjct: 73 GLLMRGLNHPNVLALIGIMLPPEGLPH-VLLPYMCHGDLLQFIR-SPQRNPTVKDLISFG 130
Query: 124 QQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 167
Q+ G+ Y + HRDL N +LD S +K+ DFG ++
Sbjct: 131 LQVARGMEYLAEQKFVHRDLAARNCMLDESFT--VKVADFGLAR 172
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 6e-14
Identities = 43/165 (26%), Positives = 62/165 (37%), Gaps = 23/165 (13%)
Query: 21 DRYELVRDIGSGNFG-----VARLMRDKKTEELVAVKYIERGDKIDEN-VQREIINHRSL 74
L ++G G FG + ++ + LVAVK ++ + QRE L
Sbjct: 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTML 100
Query: 75 RHPNIVRFKEVILTPTHLAIVMEYASGGELFE--------RICNAGRFSEDEARFFFQQL 126
+H +IVRF V L +V EY G+L AG QL
Sbjct: 101 QHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQL 160
Query: 127 I-------SGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFG 164
+ +G+ Y + HRDL N L+ +KI DFG
Sbjct: 161 LAVASQVAAGMVYLAGLHFVHRDLATRNCLV--GQGLVVKIGDFG 203
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 1e-13
Identities = 33/164 (20%), Positives = 69/164 (42%), Gaps = 19/164 (11%)
Query: 21 DRYELVRDIGSGNFG-----VARLMRDKKTEELVAVKYIERGDKIDENV--QREIINHRS 73
++ + R++G G+FG VA+ + + E VA+K + + E + E +
Sbjct: 25 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 84
Query: 74 LRHPNIVRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEAR--------FFF 123
++VR V+ ++ME + G+L + R +
Sbjct: 85 FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 144
Query: 124 QQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 167
++ G++Y ++ + HRDL N ++ + +KI DFG ++
Sbjct: 145 GEIADGMAYLNANKFVHRDLAARNCMV--AEDFTVKIGDFGMTR 186
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 1e-13
Identities = 32/169 (18%), Positives = 60/169 (35%), Gaps = 25/169 (14%)
Query: 19 DSDRYELVRDIGSGNFG-----VARLMRDKKTEELVAVKYIERG--DKIDENVQREIINH 71
+ ++G FG + + VA+K ++ + E + E +
Sbjct: 7 SLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLR 66
Query: 72 RSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL---------FERICNAGRFSEDEARFF 122
L+HPN+V V+ L+++ Y S G+L + + ++
Sbjct: 67 ARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALE 126
Query: 123 FQQLI-------SGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFG 164
+ +G+ Y S V H+DL N L+ +KI D G
Sbjct: 127 PPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLV--YDKLNVKISDLG 173
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 9e-13
Identities = 41/175 (23%), Positives = 59/175 (33%), Gaps = 38/175 (21%)
Query: 21 DRYELVRDIGSGNFG-----VARLMRDKKTEELVAVKYI-------ERGDKIDE-NVQRE 67
+R + +G+G FG A + VAVK + ER + E V
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82
Query: 68 IINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL-----------FERICNAGRFSE 116
+ H NIV ++ EY G+L + +
Sbjct: 83 L-----GNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMED 137
Query: 117 DEARFFFQQLIS-------GVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFG 164
DE + L+S G+++ S HRDL N LL KICDFG
Sbjct: 138 DELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRI--TKICDFG 190
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 1e-12
Identities = 44/178 (24%), Positives = 65/178 (36%), Gaps = 35/178 (19%)
Query: 19 DSDRYELVRDIGSGNFGV---ARLMRDKKTEELVAVKYI-------ERGDKIDE-NVQRE 67
D + + IG GNFG AR+ +D + A+K + + D E V +
Sbjct: 23 DWNDIKFQDVIGEGNFGQVLKARIKKDGLRMD-AAIKRMKEYASKDDHRDFAGELEVLCK 81
Query: 68 IINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL---------FERICNAGRFSEDE 118
+ HPNI+ +L + +EYA G L E +
Sbjct: 82 L-----GHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTA 136
Query: 119 ARFFFQQLI-------SGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 169
+ QQL+ G+ Y Q HRDL N L+ + KI DFG S+
Sbjct: 137 STLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYV--AKIADFGLSRGQ 192
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 63.7 bits (154), Expect = 2e-12
Identities = 39/196 (19%), Positives = 59/196 (30%), Gaps = 52/196 (26%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDEN---------VQREIIN 70
+++ + IG G FG T VA+K I N + EII
Sbjct: 19 TEKLQRCEKIGEGVFGEVFQTIADHTP--VAIKIIAIEGPDLVNGSHQKTFEEILPEIII 76
Query: 71 HRSL---------RHPNIVRFKEVIL------------------------------TPTH 91
+ L R + V
Sbjct: 77 SKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQ 136
Query: 92 LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCH-SMQVCHRDLKLENTLL 150
L IV+E+ GG E++ S A+ QL + ++ S++ HRDL N LL
Sbjct: 137 LFIVLEFEFGGIDLEQMRT-KLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLL 195
Query: 151 DGSPAPRLKICDFGYS 166
+ +L G S
Sbjct: 196 KKTSLKKLHYTLNGKS 211
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 3e-12
Identities = 41/175 (23%), Positives = 65/175 (37%), Gaps = 33/175 (18%)
Query: 21 DRYELVRDIGSGNFG-----VARLMRDKKTEELVAVKYIERG--DKIDENVQREIINHRS 73
+ E VRDIG G FG A + + +VAVK ++ + + QRE
Sbjct: 47 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 106
Query: 74 LRHPNIVRFKEVILTPTHLAIVMEYASGGEL-----------------FERICNAGRFSE 116
+PNIV+ V + ++ EY + G+L + A S
Sbjct: 107 FDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 166
Query: 117 DEARFFFQQLI-------SGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFG 164
+ + +G++Y + HRDL N L+ +KI DFG
Sbjct: 167 GPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLV--GENMVVKIADFG 219
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 6e-12
Identities = 34/171 (19%), Positives = 60/171 (35%), Gaps = 34/171 (19%)
Query: 21 DRYELVRDIGSGNFG-----VARLMRDKKTEELVAVK-------YIERGDKIDE-NVQRE 67
+ + + +G+G FG A + + VAVK E+ + E +
Sbjct: 46 NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 105
Query: 68 IINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFE-------RICNAGRFSEDEAR 120
+ +H NIV + ++ EY G+L + F+ +
Sbjct: 106 L-----GQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANST 160
Query: 121 FFFQQLIS-------GVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFG 164
+ L+ G+++ S HRD+ N LL + KI DFG
Sbjct: 161 ASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLL--TNGHVAKIGDFG 209
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 7e-12
Identities = 38/175 (21%), Positives = 63/175 (36%), Gaps = 33/175 (18%)
Query: 21 DRYELVRDIGSGNFG-----VARLMRDKKTEELVAVKYIERG--DKIDENVQREIINHRS 73
L + +G G FG A ++ + VAVK ++ ++ E +
Sbjct: 23 KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQ 82
Query: 74 LRHPNIVRFKEVILTPTHLAIVMEYASGGEL-----------------FERICNAGRFSE 116
+ HP++++ L +++EYA G L ++
Sbjct: 83 VNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHP 142
Query: 117 DEARFFFQQLIS-------GVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFG 164
DE LIS G+ Y M++ HRDL N L+ +KI DFG
Sbjct: 143 DERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRK--MKISDFG 195
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 4e-11
Identities = 41/188 (21%), Positives = 63/188 (33%), Gaps = 44/188 (23%)
Query: 14 MPIMHDSDRYE-------LVRDIGSGNFG-----VARLMRDKKTEELVAVKYI------- 54
+ +D+ ++E L + +G G FG A + T VAVK +
Sbjct: 13 ERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS 72
Query: 55 ERGDKIDE-NVQREIINHRSLRHPNIVRFKEVILTP-THLAIVMEYASGGEL-------- 104
E + E + I H N+V P L +++E+ G L
Sbjct: 73 EHRALMSELKILIHI-----GHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKR 127
Query: 105 -FERICNAGRFSEDEARFFFQQLIS-------GVSYCHSMQVCHRDLKLENTLLDGSPAP 156
+ + LI G+ + S + HRDL N LL
Sbjct: 128 NEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNV- 186
Query: 157 RLKICDFG 164
+KICDFG
Sbjct: 187 -VKICDFG 193
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 58.8 bits (143), Expect = 9e-11
Identities = 42/170 (24%), Positives = 68/170 (40%), Gaps = 28/170 (16%)
Query: 21 DRYELVRDIGSGNFG------VARLMRDKKTEEL-VAVKYIERGDKIDENV--QREIINH 71
D+ L + +G G FG + +DK E + VAVK ++ + E+
Sbjct: 35 DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 72 RSL-RHPNIVRFKEVILTPTHLAIVMEYASGGEL---------FERICNAGRFSEDEARF 121
+ + +H NI+ L +++EYAS G L + E +
Sbjct: 95 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 122 FFQQLIS-------GVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFG 164
F+ L+S G+ Y S + HRDL N L+ + +KI DFG
Sbjct: 155 TFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNV--MKIADFG 202
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 1e-10
Identities = 42/170 (24%), Positives = 67/170 (39%), Gaps = 28/170 (16%)
Query: 21 DRYELVRDIGSGNFG-----VARLMRDKKTEE--LVAVKYIERGDKIDENV--QREIINH 71
D+ L + +G G FG A + K +E VAVK ++ + E+
Sbjct: 81 DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 140
Query: 72 RSL-RHPNIVRFKEVILTPTHLAIVMEYASGGEL---------FERICNAGRFSEDEARF 121
+ + +H NI+ L +++EYAS G L + E +
Sbjct: 141 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 200
Query: 122 FFQQLIS-------GVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFG 164
F+ L+S G+ Y S + HRDL N L+ + +KI DFG
Sbjct: 201 TFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLV--TENNVMKIADFG 248
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 1e-10
Identities = 44/175 (25%), Positives = 65/175 (37%), Gaps = 38/175 (21%)
Query: 21 DRYELVRDIGSGNFG-----VARLMRDKKTEE--LVAVKYI-------ERGDKIDE-NVQ 65
DR L + +G G FG A + K VAVK + + D I E +
Sbjct: 69 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 128
Query: 66 REIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL---------FERICNAGRFSE 116
+ I +H NI+ L +++EYAS G L +
Sbjct: 129 KMIG-----KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHN 183
Query: 117 DEARFFFQQLIS-------GVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFG 164
E + + L+S G+ Y S + HRDL N L+ + +KI DFG
Sbjct: 184 PEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV--TEDNVMKIADFG 236
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 1e-10
Identities = 39/180 (21%), Positives = 58/180 (32%), Gaps = 43/180 (23%)
Query: 21 DRYELVRDIGSGNFG-----VARLMRDKKTEELVAVKYI-------ERGDKIDE-NVQRE 67
+ E + +GSG FG A + VAVK + ER + E + +
Sbjct: 45 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 104
Query: 68 IINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL----------------FERICNA 111
+ H NIV + ++ EY G+L
Sbjct: 105 L-----GSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKR 159
Query: 112 GRFSEDEARFFFQQLIS-------GVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFG 164
ED F+ L+ G+ + HRDL N L+ +KICDFG
Sbjct: 160 LEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKV--VKICDFG 217
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 55.9 bits (135), Expect = 1e-09
Identities = 30/167 (17%), Positives = 60/167 (35%), Gaps = 24/167 (14%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVR 81
++ L + IGSG FG+ L E A ++ + + + E+ ++ + + ++
Sbjct: 38 QWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIK 97
Query: 82 FKEVILTPTHLAI-------------------VMEY--ASGGELFERICNAGRFSEDEAR 120
+L I VME ++ N G F +
Sbjct: 98 KWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISG--QN-GTFKKSTVL 154
Query: 121 FFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 167
+++ + Y H + H D+K N LL ++ + D+G S
Sbjct: 155 QLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSY 201
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 1e-09
Identities = 22/171 (12%), Positives = 57/171 (33%), Gaps = 29/171 (16%)
Query: 22 RYELVRDIGSGNFGV--------ARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRS 73
+++L N G+ ++ ++K ++ D N Q R+
Sbjct: 43 QWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLK-LDAKDGRLFNEQN--FFQRA 99
Query: 74 LRHPNIVRFKEVILTPT---------------HLAIVMEY--ASGGELFERICNAGRFSE 116
+ + ++K++ TP + +V+ S + SE
Sbjct: 100 AKPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGRSLQSALDV-SPKHVLSE 158
Query: 117 DEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 167
+L+ + + H + H ++ EN +D ++ + +G++
Sbjct: 159 RSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAF 209
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 52.6 bits (127), Expect = 1e-08
Identities = 54/183 (29%), Positives = 74/183 (40%), Gaps = 41/183 (22%)
Query: 29 IGSGNFG-VAR-LMRDKKTEELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRF-- 82
IG G FG V + ++RD VA+K I+E + EI RHP++V
Sbjct: 47 IGHGVFGKVYKGVLRDGAK---VALKRRTPESSQGIEE-FETEIETLSFCRHPHLVSLIG 102
Query: 83 --KEVILTPTHLAIVMEYASGGELFERICNAGRFSE------------DEARFFFQQLIS 128
E + ++ +Y G L + + + AR
Sbjct: 103 FCDE----RNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAAR-------- 150
Query: 129 GVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK-STV--GTPAYI 185
G+ Y H+ + HRD+K N LLD + P KI DFG SK Q STV GT YI
Sbjct: 151 GLHYLHTRAIIHRDVKSINILLDENFVP--KITDFGISKKGTELDQTHLSTVVKGTLGYI 208
Query: 186 APE 188
PE
Sbjct: 209 DPE 211
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 51.7 bits (124), Expect = 3e-08
Identities = 27/169 (15%), Positives = 54/169 (31%), Gaps = 25/169 (14%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEEL-----VAVK---------------YIERGDKID 61
+++ IG G FG L +E + VK Y
Sbjct: 36 AWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQ 95
Query: 62 ENVQREIINHRSLRHPNIVRF-KEVILTPTHLAIVMEY--ASGGELFERICNAGRFSEDE 118
+ L P ++ ++M+ + +++E RFS
Sbjct: 96 IQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEA-NA-KRFSRKT 153
Query: 119 ARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 167
+++ + Y H + H D+K N LL+ ++ + D+G +
Sbjct: 154 VLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAY 202
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 47.2 bits (113), Expect = 9e-07
Identities = 24/63 (38%), Positives = 34/63 (53%), Gaps = 5/63 (7%)
Query: 129 GVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK-SSVLHSQPKST--VGTPAYI 185
G+++ H HRD+K N LLD + KI DFG ++ S ++ VGT AY+
Sbjct: 145 GINFLHENHHIHRDIKSANILLDEAFTA--KISDFGLARASEKFAQTVMTSRIVGTTAYM 202
Query: 186 APE 188
APE
Sbjct: 203 APE 205
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 46.4 bits (111), Expect = 1e-06
Identities = 50/189 (26%), Positives = 74/189 (39%), Gaps = 50/189 (26%)
Query: 29 IGSGNFGV---ARLMRDKKTEELVAVKYIERGDKIDENVQRE------IINHRSLRHPNI 79
+G G FG RL D LVAVK ++ + + + +I+ H N+
Sbjct: 38 LGRGGFGKVYKGRL-ADGT---LVAVKRLKEERT--QGGELQFQTEVEMISM--AVHRNL 89
Query: 80 VRFKEVILTPTHLAIVMEYASGG----ELFERICNAGRFS--------EDEARFFFQQLI 127
+R + +TPT +V Y + G L ER + AR
Sbjct: 90 LRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSAR------- 142
Query: 128 SGVSYCH---SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV----- 179
G++Y H ++ HRD+K N LLD + DFG +K L + V
Sbjct: 143 -GLAYLHDHCDPKIIHRDVKAANILLDEEFEA--VVGDFGLAK---LMDYKDTHVTTAVR 196
Query: 180 GTPAYIAPE 188
GT +IAPE
Sbjct: 197 GTIGHIAPE 205
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 41.0 bits (95), Expect = 2e-04
Identities = 27/188 (14%), Positives = 72/188 (38%), Gaps = 38/188 (20%)
Query: 23 YELVRDIGSGNFG--VARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIV 80
+ V ++ N+ ++ + +++ ++ YIE+ D++ + Q + S R +
Sbjct: 80 QKFVEEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVS-RLQPYL 138
Query: 81 RFKEVI--LTPTHLAIV--MEYASGGE----LFERICNAGRFSEDEARFFFQQL-ISGVS 131
+ ++ + L P ++ + G + +C + + + + F+ ++ +
Sbjct: 139 KLRQALLELRPAKNVLIDGV----LGSGKTWVALDVCLSYKV---QCKMDFKIFWLN-LK 190
Query: 132 YCHS-------MQ-VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA 183
C+S +Q + ++ + D S +L+I +L S+P
Sbjct: 191 NCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKP-------- 242
Query: 184 YIAPEVLL 191
Y LL
Sbjct: 243 Y--ENCLL 248
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 39.9 bits (93), Expect = 3e-04
Identities = 31/153 (20%), Positives = 55/153 (35%), Gaps = 22/153 (14%)
Query: 18 HDSDRYE-------LVRDIGSGNFG-----VARLMRDKKTEELVAVKYIERG----DKID 61
+D+ ++E L + +G G FG A + T VAVK ++ G +
Sbjct: 12 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRA 71
Query: 62 ENVQREIINHRSLRHPNIVRFKEVILTPTH-LAIVMEYASGGELFERICNAGRFSEDEAR 120
+ +I+ H H N+V P L +++E+ G L + + R +
Sbjct: 72 LMSELKILIHIG-HHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSK-RNEFVPYK 129
Query: 121 FFFQQLISGVSYCHSMQVCHRDLKLENTLLDGS 153
+ G Y + DLK + S
Sbjct: 130 TKGARFRQGKDYVGA---IPVDLKRRLDSITSS 159
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 205 | |||
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 99.98 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 99.97 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.96 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.93 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.9 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.81 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.59 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.47 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.4 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 99.09 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.97 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.95 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.94 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.73 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.65 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.54 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.48 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.39 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 98.25 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 98.03 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 98.01 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.89 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.84 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.77 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 97.76 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.72 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.53 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.45 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 97.37 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 97.27 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.19 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 97.05 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.03 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 93.88 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 93.02 | |
| 1cja_A | 342 | Protein (actin-fragmin kinase); transferase; HET: | 91.14 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 88.31 |
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-51 Score=300.69 Aligned_cols=186 Identities=40% Similarity=0.659 Sum_probs=151.1
Q ss_pred eecCCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCc----cchHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeE
Q 028681 17 MHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHL 92 (205)
Q Consensus 17 ~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 92 (205)
+...++|++.+.||+|+||+||++.+..+++.||+|++++.. ...+.+.+|+.+++.++||||+++++++.+++.+
T Consensus 9 G~~ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~ 88 (275)
T 3hyh_A 9 GAHIGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEI 88 (275)
T ss_dssp -----CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred CCEeeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEE
Confidence 344589999999999999999999999999999999997643 2345688999999999999999999999999999
Q ss_pred EEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCC
Q 028681 93 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 172 (205)
Q Consensus 93 ~lv~~~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~ 172 (205)
++||||+ +++|.+.+.+.+++++..++.++.|++.||+|||++||+||||||+||+++.++. +||+|||+|+.....
T Consensus 89 ~ivmEy~-~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~--vkl~DFGla~~~~~~ 165 (275)
T 3hyh_A 89 IMVIEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLN--VKIADFGLSNIMTDG 165 (275)
T ss_dssp EEEEECC-CEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCC--EEECCSSCC------
T ss_pred EEEEeCC-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCC--EEEeecCCCeecCCC
Confidence 9999999 5789999988889999999999999999999999999999999999999998887 999999999877666
Q ss_pred CCCCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 173 SQPKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 173 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
....+..||+.|+|||++.+..++..++|||||
T Consensus 166 ~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSl 198 (275)
T 3hyh_A 166 NFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSC 198 (275)
T ss_dssp ---------CTTSCHHHHSSSSCCCTHHHHHHH
T ss_pred CccCCeeECcccCChhhhcCCCCCCChhhhHHH
Confidence 666677899999999999998886556999996
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-51 Score=304.44 Aligned_cols=185 Identities=30% Similarity=0.459 Sum_probs=167.7
Q ss_pred ecCCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCc----cchHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEE
Q 028681 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLA 93 (205)
Q Consensus 18 ~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 93 (205)
...++|++.+.||+|+||+||++.+..+++.||+|++.+.. ...+.+.+|+.+++.++||||+++++++.+++.+|
T Consensus 29 ~~~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~y 108 (311)
T 4aw0_A 29 KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLY 108 (311)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred CCccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEE
Confidence 34578999999999999999999999999999999997642 33467899999999999999999999999999999
Q ss_pred EEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCCC
Q 028681 94 IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 173 (205)
Q Consensus 94 lv~~~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~~ 173 (205)
+||||+++|+|.+.+.+.+.+++..++.++.|++.||+|||++||+||||||+|||++.++. +||+|||+|+......
T Consensus 109 ivmEy~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~--vKl~DFGla~~~~~~~ 186 (311)
T 4aw0_A 109 FGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMH--IQITDFGTAKVLSPES 186 (311)
T ss_dssp EEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSC--EEECCCTTCEECCTTT
T ss_pred EEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCC--EEEEEcCCceecCCCC
Confidence 99999999999999998889999999999999999999999999999999999999998887 9999999998764332
Q ss_pred ---CCCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 174 ---QPKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 174 ---~~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
...+.+||+.|+|||++.+..|+.+ +|||||
T Consensus 187 ~~~~~~~~~GTp~YmAPEvl~~~~y~~~-~DiWSl 220 (311)
T 4aw0_A 187 KQARANSFVGTAQYVSPELLTEKSACKS-SDLWAL 220 (311)
T ss_dssp TCCCBCCCCSCGGGCCHHHHHHSCBCHH-HHHHHH
T ss_pred CcccccCcccCcccCCHHHHcCCCCCcH-HHHHHH
Confidence 3345679999999999999999766 999996
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-50 Score=306.38 Aligned_cols=187 Identities=29% Similarity=0.527 Sum_probs=159.4
Q ss_pred ceecCCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCcc---chHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeE
Q 028681 16 IMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTPTHL 92 (205)
Q Consensus 16 ~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 92 (205)
.....++|++++.||+|+||+||++.+..+++.||+|++.+... ..+.+.+|+.++++++||||+++++++.+++.+
T Consensus 19 ~f~sme~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~ 98 (350)
T 4b9d_A 19 YFQSMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSL 98 (350)
T ss_dssp BCSCCCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred CCCcccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEE
Confidence 33456899999999999999999999999999999999986532 346688999999999999999999999999999
Q ss_pred EEEEEecCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeeccccccc
Q 028681 93 AIVMEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 170 (205)
Q Consensus 93 ~lv~~~~~~~sl~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~ 170 (205)
|+||||+++++|.+.+... ..+++.+++.|+.|++.||.|||++||+||||||+|||++.++. +||+|||+|+...
T Consensus 99 yiVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~--vKl~DFGla~~~~ 176 (350)
T 4b9d_A 99 YIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGT--VQLGDFGIARVLN 176 (350)
T ss_dssp EEEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCC--EEECSTTEESCCC
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCC--EEEcccccceeec
Confidence 9999999999999999653 35799999999999999999999999999999999999998887 9999999998654
Q ss_pred CCC-CCCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 171 LHS-QPKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 171 ~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
... ...+..||+.|+|||++.+..|+.+ +|||||
T Consensus 177 ~~~~~~~~~~GT~~YmAPE~l~~~~y~~~-~DiwSl 211 (350)
T 4b9d_A 177 STVELARACIGTPYYLSPEICENKPYNNK-SDIWAL 211 (350)
T ss_dssp HHHHHHHHHHSCCTTCCHHHHTTCCCCHH-HHHHHH
T ss_pred CCcccccccCCCccccCHHHHCCCCCCcH-HHHHHH
Confidence 332 2233469999999999999999866 999996
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-49 Score=300.88 Aligned_cols=182 Identities=26% Similarity=0.450 Sum_probs=164.9
Q ss_pred CCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCcc-chHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEEe
Q 028681 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (205)
Q Consensus 20 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~ 98 (205)
...|++.++||+|+||+||++.+..+|+.||+|++..... ..+.+.+|+.+++.++||||++++++|.+++.+|+||||
T Consensus 73 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy 152 (346)
T 4fih_A 73 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF 152 (346)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hHhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeC
Confidence 3579999999999999999999999999999999976543 346688999999999999999999999999999999999
Q ss_pred cCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCC-CCCCC
Q 028681 99 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKS 177 (205)
Q Consensus 99 ~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~-~~~~~ 177 (205)
+++++|.+++.. ..+++..++.++.|++.||+|||++||+||||||+|||++.++. +||+|||+|+..... ....+
T Consensus 153 ~~gg~L~~~l~~-~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~--vKl~DFGla~~~~~~~~~~~~ 229 (346)
T 4fih_A 153 LEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGR--VKLSDFGFCAQVSKEVPRRKS 229 (346)
T ss_dssp CTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCC--EEECCCTTCEECCSSSCCBCC
T ss_pred CCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCC--EEEecCcCceecCCCCCcccc
Confidence 999999998865 56999999999999999999999999999999999999998887 999999999876544 34456
Q ss_pred CCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 178 TVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 178 ~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
..||+.|+|||++.+..|+.+ +|||||
T Consensus 230 ~~GTp~YmAPEvl~~~~y~~~-~DiWSl 256 (346)
T 4fih_A 230 LVGTPYWMAPELISRLPYGPE-VDIWSL 256 (346)
T ss_dssp CCSCGGGCCHHHHTTCCBCTH-HHHHHH
T ss_pred cccCcCcCCHHHHCCCCCCcH-HHHHHH
Confidence 689999999999999999866 999996
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-49 Score=296.96 Aligned_cols=184 Identities=29% Similarity=0.498 Sum_probs=158.2
Q ss_pred cCCCeEEEeeeccccceeEEEEEec---CCCcEEEEEEeecCc---cchHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeE
Q 028681 19 DSDRYELVRDIGSGNFGVARLMRDK---KTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTHL 92 (205)
Q Consensus 19 ~~~~y~~~~~l~~g~~g~v~~~~~~---~~~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 92 (205)
++++|++.+.||+|+||+||++++. .+++.||+|++++.. .....+..|+.++++++||||+++++++.+++.+
T Consensus 22 ~p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~ 101 (304)
T 3ubd_A 22 DPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKL 101 (304)
T ss_dssp CGGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEE
T ss_pred CccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEE
Confidence 4578999999999999999999874 467899999997643 2235678899999999999999999999999999
Q ss_pred EEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccC-
Q 028681 93 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL- 171 (205)
Q Consensus 93 ~lv~~~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~- 171 (205)
++||||+++++|.+.+.+.+.+++.+++.++.|++.||.|||++||+||||||+|||++.++. +||+|||+|+....
T Consensus 102 ~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~--vKl~DFGla~~~~~~ 179 (304)
T 3ubd_A 102 YLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGH--IKLTDFGLSKESIDH 179 (304)
T ss_dssp EEEECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSC--EEEESSEEEEC----
T ss_pred EEEEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCC--EEecccccceeccCC
Confidence 999999999999999998889999999999999999999999999999999999999998887 99999999976443
Q ss_pred CCCCCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 172 HSQPKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 172 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
.....+..||+.|+|||++.+..|+.+ +|||||
T Consensus 180 ~~~~~~~~GT~~YmAPE~~~~~~y~~~-~DiwSl 212 (304)
T 3ubd_A 180 EKKAYSFCGTVEYMAPEVVNRRGHTQS-ADWWSF 212 (304)
T ss_dssp -CCCCSCCCCGGGCCHHHHHTSCCCTH-HHHHHH
T ss_pred CccccccccCcccCCHHHhccCCCCCC-Ccccch
Confidence 344456689999999999999999876 999996
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-48 Score=302.68 Aligned_cols=182 Identities=26% Similarity=0.450 Sum_probs=165.2
Q ss_pred CCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCcc-chHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEEe
Q 028681 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (205)
Q Consensus 20 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~ 98 (205)
.+.|++.+.||+|+||.||+|.+..+|+.||+|++..... ..+.+.+|+.+++.++||||++++++|.+++.+|+||||
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy 229 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF 229 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeC
Confidence 4679999999999999999999999999999999976543 346688999999999999999999999999999999999
Q ss_pred cCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCC-CCCCC
Q 028681 99 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKS 177 (205)
Q Consensus 99 ~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~-~~~~~ 177 (205)
+++++|.+++.. ..+++..++.++.|++.||+|||++||+||||||+|||++.++. +||+|||+|+..... ....+
T Consensus 230 ~~gG~L~~~i~~-~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~--vKl~DFGla~~~~~~~~~~~~ 306 (423)
T 4fie_A 230 LEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGR--VKLSDFGFCAQVSKEVPRRKS 306 (423)
T ss_dssp CTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCC--EEECCCTTCEECCSSCCCBCC
T ss_pred CCCCcHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCC--EEEecCccceECCCCCccccc
Confidence 999999998854 56999999999999999999999999999999999999998887 999999999876544 34456
Q ss_pred CCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 178 TVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 178 ~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
..||+.|+|||++.+..|+.+ +|||||
T Consensus 307 ~~GTp~YmAPEvl~~~~y~~~-~DiWSl 333 (423)
T 4fie_A 307 LVGTPYWMAPELISRLPYGPE-VDIWSL 333 (423)
T ss_dssp CEECTTTCCHHHHTTCCBCTH-HHHHHH
T ss_pred cccCcCcCCHHHHCCCCCCcH-HHHHHH
Confidence 689999999999999999876 999996
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-48 Score=296.05 Aligned_cols=184 Identities=28% Similarity=0.414 Sum_probs=161.1
Q ss_pred ceecCCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCccchHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEE
Q 028681 16 IMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV 95 (205)
Q Consensus 16 ~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 95 (205)
.....+.|++.++||+|+||.||++.+..+|+.||+|+++..... .+|+.+++.++||||+++++++.+++.+++|
T Consensus 53 ~~~~~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~~----~~E~~il~~l~HpnIV~l~~~~~~~~~~~iv 128 (336)
T 4g3f_A 53 YREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR----VEELVACAGLSSPRIVPLYGAVREGPWVNIF 128 (336)
T ss_dssp CCBTTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC----THHHHTTTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhcchhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHhH----HHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 334557899999999999999999999999999999999865432 4689999999999999999999999999999
Q ss_pred EEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCCCC-
Q 028681 96 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ- 174 (205)
Q Consensus 96 ~~~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~- 174 (205)
|||+++++|.+.+...+++++..++.++.|++.||.|||+++|+||||||+|||++.++. ++||+|||+|+.......
T Consensus 129 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~-~vKl~DFGla~~~~~~~~~ 207 (336)
T 4g3f_A 129 MELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGS-RAALCDFGHALCLQPDGLG 207 (336)
T ss_dssp ECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSC-CEEECCCTTCEEC------
T ss_pred EeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCC-EEEEeeCCCCeEccCCCcc
Confidence 999999999999998889999999999999999999999999999999999999987763 299999999986654322
Q ss_pred -----CCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 175 -----PKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 175 -----~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
.....||+.|+|||++.+..|+.+ +|||||
T Consensus 208 ~~~~~~~~~~GT~~YmAPE~~~~~~y~~~-~DiwSl 242 (336)
T 4g3f_A 208 KSLLTGDYIPGTETHMAPEVVMGKPCDAK-VDIWSS 242 (336)
T ss_dssp ------CCCCCCGGGCCHHHHTTCCCCTH-HHHHHH
T ss_pred cceecCCccccCccccCHHHHCCCCCCcH-HHHHHH
Confidence 223469999999999999999876 999996
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-47 Score=283.50 Aligned_cols=180 Identities=27% Similarity=0.435 Sum_probs=156.9
Q ss_pred CCe-EEEeeeccccceeEEEEEecCCCcEEEEEEeecCcc---chHHHHHHHHHHHhcCCCCeeEEEEEEEe----CCeE
Q 028681 21 DRY-ELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILT----PTHL 92 (205)
Q Consensus 21 ~~y-~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~ 92 (205)
++| ++.+.||+|+||+||++.+..++..||+|.+..... ..+.+.+|+.++++++||||++++++|.+ ++.+
T Consensus 25 gr~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~ 104 (290)
T 3fpq_A 25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCI 104 (290)
T ss_dssp SSEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEE
T ss_pred CceEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEE
Confidence 455 788899999999999999999999999999976432 24568899999999999999999999875 3568
Q ss_pred EEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcC--cEeecCCCCCeEecC-CCCCcEEEeeecccccc
Q 028681 93 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ--VCHRDLKLENTLLDG-SPAPRLKICDFGYSKSS 169 (205)
Q Consensus 93 ~lv~~~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~--i~H~di~p~nili~~-~~~~~~~l~df~~~~~~ 169 (205)
++||||+++++|.+.+.+.+++++..++.++.|++.||.|||+++ |+||||||+|||++. ++. +||+|||+|+..
T Consensus 105 ~lvmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~--vKl~DFGla~~~ 182 (290)
T 3fpq_A 105 VLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGS--VKIGDLGLATLK 182 (290)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSC--EEECCTTGGGGC
T ss_pred EEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCC--EEEEeCcCCEeC
Confidence 999999999999999998889999999999999999999999998 999999999999974 556 999999999754
Q ss_pred cCCCCCCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 170 VLHSQPKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 170 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
. .....+..||+.|+|||++.+ .|+.+ +|||||
T Consensus 183 ~-~~~~~~~~GTp~YmAPE~~~~-~y~~~-~DiwSl 215 (290)
T 3fpq_A 183 R-ASFAKAVIGTPEFMAPEMYEE-KYDES-VDVYAF 215 (290)
T ss_dssp C-TTSBEESCSSCCCCCGGGGGT-CCCTH-HHHHHH
T ss_pred C-CCccCCcccCccccCHHHcCC-CCCcH-HHHHHH
Confidence 3 233445679999999999865 57766 999996
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-47 Score=287.05 Aligned_cols=182 Identities=26% Similarity=0.402 Sum_probs=150.2
Q ss_pred CCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCcc--chHHHHHHHHHHHhcCCCCeeEEEEEEEeCC--------
Q 028681 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPT-------- 90 (205)
Q Consensus 21 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-------- 90 (205)
++|++.+.||+|+||+||++.+..+++.||+|.++.... ..+.+.+|+.++++++||||++++++|.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 579999999999999999999999999999999976432 3467889999999999999999999997644
Q ss_pred ----eEEEEEEecCCCchHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeee
Q 028681 91 ----HLAIVMEYASGGELFERICNAGR---FSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDF 163 (205)
Q Consensus 91 ----~~~lv~~~~~~~sl~~~~~~~~~---~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df 163 (205)
+++++|||+++++|.+.+..... .....++.++.|++.||+|||++||+||||||+|||++.++. +||+||
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~--vKl~DF 162 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDV--VKVGDF 162 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCC--EEECCC
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCc--EEEccC
Confidence 47899999999999999977554 455668899999999999999999999999999999998887 999999
Q ss_pred cccccccCCCC-------------CCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 164 GYSKSSVLHSQ-------------PKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 164 ~~~~~~~~~~~-------------~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
|+|+....... .....||+.|+|||++.+..|+.+ +|||||
T Consensus 163 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~-~DiwSl 216 (299)
T 4g31_A 163 GLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHK-VDIFSL 216 (299)
T ss_dssp CCC--------------------------CCCTTSCHHHHTTCCCCTH-HHHHHH
T ss_pred ccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCH-HHHHHH
Confidence 99976544322 123469999999999999999866 999996
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-48 Score=288.73 Aligned_cols=185 Identities=25% Similarity=0.382 Sum_probs=159.1
Q ss_pred ecCCCeEEEeeeccccceeEEEEEec-----CCCcEEEEEEeecCcc-chHHHHHHHHHHHhcCCCCeeEEEEEEEeCCe
Q 028681 18 HDSDRYELVRDIGSGNFGVARLMRDK-----KTEELVAVKYIERGDK-IDENVQREIINHRSLRHPNIVRFKEVILTPTH 91 (205)
Q Consensus 18 ~~~~~y~~~~~l~~g~~g~v~~~~~~-----~~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 91 (205)
.+.++|++.+.||+|+||+||++.+. .++..||+|.++.... ..+++.+|+.++++++||||++++|++.+++.
T Consensus 10 I~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~ 89 (299)
T 4asz_A 10 IKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDP 89 (299)
T ss_dssp CCGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred cCHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCE
Confidence 34689999999999999999999864 3578899999976543 34679999999999999999999999999999
Q ss_pred EEEEEEecCCCchHHHHHhc-------------CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcE
Q 028681 92 LAIVMEYASGGELFERICNA-------------GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRL 158 (205)
Q Consensus 92 ~~lv~~~~~~~sl~~~~~~~-------------~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~ 158 (205)
.++||||+++|+|.+++... ..+++.++..++.|++.||.|||+++|+||||||+|||++.++. +
T Consensus 90 ~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~~~--~ 167 (299)
T 4asz_A 90 LIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLL--V 167 (299)
T ss_dssp EEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC--E
T ss_pred EEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCCCc--E
Confidence 99999999999999999653 35999999999999999999999999999999999999998887 9
Q ss_pred EEeeecccccccCCCC---CCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 159 KICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 159 ~l~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
||+|||+|+....... .....||+.|+|||++.+..++.+ +|||||
T Consensus 168 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k-~DVwS~ 216 (299)
T 4asz_A 168 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTE-SDVWSL 216 (299)
T ss_dssp EECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHH-HHHHHH
T ss_pred EECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCch-hhHHHH
Confidence 9999999976543322 223358999999999999999866 999996
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-46 Score=283.88 Aligned_cols=184 Identities=20% Similarity=0.339 Sum_probs=159.4
Q ss_pred cCCCeEEEeeeccccceeEEEEEec-----CCCcEEEEEEeecCc--cchHHHHHHHHHHHhcCCCCeeEEEEEEEeCCe
Q 028681 19 DSDRYELVRDIGSGNFGVARLMRDK-----KTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTH 91 (205)
Q Consensus 19 ~~~~y~~~~~l~~g~~g~v~~~~~~-----~~~~~v~iK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 91 (205)
..+++++.+.||+|+||+||++... .+++.||+|.++... ...+++.+|+.++++++||||++++|++.+++.
T Consensus 24 ~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~ 103 (308)
T 4gt4_A 24 SLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQP 103 (308)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred CHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCE
Confidence 4578999999999999999999863 457889999997543 234779999999999999999999999999999
Q ss_pred EEEEEEecCCCchHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCC
Q 028681 92 LAIVMEYASGGELFERICNA----------------GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPA 155 (205)
Q Consensus 92 ~~lv~~~~~~~sl~~~~~~~----------------~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~ 155 (205)
.++||||+++|+|.+++... ..+++.++..++.|++.||+|||+++|+||||||+|||++.++.
T Consensus 104 ~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl~~~~~ 183 (308)
T 4gt4_A 104 LSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLN 183 (308)
T ss_dssp CEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC
T ss_pred EEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEECCCCC
Confidence 99999999999999999642 35899999999999999999999999999999999999998887
Q ss_pred CcEEEeeecccccccCCC---CCCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 156 PRLKICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 156 ~~~~l~df~~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
+||+|||+|+...... ......||+.|+|||++.+..++.+ +|||||
T Consensus 184 --~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~k-sDVwSf 233 (308)
T 4gt4_A 184 --VKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSID-SDIWSY 233 (308)
T ss_dssp --EEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHH-HHHHHH
T ss_pred --EEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCcc-chhhhH
Confidence 9999999997654332 2334568999999999999999866 999996
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-46 Score=285.29 Aligned_cols=184 Identities=26% Similarity=0.367 Sum_probs=153.7
Q ss_pred cCCCeEEEeeeccccceeEEEEEec-----CCCcEEEEEEeecCcc-chHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeE
Q 028681 19 DSDRYELVRDIGSGNFGVARLMRDK-----KTEELVAVKYIERGDK-IDENVQREIINHRSLRHPNIVRFKEVILTPTHL 92 (205)
Q Consensus 19 ~~~~y~~~~~l~~g~~g~v~~~~~~-----~~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 92 (205)
..++|.+.++||+|+||+||++... .++..||+|.++.... ..+++.+|+.++++++||||++++|+|.+++..
T Consensus 39 ~~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~ 118 (329)
T 4aoj_A 39 KRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPL 118 (329)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSE
T ss_pred CHHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 4578999999999999999999864 4578999999976543 346799999999999999999999999999999
Q ss_pred EEEEEecCCCchHHHHHhc---------------CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCc
Q 028681 93 AIVMEYASGGELFERICNA---------------GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPR 157 (205)
Q Consensus 93 ~lv~~~~~~~sl~~~~~~~---------------~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~ 157 (205)
++||||+++++|.+++... .++++.++..|+.|++.||.|||+++|+||||||+|||++.+..
T Consensus 119 ~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~~~~~-- 196 (329)
T 4aoj_A 119 LMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLV-- 196 (329)
T ss_dssp EEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTE--
T ss_pred EEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEECCCCc--
Confidence 9999999999999998653 35899999999999999999999999999999999999988877
Q ss_pred EEEeeecccccccCCCC---CCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 158 LKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 158 ~~l~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
+||+|||+|+....... .....||+.|+|||++.+..++.+ +|||||
T Consensus 197 ~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~-sDvwS~ 246 (329)
T 4aoj_A 197 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTE-SDVWSF 246 (329)
T ss_dssp EEECCCC----------------CCCCGGGCCHHHHTTCCCCHH-HHHHHH
T ss_pred EEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCcc-ccccch
Confidence 99999999976543322 233468999999999999999866 999996
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-46 Score=278.64 Aligned_cols=183 Identities=27% Similarity=0.369 Sum_probs=152.3
Q ss_pred ceecCCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCcc---chHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeE
Q 028681 16 IMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTPTHL 92 (205)
Q Consensus 16 ~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 92 (205)
+..+.+++++.++||+|+||+||++.... .||+|+++.... ..+.+.+|+.++++++||||++++|++.+ +.+
T Consensus 31 Wei~~~~l~l~~~iG~G~fG~Vy~~~~~~---~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~ 106 (307)
T 3omv_A 31 WEIEASEVMLSTRIGSGSFGTVYKGKWHG---DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNL 106 (307)
T ss_dssp CBCCTTSCCEEEECCCCSSSEEEEEESSS---EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSC
T ss_pred cEEcHHHeEEeeEEeeCCCcEEEEEEECC---cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeE
Confidence 34567899999999999999999998754 489999875432 23678999999999999999999998764 568
Q ss_pred EEEEEecCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccC
Q 028681 93 AIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 171 (205)
Q Consensus 93 ~lv~~~~~~~sl~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~ 171 (205)
++||||+++++|.+.+.. ..++++.++..|+.|++.||+|||+++|+||||||+|||++.++. +||+|||+|+....
T Consensus 107 ~iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~--~Ki~DFGla~~~~~ 184 (307)
T 3omv_A 107 AIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLT--VKIGDFGLATVKSR 184 (307)
T ss_dssp EEEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEE--EEECCCSSCBC---
T ss_pred EEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCc--EEEeeccCceeccc
Confidence 999999999999999965 457999999999999999999999999999999999999998877 99999999976543
Q ss_pred C---CCCCCCCCCCCccCCceeccC---cCCCeeeEEEeC
Q 028681 172 H---SQPKSTVGTPAYIAPEVLLKK---EYDGKVMCVYVI 205 (205)
Q Consensus 172 ~---~~~~~~~~~~~~~aPE~~~~~---~~~~~~~Dvwsl 205 (205)
. .......||+.|+|||++.+. +++.+ +|||||
T Consensus 185 ~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~k-sDVwS~ 223 (307)
T 3omv_A 185 WSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQ-SDVYSY 223 (307)
T ss_dssp ---------CCCCTTSCCHHHHHCCSSCCCCHH-HHHHHH
T ss_pred CCcceeecccccCCCccCHHHhhccCCCCCCcH-HHhHhH
Confidence 2 223445799999999999743 46655 999996
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-45 Score=283.53 Aligned_cols=183 Identities=29% Similarity=0.487 Sum_probs=158.1
Q ss_pred CCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCccc---hHHHHHHHHHHHhcCCCCeeEEEEEEEeC------C
Q 028681 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI---DENVQREIINHRSLRHPNIVRFKEVILTP------T 90 (205)
Q Consensus 20 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------~ 90 (205)
.++|++.+.||+|+||+||+|.+..+|+.||+|++++.... .+.+.+|+.+|+.++||||+++++++... +
T Consensus 53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 132 (398)
T 4b99_A 53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK 132 (398)
T ss_dssp CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence 36899999999999999999999999999999999765332 35678899999999999999999987643 5
Q ss_pred eEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeeccccccc
Q 028681 91 HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 170 (205)
Q Consensus 91 ~~~lv~~~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~ 170 (205)
.+|+||||++ ++|.+.+...+++++..++.++.|++.||.|||++||+||||||+||+++.++. +||+|||+|+...
T Consensus 133 ~~~ivmE~~~-g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~--~Ki~DFGla~~~~ 209 (398)
T 4b99_A 133 SVYVVLDLME-SDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCE--LKIGDFGMARGLC 209 (398)
T ss_dssp CEEEEEECCS-EEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCC--EEECCCTTCBCC-
T ss_pred EEEEEEeCCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCC--EEEeecceeeecc
Confidence 7899999996 579999988889999999999999999999999999999999999999998887 9999999997653
Q ss_pred CC-----CCCCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 171 LH-----SQPKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 171 ~~-----~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
.. ....+..||+.|+|||++.+..+.+.++|||||
T Consensus 210 ~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSl 249 (398)
T 4b99_A 210 TSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSV 249 (398)
T ss_dssp ------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHH
T ss_pred cCccccccccccceeChHhcCHHHhcCCCCCCChhheehh
Confidence 32 233456799999999999886654455999995
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-44 Score=291.86 Aligned_cols=185 Identities=29% Similarity=0.456 Sum_probs=160.5
Q ss_pred eecCCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCc----cchHHHHHH---HHHHHhcCCCCeeEEEEEEEeC
Q 028681 17 MHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQRE---IINHRSLRHPNIVRFKEVILTP 89 (205)
Q Consensus 17 ~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~e---~~~l~~l~h~~i~~~~~~~~~~ 89 (205)
....++|++.+.||+|+||+||+|.+..+|+.||+|++.+.. .......+| +.+++.++||||++++++|.++
T Consensus 185 ~~slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~ 264 (689)
T 3v5w_A 185 HLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTP 264 (689)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECS
T ss_pred CCchHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEEC
Confidence 334689999999999999999999999999999999997532 112223333 5566677899999999999999
Q ss_pred CeEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccc
Q 028681 90 THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 169 (205)
Q Consensus 90 ~~~~lv~~~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~ 169 (205)
+.+|+||||+++|+|.+.+.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||+|+..
T Consensus 265 ~~lylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~--vKL~DFGlA~~~ 342 (689)
T 3v5w_A 265 DKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGH--VRISDLGLACDF 342 (689)
T ss_dssp SEEEEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSC--EEECCCTTCEEC
T ss_pred CEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCC--EEecccceeeec
Confidence 999999999999999999998889999999999999999999999999999999999999998888 999999999765
Q ss_pred cCCCCCCCCCCCCCccCCceecc-CcCCCeeeEEEeC
Q 028681 170 VLHSQPKSTVGTPAYIAPEVLLK-KEYDGKVMCVYVI 205 (205)
Q Consensus 170 ~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~~Dvwsl 205 (205)
.. ....+.+||+.|+|||++.+ ..|+.+ +|||||
T Consensus 343 ~~-~~~~t~~GTp~YmAPEvl~~~~~y~~~-vDiWSL 377 (689)
T 3v5w_A 343 SK-KKPHASVGTHGYMAPEVLQKGVAYDSS-ADWFSL 377 (689)
T ss_dssp SS-CCCCSCCSCGGGCCHHHHSTTCCCCTH-HHHHHH
T ss_pred CC-CCCCCccCCcCccCHHHHhCCCCCCcH-HHHHHH
Confidence 43 33456789999999999975 467655 999996
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-45 Score=278.49 Aligned_cols=186 Identities=23% Similarity=0.337 Sum_probs=158.7
Q ss_pred eecCCCeEEEeeeccccceeEEEEEecCC-----CcEEEEEEeecCccc--hHHHHHHHHHHHhcCC-CCeeEEEEEEEe
Q 028681 17 MHDSDRYELVRDIGSGNFGVARLMRDKKT-----EELVAVKYIERGDKI--DENVQREIINHRSLRH-PNIVRFKEVILT 88 (205)
Q Consensus 17 ~~~~~~y~~~~~l~~g~~g~v~~~~~~~~-----~~~v~iK~~~~~~~~--~~~~~~e~~~l~~l~h-~~i~~~~~~~~~ 88 (205)
..+.++|++.+.||+|+||+||++.+... ++.||+|.+...... .+.+..|+.++.++.| |||++++|+|..
T Consensus 60 Ei~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~ 139 (353)
T 4ase_A 60 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTK 139 (353)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECC
T ss_pred EecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEe
Confidence 34578999999999999999999997654 367999999765432 3568899999999976 899999999976
Q ss_pred C-CeEEEEEEecCCCchHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEec
Q 028681 89 P-THLAIVMEYASGGELFERICNA----------------GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLD 151 (205)
Q Consensus 89 ~-~~~~lv~~~~~~~sl~~~~~~~----------------~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~ 151 (205)
+ +.+++||||+++|+|.+++... ..+++..+..++.|++.||+|||+++|+||||||+|||++
T Consensus 140 ~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NILl~ 219 (353)
T 4ase_A 140 PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS 219 (353)
T ss_dssp TTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC
T ss_pred cCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccceeeC
Confidence 5 5689999999999999999652 3489999999999999999999999999999999999999
Q ss_pred CCCCCcEEEeeecccccccCCCC---CCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 152 GSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 152 ~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
.++. +||+|||+|+....... .....||+.|+|||++.+..|+.+ +|||||
T Consensus 220 ~~~~--vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~k-sDVwS~ 273 (353)
T 4ase_A 220 EKNV--VKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQ-SDVWSF 273 (353)
T ss_dssp GGGC--EEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHH-HHHHHH
T ss_pred CCCC--EEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCc-ccEeeh
Confidence 8887 99999999986544322 223458999999999999999866 999996
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-45 Score=273.31 Aligned_cols=179 Identities=28% Similarity=0.329 Sum_probs=148.5
Q ss_pred CCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCccchHHHHHHHHHHHhcCCCCeeEEEEEEEeCC----eEEEEE
Q 028681 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPT----HLAIVM 96 (205)
Q Consensus 21 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----~~~lv~ 96 (205)
.+|.+.+.||+|+||+||++.+ +|+.||+|+++.........+.|+..+.+++||||+++++++.+++ .+++||
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~ 80 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccchhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEe
Confidence 5789999999999999999987 4789999999765544444556777777899999999999998654 589999
Q ss_pred EecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhc--------CcEeecCCCCCeEecCCCCCcEEEeeeccccc
Q 028681 97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM--------QVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 168 (205)
Q Consensus 97 ~~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~--------~i~H~di~p~nili~~~~~~~~~l~df~~~~~ 168 (205)
||+++++|.+.+.. .++++.....++.|++.||+|||++ +|+||||||+|||++.++. +||+|||+|+.
T Consensus 81 Ey~~~gsL~~~l~~-~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~--~Ki~DFGla~~ 157 (303)
T 3hmm_A 81 DYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGT--CCIADLGLAVR 157 (303)
T ss_dssp ECCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSC--EEECCCTTCEE
T ss_pred cCCCCCcHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCC--EEEEeCCCCcc
Confidence 99999999999965 4699999999999999999999976 9999999999999998887 99999999976
Q ss_pred ccCCCC-----CCCCCCCCCccCCceeccC------cCCCeeeEEEeC
Q 028681 169 SVLHSQ-----PKSTVGTPAYIAPEVLLKK------EYDGKVMCVYVI 205 (205)
Q Consensus 169 ~~~~~~-----~~~~~~~~~~~aPE~~~~~------~~~~~~~Dvwsl 205 (205)
...... .....||+.|+|||++.+. .++. ++|||||
T Consensus 158 ~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~-k~DVwS~ 204 (303)
T 3hmm_A 158 HDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFK-RADIYAM 204 (303)
T ss_dssp EETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHH-HHHHHHH
T ss_pred ccCCCCceeeecccccccccccCHHHhcccccccCCccCh-hHhhhhH
Confidence 544322 2334699999999999764 3443 4999996
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-44 Score=275.01 Aligned_cols=204 Identities=88% Similarity=1.375 Sum_probs=168.5
Q ss_pred CCccccccCCCcccCceecCCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCccchHHHHHHHHHHHhcCCCCee
Q 028681 1 MDRSAMTVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIV 80 (205)
Q Consensus 1 ~~~~~~~~~~~~~~~~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~ 80 (205)
|+++.+..+ +..+++....++|++.+.||+|+||.||++.+..+++.||+|++.......+.+.+|+.+++.++||||+
T Consensus 1 m~~~~~~~~-p~~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv 79 (361)
T 3uc3_A 1 MDRAPVTTG-PLDMPIMHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIV 79 (361)
T ss_dssp -----------CCCCCCCCTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSCHHHHHHHHHHHHCCCTTBC
T ss_pred CCCCCCCCC-CCCccCCCCCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccccHHHHHHHHHHHhCCCCCCC
Confidence 666655444 4677888899999999999999999999999999999999999988777778899999999999999999
Q ss_pred EEEEEEEeCCeEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEE
Q 028681 81 RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKI 160 (205)
Q Consensus 81 ~~~~~~~~~~~~~lv~~~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l 160 (205)
++++++..++..++||||+++++|.+.+...+.+++..++.++.|++.||.|||++||+||||+|+||+++.++..+++|
T Consensus 80 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl 159 (361)
T 3uc3_A 80 RFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKI 159 (361)
T ss_dssp CEEEEEECSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEE
T ss_pred cEEEEEeeCCEEEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEE
Confidence 99999999999999999999999999998888899999999999999999999999999999999999998777666999
Q ss_pred eeecccccccCCCCCCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 161 CDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 161 ~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
+|||+++............|++.|+|||++.+..++.+++|||||
T Consensus 160 ~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Diwsl 204 (361)
T 3uc3_A 160 CDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSC 204 (361)
T ss_dssp CCCCCC---------------CTTSCHHHHHCSSCCHHHHHHHHH
T ss_pred eecCccccccccCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehh
Confidence 999999765555555666799999999999998887776899986
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-44 Score=290.17 Aligned_cols=185 Identities=30% Similarity=0.506 Sum_probs=167.0
Q ss_pred CCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCcc-chHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEEe
Q 028681 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (205)
Q Consensus 20 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~ 98 (205)
.++|++.+.||+|+||.||++.+..+|+.||+|++..... ..+.+.+|+.+|+.++||||++++++|.+++.++++|||
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~ 235 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 235 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence 4789999999999999999999999999999999976543 346688999999999999999999999999999999999
Q ss_pred cCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCCCCCCC
Q 028681 99 ASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS 177 (205)
Q Consensus 99 ~~~~sl~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~~~~ 177 (205)
+++++|.+.+.. ...+++.+++.++.||+.||.|||+++|+||||||+||+++.+....+||+|||+|+..........
T Consensus 236 ~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~~~~~ 315 (573)
T 3uto_A 236 MSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKV 315 (573)
T ss_dssp CCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTSEEEE
T ss_pred cCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEccCCCceee
Confidence 999999998864 4579999999999999999999999999999999999999866444599999999988776666666
Q ss_pred CCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 178 TVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 178 ~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
..||+.|+|||++.+..|+.+ +|||||
T Consensus 316 ~~GT~~y~APEv~~~~~y~~~-~DiWSl 342 (573)
T 3uto_A 316 TTGTAEFAAPEVAEGKPVGYY-TDMWSV 342 (573)
T ss_dssp ECSSGGGCCHHHHTTCCBCHH-HHHHHH
T ss_pred eEECccccCHHHhCCCCCCcH-HHHHHH
Confidence 789999999999999999766 999985
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-43 Score=271.15 Aligned_cols=182 Identities=23% Similarity=0.335 Sum_probs=152.3
Q ss_pred cCCCeEEEeeeccccceeEEEEEec---CCCcEEEEEEeecCccchHHHHHHHHHHHhc-CCCCeeEEEEEEEeCCeEEE
Q 028681 19 DSDRYELVRDIGSGNFGVARLMRDK---KTEELVAVKYIERGDKIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAI 94 (205)
Q Consensus 19 ~~~~y~~~~~l~~g~~g~v~~~~~~---~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~l 94 (205)
..++|++.+.||+|+||+||+|.++ .+++.||+|.+.+.. ...++..|+.+++.+ .||||+++++++.+++++++
T Consensus 19 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~-~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~l 97 (361)
T 4f9c_A 19 LSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS-HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVI 97 (361)
T ss_dssp GGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS-CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEEE
T ss_pred ccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc-CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEEE
Confidence 3578999999999999999999875 457889999887543 345678899999988 69999999999999999999
Q ss_pred EEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCCC-
Q 028681 95 VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS- 173 (205)
Q Consensus 95 v~~~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~~- 173 (205)
||||+++++|.+.+. .+++.+++.++.|++.||+|||++||+||||||+|||++.+.. .+||+|||+|+......
T Consensus 98 vmE~~~g~~L~~~~~---~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~-~~kl~DFGla~~~~~~~~ 173 (361)
T 4f9c_A 98 AMPYLEHESFLDILN---SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLK-KYALVDFGLAQGTHDTKI 173 (361)
T ss_dssp EEECCCCCCHHHHHT---TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTT-EEEECCCTTCEECTTCSC
T ss_pred EEeCCCcccHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCC-eEEECcCCCCcccCCccc
Confidence 999999999999884 4999999999999999999999999999999999999976522 39999999997543221
Q ss_pred ----------------------------CCCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 174 ----------------------------QPKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 174 ----------------------------~~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
...+..||+.|+|||++.+....+.++|||||
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSl 233 (361)
T 4f9c_A 174 ELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSA 233 (361)
T ss_dssp GGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHH
T ss_pred cccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhh
Confidence 12334699999999999886543344999995
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-42 Score=261.35 Aligned_cols=184 Identities=41% Similarity=0.683 Sum_probs=168.1
Q ss_pred CCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCcc---chHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEE
Q 028681 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (205)
Q Consensus 20 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 96 (205)
.++|++.+.||+|+||.||++.+..+++.||+|++..... ..+.+.+|+.+++.++||||+++++++..++..++||
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 93 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM 93 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence 5899999999999999999999999999999999976432 2356789999999999999999999999999999999
Q ss_pred EecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCCCCCC
Q 028681 97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK 176 (205)
Q Consensus 97 ~~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~~~ 176 (205)
||+++++|.+.+...+.+++..+..++.|++.||.|||++|++||||+|+||+++.++. ++|+|||++..........
T Consensus 94 e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~--~kl~DFG~a~~~~~~~~~~ 171 (328)
T 3fe3_A 94 EYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMN--IKIADFGFSNEFTVGGKLD 171 (328)
T ss_dssp CCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSC--EEECSTTCCGGGSSSCGGG
T ss_pred ECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCC--EEEeeccCceecCCCCccc
Confidence 99999999999988888999999999999999999999999999999999999988887 9999999998776666566
Q ss_pred CCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 177 STVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 177 ~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
...|++.|+|||++.+..++..++|||||
T Consensus 172 ~~~gt~~y~aPE~~~~~~~~~~~~Diwsl 200 (328)
T 3fe3_A 172 AFCGAPPYAAPELFQGKKYDGPEVDVWSL 200 (328)
T ss_dssp TTSSSGGGCCHHHHHTCCCCSHHHHHHHH
T ss_pred cccCCcceeCcccccCCCcCCchhhhhhh
Confidence 67899999999999998887666999986
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-41 Score=262.80 Aligned_cols=187 Identities=29% Similarity=0.476 Sum_probs=165.3
Q ss_pred ceecCCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCcc----chHHHHHHHHHHHhc-CCCCeeEEEEEEEeCC
Q 028681 16 IMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK----IDENVQREIINHRSL-RHPNIVRFKEVILTPT 90 (205)
Q Consensus 16 ~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~ 90 (205)
.....++|++.+.||+|+||.||++.+..+++.||+|++++... ..+.+..|..++.++ +||||+++++++.+++
T Consensus 47 ~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~ 126 (396)
T 4dc2_A 47 SSLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTES 126 (396)
T ss_dssp --CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSS
T ss_pred cCCChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECC
Confidence 34456899999999999999999999999999999999986432 234577888888877 8999999999999999
Q ss_pred eEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccc-
Q 028681 91 HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS- 169 (205)
Q Consensus 91 ~~~lv~~~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~- 169 (205)
..++||||+++++|...+...+.+++..++.++.|++.||+|||++||+||||+|+||+++.++. +||+|||+++..
T Consensus 127 ~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~--ikL~DFGla~~~~ 204 (396)
T 4dc2_A 127 RLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGH--IKLTDYGMCKEGL 204 (396)
T ss_dssp EEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSC--EEECCCTTCBCCC
T ss_pred EEEEEEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCC--EEEeecceeeecc
Confidence 99999999999999999988888999999999999999999999999999999999999998887 999999999763
Q ss_pred cCCCCCCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 170 VLHSQPKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 170 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
..........||+.|+|||++.+..++.+ +|||||
T Consensus 205 ~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~-~Diwsl 239 (396)
T 4dc2_A 205 RPGDTTSTFCGTPNYIAPEILRGEDYGFS-VDWWAL 239 (396)
T ss_dssp CTTCCBCCCCBCGGGCCHHHHTTCCBCTH-HHHHHH
T ss_pred cCCCccccccCCcccCCchhhcCCCCChH-HHHHHH
Confidence 33444556679999999999999988766 999986
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-41 Score=257.12 Aligned_cols=183 Identities=34% Similarity=0.553 Sum_probs=164.7
Q ss_pred CCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCc----cchHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEE
Q 028681 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV 95 (205)
Q Consensus 20 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 95 (205)
.++|++.+.||+|+||.||++.+..+++.||+|++.+.. ...+.+..|+.+++.++||||+++++++...+..++|
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv 83 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence 579999999999999999999999999999999997642 2346688899999999999999999999999999999
Q ss_pred EEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccC-CCC
Q 028681 96 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQ 174 (205)
Q Consensus 96 ~~~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~-~~~ 174 (205)
|||+++++|...+...+.+++..++.++.|++.||+|||++||+||||+|+||+++.++. ++|+|||+++.... ...
T Consensus 84 ~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~--vkL~DFG~a~~~~~~~~~ 161 (337)
T 1o6l_A 84 MEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGH--IKITDFGLCKEGISDGAT 161 (337)
T ss_dssp EECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSC--EEECCCTTCBCSCCTTCC
T ss_pred EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCC--EEEeeccchhhcccCCCc
Confidence 999999999999988888999999999999999999999999999999999999998887 99999999976433 333
Q ss_pred CCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 175 PKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 175 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
.....||+.|+|||++.+..++.+ +|||||
T Consensus 162 ~~~~~gt~~y~aPE~~~~~~~~~~-~Diwsl 191 (337)
T 1o6l_A 162 MKTFCGTPEYLAPEVLEDNDYGRA-VDWWGL 191 (337)
T ss_dssp BCCCEECGGGCCGGGGSSSCBCTT-HHHHHH
T ss_pred ccccccChhhCChhhhcCCCCCch-hhcccc
Confidence 455679999999999999888766 999986
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-41 Score=257.33 Aligned_cols=186 Identities=32% Similarity=0.557 Sum_probs=167.5
Q ss_pred cCCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCcc-------chHHHHHHHHHHHhcCCCCeeEEEEEEEeCCe
Q 028681 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK-------IDENVQREIINHRSLRHPNIVRFKEVILTPTH 91 (205)
Q Consensus 19 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~-------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 91 (205)
..++|++.+.||+|+||.||.+.+..++..||+|++.+... ..+.+..|+.+++.++||||+++++++.++..
T Consensus 10 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ 89 (361)
T 2yab_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTD 89 (361)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred hhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCE
Confidence 35789999999999999999999999999999999986532 23678999999999999999999999999999
Q ss_pred EEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCC--CcEEEeeecccccc
Q 028681 92 LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPA--PRLKICDFGYSKSS 169 (205)
Q Consensus 92 ~~lv~~~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~--~~~~l~df~~~~~~ 169 (205)
.++||||+++++|.+.+.....+++..+..++.|++.||.|||++||+|+||+|+||+++.++. ..++|+|||++...
T Consensus 90 ~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~~ 169 (361)
T 2yab_A 90 VVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI 169 (361)
T ss_dssp EEEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSCEEC
T ss_pred EEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCceEc
Confidence 9999999999999999988888999999999999999999999999999999999999976652 24999999999877
Q ss_pred cCCCCCCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 170 VLHSQPKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 170 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
..........|++.|+|||++.+..++.+ +|||||
T Consensus 170 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~Diwsl 204 (361)
T 2yab_A 170 EDGVEFKNIFGTPEFVAPEIVNYEPLGLE-ADMWSI 204 (361)
T ss_dssp CTTCCCCCCCSCGGGCCHHHHTTCCCCTH-HHHHHH
T ss_pred CCCCccccCCCCccEECchHHcCCCCCcc-ccHHHH
Confidence 66655666789999999999998888766 999986
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-41 Score=259.57 Aligned_cols=185 Identities=25% Similarity=0.459 Sum_probs=166.9
Q ss_pred ecCCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCc----cchHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEE
Q 028681 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLA 93 (205)
Q Consensus 18 ~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 93 (205)
...++|++.+.||+|+||.||.+.+..+++.||+|++.+.. ...+.+..|+.+++.++||||+++++++.+.+..+
T Consensus 12 v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~ 91 (384)
T 4fr4_A 12 VNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMF 91 (384)
T ss_dssp CCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 34689999999999999999999999999999999997543 23467889999999999999999999999999999
Q ss_pred EEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCCC
Q 028681 94 IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 173 (205)
Q Consensus 94 lv~~~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~~ 173 (205)
+|+||+.+++|.+.+.....+++..++.++.|++.||.|||++||+||||+|+||+++.++. ++|+|||++.......
T Consensus 92 lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~--vkL~DFG~a~~~~~~~ 169 (384)
T 4fr4_A 92 MVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGH--VHITDFNIAAMLPRET 169 (384)
T ss_dssp EEECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC--EEECCCTTCEECCTTC
T ss_pred EEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCC--EEEeccceeeeccCCC
Confidence 99999999999999988888999999999999999999999999999999999999998887 9999999998776666
Q ss_pred CCCCCCCCCCccCCceecc---CcCCCeeeEEEeC
Q 028681 174 QPKSTVGTPAYIAPEVLLK---KEYDGKVMCVYVI 205 (205)
Q Consensus 174 ~~~~~~~~~~~~aPE~~~~---~~~~~~~~Dvwsl 205 (205)
......||+.|+|||++.+ ..++.+ +|||||
T Consensus 170 ~~~~~~gt~~Y~aPE~~~~~~~~~~~~~-~DiwSl 203 (384)
T 4fr4_A 170 QITTMAGTKPYMAPEMFSSRKGAGYSFA-VDWWSL 203 (384)
T ss_dssp CBCCCCSCGGGCCGGGTCCCSSCCBCTT-HHHHHH
T ss_pred ceeccCCCccccCCeeeccCCCCCCCcc-ceeech
Confidence 6677789999999999974 346655 999986
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-41 Score=258.98 Aligned_cols=186 Identities=33% Similarity=0.510 Sum_probs=159.4
Q ss_pred eecCCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCc----cchHHHHHHHHHHHhc-CCCCeeEEEEEEEeCCe
Q 028681 17 MHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSL-RHPNIVRFKEVILTPTH 91 (205)
Q Consensus 17 ~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~ 91 (205)
....++|++.+.||+|+||.||++.+..+++.||+|++.+.. ...+.+..|..+++.+ .||||+++++++.+++.
T Consensus 19 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~ 98 (353)
T 3txo_A 19 RLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDR 98 (353)
T ss_dssp ----CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred CCchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCE
Confidence 345689999999999999999999999999999999998642 2345677889999888 69999999999999999
Q ss_pred EEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccC
Q 028681 92 LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 171 (205)
Q Consensus 92 ~~lv~~~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~ 171 (205)
.++||||+++++|.+.+...+.+++..++.++.|++.||+|||++||+||||+|+||+++.++. ++|+|||+++....
T Consensus 99 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~--ikL~DFG~a~~~~~ 176 (353)
T 3txo_A 99 LFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGH--CKLADFGMCKEGIC 176 (353)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSC--EEECCCTTCBCSCC
T ss_pred EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCC--EEEccccceeeccc
Confidence 9999999999999999988888999999999999999999999999999999999999998887 99999999975433
Q ss_pred -CCCCCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 172 -HSQPKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 172 -~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
........||+.|+|||++.+..++.+ +|||||
T Consensus 177 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~Diwsl 210 (353)
T 3txo_A 177 NGVTTATFCGTPDYIAPEILQEMLYGPA-VDWWAM 210 (353)
T ss_dssp ---------CCGGGCCHHHHHHHHCTTH-HHHHHH
T ss_pred CCccccccCCCcCeEChhhcCCCCcCCc-cCCCcc
Confidence 334445579999999999998888766 999986
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=254.75 Aligned_cols=184 Identities=42% Similarity=0.701 Sum_probs=166.1
Q ss_pred cCCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCc----cchHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEE
Q 028681 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 94 (205)
Q Consensus 19 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 94 (205)
..++|++.+.||+|+||.||++.+..+++.||+|++.... .....+.+|+.+++.++||||+++++++..++..++
T Consensus 7 ~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l 86 (336)
T 3h4j_B 7 HIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVM 86 (336)
T ss_dssp EETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence 3589999999999999999999999999999999987532 234678899999999999999999999999999999
Q ss_pred EEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCCCC
Q 028681 95 VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 174 (205)
Q Consensus 95 v~~~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~ 174 (205)
||||+ +++|.+.+...+.+++..++.++.|++.||.|||+.|++||||+|+||+++.++. ++|+|||++........
T Consensus 87 v~E~~-~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~--~kl~DFG~s~~~~~~~~ 163 (336)
T 3h4j_B 87 VIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLN--VKIADFGLSNIMTDGNF 163 (336)
T ss_dssp EECCC-CEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCC--EEECCSSCTBTTTTSBT
T ss_pred EEECC-CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCC--EEEEEeccceeccCCcc
Confidence 99999 6789888888888999999999999999999999999999999999999998877 99999999987766666
Q ss_pred CCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 175 PKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 175 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
.....|++.|+|||++.+..+.+.++|||||
T Consensus 164 ~~~~~gt~~y~aPE~~~~~~~~~~~~Diwsl 194 (336)
T 3h4j_B 164 LKTSCGSPNYAAPEVINGKLYAGPEVDVWSC 194 (336)
T ss_dssp TCCCTTSTTTSCGGGSCCSGGGCHHHHHHHH
T ss_pred cccccCCcCcCCHHHHcCCCCCCCccchhHH
Confidence 6677899999999999988875556999986
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=252.75 Aligned_cols=186 Identities=33% Similarity=0.584 Sum_probs=166.9
Q ss_pred cCCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCcc-------chHHHHHHHHHHHhcCCCCeeEEEEEEEeCCe
Q 028681 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK-------IDENVQREIINHRSLRHPNIVRFKEVILTPTH 91 (205)
Q Consensus 19 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~-------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 91 (205)
..++|++.+.||+|+||.||.+.+..++..||+|.+..... ..+.+.+|+.+++.++||||+++++++.++..
T Consensus 9 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 88 (326)
T 2y0a_A 9 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTD 88 (326)
T ss_dssp HHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred cccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCE
Confidence 35789999999999999999999999999999999976432 24678899999999999999999999999999
Q ss_pred EEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCC--CcEEEeeecccccc
Q 028681 92 LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPA--PRLKICDFGYSKSS 169 (205)
Q Consensus 92 ~~lv~~~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~--~~~~l~df~~~~~~ 169 (205)
.+++||++++++|.+.+.....+++..+..++.|++.||.|||+.|++|+||+|+||+++.++. ..++|+|||++...
T Consensus 89 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~ 168 (326)
T 2y0a_A 89 VILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI 168 (326)
T ss_dssp EEEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCEEC
T ss_pred EEEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCeEC
Confidence 9999999999999999988888999999999999999999999999999999999999987661 24999999999877
Q ss_pred cCCCCCCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 170 VLHSQPKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 170 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
..........|++.|+|||++.+..++.+ +|||||
T Consensus 169 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~Diwsl 203 (326)
T 2y0a_A 169 DFGNEFKNIFGTPEFVAPEIVNYEPLGLE-ADMWSI 203 (326)
T ss_dssp CTTSCCCCCCSCTTTCCHHHHTTCCCCTH-HHHHHH
T ss_pred CCCCccccccCCcCcCCceeecCCCCCcH-HHHHHH
Confidence 65555566679999999999998888766 999986
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-41 Score=254.55 Aligned_cols=185 Identities=23% Similarity=0.395 Sum_probs=165.7
Q ss_pred CCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCccchHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEEec
Q 028681 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA 99 (205)
Q Consensus 20 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~~ 99 (205)
.++|++.+.||+|+||.||.+.+..++..+++|.+.......+.+.+|+.+++.++||||+++++++.+.+..+++|||+
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~ 83 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFI 83 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCcccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEeC
Confidence 58999999999999999999999999999999999876656677889999999999999999999999999999999999
Q ss_pred CCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCCCCCCCC
Q 028681 100 SGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST 178 (205)
Q Consensus 100 ~~~sl~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~~~~~ 178 (205)
++++|.+.+... ..+++..+..++.|++.||.|||++|++|+||+|+||+++.+....++|+|||++............
T Consensus 84 ~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~ 163 (321)
T 1tki_A 84 SGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLL 163 (321)
T ss_dssp CCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCEEEEE
T ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCCccccc
Confidence 999999998664 3699999999999999999999999999999999999998743344999999999876655544555
Q ss_pred CCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 179 VGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 179 ~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
.+++.|+|||++.+..++.+ +|||||
T Consensus 164 ~gt~~y~aPE~~~~~~~~~~-~Diwsl 189 (321)
T 1tki_A 164 FTAPEYYAPEVHQHDVVSTA-TDMWSL 189 (321)
T ss_dssp ESCGGGSCHHHHTTCEECHH-HHHHHH
T ss_pred cCChhhcCcHHhcCCCCCch-hhHHHH
Confidence 78999999999998887755 999986
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=253.96 Aligned_cols=187 Identities=32% Similarity=0.500 Sum_probs=163.8
Q ss_pred ceecCCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCc----cchHHHHHHHHHHHhc-CCCCeeEEEEEEEeCC
Q 028681 16 IMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSL-RHPNIVRFKEVILTPT 90 (205)
Q Consensus 16 ~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~ 90 (205)
.....++|++.+.||+|+||.||++.+..+++.||+|.+++.. ...+.+..|..++..+ +||||+++++++.+++
T Consensus 12 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~ 91 (345)
T 1xjd_A 12 IKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKE 91 (345)
T ss_dssp ----CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSS
T ss_pred CCCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCC
Confidence 3456799999999999999999999999999999999998642 2345677888888877 8999999999999999
Q ss_pred eEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeeccccccc
Q 028681 91 HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 170 (205)
Q Consensus 91 ~~~lv~~~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~ 170 (205)
..++||||+++++|.+.+.....+++..++.++.|++.||+|||++||+||||+|+||+++.++. ++|+|||+++...
T Consensus 92 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~--vkL~DFG~a~~~~ 169 (345)
T 1xjd_A 92 NLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGH--IKIADFGMCKENM 169 (345)
T ss_dssp EEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSC--EEECCCTTCBCCC
T ss_pred EEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCC--EEEeEChhhhhcc
Confidence 99999999999999999988888999999999999999999999999999999999999998887 9999999997543
Q ss_pred C-CCCCCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 171 L-HSQPKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 171 ~-~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
. ........||+.|+|||++.+..++.+ +|||||
T Consensus 170 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~Diwsl 204 (345)
T 1xjd_A 170 LGDAKTNTFCGTPDYIAPEILLGQKYNHS-VDWWSF 204 (345)
T ss_dssp CTTCCBCCCCSCGGGCCHHHHTTCCBCTH-HHHHHH
T ss_pred cCCCcccCCCCCcccCChhhhcCCCCCCh-hhhHHH
Confidence 3 233455679999999999999888766 999986
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-40 Score=252.86 Aligned_cols=184 Identities=30% Similarity=0.500 Sum_probs=164.0
Q ss_pred cCCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCcc----chHHHHHHHHHHHhc-CCCCeeEEEEEEEeCCeEE
Q 028681 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK----IDENVQREIINHRSL-RHPNIVRFKEVILTPTHLA 93 (205)
Q Consensus 19 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~ 93 (205)
..++|++.+.||+|+||.||++.+..+++.||+|++.+... ..+.+..|..++..+ +||||+++++++.+++..+
T Consensus 7 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~ 86 (345)
T 3a8x_A 7 GLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLF 86 (345)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred chhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEE
Confidence 35899999999999999999999999999999999986532 234577889999887 8999999999999999999
Q ss_pred EEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeeccccccc-CC
Q 028681 94 IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV-LH 172 (205)
Q Consensus 94 lv~~~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~-~~ 172 (205)
+||||+++++|.+.+...+.+++..++.++.|++.||+|||++||+||||+|+||+++.++. ++|+|||+++... ..
T Consensus 87 lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~--~kL~DFG~a~~~~~~~ 164 (345)
T 3a8x_A 87 FVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGH--IKLTDYGMCKEGLRPG 164 (345)
T ss_dssp EEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSC--EEECCGGGCBCSCCTT
T ss_pred EEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCC--EEEEeccccccccCCC
Confidence 99999999999999988888999999999999999999999999999999999999988887 9999999997533 33
Q ss_pred CCCCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 173 SQPKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 173 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
.......||+.|+|||++.+..++.+ +|||||
T Consensus 165 ~~~~~~~gt~~y~aPE~~~~~~~~~~-~Diwsl 196 (345)
T 3a8x_A 165 DTTSTFCGTPNYIAPEILRGEDYGFS-VDWWAL 196 (345)
T ss_dssp CCBCCCCSCGGGCCHHHHTTCCBCTH-HHHHHH
T ss_pred CcccccCCCccccCccccCCCCCChH-HhHHHH
Confidence 34455679999999999999888766 999986
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=250.97 Aligned_cols=182 Identities=31% Similarity=0.541 Sum_probs=164.2
Q ss_pred cCCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCc----cchHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEE
Q 028681 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 94 (205)
Q Consensus 19 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 94 (205)
..++|++.+.||+|+||.||++.+..+++.||+|++.+.. ...+.+.+|..+++.++||||+++++++.+....++
T Consensus 4 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 83 (318)
T 1fot_A 4 SLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFM 83 (318)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEE
T ss_pred ChHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEE
Confidence 3589999999999999999999999999999999997642 234667889999999999999999999999999999
Q ss_pred EEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCCCC
Q 028681 95 VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 174 (205)
Q Consensus 95 v~~~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~ 174 (205)
+|||+++++|.+.+.....+++..++.++.|++.||.|||++||+||||+|+||+++.++. ++|+|||+++.... .
T Consensus 84 v~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~--~kL~Dfg~a~~~~~--~ 159 (318)
T 1fot_A 84 IMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGH--IKITDFGFAKYVPD--V 159 (318)
T ss_dssp EECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSC--EEECCCSSCEECSS--C
T ss_pred EEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCC--EEEeecCcceecCC--c
Confidence 9999999999999988888999999999999999999999999999999999999988887 99999999976543 2
Q ss_pred CCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 175 PKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 175 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
.....||+.|+|||++.+..++.+ +|||||
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~-~Diwsl 189 (318)
T 1fot_A 160 TYTLCGTPDYIAPEVVSTKPYNKS-IDWWSF 189 (318)
T ss_dssp BCCCCSCTTTCCHHHHTTCCBCTT-HHHHHH
T ss_pred cccccCCccccCHhHhcCCCCCcc-cchhhh
Confidence 345579999999999999888766 999986
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-40 Score=247.90 Aligned_cols=186 Identities=28% Similarity=0.476 Sum_probs=165.3
Q ss_pred ceecCCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCcc-chHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEE
Q 028681 16 IMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 94 (205)
Q Consensus 16 ~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 94 (205)
.....++|++.+.||+|+||.||.+.+..+++.||+|.+..... ..+.+.+|+.+++.++||||+++++++..++..++
T Consensus 15 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 94 (297)
T 3fxz_A 15 VGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWV 94 (297)
T ss_dssp SSCGGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred cCChhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEE
Confidence 34456899999999999999999999999999999999876543 35668899999999999999999999999999999
Q ss_pred EEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCCCC
Q 028681 95 VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 174 (205)
Q Consensus 95 v~~~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~ 174 (205)
||||+++++|.+.+.. ..+++..+..++.|++.||.|||++|++|+||+|+||+++.++. ++|+|||++........
T Consensus 95 v~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~ 171 (297)
T 3fxz_A 95 VMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGS--VKLTDFGFCAQITPEQS 171 (297)
T ss_dssp EEECCTTCBHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCC--EEECCCTTCEECCSTTC
T ss_pred EEECCCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCC--EEEeeCCCceecCCccc
Confidence 9999999999998865 46999999999999999999999999999999999999988887 99999999876654433
Q ss_pred -CCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 175 -PKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 175 -~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
.....|++.|+|||++.+..++.+ +|||||
T Consensus 172 ~~~~~~gt~~y~aPE~~~~~~~~~~-~Diwsl 202 (297)
T 3fxz_A 172 KRSTMVGTPYWMAPEVVTRKAYGPK-VDIWSL 202 (297)
T ss_dssp CBCCCCSCGGGCCHHHHHCSCBCTH-HHHHHH
T ss_pred ccCCccCCcCccChhhhcCCCCCcH-HHHHHH
Confidence 344579999999999999988766 999986
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-40 Score=247.88 Aligned_cols=185 Identities=28% Similarity=0.480 Sum_probs=162.8
Q ss_pred ecCCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCc-cchHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEE
Q 028681 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (205)
Q Consensus 18 ~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 96 (205)
...++|++.+.||+|+||.||.+.+..++..|++|.+.... ...+.+..|+.+++.++||||+++++++.+++..++||
T Consensus 7 ~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 86 (310)
T 3s95_A 7 FRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFIT 86 (310)
T ss_dssp ECGGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred eChhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEE
Confidence 45789999999999999999999999999999999886543 34567889999999999999999999999999999999
Q ss_pred EecCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCCCCC
Q 028681 97 EYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 175 (205)
Q Consensus 97 ~~~~~~sl~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~~ 175 (205)
||+++++|.+.+.. ...+++..+..++.|++.||.|||+.|++|+||+|+||+++.++. ++|+|||++.........
T Consensus 87 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~ 164 (310)
T 3s95_A 87 EYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKN--VVVADFGLARLMVDEKTQ 164 (310)
T ss_dssp ECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSC--EEECCCTTCEECC-----
T ss_pred EecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCC--EEEeecccceeccccccc
Confidence 99999999999977 567999999999999999999999999999999999999988877 999999999755333221
Q ss_pred ---------------CCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 176 ---------------KSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 176 ---------------~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
....|++.|+|||++.+..++.+ +|||||
T Consensus 165 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~Di~sl 208 (310)
T 3s95_A 165 PEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEK-VDVFSF 208 (310)
T ss_dssp ---------------CCCCSCGGGCCHHHHTTCCCCTH-HHHHHH
T ss_pred ccccccccccccccccccCCCcceeCHHHhcCCCCCcH-HHHHHH
Confidence 14468999999999999888766 999986
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=254.11 Aligned_cols=186 Identities=31% Similarity=0.478 Sum_probs=163.6
Q ss_pred eecCCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCc----cchHHHHHHHHHHHhc-CCCCeeEEEEEEEeCCe
Q 028681 17 MHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSL-RHPNIVRFKEVILTPTH 91 (205)
Q Consensus 17 ~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~ 91 (205)
....++|++.+.||+|+||.||++.+..+++.||+|++.+.. ...+.+..|..++..+ .||+|+++++++.+.+.
T Consensus 16 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~ 95 (353)
T 2i0e_A 16 RMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDR 95 (353)
T ss_dssp ---CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSE
T ss_pred CCchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCE
Confidence 345689999999999999999999999999999999997642 2345677888888877 79999999999999999
Q ss_pred EEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccC
Q 028681 92 LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 171 (205)
Q Consensus 92 ~~lv~~~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~ 171 (205)
.++||||+++++|.+.+...+.+++..++.++.|++.||.|||++||+||||+|+||+++.++. ++|+|||+++....
T Consensus 96 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~--vkL~DFG~a~~~~~ 173 (353)
T 2i0e_A 96 LYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGH--IKIADFGMCKENIW 173 (353)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSC--EEECCCTTCBCCCC
T ss_pred EEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCc--EEEEeCCccccccc
Confidence 9999999999999999988888999999999999999999999999999999999999998887 99999999975432
Q ss_pred -CCCCCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 172 -HSQPKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 172 -~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
........||+.|+|||++.+..++.+ +|||||
T Consensus 174 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~Diwsl 207 (353)
T 2i0e_A 174 DGVTTKTFCGTPDYIAPEIIAYQPYGKS-VDWWAF 207 (353)
T ss_dssp TTCCBCCCCSCGGGCCHHHHTTCCBSTH-HHHHHH
T ss_pred CCcccccccCCccccChhhhcCCCcCCc-ccccch
Confidence 333455679999999999999888766 999986
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-40 Score=252.71 Aligned_cols=185 Identities=34% Similarity=0.543 Sum_probs=165.2
Q ss_pred CCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCcc---chHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEE
Q 028681 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (205)
Q Consensus 20 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 96 (205)
.++|++.+.||+|+||.||.+.+..++..||+|++..... ..+.+.+|+.+++.++||||+++++++.+++..++||
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~ 107 (362)
T 2bdw_A 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 107 (362)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 4589999999999999999999999999999999976543 2356889999999999999999999999999999999
Q ss_pred EecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCC-CcEEEeeecccccccCCCCC
Q 028681 97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPA-PRLKICDFGYSKSSVLHSQP 175 (205)
Q Consensus 97 ~~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~-~~~~l~df~~~~~~~~~~~~ 175 (205)
|++++++|.+.+.....+++..+..++.|++.||.|||++||+|+||+|+||+++.++. ..++|+|||++.........
T Consensus 108 e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~~~~ 187 (362)
T 2bdw_A 108 DLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAW 187 (362)
T ss_dssp CCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTCCSC
T ss_pred ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecCCccc
Confidence 99999999999988888999999999999999999999999999999999999976432 34999999999876655555
Q ss_pred CCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 176 KSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 176 ~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
....|++.|+|||++.+..++.+ +|||||
T Consensus 188 ~~~~gt~~y~aPE~~~~~~~~~~-~Diwsl 216 (362)
T 2bdw_A 188 HGFAGTPGYLSPEVLKKDPYSKP-VDIWAC 216 (362)
T ss_dssp CCSCSCTTTCCHHHHTTCCCCTH-HHHHHH
T ss_pred ccCCCCccccCHHHHccCCCCch-hhHHHH
Confidence 55679999999999998888766 999986
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-40 Score=247.38 Aligned_cols=184 Identities=33% Similarity=0.455 Sum_probs=159.0
Q ss_pred cCCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCcc----chHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEE
Q 028681 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK----IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 94 (205)
Q Consensus 19 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 94 (205)
..++|++.+.||+|++|.||++.+..++..|++|.+..... ..+.+..|+.+++.++||||+++++++..++..++
T Consensus 9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 88 (294)
T 4eqm_A 9 INERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYL 88 (294)
T ss_dssp EETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEE
T ss_pred hhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEE
Confidence 35789999999999999999999999999999999865432 23567899999999999999999999999999999
Q ss_pred EEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCCCC
Q 028681 95 VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 174 (205)
Q Consensus 95 v~~~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~ 174 (205)
+|||+++++|.+.+...+++++..+..++.|++.||.|||++|++|+||+|+||+++.++. ++|+|||++........
T Consensus 89 v~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~ 166 (294)
T 4eqm_A 89 VMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKT--LKIFDFGIAKALSETSL 166 (294)
T ss_dssp EEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSC--EEECCCSSSTTC-----
T ss_pred EEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCC--EEEEeCCCccccccccc
Confidence 9999999999999988888999999999999999999999999999999999999988877 99999999976543322
Q ss_pred --CCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 175 --PKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 175 --~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
.....|++.|+|||.+.+..++.+ +|||||
T Consensus 167 ~~~~~~~gt~~y~aPE~~~~~~~~~~-~Di~sl 198 (294)
T 4eqm_A 167 TQTNHVLGTVQYFSPEQAKGEATDEC-TDIYSI 198 (294)
T ss_dssp --------CCSSCCHHHHHTCCCCTT-HHHHHH
T ss_pred cccCccccCccccCHhHhcCCCCCch-HhHHHH
Confidence 233468999999999999888766 999986
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=244.97 Aligned_cols=182 Identities=29% Similarity=0.482 Sum_probs=157.3
Q ss_pred CCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCccc---hHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEE
Q 028681 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI---DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (205)
Q Consensus 21 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~ 97 (205)
++|++.+.||+|++|+||++.+..+++.||+|.+...... .+.+.+|+.+++.++||||+++++++.+++..+++||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 6899999999999999999999999999999999765332 3668899999999999999999999999999999999
Q ss_pred ecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCC-CCCC
Q 028681 98 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPK 176 (205)
Q Consensus 98 ~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~-~~~~ 176 (205)
+++++.+..+....+.+++..++.++.|++.||.|||++||+|+||+|+||+++.++. ++|+|||++...... ....
T Consensus 82 ~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~~~ 159 (292)
T 3o0g_A 82 FCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGE--LKLANFGLARAFGIPVRCYS 159 (292)
T ss_dssp CCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC--EEECCCTTCEECCSCCSCCC
T ss_pred cCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCC--EEEeecccceecCCcccccc
Confidence 9976444444444678999999999999999999999999999999999999998887 999999999765433 3334
Q ss_pred CCCCCCCccCCceeccCc-CCCeeeEEEeC
Q 028681 177 STVGTPAYIAPEVLLKKE-YDGKVMCVYVI 205 (205)
Q Consensus 177 ~~~~~~~~~aPE~~~~~~-~~~~~~Dvwsl 205 (205)
...+++.|+|||++.+.. ++.+ +|||||
T Consensus 160 ~~~~t~~y~aPE~~~~~~~~~~~-~Diwsl 188 (292)
T 3o0g_A 160 AEVVTLWYRPPDVLFGAKLYSTS-IDMWSA 188 (292)
T ss_dssp SCCSCGGGCCHHHHTTCSCCCTH-HHHHHH
T ss_pred CCccccCCcChHHHcCCCCcCch-HHHHHH
Confidence 457899999999998776 4544 999986
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-40 Score=252.33 Aligned_cols=183 Identities=31% Similarity=0.554 Sum_probs=165.0
Q ss_pred ecCCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCc----cchHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEE
Q 028681 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLA 93 (205)
Q Consensus 18 ~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 93 (205)
...++|++.+.||+|+||.||++.+..+++.||+|++.+.. ...+.+.+|+.+++.++||||+++++++.+++..+
T Consensus 38 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 117 (350)
T 1rdq_E 38 AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLY 117 (350)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred CCHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEE
Confidence 45689999999999999999999999999999999997643 23466888999999999999999999999999999
Q ss_pred EEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCCC
Q 028681 94 IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 173 (205)
Q Consensus 94 lv~~~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~~ 173 (205)
+||||+++++|.+.+...+.+++..++.++.|++.||.|||++||+||||+|+||+++.++. ++|+|||+++.....
T Consensus 118 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~--~kL~DFg~a~~~~~~- 194 (350)
T 1rdq_E 118 MVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGY--IQVTDFGFAKRVKGR- 194 (350)
T ss_dssp EEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC--EEECCCTTCEECSSC-
T ss_pred EEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCC--EEEcccccceeccCC-
Confidence 99999999999999988888999999999999999999999999999999999999988887 999999999765432
Q ss_pred CCCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 174 QPKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 174 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
.....||+.|+|||++.+..++.+ +|||||
T Consensus 195 -~~~~~gt~~y~aPE~~~~~~~~~~-~Diwsl 224 (350)
T 1rdq_E 195 -TWTLCGTPEALAPEIILSKGYNKA-VDWWAL 224 (350)
T ss_dssp -BCCCEECGGGCCHHHHTTCCBCTH-HHHHHH
T ss_pred -cccccCCccccCHHHhcCCCCCCc-CCEecc
Confidence 344579999999999999888766 999986
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-40 Score=252.89 Aligned_cols=185 Identities=32% Similarity=0.565 Sum_probs=157.7
Q ss_pred ecCCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCccc----hHHHHHHHHH-HHhcCCCCeeEEEEEEEeCCeE
Q 028681 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI----DENVQREIIN-HRSLRHPNIVRFKEVILTPTHL 92 (205)
Q Consensus 18 ~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~----~~~~~~e~~~-l~~l~h~~i~~~~~~~~~~~~~ 92 (205)
...++|++.+.||+|+||.||++.+..++..||+|++.+.... ...+..|..+ ++.++||||+++++++.+.+..
T Consensus 35 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~ 114 (373)
T 2r5t_A 35 AKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKL 114 (373)
T ss_dssp CCGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEE
T ss_pred CChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEE
Confidence 3568999999999999999999999999999999999865422 2334555554 4678999999999999999999
Q ss_pred EEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeeccccccc-C
Q 028681 93 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV-L 171 (205)
Q Consensus 93 ~lv~~~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~-~ 171 (205)
++||||+++++|.+.+...+.+++..++.++.|++.||+|||++||+||||+|+||+++.++. ++|+|||+++... .
T Consensus 115 ~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~--ikL~DFG~a~~~~~~ 192 (373)
T 2r5t_A 115 YFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGH--IVLTDFGLCKENIEH 192 (373)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSC--EEECCCCBCGGGBCC
T ss_pred EEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCC--EEEeeCccccccccC
Confidence 999999999999999988888999999999999999999999999999999999999998887 9999999997633 3
Q ss_pred CCCCCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 172 HSQPKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 172 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
........||+.|+|||++.+..++.+ +|||||
T Consensus 193 ~~~~~~~~gt~~y~aPE~~~~~~~~~~-~Diwsl 225 (373)
T 2r5t_A 193 NSTTSTFCGTPEYLAPEVLHKQPYDRT-VDWWCL 225 (373)
T ss_dssp CCCCCSBSCCCCCCCHHHHTTCCCCTH-HHHHHH
T ss_pred CCccccccCCccccCHHHhCCCCCCch-hhhHHH
Confidence 344556679999999999999888766 999986
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-40 Score=254.04 Aligned_cols=188 Identities=27% Similarity=0.445 Sum_probs=165.8
Q ss_pred eecCCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCcc-chHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEE
Q 028681 17 MHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV 95 (205)
Q Consensus 17 ~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 95 (205)
....++|++.+.||+|+||.||.+.+..+++.||+|++..... ....+.+|+.+++.++||||+++++++.++...+++
T Consensus 47 ~~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv 126 (387)
T 1kob_A 47 GSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLI 126 (387)
T ss_dssp SCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEE
T ss_pred CccccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEE
Confidence 3446789999999999999999999999999999999976533 345688999999999999999999999999999999
Q ss_pred EEecCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCCCC
Q 028681 96 MEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 174 (205)
Q Consensus 96 ~~~~~~~sl~~~~~~~~-~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~ 174 (205)
|||+++++|.+.+.... .+++..+..++.|++.||.|||++||+|+||+|+||+++.+....++|+|||++........
T Consensus 127 ~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~~ 206 (387)
T 1kob_A 127 LEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI 206 (387)
T ss_dssp EECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSC
T ss_pred EEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecCCCcc
Confidence 99999999999886543 69999999999999999999999999999999999999865444599999999987665554
Q ss_pred CCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 175 PKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 175 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
.....+++.|+|||++.+..++.+ +|||||
T Consensus 207 ~~~~~gt~~y~aPE~~~~~~~~~~-~DiwSl 236 (387)
T 1kob_A 207 VKVTTATAEFAAPEIVDREPVGFY-TDMWAI 236 (387)
T ss_dssp EEEECSSGGGCCHHHHTTCCBCHH-HHHHHH
T ss_pred eeeeccCCCccCchhccCCCCCCc-ccEeeH
Confidence 455579999999999998888766 999986
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-40 Score=250.46 Aligned_cols=184 Identities=36% Similarity=0.588 Sum_probs=161.4
Q ss_pred CCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCcc--chHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEE
Q 028681 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (205)
Q Consensus 20 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~ 97 (205)
.++|++.+.||+|+||.||++.+..+++.||+|++..... ..+.+.+|+.+++.++||||+++++++.+++..+++||
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 85 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence 5899999999999999999999999999999999875432 23568899999999999999999999999999999999
Q ss_pred ecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCC---CC
Q 028681 98 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH---SQ 174 (205)
Q Consensus 98 ~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~---~~ 174 (205)
|+++++|.+.+.....+++..+..++.|++.||.|||++||+|+||+|+||+++.++. ++|+|||++...... ..
T Consensus 86 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~--~kl~Dfg~a~~~~~~~~~~~ 163 (323)
T 3tki_A 86 YCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDN--LKISDFGLATVFRYNNRERL 163 (323)
T ss_dssp CCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC--EEECCCTTCEECEETTEECC
T ss_pred cCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCC--EEEEEeeccceeccCCcccc
Confidence 9999999999987778999999999999999999999999999999999999988877 999999999754322 22
Q ss_pred CCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 175 PKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 175 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
.....|++.|+|||++.+..+.+.++|||||
T Consensus 164 ~~~~~gt~~y~aPE~~~~~~~~~~~~Diwsl 194 (323)
T 3tki_A 164 LNKMCGTLPYVAPELLKRREFHAEPVDVWSC 194 (323)
T ss_dssp BCSCCSCGGGSCHHHHHCSSBCHHHHHHHHH
T ss_pred cCCCccCcCccCcHHhccCCCCCCcccHHHH
Confidence 3345789999999999988775556999986
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-40 Score=260.06 Aligned_cols=185 Identities=41% Similarity=0.697 Sum_probs=167.7
Q ss_pred cCCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCc----cchHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEE
Q 028681 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 94 (205)
Q Consensus 19 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 94 (205)
..++|++.+.||+|+||.||.+.+..+|+.||+|++.... ...+.+.+|+.+++.++||||+++++++..++..++
T Consensus 14 ~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~l 93 (476)
T 2y94_A 14 KIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFM 93 (476)
T ss_dssp EETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred eecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 4589999999999999999999999999999999997643 223578899999999999999999999999999999
Q ss_pred EEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCCCC
Q 028681 95 VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 174 (205)
Q Consensus 95 v~~~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~ 174 (205)
|+||+++++|.+.+...+.+++..++.++.|++.||.|||+.||+||||+|+||+++.++. ++|+|||++........
T Consensus 94 v~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~--vkL~DFG~a~~~~~~~~ 171 (476)
T 2y94_A 94 VMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMN--AKIADFGLSNMMSDGEF 171 (476)
T ss_dssp EEECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCC--EEECCCSSCEECCTTCC
T ss_pred EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCC--eEEEeccchhhcccccc
Confidence 9999999999999988888999999999999999999999999999999999999988877 99999999987665555
Q ss_pred CCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 175 PKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 175 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
.....|++.|+|||++.+..+...++|||||
T Consensus 172 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSl 202 (476)
T 2y94_A 172 LRTSCGSPNYAAPEVISGRLYAGPEVDIWSS 202 (476)
T ss_dssp BCCCCSCSTTCCHHHHTTCCBCSHHHHHHHH
T ss_pred ccccCCCcCeEChhhccCCCCCCCcceehhh
Confidence 5667899999999999988876566999986
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-40 Score=256.59 Aligned_cols=183 Identities=32% Similarity=0.465 Sum_probs=161.0
Q ss_pred cCCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCc----cchHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEE
Q 028681 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 94 (205)
Q Consensus 19 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 94 (205)
..++|++.+.||+|+||.||++.+..+++.||+|++.+.. ...+.+.+|..+++.++||||+++++++.+++..++
T Consensus 67 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~l 146 (410)
T 3v8s_A 67 KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYM 146 (410)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred CccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEE
Confidence 4689999999999999999999999999999999997632 223457889999999999999999999999999999
Q ss_pred EEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCCC-
Q 028681 95 VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS- 173 (205)
Q Consensus 95 v~~~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~~- 173 (205)
||||+++++|.+.+.. ..+++..++.++.|++.||.|||++||+||||+|+||+++.++. +||+|||+++......
T Consensus 147 V~E~~~gg~L~~~l~~-~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~--ikL~DFG~a~~~~~~~~ 223 (410)
T 3v8s_A 147 VMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGH--LKLADFGTCMKMNKEGM 223 (410)
T ss_dssp EECCCTTEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC--EEECCCTTCEECCTTSE
T ss_pred EEeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCC--EEEeccceeEeeccCCc
Confidence 9999999999998865 56999999999999999999999999999999999999998887 9999999997654433
Q ss_pred -CCCCCCCCCCccCCceeccCc----CCCeeeEEEeC
Q 028681 174 -QPKSTVGTPAYIAPEVLLKKE----YDGKVMCVYVI 205 (205)
Q Consensus 174 -~~~~~~~~~~~~aPE~~~~~~----~~~~~~Dvwsl 205 (205)
...+..||+.|+|||++.+.. ++.+ +|||||
T Consensus 224 ~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~-~DiwSl 259 (410)
T 3v8s_A 224 VRCDTAVGTPDYISPEVLKSQGGDGYYGRE-CDWWSV 259 (410)
T ss_dssp EECCSCCSCGGGCCHHHHHTTTTTCEEETH-HHHHHH
T ss_pred ccccCCcCCccccCHHHhhccCCCcCCCCc-ceEecc
Confidence 234567999999999998765 5544 999986
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-40 Score=258.15 Aligned_cols=184 Identities=24% Similarity=0.464 Sum_probs=161.2
Q ss_pred cCCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCc----cchHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEE
Q 028681 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 94 (205)
Q Consensus 19 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 94 (205)
..++|++.+.||+|+||+||++.+..+++.||+|++.+.. .....+.+|..++..++||||+++++++.+++..++
T Consensus 72 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~l 151 (437)
T 4aw2_A 72 HREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYL 151 (437)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEE
T ss_pred ChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEEE
Confidence 3579999999999999999999999999999999997532 122347889999999999999999999999999999
Q ss_pred EEEecCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCCC
Q 028681 95 VMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 173 (205)
Q Consensus 95 v~~~~~~~sl~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~~ 173 (205)
||||+++++|.+.+.. ...+++..++.++.|++.||.|||++||+||||||+||+++.++. +||+|||+++......
T Consensus 152 V~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~--vkL~DFGla~~~~~~~ 229 (437)
T 4aw2_A 152 VMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGH--IRLADFGSCLKLMEDG 229 (437)
T ss_dssp EECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC--EEECCCTTCEECCTTS
T ss_pred EEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCC--EEEcchhhhhhcccCC
Confidence 9999999999999977 567999999999999999999999999999999999999998887 9999999997654433
Q ss_pred C--CCCCCCCCCccCCceec-----cCcCCCeeeEEEeC
Q 028681 174 Q--PKSTVGTPAYIAPEVLL-----KKEYDGKVMCVYVI 205 (205)
Q Consensus 174 ~--~~~~~~~~~~~aPE~~~-----~~~~~~~~~Dvwsl 205 (205)
. .....||+.|+|||++. ...++.+ +|||||
T Consensus 230 ~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~-~DvwSl 267 (437)
T 4aw2_A 230 TVQSSVAVGTPDYISPEILQAMEGGKGRYGPE-CDWWSL 267 (437)
T ss_dssp CEECCSCCSCGGGCCHHHHHHHHTSCCEECTH-HHHHHH
T ss_pred CcccccccCCcCeeChHHHhhcccCCCCCCCc-CeeHHH
Confidence 2 23357999999999997 4556655 999986
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=247.11 Aligned_cols=186 Identities=28% Similarity=0.468 Sum_probs=155.1
Q ss_pred eecCCCeEEEeeeccccceeEEEEEec---CCCcEEEEEEeecCc-----cchHHHHHHHHHHHhcCCCCeeEEEEEEEe
Q 028681 17 MHDSDRYELVRDIGSGNFGVARLMRDK---KTEELVAVKYIERGD-----KIDENVQREIINHRSLRHPNIVRFKEVILT 88 (205)
Q Consensus 17 ~~~~~~y~~~~~l~~g~~g~v~~~~~~---~~~~~v~iK~~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 88 (205)
....++|++.+.||+|+||.||.+.+. .+++.||+|++.+.. .....+..|+.+++.++||||+++++++..
T Consensus 13 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 92 (327)
T 3a62_A 13 KIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQT 92 (327)
T ss_dssp CCCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEEC
T ss_pred CCCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEc
Confidence 344689999999999999999999985 678999999997642 223457789999999999999999999999
Q ss_pred CCeEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeeccccc
Q 028681 89 PTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 168 (205)
Q Consensus 89 ~~~~~lv~~~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~ 168 (205)
++..+++|||+++++|.+.+...+.+++..+..++.|++.||.|||++||+|+||+|+||+++.++. ++|+|||+++.
T Consensus 93 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~--~kl~Dfg~~~~ 170 (327)
T 3a62_A 93 GGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGH--VKLTDFGLCKE 170 (327)
T ss_dssp SSCEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSC--EEECCCSCC--
T ss_pred CCEEEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCc--EEEEeCCcccc
Confidence 9999999999999999999988888999999999999999999999999999999999999988877 99999999875
Q ss_pred ccCC-CCCCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 169 SVLH-SQPKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 169 ~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
.... .......|++.|+|||++.+..++.+ +|||||
T Consensus 171 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~Diwsl 207 (327)
T 3a62_A 171 SIHDGTVTHTFCGTIEYMAPEILMRSGHNRA-VDWWSL 207 (327)
T ss_dssp --------CTTSSCCTTSCHHHHTTSCCCTH-HHHHHH
T ss_pred cccCCccccccCCCcCccCHhhCcCCCCCCc-ccchhH
Confidence 4332 33344579999999999998888766 999986
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=255.87 Aligned_cols=186 Identities=33% Similarity=0.510 Sum_probs=162.3
Q ss_pred cCCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCcc---chHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEE
Q 028681 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV 95 (205)
Q Consensus 19 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 95 (205)
-.++|++.+.||+|+||.||++.+..++..+++|.+..... ..+.+.+|+.+++.++||||+++++++.+++..+++
T Consensus 9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv 88 (444)
T 3soa_A 9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLI 88 (444)
T ss_dssp HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEE
T ss_pred ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEE
Confidence 35789999999999999999999999999999999986543 235688999999999999999999999999999999
Q ss_pred EEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCC-CCCcEEEeeecccccccCCCC
Q 028681 96 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGS-PAPRLKICDFGYSKSSVLHSQ 174 (205)
Q Consensus 96 ~~~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~-~~~~~~l~df~~~~~~~~~~~ 174 (205)
||++.+++|.+.+.....+++..+..++.|++.||.|||++||+||||+|+||+++.+ ....+||+|||++........
T Consensus 89 ~E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~~~ 168 (444)
T 3soa_A 89 FDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQ 168 (444)
T ss_dssp ECCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTTCC
T ss_pred EEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEecCCCc
Confidence 9999999999999888889999999999999999999999999999999999999843 223499999999976654332
Q ss_pred -CCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 175 -PKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 175 -~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
.....|++.|+|||++.+..++.+ +|||||
T Consensus 169 ~~~~~~gt~~Y~APE~l~~~~~~~~-~DIwSl 199 (444)
T 3soa_A 169 AWFGFAGTPGYLSPEVLRKDPYGKP-VDLWAC 199 (444)
T ss_dssp BCCCSCSCGGGCCHHHHTTCCBCTH-HHHHHH
T ss_pred eeecccCCcccCCHHHhcCCCCCCc-cccHHH
Confidence 244579999999999998888766 999996
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=254.38 Aligned_cols=184 Identities=25% Similarity=0.424 Sum_probs=161.3
Q ss_pred cCCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCc----cchHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEE
Q 028681 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 94 (205)
Q Consensus 19 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 94 (205)
..++|++.+.||+|+||.||++.+..+++.||+|++.+.. ...+.+.+|..++..++|+||+++++++.+++..++
T Consensus 59 ~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~l 138 (412)
T 2vd5_A 59 QRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYL 138 (412)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEE
T ss_pred ChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEE
Confidence 4689999999999999999999999999999999997632 123457889999999999999999999999999999
Q ss_pred EEEecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCCC
Q 028681 95 VMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 173 (205)
Q Consensus 95 v~~~~~~~sl~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~~ 173 (205)
||||+++++|.+.+.+. ..+++..++.++.|++.||+|||++||+||||+|+||+++.++. +||+|||+++......
T Consensus 139 VmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~--vkL~DFGla~~~~~~~ 216 (412)
T 2vd5_A 139 VMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGH--IRLADFGSCLKLRADG 216 (412)
T ss_dssp EECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC--EEECCCTTCEECCTTS
T ss_pred EEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCC--EEEeechhheeccCCC
Confidence 99999999999999764 47999999999999999999999999999999999999998887 9999999997665443
Q ss_pred C--CCCCCCCCCccCCceec-------cCcCCCeeeEEEeC
Q 028681 174 Q--PKSTVGTPAYIAPEVLL-------KKEYDGKVMCVYVI 205 (205)
Q Consensus 174 ~--~~~~~~~~~~~aPE~~~-------~~~~~~~~~Dvwsl 205 (205)
. .....||+.|+|||++. ...++.+ +|||||
T Consensus 217 ~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~-~DiwSl 256 (412)
T 2vd5_A 217 TVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPE-CDWWAL 256 (412)
T ss_dssp CEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTH-HHHHHH
T ss_pred ccccceeccccCcCCHHHHhhcccCcCCCCCChH-HhhhHH
Confidence 2 23457999999999998 3456655 999986
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=250.28 Aligned_cols=184 Identities=36% Similarity=0.564 Sum_probs=146.7
Q ss_pred CCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCccchHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEEec
Q 028681 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA 99 (205)
Q Consensus 20 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~~ 99 (205)
.++|++.+.||+|++|.||++.+..+++.||+|++.... ..+.+..|+.+++.++||||+++++++..++..+++|||+
T Consensus 52 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 130 (349)
T 2w4o_A 52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV-DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELV 130 (349)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC-----------CHHHHHCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred cCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch-hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEeC
Confidence 466999999999999999999999999999999987643 3456788999999999999999999999999999999999
Q ss_pred CCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecC-CCCCcEEEeeecccccccCCCCCCCC
Q 028681 100 SGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVLHSQPKST 178 (205)
Q Consensus 100 ~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~-~~~~~~~l~df~~~~~~~~~~~~~~~ 178 (205)
++++|.+.+...+.+++..+..++.|++.||.|||+.|++|+||+|+||+++. +....++|+|||+++...........
T Consensus 131 ~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~ 210 (349)
T 2w4o_A 131 TGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTV 210 (349)
T ss_dssp CSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC--------------
T ss_pred CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccccCcccccccc
Confidence 99999999988888999999999999999999999999999999999999975 22234999999999766555444556
Q ss_pred CCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 179 VGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 179 ~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
.|++.|+|||++.+..++.+ +|||||
T Consensus 211 ~gt~~y~aPE~~~~~~~~~~-~Diwsl 236 (349)
T 2w4o_A 211 CGTPGYCAPEILRGCAYGPE-VDMWSV 236 (349)
T ss_dssp --CGGGSCHHHHTTCCCCTH-HHHHHH
T ss_pred cCCCCccCHHHhcCCCCCcc-cchHHH
Confidence 79999999999998888766 999986
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-40 Score=250.88 Aligned_cols=185 Identities=30% Similarity=0.451 Sum_probs=165.2
Q ss_pred cCCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCcc---------chHHHHHHHHHHHhcCCCCeeEEEEEEEeC
Q 028681 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---------IDENVQREIINHRSLRHPNIVRFKEVILTP 89 (205)
Q Consensus 19 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~---------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 89 (205)
..++|++.+.||+|+||.||++.+..++..||+|++..... ..+.+..|+.+++.++||||+++++++.+.
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 101 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ 101 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence 35789999999999999999999999999999999986532 223567899999999999999999999999
Q ss_pred CeEEEEEEecCCC-chHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeeccccc
Q 028681 90 THLAIVMEYASGG-ELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 168 (205)
Q Consensus 90 ~~~~lv~~~~~~~-sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~ 168 (205)
+..++++|++..+ +|.+.+...+.+++..+..++.|++.||.|||+.||+|+||+|+||+++.++. ++|+|||++..
T Consensus 102 ~~~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~--~kL~Dfg~a~~ 179 (335)
T 3dls_A 102 GFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFT--IKLIDFGSAAY 179 (335)
T ss_dssp SEEEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSC--EEECCCTTCEE
T ss_pred CEEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCc--EEEeecccceE
Confidence 9999999998666 99999988888999999999999999999999999999999999999988877 99999999987
Q ss_pred ccCCCCCCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 169 SVLHSQPKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 169 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
...........|++.|+|||++.+..+.+.++|||||
T Consensus 180 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Diwsl 216 (335)
T 3dls_A 180 LERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSL 216 (335)
T ss_dssp CCTTCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHH
T ss_pred CCCCCceeccCCCccccChhhhcCCCCCCCcccchhH
Confidence 7665555566799999999999988875566999986
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-39 Score=245.18 Aligned_cols=186 Identities=31% Similarity=0.538 Sum_probs=166.7
Q ss_pred cCCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCcc-------chHHHHHHHHHHHhcCCCCeeEEEEEEEeCCe
Q 028681 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK-------IDENVQREIINHRSLRHPNIVRFKEVILTPTH 91 (205)
Q Consensus 19 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~-------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 91 (205)
..++|++.+.||+|++|.||.+.+..++..|++|.+..... ..+.+.+|+.+++.++||||+++++++.+.+.
T Consensus 10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 89 (321)
T 2a2a_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTD 89 (321)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred hhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCE
Confidence 35789999999999999999999999999999999976432 24678999999999999999999999999999
Q ss_pred EEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCC--cEEEeeecccccc
Q 028681 92 LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAP--RLKICDFGYSKSS 169 (205)
Q Consensus 92 ~~lv~~~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~--~~~l~df~~~~~~ 169 (205)
.+++||++++++|.+.+.....+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.. .++|+|||++...
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~~ 169 (321)
T 2a2a_A 90 VVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI 169 (321)
T ss_dssp EEEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTCEEC
T ss_pred EEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCccceec
Confidence 99999999999999999888889999999999999999999999999999999999999877621 3999999999876
Q ss_pred cCCCCCCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 170 VLHSQPKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 170 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
..........+++.|+|||++.+..++.+ +|||||
T Consensus 170 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~Di~sl 204 (321)
T 2a2a_A 170 EDGVEFKNIFGTPEFVAPEIVNYEPLGLE-ADMWSI 204 (321)
T ss_dssp CTTCCCCCCCSCGGGCCHHHHTTCCCCTH-HHHHHH
T ss_pred CccccccccCCCCCccCcccccCCCCCCc-cccHHH
Confidence 66555566679999999999998888766 999986
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-39 Score=245.14 Aligned_cols=183 Identities=26% Similarity=0.384 Sum_probs=156.1
Q ss_pred CCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCc--cchHHHHHHHHHHHhcCCCCeeEEEEEEEeCC-------
Q 028681 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPT------- 90 (205)
Q Consensus 20 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~------- 90 (205)
.++|++.+.||+|+||.||++.+..+++.||+|++.... ...+.+..|+.+++.++||||+++++++.+..
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 84 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE 84 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence 468999999999999999999999999999999997543 33467899999999999999999999986543
Q ss_pred --------------------------------------------------eEEEEEEecCCCchHHHHHhcCC---CCHH
Q 028681 91 --------------------------------------------------HLAIVMEYASGGELFERICNAGR---FSED 117 (205)
Q Consensus 91 --------------------------------------------------~~~lv~~~~~~~sl~~~~~~~~~---~~~~ 117 (205)
..+++|||+++++|.+.+..... .++.
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~ 164 (332)
T 3qd2_B 85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG 164 (332)
T ss_dssp HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHH
T ss_pred hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhH
Confidence 38999999999999999977543 5666
Q ss_pred HHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCCC-------------CCCCCCCCCCc
Q 028681 118 EARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-------------QPKSTVGTPAY 184 (205)
Q Consensus 118 ~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~~-------------~~~~~~~~~~~ 184 (205)
.+..++.|++.||.|||++|++|+||+|+||+++.++. ++|+|||+++...... ......|++.|
T Consensus 165 ~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~--~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y 242 (332)
T 3qd2_B 165 VCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDV--VKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLY 242 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC--EEECCCTTCEECSCC--------------CCCSCC-CGGG
T ss_pred HHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCC--EEEeecCcccccccchhhccccccccccccccccCCCcCc
Confidence 78999999999999999999999999999999988876 9999999997665432 22334689999
Q ss_pred cCCceeccCcCCCeeeEEEeC
Q 028681 185 IAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 185 ~aPE~~~~~~~~~~~~Dvwsl 205 (205)
+|||++.+..++.+ +|||||
T Consensus 243 ~aPE~~~~~~~~~~-~Di~sl 262 (332)
T 3qd2_B 243 MSPEQIHGNNYSHK-VDIFSL 262 (332)
T ss_dssp SCHHHHHCCCCCTH-HHHHHH
T ss_pred cChHHhcCCCCcch-hhHHHH
Confidence 99999999888766 999986
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-39 Score=259.78 Aligned_cols=185 Identities=26% Similarity=0.363 Sum_probs=165.6
Q ss_pred ecCCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCc----cchHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEE
Q 028681 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLA 93 (205)
Q Consensus 18 ~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 93 (205)
...++|++.+.||+|+||.||.+.+..+++.||+|.+.+.. .....+..|+.+++.++||||+++++++.+.+..+
T Consensus 181 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~ 260 (576)
T 2acx_A 181 VTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALC 260 (576)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred ccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEE
Confidence 34678999999999999999999999999999999997542 23356788999999999999999999999999999
Q ss_pred EEEEecCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccC
Q 028681 94 IVMEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 171 (205)
Q Consensus 94 lv~~~~~~~sl~~~~~~~~--~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~ 171 (205)
+||||+++++|.+.+...+ .+++..++.++.|++.||+|||++||+||||+|+||+++.++. ++|+|||+++....
T Consensus 261 lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~--vKL~DFGla~~~~~ 338 (576)
T 2acx_A 261 LVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGH--IRISDLGLAVHVPE 338 (576)
T ss_dssp EEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSC--EEECCCTTCEECCT
T ss_pred EEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCC--eEEEecccceeccc
Confidence 9999999999999887644 4999999999999999999999999999999999999998887 99999999987765
Q ss_pred CCCCCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 172 HSQPKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 172 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
........||+.|+|||++.+..++.+ +|||||
T Consensus 339 ~~~~~~~~GT~~Y~APEvl~~~~~~~~-~DiwSL 371 (576)
T 2acx_A 339 GQTIKGRVGTVGYMAPEVVKNERYTFS-PDWWAL 371 (576)
T ss_dssp TCCEECCCSCGGGCCHHHHTTCEESSH-HHHHHH
T ss_pred CccccccCCCccccCHHHHcCCCCCcc-chHHHH
Confidence 555556689999999999999888766 999986
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=247.73 Aligned_cols=194 Identities=25% Similarity=0.382 Sum_probs=165.9
Q ss_pred CCCcccCceecCCCeEEEeeeccc--cceeEEEEEecCCCcEEEEEEeecCccc---hHHHHHHHHHHHhcCCCCeeEEE
Q 028681 9 GPGMDMPIMHDSDRYELVRDIGSG--NFGVARLMRDKKTEELVAVKYIERGDKI---DENVQREIINHRSLRHPNIVRFK 83 (205)
Q Consensus 9 ~~~~~~~~~~~~~~y~~~~~l~~g--~~g~v~~~~~~~~~~~v~iK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~ 83 (205)
......++....++|++.+.||+| ++|.||++.+..+++.||+|++...... .+.+.+|+.+++.++||||++++
T Consensus 13 ~~~~~s~~~~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~ 92 (389)
T 3gni_B 13 YFQGMSSFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYR 92 (389)
T ss_dssp CCC--CCCCCCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred hhhhhhcccCCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEe
Confidence 344556677788999999999999 9999999999999999999999865432 35678899999999999999999
Q ss_pred EEEEeCCeEEEEEEecCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEe
Q 028681 84 EVILTPTHLAIVMEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKIC 161 (205)
Q Consensus 84 ~~~~~~~~~~lv~~~~~~~sl~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~ 161 (205)
+++.+++..++||||+++++|.+++... ..+++..++.++.|++.||.|||++||+||||+|+||+++.++. ++|+
T Consensus 93 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~--~kl~ 170 (389)
T 3gni_B 93 ATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGK--VYLS 170 (389)
T ss_dssp EEEEETTEEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCC--EEEC
T ss_pred EEEEECCEEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCC--EEEc
Confidence 9999999999999999999999999765 67999999999999999999999999999999999999988877 9999
Q ss_pred eecccccccCC--------CCCCCCCCCCCccCCceecc--CcCCCeeeEEEeC
Q 028681 162 DFGYSKSSVLH--------SQPKSTVGTPAYIAPEVLLK--KEYDGKVMCVYVI 205 (205)
Q Consensus 162 df~~~~~~~~~--------~~~~~~~~~~~~~aPE~~~~--~~~~~~~~Dvwsl 205 (205)
|||.+...... .......|++.|+|||++.+ ..++.+ +|||||
T Consensus 171 dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~-~Diwsl 223 (389)
T 3gni_B 171 GLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAK-SDIYSV 223 (389)
T ss_dssp CGGGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTH-HHHHHH
T ss_pred ccccceeeccccccccccccccccccccccccCHHHHhccCCCCCcH-hHHHHH
Confidence 99987543211 12233468899999999987 567665 999986
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=237.44 Aligned_cols=182 Identities=35% Similarity=0.540 Sum_probs=163.8
Q ss_pred CCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCc-cchHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEEe
Q 028681 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (205)
Q Consensus 20 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~ 98 (205)
.++|++.+.||+|++|.||.+.+..++..+++|.+.... ...+.+..|+.+++.++||||+++++++.++...+++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMEL 87 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEec
Confidence 578999999999999999999999999999999987653 3357789999999999999999999999999999999999
Q ss_pred cCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEe---cCCCCCcEEEeeecccccccCCCCC
Q 028681 99 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLL---DGSPAPRLKICDFGYSKSSVLHSQP 175 (205)
Q Consensus 99 ~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili---~~~~~~~~~l~df~~~~~~~~~~~~ 175 (205)
+++++|.+.+...+.+++..+..++.|++.||.+||++|++|+||+|+||++ +.++. ++|+|||++.........
T Consensus 88 ~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~--~~l~Dfg~~~~~~~~~~~ 165 (277)
T 3f3z_A 88 CTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSP--LKLIDFGLAARFKPGKMM 165 (277)
T ss_dssp CCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCC--EEECCCTTCEECCTTSCB
T ss_pred cCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCc--EEEEecccceeccCccch
Confidence 9999999999888889999999999999999999999999999999999999 55555 999999999877666666
Q ss_pred CCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 176 KSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 176 ~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
....+++.|+|||++.+. ++.+ +|||||
T Consensus 166 ~~~~~t~~y~aPE~~~~~-~~~~-~Di~sl 193 (277)
T 3f3z_A 166 RTKVGTPYYVSPQVLEGL-YGPE-CDEWSA 193 (277)
T ss_dssp CCCCSCTTTCCHHHHTTC-BCTT-HHHHHH
T ss_pred hccCCCCCccChHHhccc-CCch-hhehhH
Confidence 667899999999998765 6555 999986
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-39 Score=246.87 Aligned_cols=185 Identities=30% Similarity=0.478 Sum_probs=160.5
Q ss_pred CCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCc------cchHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEE
Q 028681 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD------KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLA 93 (205)
Q Consensus 20 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 93 (205)
.++|++.+.||+|+||.||++.+..+++.||+|++.... ...+.+.+|+.+++.++||||+++++++.+++..+
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 102 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY 102 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 468999999999999999999999999999999986432 23567899999999999999999999999999999
Q ss_pred EEEEecCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCC-CcEEEeeeccccc
Q 028681 94 IVMEYASGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPA-PRLKICDFGYSKS 168 (205)
Q Consensus 94 lv~~~~~~~sl~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~-~~~~l~df~~~~~ 168 (205)
+||||+++++|.+.+.. ...+++..+..++.|++.||.|||++||+|+||+|+||+++.++. ..++|+|||++..
T Consensus 103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~ 182 (351)
T 3c0i_A 103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQ 182 (351)
T ss_dssp EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTTCEE
T ss_pred EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCcceeE
Confidence 99999999999877754 235899999999999999999999999999999999999976442 3499999999976
Q ss_pred ccCCCC-CCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 169 SVLHSQ-PKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 169 ~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
...... .....|++.|+|||++.+..++.+ +|||||
T Consensus 183 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~Diwsl 219 (351)
T 3c0i_A 183 LGESGLVAGGRVGTPHFMAPEVVKREPYGKP-VDVWGC 219 (351)
T ss_dssp CCTTSCBCCCCCSCGGGCCHHHHTTCCBCTH-HHHHHH
T ss_pred ecCCCeeecCCcCCcCccCHHHHcCCCCCch-HhhHHH
Confidence 654432 344579999999999998888766 999986
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-39 Score=243.43 Aligned_cols=184 Identities=24% Similarity=0.375 Sum_probs=160.3
Q ss_pred cCCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCc--cchHHHHHHHHHHHhcCCCCeeEEEEEEEeCC--eEEE
Q 028681 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPT--HLAI 94 (205)
Q Consensus 19 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~l 94 (205)
..++|++.+.||+|+||.||++.+..+++.||+|++.... ...+.+..|+.+++.++||||+++++++.... ..++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 86 (319)
T 4euu_A 7 SNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVL 86 (319)
T ss_dssp SSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEE
T ss_pred CCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEE
Confidence 4578999999999999999999999999999999997643 23466789999999999999999999998765 7899
Q ss_pred EEEecCCCchHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEe----cCCCCCcEEEeeecccc
Q 028681 95 VMEYASGGELFERICNAG---RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLL----DGSPAPRLKICDFGYSK 167 (205)
Q Consensus 95 v~~~~~~~sl~~~~~~~~---~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili----~~~~~~~~~l~df~~~~ 167 (205)
||||+++++|.+++.... .+++..+..++.|++.||.|||++||+|+||+|+||++ +.+.. ++|+|||+++
T Consensus 87 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~--~kL~Dfg~a~ 164 (319)
T 4euu_A 87 IMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSV--YKLTDFGAAR 164 (319)
T ss_dssp EEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEE--EEECCCTTCE
T ss_pred EEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCce--EEEccCCCce
Confidence 999999999999997643 39999999999999999999999999999999999998 44444 9999999998
Q ss_pred cccCCCCCCCCCCCCCccCCceec--------cCcCCCeeeEEEeC
Q 028681 168 SSVLHSQPKSTVGTPAYIAPEVLL--------KKEYDGKVMCVYVI 205 (205)
Q Consensus 168 ~~~~~~~~~~~~~~~~~~aPE~~~--------~~~~~~~~~Dvwsl 205 (205)
............+++.|+|||++. +..++.+ +|||||
T Consensus 165 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~-~Diwsl 209 (319)
T 4euu_A 165 ELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGAT-VDLWSI 209 (319)
T ss_dssp ECCTTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTT-HHHHHH
T ss_pred ecCCCCceeecccCCCccCHHHhhhccccccccCCCCcH-HHHHHH
Confidence 776666656677999999999987 4566655 999986
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=237.13 Aligned_cols=185 Identities=34% Similarity=0.546 Sum_probs=165.6
Q ss_pred CCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCccc---hHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEE
Q 028681 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI---DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (205)
Q Consensus 20 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 96 (205)
.++|++.+.||+|++|.||.+.+..++..|++|++...... .+.+..|+.+++.++||||+++++++..++..++++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 84 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 84 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence 58999999999999999999999999999999999765432 356788999999999999999999999999999999
Q ss_pred EecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCC-CcEEEeeecccccccCCCCC
Q 028681 97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPA-PRLKICDFGYSKSSVLHSQP 175 (205)
Q Consensus 97 ~~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~-~~~~l~df~~~~~~~~~~~~ 175 (205)
|++++++|.+.+.....+++..+..++.|++.||.+||++|++|+||+|+||+++.++. ..++|+|||.+.........
T Consensus 85 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~ 164 (284)
T 3kk8_A 85 DLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAW 164 (284)
T ss_dssp CCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSSCBC
T ss_pred ecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccCccc
Confidence 99999999999988888999999999999999999999999999999999999975543 34999999999776665555
Q ss_pred CCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 176 KSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 176 ~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
....+++.|+|||++.+..++.+ +|||||
T Consensus 165 ~~~~~~~~y~aPE~~~~~~~~~~-~Di~sl 193 (284)
T 3kk8_A 165 HGFAGTPGYLSPEVLKKDPYSKP-VDIWAC 193 (284)
T ss_dssp CCSCSCGGGCCHHHHTTCCBCTH-HHHHHH
T ss_pred cCCCCCcCCcCchhhcCCCCCcc-cchHHH
Confidence 56679999999999999888766 999986
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-39 Score=242.48 Aligned_cols=186 Identities=29% Similarity=0.502 Sum_probs=155.1
Q ss_pred CceecCCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCcc---chHHHHHHHHHHHhcCCCCeeEEEEEEEeCCe
Q 028681 15 PIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTPTH 91 (205)
Q Consensus 15 ~~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 91 (205)
......++|++.+.||+|+||.||++.+.. ++.||+|.+..... ..+.+.+|+.+++.++||||+++++++.+++.
T Consensus 15 ~~q~l~~~y~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 93 (311)
T 3niz_A 15 YFQGLMEKYQKLEKVGEGTYGVVYKAKDSQ-GRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERC 93 (311)
T ss_dssp CEECSSCEEEEEEEEEECSSCEEEEEEETT-SCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSC
T ss_pred eecchHhhhHhhhhccCCCCeEEEEEEECC-CCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCE
Confidence 334457999999999999999999999864 88999999875432 23668899999999999999999999999999
Q ss_pred EEEEEEecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeeccccccc
Q 028681 92 LAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 170 (205)
Q Consensus 92 ~~lv~~~~~~~sl~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~ 170 (205)
.++||||+++ +|.+.+... ..+++..++.++.|++.||.|||++||+|+||+|+||+++.++. ++|+|||+++...
T Consensus 94 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~--~kl~Dfg~a~~~~ 170 (311)
T 3niz_A 94 LTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGA--LKLADFGLARAFG 170 (311)
T ss_dssp EEEEEECCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC--EEECCCTTCEETT
T ss_pred EEEEEcCCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCC--EEEccCcCceecC
Confidence 9999999975 777777554 45999999999999999999999999999999999999988887 9999999997654
Q ss_pred CC-CCCCCCCCCCCccCCceeccC-cCCCeeeEEEeC
Q 028681 171 LH-SQPKSTVGTPAYIAPEVLLKK-EYDGKVMCVYVI 205 (205)
Q Consensus 171 ~~-~~~~~~~~~~~~~aPE~~~~~-~~~~~~~Dvwsl 205 (205)
.. .......+++.|+|||++.+. .++.+ +|||||
T Consensus 171 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~-~Diwsl 206 (311)
T 3niz_A 171 IPVRSYTHEVVTLWYRAPDVLMGSKKYSTS-VDIWSI 206 (311)
T ss_dssp SCCC---CCCCCCTTCCHHHHTTCCSCCTH-HHHHHH
T ss_pred CCcccccCCcccCCcCCHHHhcCCCCCCch-HHhHHH
Confidence 33 333445689999999999874 45544 999986
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=256.59 Aligned_cols=184 Identities=35% Similarity=0.553 Sum_probs=155.4
Q ss_pred cCCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCc----cchHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEE
Q 028681 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 94 (205)
Q Consensus 19 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 94 (205)
..++|++.+.||+|+||.||++.+..++..||+|++.... .....+..|+.+++.++||||+++++++...+..++
T Consensus 146 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~l 225 (446)
T 4ejn_A 146 TMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCF 225 (446)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEE
T ss_pred ChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEE
Confidence 3578999999999999999999999999999999997532 223456788999999999999999999999999999
Q ss_pred EEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-cCcEeecCCCCCeEecCCCCCcEEEeeecccccccC-C
Q 028681 95 VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS-MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-H 172 (205)
Q Consensus 95 v~~~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~-~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~-~ 172 (205)
||||+++++|.+.+.....+++..+..++.|++.||.|||+ .||+||||+|+||+++.++. ++|+|||+++.... .
T Consensus 226 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~--~kl~DFG~a~~~~~~~ 303 (446)
T 4ejn_A 226 VMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGH--IKITDFGLCKEGIKDG 303 (446)
T ss_dssp EECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSC--EEECCCCCCCTTCC--
T ss_pred EEeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCC--EEEccCCCceeccCCC
Confidence 99999999999999888889999999999999999999998 99999999999999998887 99999999975433 3
Q ss_pred CCCCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 173 SQPKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 173 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
.......||+.|+|||++.+..++.+ +|||||
T Consensus 304 ~~~~~~~gt~~y~aPE~~~~~~~~~~-~Diwsl 335 (446)
T 4ejn_A 304 ATMKTFCGTPEYLAPEVLEDNDYGRA-VDWWGL 335 (446)
T ss_dssp ---CCSSSCGGGCCHHHHHTSCCCTH-HHHHHH
T ss_pred cccccccCCccccCHhhcCCCCCCCc-cchhhh
Confidence 33455679999999999999888766 999986
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=239.35 Aligned_cols=182 Identities=29% Similarity=0.476 Sum_probs=156.1
Q ss_pred CCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCc------cchHHHHHHHHHHHhcC---CCCeeEEEEEEEeCC
Q 028681 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD------KIDENVQREIINHRSLR---HPNIVRFKEVILTPT 90 (205)
Q Consensus 20 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~------~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~~~ 90 (205)
.++|++.+.||+|++|.||++.+..+++.||+|.+.... .....+..|+.+++.++ ||||+++++++....
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~ 87 (308)
T 3g33_A 8 TSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSR 87 (308)
T ss_dssp --CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccC
Confidence 579999999999999999999999999999999987432 12345667777776664 999999999998765
Q ss_pred -----eEEEEEEecCCCchHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeee
Q 028681 91 -----HLAIVMEYASGGELFERICNAGR--FSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDF 163 (205)
Q Consensus 91 -----~~~lv~~~~~~~sl~~~~~~~~~--~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df 163 (205)
..++++|++. ++|.+.+..... +++..++.++.|++.||.|||++|++|+||+|+||+++.++. ++|+||
T Consensus 88 ~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~--~kl~Df 164 (308)
T 3g33_A 88 TDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGT--VKLADF 164 (308)
T ss_dssp SSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSC--EEECSC
T ss_pred CCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCC--EEEeeC
Confidence 5889999997 599998877554 999999999999999999999999999999999999988877 999999
Q ss_pred cccccccCCCCCCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 164 GYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
|+++............+++.|+|||++.+..++.+ +|||||
T Consensus 165 g~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~Diwsl 205 (308)
T 3g33_A 165 GLARIYSYQMALTPVVVTLWYRAPEVLLQSTYATP-VDMWSV 205 (308)
T ss_dssp SCTTTSTTCCCSGGGGCCCSSCCHHHHHTSCCCST-HHHHHH
T ss_pred ccccccCCCcccCCccccccccCchHHcCCCCCch-HHHHHH
Confidence 99987665555566679999999999998888766 999986
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-39 Score=247.44 Aligned_cols=184 Identities=17% Similarity=0.171 Sum_probs=156.0
Q ss_pred eecCCCeEEEeeeccccceeEEEEE-----ecCCCcEEEEEEeecCccchHHHHHHHHHHHhcC---CCCeeEEEEEEEe
Q 028681 17 MHDSDRYELVRDIGSGNFGVARLMR-----DKKTEELVAVKYIERGDKIDENVQREIINHRSLR---HPNIVRFKEVILT 88 (205)
Q Consensus 17 ~~~~~~y~~~~~l~~g~~g~v~~~~-----~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~ 88 (205)
....++|++.+.||+|+||.||++. +..+++.||+|++... ...++..|..++..++ |+|++.+++++..
T Consensus 61 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~ 138 (365)
T 3e7e_A 61 QLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA--NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLF 138 (365)
T ss_dssp ECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC--CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEEC
T ss_pred EECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC--ChhHHHHHHHHHHHhhhhhhhhhhhhheeeec
Confidence 3446789999999999999999994 6677899999998754 3456777777777776 8999999999999
Q ss_pred CCeEEEEEEecCCCchHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecC-----------
Q 028681 89 PTHLAIVMEYASGGELFERICN-----AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDG----------- 152 (205)
Q Consensus 89 ~~~~~lv~~~~~~~sl~~~~~~-----~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~----------- 152 (205)
++..++||||+++++|.+.+.. ...+++..++.++.|++.||+|||++||+||||||+||+++.
T Consensus 139 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~~~~~ 218 (365)
T 3e7e_A 139 QNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDL 218 (365)
T ss_dssp SSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC------
T ss_pred CCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCccccccc
Confidence 9999999999999999999973 456999999999999999999999999999999999999987
Q ss_pred CCCCcEEEeeeccccccc---CCCCCCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 153 SPAPRLKICDFGYSKSSV---LHSQPKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 153 ~~~~~~~l~df~~~~~~~---~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
++. +||+|||+|+... .........||+.|+|||++.+..++.+ +|||||
T Consensus 219 ~~~--~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~Diwsl 271 (365)
T 3e7e_A 219 SAG--LALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQ-IDYFGV 271 (365)
T ss_dssp CTT--EEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTH-HHHHHH
T ss_pred cCC--EEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCcc-ccHHHH
Confidence 455 9999999996432 2333345579999999999999988766 999996
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=237.42 Aligned_cols=185 Identities=34% Similarity=0.606 Sum_probs=160.5
Q ss_pred CCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCcc-------chHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeE
Q 028681 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK-------IDENVQREIINHRSLRHPNIVRFKEVILTPTHL 92 (205)
Q Consensus 20 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~-------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 92 (205)
.++|++.+.||+|++|.||.+.+..+++.|++|.+..... ..+.+..|+.+++.++||||+++++++.++...
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T 3bhy_A 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV 83 (283)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence 3679999999999999999999999999999999876422 246789999999999999999999999999999
Q ss_pred EEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCC--CCcEEEeeeccccccc
Q 028681 93 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSP--APRLKICDFGYSKSSV 170 (205)
Q Consensus 93 ~lv~~~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~--~~~~~l~df~~~~~~~ 170 (205)
++++|++++++|.+.+.....+++..+..++.|++.||.+||++|++|+||+|+||+++.++ ...++|+|||.+....
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~~ 163 (283)
T 3bhy_A 84 VLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIE 163 (283)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEECC
T ss_pred EEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecccceecc
Confidence 99999999999999998888899999999999999999999999999999999999998765 1249999999997765
Q ss_pred CCCCCCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 171 LHSQPKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 171 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
.........+++.|+|||.+.+..++.+ +|||||
T Consensus 164 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~sl 197 (283)
T 3bhy_A 164 AGNEFKNIFGTPEFVAPEIVNYEPLGLE-ADMWSI 197 (283)
T ss_dssp --------CCCGGGCCHHHHTTCCCCTH-HHHHHH
T ss_pred CCCcccccCCCcCccCcceecCCCCCcc-hhhhhH
Confidence 5555555678999999999998888766 999986
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=251.67 Aligned_cols=190 Identities=29% Similarity=0.438 Sum_probs=159.6
Q ss_pred cccCceecCCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCcc---chHHHHHHHHHHHhcCCCCeeEEEEEEEe
Q 028681 12 MDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILT 88 (205)
Q Consensus 12 ~~~~~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 88 (205)
+.+......++|++.+.||+|++|.||.+.+..+++.||+|++..... ..+.+.+|+.+++.++|+||+++++++..
T Consensus 17 Q~~~~~~i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~ 96 (432)
T 3n9x_A 17 QGIKNVHVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIP 96 (432)
T ss_dssp TCGGGCCCCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCC
T ss_pred cCCCcceecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEec
Confidence 334455567999999999999999999999999999999999976422 23678899999999999999999999987
Q ss_pred C-----CeEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeee
Q 028681 89 P-----THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDF 163 (205)
Q Consensus 89 ~-----~~~~lv~~~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df 163 (205)
. ...++|||++. ++|.+.+.....+++..++.++.|++.||.|||+.||+||||+|+||+++.++. +||+||
T Consensus 97 ~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~--~kL~DF 173 (432)
T 3n9x_A 97 DDLLKFDELYIVLEIAD-SDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCS--VKVCDF 173 (432)
T ss_dssp SCTTTCCCEEEEEECCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC--EEECCC
T ss_pred CCCCcCCeEEEEEecCC-cCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCC--EEEccC
Confidence 6 57899999986 599999988888999999999999999999999999999999999999988877 999999
Q ss_pred cccccccCCCC-----------------------CCCCCCCCCccCCceec-cCcCCCeeeEEEeC
Q 028681 164 GYSKSSVLHSQ-----------------------PKSTVGTPAYIAPEVLL-KKEYDGKVMCVYVI 205 (205)
Q Consensus 164 ~~~~~~~~~~~-----------------------~~~~~~~~~~~aPE~~~-~~~~~~~~~Dvwsl 205 (205)
|+++....... .....||+.|+|||++. ...++.+ +|||||
T Consensus 174 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~-~DiwSl 238 (432)
T 3n9x_A 174 GLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKS-IDIWST 238 (432)
T ss_dssp TTCEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTH-HHHHHH
T ss_pred CCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcc-cccchH
Confidence 99976543321 24457899999999975 4456544 999996
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=237.03 Aligned_cols=185 Identities=42% Similarity=0.678 Sum_probs=156.6
Q ss_pred cCCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCc----cchHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEE
Q 028681 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 94 (205)
Q Consensus 19 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 94 (205)
..++|++.+.||+|++|.||.+.+..+++.|++|.+.... ...+.+..|+..++.++||||+++++++..++..++
T Consensus 9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 88 (276)
T 2h6d_A 9 KIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFM 88 (276)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred eeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEE
Confidence 4589999999999999999999999999999999987542 234578899999999999999999999999999999
Q ss_pred EEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCCCC
Q 028681 95 VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 174 (205)
Q Consensus 95 v~~~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~ 174 (205)
++|++++++|.+.+.....+++..+..++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||++........
T Consensus 89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~--~~l~dfg~~~~~~~~~~ 166 (276)
T 2h6d_A 89 VMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMN--AKIADFGLSNMMSDGEF 166 (276)
T ss_dssp EEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSC--EEECCCCGGGCCCC---
T ss_pred EEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCC--EEEeecccccccCCCcc
Confidence 9999999999999988888999999999999999999999999999999999999988877 99999999977655554
Q ss_pred CCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 175 PKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 175 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
.....+++.|+|||.+.+..+.+.++|||||
T Consensus 167 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~sl 197 (276)
T 2h6d_A 167 LRTSCGSPNYAAPEVISGRLYAGPEVDIWSC 197 (276)
T ss_dssp ----------CCTGGGTTSCCCHHHHHHHHH
T ss_pred eecccCCccccCHHHHcCCCCCCccchHHHH
Confidence 4556789999999999987775556999986
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=254.13 Aligned_cols=185 Identities=37% Similarity=0.584 Sum_probs=162.7
Q ss_pred cCCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCc--------------cchHHHHHHHHHHHhcCCCCeeEEEE
Q 028681 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD--------------KIDENVQREIINHRSLRHPNIVRFKE 84 (205)
Q Consensus 19 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~--------------~~~~~~~~e~~~l~~l~h~~i~~~~~ 84 (205)
..++|++.+.||+|+||.||++.+..++..||+|++.... ...+.+.+|+.+++.++||||+++++
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 113 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD 113 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 4688999999999999999999999999999999997643 23467889999999999999999999
Q ss_pred EEEeCCeEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCC-CcEEEeee
Q 028681 85 VILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPA-PRLKICDF 163 (205)
Q Consensus 85 ~~~~~~~~~lv~~~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~-~~~~l~df 163 (205)
++.++...++||||+++++|.+.+.....+++..+..++.|++.||.|||++||+||||+|+||+++.++. ..++|+||
T Consensus 114 ~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Df 193 (504)
T 3q5i_A 114 VFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDF 193 (504)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEECCC
T ss_pred EEEcCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEEEEC
Confidence 99999999999999999999999988888999999999999999999999999999999999999987653 24999999
Q ss_pred cccccccCCCCCCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 164 GYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
|++.............|++.|+|||++.+ .++.+ +|||||
T Consensus 194 g~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~-~Diwsl 233 (504)
T 3q5i_A 194 GLSSFFSKDYKLRDRLGTAYYIAPEVLKK-KYNEK-CDVWSC 233 (504)
T ss_dssp TTCEECCTTSCBCCCCSCTTTCCHHHHTT-CBCTH-HHHHHH
T ss_pred CCCEEcCCCCccccccCCcCCCCHHHhcc-CCCch-HHHHHH
Confidence 99987776666666789999999999874 56655 999985
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=240.68 Aligned_cols=183 Identities=30% Similarity=0.476 Sum_probs=154.7
Q ss_pred CCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCccc---hHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEE
Q 028681 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI---DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (205)
Q Consensus 20 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 96 (205)
.++|++.+.||+|++|.||.+.+..+++.|++|.+...... .+.+..|+.+++.++||||+++++++..++..+++|
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVF 81 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEE
Confidence 47899999999999999999999999999999998665432 355778999999999999999999999999999999
Q ss_pred EecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCC-CCC
Q 028681 97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQP 175 (205)
Q Consensus 97 ~~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~-~~~ 175 (205)
|++++++|.+++.....+++..+..++.|++.||.|||+.|++|+||+|+||+++.++. ++|+|||++...... ...
T Consensus 82 e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~~ 159 (311)
T 4agu_A 82 EYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSV--IKLCDFGFARLLTGPSDYY 159 (311)
T ss_dssp ECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC--EEECCCTTCEECC------
T ss_pred EeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCC--EEEeeCCCchhccCccccc
Confidence 99999999998887888999999999999999999999999999999999999988877 999999999765432 333
Q ss_pred CCCCCCCCccCCceeccC-cCCCeeeEEEeC
Q 028681 176 KSTVGTPAYIAPEVLLKK-EYDGKVMCVYVI 205 (205)
Q Consensus 176 ~~~~~~~~~~aPE~~~~~-~~~~~~~Dvwsl 205 (205)
....++..|+|||++.+. .++. ++|||||
T Consensus 160 ~~~~~~~~y~aPE~~~~~~~~~~-~~Di~sl 189 (311)
T 4agu_A 160 DDEVATRWYRSPELLVGDTQYGP-PVDVWAI 189 (311)
T ss_dssp ------GGGCCHHHHHTCSCCCT-HHHHHHH
T ss_pred CCCcCCccccChHHHhcCCCCCc-chhhHHH
Confidence 445689999999999874 4554 4999986
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=255.32 Aligned_cols=184 Identities=30% Similarity=0.411 Sum_probs=163.7
Q ss_pred cCCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCc----cchHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEE
Q 028681 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 94 (205)
Q Consensus 19 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 94 (205)
..++|++.+.||+|+||.||++.+..+++.||+|++.+.. ...+.+..|..+++.++||||+++++++.+....++
T Consensus 183 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~l 262 (543)
T 3c4z_A 183 GEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCL 262 (543)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred ChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEE
Confidence 4589999999999999999999999999999999997642 223568889999999999999999999999999999
Q ss_pred EEEecCCCchHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeeccccccc
Q 028681 95 VMEYASGGELFERICNA----GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 170 (205)
Q Consensus 95 v~~~~~~~sl~~~~~~~----~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~ 170 (205)
||||+++++|.+.+... ..+++..++.++.|++.||.|||++||+||||+|+||+++.++. +||+|||+++...
T Consensus 263 VmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~--vkL~DFGla~~~~ 340 (543)
T 3c4z_A 263 VMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGN--VRISDLGLAVELK 340 (543)
T ss_dssp EECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSC--EEECCCTTCEECC
T ss_pred EEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCC--EEEeecceeeecc
Confidence 99999999999988653 36999999999999999999999999999999999999998887 9999999998765
Q ss_pred CCCCC-CCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 171 LHSQP-KSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 171 ~~~~~-~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
..... ....||+.|+|||++.+..++.+ +|||||
T Consensus 341 ~~~~~~~~~~GT~~Y~APE~l~~~~~~~~-~DiwSl 375 (543)
T 3c4z_A 341 AGQTKTKGYAGTPGFMAPELLLGEEYDFS-VDYFAL 375 (543)
T ss_dssp TTCCCBCCCCSCTTTSCHHHHTTCCBCTH-HHHHHH
T ss_pred CCCcccccccCCccccChhhhcCCCCChH-HhcCcc
Confidence 44333 34479999999999999888866 999996
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-39 Score=239.28 Aligned_cols=189 Identities=22% Similarity=0.361 Sum_probs=162.1
Q ss_pred ccCceecCCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCccchHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeE
Q 028681 13 DMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHL 92 (205)
Q Consensus 13 ~~~~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 92 (205)
...+....++|++.+.||+|+||.||.+.+. ++..|++|.+.......+.+.+|+.+++.++|+||+++++++.+++..
T Consensus 16 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 94 (283)
T 3gen_A 16 YGSWEIDPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPI 94 (283)
T ss_dssp CCTTBCCGGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSE
T ss_pred CCCccCCHHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCCCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCe
Confidence 3455567899999999999999999999877 467799999998777778899999999999999999999999999999
Q ss_pred EEEEEecCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccC
Q 028681 93 AIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 171 (205)
Q Consensus 93 ~lv~~~~~~~sl~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~ 171 (205)
+++||++++++|.+.+.. ...+++..+..++.|++.||.+||++|++|+||+|+||+++.++. ++|+|||++.....
T Consensus 95 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~--~kl~Dfg~~~~~~~ 172 (283)
T 3gen_A 95 FIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGV--VKVSDFGLSRYVLD 172 (283)
T ss_dssp EEEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSC--EEECSTTGGGGBCC
T ss_pred EEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCC--EEEccccccccccc
Confidence 999999999999999976 457999999999999999999999999999999999999988877 99999999875533
Q ss_pred C--CCCCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 172 H--SQPKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 172 ~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
. .......+++.|+|||.+.+..++.+ +|||||
T Consensus 173 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~sl 207 (283)
T 3gen_A 173 DEYTSSVGSKFPVRWSPPEVLMYSKFSSK-SDIWAF 207 (283)
T ss_dssp HHHHSTTSTTSCGGGCCHHHHHHCCCSHH-HHHHHH
T ss_pred cccccccCCccCcccCCHHHhccCCCCch-hhHHHH
Confidence 2 12223346788999999998888755 999986
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-39 Score=255.38 Aligned_cols=190 Identities=37% Similarity=0.556 Sum_probs=163.9
Q ss_pred cCceecCCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecC---ccchHHHHHHHHHHHhcCCCCeeEEEEEEEeCC
Q 028681 14 MPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG---DKIDENVQREIINHRSLRHPNIVRFKEVILTPT 90 (205)
Q Consensus 14 ~~~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 90 (205)
...+...++|++.+.||+|+||.||++.+..++..||+|++... ....+.+..|+.+++.++||||+++++++.+..
T Consensus 15 ~~~g~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 94 (486)
T 3mwu_A 15 YFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSS 94 (486)
T ss_dssp TTCCHHHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred cccCChhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCC
Confidence 33444568999999999999999999999999999999998653 234567889999999999999999999999999
Q ss_pred eEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCC-CCcEEEeeecccccc
Q 028681 91 HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSP-APRLKICDFGYSKSS 169 (205)
Q Consensus 91 ~~~lv~~~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~-~~~~~l~df~~~~~~ 169 (205)
..++++|++.+++|.+.+.....+++..+..++.|++.||.|||++||+||||+|+||+++..+ ...++|+|||++...
T Consensus 95 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~ 174 (486)
T 3mwu_A 95 SFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF 174 (486)
T ss_dssp EEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTB
T ss_pred EEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeEC
Confidence 9999999999999999998888899999999999999999999999999999999999996432 234999999999877
Q ss_pred cCCCCCCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 170 VLHSQPKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 170 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
..........|++.|+|||++.+. ++.+ +|||||
T Consensus 175 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-~Diwsl 208 (486)
T 3mwu_A 175 QQNTKMKDRIGTAYYIAPEVLRGT-YDEK-CDVWSA 208 (486)
T ss_dssp CCC----CCTTGGGGCCGGGGGSC-CCHH-HHHHHH
T ss_pred CCCCccCCCcCCCCCCCHHHhCCC-CCch-hhHHHH
Confidence 666666667899999999999764 6655 999986
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-39 Score=237.56 Aligned_cols=186 Identities=26% Similarity=0.396 Sum_probs=163.1
Q ss_pred ceecCCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCccchHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEE
Q 028681 16 IMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV 95 (205)
Q Consensus 16 ~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 95 (205)
+....++|++.+.||+|++|.||.+.+.. +..|++|.+.......+.+.+|+.++++++||||+++++++.+++..+++
T Consensus 5 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (269)
T 4hcu_A 5 WVIDPSELTFVQEIGSGQFGLVHLGYWLN-KDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLV 83 (269)
T ss_dssp CBCCGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEE
T ss_pred EEeChhhceeeheecCCCccEEEEEEecC-CCeEEEEEecccccCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEE
Confidence 34567899999999999999999999874 66799999998777778899999999999999999999999999999999
Q ss_pred EEecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCCC-
Q 028681 96 MEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS- 173 (205)
Q Consensus 96 ~~~~~~~sl~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~~- 173 (205)
|||+++++|.+.+... ..+++..+..++.|++.|+.+||+.|++|+||+|+||+++.++. ++|+|||++.......
T Consensus 84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~ 161 (269)
T 4hcu_A 84 FEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQV--IKVSDFGMTRFVLDDQY 161 (269)
T ss_dssp EECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGC--EEECCTTGGGGBCCHHH
T ss_pred EEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCC--EEecccccccccccccc
Confidence 9999999999999653 45999999999999999999999999999999999999988776 9999999997553322
Q ss_pred -CCCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 174 -QPKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 174 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
......+++.|+|||.+.+..++.+ +|||||
T Consensus 162 ~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~sl 193 (269)
T 4hcu_A 162 TSSTGTKFPVKWASPEVFSFSRYSSK-SDVWSF 193 (269)
T ss_dssp HSTTSTTCCGGGCCHHHHHHCCCCHH-HHHHHH
T ss_pred ccccCcccccccCCHHHhcCCCCCch-hhhHHH
Confidence 2233456788999999998888766 999986
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=239.75 Aligned_cols=190 Identities=24% Similarity=0.315 Sum_probs=153.0
Q ss_pred ccCceecCCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCccc----hHHHHHHHHHHHhcCCCCeeEEEEEEEe
Q 028681 13 DMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI----DENVQREIINHRSLRHPNIVRFKEVILT 88 (205)
Q Consensus 13 ~~~~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 88 (205)
........++|++.+.||+|++|.||.+.+..+++.|++|++...... .+.+..|+.+++.++||||+++++++..
T Consensus 26 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~ 105 (309)
T 2h34_A 26 ESREGTQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEI 105 (309)
T ss_dssp --------CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE
T ss_pred ccCCCcEeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEee
Confidence 344556679999999999999999999999999999999998764322 3668899999999999999999999999
Q ss_pred CCeEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeeccccc
Q 028681 89 PTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 168 (205)
Q Consensus 89 ~~~~~lv~~~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~ 168 (205)
++..++++|++++++|.+.+....++++..+..++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||++..
T Consensus 106 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~--~kl~Dfg~~~~ 183 (309)
T 2h34_A 106 DGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDF--AYLVDFGIASA 183 (309)
T ss_dssp TTEEEEEEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSC--EEECSCCC---
T ss_pred CCeEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCC--EEEecCccCcc
Confidence 9999999999999999999988888999999999999999999999999999999999999988877 99999999875
Q ss_pred ccCCC--CCCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 169 SVLHS--QPKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 169 ~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
..... ......+++.|+|||.+.+..++.+ +|||||
T Consensus 184 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~sl 221 (309)
T 2h34_A 184 TTDEKLTQLGNTVGTLYYMAPERFSESHATYR-ADIYAL 221 (309)
T ss_dssp -------------CCGGGCCGGGTCC----CC-CHHHHH
T ss_pred ccccccccccccCCCcCccCHHHHcCCCCCch-HhHHHH
Confidence 54332 2233468999999999998888765 999986
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=241.35 Aligned_cols=186 Identities=32% Similarity=0.486 Sum_probs=152.2
Q ss_pred CceecCCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCccc---hHHHHHHHHHHHhcCCCCeeEEEEEEEeCCe
Q 028681 15 PIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI---DENVQREIINHRSLRHPNIVRFKEVILTPTH 91 (205)
Q Consensus 15 ~~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 91 (205)
.+....++|++.+.||+|+||.||++.+ ++..||+|++...... .+.+.+|+.++++++||||+++++++.+.+.
T Consensus 31 ~~~i~~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 108 (309)
T 3p86_A 31 DMDIPWCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPN 108 (309)
T ss_dssp -CBCCGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTC
T ss_pred cccCChhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCc
Confidence 3444578999999999999999999987 4778999998765433 3467889999999999999999999999999
Q ss_pred EEEEEEecCCCchHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHhcC--cEeecCCCCCeEecCCCCCcEEEeeeccc
Q 028681 92 LAIVMEYASGGELFERICNAGR---FSEDEARFFFQQLISGVSYCHSMQ--VCHRDLKLENTLLDGSPAPRLKICDFGYS 166 (205)
Q Consensus 92 ~~lv~~~~~~~sl~~~~~~~~~---~~~~~~~~i~~~i~~~l~~lh~~~--i~H~di~p~nili~~~~~~~~~l~df~~~ 166 (205)
.+++|||+++++|.+.+..... +++..+..++.|++.||.|||+.| ++|+||+|+||+++.++. ++|+|||++
T Consensus 109 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~--~kL~Dfg~a 186 (309)
T 3p86_A 109 LSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYT--VKVCDFGLS 186 (309)
T ss_dssp CEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCC--EEECCCC--
T ss_pred eEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCc--EEECCCCCC
Confidence 9999999999999999976543 999999999999999999999999 999999999999988877 999999999
Q ss_pred ccccCCC-CCCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 167 KSSVLHS-QPKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 167 ~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
+...... ......|++.|+|||++.+..++.+ +|||||
T Consensus 187 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~Diwsl 225 (309)
T 3p86_A 187 RLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEK-SDVYSF 225 (309)
T ss_dssp ---------------CCTTSCHHHHTTCCCCTT-HHHHHH
T ss_pred ccccccccccccCCCCccccChhhhcCCCCCch-hhHHHH
Confidence 7544332 2344568999999999998888766 999986
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=245.22 Aligned_cols=185 Identities=29% Similarity=0.404 Sum_probs=154.9
Q ss_pred ecCCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCccc----hHHHHHHHHHHHhcCCCCeeEEEEEEEeCC---
Q 028681 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI----DENVQREIINHRSLRHPNIVRFKEVILTPT--- 90 (205)
Q Consensus 18 ~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--- 90 (205)
...++|++.+.||+|++|.||++.+..+++.||+|++...... ...+.+|+.+++.++||||+++++++....
T Consensus 9 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 88 (311)
T 3ork_A 9 HLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAG 88 (311)
T ss_dssp EETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTE
T ss_pred eecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCC
Confidence 3468999999999999999999999999999999999765322 246788999999999999999999987654
Q ss_pred -eEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccc
Q 028681 91 -HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 169 (205)
Q Consensus 91 -~~~lv~~~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~ 169 (205)
..++||||+++++|.+++...+++++..+..++.|++.||.|||++|++|+||+|+||+++.++. ++|+|||++...
T Consensus 89 ~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~--~kl~Dfg~a~~~ 166 (311)
T 3ork_A 89 PLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNA--VKVMDFGIARAI 166 (311)
T ss_dssp EEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSC--EEECCCSCC---
T ss_pred cccEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCC--EEEeeccCcccc
Confidence 34999999999999999988888999999999999999999999999999999999999988877 999999999765
Q ss_pred cCCCC----CCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 170 VLHSQ----PKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 170 ~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
..... .....|++.|+|||++.+..++.+ +|||||
T Consensus 167 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~Di~sl 205 (311)
T 3ork_A 167 ADSGNSVTQTAAVIGTAQYLSPEQARGDSVDAR-SDVYSL 205 (311)
T ss_dssp ---------------CCTTCCHHHHHTCCCCHH-HHHHHH
T ss_pred cccccccccccccCcCcccCCHHHhcCCCCCch-HhHHHH
Confidence 43322 223458999999999998888766 999986
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-38 Score=241.61 Aligned_cols=185 Identities=34% Similarity=0.480 Sum_probs=164.7
Q ss_pred ecCCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCc----cchHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEE
Q 028681 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLA 93 (205)
Q Consensus 18 ~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 93 (205)
...++|++.+.||+|+||.||.+.+..+++.|++|++.... ...+.+..|+.+++.++|+||+++++++.+.+..+
T Consensus 38 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 117 (335)
T 2owb_A 38 RSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVF 117 (335)
T ss_dssp TTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred ccCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEE
Confidence 34678999999999999999999999999999999987643 23466888999999999999999999999999999
Q ss_pred EEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCC-
Q 028681 94 IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH- 172 (205)
Q Consensus 94 lv~~~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~- 172 (205)
++|||+.+++|.+.+.....+++..+..++.|++.||.|||++|++|+||+|+||+++.++. ++|+|||++......
T Consensus 118 lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~--~kl~Dfg~~~~~~~~~ 195 (335)
T 2owb_A 118 VVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLE--VKIGDFGLATKVEYDG 195 (335)
T ss_dssp EEECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCC--EEECCCTTCEECCSTT
T ss_pred EEEecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCC--EEEeeccCceecccCc
Confidence 99999999999999988888999999999999999999999999999999999999988877 999999999765433
Q ss_pred CCCCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 173 SQPKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 173 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
.......+++.|+|||.+.+..++.+ +|||||
T Consensus 196 ~~~~~~~gt~~y~aPE~~~~~~~~~~-~Di~sl 227 (335)
T 2owb_A 196 ERKKVLCGTPNYIAPEVLSKKGHSFE-VDVWSI 227 (335)
T ss_dssp CCBCCCCSCCSSCCHHHHHTSCBCTH-HHHHHH
T ss_pred ccccccCCCccccCHHHhccCCCCch-hhHHHH
Confidence 23344568999999999998888766 999986
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-39 Score=240.54 Aligned_cols=184 Identities=35% Similarity=0.577 Sum_probs=154.5
Q ss_pred cCCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCcc---------------------------chHHHHHHHHHH
Q 028681 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---------------------------IDENVQREIINH 71 (205)
Q Consensus 19 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~---------------------------~~~~~~~e~~~l 71 (205)
..++|++.+.||+|+||.||++.+..+++.||+|++..... ..+.+..|+.++
T Consensus 11 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 90 (298)
T 2zv2_A 11 QLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAIL 90 (298)
T ss_dssp EETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHH
T ss_pred eecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHH
Confidence 45899999999999999999999999999999999876431 124578999999
Q ss_pred HhcCCCCeeEEEEEEEe--CCeEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeE
Q 028681 72 RSLRHPNIVRFKEVILT--PTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTL 149 (205)
Q Consensus 72 ~~l~h~~i~~~~~~~~~--~~~~~lv~~~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nil 149 (205)
+.++||||+++++++.+ ....+++||++++++|.+.. ...++++..+..++.|++.||.|||+.|++|+||+|+||+
T Consensus 91 ~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil 169 (298)
T 2zv2_A 91 KKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP-TLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLL 169 (298)
T ss_dssp HTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSS-CSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEE
T ss_pred HhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEE
Confidence 99999999999999987 56899999999999988765 4457999999999999999999999999999999999999
Q ss_pred ecCCCCCcEEEeeecccccccCCC-CCCCCCCCCCccCCceeccCcC--CCeeeEEEeC
Q 028681 150 LDGSPAPRLKICDFGYSKSSVLHS-QPKSTVGTPAYIAPEVLLKKEY--DGKVMCVYVI 205 (205)
Q Consensus 150 i~~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~--~~~~~Dvwsl 205 (205)
++.++. ++|+|||++....... ......|++.|+|||.+.+... ...++|||||
T Consensus 170 ~~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~sl 226 (298)
T 2zv2_A 170 VGEDGH--IKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAM 226 (298)
T ss_dssp ECTTSC--EEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHH
T ss_pred ECCCCC--EEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhH
Confidence 988877 9999999997654332 2234578999999999987653 2455899986
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-39 Score=254.16 Aligned_cols=183 Identities=30% Similarity=0.458 Sum_probs=145.2
Q ss_pred cCCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCcc---chHHHHHHHHHHHhcCCCCeeEEEEEEEeC-----C
Q 028681 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTP-----T 90 (205)
Q Consensus 19 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~ 90 (205)
..++|++.+.||+|+||.||.+.+..+++.||+|++..... ..+.+..|+.+++.++|+||+++++++... .
T Consensus 51 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 130 (458)
T 3rp9_A 51 IPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFD 130 (458)
T ss_dssp SCTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred cCCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCc
Confidence 45889999999999999999999999999999999875422 235688999999999999999999998543 5
Q ss_pred eEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeeccccccc
Q 028681 91 HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 170 (205)
Q Consensus 91 ~~~lv~~~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~ 170 (205)
.+++|||++ +++|.+.+.....+++..++.++.|++.||.|||+.||+||||||+||+++.++. +||+|||+++...
T Consensus 131 ~~~lv~e~~-~~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~--~kl~DFGla~~~~ 207 (458)
T 3rp9_A 131 ELYVVLEIA-DSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCS--VKVCDFGLARTVD 207 (458)
T ss_dssp CEEEEECCC-SEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCC--EEECCCTTCBCTT
T ss_pred eEEEEEecc-ccchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCC--Eeecccccchhcc
Confidence 689999988 4689999988888999999999999999999999999999999999999998887 9999999997654
Q ss_pred CCC----------------------------CCCCCCCCCCccCCceec-cCcCCCeeeEEEeC
Q 028681 171 LHS----------------------------QPKSTVGTPAYIAPEVLL-KKEYDGKVMCVYVI 205 (205)
Q Consensus 171 ~~~----------------------------~~~~~~~~~~~~aPE~~~-~~~~~~~~~Dvwsl 205 (205)
... ......||+.|+|||++. ...++.+ +|||||
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~-~DiwSl 270 (458)
T 3rp9_A 208 YPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEA-IDVWSI 270 (458)
T ss_dssp SCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTH-HHHHHH
T ss_pred CccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcH-hHHHHH
Confidence 221 122335799999999875 4556655 999996
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=261.15 Aligned_cols=184 Identities=32% Similarity=0.496 Sum_probs=163.7
Q ss_pred cCCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecC----ccchHHHHHHHHHHHhc-CCCCeeEEEEEEEeCCeEE
Q 028681 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG----DKIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLA 93 (205)
Q Consensus 19 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~----~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~ 93 (205)
..++|++.+.||+|+||.||++.+..+++.||+|++.+. ....+.+..|..++..+ .|++|+++++++.+.+.++
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~ 418 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 418 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence 467899999999999999999999999999999999753 23345677888888877 6999999999999999999
Q ss_pred EEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeeccccccc-CC
Q 028681 94 IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV-LH 172 (205)
Q Consensus 94 lv~~~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~-~~ 172 (205)
+||||+++++|.+.+...+.+++..++.++.|++.||+|||+.||+||||+|+||+++.++. +||+|||+++... ..
T Consensus 419 lV~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~--ikL~DFGla~~~~~~~ 496 (674)
T 3pfq_A 419 FVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGH--IKIADFGMCKENIWDG 496 (674)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSC--EEECCCTTCEECCCTT
T ss_pred EEEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCc--EEEeecceeeccccCC
Confidence 99999999999999988888999999999999999999999999999999999999998887 9999999997533 33
Q ss_pred CCCCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 173 SQPKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 173 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
.......||+.|+|||++.+..++.+ +|||||
T Consensus 497 ~~~~~~~GT~~Y~APE~l~~~~~~~~-~DvwSl 528 (674)
T 3pfq_A 497 VTTKTFCGTPDYIAPEIIAYQPYGKS-VDWWAF 528 (674)
T ss_dssp CCBCCCCSCSSSCCHHHHTCCCBSTH-HHHHHH
T ss_pred cccccccCCCcccCHhhhcCCCCCcc-ceEech
Confidence 44455679999999999999999766 999996
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=236.08 Aligned_cols=187 Identities=30% Similarity=0.468 Sum_probs=144.3
Q ss_pred ceecCCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCc----cchHHHHHHHHHHHhcCCCCeeEEEEEEEeCCe
Q 028681 16 IMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTH 91 (205)
Q Consensus 16 ~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 91 (205)
++...++|++.+.||+|++|.||.+.+..+++.|++|.+.... ...+.+.+|+.+++.++|||++++++++.+.+.
T Consensus 6 ~g~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 85 (278)
T 3cok_A 6 IGEKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNY 85 (278)
T ss_dssp HCSSGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSE
T ss_pred cccccccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCe
Confidence 4455689999999999999999999999999999999997542 223678899999999999999999999999999
Q ss_pred EEEEEEecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeeccccccc
Q 028681 92 LAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 170 (205)
Q Consensus 92 ~~lv~~~~~~~sl~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~ 170 (205)
.++++|++++++|.+.+... .++++..+..++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||++....
T Consensus 86 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~--~kl~dfg~~~~~~ 163 (278)
T 3cok_A 86 VYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMN--IKIADFGLATQLK 163 (278)
T ss_dssp EEEEEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCC--EEECCCTTCEECC
T ss_pred EEEEEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCC--EEEEeecceeecc
Confidence 99999999999999998764 57999999999999999999999999999999999999988877 9999999987654
Q ss_pred CC-CCCCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 171 LH-SQPKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 171 ~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
.. .......+++.|+|||.+.+..++.+ +|||||
T Consensus 164 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~sl 198 (278)
T 3cok_A 164 MPHEKHYTLCGTPNYISPEIATRSAHGLE-SDVWSL 198 (278)
T ss_dssp ----------------------------C-THHHHH
T ss_pred CCCCcceeccCCCCcCCcchhcCCCCCch-hhHHHH
Confidence 33 22334568999999999988877655 999986
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=244.76 Aligned_cols=186 Identities=24% Similarity=0.337 Sum_probs=158.7
Q ss_pred eecCCCeEEEeeeccccceeEEEEEec-------CCCcEEEEEEeecCcc--chHHHHHHHHHHHhc-CCCCeeEEEEEE
Q 028681 17 MHDSDRYELVRDIGSGNFGVARLMRDK-------KTEELVAVKYIERGDK--IDENVQREIINHRSL-RHPNIVRFKEVI 86 (205)
Q Consensus 17 ~~~~~~y~~~~~l~~g~~g~v~~~~~~-------~~~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l-~h~~i~~~~~~~ 86 (205)
....++|++.+.||+|+||.||++.+. .++..||+|.++.... ..+.+..|+.+++.+ +||||+++++++
T Consensus 77 ~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~ 156 (370)
T 2psq_A 77 EFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC 156 (370)
T ss_dssp BCCGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEE
T ss_pred cccHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEE
Confidence 345689999999999999999999874 3456799999976532 235688999999999 899999999999
Q ss_pred EeCCeEEEEEEecCCCchHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEe
Q 028681 87 LTPTHLAIVMEYASGGELFERICNAG----------------RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLL 150 (205)
Q Consensus 87 ~~~~~~~lv~~~~~~~sl~~~~~~~~----------------~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili 150 (205)
.+++..++||||+++++|.+++.... .+++..+..++.|++.||.|||++||+|+||+|+||++
T Consensus 157 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll 236 (370)
T 2psq_A 157 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLV 236 (370)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE
T ss_pred ccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhEEE
Confidence 99999999999999999999997643 37899999999999999999999999999999999999
Q ss_pred cCCCCCcEEEeeecccccccCCCC---CCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 151 DGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 151 ~~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
+.++. +||+|||+++....... .....+++.|+|||++.+..++.+ +|||||
T Consensus 237 ~~~~~--~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~-~Dvwsl 291 (370)
T 2psq_A 237 TENNV--MKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQ-SDVWSF 291 (370)
T ss_dssp CTTCC--EEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHH-HHHHHH
T ss_pred CCCCC--EEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcH-HHHHHH
Confidence 88887 99999999975543322 223346788999999998888766 999986
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=240.45 Aligned_cols=183 Identities=28% Similarity=0.459 Sum_probs=144.0
Q ss_pred cCCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCc--cchHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEE
Q 028681 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (205)
Q Consensus 19 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 96 (205)
..++|++.+.||+|++|.||++.+..+++.||+|.+.... ...+.+.+|+.+++.++||||+++++++..++..++||
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 82 (317)
T 2pmi_A 3 SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVF 82 (317)
T ss_dssp ----------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEE
T ss_pred cccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEE
Confidence 3578999999999999999999999999999999997643 23467889999999999999999999999999999999
Q ss_pred EecCCCchHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeeccccccc
Q 028681 97 EYASGGELFERICNA------GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 170 (205)
Q Consensus 97 ~~~~~~sl~~~~~~~------~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~ 170 (205)
||++ ++|.+.+... ..+++..+..++.|++.||.|||++||+|+||+|+||+++.++. ++|+|||++....
T Consensus 83 e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~--~kl~Dfg~~~~~~ 159 (317)
T 2pmi_A 83 EFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQ--LKLGDFGLARAFG 159 (317)
T ss_dssp ECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC--EEECCCSSCEETT
T ss_pred EecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCC--EEECcCccceecC
Confidence 9997 4888887643 35899999999999999999999999999999999999988887 9999999997654
Q ss_pred CC-CCCCCCCCCCCccCCceeccC-cCCCeeeEEEeC
Q 028681 171 LH-SQPKSTVGTPAYIAPEVLLKK-EYDGKVMCVYVI 205 (205)
Q Consensus 171 ~~-~~~~~~~~~~~~~aPE~~~~~-~~~~~~~Dvwsl 205 (205)
.. .......+++.|+|||++.+. .++.+ +|||||
T Consensus 160 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~-~Diwsl 195 (317)
T 2pmi_A 160 IPVNTFSSEVVTLWYRAPDVLMGSRTYSTS-IDIWSC 195 (317)
T ss_dssp SCCCCCCCCCSCCTTCCHHHHTTCCCCCTH-HHHHHH
T ss_pred CCcccCCCCcccccccCchHhhCCCCCCcH-HHHHHH
Confidence 33 233445789999999999865 45555 999986
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=237.25 Aligned_cols=180 Identities=31% Similarity=0.514 Sum_probs=152.1
Q ss_pred CCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCcc---chHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEE
Q 028681 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (205)
Q Consensus 21 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~ 97 (205)
++|++.+.||+|+||.||++.+ .+++.||+|.+..... ..+.+.+|+.+++.++||||+++++++.+++..+++||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFE 80 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred ccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEE
Confidence 6899999999999999999998 5688899999875432 23678899999999999999999999999999999999
Q ss_pred ecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCC-CCC
Q 028681 98 YASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQP 175 (205)
Q Consensus 98 ~~~~~sl~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~-~~~ 175 (205)
++++ +|.+.+... ..+++..+..++.|++.||.|||++|++|+||+|+||+++.++. ++|+|||++...... ...
T Consensus 81 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~~ 157 (288)
T 1ob3_A 81 HLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGE--LKIADFGLARAFGIPVRKY 157 (288)
T ss_dssp CCSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSC--EEECCTTHHHHHCC-----
T ss_pred ecCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCC--EEEeECccccccCcccccc
Confidence 9975 888888653 57999999999999999999999999999999999999988877 999999999765432 223
Q ss_pred CCCCCCCCccCCceeccCc-CCCeeeEEEeC
Q 028681 176 KSTVGTPAYIAPEVLLKKE-YDGKVMCVYVI 205 (205)
Q Consensus 176 ~~~~~~~~~~aPE~~~~~~-~~~~~~Dvwsl 205 (205)
....+++.|+|||++.+.. ++.+ +|||||
T Consensus 158 ~~~~~t~~y~aPE~~~~~~~~~~~-~Diwsl 187 (288)
T 1ob3_A 158 THEIVTLWYRAPDVLMGSKKYSTT-IDIWSV 187 (288)
T ss_dssp ----CCCTTCCHHHHTTCCSCCTH-HHHHHH
T ss_pred ccccccccccCchheeCCCCCCcH-HHHHHH
Confidence 3446899999999997654 5544 999986
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-38 Score=241.46 Aligned_cols=184 Identities=24% Similarity=0.423 Sum_probs=160.9
Q ss_pred ecCCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCccchHHHHHHHHHHHhcC-----CCCeeEEEEEEEeCCeE
Q 028681 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLR-----HPNIVRFKEVILTPTHL 92 (205)
Q Consensus 18 ~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~-----h~~i~~~~~~~~~~~~~ 92 (205)
...++|++.+.||+|+||.||++.+..+++.||+|++.......+.+..|+.+++.++ |+||+++++++...+..
T Consensus 32 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~~~ 111 (360)
T 3llt_A 32 LLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDHM 111 (360)
T ss_dssp EETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETTEE
T ss_pred EecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccchhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECCee
Confidence 3468999999999999999999999999999999999876666677888999999986 99999999999999999
Q ss_pred EEEEEecCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCC-----------------
Q 028681 93 AIVMEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGS----------------- 153 (205)
Q Consensus 93 ~lv~~~~~~~sl~~~~~~~~--~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~----------------- 153 (205)
+++||++ +++|.+.+.... .+++..++.++.|++.||.|||++||+|+||+|+||+++.+
T Consensus 112 ~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~~~ 190 (360)
T 3llt_A 112 CLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKK 190 (360)
T ss_dssp EEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEEECTTTCCE
T ss_pred EEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccchhccccccc
Confidence 9999999 889999997654 59999999999999999999999999999999999999751
Q ss_pred ------CCCcEEEeeecccccccCCCCCCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 154 ------PAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 154 ------~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
....++|+|||++..... ......|++.|+|||++.+..++.+ +|||||
T Consensus 191 ~~~~~~~~~~~kl~DFG~a~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~-~Diwsl 245 (360)
T 3llt_A 191 IQIYRTKSTGIKLIDFGCATFKSD--YHGSIINTRQYRAPEVILNLGWDVS-SDMWSF 245 (360)
T ss_dssp EEEEEESCCCEEECCCTTCEETTS--CCCSCCSCGGGCCHHHHTTCCCCTT-HHHHHH
T ss_pred ccccccCCCCEEEEeccCceecCC--CCcCccCcccccCcHHHcCCCCCCc-cchHHH
Confidence 123499999999975432 2345578999999999999888866 999996
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-38 Score=235.78 Aligned_cols=186 Identities=33% Similarity=0.473 Sum_probs=164.9
Q ss_pred eecCCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCc----cchHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeE
Q 028681 17 MHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHL 92 (205)
Q Consensus 17 ~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 92 (205)
....++|++.+.||+|++|.||.+.+..+++.+++|++.... ...+.+..|+.+++.++|+||+++++++.+++..
T Consensus 11 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (294)
T 2rku_A 11 PRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFV 90 (294)
T ss_dssp TTTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred CCcccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEE
Confidence 345689999999999999999999999999999999987643 2345688899999999999999999999999999
Q ss_pred EEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCC
Q 028681 93 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 172 (205)
Q Consensus 93 ~lv~~~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~ 172 (205)
++++|++++++|.+.+.....+++..+..++.|++.|+.+||+.|++|+||+|+||+++.++. ++|+|||++......
T Consensus 91 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~--~kl~dfg~~~~~~~~ 168 (294)
T 2rku_A 91 FVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLE--VKIGDFGLATKVEYD 168 (294)
T ss_dssp EEEEECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC--EEECCCTTCEECCST
T ss_pred EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCC--EEEEeccCceecccC
Confidence 999999999999999988888999999999999999999999999999999999999988877 999999998765433
Q ss_pred -CCCCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 173 -SQPKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 173 -~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
.......+++.|+|||.+.+..++.+ +|||||
T Consensus 169 ~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~sl 201 (294)
T 2rku_A 169 GERKKVLCGTPNYIAPEVLSKKGHSFE-VDVWSI 201 (294)
T ss_dssp TCCBCCCCSCCSSCCHHHHTTSCBCTH-HHHHHH
T ss_pred ccccccccCCCCcCCcchhccCCCCch-hhHHHH
Confidence 22344568999999999998888766 999985
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=235.66 Aligned_cols=184 Identities=28% Similarity=0.410 Sum_probs=161.6
Q ss_pred ecCCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCccchHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEE
Q 028681 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (205)
Q Consensus 18 ~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~ 97 (205)
...++|++.+.||+|++|.||.+.+.. +..|++|.+.......+++..|+.+++.++||||+++++++.+++..+++||
T Consensus 5 l~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (268)
T 3sxs_A 5 LKREEITLLKELGSGQFGVVKLGKWKG-QYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTE 83 (268)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETT-TEEEEEEEECBTTBCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred echhheeeeeeeccCCCceEEEEEecC-ceeEEEEEeccCCCcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEE
Confidence 456899999999999999999998764 6679999998877777889999999999999999999999999999999999
Q ss_pred ecCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCCCC--
Q 028681 98 YASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-- 174 (205)
Q Consensus 98 ~~~~~sl~~~~~~~~-~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~-- 174 (205)
++++++|.+.+.... .+++..+..++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||++........
T Consensus 84 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~--~~l~Dfg~~~~~~~~~~~~ 161 (268)
T 3sxs_A 84 YISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLC--VKVSDFGMTRYVLDDQYVS 161 (268)
T ss_dssp CCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCC--EEECCTTCEEECCTTCEEE
T ss_pred ccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCC--EEEccCccceecchhhhhc
Confidence 999999999997643 5999999999999999999999999999999999999988877 99999999875543322
Q ss_pred CCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 175 PKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 175 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
.....+++.|+|||.+.+..++.+ +|||||
T Consensus 162 ~~~~~~~~~y~aPE~~~~~~~~~~-~Di~sl 191 (268)
T 3sxs_A 162 SVGTKFPVKWSAPEVFHYFKYSSK-SDVWAF 191 (268)
T ss_dssp CCSCCCCGGGCCHHHHHHSEEETT-HHHHHH
T ss_pred ccCCCcCcccCCHHHHhccCCchh-hhhHHH
Confidence 223346678999999998888766 999986
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=245.48 Aligned_cols=181 Identities=30% Similarity=0.462 Sum_probs=154.3
Q ss_pred EEEeeeccccceeEEEEEecCCCcEEEEEEeecCc-cchHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEEecCCC
Q 028681 24 ELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGG 102 (205)
Q Consensus 24 ~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~~~~~ 102 (205)
...+.||+|+||.||++.+..++..||+|++.... ...+.+.+|+.+++.++||||+++++++...+..++||||++++
T Consensus 92 ~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~ 171 (373)
T 2x4f_A 92 SKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGG 171 (373)
T ss_dssp EEEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTC
T ss_pred ecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCC
Confidence 34678999999999999999999999999998654 34567899999999999999999999999999999999999999
Q ss_pred chHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCCCCCCCCCCC
Q 028681 103 ELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGT 181 (205)
Q Consensus 103 sl~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~ 181 (205)
+|.+.+... ..+++..+..++.|++.||.|||+.||+|+||+|+||++..+....++|+|||+++............|+
T Consensus 172 ~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~~~~~~gt 251 (373)
T 2x4f_A 172 ELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFGT 251 (373)
T ss_dssp EEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCBCCCCCSS
T ss_pred cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccccccccCC
Confidence 998888653 4699999999999999999999999999999999999995444445999999999877666655666799
Q ss_pred CCccCCceeccCcCCCeeeEEEeC
Q 028681 182 PAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 182 ~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
+.|+|||++.+..++.+ +|||||
T Consensus 252 ~~y~aPE~~~~~~~~~~-~Diwsl 274 (373)
T 2x4f_A 252 PEFLAPEVVNYDFVSFP-TDMWSV 274 (373)
T ss_dssp CTTCCHHHHTTCBCCHH-HHHHHH
T ss_pred CcEeChhhccCCCCCcH-HhHHHH
Confidence 99999999988887765 999986
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=242.01 Aligned_cols=182 Identities=37% Similarity=0.593 Sum_probs=142.9
Q ss_pred CCeEEE---eeeccccceeEEEEEecCCCcEEEEEEeecCccchHHHHHHHHHHHhcC-CCCeeEEEEEEEeCCeEEEEE
Q 028681 21 DRYELV---RDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLR-HPNIVRFKEVILTPTHLAIVM 96 (205)
Q Consensus 21 ~~y~~~---~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~ 96 (205)
++|++. +.||+|+||.||.+.+..+++.||+|++... ....+..|+..++.+. ||||+++++++.++...++||
T Consensus 8 ~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~ 85 (325)
T 3kn6_A 8 QHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR--MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVM 85 (325)
T ss_dssp HHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGG--GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred hccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChh--hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEE
Confidence 567775 7899999999999999999999999999753 3466788999999997 999999999999999999999
Q ss_pred EecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCC-CCcEEEeeecccccccCCC-C
Q 028681 97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSP-APRLKICDFGYSKSSVLHS-Q 174 (205)
Q Consensus 97 ~~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~-~~~~~l~df~~~~~~~~~~-~ 174 (205)
|++++++|.+.+...+.+++..+..++.|++.||.|||++||+|+||+|+||+++.++ ...++|+|||+++...... .
T Consensus 86 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~ 165 (325)
T 3kn6_A 86 ELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQP 165 (325)
T ss_dssp CCCCSCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC----
T ss_pred EccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCCc
Confidence 9999999999999888999999999999999999999999999999999999997654 2249999999997654432 3
Q ss_pred CCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 175 PKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 175 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
.....+++.|+|||++.+..++.+ +|||||
T Consensus 166 ~~~~~~t~~y~aPE~~~~~~~~~~-~Diwsl 195 (325)
T 3kn6_A 166 LKTPCFTLHYAAPELLNQNGYDES-CDLWSL 195 (325)
T ss_dssp ------------------CCCCHH-HHHHHH
T ss_pred ccccCCCcCccCHHHhcCCCCCCc-cchHHH
Confidence 344568999999999998888766 999986
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-38 Score=235.14 Aligned_cols=187 Identities=30% Similarity=0.449 Sum_probs=163.5
Q ss_pred ceecCCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCc----------cchHHHHHHHHHHHhcC-CCCeeEEEE
Q 028681 16 IMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----------KIDENVQREIINHRSLR-HPNIVRFKE 84 (205)
Q Consensus 16 ~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~----------~~~~~~~~e~~~l~~l~-h~~i~~~~~ 84 (205)
.....++|++.+.||+|++|.||.+.+..+++.|++|++.... ...+.+..|+.+++++. ||||+++++
T Consensus 12 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~ 91 (298)
T 1phk_A 12 THGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKD 91 (298)
T ss_dssp ---CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEE
T ss_pred CcchhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeee
Confidence 3455799999999999999999999999999999999997543 12355778999999996 999999999
Q ss_pred EEEeCCeEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeec
Q 028681 85 VILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFG 164 (205)
Q Consensus 85 ~~~~~~~~~lv~~~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~ 164 (205)
++..++..++++|++++++|.+.+.....+++..+..++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||
T Consensus 92 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~--~kl~dfg 169 (298)
T 1phk_A 92 TYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMN--IKLTDFG 169 (298)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC--EEECCCT
T ss_pred eeccCCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCc--EEEeccc
Confidence 99999999999999999999999988888999999999999999999999999999999999999988877 9999999
Q ss_pred ccccccCCCCCCCCCCCCCccCCceec------cCcCCCeeeEEEeC
Q 028681 165 YSKSSVLHSQPKSTVGTPAYIAPEVLL------KKEYDGKVMCVYVI 205 (205)
Q Consensus 165 ~~~~~~~~~~~~~~~~~~~~~aPE~~~------~~~~~~~~~Dvwsl 205 (205)
++.............+++.|+|||++. ...++.+ +|||||
T Consensus 170 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~-~Di~sl 215 (298)
T 1phk_A 170 FSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKE-VDMWST 215 (298)
T ss_dssp TCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTH-HHHHHH
T ss_pred chhhcCCCcccccccCCccccCHHHhccccccccccCCcc-cccHhH
Confidence 998776655556667999999999986 3345545 999986
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-38 Score=234.78 Aligned_cols=183 Identities=31% Similarity=0.578 Sum_probs=159.8
Q ss_pred cCCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCc----cchHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEE
Q 028681 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 94 (205)
Q Consensus 19 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 94 (205)
..++|++.+.||+|++|.||.+.+..++..|++|++.... .....+..|+.+++.++||||+++++++.+....++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 86 (279)
T 3fdn_A 7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL 86 (279)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEE
Confidence 4589999999999999999999999999999999986542 224568889999999999999999999999999999
Q ss_pred EEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCCCC
Q 028681 95 VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 174 (205)
Q Consensus 95 v~~~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~ 174 (205)
+|||+++++|.+.+.....+++..+..++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||++...... .
T Consensus 87 v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~--~~l~Dfg~~~~~~~~-~ 163 (279)
T 3fdn_A 87 ILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGE--LKIADFGWSVHAPSS-R 163 (279)
T ss_dssp EECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSC--EEECSCCEESCC-----
T ss_pred EEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCC--EEEEeccccccCCcc-c
Confidence 9999999999999988888999999999999999999999999999999999999988887 999999988544332 2
Q ss_pred CCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 175 PKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 175 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
.....+++.|+|||.+.+..++.+ +|||||
T Consensus 164 ~~~~~~~~~y~aPE~~~~~~~~~~-~Di~sl 193 (279)
T 3fdn_A 164 RTDLCGTLDYLPPEMIEGRMHDEK-VDLWSL 193 (279)
T ss_dssp ----CCCCTTCCHHHHTTCCCCTT-HHHHHH
T ss_pred ccccCCCCCccCHhHhccCCCCcc-chhHhH
Confidence 344568999999999988888766 999986
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=238.85 Aligned_cols=188 Identities=22% Similarity=0.287 Sum_probs=165.6
Q ss_pred CceecCCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCccchHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEE
Q 028681 15 PIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 94 (205)
Q Consensus 15 ~~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 94 (205)
......++|++.+.||+|++|.||.+.+..++..|++|.+.......+.+..|+.+++.++||||+++++++.+++..++
T Consensus 7 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 86 (288)
T 3kfa_A 7 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI 86 (288)
T ss_dssp TTBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCSTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEE
T ss_pred cccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEE
Confidence 33446789999999999999999999999999999999998777677889999999999999999999999999999999
Q ss_pred EEEecCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCC
Q 028681 95 VMEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 172 (205)
Q Consensus 95 v~~~~~~~sl~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~ 172 (205)
+||++++++|.+.+... ..+++..+..++.|++.||.+||++|++|+||+|+||+++.++. ++|+|||++......
T Consensus 87 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~--~~l~Dfg~~~~~~~~ 164 (288)
T 3kfa_A 87 ITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHL--VKVADFGLSRLMTGD 164 (288)
T ss_dssp EEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGC--EEECCCCGGGTSCSS
T ss_pred EEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCC--EEEccCccceeccCC
Confidence 99999999999999763 45999999999999999999999999999999999999988777 999999999765433
Q ss_pred CCC--CCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 173 SQP--KSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 173 ~~~--~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
... ....+++.|+|||.+.+..++.+ +|||||
T Consensus 165 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~sl 198 (288)
T 3kfa_A 165 TYTAHAGAKFPIKWTAPESLAYNKFSIK-SDVWAF 198 (288)
T ss_dssp SSEEETTEEECGGGCCHHHHHHCCCCHH-HHHHHH
T ss_pred ccccccCCccccCcCChhhhccCCCCch-hhHHHH
Confidence 321 22246778999999998888755 999986
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-38 Score=240.57 Aligned_cols=184 Identities=26% Similarity=0.266 Sum_probs=159.7
Q ss_pred cCCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCccchHHHHHHHHHHHhc-CCCCeeEEEEEEEeCCeEEEEEE
Q 028681 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIVME 97 (205)
Q Consensus 19 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~~ 97 (205)
..++|++.+.||+|+||.||++.+..+++.||+|++.... ..+.+..|+.+++.+ +|+||+++++++..++..+++||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e 85 (330)
T 2izr_A 7 VGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKS-RAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLE 85 (330)
T ss_dssp ETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTC-SSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEE
T ss_pred EcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEecccc-chHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEE
Confidence 3589999999999999999999999999999999987543 345688999999999 99999999999999999999999
Q ss_pred ecCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCC---cEEEeeecccccccCCC
Q 028681 98 YASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAP---RLKICDFGYSKSSVLHS 173 (205)
Q Consensus 98 ~~~~~sl~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~---~~~l~df~~~~~~~~~~ 173 (205)
++ +++|.+++.. ...+++..+..++.|++.||+|||+.||+|+||+|+||+++.++.. .++|+|||+++......
T Consensus 86 ~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~~~ 164 (330)
T 2izr_A 86 LL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPE 164 (330)
T ss_dssp CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBCTT
T ss_pred eC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceeeecCC
Confidence 99 8899999976 4679999999999999999999999999999999999999765532 29999999997654332
Q ss_pred C--------CCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 174 Q--------PKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 174 ~--------~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
. .....||+.|+|||++.+..++.+ +|||||
T Consensus 165 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~Di~sl 203 (330)
T 2izr_A 165 TKKHIPYREHKSLTGTARYMSINTHLGKEQSRR-DDLEAL 203 (330)
T ss_dssp TCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHH-HHHHHH
T ss_pred CCccccccccCCcCCCccccChHHHcCCCCCch-hHHHHH
Confidence 2 234569999999999999888765 999996
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-38 Score=237.48 Aligned_cols=180 Identities=28% Similarity=0.471 Sum_probs=160.3
Q ss_pred CeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCcc-chHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEEecC
Q 028681 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYAS 100 (205)
Q Consensus 22 ~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~~~ 100 (205)
.|...+.||+|++|.||.+.+..+|+.||+|++..... ..+.+.+|+.+++.++||||+++++++...+..+++|||++
T Consensus 46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 125 (321)
T 2c30_A 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQ 125 (321)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECCCC
T ss_pred hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEecCC
Confidence 48888999999999999999998999999999976543 34678899999999999999999999999999999999999
Q ss_pred CCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCCC-CCCCCC
Q 028681 101 GGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKSTV 179 (205)
Q Consensus 101 ~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~~-~~~~~~ 179 (205)
+++|.+.+.. ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++. ++|+|||++....... ......
T Consensus 126 ~~~L~~~l~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~ 202 (321)
T 2c30_A 126 GGALTDIVSQ-VRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGR--VKLSDFGFCAQISKDVPKRKSLV 202 (321)
T ss_dssp SCBHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCC--EEECCCTTCEECCSSSCCBCCCC
T ss_pred CCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCc--EEEeeeeeeeecccCcccccccc
Confidence 9999998754 56999999999999999999999999999999999999988877 9999999987655433 234457
Q ss_pred CCCCccCCceeccCcCCCeeeEEEeC
Q 028681 180 GTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 180 ~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
|++.|+|||++.+..++.+ +|||||
T Consensus 203 gt~~y~aPE~~~~~~~~~~-~Dv~sl 227 (321)
T 2c30_A 203 GTPYWMAPEVISRSLYATE-VDIWSL 227 (321)
T ss_dssp SCGGGCCHHHHTTCCBCTH-HHHHHH
T ss_pred CCccccCHhhhcCCCCCch-hhHHHH
Confidence 9999999999998888766 999986
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-38 Score=251.92 Aligned_cols=184 Identities=38% Similarity=0.586 Sum_probs=159.8
Q ss_pred CCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCc---cchHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEE
Q 028681 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (205)
Q Consensus 20 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 96 (205)
.++|++.+.||+|+||.||++.+..++..||+|++.... ...+.+.+|+.+++.++||||+++++++.+....++||
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 115 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM 115 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 347999999999999999999999999999999997643 33567889999999999999999999999999999999
Q ss_pred EecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCC-CCcEEEeeecccccccCCCCC
Q 028681 97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSP-APRLKICDFGYSKSSVLHSQP 175 (205)
Q Consensus 97 ~~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~-~~~~~l~df~~~~~~~~~~~~ 175 (205)
||+++++|.+.+....++++..+..++.|++.||.|||++||+||||+|+||+++..+ ...++|+|||++.........
T Consensus 116 e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~~~~ 195 (494)
T 3lij_A 116 ECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKM 195 (494)
T ss_dssp ECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTTBCB
T ss_pred ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCCccc
Confidence 9999999999998888899999999999999999999999999999999999997533 234999999999877666666
Q ss_pred CCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 176 KSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 176 ~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
....|++.|+|||++. ..++.+ +|||||
T Consensus 196 ~~~~gt~~y~aPE~l~-~~~~~~-~Diwsl 223 (494)
T 3lij_A 196 KERLGTAYYIAPEVLR-KKYDEK-CDVWSI 223 (494)
T ss_dssp CCCCSCTTTCCHHHHT-TCBCTH-HHHHHH
T ss_pred cccCCCcCeeCHHHHc-ccCCCc-hhHHHH
Confidence 6678999999999986 456655 999985
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-39 Score=255.49 Aligned_cols=185 Identities=39% Similarity=0.567 Sum_probs=162.9
Q ss_pred cCCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCc----cchHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEE
Q 028681 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 94 (205)
Q Consensus 19 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 94 (205)
..++|++.+.||+|+||.||.+.+..+++.||+|++.... ...+.+..|+.+++.++||||+++++++.+.+..++
T Consensus 24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 103 (484)
T 3nyv_A 24 FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYL 103 (484)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 3578999999999999999999999999999999987542 335678999999999999999999999999999999
Q ss_pred EEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCC-CCCcEEEeeecccccccCCC
Q 028681 95 VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGS-PAPRLKICDFGYSKSSVLHS 173 (205)
Q Consensus 95 v~~~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~-~~~~~~l~df~~~~~~~~~~ 173 (205)
++|++.+++|.+.+.....+++..+..++.|++.||.|||++||+||||+|+||+++.. ....++|+|||++.......
T Consensus 104 v~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~ 183 (484)
T 3nyv_A 104 VGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASK 183 (484)
T ss_dssp EECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCCCC
T ss_pred EEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEccccc
Confidence 99999999999999888889999999999999999999999999999999999999532 22249999999998766555
Q ss_pred CCCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 174 QPKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 174 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
......|++.|+|||++.+ .++.+ +|||||
T Consensus 184 ~~~~~~gt~~y~aPE~~~~-~~~~~-~Diwsl 213 (484)
T 3nyv_A 184 KMKDKIGTAYYIAPEVLHG-TYDEK-CDVWST 213 (484)
T ss_dssp SHHHHTTGGGTCCHHHHHT-CCCTH-HHHHHH
T ss_pred ccccCCCCccccCceeecC-CCCCc-ceeHHH
Confidence 5455579999999999976 56655 999986
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=242.72 Aligned_cols=186 Identities=24% Similarity=0.329 Sum_probs=157.5
Q ss_pred eecCCCeEEEeeeccccceeEEEEEecCCCc---EEEEEEeecCc--cchHHHHHHHHHHHhcCCCCeeEEEEEEEeCCe
Q 028681 17 MHDSDRYELVRDIGSGNFGVARLMRDKKTEE---LVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTH 91 (205)
Q Consensus 17 ~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~---~v~iK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 91 (205)
....++|++.+.||+|+||.||.+.+..++. .||+|.+.... ...+.+..|+.+++.++||||+++++++.+++.
T Consensus 45 ~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 124 (325)
T 3kul_A 45 EIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRL 124 (325)
T ss_dssp BCCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGC
T ss_pred ccChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCc
Confidence 3456899999999999999999999975544 59999998643 234668899999999999999999999999999
Q ss_pred EEEEEEecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeeccccccc
Q 028681 92 LAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 170 (205)
Q Consensus 92 ~~lv~~~~~~~sl~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~ 170 (205)
.++||||+++++|.+++... ..+++..+..++.|++.||.|||+.||+|+||+|+||+++.++. ++|+|||+++...
T Consensus 125 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~--~kl~Dfg~a~~~~ 202 (325)
T 3kul_A 125 AMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLV--CKVSDFGLSRVLE 202 (325)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC--EEECCCSSCEECC
T ss_pred cEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCC--EEECCCCcccccc
Confidence 99999999999999999654 57999999999999999999999999999999999999988877 9999999997654
Q ss_pred CCCCC----CCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 171 LHSQP----KSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 171 ~~~~~----~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
..... ....+++.|+|||++.+..++.+ +|||||
T Consensus 203 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~-~Di~sl 240 (325)
T 3kul_A 203 DDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSA-SDVWSF 240 (325)
T ss_dssp ----CCEECC---CCGGGSCHHHHHHCEECHH-HHHHHH
T ss_pred cCccceeeccCCCCcccccCHhHhcCCCCCcH-HHHHHH
Confidence 43221 12235678999999998888766 999986
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-38 Score=237.28 Aligned_cols=180 Identities=22% Similarity=0.309 Sum_probs=149.7
Q ss_pred CCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCccc---hHHHHHHHHHHHhc-CCCCeeEEEEEEEeCCeEEEEE
Q 028681 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI---DENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIVM 96 (205)
Q Consensus 21 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~---~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~ 96 (205)
++|++.+.||+|+||+||++.+..+++.||+|++...... ......|+..+..+ +|+||+++++++.+++..+++|
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~ 136 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQT 136 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEE
Confidence 6799999999999999999999999999999988654322 23344455555444 8999999999999999999999
Q ss_pred EecCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCCCCC
Q 028681 97 EYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 175 (205)
Q Consensus 97 ~~~~~~sl~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~~ 175 (205)
|++ +++|.+.+.. ...+++..+..++.|++.||.|||+.+|+|+||+|+||+++.++. +||+|||++.........
T Consensus 137 e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~--~kl~DFG~a~~~~~~~~~ 213 (311)
T 3p1a_A 137 ELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGR--CKLGDFGLLVELGTAGAG 213 (311)
T ss_dssp ECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGC--EEECCCTTCEECC-----
T ss_pred ecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCC--EEEccceeeeecccCCCC
Confidence 999 5578777765 446999999999999999999999999999999999999988887 999999999877666666
Q ss_pred CCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 176 KSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 176 ~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
....|++.|+|||++.+ .++.+ +|||||
T Consensus 214 ~~~~gt~~y~aPE~~~~-~~~~~-~Diwsl 241 (311)
T 3p1a_A 214 EVQEGDPRYMAPELLQG-SYGTA-ADVFSL 241 (311)
T ss_dssp -CCCCCGGGCCGGGGGT-CCSTH-HHHHHH
T ss_pred cccCCCccccCHhHhcC-CCCch-hhHHHH
Confidence 66679999999999876 56655 999986
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-38 Score=236.60 Aligned_cols=186 Identities=32% Similarity=0.508 Sum_probs=155.4
Q ss_pred ecCCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCcc--chHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEE
Q 028681 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV 95 (205)
Q Consensus 18 ~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 95 (205)
...++|++.+.||+|+||.||++.+..++..+++|.+..... ..+.+..|+.+++.++||||+++++++.+....+++
T Consensus 19 ~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 98 (285)
T 3is5_A 19 TIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIV 98 (285)
T ss_dssp CHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ChhhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEE
Confidence 345889999999999999999999999999999999876542 347789999999999999999999999999999999
Q ss_pred EEecCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCC-CCCcEEEeeeccccccc
Q 028681 96 MEYASGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGS-PAPRLKICDFGYSKSSV 170 (205)
Q Consensus 96 ~~~~~~~sl~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~-~~~~~~l~df~~~~~~~ 170 (205)
||++++++|.+.+.. ...+++..+..++.|++.||.+||+.|++|+||+|+||+++.+ ....++|+|||++....
T Consensus 99 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~ 178 (285)
T 3is5_A 99 METCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK 178 (285)
T ss_dssp ECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC--
T ss_pred EEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeecceecC
Confidence 999999999888854 3679999999999999999999999999999999999999542 22349999999997766
Q ss_pred CCCCCCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 171 LHSQPKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 171 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
.........+++.|+|||++.+ .++.+ +|||||
T Consensus 179 ~~~~~~~~~~t~~y~aPE~~~~-~~~~~-~Di~sl 211 (285)
T 3is5_A 179 SDEHSTNAAGTALYMAPEVFKR-DVTFK-CDIWSA 211 (285)
T ss_dssp --------CTTGGGCCHHHHTT-CCCHH-HHHHHH
T ss_pred CcccCcCcccccCcCChHHhcc-CCCcc-cCeehH
Confidence 5555566679999999999864 45544 999986
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-38 Score=239.44 Aligned_cols=187 Identities=29% Similarity=0.475 Sum_probs=158.2
Q ss_pred ceecCCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCccc---hHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeE
Q 028681 16 IMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI---DENVQREIINHRSLRHPNIVRFKEVILTPTHL 92 (205)
Q Consensus 16 ~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 92 (205)
.....++|++.+.||+|++|.||.+.+..+++.|++|.+...... .+.+..|+.+++.++||||+++++++.+.+..
T Consensus 20 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 99 (331)
T 4aaa_A 20 YFQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRW 99 (331)
T ss_dssp CCBCGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred hhhhhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEE
Confidence 344578999999999999999999999999999999998765332 34577899999999999999999999999999
Q ss_pred EEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCC
Q 028681 93 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 172 (205)
Q Consensus 93 ~lv~~~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~ 172 (205)
+++||++++++|.++......+++..+..++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||++......
T Consensus 100 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~ 177 (331)
T 4aaa_A 100 YLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGV--VKLCDFGFARTLAAP 177 (331)
T ss_dssp EEEEECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSC--EEECCCTTC------
T ss_pred EEEEecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCc--EEEEeCCCceeecCC
Confidence 999999999888888777778999999999999999999999999999999999999988877 999999999765432
Q ss_pred -CCCCCCCCCCCccCCceeccC-cCCCeeeEEEeC
Q 028681 173 -SQPKSTVGTPAYIAPEVLLKK-EYDGKVMCVYVI 205 (205)
Q Consensus 173 -~~~~~~~~~~~~~aPE~~~~~-~~~~~~~Dvwsl 205 (205)
.......+++.|+|||++.+. .++. ++|||||
T Consensus 178 ~~~~~~~~~t~~y~aPE~~~~~~~~~~-~~Di~sl 211 (331)
T 4aaa_A 178 GEVYDDEVATRWYRAPELLVGDVKYGK-AVDVWAI 211 (331)
T ss_dssp ------CCCCCTTCCHHHHTTCTTCCT-HHHHHHH
T ss_pred ccccCCCcCCccccCcccccCCCCcch-HHHHHHH
Confidence 333445689999999999876 4554 4999986
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-38 Score=242.09 Aligned_cols=183 Identities=32% Similarity=0.488 Sum_probs=158.4
Q ss_pred cCCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCccchHHHHHHHHHHHhc-CCCCeeEEEEEEEeCCeEEEEEE
Q 028681 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIVME 97 (205)
Q Consensus 19 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~~ 97 (205)
..++|++.+.||+|+||.||++.+..+++.||+|++.+.... ...|+.++.++ +||||+++++++.+++..++|||
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~---~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E 96 (342)
T 2qr7_A 20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD---PTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTE 96 (342)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC---CHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEEC
T ss_pred ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC---hHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEe
Confidence 357899999999999999999999999999999999865432 34577777777 79999999999999999999999
Q ss_pred ecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCC--CcEEEeeecccccccCC-CC
Q 028681 98 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPA--PRLKICDFGYSKSSVLH-SQ 174 (205)
Q Consensus 98 ~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~--~~~~l~df~~~~~~~~~-~~ 174 (205)
|+++++|.+.+...+.+++..+..++.|++.||.|||++||+||||+|+||++..+.. ..++|+|||++...... ..
T Consensus 97 ~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~~~ 176 (342)
T 2qr7_A 97 LMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGL 176 (342)
T ss_dssp CCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCTTCC
T ss_pred CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCCCCc
Confidence 9999999999988888999999999999999999999999999999999999854322 24999999999765443 33
Q ss_pred CCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 175 PKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 175 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
.....+++.|+|||++.+..++.+ +|||||
T Consensus 177 ~~~~~gt~~y~aPE~~~~~~~~~~-~Diwsl 206 (342)
T 2qr7_A 177 LMTPCYTANFVAPEVLERQGYDAA-CDIWSL 206 (342)
T ss_dssp BCCSSCCSSCCCHHHHHHHHHHHH-HHHHHH
T ss_pred eeccCCCccccCHHHhcCCCCCCc-cCeeeH
Confidence 345578999999999998877755 999986
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-38 Score=244.24 Aligned_cols=183 Identities=34% Similarity=0.527 Sum_probs=148.4
Q ss_pred ecCCCeEEE-eeeccccceeEEEEEecCCCcEEEEEEeecCccchHHHHHHHHHHH-hcCCCCeeEEEEEEEe----CCe
Q 028681 18 HDSDRYELV-RDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHR-SLRHPNIVRFKEVILT----PTH 91 (205)
Q Consensus 18 ~~~~~y~~~-~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~-~l~h~~i~~~~~~~~~----~~~ 91 (205)
...++|.+. +.||+|+||+||.+.+..+++.||+|++... ..+..|+.++. ..+|+||+++++++.. ...
T Consensus 58 ~~~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~ 133 (400)
T 1nxk_A 58 AIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKC 133 (400)
T ss_dssp CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred cccccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcE
Confidence 345778887 7899999999999999999999999998743 45667777764 4589999999999876 567
Q ss_pred EEEEEEecCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCC-CCcEEEeeeccccc
Q 028681 92 LAIVMEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSP-APRLKICDFGYSKS 168 (205)
Q Consensus 92 ~~lv~~~~~~~sl~~~~~~~~--~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~-~~~~~l~df~~~~~ 168 (205)
+++||||+++++|.+.+.... .+++..++.++.|++.||.|||++||+||||+|+||+++.+. ...+||+|||+++.
T Consensus 134 ~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~ 213 (400)
T 1nxk_A 134 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE 213 (400)
T ss_dssp EEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred EEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEecccccc
Confidence 899999999999999997643 599999999999999999999999999999999999998721 23499999999987
Q ss_pred ccCCCCCCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 169 SVLHSQPKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 169 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
...........||+.|+|||++.+..++.+ +|||||
T Consensus 214 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~Diwsl 249 (400)
T 1nxk_A 214 TTSHNSLTTPCYTPYYVAPEVLGPEKYDKS-CDMWSL 249 (400)
T ss_dssp CC-----------CTTCCGGGSCCCCSSSH-HHHHHH
T ss_pred cCCCCccccCCCCCCccCHhhcCCCCCCCc-ccHHHH
Confidence 665555556678999999999998888766 999986
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=242.00 Aligned_cols=189 Identities=33% Similarity=0.488 Sum_probs=152.5
Q ss_pred CceecCCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCccc---hHHHHHHHHHHHhcCCCCeeEEEEEEEeCCe
Q 028681 15 PIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI---DENVQREIINHRSLRHPNIVRFKEVILTPTH 91 (205)
Q Consensus 15 ~~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 91 (205)
+.....++|++.+.||+|++|.||++.+..+++.||+|++...... .+.+..|+.+++.++||||+++++++.+++.
T Consensus 28 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 107 (329)
T 3gbz_A 28 PSATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHR 107 (329)
T ss_dssp ----CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTE
T ss_pred CcccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCE
Confidence 3445578999999999999999999999999999999999754322 3457789999999999999999999999999
Q ss_pred EEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCC---CCcEEEeeeccccc
Q 028681 92 LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSP---APRLKICDFGYSKS 168 (205)
Q Consensus 92 ~~lv~~~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~---~~~~~l~df~~~~~ 168 (205)
.++||||+++ +|.+.+...+.+++..++.++.|++.||.|||++||+|+||+|+||+++.++ ...++|+|||++..
T Consensus 108 ~~lv~e~~~~-~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~ 186 (329)
T 3gbz_A 108 LHLIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARA 186 (329)
T ss_dssp EEEEEECCSE-EHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHH
T ss_pred EEEEEecCCC-CHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCccc
Confidence 9999999975 9999998888899999999999999999999999999999999999995322 22499999999976
Q ss_pred ccCC-CCCCCCCCCCCccCCceeccCc-CCCeeeEEEeC
Q 028681 169 SVLH-SQPKSTVGTPAYIAPEVLLKKE-YDGKVMCVYVI 205 (205)
Q Consensus 169 ~~~~-~~~~~~~~~~~~~aPE~~~~~~-~~~~~~Dvwsl 205 (205)
.... .......+++.|+|||++.+.. ++.+ +|||||
T Consensus 187 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~-~Diwsl 224 (329)
T 3gbz_A 187 FGIPIRQFTHEIITLWYRPPEILLGSRHYSTS-VDIWSI 224 (329)
T ss_dssp HC-----------CCTTCCHHHHTTCCCCCTH-HHHHHH
T ss_pred cCCcccccCCCcCCccccCHHHhcCCCCCCcH-HHHHHH
Confidence 5433 3334456899999999998755 5544 999986
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-38 Score=250.46 Aligned_cols=181 Identities=27% Similarity=0.405 Sum_probs=151.7
Q ss_pred cCCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCc---cchHHHHHHHHHHHhcCCCCeeEEEEEEEeC------
Q 028681 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTP------ 89 (205)
Q Consensus 19 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------ 89 (205)
..++|++.+.||+|+||.||.+.+..+++.||+|++.... ...+.+.+|+.+++.++||||+++++++...
T Consensus 60 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~ 139 (464)
T 3ttj_A 60 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF 139 (464)
T ss_dssp EETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred ecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccC
Confidence 3588999999999999999999999999999999997642 2346678999999999999999999999755
Q ss_pred CeEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccc
Q 028681 90 THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 169 (205)
Q Consensus 90 ~~~~lv~~~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~ 169 (205)
...++||||+++ .+.+.+.. .+++..++.++.|++.||.|||+.||+||||+|+||+++.++. +||+|||+++..
T Consensus 140 ~~~~lv~E~~~~-~l~~~~~~--~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~--~kl~DFG~a~~~ 214 (464)
T 3ttj_A 140 QDVYLVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTA 214 (464)
T ss_dssp CEEEEEEECCSE-EHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSC--EEECCCCCC---
T ss_pred CeEEEEEeCCCC-CHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCC--EEEEEEEeeeec
Confidence 357999999976 46555533 4999999999999999999999999999999999999998877 999999999877
Q ss_pred cCCCCCCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 170 VLHSQPKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 170 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
..........||+.|+|||++.+..++.+ +|||||
T Consensus 215 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwSl 249 (464)
T 3ttj_A 215 GTSFMMTPYVVTRYYRAPEVILGMGYKEN-VDIWSV 249 (464)
T ss_dssp --CCCC----CCCTTCCHHHHTTCCCCTT-HHHHHH
T ss_pred CCCcccCCCcccccccCHHHHcCCCCCHH-HHHHHH
Confidence 66655666789999999999999988866 999986
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-38 Score=242.80 Aligned_cols=187 Identities=25% Similarity=0.333 Sum_probs=159.9
Q ss_pred ceecCCCeEEEeeeccccceeEEEEEecCC-------CcEEEEEEeecCccc--hHHHHHHHHHHHhc-CCCCeeEEEEE
Q 028681 16 IMHDSDRYELVRDIGSGNFGVARLMRDKKT-------EELVAVKYIERGDKI--DENVQREIINHRSL-RHPNIVRFKEV 85 (205)
Q Consensus 16 ~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~-------~~~v~iK~~~~~~~~--~~~~~~e~~~l~~l-~h~~i~~~~~~ 85 (205)
.....++|++.+.||+|+||.||++.+... +..||+|++...... .+.+..|+.+++.+ +||||++++++
T Consensus 64 ~~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~ 143 (382)
T 3tt0_A 64 WELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGA 143 (382)
T ss_dssp TBCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheee
Confidence 344568999999999999999999997543 357999998765332 36688999999999 89999999999
Q ss_pred EEeCCeEEEEEEecCCCchHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeE
Q 028681 86 ILTPTHLAIVMEYASGGELFERICNAG----------------RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTL 149 (205)
Q Consensus 86 ~~~~~~~~lv~~~~~~~sl~~~~~~~~----------------~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nil 149 (205)
+..++..++|||++++++|.+++.... .+++..+..++.|++.||.|||+.||+|+||+|+||+
T Consensus 144 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIl 223 (382)
T 3tt0_A 144 CTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVL 223 (382)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEE
T ss_pred eccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcceEE
Confidence 999999999999999999999997643 4999999999999999999999999999999999999
Q ss_pred ecCCCCCcEEEeeecccccccCCC---CCCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 150 LDGSPAPRLKICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 150 i~~~~~~~~~l~df~~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
++.++. ++|+|||+++...... ......+++.|+|||++.+..++.+ +|||||
T Consensus 224 l~~~~~--~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~-~Diwsl 279 (382)
T 3tt0_A 224 VTEDNV--MKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQ-SDVWSF 279 (382)
T ss_dssp ECTTCC--EEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHH-HHHHHH
T ss_pred EcCCCc--EEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCch-hHHHHH
Confidence 988877 9999999997654332 2233346788999999998888766 999986
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-38 Score=240.68 Aligned_cols=189 Identities=28% Similarity=0.449 Sum_probs=158.5
Q ss_pred ccCceecCCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCcc---chHHHHHHHHHHHhcCCCCeeEEEEEEEeC
Q 028681 13 DMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTP 89 (205)
Q Consensus 13 ~~~~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 89 (205)
..+.+...++|++.+.||+|++|.||++.+..+++.||+|.+..... ....+..|+.+++.++||||+++++++...
T Consensus 9 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 88 (351)
T 3mi9_A 9 ECPFCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTK 88 (351)
T ss_dssp CCTTSCBGGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC
T ss_pred cccccccccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeecc
Confidence 34566678999999999999999999999999999999999865432 245678999999999999999999999874
Q ss_pred --------CeEEEEEEecCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEE
Q 028681 90 --------THLAIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKI 160 (205)
Q Consensus 90 --------~~~~lv~~~~~~~sl~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l 160 (205)
+..++||||+++ +|.+.+.. ...+++..++.++.|++.||.|||++||+|+||+|+||+++.++. ++|
T Consensus 89 ~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~--~kl 165 (351)
T 3mi9_A 89 ASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGV--LKL 165 (351)
T ss_dssp --------CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC--EEE
T ss_pred ccccccCCceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCC--EEE
Confidence 468999999975 66666654 357999999999999999999999999999999999999988887 999
Q ss_pred eeecccccccCC-----CCCCCCCCCCCccCCceeccCc-CCCeeeEEEeC
Q 028681 161 CDFGYSKSSVLH-----SQPKSTVGTPAYIAPEVLLKKE-YDGKVMCVYVI 205 (205)
Q Consensus 161 ~df~~~~~~~~~-----~~~~~~~~~~~~~aPE~~~~~~-~~~~~~Dvwsl 205 (205)
+|||++...... .......+++.|+|||++.+.. ++.+ +|||||
T Consensus 166 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~-~Diwsl 215 (351)
T 3mi9_A 166 ADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPP-IDLWGA 215 (351)
T ss_dssp CCCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTH-HHHHHH
T ss_pred ccchhcccccccccccccccCCcccccCccCchhhcCCCCCCcH-hHHHHH
Confidence 999999765422 2223346899999999998754 5544 999986
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-38 Score=233.49 Aligned_cols=183 Identities=32% Similarity=0.596 Sum_probs=163.2
Q ss_pred cCCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCc----cchHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEE
Q 028681 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 94 (205)
Q Consensus 19 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 94 (205)
..++|++.+.||+|++|.||.+.+..++..|++|.+.... ...+.+..|+.+++.++|+|++++++++.+.+..++
T Consensus 12 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 91 (284)
T 2vgo_A 12 TIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYL 91 (284)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred hhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEE
Confidence 4589999999999999999999999999999999987542 224678899999999999999999999999999999
Q ss_pred EEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCCCC
Q 028681 95 VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 174 (205)
Q Consensus 95 v~~~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~ 174 (205)
++|++++++|.+.+...+.+++..+..++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||++..... ..
T Consensus 92 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~--~kl~Dfg~~~~~~~-~~ 168 (284)
T 2vgo_A 92 MLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGE--LKIADFGWSVHAPS-LR 168 (284)
T ss_dssp EECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCC--EEECCCTTCEECSS-SC
T ss_pred EEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCC--EEEecccccccCcc-cc
Confidence 9999999999999988888999999999999999999999999999999999999988877 99999998865433 22
Q ss_pred CCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 175 PKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 175 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
.....+++.|+|||.+.+..++.+ +|||||
T Consensus 169 ~~~~~~~~~y~aPE~~~~~~~~~~-~Di~sl 198 (284)
T 2vgo_A 169 RRTMCGTLDYLPPEMIEGKTHDEK-VDLWCA 198 (284)
T ss_dssp BCCCCSCGGGCCHHHHTTCCBCTT-HHHHHH
T ss_pred cccccCCCCcCCHHHhccCCCCcc-cchhhH
Confidence 344568999999999998888766 999986
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=233.24 Aligned_cols=183 Identities=25% Similarity=0.381 Sum_probs=156.5
Q ss_pred CCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCc---cchHHHHHHHHHHHhc-CCCCeeEEEEEEEeCCeEEEE
Q 028681 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIV 95 (205)
Q Consensus 20 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv 95 (205)
.++|++.+.||+|++|.||.+.+..+++.|++|.+.... .....+..|+..+..+ +||||+++++++.+++..+++
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv 89 (289)
T 1x8b_A 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQ 89 (289)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEE
T ss_pred cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence 478999999999999999999999999999999998642 2345677888888888 899999999999999999999
Q ss_pred EEecCCCchHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCC-----------------
Q 028681 96 MEYASGGELFERICNA----GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSP----------------- 154 (205)
Q Consensus 96 ~~~~~~~sl~~~~~~~----~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~----------------- 154 (205)
+|++++++|.+.+... ..+++..+..++.|++.||.|||++|++|+||+|+||+++.++
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~~ 169 (289)
T 1x8b_A 90 NEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASN 169 (289)
T ss_dssp EECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC--------------------
T ss_pred EEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccccccccCC
Confidence 9999999999999764 6799999999999999999999999999999999999998543
Q ss_pred CCcEEEeeecccccccCCCCCCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 155 APRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 155 ~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
...++|+|||.+...... ....+++.|+|||.+.+....+.++|||||
T Consensus 170 ~~~~kl~Dfg~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~Di~sl 217 (289)
T 1x8b_A 170 KVMFKIGDLGHVTRISSP---QVEEGDSRFLANEVLQENYTHLPKADIFAL 217 (289)
T ss_dssp CCCEEECCCTTCEETTCS---CCCCCCGGGCCHHHHTTCCTTHHHHHHHHH
T ss_pred ceEEEEcccccccccCCc---cccCCCccccChhHhcCCCCCCchhhHHHH
Confidence 224999999998765432 234589999999999876444455999986
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-38 Score=234.24 Aligned_cols=184 Identities=36% Similarity=0.590 Sum_probs=162.3
Q ss_pred CCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCc--cchHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEE
Q 028681 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (205)
Q Consensus 20 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~ 97 (205)
.++|++.+.||+|++|.||.+.+..+++.|++|.+.... ...+.+.+|+.+++.++|||++++++++.+++..++++|
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 85 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence 478999999999999999999999999999999987543 234678899999999999999999999999999999999
Q ss_pred ecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCC---CC
Q 028681 98 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH---SQ 174 (205)
Q Consensus 98 ~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~---~~ 174 (205)
++++++|.+.+.....+++..+..++.|++.||.+||++|++|+||+|+||+++.++. ++|+|||.+...... ..
T Consensus 86 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~--~kl~dfg~~~~~~~~~~~~~ 163 (276)
T 2yex_A 86 YCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDN--LKISDFGLATVFRYNNRERL 163 (276)
T ss_dssp CCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC--EEECCCTTCEECEETTEECC
T ss_pred ecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCC--EEEeeCCCccccCCCcchhc
Confidence 9999999999877778999999999999999999999999999999999999988777 999999998754322 22
Q ss_pred CCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 175 PKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 175 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
.....+++.|+|||.+.+..+.+.++|||||
T Consensus 164 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~sl 194 (276)
T 2yex_A 164 LNKMCGTLPYVAPELLKRREFHAEPVDVWSC 194 (276)
T ss_dssp BCCCCSCGGGCCGGGGTCSSBCHHHHHHHHH
T ss_pred ccCCccccCccChHHHhcCCCCCCcchHHHH
Confidence 3345689999999999887775556999986
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-38 Score=234.30 Aligned_cols=180 Identities=27% Similarity=0.418 Sum_probs=159.9
Q ss_pred CCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCccchHHHHHHHHHHHhcCCCCeeEEEEEEEe-----------
Q 028681 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILT----------- 88 (205)
Q Consensus 20 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----------- 88 (205)
.++|++.+.||+|++|.||.+.+..+++.|++|.+.... +.+.+|+.+++.++|||++++++++..
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 86 (284)
T 2a19_B 10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN---EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKN 86 (284)
T ss_dssp HHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS---GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-------
T ss_pred ccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc---HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccccc
Confidence 478999999999999999999999999999999997643 456789999999999999999998864
Q ss_pred -----CCeEEEEEEecCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEe
Q 028681 89 -----PTHLAIVMEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKIC 161 (205)
Q Consensus 89 -----~~~~~lv~~~~~~~sl~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~ 161 (205)
....+++|||+++++|.+++... ..+++..+..++.|++.||.+||+.|++|+||+|+||+++.++. ++|+
T Consensus 87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~--~kl~ 164 (284)
T 2a19_B 87 SSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQ--VKIG 164 (284)
T ss_dssp --CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTE--EEEC
T ss_pred ccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCCC--EEEC
Confidence 34589999999999999999653 57999999999999999999999999999999999999988776 9999
Q ss_pred eecccccccCCCCCCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 162 DFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 162 df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
|||++.............+++.|+|||.+.+..++.+ +|||||
T Consensus 165 Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~sl 207 (284)
T 2a19_B 165 DFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKE-VDLYAL 207 (284)
T ss_dssp CCTTCEESSCCSCCCCCCSCCTTSCHHHHHCSCCCTH-HHHHHH
T ss_pred cchhheeccccccccccCCcccccChhhhccCCCcch-hhhHHH
Confidence 9999987766555566679999999999998888766 999986
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=239.72 Aligned_cols=182 Identities=30% Similarity=0.486 Sum_probs=161.9
Q ss_pred CCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCcc---------chHHHHHHHHHHHhc-CCCCeeEEEEEEEeCC
Q 028681 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---------IDENVQREIINHRSL-RHPNIVRFKEVILTPT 90 (205)
Q Consensus 21 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~---------~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~ 90 (205)
++|++.+.||+|++|.||++.+..+|+.||+|++..... ..+.+..|+.+++.+ .||||+++++++...+
T Consensus 94 ~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 173 (365)
T 2y7j_A 94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSS 173 (365)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSS
T ss_pred hhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCC
Confidence 679999999999999999999998999999999876431 134577899999999 7999999999999999
Q ss_pred eEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeeccccccc
Q 028681 91 HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 170 (205)
Q Consensus 91 ~~~lv~~~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~ 170 (205)
..+++|||+++++|.+.+.....+++..+..++.|++.||.|||+.|++|+||+|+||+++.++. ++|+|||++....
T Consensus 174 ~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~--ikl~DfG~~~~~~ 251 (365)
T 2y7j_A 174 FMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQ--IRLSDFGFSCHLE 251 (365)
T ss_dssp EEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC--EEECCCTTCEECC
T ss_pred EEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCC--EEEEecCcccccC
Confidence 99999999999999999988888999999999999999999999999999999999999988877 9999999998776
Q ss_pred CCCCCCCCCCCCCccCCceeccC------cCCCeeeEEEeC
Q 028681 171 LHSQPKSTVGTPAYIAPEVLLKK------EYDGKVMCVYVI 205 (205)
Q Consensus 171 ~~~~~~~~~~~~~~~aPE~~~~~------~~~~~~~Dvwsl 205 (205)
.........|++.|+|||++.+. .++.+ +|||||
T Consensus 252 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~-~Di~sl 291 (365)
T 2y7j_A 252 PGEKLRELCGTPGYLAPEILKCSMDETHPGYGKE-VDLWAC 291 (365)
T ss_dssp TTCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTT-HHHHHH
T ss_pred CCcccccCCCCCCccChhhccccccccCcCCCch-hhHHhH
Confidence 66655667899999999999743 45545 999986
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-38 Score=238.38 Aligned_cols=189 Identities=21% Similarity=0.292 Sum_probs=161.0
Q ss_pred cCceecCCCeEEEeeeccccceeEEEEEec-----CCCcEEEEEEeecCcc--chHHHHHHHHHHHhcCCCCeeEEEEEE
Q 028681 14 MPIMHDSDRYELVRDIGSGNFGVARLMRDK-----KTEELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVI 86 (205)
Q Consensus 14 ~~~~~~~~~y~~~~~l~~g~~g~v~~~~~~-----~~~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~ 86 (205)
-......++|++.+.||+|+||.||.+.+. .++..|++|.+..... ..+.+..|+.+++.++||||+++++++
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 95 (314)
T 2ivs_A 16 PKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGAC 95 (314)
T ss_dssp TTTBCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred cccccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEE
Confidence 344556789999999999999999999883 4458899999876432 236688999999999999999999999
Q ss_pred EeCCeEEEEEEecCCCchHHHHHhcCC------------------------CCHHHHHHHHHHHHHHHHHHHhcCcEeec
Q 028681 87 LTPTHLAIVMEYASGGELFERICNAGR------------------------FSEDEARFFFQQLISGVSYCHSMQVCHRD 142 (205)
Q Consensus 87 ~~~~~~~lv~~~~~~~sl~~~~~~~~~------------------------~~~~~~~~i~~~i~~~l~~lh~~~i~H~d 142 (205)
.+++..++++||+++++|.+++..... +++..+..++.|++.||.|||++|++|+|
T Consensus 96 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~d 175 (314)
T 2ivs_A 96 SQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRD 175 (314)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECCC
T ss_pred ecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCcccc
Confidence 999999999999999999999976433 89999999999999999999999999999
Q ss_pred CCCCCeEecCCCCCcEEEeeecccccccCCCC---CCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 143 LKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 143 i~p~nili~~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
|+|+||+++.++. ++|+|||++........ .....+++.|+|||.+.+..++.+ +|||||
T Consensus 176 ikp~NIli~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~sl 238 (314)
T 2ivs_A 176 LAARNILVAEGRK--MKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQ-SDVWSF 238 (314)
T ss_dssp CSGGGEEEETTTE--EEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHH-HHHHHH
T ss_pred cchheEEEcCCCC--EEEccccccccccccccceeccCCCCcccccChhhhcCCCcCch-hhHHHH
Confidence 9999999988776 99999999875543322 223346788999999998888766 999986
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=240.53 Aligned_cols=184 Identities=26% Similarity=0.328 Sum_probs=157.0
Q ss_pred ceecCCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCccchHHHHHHHHHHHhcCCCCeeEEEEEEEeCC----e
Q 028681 16 IMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPT----H 91 (205)
Q Consensus 16 ~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----~ 91 (205)
+....++|++.+.||+|+||.||++.+. ++.||+|++............|+.+++.++||||+++++++.... .
T Consensus 19 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 96 (322)
T 3soc_A 19 LYFQSMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVD 96 (322)
T ss_dssp EEETTEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cccchhhchhhheecccCceEEEEEEEC--CCEEEEEEeecCchHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCce
Confidence 4456789999999999999999999876 688999999876655666777899999999999999999998754 4
Q ss_pred EEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhc----------CcEeecCCCCCeEecCCCCCcEEEe
Q 028681 92 LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM----------QVCHRDLKLENTLLDGSPAPRLKIC 161 (205)
Q Consensus 92 ~~lv~~~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~----------~i~H~di~p~nili~~~~~~~~~l~ 161 (205)
+++||||+++++|.+++.. ..+++..+..++.|++.||.|||+. +|+|+||+|+||+++.++. +||+
T Consensus 97 ~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~--~kL~ 173 (322)
T 3soc_A 97 LWLITAFHEKGSLSDFLKA-NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLT--ACIA 173 (322)
T ss_dssp EEEEEECCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCC--EEEC
T ss_pred EEEEEecCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCe--EEEc
Confidence 7999999999999999965 4599999999999999999999999 9999999999999988877 9999
Q ss_pred eecccccccCCCC---CCCCCCCCCccCCceeccC-----cCCCeeeEEEeC
Q 028681 162 DFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKK-----EYDGKVMCVYVI 205 (205)
Q Consensus 162 df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~-----~~~~~~~Dvwsl 205 (205)
|||+++....... .....|++.|+|||++.+. .++. ++|||||
T Consensus 174 DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~-~~Diwsl 224 (322)
T 3soc_A 174 DFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFL-RIDMYAM 224 (322)
T ss_dssp CCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHH-HHHHHHH
T ss_pred cCCcccccccccCccccccCccCccccCHhhcccccccCcCCCc-cchhHHH
Confidence 9999976544332 2334689999999999863 3333 4899986
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-37 Score=232.44 Aligned_cols=192 Identities=29% Similarity=0.504 Sum_probs=166.3
Q ss_pred CCcccCceecCCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCc--cchHHHHHHHHHHHhcCCCCeeEEEEEEE
Q 028681 10 PGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVIL 87 (205)
Q Consensus 10 ~~~~~~~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 87 (205)
+++........+.|++.+.||+|++|.||.+.+..+++.|++|.+.... ...+.+..|+.+++.++|||++++++++.
T Consensus 11 p~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 90 (303)
T 3a7i_A 11 PGMQNLKADPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYL 90 (303)
T ss_dssp --CTTCEECGGGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred CchhcCCCChHHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEe
Confidence 3344444556678999999999999999999999999999999997653 33477899999999999999999999999
Q ss_pred eCCeEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccc
Q 028681 88 TPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 167 (205)
Q Consensus 88 ~~~~~~lv~~~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~ 167 (205)
.+...+++||++++++|.+++.. .++++..+..++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||++.
T Consensus 91 ~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~--~kl~Dfg~~~ 167 (303)
T 3a7i_A 91 KDTKLWIIMEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGE--VKLADFGVAG 167 (303)
T ss_dssp ETTEEEEEEECCTTEEHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC--EEECCCTTCE
T ss_pred cCCeEEEEEEeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCC--EEEeecccce
Confidence 99999999999999999998854 57999999999999999999999999999999999999988877 9999999987
Q ss_pred cccCCC-CCCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 168 SSVLHS-QPKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 168 ~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
...... ......+++.|+|||.+.+..++.+ +|||||
T Consensus 168 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~sl 205 (303)
T 3a7i_A 168 QLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSK-ADIWSL 205 (303)
T ss_dssp ECBTTBCCBCCCCSCGGGCCHHHHTTCCBCTH-HHHHHH
T ss_pred ecCccccccCccCCCcCccCHHHHhcCCCCch-hhhHHH
Confidence 654433 2344568999999999998888766 999986
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-38 Score=235.09 Aligned_cols=187 Identities=27% Similarity=0.407 Sum_probs=158.4
Q ss_pred ceecCCCeEEEeeeccccceeEEEEE----ecCCCcEEEEEEeecCc--cchHHHHHHHHHHHhcCCCCeeEEEEEEEeC
Q 028681 16 IMHDSDRYELVRDIGSGNFGVARLMR----DKKTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTP 89 (205)
Q Consensus 16 ~~~~~~~y~~~~~l~~g~~g~v~~~~----~~~~~~~v~iK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 89 (205)
.......|++.+.||+|++|.||.+. +..+++.||+|.+.... ...+.+..|+.+++.++|+||+++++++..+
T Consensus 16 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 95 (302)
T 4e5w_A 16 THFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTED 95 (302)
T ss_dssp TBCCGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-
T ss_pred hhhhhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecC
Confidence 33445679999999999999999999 56788999999987543 2346789999999999999999999999877
Q ss_pred --CeEEEEEEecCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeeccc
Q 028681 90 --THLAIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYS 166 (205)
Q Consensus 90 --~~~~lv~~~~~~~sl~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~ 166 (205)
...+++||++++++|.+.+.. ...+++..+..++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||++
T Consensus 96 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~--~kl~Dfg~~ 173 (302)
T 4e5w_A 96 GGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQ--VKIGDFGLT 173 (302)
T ss_dssp --CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTE--EEECCCTTC
T ss_pred CCceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCC--EEECccccc
Confidence 668999999999999999954 456999999999999999999999999999999999999988776 999999999
Q ss_pred ccccCCC----CCCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 167 KSSVLHS----QPKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 167 ~~~~~~~----~~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
....... ......++..|+|||.+.+..++.+ +|||||
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~sl 215 (302)
T 4e5w_A 174 KAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIA-SDVWSF 215 (302)
T ss_dssp EECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHH-HHHHHH
T ss_pred ccccCCCcceeccCCCCCCccccCCeeecCCCCCcc-hhHHHH
Confidence 7655443 2233457888999999998888755 999986
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=239.16 Aligned_cols=186 Identities=27% Similarity=0.433 Sum_probs=155.5
Q ss_pred eecCCCeEEEeeeccccceeEEEEE----ecCCCcEEEEEEeecCccc-hHHHHHHHHHHHhcCCCCeeEEEEEEEeC--
Q 028681 17 MHDSDRYELVRDIGSGNFGVARLMR----DKKTEELVAVKYIERGDKI-DENVQREIINHRSLRHPNIVRFKEVILTP-- 89 (205)
Q Consensus 17 ~~~~~~y~~~~~l~~g~~g~v~~~~----~~~~~~~v~iK~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-- 89 (205)
....++|++.+.||+|+||.||++. +..++..||+|++...... .+.+..|+.+++.++||||+++++++...
T Consensus 6 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 85 (295)
T 3ugc_A 6 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGR 85 (295)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHH
T ss_pred cCCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC
Confidence 3456899999999999999999998 5678899999998765433 46788999999999999999999998654
Q ss_pred CeEEEEEEecCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeeccccc
Q 028681 90 THLAIVMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 168 (205)
Q Consensus 90 ~~~~lv~~~~~~~sl~~~~~~~~-~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~ 168 (205)
...++||||+++++|.+.+.... .+++..+..++.|++.||.|||+.|++|+||+|+||+++.++. ++|+|||++..
T Consensus 86 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~--~kl~Dfg~~~~ 163 (295)
T 3ugc_A 86 RNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENR--VKIGDFGLTKV 163 (295)
T ss_dssp TSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTE--EEECCCCSCC-
T ss_pred CceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCe--EEEccCccccc
Confidence 56899999999999999997644 5999999999999999999999999999999999999988776 99999999976
Q ss_pred ccCCCC----CCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 169 SVLHSQ----PKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 169 ~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
...... .....++..|+|||.+.+..++.+ +|||||
T Consensus 164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~sl 203 (295)
T 3ugc_A 164 LPQDKEFFKVKEPGESPIFWYAPESLTESKFSVA-SDVWSF 203 (295)
T ss_dssp ------------CTTCGGGGCCHHHHHHCCCCHH-HHHHHH
T ss_pred ccCCcceeeeccCCCCccceeCcHHhcCCCCChH-HHHHHH
Confidence 544322 122346677999999998888766 999986
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-38 Score=252.94 Aligned_cols=186 Identities=22% Similarity=0.290 Sum_probs=164.4
Q ss_pred eecCCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCccchHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEE
Q 028681 17 MHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (205)
Q Consensus 17 ~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 96 (205)
....++|++.+.||+|+||.||.+.+..++..||+|.+.......+.+.+|+.+++.++||||+++++++......++||
T Consensus 216 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 295 (495)
T 1opk_A 216 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT 295 (495)
T ss_dssp BCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred ccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEE
Confidence 34567899999999999999999999988999999999887767788999999999999999999999999999999999
Q ss_pred EecCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCCC-
Q 028681 97 EYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS- 173 (205)
Q Consensus 97 ~~~~~~sl~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~~- 173 (205)
||+++++|.+++... ..+++..+..++.|++.||.|||+++|+||||+|+||+++.++. +||+|||+++......
T Consensus 296 E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~--~kl~DFG~a~~~~~~~~ 373 (495)
T 1opk_A 296 EFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHL--VKVADFGLSRLMTGDTY 373 (495)
T ss_dssp ECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGC--EEECCTTCEECCTTCCE
T ss_pred EccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCc--EEEeecccceeccCCce
Confidence 999999999999763 45899999999999999999999999999999999999988777 9999999997654322
Q ss_pred -CCCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 174 -QPKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 174 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
......+++.|+|||++....++.+ +|||||
T Consensus 374 ~~~~~~~~~~~y~aPE~~~~~~~~~~-sDvwSl 405 (495)
T 1opk_A 374 TAHAGAKFPIKWTAPESLAYNKFSIK-SDVWAF 405 (495)
T ss_dssp ECCTTCCCCGGGCCHHHHHHCEECHH-HHHHHH
T ss_pred eecCCCcCCcceeCHhHHhcCCCCcH-HhHHhH
Confidence 1222346778999999998888766 999996
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=246.80 Aligned_cols=184 Identities=24% Similarity=0.377 Sum_probs=159.3
Q ss_pred cCCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCc--cchHHHHHHHHHHHhcCCCCeeEEEEEEEeCC--eEEE
Q 028681 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPT--HLAI 94 (205)
Q Consensus 19 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~l 94 (205)
..++|++.+.||+|+||.||++.+..+++.||+|++.... ...+.+..|+.+++.++||||+++++++.... ..++
T Consensus 7 ~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~l 86 (396)
T 4eut_A 7 SNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVL 86 (396)
T ss_dssp SSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEE
T ss_pred CCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEE
Confidence 3678999999999999999999999999999999997643 23466789999999999999999999998765 7899
Q ss_pred EEEecCCCchHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEe----cCCCCCcEEEeeecccc
Q 028681 95 VMEYASGGELFERICNAG---RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLL----DGSPAPRLKICDFGYSK 167 (205)
Q Consensus 95 v~~~~~~~sl~~~~~~~~---~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili----~~~~~~~~~l~df~~~~ 167 (205)
||||+++++|.+++.... .+++..++.++.|++.||.|||++||+||||+|+||++ +.+.. ++|+|||+++
T Consensus 87 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~--~kL~DFG~a~ 164 (396)
T 4eut_A 87 IMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSV--YKLTDFGAAR 164 (396)
T ss_dssp EECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEE--EEECCGGGCE
T ss_pred EEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCcee--EEEecCCCce
Confidence 999999999999986543 39999999999999999999999999999999999998 44443 9999999998
Q ss_pred cccCCCCCCCCCCCCCccCCceecc--------CcCCCeeeEEEeC
Q 028681 168 SSVLHSQPKSTVGTPAYIAPEVLLK--------KEYDGKVMCVYVI 205 (205)
Q Consensus 168 ~~~~~~~~~~~~~~~~~~aPE~~~~--------~~~~~~~~Dvwsl 205 (205)
............|++.|+|||++.+ ..++.+ +|||||
T Consensus 165 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~-~DiwSl 209 (396)
T 4eut_A 165 ELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGAT-VDLWSI 209 (396)
T ss_dssp ECCCGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHH-HHHHHH
T ss_pred EccCCCccccccCCccccCHHHhhccccccccccCCCcH-HHHHHH
Confidence 7766665566779999999999875 445544 999986
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-38 Score=238.78 Aligned_cols=185 Identities=25% Similarity=0.306 Sum_probs=158.1
Q ss_pred ecCCCeEEEeeeccccceeEEEEEecCCCcEE--EEEEeecCc--cchHHHHHHHHHHHhc-CCCCeeEEEEEEEeCCeE
Q 028681 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELV--AVKYIERGD--KIDENVQREIINHRSL-RHPNIVRFKEVILTPTHL 92 (205)
Q Consensus 18 ~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v--~iK~~~~~~--~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~ 92 (205)
...++|++.+.||+|++|.||.+.+..++..+ ++|.+.... ...+.+..|+.+++++ +||||+++++++.+.+..
T Consensus 22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~ 101 (327)
T 1fvr_A 22 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYL 101 (327)
T ss_dssp CCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEE
T ss_pred ccHHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCce
Confidence 45689999999999999999999998888755 899887532 2346688999999999 899999999999999999
Q ss_pred EEEEEecCCCchHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCC
Q 028681 93 AIVMEYASGGELFERICNAG----------------RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAP 156 (205)
Q Consensus 93 ~lv~~~~~~~sl~~~~~~~~----------------~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~ 156 (205)
+++||++++++|.+++.... .+++..++.++.|++.||.+||++|++|+||+|+||+++.++.
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~- 180 (327)
T 1fvr_A 102 YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYV- 180 (327)
T ss_dssp EEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGC-
T ss_pred EEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcCCCe-
Confidence 99999999999999997653 6999999999999999999999999999999999999988777
Q ss_pred cEEEeeecccccccCCCCCCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 157 RLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 157 ~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
++|+|||+++............+++.|+|||.+.+..++.+ +|||||
T Consensus 181 -~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~sl 227 (327)
T 1fvr_A 181 -AKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTN-SDVWSY 227 (327)
T ss_dssp -EEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHH-HHHHHH
T ss_pred -EEEcccCcCccccccccccCCCCCccccChhhhccccCCch-hcchHH
Confidence 99999999975544444445567889999999988888765 999986
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-38 Score=235.85 Aligned_cols=183 Identities=35% Similarity=0.584 Sum_probs=158.6
Q ss_pred cCCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCcc-chHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEE
Q 028681 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (205)
Q Consensus 19 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~ 97 (205)
..++|++.+.||+|++|.||.+.+..+++.|++|.+..... ..+.+.+|+.+++.++||||+++++++.+.+..++++|
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (304)
T 2jam_A 7 IRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQ 86 (304)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEE
Confidence 35789999999999999999999999999999999986543 34568899999999999999999999999999999999
Q ss_pred ecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEe---cCCCCCcEEEeeecccccccCCCC
Q 028681 98 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLL---DGSPAPRLKICDFGYSKSSVLHSQ 174 (205)
Q Consensus 98 ~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili---~~~~~~~~~l~df~~~~~~~~~~~ 174 (205)
++++++|.+.+...+.+++..+..++.|++.||.+||+.|++|+||+|+||++ +.++. ++|+|||++...... .
T Consensus 87 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~--~kl~Dfg~~~~~~~~-~ 163 (304)
T 2jam_A 87 LVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSK--IMITDFGLSKMEQNG-I 163 (304)
T ss_dssp CCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCC--EEBCSCSTTCCCCCB-T
T ss_pred cCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCC--EEEccCCcceecCCC-c
Confidence 99999999999888889999999999999999999999999999999999999 44444 999999998644322 2
Q ss_pred CCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 175 PKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 175 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
.....+++.|+|||.+.+..++.+ +|||||
T Consensus 164 ~~~~~~~~~y~aPE~~~~~~~~~~-~Di~sl 193 (304)
T 2jam_A 164 MSTACGTPGYVAPEVLAQKPYSKA-VDCWSI 193 (304)
T ss_dssp THHHHSCCCBCCTTTBSSCSCCHH-HHHHHH
T ss_pred cccccCCCCccChHHhccCCCCch-hhHHHH
Confidence 223358999999999998888755 999986
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=247.39 Aligned_cols=187 Identities=27% Similarity=0.333 Sum_probs=160.0
Q ss_pred ceecCCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCcc--chHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEE
Q 028681 16 IMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLA 93 (205)
Q Consensus 16 ~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 93 (205)
+....++|++.+.||+|+||.||.+.+..++..||+|.+..... ..+.+.+|+.+++.++||||+++++++..++..+
T Consensus 109 ~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 188 (377)
T 3cbl_A 109 WVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIY 188 (377)
T ss_dssp TBCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCE
T ss_pred cEEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcE
Confidence 34456899999999999999999999998999999999875432 2345788999999999999999999999999999
Q ss_pred EEEEecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCC
Q 028681 94 IVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 172 (205)
Q Consensus 94 lv~~~~~~~sl~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~ 172 (205)
+||||+++++|.+.+... ..+++..+..++.|++.||+|||+.|++|+||+|+||+++.++. +||+|||+++.....
T Consensus 189 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~--~kl~DfG~s~~~~~~ 266 (377)
T 3cbl_A 189 IVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNV--LKISDFGMSREEADG 266 (377)
T ss_dssp EEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC--EEECCGGGCEECTTS
T ss_pred EEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCc--EEECcCCCceecCCC
Confidence 999999999999998764 35999999999999999999999999999999999999988877 999999998754332
Q ss_pred CCC---CCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 173 SQP---KSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 173 ~~~---~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
... ....++..|+|||++.+..++.+ +|||||
T Consensus 267 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Dvwsl 301 (377)
T 3cbl_A 267 VYAASGGLRQVPVKWTAPEALNYGRYSSE-SDVWSF 301 (377)
T ss_dssp EEECCSSCCEEEGGGSCHHHHHHCEEEHH-HHHHHH
T ss_pred ceeecCCCCCCCcCcCCHhHhccCCCCch-hhHHHH
Confidence 111 11234677999999998888765 999996
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=241.44 Aligned_cols=180 Identities=27% Similarity=0.497 Sum_probs=152.2
Q ss_pred cCCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCccchHHHHHHHHHHHhcCCCCeeEEEEEEEe----------
Q 028681 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILT---------- 88 (205)
Q Consensus 19 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---------- 88 (205)
..++|++.+.||+|+||.||.+.+..+++.||+|.+...... ..+|+.+++.++|+||+++++++..
T Consensus 5 ~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~---~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~ 81 (383)
T 3eb0_A 5 SSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY---KNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQ 81 (383)
T ss_dssp -CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS---CCHHHHHHTTCCCTTBCCEEEEEEEC---------
T ss_pred ccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch---HHHHHHHHHHcCCCCccchhheeeecCcccccccc
Confidence 467999999999999999999999999999999998765332 2368999999999999999999854
Q ss_pred ----------------------------CCeEEEEEEecCCCchHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhc
Q 028681 89 ----------------------------PTHLAIVMEYASGGELFERIC----NAGRFSEDEARFFFQQLISGVSYCHSM 136 (205)
Q Consensus 89 ----------------------------~~~~~lv~~~~~~~sl~~~~~----~~~~~~~~~~~~i~~~i~~~l~~lh~~ 136 (205)
..+.++||||+++ +|.+.+. ....+++..++.++.|++.||.|||++
T Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~ 160 (383)
T 3eb0_A 82 PPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSL 160 (383)
T ss_dssp ----------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT
T ss_pred cccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 3358899999975 6665553 456799999999999999999999999
Q ss_pred CcEeecCCCCCeEec-CCCCCcEEEeeecccccccCCCCCCCCCCCCCccCCceeccCc-CCCeeeEEEeC
Q 028681 137 QVCHRDLKLENTLLD-GSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKE-YDGKVMCVYVI 205 (205)
Q Consensus 137 ~i~H~di~p~nili~-~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~-~~~~~~Dvwsl 205 (205)
||+||||+|+||+++ .++. ++|+|||+++............++..|+|||++.+.. ++.+ +|||||
T Consensus 161 gi~H~Dikp~Nil~~~~~~~--~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~-~Diwsl 228 (383)
T 3eb0_A 161 GICHRDIKPQNLLVNSKDNT--LKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPS-IDLWSI 228 (383)
T ss_dssp TEECSCCCGGGEEEETTTTE--EEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTTCSSCCTH-HHHHHH
T ss_pred cCccCccCHHHEEEcCCCCc--EEEEECCCCcccCCCCCCcCcccCCCccCHHHhcCCCCCCcc-hhhhhH
Confidence 999999999999997 4555 9999999998776666666778999999999998765 5555 999985
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-38 Score=235.45 Aligned_cols=197 Identities=26% Similarity=0.347 Sum_probs=151.4
Q ss_pred CCccccccCCCcccCceecCCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCccchHHHHHHHHHHHhcCCCCee
Q 028681 1 MDRSAMTVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIV 80 (205)
Q Consensus 1 ~~~~~~~~~~~~~~~~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~ 80 (205)
|+++.++........+....++|++.+.||+|++|.||.+.+. +..|++|.+.... ..+.+.+|+.+++.++|||++
T Consensus 1 mg~s~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~-~~~~~~~E~~~l~~l~h~~iv 77 (278)
T 1byg_A 1 MGGSVAAQDEFYRSGWALNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLV 77 (278)
T ss_dssp --------------CCBCCGGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCCC---HHHHHTHHHHTTCCCTTBC
T ss_pred CCCCccchhhhhhccccCChhhceEEeEEecCCCceEEEEEEc--CCEEEEEEecchh-HHHHHHHHHHHHHhCCCCCEe
Confidence 6777777776666667777899999999999999999999875 7789999987543 457788999999999999999
Q ss_pred EEEEEEEeC-CeEEEEEEecCCCchHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCc
Q 028681 81 RFKEVILTP-THLAIVMEYASGGELFERICNAGR--FSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPR 157 (205)
Q Consensus 81 ~~~~~~~~~-~~~~lv~~~~~~~sl~~~~~~~~~--~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~ 157 (205)
++++++... +..++++|++++++|.+.+..... +++..+..++.|++.||.+||++|++|+||+|+||+++.++.
T Consensus 78 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~-- 155 (278)
T 1byg_A 78 QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNV-- 155 (278)
T ss_dssp CEEEEECCC--CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSC--
T ss_pred eEEEEEEcCCCceEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCc--
Confidence 999987655 478999999999999999976443 899999999999999999999999999999999999988877
Q ss_pred EEEeeecccccccCCCCCCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 158 LKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 158 ~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
++|+|||++...... .....++..|+|||.+.+..++.+ +|||||
T Consensus 156 ~~l~Dfg~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~-~Di~sl 200 (278)
T 1byg_A 156 AKVSDFGLTKEASST--QDTGKLPVKWTAPEALREKKFSTK-SDVWSF 200 (278)
T ss_dssp EEECCCCC--------------CCTTTSCHHHHHHCCCCHH-HHHHHH
T ss_pred EEEeecccccccccc--ccCCCccccccCHHHhCCCCCCch-hcHHHH
Confidence 999999998654332 223357889999999998888765 999986
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-37 Score=234.46 Aligned_cols=189 Identities=28% Similarity=0.467 Sum_probs=157.6
Q ss_pred cCceecCCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCccchHHHHHHHHHHHhc-CCCCeeEEEEEEEe----
Q 028681 14 MPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSL-RHPNIVRFKEVILT---- 88 (205)
Q Consensus 14 ~~~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~---- 88 (205)
..+....++|++.+.||+|++|.||.+.+..+++.|++|++.......+.+..|+.+++.+ +||||+++++++..
T Consensus 17 ~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~ 96 (326)
T 2x7f_A 17 SALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPP 96 (326)
T ss_dssp CCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--
T ss_pred hhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCc
Confidence 3455667999999999999999999999999999999999987766678899999999999 79999999999987
Q ss_pred --CCeEEEEEEecCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeec
Q 028681 89 --PTHLAIVMEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFG 164 (205)
Q Consensus 89 --~~~~~lv~~~~~~~sl~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~ 164 (205)
.+..+++||++++++|.+++... ..+++..+..++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||
T Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~--~kl~Dfg 174 (326)
T 2x7f_A 97 GMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAE--VKLVDFG 174 (326)
T ss_dssp CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCC--EEECCCT
T ss_pred cccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCC--EEEeeCc
Confidence 46789999999999999999763 46999999999999999999999999999999999999988877 9999999
Q ss_pred ccccccCC-CCCCCCCCCCCccCCceec-----cCcCCCeeeEEEeC
Q 028681 165 YSKSSVLH-SQPKSTVGTPAYIAPEVLL-----KKEYDGKVMCVYVI 205 (205)
Q Consensus 165 ~~~~~~~~-~~~~~~~~~~~~~aPE~~~-----~~~~~~~~~Dvwsl 205 (205)
++...... .......+++.|+|||++. +..++.+ +|||||
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~-~Di~sl 220 (326)
T 2x7f_A 175 VSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFK-SDLWSL 220 (326)
T ss_dssp TTC-------------CCGGGCCHHHHC--------CCTT-HHHHHH
T ss_pred CceecCcCccccccccCCccccChhhhccccccCcCCCcc-chHHHH
Confidence 98755432 2233456899999999997 4456555 999986
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-38 Score=246.37 Aligned_cols=184 Identities=34% Similarity=0.552 Sum_probs=150.0
Q ss_pred CCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCcc---------chHHHHHHHHHHHhcCCCCeeEEEEEEEeCC
Q 028681 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---------IDENVQREIINHRSLRHPNIVRFKEVILTPT 90 (205)
Q Consensus 20 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~---------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 90 (205)
.++|++.+.||+|+||.||++.+..+++.||+|++.+... ....+..|+.++++++||||+++++++. .+
T Consensus 134 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-~~ 212 (419)
T 3i6u_A 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD-AE 212 (419)
T ss_dssp HTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-SS
T ss_pred hccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-cC
Confidence 5789999999999999999999999999999999876421 1124788999999999999999999875 45
Q ss_pred eEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCC-CCcEEEeeecccccc
Q 028681 91 HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSP-APRLKICDFGYSKSS 169 (205)
Q Consensus 91 ~~~lv~~~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~-~~~~~l~df~~~~~~ 169 (205)
..++||||+++++|.+.+.....+++..+..++.|++.||.|||++||+|+||+|+||+++.++ ...+||+|||+++..
T Consensus 213 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~ 292 (419)
T 3i6u_A 213 DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL 292 (419)
T ss_dssp EEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTTTSC
T ss_pred ceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeecccceec
Confidence 6789999999999999988888899999999999999999999999999999999999997533 234999999999877
Q ss_pred cCCCCCCCCCCCCCccCCceecc---CcCCCeeeEEEeC
Q 028681 170 VLHSQPKSTVGTPAYIAPEVLLK---KEYDGKVMCVYVI 205 (205)
Q Consensus 170 ~~~~~~~~~~~~~~~~aPE~~~~---~~~~~~~~Dvwsl 205 (205)
..........|++.|+|||++.+ ..++. ++|||||
T Consensus 293 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~-~~Diwsl 330 (419)
T 3i6u_A 293 GETSLMRTLCGTPTYLAPEVLVSVGTAGYNR-AVDCWSL 330 (419)
T ss_dssp C-----------CTTCCTTTTC----CTTHH-HHHHHHH
T ss_pred CCCccccccCCCCCccCceeeecCCCCCCCc-hhhhHhH
Confidence 66555566779999999999864 44544 4999986
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-37 Score=235.12 Aligned_cols=181 Identities=24% Similarity=0.473 Sum_probs=159.8
Q ss_pred ecCCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCccchHHHHHHHHHHHhcC-CCCeeEEEEEEEe--CCeEEE
Q 028681 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLR-HPNIVRFKEVILT--PTHLAI 94 (205)
Q Consensus 18 ~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~--~~~~~l 94 (205)
...++|++.+.||+|++|.||.+.+..+++.||+|++... ..+.+..|+.+++.++ |+||+++++++.+ ....++
T Consensus 33 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~l 110 (330)
T 3nsz_A 33 GNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV--KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPAL 110 (330)
T ss_dssp EEGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC--CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEE
T ss_pred cCCCceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc--chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEE
Confidence 4468899999999999999999999999999999998743 3577889999999997 9999999999998 567899
Q ss_pred EEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCCCC
Q 028681 95 VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 174 (205)
Q Consensus 95 v~~~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~ 174 (205)
+||++.+++|.+.+.. +++..+..++.|++.||.|||++|++|+||+|+||+++.++. .++|+|||+++.......
T Consensus 111 v~e~~~~~~l~~~~~~---~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~-~~kl~Dfg~a~~~~~~~~ 186 (330)
T 3nsz_A 111 VFEHVNNTDFKQLYQT---LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHR-KLRLIDWGLAEFYHPGQE 186 (330)
T ss_dssp EEECCCCCCHHHHGGG---CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTT-EEEECCCTTCEECCTTCC
T ss_pred EEeccCchhHHHHHHh---CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCC-EEEEEeCCCceEcCCCCc
Confidence 9999999999888854 899999999999999999999999999999999999986652 399999999987776666
Q ss_pred CCCCCCCCCccCCceecc-CcCCCeeeEEEeC
Q 028681 175 PKSTVGTPAYIAPEVLLK-KEYDGKVMCVYVI 205 (205)
Q Consensus 175 ~~~~~~~~~~~aPE~~~~-~~~~~~~~Dvwsl 205 (205)
.....++..|+|||++.+ ..++.+ +|||||
T Consensus 187 ~~~~~~~~~y~aPE~~~~~~~~~~~-~Diwsl 217 (330)
T 3nsz_A 187 YNVRVASRYFKGPELLVDYQMYDYS-LDMWSL 217 (330)
T ss_dssp CCSCCSCGGGCCHHHHTTCCCCCTH-HHHHHH
T ss_pred cccccccccccChhhhcCCCcCCch-hhHHHH
Confidence 666789999999999987 455545 999986
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-38 Score=241.05 Aligned_cols=187 Identities=26% Similarity=0.381 Sum_probs=160.1
Q ss_pred ceecCCCeEEEeeeccccceeEEEEEecC-----CCcEEEEEEeecCcc--chHHHHHHHHHHHhcCCCCeeEEEEEEEe
Q 028681 16 IMHDSDRYELVRDIGSGNFGVARLMRDKK-----TEELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILT 88 (205)
Q Consensus 16 ~~~~~~~y~~~~~l~~g~~g~v~~~~~~~-----~~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 88 (205)
.....++|++.+.||+|+||.||++.+.. ++..|++|.+..... ..+.+.+|+.+++.++||||+++++++.+
T Consensus 42 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 121 (343)
T 1luf_A 42 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAV 121 (343)
T ss_dssp TBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred eEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcc
Confidence 34567899999999999999999999873 458899999976532 24668899999999999999999999999
Q ss_pred CCeEEEEEEecCCCchHHHHHhc------------------------CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCC
Q 028681 89 PTHLAIVMEYASGGELFERICNA------------------------GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLK 144 (205)
Q Consensus 89 ~~~~~lv~~~~~~~sl~~~~~~~------------------------~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~ 144 (205)
++..+++|||+++++|.+++... .++++..++.++.|++.||.|||++|++|+||+
T Consensus 122 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlk 201 (343)
T 1luf_A 122 GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLA 201 (343)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCS
T ss_pred CCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCC
Confidence 99999999999999999999763 569999999999999999999999999999999
Q ss_pred CCCeEecCCCCCcEEEeeecccccccCCC---CCCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 145 LENTLLDGSPAPRLKICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 145 p~nili~~~~~~~~~l~df~~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
|+||+++.++. ++|+|||++....... ......+++.|+|||.+.+..++.+ +|||||
T Consensus 202 p~NIl~~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~-~Di~sl 262 (343)
T 1luf_A 202 TRNCLVGENMV--VKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTE-SDVWAY 262 (343)
T ss_dssp GGGEEECGGGC--EEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHH-HHHHHH
T ss_pred cceEEECCCCe--EEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcc-cccHHH
Confidence 99999988877 9999999987543322 2233457889999999998888765 999986
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-38 Score=242.81 Aligned_cols=188 Identities=23% Similarity=0.351 Sum_probs=159.0
Q ss_pred CceecCCCeEEEeeeccccceeEEEEE-----ecCCCcEEEEEEeecCccc--hHHHHHHHHHHHhc-CCCCeeEEEEEE
Q 028681 15 PIMHDSDRYELVRDIGSGNFGVARLMR-----DKKTEELVAVKYIERGDKI--DENVQREIINHRSL-RHPNIVRFKEVI 86 (205)
Q Consensus 15 ~~~~~~~~y~~~~~l~~g~~g~v~~~~-----~~~~~~~v~iK~~~~~~~~--~~~~~~e~~~l~~l-~h~~i~~~~~~~ 86 (205)
.+....++|++.+.||+|+||.||.+. +..+++.||+|.+...... .+.+..|+.++..+ +||||+++++++
T Consensus 16 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~ 95 (359)
T 3vhe_A 16 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGAC 95 (359)
T ss_dssp HHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeee
Confidence 445567999999999999999999998 5566789999999865332 35688999999999 789999999999
Q ss_pred EeCC-eEEEEEEecCCCchHHHHHhcCC----------------------------------------------------
Q 028681 87 LTPT-HLAIVMEYASGGELFERICNAGR---------------------------------------------------- 113 (205)
Q Consensus 87 ~~~~-~~~lv~~~~~~~sl~~~~~~~~~---------------------------------------------------- 113 (205)
.+++ ..+++|||+++++|.+++.....
T Consensus 96 ~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 175 (359)
T 3vhe_A 96 TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSD 175 (359)
T ss_dssp CSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC----------------------------------------------
T ss_pred ecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccch
Confidence 8765 48999999999999999976432
Q ss_pred --------------CCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCCCC---CC
Q 028681 114 --------------FSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PK 176 (205)
Q Consensus 114 --------------~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~---~~ 176 (205)
+++..+..++.|++.||.|||++||+|+||+|+||+++.++. ++|+|||++........ ..
T Consensus 176 ~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~--~kl~Dfg~a~~~~~~~~~~~~~ 253 (359)
T 3vhe_A 176 VEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNV--VKICDFGLARDIYKDPDYVRKG 253 (359)
T ss_dssp --------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC--EEECCCGGGSCTTSCTTCEEC-
T ss_pred hhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCc--EEEEeccceeeecccccchhcc
Confidence 889999999999999999999999999999999999988777 99999999975533322 22
Q ss_pred CCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 177 STVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 177 ~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
...+++.|+|||++.+..++.+ +|||||
T Consensus 254 ~~~~t~~y~aPE~~~~~~~~~~-~Di~sl 281 (359)
T 3vhe_A 254 DARLPLKWMAPETIFDRVYTIQ-SDVWSF 281 (359)
T ss_dssp -CEECGGGCCHHHHHHCCCCHH-HHHHHH
T ss_pred ccCCCceeEChhhhcCCCCCch-hhhhhH
Confidence 3457889999999998888766 999986
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-38 Score=241.67 Aligned_cols=183 Identities=28% Similarity=0.441 Sum_probs=161.4
Q ss_pred cCCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCc--cchHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEE
Q 028681 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (205)
Q Consensus 19 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 96 (205)
..++|++.+.||+|++|.||++.+..++..|++|++.... ...+.+..|+.+++.++||||+++++++..++..+++|
T Consensus 31 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 110 (360)
T 3eqc_A 31 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 110 (360)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEE
Confidence 4679999999999999999999999999999999998653 23467889999999999999999999999999999999
Q ss_pred EecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhc-CcEeecCCCCCeEecCCCCCcEEEeeecccccccCCCCC
Q 028681 97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM-QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 175 (205)
Q Consensus 97 ~~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~-~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~~ 175 (205)
||+++++|.+.+...+.+++..+..++.|++.||.|||+. |++|+||+|+||+++.++. ++|+|||++...... ..
T Consensus 111 e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~-~~ 187 (360)
T 3eqc_A 111 EHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGE--IKLCDFGVSGQLIDS-MA 187 (360)
T ss_dssp CCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCC--EEECCCCCCHHHHHH-C-
T ss_pred ECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCC--EEEEECCCCcccccc-cc
Confidence 9999999999998888899999999999999999999985 9999999999999998877 999999988654322 23
Q ss_pred CCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 176 KSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 176 ~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
....+++.|+|||++.+..++.+ +|||||
T Consensus 188 ~~~~gt~~y~aPE~~~~~~~~~~-~Di~sl 216 (360)
T 3eqc_A 188 NSFVGTRSYMSPERLQGTHYSVQ-SDIWSM 216 (360)
T ss_dssp ---CCCCTTCCHHHHTTCCCSHH-HHHHHH
T ss_pred cCCCCCCCeECHHHHcCCCCCch-hhHHHH
Confidence 34578999999999998888765 999986
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=241.35 Aligned_cols=181 Identities=31% Similarity=0.451 Sum_probs=144.6
Q ss_pred CCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCc---cchHHHHHHHHHHHhcC-CCCeeEEEEEEEeCC--eEE
Q 028681 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLR-HPNIVRFKEVILTPT--HLA 93 (205)
Q Consensus 20 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~--~~~ 93 (205)
.++|++.+.||+|+||.||.+.+..+++.||+|.+.... .....+..|+.+++.+. |+||+++++++..++ .++
T Consensus 8 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~ 87 (388)
T 3oz6_A 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVY 87 (388)
T ss_dssp HTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEE
T ss_pred cCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEE
Confidence 579999999999999999999999999999999986532 23456778999999997 999999999998654 789
Q ss_pred EEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCC-
Q 028681 94 IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH- 172 (205)
Q Consensus 94 lv~~~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~- 172 (205)
+||||++ ++|...+.. ..+++..+..++.|++.||.|||+.||+||||+|+||+++.++. ++|+|||+++.....
T Consensus 88 lv~e~~~-~~L~~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~--~kl~DFG~a~~~~~~~ 163 (388)
T 3oz6_A 88 LVFDYME-TDLHAVIRA-NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECH--VKVADFGLSRSFVNIR 163 (388)
T ss_dssp EEEECCS-EEHHHHHHH-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC--EEECCCTTCEESSSCC
T ss_pred EEecccC-cCHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCC--EEecCCcccccccccc
Confidence 9999997 588888755 57999999999999999999999999999999999999988877 999999999754321
Q ss_pred ---------------------CCCCCCCCCCCccCCceecc-CcCCCeeeEEEeC
Q 028681 173 ---------------------SQPKSTVGTPAYIAPEVLLK-KEYDGKVMCVYVI 205 (205)
Q Consensus 173 ---------------------~~~~~~~~~~~~~aPE~~~~-~~~~~~~~Dvwsl 205 (205)
.......||+.|+|||++.+ ..++.+ +|||||
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~-~DiwSl 217 (388)
T 3oz6_A 164 RVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKG-IDMWSL 217 (388)
T ss_dssp CCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTH-HHHHHH
T ss_pred cccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCCh-hhHHHH
Confidence 11223468999999999987 455544 999996
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-37 Score=241.16 Aligned_cols=187 Identities=27% Similarity=0.382 Sum_probs=162.5
Q ss_pred CceecCCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCccchHHHHHHHHHHHhc------CCCCeeEEEEEEEe
Q 028681 15 PIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSL------RHPNIVRFKEVILT 88 (205)
Q Consensus 15 ~~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l------~h~~i~~~~~~~~~ 88 (205)
+.....++|++.+.||+|+||.||++.+..++..||+|++.......+.+..|+.+++.+ .|+|++++++++..
T Consensus 91 ~~~~~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~ 170 (429)
T 3kvw_A 91 PHDHVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTF 170 (429)
T ss_dssp TTCEETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEE
T ss_pred CCCcccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeeccc
Confidence 344556789999999999999999999999999999999987666667788888888877 46799999999999
Q ss_pred CCeEEEEEEecCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeeccc
Q 028681 89 PTHLAIVMEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYS 166 (205)
Q Consensus 89 ~~~~~lv~~~~~~~sl~~~~~~~~--~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~ 166 (205)
.+..+++||++. ++|.+.+.... .+++..++.++.|++.||.|||+++|+||||+|+||+++.++...++|+|||++
T Consensus 171 ~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a 249 (429)
T 3kvw_A 171 RNHICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSS 249 (429)
T ss_dssp TTEEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCCTTC
T ss_pred CCeEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeecccc
Confidence 999999999996 58888887644 499999999999999999999999999999999999998877656999999998
Q ss_pred ccccCCCCCCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 167 KSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 167 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
.... .......+++.|+|||++.+..++.+ +|||||
T Consensus 250 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwSl 285 (429)
T 3kvw_A 250 CYEH--QRVYTYIQSRFYRAPEVILGARYGMP-IDMWSL 285 (429)
T ss_dssp EETT--CCCCSSCSCGGGCCHHHHHTBCCCTH-HHHHHH
T ss_pred eecC--CcccccCCCCCccChHHHhCCCCCch-HHHHhH
Confidence 6543 23345678999999999999888766 999996
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-37 Score=244.76 Aligned_cols=181 Identities=28% Similarity=0.392 Sum_probs=156.4
Q ss_pred eecCCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCccchHHHHHHHHHHHhcCCCCeeEEEEEEEeCC-eEEEE
Q 028681 17 MHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPT-HLAIV 95 (205)
Q Consensus 17 ~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~lv 95 (205)
....++|++.+.||+|+||.||.+... +..||+|.++... ..+.+..|+.++++++||||+++++++.... ..++|
T Consensus 189 ~i~~~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv 265 (450)
T 1k9a_A 189 ALNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIV 265 (450)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCT-TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEE
T ss_pred ccChHHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCch-HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEE
Confidence 456789999999999999999999876 6789999987654 5678899999999999999999999988765 79999
Q ss_pred EEecCCCchHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCCC
Q 028681 96 MEYASGGELFERICNAGR--FSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 173 (205)
Q Consensus 96 ~~~~~~~sl~~~~~~~~~--~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~~ 173 (205)
|||+++++|.+.+...+. +++..+..++.|++.||.|||+++++||||+|+||+++.++. +||+|||+++.....
T Consensus 266 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~--~kl~DfG~a~~~~~~- 342 (450)
T 1k9a_A 266 TEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNV--AKVSDFGLTKEASST- 342 (450)
T ss_dssp EECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSC--EEECCCTTCEECC---
T ss_pred EEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCC--EEEeeCCCccccccc-
Confidence 999999999999976543 799999999999999999999999999999999999988877 999999998754322
Q ss_pred CCCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 174 QPKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 174 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
.....++..|+|||++.+..++.+ +|||||
T Consensus 343 -~~~~~~~~~y~aPE~~~~~~~~~~-sDvwsl 372 (450)
T 1k9a_A 343 -QDTGKLPVKWTAPEALREKKFSTK-SDVWSF 372 (450)
T ss_dssp -----CCCTTTSCHHHHHSSCCCHH-HHHHHH
T ss_pred -ccCCCCCcceeCHHHhcCCCCCcH-HHHHHH
Confidence 222356889999999999888766 999996
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=230.74 Aligned_cols=185 Identities=26% Similarity=0.399 Sum_probs=162.2
Q ss_pred eecCCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCccchHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEE
Q 028681 17 MHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (205)
Q Consensus 17 ~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 96 (205)
..+.++|++.+.||+|++|.||.+.+. ++..|++|.+.......+.+.+|+.+++.++|||++++++++.+++..++++
T Consensus 4 ~i~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 82 (267)
T 3t9t_A 4 VIDPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVT 82 (267)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred EEchhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCCCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEE
Confidence 345789999999999999999999987 4678999999887767788999999999999999999999999999999999
Q ss_pred EecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCC--C
Q 028681 97 EYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH--S 173 (205)
Q Consensus 97 ~~~~~~sl~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~--~ 173 (205)
|++++++|.+++... ..+++..+..++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||++...... .
T Consensus 83 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~--~kl~dfg~~~~~~~~~~~ 160 (267)
T 3t9t_A 83 EFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQV--IKVSDFGMTRFVLDDQYT 160 (267)
T ss_dssp CCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGC--EEECCTTGGGGBCCHHHH
T ss_pred eCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCC--EEEccccccccccccccc
Confidence 999999999999764 46899999999999999999999999999999999999988777 999999998755332 1
Q ss_pred CCCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 174 QPKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 174 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
......++..|+|||++.+..++.+ +|||||
T Consensus 161 ~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~sl 191 (267)
T 3t9t_A 161 SSTGTKFPVKWASPEVFSFSRYSSK-SDVWSF 191 (267)
T ss_dssp STTSTTCCGGGCCHHHHHHCCCCHH-HHHHHH
T ss_pred ccccccccccccChhhhcCCCccch-hchhhh
Confidence 2233456788999999998888755 999986
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-38 Score=240.28 Aligned_cols=188 Identities=29% Similarity=0.438 Sum_probs=151.5
Q ss_pred CceecCCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCcc------chHHHHHHHHHHHhcCCCCeeEEEEEEEe
Q 028681 15 PIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK------IDENVQREIINHRSLRHPNIVRFKEVILT 88 (205)
Q Consensus 15 ~~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 88 (205)
.+....++|++.+.||+|++|.||.+.+..+++.||+|.+..... ..+.+.+|+.+++.++||||+++++++.+
T Consensus 4 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 83 (346)
T 1ua2_A 4 DVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGH 83 (346)
T ss_dssp ---------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECC
T ss_pred hhHHHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEee
Confidence 344557899999999999999999999999999999999875322 12467889999999999999999999999
Q ss_pred CCeEEEEEEecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccc
Q 028681 89 PTHLAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 167 (205)
Q Consensus 89 ~~~~~lv~~~~~~~sl~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~ 167 (205)
.+..++++|++++ +|.+.+... ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++. ++|+|||+++
T Consensus 84 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~--~kl~Dfg~a~ 160 (346)
T 1ua2_A 84 KSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGV--LKLADFGLAK 160 (346)
T ss_dssp TTCCEEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCC--EEECCCGGGS
T ss_pred CCceEEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCC--EEEEecccce
Confidence 9999999999976 787777654 36899999999999999999999999999999999999988877 9999999997
Q ss_pred cccCC-CCCCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 168 SSVLH-SQPKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 168 ~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
..... .......+++.|+|||++.+....+.++|||||
T Consensus 161 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diwsl 199 (346)
T 1ua2_A 161 SFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAV 199 (346)
T ss_dssp TTTSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHH
T ss_pred eccCCcccCCcccccccccCchHhhCCCCCCchhhhHhH
Confidence 65433 333445789999999999765433345999986
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=239.66 Aligned_cols=181 Identities=28% Similarity=0.404 Sum_probs=147.9
Q ss_pred cCCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCc---cchHHHHHHHHHHHhcCCCCeeEEEEEEEeCC-----
Q 028681 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPT----- 90 (205)
Q Consensus 19 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----- 90 (205)
..++|++.+.||+|+||.||.+.+..+++.||+|.+.... ...+.+..|+.+++.++||||+++++++...+
T Consensus 23 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 102 (371)
T 2xrw_A 23 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 102 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTC
T ss_pred hhhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccc
Confidence 3589999999999999999999999999999999997643 22356788999999999999999999998665
Q ss_pred -eEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccc
Q 028681 91 -HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 169 (205)
Q Consensus 91 -~~~lv~~~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~ 169 (205)
..++|||++++ +|.+.+. ..+++..+..++.|++.||.|||++||+|+||+|+||+++.++. ++|+|||+++..
T Consensus 103 ~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~--~kl~Dfg~a~~~ 177 (371)
T 2xrw_A 103 QDVYIVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTA 177 (371)
T ss_dssp CEEEEEEECCSE-EHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSC--EEECCCCC----
T ss_pred cceEEEEEcCCC-CHHHHHh--hccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCC--EEEEEeeccccc
Confidence 78999999975 7777775 34999999999999999999999999999999999999998877 999999999876
Q ss_pred cCCCCCCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 170 VLHSQPKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 170 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
..........+++.|+|||++.+..++.+ +|||||
T Consensus 178 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~Diwsl 212 (371)
T 2xrw_A 178 GTSFMMTPYVVTRYYRAPEVILGMGYKEN-VDIWSV 212 (371)
T ss_dssp ------------CTTCCHHHHTTCCCCTT-HHHHHH
T ss_pred ccccccCCceecCCccCHHHhcCCCCCch-HhHHHH
Confidence 55544555678999999999999888766 999986
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-38 Score=240.96 Aligned_cols=187 Identities=30% Similarity=0.497 Sum_probs=155.8
Q ss_pred ecCCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecC------ccchHHHHHHHHHHHhcCCCCeeEEEEEEEeCCe
Q 028681 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG------DKIDENVQREIINHRSLRHPNIVRFKEVILTPTH 91 (205)
Q Consensus 18 ~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 91 (205)
...++|++.+.||+|++|.||.+.+..++..||+|++... ....+.+..|+.+++.++||||+++++++.+.+.
T Consensus 23 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 102 (345)
T 3hko_A 23 ELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQY 102 (345)
T ss_dssp HHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred hhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCe
Confidence 3468899999999999999999999999999999998753 2334678899999999999999999999999999
Q ss_pred EEEEEEecCCCchHHHHHh----------------------------------------cCCCCHHHHHHHHHHHHHHHH
Q 028681 92 LAIVMEYASGGELFERICN----------------------------------------AGRFSEDEARFFFQQLISGVS 131 (205)
Q Consensus 92 ~~lv~~~~~~~sl~~~~~~----------------------------------------~~~~~~~~~~~i~~~i~~~l~ 131 (205)
.++||||+++++|.+.+.. ...+++..++.++.|++.||.
T Consensus 103 ~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~ 182 (345)
T 3hko_A 103 ICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALH 182 (345)
T ss_dssp EEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHH
Confidence 9999999999999988842 112467788899999999999
Q ss_pred HHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCCC-----CCCCCCCCCCccCCceecc--CcCCCeeeEEEe
Q 028681 132 YCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-----QPKSTVGTPAYIAPEVLLK--KEYDGKVMCVYV 204 (205)
Q Consensus 132 ~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~~-----~~~~~~~~~~~~aPE~~~~--~~~~~~~~Dvws 204 (205)
|||+.+++|+||+|+||+++.++...++|+|||++....... ......+++.|+|||++.. ..++.+ +||||
T Consensus 183 ~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~-~Diws 261 (345)
T 3hko_A 183 YLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPK-CDAWS 261 (345)
T ss_dssp HHHHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTH-HHHHH
T ss_pred HHHHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcH-HHHHH
Confidence 999999999999999999987764459999999997543322 2234568999999999975 556655 99998
Q ss_pred C
Q 028681 205 I 205 (205)
Q Consensus 205 l 205 (205)
|
T Consensus 262 l 262 (345)
T 3hko_A 262 A 262 (345)
T ss_dssp H
T ss_pred H
Confidence 6
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-38 Score=242.41 Aligned_cols=186 Identities=21% Similarity=0.284 Sum_probs=155.7
Q ss_pred cCCCeEEEeeeccccceeEEEEE-----ecCCCcEEEEEEeecCc--cchHHHHHHHHHHHhcCCCCeeEEEEEEEeCCe
Q 028681 19 DSDRYELVRDIGSGNFGVARLMR-----DKKTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTH 91 (205)
Q Consensus 19 ~~~~y~~~~~l~~g~~g~v~~~~-----~~~~~~~v~iK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 91 (205)
..++|++.+.||+|+||.||++. +..++..||+|.+.... .....+..|+.+++.++||||+++++++.++..
T Consensus 69 ~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~ 148 (367)
T 3l9p_A 69 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP 148 (367)
T ss_dssp CGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred CHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCC
Confidence 35789999999999999999999 44567889999987543 223567889999999999999999999999999
Q ss_pred EEEEEEecCCCchHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCC-CcEEEeee
Q 028681 92 LAIVMEYASGGELFERICNAG-------RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPA-PRLKICDF 163 (205)
Q Consensus 92 ~~lv~~~~~~~sl~~~~~~~~-------~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~-~~~~l~df 163 (205)
.++||||+++++|.+++.... .+++..+..++.|++.||.|||++||+||||+|+||+++.++. ..++|+||
T Consensus 149 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~kL~DF 228 (367)
T 3l9p_A 149 RFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDF 228 (367)
T ss_dssp CEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECCC
T ss_pred CEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceEEECCC
Confidence 999999999999999997643 4899999999999999999999999999999999999985432 24999999
Q ss_pred cccccccCC---CCCCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 164 GYSKSSVLH---SQPKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 164 ~~~~~~~~~---~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
|+++..... .......+++.|+|||++.+..++.+ +|||||
T Consensus 229 G~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~-~Dvwsl 272 (367)
T 3l9p_A 229 GMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSK-TDTWSF 272 (367)
T ss_dssp HHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHH-HHHHHH
T ss_pred ccccccccccccccCCCcCCcccEECHHHhcCCCCCcH-HHHHHH
Confidence 999754222 22333457889999999998888766 999996
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-38 Score=239.07 Aligned_cols=181 Identities=28% Similarity=0.501 Sum_probs=148.4
Q ss_pred CCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCccc--hHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEEe
Q 028681 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI--DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (205)
Q Consensus 21 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~ 98 (205)
++|++.+.||+|++|.||.+.+..+++.||+|.+...... ...+..|+.+++.++||||+++++++..++..++||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 6899999999999999999999999999999998754322 12345789999999999999999999999999999999
Q ss_pred cCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCC-CCCC
Q 028681 99 ASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPK 176 (205)
Q Consensus 99 ~~~~sl~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~-~~~~ 176 (205)
+++ +|.+.+... ..+++..++.++.|++.||.|||+.||+|+||+|+||+++.++. ++|+|||++...... ....
T Consensus 82 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~--~kl~Dfg~a~~~~~~~~~~~ 158 (324)
T 3mtl_A 82 LDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGE--LKLADFGLARAKSIPTKTYD 158 (324)
T ss_dssp CSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCC--EEECSSSEEECC--------
T ss_pred ccc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCC--EEEccCcccccccCCccccc
Confidence 975 788877654 45999999999999999999999999999999999999988877 999999999755433 2233
Q ss_pred CCCCCCCccCCceeccC-cCCCeeeEEEeC
Q 028681 177 STVGTPAYIAPEVLLKK-EYDGKVMCVYVI 205 (205)
Q Consensus 177 ~~~~~~~~~aPE~~~~~-~~~~~~~Dvwsl 205 (205)
...+++.|+|||++.+. .++.+ +|||||
T Consensus 159 ~~~~t~~y~aPE~~~~~~~~~~~-~Diwsl 187 (324)
T 3mtl_A 159 NEVVTLWYRPPDILLGSTDYSTQ-IDMWGV 187 (324)
T ss_dssp ----CGGGCCHHHHTTCCCCCTH-HHHHHH
T ss_pred cccCcccccChhhhcCCCCCCcH-HHHHHH
Confidence 44689999999999874 45545 999986
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=236.78 Aligned_cols=195 Identities=27% Similarity=0.407 Sum_probs=162.1
Q ss_pred cCCCcccCceecCCCeEEEeeeccccceeEEEEE----ecCCCcEEEEEEeecCcc-chHHHHHHHHHHHhcCCCCeeEE
Q 028681 8 VGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMR----DKKTEELVAVKYIERGDK-IDENVQREIINHRSLRHPNIVRF 82 (205)
Q Consensus 8 ~~~~~~~~~~~~~~~y~~~~~l~~g~~g~v~~~~----~~~~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~ 82 (205)
.+....+......++|++.+.||+|++|.||++. +..++..|++|.+..... ..+.+.+|+.+++.++|+||+++
T Consensus 10 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 89 (327)
T 3lxl_A 10 QLYACQDPTIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKY 89 (327)
T ss_dssp -------CCBCCGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCE
T ss_pred HHhhcChhhhhchhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEE
Confidence 3445556666778999999999999999999999 567889999999876543 34568899999999999999999
Q ss_pred EEEEE--eCCeEEEEEEecCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEE
Q 028681 83 KEVIL--TPTHLAIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLK 159 (205)
Q Consensus 83 ~~~~~--~~~~~~lv~~~~~~~sl~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~ 159 (205)
++++. .....+++|||+++++|.+++.. ...+++..+..++.|++.||.+||+.|++|+||+|+||+++.++. ++
T Consensus 90 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~--~k 167 (327)
T 3lxl_A 90 RGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAH--VK 167 (327)
T ss_dssp EEEEECSSSCEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTE--EE
T ss_pred EEEEecCCCceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCC--EE
Confidence 99987 44678999999999999999976 456999999999999999999999999999999999999988777 99
Q ss_pred EeeecccccccCCC----CCCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 160 ICDFGYSKSSVLHS----QPKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 160 l~df~~~~~~~~~~----~~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
|+|||++....... ......++..|+|||++.+..++.+ +|||||
T Consensus 168 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~sl 216 (327)
T 3lxl_A 168 IADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQ-SDVWSF 216 (327)
T ss_dssp ECCGGGCEECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHH-HHHHHH
T ss_pred EcccccceecccCCccceeeccCCccccccCHHHhccCCCChH-HhHHHH
Confidence 99999997654332 2233457888999999998888655 999986
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-37 Score=238.03 Aligned_cols=185 Identities=30% Similarity=0.490 Sum_probs=156.8
Q ss_pred ceecCCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCcc--chHHHHHHHHHHHhcCCCCeeEEEEEEEeC----
Q 028681 16 IMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTP---- 89 (205)
Q Consensus 16 ~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---- 89 (205)
.....++|++.+.||+|++|.||.+.+..++..||+|.+..... ..+.+..|+.+++.++||||+++++++...
T Consensus 22 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 101 (364)
T 3qyz_A 22 VFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQ 101 (364)
T ss_dssp BCCCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTT
T ss_pred eccccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccc
Confidence 33445799999999999999999999999999999999975432 236688999999999999999999999765
Q ss_pred -CeEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeeccccc
Q 028681 90 -THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 168 (205)
Q Consensus 90 -~~~~lv~~~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~ 168 (205)
...+++++++. ++|.+.+.. ..+++..+..++.|++.||.|||++||+|+||+|+||+++.++. ++|+|||++..
T Consensus 102 ~~~~~iv~e~~~-~~L~~~l~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~--~kl~Dfg~a~~ 177 (364)
T 3qyz_A 102 MKDVYIVQDLME-TDLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCD--LKICDFGLARV 177 (364)
T ss_dssp CCCEEEEEECCS-EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC--EEECCCTTCEE
T ss_pred cceEEEEEcccC-cCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCC--EEEEeCcceEe
Confidence 36899999997 488888855 56999999999999999999999999999999999999988877 99999999976
Q ss_pred ccCCCC----CCCCCCCCCccCCceeccCc-CCCeeeEEEeC
Q 028681 169 SVLHSQ----PKSTVGTPAYIAPEVLLKKE-YDGKVMCVYVI 205 (205)
Q Consensus 169 ~~~~~~----~~~~~~~~~~~aPE~~~~~~-~~~~~~Dvwsl 205 (205)
...... .....|++.|+|||++.+.. ++. ++|||||
T Consensus 178 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~~Diwsl 218 (364)
T 3qyz_A 178 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK-SIDIWSV 218 (364)
T ss_dssp CCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCST-HHHHHHH
T ss_pred cCCCCCccccccccccccCCCCCHHhcCCCCCCc-chhHHHH
Confidence 554322 23347899999999987655 554 4999986
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-37 Score=233.76 Aligned_cols=186 Identities=28% Similarity=0.417 Sum_probs=155.7
Q ss_pred cCCCeEEE-eeeccccceeEEEEEecCCCcEEEEEEeecCcc-chHHHHHHHHHHHhc-CCCCeeEEEEEEEeCCeEEEE
Q 028681 19 DSDRYELV-RDIGSGNFGVARLMRDKKTEELVAVKYIERGDK-IDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIV 95 (205)
Q Consensus 19 ~~~~y~~~-~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv 95 (205)
..+.|++. +.||+|++|.||.+.+..+++.||+|++..... ..+.+.+|+.++.++ .||||+++++++.+++..++|
T Consensus 10 ~~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv 89 (316)
T 2ac3_A 10 FEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLV 89 (316)
T ss_dssp TTTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred cceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEE
Confidence 35789985 789999999999999999999999999976543 356788999999885 799999999999999999999
Q ss_pred EEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCC-CcEEEeeecccccccCCC-
Q 028681 96 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPA-PRLKICDFGYSKSSVLHS- 173 (205)
Q Consensus 96 ~~~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~-~~~~l~df~~~~~~~~~~- 173 (205)
||++++++|.+.+.....+++..+..++.|++.||.|||++|++|+||+|+||+++.++. ..++|+|||++.......
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~ 169 (316)
T 2ac3_A 90 FEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGD 169 (316)
T ss_dssp EECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-------
T ss_pred EEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCccccccCCc
Confidence 999999999999988888999999999999999999999999999999999999986553 348999999986543221
Q ss_pred -------CCCCCCCCCCccCCceecc-----CcCCCeeeEEEeC
Q 028681 174 -------QPKSTVGTPAYIAPEVLLK-----KEYDGKVMCVYVI 205 (205)
Q Consensus 174 -------~~~~~~~~~~~~aPE~~~~-----~~~~~~~~Dvwsl 205 (205)
......|++.|+|||++.. ..++.+ +|||||
T Consensus 170 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~-~Diwsl 212 (316)
T 2ac3_A 170 CSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKR-CDLWSL 212 (316)
T ss_dssp ------------CCSGGGCCHHHHHHTSHHHHHHTTT-HHHHHH
T ss_pred cccccccccccccCCcCccChHHhhcccccccCCCcc-cccHhH
Confidence 1123358999999999975 456655 999986
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=234.06 Aligned_cols=183 Identities=31% Similarity=0.488 Sum_probs=153.1
Q ss_pred CCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCccchHHHHHHHHHHHhcCCCCeeEEEEEEEe-----------
Q 028681 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILT----------- 88 (205)
Q Consensus 20 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----------- 88 (205)
.++|++.+.||+|++|.||.+.+..+++.|++|.+.......+.+.+|+.+++.++|||++++++++.+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 84 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAV 84 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC-----
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhccc
Confidence 468999999999999999999999999999999997665556778899999999999999999998865
Q ss_pred --CCeEEEEEEecCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecc
Q 028681 89 --PTHLAIVMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGY 165 (205)
Q Consensus 89 --~~~~~lv~~~~~~~sl~~~~~~~~-~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~ 165 (205)
.+..++++|++++++|.+.+.... .+++..+..++.|++.||.+||++|++|+||+|+||+++.++. ++|+|||+
T Consensus 85 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~--~kl~dfg~ 162 (303)
T 1zy4_A 85 KKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRN--VKIGDFGL 162 (303)
T ss_dssp -CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSC--EEECCCCC
T ss_pred ccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCC--EEEeeCcc
Confidence 356899999999999999997543 5888999999999999999999999999999999999988877 99999999
Q ss_pred cccccCC---------------CCCCCCCCCCCccCCceeccC-cCCCeeeEEEeC
Q 028681 166 SKSSVLH---------------SQPKSTVGTPAYIAPEVLLKK-EYDGKVMCVYVI 205 (205)
Q Consensus 166 ~~~~~~~---------------~~~~~~~~~~~~~aPE~~~~~-~~~~~~~Dvwsl 205 (205)
+...... .......+++.|+|||++.+. .++.+ +|||||
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~-~Di~sl 217 (303)
T 1zy4_A 163 AKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEK-IDMYSL 217 (303)
T ss_dssp CSCTTC-------------------------CTTSCHHHHTSCSCCCTH-HHHHHH
T ss_pred hhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcch-hhHHHH
Confidence 8754321 122334589999999999865 45544 999986
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-37 Score=231.09 Aligned_cols=184 Identities=26% Similarity=0.454 Sum_probs=157.1
Q ss_pred ecCCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCccchHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEE
Q 028681 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (205)
Q Consensus 18 ~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~ 97 (205)
...++|++.+.||+|++|.||.+.+..++..|++|.+.... ..+.+..|+.+++.++||||+++++++..++..++++|
T Consensus 26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 104 (314)
T 3com_A 26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES-DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVME 104 (314)
T ss_dssp ----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS-CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH-HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEee
Confidence 34678999999999999999999999999999999987643 45678899999999999999999999999999999999
Q ss_pred ecCCCchHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCCC-CC
Q 028681 98 YASGGELFERIC-NAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QP 175 (205)
Q Consensus 98 ~~~~~sl~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~~-~~ 175 (205)
++++++|.+++. ....+++..+..++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||++....... ..
T Consensus 105 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~--~kl~dfg~~~~~~~~~~~~ 182 (314)
T 3com_A 105 YCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGH--AKLADFGVAGQLTDTMAKR 182 (314)
T ss_dssp CCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCC--EEECCCTTCEECBTTBSCB
T ss_pred cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCC--EEEeecccchhhhhhcccc
Confidence 999999999986 4567999999999999999999999999999999999999988877 9999999987654432 23
Q ss_pred CCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 176 KSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 176 ~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
....+++.|+|||.+.+..++.+ +|||||
T Consensus 183 ~~~~~~~~y~aPE~~~~~~~~~~-~Di~sl 211 (314)
T 3com_A 183 NTVIGTPFWMAPEVIQEIGYNCV-ADIWSL 211 (314)
T ss_dssp CCCCSCGGGCCHHHHSSSCBCTT-HHHHHH
T ss_pred CccCCCCCccChhhcCCCCCCcc-ccHHHH
Confidence 34568999999999998888766 999986
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-37 Score=235.49 Aligned_cols=178 Identities=32% Similarity=0.527 Sum_probs=154.8
Q ss_pred CCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCccc----hHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEE
Q 028681 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI----DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (205)
Q Consensus 21 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 96 (205)
+.|++.+.||+|+||.||++.+..++..||+|.+...... .+.+..|+.+++.++||||+++++++..++..++||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 5699999999999999999999999999999999764322 256789999999999999999999999999999999
Q ss_pred EecCCCchHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCCCCC
Q 028681 97 EYASGGELFERIC-NAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 175 (205)
Q Consensus 97 ~~~~~~sl~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~~ 175 (205)
||+. +++.+.+. ...++++..+..++.|++.||.|||++|++|+||+|+||+++.++. ++|+|||++......
T Consensus 134 e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~--~kL~DfG~a~~~~~~--- 207 (348)
T 1u5q_A 134 EYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGL--VKLGDFGSASIMAPA--- 207 (348)
T ss_dssp ECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTE--EEECCCTTCBSSSSB---
T ss_pred ecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCC--EEEeeccCceecCCC---
Confidence 9997 57777774 4567999999999999999999999999999999999999988776 999999998765432
Q ss_pred CCCCCCCCccCCceec---cCcCCCeeeEEEeC
Q 028681 176 KSTVGTPAYIAPEVLL---KKEYDGKVMCVYVI 205 (205)
Q Consensus 176 ~~~~~~~~~~aPE~~~---~~~~~~~~~Dvwsl 205 (205)
....|++.|+|||++. ...++.+ +|||||
T Consensus 208 ~~~~gt~~y~aPE~~~~~~~~~~~~~-~Diwsl 239 (348)
T 1u5q_A 208 NSFVGTPYWMAPEVILAMDEGQYDGK-VDVWSL 239 (348)
T ss_dssp CCCCSCGGGCCHHHHHTTSSCCBCTH-HHHHHH
T ss_pred CcccCCcceeCHhhhccccCCCCCcH-HHHHHH
Confidence 3456899999999985 4566655 999986
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-37 Score=238.52 Aligned_cols=185 Identities=16% Similarity=0.209 Sum_probs=149.5
Q ss_pred cCCCeEEEeeeccccceeEEEEEecCC-----CcEEEEEEeecCccc------------hHHHHHHHHHHHhcCCCCeeE
Q 028681 19 DSDRYELVRDIGSGNFGVARLMRDKKT-----EELVAVKYIERGDKI------------DENVQREIINHRSLRHPNIVR 81 (205)
Q Consensus 19 ~~~~y~~~~~l~~g~~g~v~~~~~~~~-----~~~v~iK~~~~~~~~------------~~~~~~e~~~l~~l~h~~i~~ 81 (205)
..++|++.+.||+|+||.||++.+..+ ++.||+|++...... ......++..++.++|+||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 345999999999999999999998764 578999998765321 112334555667778999999
Q ss_pred EEEEEEeC----CeEEEEEEecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCC
Q 028681 82 FKEVILTP----THLAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAP 156 (205)
Q Consensus 82 ~~~~~~~~----~~~~lv~~~~~~~sl~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~ 156 (205)
+++++... ...+++|||+ +++|.+++... ..+++..+..++.|++.||.|||+.||+||||+|+||+++.+...
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~~~ 191 (364)
T 3op5_A 113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPD 191 (364)
T ss_dssp EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSCTT
T ss_pred EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCCCC
Confidence 99998875 4589999999 88999999765 579999999999999999999999999999999999999833333
Q ss_pred cEEEeeecccccccCCCCC--------CCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 157 RLKICDFGYSKSSVLHSQP--------KSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 157 ~~~l~df~~~~~~~~~~~~--------~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
.++|+|||+++........ ....||+.|+|||++.+..++.+ +|||||
T Consensus 192 ~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~Di~sl 247 (364)
T 3op5_A 192 QVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRR-GDLEIL 247 (364)
T ss_dssp CEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHH-HHHHHH
T ss_pred eEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCch-hhHHHH
Confidence 4999999999765433222 22349999999999998888766 999996
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-38 Score=243.24 Aligned_cols=187 Identities=24% Similarity=0.340 Sum_probs=150.6
Q ss_pred ceecCCCeEEEeeeccccceeEEEEEec---CCCcEEEEEEeecCc--cchHHHHHHHHHHHhcCCCCeeEEEEEEEeCC
Q 028681 16 IMHDSDRYELVRDIGSGNFGVARLMRDK---KTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPT 90 (205)
Q Consensus 16 ~~~~~~~y~~~~~l~~g~~g~v~~~~~~---~~~~~v~iK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 90 (205)
.....++|++.+.||+|+||.||.+.+. .++..||+|.++... ...+.+.+|+.++++++||||+++++++..++
T Consensus 40 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 119 (373)
T 2qol_A 40 KELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSK 119 (373)
T ss_dssp CBCCGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred hhcCHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCC
Confidence 3445678999999999999999999886 457789999987643 23467889999999999999999999999999
Q ss_pred eEEEEEEecCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccc
Q 028681 91 HLAIVMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 169 (205)
Q Consensus 91 ~~~lv~~~~~~~sl~~~~~~~~-~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~ 169 (205)
..++||||+++++|.+++.... .+++..+..++.|++.||.|||+.||+|+||+|+||+++.++. +||+|||+++..
T Consensus 120 ~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~--~kl~Dfg~a~~~ 197 (373)
T 2qol_A 120 PVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLV--CKVSDFGLGRVL 197 (373)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCC--EEECCC------
T ss_pred ceEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCC--EEECcCcccccc
Confidence 9999999999999999997644 6999999999999999999999999999999999999988877 999999999765
Q ss_pred cCCCCCC----CCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 170 VLHSQPK----STVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 170 ~~~~~~~----~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
....... ...+++.|+|||++.+..++.+ +|||||
T Consensus 198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~Sl 236 (373)
T 2qol_A 198 EDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSA-SDVWSY 236 (373)
T ss_dssp ----------------CTTSCHHHHHHCCCCHH-HHHHHH
T ss_pred ccCCccceeccCCCcCCCccChhhhccCCcCch-hcHHHH
Confidence 4332211 1234678999999998888766 999986
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-37 Score=235.15 Aligned_cols=188 Identities=24% Similarity=0.337 Sum_probs=158.9
Q ss_pred CceecCCCeEEEeeeccccceeEEEEEec-------CCCcEEEEEEeecCcc--chHHHHHHHHHHHhc-CCCCeeEEEE
Q 028681 15 PIMHDSDRYELVRDIGSGNFGVARLMRDK-------KTEELVAVKYIERGDK--IDENVQREIINHRSL-RHPNIVRFKE 84 (205)
Q Consensus 15 ~~~~~~~~y~~~~~l~~g~~g~v~~~~~~-------~~~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l-~h~~i~~~~~ 84 (205)
.+....++|++.+.||+|+||.||.+.+. .++..|++|++..... ..+.+..|+.+++.+ +||||+++++
T Consensus 29 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~ 108 (334)
T 2pvf_A 29 KWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLG 108 (334)
T ss_dssp TTBCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred cccCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEE
Confidence 34455789999999999999999999975 3567899999976532 335688999999999 8999999999
Q ss_pred EEEeCCeEEEEEEecCCCchHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCe
Q 028681 85 VILTPTHLAIVMEYASGGELFERICNAG----------------RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENT 148 (205)
Q Consensus 85 ~~~~~~~~~lv~~~~~~~sl~~~~~~~~----------------~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~ni 148 (205)
++..++..++|+|++++++|.+++.... .+++..+..++.|++.||.|||+.|++|+||+|+||
T Consensus 109 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NI 188 (334)
T 2pvf_A 109 ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNV 188 (334)
T ss_dssp EECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGE
T ss_pred EEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccceE
Confidence 9999999999999999999999997643 389999999999999999999999999999999999
Q ss_pred EecCCCCCcEEEeeecccccccCCC---CCCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 149 LLDGSPAPRLKICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 149 li~~~~~~~~~l~df~~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
+++.++. ++|+|||++....... ......+++.|+|||++.+..++.+ +|||||
T Consensus 189 ll~~~~~--~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~sl 245 (334)
T 2pvf_A 189 LVTENNV--MKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQ-SDVWSF 245 (334)
T ss_dssp EECTTCC--EEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHH-HHHHHH
T ss_pred EEcCCCC--EEEccccccccccccccccccCCCCcccceeChHHhcCCCcChH-HHHHHH
Confidence 9988877 9999999997654332 2233356788999999988888766 999986
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=238.42 Aligned_cols=185 Identities=21% Similarity=0.252 Sum_probs=151.5
Q ss_pred cCCCeEEEeeeccccceeEEEEEecC---CCcEEEEEEeecCccc------------hHHHHHHHHHHHhcCCCCeeEEE
Q 028681 19 DSDRYELVRDIGSGNFGVARLMRDKK---TEELVAVKYIERGDKI------------DENVQREIINHRSLRHPNIVRFK 83 (205)
Q Consensus 19 ~~~~y~~~~~l~~g~~g~v~~~~~~~---~~~~v~iK~~~~~~~~------------~~~~~~e~~~l~~l~h~~i~~~~ 83 (205)
..++|++.+.||+|+||.||++.+.. ++..+++|........ ...+..|+..++.++|+||++++
T Consensus 35 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~ 114 (345)
T 2v62_A 35 EGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFY 114 (345)
T ss_dssp TSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEE
T ss_pred cCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceee
Confidence 34789999999999999999999987 7889999998765321 13355677888889999999999
Q ss_pred EEEEe----CCeEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEE
Q 028681 84 EVILT----PTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLK 159 (205)
Q Consensus 84 ~~~~~----~~~~~lv~~~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~ 159 (205)
+++.. ....+++||++ +++|.+++...+.+++..+..++.|++.||.|||+.||+|+||+|+||+++.++...++
T Consensus 115 ~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~k 193 (345)
T 2v62_A 115 GSGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVY 193 (345)
T ss_dssp EEEEEESSSCEEEEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTTSEE
T ss_pred cccccccCCCcEEEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCCcEE
Confidence 99988 77899999999 88999999877789999999999999999999999999999999999999877733599
Q ss_pred EeeecccccccCCCCC--------CCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 160 ICDFGYSKSSVLHSQP--------KSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 160 l~df~~~~~~~~~~~~--------~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
|+|||+++........ ....|++.|+|||++.+..++.+ +|||||
T Consensus 194 L~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~Di~sl 246 (345)
T 2v62_A 194 LADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRR-SDVEIL 246 (345)
T ss_dssp ECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHH-HHHHHH
T ss_pred EEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCch-hhHHHH
Confidence 9999999765433211 33468999999999998888766 999996
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=237.65 Aligned_cols=187 Identities=24% Similarity=0.327 Sum_probs=157.8
Q ss_pred ceecCCCeEEEeeeccccceeEEEEEec-----CCCcEEEEEEeecCc--cchHHHHHHHHHHHhc-CCCCeeEEEEEEE
Q 028681 16 IMHDSDRYELVRDIGSGNFGVARLMRDK-----KTEELVAVKYIERGD--KIDENVQREIINHRSL-RHPNIVRFKEVIL 87 (205)
Q Consensus 16 ~~~~~~~y~~~~~l~~g~~g~v~~~~~~-----~~~~~v~iK~~~~~~--~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~ 87 (205)
.....++|++.+.||+|++|.||.+.+. .++..|++|.+.... ...+.+..|+.+++.+ +||||+++++++.
T Consensus 40 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~ 119 (344)
T 1rjb_A 40 WEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACT 119 (344)
T ss_dssp GBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe
Confidence 3445689999999999999999999973 456789999987542 3346789999999999 8999999999999
Q ss_pred eCCeEEEEEEecCCCchHHHHHhcC-----------------------CCCHHHHHHHHHHHHHHHHHHHhcCcEeecCC
Q 028681 88 TPTHLAIVMEYASGGELFERICNAG-----------------------RFSEDEARFFFQQLISGVSYCHSMQVCHRDLK 144 (205)
Q Consensus 88 ~~~~~~lv~~~~~~~sl~~~~~~~~-----------------------~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~ 144 (205)
.++..+++|||+++++|.+.+.... .+++..+..++.|++.||.|||+.||+|+||+
T Consensus 120 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dik 199 (344)
T 1rjb_A 120 LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLA 199 (344)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCS
T ss_pred eCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCC
Confidence 9999999999999999999997643 27899999999999999999999999999999
Q ss_pred CCCeEecCCCCCcEEEeeecccccccCCCCC---CCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 145 LENTLLDGSPAPRLKICDFGYSKSSVLHSQP---KSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 145 p~nili~~~~~~~~~l~df~~~~~~~~~~~~---~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
|+||+++.++. ++|+|||++......... ....+++.|+|||.+.+..++.+ +|||||
T Consensus 200 p~NIll~~~~~--~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~-~Di~sl 260 (344)
T 1rjb_A 200 ARNVLVTHGKV--VKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIK-SDVWSY 260 (344)
T ss_dssp GGGEEEETTTE--EEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHH-HHHHHH
T ss_pred hhhEEEcCCCc--EEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChh-HhHHHH
Confidence 99999988776 999999999765433221 22346788999999998888765 999986
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-37 Score=233.97 Aligned_cols=187 Identities=23% Similarity=0.308 Sum_probs=160.6
Q ss_pred ceecCCCeEEEeeeccccceeEEEEEe-----cCCCcEEEEEEeecCcc--chHHHHHHHHHHHhc-CCCCeeEEEEEEE
Q 028681 16 IMHDSDRYELVRDIGSGNFGVARLMRD-----KKTEELVAVKYIERGDK--IDENVQREIINHRSL-RHPNIVRFKEVIL 87 (205)
Q Consensus 16 ~~~~~~~y~~~~~l~~g~~g~v~~~~~-----~~~~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l-~h~~i~~~~~~~~ 87 (205)
.....++|++.+.||+|+||.||.+.+ ..++..|++|.+..... ..+.+.+|+.+++.+ +||||+++++++.
T Consensus 18 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 97 (313)
T 1t46_A 18 WEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACT 97 (313)
T ss_dssp GBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEe
Confidence 344568999999999999999999985 45678999999986543 346788999999999 8999999999999
Q ss_pred eCCeEEEEEEecCCCchHHHHHhcC------------------CCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeE
Q 028681 88 TPTHLAIVMEYASGGELFERICNAG------------------RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTL 149 (205)
Q Consensus 88 ~~~~~~lv~~~~~~~sl~~~~~~~~------------------~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nil 149 (205)
.++..+++||++++++|.+.+.... ++++..+..++.|++.||.+||++|++|+||+|+||+
T Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil 177 (313)
T 1t46_A 98 IGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNIL 177 (313)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred cCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEE
Confidence 9999999999999999999997643 4899999999999999999999999999999999999
Q ss_pred ecCCCCCcEEEeeecccccccCCCC---CCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 150 LDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 150 i~~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
++.++. ++|+|||++........ .....+++.|+|||.+.+..++.+ +|||||
T Consensus 178 ~~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~sl 233 (313)
T 1t46_A 178 LTHGRI--TKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFE-SDVWSY 233 (313)
T ss_dssp EETTTE--EEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHH-HHHHHH
T ss_pred EcCCCC--EEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChH-HHHHHH
Confidence 988776 99999999976554432 223346788999999998888765 999986
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=232.71 Aligned_cols=188 Identities=26% Similarity=0.326 Sum_probs=156.2
Q ss_pred cCceecCCCeEEEe-eeccccceeEEEEE--ecCCCcEEEEEEeecCcc---chHHHHHHHHHHHhcCCCCeeEEEEEEE
Q 028681 14 MPIMHDSDRYELVR-DIGSGNFGVARLMR--DKKTEELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVIL 87 (205)
Q Consensus 14 ~~~~~~~~~y~~~~-~l~~g~~g~v~~~~--~~~~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 87 (205)
.......++|++.+ .||+|++|.||.+. ...++..|++|++..... ..+.+..|+.+++.++||||+++++++
T Consensus 9 ~~~~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~- 87 (291)
T 1xbb_A 9 KEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC- 87 (291)
T ss_dssp --CBCCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-
T ss_pred ceeeecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-
Confidence 34445678999998 99999999999995 456678999999876532 246788999999999999999999998
Q ss_pred eCCeEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccc
Q 028681 88 TPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 167 (205)
Q Consensus 88 ~~~~~~lv~~~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~ 167 (205)
..+..++++|++++++|.+++...+.+++..+..++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||++.
T Consensus 88 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~--~kl~Dfg~~~ 165 (291)
T 1xbb_A 88 EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHY--AKISDFGLSK 165 (291)
T ss_dssp ESSSEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTE--EEECCCTTCE
T ss_pred CCCCcEEEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCc--EEEccCCcce
Confidence 56778899999999999999988888999999999999999999999999999999999999988776 9999999987
Q ss_pred cccCCCC----CCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 168 SSVLHSQ----PKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 168 ~~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
....... .....+++.|+|||.+.+..++.+ +|||||
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~sl 206 (291)
T 1xbb_A 166 ALRADENYYKAQTHGKWPVKWYAPECINYYKFSSK-SDVWSF 206 (291)
T ss_dssp ECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHH-HHHHHH
T ss_pred eeccCCCcccccccCCCCceeeChHHhccCCCChh-hhHHHH
Confidence 6543322 122245688999999988887755 999986
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=236.30 Aligned_cols=186 Identities=21% Similarity=0.308 Sum_probs=151.6
Q ss_pred ceecCCCeEEEeeeccccceeEEEEEecCCCcE----EEEEEeecCc--cchHHHHHHHHHHHhcCCCCeeEEEEEEEeC
Q 028681 16 IMHDSDRYELVRDIGSGNFGVARLMRDKKTEEL----VAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTP 89 (205)
Q Consensus 16 ~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~----v~iK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 89 (205)
-....++|++.+.||+|+||.||++.+..++.. |++|.+.... ...+.+.+|+.+++.++||||+++++++..+
T Consensus 10 ~~l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 89 (327)
T 3poz_A 10 RILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS 89 (327)
T ss_dssp EECCGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS
T ss_pred hhcCHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC
Confidence 334568999999999999999999998877654 4777775432 3446789999999999999999999999876
Q ss_pred CeEEEEEEecCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeeccccc
Q 028681 90 THLAIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 168 (205)
Q Consensus 90 ~~~~lv~~~~~~~sl~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~ 168 (205)
. .+++++++.+++|.+.+.. ...+++..+..++.|++.||.|||++||+||||+|+||+++.++. ++|+|||+++.
T Consensus 90 ~-~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~--~kl~Dfg~a~~ 166 (327)
T 3poz_A 90 T-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQH--VKITDFGLAKL 166 (327)
T ss_dssp S-EEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTE--EEECCTTHHHH
T ss_pred C-eEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCC--EEEccCcceeE
Confidence 5 7788999999999999876 456999999999999999999999999999999999999988777 99999999976
Q ss_pred ccCCCCCC---CCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 169 SVLHSQPK---STVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 169 ~~~~~~~~---~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
........ ...+++.|+|||.+.+..++.+ +|||||
T Consensus 167 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~-~Di~sl 205 (327)
T 3poz_A 167 LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQ-SDVWSY 205 (327)
T ss_dssp HTTTCC-------CCCGGGSCHHHHHHCCCCHH-HHHHHH
T ss_pred ccCCcccccccCCCccccccChHHhccCCCCch-hhhhhh
Confidence 54433322 2346778999999999888766 999996
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-37 Score=235.40 Aligned_cols=183 Identities=22% Similarity=0.352 Sum_probs=151.9
Q ss_pred eecCCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCccc---hHHHHHHHHHHHhcCC--CCeeEEEEEEEeCCe
Q 028681 17 MHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI---DENVQREIINHRSLRH--PNIVRFKEVILTPTH 91 (205)
Q Consensus 17 ~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~---~~~~~~e~~~l~~l~h--~~i~~~~~~~~~~~~ 91 (205)
....++|++.+.||+|+||.||.+.+. ++..||+|++...... .+.+..|+.+++.++| +||+++++++..+..
T Consensus 5 ~~~~~~y~i~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~ 83 (343)
T 3dbq_A 5 SVKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQY 83 (343)
T ss_dssp ESSSCEEEEEEEESCCSSEEEEEEECT-TSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred eeecCEEEEEEEEecCCCeEEEEEEeC-CCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCE
Confidence 445788999999999999999999885 5888999999765432 3567899999999986 999999999999999
Q ss_pred EEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccC
Q 028681 92 LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 171 (205)
Q Consensus 92 ~~lv~~~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~ 171 (205)
.+++|| +.+++|.+.+.....+++..+..++.|++.||.|||+.||+||||+|+||+++ ++. ++|+|||+++....
T Consensus 84 ~~lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~--~kl~DFG~a~~~~~ 159 (343)
T 3dbq_A 84 IYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGM--LKLIDFGIANQMQP 159 (343)
T ss_dssp EEEEEC-CCSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTE--EEECCCSSSCCC--
T ss_pred EEEEEe-CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CCc--EEEeecccccccCc
Confidence 999999 45779999999888999999999999999999999999999999999999996 344 99999999976544
Q ss_pred CCC---CCCCCCCCCccCCceecc-----------CcCCCeeeEEEeC
Q 028681 172 HSQ---PKSTVGTPAYIAPEVLLK-----------KEYDGKVMCVYVI 205 (205)
Q Consensus 172 ~~~---~~~~~~~~~~~aPE~~~~-----------~~~~~~~~Dvwsl 205 (205)
... .....|++.|+|||++.+ ..++.+ +|||||
T Consensus 160 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~-~Diwsl 206 (343)
T 3dbq_A 160 DTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPK-SDVWSL 206 (343)
T ss_dssp ----------CCCCSSCCHHHHHHCC-----------CCHH-HHHHHH
T ss_pred ccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCch-hhHHHH
Confidence 332 234569999999999965 455544 999986
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=228.54 Aligned_cols=184 Identities=21% Similarity=0.241 Sum_probs=159.0
Q ss_pred cCCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCccchHHHHHHHHHHHhc-CCCCeeEEEEEEEeCCeEEEEEE
Q 028681 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIVME 97 (205)
Q Consensus 19 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~~ 97 (205)
..++|++.+.||+|++|.||.+.+..+++.||+|++.... ..+.+..|+..++.+ +|++++++++++..+...++++|
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e 86 (298)
T 1csn_A 8 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS-DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 86 (298)
T ss_dssp ETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT-TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred cccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC-ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEE
Confidence 4688999999999999999999999999999999886543 345678899999999 79999999999999999999999
Q ss_pred ecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCC---CcEEEeeecccccccCCC
Q 028681 98 YASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPA---PRLKICDFGYSKSSVLHS 173 (205)
Q Consensus 98 ~~~~~sl~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~---~~~~l~df~~~~~~~~~~ 173 (205)
++ +++|.+++... .++++..+..++.|++.||.|||++|++|+||+|+||+++.++. ..++|+|||++.......
T Consensus 87 ~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~~ 165 (298)
T 1csn_A 87 LL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPV 165 (298)
T ss_dssp CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTT
T ss_pred ec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECcccccccccc
Confidence 99 88999999764 45999999999999999999999999999999999999976442 249999999997654432
Q ss_pred C--------CCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 174 Q--------PKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 174 ~--------~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
. .....|++.|+|||++.+..++.+ +|||||
T Consensus 166 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~Di~sl 204 (298)
T 1csn_A 166 TKQHIPYREKKNLSGTARYMSINTHLGREQSRR-DDLEAL 204 (298)
T ss_dssp TCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHH-HHHHHH
T ss_pred ccccccccCccCCCCCcccCCchhhcCCCCChH-HHHHHH
Confidence 2 234468999999999998888755 999986
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=239.73 Aligned_cols=187 Identities=28% Similarity=0.452 Sum_probs=148.9
Q ss_pred CceecCCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCccchHHHHHHHHHHHhcCCCCeeEEEEEEEeCC----
Q 028681 15 PIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPT---- 90 (205)
Q Consensus 15 ~~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~---- 90 (205)
......++|++.+.||+|+||.||++.+..++..||+|.+............++..++.++||||+++++++....
T Consensus 17 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~ 96 (360)
T 3e3p_A 17 RSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDR 96 (360)
T ss_dssp HHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCT
T ss_pred hchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccccHHHHHHHHHHHhcCCCCcccHHHhhhccccccc
Confidence 3445678999999999999999999999999999999999876666667788888899999999999999997543
Q ss_pred ---eEEEEEEecCCCchHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHH--hcCcEeecCCCCCeEecC-CCCCcEEE
Q 028681 91 ---HLAIVMEYASGGELFERI----CNAGRFSEDEARFFFQQLISGVSYCH--SMQVCHRDLKLENTLLDG-SPAPRLKI 160 (205)
Q Consensus 91 ---~~~lv~~~~~~~sl~~~~----~~~~~~~~~~~~~i~~~i~~~l~~lh--~~~i~H~di~p~nili~~-~~~~~~~l 160 (205)
+.+++|||+++ +|...+ .....+++..+..++.|++.|+.+|| +.||+|+||+|+||+++. ++. ++|
T Consensus 97 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~--~kl 173 (360)
T 3e3p_A 97 RDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGT--LKL 173 (360)
T ss_dssp TCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTE--EEE
T ss_pred cceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCc--EEE
Confidence 38899999976 444333 34567999999999999999999999 999999999999999986 555 999
Q ss_pred eeecccccccCCCCCCCCCCCCCccCCceeccCc-CCCeeeEEEeC
Q 028681 161 CDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKE-YDGKVMCVYVI 205 (205)
Q Consensus 161 ~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~-~~~~~~Dvwsl 205 (205)
+|||++.............+++.|+|||++.+.. ++.+ +|||||
T Consensus 174 ~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~-~Di~sl 218 (360)
T 3e3p_A 174 CDFGSAKKLSPSEPNVAYICSRYYRAPELIFGNQHYTTA-VDIWSV 218 (360)
T ss_dssp CCCTTCBCCCTTSCCCSTTSCGGGCCHHHHTTCSSCCTH-HHHHHH
T ss_pred eeCCCceecCCCCCcccccCCcceeCHHHHcCCCCCCcH-HHHHHH
Confidence 9999998777666666677899999999997665 5544 999986
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=236.40 Aligned_cols=187 Identities=21% Similarity=0.319 Sum_probs=142.8
Q ss_pred ceecCCCeEEEeeeccccceeEEEEEecCCCc---EEEEEEeecCc---cchHHHHHHHHHHHhcCCCCeeEEEEEEEeC
Q 028681 16 IMHDSDRYELVRDIGSGNFGVARLMRDKKTEE---LVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTP 89 (205)
Q Consensus 16 ~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~---~v~iK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 89 (205)
.....++|++.+.||+|++|.||.+.+..++. .||+|.+.... ...+.+.+|+.+++.++||||+++++++...
T Consensus 18 ~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 97 (323)
T 3qup_A 18 VLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRS 97 (323)
T ss_dssp TBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC
T ss_pred cccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecc
Confidence 34456899999999999999999999887664 79999987642 2346788999999999999999999999887
Q ss_pred CeE------EEEEEecCCCchHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCc
Q 028681 90 THL------AIVMEYASGGELFERICNAG------RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPR 157 (205)
Q Consensus 90 ~~~------~lv~~~~~~~sl~~~~~~~~------~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~ 157 (205)
... ++++||+.+++|.+.+.... .+++..+..++.|++.||.|||++|++|+||+|+||+++.++.
T Consensus 98 ~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~~-- 175 (323)
T 3qup_A 98 RAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMT-- 175 (323)
T ss_dssp -------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSC--
T ss_pred ccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCCC--
Confidence 655 89999999999999886432 5999999999999999999999999999999999999988877
Q ss_pred EEEeeecccccccCCCCC---CCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 158 LKICDFGYSKSSVLHSQP---KSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 158 ~~l~df~~~~~~~~~~~~---~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
++|+|||+++........ ....+++.|+|||.+.+..++.+ +|||||
T Consensus 176 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~sl 225 (323)
T 3qup_A 176 VCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVH-SDVWAF 225 (323)
T ss_dssp EEECCCCC-----------------CCGGGCCHHHHHHCCCCHH-HHHHHH
T ss_pred EEEeeccccccccccccccccccccCcccccCchhhcCCCCCCc-cchhhH
Confidence 999999999765443322 22346778999999998888766 999986
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-37 Score=238.58 Aligned_cols=183 Identities=28% Similarity=0.507 Sum_probs=156.8
Q ss_pred CCCeEEEeeeccccceeEEEEEec---CCCcEEEEEEeecCc-----cchHHHHHHHHHHHhc-CCCCeeEEEEEEEeCC
Q 028681 20 SDRYELVRDIGSGNFGVARLMRDK---KTEELVAVKYIERGD-----KIDENVQREIINHRSL-RHPNIVRFKEVILTPT 90 (205)
Q Consensus 20 ~~~y~~~~~l~~g~~g~v~~~~~~---~~~~~v~iK~~~~~~-----~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~ 90 (205)
.++|++.+.||+|+||.||++.+. .+++.||+|+++... ...+.+..|+.+++.+ +|+||+++++++..++
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 132 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 132 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence 379999999999999999999984 578999999987532 2335577889999999 6999999999999999
Q ss_pred eEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeeccccccc
Q 028681 91 HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 170 (205)
Q Consensus 91 ~~~lv~~~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~ 170 (205)
..++||||+++++|.+.+.....+++..+..++.|++.||.|||++||+|+||+|+||+++.++. ++|+|||+++...
T Consensus 133 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~--~kl~DfG~a~~~~ 210 (355)
T 1vzo_A 133 KLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGH--VVLTDFGLSKEFV 210 (355)
T ss_dssp EEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSC--EEESCSSEEEECC
T ss_pred eEEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCc--EEEeeCCCCeecc
Confidence 99999999999999999988888999999999999999999999999999999999999988877 9999999997553
Q ss_pred CCC--CCCCCCCCCCccCCceeccC--cCCCeeeEEEeC
Q 028681 171 LHS--QPKSTVGTPAYIAPEVLLKK--EYDGKVMCVYVI 205 (205)
Q Consensus 171 ~~~--~~~~~~~~~~~~aPE~~~~~--~~~~~~~Dvwsl 205 (205)
... ......|++.|+|||++.+. .++.+ +|||||
T Consensus 211 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~-~Dvwsl 248 (355)
T 1vzo_A 211 ADETERAYDFCGTIEYMAPDIVRGGDSGHDKA-VDWWSL 248 (355)
T ss_dssp GGGGGGGCGGGSCCTTCCHHHHTTCC---CTH-HHHHHH
T ss_pred cCCCCcccCcccCcCccChhhhcCCCCCCCch-hhHHHH
Confidence 322 22334689999999999863 34544 999986
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-37 Score=237.54 Aligned_cols=184 Identities=23% Similarity=0.359 Sum_probs=153.3
Q ss_pred ceecCCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCcc---chHHHHHHHHHHHhcC--CCCeeEEEEEEEeCC
Q 028681 16 IMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---IDENVQREIINHRSLR--HPNIVRFKEVILTPT 90 (205)
Q Consensus 16 ~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~ 90 (205)
+.....+|++.+.||+|+||.||++.+.. +..||+|++..... ..+.+.+|+.+++.++ |+||+++++++..++
T Consensus 51 ~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~ 129 (390)
T 2zmd_A 51 ISVKGRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQ 129 (390)
T ss_dssp EEETTEEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred ccccCCceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCC
Confidence 34445679999999999999999999876 88999999976532 2366889999999997 599999999999999
Q ss_pred eEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeeccccccc
Q 028681 91 HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 170 (205)
Q Consensus 91 ~~~lv~~~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~ 170 (205)
..+++|| +.+++|.+++.....+++..+..++.|++.||.|||++||+||||+|+||++++ +. +||+|||+++...
T Consensus 130 ~~~lv~E-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~-~~--~kl~DFG~a~~~~ 205 (390)
T 2zmd_A 130 YIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD-GM--LKLIDFGIANQMQ 205 (390)
T ss_dssp EEEEEEE-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEESS-SC--EEECCCSSSCCC-
T ss_pred EEEEEEe-cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEEC-Ce--EEEEecCcccccc
Confidence 9999999 567899999988888999999999999999999999999999999999999963 44 9999999997654
Q ss_pred CCC---CCCCCCCCCCccCCceecc-----------CcCCCeeeEEEeC
Q 028681 171 LHS---QPKSTVGTPAYIAPEVLLK-----------KEYDGKVMCVYVI 205 (205)
Q Consensus 171 ~~~---~~~~~~~~~~~~aPE~~~~-----------~~~~~~~~Dvwsl 205 (205)
... ......|++.|+|||++.+ ..++.+ +|||||
T Consensus 206 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~-~DiwSl 253 (390)
T 2zmd_A 206 PDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPK-SDVWSL 253 (390)
T ss_dssp --------CCSCCCGGGCCHHHHHCC------------CCHH-HHHHHH
T ss_pred CCCccccCCCCCcCCCccChHHhhhccccccccccccCCCCh-hhHHHH
Confidence 432 2234579999999999975 245544 999986
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=236.45 Aligned_cols=186 Identities=26% Similarity=0.320 Sum_probs=159.9
Q ss_pred ceecCCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCcc-chHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEE
Q 028681 16 IMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 94 (205)
Q Consensus 16 ~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 94 (205)
+....++|++.+.||+|+||.||.+.+. ++..|++|.+..... ..+.+.+|+.+++.++||||+++++++...+..++
T Consensus 34 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 112 (321)
T 2qkw_B 34 LEEATNNFDHKFLIGHGVFGKVYKGVLR-DGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMIL 112 (321)
T ss_dssp CCCCCCCCSCCCCSCBCSSSEEEEEECT-TCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEE
T ss_pred HHHHHhccCccceeecCCCeeEEEEEEC-CCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEE
Confidence 3445689999999999999999999965 578899998876543 34678899999999999999999999999999999
Q ss_pred EEEecCCCchHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeeccccccc
Q 028681 95 VMEYASGGELFERICNAG----RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 170 (205)
Q Consensus 95 v~~~~~~~sl~~~~~~~~----~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~ 170 (205)
+|||+++++|.+.+.... .+++..+..++.|++.||.|||++|++|+||+|+||+++.++. ++|+|||++....
T Consensus 113 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~ 190 (321)
T 2qkw_B 113 IYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFV--PKITDFGISKKGT 190 (321)
T ss_dssp EEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCC--EEECCCTTCEECS
T ss_pred EEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCC--EEEeecccccccc
Confidence 999999999998886533 5899999999999999999999999999999999999988877 9999999987543
Q ss_pred CCCC---CCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 171 LHSQ---PKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 171 ~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
.... .....|++.|+|||++.+..++.+ +|||||
T Consensus 191 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~Di~sl 227 (321)
T 2qkw_B 191 ELDQTHLSTVVKGTLGYIDPEYFIKGRLTEK-SDVYSF 227 (321)
T ss_dssp SSSCCCCBCCCEEETTTCCHHHHHHCBCCTH-HHHHHH
T ss_pred cccccccccccCCCccccCHHHhcCCCCCcc-cchHhH
Confidence 3222 223358899999999998888766 999986
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-37 Score=230.54 Aligned_cols=184 Identities=27% Similarity=0.404 Sum_probs=150.0
Q ss_pred cCCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCc----cchHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEE
Q 028681 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 94 (205)
Q Consensus 19 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 94 (205)
..++|++.+.||+|++|.||.+.+..++..|++|.+.... ...+.+.+|+.+++.++|+||+++++++..++..++
T Consensus 30 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 109 (310)
T 2wqm_A 30 TLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNI 109 (310)
T ss_dssp SGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred cccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEE
Confidence 4578999999999999999999999999999999987532 234568899999999999999999999999999999
Q ss_pred EEEecCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeeccccccc
Q 028681 95 VMEYASGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 170 (205)
Q Consensus 95 v~~~~~~~sl~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~ 170 (205)
++|++++++|.+++.. ...+++..+..++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||++....
T Consensus 110 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~--~kl~Dfg~~~~~~ 187 (310)
T 2wqm_A 110 VLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGV--VKLGDLGLGRFFS 187 (310)
T ss_dssp EEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSC--EEECCC-------
T ss_pred EEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCC--EEEEeccceeeec
Confidence 9999999999988864 456999999999999999999999999999999999999988777 9999999987654
Q ss_pred CCC-CCCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 171 LHS-QPKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 171 ~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
... ......+++.|+|||.+.+..++.+ +|||||
T Consensus 188 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~sl 222 (310)
T 2wqm_A 188 SKTTAAHSLVGTPYYMSPERIHENGYNFK-SDIWSL 222 (310)
T ss_dssp -----------CCSSCCHHHHTTCCCCHH-HHHHHH
T ss_pred CCCccccccCCCeeEeChHHhCCCCCCch-hhHHHH
Confidence 332 2233468999999999998888765 999986
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-37 Score=229.96 Aligned_cols=184 Identities=38% Similarity=0.597 Sum_probs=161.5
Q ss_pred CCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCc---cchHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEE
Q 028681 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (205)
Q Consensus 20 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 96 (205)
.++|++.+.||+|++|.||.+.+..+++.|++|++.... ...+.+.+|+.++++++||||+++++++.+.+..++++
T Consensus 21 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 100 (287)
T 2wei_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG 100 (287)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEE
Confidence 478999999999999999999999999999999987543 33567889999999999999999999999999999999
Q ss_pred EecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCC-CCcEEEeeecccccccCCCCC
Q 028681 97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSP-APRLKICDFGYSKSSVLHSQP 175 (205)
Q Consensus 97 ~~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~-~~~~~l~df~~~~~~~~~~~~ 175 (205)
|++++++|.+.+.....+++..+..++.|++.||.+||++|++|+||+|+||+++.++ ...++|+|||++.........
T Consensus 101 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~~~~ 180 (287)
T 2wei_A 101 ELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM 180 (287)
T ss_dssp CCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCCSSC
T ss_pred EccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeecCCCcc
Confidence 9999999999988878899999999999999999999999999999999999997643 234999999999766555444
Q ss_pred CCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 176 KSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 176 ~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
....+++.|+|||.+.+. ++.+ +|||||
T Consensus 181 ~~~~~~~~y~aPE~~~~~-~~~~-~Di~sl 208 (287)
T 2wei_A 181 KDRIGTAYYIAPEVLRGT-YDEK-CDVWSA 208 (287)
T ss_dssp SCHHHHHTTCCHHHHTTC-CCTH-HHHHHH
T ss_pred ccccCcccccChHHhcCC-CCCc-hhhHhH
Confidence 455688999999998764 5555 999986
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-37 Score=229.22 Aligned_cols=186 Identities=22% Similarity=0.315 Sum_probs=159.5
Q ss_pred CceecCCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCccchHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEE
Q 028681 15 PIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 94 (205)
Q Consensus 15 ~~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 94 (205)
.+....++|++.+.||+|++|.||.+.+. ++..|++|.+.......+.+..|+.+++.++|||++++++++.. +..++
T Consensus 7 ~~~v~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~ 84 (279)
T 1qpc_A 7 EWEVPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYI 84 (279)
T ss_dssp TTBCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEE
T ss_pred hcccCHHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCcccHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEE
Confidence 34455689999999999999999999976 46679999998776667889999999999999999999998764 56889
Q ss_pred EEEecCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCC
Q 028681 95 VMEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 172 (205)
Q Consensus 95 v~~~~~~~sl~~~~~~~~--~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~ 172 (205)
++|++++++|.+.+.... .+++..+..++.|++.||.+||++|++|+||+|+||+++.++. ++|+|||++......
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~--~kl~Dfg~~~~~~~~ 162 (279)
T 1qpc_A 85 ITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLS--CKIADFGLARLIEDN 162 (279)
T ss_dssp EEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSC--EEECCCTTCEECSSS
T ss_pred EEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCC--EEECCCcccccccCc
Confidence 999999999999986533 6999999999999999999999999999999999999988777 999999998765433
Q ss_pred C--CCCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 173 S--QPKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 173 ~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
. ......++..|+|||.+.+..++.+ +|||||
T Consensus 163 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~sl 196 (279)
T 1qpc_A 163 EYTAREGAKFPIKWTAPEAINYGTFTIK-SDVWSF 196 (279)
T ss_dssp CEECCTTCCCCTTTSCHHHHHHCEECHH-HHHHHH
T ss_pred ccccccCCCCccCccChhhhccCCCCch-hhhHHH
Confidence 2 2223356788999999988888755 999986
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-37 Score=234.24 Aligned_cols=184 Identities=29% Similarity=0.484 Sum_probs=155.7
Q ss_pred cCCCeEEE-eeeccccceeEEEEEecCCCcEEEEEEeecCc---cchHHHHHHHHHHHhcC-CCCeeEEEEEEEeCCeEE
Q 028681 19 DSDRYELV-RDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLR-HPNIVRFKEVILTPTHLA 93 (205)
Q Consensus 19 ~~~~y~~~-~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~ 93 (205)
-.++|.+. +.||+|+||.||++.+..+++.||+|++.... .....+..|+.+++.+. ||||+++++++..++..+
T Consensus 26 ~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~ 105 (327)
T 3lm5_A 26 FNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEII 105 (327)
T ss_dssp HHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred hhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEE
Confidence 35678887 89999999999999999999999999987643 23467889999999985 699999999999999999
Q ss_pred EEEEecCCCchHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecC---CCCCcEEEeeeccccc
Q 028681 94 IVMEYASGGELFERICN--AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDG---SPAPRLKICDFGYSKS 168 (205)
Q Consensus 94 lv~~~~~~~sl~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~---~~~~~~~l~df~~~~~ 168 (205)
++|||+.+++|.+.+.. ...+++..++.++.|++.||++||++|++|+||+|+||+++. ++. ++|+|||++..
T Consensus 106 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~--~kL~Dfg~a~~ 183 (327)
T 3lm5_A 106 LILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGD--IKIVDFGMSRK 183 (327)
T ss_dssp EEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCC--EEECCGGGCEE
T ss_pred EEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCc--EEEeeCccccc
Confidence 99999999999998854 356999999999999999999999999999999999999986 444 99999999987
Q ss_pred ccCCCCCCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 169 SVLHSQPKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 169 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
...........+++.|+|||++.+..++.+ +|||||
T Consensus 184 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~Diwsl 219 (327)
T 3lm5_A 184 IGHACELREIMGTPEYLAPEILNYDPITTA-TDMWNI 219 (327)
T ss_dssp C---------CCCGGGCCHHHHTTCCCCTH-HHHHHH
T ss_pred cCCccccccccCCcCccCCeeecCCCCCch-hhHHHH
Confidence 766655566679999999999998888766 999986
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-37 Score=243.98 Aligned_cols=186 Identities=22% Similarity=0.315 Sum_probs=160.6
Q ss_pred CceecCCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCccchHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEE
Q 028681 15 PIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 94 (205)
Q Consensus 15 ~~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 94 (205)
......++|++.+.||+|+||.||.+.+.. +..||+|.++......+.+..|+.+++.++||||+++++++. .+..++
T Consensus 182 ~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~l 259 (454)
T 1qcf_A 182 AWEIPRESLKLEKKLGAGQFGEVWMATYNK-HTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYI 259 (454)
T ss_dssp CSBCCGGGEEEEEEEECCSSEEEEEEEETT-TEEEEEEEECTTSBCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEE
T ss_pred ceeechHHeEEEEEcccCCceEEEEEEECC-ccEEEEEEecCCCccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEE
Confidence 345567899999999999999999999864 677999999887767788999999999999999999999886 567899
Q ss_pred EEEecCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCC
Q 028681 95 VMEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 172 (205)
Q Consensus 95 v~~~~~~~sl~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~ 172 (205)
||||+++++|.+++... ..++...+..++.|++.||+|||+++|+||||+|+||+++.++. +||+|||+++.....
T Consensus 260 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~--~kl~DFG~a~~~~~~ 337 (454)
T 1qcf_A 260 ITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLV--CKIADFGLARVIEDN 337 (454)
T ss_dssp EECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCC--EEECSTTGGGGBCCH
T ss_pred EEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCc--EEEeeCCCceEcCCC
Confidence 99999999999999753 36899999999999999999999999999999999999988877 999999999765332
Q ss_pred C--CCCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 173 S--QPKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 173 ~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
. ......+++.|+|||++....++.+ +|||||
T Consensus 338 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Dvwsl 371 (454)
T 1qcf_A 338 EYTAREGAKFPIKWTAPEAINFGSFTIK-SDVWSF 371 (454)
T ss_dssp HHHTTCSSSSCGGGSCHHHHHHCCCCHH-HHHHHH
T ss_pred ceeccCCCcccccccCHHHhccCCCCcH-HHHHhH
Confidence 1 1223346788999999998888766 999996
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-37 Score=229.87 Aligned_cols=184 Identities=26% Similarity=0.352 Sum_probs=142.3
Q ss_pred ecCCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCccch---HHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEE
Q 028681 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID---ENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 94 (205)
Q Consensus 18 ~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~---~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 94 (205)
...++|++.+.||+|++|.||++.+..+++.||+|++....... +.+.++...++.++|||++++++++.+++..++
T Consensus 4 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~l 83 (290)
T 3fme_A 4 VKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWI 83 (290)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEE
T ss_pred ccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEE
Confidence 34689999999999999999999999999999999997653222 234455555778899999999999999999999
Q ss_pred EEEecCCCchHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhc-CcEeecCCCCCeEecCCCCCcEEEeeecccccc
Q 028681 95 VMEYASGGELFERIC----NAGRFSEDEARFFFQQLISGVSYCHSM-QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 169 (205)
Q Consensus 95 v~~~~~~~sl~~~~~----~~~~~~~~~~~~i~~~i~~~l~~lh~~-~i~H~di~p~nili~~~~~~~~~l~df~~~~~~ 169 (205)
+||++++ +|.+.+. ....+++..+..++.|++.||.|||+. |++|+||+|+||+++.++. ++|+|||++...
T Consensus 84 v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~--~kl~Dfg~~~~~ 160 (290)
T 3fme_A 84 CMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQ--VKMCDFGISGYL 160 (290)
T ss_dssp EEECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCC--EEBCCC------
T ss_pred EEehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCC--EEEeecCCcccc
Confidence 9999975 7766664 356799999999999999999999998 9999999999999988776 999999999877
Q ss_pred cCCCCCCCCCCCCCccCCcee----ccCcCCCeeeEEEeC
Q 028681 170 VLHSQPKSTVGTPAYIAPEVL----LKKEYDGKVMCVYVI 205 (205)
Q Consensus 170 ~~~~~~~~~~~~~~~~aPE~~----~~~~~~~~~~Dvwsl 205 (205)
..........+++.|+|||.+ .+..++.+ +|||||
T Consensus 161 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~-~Di~sl 199 (290)
T 3fme_A 161 VDDVAKDIDAGCKPYMAPERINPELNQKGYSVK-SDIWSL 199 (290)
T ss_dssp ---------CCCCCCSCHHHHSCCTTC--CCHH-HHHHHH
T ss_pred cccccccccCCCccccChhhcChhhcCcCCCcH-HHHHHH
Confidence 666555666799999999997 34455544 999985
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-36 Score=226.22 Aligned_cols=185 Identities=25% Similarity=0.392 Sum_probs=157.8
Q ss_pred ceecCCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCcc---chHHHHHHHHHHHhcCCCCeeEEEEEEEe----
Q 028681 16 IMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILT---- 88 (205)
Q Consensus 16 ~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---- 88 (205)
+......|++.+.||+|++|.||.+.+..++..|++|.+..... ..+.+..|+.+++.++||||+++++++..
T Consensus 21 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 100 (290)
T 1t4h_A 21 MSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKG 100 (290)
T ss_dssp ECTTSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSS
T ss_pred cccCceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCC
Confidence 34445668999999999999999999999999999999876432 33568899999999999999999999875
Q ss_pred CCeEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcC--cEeecCCCCCeEec-CCCCCcEEEeeecc
Q 028681 89 PTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ--VCHRDLKLENTLLD-GSPAPRLKICDFGY 165 (205)
Q Consensus 89 ~~~~~lv~~~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~--i~H~di~p~nili~-~~~~~~~~l~df~~ 165 (205)
....+++|||+++++|.+.+.....+++..+..++.|++.||.|||+.+ ++|+||+|+||+++ .++. ++|+|||+
T Consensus 101 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~--~kl~Dfg~ 178 (290)
T 1t4h_A 101 KKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGS--VKIGDLGL 178 (290)
T ss_dssp CEEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSC--EEECCTTG
T ss_pred CceEEEEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCC--EEEeeCCC
Confidence 3568999999999999999988888999999999999999999999999 99999999999997 5555 99999999
Q ss_pred cccccCCCCCCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 166 SKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 166 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
+...... ......+++.|+|||++.+ .++.+ +|||||
T Consensus 179 ~~~~~~~-~~~~~~~t~~y~aPE~~~~-~~~~~-~Di~sl 215 (290)
T 1t4h_A 179 ATLKRAS-FAKAVIGTPEFMAPEMYEE-KYDES-VDVYAF 215 (290)
T ss_dssp GGGCCTT-SBEESCSSCCCCCGGGGGT-CCCTH-HHHHHH
T ss_pred ccccccc-ccccccCCcCcCCHHHHhc-cCCCc-chHHHH
Confidence 8644332 2234568999999998875 46555 999986
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-37 Score=235.08 Aligned_cols=185 Identities=21% Similarity=0.296 Sum_probs=154.4
Q ss_pred eecCCCeEEEeeeccccceeEEEEEecCCCcE----EEEEEeecCc--cchHHHHHHHHHHHhcCCCCeeEEEEEEEeCC
Q 028681 17 MHDSDRYELVRDIGSGNFGVARLMRDKKTEEL----VAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPT 90 (205)
Q Consensus 17 ~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~----v~iK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 90 (205)
....++|++.+.||+|+||.||++.+..++.. |++|.+.... ...+.+..|+.+++.++||||+++++++. ++
T Consensus 9 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~ 87 (325)
T 3kex_A 9 IFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GS 87 (325)
T ss_dssp BCCTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BS
T ss_pred hcCHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CC
Confidence 34568999999999999999999999887765 7777765432 22355778899999999999999999886 45
Q ss_pred eEEEEEEecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccc
Q 028681 91 HLAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 169 (205)
Q Consensus 91 ~~~lv~~~~~~~sl~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~ 169 (205)
..+++++|+.+++|.+.+... ..+++..+..++.|++.||.|||++|++|+||+|+||+++.++. ++|+|||+++..
T Consensus 88 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~--~kl~Dfg~a~~~ 165 (325)
T 3kex_A 88 SLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQ--VQVADFGVADLL 165 (325)
T ss_dssp SEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSC--EEECSCSGGGGS
T ss_pred ccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCe--EEECCCCccccc
Confidence 688999999999999998764 46999999999999999999999999999999999999988877 999999999876
Q ss_pred cCCCCC---CCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 170 VLHSQP---KSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 170 ~~~~~~---~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
...... ....++..|+|||++.+..++.+ +|||||
T Consensus 166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~sl 203 (325)
T 3kex_A 166 PPDDKQLLYSEAKTPIKWMALESIHFGKYTHQ-SDVWSY 203 (325)
T ss_dssp CCCTTCCC-----CCTTTSCHHHHHHCCCCHH-HHHHHH
T ss_pred CcccccccccCCCCcccccChHHhccCCCChh-hHhHHh
Confidence 544322 23357789999999998888765 999986
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-37 Score=236.50 Aligned_cols=181 Identities=27% Similarity=0.438 Sum_probs=150.4
Q ss_pred ecCCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCcc---chHHHHHHHHHHHhcCCCCeeEEEEEEEeCC----
Q 028681 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTPT---- 90 (205)
Q Consensus 18 ~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~---- 90 (205)
...++|++.+.||+|+||.||.+.+..+++.||+|.+..... ..+.+.+|+.+++.++||||+++++++..+.
T Consensus 22 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~ 101 (367)
T 1cm8_A 22 EVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDD 101 (367)
T ss_dssp CCBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTT
T ss_pred eecceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCcccc
Confidence 446899999999999999999999999999999999865322 2356789999999999999999999998763
Q ss_pred --eEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeeccccc
Q 028681 91 --HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 168 (205)
Q Consensus 91 --~~~lv~~~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~ 168 (205)
.++++||++ +++|.+++.. ..+++..+..++.|++.||.|||++|++|+||+|+||+++.++. +||+|||+++.
T Consensus 102 ~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~--~kl~Dfg~a~~ 177 (367)
T 1cm8_A 102 FTDFYLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCE--LKILDFGLARQ 177 (367)
T ss_dssp CCCCEEEEECC-SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC--EEECCCTTCEE
T ss_pred CceEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCC--EEEEeeecccc
Confidence 469999999 7789888865 57999999999999999999999999999999999999988877 99999999976
Q ss_pred ccCCCCCCCCCCCCCccCCceecc-CcCCCeeeEEEeC
Q 028681 169 SVLHSQPKSTVGTPAYIAPEVLLK-KEYDGKVMCVYVI 205 (205)
Q Consensus 169 ~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~~Dvwsl 205 (205)
... ......+++.|+|||++.+ ..++.+ +|||||
T Consensus 178 ~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~-~Diwsl 212 (367)
T 1cm8_A 178 ADS--EMTGYVVTRWYRAPEVILNWMRYTQT-VDIWSV 212 (367)
T ss_dssp CCS--SCCSSCSCGGGCCTHHHHTTTCCCTT-HHHHHH
T ss_pred ccc--ccCcCcCCCCcCCHHHHhCCCCCChh-hhHHHH
Confidence 543 2344578999999999987 556655 999985
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=235.80 Aligned_cols=184 Identities=35% Similarity=0.551 Sum_probs=154.4
Q ss_pred CCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCcc---------chHHHHHHHHHHHhcCCCCeeEEEEEEEeCC
Q 028681 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---------IDENVQREIINHRSLRHPNIVRFKEVILTPT 90 (205)
Q Consensus 20 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~---------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 90 (205)
.++|++.+.||+|+||.||.+.+..+++.||+|.+..... ....+..|+.+++.++||||+++++++..+.
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 88 (322)
T 2ycf_A 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED 88 (322)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS
T ss_pred hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc
Confidence 4789999999999999999999999999999999875421 1234788999999999999999999987655
Q ss_pred eEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCC-CCcEEEeeecccccc
Q 028681 91 HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSP-APRLKICDFGYSKSS 169 (205)
Q Consensus 91 ~~~lv~~~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~-~~~~~l~df~~~~~~ 169 (205)
.+++||++++++|.+.+.....+++..+..++.|++.||.|||++|++|+||+|+||+++.++ ...++|+|||++...
T Consensus 89 -~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~ 167 (322)
T 2ycf_A 89 -YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL 167 (322)
T ss_dssp -EEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTCEEC
T ss_pred -eEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCccceec
Confidence 899999999999999998888899999999999999999999999999999999999997654 234999999998765
Q ss_pred cCCCCCCCCCCCCCccCCceec---cCcCCCeeeEEEeC
Q 028681 170 VLHSQPKSTVGTPAYIAPEVLL---KKEYDGKVMCVYVI 205 (205)
Q Consensus 170 ~~~~~~~~~~~~~~~~aPE~~~---~~~~~~~~~Dvwsl 205 (205)
..........+++.|+|||++. ...++.+ +|||||
T Consensus 168 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~-~Di~sl 205 (322)
T 2ycf_A 168 GETSLMRTLCGTPTYLAPEVLVSVGTAGYNRA-VDCWSL 205 (322)
T ss_dssp CCCHHHHHHHSCCTTCCHHHHHHTTTTTCTTH-HHHHHH
T ss_pred ccccccccccCCcCccCchhhccCCCCCCCch-hhHHHH
Confidence 4333223345899999999984 4455555 999986
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-37 Score=244.13 Aligned_cols=186 Identities=24% Similarity=0.302 Sum_probs=156.2
Q ss_pred CceecCCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCccchHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEE
Q 028681 15 PIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 94 (205)
Q Consensus 15 ~~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 94 (205)
.+....++|++.+.||+|+||.||.+.+.. +..||+|.++......+.+.+|+.+++.++||||+++++++.+ +..++
T Consensus 178 ~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~i 255 (452)
T 1fmk_A 178 AWEIPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYI 255 (452)
T ss_dssp CSBCCGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEE
T ss_pred ccccChhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEE
Confidence 344567889999999999999999999876 4669999998776667889999999999999999999999876 67899
Q ss_pred EEEecCCCchHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCC
Q 028681 95 VMEYASGGELFERICN--AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 172 (205)
Q Consensus 95 v~~~~~~~sl~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~ 172 (205)
||||+++++|.+++.. ...+++..+..++.|++.||+|||+++++||||+|+||+++.++. +||+|||+++.....
T Consensus 256 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~--~kl~DfG~a~~~~~~ 333 (452)
T 1fmk_A 256 VTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLV--CKVADFGLARLIEDN 333 (452)
T ss_dssp EECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC--EEECCCCTTC-----
T ss_pred EehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCC--EEECCCccceecCCC
Confidence 9999999999999964 356999999999999999999999999999999999999988777 999999999765432
Q ss_pred CC--CCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 173 SQ--PKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 173 ~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
.. .....++..|+|||++.+..++.+ +|||||
T Consensus 334 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~-sDvwsl 367 (452)
T 1fmk_A 334 EYTARQGAKFPIKWTAPEAALYGRFTIK-SDVWSF 367 (452)
T ss_dssp ---------CCGGGSCHHHHHHCCCCHH-HHHHHH
T ss_pred ceecccCCcccccccCHhHHhcCCCCcc-ccHHhH
Confidence 21 122346788999999998888766 999996
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-37 Score=227.42 Aligned_cols=183 Identities=31% Similarity=0.394 Sum_probs=146.1
Q ss_pred ecCCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCcc-----chHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeE
Q 028681 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK-----IDENVQREIINHRSLRHPNIVRFKEVILTPTHL 92 (205)
Q Consensus 18 ~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 92 (205)
...++|++.+.||+|++|.||.+.+. +..|++|++..... ..+.+..|+.+++.++||||+++++++..++..
T Consensus 4 ~~~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (271)
T 3dtc_A 4 IDFAELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNL 81 (271)
T ss_dssp CCTTSEEEEEEEEEETTEEEEEEEET--TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--C
T ss_pred cchhheeeeeeeccCCCeEEEEEEEc--CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCce
Confidence 35689999999999999999999975 77899999875432 236788999999999999999999999999999
Q ss_pred EEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcC---cEeecCCCCCeEecCCC------CCcEEEeee
Q 028681 93 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ---VCHRDLKLENTLLDGSP------APRLKICDF 163 (205)
Q Consensus 93 ~lv~~~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~di~p~nili~~~~------~~~~~l~df 163 (205)
+++|||+++++|.+.+. ..++++..+..++.|++.|+.+||+.| ++|+||+|+||+++.+. ...++|+||
T Consensus 82 ~lv~e~~~~~~L~~~~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Df 160 (271)
T 3dtc_A 82 CLVMEFARGGPLNRVLS-GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDF 160 (271)
T ss_dssp EEEEECCTTEEHHHHHT-SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCC
T ss_pred EEEEEcCCCCCHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccC
Confidence 99999999999988884 567999999999999999999999999 89999999999998521 234999999
Q ss_pred cccccccCCCCCCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 164 GYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
|++....... .....+++.|+|||.+.+..++.+ +|||||
T Consensus 161 g~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~-~Di~sl 200 (271)
T 3dtc_A 161 GLAREWHRTT-KMSAAGAYAWMAPEVIRASMFSKG-SDVWSY 200 (271)
T ss_dssp CC--------------CCGGGSCHHHHHHCCCSHH-HHHHHH
T ss_pred Cccccccccc-ccCCCCccceeCHHHhccCCCCch-hhHHHH
Confidence 9987554332 234568999999999998888755 999986
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-37 Score=230.33 Aligned_cols=186 Identities=24% Similarity=0.322 Sum_probs=147.5
Q ss_pred ceecCCCeEEEeeeccccceeEEEEEecCC---CcEEEEEEeecCc--cchHHHHHHHHHHHhcCCCCeeEEEEEEEeCC
Q 028681 16 IMHDSDRYELVRDIGSGNFGVARLMRDKKT---EELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPT 90 (205)
Q Consensus 16 ~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~---~~~v~iK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 90 (205)
+....++|++.+.||+|+||.||.+.+..+ +..|++|.+.... ...+.+..|+..++.++||||+++++++. ++
T Consensus 10 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~ 88 (281)
T 1mp8_A 10 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-EN 88 (281)
T ss_dssp CBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SS
T ss_pred eEEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cC
Confidence 344578999999999999999999998653 4579999887643 23466889999999999999999999874 56
Q ss_pred eEEEEEEecCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccc
Q 028681 91 HLAIVMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 169 (205)
Q Consensus 91 ~~~lv~~~~~~~sl~~~~~~~~-~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~ 169 (205)
..+++||++++++|.+.+.... .+++..+..++.|++.||.+||++|++|+||+|+||+++.++. ++|+|||++...
T Consensus 89 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~--~kl~Dfg~~~~~ 166 (281)
T 1mp8_A 89 PVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDC--VKLGDFGLSRYM 166 (281)
T ss_dssp SCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTE--EEECC-------
T ss_pred ccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCC--EEECcccccccc
Confidence 7889999999999999997644 6999999999999999999999999999999999999987776 999999999765
Q ss_pred cCCCC--CCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 170 VLHSQ--PKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 170 ~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
..... .....+++.|+|||++.+..++.+ +|||||
T Consensus 167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~sl 203 (281)
T 1mp8_A 167 EDSTYYKASKGKLPIKWMAPESINFRRFTSA-SDVWMF 203 (281)
T ss_dssp ------------CCGGGCCHHHHHHCCCSHH-HHHHHH
T ss_pred CcccccccccCCCcccccChhhcccCCCCCc-cCchHH
Confidence 43322 222346778999999998888765 999986
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-37 Score=232.98 Aligned_cols=188 Identities=24% Similarity=0.395 Sum_probs=155.7
Q ss_pred CceecCCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCc-cchHHHHHHHHHHHhcCCCCeeEEEEEEEe----C
Q 028681 15 PIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKEVILT----P 89 (205)
Q Consensus 15 ~~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~ 89 (205)
.+....++|++.+.||+|++|.||++.+..+++.||+|.+.... ...+.+..|+.+++.++||||+++++++.. .
T Consensus 23 ~~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 102 (317)
T 2buj_A 23 MVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAK 102 (317)
T ss_dssp EEEETTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTE
T ss_pred EEEECCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCC
Confidence 34456789999999999999999999999999999999886543 334678899999999999999999999873 3
Q ss_pred CeEEEEEEecCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecc
Q 028681 90 THLAIVMEYASGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGY 165 (205)
Q Consensus 90 ~~~~lv~~~~~~~sl~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~ 165 (205)
...++++|++.+++|.+.+.. ...+++..+..++.|++.||.+||++|++|+||+|+||+++.++. ++|+|||+
T Consensus 103 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~--~kl~dfg~ 180 (317)
T 2buj_A 103 HEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQ--PVLMDLGS 180 (317)
T ss_dssp EEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSC--EEECCCSS
T ss_pred ceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCC--EEEEecCc
Confidence 478999999999999998865 467999999999999999999999999999999999999988877 99999998
Q ss_pred cccccCCCCC----------CCCCCCCCccCCceeccCc---CCCeeeEEEeC
Q 028681 166 SKSSVLHSQP----------KSTVGTPAYIAPEVLLKKE---YDGKVMCVYVI 205 (205)
Q Consensus 166 ~~~~~~~~~~----------~~~~~~~~~~aPE~~~~~~---~~~~~~Dvwsl 205 (205)
+......... ....+++.|+|||.+.... ++.+ +|||||
T Consensus 181 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~-~Di~sl 232 (317)
T 2buj_A 181 MNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDER-TDVWSL 232 (317)
T ss_dssp CEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTH-HHHHHH
T ss_pred chhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCch-hhHHHH
Confidence 7654322111 1123689999999997553 4545 999986
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=232.85 Aligned_cols=183 Identities=15% Similarity=0.142 Sum_probs=156.3
Q ss_pred cCCCeEEEeeeccccceeEEEEEecCCC-------cEEEEEEeecCc-cchHHHHHHHHHHHhcCCCCeeEEEEEEEeCC
Q 028681 19 DSDRYELVRDIGSGNFGVARLMRDKKTE-------ELVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKEVILTPT 90 (205)
Q Consensus 19 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~-------~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 90 (205)
..++|++.+.||+|+||.||++.+..++ ..|++|.+.... ...+.+.+|+.+++.++||||+++++++.+++
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 85 (289)
T 4fvq_A 6 RNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGD 85 (289)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTT
T ss_pred chhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCC
Confidence 4689999999999999999999998766 479999987654 33567899999999999999999999999999
Q ss_pred eEEEEEEecCCCchHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCC------cEEEeee
Q 028681 91 HLAIVMEYASGGELFERICNAGR-FSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAP------RLKICDF 163 (205)
Q Consensus 91 ~~~lv~~~~~~~sl~~~~~~~~~-~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~------~~~l~df 163 (205)
..+++|||+++++|.+++...+. +++..+..++.|++.||.|||++|++|+||+|+||+++.++.. .++|+||
T Consensus 86 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~Df 165 (289)
T 4fvq_A 86 ENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDP 165 (289)
T ss_dssp CCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEEEECCC
T ss_pred CCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCcccccccceeeeccC
Confidence 99999999999999999976554 9999999999999999999999999999999999999766642 2899999
Q ss_pred cccccccCCCCCCCCCCCCCccCCceecc-CcCCCeeeEEEeC
Q 028681 164 GYSKSSVLHSQPKSTVGTPAYIAPEVLLK-KEYDGKVMCVYVI 205 (205)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~~Dvwsl 205 (205)
|++...... ....+++.|+|||++.+ ..++ .++|||||
T Consensus 166 g~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~-~~~Diwsl 204 (289)
T 4fvq_A 166 GISITVLPK---DILQERIPWVPPECIENPKNLN-LATDKWSF 204 (289)
T ss_dssp CSCTTTSCH---HHHHHTTTTSCHHHHHCGGGCC-HHHHHHHH
T ss_pred cccccccCc---cccCCcCcccCHHHhCCCCCCC-chhHHHHH
Confidence 988544221 22347888999999988 5555 45999986
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=234.52 Aligned_cols=189 Identities=31% Similarity=0.468 Sum_probs=140.7
Q ss_pred cCceecCCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCc--cchHHHHHHHHHHHhcCCCCeeEEEEEEEeCCe
Q 028681 14 MPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTH 91 (205)
Q Consensus 14 ~~~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 91 (205)
.++....++|++.+.||+|++|.||.+.+..++..|++|.+.... ...+.+..|+..++.++||||+++++++..++.
T Consensus 8 ~p~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 87 (303)
T 2vwi_A 8 LPWSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDE 87 (303)
T ss_dssp -----CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSC
T ss_pred cccccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCC
Confidence 455666899999999999999999999999889999999887543 234667889999999999999999999999999
Q ss_pred EEEEEEecCCCchHHHHHh--------cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeee
Q 028681 92 LAIVMEYASGGELFERICN--------AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDF 163 (205)
Q Consensus 92 ~~lv~~~~~~~sl~~~~~~--------~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df 163 (205)
.++++|++++++|.+.+.. ...+++..+..++.|++.||.+||+.|++|+||+|+||+++.++. ++|+||
T Consensus 88 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~--~kl~df 165 (303)
T 2vwi_A 88 LWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGS--VQIADF 165 (303)
T ss_dssp EEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCC--EEECCC
T ss_pred cEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCC--EEEEec
Confidence 9999999999999998863 446999999999999999999999999999999999999988877 999999
Q ss_pred cccccccCCC------CCCCCCCCCCccCCceecc-CcCCCeeeEEEeC
Q 028681 164 GYSKSSVLHS------QPKSTVGTPAYIAPEVLLK-KEYDGKVMCVYVI 205 (205)
Q Consensus 164 ~~~~~~~~~~------~~~~~~~~~~~~aPE~~~~-~~~~~~~~Dvwsl 205 (205)
|++....... ......+++.|+|||.+.. ..++.+ +|||||
T Consensus 166 g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~-~Di~sl 213 (303)
T 2vwi_A 166 GVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFK-ADIWSF 213 (303)
T ss_dssp HHHHHCC---------------CCCTTCCHHHHHHHHCCCTH-HHHHHH
T ss_pred cchheeccCCCccchhhhcccCCCccccCHHHhccccCCCch-hhHHHH
Confidence 9987554322 1233468999999999976 445545 999986
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-36 Score=231.09 Aligned_cols=182 Identities=32% Similarity=0.424 Sum_probs=157.8
Q ss_pred CCCeEEEeeeccccceeEEEEEe-cCCCcEEEEEEeecCccchHHHHHHHHHHHhcCCC------CeeEEEEEEEeCCeE
Q 028681 20 SDRYELVRDIGSGNFGVARLMRD-KKTEELVAVKYIERGDKIDENVQREIINHRSLRHP------NIVRFKEVILTPTHL 92 (205)
Q Consensus 20 ~~~y~~~~~l~~g~~g~v~~~~~-~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~------~i~~~~~~~~~~~~~ 92 (205)
.++|++.+.||+|++|.||.+.+ ..+++.||+|++.......+.+..|+.+++.++|+ +++++++++...+..
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~~ 92 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHI 92 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTEE
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCCchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCcE
Confidence 57999999999999999999998 56789999999987666667788999999888654 499999999999999
Q ss_pred EEEEEecCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCC----------------
Q 028681 93 AIVMEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSP---------------- 154 (205)
Q Consensus 93 ~lv~~~~~~~sl~~~~~~~~--~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~---------------- 154 (205)
+++||++ +++|.+.+.... ++++..+..++.|++.||.|||++|++|+||+|+||+++.++
T Consensus 93 ~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~~~~ 171 (339)
T 1z57_A 93 CIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTL 171 (339)
T ss_dssp EEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC----CEEEEE
T ss_pred EEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCccccccccc
Confidence 9999999 778999887655 689999999999999999999999999999999999998733
Q ss_pred -CCcEEEeeecccccccCCCCCCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 155 -APRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 155 -~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
...++|+|||++..... ......+++.|+|||++.+..++.+ +|||||
T Consensus 172 ~~~~~kl~Dfg~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~-~Di~sl 220 (339)
T 1z57_A 172 INPDIKVVDFGSATYDDE--HHSTLVSTRHYRAPEVILALGWSQP-CDVWSI 220 (339)
T ss_dssp SCCCEEECCCSSCEETTS--CCCSSCSCGGGCCHHHHTTSCCCTH-HHHHHH
T ss_pred cCCCceEeeCcccccCcc--ccccccCCccccChHHhhCCCCCcc-hhhHHH
Confidence 33499999999875432 2345578999999999998888766 999986
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-37 Score=238.44 Aligned_cols=182 Identities=25% Similarity=0.399 Sum_probs=155.3
Q ss_pred CCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCccchHHHHHHHHHHHhcC--------CCCeeEEEEEEE----
Q 028681 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLR--------HPNIVRFKEVIL---- 87 (205)
Q Consensus 20 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~--------h~~i~~~~~~~~---- 87 (205)
.++|++.+.||+|+||.||++.+..+++.||+|++.......+.+.+|+.+++.++ |+||+++++++.
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~~ 115 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGV 115 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEET
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecCC
Confidence 47899999999999999999999999999999999876666678889999999986 778999999988
Q ss_pred eCCeEEEEEEecCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhc-CcEeecCCCCCeEecCCCC---------
Q 028681 88 TPTHLAIVMEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSM-QVCHRDLKLENTLLDGSPA--------- 155 (205)
Q Consensus 88 ~~~~~~lv~~~~~~~sl~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~~-~i~H~di~p~nili~~~~~--------- 155 (205)
.....++|||++.+ ++.+.+... ..+++..++.++.|++.||.|||+. ||+||||+|+||+++.++.
T Consensus 116 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~~~~~~~~ 194 (397)
T 1wak_A 116 NGTHICMVFEVLGH-HLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEA 194 (397)
T ss_dssp TEEEEEEEECCCCC-BHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHHHHHHHHH
T ss_pred CCceEEEEEeccCc-cHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhhhhhhhhh
Confidence 45689999999955 555555443 4699999999999999999999998 9999999999999986641
Q ss_pred --------------------------------------CcEEEeeecccccccCCCCCCCCCCCCCccCCceeccCcCCC
Q 028681 156 --------------------------------------PRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDG 197 (205)
Q Consensus 156 --------------------------------------~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ 197 (205)
..++|+|||++...... .....+|+.|+|||++.+..++.
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~ 272 (397)
T 1wak_A 195 TEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH--FTEDIQTRQYRSLEVLIGSGYNT 272 (397)
T ss_dssp C---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC--SCSCCSCGGGCCHHHHHTSCCCT
T ss_pred HHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc--CccCCCCCcccCChhhcCCCCCc
Confidence 14999999999765432 34457899999999999988886
Q ss_pred eeeEEEeC
Q 028681 198 KVMCVYVI 205 (205)
Q Consensus 198 ~~~Dvwsl 205 (205)
+ +|||||
T Consensus 273 ~-~Diwsl 279 (397)
T 1wak_A 273 P-ADIWST 279 (397)
T ss_dssp H-HHHHHH
T ss_pred H-HHHHHH
Confidence 6 999996
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-39 Score=245.95 Aligned_cols=179 Identities=22% Similarity=0.279 Sum_probs=148.4
Q ss_pred ecCCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCcc---------chHHHHHHHHHHHhcC---------CCCe
Q 028681 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---------IDENVQREIINHRSLR---------HPNI 79 (205)
Q Consensus 18 ~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~---------~~~~~~~e~~~l~~l~---------h~~i 79 (205)
...++|++.+.||+|+||.||++.+ +++.||+|++..... ..+.+..|+.+++.++ |+|+
T Consensus 17 ~~~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~ni 94 (336)
T 2vuw_A 17 LPTEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGF 94 (336)
T ss_dssp SCHHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCB
T ss_pred cccccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCch
Confidence 3458899999999999999999998 578999999986532 1267888999988885 8888
Q ss_pred eEEEEEEE------------------------------eCCeEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHH
Q 028681 80 VRFKEVIL------------------------------TPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISG 129 (205)
Q Consensus 80 ~~~~~~~~------------------------------~~~~~~lv~~~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~ 129 (205)
+++.+++. .++..++||||++++++.+.+.+ ..+++..++.++.|++.|
T Consensus 95 v~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-~~~~~~~~~~i~~qi~~a 173 (336)
T 2vuw_A 95 IGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-KLSSLATAKSILHQLTAS 173 (336)
T ss_dssp CCEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-TCCCHHHHHHHHHHHHHH
T ss_pred hhhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-cCCCHHHHHHHHHHHHHH
Confidence 88877653 26789999999988876666633 568999999999999999
Q ss_pred HHHHH-hcCcEeecCCCCCeEecCCCC------------------CcEEEeeecccccccCCCCCCCCCCCCCccCCcee
Q 028681 130 VSYCH-SMQVCHRDLKLENTLLDGSPA------------------PRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL 190 (205)
Q Consensus 130 l~~lh-~~~i~H~di~p~nili~~~~~------------------~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~ 190 (205)
|.||| ++||+||||||+||+++.++. ..+||+|||+|+..... ...||+.|+|||++
T Consensus 174 L~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~----~~~gt~~y~aPE~~ 249 (336)
T 2vuw_A 174 LAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG----IVVFCDVSMDEDLF 249 (336)
T ss_dssp HHHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT----EEECCCCTTCSGGG
T ss_pred HHHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC----cEEEeecccChhhh
Confidence 99999 999999999999999987751 14999999999765432 34799999999999
Q ss_pred ccCcCCCeeeEEEeC
Q 028681 191 LKKEYDGKVMCVYVI 205 (205)
Q Consensus 191 ~~~~~~~~~~Dvwsl 205 (205)
.+.. + .++|||||
T Consensus 250 ~g~~-~-~~~Diwsl 262 (336)
T 2vuw_A 250 TGDG-D-YQFDIYRL 262 (336)
T ss_dssp CCCS-S-HHHHHHHH
T ss_pred cCCC-c-cceehhhh
Confidence 8776 4 45999985
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-37 Score=233.41 Aligned_cols=187 Identities=22% Similarity=0.301 Sum_probs=159.8
Q ss_pred ceecCCCeEEEeeeccccceeEEEEEecCCCc-----EEEEEEeecCcc--chHHHHHHHHHHHhc-CCCCeeEEEEEEE
Q 028681 16 IMHDSDRYELVRDIGSGNFGVARLMRDKKTEE-----LVAVKYIERGDK--IDENVQREIINHRSL-RHPNIVRFKEVIL 87 (205)
Q Consensus 16 ~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~-----~v~iK~~~~~~~--~~~~~~~e~~~l~~l-~h~~i~~~~~~~~ 87 (205)
.....++|++.+.||+|+||.||.+.+..++. .|++|.+..... ..+.+..|+.+++.+ +||||+++++++.
T Consensus 41 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 120 (333)
T 2i1m_A 41 WEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACT 120 (333)
T ss_dssp GBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe
Confidence 45567899999999999999999999876654 799999876532 346688999999999 8999999999999
Q ss_pred eCCeEEEEEEecCCCchHHHHHhc--------------CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCC
Q 028681 88 TPTHLAIVMEYASGGELFERICNA--------------GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGS 153 (205)
Q Consensus 88 ~~~~~~lv~~~~~~~sl~~~~~~~--------------~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~ 153 (205)
+++..+++||++++++|.+.+... ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.+
T Consensus 121 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~ 200 (333)
T 2i1m_A 121 HGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNG 200 (333)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEEEGG
T ss_pred cCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEECCC
Confidence 999999999999999999988642 358999999999999999999999999999999999999877
Q ss_pred CCCcEEEeeecccccccCCCC---CCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 154 PAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 154 ~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
+. ++|+|||++........ .....+++.|+|||.+.+..++.+ +|||||
T Consensus 201 ~~--~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~sl 252 (333)
T 2i1m_A 201 HV--AKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQ-SDVWSY 252 (333)
T ss_dssp GE--EEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHH-HHHHHH
T ss_pred Ce--EEECccccccccccccceeecCCCCCCccccCHHHhccCCCChH-HHHHHH
Confidence 76 99999999975543322 223346788999999998888755 999986
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-37 Score=232.05 Aligned_cols=192 Identities=30% Similarity=0.436 Sum_probs=155.0
Q ss_pred ccCCCcccCceecCCCe-EEEeeeccccceeEEEEE----ecCCCcEEEEEEeecCc--cchHHHHHHHHHHHhcCCCCe
Q 028681 7 TVGPGMDMPIMHDSDRY-ELVRDIGSGNFGVARLMR----DKKTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNI 79 (205)
Q Consensus 7 ~~~~~~~~~~~~~~~~y-~~~~~l~~g~~g~v~~~~----~~~~~~~v~iK~~~~~~--~~~~~~~~e~~~l~~l~h~~i 79 (205)
...|+.+..+ .++| ++.+.||+|+||.||.+. +..+++.||+|++.... ...+.+..|+.+++.++||||
T Consensus 19 ~~~pg~~~~~---~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i 95 (318)
T 3lxp_A 19 FQGPGDPTVF---HKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHI 95 (318)
T ss_dssp -----CCCBC---CGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTB
T ss_pred ecCCCCCcee---cHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcch
Confidence 3444444333 3445 999999999999997765 44578899999998653 234668899999999999999
Q ss_pred eEEEEEEEeC--CeEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCc
Q 028681 80 VRFKEVILTP--THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPR 157 (205)
Q Consensus 80 ~~~~~~~~~~--~~~~lv~~~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~ 157 (205)
+++++++.+. ...+++||++++++|.+++.. ..+++..+..++.|++.||.+||+.|++|+||+|+||+++.++.
T Consensus 96 v~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~-- 172 (318)
T 3lxp_A 96 IKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPR-HSIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRL-- 172 (318)
T ss_dssp CCEEEEEEETTTTEEEEEECCCTTCBHHHHGGG-SCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC--
T ss_pred hhEEEEEecCCCceEEEEEecccCCcHHHHHhh-CCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCC--
Confidence 9999999984 678999999999999999865 45999999999999999999999999999999999999988877
Q ss_pred EEEeeecccccccCCCC----CCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 158 LKICDFGYSKSSVLHSQ----PKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 158 ~~l~df~~~~~~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
++|+|||++........ .....++..|+|||.+.+..++.+ +|||||
T Consensus 173 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~sl 223 (318)
T 3lxp_A 173 VKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYA-SDVWSF 223 (318)
T ss_dssp EEECCGGGCEECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHH-HHHHHH
T ss_pred EEECCccccccccccccccccccCCCCCceeeChHHhcCCCCCcH-HHHHHH
Confidence 99999999976654322 233457788999999998888755 999986
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-36 Score=231.79 Aligned_cols=187 Identities=23% Similarity=0.292 Sum_probs=153.2
Q ss_pred ceecCCCeEEEeeeccccceeEEEEEecCCC----cEEEEEEeecCcc--chHHHHHHHHHHHhcCCCCeeEEEEEEEeC
Q 028681 16 IMHDSDRYELVRDIGSGNFGVARLMRDKKTE----ELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTP 89 (205)
Q Consensus 16 ~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~----~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 89 (205)
.....++|++.+.||+|++|.||++.+..++ ..|++|.+..... ....+..|+.+++.++||||+++++++...
T Consensus 39 ~~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 118 (333)
T 1mqb_A 39 TEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKY 118 (333)
T ss_dssp CBCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred ccCChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecC
Confidence 3456789999999999999999999987543 4599999876432 235688999999999999999999999999
Q ss_pred CeEEEEEEecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeeccccc
Q 028681 90 THLAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 168 (205)
Q Consensus 90 ~~~~lv~~~~~~~sl~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~ 168 (205)
+..+++||++++++|.+++... ..+++..+..++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||++..
T Consensus 119 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~--~kl~Dfg~~~~ 196 (333)
T 1mqb_A 119 KPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLV--CKVSDFGLSRV 196 (333)
T ss_dssp SSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCC--EEECCCCC---
T ss_pred CCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCc--EEECCCCcchh
Confidence 9999999999999999999764 57999999999999999999999999999999999999988777 99999999976
Q ss_pred ccCCCCC----CCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 169 SVLHSQP----KSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 169 ~~~~~~~----~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
....... ....+++.|+|||++.+..++.+ +|||||
T Consensus 197 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~sl 236 (333)
T 1mqb_A 197 LEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSA-SDVWSF 236 (333)
T ss_dssp --------------CCCGGGSCHHHHHSCCCCHH-HHHHHH
T ss_pred hccccccccccCCCCccccccCchhcccCCCCch-hhhHHH
Confidence 5433221 12235778999999998888765 999986
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=229.43 Aligned_cols=185 Identities=28% Similarity=0.465 Sum_probs=154.8
Q ss_pred ecCCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCc-cchHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEE
Q 028681 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (205)
Q Consensus 18 ~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 96 (205)
...++|++.+.||+|++|.||.+.+..++..|++|.+.... ...+.+..|+.+++.++||||+++++++..++..++++
T Consensus 16 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 95 (302)
T 2j7t_A 16 DPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMI 95 (302)
T ss_dssp CGGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEE
T ss_pred CCccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEE
Confidence 34688999999999999999999999999999999987653 33577889999999999999999999999999999999
Q ss_pred EecCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccC-CCC
Q 028681 97 EYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQ 174 (205)
Q Consensus 97 ~~~~~~sl~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~-~~~ 174 (205)
|++++++|.+.+.. ...+++..+..++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||++..... ...
T Consensus 96 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~ 173 (302)
T 2j7t_A 96 EFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGD--IRLADFGVSAKNLKTLQK 173 (302)
T ss_dssp ECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSC--EEECCCHHHHHHHHHHHC
T ss_pred EeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCC--EEEEECCCCccccccccc
Confidence 99999999988865 467999999999999999999999999999999999999988877 99999998753321 122
Q ss_pred CCCCCCCCCccCCceec-----cCcCCCeeeEEEeC
Q 028681 175 PKSTVGTPAYIAPEVLL-----KKEYDGKVMCVYVI 205 (205)
Q Consensus 175 ~~~~~~~~~~~aPE~~~-----~~~~~~~~~Dvwsl 205 (205)
.....+++.|+|||++. ...++.+ +|||||
T Consensus 174 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~-~Di~sl 208 (302)
T 2j7t_A 174 RDSFIGTPYWMAPEVVMCETMKDTPYDYK-ADIWSL 208 (302)
T ss_dssp -----CCGGGCCHHHHHHHHTTSTTTTTH-HHHHHH
T ss_pred cccccCChhhcCCeeeccccCCCCCCchh-hhHHHH
Confidence 33456899999999984 4556555 999986
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-37 Score=231.05 Aligned_cols=178 Identities=26% Similarity=0.354 Sum_probs=147.1
Q ss_pred CCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCccchHHHHHHHHHHHh--cCCCCeeEEEEEEEeC----CeEE
Q 028681 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRS--LRHPNIVRFKEVILTP----THLA 93 (205)
Q Consensus 20 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~--l~h~~i~~~~~~~~~~----~~~~ 93 (205)
.++|++.+.||+|+||.||++.+ +++.||+|++.... ...+..|.+++.. ++||||+++++++... ...+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~--~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~ 82 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSRD--EKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLW 82 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGGG--HHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred cCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEecccc--chhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeE
Confidence 57999999999999999999987 47889999987543 3444455555555 7999999999987643 4689
Q ss_pred EEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH--------hcCcEeecCCCCCeEecCCCCCcEEEeeecc
Q 028681 94 IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCH--------SMQVCHRDLKLENTLLDGSPAPRLKICDFGY 165 (205)
Q Consensus 94 lv~~~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh--------~~~i~H~di~p~nili~~~~~~~~~l~df~~ 165 (205)
++|||+++++|.+++. ...+++..+..++.|++.||.||| +.+++|+||+|+||+++.++. ++|+|||+
T Consensus 83 lv~e~~~~g~L~~~l~-~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~--~kl~Dfg~ 159 (301)
T 3q4u_A 83 LITHYHEMGSLYDYLQ-LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQ--CCIADLGL 159 (301)
T ss_dssp EEECCCTTCBHHHHHT-TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSC--EEECCCTT
T ss_pred EehhhccCCCHHHHHh-hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCC--EEEeeCCC
Confidence 9999999999999994 457999999999999999999999 999999999999999988877 99999999
Q ss_pred cccccCCCC-----CCCCCCCCCccCCceeccC------cCCCeeeEEEeC
Q 028681 166 SKSSVLHSQ-----PKSTVGTPAYIAPEVLLKK------EYDGKVMCVYVI 205 (205)
Q Consensus 166 ~~~~~~~~~-----~~~~~~~~~~~aPE~~~~~------~~~~~~~Dvwsl 205 (205)
++....... .....|++.|+|||++.+. .++ .++|||||
T Consensus 160 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~-~~~Dvwsl 209 (301)
T 3q4u_A 160 AVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSY-KRVDIWAF 209 (301)
T ss_dssp CEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHH-HHHHHHHH
T ss_pred eeecccccccccccccccccccceeChhhhcCcCCCCcccCC-chhhHHHH
Confidence 865433322 2334689999999999876 333 34999986
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-37 Score=233.17 Aligned_cols=187 Identities=21% Similarity=0.307 Sum_probs=151.4
Q ss_pred CceecCCCeEEEeeeccccceeEEEEEecCCCcEE----EEEEeecC--ccchHHHHHHHHHHHhcCCCCeeEEEEEEEe
Q 028681 15 PIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELV----AVKYIERG--DKIDENVQREIINHRSLRHPNIVRFKEVILT 88 (205)
Q Consensus 15 ~~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v----~iK~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 88 (205)
......++|++.+.||+|+||.||++.+..++..+ ++|.+... ....+.+..|+.+++.++||||+++++++..
T Consensus 9 ~~~l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 88 (327)
T 3lzb_A 9 LRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT 88 (327)
T ss_dssp CEECCTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEES
T ss_pred hcccCHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEec
Confidence 33455789999999999999999999998777654 66666443 2345778999999999999999999999987
Q ss_pred CCeEEEEEEecCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccc
Q 028681 89 PTHLAIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 167 (205)
Q Consensus 89 ~~~~~lv~~~~~~~sl~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~ 167 (205)
+. .+++++++.+++|.+.+.. ...+++..+..++.|++.||.|||++||+|+||+|+||+++.++. ++|+|||+++
T Consensus 89 ~~-~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~--~kL~DfG~a~ 165 (327)
T 3lzb_A 89 ST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQH--VKITDFGLAK 165 (327)
T ss_dssp SS-EEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTE--EEECCTTC--
T ss_pred CC-ceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCC--EEEccCccee
Confidence 65 7788999999999999876 456999999999999999999999999999999999999988776 9999999997
Q ss_pred cccCCCCC---CCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 168 SSVLHSQP---KSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 168 ~~~~~~~~---~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
........ ....+++.|+|||.+.+..++.+ +|||||
T Consensus 166 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~-~Di~sl 205 (327)
T 3lzb_A 166 LLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQ-SDVWSY 205 (327)
T ss_dssp --------------CCCGGGSCHHHHHHCCCCHH-HHHHHH
T ss_pred EccCccccccccCCCccccccCHHHHcCCCCChH-HHHHHH
Confidence 65433322 22346778999999999888766 999986
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-37 Score=230.60 Aligned_cols=185 Identities=32% Similarity=0.553 Sum_probs=156.2
Q ss_pred ecCCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCcc---chHHHHHHHHHHHhcCCCCeeEEEEEEEe--CCeE
Q 028681 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILT--PTHL 92 (205)
Q Consensus 18 ~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~ 92 (205)
...++|++.+.||+|++|.||.+.+..+++.|++|.+..... ..+.+..|+.+++.++||||+++++++.. +...
T Consensus 3 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 82 (279)
T 2w5a_A 3 SRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTL 82 (279)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEE
T ss_pred CchhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceE
Confidence 356899999999999999999999999999999999976432 34568899999999999999999998864 5689
Q ss_pred EEEEEecCCCchHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhcC-----cEeecCCCCCeEecCCCCCcEEEeee
Q 028681 93 AIVMEYASGGELFERICNA----GRFSEDEARFFFQQLISGVSYCHSMQ-----VCHRDLKLENTLLDGSPAPRLKICDF 163 (205)
Q Consensus 93 ~lv~~~~~~~sl~~~~~~~----~~~~~~~~~~i~~~i~~~l~~lh~~~-----i~H~di~p~nili~~~~~~~~~l~df 163 (205)
+++|||+++++|.+.+... ..+++..+..++.|++.||.+||+.+ ++|+||+|+||+++.++. ++|+||
T Consensus 83 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~--~kl~df 160 (279)
T 2w5a_A 83 YIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQN--VKLGDF 160 (279)
T ss_dssp EEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSC--EEECCC
T ss_pred EEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCC--EEEecC
Confidence 9999999999999998653 34999999999999999999999999 999999999999988877 999999
Q ss_pred cccccccCCCC-CCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 164 GYSKSSVLHSQ-PKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 164 ~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
|++........ .....+++.|+|||.+.+..++.+ +|||||
T Consensus 161 g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~sl 202 (279)
T 2w5a_A 161 GLARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEK-SDIWSL 202 (279)
T ss_dssp CHHHHC---CHHHHHHHSCCTTCCHHHHHCC-CCHH-HHHHHH
T ss_pred chheeeccccccccccCCCccccChHHhccCCCCch-hhHHHH
Confidence 99876543221 122358999999999998888755 999986
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-36 Score=224.30 Aligned_cols=183 Identities=28% Similarity=0.474 Sum_probs=153.7
Q ss_pred ecCCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCccch--------HHHHHHHHHHHhcCCCCeeEEEEEEEeC
Q 028681 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID--------ENVQREIINHRSLRHPNIVRFKEVILTP 89 (205)
Q Consensus 18 ~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~--------~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 89 (205)
...++|++.+.||+|++|.||.+.+..+++.||+|.+....... +.+..|+.+++.++||||+++++++.+.
T Consensus 16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 95 (287)
T 4f0f_A 16 LADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNP 95 (287)
T ss_dssp CCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTT
T ss_pred hhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCC
Confidence 45689999999999999999999999999999999986543221 5788999999999999999999998766
Q ss_pred CeEEEEEEecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcC--cEeecCCCCCeEecCCCC---CcEEEeee
Q 028681 90 THLAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQ--VCHRDLKLENTLLDGSPA---PRLKICDF 163 (205)
Q Consensus 90 ~~~~lv~~~~~~~sl~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~--i~H~di~p~nili~~~~~---~~~~l~df 163 (205)
. +++|||+++++|.+.+... .++++..+..++.|++.||.|||+.| ++|+||+|+||+++.++. ..++|+||
T Consensus 96 ~--~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~Df 173 (287)
T 4f0f_A 96 P--RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADF 173 (287)
T ss_dssp T--EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEECCC
T ss_pred C--eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeCCC
Confidence 6 5899999999998887654 46999999999999999999999999 999999999999976543 23899999
Q ss_pred cccccccCCCCCCCCCCCCCccCCceec--cCcCCCeeeEEEeC
Q 028681 164 GYSKSSVLHSQPKSTVGTPAYIAPEVLL--KKEYDGKVMCVYVI 205 (205)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~--~~~~~~~~~Dvwsl 205 (205)
|+++.... ......+++.|+|||++. ...++.+ +|||||
T Consensus 174 g~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~-~Di~sl 214 (287)
T 4f0f_A 174 GLSQQSVH--SVSGLLGNFQWMAPETIGAEEESYTEK-ADTYSF 214 (287)
T ss_dssp TTCBCCSS--CEECCCCCCTTSCGGGSSCSSCEECHH-HHHHHH
T ss_pred Cccccccc--cccccCCCccccCchhhccCCCCcCch-hhHHHH
Confidence 99874432 233456899999999994 4445544 999986
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-37 Score=236.35 Aligned_cols=182 Identities=20% Similarity=0.395 Sum_probs=159.0
Q ss_pred cCCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCccch------------------HHHHHHHHHHHhcCCCCee
Q 028681 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID------------------ENVQREIINHRSLRHPNIV 80 (205)
Q Consensus 19 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~------------------~~~~~e~~~l~~l~h~~i~ 80 (205)
..++|++.+.||+|++|.||.+.+ ++..|++|.+....... +.+.+|+.+++.++||||+
T Consensus 29 ~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~ 106 (348)
T 2pml_X 29 YINDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCL 106 (348)
T ss_dssp EETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBC
T ss_pred ccCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcc
Confidence 358999999999999999999999 78999999987542211 7889999999999999999
Q ss_pred EEEEEEEeCCeEEEEEEecCCCchHHH------HHh--cCCCCHHHHHHHHHHHHHHHHHHHh-cCcEeecCCCCCeEec
Q 028681 81 RFKEVILTPTHLAIVMEYASGGELFER------ICN--AGRFSEDEARFFFQQLISGVSYCHS-MQVCHRDLKLENTLLD 151 (205)
Q Consensus 81 ~~~~~~~~~~~~~lv~~~~~~~sl~~~------~~~--~~~~~~~~~~~i~~~i~~~l~~lh~-~~i~H~di~p~nili~ 151 (205)
++++++.+++..+++|||+++++|.++ +.. ...+++..+..++.|++.||.+||+ .|++|+||+|+||+++
T Consensus 107 ~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Nil~~ 186 (348)
T 2pml_X 107 TCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMD 186 (348)
T ss_dssp CCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGEEEC
T ss_pred eEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhEEEc
Confidence 999999999999999999999999887 654 5679999999999999999999999 9999999999999998
Q ss_pred CCCCCcEEEeeecccccccCCCCCCCCCCCCCccCCceeccC-cCCCeeeEEEeC
Q 028681 152 GSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKK-EYDGKVMCVYVI 205 (205)
Q Consensus 152 ~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~~Dvwsl 205 (205)
.++. ++|+|||.+...... ......++..|+|||++.+. .++..++|||||
T Consensus 187 ~~~~--~kl~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~sl 238 (348)
T 2pml_X 187 KNGR--VKLSDFGESEYMVDK-KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSL 238 (348)
T ss_dssp TTSC--EEECCCTTCEECBTT-EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHH
T ss_pred CCCc--EEEeccccccccccc-cccCCCCCcCccCchhhcCCCCCCcchhhHHHH
Confidence 8877 999999998765433 33445689999999999887 555535999986
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-37 Score=232.26 Aligned_cols=185 Identities=27% Similarity=0.415 Sum_probs=160.0
Q ss_pred ecCCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCccc-------hHHHHHHHHHHHhcC--CCCeeEEEEEEEe
Q 028681 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI-------DENVQREIINHRSLR--HPNIVRFKEVILT 88 (205)
Q Consensus 18 ~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~-------~~~~~~e~~~l~~l~--h~~i~~~~~~~~~ 88 (205)
...++|++.+.||+|+||.||.+.+..+++.||+|.+...... .+.+..|+.+++.++ |+|++++++++..
T Consensus 40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~ 119 (320)
T 3a99_A 40 PLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFER 119 (320)
T ss_dssp CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEEC
T ss_pred CccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEec
Confidence 3468899999999999999999999999999999999765321 245677899999996 5999999999999
Q ss_pred CCeEEEEEEecCC-CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEec-CCCCCcEEEeeeccc
Q 028681 89 PTHLAIVMEYASG-GELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLD-GSPAPRLKICDFGYS 166 (205)
Q Consensus 89 ~~~~~lv~~~~~~-~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~-~~~~~~~~l~df~~~ 166 (205)
++..+++++++.+ ++|.+.+.....+++..+..++.|++.||.|||++||+|+||+|+||+++ .++. ++|+|||++
T Consensus 120 ~~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~--~kL~Dfg~~ 197 (320)
T 3a99_A 120 PDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGE--LKLIDFGSG 197 (320)
T ss_dssp SSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTE--EEECCCTTC
T ss_pred CCcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCC--EEEeeCccc
Confidence 9999999999975 89999998888899999999999999999999999999999999999998 4555 999999998
Q ss_pred ccccCCCCCCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 167 KSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 167 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
...... ......+++.|+|||++.+..+.+.++|||||
T Consensus 198 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~sl 235 (320)
T 3a99_A 198 ALLKDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSL 235 (320)
T ss_dssp EECCSS-CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHH
T ss_pred cccccc-cccCCCCCccCCChHHhccCCCCCccchHHhH
Confidence 765432 23345689999999999887775566899986
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-37 Score=235.48 Aligned_cols=183 Identities=25% Similarity=0.370 Sum_probs=145.1
Q ss_pred ecCCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCccc------------hHHHHHHHHHHHhcCCCCeeEEEEE
Q 028681 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI------------DENVQREIINHRSLRHPNIVRFKEV 85 (205)
Q Consensus 18 ~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~------------~~~~~~e~~~l~~l~h~~i~~~~~~ 85 (205)
...++|++.+.||+|++|.||.+.+.. +..||+|.+...... .+.+.+|+.+++.++||||++++++
T Consensus 19 ~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 97 (362)
T 3pg1_A 19 AMQSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDI 97 (362)
T ss_dssp HTTCSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEE
T ss_pred HhccceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeee
Confidence 346899999999999999999999866 889999998653211 2678899999999999999999999
Q ss_pred EEe-----CCeEEEEEEecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEE
Q 028681 86 ILT-----PTHLAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLK 159 (205)
Q Consensus 86 ~~~-----~~~~~lv~~~~~~~sl~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~ 159 (205)
+.. ....+++||++. ++|.+.+... ..+++..+..++.|++.||.|||++|++|+||+|+||+++.++. ++
T Consensus 98 ~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~--~k 174 (362)
T 3pg1_A 98 FVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNND--IT 174 (362)
T ss_dssp EEECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCC--EE
T ss_pred EEeccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCC--EE
Confidence 854 246899999997 4777777553 46999999999999999999999999999999999999988877 99
Q ss_pred EeeecccccccCCCCCCCCCCCCCccCCceecc-CcCCCeeeEEEeC
Q 028681 160 ICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLK-KEYDGKVMCVYVI 205 (205)
Q Consensus 160 l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~~Dvwsl 205 (205)
|+|||++.............+++.|+|||++.+ ..++.+ +|||||
T Consensus 175 l~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~-~Diwsl 220 (362)
T 3pg1_A 175 ICDFNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKL-VDMWSA 220 (362)
T ss_dssp ECCTTC---------------CGGGCCHHHHTTCTTCCTH-HHHHHH
T ss_pred EEecCcccccccccccceecccceecCcHHhcCCCCCCcH-hHHHhH
Confidence 999999976665555566678999999999987 455544 999986
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-38 Score=242.77 Aligned_cols=181 Identities=12% Similarity=0.062 Sum_probs=147.9
Q ss_pred ecCCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecC----ccchHHHHHHH---HHHHhcCCCCeeEEE-------
Q 028681 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG----DKIDENVQREI---INHRSLRHPNIVRFK------- 83 (205)
Q Consensus 18 ~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~----~~~~~~~~~e~---~~l~~l~h~~i~~~~------- 83 (205)
...++|++.+.||+|+||.||++.+..+++.||+|++... ....+.+.+|+ ..++.++||||++++
T Consensus 70 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~ 149 (377)
T 3byv_A 70 ERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPF 149 (377)
T ss_dssp CCCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCS
T ss_pred CCCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhh
Confidence 3458899999999999999999999999999999999743 22346788899 455556899999988
Q ss_pred EEEEeCC-----------------eEEEEEEecCCCchHHHHHhcCCCCH-------HHHHHHHHHHHHHHHHHHhcCcE
Q 028681 84 EVILTPT-----------------HLAIVMEYASGGELFERICNAGRFSE-------DEARFFFQQLISGVSYCHSMQVC 139 (205)
Q Consensus 84 ~~~~~~~-----------------~~~lv~~~~~~~sl~~~~~~~~~~~~-------~~~~~i~~~i~~~l~~lh~~~i~ 139 (205)
+++..++ ..+++|||+ +++|.+.+...+.+++ ..+..++.|++.||+|||++||+
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iv 228 (377)
T 3byv_A 150 DLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLV 228 (377)
T ss_dssp EEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred hhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCCee
Confidence 6666553 278999999 5799999976544554 77888999999999999999999
Q ss_pred eecCCCCCeEecCCCCCcEEEeeecccccccCCCCCCCCCCCCCccCCceeccC-----------cCCCeeeEEEeC
Q 028681 140 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKK-----------EYDGKVMCVYVI 205 (205)
Q Consensus 140 H~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-----------~~~~~~~Dvwsl 205 (205)
|+||+|+||+++.++. +||+|||+++.... ......| +.|+|||++.+. .++.+ +|||||
T Consensus 229 HrDikp~NIll~~~~~--~kL~DFG~a~~~~~--~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~-~DvwSl 299 (377)
T 3byv_A 229 HTYLRPVDIVLDQRGG--VFLTGFEHLVRDGA--RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFS-FDAWAL 299 (377)
T ss_dssp CSCCCGGGEEECTTCC--EEECCGGGCEETTC--EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHH-HHHHHH
T ss_pred cCCCCHHHEEEcCCCC--EEEEechhheecCC--cccCCCC-cCccChhhhcccccccccccccccCChh-hhHHHH
Confidence 9999999999998876 99999999975332 2234457 999999999987 77755 999996
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-36 Score=237.62 Aligned_cols=180 Identities=30% Similarity=0.490 Sum_probs=150.2
Q ss_pred CCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCccchHHHHHHHHHHHhcCCCCeeEEEEEEEeC------CeEE
Q 028681 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTP------THLA 93 (205)
Q Consensus 20 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------~~~~ 93 (205)
..+|++.+.||+|+||.||++.+..+++.||+|.+..... ...+|+.+++.++|+||+++++++... .+++
T Consensus 53 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~---~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~ 129 (420)
T 1j1b_A 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR---FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN 129 (420)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT---SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred cceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch---hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence 3479999999999999999999999999999999876432 234689999999999999999988642 2477
Q ss_pred EEEEecCCCchHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccc
Q 028681 94 IVMEYASGGELFERIC----NAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 169 (205)
Q Consensus 94 lv~~~~~~~sl~~~~~----~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~ 169 (205)
+++||+++ ++.+.+. ....+++..++.++.|++.||.|||++||+||||+|+||+++.++. .+||+|||+++..
T Consensus 130 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~-~~kl~DFG~a~~~ 207 (420)
T 1j1b_A 130 LVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTA-VLKLCDFGSAKQL 207 (420)
T ss_dssp EEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTT-EEEECCCTTCEEC
T ss_pred eehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCC-eEEeccchhhhhc
Confidence 99999975 5555543 3567999999999999999999999999999999999999985543 3899999999876
Q ss_pred cCCCCCCCCCCCCCccCCceeccC-cCCCeeeEEEeC
Q 028681 170 VLHSQPKSTVGTPAYIAPEVLLKK-EYDGKVMCVYVI 205 (205)
Q Consensus 170 ~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~~Dvwsl 205 (205)
..........+++.|+|||++.+. .++.+ +|||||
T Consensus 208 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~-~DiwSl 243 (420)
T 1j1b_A 208 VRGEPNVSYICSRYYRAPELIFGATDYTSS-IDVWSA 243 (420)
T ss_dssp CTTCCCCSCCSCTTSCCHHHHTTCSSCCTH-HHHHHH
T ss_pred ccCCCceeeeeCCCcCCHHHHcCCCCCCch-hhhHHH
Confidence 655555666789999999999765 56655 999986
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=231.13 Aligned_cols=186 Identities=19% Similarity=0.269 Sum_probs=158.2
Q ss_pred eecCCCeEEEeeeccccceeEEEEEec-----CCCcEEEEEEeecCcc--chHHHHHHHHHHHhcCCCCeeEEEEEEEeC
Q 028681 17 MHDSDRYELVRDIGSGNFGVARLMRDK-----KTEELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTP 89 (205)
Q Consensus 17 ~~~~~~y~~~~~l~~g~~g~v~~~~~~-----~~~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 89 (205)
....++|++.+.||+|++|.||.+.+. .++..|++|.+..... ....+.+|+.+++.++|+||+++++++.++
T Consensus 21 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 100 (322)
T 1p4o_A 21 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG 100 (322)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSS
T ss_pred cchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccC
Confidence 445689999999999999999999876 3577899999876533 234688999999999999999999999999
Q ss_pred CeEEEEEEecCCCchHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEE
Q 028681 90 THLAIVMEYASGGELFERICNA----------GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLK 159 (205)
Q Consensus 90 ~~~~lv~~~~~~~sl~~~~~~~----------~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~ 159 (205)
+..+++||++++++|.+++... .++++..+..++.|++.||.+||++|++|+||+|+||+++.++. ++
T Consensus 101 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~--~k 178 (322)
T 1p4o_A 101 QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFT--VK 178 (322)
T ss_dssp SSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCC--EE
T ss_pred CccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCCe--EE
Confidence 9999999999999999988652 35799999999999999999999999999999999999998877 99
Q ss_pred EeeecccccccCCCC---CCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 160 ICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 160 l~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
|+|||++........ .....+++.|+|||.+.+..++.+ +|||||
T Consensus 179 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~sl 226 (322)
T 1p4o_A 179 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTY-SDVWSF 226 (322)
T ss_dssp ECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHH-HHHHHH
T ss_pred ECcCccccccccccccccccCCCCCCCccChhhhccCCCCch-hhHHHH
Confidence 999999875433321 122346788999999998888765 999986
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-36 Score=229.98 Aligned_cols=190 Identities=24% Similarity=0.314 Sum_probs=138.8
Q ss_pred cccCceecCCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCcc--chHHHHHHHH-HHHhcCCCCeeEEEEEEEe
Q 028681 12 MDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK--IDENVQREII-NHRSLRHPNIVRFKEVILT 88 (205)
Q Consensus 12 ~~~~~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~e~~-~l~~l~h~~i~~~~~~~~~ 88 (205)
....+....++|++.+.||+|+||.||.+.+..+++.|++|.+..... ....+..|+. +++.++||||+++++++..
T Consensus 13 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~ 92 (327)
T 3aln_A 13 PEQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFR 92 (327)
T ss_dssp CCEEECCCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEEC
T ss_pred hHHhcccCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEe
Confidence 333445567999999999999999999999999999999999976532 2234444554 6677899999999999999
Q ss_pred CCeEEEEEEecCCCchHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhc-CcEeecCCCCCeEecCCCCCcEEEee
Q 028681 89 PTHLAIVMEYASGGELFERICN-----AGRFSEDEARFFFQQLISGVSYCHSM-QVCHRDLKLENTLLDGSPAPRLKICD 162 (205)
Q Consensus 89 ~~~~~lv~~~~~~~sl~~~~~~-----~~~~~~~~~~~i~~~i~~~l~~lh~~-~i~H~di~p~nili~~~~~~~~~l~d 162 (205)
++..+++||++++ +|.+.+.. ...+++..+..++.|++.||.+||+. |++|+||+|+||+++.++. ++|+|
T Consensus 93 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~--~kl~D 169 (327)
T 3aln_A 93 EGDCWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGN--IKLCD 169 (327)
T ss_dssp SSEEEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTE--EEECC
T ss_pred CCceEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCC--EEEcc
Confidence 9999999999975 77777753 56799999999999999999999998 9999999999999988776 99999
Q ss_pred ecccccccCCCCCCCCCCCCCccCCcee----ccCcCCCeeeEEEeC
Q 028681 163 FGYSKSSVLHSQPKSTVGTPAYIAPEVL----LKKEYDGKVMCVYVI 205 (205)
Q Consensus 163 f~~~~~~~~~~~~~~~~~~~~~~aPE~~----~~~~~~~~~~Dvwsl 205 (205)
||++.............+++.|+|||++ .+..++.+ +|||||
T Consensus 170 fg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~-~Di~sl 215 (327)
T 3aln_A 170 FGISGQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVR-SDVWSL 215 (327)
T ss_dssp CSSSCC------------------------------CCSH-HHHHHH
T ss_pred CCCceecccccccccCCCCccccCceeeccccCcCCCCch-hhHHHH
Confidence 9999766555444555799999999999 45556655 999986
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-37 Score=234.46 Aligned_cols=185 Identities=25% Similarity=0.303 Sum_probs=158.4
Q ss_pred eecCCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCcc--chHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEE
Q 028681 17 MHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 94 (205)
Q Consensus 17 ~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 94 (205)
....++|++.+.||+|++|.||.+... ++..||+|++..... ....+..|+.+++.++||||+++++++..++..++
T Consensus 26 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 104 (326)
T 3uim_A 26 QVASDNFSNKNILGRGGFGKVYKGRLA-DGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLL 104 (326)
T ss_dssp HTTTTSSCSTTEEECCSSSEEEEECCS-SSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEECCSSCCEE
T ss_pred HHHhhccccceeEecCCCcEEEEEEec-CCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEEecCCceEE
Confidence 345689999999999999999999854 578899999876432 23468899999999999999999999999999999
Q ss_pred EEEecCCCchHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhc---CcEeecCCCCCeEecCCCCCcEEEeeecccc
Q 028681 95 VMEYASGGELFERICNAG----RFSEDEARFFFQQLISGVSYCHSM---QVCHRDLKLENTLLDGSPAPRLKICDFGYSK 167 (205)
Q Consensus 95 v~~~~~~~sl~~~~~~~~----~~~~~~~~~i~~~i~~~l~~lh~~---~i~H~di~p~nili~~~~~~~~~l~df~~~~ 167 (205)
+|||+++++|.+.+.... ++++..+..++.|++.||.|||+. |++|+||+|+||+++.++. ++|+|||++.
T Consensus 105 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~--~kl~Dfg~~~ 182 (326)
T 3uim_A 105 VYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFE--AVVGDFGLAK 182 (326)
T ss_dssp EEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCC--EEECCCSSCE
T ss_pred EEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCC--EEeccCcccc
Confidence 999999999999997543 499999999999999999999999 9999999999999988877 9999999997
Q ss_pred cccCCCC--CCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 168 SSVLHSQ--PKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 168 ~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
....... .....|++.|+|||++.+..++.+ +|||||
T Consensus 183 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~Di~sl 221 (326)
T 3uim_A 183 LMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEK-TDVFGY 221 (326)
T ss_dssp ECCSSSSCEECCCCSCGGGCCHHHHHHSEECHH-HHHHHH
T ss_pred ccCcccccccccccCCcCccCHHHhccCCCCcc-ccchhH
Confidence 6543322 233458999999999988888765 999986
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-36 Score=230.61 Aligned_cols=181 Identities=24% Similarity=0.382 Sum_probs=147.4
Q ss_pred CCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCccchHHHHHHHHHHHhcCCCCeeEEEEEEEeC----CeEEEE
Q 028681 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTP----THLAIV 95 (205)
Q Consensus 20 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~----~~~~lv 95 (205)
.++|++.+.||+|+||.||++.+. +..||+|++............++.....++|+||+++++++... ...+++
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv 113 (337)
T 3mdy_A 36 AKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTEEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLI 113 (337)
T ss_dssp HHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEEEEE
T ss_pred ccceEEEeEeecCCCeEEEEEEEC--CceEEEEEEeccccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCceEEE
Confidence 478999999999999999999876 78899999875443222333333333445899999999999987 789999
Q ss_pred EEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhc--------CcEeecCCCCCeEecCCCCCcEEEeeecccc
Q 028681 96 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM--------QVCHRDLKLENTLLDGSPAPRLKICDFGYSK 167 (205)
Q Consensus 96 ~~~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~--------~i~H~di~p~nili~~~~~~~~~l~df~~~~ 167 (205)
|||+++++|.+.+.. ..+++..+..++.|++.||.|||+. |++|+||+|+||+++.++. ++|+|||++.
T Consensus 114 ~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~--~kl~Dfg~a~ 190 (337)
T 3mdy_A 114 TDYHENGSLYDYLKS-TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGT--CCIADLGLAV 190 (337)
T ss_dssp ECCCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSC--EEECCCTTCE
T ss_pred EeccCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCC--EEEEeCCCce
Confidence 999999999999955 4699999999999999999999998 9999999999999988877 9999999996
Q ss_pred cccCCCCC-----CCCCCCCCccCCceeccCcCCCe-----eeEEEeC
Q 028681 168 SSVLHSQP-----KSTVGTPAYIAPEVLLKKEYDGK-----VMCVYVI 205 (205)
Q Consensus 168 ~~~~~~~~-----~~~~~~~~~~aPE~~~~~~~~~~-----~~Dvwsl 205 (205)
........ ....|++.|+|||++.+...... ++|||||
T Consensus 191 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Diwsl 238 (337)
T 3mdy_A 191 KFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSF 238 (337)
T ss_dssp ECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHH
T ss_pred eeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHH
Confidence 55433222 24468999999999987766543 3899986
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-36 Score=228.22 Aligned_cols=184 Identities=30% Similarity=0.460 Sum_probs=155.5
Q ss_pred ecCCCeEEEeeeccccceeEEEEEec-CCCcEEEEEEeecCcc---chHHHHHHHHHHHhc---CCCCeeEEEEEEE---
Q 028681 18 HDSDRYELVRDIGSGNFGVARLMRDK-KTEELVAVKYIERGDK---IDENVQREIINHRSL---RHPNIVRFKEVIL--- 87 (205)
Q Consensus 18 ~~~~~y~~~~~l~~g~~g~v~~~~~~-~~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l---~h~~i~~~~~~~~--- 87 (205)
...++|++.+.||+|++|.||.+.+. .+++.|++|++..... ....+..|+.+++.+ .||||+++++++.
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~ 87 (326)
T 1blx_A 8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR 87 (326)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred CchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecc
Confidence 44589999999999999999999995 6788999999875322 223566677776666 8999999999987
Q ss_pred --eCCeEEEEEEecCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeee
Q 028681 88 --TPTHLAIVMEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDF 163 (205)
Q Consensus 88 --~~~~~~lv~~~~~~~sl~~~~~~~~--~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df 163 (205)
.....++++|++. ++|.+.+.... .+++..+..++.|++.||.+||+.|++|+||+|+||+++.++. ++|+||
T Consensus 88 ~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~--~kl~Df 164 (326)
T 1blx_A 88 TDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQ--IKLADF 164 (326)
T ss_dssp CSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCC--EEECSC
T ss_pred cCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCC--EEEecC
Confidence 4567899999997 58999887643 4999999999999999999999999999999999999988877 999999
Q ss_pred cccccccCCCCCCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 164 GYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
|++.............++..|+|||++.+..++.+ +|||||
T Consensus 165 g~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~sl 205 (326)
T 1blx_A 165 GLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATP-VDLWSV 205 (326)
T ss_dssp CSCCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTH-HHHHHH
T ss_pred cccccccCCCCccccccccceeCHHHHhcCCCCcc-hhHHHH
Confidence 99976655544455678999999999998888766 999986
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-36 Score=230.67 Aligned_cols=187 Identities=27% Similarity=0.429 Sum_probs=158.0
Q ss_pred ceecCCCeEEEeeeccccceeEEEEE----ecCCCcEEEEEEeecCcc-chHHHHHHHHHHHhcCCCCeeEEEEEEEeCC
Q 028681 16 IMHDSDRYELVRDIGSGNFGVARLMR----DKKTEELVAVKYIERGDK-IDENVQREIINHRSLRHPNIVRFKEVILTPT 90 (205)
Q Consensus 16 ~~~~~~~y~~~~~l~~g~~g~v~~~~----~~~~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 90 (205)
.....++|++.+.||+|++|.||.+. +..++..|++|.+..... ..+.+.+|+.+++.++|+||+++++++...+
T Consensus 36 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 115 (326)
T 2w1i_A 36 TQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAG 115 (326)
T ss_dssp -CCCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC--
T ss_pred cccCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecC
Confidence 33456789999999999999999998 466789999999876543 3467889999999999999999999987654
Q ss_pred --eEEEEEEecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccc
Q 028681 91 --HLAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 167 (205)
Q Consensus 91 --~~~lv~~~~~~~sl~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~ 167 (205)
..++++|++++++|.+.+... ..+++..+..++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||++.
T Consensus 116 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~--~kL~Dfg~~~ 193 (326)
T 2w1i_A 116 RRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENR--VKIGDFGLTK 193 (326)
T ss_dssp --CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTE--EEECCCTTCE
T ss_pred CCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCc--EEEecCcchh
Confidence 689999999999999999765 45999999999999999999999999999999999999988776 9999999997
Q ss_pred cccCCCC----CCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 168 SSVLHSQ----PKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 168 ~~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
....... .....++..|+|||.+.+..++.+ +|||||
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~sl 234 (326)
T 2w1i_A 194 VLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVA-SDVWSF 234 (326)
T ss_dssp ECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHH-HHHHHH
T ss_pred hccccccccccccCCCCceeEECchhhcCCCCCch-hhHHHH
Confidence 6544322 223346778999999998887755 999986
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-36 Score=244.33 Aligned_cols=185 Identities=24% Similarity=0.306 Sum_probs=159.9
Q ss_pred ceecCCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCccchHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEE
Q 028681 16 IMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV 95 (205)
Q Consensus 16 ~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 95 (205)
+....++|++.+.||+|+||.||++.+.. +..||+|+++......+.+.+|+.+++.++|+||+++++++.+ +..++|
T Consensus 262 ~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv 339 (535)
T 2h8h_A 262 WEIPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIV 339 (535)
T ss_dssp SBCCGGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEE
T ss_pred eecchhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEe
Confidence 44567889999999999999999999876 4669999998876667889999999999999999999999876 678999
Q ss_pred EEecCCCchHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCCC
Q 028681 96 MEYASGGELFERICN--AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 173 (205)
Q Consensus 96 ~~~~~~~sl~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~~ 173 (205)
|||+.+++|.+++.. ...+++..+..++.|++.||.|||+++|+||||+|+||+++.++. +||+|||+++......
T Consensus 340 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~--~kl~DFG~a~~~~~~~ 417 (535)
T 2h8h_A 340 TEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLV--CKVADFGLARLIEDNE 417 (535)
T ss_dssp ECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC--EEECCTTSTTTCCCHH
T ss_pred eehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCc--EEEcccccceecCCCc
Confidence 999999999999964 356999999999999999999999999999999999999988776 9999999997553221
Q ss_pred --CCCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 174 --QPKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 174 --~~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
......++..|+|||++.+..++.+ +|||||
T Consensus 418 ~~~~~~~~~~~~y~aPE~~~~~~~~~~-sDvwSl 450 (535)
T 2h8h_A 418 YTARQGAKFPIKWTAPEAALYGRFTIK-SDVWSF 450 (535)
T ss_dssp HHTTCSTTSCGGGSCHHHHHHCCCCHH-HHHHHH
T ss_pred eecccCCcCcccccCHHHhccCCCCch-hhHHHH
Confidence 1223346788999999998888766 999996
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-35 Score=222.83 Aligned_cols=182 Identities=26% Similarity=0.255 Sum_probs=153.8
Q ss_pred cCCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCccchHHHHHHHHHHHhcCCCCeeEEEE-EEEeCCeEEEEEE
Q 028681 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKE-VILTPTHLAIVME 97 (205)
Q Consensus 19 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~-~~~~~~~~~lv~~ 97 (205)
..++|++.+.||+|++|.||.+.+..+++.||+|++.... ..+.+..|+.+++.++|++++..+. +...+...++++|
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e 85 (296)
T 3uzp_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT-KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 85 (296)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCS-SCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred eccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCc-chhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEE
Confidence 3689999999999999999999999999999999887643 3456889999999999877555444 4466788899999
Q ss_pred ecCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEec---CCCCCcEEEeeecccccccCCC
Q 028681 98 YASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLD---GSPAPRLKICDFGYSKSSVLHS 173 (205)
Q Consensus 98 ~~~~~sl~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~---~~~~~~~~l~df~~~~~~~~~~ 173 (205)
++ +++|.+++.. ..++++..+..++.|++.||.|||++|++|+||+|+||+++ .++. ++|+|||++.......
T Consensus 86 ~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~--~kl~Dfg~~~~~~~~~ 162 (296)
T 3uzp_A 86 LL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNL--VYIIDFGLAKKYRDAR 162 (296)
T ss_dssp CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTC--EEECCCTTCEECBCTT
T ss_pred ec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCe--EEEeeCCCcccccccc
Confidence 99 8899999974 45799999999999999999999999999999999999994 5555 9999999997654433
Q ss_pred C--------CCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 174 Q--------PKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 174 ~--------~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
. .....+++.|+|||.+.+..++.+ +|||||
T Consensus 163 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~Di~sl 201 (296)
T 3uzp_A 163 THQHIPYRENKNLTGTARYASINTHLGIEQSRR-DDLESL 201 (296)
T ss_dssp TCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHH-HHHHHH
T ss_pred cccccccccccccccccccCChhhhcCCCCCcc-hhhHHH
Confidence 2 234468999999999998888755 999986
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-36 Score=225.04 Aligned_cols=185 Identities=27% Similarity=0.377 Sum_probs=155.9
Q ss_pred eecCCCeEEEe-eeccccceeEEEEEec--CCCcEEEEEEeecCc--cchHHHHHHHHHHHhcCCCCeeEEEEEEEeCCe
Q 028681 17 MHDSDRYELVR-DIGSGNFGVARLMRDK--KTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTH 91 (205)
Q Consensus 17 ~~~~~~y~~~~-~l~~g~~g~v~~~~~~--~~~~~v~iK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 91 (205)
....++|.+.+ .||+|++|.||.+.+. .++..|++|.+.... ...+.+..|+.+++.++||||+++++++ ..+.
T Consensus 5 ~~~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~ 83 (287)
T 1u59_A 5 FLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEA 83 (287)
T ss_dssp BCCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSS
T ss_pred cccHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCC
Confidence 34568888887 9999999999999854 467889999998743 2346788999999999999999999998 5567
Q ss_pred EEEEEEecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeeccccccc
Q 028681 92 LAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 170 (205)
Q Consensus 92 ~~lv~~~~~~~sl~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~ 170 (205)
.++++|++++++|.+++... ..+++..+..++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||++....
T Consensus 84 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~--~kl~Dfg~~~~~~ 161 (287)
T 1u59_A 84 LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHY--AKISDFGLSKALG 161 (287)
T ss_dssp EEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTE--EEECCCTTCEECT
T ss_pred cEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCC--EEECcccceeeec
Confidence 89999999999999988643 46999999999999999999999999999999999999987776 9999999997654
Q ss_pred CCCC----CCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 171 LHSQ----PKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 171 ~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
.... .....+++.|+|||.+.+..++.+ +|||||
T Consensus 162 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~sl 199 (287)
T 1u59_A 162 ADDSYYTARSAGKWPLKWYAPECINFRKFSSR-SDVWSY 199 (287)
T ss_dssp TCSCEECCCCSSCCCGGGCCHHHHHHCEECHH-HHHHHH
T ss_pred cCcceeeccccccccccccCHHHhccCCCCch-hhHHHH
Confidence 3322 222346788999999988888765 999986
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-36 Score=228.13 Aligned_cols=186 Identities=25% Similarity=0.374 Sum_probs=142.3
Q ss_pred ceecCCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCcc-chHHHHHHHHHHHhcC-CCCeeEEEEEEE------
Q 028681 16 IMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK-IDENVQREIINHRSLR-HPNIVRFKEVIL------ 87 (205)
Q Consensus 16 ~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~-h~~i~~~~~~~~------ 87 (205)
+.....+|++.+.||+|+||.||++.+..+++.||+|.+..... ..+.+..|+.+++.+. ||||+++++++.
T Consensus 23 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~ 102 (337)
T 3ll6_A 23 VELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEES 102 (337)
T ss_dssp EEETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTS
T ss_pred eeccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhcccccccccccc
Confidence 34456699999999999999999999999999999998865443 3466889999999996 999999999994
Q ss_pred --eCCeEEEEEEecCCCchHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhcC--cEeecCCCCCeEecCCCCCcEEE
Q 028681 88 --TPTHLAIVMEYASGGELFERICN---AGRFSEDEARFFFQQLISGVSYCHSMQ--VCHRDLKLENTLLDGSPAPRLKI 160 (205)
Q Consensus 88 --~~~~~~lv~~~~~~~sl~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lh~~~--i~H~di~p~nili~~~~~~~~~l 160 (205)
....++++++++. ++|.+.+.. ..++++..+..++.|++.||.|||+.| ++|+||+|+||+++.++. ++|
T Consensus 103 ~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~--~kl 179 (337)
T 3ll6_A 103 DTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGT--IKL 179 (337)
T ss_dssp TTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSC--EEB
T ss_pred ccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCC--EEE
Confidence 3345889999996 688887754 456999999999999999999999999 999999999999988877 999
Q ss_pred eeecccccccCCCCC-------------CCCCCCCCccCCcee---ccCcCCCeeeEEEeC
Q 028681 161 CDFGYSKSSVLHSQP-------------KSTVGTPAYIAPEVL---LKKEYDGKVMCVYVI 205 (205)
Q Consensus 161 ~df~~~~~~~~~~~~-------------~~~~~~~~~~aPE~~---~~~~~~~~~~Dvwsl 205 (205)
+|||++......... ....+++.|+|||++ .+..++.+ +|||||
T Consensus 180 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~-~Dv~sl 239 (337)
T 3ll6_A 180 CDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEK-QDIWAL 239 (337)
T ss_dssp CCCTTCBCCSSCC-------------------------------CCTTSCSSHH-HHHHHH
T ss_pred ecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChH-HhHHHH
Confidence 999999765443221 134588999999999 45556544 999986
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-37 Score=231.30 Aligned_cols=187 Identities=23% Similarity=0.351 Sum_probs=157.9
Q ss_pred ceecCCCeEEEeeeccccceeEEEEEe-----cCCCcEEEEEEeecCcc--chHHHHHHHHHHHhc-CCCCeeEEEEEEE
Q 028681 16 IMHDSDRYELVRDIGSGNFGVARLMRD-----KKTEELVAVKYIERGDK--IDENVQREIINHRSL-RHPNIVRFKEVIL 87 (205)
Q Consensus 16 ~~~~~~~y~~~~~l~~g~~g~v~~~~~-----~~~~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l-~h~~i~~~~~~~~ 87 (205)
+....++|++.+.||+|++|.||.+.+ ..+++.|++|++..... ..+.+..|+.+++.+ +||||+++++++.
T Consensus 22 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~ 101 (316)
T 2xir_A 22 WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACT 101 (316)
T ss_dssp HBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred eecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEe
Confidence 345578999999999999999999985 35678999999976543 235688999999999 6899999999988
Q ss_pred eCC-eEEEEEEecCCCchHHHHHhcCC----------------CCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEe
Q 028681 88 TPT-HLAIVMEYASGGELFERICNAGR----------------FSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLL 150 (205)
Q Consensus 88 ~~~-~~~lv~~~~~~~sl~~~~~~~~~----------------~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili 150 (205)
.++ ..++++|++++++|.+++..... +++..+..++.|++.||.|||+.|++|+||+|+||++
T Consensus 102 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~ 181 (316)
T 2xir_A 102 KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILL 181 (316)
T ss_dssp CTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred cCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEE
Confidence 764 58999999999999999976543 8899999999999999999999999999999999999
Q ss_pred cCCCCCcEEEeeecccccccCCCC---CCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 151 DGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 151 ~~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
+.++. ++|+|||++........ .....+++.|+|||++.+..++.+ +|||||
T Consensus 182 ~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~-~Di~sl 236 (316)
T 2xir_A 182 SEKNV--VKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQ-SDVWSF 236 (316)
T ss_dssp CGGGC--EEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHH-HHHHHH
T ss_pred CCCCC--EEECCCccccccccCccceeccCCCcceeecCchhhccccccch-hHHHHH
Confidence 87777 99999999975543322 122346788999999998888766 999986
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=234.27 Aligned_cols=180 Identities=12% Similarity=0.124 Sum_probs=152.8
Q ss_pred CCCeEEEeeeccccceeEEEEEecC--------CCcEEEEEEeecCccchHHHHHHHHHHHhcCCCCeeE----------
Q 028681 20 SDRYELVRDIGSGNFGVARLMRDKK--------TEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVR---------- 81 (205)
Q Consensus 20 ~~~y~~~~~l~~g~~g~v~~~~~~~--------~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~---------- 81 (205)
.++|++.+.||+|++|.||.+.+.. .+..||+|.+... +.+..|+.+++.++|||+++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 116 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPL 116 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT----STHHHHHHHHHHHCCHHHHHHHHHHTTCTT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc----chHHHHHHHHHHhcccchhhhhhhhccCCc
Confidence 5899999999999999999999987 4789999998754 45788999999999988876
Q ss_pred -----EEEEEEe-CCeEEEEEEecCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCC
Q 028681 82 -----FKEVILT-PTHLAIVMEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGS 153 (205)
Q Consensus 82 -----~~~~~~~-~~~~~lv~~~~~~~sl~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~ 153 (205)
+++++.. +...+++||++ +++|.+++... ..+++..+..++.|++.||.|||++|++|+||+|+||+++.+
T Consensus 117 ~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl~~~~ 195 (352)
T 2jii_A 117 LAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPE 195 (352)
T ss_dssp CSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEEEETT
T ss_pred cCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEEcCC
Confidence 6777776 67899999999 89999999875 679999999999999999999999999999999999999887
Q ss_pred CCCcEEEeeecccccccCCCC--------CCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 154 PAPRLKICDFGYSKSSVLHSQ--------PKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 154 ~~~~~~l~df~~~~~~~~~~~--------~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
+...++|+|||+++....... .....+++.|+|||++.+..++.+ +|||||
T Consensus 196 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~Di~sl 254 (352)
T 2jii_A 196 DQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRR-SDLQSL 254 (352)
T ss_dssp EEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHH-HHHHHH
T ss_pred CCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCch-hhHHHH
Confidence 622499999999976543322 123368999999999998888765 999996
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-36 Score=228.77 Aligned_cols=188 Identities=22% Similarity=0.303 Sum_probs=148.5
Q ss_pred CceecCCCeEEEeeeccccceeEEEEEecC---CCcEEEEEEeecCccc---hHHHHHHHHHHHhcCCCCeeEEEEEEEe
Q 028681 15 PIMHDSDRYELVRDIGSGNFGVARLMRDKK---TEELVAVKYIERGDKI---DENVQREIINHRSLRHPNIVRFKEVILT 88 (205)
Q Consensus 15 ~~~~~~~~y~~~~~l~~g~~g~v~~~~~~~---~~~~v~iK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 88 (205)
.+....++|++.+.||+|++|.||.+.... ++..|++|.+...... .+.+..|+.+++.++||||+++++++..
T Consensus 28 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 107 (313)
T 3brb_A 28 DVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIE 107 (313)
T ss_dssp TTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC
T ss_pred hcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEee
Confidence 344567899999999999999999998765 4558999998765322 3568899999999999999999999987
Q ss_pred CC-----eEEEEEEecCCCchHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCc
Q 028681 89 PT-----HLAIVMEYASGGELFERICN------AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPR 157 (205)
Q Consensus 89 ~~-----~~~lv~~~~~~~sl~~~~~~------~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~ 157 (205)
.. ..+++++++++++|.+.+.. ...+++..++.++.|++.||.|||++|++|+||+|+||+++.++.
T Consensus 108 ~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~-- 185 (313)
T 3brb_A 108 MSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMT-- 185 (313)
T ss_dssp -------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTSC--
T ss_pred ccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCc--
Confidence 65 35899999999999998842 346999999999999999999999999999999999999988877
Q ss_pred EEEeeecccccccCCCC---CCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 158 LKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 158 ~~l~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
++|+|||++........ .....+++.|+|||.+.+..++.+ +|||||
T Consensus 186 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~sl 235 (313)
T 3brb_A 186 VCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSK-SDVWAF 235 (313)
T ss_dssp EEECSCSCC----------------CCGGGSCHHHHHSSCCCHH-HHHHHH
T ss_pred EEEeecCcceecccccccCcccccCCCccccCchhhcCCCccch-hhhHHH
Confidence 99999999876543321 223346788999999998888766 999986
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-36 Score=223.94 Aligned_cols=181 Identities=18% Similarity=0.278 Sum_probs=155.0
Q ss_pred eecCCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCcc---chHHHHHHHHHHHhcCCCCeeEEEEEEEeC--Ce
Q 028681 17 MHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTP--TH 91 (205)
Q Consensus 17 ~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~ 91 (205)
....++|++.+.||+|++|.||++.+. +..|++|++..... ..+.+.+|+.+++.++||||+++++++.+. +.
T Consensus 6 ~i~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 83 (271)
T 3kmu_A 6 GIDFKQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPH 83 (271)
T ss_dssp CCCGGGCEEEEEEEEETTEEEEEEEET--TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSS
T ss_pred CCCHHHhHHHHHhcCCCcceEEEEEEC--CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCC
Confidence 445789999999999999999999985 77899999886532 235688999999999999999999999887 78
Q ss_pred EEEEEEecCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcC--cEeecCCCCCeEecCCCCCcEEEeeecccc
Q 028681 92 LAIVMEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQ--VCHRDLKLENTLLDGSPAPRLKICDFGYSK 167 (205)
Q Consensus 92 ~~lv~~~~~~~sl~~~~~~~~--~~~~~~~~~i~~~i~~~l~~lh~~~--i~H~di~p~nili~~~~~~~~~l~df~~~~ 167 (205)
.++++|++++++|.+.+.... .+++..+..++.|++.||.|||+++ ++|+||+|+||+++.++. ++|.||+++.
T Consensus 84 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~--~~l~~~~~~~ 161 (271)
T 3kmu_A 84 PTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMT--ARISMADVKF 161 (271)
T ss_dssp CEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSC--EEEEGGGSCC
T ss_pred eEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcc--eeEEecccee
Confidence 899999999999999998755 4899999999999999999999999 999999999999998877 8888887654
Q ss_pred cccCCCCCCCCCCCCCccCCceeccCcCCC--eeeEEEeC
Q 028681 168 SSVLHSQPKSTVGTPAYIAPEVLLKKEYDG--KVMCVYVI 205 (205)
Q Consensus 168 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~--~~~Dvwsl 205 (205)
. .......+++.|+|||.+.+..++. .++|||||
T Consensus 162 ~----~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~sl 197 (271)
T 3kmu_A 162 S----FQSPGRMYAPAWVAPEALQKKPEDTNRRSADMWSF 197 (271)
T ss_dssp T----TSCTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHH
T ss_pred e----ecccCccCCccccChhhhccCCCCCCCchhhHHHH
Confidence 3 2223456899999999998776543 25999986
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-36 Score=233.92 Aligned_cols=182 Identities=27% Similarity=0.447 Sum_probs=139.3
Q ss_pred eecCCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCc---cchHHHHHHHHHHHhcCCCCeeEEEEEEEeC----
Q 028681 17 MHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTP---- 89 (205)
Q Consensus 17 ~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---- 89 (205)
....++|++.+.||+|++|.||.+.+..+++.||+|++.... ...+.+.+|+.+++.++||||+++++++...
T Consensus 25 ~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 104 (367)
T 2fst_X 25 WEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLE 104 (367)
T ss_dssp EEEETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGG
T ss_pred cCCCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccc
Confidence 344689999999999999999999999999999999987542 2345678999999999999999999998754
Q ss_pred --CeEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccc
Q 028681 90 --THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 167 (205)
Q Consensus 90 --~~~~lv~~~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~ 167 (205)
...+++++++ +++|.+++.. ..+++..+..++.|++.||.|||+.|++||||+|+||+++.++. ++|+|||+++
T Consensus 105 ~~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~--~kL~DFG~a~ 180 (367)
T 2fst_X 105 EFNDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCE--LKILDFGLAR 180 (367)
T ss_dssp GCCCCEEEEECC-CEECC------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCC--EEECC-----
T ss_pred cCCeEEEEeccc-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCC--EEEeeccccc
Confidence 5678999998 6788888754 67999999999999999999999999999999999999988877 9999999997
Q ss_pred cccCCCCCCCCCCCCCccCCceecc-CcCCCeeeEEEeC
Q 028681 168 SSVLHSQPKSTVGTPAYIAPEVLLK-KEYDGKVMCVYVI 205 (205)
Q Consensus 168 ~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~~Dvwsl 205 (205)
..... .....++..|+|||++.+ ..++.+ +|||||
T Consensus 181 ~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~-~Diwsl 216 (367)
T 2fst_X 181 HTADE--MTGYVATRWYRAPEIMLNWMHYNQT-VDIWSV 216 (367)
T ss_dssp ------------CCCTTCCHHHHTTCCSCCTT-HHHHHH
T ss_pred ccccc--CCCcCcCcCccChHHHcCCcCCCch-hhHHHH
Confidence 54322 334578999999999987 455544 999986
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-36 Score=230.27 Aligned_cols=182 Identities=31% Similarity=0.448 Sum_probs=153.0
Q ss_pred cCCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCcc--chHHHHHHHHHHHhcCCCCeeEEEEEEEeC-----Ce
Q 028681 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTP-----TH 91 (205)
Q Consensus 19 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~ 91 (205)
..++|++.+.||+|++|.||.+.+..+++.||+|.+..... ....+..|+.+++.++||||+++++++..+ ..
T Consensus 9 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 88 (353)
T 2b9h_A 9 ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNE 88 (353)
T ss_dssp SCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCC
T ss_pred cccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccce
Confidence 46899999999999999999999999999999999975432 235678899999999999999999988764 67
Q ss_pred EEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccC
Q 028681 92 LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 171 (205)
Q Consensus 92 ~~lv~~~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~ 171 (205)
.++++|++. ++|.+.+.. ..+++..+..++.|++.||.+||++|++|+||+|+||+++.++. ++|+|||++.....
T Consensus 89 ~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~--~kl~Dfg~a~~~~~ 164 (353)
T 2b9h_A 89 VYIIQELMQ-TDLHRVIST-QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCD--LKVCDFGLARIIDE 164 (353)
T ss_dssp EEEEECCCS-EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCC--EEECCCTTCEECC-
T ss_pred EEEEEeccC-ccHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCc--EEEEeccccccccc
Confidence 899999997 588888765 57999999999999999999999999999999999999988877 99999999876543
Q ss_pred CCC-----------CCCCCCCCCccCCceecc-CcCCCeeeEEEeC
Q 028681 172 HSQ-----------PKSTVGTPAYIAPEVLLK-KEYDGKVMCVYVI 205 (205)
Q Consensus 172 ~~~-----------~~~~~~~~~~~aPE~~~~-~~~~~~~~Dvwsl 205 (205)
... .....|++.|+|||++.+ ..++ .++|||||
T Consensus 165 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-~~~Di~sl 209 (353)
T 2b9h_A 165 SAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYS-RAMDVWSC 209 (353)
T ss_dssp ---------------CCCCCCGGGCCHHHHHSCCCCC-HHHHHHHH
T ss_pred ccccccCccccccchhhccccccccCCeeeccCCCcc-chhhHHHH
Confidence 221 122357999999999876 4455 45999986
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-36 Score=234.72 Aligned_cols=179 Identities=28% Similarity=0.452 Sum_probs=147.5
Q ss_pred CCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCccchHHHHHHHHHHHhcCCCCeeEEEEEEEeCC------eEE
Q 028681 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPT------HLA 93 (205)
Q Consensus 20 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~------~~~ 93 (205)
..+|++.+.||+|+||.||.+.+..++. +++|.+...... ..+|+.+++.++||||+++++++.... +.+
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~~---~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~ 114 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRF---KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLN 114 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTTS---CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEE
T ss_pred cceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcch---HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEE
Confidence 4679999999999999999999987666 777777654322 236899999999999999999996543 388
Q ss_pred EEEEecCCCchHHHH---HhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEec-CCCCCcEEEeeecccccc
Q 028681 94 IVMEYASGGELFERI---CNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLD-GSPAPRLKICDFGYSKSS 169 (205)
Q Consensus 94 lv~~~~~~~sl~~~~---~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~-~~~~~~~~l~df~~~~~~ 169 (205)
+||||++++.+.... .....+++..++.++.|++.||.|||++||+||||+|+||+++ .++. +||+|||+++..
T Consensus 115 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~--~kL~DFG~a~~~ 192 (394)
T 4e7w_A 115 LVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGV--LKLIDFGSAKIL 192 (394)
T ss_dssp EEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTE--EEECCCTTCEEC
T ss_pred EEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCc--EEEeeCCCcccc
Confidence 999999765333222 2356799999999999999999999999999999999999998 5665 999999999877
Q ss_pred cCCCCCCCCCCCCCccCCceeccCc-CCCeeeEEEeC
Q 028681 170 VLHSQPKSTVGTPAYIAPEVLLKKE-YDGKVMCVYVI 205 (205)
Q Consensus 170 ~~~~~~~~~~~~~~~~aPE~~~~~~-~~~~~~Dvwsl 205 (205)
..........+++.|+|||++.+.. ++.+ +|||||
T Consensus 193 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~-~DiwSl 228 (394)
T 4e7w_A 193 IAGEPNVSYICSRYYRAPELIFGATNYTTN-IDIWST 228 (394)
T ss_dssp CTTCCCCSSCSCGGGCCHHHHTTCSSCCTH-HHHHHH
T ss_pred cCCCCCcccccCcCccCHHHHcCCCCCCcH-HHHHHH
Confidence 6666666778999999999997754 5555 999985
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-36 Score=224.41 Aligned_cols=188 Identities=29% Similarity=0.431 Sum_probs=156.7
Q ss_pred CceecCCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCcc-chHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEE
Q 028681 15 PIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLA 93 (205)
Q Consensus 15 ~~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 93 (205)
......+.|.....||+|++|.||.+.+..++..|++|.+..... ..+.+.+|+.+++.++||||+++++++...+..+
T Consensus 16 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 95 (295)
T 2clq_A 16 EYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIK 95 (295)
T ss_dssp CEEECBCTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred cccccccCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEE
Confidence 344455566666799999999999999999999999999876543 3567889999999999999999999999999999
Q ss_pred EEEEecCCCchHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecC-CCCCcEEEeeecccccc
Q 028681 94 IVMEYASGGELFERICNA---GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDG-SPAPRLKICDFGYSKSS 169 (205)
Q Consensus 94 lv~~~~~~~sl~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~-~~~~~~~l~df~~~~~~ 169 (205)
+++|++++++|.+++... ..+++..+..++.|++.||.+||+.|++|+||+|+||+++. ++. ++|+|||++...
T Consensus 96 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~--~kl~Dfg~~~~~ 173 (295)
T 2clq_A 96 IFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGV--LKISDFGTSKRL 173 (295)
T ss_dssp EEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCC--EEECCTTTCEES
T ss_pred EEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCC--EEEeeccccccc
Confidence 999999999999998764 24678999999999999999999999999999999999986 555 999999998765
Q ss_pred cCC-CCCCCCCCCCCccCCceeccCc--CCCeeeEEEeC
Q 028681 170 VLH-SQPKSTVGTPAYIAPEVLLKKE--YDGKVMCVYVI 205 (205)
Q Consensus 170 ~~~-~~~~~~~~~~~~~aPE~~~~~~--~~~~~~Dvwsl 205 (205)
... .......+++.|+|||++.+.. ++. ++|||||
T Consensus 174 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~-~~Di~sl 211 (295)
T 2clq_A 174 AGINPCTETFTGTLQYMAPEIIDKGPRGYGK-AADIWSL 211 (295)
T ss_dssp CC-----CCCCCCGGGCCHHHHHHGGGGCSH-HHHHHHH
T ss_pred CCCCCcccccCCCccccChhhhcCCCCCCCc-HHHHHHH
Confidence 432 2234456899999999997654 554 4999986
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-36 Score=225.15 Aligned_cols=185 Identities=22% Similarity=0.266 Sum_probs=153.5
Q ss_pred eecCCCeEEEeeeccccceeEEEEEecC---CCcEEEEEEeecCc--cchHHHHHHHHHHHhcCCCCeeEEEEEEEeCCe
Q 028681 17 MHDSDRYELVRDIGSGNFGVARLMRDKK---TEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTH 91 (205)
Q Consensus 17 ~~~~~~y~~~~~l~~g~~g~v~~~~~~~---~~~~v~iK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 91 (205)
....++|++.+.||+|++|.||.+.+.. ++..|++|.+.... ...+.+.+|+.+++.++||||+++++++.+ +.
T Consensus 8 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~ 86 (281)
T 3cc6_A 8 GIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EP 86 (281)
T ss_dssp SCCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SS
T ss_pred eecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CC
Confidence 3456899999999999999999998654 34569999987653 234678899999999999999999998765 45
Q ss_pred EEEEEEecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeeccccccc
Q 028681 92 LAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 170 (205)
Q Consensus 92 ~~lv~~~~~~~sl~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~ 170 (205)
.++++|++++++|.+.+... ..+++..+..++.|++.||.+||++|++|+||+|+||+++.++. ++|+|||++....
T Consensus 87 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~ 164 (281)
T 3cc6_A 87 TWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPEC--VKLGDFGLSRYIE 164 (281)
T ss_dssp CEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTE--EEECCCCGGGCC-
T ss_pred CEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCc--EEeCccCCCcccc
Confidence 68999999999999999764 45999999999999999999999999999999999999988776 9999999997654
Q ss_pred CCCC--CCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 171 LHSQ--PKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 171 ~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
.... .....+++.|+|||.+.+..++.+ +|||||
T Consensus 165 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~sl 200 (281)
T 3cc6_A 165 DEDYYKASVTRLPIKWMSPESINFRRFTTA-SDVWMF 200 (281)
T ss_dssp --------CCCCCGGGCCHHHHHHCCCCHH-HHHHHH
T ss_pred cccccccccCCCCcceeCchhhccCCCCch-hccHHH
Confidence 4322 223356788999999988888765 999986
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-35 Score=230.62 Aligned_cols=183 Identities=30% Similarity=0.384 Sum_probs=157.5
Q ss_pred cCCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCccchHHHHHHHHHHHhcC-CC-----CeeEEEEEEEeCCeE
Q 028681 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLR-HP-----NIVRFKEVILTPTHL 92 (205)
Q Consensus 19 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~-h~-----~i~~~~~~~~~~~~~ 92 (205)
..++|++.+.||+|+||.||++.+..+++.||+|++.......+.+..|+.+++.++ |+ +++++.+++...+..
T Consensus 52 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~ 131 (382)
T 2vx3_A 52 WMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHL 131 (382)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTEE
T ss_pred eeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCce
Confidence 368999999999999999999999999999999999876555667788888888885 44 499999999999999
Q ss_pred EEEEEecCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH--hcCcEeecCCCCCeEecCCCCCcEEEeeeccccc
Q 028681 93 AIVMEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCH--SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 168 (205)
Q Consensus 93 ~lv~~~~~~~sl~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh--~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~ 168 (205)
++|||++++ +|.+.+... ..+++..++.++.|++.||.||| +.||+||||+|+||+++.+....+||+|||+++.
T Consensus 132 ~lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a~~ 210 (382)
T 2vx3_A 132 CLVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQ 210 (382)
T ss_dssp EEEEECCCC-BHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECCCTTCEE
T ss_pred EEEEecCCC-CHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEeccCcee
Confidence 999999965 899888764 45999999999999999999999 5799999999999999654444599999999976
Q ss_pred ccCCCCCCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 169 SVLHSQPKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 169 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
... ......+++.|+|||++.+..++.+ +|||||
T Consensus 211 ~~~--~~~~~~~t~~y~aPE~~~~~~~~~~-~DiwSl 244 (382)
T 2vx3_A 211 LGQ--RIYQYIQSRFYRSPEVLLGMPYDLA-IDMWSL 244 (382)
T ss_dssp TTC--CCCSSCSCGGGCCHHHHTTCCCCTH-HHHHHH
T ss_pred ccc--ccccccCCccccChHHHcCCCCCcH-HHHHHH
Confidence 543 2345678999999999999888866 999996
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-36 Score=225.56 Aligned_cols=190 Identities=26% Similarity=0.354 Sum_probs=158.3
Q ss_pred ccCceecCCCeEEEeeeccccceeEEEEEecCCCc---EEEEEEeecCcc--chHHHHHHHHHHHhcCCCCeeEEEEEEE
Q 028681 13 DMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEE---LVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVIL 87 (205)
Q Consensus 13 ~~~~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~---~v~iK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 87 (205)
+..+....-.|++.+.||+|+||.||.+.+..++. .+++|.+..... ..+.+.+|+.+++.++||||+++++++.
T Consensus 13 ~~~i~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 92 (298)
T 3pls_A 13 DVLIPHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIML 92 (298)
T ss_dssp GGBCCGGGEEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEC
T ss_pred heEccccceEEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEe
Confidence 33445555678888999999999999999765444 799999876433 2366889999999999999999999998
Q ss_pred eCCeE-EEEEEecCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecc
Q 028681 88 TPTHL-AIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGY 165 (205)
Q Consensus 88 ~~~~~-~lv~~~~~~~sl~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~ 165 (205)
+.+.. +++++++.+++|.+.+.. ...+++..+..++.|++.||.+||++|++|+||+|+||+++.++. ++|+|||+
T Consensus 93 ~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~--~kl~Dfg~ 170 (298)
T 3pls_A 93 PPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFT--VKVADFGL 170 (298)
T ss_dssp CSSSCCEEEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCC--EEECCTTS
T ss_pred cCCCCcEEEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCc--EEeCcCCC
Confidence 76655 899999999999999976 456899999999999999999999999999999999999988877 99999999
Q ss_pred cccccCC-----CCCCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 166 SKSSVLH-----SQPKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 166 ~~~~~~~-----~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
++..... .......++..|+|||.+.+..++.+ +|||||
T Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~sl 214 (298)
T 3pls_A 171 ARDILDREYYSVQQHRHARLPVKWTALESLQTYRFTTK-SDVWSF 214 (298)
T ss_dssp SCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHH-HHHHHH
T ss_pred cccccCCcccccccCcCCCCCccccChhhhccCCCChh-hchhhH
Confidence 8754322 22233457889999999998888765 999986
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-36 Score=226.03 Aligned_cols=186 Identities=31% Similarity=0.428 Sum_probs=148.5
Q ss_pred CceecCCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCcc-chHHHHHHHHHHHhcCCCCeeEEEEEEE------
Q 028681 15 PIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK-IDENVQREIINHRSLRHPNIVRFKEVIL------ 87 (205)
Q Consensus 15 ~~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~------ 87 (205)
+.....++|++.+.||+|++|.||++.+..+++.|++|.+..... ..+.+.+|+.+++.++|||++++++++.
T Consensus 5 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (320)
T 2i6l_A 5 HGFDLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQL 84 (320)
T ss_dssp -CEEETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBC
T ss_pred ccCccCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccc
Confidence 344557899999999999999999999999999999999876543 3467889999999999999999999873
Q ss_pred --------eCCeEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecC-CCCCcE
Q 028681 88 --------TPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDG-SPAPRL 158 (205)
Q Consensus 88 --------~~~~~~lv~~~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~-~~~~~~ 158 (205)
.....++++|++. ++|.+.+. ..++++..++.++.|++.||.+||++|++|+||+|+||+++. +.. +
T Consensus 85 ~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~--~ 160 (320)
T 2i6l_A 85 TDDVGSLTELNSVYIVQEYME-TDLANVLE-QGPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLV--L 160 (320)
T ss_dssp CC----CCSCSEEEEEEECCS-EEHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTE--E
T ss_pred ccccccccccCceeEEeeccC-CCHHHHhh-cCCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCe--E
Confidence 3467899999997 58988885 467999999999999999999999999999999999999974 434 9
Q ss_pred EEeeecccccccCCC----CCCCCCCCCCccCCceecc-CcCCCeeeEEEeC
Q 028681 159 KICDFGYSKSSVLHS----QPKSTVGTPAYIAPEVLLK-KEYDGKVMCVYVI 205 (205)
Q Consensus 159 ~l~df~~~~~~~~~~----~~~~~~~~~~~~aPE~~~~-~~~~~~~~Dvwsl 205 (205)
+|+|||++....... ......++..|+|||.+.+ ..++ .++|||||
T Consensus 161 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~~Di~sl 211 (320)
T 2i6l_A 161 KIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYT-KAIDMWAA 211 (320)
T ss_dssp EECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCC-HHHHHHHH
T ss_pred EEccCccccccCCCcccccccccccccccccCcHHhcCcccCC-chhhhHhH
Confidence 999999997654322 2223357889999999876 4555 45999986
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-36 Score=225.88 Aligned_cols=184 Identities=27% Similarity=0.367 Sum_probs=144.0
Q ss_pred CceecCCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCccc---hHHHHHHHHHHHhcCCCCeeEEEEEEEeCCe
Q 028681 15 PIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI---DENVQREIINHRSLRHPNIVRFKEVILTPTH 91 (205)
Q Consensus 15 ~~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 91 (205)
+.....++|++.+.||+|+||.||.+.+.. .+++|.+...... .+.+.+|+.+++.++|+|+++++++. ....
T Consensus 18 ~~ei~~~~y~~~~~lG~G~~g~Vy~~~~~~---~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~ 93 (289)
T 3og7_A 18 DWEIPDGQITVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQ 93 (289)
T ss_dssp CCBCCTTSCEEEEEEEECSSEEEEEEESSS---EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSS
T ss_pred CCccCccceeeeeEecCCCCeEEEEEEEcC---ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCc
Confidence 445567899999999999999999998754 4999998764332 35688999999999999999999954 5567
Q ss_pred EEEEEEecCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeeccccccc
Q 028681 92 LAIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 170 (205)
Q Consensus 92 ~~lv~~~~~~~sl~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~ 170 (205)
.+++++++.+++|.+.+.. ...+++..+..++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||++....
T Consensus 94 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~--~kl~Dfg~~~~~~ 171 (289)
T 3og7_A 94 LAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNT--VKIGDFGLATEKS 171 (289)
T ss_dssp CEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTE--EEECCCC------
T ss_pred cEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCC--EEEccceeccccc
Confidence 8999999999999998854 456999999999999999999999999999999999999988776 9999999987543
Q ss_pred CC---CCCCCCCCCCCccCCceec---cCcCCCeeeEEEeC
Q 028681 171 LH---SQPKSTVGTPAYIAPEVLL---KKEYDGKVMCVYVI 205 (205)
Q Consensus 171 ~~---~~~~~~~~~~~~~aPE~~~---~~~~~~~~~Dvwsl 205 (205)
.. .......|++.|+|||++. +..++.+ +|||||
T Consensus 172 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~-~Di~sl 211 (289)
T 3og7_A 172 RWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQ-SDVYAF 211 (289)
T ss_dssp ------------CCCTTCCHHHHC----CCSCHH-HHHHHH
T ss_pred cccccccccccCCCccccCchhhcccCCCCCCcc-cchHHH
Confidence 32 2223346899999999997 4555544 999986
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-36 Score=226.64 Aligned_cols=189 Identities=23% Similarity=0.267 Sum_probs=155.1
Q ss_pred cCceecCCCeEEEeeeccccceeEEEEEecCC---CcEEEEEEeecCcc--chHHHHHHHHHHHhcCCCCeeEEEEEEE-
Q 028681 14 MPIMHDSDRYELVRDIGSGNFGVARLMRDKKT---EELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVIL- 87 (205)
Q Consensus 14 ~~~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~---~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~- 87 (205)
..+.....+|++.+.||+|+||.||++.+..+ ...+++|.+..... ..+.+..|+.++++++||||+++++++.
T Consensus 18 ~~i~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 97 (298)
T 3f66_A 18 VVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLR 97 (298)
T ss_dssp GBCCGGGEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECC
T ss_pred eecCccceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEc
Confidence 34555667899999999999999999997543 34689998876433 3366889999999999999999999865
Q ss_pred eCCeEEEEEEecCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeeccc
Q 028681 88 TPTHLAIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYS 166 (205)
Q Consensus 88 ~~~~~~lv~~~~~~~sl~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~ 166 (205)
.++..+++||++++++|.+.+.. ...+++..+..++.|++.||.+||++|++|+||+|+||+++.++. ++|+|||++
T Consensus 98 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~--~kl~Dfg~a 175 (298)
T 3f66_A 98 SEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFT--VKVADFGLA 175 (298)
T ss_dssp SSSCCEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCC--EEECSCGGG
T ss_pred CCCceEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCC--EEECccccc
Confidence 45678999999999999999975 446899999999999999999999999999999999999988777 999999999
Q ss_pred ccccCCC-----CCCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 167 KSSVLHS-----QPKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 167 ~~~~~~~-----~~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
....... ......+++.|+|||.+.+..++.+ +|||||
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~sl 218 (298)
T 3f66_A 176 RDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTK-SDVWSF 218 (298)
T ss_dssp CCCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHH-HHHHHH
T ss_pred ccccccchhccccccCCCCCccccChHHhcCCCCChH-HHHHHH
Confidence 7554322 1222346788999999998888765 999986
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-36 Score=231.74 Aligned_cols=183 Identities=27% Similarity=0.319 Sum_probs=146.2
Q ss_pred eecCCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCccchHHHHHHHHHHHhcCCCCeeEEEEEEEe-----CCe
Q 028681 17 MHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILT-----PTH 91 (205)
Q Consensus 17 ~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~ 91 (205)
....++|++.+.||+|+||.||++.. +++.||+|++............++..+..++|+|++++++.+.. ...
T Consensus 9 ~~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 86 (336)
T 3g2f_A 9 SLDLDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFANRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRME 86 (336)
T ss_dssp CCCTTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEE
T ss_pred CcChHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccchhhHHHHHHHHHHHhccCcchhhheecccccccCCCce
Confidence 34579999999999999999999976 57899999997654333333444444556899999999886542 236
Q ss_pred EEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhc---------CcEeecCCCCCeEecCCCCCcEEEee
Q 028681 92 LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM---------QVCHRDLKLENTLLDGSPAPRLKICD 162 (205)
Q Consensus 92 ~~lv~~~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---------~i~H~di~p~nili~~~~~~~~~l~d 162 (205)
+++||||+++++|.+++... ..++..+..++.|++.||.|||+. ||+|+||+|+||+++.++. +||+|
T Consensus 87 ~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~--~kL~D 163 (336)
T 3g2f_A 87 YLLVMEYYPNGSLXKYLSLH-TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGT--CVISD 163 (336)
T ss_dssp EEEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSC--EEECC
T ss_pred EEEEEecCCCCcHHHHHhhc-ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCc--EEEee
Confidence 78999999999999999654 458899999999999999999999 9999999999999988777 99999
Q ss_pred ecccccccCCC---------CCCCCCCCCCccCCceecc-------CcCCCeeeEEEeC
Q 028681 163 FGYSKSSVLHS---------QPKSTVGTPAYIAPEVLLK-------KEYDGKVMCVYVI 205 (205)
Q Consensus 163 f~~~~~~~~~~---------~~~~~~~~~~~~aPE~~~~-------~~~~~~~~Dvwsl 205 (205)
||+++...... ......|++.|+|||++.+ ..++. ++|||||
T Consensus 164 FG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~-~~Diwsl 221 (336)
T 3g2f_A 164 FGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALK-QVDMYAL 221 (336)
T ss_dssp CTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHH-HHHHHHH
T ss_pred ccceeecccccccCccccccccccCCCccceeCchhhcCCccccccccccc-ccchHHH
Confidence 99997654321 1223468999999999986 34443 4999986
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-36 Score=245.33 Aligned_cols=182 Identities=26% Similarity=0.332 Sum_probs=150.9
Q ss_pred CCCeEEE-eeeccccceeEEEEEe--cCCCcEEEEEEeecCcc---chHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEE
Q 028681 20 SDRYELV-RDIGSGNFGVARLMRD--KKTEELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTPTHLA 93 (205)
Q Consensus 20 ~~~y~~~-~~l~~g~~g~v~~~~~--~~~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 93 (205)
...+.+. +.||+|+||.||++.. ..+++.||+|+++.... ..+++..|+.+++.++||||+++++++.. +..+
T Consensus 367 ~~~~~l~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~ 445 (635)
T 4fl3_A 367 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWM 445 (635)
T ss_dssp GGGEEEEEEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEE
T ss_pred chhccccCCEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEE
Confidence 3445553 4899999999999954 45668899999976432 24678999999999999999999999865 5578
Q ss_pred EEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCCC
Q 028681 94 IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 173 (205)
Q Consensus 94 lv~~~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~~ 173 (205)
+||||+.+++|.+++.....+++..+..++.|++.||.|||++||+||||+|+||+++.++. +||+|||+++......
T Consensus 446 lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~--~kL~DFGla~~~~~~~ 523 (635)
T 4fl3_A 446 LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHY--AKISDFGLSKALRADE 523 (635)
T ss_dssp EEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTE--EEECCTTHHHHTTC--
T ss_pred EEEEccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCC--EEEEEcCCccccccCc
Confidence 99999999999999988888999999999999999999999999999999999999988776 9999999997654332
Q ss_pred C----CCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 174 Q----PKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 174 ~----~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
. .....+++.|+|||++.+..++.+ +|||||
T Consensus 524 ~~~~~~~~~~~t~~y~APE~~~~~~~~~~-sDvwSl 558 (635)
T 4fl3_A 524 NYYKAQTHGKWPVKWYAPECINYYKFSSK-SDVWSF 558 (635)
T ss_dssp -----------CGGGSCHHHHHHCCCCHH-HHHHHH
T ss_pred cccccccCCCCceeeeChhhhcCCCCCcH-HHHHHH
Confidence 2 122246788999999998888766 999996
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-36 Score=230.24 Aligned_cols=186 Identities=22% Similarity=0.292 Sum_probs=152.2
Q ss_pred cCCCeEEEeeeccccceeEEEEE-----ecCCCcEEEEEEeecCc--cchHHHHHHHHHHHhcCCCCeeEEEEEEEeCCe
Q 028681 19 DSDRYELVRDIGSGNFGVARLMR-----DKKTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTH 91 (205)
Q Consensus 19 ~~~~y~~~~~l~~g~~g~v~~~~-----~~~~~~~v~iK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 91 (205)
..++|++.+.||+|++|.||++. +..++..|++|.+.... .....+..|+.+++.++||||+++++++..+..
T Consensus 28 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 107 (327)
T 2yfx_A 28 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP 107 (327)
T ss_dssp CGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred ChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCC
Confidence 45899999999999999999999 55678899999997543 234568889999999999999999999999999
Q ss_pred EEEEEEecCCCchHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCC-CCcEEEeee
Q 028681 92 LAIVMEYASGGELFERICNAG-------RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSP-APRLKICDF 163 (205)
Q Consensus 92 ~~lv~~~~~~~sl~~~~~~~~-------~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~-~~~~~l~df 163 (205)
.+++||++++++|.+++.... .+++..+..++.|++.||.|||+.|++|+||+|+||+++.++ ...++|+||
T Consensus 108 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~kl~Df 187 (327)
T 2yfx_A 108 RFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDF 187 (327)
T ss_dssp CEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECCC
T ss_pred cEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceEEECcc
Confidence 999999999999999997643 489999999999999999999999999999999999998433 224999999
Q ss_pred cccccccCCC---CCCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 164 GYSKSSVLHS---QPKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 164 ~~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
|++....... ......+++.|+|||.+.+..++.+ +|||||
T Consensus 188 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~sl 231 (327)
T 2yfx_A 188 GMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSK-TDTWSF 231 (327)
T ss_dssp HHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHH-HHHHHH
T ss_pred ccccccccccccccCCCcCCCcceeCHhHhcCCCCCch-hhHHHH
Confidence 9986543222 2233457889999999988888765 999986
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-35 Score=227.65 Aligned_cols=183 Identities=26% Similarity=0.368 Sum_probs=154.5
Q ss_pred cCCCeEEEeeeccccceeEEEEEecCCC-cEEEEEEeecCccchHHHHHHHHHHHhcCCCC------eeEEEEEEEeCCe
Q 028681 19 DSDRYELVRDIGSGNFGVARLMRDKKTE-ELVAVKYIERGDKIDENVQREIINHRSLRHPN------IVRFKEVILTPTH 91 (205)
Q Consensus 19 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~-~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~------i~~~~~~~~~~~~ 91 (205)
..++|++.+.||+|++|.||.+.+..++ ..||+|++.......+.+..|+.+++.++|++ ++.+.+++...+.
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 96 (355)
T 2eu9_A 17 LQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGH 96 (355)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTE
T ss_pred ecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCe
Confidence 3689999999999999999999998776 68999999876666677888999999987655 8999999999999
Q ss_pred EEEEEEecCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCC----------------
Q 028681 92 LAIVMEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGS---------------- 153 (205)
Q Consensus 92 ~~lv~~~~~~~sl~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~---------------- 153 (205)
.+++||++. +++.+.+... .++++..+..++.|++.||.|||++||+|+||+|+||++..+
T Consensus 97 ~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~~~ 175 (355)
T 2eu9_A 97 MCIAFELLG-KNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKS 175 (355)
T ss_dssp EEEEEECCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC-CCCEEE
T ss_pred EEEEEeccC-CChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecccccccccccccccccc
Confidence 999999995 5666666543 369999999999999999999999999999999999999432
Q ss_pred -CCCcEEEeeecccccccCCCCCCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 154 -PAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 154 -~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
....++|+|||++..... ......|++.|+|||++.+..++.+ +|||||
T Consensus 176 ~~~~~~kl~Dfg~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~-~Di~sl 225 (355)
T 2eu9_A 176 VKNTSIRVADFGSATFDHE--HHTTIVATRHYRPPEVILELGWAQP-CDVWSI 225 (355)
T ss_dssp ESCCCEEECCCTTCEETTS--CCCSSCSCGGGCCHHHHTTCCCCTH-HHHHHH
T ss_pred cCCCcEEEeecCccccccc--cccCCcCCCcccCCeeeecCCCCCc-cchHHH
Confidence 122399999999975432 2344578999999999998888766 999986
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=230.06 Aligned_cols=186 Identities=27% Similarity=0.399 Sum_probs=151.7
Q ss_pred eecCCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCccc-------hHHHHHHHHHHHhc----CCCCeeEEEEE
Q 028681 17 MHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI-------DENVQREIINHRSL----RHPNIVRFKEV 85 (205)
Q Consensus 17 ~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~-------~~~~~~e~~~l~~l----~h~~i~~~~~~ 85 (205)
....++|++.+.||+|++|.||.+.+..+++.|++|.+...... ...+..|+.+++.+ +|+||++++++
T Consensus 27 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~ 106 (312)
T 2iwi_A 27 EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDW 106 (312)
T ss_dssp ------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEE
T ss_pred hhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEE
Confidence 34467899999999999999999999999999999999765321 23355688888888 89999999999
Q ss_pred EEeCCeEEEEEEe-cCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEec-CCCCCcEEEeee
Q 028681 86 ILTPTHLAIVMEY-ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLD-GSPAPRLKICDF 163 (205)
Q Consensus 86 ~~~~~~~~lv~~~-~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~-~~~~~~~~l~df 163 (205)
+...+..++++++ +.+++|.+.+....++++..+..++.|++.||.+||+.|++|+||+|+||+++ .++. ++|+||
T Consensus 107 ~~~~~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~--~kl~df 184 (312)
T 2iwi_A 107 FETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGC--AKLIDF 184 (312)
T ss_dssp C-----CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTE--EEECCC
T ss_pred EecCCeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCe--EEEEEc
Confidence 9999999999999 78899999998888899999999999999999999999999999999999998 5555 999999
Q ss_pred cccccccCCCCCCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 164 GYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
|++...... ......++..|+|||++.+..+...++|||||
T Consensus 185 g~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~sl 225 (312)
T 2iwi_A 185 GSGALLHDE-PYTDFDGTRVYSPPEWISRHQYHALPATVWSL 225 (312)
T ss_dssp SSCEECCSS-CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHH
T ss_pred chhhhcccC-cccccCCcccccCceeeecCCCCCccchHHHH
Confidence 998765433 23445689999999999887776655999986
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-35 Score=222.41 Aligned_cols=181 Identities=26% Similarity=0.262 Sum_probs=149.4
Q ss_pred CCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCccchHHHHHHHHHHHhcCCCCeeEEEE-EEEeCCeEEEEEEe
Q 028681 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKE-VILTPTHLAIVMEY 98 (205)
Q Consensus 20 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~-~~~~~~~~~lv~~~ 98 (205)
.++|++.+.||+|++|.||.+.+..+++.||+|++.... ..+.+..|+.+++.++|++++..++ ++......+++||+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~ 86 (296)
T 4hgt_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT-KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL 86 (296)
T ss_dssp ---CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred CCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccc-cchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEEc
Confidence 488999999999999999999999999999999866543 2345788999999998877555544 44677889999999
Q ss_pred cCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEe---cCCCCCcEEEeeecccccccCCCC
Q 028681 99 ASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLL---DGSPAPRLKICDFGYSKSSVLHSQ 174 (205)
Q Consensus 99 ~~~~sl~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili---~~~~~~~~~l~df~~~~~~~~~~~ 174 (205)
+ +++|.+++.. ..++++..+..++.|++.||.|||++|++|+||+|+||++ +.++. ++|+|||++........
T Consensus 87 ~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~--~kL~Dfg~a~~~~~~~~ 163 (296)
T 4hgt_A 87 L-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNL--VYIIDFGLAKKYRDART 163 (296)
T ss_dssp C-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTC--EEECCCTTCEECBCTTT
T ss_pred c-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCe--EEEecCccceeccCccc
Confidence 9 8899999874 5579999999999999999999999999999999999999 56666 99999999976544322
Q ss_pred --------CCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 175 --------PKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 175 --------~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
.....+++.|+|||.+.+..++.+ +|||||
T Consensus 164 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~Di~sl 201 (296)
T 4hgt_A 164 HQHIPYRENKNLTGTARYASINTHLGIEQSRR-DDLESL 201 (296)
T ss_dssp CCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHH-HHHHHH
T ss_pred CccCCCCcccccCCCccccchHHhcCCCCCch-hHHHHH
Confidence 234468999999999998888755 999986
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-36 Score=231.35 Aligned_cols=179 Identities=28% Similarity=0.462 Sum_probs=150.2
Q ss_pred cCCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCcc---chHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeE---
Q 028681 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTPTHL--- 92 (205)
Q Consensus 19 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~--- 92 (205)
..++|++.+.||+|++|.||++.+..+++.||+|++..... ..+.+..|+.+++.++||||+++++++...+..
T Consensus 40 l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 119 (371)
T 4exu_A 40 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF 119 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTC
T ss_pred ccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccc
Confidence 35799999999999999999999999999999999976432 246678999999999999999999999877654
Q ss_pred ---EEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccc
Q 028681 93 ---AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 169 (205)
Q Consensus 93 ---~lv~~~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~ 169 (205)
++++|++. ++|.+.+. ..+++..+..++.|++.||.|||+.||+|+||+|+||+++.++. ++|+|||+++..
T Consensus 120 ~~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~--~kL~Dfg~a~~~ 194 (371)
T 4exu_A 120 YDFYLVMPFMQ-TDLQKIMG--MEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCE--LKILDFGLARHA 194 (371)
T ss_dssp CCCEEEEECCC-EEHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCC--EEECSTTCC---
T ss_pred eeEEEEEcccc-ccHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCC--EEEEecCccccc
Confidence 99999997 57777663 34999999999999999999999999999999999999988877 999999999754
Q ss_pred cCCCCCCCCCCCCCccCCceecc-CcCCCeeeEEEeC
Q 028681 170 VLHSQPKSTVGTPAYIAPEVLLK-KEYDGKVMCVYVI 205 (205)
Q Consensus 170 ~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~~Dvwsl 205 (205)
.. ......+++.|+|||++.+ ..++.+ +|||||
T Consensus 195 ~~--~~~~~~~t~~y~aPE~~~~~~~~~~~-~Diwsl 228 (371)
T 4exu_A 195 DA--EMTGYVVTRWYRAPEVILSWMHYNQT-VDIWSV 228 (371)
T ss_dssp -------CTTCCCTTSCHHHHSCCSCCCTT-HHHHHH
T ss_pred cc--CcCCcccCccccCHHHhcCCCCCCcH-HhHHHH
Confidence 33 2344568999999999987 555555 999986
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-35 Score=226.69 Aligned_cols=183 Identities=31% Similarity=0.454 Sum_probs=134.6
Q ss_pred ecCCCeEEEe-eeccccceeEEEEEecCCCcEEEEEEeecCccchHHHHHHHHHHHhcCCCCeeEEEEEEEe----CCeE
Q 028681 18 HDSDRYELVR-DIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILT----PTHL 92 (205)
Q Consensus 18 ~~~~~y~~~~-~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~ 92 (205)
...++|++.+ .||+|++|.||.+.+..+++.||+|++...... ..+....++.+.|+|++++++++.. +...
T Consensus 25 ~~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 101 (336)
T 3fhr_A 25 AVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKA---RQEVDHHWQASGGPHIVCILDVYENMHHGKRCL 101 (336)
T ss_dssp CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSHHH---HHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred cccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcHHH---HHHHHHHHHhcCCCChHHHHHHHhhccCCCceE
Confidence 3468999965 699999999999999999999999998764322 2223334567789999999999876 4568
Q ss_pred EEEEEecCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCC-CCcEEEeeecccccc
Q 028681 93 AIVMEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSP-APRLKICDFGYSKSS 169 (205)
Q Consensus 93 ~lv~~~~~~~sl~~~~~~~~--~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~-~~~~~l~df~~~~~~ 169 (205)
+++|||+++++|.+.+.... .+++..++.++.|++.||.|||++|++|+||+|+||+++.++ ...++|+|||++...
T Consensus 102 ~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~ 181 (336)
T 3fhr_A 102 LIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKET 181 (336)
T ss_dssp EEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC
T ss_pred EEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEeccccceec
Confidence 99999999999999997653 699999999999999999999999999999999999997533 234999999998755
Q ss_pred cCCCCCCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 170 VLHSQPKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 170 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
... ......+++.|+|||++.+..++.+ +|||||
T Consensus 182 ~~~-~~~~~~~t~~y~aPE~~~~~~~~~~-~Di~sl 215 (336)
T 3fhr_A 182 TQN-ALQTPCYTPYYVAPEVLGPEKYDKS-CDMWSL 215 (336)
T ss_dssp -----------------------CHHHHH-HHHHHH
T ss_pred ccc-ccccCCCCcCccChhhhCCCCCCch-hhHHHH
Confidence 432 2344568999999999988888755 999986
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-36 Score=233.97 Aligned_cols=180 Identities=17% Similarity=0.163 Sum_probs=136.0
Q ss_pred CCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCcc----chHHHHHHHHHHHhc--CCCCeeEEE-------EEE
Q 028681 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK----IDENVQREIINHRSL--RHPNIVRFK-------EVI 86 (205)
Q Consensus 20 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l--~h~~i~~~~-------~~~ 86 (205)
..+|++.+.||+|+||.||.+.+..+++.||+|++..... ..+.+.+|+.+++.+ +|||+++++ +++
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence 4569999999999999999999999999999999987543 234567775555555 599988855 444
Q ss_pred EeC-----------------CeEEEEEEecCCCchHHHHHhc-CCCCHHHH------HHHHHHHHHHHHHHHhcCcEeec
Q 028681 87 LTP-----------------THLAIVMEYASGGELFERICNA-GRFSEDEA------RFFFQQLISGVSYCHSMQVCHRD 142 (205)
Q Consensus 87 ~~~-----------------~~~~lv~~~~~~~sl~~~~~~~-~~~~~~~~------~~i~~~i~~~l~~lh~~~i~H~d 142 (205)
..+ ...++||||++ ++|.+++... ..+..... ..++.|++.||+|||++||+|||
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrD 219 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGH 219 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETT
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCc
Confidence 433 33899999998 7999999763 33444445 67779999999999999999999
Q ss_pred CCCCCeEecCCCCCcEEEeeecccccccCCCCCCCCCCCCCccCCceecc--CcCCCeeeEEEeC
Q 028681 143 LKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLK--KEYDGKVMCVYVI 205 (205)
Q Consensus 143 i~p~nili~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~--~~~~~~~~Dvwsl 205 (205)
|+|+||+++.++. +||+|||+++...... ....+++.|+|||++.+ ..++.+ +|||||
T Consensus 220 ikp~NIll~~~~~--~kL~DFG~a~~~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~-~DiwSl 279 (371)
T 3q60_A 220 FTPDNLFIMPDGR--LMLGDVSALWKVGTRG--PASSVPVTYAPREFLNASTATFTHA-LNAWQL 279 (371)
T ss_dssp CSGGGEEECTTSC--EEECCGGGEEETTCEE--EGGGSCGGGCCHHHHTCSEEECCHH-HHHHHH
T ss_pred CCHHHEEECCCCC--EEEEecceeeecCCCc--cCccCCcCCcChhhccCCCCCcCcc-ccHHHH
Confidence 9999999998877 9999999997553222 13456799999999987 667655 999996
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-35 Score=241.59 Aligned_cols=184 Identities=27% Similarity=0.365 Sum_probs=151.5
Q ss_pred ecCCCeEEEe-eeccccceeEEEEEec--CCCcEEEEEEeecCc--cchHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeE
Q 028681 18 HDSDRYELVR-DIGSGNFGVARLMRDK--KTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHL 92 (205)
Q Consensus 18 ~~~~~y~~~~-~l~~g~~g~v~~~~~~--~~~~~v~iK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 92 (205)
...+++.+.+ .||+|+||.||.+... .++..||+|+++... ...+.+.+|+.+++.++||||+++++++.. +..
T Consensus 332 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~ 410 (613)
T 2ozo_A 332 LKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EAL 410 (613)
T ss_dssp CCTTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSE
T ss_pred ccccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCe
Confidence 3455666666 8999999999999875 345679999998653 345779999999999999999999999876 568
Q ss_pred EEEEEecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccC
Q 028681 93 AIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 171 (205)
Q Consensus 93 ~lv~~~~~~~sl~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~ 171 (205)
++||||+++++|.+++... ..+++..+..++.|++.||.|||+++|+||||+|+||+++.++. +||+|||+++....
T Consensus 411 ~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~--vkL~DFGla~~~~~ 488 (613)
T 2ozo_A 411 MLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHY--AKISDFGLSKALGA 488 (613)
T ss_dssp EEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTE--EEECCCSTTTTCC-
T ss_pred EEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCc--EEEeeccCcccccC
Confidence 9999999999999988653 45999999999999999999999999999999999999988776 99999999976543
Q ss_pred CCCC----CCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 172 HSQP----KSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 172 ~~~~----~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
.... ....+++.|+|||++.+..++.+ +|||||
T Consensus 489 ~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~-sDvwSl 525 (613)
T 2ozo_A 489 DDSYYTARSAGKWPLKWYAPECINFRKFSSR-SDVWSY 525 (613)
T ss_dssp -------------CCTTSCHHHHHHCCCCHH-HHHHHH
T ss_pred CCceeeeccCCCCccceeCHhhhcCCCCCcH-HHHHHH
Confidence 3221 11235688999999998888766 999996
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-35 Score=224.43 Aligned_cols=183 Identities=28% Similarity=0.453 Sum_probs=151.6
Q ss_pred CCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCc-----cchHHHHHHHHHHHhcCCCCeeEEEEEEE--eCCeE
Q 028681 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD-----KIDENVQREIINHRSLRHPNIVRFKEVIL--TPTHL 92 (205)
Q Consensus 20 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~ 92 (205)
.++|++.+.||+|++|.||.+.+..++..|++|++.... ...+.+..|+.+++.++|+||+++++++. +....
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 578999999999999999999999999999999987542 23467889999999999999999999985 44578
Q ss_pred EEEEEecCCCchHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeeccccccc
Q 028681 93 AIVMEYASGGELFERICN--AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 170 (205)
Q Consensus 93 ~lv~~~~~~~sl~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~ 170 (205)
+++||++.++ +.+.+.. ...+++..+..++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||++....
T Consensus 84 ~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~--~kl~dfg~~~~~~ 160 (305)
T 2wtk_C 84 YMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGT--LKISALGVAEALH 160 (305)
T ss_dssp EEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC--EEECCCTTCEECC
T ss_pred EEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCc--EEeeccccccccC
Confidence 9999999775 6666654 456999999999999999999999999999999999999988877 9999999987654
Q ss_pred CCC---CCCCCCCCCCccCCceeccCcC-CCeeeEEEeC
Q 028681 171 LHS---QPKSTVGTPAYIAPEVLLKKEY-DGKVMCVYVI 205 (205)
Q Consensus 171 ~~~---~~~~~~~~~~~~aPE~~~~~~~-~~~~~Dvwsl 205 (205)
... ......+++.|+|||++.+... .+.++|||||
T Consensus 161 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~sl 199 (305)
T 2wtk_C 161 PFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSA 199 (305)
T ss_dssp TTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHH
T ss_pred ccccccccccCCCCCCCcChhhccCcccCCcchhhHHHH
Confidence 322 2234468999999999986432 2345999986
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-35 Score=229.60 Aligned_cols=185 Identities=24% Similarity=0.330 Sum_probs=158.3
Q ss_pred eecCCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCccchHHHHHHHHHHHhcC-----------CCCeeEEEEE
Q 028681 17 MHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLR-----------HPNIVRFKEV 85 (205)
Q Consensus 17 ~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~-----------h~~i~~~~~~ 85 (205)
....++|++.+.||+|++|.||++.+..+++.||+|++.......+.+..|+.+++.++ |+||++++++
T Consensus 15 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~ 94 (373)
T 1q8y_A 15 PYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDH 94 (373)
T ss_dssp EETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEE
T ss_pred cccCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHH
Confidence 34568999999999999999999999999999999999876666677888999988886 7899999999
Q ss_pred EEeCC----eEEEEEEecCCCchHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhc-CcEeecCCCCCeEecCCC----
Q 028681 86 ILTPT----HLAIVMEYASGGELFERICN--AGRFSEDEARFFFQQLISGVSYCHSM-QVCHRDLKLENTLLDGSP---- 154 (205)
Q Consensus 86 ~~~~~----~~~lv~~~~~~~sl~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lh~~-~i~H~di~p~nili~~~~---- 154 (205)
+...+ ..++++|++ +++|.+.+.. ...+++..+..++.|++.||.|||+. ||+|+||+|+||+++.++
T Consensus 95 ~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~~~~ 173 (373)
T 1q8y_A 95 FNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPEN 173 (373)
T ss_dssp EEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTT
T ss_pred hhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCCCcC
Confidence 98654 789999999 7899998876 34599999999999999999999998 999999999999995432
Q ss_pred CCcEEEeeecccccccCCCCCCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 155 APRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 155 ~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
...++|+|||++..... ......+++.|+|||++.+..++.+ +|||||
T Consensus 174 ~~~~kl~Dfg~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~-~Di~sl 221 (373)
T 1q8y_A 174 LIQIKIADLGNACWYDE--HYTNSIQTREYRSPEVLLGAPWGCG-ADIWST 221 (373)
T ss_dssp EEEEEECCCTTCEETTB--CCCSCCSCGGGCCHHHHHTCCCCTH-HHHHHH
T ss_pred cceEEEcccccccccCC--CCCCCCCCccccCcHHHhCCCCCch-HhHHHH
Confidence 22499999999976543 2344578999999999999888766 999986
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-35 Score=232.68 Aligned_cols=182 Identities=26% Similarity=0.292 Sum_probs=155.3
Q ss_pred cCCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCccchHHHHHHHHHHHhcCC-CCeeEEEEEEEeCCeEEEEEE
Q 028681 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRH-PNIVRFKEVILTPTHLAIVME 97 (205)
Q Consensus 19 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~~ 97 (205)
..++|++.+.||+|+||.||++.+..++..||+|++..... .+.+..|+.+++.++| +++..+..++......+++||
T Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme 83 (483)
T 3sv0_A 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (483)
T ss_dssp ETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS-SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred cCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc-cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence 35899999999999999999999999999999998775433 3457889999999986 566667777778889999999
Q ss_pred ecCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEec---CCCCCcEEEeeecccccccCCC
Q 028681 98 YASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLD---GSPAPRLKICDFGYSKSSVLHS 173 (205)
Q Consensus 98 ~~~~~sl~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~---~~~~~~~~l~df~~~~~~~~~~ 173 (205)
++ +++|.+++.. ...+++..++.++.||+.||.|||++||+|+||+|+||+++ .++. ++|+|||+++......
T Consensus 84 ~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~--vkL~DFGla~~~~~~~ 160 (483)
T 3sv0_A 84 LL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQ--VYIIDFGLAKKYRDTS 160 (483)
T ss_dssp CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTC--EEECCCTTCEECBCTT
T ss_pred CC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCe--EEEEeCCcceeccCCc
Confidence 99 8899999975 56799999999999999999999999999999999999994 5555 9999999997655433
Q ss_pred CC--------CCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 174 QP--------KSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 174 ~~--------~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
.. ....|+..|+|||++.+..++.+ +|||||
T Consensus 161 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~-sDvwSl 199 (483)
T 3sv0_A 161 THQHIPYRENKNLTGTARYASVNTHLGIEQSRR-DDLESL 199 (483)
T ss_dssp TCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHH-HHHHHH
T ss_pred cccccccccccccCCCccccCHHHhcCCCCChH-HHHHHH
Confidence 22 24568999999999999888766 999986
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-36 Score=224.41 Aligned_cols=189 Identities=27% Similarity=0.405 Sum_probs=148.3
Q ss_pred ccCceecCCCeEEEeeeccccceeEEEEEecC-CC--cEEEEEEeecCc----cchHHHHHHHHHHHhcCCCCeeEEEEE
Q 028681 13 DMPIMHDSDRYELVRDIGSGNFGVARLMRDKK-TE--ELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEV 85 (205)
Q Consensus 13 ~~~~~~~~~~y~~~~~l~~g~~g~v~~~~~~~-~~--~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~ 85 (205)
........++|++.+.||+|++|.||.+.+.. ++ ..|++|.+.... ...+.+..|+.+++.++||||++++++
T Consensus 10 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~ 89 (291)
T 1u46_A 10 SLTCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGV 89 (291)
T ss_dssp -CCEECCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ccccccchhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEE
Confidence 33455667899999999999999999998643 23 368999887542 234678899999999999999999999
Q ss_pred EEeCCeEEEEEEecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeec
Q 028681 86 ILTPTHLAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFG 164 (205)
Q Consensus 86 ~~~~~~~~lv~~~~~~~sl~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~ 164 (205)
+..+. .++++|++++++|.+.+... ..+++..+..++.|++.||.+||++|++|+||+|+||+++.++. ++|+|||
T Consensus 90 ~~~~~-~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~--~kl~Dfg 166 (291)
T 1u46_A 90 VLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDL--VKIGDFG 166 (291)
T ss_dssp ECSSS-CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTE--EEECCCT
T ss_pred EccCC-ceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCC--EEEcccc
Confidence 88765 78999999999999988764 56999999999999999999999999999999999999987776 9999999
Q ss_pred ccccccCCCC----CCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 165 YSKSSVLHSQ----PKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 165 ~~~~~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
++........ .....++..|+|||.+.+..++.+ +|||||
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~sl 210 (291)
T 1u46_A 167 LMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHA-SDTWMF 210 (291)
T ss_dssp TCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHH-HHHHHH
T ss_pred ccccccccccchhhhccCCCCceeeCchhhcCCCCCch-hhHHHH
Confidence 9876544332 223356778999999988887655 999986
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-35 Score=245.20 Aligned_cols=176 Identities=25% Similarity=0.350 Sum_probs=149.7
Q ss_pred CCCeEEEeeeccccceeEEEEEecC-CCcEEEEEEeecCc--cchHHHHHHHHHHHhcCCCCeeEEEEEEEeCCe-----
Q 028681 20 SDRYELVRDIGSGNFGVARLMRDKK-TEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTH----- 91 (205)
Q Consensus 20 ~~~y~~~~~l~~g~~g~v~~~~~~~-~~~~v~iK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~----- 91 (205)
.++|++.+.||+|+||.||.+.+.. +++.|++|.+.... ...+.+..|+.+++.++||||+++++++...+.
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 158 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV 158 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence 4899999999999999999999976 68999999887543 233567899999999999999999999987655
Q ss_pred EEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccC
Q 028681 92 LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 171 (205)
Q Consensus 92 ~~lv~~~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~ 171 (205)
.++||||+++++|.+.+.. ++++..+..++.|++.||.|||++||+|+||||+||+++.+ . +||+|||+++....
T Consensus 159 ~~lv~E~~~g~~L~~~~~~--~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~-~--~kl~DFG~a~~~~~ 233 (681)
T 2pzi_A 159 GYIVMEYVGGQSLKRSKGQ--KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-Q--LKLIDLGAVSRINS 233 (681)
T ss_dssp EEEEEECCCCEECC----C--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-C--EEECCCTTCEETTC
T ss_pred eEEEEEeCCCCcHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC-c--EEEEecccchhccc
Confidence 7999999999999887654 69999999999999999999999999999999999999875 3 99999999976543
Q ss_pred CCCCCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 172 HSQPKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 172 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
. ....||+.|+|||++.+.. + .++|||||
T Consensus 234 ~---~~~~gt~~y~aPE~~~~~~-~-~~sDi~sl 262 (681)
T 2pzi_A 234 F---GYLYGTPGFQAPEIVRTGP-T-VATDIYTV 262 (681)
T ss_dssp C---SCCCCCTTTSCTTHHHHCS-C-HHHHHHHH
T ss_pred C---CccCCCccccCHHHHcCCC-C-Cceehhhh
Confidence 3 4457999999999997654 4 45999986
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-36 Score=231.40 Aligned_cols=187 Identities=23% Similarity=0.256 Sum_probs=147.1
Q ss_pred ceecCCCeEEEeeeccccceeEEEEEecCC---CcEEEEEEeecCcc--chHHHHHHHHHHHhcCCCCeeEEEEEEEe-C
Q 028681 16 IMHDSDRYELVRDIGSGNFGVARLMRDKKT---EELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILT-P 89 (205)
Q Consensus 16 ~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~---~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~ 89 (205)
+......|++.+.||+|+||.||++....+ +..|++|.+..... ..+.+..|+.++++++||||+++++++.. +
T Consensus 84 i~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~ 163 (373)
T 3c1x_A 84 IGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSE 163 (373)
T ss_dssp CCSTTEEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCS
T ss_pred cChhhceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCC
Confidence 344455689999999999999999987543 34689998875432 34678899999999999999999998764 4
Q ss_pred CeEEEEEEecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeeccccc
Q 028681 90 THLAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 168 (205)
Q Consensus 90 ~~~~lv~~~~~~~sl~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~ 168 (205)
+..+++|||+++++|.+++... ..+++..+..++.|++.||.|||+.||+||||+|+||+++.++. +||+|||+++.
T Consensus 164 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~--~kL~DFG~a~~ 241 (373)
T 3c1x_A 164 GSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFT--VKVADFGLARD 241 (373)
T ss_dssp SCCEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCC--EEECCC-----
T ss_pred CCeEEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCC--EEEeecccccc
Confidence 5788999999999999999764 45899999999999999999999999999999999999988877 99999999975
Q ss_pred ccCCCC-----CCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 169 SVLHSQ-----PKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 169 ~~~~~~-----~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
...... .....+++.|+|||++.+..++.+ +|||||
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~DvwSl 282 (373)
T 3c1x_A 242 MYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTK-SDVWSF 282 (373)
T ss_dssp ----------------CCGGGSCHHHHHHCCCCHH-HHHHHH
T ss_pred ccccccccccccCCCCCcccccChHHhcCCCCCcH-HHHHHH
Confidence 433221 122346788999999998888765 999986
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-35 Score=221.32 Aligned_cols=186 Identities=28% Similarity=0.367 Sum_probs=138.5
Q ss_pred ceecCCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCccch---HHHHHHHHHHHhcCCCCeeEEEEEEEeCCeE
Q 028681 16 IMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID---ENVQREIINHRSLRHPNIVRFKEVILTPTHL 92 (205)
Q Consensus 16 ~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~---~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 92 (205)
.....++|++.+.||+|++|.||.+.+..+++.|++|.+....... +.+.++..+++.++||||+++++++..++..
T Consensus 20 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~ 99 (318)
T 2dyl_A 20 YQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDV 99 (318)
T ss_dssp EECCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred hhhhhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcE
Confidence 3445789999999999999999999999999999999998654322 2344455567788999999999999999999
Q ss_pred EEEEEecCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhc-CcEeecCCCCCeEecCCCCCcEEEeeeccccccc
Q 028681 93 AIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSM-QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 170 (205)
Q Consensus 93 ~lv~~~~~~~sl~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lh~~-~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~ 170 (205)
+++||++ ++.+..+... ...+++..+..++.|++.||.|||+. |++|+||+|+||+++.++. ++|+|||++....
T Consensus 100 ~lv~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~--~kl~dfg~~~~~~ 176 (318)
T 2dyl_A 100 FIAMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQ--IKLCDFGISGRLV 176 (318)
T ss_dssp EEEECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSC--EEECCCTTC----
T ss_pred EEEEecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCC--EEEEECCCchhcc
Confidence 9999999 4455555543 56799999999999999999999985 9999999999999988877 9999999987665
Q ss_pred CCCCCCCCCCCCCccCCceec-----cCcCCCeeeEEEeC
Q 028681 171 LHSQPKSTVGTPAYIAPEVLL-----KKEYDGKVMCVYVI 205 (205)
Q Consensus 171 ~~~~~~~~~~~~~~~aPE~~~-----~~~~~~~~~Dvwsl 205 (205)
.........+++.|+|||++. +..++.+ +|||||
T Consensus 177 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~-~Di~sl 215 (318)
T 2dyl_A 177 DDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIR-ADVWSL 215 (318)
T ss_dssp ----------CCTTCCHHHHC--------CCTH-HHHHHH
T ss_pred CCccccccCCCccccChhhcccccccccCCccc-cchhhH
Confidence 555455567899999999995 4455545 999985
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-35 Score=222.30 Aligned_cols=179 Identities=34% Similarity=0.484 Sum_probs=147.1
Q ss_pred ecCCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCccchHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEE
Q 028681 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (205)
Q Consensus 18 ~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~ 97 (205)
.+.++|++.+.||+|+||.||.+... ++.|++|.+... ...+.+..|+.++++++||||+++++++.+ ..+++||
T Consensus 5 i~~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e 79 (307)
T 2eva_A 5 IDYKEIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIESE-SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVME 79 (307)
T ss_dssp CCGGGEEEEEEEECCSSSEEEEEEET--TEEEEEEECSST-THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEE
T ss_pred CCHhHeeeeeEeecCCCceEEEEEEC--CeeEEEEEecCh-hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEE
Confidence 35689999999999999999999875 678999988643 345678899999999999999999998874 4789999
Q ss_pred ecCCCchHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHh---cCcEeecCCCCCeEecCCCCCcEEEeeecccccccC
Q 028681 98 YASGGELFERICNAG---RFSEDEARFFFQQLISGVSYCHS---MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 171 (205)
Q Consensus 98 ~~~~~sl~~~~~~~~---~~~~~~~~~i~~~i~~~l~~lh~---~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~ 171 (205)
|+++++|.+.+.... .++...+..++.|++.||.|||+ .|++|+||+|+||+++.++. .++|+|||++.....
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~-~~kl~Dfg~~~~~~~ 158 (307)
T 2eva_A 80 YAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGT-VLKICDFGTACDIQT 158 (307)
T ss_dssp CCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTT-EEEECCCCC------
T ss_pred cCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCC-EEEEccccccccccc
Confidence 999999999997654 37899999999999999999999 89999999999999986654 279999999865432
Q ss_pred CCCCCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 172 HSQPKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 172 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
. .....|++.|+|||++.+..++.+ +|||||
T Consensus 159 ~--~~~~~gt~~y~aPE~~~~~~~~~~-~Di~sl 189 (307)
T 2eva_A 159 H--MTNNKGSAAWMAPEVFEGSNYSEK-CDVFSW 189 (307)
T ss_dssp --------CCTTSSCHHHHTCCCCCTH-HHHHHH
T ss_pred c--cccCCCCCceEChhhhCCCCCCcH-HHHHHH
Confidence 2 233468999999999998888766 999986
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-35 Score=227.84 Aligned_cols=179 Identities=28% Similarity=0.461 Sum_probs=149.6
Q ss_pred cCCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCcc---chHHHHHHHHHHHhcCCCCeeEEEEEEEeCCe----
Q 028681 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTPTH---- 91 (205)
Q Consensus 19 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~---- 91 (205)
..++|++.+.||+|++|.||.+.+..+++.||+|.+..... ..+.+.+|+.+++.++||||+++++++.....
T Consensus 22 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 101 (353)
T 3coi_A 22 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF 101 (353)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred cCceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccc
Confidence 35899999999999999999999999999999999876432 23567889999999999999999999987653
Q ss_pred --EEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccc
Q 028681 92 --LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 169 (205)
Q Consensus 92 --~~lv~~~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~ 169 (205)
.+++||++. ++|.+.+.. .+++..+..++.|++.||.|||++|++|+||+|+||+++.++. ++|+|||++...
T Consensus 102 ~~~~lv~e~~~-~~l~~~~~~--~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~--~kl~Dfg~~~~~ 176 (353)
T 3coi_A 102 YDFYLVMPFMQ-TDLQKIMGL--KFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCE--LKILDFGLARHA 176 (353)
T ss_dssp CCCEEEEECCS-EEGGGTTTS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCC--EEECSTTCTTC-
T ss_pred eeEEEEecccc-CCHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCc--EEEeecccccCC
Confidence 499999997 578776643 4999999999999999999999999999999999999998877 999999998754
Q ss_pred cCCCCCCCCCCCCCccCCceecc-CcCCCeeeEEEeC
Q 028681 170 VLHSQPKSTVGTPAYIAPEVLLK-KEYDGKVMCVYVI 205 (205)
Q Consensus 170 ~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~~Dvwsl 205 (205)
... .....+++.|+|||++.+ ..++.+ +|||||
T Consensus 177 ~~~--~~~~~~t~~y~aPE~~~~~~~~~~~-~Di~sl 210 (353)
T 3coi_A 177 DAE--MTGYVVTRWYRAPEVILSWMHYNQT-VDIWSV 210 (353)
T ss_dssp ---------CCSBCCSCHHHHSCCSCCCTT-HHHHHH
T ss_pred CCC--ccccccCcCcCCHHHHhCcCCCCch-hhHHHH
Confidence 322 334568999999999987 455544 999986
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-36 Score=245.03 Aligned_cols=190 Identities=30% Similarity=0.397 Sum_probs=159.4
Q ss_pred CceecCCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCc--cchHHHHHHHHHHHhcCCCCeeEEEEEEEe----
Q 028681 15 PIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILT---- 88 (205)
Q Consensus 15 ~~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---- 88 (205)
......++|++.+.||+|+||.||++.+..++..||+|++.... ...+.+..|+.+++.++||||+++++++..
T Consensus 8 ~pg~~~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~ 87 (676)
T 3qa8_A 8 LPTQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKL 87 (676)
T ss_dssp ---------CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCC
T ss_pred CCCCCCCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccc
Confidence 33444689999999999999999999999999999999987642 234668899999999999999999998765
Q ss_pred --CCeEEEEEEecCCCchHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCC-CcEEEee
Q 028681 89 --PTHLAIVMEYASGGELFERICNAG---RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPA-PRLKICD 162 (205)
Q Consensus 89 --~~~~~lv~~~~~~~sl~~~~~~~~---~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~-~~~~l~d 162 (205)
++..++||||+++++|.+++.... .+++..++.++.|++.||.|||+.|++|+||+|+||+++.++. ..++|+|
T Consensus 88 ~~~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~D 167 (676)
T 3qa8_A 88 APNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIID 167 (676)
T ss_dssp CTTSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECS
T ss_pred cCCCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEcc
Confidence 667899999999999999997644 5899999999999999999999999999999999999986653 2489999
Q ss_pred ecccccccCCCCCCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 163 FGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 163 f~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
||++.............+++.|+|||++.+..++.+ +|||||
T Consensus 168 FG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~k-sDIwSL 209 (676)
T 3qa8_A 168 LGYAKELDQGELCTEFVGTLQYLAPELLEQKKYTVT-VDYWSF 209 (676)
T ss_dssp CCCCCBTTSCCCCCCCCSCCTTCSSCSSCCSCCSTT-HHHHHH
T ss_pred cccccccccccccccccCCcccCChHHhccCCCCch-hHHHHH
Confidence 999987766666666789999999999998888766 999986
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-35 Score=224.55 Aligned_cols=179 Identities=28% Similarity=0.337 Sum_probs=152.0
Q ss_pred CCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCccchHHHHHHHHHHHh--cCCCCeeEEEEEEEeCC----eEE
Q 028681 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRS--LRHPNIVRFKEVILTPT----HLA 93 (205)
Q Consensus 20 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~--l~h~~i~~~~~~~~~~~----~~~ 93 (205)
.++|++.+.||+|++|.||++.+. ++.||+|.+... ....+..|..++.. ++||||+++++++.... ..+
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~--~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~ 116 (342)
T 1b6c_B 41 ARTIVLQESIGKGRFGEVWRGKWR--GEEVAVKIFSSR--EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLW 116 (342)
T ss_dssp HHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEECGG--GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCCEE
T ss_pred cccEEEEeeecCCCCcEEEEEEEc--CccEEEEEeCch--hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccceeE
Confidence 478999999999999999999884 789999998753 34566777888777 78999999999998876 799
Q ss_pred EEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH--------hcCcEeecCCCCCeEecCCCCCcEEEeeecc
Q 028681 94 IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCH--------SMQVCHRDLKLENTLLDGSPAPRLKICDFGY 165 (205)
Q Consensus 94 lv~~~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh--------~~~i~H~di~p~nili~~~~~~~~~l~df~~ 165 (205)
+++||+++++|.+.+.. ..+++..+..++.|++.||.+|| +.+++|+||+|+||+++.++. ++|+|||+
T Consensus 117 lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~--~kL~Dfg~ 193 (342)
T 1b6c_B 117 LVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGT--CCIADLGL 193 (342)
T ss_dssp EEECCCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSC--EEECCCTT
T ss_pred EEEeecCCCcHHHHHhc-cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCC--EEEEECCC
Confidence 99999999999999965 46999999999999999999999 899999999999999988877 99999999
Q ss_pred cccccCCC-----CCCCCCCCCCccCCceeccCcCCC-----eeeEEEeC
Q 028681 166 SKSSVLHS-----QPKSTVGTPAYIAPEVLLKKEYDG-----KVMCVYVI 205 (205)
Q Consensus 166 ~~~~~~~~-----~~~~~~~~~~~~aPE~~~~~~~~~-----~~~Dvwsl 205 (205)
+....... ......+++.|+|||.+.+..... .++|||||
T Consensus 194 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~sl 243 (342)
T 1b6c_B 194 AVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAM 243 (342)
T ss_dssp CEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHH
T ss_pred ceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHH
Confidence 87654433 234457999999999998763221 35899986
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-35 Score=220.73 Aligned_cols=177 Identities=28% Similarity=0.363 Sum_probs=150.0
Q ss_pred eEEEeeeccccceeEEEEEecCCCcEEEEEEeecCc-----cchHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEE
Q 028681 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD-----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (205)
Q Consensus 23 y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~ 97 (205)
|...+.||+|++|.||.+.. ++..|++|.+.... ...+.+..|+.+++.++||||+++++++.+++..+++|+
T Consensus 33 ~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 110 (307)
T 2nru_A 33 SVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYV 110 (307)
T ss_dssp TTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred cccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEEE
Confidence 44458999999999999986 47789999987532 234678899999999999999999999999999999999
Q ss_pred ecCCCchHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCCCC
Q 028681 98 YASGGELFERICN---AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 174 (205)
Q Consensus 98 ~~~~~sl~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~ 174 (205)
++++++|.+.+.. ..++++..+..++.|++.||.|||+.|++|+||+|+||+++.++. ++|+|||++........
T Consensus 111 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~--~kl~Dfg~~~~~~~~~~ 188 (307)
T 2nru_A 111 YMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFT--AKISDFGLARASEKFAQ 188 (307)
T ss_dssp CCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCC--EEECCCTTCEECCSCSS
T ss_pred ecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCc--EEEeecccccccccccc
Confidence 9999999998863 346999999999999999999999999999999999999988777 99999999875543222
Q ss_pred ---CCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 175 ---PKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 175 ---~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
.....|++.|+|||.+.+. ++.+ +|||||
T Consensus 189 ~~~~~~~~g~~~y~aPE~~~~~-~~~~-~Dv~sl 220 (307)
T 2nru_A 189 TVMTSRIVGTTAYMAPEALRGE-ITPK-SDIYSF 220 (307)
T ss_dssp CEECSSCCSCGGGCCHHHHTTE-ECTH-HHHHHH
T ss_pred cccccccCCCcCcCChHHhcCC-CCcc-chhHHH
Confidence 2334689999999998654 5555 999986
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-35 Score=231.66 Aligned_cols=181 Identities=29% Similarity=0.431 Sum_probs=136.9
Q ss_pred CCeEE-EeeeccccceeEEEEEec--CCCcEEEEEEeecCccchHHHHHHHHHHHhcCCCCeeEEEEEEEe--CCeEEEE
Q 028681 21 DRYEL-VRDIGSGNFGVARLMRDK--KTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILT--PTHLAIV 95 (205)
Q Consensus 21 ~~y~~-~~~l~~g~~g~v~~~~~~--~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv 95 (205)
+.|++ .++||+|+||.||++.+. .++..||+|.+.... ....+..|+.+++.++||||+++++++.. +...++|
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv 98 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG-ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLL 98 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS-CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEE
T ss_pred hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC-CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEE
Confidence 45776 558999999999999965 568899999987543 34578899999999999999999999965 6789999
Q ss_pred EEecCCCchHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEe----cCCCCCcEEEee
Q 028681 96 MEYASGGELFERICNA---------GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLL----DGSPAPRLKICD 162 (205)
Q Consensus 96 ~~~~~~~sl~~~~~~~---------~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili----~~~~~~~~~l~d 162 (205)
|||+.+ +|.+.+... ..+++..++.++.|++.||.|||++||+||||+|+||++ +.++. ++|+|
T Consensus 99 ~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~--~kl~D 175 (405)
T 3rgf_A 99 FDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGR--VKIAD 175 (405)
T ss_dssp EECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTC--EEECC
T ss_pred EeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCc--EEEEE
Confidence 999965 777776421 249999999999999999999999999999999999999 44444 99999
Q ss_pred ecccccccCC----CCCCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 163 FGYSKSSVLH----SQPKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 163 f~~~~~~~~~----~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
||+++..... .......||+.|+|||++.+....+.++|||||
T Consensus 176 fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSl 222 (405)
T 3rgf_A 176 MGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAI 222 (405)
T ss_dssp TTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHH
T ss_pred CCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHH
Confidence 9999765432 222345689999999999875533355999986
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-35 Score=220.68 Aligned_cols=184 Identities=22% Similarity=0.354 Sum_probs=151.0
Q ss_pred ceecCCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCcc---chHHHHHHHHHHHhcC--CCCeeEEEEEEEeCC
Q 028681 16 IMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---IDENVQREIINHRSLR--HPNIVRFKEVILTPT 90 (205)
Q Consensus 16 ~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~ 90 (205)
+....++|++.+.||+|++|.||++.+.. +..|++|.+..... ..+.+.+|+.+++.++ |+|++++++++..++
T Consensus 23 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~ 101 (313)
T 3cek_A 23 MSVKGRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQ 101 (313)
T ss_dssp EEETTEEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSS
T ss_pred eeeccceEEEEEEecCCCCEEEEEEEcCC-CcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCC
Confidence 45567889999999999999999999864 88899999976432 2366889999999997 599999999999999
Q ss_pred eEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeeccccccc
Q 028681 91 HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 170 (205)
Q Consensus 91 ~~~lv~~~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~ 170 (205)
..+++|| +.+++|.+.+.....+++..+..++.|++.||.+||+.|++|+||+|+||++++ +. ++|+|||++....
T Consensus 102 ~~~lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~-~~--~kL~Dfg~~~~~~ 177 (313)
T 3cek_A 102 YIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD-GM--LKLIDFGIANQMQ 177 (313)
T ss_dssp EEEEEEC-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEET-TE--EEECCCSSSCC--
T ss_pred EEEEEEe-cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEEC-Ce--EEEeecccccccc
Confidence 9999999 557899999988888999999999999999999999999999999999999964 33 9999999997654
Q ss_pred CCCC---CCCCCCCCCccCCceecc-----------CcCCCeeeEEEeC
Q 028681 171 LHSQ---PKSTVGTPAYIAPEVLLK-----------KEYDGKVMCVYVI 205 (205)
Q Consensus 171 ~~~~---~~~~~~~~~~~aPE~~~~-----------~~~~~~~~Dvwsl 205 (205)
.... .....+++.|+|||.+.+ ..++. ++|||||
T Consensus 178 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~-~~Di~sl 225 (313)
T 3cek_A 178 PDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISP-KSDVWSL 225 (313)
T ss_dssp ------------CCGGGCCHHHHTTCC----------CCCH-HHHHHHH
T ss_pred CccccccccCCCCCCCcCCHHHHhhcccccccccccccCCc-hHHHHHH
Confidence 3322 233468999999999975 34544 4999986
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-35 Score=239.18 Aligned_cols=185 Identities=24% Similarity=0.321 Sum_probs=153.5
Q ss_pred eecCCCeEEEeeeccccceeEEEEEecCC---CcEEEEEEeecCcc--chHHHHHHHHHHHhcCCCCeeEEEEEEEeCCe
Q 028681 17 MHDSDRYELVRDIGSGNFGVARLMRDKKT---EELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTH 91 (205)
Q Consensus 17 ~~~~~~y~~~~~l~~g~~g~v~~~~~~~~---~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 91 (205)
....++|++.+.||+|+||.||.+.+..+ +..|++|.+..... ..+.+..|+.+++.++||||+++++++. ++.
T Consensus 386 ~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~ 464 (656)
T 2j0j_A 386 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENP 464 (656)
T ss_dssp BCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSS
T ss_pred ccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCc
Confidence 34467899999999999999999998643 46799998875432 2367889999999999999999999985 466
Q ss_pred EEEEEEecCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeeccccccc
Q 028681 92 LAIVMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 170 (205)
Q Consensus 92 ~~lv~~~~~~~sl~~~~~~~~-~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~ 170 (205)
.++||||+++++|.+.+.... .+++..+..++.|++.||.|||++||+||||+|+||+++.++. ++|+|||+++...
T Consensus 465 ~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~--vkL~DFG~a~~~~ 542 (656)
T 2j0j_A 465 VWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDC--VKLGDFGLSRYME 542 (656)
T ss_dssp CEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTE--EEECCCCCCCSCC
T ss_pred eEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCC--EEEEecCCCeecC
Confidence 899999999999999997644 6999999999999999999999999999999999999988776 9999999997654
Q ss_pred CCCCC--CCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 171 LHSQP--KSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 171 ~~~~~--~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
..... ....+++.|+|||++.+..++.+ +|||||
T Consensus 543 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~-~DiwSl 578 (656)
T 2j0j_A 543 DSTYYKASKGKLPIKWMAPESINFRRFTSA-SDVWMF 578 (656)
T ss_dssp C----------CCGGGCCHHHHHHCCCCHH-HHHHHH
T ss_pred CCcceeccCCCCCcceeCHHHhcCCCCCch-hhHHHH
Confidence 33222 22346788999999998888765 999986
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-34 Score=227.26 Aligned_cols=185 Identities=25% Similarity=0.279 Sum_probs=144.8
Q ss_pred ceecCCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCccchHHHHHHHHHHHhc-CCCCeeEEEEEEEeCCeEEE
Q 028681 16 IMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAI 94 (205)
Q Consensus 16 ~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~l 94 (205)
+.....+|++.+.||+|++|+|+. ....+++.||+|++..... +.+..|+.+++.+ +||||+++++++.+....++
T Consensus 19 ~~i~~~~y~~~~~LG~G~~G~V~~-~~~~~~~~vAvK~~~~~~~--~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~l 95 (432)
T 3p23_A 19 VIVGKISFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPECF--SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYI 95 (432)
T ss_dssp EEETTEEEEEEEEEEECGGGCEEE-EEESSSSEEEEEEECTTTE--EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEE
T ss_pred EEEccEEEecCCeeecCcCEEEEE-EEEeCCeEEEEEEECHHHH--HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEE
Confidence 334456799999999999999763 4456688999999875432 2356789999999 79999999999999999999
Q ss_pred EEEecCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecC---CCCCcEEEeeeccccccc
Q 028681 95 VMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDG---SPAPRLKICDFGYSKSSV 170 (205)
Q Consensus 95 v~~~~~~~sl~~~~~~~~-~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~---~~~~~~~l~df~~~~~~~ 170 (205)
+||++. ++|.+.+.... ...+..+..++.|++.||.|||++||+||||+|+||+++. ++..+++|+|||+++...
T Consensus 96 v~E~~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~ 174 (432)
T 3p23_A 96 AIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLA 174 (432)
T ss_dssp EEECCS-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC-
T ss_pred EEECCC-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeecc
Confidence 999996 58988886643 4556677899999999999999999999999999999953 333458899999997665
Q ss_pred CCC----CCCCCCCCCCccCCceecc---CcCCCeeeEEEeC
Q 028681 171 LHS----QPKSTVGTPAYIAPEVLLK---KEYDGKVMCVYVI 205 (205)
Q Consensus 171 ~~~----~~~~~~~~~~~~aPE~~~~---~~~~~~~~Dvwsl 205 (205)
... ......||+.|+|||++.+ ..++.+ +|||||
T Consensus 175 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~-~DiwSl 215 (432)
T 3p23_A 175 VGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYT-VDIFSA 215 (432)
T ss_dssp -----------CCSCTTSCCGGGTSCC---CCCTH-HHHHHH
T ss_pred CCCcceeeccccCCCcCccChhhhhcccccCCCcH-HHHHHH
Confidence 432 2334569999999999984 444444 999986
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-34 Score=223.28 Aligned_cols=181 Identities=25% Similarity=0.299 Sum_probs=139.7
Q ss_pred CCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCccchHHHHHHHHHHHhc-CCCCeeEEEEEEEeCCeEEEEEEe
Q 028681 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIVMEY 98 (205)
Q Consensus 20 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~~~ 98 (205)
.+.|.+.+.||+|+||+||.+ ...+|+.||+|.+... ..+.+..|+.+++.+ +||||+++++++.+++..+++||+
T Consensus 14 ~~~~~~~~~LG~G~~g~V~~~-~~~~g~~vAvK~~~~~--~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~ 90 (434)
T 2rio_A 14 KNLVVSEKILGYGSSGTVVFQ-GSFQGRPVAVKRMLID--FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALEL 90 (434)
T ss_dssp SSCEEEEEEEEECSTTCEEEE-EESSSSEEEEEEEEGG--GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECC
T ss_pred hheeeccCeEeeCCCeEEEEE-EEECCeEEEEEEEcHH--HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEec
Confidence 355667899999999999865 4556899999998753 245678899999876 899999999999999999999999
Q ss_pred cCCCchHHHHHhcCCC-------CHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCC-----------CCcEEE
Q 028681 99 ASGGELFERICNAGRF-------SEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSP-----------APRLKI 160 (205)
Q Consensus 99 ~~~~sl~~~~~~~~~~-------~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~-----------~~~~~l 160 (205)
+. ++|.+.+...... ++..+..++.|++.||.|||++||+||||+|+||+++.++ ...++|
T Consensus 91 ~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL 169 (434)
T 2rio_A 91 CN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILI 169 (434)
T ss_dssp CS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEE
T ss_pred CC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCCceEEEE
Confidence 96 5999999765432 2234567999999999999999999999999999997542 335999
Q ss_pred eeecccccccCCCC-----CCCCCCCCCccCCceecc-------CcCCCeeeEEEeC
Q 028681 161 CDFGYSKSSVLHSQ-----PKSTVGTPAYIAPEVLLK-------KEYDGKVMCVYVI 205 (205)
Q Consensus 161 ~df~~~~~~~~~~~-----~~~~~~~~~~~aPE~~~~-------~~~~~~~~Dvwsl 205 (205)
+|||+++....... .....|++.|+|||++.+ ..++.+ +|||||
T Consensus 170 ~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~-~DiwSl 225 (434)
T 2rio_A 170 SDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRS-IDIFSM 225 (434)
T ss_dssp CCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTH-HHHHHH
T ss_pred cccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchh-hhhHhH
Confidence 99999976654322 223469999999999975 455545 999996
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-35 Score=220.77 Aligned_cols=183 Identities=26% Similarity=0.402 Sum_probs=149.6
Q ss_pred ceecCCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCc---cchHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeE
Q 028681 16 IMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTHL 92 (205)
Q Consensus 16 ~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 92 (205)
.....++|++.+.||+|++|.||.+.+.. .+++|.+.... ...+.+..|+.+++.++|+||+++++++.+++..
T Consensus 28 ~~i~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 104 (319)
T 2y4i_B 28 WDIPFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHL 104 (319)
T ss_dssp SSSCCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCE
T ss_pred ccCCHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCce
Confidence 34457899999999999999999998864 38999887542 2235577899999999999999999999999999
Q ss_pred EEEEEecCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccC
Q 028681 93 AIVMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 171 (205)
Q Consensus 93 ~lv~~~~~~~sl~~~~~~~~-~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~ 171 (205)
++++|++++++|.+++...+ .+++..+..++.|++.||.+||++|++|+||+|+||+++ ++. ++|+|||++.....
T Consensus 105 ~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~~--~~l~Dfg~~~~~~~ 181 (319)
T 2y4i_B 105 AIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGK--VVITDFGLFSISGV 181 (319)
T ss_dssp EEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---C--CEECCCSCCC----
T ss_pred EEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CCC--EEEeecCCcccccc
Confidence 99999999999999997654 699999999999999999999999999999999999997 444 89999998765432
Q ss_pred C------CCCCCCCCCCCccCCceecc---------CcCCCeeeEEEeC
Q 028681 172 H------SQPKSTVGTPAYIAPEVLLK---------KEYDGKVMCVYVI 205 (205)
Q Consensus 172 ~------~~~~~~~~~~~~~aPE~~~~---------~~~~~~~~Dvwsl 205 (205)
. .......|++.|+|||++.. ..++ .++|||||
T Consensus 182 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~-~~~Di~sl 229 (319)
T 2y4i_B 182 LQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFS-KHSDVFAL 229 (319)
T ss_dssp ------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCC-HHHHHHHH
T ss_pred ccccccccccccCCCcccccChHHhhhccccccccccCCC-chhhHHHH
Confidence 1 22223358899999999975 2344 44999986
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-32 Score=205.93 Aligned_cols=141 Identities=16% Similarity=0.110 Sum_probs=127.0
Q ss_pred cCCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCccc----hHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEE
Q 028681 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI----DENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 94 (205)
Q Consensus 19 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 94 (205)
..++|++.+.||+|++|.||++.+..+++.||+|++...... .+.+..|+..+..++|+||+++++++..++..++
T Consensus 29 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 108 (286)
T 3uqc_A 29 ANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLV 108 (286)
T ss_dssp TTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred ecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEE
Confidence 457899999999999999999999999999999999875433 2678899999999999999999999999999999
Q ss_pred EEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeee
Q 028681 95 VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDF 163 (205)
Q Consensus 95 v~~~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df 163 (205)
||||+++++|.+++..+ ....++..++.|++.||.|||++||+|+||+|+||+++.++. ++|+++
T Consensus 109 v~e~~~g~~L~~~l~~~--~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~--~kl~~~ 173 (286)
T 3uqc_A 109 VAEWIRGGSLQEVADTS--PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGD--VVLAYP 173 (286)
T ss_dssp EEECCCEEEHHHHHTTC--CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSC--EEECSC
T ss_pred EEEecCCCCHHHHHhcC--CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCC--EEEEec
Confidence 99999999999998543 466778899999999999999999999999999999998887 888744
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-33 Score=228.80 Aligned_cols=171 Identities=13% Similarity=0.037 Sum_probs=125.9
Q ss_pred eeccccceeEEEEEecCCCcEEEEEEeecCc-----------cchHHHHHHHHHHHhc-CCCCeeEEEEEEEeCCeEEEE
Q 028681 28 DIGSGNFGVARLMRDKKTEELVAVKYIERGD-----------KIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIV 95 (205)
Q Consensus 28 ~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~-----------~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv 95 (205)
....|+.|....++..-.|..+++|++.+.. ...+++.+|+.+|+++ .|+|++++++++++++..|+|
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV 320 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV 320 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence 3445556555555555568889999997642 1235688999999999 699999999999999999999
Q ss_pred EEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCCC-C
Q 028681 96 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-Q 174 (205)
Q Consensus 96 ~~~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~~-~ 174 (205)
|||++|++|.+.+...+++++. .|+.||+.||+|+|++||+||||||+|||++.++. +||+|||+|+...... .
T Consensus 321 MEyv~G~~L~d~i~~~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~--vKL~DFGlAr~~~~~~~~ 395 (569)
T 4azs_A 321 MEKLPGRLLSDMLAAGEEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQH--ARLIDFGSIVTTPQDCSW 395 (569)
T ss_dssp EECCCSEEHHHHHHTTCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSC--EEECCCTTEESCC---CC
T ss_pred EecCCCCcHHHHHHhCCCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCCC--EEEeecccCeeCCCCCcc
Confidence 9999999999999988888775 47899999999999999999999999999998887 9999999997654432 2
Q ss_pred CCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 175 PKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 175 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
..+..||+.|+|||++.+... .++|+||+
T Consensus 396 ~~t~vGTp~YmAPE~l~g~~~--~~~d~~s~ 424 (569)
T 4azs_A 396 PTNLVQSFFVFVNELFAENKS--WNGFWRSA 424 (569)
T ss_dssp SHHHHHHHHHHHHHHC---------------
T ss_pred ccCceechhhccHHHhCCCCC--Cccccccc
Confidence 334469999999999987643 34899985
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=6.7e-32 Score=203.17 Aligned_cols=153 Identities=34% Similarity=0.529 Sum_probs=131.1
Q ss_pred cccCceecCCCeEEE-eeeccccceeEEEEEecCCCcEEEEEEeecCccchHHHHHHHHHH-HhcCCCCeeEEEEEEEe-
Q 028681 12 MDMPIMHDSDRYELV-RDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINH-RSLRHPNIVRFKEVILT- 88 (205)
Q Consensus 12 ~~~~~~~~~~~y~~~-~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l-~~l~h~~i~~~~~~~~~- 88 (205)
..+......++|.+. +.||+|++|.||.+.+..+++.||+|++... .....|+.++ +..+||||+++++++..
T Consensus 8 ~~~~~~~~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~ 83 (299)
T 3m2w_A 8 LQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC----PKARREVELHWRASQCPHIVRIVDVYENL 83 (299)
T ss_dssp CCCBCSCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS----HHHHHHHHHHHHHTTSTTBCCEEEEEEEE
T ss_pred ccCcccccccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc----HHHHHHHHHHHHhccCCCchhHHhhhhhh
Confidence 444455567889988 7899999999999999999999999998743 4566777777 55689999999999987
Q ss_pred ---CCeEEEEEEecCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCC-CCcEEEee
Q 028681 89 ---PTHLAIVMEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSP-APRLKICD 162 (205)
Q Consensus 89 ---~~~~~lv~~~~~~~sl~~~~~~~~--~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~-~~~~~l~d 162 (205)
....+++|||+++++|.+.+.... .+++..+..++.|++.||.|||++|++|+||+|+||+++.+. ...++|+|
T Consensus 84 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~D 163 (299)
T 3m2w_A 84 YAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTD 163 (299)
T ss_dssp ETTEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECC
T ss_pred cCCCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEec
Confidence 678899999999999999997754 699999999999999999999999999999999999998732 22499999
Q ss_pred eccccc
Q 028681 163 FGYSKS 168 (205)
Q Consensus 163 f~~~~~ 168 (205)
||++..
T Consensus 164 fg~a~~ 169 (299)
T 3m2w_A 164 FGFAKE 169 (299)
T ss_dssp CTTCEE
T ss_pred cccccc
Confidence 998854
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.97 E-value=3.3e-32 Score=213.38 Aligned_cols=180 Identities=14% Similarity=0.066 Sum_probs=135.9
Q ss_pred cCCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCc----cchHHHHHHHHHHHhcCC-CC---------e-----
Q 028681 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRH-PN---------I----- 79 (205)
Q Consensus 19 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~h-~~---------i----- 79 (205)
...+|++.+.||+|+||.||++.+..+++.||+|++.... ...+.+.+|+.+++.++| ++ +
T Consensus 76 ~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~ 155 (413)
T 3dzo_A 76 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD 155 (413)
T ss_dssp CCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCE
T ss_pred CceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchh
Confidence 3456889999999999999999999999999999987432 224678899999988876 21 1
Q ss_pred -------eEEEEEEEe-----CCeEEEEEEecCCCchHHHHHh-------cCCCCHHHHHHHHHHHHHHHHHHHhcCcEe
Q 028681 80 -------VRFKEVILT-----PTHLAIVMEYASGGELFERICN-------AGRFSEDEARFFFQQLISGVSYCHSMQVCH 140 (205)
Q Consensus 80 -------~~~~~~~~~-----~~~~~lv~~~~~~~sl~~~~~~-------~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H 140 (205)
..+..++.. ...++++++.+ .++|.+++.. ..++++..+..++.|++.||.|||++||+|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiH 234 (413)
T 3dzo_A 156 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVH 234 (413)
T ss_dssp EEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred hcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCccc
Confidence 111111111 12356677765 5688888741 234777888999999999999999999999
Q ss_pred ecCCCCCeEecCCCCCcEEEeeecccccccCCCCCCCCCCCCCccCCcee----------ccCcCCCeeeEEEeC
Q 028681 141 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL----------LKKEYDGKVMCVYVI 205 (205)
Q Consensus 141 ~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~----------~~~~~~~~~~Dvwsl 205 (205)
|||||+||+++.++. +||+|||+++..... .....| +.|+|||++ .+..++.+ +|||||
T Consensus 235 rDiKp~NILl~~~~~--~kL~DFG~a~~~~~~--~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~-~DvwSl 303 (413)
T 3dzo_A 235 TYLRPVDIVLDQRGG--VFLTGFEHLVRDGAS--AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFA-FDTWTL 303 (413)
T ss_dssp SCCCGGGEEECTTCC--EEECCGGGCEETTEE--ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHH-HHHHHH
T ss_pred CCcccceEEEecCCe--EEEEeccceeecCCc--cccCCC-CceeCchhhhccccccccccCcCCCch-hhHHHH
Confidence 999999999998888 999999998765433 344567 999999999 45556655 999996
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.3e-30 Score=210.14 Aligned_cols=165 Identities=20% Similarity=0.111 Sum_probs=126.1
Q ss_pred EEeeeccccceeEEEEEecCCCcEEEEEEeecCccc---------hHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEE
Q 028681 25 LVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI---------DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV 95 (205)
Q Consensus 25 ~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~---------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 95 (205)
..+.||+|+||.||++.. .+..+++|........ .+++.+|+.++++++||||+++..++...+..+++
T Consensus 340 ~~~~LG~G~fg~Vy~~~~--~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV 417 (540)
T 3en9_A 340 PEHLIGKGAEADIKRDSY--LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM 417 (540)
T ss_dssp --------CCEEEEEEEC--SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred CCCEEeeCCCEEEEEEEE--CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence 356899999999999943 4677888876542211 23478999999999999999655566677778999
Q ss_pred EEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCCCCC
Q 028681 96 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 175 (205)
Q Consensus 96 ~~~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~~ 175 (205)
|||+++++|.+.+.. ...++.|++.||.|||+++|+||||||+||+++. . +||+|||+++........
T Consensus 418 mE~~~ggsL~~~l~~--------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--~--~kL~DFGla~~~~~~~~~ 485 (540)
T 3en9_A 418 MSYINGKLAKDVIED--------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--D--LYIIDFGLGKISNLDEDK 485 (540)
T ss_dssp EECCCSEEHHHHSTT--------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS--S--EEECCCTTCEECCCHHHH
T ss_pred EECCCCCCHHHHHHH--------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC--e--EEEEECccCEECCCcccc
Confidence 999999999998865 6689999999999999999999999999999987 4 999999999866543221
Q ss_pred --------CCCCCCCCccCCceecc--CcCCCeeeEEEe
Q 028681 176 --------KSTVGTPAYIAPEVLLK--KEYDGKVMCVYV 204 (205)
Q Consensus 176 --------~~~~~~~~~~aPE~~~~--~~~~~~~~Dvws 204 (205)
....||+.|+|||++.. ..|+.. +|+||
T Consensus 486 ~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~-~d~ws 523 (540)
T 3en9_A 486 AVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSV-YDRWE 523 (540)
T ss_dssp HHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHH-CTTHH
T ss_pred ccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHH-HhHHH
Confidence 23468999999999987 555544 68876
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.9e-26 Score=171.87 Aligned_cols=142 Identities=18% Similarity=0.174 Sum_probs=112.8
Q ss_pred EEEeeeccccceeEEEEEecCCCcEEEEEEeecCcc-------------------chHHHHHHHHHHHhcCCCCeeEEEE
Q 028681 24 ELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK-------------------IDENVQREIINHRSLRHPNIVRFKE 84 (205)
Q Consensus 24 ~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~-------------------~~~~~~~e~~~l~~l~h~~i~~~~~ 84 (205)
++.+.||+|++|.||.+.+ .++..||+|.+..... ....+..|+.+++.++| +++.+
T Consensus 93 ~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~~---~~v~~ 168 (282)
T 1zar_A 93 AIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQG---LAVPK 168 (282)
T ss_dssp EEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTT---SSSCC
T ss_pred EecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhccC---CCcCe
Confidence 3449999999999999999 7799999999865321 23568899999999984 55555
Q ss_pred EEEeCCeEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeec
Q 028681 85 VILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFG 164 (205)
Q Consensus 85 ~~~~~~~~~lv~~~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~ 164 (205)
++.. +..++||||+++++|.+ +.. .....++.|++.|+.+||++||+|+||+|+||+++ ++. ++|+|||
T Consensus 169 ~~~~-~~~~lvmE~~~g~~L~~-l~~------~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~~--vkl~DFG 237 (282)
T 1zar_A 169 VYAW-EGNAVLMELIDAKELYR-VRV------ENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EEG--IWIIDFP 237 (282)
T ss_dssp EEEE-ETTEEEEECCCCEEGGG-CCC------SCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TTE--EEECCCT
T ss_pred EEec-cceEEEEEecCCCcHHH-cch------hhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CCc--EEEEECC
Confidence 4433 45689999999999987 421 23457999999999999999999999999999998 655 9999999
Q ss_pred ccccccCCCCCCCCCCCCCccCCceecc
Q 028681 165 YSKSSVLHSQPKSTVGTPAYIAPEVLLK 192 (205)
Q Consensus 165 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~ 192 (205)
+|+. +..+.|||.+.+
T Consensus 238 ~a~~------------~~~~~a~e~l~r 253 (282)
T 1zar_A 238 QSVE------------VGEEGWREILER 253 (282)
T ss_dssp TCEE------------TTSTTHHHHHHH
T ss_pred CCeE------------CCCCCHHHHHHH
Confidence 9863 234678888864
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=2.1e-23 Score=153.65 Aligned_cols=138 Identities=14% Similarity=0.083 Sum_probs=106.9
Q ss_pred CCeEEEeeeccccceeEEEEEecCCCcE--EEEEEeecCccc-------------------------hHHHHHHHHHHHh
Q 028681 21 DRYELVRDIGSGNFGVARLMRDKKTEEL--VAVKYIERGDKI-------------------------DENVQREIINHRS 73 (205)
Q Consensus 21 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~--v~iK~~~~~~~~-------------------------~~~~~~e~~~l~~ 73 (205)
.-|++.+.||+|++|.||.+.+..+|.. ||+|+++..... ...+..|+..+..
T Consensus 47 ~~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 126 (258)
T 1zth_A 47 YITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLER 126 (258)
T ss_dssp SEEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHH
T ss_pred CchhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHH
Confidence 4478999999999999999999777888 999987543211 1357889999999
Q ss_pred cCCCCe--eEEEEEEEeCCeEEEEEEecCC-C----chHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH-hcCcEeecCCC
Q 028681 74 LRHPNI--VRFKEVILTPTHLAIVMEYASG-G----ELFERICNAGRFSEDEARFFFQQLISGVSYCH-SMQVCHRDLKL 145 (205)
Q Consensus 74 l~h~~i--~~~~~~~~~~~~~~lv~~~~~~-~----sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh-~~~i~H~di~p 145 (205)
+.|+++ +.+++. ...++||||+.+ + +|.+.... .++..+..++.|++.++.+|| ++||+||||+|
T Consensus 127 l~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp 199 (258)
T 1zth_A 127 AKEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE---LKELDVEGIFNDVVENVKRLYQEAELVHADLSE 199 (258)
T ss_dssp HHHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG---GGGSCHHHHHHHHHHHHHHHHHTSCEECSSCST
T ss_pred HHhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc---cChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCH
Confidence 987753 334332 346799999942 2 56555432 235567889999999999999 99999999999
Q ss_pred CCeEecCCCCCcEEEeeecccccc
Q 028681 146 ENTLLDGSPAPRLKICDFGYSKSS 169 (205)
Q Consensus 146 ~nili~~~~~~~~~l~df~~~~~~ 169 (205)
+||+++. . ++|+|||+|...
T Consensus 200 ~NILl~~--~--~~liDFG~a~~~ 219 (258)
T 1zth_A 200 YNIMYID--K--VYFIDMGQAVTL 219 (258)
T ss_dssp TSEEESS--S--EEECCCTTCEET
T ss_pred HHEEEcC--c--EEEEECcccccC
Confidence 9999986 4 999999998644
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.81 E-value=1.2e-19 Score=139.37 Aligned_cols=136 Identities=15% Similarity=0.118 Sum_probs=99.1
Q ss_pred CCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCccc---------------h--------HHHHHHHHHHHhcCCC
Q 028681 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI---------------D--------ENVQREIINHRSLRHP 77 (205)
Q Consensus 21 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~---------------~--------~~~~~e~~~l~~l~h~ 77 (205)
.-|++.++||+|++|.||.|.+. +|+.||+|+++..... . -....|...+.++.+.
T Consensus 95 ~iY~I~~~IG~Gk~a~VY~a~d~-~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~ 173 (397)
T 4gyi_A 95 DVYSVGSRIGVGKESDIMIVADE-KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEE 173 (397)
T ss_dssp SCSEEEEEEEECSSEEEEEEECT-TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHT
T ss_pred CEEEecCEeeeCCceEEEEEECC-CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhc
Confidence 34899999999999999999985 5889999987542110 0 0123567777777554
Q ss_pred Cee--EEEEEEEeCCeEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCC
Q 028681 78 NIV--RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPA 155 (205)
Q Consensus 78 ~i~--~~~~~~~~~~~~~lv~~~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~ 155 (205)
++. ..++. . ..++||||+++.+|..... ......++.|++.++.+||++||+||||||.|||+++++.
T Consensus 174 gv~vp~p~~~--~--~~~LVME~i~G~~L~~l~~------~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd 243 (397)
T 4gyi_A 174 GFPVPEPIAQ--S--RHTIVMSLVDALPMRQVSS------VPDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKD 243 (397)
T ss_dssp TCSCCCEEEE--E--TTEEEEECCSCEEGGGCCC------CSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEEC
T ss_pred CCCCCeeeec--c--CceEEEEecCCccHhhhcc------cHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCC
Confidence 432 22221 2 2369999999888754331 1234678899999999999999999999999999987653
Q ss_pred C--------cEEEeeecccc
Q 028681 156 P--------RLKICDFGYSK 167 (205)
Q Consensus 156 ~--------~~~l~df~~~~ 167 (205)
. .+.|+||+.+.
T Consensus 244 ~~d~~~~~~~~~iID~~Q~V 263 (397)
T 4gyi_A 244 AEDPSSITLTPIIIXFPQMV 263 (397)
T ss_dssp SSCTTSEEEEEEECCCTTCE
T ss_pred cccccccccceEEEEeCCcc
Confidence 2 37899999775
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.59 E-value=1.2e-14 Score=107.04 Aligned_cols=140 Identities=16% Similarity=0.122 Sum_probs=109.8
Q ss_pred CCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCc-cchHHHHHHHHHHHhcC-CCCeeEEEEEEEeCCeEEEEEE
Q 028681 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD-KIDENVQREIINHRSLR-HPNIVRFKEVILTPTHLAIVME 97 (205)
Q Consensus 20 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~~ 97 (205)
.+.|++...++.++.+.||.+... +..+++|+..... .....+..|..+++.+. +..+.++++++...+..+++|+
T Consensus 13 l~~~~~~~~~~g~s~~~v~~~~~~--~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e 90 (263)
T 3tm0_A 13 IEKYRCVKDTEGMSPAKVYKLVGE--NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMS 90 (263)
T ss_dssp HTTSEEEECCSCCSSSEEEEEECS--SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEE
T ss_pred hccceeEeeccCCCCCeEEEEECC--CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEE
Confidence 467999999998999999999754 5789999887532 22346888999998885 5667889998888889999999
Q ss_pred ecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh------------------------------------------
Q 028681 98 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS------------------------------------------ 135 (205)
Q Consensus 98 ~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~------------------------------------------ 135 (205)
+++|.++.+... +......++.++..++..||+
T Consensus 91 ~i~G~~l~~~~~-----~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (263)
T 3tm0_A 91 EADGVLCSEEYE-----DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFK 165 (263)
T ss_dssp CCSSEEHHHHCC-----TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSS
T ss_pred ecCCeehhhccC-----CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCC
Confidence 999998876531 122344678889999999998
Q ss_pred -----------------cCcEeecCCCCCeEecCCCCCcEEEeeeccccc
Q 028681 136 -----------------MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 168 (205)
Q Consensus 136 -----------------~~i~H~di~p~nili~~~~~~~~~l~df~~~~~ 168 (205)
..++|+|++|.||+++++.. +.|+||+.+..
T Consensus 166 ~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~--~~lIDwe~a~~ 213 (263)
T 3tm0_A 166 DPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKV--SGFIDLGRSGR 213 (263)
T ss_dssp SHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEE--EEECCCTTCEE
T ss_pred CHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcE--EEEEEchhccc
Confidence 45899999999999975432 56999997743
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.47 E-value=7.5e-13 Score=97.03 Aligned_cols=138 Identities=13% Similarity=0.104 Sum_probs=98.6
Q ss_pred cCCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCccchHHHHHHHHHHHhcCCCC--eeEEEEEEEeCCeEEEEE
Q 028681 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPN--IVRFKEVILTPTHLAIVM 96 (205)
Q Consensus 19 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~--i~~~~~~~~~~~~~~lv~ 96 (205)
....+.+....+.|..+.||.+.. .+|..+++|+.... ....+..|+..++.+.+.+ +.+++++...++..+++|
T Consensus 18 ~~~~~~~~~~~~gg~~~~v~~~~~-~~g~~~vlK~~~~~--~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~ 94 (264)
T 1nd4_A 18 RLFGYDWAQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSG--ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLL 94 (264)
T ss_dssp TTTTCEEEECSCTTSSCEEEEEEC-TTSCCEEEEEECSC--TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEE
T ss_pred hcCCCceEecccCCCCceEEEEec-CCCCeEEEEeCCcc--cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEE
Confidence 345677765555666789999965 44667999987654 3355778888888886544 456888888878899999
Q ss_pred EecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcC---------------------------------------
Q 028681 97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ--------------------------------------- 137 (205)
Q Consensus 97 ~~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~--------------------------------------- 137 (205)
+++++.++. .. ..+ ...++.++...+..||+..
T Consensus 95 e~i~G~~l~--~~---~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (264)
T 1nd4_A 95 GEVPGQDLL--SS---HLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLA 166 (264)
T ss_dssp ECCSSEETT--TS---CCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCC
T ss_pred EecCCcccC--cC---cCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCcc
Confidence 999998873 21 122 1245666666677776533
Q ss_pred -------------------cEeecCCCCCeEecCCCCCcEEEeeecccccc
Q 028681 138 -------------------VCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 169 (205)
Q Consensus 138 -------------------i~H~di~p~nili~~~~~~~~~l~df~~~~~~ 169 (205)
++|+|++|.||+++++.. +.|+||+.+...
T Consensus 167 ~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~--~~liD~~~a~~g 215 (264)
T 1nd4_A 167 PAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRF--SGFIDCGRLGVA 215 (264)
T ss_dssp HHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEE--EEECCCTTCEEE
T ss_pred HHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcE--EEEEcchhcccC
Confidence 999999999999976543 569999987543
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.40 E-value=2.1e-12 Score=99.23 Aligned_cols=142 Identities=14% Similarity=0.199 Sum_probs=105.0
Q ss_pred eEEEeeeccccceeEEEEEecCCCcEEEEEEee--cCc--cchHHHHHHHHHHHhcCC--CCeeEEEEEEEeC---CeEE
Q 028681 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIE--RGD--KIDENVQREIINHRSLRH--PNIVRFKEVILTP---THLA 93 (205)
Q Consensus 23 y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~--~~~--~~~~~~~~e~~~l~~l~h--~~i~~~~~~~~~~---~~~~ 93 (205)
....+.++.|.++.+|.+... +..+++|+.. .+. .....+..|..+++.+.. ..+++++.++.+. +..+
T Consensus 40 ~~~~~~l~~G~sn~~y~v~~~--~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~ 117 (359)
T 3dxp_A 40 PLSVEQFKGGQSNPTFKLVTP--GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAF 117 (359)
T ss_dssp CCEEEECCC-CCSCEEEEECS--SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCE
T ss_pred CceEEEcCCcccceEEEEEEC--CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeE
Confidence 345778899999999998765 3578888776 433 224567889999998874 4577888887766 4578
Q ss_pred EEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh--------------------------------------
Q 028681 94 IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS-------------------------------------- 135 (205)
Q Consensus 94 lv~~~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~-------------------------------------- 135 (205)
++|+++++..+.+.. ...++......++.++..+|..||+
T Consensus 118 ~vme~v~G~~l~~~~--~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (359)
T 3dxp_A 118 YIMEFVSGRVLWDQS--LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIP 195 (359)
T ss_dssp EEEECCCCBCCCCTT--CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCH
T ss_pred EEEEecCCeecCCCc--cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCCh
Confidence 999999987774321 1237788888899999999999996
Q ss_pred --------------------cCcEeecCCCCCeEecCCCCCcEEEeeeccccc
Q 028681 136 --------------------MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 168 (205)
Q Consensus 136 --------------------~~i~H~di~p~nili~~~~~~~~~l~df~~~~~ 168 (205)
..++|+|++|.||+++.++...+.|+||+.+..
T Consensus 196 ~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 196 AMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 368999999999999876543368999998864
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.97 E-value=2.1e-08 Score=75.30 Aligned_cols=136 Identities=18% Similarity=0.123 Sum_probs=87.1
Q ss_pred EeeeccccceeEEEEEecCCCcEEEEEEeecCccchHHHHHHHHHHHhcCCC---CeeEEEEEEE-eCCeEEEEEEecCC
Q 028681 26 VRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHP---NIVRFKEVIL-TPTHLAIVMEYASG 101 (205)
Q Consensus 26 ~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~---~i~~~~~~~~-~~~~~~lv~~~~~~ 101 (205)
.+.++.|....+|.+ +..+++|+. ........+..|...++.+.+. .+.+++.+.. ..+..+++|++++|
T Consensus 24 v~~l~~G~~n~v~~v-----g~~~VlR~~-~~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G 97 (306)
T 3tdw_A 24 VESLGEGFRNYAILV-----NGDWVFRFP-KSQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG 97 (306)
T ss_dssp EEEEEECSSEEEEEE-----TTTEEEEEE-SSHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred eeecCCCcceeEEEE-----CCEEEEEec-CCchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence 455777888888888 355888874 3333456788999999998642 2455666554 34567899999998
Q ss_pred CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh----------------------------------------------
Q 028681 102 GELFERICNAGRFSEDEARFFFQQLISGVSYCHS---------------------------------------------- 135 (205)
Q Consensus 102 ~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~---------------------------------------------- 135 (205)
.++...... .++......++.++...+..||+
T Consensus 98 ~~l~~~~~~--~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~ 175 (306)
T 3tdw_A 98 QILGEDGMA--VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTLR 175 (306)
T ss_dssp EECHHHHHT--TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHHH
T ss_pred eECchhhhh--hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHHHH
Confidence 877653211 12333333333333333333332
Q ss_pred --------------cCcEeecCCCCCeEecC---CCCCcEEEeeeccccccc
Q 028681 136 --------------MQVCHRDLKLENTLLDG---SPAPRLKICDFGYSKSSV 170 (205)
Q Consensus 136 --------------~~i~H~di~p~nili~~---~~~~~~~l~df~~~~~~~ 170 (205)
..++|+|++|.||+++. ++. .+.|+||+.+....
T Consensus 176 ~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~-~~~~iD~~~a~~gd 226 (306)
T 3tdw_A 176 FQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTP-LTGIIDFGDAAISD 226 (306)
T ss_dssp HHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCC-EEEECCCTTCEEEC
T ss_pred HHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCc-eEEEEehhhcCCCC
Confidence 24699999999999986 232 24899999876543
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.95 E-value=2.6e-09 Score=80.12 Aligned_cols=137 Identities=18% Similarity=0.122 Sum_probs=94.7
Q ss_pred EeeeccccceeEEEEEecCCCcEEEEEEeecCccchHHHHHHHHHHHhcC-CCC--eeEEEEEEEeCC---eEEEEEEec
Q 028681 26 VRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLR-HPN--IVRFKEVILTPT---HLAIVMEYA 99 (205)
Q Consensus 26 ~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~-h~~--i~~~~~~~~~~~---~~~lv~~~~ 99 (205)
.+.++.|....+|.+. ..+++|+... ......+..|...++.+. +.. +..++....... ..|+||+++
T Consensus 25 i~~~~~G~~n~v~~v~-----~~~vlR~~~~-~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i 98 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN-----RDFIFKFPKH-SRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI 98 (304)
T ss_dssp CCEEEECSSEEEEEST-----TSEEEEEESS-HHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred eEecCCCCcceEEEEC-----CEEEEEecCC-cchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence 3458889999988874 3488887543 334567888999998873 322 344444433333 347889999
Q ss_pred CCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh--------------------------------------------
Q 028681 100 SGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS-------------------------------------------- 135 (205)
Q Consensus 100 ~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~-------------------------------------------- 135 (205)
+|.++...... .++..+...++.++...+..||+
T Consensus 99 ~G~~l~~~~~~--~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 176 (304)
T 3sg8_A 99 KGVPLTPLLLN--NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDDF 176 (304)
T ss_dssp CCEECCHHHHH--TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHHH
T ss_pred CCeECCccccc--cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHHH
Confidence 99888654322 36777777777777777777775
Q ss_pred --------------cCcEeecCCCCCeEecCCCCCcEEEeeeccccccc
Q 028681 136 --------------MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 170 (205)
Q Consensus 136 --------------~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~ 170 (205)
..++|+|++|.||+++.+....+.|+||+.+....
T Consensus 177 ~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~ 225 (304)
T 3sg8_A 177 YRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISD 225 (304)
T ss_dssp HHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEEC
T ss_pred HHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCC
Confidence 24799999999999987422237899999876543
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.94 E-value=3.7e-08 Score=72.46 Aligned_cols=133 Identities=19% Similarity=0.205 Sum_probs=89.3
Q ss_pred eccccce-eEEEEEecCCCcEEEEEEeecCccchHHHHHHHHHHHhcC-CCCeeEEEEEEEeCCeEEEEEEecCCCchHH
Q 028681 29 IGSGNFG-VARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLR-HPNIVRFKEVILTPTHLAIVMEYASGGELFE 106 (205)
Q Consensus 29 l~~g~~g-~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~~~~~~~sl~~ 106 (205)
+..|..+ .||+......+..+++|+-... ....+..|...++.+. +--+.+++.++.+++..+++|+++++.++.+
T Consensus 32 ~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~--~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~~~ 109 (272)
T 4gkh_A 32 DNVGQSGATIYRLYGKPNAPELFLKHGKGS--VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAFQ 109 (272)
T ss_dssp EECSSSSCEEEEEECCTTCCCEEEEEEETH--HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEHHH
T ss_pred ccCCCcCCeEEEEEecCCCeEEEEEECCCC--CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccccc
Confidence 4445444 6899888777788999976643 3456778888888774 2236678888888999999999999877765
Q ss_pred HHHhcCCCCHHHHHHHHHHHHHHHHHHHh---------------------------------------------------
Q 028681 107 RICNAGRFSEDEARFFFQQLISGVSYCHS--------------------------------------------------- 135 (205)
Q Consensus 107 ~~~~~~~~~~~~~~~i~~~i~~~l~~lh~--------------------------------------------------- 135 (205)
..... ......+..++...+..||.
T Consensus 110 ~~~~~----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 185 (272)
T 4gkh_A 110 VLEEY----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKEMHK 185 (272)
T ss_dssp HHHHC----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHHHHT
T ss_pred cccCC----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHHHHHh
Confidence 44321 11112233333333333332
Q ss_pred -------cCcEeecCCCCCeEecCCCCCcEEEeeecccccc
Q 028681 136 -------MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 169 (205)
Q Consensus 136 -------~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~ 169 (205)
..++|+|+++.||+++.++. +-|+||+.+...
T Consensus 186 ~~~~~~~~~l~HGDl~~~Nil~~~~~~--~~viDwe~a~~g 224 (272)
T 4gkh_A 186 LLPFSPDSVVTHGDFSLDNLIFDEGKL--IGCIDVGRVGIA 224 (272)
T ss_dssp TCCCCCCEEEECSCCCTTSEEEETTEE--EEECCCTTCEEE
T ss_pred cccccCCcEEEcCCCCCCeEEEECCeE--EEEEECcccccC
Confidence 12789999999999986543 679999987543
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.65 E-value=2.5e-07 Score=71.84 Aligned_cols=76 Identities=17% Similarity=0.095 Sum_probs=49.0
Q ss_pred EEeeeccccceeEEEEEecCCCcEEEEEEeecCc--------cchHHHHHHHHHHHhcCC--C-CeeEEEEEEEeCCeEE
Q 028681 25 LVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD--------KIDENVQREIINHRSLRH--P-NIVRFKEVILTPTHLA 93 (205)
Q Consensus 25 ~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~--------~~~~~~~~e~~~l~~l~h--~-~i~~~~~~~~~~~~~~ 93 (205)
..+.||.|..+.||++....+++.+++|...... ...+....|...++.+.. + .+.+++.+ +....+
T Consensus 34 ~~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~ 111 (397)
T 2olc_A 34 TCQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAV 111 (397)
T ss_dssp EEEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTE
T ss_pred EEEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccE
Confidence 4678899999999999776567789999765321 123456778888877742 2 34455543 344567
Q ss_pred EEEEecCCC
Q 028681 94 IVMEYASGG 102 (205)
Q Consensus 94 lv~~~~~~~ 102 (205)
++||++++.
T Consensus 112 lvmE~l~g~ 120 (397)
T 2olc_A 112 TVMEDLSHL 120 (397)
T ss_dssp EEECCCTTS
T ss_pred EEEEeCCCc
Confidence 999999763
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.54 E-value=1.4e-07 Score=72.22 Aligned_cols=81 Identities=9% Similarity=0.108 Sum_probs=54.2
Q ss_pred EEEeee-ccccceeEEEEEec---C---CCcEEEEEEeecCc---c-chHHHHHHHHHHHhcCC---CCeeEEEEEEEeC
Q 028681 24 ELVRDI-GSGNFGVARLMRDK---K---TEELVAVKYIERGD---K-IDENVQREIINHRSLRH---PNIVRFKEVILTP 89 (205)
Q Consensus 24 ~~~~~l-~~g~~g~v~~~~~~---~---~~~~v~iK~~~~~~---~-~~~~~~~e~~~l~~l~h---~~i~~~~~~~~~~ 89 (205)
...+.| +.|....+|.+... . ++..+++|...... . ....+..|...++.+.. -.+.+++.+..+.
T Consensus 23 ~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~ 102 (357)
T 3ats_A 23 TVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTG 102 (357)
T ss_dssp EEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSS
T ss_pred EEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCC
Confidence 445777 78888899988754 1 15578889765433 1 23557778888877742 3466677776554
Q ss_pred ---CeEEEEEEecCCCch
Q 028681 90 ---THLAIVMEYASGGEL 104 (205)
Q Consensus 90 ---~~~~lv~~~~~~~sl 104 (205)
+..+++|+++++.++
T Consensus 103 ~~~g~~~~v~e~l~G~~l 120 (357)
T 3ats_A 103 DVLGTPFFLMDYVEGVVP 120 (357)
T ss_dssp TTTSSCEEEEECCCCBCC
T ss_pred CccCCceEEEEecCCCCh
Confidence 346789999987654
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.48 E-value=2.4e-06 Score=64.67 Aligned_cols=74 Identities=18% Similarity=0.242 Sum_probs=41.2
Q ss_pred EeeeccccceeEEEEEecCCCcEEEEEEeecCccchHHHHHHHHHHHhcC-----CCCeeEEE-E--EEEeCCeEEEEEE
Q 028681 26 VRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLR-----HPNIVRFK-E--VILTPTHLAIVME 97 (205)
Q Consensus 26 ~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~-----h~~i~~~~-~--~~~~~~~~~lv~~ 97 (205)
.+.|+.|....+|.+.... ..+++|..... .+.+..|...++.+. .|.++... | +....+..+++++
T Consensus 37 ~~~l~gG~~n~~~~v~~~~--~~~vlk~~~~~---~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~ 111 (346)
T 2q83_A 37 IDVIQGNQMALVWKVHTDS--GAVCLKRIHRP---EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYD 111 (346)
T ss_dssp EEECC----CEEEEEEETT--EEEEEEEECSC---HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEE
T ss_pred eeeccccccCcEEEEEeCC--CCEEEEecCCC---HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEE
Confidence 4556666788999987643 35899988753 233444555555543 23333210 1 1234667899999
Q ss_pred ecCCCch
Q 028681 98 YASGGEL 104 (205)
Q Consensus 98 ~~~~~sl 104 (205)
++++.++
T Consensus 112 ~i~G~~~ 118 (346)
T 2q83_A 112 WIEGRPF 118 (346)
T ss_dssp CCCCBCC
T ss_pred eecCccC
Confidence 9987543
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=98.25 E-value=1.8e-06 Score=64.54 Aligned_cols=71 Identities=13% Similarity=0.113 Sum_probs=43.4
Q ss_pred EeeeccccceeEEEEEecCCCcEEEEEEeecCccchHHHHHHHHHHHhcCCCCe-eEEEEEEEeCCeEEEEEEec-CCCc
Q 028681 26 VRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNI-VRFKEVILTPTHLAIVMEYA-SGGE 103 (205)
Q Consensus 26 ~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i-~~~~~~~~~~~~~~lv~~~~-~~~s 103 (205)
.+.|+.|-...+|.+ ..+++|+.............|...++.+...++ .+++.. ++...+++++|+ ++.+
T Consensus 23 i~~l~gG~tN~~~~~------~~~vlR~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~g~~ 94 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA------GDLCLRIPGKGTEEYINRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAGAQT 94 (301)
T ss_dssp CEEEESCSSEEEEEE------TTEEEEEECC----CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTTCEE
T ss_pred eeEcCCcccccccee------eeEEEECCCCCccceeCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCCCcc
Confidence 678888888999998 348899877643322233567777766643222 345443 333456889999 6654
Q ss_pred h
Q 028681 104 L 104 (205)
Q Consensus 104 l 104 (205)
+
T Consensus 95 l 95 (301)
T 3dxq_A 95 M 95 (301)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=98.03 E-value=3.7e-05 Score=60.11 Aligned_cols=34 Identities=15% Similarity=0.216 Sum_probs=27.7
Q ss_pred HhcCcEeecCCCCCeEecCCCCCcEEEeeeccccccc
Q 028681 134 HSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 170 (205)
Q Consensus 134 h~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~ 170 (205)
+...++|||++|.||+++.++ +.++||+.+...+
T Consensus 230 ~~~~liHGDl~~~Nil~~~~~---~~lID~e~a~~G~ 263 (420)
T 2pyw_A 230 RAQALIHGDLHTGSVMVTQDS---TQVIDPEFSFYGP 263 (420)
T ss_dssp BCCEEECSCCSGGGEEECSSC---EEECCCTTCEEEC
T ss_pred CCCeEEecCCCCCcEEEeCCC---CEEEeCcccccCc
Confidence 456899999999999997654 8999998775443
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=98.01 E-value=2.9e-05 Score=59.85 Aligned_cols=143 Identities=16% Similarity=0.160 Sum_probs=81.6
Q ss_pred CCeEEEeeeccccceeEEEEEecC-------CCcEEEEEEeecCccchHHHHHHHHHHHhcCCCC-eeEEEEEEEeCCeE
Q 028681 21 DRYELVRDIGSGNFGVARLMRDKK-------TEELVAVKYIERGDKIDENVQREIINHRSLRHPN-IVRFKEVILTPTHL 92 (205)
Q Consensus 21 ~~y~~~~~l~~g~~g~v~~~~~~~-------~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~-i~~~~~~~~~~~~~ 92 (205)
+..+ .+.+..|-...+|++.... .+..+++|+.............|..+++.+...+ ..++++.+.+
T Consensus 51 ~~l~-v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~---- 125 (379)
T 3feg_A 51 EELR-VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAILQGVDSLVLESVMFAILAERSLGPQLYGVFPE---- 125 (379)
T ss_dssp GGCC-CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC---CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----
T ss_pred CceE-EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCccchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----
Confidence 3444 3456667777888887642 3578999987554334566778888888775322 2455555432
Q ss_pred EEEEEecCCCchH--------------HHHH---h-c----CCCC--HHHHHHHHHHHHH-------------------H
Q 028681 93 AIVMEYASGGELF--------------ERIC---N-A----GRFS--EDEARFFFQQLIS-------------------G 129 (205)
Q Consensus 93 ~lv~~~~~~~sl~--------------~~~~---~-~----~~~~--~~~~~~i~~~i~~-------------------~ 129 (205)
.++++|+++.++. +.++ . . ++.. ..++..+..++-. .
T Consensus 126 g~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~ 205 (379)
T 3feg_A 126 GRLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDE 205 (379)
T ss_dssp EEEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHH
T ss_pred ccEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHH
Confidence 2899999875442 1111 1 1 1122 3455555544422 1
Q ss_pred HHHH----Hh----cCcEeecCCCCCeEecCCC--CCcEEEeeeccccc
Q 028681 130 VSYC----HS----MQVCHRDLKLENTLLDGSP--APRLKICDFGYSKS 168 (205)
Q Consensus 130 l~~l----h~----~~i~H~di~p~nili~~~~--~~~~~l~df~~~~~ 168 (205)
+..| .+ ..++|+|+.+.||+++.+. ...+.++||..+..
T Consensus 206 ~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 206 MGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 2333 22 3689999999999998761 12389999998753
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.89 E-value=9.7e-05 Score=55.61 Aligned_cols=75 Identities=9% Similarity=0.048 Sum_probs=46.9
Q ss_pred eeeccccceeEEEEEecCCCcEEEEEEeecCccchHHHHHHHHHHHhcCCCC--eeEEEEE-----EEeCCeEEEEEEec
Q 028681 27 RDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPN--IVRFKEV-----ILTPTHLAIVMEYA 99 (205)
Q Consensus 27 ~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~--i~~~~~~-----~~~~~~~~lv~~~~ 99 (205)
+.++ |....+|.+... +|..+++|.........+.+..|...++.+.... +++++.. ...++..+++++++
T Consensus 32 ~~l~-g~~n~~y~v~~~-~g~~~vlK~~~~~~~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i 109 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDE-DRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSV 109 (328)
T ss_dssp EEEC-CSSSEEEEECCT-TCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECC
T ss_pred Eeec-CcccceEEEEcC-CCCEEEEEEcCCCCCCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEec
Confidence 3455 777788887653 3556899988754444566777888777774222 2333322 22345678899999
Q ss_pred CCCc
Q 028681 100 SGGE 103 (205)
Q Consensus 100 ~~~s 103 (205)
++.+
T Consensus 110 ~G~~ 113 (328)
T 1zyl_A 110 GGRQ 113 (328)
T ss_dssp CCEE
T ss_pred CCCC
Confidence 7744
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.84 E-value=5.9e-05 Score=59.18 Aligned_cols=74 Identities=12% Similarity=0.119 Sum_probs=48.2
Q ss_pred EEeeeccccceeEEEEEecC-------CCcEEEEEEeecCccchHHHHHHHHHHHhcCCCCe-eEEEEEEEeCCeEEEEE
Q 028681 25 LVRDIGSGNFGVARLMRDKK-------TEELVAVKYIERGDKIDENVQREIINHRSLRHPNI-VRFKEVILTPTHLAIVM 96 (205)
Q Consensus 25 ~~~~l~~g~~g~v~~~~~~~-------~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i-~~~~~~~~~~~~~~lv~ 96 (205)
-.+.|+.|-...+|.+.... .+..+++|+.... ...+.+..|..+++.+...++ .++++.+. + .+++
T Consensus 77 ~v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~-~~~~~li~E~~~l~~L~~~g~~P~l~~~~~--~--g~v~ 151 (429)
T 1nw1_A 77 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP-ETESHLVAESVIFTLLSERHLGPKLYGIFS--G--GRLE 151 (429)
T ss_dssp EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC-CCHHHHHHHHHHHHHHHHTTSSSCEEEEET--T--EEEE
T ss_pred EEEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC-CcHHHHHHHHHHHHHHHhCCCCCcEEEEeC--C--CEEE
Confidence 35667778888999998653 2567899987432 122556678888888754333 45666543 2 2788
Q ss_pred EecCCCc
Q 028681 97 EYASGGE 103 (205)
Q Consensus 97 ~~~~~~s 103 (205)
+|+++.+
T Consensus 152 e~l~G~~ 158 (429)
T 1nw1_A 152 EYIPSRP 158 (429)
T ss_dssp CCCCEEE
T ss_pred EEeCCcc
Confidence 9987643
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.77 E-value=9.4e-05 Score=55.52 Aligned_cols=140 Identities=14% Similarity=0.109 Sum_probs=75.5
Q ss_pred eEEEeeeccccceeEEEEEecCCCcEEEEEEeecCccchHHHHHHHHHHHhcCCCC--eeEEEEE------EEeCCeEEE
Q 028681 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPN--IVRFKEV------ILTPTHLAI 94 (205)
Q Consensus 23 y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~--i~~~~~~------~~~~~~~~l 94 (205)
..-.+.|+.|....+|.+.... + .+++|..... ...+.+..|..+++.+...+ +.+++.. ....+..++
T Consensus 24 ~~~~~~i~~G~~n~~~~v~~~~-g-~~vlk~~~~~-~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~ 100 (322)
T 2ppq_A 24 LTSYKGIAEGVENSNFLLHTTK-D-PLILTLYEKR-VEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAA 100 (322)
T ss_dssp EEEEEEECC---EEEEEEEESS-C-CEEEEEECC----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEE
T ss_pred ceEeeccCCCcccceEEEEeCC-c-cEEEEEeCCC-CCHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEE
Confidence 3446677778888899987643 3 5889987753 22345666777776664222 2222211 123456789
Q ss_pred EEEecCCCchH---------------HHHHhcCC--------CCHHHHHHHH---------------HHHHHHHHHHH--
Q 028681 95 VMEYASGGELF---------------ERICNAGR--------FSEDEARFFF---------------QQLISGVSYCH-- 134 (205)
Q Consensus 95 v~~~~~~~sl~---------------~~~~~~~~--------~~~~~~~~i~---------------~~i~~~l~~lh-- 134 (205)
+++++++..+. .+...... .........+ ..+...+..+.
T Consensus 101 l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~ 180 (322)
T 2ppq_A 101 LISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAH 180 (322)
T ss_dssp EEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHH
T ss_pred EEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhh
Confidence 99999875431 11111111 1111111100 01233344444
Q ss_pred -----hcCcEeecCCCCCeEecCCCCCcEEEeeecccc
Q 028681 135 -----SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 167 (205)
Q Consensus 135 -----~~~i~H~di~p~nili~~~~~~~~~l~df~~~~ 167 (205)
..+++|+|+++.||+++++.. +.|+||+.+.
T Consensus 181 ~~~~~~~~liHgDl~~~Nil~~~~~~--~~lIDf~~a~ 216 (322)
T 2ppq_A 181 WPKDLPAGVIHADLFQDNVFFLGDEL--SGLIDFYFAC 216 (322)
T ss_dssp CCCSSCEEEECSCCCGGGEEEETTEE--EEECCCTTCE
T ss_pred CcccCCcccCCCCCCccCEEEeCCce--EEEecchhcc
Confidence 247999999999999976542 5799998774
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=97.76 E-value=0.00011 Score=56.47 Aligned_cols=75 Identities=13% Similarity=0.018 Sum_probs=43.6
Q ss_pred EEeeeccccceeEEEEEecC--------CCcEEEEEEeecCccchHHHHHHHHHHHhcCCCC-eeEEEEEEEeCCeEEEE
Q 028681 25 LVRDIGSGNFGVARLMRDKK--------TEELVAVKYIERGDKIDENVQREIINHRSLRHPN-IVRFKEVILTPTHLAIV 95 (205)
Q Consensus 25 ~~~~l~~g~~g~v~~~~~~~--------~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~-i~~~~~~~~~~~~~~lv 95 (205)
-.+.++.|....+|.+.... .+..+++|+.............|...++.+...+ ..++++.. ++ +++
T Consensus 37 ~~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~~--~~v 112 (369)
T 3c5i_A 37 RVKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDELYNTISEFEVYKTMSKYKIAPQLLNTF--NG--GRI 112 (369)
T ss_dssp EEEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGGTSCHHHHHHHHHHHHHTTSSCCEEEEE--TT--EEE
T ss_pred EEEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccceecHHHHHHHHHHHHhcCCCCceEEec--CC--cEE
Confidence 34567777778899887653 1257889987654332223456777777775333 34555443 22 678
Q ss_pred EEecCCCc
Q 028681 96 MEYASGGE 103 (205)
Q Consensus 96 ~~~~~~~s 103 (205)
++++++.+
T Consensus 113 ~e~i~G~~ 120 (369)
T 3c5i_A 113 EEWLYGDP 120 (369)
T ss_dssp EECCCSEE
T ss_pred EEEecCCc
Confidence 99998754
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.72 E-value=0.00048 Score=51.98 Aligned_cols=36 Identities=28% Similarity=0.338 Sum_probs=27.6
Q ss_pred hcCcEeecCCCCCeEecCCC--CCcEEEeeeccccccc
Q 028681 135 SMQVCHRDLKLENTLLDGSP--APRLKICDFGYSKSSV 170 (205)
Q Consensus 135 ~~~i~H~di~p~nili~~~~--~~~~~l~df~~~~~~~ 170 (205)
...++|||+++.||+++.+. ...+.|+||+.+...+
T Consensus 182 ~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G~ 219 (333)
T 3csv_A 182 DMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLGH 219 (333)
T ss_dssp CCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEEC
T ss_pred CCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcCC
Confidence 34799999999999997641 1248999999886543
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.53 E-value=0.0026 Score=46.92 Aligned_cols=77 Identities=12% Similarity=0.058 Sum_probs=52.8
Q ss_pred CCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCcc-chHHHHHHHHHHHhcCCC---CeeEEEEEEEeCCeEEEEE
Q 028681 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK-IDENVQREIINHRSLRHP---NIVRFKEVILTPTHLAIVM 96 (205)
Q Consensus 21 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~h~---~i~~~~~~~~~~~~~~lv~ 96 (205)
....-++.+|.|..+.||++... +|+.+++|+...... ....+..|...|+.+... -+++++++ .. .+++|
T Consensus 15 ~~v~~v~~~g~G~~~~vyrv~l~-DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~--~~--~~lv~ 89 (288)
T 3f7w_A 15 REVAAVAERGHSHRWHLYRVELA-DGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW--DD--RTLAM 89 (288)
T ss_dssp CCEEEEEEEEEETTEEEEEEEET-TSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE--ET--TEEEE
T ss_pred CCeEEEEecCCCCCeEEEEEEEC-CCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEec--cC--ceEEE
Confidence 45567888999999999999865 477899997665433 235678898888887421 23444443 22 36788
Q ss_pred EecCCC
Q 028681 97 EYASGG 102 (205)
Q Consensus 97 ~~~~~~ 102 (205)
|++.+.
T Consensus 90 e~l~~~ 95 (288)
T 3f7w_A 90 EWVDER 95 (288)
T ss_dssp ECCCCC
T ss_pred Eeeccc
Confidence 888654
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.45 E-value=0.0018 Score=51.25 Aligned_cols=76 Identities=16% Similarity=0.104 Sum_probs=47.9
Q ss_pred EEeeeccccceeEEEEEecCCCcEEEEEEeecCccchHHHHHHHHHHHhcCCCCe-eEEEEEEEeCCeEEEEEEecCCCc
Q 028681 25 LVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNI-VRFKEVILTPTHLAIVMEYASGGE 103 (205)
Q Consensus 25 ~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i-~~~~~~~~~~~~~~lv~~~~~~~s 103 (205)
-.+.|+.|-...+|.+.....+..+++|+........-....|..+++.+...++ .++++.+ ++ ..+++|+++.+
T Consensus 112 ~i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~idR~~E~~vl~~L~~~gl~P~ll~~~--~~--G~v~e~I~G~~ 187 (458)
T 2qg7_A 112 EFQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEIINREREKKISCILYNKNIAKKIYVFF--TN--GRIEEFMDGYA 187 (458)
T ss_dssp EEEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCSCHHHHHHHHHHHTTSSSBCCEEEEE--TT--EEEEECCCSEE
T ss_pred EEEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhcCHHHHHHHHHHHHhcCCCCCEEEEe--CC--eEEEEeeCCcc
Confidence 3566777888899999876545778999876543222223578888888865444 4566665 23 25999997644
Q ss_pred h
Q 028681 104 L 104 (205)
Q Consensus 104 l 104 (205)
+
T Consensus 188 l 188 (458)
T 2qg7_A 188 L 188 (458)
T ss_dssp C
T ss_pred C
Confidence 3
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=97.37 E-value=0.0049 Score=46.66 Aligned_cols=33 Identities=21% Similarity=0.404 Sum_probs=27.1
Q ss_pred cCcEeecCCCCCeEecCCCCCcEEEeeeccccccc
Q 028681 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 170 (205)
Q Consensus 136 ~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~ 170 (205)
..++|+|+.+.||+++.++. +.|+||+.+....
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~--~~~iD~e~~~~~~ 238 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEES--IYIIDWDEPMLAP 238 (339)
T ss_dssp CEEECSCCCGGGEEECGGGC--EEECCCSSCEEEC
T ss_pred ceeEeCCCCcCCEEEeCCCe--EEEEECCCCeeCC
Confidence 46999999999999986655 8999998775443
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.19 E-value=0.0077 Score=45.09 Aligned_cols=96 Identities=18% Similarity=0.129 Sum_probs=71.1
Q ss_pred EEEeeeccccceeEEEEEecCCCcEEEEEEeecCccchHHHHHHHHHHHhcC---CCCeeEEEEEEEeCCeEEEEEEecC
Q 028681 24 ELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLR---HPNIVRFKEVILTPTHLAIVMEYAS 100 (205)
Q Consensus 24 ~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~~~~~~lv~~~~~ 100 (205)
.-.+.|+.|....+|.+... +..+++|+.... ....+..|...++.+. ...+++++.+...++..+++|++++
T Consensus 39 ~~~~~l~gG~~n~~y~v~~~--~~~~vlK~~~~~--~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~ 114 (312)
T 3jr1_A 39 KHKEKLYSGEMNEIWLINDE--VQTVFVKINERS--YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALN 114 (312)
T ss_dssp CEEEEECCSSSSEEEEEESS--SCEEEEEEEEGG--GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCC
T ss_pred eeeEEeCCccceeeeEEEEC--CCeEEEEeCCcc--cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEecc
Confidence 34677888999999999763 567889977643 3466788888888774 2457778888877788999999998
Q ss_pred CCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcC
Q 028681 101 GGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ 137 (205)
Q Consensus 101 ~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~ 137 (205)
+..+.. ....++...|+.||+.+
T Consensus 115 G~~~~~--------------~~~~~lG~~LA~LH~~~ 137 (312)
T 3jr1_A 115 KSKNKQ--------------SSFTIFAEKIAQLHQIQ 137 (312)
T ss_dssp CCCCCT--------------THHHHHHHHHHHHHHCC
T ss_pred CCCCCc--------------hhHHHHHHHHHHHHcCC
Confidence 865421 24467778888899754
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=97.05 E-value=0.0021 Score=50.32 Aligned_cols=75 Identities=15% Similarity=0.059 Sum_probs=46.5
Q ss_pred EEeeeccccceeEEEEEecCC-------CcEEEEEEeecCccchHHHHHHHHHHHhcCCCC-eeEEEEEEEeCCeEEEEE
Q 028681 25 LVRDIGSGNFGVARLMRDKKT-------EELVAVKYIERGDKIDENVQREIINHRSLRHPN-IVRFKEVILTPTHLAIVM 96 (205)
Q Consensus 25 ~~~~l~~g~~g~v~~~~~~~~-------~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~-i~~~~~~~~~~~~~~lv~ 96 (205)
-++.+..|-...+|++..... +..+++|+........-....|..+++.+...+ ..++++.+ .+ ++++
T Consensus 74 ~v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~idR~~E~~~l~~L~~~gi~P~l~~~~--~~--~~I~ 149 (424)
T 3mes_A 74 EVKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKFYDSKVELDVFRYLSNINIAPNIIADF--PE--GRIE 149 (424)
T ss_dssp EEEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CCCCHHHHHHHHHHHHHTTSSCCEEEEE--TT--EEEE
T ss_pred EEEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchhcCHHHHHHHHHHHHhcCCCCCEEEEc--CC--CEEE
Confidence 345566677778888886521 577999987654433223456777777774322 34455433 22 6889
Q ss_pred EecCCCc
Q 028681 97 EYASGGE 103 (205)
Q Consensus 97 ~~~~~~s 103 (205)
+|+++.+
T Consensus 150 efI~G~~ 156 (424)
T 3mes_A 150 EFIDGEP 156 (424)
T ss_dssp ECCCSEE
T ss_pred EEeCCcc
Confidence 9998755
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=96.03 E-value=0.044 Score=42.44 Aligned_cols=32 Identities=34% Similarity=0.514 Sum_probs=24.5
Q ss_pred CcEeecCCCCCeEecCC----CCCcEEEeeeccccc
Q 028681 137 QVCHRDLKLENTLLDGS----PAPRLKICDFGYSKS 168 (205)
Q Consensus 137 ~i~H~di~p~nili~~~----~~~~~~l~df~~~~~ 168 (205)
.++|+|+.+.||++..+ ....+.++||..|..
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 47899999999999431 223499999998853
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=93.88 E-value=0.47 Score=33.39 Aligned_cols=87 Identities=14% Similarity=0.027 Sum_probs=59.8
Q ss_pred CCCCeeEEEEEEEeCCeEEEEEEecCC-CchHHHHHhcCCCCHHHHHHHHHHHHHHHH-HHHhcCcEeecCCCCCeEecC
Q 028681 75 RHPNIVRFKEVILTPTHLAIVMEYASG-GELFERICNAGRFSEDEARFFFQQLISGVS-YCHSMQVCHRDLKLENTLLDG 152 (205)
Q Consensus 75 ~h~~i~~~~~~~~~~~~~~lv~~~~~~-~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~-~lh~~~i~H~di~p~nili~~ 152 (205)
.||++ + ..+-.+++.+.+.++.-+. .++. .+.. .+....+.++.+++.... ++ ..-.|--++|+||+++.
T Consensus 48 ~~~~f-~-~~I~~~eD~~~i~y~~~~~~~~f~-~i~~---~~~~eKlrll~nl~~L~~~~~--~~r~tf~l~P~NL~f~~ 119 (219)
T 4ano_A 48 VDPCI-V-RDIDVSEDEVKVVIKPPSSFLTFA-AIRK---TTLLSRIRAAIHLVSKVKHHS--ARRLIFIVCPENLMFNR 119 (219)
T ss_dssp SCSSS-E-EEEEECSSEEEEEEECCTTCEEHH-HHHT---SCHHHHHHHHHHHHHHHSSCC--SSSEECCCCGGGEEECT
T ss_pred cCCCC-C-eEEEEeCCEEEEEEEcCcccCcHH-HHHh---cCHHHHHHHHHHHHHHHHHhh--hCceeEEEeCceEEEeC
Confidence 57888 3 3444666777777776533 3343 3333 778888888888877555 33 45578899999999998
Q ss_pred CCCCcEEEeeecccccccC
Q 028681 153 SPAPRLKICDFGYSKSSVL 171 (205)
Q Consensus 153 ~~~~~~~l~df~~~~~~~~ 171 (205)
+.. +++.-.|+-...+|
T Consensus 120 ~~~--p~i~hRGi~~~lpP 136 (219)
T 4ano_A 120 ALE--PFFLHVGVKESLPP 136 (219)
T ss_dssp TCC--EEESCCEETTTBSS
T ss_pred CCc--EEEEEcCCcccCCC
Confidence 888 88887776544433
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=93.02 E-value=0.41 Score=33.57 Aligned_cols=89 Identities=9% Similarity=0.004 Sum_probs=61.5
Q ss_pred CCCCeeEEEEEEEeCCeEEEEEEecC-CCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCC
Q 028681 75 RHPNIVRFKEVILTPTHLAIVMEYAS-GGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGS 153 (205)
Q Consensus 75 ~h~~i~~~~~~~~~~~~~~lv~~~~~-~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~ 153 (205)
.+|+++++ .+-.+.+.+.+.++.-+ ..++.. +.+ .+....+.++.+|+....++ ..-+|--++|+|++++.+
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~-ik~---~~~~eKlr~l~ni~~l~~~~--~~r~tf~L~P~NL~f~~~ 115 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDN-IKS---FTKNEKLRYLLNIKNLEEVN--RTRYTFVLAPDELFFTRD 115 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGG-GGG---SCHHHHHHHHHHGGGGGGGG--GSSEECCCSGGGEEECTT
T ss_pred cCCcccce-EEEEcccEEEEEEEcCcccCCHHH-HHh---cCHHHHHHHHHHHHHHHHHh--cCceEEEEecceEEEcCC
Confidence 58888877 45566666666666544 334433 333 67888888888888776433 334688999999999988
Q ss_pred CCCcEEEeeecccccccCC
Q 028681 154 PAPRLKICDFGYSKSSVLH 172 (205)
Q Consensus 154 ~~~~~~l~df~~~~~~~~~ 172 (205)
.. +++.-.|+-...+|.
T Consensus 116 ~~--p~i~~RGik~~l~P~ 132 (215)
T 4ann_A 116 GL--PIAKTRGLQNVVDPL 132 (215)
T ss_dssp SC--EEESCCEETTTBSCC
T ss_pred CC--EEEEEccCccCCCCC
Confidence 88 888877765444433
|
| >1cja_A Protein (actin-fragmin kinase); transferase; HET: AMP; 2.90A {Physarum polycephalum} SCOP: d.144.1.3 | Back alignment and structure |
|---|
Probab=91.14 E-value=1.9 Score=32.48 Aligned_cols=140 Identities=12% Similarity=0.078 Sum_probs=76.3
Q ss_pred CeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCccchHHHHHHHHHHHhcCCCCeeEEEEE----------------
Q 028681 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEV---------------- 85 (205)
Q Consensus 22 ~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~---------------- 85 (205)
+++.++...+|..|.++... ++..+++|.. .....|.+-.++...-.++.|+..-+...
T Consensus 70 ~v~~I~~s~~Gstgvff~~t---d~~~~VVK~s--~~l~~E~l~s~LA~~LGlpiP~~Riv~~~~~E~~e~~~~L~~~~~ 144 (342)
T 1cja_A 70 QFKGIERSEKGTEGLFFVET---ESGVFIVKRS--TNIESETFCSLLCMRLGLHAPKVRVVSSNSEEGTNMLECLAAIDK 144 (342)
T ss_dssp GEEEEEECCSTTSCEEEEEE---SSCEEEEECC--TTHHHHHHHHHHHHHHTCCCCCEEEEESSSHHHHHHHHHHHHHCS
T ss_pred CeeEEEeccCCCCCeEEEEe---CCCEEEEeCc--HHHHHHHHHHHHHHHhCCCCCCeeEEeeCcHHHHHHHHHHHHhhh
Confidence 48888888888766555554 3667899944 23334555555555555666664333211
Q ss_pred ------EEeCCeEEEEEEecCCCchHHHHHh--cCCCCHHHHHHHHHHHHHHHHHH-HhcCcEee----cCCCCCeEecC
Q 028681 86 ------ILTPTHLAIVMEYASGGELFERICN--AGRFSEDEARFFFQQLISGVSYC-HSMQVCHR----DLKLENTLLDG 152 (205)
Q Consensus 86 ------~~~~~~~~lv~~~~~~~sl~~~~~~--~~~~~~~~~~~i~~~i~~~l~~l-h~~~i~H~----di~p~nili~~ 152 (205)
....+.++++|+|.++..|.+.-.. ...++.+....+.. +-++..+ +..+=... .-+++||+++.
T Consensus 145 ~~~~l~~l~~~~~~l~meyv~G~~L~e~~~~~~~~~f~~~~~k~LG~--Ii~FDi~InN~DR~Pl~W~n~GN~~NIL~~~ 222 (342)
T 1cja_A 145 SFRVITTLANQANILLMELVRGITLNKLTTTSAPEVLTKSTMQQLGS--LMALDVIVNNSDRLPIAWTNEGNLDNIMLSE 222 (342)
T ss_dssp SSCHHHHHTTCSEEEEEECCCEEESTTCCSSSHHHHSCHHHHHHHHH--HHHHHHHHTCCSSSCSSSCSCCCGGGEEEES
T ss_pred hhHHHHHhhcccceehhhhcCCCccccchhhhhhhhcCHHHHHhhch--hheehhhhcCCccCcccccCCCChhheEEeC
Confidence 0012357799999987665432211 01133333222111 2233433 33221122 34899999987
Q ss_pred CCCCcEEEeeecccccc
Q 028681 153 SPAPRLKICDFGYSKSS 169 (205)
Q Consensus 153 ~~~~~~~l~df~~~~~~ 169 (205)
++. ++.++|-+++...
T Consensus 223 ~n~-~~~~IDhn~af~~ 238 (342)
T 1cja_A 223 RGA-TVVPIDSKIIPLD 238 (342)
T ss_dssp BTT-CEEECSCCCCCCC
T ss_pred CCC-eEEEEcCCccccC
Confidence 554 5889999888543
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=88.31 E-value=1.6 Score=30.80 Aligned_cols=59 Identities=15% Similarity=0.004 Sum_probs=43.4
Q ss_pred CCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHh-cCcEeecCCCCCeEecCCCCCcEEEe
Q 028681 101 GGELFERICN-AGRFSEDEARFFFQQLISGVSYCHS-MQVCHRDLKLENTLLDGSPAPRLKIC 161 (205)
Q Consensus 101 ~~sl~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lh~-~~i~H~di~p~nili~~~~~~~~~l~ 161 (205)
.-||.+++.. +.++++++++.+++|++.+|..+-. ..-...=+.|..|++..+|. |.+.
T Consensus 32 ~vSL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~--V~f~ 92 (229)
T 2yle_A 32 ALSLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGA--VTLA 92 (229)
T ss_dssp EEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSC--EEEC
T ss_pred cccHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCc--eecc
Confidence 3578898864 6789999999999999999887622 22123345568888888887 6555
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 205 | ||||
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 9e-57 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 2e-56 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 5e-56 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 1e-55 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 6e-55 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 2e-53 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 8e-53 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 2e-52 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 4e-52 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 1e-51 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 9e-51 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 3e-49 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 6e-49 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 2e-48 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 1e-47 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 2e-47 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 2e-47 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 7e-45 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 1e-44 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 7e-44 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 3e-43 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 4e-43 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 9e-43 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 2e-42 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 2e-42 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 3e-42 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 7e-42 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 1e-41 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 4e-41 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 8e-41 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 9e-41 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 1e-40 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 1e-39 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 3e-39 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 4e-39 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 4e-39 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 6e-39 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 6e-39 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 7e-39 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 9e-39 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 1e-38 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 2e-38 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 6e-38 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 8e-38 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 2e-37 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 2e-37 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 3e-37 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 5e-37 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 1e-36 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 6e-36 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 3e-35 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 4e-35 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 5e-35 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 5e-35 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 5e-34 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 5e-33 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 1e-32 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 2e-32 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 3e-32 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 1e-31 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 5e-31 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 3e-27 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 9e-15 |
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 181 bits (459), Expect = 9e-57
Identities = 51/178 (28%), Positives = 86/178 (48%), Gaps = 2/178 (1%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID-ENVQREIINHRSLRHPNI 79
D Y+++ ++GSG FGV +K T + K+I +D V+ EI L HP +
Sbjct: 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKL 88
Query: 80 VRFKEVILTPTHLAIVMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQV 138
+ + + +++E+ SGGELF+RI + SE E + +Q G+ + H +
Sbjct: 89 INLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSI 148
Query: 139 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYD 196
H D+K EN + + A +KI DFG + K T T + APE++ ++
Sbjct: 149 VHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPVG 206
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 179 bits (456), Expect = 2e-56
Identities = 57/190 (30%), Positives = 93/190 (48%), Gaps = 2/190 (1%)
Query: 12 MDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID-ENVQREIIN 70
+++ H D Y++ ++G+G FGV + ++ T A K++ + D E V++EI
Sbjct: 17 VEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQT 76
Query: 71 HRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISG 129
LRHP +V + + ++ E+ SGGELFE++ + + SEDEA + +Q+ G
Sbjct: 77 MSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKG 136
Query: 130 VSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEV 189
+ + H H DLK EN + + LK+ DFG + K T GT + APEV
Sbjct: 137 LCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEV 196
Query: 190 LLKKEYDGKV 199
K
Sbjct: 197 AEGKPVGYYT 206
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (452), Expect = 5e-56
Identities = 54/182 (29%), Positives = 86/182 (47%), Gaps = 6/182 (3%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYI--ERGDKIDENVQREIINHRSLRHPN 78
D +E + ++G+GN GV + K + ++A K I E I + RE+ P
Sbjct: 6 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ- 137
IV F + ++I ME+ GG L + + AGR E +I G++Y
Sbjct: 66 IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK 125
Query: 138 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDG 197
+ HRD+K N L++ +K+CDFG S ++ S S VGT +Y++PE L Y
Sbjct: 126 IMHRDVKPSNILVNSR--GEIKLCDFGVSG-QLIDSMANSFVGTRSYMSPERLQGTHYSV 182
Query: 198 KV 199
+
Sbjct: 183 QS 184
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (445), Expect = 1e-55
Identities = 66/183 (36%), Positives = 105/183 (57%), Gaps = 7/183 (3%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYI--ERGDKIDENVQREIINHRSLRHPN 78
+ ++LV+ +G G +G +L ++ TEE VAVK + +R EN+++EI ++ L H N
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQV 138
+V+F + +EY SGGELF+RI E +A+ FF QL++GV Y H + +
Sbjct: 65 VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGI 124
Query: 139 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST---VGTPAYIAPEVLLKKEY 195
HRD+K EN LLD LKI DFG + +++ + GT Y+APE+L ++E+
Sbjct: 125 THRDIKPENLLLDER--DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 182
Query: 196 DGK 198
+
Sbjct: 183 HAE 185
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (440), Expect = 6e-55
Identities = 59/183 (32%), Positives = 99/183 (54%), Gaps = 7/183 (3%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENV----QREIINHRSLRH 76
+ +E+ R +G G FG L R+K+++ ++A+K + + V +RE+ LRH
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
PNI+R T + +++EYA G ++ + +F E + +L + +SYCHS
Sbjct: 66 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK 125
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYD 196
+V HRD+K EN LL + LKI DFG+S + S+ + GT Y+ PE++ + +D
Sbjct: 126 RVIHRDIKPENLLLGSA--GELKIADFGWSVHAP-SSRRTTLCGTLDYLPPEMIEGRMHD 182
Query: 197 GKV 199
KV
Sbjct: 183 EKV 185
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 171 bits (434), Expect = 2e-53
Identities = 66/183 (36%), Positives = 100/183 (54%), Gaps = 3/183 (1%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG--DKIDENVQREIINHRSLRHP 77
D Y+ +G+G F L DK+T++LVA+K I + + + +++ EI ++HP
Sbjct: 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHP 67
Query: 78 NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ 137
NIV ++ + HL ++M+ SGGELF+RI G ++E +A Q++ V Y H +
Sbjct: 68 NIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLG 127
Query: 138 VCHRDLKLENTLLDGSPAP-RLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYD 196
+ HRDLK EN L ++ I DFG SK S + GTP Y+APEVL +K Y
Sbjct: 128 IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKPYS 187
Query: 197 GKV 199
V
Sbjct: 188 KAV 190
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (428), Expect = 8e-53
Identities = 51/182 (28%), Positives = 93/182 (51%), Gaps = 5/182 (2%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID-ENVQREIINHRSLRHPN 78
D +E++ ++G G FG ++K+T L A K I+ + + E+ EI S HPN
Sbjct: 11 EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPN 70
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGR-FSEDEARFFFQQLISGVSYCHSMQ 137
IV+ + +L I++E+ +GG + + R +E + + +Q + ++Y H +
Sbjct: 71 IVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNK 130
Query: 138 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKEYD 196
+ HRDLK N L +K+ DFG S + Q + + +GTP ++APEV++ +
Sbjct: 131 IIHRDLKAGNILFTLD--GDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSK 188
Query: 197 GK 198
+
Sbjct: 189 DR 190
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (428), Expect = 2e-52
Identities = 43/180 (23%), Positives = 80/180 (44%), Gaps = 1/180 (0%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIV 80
++Y + D+G G FG+ + +++ K+++ V++EI RH NI+
Sbjct: 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNIL 64
Query: 81 RFKEVILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHSMQVC 139
E + L ++ E+ SG ++FERI +A +E E + Q+ + + HS +
Sbjct: 65 HLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIG 124
Query: 140 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKV 199
H D++ EN + + +KI +FG ++ + P Y APEV
Sbjct: 125 HFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVVSTAT 184
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 167 bits (425), Expect = 4e-52
Identities = 57/187 (30%), Positives = 92/187 (49%), Gaps = 12/187 (6%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID----ENVQREIINHRSLR 75
+ +R+IG G+FG RD + E+VA+K + K +++ +E+ + LR
Sbjct: 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73
Query: 76 HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 135
HPN ++++ L +VMEY G + E E + G++Y HS
Sbjct: 74 HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHS 133
Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL---K 192
+ HRD+K N LL +K+ DFG + + + S VGTP ++APEV+L +
Sbjct: 134 HNMIHRDVKAGNILLSEP--GLVKLGDFGSAS---IMAPANSFVGTPYWMAPEVILAMDE 188
Query: 193 KEYDGKV 199
+YDGKV
Sbjct: 189 GQYDGKV 195
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (420), Expect = 1e-51
Identities = 54/186 (29%), Positives = 83/186 (44%), Gaps = 9/186 (4%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINH----RSLRH 76
+ ++ + +G G+F L R+ T A+K +E+ I EN + L H
Sbjct: 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 67
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
P V+ L + YA GEL + I G F E RF+ +++S + Y H
Sbjct: 68 PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 127
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST---VGTPAYIAPEVLLKK 193
+ HRDLK EN LL+ ++I DFG +K S+ VGT Y++PE+L +K
Sbjct: 128 GIIHRDLKPENILLNED--MHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEK 185
Query: 194 EYDGKV 199
Sbjct: 186 SACKSS 191
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (415), Expect = 9e-51
Identities = 56/182 (30%), Positives = 88/182 (48%), Gaps = 5/182 (2%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID-ENVQREIINHRSLRHPN 78
+Y IG G G D T + VA++ + + E + EI+ R ++PN
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQV 138
IV + + L L +VMEY +GG L + + E + ++ + + + HS QV
Sbjct: 79 IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQV 137
Query: 139 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKEYDG 197
HRD+K +N LL +K+ DFG+ +ST VGTP ++APEV+ +K Y
Sbjct: 138 IHRDIKSDNILLGMD--GSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGP 195
Query: 198 KV 199
KV
Sbjct: 196 KV 197
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (408), Expect = 3e-49
Identities = 65/198 (32%), Positives = 102/198 (51%), Gaps = 13/198 (6%)
Query: 11 GMDMPIMHDSDRYELVRD-IGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREI- 68
G+ + D Y++ +G G G + +K+T+E A+K ++ K +RE+
Sbjct: 1 GLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKA----RREVE 56
Query: 69 INHRSLRHPNIVRFKEVILTP----THLAIVMEYASGGELFERICNAG--RFSEDEARFF 122
++ R+ + P+IVR +V L IVME GGELF RI + G F+E EA
Sbjct: 57 LHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEI 116
Query: 123 FQQLISGVSYCHSMQVCHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVLHSQPKSTVGT 181
+ + + Y HS+ + HRD+K EN L P LK+ DFG++K + H+ + T
Sbjct: 117 MKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYT 176
Query: 182 PAYIAPEVLLKKEYDGKV 199
P Y+APEVL ++YD
Sbjct: 177 PYYVAPEVLGPEKYDKSC 194
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 158 bits (401), Expect = 6e-49
Identities = 57/189 (30%), Positives = 86/189 (45%), Gaps = 13/189 (6%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYI----------ERGDKIDENVQREIIN 70
+ YE +G G V R K T + AVK I E ++ E +E+
Sbjct: 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62
Query: 71 HRSLR-HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISG 129
R + HPNI++ K+ T T +V + GELF+ + SE E R + L+
Sbjct: 63 LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEV 122
Query: 130 VSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEV 189
+ H + + HRDLK EN LLD +K+ DFG+S + + GTP+Y+APE+
Sbjct: 123 ICALHKLNIVHRDLKPENILLDDD--MNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEI 180
Query: 190 LLKKEYDGK 198
+ D
Sbjct: 181 IECSMNDNH 189
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (398), Expect = 2e-48
Identities = 62/186 (33%), Positives = 103/186 (55%), Gaps = 9/186 (4%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYI-------ERGDKIDENVQREIINHR 72
D Y+ ++GSG F V + R+K T A K+I R E+++RE+ +
Sbjct: 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 68
Query: 73 SLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 132
++HPN++ EV T + +++E +GGELF+ + +E+EA F +Q+++GV Y
Sbjct: 69 EIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYY 128
Query: 133 CHSMQVCHRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL 190
HS+Q+ H DLK EN +L P PR+KI DFG + ++ K+ GTP ++APE++
Sbjct: 129 LHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIV 188
Query: 191 LKKEYD 196
+
Sbjct: 189 NYEPLG 194
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (391), Expect = 1e-47
Identities = 60/194 (30%), Positives = 93/194 (47%), Gaps = 17/194 (8%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQ---REIINHRSLRHP 77
+ YE++ IG+G++G + +R K +++ K ++ G + Q E+ R L+HP
Sbjct: 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 63
Query: 78 NIVRFKEVIL--TPTHLAIVMEYASGGELFERICNAGR----FSEDEARFFFQQLISGVS 131
NIVR+ + I+ T T L IVMEY GG+L I + E+ QL +
Sbjct: 64 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 123
Query: 132 YCH-----SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV-GTPAYI 185
CH V HRDLK N LDG +K+ DFG ++ + GTP Y+
Sbjct: 124 ECHRRSDGGHTVLHRDLKPANVFLDGK--QNVKLGDFGLARILNHDTSFAKAFVGTPYYM 181
Query: 186 APEVLLKKEYDGKV 199
+PE + + Y+ K
Sbjct: 182 SPEQMNRMSYNEKS 195
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 154 bits (391), Expect = 2e-47
Identities = 50/192 (26%), Positives = 76/192 (39%), Gaps = 10/192 (5%)
Query: 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYI----ERGDKIDENVQREIINHRS 73
H SDRYEL +G G L RD + VAVK + R +RE N +
Sbjct: 4 HLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAA 63
Query: 74 LRHPNIVRFKEVILTPTH----LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISG 129
L HP IV + T IVMEY G L + + G + A
Sbjct: 64 LNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQA 123
Query: 130 VSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFG--YSKSSVLHSQPKSTVGTPAYIAP 187
+++ H + HRD+K N ++ + A ++ + S +Q + +GT Y++P
Sbjct: 124 LNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSP 183
Query: 188 EVLLKKEYDGKV 199
E D +
Sbjct: 184 EQARGDSVDARS 195
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (394), Expect = 2e-47
Identities = 60/185 (32%), Positives = 98/185 (52%), Gaps = 8/185 (4%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG-----DKIDENVQREIINHRSLR 75
+ + L + +G G+FG L KKT + A+K +++ D ++ + + + +
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 76 HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 135
HP + T +L VMEY +GG+L I + +F A F+ ++I G+ + HS
Sbjct: 62 HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHS 121
Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKE 194
+ +RDLKL+N LLD +KI DFG K ++L +T GTP YIAPE+LL ++
Sbjct: 122 KGIVYRDLKLDNILLDKD--GHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQK 179
Query: 195 YDGKV 199
Y+ V
Sbjct: 180 YNHSV 184
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (373), Expect = 7e-45
Identities = 49/193 (25%), Positives = 87/193 (45%), Gaps = 12/193 (6%)
Query: 16 IMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID---ENVQREIINHR 72
+ +D + +IG G+F D +T VA ++ + + E +
Sbjct: 4 MSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLK 63
Query: 73 SLRHPNIVRFKEVILTPT----HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLIS 128
L+HPNIVRF + + + +V E + G L + R + +Q++
Sbjct: 64 GLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILK 123
Query: 129 GVSYCHSM--QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIA 186
G+ + H+ + HRDLK +N + G P +KI D G + S K+ +GTP ++A
Sbjct: 124 GLQFLHTRTPPIIHRDLKCDNIFITG-PTGSVKIGDLGLATLKR-ASFAKAVIGTPEFMA 181
Query: 187 PEVLLKKEYDGKV 199
PE+ +++YD V
Sbjct: 182 PEM-YEEKYDESV 193
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 148 bits (375), Expect = 1e-44
Identities = 55/185 (29%), Positives = 95/185 (51%), Gaps = 8/185 (4%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID----ENVQREIINHRSLRH 76
++++R +G+G+FG L+R + A+K +++ + E+ E + + H
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
P I+R + ++M+Y GGELF + + RF A+F+ ++ + Y HS
Sbjct: 64 PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSK 123
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYD 196
+ +RDLK EN LLD + +KI DFG++K + + GTP YIAPEV+ K Y+
Sbjct: 124 DIIYRDLKPENILLDKN--GHIKITDFGFAK--YVPDVTYTLCGTPDYIAPEVVSTKPYN 179
Query: 197 GKVMC 201
+
Sbjct: 180 KSIDW 184
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 147 bits (373), Expect = 7e-44
Identities = 53/185 (28%), Positives = 88/185 (47%), Gaps = 10/185 (5%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHR-------S 73
+ + + R IG G FG R T ++ A+K +++ + + +N R +
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 74 LRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYC 133
P IV TP L+ +++ +GG+L + G FSE + RF+ ++I G+ +
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHM 123
Query: 134 HSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKK 193
H+ V +RDLK N LLD ++I D G + +P ++VGT Y+APEVL K
Sbjct: 124 HNRFVVYRDLKPANILLD--EHGHVRISDLGLACDFS-KKKPHASVGTHGYMAPEVLQKG 180
Query: 194 EYDGK 198
Sbjct: 181 VAYDS 185
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (362), Expect = 3e-43
Identities = 43/186 (23%), Positives = 77/186 (41%), Gaps = 6/186 (3%)
Query: 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPN 78
D ++++G+G FGV + + + + VA+K I+ G ++ E +L H
Sbjct: 2 DPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEK 60
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQ 137
+V+ V + I+ EY + G L + RF + + + + Y S Q
Sbjct: 61 LVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ 120
Query: 138 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVLLKKEY 195
HRDL N L++ +K+ DFG S+ + S + PEVL+ ++
Sbjct: 121 FLHRDLAARNCLVNDQ--GVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKF 178
Query: 196 DGKVMC 201
K
Sbjct: 179 SSKSDI 184
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (362), Expect = 4e-43
Identities = 51/193 (26%), Positives = 85/193 (44%), Gaps = 12/193 (6%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDEN-------VQREIINHRS 73
+Y++ +GSG FG VA+K++E+ D V E++ +
Sbjct: 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63
Query: 74 LR--HPNIVRFKEVILTPTHLAIVMEYASGG-ELFERICNAGRFSEDEARFFFQQLISGV 130
+ ++R + P +++E +LF+ I G E+ AR FF Q++ V
Sbjct: 64 VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAV 123
Query: 131 SYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL 190
+CH+ V HRD+K EN L+D + LK+ DFG + + GT Y PE +
Sbjct: 124 RHCHNCGVLHRDIKDENILIDLNR-GELKLIDFGSGA-LLKDTVYTDFDGTRVYSPPEWI 181
Query: 191 LKKEYDGKVMCVY 203
Y G+ V+
Sbjct: 182 RYHRYHGRSAAVW 194
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (359), Expect = 9e-43
Identities = 51/184 (27%), Positives = 76/184 (41%), Gaps = 10/184 (5%)
Query: 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPN 78
+ +L++ IG G FG L + + VAVK I + D + E LRH N
Sbjct: 5 NMKELKLLQTIGKGEFGDVMLGDYRGNK--VAVKCI-KNDATAQAFLAEASVMTQLRHSN 61
Query: 79 IVRFKEVIL-TPTHLAIVMEYASGGELFERICNAGR--FSEDEARFFFQQLISGVSYCHS 135
+V+ VI+ L IV EY + G L + + + GR D F + + Y
Sbjct: 62 LVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG 121
Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEY 195
HRDL N L+ K+ DFG +K S + + APE L +K++
Sbjct: 122 NNFVHRDLAARNVLVSED--NVAKVSDFGLTKE--ASSTQDTGKLPVKWTAPEALREKKF 177
Query: 196 DGKV 199
K
Sbjct: 178 STKS 181
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (357), Expect = 2e-42
Identities = 48/186 (25%), Positives = 78/186 (41%), Gaps = 13/186 (6%)
Query: 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQ---REIINHRSLR 75
+ + + IGSG+FG + VAVK + + +Q E+ R R
Sbjct: 6 PDGQITVGQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTR 62
Query: 76 HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCH 134
H NI+ F T LAIV ++ G L+ + +F + +Q G+ Y H
Sbjct: 63 HVNILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH 121
Query: 135 SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQPKSTVGTPAYIAPEVLL 191
+ + HRDLK N L +KI DFG + Q + G+ ++APEV+
Sbjct: 122 AKSIIHRDLKSNNIFLHED--LTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIR 179
Query: 192 KKEYDG 197
++ +
Sbjct: 180 MQDKNP 185
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 143 bits (362), Expect = 2e-42
Identities = 56/188 (29%), Positives = 105/188 (55%), Gaps = 8/188 (4%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID----ENVQREIINHRSLRH 76
D+++ ++ +G+G+FG L++ K++ A+K +++ + E+ E +++
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
P +V+ + ++L +VMEY +GGE+F + GRFSE ARF+ Q++ Y HS+
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL 160
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYD 196
+ +RDLK EN L+D +++ DFG++K + + GTP +APE++L K Y+
Sbjct: 161 DLIYRDLKPENLLIDQQ--GYIQVTDFGFAKRV--KGRTWTLCGTPEALAPEIILSKGYN 216
Query: 197 GKVMCVYV 204
V +
Sbjct: 217 KAVDWWAL 224
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (360), Expect = 3e-42
Identities = 64/184 (34%), Positives = 97/184 (52%), Gaps = 7/184 (3%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDEN----VQREIINHRSLRH 76
+ ++ ++ +G G FG L+R+K T A+K + + I ++ E ++ RH
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
P + K T L VMEYA+GGELF + F+E+ ARF+ +++S + Y HS
Sbjct: 65 PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSR 124
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP-KSTVGTPAYIAPEVLLKKEY 195
V +RD+KLEN +LD +KI DFG K + K+ GTP Y+APEVL +Y
Sbjct: 125 DVVYRDIKLENLMLDKD--GHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDY 182
Query: 196 DGKV 199
V
Sbjct: 183 GRAV 186
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 140 bits (354), Expect = 7e-42
Identities = 41/187 (21%), Positives = 72/187 (38%), Gaps = 6/187 (3%)
Query: 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPN 78
+ + +G G +G KK VAVK ++ E +E + ++HPN
Sbjct: 15 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPN 74
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGR--FSEDEARFFFQQLISGVSYCHSM 136
+V+ V I+ E+ + G L + + R S + Q+ S + Y
Sbjct: 75 LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK 134
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSK--SSVLHSQPKSTVGTPAYIAPEVLLKKE 194
HRDL N L+ + +K+ DFG S+ + ++ + APE L +
Sbjct: 135 NFIHRDLAARNCLVGEN--HLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNK 192
Query: 195 YDGKVMC 201
+ K
Sbjct: 193 FSIKSDV 199
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 141 bits (356), Expect = 1e-41
Identities = 44/181 (24%), Positives = 87/181 (48%), Gaps = 9/181 (4%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLR-HPNI 79
D Y+LVR +G G + + E V VK ++ K + ++REI +LR PNI
Sbjct: 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKK--KKIKREIKILENLRGGPNI 92
Query: 80 VRFKEVILTPTH--LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ 137
+ +++ P A+V E+ + + + ++ + RF+ +++ + YCHSM
Sbjct: 93 ITLADIVKDPVSRTPALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSMG 149
Query: 138 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDG 197
+ HRD+K N ++D +L++ D+G ++ + V + + PE+L+ +
Sbjct: 150 IMHRDVKPHNVMID-HEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYD 208
Query: 198 K 198
Sbjct: 209 Y 209
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (353), Expect = 4e-41
Identities = 56/201 (27%), Positives = 84/201 (41%), Gaps = 16/201 (7%)
Query: 7 TVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQR 66
T G G D P Y + IG+G+FGV + + ELVA+K + + R
Sbjct: 9 TPGQGPDRP---QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV---LQDKRFKNR 62
Query: 67 EIINHRSLRHPNIVRFKEVILTP------THLAIVMEYASGG---ELFERICNAGRFSED 117
E+ R L H NIVR + + +L +V++Y
Sbjct: 63 ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI 122
Query: 118 EARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS 177
+ + QL ++Y HS +CHRD+K +N LLD A K+CDFG +K V S
Sbjct: 123 YVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVL-KLCDFGSAKQLVRGEPNVS 181
Query: 178 TVGTPAYIAPEVLLKKEYDGK 198
+ + Y APE++
Sbjct: 182 YICSRYYRAPELIFGATDYTS 202
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (348), Expect = 8e-41
Identities = 52/189 (27%), Positives = 85/189 (44%), Gaps = 9/189 (4%)
Query: 24 ELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG------DKIDENVQREIINHRSLRHP 77
E + +G G F RDK T ++VA+K I+ G D I+ REI + L HP
Sbjct: 1 EKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHP 60
Query: 78 NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ 137
NI+ + +++++V ++ N+ + + + + G+ Y H
Sbjct: 61 NIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW 120
Query: 138 VCHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKSTVGTPAYIAPEVLLKKEYD 196
+ HRDLK N LLD + LK+ DFG +KS + V T Y APE+L
Sbjct: 121 ILHRDLKPNNLLLDEN--GVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMY 178
Query: 197 GKVMCVYVI 205
G + ++ +
Sbjct: 179 GVGVDMWAV 187
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (345), Expect = 9e-41
Identities = 47/184 (25%), Positives = 76/184 (41%), Gaps = 6/184 (3%)
Query: 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPN 78
D V++IGSG FG+ L ++ VA+K I G +E+ E L HP
Sbjct: 3 DPSELTFVQEIGSGQFGLVHLGYWLNKDK-VAIKTIREGAMSEEDFIEEAEVMMKLSHPK 61
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFE-RICNAGRFSEDEARFFFQQLISGVSYCHSMQ 137
+V+ V L + +V E+ G L + G F+ + + G++Y
Sbjct: 62 LVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC 121
Query: 138 VCHRDLKLENTLLDGSPAPRLKICDFGYSK--SSVLHSQPKSTVGTPAYIAPEVLLKKEY 195
V HRDL N L+ + +K+ DFG ++ ++ T + +PEV Y
Sbjct: 122 VIHRDLAARNCLVGEN--QVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRY 179
Query: 196 DGKV 199
K
Sbjct: 180 SSKS 183
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (347), Expect = 1e-40
Identities = 50/205 (24%), Positives = 90/205 (43%), Gaps = 19/205 (9%)
Query: 12 MDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYI---ERGDKIDENVQREI 68
++ P + +YE + IG G FG R +KT + VA+K + + REI
Sbjct: 1 VECPFCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREI 60
Query: 69 INHRSLRHPNIVRFKEVILTPT--------HLAIVMEYASGGELFERICNAGRFSEDEAR 120
+ L+H N+V E+ T + +V ++ +F+ E +
Sbjct: 61 KILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIK 120
Query: 121 FFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK-----SSVLHSQP 175
Q L++G+ Y H ++ HRD+K N L+ LK+ DFG ++ + ++
Sbjct: 121 RVMQMLLNGLYYIHRNKILHRDMKAANVLITRD--GVLKLADFGLARAFSLAKNSQPNRY 178
Query: 176 KSTVGTPAYIAPEVLL-KKEYDGKV 199
+ V T Y PE+LL +++Y +
Sbjct: 179 TNRVVTLWYRPPELLLGERDYGPPI 203
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 135 bits (341), Expect = 1e-39
Identities = 49/198 (24%), Positives = 79/198 (39%), Gaps = 14/198 (7%)
Query: 12 MDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINH 71
M++ + +RY L R IGSG+FG L D E VA+K +E + E +
Sbjct: 1 MELRV---GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIK-LECVKTKHPQLHIESKIY 56
Query: 72 RSLRHPN-IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGV 130
+ ++ I + + +VME + +FS Q+IS +
Sbjct: 57 KMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRI 116
Query: 131 SYCHSMQVCHRDLKLENTLL-DGSPAPRLKICDFGYSK--------SSVLHSQPKSTVGT 181
Y HS HRD+K +N L+ G + I DFG +K + + + K+ GT
Sbjct: 117 EYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGT 176
Query: 182 PAYIAPEVLLKKEYDGKV 199
Y + L E +
Sbjct: 177 ARYASINTHLGIEQSRRD 194
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 134 bits (338), Expect = 3e-39
Identities = 45/193 (23%), Positives = 80/193 (41%), Gaps = 14/193 (7%)
Query: 19 DSDRYELVRDIGSGNFGV---ARLMRDKKTEELVAVKYIERG--DKIDENVQREIINHRS 73
D ++ + IG+G FG L K E VA+K ++ G +K + E
Sbjct: 24 DISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQ 83
Query: 74 LRHPNIVRFKEVILTPTHLAIVMEYASGGELFE-RICNAGRFSEDEARFFFQQLISGVSY 132
HPN++ + V+ T + I+ E+ G L N G+F+ + + + +G+ Y
Sbjct: 84 FDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKY 143
Query: 133 CHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK------SSVLHSQPKSTVGTPAYIA 186
M HRDL N L++ + K+ DFG S+ S ++ + A
Sbjct: 144 LADMNYVHRDLAARNILVNSN--LVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTA 201
Query: 187 PEVLLKKEYDGKV 199
PE + +++
Sbjct: 202 PEAIQYRKFTSAS 214
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (335), Expect = 4e-39
Identities = 40/185 (21%), Positives = 75/185 (40%), Gaps = 8/185 (4%)
Query: 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPN 78
+ +LV +G+G FG + + VAVK +++G + E + L+H
Sbjct: 11 PRETLKLVERLGAGQFGEVWMGYYNGHTK-VAVKSLKQGSMSPDAFLAEANLMKQLQHQR 69
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFERI--CNAGRFSEDEARFFFQQLISGVSYCHSM 136
+VR V+ T + I+ EY G L + + + + + ++ Q+ G+++
Sbjct: 70 LVRLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER 128
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVLLKKE 194
HRDL+ N L+ KI DFG ++ + + APE +
Sbjct: 129 NYIHRDLRAANILVS--DTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGT 186
Query: 195 YDGKV 199
+ K
Sbjct: 187 FTIKS 191
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (336), Expect = 4e-39
Identities = 44/185 (23%), Positives = 74/185 (40%), Gaps = 8/185 (4%)
Query: 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPN 78
+ L +G G FG + T VA+K ++ G E +E + LRH
Sbjct: 15 PRESLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLRHEK 73
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFE--RICNAGRFSEDEARFFFQQLISGVSYCHSM 136
+V+ V+ + + IV EY S G L + + + Q+ SG++Y M
Sbjct: 74 LVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM 132
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSK--SSVLHSQPKSTVGTPAYIAPEVLLKKE 194
HRDL+ N L+ + K+ DFG ++ ++ + + APE L
Sbjct: 133 NYVHRDLRAANILVGEN--LVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR 190
Query: 195 YDGKV 199
+ K
Sbjct: 191 FTIKS 195
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (338), Expect = 6e-39
Identities = 55/188 (29%), Positives = 82/188 (43%), Gaps = 13/188 (6%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYI--ERGDKIDENVQREIINHRSLRHPN 78
RY + IG G +G+ D + VA+K I + REI RH N
Sbjct: 8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHEN 67
Query: 79 IVRFKEVILTPTH----LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCH 134
I+ ++I PT ++ + G +L++ + S D +F Q++ G+ Y H
Sbjct: 68 IIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLL-KTQHLSNDHICYFLYQILRGLKYIH 126
Query: 135 SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK----SSVLHSQPKSTVGTPAYIAPEVL 190
S V HRDLK N LL+ + LKICDFG ++ V T Y APE++
Sbjct: 127 SANVLHRDLKPSNLLLNTT--CDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 184
Query: 191 LKKEYDGK 198
L + K
Sbjct: 185 LNSKGYTK 192
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (337), Expect = 6e-39
Identities = 43/217 (19%), Positives = 72/217 (33%), Gaps = 36/217 (16%)
Query: 19 DSDRYELVRDIGSGNFGVARLMRDKKTEEL-----VAVKYI--ERGDKIDENVQREIINH 71
+ E + +GSG FG + VAVK + + E + E+
Sbjct: 35 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMM 94
Query: 72 RSL-RHPNIVRFKEVILTPTHLAIVMEYASGGELFERI---------------------- 108
L H NIV + ++ EY G+L +
Sbjct: 95 TQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEE 154
Query: 109 -CNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 167
+ + ++ F Q+ G+ + HRDL N L+ +KICDFG ++
Sbjct: 155 EEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHG--KVVKICDFGLAR 212
Query: 168 ---SSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKVMC 201
S + + ++APE L + Y K
Sbjct: 213 DIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDV 249
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (338), Expect = 7e-39
Identities = 49/187 (26%), Positives = 82/187 (43%), Gaps = 15/187 (8%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER---GDKIDENVQREIINHRSLRHP 77
Y ++ +GSG +G D +T VA+K + R + + RE+ + +RH
Sbjct: 18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHE 77
Query: 78 NIVRFKEVILTP------THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS 131
N++ +V T +VM + G ++ + ED +F Q++ G+
Sbjct: 78 NVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHEKLGEDRIQFLVYQMLKGLR 135
Query: 132 YCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL 191
Y H+ + HRDLK N ++ LKI DFG ++ S+ V T Y APEV+L
Sbjct: 136 YIHAAGIIHRDLKPGNLAVNED--CELKILDFGLARQ--ADSEMTGYVVTRWYRAPEVIL 191
Query: 192 KKEYDGK 198
+
Sbjct: 192 NWMRYTQ 198
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (333), Expect = 9e-39
Identities = 48/189 (25%), Positives = 80/189 (42%), Gaps = 11/189 (5%)
Query: 19 DSDRYELVRDIGSGNFGV---ARLMRDKKTEELVAVKYIERG--DKIDENVQREIINHRS 73
+R EL R IG G FG M + VA+K + D + E +E + R
Sbjct: 5 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQ 64
Query: 74 LRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSY 132
HP+IV+ VI T + I+ME + GEL + + QL + ++Y
Sbjct: 65 FDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAY 123
Query: 133 CHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVL 190
S + HRD+ N L+ + +K+ DFG S+ + K++ ++APE +
Sbjct: 124 LESKRFVHRDIAARNVLVSSN--DCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESI 181
Query: 191 LKKEYDGKV 199
+ +
Sbjct: 182 NFRRFTSAS 190
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (332), Expect = 1e-38
Identities = 50/198 (25%), Positives = 80/198 (40%), Gaps = 15/198 (7%)
Query: 14 MPIMHDSDRYELVRDIGSGNFGV---ARLMRDKKTEELVAVKYIERGDKID----ENVQR 66
+ + L+ +G G+FGV VAVK ++ ++ R
Sbjct: 1 LTCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIR 60
Query: 67 EIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERIC-NAGRFSEDEARFFFQQ 125
E+ SL H N++R V+LTP + +V E A G L +R+ + G F + Q
Sbjct: 61 EVNAMHSLDHRNLIRLYGVVLTP-PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQ 119
Query: 126 LISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK----SSVLHSQPKSTVGT 181
+ G+ Y S + HRDL N LL +KI DFG + + + +
Sbjct: 120 VAEGMGYLESKRFIHRDLAARNLLLATR--DLVKIGDFGLMRALPQNDDHYVMQEHRKVP 177
Query: 182 PAYIAPEVLLKKEYDGKV 199
A+ APE L + +
Sbjct: 178 FAWCAPESLKTRTFSHAS 195
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (330), Expect = 2e-38
Identities = 48/191 (25%), Positives = 76/191 (39%), Gaps = 15/191 (7%)
Query: 21 DRYELV---RDIGSGNFGVARL--MRDKKTEELVAVKYIERG---DKIDENVQREIINHR 72
DR L +++GSGNFG + + KK + VAVK ++ + + + E +
Sbjct: 4 DRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQ 63
Query: 73 SLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 132
L +P IVR + + + +VME A G L + + + Q+ G+ Y
Sbjct: 64 QLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKY 122
Query: 133 CHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS----SVLHSQPKSTVGTPAYIAPE 188
HRDL N LL KI DFG SK+ + + APE
Sbjct: 123 LEESNFVHRDLAARNVLLV--TQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPE 180
Query: 189 VLLKKEYDGKV 199
+ ++ K
Sbjct: 181 CINYYKFSSKS 191
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 130 bits (328), Expect = 6e-38
Identities = 37/191 (19%), Positives = 72/191 (37%), Gaps = 13/191 (6%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRH-PNI 79
Y++ R IG G+FGV + + VA+K+ R ++ E ++ L I
Sbjct: 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPR-RSDAPQLRDEYRTYKLLAGCTGI 63
Query: 80 VRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVC 139
H +V++ +FS +Q+++ V H +
Sbjct: 64 PNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLV 123
Query: 140 HRDLKLENTLLDGSPAP---RLKICDFGYSK--------SSVLHSQPKSTVGTPAYIAPE 188
+RD+K +N L+ + + + DFG K + + + K+ GT Y++
Sbjct: 124 YRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSIN 183
Query: 189 VLLKKEYDGKV 199
L +E +
Sbjct: 184 THLGREQSRRD 194
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (329), Expect = 8e-38
Identities = 38/197 (19%), Positives = 74/197 (37%), Gaps = 12/197 (6%)
Query: 14 MPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYI------ERGDKIDENVQRE 67
+ I+ +++ ++ ++ +GSG FG E V + K ++ + E
Sbjct: 3 LRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDE 61
Query: 68 IINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLI 127
S+ +P++ R + LT T I G L + + Q+
Sbjct: 62 AYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIA 121
Query: 128 SGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQPKSTVGTPAY 184
G++Y ++ HRDL N L+ +KI DFG +K + + +
Sbjct: 122 KGMNYLEDRRLVHRDLAARNVLVKTP--QHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 179
Query: 185 IAPEVLLKKEYDGKVMC 201
+A E +L + Y +
Sbjct: 180 MALESILHRIYTHQSDV 196
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (326), Expect = 2e-37
Identities = 57/183 (31%), Positives = 92/183 (50%), Gaps = 7/183 (3%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYI---ERGDKIDENVQREIINHRSLRHP 77
+ ++ V IG G +GV R+K T E+VA+K I + + REI + L HP
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 78 NIVRFKEVILTPTHLAIVMEYAS-GGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
NIV+ +VI T L +V E+ + F + + QL+ G+++CHS
Sbjct: 62 NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 121
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKEY 195
+V HRDLK +N L++ +K+ DFG +++ + + + V T Y APE+LL +Y
Sbjct: 122 RVLHRDLKPQNLLINTE--GAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKY 179
Query: 196 DGK 198
Sbjct: 180 YST 182
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (324), Expect = 2e-37
Identities = 49/189 (25%), Positives = 76/189 (40%), Gaps = 13/189 (6%)
Query: 21 DRYELV-RDIGSGNFGVARL--MRDKKTEELVAVKYIERGDKID--ENVQREIINHRSLR 75
D + ++G GNFG R R +K + VA+K +++G + E + RE L
Sbjct: 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLD 67
Query: 76 HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCH 134
+P IVR V L +VME A GG L + + Q+ G+ Y
Sbjct: 68 NPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLE 126
Query: 135 SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK----SSVLHSQPKSTVGTPAYIAPEVL 190
HRDL N LL + I DFG SK ++ + + APE +
Sbjct: 127 EKNFVHRDLAARNVLLVNRHYAK--ISDFGLSKALGADDSYYTARSAGKWPLKWYAPECI 184
Query: 191 LKKEYDGKV 199
+++ +
Sbjct: 185 NFRKFSSRS 193
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (324), Expect = 3e-37
Identities = 52/182 (28%), Positives = 89/182 (48%), Gaps = 6/182 (3%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHP 77
+YE + IG G +G ++++T E+VA+K + D + + REI + L+H
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 78 NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ 137
NIVR +V+ + L +V E+ G + + F QL+ G+ +CHS
Sbjct: 62 NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN 121
Query: 138 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS-TVGTPAYIAPEVLLKKEYD 196
V HRDLK +N L++ + LK+ +FG +++ + + S V T Y P+VL +
Sbjct: 122 VLHRDLKPQNLLINRN--GELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLY 179
Query: 197 GK 198
Sbjct: 180 ST 181
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (323), Expect = 5e-37
Identities = 57/193 (29%), Positives = 85/193 (44%), Gaps = 15/193 (7%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKT-EELVAVKYI---ERGDKIDENVQREIINHRSL-- 74
+YE V +IG G +G RD K VA+K + + + + RE+ R L
Sbjct: 7 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLET 66
Query: 75 -RHPNIVRFKEVILTP-----THLAIVMEYASGGEL-FERICNAGRFSEDEARFFFQQLI 127
HPN+VR +V T L +V E+ + + + QL+
Sbjct: 67 FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLL 126
Query: 128 SGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAP 187
G+ + HS +V HRDLK +N L+ S ++K+ DFG ++ S V T Y AP
Sbjct: 127 RGLDFLHSHRVVHRDLKPQNILVTSS--GQIKLADFGLARIYSFQMALTSVVVTLWYRAP 184
Query: 188 EVLLKKEYDGKVM 200
EVLL+ Y V
Sbjct: 185 EVLLQSSYATPVD 197
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 127 bits (319), Expect = 1e-36
Identities = 54/182 (29%), Positives = 88/182 (48%), Gaps = 7/182 (3%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYI---ERGDKIDENVQREIINHRSLRHP 77
++Y + IG G +GV ++ E A+K I + + I REI + L+H
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHS 60
Query: 78 NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ 137
NIV+ +VI T L +V E+ G A+ F QL++G++YCH +
Sbjct: 61 NIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR 120
Query: 138 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKEYD 196
V HRDLK +N L++ LKI DFG +++ + + + + T Y AP+VL+ +
Sbjct: 121 VLHRDLKPQNLLINRE--GELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKY 178
Query: 197 GK 198
Sbjct: 179 ST 180
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (316), Expect = 6e-36
Identities = 47/202 (23%), Positives = 71/202 (35%), Gaps = 23/202 (11%)
Query: 19 DSDRYELVRDIGSGNFGVARLMRDKKTEEL--VAVKYIERGDKID--ENVQREIINHRSL 74
D + + IG GNFG R KK A+K ++ D + E+ L
Sbjct: 8 DWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKL 67
Query: 75 -RHPNIVRFKEVILTPTHLAIVMEYASGGELFERI----------------CNAGRFSED 117
HPNI+ +L + +EYA G L + + A S
Sbjct: 68 GHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQ 127
Query: 118 EARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS 177
+ F + G+ Y Q HRDL N L+ + KI DFG S+ ++ +
Sbjct: 128 QLLHFAADVARGMDYLSQKQFIHRDLAARNILVGEN--YVAKIADFGLSRGQEVYVKKTM 185
Query: 178 TVGTPAYIAPEVLLKKEYDGKV 199
++A E L Y
Sbjct: 186 GRLPVRWMAIESLNYSVYTTNS 207
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (310), Expect = 3e-35
Identities = 52/196 (26%), Positives = 75/196 (38%), Gaps = 22/196 (11%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNI 79
+ L IG G FG + + E VAVK ++ + EI LRH NI
Sbjct: 2 ARTIVLQESIGKGRFGEVWRGKWRGEE--VAVKIFSSREERSWFREAEIYQTVMLRHENI 59
Query: 80 VRFKEVI----LTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 135
+ F T T L +V +Y G LF+ + N + + SG+++ H
Sbjct: 60 LGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL-NRYTVTVEGMIKLALSTASGLAHLHM 118
Query: 136 --------MQVCHRDLKLENTLLDGSPAPRLKICDFG-----YSKSSVLHSQPKSTVGTP 182
+ HRDLK +N L+ + I D G S + + P VGT
Sbjct: 119 EIVGTQGKPAIAHRDLKSKNILVKKN--GTCCIADLGLAVRHDSATDTIDIAPNHRVGTK 176
Query: 183 AYIAPEVLLKKEYDGK 198
Y+APEVL
Sbjct: 177 RYMAPEVLDDSINMKH 192
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 123 bits (310), Expect = 4e-35
Identities = 49/213 (23%), Positives = 81/213 (38%), Gaps = 36/213 (16%)
Query: 21 DRYELVRDIGSGNFGVARLMRDK-----KTEELVAVKYI--ERGDKIDENVQREIINHRS 73
+ E VRDIG G FG R + +VAVK + E + + QRE
Sbjct: 13 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 72
Query: 74 LRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR-------------------- 113
+PNIV+ V + ++ EY + G+L E + +
Sbjct: 73 FDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 132
Query: 114 ----FSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK-- 167
S E +Q+ +G++Y + HRDL N L+ + +KI DFG S+
Sbjct: 133 GPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGEN--MVVKIADFGLSRNI 190
Query: 168 -SSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKV 199
S+ + + ++ PE + Y +
Sbjct: 191 YSADYYKADGNDAIPIRWMPPESIFYNRYTTES 223
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (312), Expect = 5e-35
Identities = 48/193 (24%), Positives = 77/193 (39%), Gaps = 14/193 (7%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER---GDKIDENVQREIINHRSLRHP 77
RY+ ++ IGSG G+ D + VA+K + R + RE++ + + H
Sbjct: 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 76
Query: 78 NIVRFKEVILTP------THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS 131
NI+ V + +VME + + Q++ G+
Sbjct: 77 NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ---MELDHERMSYLLYQMLCGIK 133
Query: 132 YCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL 191
+ HS + HRDLK N ++ LKI DFG ++++ V T Y APEV+L
Sbjct: 134 HLHSAGIIHRDLKPSNIVVKSD--CTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL 191
Query: 192 KKEYDGKVMCVYV 204
Y V V
Sbjct: 192 GMGYKENVDIWSV 204
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (310), Expect = 5e-35
Identities = 43/213 (20%), Positives = 70/213 (32%), Gaps = 31/213 (14%)
Query: 19 DSDRYELVRDIGSGNFGV-----ARLMRDKKTEELVAVKYIERGDKID--ENVQREIINH 71
+R + +G+G FG A + VAVK ++ + E + E+
Sbjct: 21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVL 80
Query: 72 RSL-RHPNIVRFKEVILTPTHLAIVMEYASGGELFERIC------------------NAG 112
L H NIV ++ EY G+L + +
Sbjct: 81 SYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDEL 140
Query: 113 RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 172
++ F Q+ G+++ S HRDL N LL KICDFG ++
Sbjct: 141 ALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHG--RITKICDFGLARDIKND 198
Query: 173 SQPKST---VGTPAYIAPEVLLKKEYDGKVMCV 202
S ++APE + Y +
Sbjct: 199 SNYVVKGNARLPVKWMAPESIFNCVYTFESDVW 231
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (305), Expect = 5e-34
Identities = 48/187 (25%), Positives = 83/187 (44%), Gaps = 13/187 (6%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID---ENVQREIINHRSLRH 76
+RY+ + +GSG +G D KT VAVK + R + + RE+ + ++H
Sbjct: 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 76
Query: 77 PNIVRFKEVILTPTHLA-----IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS 131
N++ +V L ++ + G I + ++D +F Q++ G+
Sbjct: 77 ENVIGLLDVFTPARSLEEFNDVYLVTHLMGA-DLNNIVKCQKLTDDHVQFLIYQILRGLK 135
Query: 132 YCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL 191
Y HS + HRDLK N ++ LKI DFG ++ + V T Y APE++L
Sbjct: 136 YIHSADIIHRDLKPSNLAVN--EDCELKILDFGLARH--TDDEMTGYVATRWYRAPEIML 191
Query: 192 KKEYDGK 198
+ +
Sbjct: 192 NWMHYNQ 198
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (297), Expect = 5e-33
Identities = 45/184 (24%), Positives = 88/184 (47%), Gaps = 9/184 (4%)
Query: 21 DRYELVRDIGSGNFGV---ARLMRDKKTEELVAVKYIERGD-----KIDENVQREIINHR 72
+ +EL++ +G+G +G R + T +L A+K +++ K E+ + E
Sbjct: 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83
Query: 73 SLRH-PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS 131
+R P +V T T L ++++Y +GGELF + RF+E E + + +++ +
Sbjct: 84 HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALE 143
Query: 132 YCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL 191
+ H + + +RD+KLEN LLD + L + + GT Y+AP+++
Sbjct: 144 HLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVR 203
Query: 192 KKEY 195
+
Sbjct: 204 GGDS 207
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (291), Expect = 1e-32
Identities = 44/192 (22%), Positives = 74/192 (38%), Gaps = 13/192 (6%)
Query: 19 DSDRYELVRDIGSGNFGVARLMRDKKT----EELVAVKYIERG--DKIDENVQREIINHR 72
+ IG+G FG K + E VA+K ++ G +K + E
Sbjct: 5 HPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMG 64
Query: 73 SLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVS 131
H NI+R + VI + I+ EY G L + + G FS + + + +G+
Sbjct: 65 QFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMK 124
Query: 132 YCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK----SSVLHSQPKSTVGTPAYIAP 187
Y +M HRDL N L++ + K+ DFG S+ + AP
Sbjct: 125 YLANMNYVHRDLAARNILVNSN--LVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAP 182
Query: 188 EVLLKKEYDGKV 199
E + +++
Sbjct: 183 EAISYRKFTSAS 194
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (291), Expect = 2e-32
Identities = 35/203 (17%), Positives = 77/203 (37%), Gaps = 22/203 (10%)
Query: 19 DSDRYELVRDIGSGNFGVARLMRDK-----KTEELVAVKYIERGDKIDE--NVQREIINH 71
++ + R++G G+FG+ K + E VA+K + + E E
Sbjct: 18 AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 77
Query: 72 RSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRF----------SEDEARF 121
+ ++VR V+ ++ME + G+L + + S +
Sbjct: 78 KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQ 137
Query: 122 FFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQPKST 178
++ G++Y ++ + HRDL N ++ +KI DFG ++ + + +
Sbjct: 138 MAGEIADGMAYLNANKFVHRDLAARNCMVAED--FTVKIGDFGMTRDIYETDYYRKGGKG 195
Query: 179 VGTPAYIAPEVLLKKEYDGKVMC 201
+ +++PE L +
Sbjct: 196 LLPVRWMSPESLKDGVFTTYSDV 218
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (291), Expect = 3e-32
Identities = 43/199 (21%), Positives = 73/199 (36%), Gaps = 14/199 (7%)
Query: 13 DMPIMHDSDRYELVRDIGSGNFGV---ARLMRDKKTEELVAVKYIERGDKIDE--NVQRE 67
+ I S IG G+FG L+ + + AVK + R I E E
Sbjct: 19 HVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTE 78
Query: 68 IINHRSLRHPNIVRFKEVIL-TPTHLAIVMEYASGGELFE-RICNAGRFSEDEARFFFQQ 125
I + HPN++ + L + +V+ Y G+L + + F Q
Sbjct: 79 GIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQ 138
Query: 126 LISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK-----SSVLHSQPKSTVG 180
+ G+ + S + HRDL N +LD +K+ DFG ++
Sbjct: 139 VAKGMKFLASKKFVHRDLAARNCMLDEK--FTVKVADFGLARDMYDKEFDSVHNKTGAKL 196
Query: 181 TPAYIAPEVLLKKEYDGKV 199
++A E L +++ K
Sbjct: 197 PVKWMALESLQTQKFTTKS 215
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (285), Expect = 1e-31
Identities = 41/208 (19%), Positives = 74/208 (35%), Gaps = 27/208 (12%)
Query: 19 DSDRYELVRDIGSGNFGVARLMRDKKTEE-------LVAVKYI--ERGDKIDENVQREII 69
DR L + +G G FG L ++ VAVK + + +K ++ E+
Sbjct: 11 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEME 70
Query: 70 NHRSL-RHPNIVRFKEVILTPTHLAIVMEYASGGELFERI----------------CNAG 112
+ + +H NI+ L +++EYAS G L E +
Sbjct: 71 MMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEE 130
Query: 113 RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRL-KICDFGYSKSSVL 171
+ S + Q+ G+ Y S + HRDL N L+ ++
Sbjct: 131 QLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDY 190
Query: 172 HSQPKSTVGTPAYIAPEVLLKKEYDGKV 199
+ + + ++APE L + Y +
Sbjct: 191 YKKTTNGRLPVKWMAPEALFDRIYTHQS 218
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 112 bits (281), Expect = 5e-31
Identities = 44/211 (20%), Positives = 76/211 (36%), Gaps = 30/211 (14%)
Query: 19 DSDRYELVRDIGSGNFGV-----ARLMRDKKTEELVAVKYIERGDKIDEN---VQREIIN 70
DR +L + +G G FG A + T VAVK ++ G E+ + I
Sbjct: 11 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKIL 70
Query: 71 HRSLRHPNIVRFKEVILTP-THLAIVMEYASGGELFERICNAGR---------------- 113
H N+V P L +++E+ G L + +
Sbjct: 71 IHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDF 130
Query: 114 FSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK---SSV 170
+ + + Q+ G+ + S + HRDL N LL +KICDFG ++
Sbjct: 131 LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEK--NVVKICDFGLARDIYKDP 188
Query: 171 LHSQPKSTVGTPAYIAPEVLLKKEYDGKVMC 201
+ + ++APE + + Y +
Sbjct: 189 DYVRKGDARLPLKWMAPETIFDRVYTIQSDV 219
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 103 bits (258), Expect = 3e-27
Identities = 42/197 (21%), Positives = 71/197 (36%), Gaps = 19/197 (9%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVR 81
RY LVR +G G+F L +D VA+K + E + EI + + + +
Sbjct: 14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTK 73
Query: 82 ---------------FKEVILTPTHLAIVMEYASGGEL-FERICNAGRFSEDEARFFFQQ 125
F H+ +V E L + + +Q
Sbjct: 74 EDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQ 133
Query: 126 LISGVSYCHSMQ-VCHRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQPKSTVGTP 182
L+ G+ Y H + H D+K EN L++ SP ++I + +++ T
Sbjct: 134 LLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTR 193
Query: 183 AYIAPEVLLKKEYDGKV 199
Y +PEVLL +
Sbjct: 194 EYRSPEVLLGAPWGCGA 210
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 67.5 bits (164), Expect = 9e-15
Identities = 24/161 (14%), Positives = 47/161 (29%), Gaps = 26/161 (16%)
Query: 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG-----------DKIDENVQREIINH 71
+ + +G G +K E VK+ + G D D + I
Sbjct: 2 DAIGKLMGEGKESAVFNCYSEKFGE-CVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRS 60
Query: 72 RSLRHPNIVRFKEVILTPTH----LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLI 127
+ + + + + + A++ME R + ++
Sbjct: 61 ARNEFRALQKLQGLAVPKVYAWEGNAVLMEL-------IDAKELYRVRVENPDEVLDMIL 113
Query: 128 SGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 168
V+ + + H DL N L+ + I DF S
Sbjct: 114 EEVAKFYHRGIVHGDLSQYNVLVSE---EGIWIIDFPQSVE 151
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 205 | |||
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.92 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.86 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 98.53 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.46 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 98.09 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 97.62 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 97.59 |
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-49 Score=292.50 Aligned_cols=184 Identities=36% Similarity=0.588 Sum_probs=163.3
Q ss_pred CCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCcc--chHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEE
Q 028681 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (205)
Q Consensus 20 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~ 97 (205)
.++|++.+.||+|+||+||++.+..+++.||+|++..... ..+.+.+|+.++++++||||+++++++.+++..++|||
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE 83 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 83 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEe
Confidence 4789999999999999999999999999999999976532 23568899999999999999999999999999999999
Q ss_pred ecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCC---CC
Q 028681 98 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH---SQ 174 (205)
Q Consensus 98 ~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~---~~ 174 (205)
|+++++|.+.+.....+++..++.++.|++.||.|||++||+||||||+||+++.++. +||+|||+|+..... ..
T Consensus 84 y~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~--~KL~DFG~a~~~~~~~~~~~ 161 (271)
T d1nvra_ 84 YCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDN--LKISDFGLATVFRYNNRERL 161 (271)
T ss_dssp CCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCC--EEECCCTTCEECEETTEECC
T ss_pred ccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCC--EEEccchhheeeccCCcccc
Confidence 9999999999988788999999999999999999999999999999999999988877 999999999865433 22
Q ss_pred CCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 175 PKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 175 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
.....||+.|+|||++.+..+++.++|||||
T Consensus 162 ~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSl 192 (271)
T d1nvra_ 162 LNKMCGTLPYVAPELLKRREFHAEPVDVWSC 192 (271)
T ss_dssp BCCCCSCGGGSCTHHHHCSSBCHHHHHHHHH
T ss_pred ccceeeCcCccCHhHhcCCCCCCCceeeeHh
Confidence 3445799999999999998886666999996
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-48 Score=285.05 Aligned_cols=182 Identities=31% Similarity=0.588 Sum_probs=164.8
Q ss_pred CCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCc----cchHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEE
Q 028681 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV 95 (205)
Q Consensus 20 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 95 (205)
.++|++.+.||+|+||+||++.+..+++.||+|++.+.. ...+.+.+|+.+++.++||||+++++++.+++..++|
T Consensus 5 l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~iv 84 (263)
T d2j4za1 5 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI 84 (263)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEE
Confidence 478999999999999999999999999999999987532 3346788999999999999999999999999999999
Q ss_pred EEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCCCCC
Q 028681 96 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 175 (205)
Q Consensus 96 ~~~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~~ 175 (205)
|||+++++|.+.+...+++++..++.++.|++.||.|||++||+||||||+||+++.++. +||+|||+|+.... ...
T Consensus 85 mEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~--~kl~DFG~a~~~~~-~~~ 161 (263)
T d2j4za1 85 LEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGE--LKIADFGWSVHAPS-SRR 161 (263)
T ss_dssp EECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSC--EEECCCCSCSCCCC-CCC
T ss_pred EeecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCC--EeecccceeeecCC-Ccc
Confidence 999999999999988889999999999999999999999999999999999999998877 99999999975543 333
Q ss_pred CCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 176 KSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 176 ~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
....||+.|+|||++.+..++.+ +|||||
T Consensus 162 ~~~~Gt~~Y~APE~~~~~~~~~~-~DiwSl 190 (263)
T d2j4za1 162 TTLCGTLDYLPPEMIEGRMHDEK-VDLWSL 190 (263)
T ss_dssp EETTEEGGGCCHHHHTTCCCCTT-HHHHHH
T ss_pred cccCCCCcccCHHHHcCCCCCch-hhhhhH
Confidence 45579999999999999988766 999996
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-47 Score=285.46 Aligned_cols=183 Identities=29% Similarity=0.486 Sum_probs=164.6
Q ss_pred cCCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCcc-chHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEE
Q 028681 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (205)
Q Consensus 19 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~ 97 (205)
..++|++.+.||+|+||+||+|.+..+|+.||+|.+..... ..+.+.+|+.+++.++||||+++++++.+++.+++|||
T Consensus 18 p~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE 97 (293)
T d1yhwa1 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 97 (293)
T ss_dssp TTTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cccccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEE
Confidence 34689999999999999999999999999999999976543 45678999999999999999999999999999999999
Q ss_pred ecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCCC-CCC
Q 028681 98 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPK 176 (205)
Q Consensus 98 ~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~~-~~~ 176 (205)
|+++++|.+++.. ..+++.+++.++.|++.||.|||++||+||||||+||+++.++. +||+|||+|+...... ...
T Consensus 98 y~~gg~L~~~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~--vkl~DFG~a~~~~~~~~~~~ 174 (293)
T d1yhwa1 98 YLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGS--VKLTDFGFCAQITPEQSKRS 174 (293)
T ss_dssp CCTTCBHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCC--EEECCCTTCEECCSTTCCBC
T ss_pred ecCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCc--Eeeccchhheeecccccccc
Confidence 9999999987755 56999999999999999999999999999999999999988877 9999999998765443 345
Q ss_pred CCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 177 STVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 177 ~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
...||+.|+|||++.+..++.+ +|||||
T Consensus 175 ~~~gt~~Y~aPE~~~~~~~~~~-~DiwSl 202 (293)
T d1yhwa1 175 TMVGTPYWMAPEVVTRKAYGPK-VDIWSL 202 (293)
T ss_dssp CCCSCGGGCCHHHHSSSCBCTH-HHHHHH
T ss_pred ccccCCCccChhhhcCCCCCch-hceehH
Confidence 5579999999999999988866 999996
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.2e-48 Score=286.27 Aligned_cols=184 Identities=30% Similarity=0.460 Sum_probs=163.3
Q ss_pred cCCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCc----cchHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEE
Q 028681 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 94 (205)
Q Consensus 19 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 94 (205)
..++|++.+.||+|+||+||+|.+..+++.||+|++.+.. ...+.+.+|+.++++++||||+++++++.+++.+++
T Consensus 6 ~p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 85 (288)
T d1uu3a_ 6 RPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYF 85 (288)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEE
T ss_pred CCCCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEE
Confidence 3578999999999999999999999999999999987532 234678899999999999999999999999999999
Q ss_pred EEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCCC-
Q 028681 95 VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS- 173 (205)
Q Consensus 95 v~~~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~~- 173 (205)
||||+++++|.+.+...+.+++..++.++.|++.||.|||++||+||||||+||+++.++. ++|+|||+|+......
T Consensus 86 vmEy~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~--vkl~DFG~a~~~~~~~~ 163 (288)
T d1uu3a_ 86 GLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMH--IQITDFGTAKVLSPESK 163 (288)
T ss_dssp EECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSC--EEECCCTTCEECC----
T ss_pred EEEccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCce--EEecccccceecccCCc
Confidence 9999999999999988889999999999999999999999999999999999999998887 9999999998664332
Q ss_pred --CCCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 174 --QPKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 174 --~~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
......||+.|+|||++.+..++.+ +|||||
T Consensus 164 ~~~~~~~~GT~~Y~APE~~~~~~~~~~-~DiwSl 196 (288)
T d1uu3a_ 164 QARANSFVGTAQYVSPELLTEKSACKS-SDLWAL 196 (288)
T ss_dssp ------CCCCGGGCCHHHHHTCCCCHH-HHHHHH
T ss_pred ccccccccCCccccCceeeccCCCCcc-cceehh
Confidence 2334579999999999999988765 999996
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=2.8e-47 Score=290.10 Aligned_cols=187 Identities=30% Similarity=0.506 Sum_probs=167.4
Q ss_pred ecCCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCcc-chHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEE
Q 028681 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (205)
Q Consensus 18 ~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 96 (205)
...++|++.+.||+|+||.||+|.+..+|+.||+|++..... ..+.+.+|+.++++++||||+++++++.+++.+++||
T Consensus 23 ~il~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 102 (350)
T d1koaa2 23 HVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIY 102 (350)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEE
T ss_pred CCccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 446799999999999999999999999999999999976543 3466889999999999999999999999999999999
Q ss_pred EecCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCCCCC
Q 028681 97 EYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 175 (205)
Q Consensus 97 ~~~~~~sl~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~~ 175 (205)
||+++++|.+.+.. .+++++..++.++.||+.||.|||++||+||||||+||+++.+....+||+|||+|+........
T Consensus 103 E~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~~~ 182 (350)
T d1koaa2 103 EFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSV 182 (350)
T ss_dssp CCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTSCE
T ss_pred EcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheeccccccc
Confidence 99999999998854 45799999999999999999999999999999999999997654445999999999877766666
Q ss_pred CCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 176 KSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 176 ~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
....||+.|+|||++.+..++.+ +|||||
T Consensus 183 ~~~~gT~~Y~aPEv~~~~~~~~~-~DiwSl 211 (350)
T d1koaa2 183 KVTTGTAEFAAPEVAEGKPVGYY-TDMWSV 211 (350)
T ss_dssp EEECSCTTTCCHHHHHTCCBCHH-HHHHHH
T ss_pred ceecCcccccCHHHHcCCCCChh-Hhhhhh
Confidence 66789999999999999988766 999996
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.6e-47 Score=286.89 Aligned_cols=185 Identities=36% Similarity=0.601 Sum_probs=148.4
Q ss_pred CCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCcc--chHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEE
Q 028681 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (205)
Q Consensus 20 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~ 97 (205)
.+.|++.+.||+|+||+||+|.+..+++.||+|++.+... ..+.+.+|+.+++.++||||+++++++.+++.+++|||
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE 87 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ 87 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 4669999999999999999999999999999999976532 23567889999999999999999999999999999999
Q ss_pred ecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecC-CCCCcEEEeeecccccccCCCCCC
Q 028681 98 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVLHSQPK 176 (205)
Q Consensus 98 ~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~-~~~~~~~l~df~~~~~~~~~~~~~ 176 (205)
|+++++|.+.+...+.+++..+..++.|++.||.|||++||+||||+|+||++.. +....+||+|||+|+.........
T Consensus 88 ~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~~~~ 167 (307)
T d1a06a_ 88 LVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLS 167 (307)
T ss_dssp CCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC-------------
T ss_pred ccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEccCCCeee
Confidence 9999999999988889999999999999999999999999999999999999964 222349999999998776666666
Q ss_pred CCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 177 STVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 177 ~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
+..||+.|+|||++.+..++.+ +|||||
T Consensus 168 ~~~GT~~y~APE~~~~~~~~~~-~DiwSl 195 (307)
T d1a06a_ 168 TACGTPGYVAPEVLAQKPYSKA-VDCWSI 195 (307)
T ss_dssp -----CTTSCHHHHTTCCCCTH-HHHHHH
T ss_pred eeeeCccccCcHHHcCCCCCcH-HHhhhh
Confidence 7789999999999999988866 999996
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1e-47 Score=285.63 Aligned_cols=186 Identities=22% Similarity=0.294 Sum_probs=166.5
Q ss_pred eecCCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCccchHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEE
Q 028681 17 MHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (205)
Q Consensus 17 ~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 96 (205)
..+.++|++.+.||+|+||+||++.+..+++.||+|.++.+....+++.+|+.++++++||||+++++++.+++..+++|
T Consensus 13 ei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~ 92 (287)
T d1opja_ 13 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT 92 (287)
T ss_dssp BCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred EecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccchHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEe
Confidence 34578999999999999999999999999999999999887777788999999999999999999999999999999999
Q ss_pred EecCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCCCC
Q 028681 97 EYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 174 (205)
Q Consensus 97 ~~~~~~sl~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~ 174 (205)
||+++++|.+.+... ..+++..+..++.|++.||.|||++||+||||||+||+++.++. +||+|||+|+.......
T Consensus 93 E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~--~Kl~DFG~a~~~~~~~~ 170 (287)
T d1opja_ 93 EFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHL--VKVADFGLSRLMTGDTY 170 (287)
T ss_dssp ECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC--EEECCCCCTTTCCSSSS
T ss_pred ecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCc--EEEccccceeecCCCCc
Confidence 999999999998653 46899999999999999999999999999999999999998877 99999999986544332
Q ss_pred C--CCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 175 P--KSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 175 ~--~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
. ....+++.|+|||++.+..++.+ +|||||
T Consensus 171 ~~~~~~~g~~~y~aPE~~~~~~~~~k-~DiwS~ 202 (287)
T d1opja_ 171 TAHAGAKFPIKWTAPESLAYNKFSIK-SDVWAF 202 (287)
T ss_dssp EEETTEEECGGGCCHHHHHHCCCSHH-HHHHHH
T ss_pred eeeccccccccccChHHHcCCCCCch-hhhhhH
Confidence 2 22347889999999999998865 999996
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-47 Score=289.17 Aligned_cols=183 Identities=28% Similarity=0.441 Sum_probs=163.8
Q ss_pred cCCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCc--cchHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEE
Q 028681 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (205)
Q Consensus 19 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 96 (205)
..++|++.+.||+|+||+||++.+..++..||+|+++... ...+.+.+|+.+++.++||||++++++|.+++.+++||
T Consensus 4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVm 83 (322)
T d1s9ja_ 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 83 (322)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 4579999999999999999999999999999999997643 33467889999999999999999999999999999999
Q ss_pred EecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-cCcEeecCCCCCeEecCCCCCcEEEeeecccccccCCCCC
Q 028681 97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS-MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 175 (205)
Q Consensus 97 ~~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~-~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~~ 175 (205)
||+++++|.+++.+.+.+++..++.++.|++.||.|||+ +||+||||||+||+++.++. +||+|||+|+..... ..
T Consensus 84 Ey~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~--vkl~DFGla~~~~~~-~~ 160 (322)
T d1s9ja_ 84 EHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGE--IKLCDFGVSGQLIDS-MA 160 (322)
T ss_dssp ECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCC--EEECCCCCCHHHHHH-TC
T ss_pred EcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCC--EEEeeCCCccccCCC-cc
Confidence 999999999999888889999999999999999999996 59999999999999988877 999999999765432 33
Q ss_pred CCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 176 KSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 176 ~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
.+..||+.|+|||++.+..++.+ +|||||
T Consensus 161 ~~~~GT~~Y~APEvl~~~~y~~~-~DiWSl 189 (322)
T d1s9ja_ 161 NSFVGTRSYMSPERLQGTHYSVQ-SDIWSM 189 (322)
T ss_dssp ---CCSSCCCCHHHHHCSCCCTT-HHHHHH
T ss_pred ccccCCccccCchHHcCCCCCcH-HHHHHH
Confidence 45689999999999999999876 999996
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.6e-47 Score=285.65 Aligned_cols=183 Identities=34% Similarity=0.553 Sum_probs=166.8
Q ss_pred CCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCc----cchHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEE
Q 028681 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV 95 (205)
Q Consensus 20 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 95 (205)
.++|++.+.||+|+||.||+|.+..+++.||+|++.+.. ...+.+.+|+.+++.++||||+++++++.+++.+++|
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv 83 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccc
Confidence 578999999999999999999999999999999997642 2346688999999999999999999999999999999
Q ss_pred EEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccC-CCC
Q 028681 96 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQ 174 (205)
Q Consensus 96 ~~~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~-~~~ 174 (205)
|||+++++|.+.+...+.+++..++.++.|++.||+|||++||+||||||+||+++.++. +||+|||+|+.... ...
T Consensus 84 ~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~--vkl~DFG~a~~~~~~~~~ 161 (337)
T d1o6la_ 84 MEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGH--IKITDFGLCKEGISDGAT 161 (337)
T ss_dssp EECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSC--EEECCCTTCBCSCCTTCC
T ss_pred eeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCC--EEEeecccccccccCCcc
Confidence 999999999999999899999999999999999999999999999999999999998887 99999999986544 334
Q ss_pred CCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 175 PKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 175 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
.....||+.|+|||++.+..++.+ +|||||
T Consensus 162 ~~~~~GT~~Y~aPE~~~~~~y~~~-~DiwSl 191 (337)
T d1o6la_ 162 MKTFCGTPEYLAPEVLEDNDYGRA-VDWWGL 191 (337)
T ss_dssp BCCCEECGGGCCGGGGSSSCBCTT-HHHHHH
T ss_pred cccceeCHHHhhhhhccCCCCChh-hcccch
Confidence 455679999999999999999866 999996
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-46 Score=279.28 Aligned_cols=185 Identities=33% Similarity=0.589 Sum_probs=167.8
Q ss_pred CCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCc-------cchHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeE
Q 028681 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD-------KIDENVQREIINHRSLRHPNIVRFKEVILTPTHL 92 (205)
Q Consensus 20 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~-------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 92 (205)
.++|++.+.||+|+||+||+|.+..+|+.||+|++.+.. ...+.+.+|+.++++++||||+++++++.+++.+
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 88 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 367999999999999999999999999999999987532 2246789999999999999999999999999999
Q ss_pred EEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCC--CcEEEeeeccccccc
Q 028681 93 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPA--PRLKICDFGYSKSSV 170 (205)
Q Consensus 93 ~lv~~~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~--~~~~l~df~~~~~~~ 170 (205)
++||||+++++|.+.+...+.+++..++.++.|++.||+|||+++|+||||+|+||+++.++. ..+||+|||+|....
T Consensus 89 ~iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~~ 168 (293)
T d1jksa_ 89 ILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID 168 (293)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEECT
T ss_pred EEEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhhhcC
Confidence 999999999999999988889999999999999999999999999999999999999986653 249999999998877
Q ss_pred CCCCCCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 171 LHSQPKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 171 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
.........+++.|+|||++.+..++.+ +|||||
T Consensus 169 ~~~~~~~~~~t~~y~APE~~~~~~~~~~-~DiwSl 202 (293)
T d1jksa_ 169 FGNEFKNIFGTPEFVAPEIVNYEPLGLE-ADMWSI 202 (293)
T ss_dssp TSCBCSCCCCCGGGCCHHHHTTCCBCTH-HHHHHH
T ss_pred CCccccccCCCCcccCHHHHcCCCCCCc-ccchhh
Confidence 6666677789999999999999888766 999996
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=1e-46 Score=287.24 Aligned_cols=187 Identities=27% Similarity=0.446 Sum_probs=167.0
Q ss_pred ecCCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCcc-chHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEE
Q 028681 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (205)
Q Consensus 18 ~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 96 (205)
...++|++.+.||+|+||.||+|.+..+|+.||+|+++.... ..+.+.+|+.++++++||||++++++|.+++.+++||
T Consensus 26 ~~~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 105 (352)
T d1koba_ 26 SVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLIL 105 (352)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CcccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 345789999999999999999999999999999999986543 3456788999999999999999999999999999999
Q ss_pred EecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCCCCC
Q 028681 97 EYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 175 (205)
Q Consensus 97 ~~~~~~sl~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~~ 175 (205)
||+++++|.+.+... .++++.+++.++.|++.||.|||++||+||||||+|||++.....++||+|||+|+........
T Consensus 106 E~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~~~ 185 (352)
T d1koba_ 106 EFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIV 185 (352)
T ss_dssp ECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSCE
T ss_pred EcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecCCCCce
Confidence 999999998877554 4699999999999999999999999999999999999998544445999999999888776666
Q ss_pred CCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 176 KSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 176 ~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
....+++.|+|||++.+..++.+ +|||||
T Consensus 186 ~~~~gt~~y~aPE~~~~~~~~~~-~DiwSl 214 (352)
T d1koba_ 186 KVTTATAEFAAPEIVDREPVGFY-TDMWAI 214 (352)
T ss_dssp EEECSSGGGCCHHHHTTCCBCHH-HHHHHH
T ss_pred eeccCcccccCHHHHcCCCCCCc-cchHHH
Confidence 66789999999999999999866 999996
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.6e-47 Score=280.58 Aligned_cols=182 Identities=30% Similarity=0.491 Sum_probs=160.3
Q ss_pred CCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCc-cchHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEEec
Q 028681 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA 99 (205)
Q Consensus 21 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~~ 99 (205)
+.|++.+.||+|+||+||++.+..++..||+|++.... ...+.+..|+.++++++||||+++++++.+++..++||||+
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~ 91 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 91 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence 57999999999999999999999999999999997653 34467889999999999999999999999999999999999
Q ss_pred CCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCC-CCCCC
Q 028681 100 SGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKS 177 (205)
Q Consensus 100 ~~~sl~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~-~~~~~ 177 (205)
++++|.+.+.. .+++++..++.++.|++.||.|||++||+||||||+||+++.++. +||+|||+|+..... .....
T Consensus 92 ~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~--~Kl~DFG~a~~~~~~~~~~~~ 169 (288)
T d2jfla1 92 AGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGD--IKLADFGVSAKNTRTIQRRDS 169 (288)
T ss_dssp TTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC--EEECCCTTCEECHHHHHHHTC
T ss_pred CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCC--EEEEechhhhccCCCcccccc
Confidence 99999998754 567999999999999999999999999999999999999998887 999999998654332 22345
Q ss_pred CCCCCCccCCceec-----cCcCCCeeeEEEeC
Q 028681 178 TVGTPAYIAPEVLL-----KKEYDGKVMCVYVI 205 (205)
Q Consensus 178 ~~~~~~~~aPE~~~-----~~~~~~~~~Dvwsl 205 (205)
..||+.|+|||++. +..++.+ +|||||
T Consensus 170 ~~Gt~~y~APE~l~~~~~~~~~y~~k-~DiwSl 201 (288)
T d2jfla1 170 FIGTPYWMAPEVVMCETSKDRPYDYK-ADVWSL 201 (288)
T ss_dssp CCSCCTTCCHHHHTTCSTTTSSTTTH-HHHHHH
T ss_pred cccccccCCHHHHhhcccCCCCCChh-hhHHHH
Confidence 67999999999985 3456655 999996
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=3.1e-46 Score=280.93 Aligned_cols=181 Identities=31% Similarity=0.543 Sum_probs=165.0
Q ss_pred CCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCc----cchHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEE
Q 028681 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV 95 (205)
Q Consensus 20 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 95 (205)
.++|++.+.||+|+||+||+|.+..+|+.||+|++++.. ...+.+.+|+.+++.++||||+++++++.+++..++|
T Consensus 3 l~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv 82 (316)
T d1fota_ 3 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 82 (316)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hhHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeE
Confidence 578999999999999999999999999999999997542 3346788999999999999999999999999999999
Q ss_pred EEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCCCCC
Q 028681 96 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 175 (205)
Q Consensus 96 ~~~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~~ 175 (205)
|||+.+++|...+.....+++..++.++.|++.||.|||++||+||||||+||+++.++. +||+|||+|+.... ..
T Consensus 83 mE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~--vkL~DFG~a~~~~~--~~ 158 (316)
T d1fota_ 83 MDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGH--IKITDFGFAKYVPD--VT 158 (316)
T ss_dssp ECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSC--EEECCCSSCEECSS--CB
T ss_pred eeecCCccccccccccccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCC--EEEecCccceEecc--cc
Confidence 999999999999998889999999999999999999999999999999999999998887 99999999976543 23
Q ss_pred CCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 176 KSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 176 ~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
.+..||+.|+|||++.+..++.+ +|||||
T Consensus 159 ~~~~Gt~~Y~APE~l~~~~y~~~-~DiwSl 187 (316)
T d1fota_ 159 YTLCGTPDYIAPEVVSTKPYNKS-IDWWSF 187 (316)
T ss_dssp CCCCSCTTTCCHHHHTTCCBCTT-HHHHHH
T ss_pred ccccCcccccCHHHHcCCCCCch-hhcccc
Confidence 45679999999999999989866 999996
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-46 Score=283.67 Aligned_cols=186 Identities=23% Similarity=0.396 Sum_probs=169.5
Q ss_pred cCCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCccchHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEEe
Q 028681 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (205)
Q Consensus 19 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~ 98 (205)
..++|++.+.||+|+||+||+|.+..+++.||+|.++........+.+|+.+++.++||||+++++++.+++.+++||||
T Consensus 3 ~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~ 82 (321)
T d1tkia_ 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred CccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEec
Confidence 36899999999999999999999999999999999987766666788999999999999999999999999999999999
Q ss_pred cCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCCCCCCC
Q 028681 99 ASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS 177 (205)
Q Consensus 99 ~~~~sl~~~~~~~~-~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~~~~ 177 (205)
+++++|.+.+...+ ++++.+++.++.|++.||.|||+.||+||||+|+||+++.+...+++|+|||+++..........
T Consensus 83 ~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~~~~~ 162 (321)
T d1tkia_ 83 ISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL 162 (321)
T ss_dssp CCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCEEEE
T ss_pred CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhccccCCcccc
Confidence 99999999997654 79999999999999999999999999999999999999876666699999999987766555566
Q ss_pred CCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 178 TVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 178 ~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
..+++.|+|||.+.+..++.+ +|||||
T Consensus 163 ~~~t~~y~ape~~~~~~~~~~-~DiWSl 189 (321)
T d1tkia_ 163 LFTAPEYYAPEVHQHDVVSTA-TDMWSL 189 (321)
T ss_dssp EESCGGGSCHHHHTTCEECHH-HHHHHH
T ss_pred cccccccccchhccCCCCCch-hhcccH
Confidence 679999999999999988765 999996
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-46 Score=276.92 Aligned_cols=184 Identities=33% Similarity=0.552 Sum_probs=150.4
Q ss_pred cCCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCccc---hHHHHHHHHHHHhcCCCCeeEEEEEEEe--CCeEE
Q 028681 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI---DENVQREIINHRSLRHPNIVRFKEVILT--PTHLA 93 (205)
Q Consensus 19 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~ 93 (205)
+.++|++.+.||+|+||+||++.+..+|+.||+|.+...... .+.+.+|+.++++++||||+++++++.+ ++.++
T Consensus 2 r~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ 81 (269)
T d2java1 2 RAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLY 81 (269)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEE
T ss_pred CchhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEE
Confidence 357899999999999999999999999999999998765432 3568899999999999999999999975 45689
Q ss_pred EEEEecCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhcC-----cEeecCCCCCeEecCCCCCcEEEeeec
Q 028681 94 IVMEYASGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHSMQ-----VCHRDLKLENTLLDGSPAPRLKICDFG 164 (205)
Q Consensus 94 lv~~~~~~~sl~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lh~~~-----i~H~di~p~nili~~~~~~~~~l~df~ 164 (205)
+||||+++++|.+++.+ ...+++..++.++.|++.||.|||+++ |+||||||+||+++.++. +||+|||
T Consensus 82 ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~--vkl~DFG 159 (269)
T d2java1 82 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQN--VKLGDFG 159 (269)
T ss_dssp EEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSC--EEECCHH
T ss_pred EEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCc--EEEeecc
Confidence 99999999999998853 457999999999999999999999876 999999999999998877 9999999
Q ss_pred ccccccCCC-CCCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 165 YSKSSVLHS-QPKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 165 ~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
+|+...... ......||+.|+|||++.+..++.+ +|||||
T Consensus 160 ~a~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~-~DIwSl 200 (269)
T d2java1 160 LARILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEK-SDIWSL 200 (269)
T ss_dssp HHHHC-----------CCCSCCCHHHHTTCCCCHH-HHHHHH
T ss_pred ceeecccCCCccccCCCCcccCCHHHHcCCCCChH-HHHHhh
Confidence 998765443 3345679999999999999888765 999996
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-46 Score=275.75 Aligned_cols=183 Identities=26% Similarity=0.403 Sum_probs=155.0
Q ss_pred cCCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCccchHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEEe
Q 028681 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (205)
Q Consensus 19 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~ 98 (205)
++++|++.+.||+|+||+||++.+.. +..||+|.++......+++.+|+.++++++||||++++|++..++..++||||
T Consensus 3 dp~~~~~~~~iG~G~fg~Vy~~~~~~-~~~vAvK~i~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~ 81 (263)
T d1sm2a_ 3 DPSELTFVQEIGSGQFGLVHLGYWLN-KDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEF 81 (263)
T ss_dssp CCSCEEEEEEEECCSSCCEEEEEETT-TEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred ChHHcEEEEEEeeCCCeEEEEEEECC-CCEEEEEEECCCcCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEe
Confidence 56899999999999999999999864 66799999988777778899999999999999999999999999999999999
Q ss_pred cCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCCCCC--
Q 028681 99 ASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP-- 175 (205)
Q Consensus 99 ~~~~sl~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~~-- 175 (205)
+++++|.+++... ..+++..+..++.|++.||.|||+++|+||||+|+||+++.++. +||+|||+++........
T Consensus 82 ~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~--~Kl~DFGla~~~~~~~~~~~ 159 (263)
T d1sm2a_ 82 MEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQV--IKVSDFGMTRFVLDDQYTSS 159 (263)
T ss_dssp CTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGC--EEECSCC-------------
T ss_pred cCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCC--eEecccchheeccCCCceee
Confidence 9999999988654 56899999999999999999999999999999999999998887 999999999765443322
Q ss_pred CCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 176 KSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 176 ~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
....||+.|+|||++.+..++.+ +|||||
T Consensus 160 ~~~~gt~~y~aPE~l~~~~~~~k-~DVwS~ 188 (263)
T d1sm2a_ 160 TGTKFPVKWASPEVFSFSRYSSK-SDVWSF 188 (263)
T ss_dssp -----CTTSCCHHHHTTCCCCHH-HHHHHH
T ss_pred cceecCcccCChHHhcCCCCCch-hhhcch
Confidence 23468999999999999998866 999996
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5.5e-46 Score=278.63 Aligned_cols=178 Identities=32% Similarity=0.505 Sum_probs=158.4
Q ss_pred CeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCccc----hHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEE
Q 028681 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI----DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (205)
Q Consensus 22 ~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~ 97 (205)
.|+.++.||+|+||+||+|.+..+++.||+|.+...... .+.+.+|+.++++++||||+++++++.+++..++|||
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E 95 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence 599999999999999999999999999999999765432 2457889999999999999999999999999999999
Q ss_pred ecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCCCCCCC
Q 028681 98 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS 177 (205)
Q Consensus 98 ~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~~~~ 177 (205)
|+.++++........++++..++.++.|++.||.|||++||+||||||+||+++.++. +||+|||+|..... ...
T Consensus 96 ~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~--~Kl~DFG~a~~~~~---~~~ 170 (309)
T d1u5ra_ 96 YCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGL--VKLGDFGSASIMAP---ANS 170 (309)
T ss_dssp CCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTE--EEECCCTTCBSSSS---BCC
T ss_pred ecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCC--EEEeecccccccCC---CCc
Confidence 9999988877777788999999999999999999999999999999999999988777 99999999976543 234
Q ss_pred CCCCCCccCCceecc---CcCCCeeeEEEeC
Q 028681 178 TVGTPAYIAPEVLLK---KEYDGKVMCVYVI 205 (205)
Q Consensus 178 ~~~~~~~~aPE~~~~---~~~~~~~~Dvwsl 205 (205)
..||+.|+|||++.+ ..|+.+ +|||||
T Consensus 171 ~~GT~~Y~APE~~~~~~~~~y~~~-~DiwSl 200 (309)
T d1u5ra_ 171 FVGTPYWMAPEVILAMDEGQYDGK-VDVWSL 200 (309)
T ss_dssp CCSCGGGCCHHHHTTTTSCCBCTH-HHHHHH
T ss_pred cccCccccCHHHHhccCCCCcCch-hhhhhH
Confidence 579999999999964 346655 999996
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.8e-45 Score=280.20 Aligned_cols=181 Identities=31% Similarity=0.560 Sum_probs=164.9
Q ss_pred CCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCc----cchHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEE
Q 028681 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV 95 (205)
Q Consensus 20 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 95 (205)
.++|++++.||+|+||.||+|.+..+|+.||+|++.+.. ...+.+.+|+.+++.++||||+++++++.+....+++
T Consensus 40 ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v 119 (350)
T d1rdqe_ 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccccccccc
Confidence 579999999999999999999999999999999987532 2346688999999999999999999999999999999
Q ss_pred EEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCCCCC
Q 028681 96 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 175 (205)
Q Consensus 96 ~~~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~~ 175 (205)
++++.+++|...+...+.+++..++.++.||+.||.|||+++|+||||||+|||++.++. +||+|||+|+..... .
T Consensus 120 ~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~--ikL~DFG~a~~~~~~--~ 195 (350)
T d1rdqe_ 120 MEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGY--IQVTDFGFAKRVKGR--T 195 (350)
T ss_dssp EECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC--EEECCCTTCEECSSC--B
T ss_pred cccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCC--EEeeeceeeeecccc--c
Confidence 999999999999988889999999999999999999999999999999999999988877 999999999866432 3
Q ss_pred CCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 176 KSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 176 ~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
....||+.|+|||++.+..++.+ +|||||
T Consensus 196 ~~~~Gt~~Y~APE~~~~~~~~~~-~DiwSl 224 (350)
T d1rdqe_ 196 WTLCGTPEALAPEIILSKGYNKA-VDWWAL 224 (350)
T ss_dssp CCCEECGGGCCHHHHTTCCBCTH-HHHHHH
T ss_pred ccccCccccCCHHHHcCCCCCcc-ccccch
Confidence 45679999999999999999866 999996
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-45 Score=268.36 Aligned_cols=179 Identities=27% Similarity=0.436 Sum_probs=155.0
Q ss_pred Ce-EEEeeeccccceeEEEEEecCCCcEEEEEEeecCcc---chHHHHHHHHHHHhcCCCCeeEEEEEEEe----CCeEE
Q 028681 22 RY-ELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILT----PTHLA 93 (205)
Q Consensus 22 ~y-~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~~ 93 (205)
+| ++.+.||+|+||+||++.+..++..||+|.+..... ..+.+.+|+.++++++||||+++++++.+ +..++
T Consensus 9 ry~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ 88 (270)
T d1t4ha_ 9 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV 88 (270)
T ss_dssp CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred CEEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEE
Confidence 44 788899999999999999999999999999876432 23568899999999999999999999875 35689
Q ss_pred EEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcC--cEeecCCCCCeEecC-CCCCcEEEeeeccccccc
Q 028681 94 IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ--VCHRDLKLENTLLDG-SPAPRLKICDFGYSKSSV 170 (205)
Q Consensus 94 lv~~~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~--i~H~di~p~nili~~-~~~~~~~l~df~~~~~~~ 170 (205)
+||||+++++|.+.+.+...+++..++.++.|++.||.|||+++ |+||||||+||+++. ++. +||+|||+|+...
T Consensus 89 ivmE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~--~Kl~DFGla~~~~ 166 (270)
T d1t4ha_ 89 LVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGS--VKIGDLGLATLKR 166 (270)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSC--EEECCTTGGGGCC
T ss_pred EEEeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCC--EEEeecCcceecc
Confidence 99999999999999988889999999999999999999999998 999999999999964 555 9999999997543
Q ss_pred CCCCCCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 171 LHSQPKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 171 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
. .......||+.|+|||++.+ .++.+ +|||||
T Consensus 167 ~-~~~~~~~GT~~Y~aPE~~~~-~~~~~-~DIwSl 198 (270)
T d1t4ha_ 167 A-SFAKAVIGTPEFMAPEMYEE-KYDES-VDVYAF 198 (270)
T ss_dssp T-TSBEESCSSCCCCCGGGGGT-CCCTH-HHHHHH
T ss_pred C-CccCCcccCccccCHHHhCC-CCCCc-CchhhH
Confidence 2 23345679999999999865 47755 999996
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-45 Score=271.99 Aligned_cols=186 Identities=22% Similarity=0.307 Sum_probs=161.6
Q ss_pred CceecCCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCccchHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEE
Q 028681 15 PIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 94 (205)
Q Consensus 15 ~~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 94 (205)
.+....++|++.+.||+|+||.||++.++ ++..||+|.++......+.+.+|+.++++++||||++++|++.+ +..++
T Consensus 7 ~wei~~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~i 84 (272)
T d1qpca_ 7 EWEVPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYI 84 (272)
T ss_dssp TTBCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEE
T ss_pred CeecCHHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCcCCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEE
Confidence 34445789999999999999999999976 46789999998877777889999999999999999999998754 56789
Q ss_pred EEEecCCCchHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCC
Q 028681 95 VMEYASGGELFERICN--AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 172 (205)
Q Consensus 95 v~~~~~~~sl~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~ 172 (205)
||||+++++|.+.+.. ..++++..+..++.|++.||.|||+++|+||||||+||+++.++. +||+|||+|+.....
T Consensus 85 v~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~--~Kl~DFGla~~~~~~ 162 (272)
T d1qpca_ 85 ITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLS--CKIADFGLARLIEDN 162 (272)
T ss_dssp EEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSC--EEECCCTTCEECSSS
T ss_pred EEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccc--eeeccccceEEccCC
Confidence 9999999999887744 335999999999999999999999999999999999999998887 999999999866543
Q ss_pred C--CCCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 173 S--QPKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 173 ~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
. ......+++.|+|||++.+..++.+ +|||||
T Consensus 163 ~~~~~~~~~gt~~y~APE~~~~~~~~~~-sDvwS~ 196 (272)
T d1qpca_ 163 EYTAREGAKFPIKWTAPEAINYGTFTIK-SDVWSF 196 (272)
T ss_dssp CEECCTTCCCCTTTSCHHHHHHCEECHH-HHHHHH
T ss_pred ccccccccCCcccccChHHHhCCCCCch-hhhhhh
Confidence 2 2334568999999999998888765 999996
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=6.8e-45 Score=268.88 Aligned_cols=183 Identities=31% Similarity=0.445 Sum_probs=164.2
Q ss_pred CCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCccc----------hHHHHHHHHHHHhcC-CCCeeEEEEEEEe
Q 028681 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI----------DENVQREIINHRSLR-HPNIVRFKEVILT 88 (205)
Q Consensus 20 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~----------~~~~~~e~~~l~~l~-h~~i~~~~~~~~~ 88 (205)
.++|++.+.||+|+||+||++++..+++.||+|++.+.... .+.+.+|+.++++++ ||||+++++++.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence 47999999999999999999999999999999999765321 235778999999997 9999999999999
Q ss_pred CCeEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeeccccc
Q 028681 89 PTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 168 (205)
Q Consensus 89 ~~~~~lv~~~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~ 168 (205)
++..++||||+++++|.+.+...+++++.+++.++.|++.||+|||++||+||||+|+||+++.++. +||+|||+++.
T Consensus 82 ~~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~--~kl~DFG~a~~ 159 (277)
T d1phka_ 82 NTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMN--IKLTDFGFSCQ 159 (277)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC--EEECCCTTCEE
T ss_pred CcceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCC--eEEccchheeE
Confidence 9999999999999999999988889999999999999999999999999999999999999988887 99999999988
Q ss_pred ccCCCCCCCCCCCCCccCCceeccC------cCCCeeeEEEeC
Q 028681 169 SVLHSQPKSTVGTPAYIAPEVLLKK------EYDGKVMCVYVI 205 (205)
Q Consensus 169 ~~~~~~~~~~~~~~~~~aPE~~~~~------~~~~~~~Dvwsl 205 (205)
...........||+.|+|||.+.+. .++. ++|||||
T Consensus 160 ~~~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~-~~Diwsl 201 (277)
T d1phka_ 160 LDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGK-EVDMWST 201 (277)
T ss_dssp CCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCT-HHHHHHH
T ss_pred ccCCCceeeeeccCCCCCHHHhhccccccCCCCCc-hheEccc
Confidence 7776666667899999999999743 2344 4999985
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-45 Score=269.03 Aligned_cols=183 Identities=23% Similarity=0.388 Sum_probs=163.4
Q ss_pred cCCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCccchHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEEe
Q 028681 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (205)
Q Consensus 19 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~~ 98 (205)
++++|++.++||+|+||+||+++++ ++..||+|.++++....+++.+|+.++++++||||++++|++.+++.+++||||
T Consensus 2 ~~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey 80 (258)
T d1k2pa_ 2 DPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEY 80 (258)
T ss_dssp CCCCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSSCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEEC
T ss_pred ChHHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCcCCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEc
Confidence 4689999999999999999999985 577899999998877788999999999999999999999999999999999999
Q ss_pred cCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCCCCC--
Q 028681 99 ASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP-- 175 (205)
Q Consensus 99 ~~~~sl~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~~-- 175 (205)
+++++|...+.. ...+++..+..++.|++.||+|||+.||+||||+|+||+++.++. +||+|||+++........
T Consensus 81 ~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~--~kl~DfG~a~~~~~~~~~~~ 158 (258)
T d1k2pa_ 81 MANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGV--VKVSDFGLSRYVLDDEYTSS 158 (258)
T ss_dssp CTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCC--EEECCCSSCCBCSSSSCCCC
T ss_pred cCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCc--EEECcchhheeccCCCceee
Confidence 999999888654 456999999999999999999999999999999999999998877 999999999765443322
Q ss_pred CCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 176 KSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 176 ~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
....+++.|+|||.+.+..++.+ +|||||
T Consensus 159 ~~~~~t~~y~aPE~~~~~~~~~k-sDiwS~ 187 (258)
T d1k2pa_ 159 VGSKFPVRWSPPEVLMYSKFSSK-SDIWAF 187 (258)
T ss_dssp CCSCCCGGGCCHHHHHHCCCCHH-HHHHHH
T ss_pred cccCCCCCcCCcHHhcCCCCCcc-eeeccc
Confidence 23468899999999999998865 999996
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-44 Score=272.04 Aligned_cols=182 Identities=32% Similarity=0.510 Sum_probs=161.0
Q ss_pred CCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCc----cchHHHHHHHHHH-HhcCCCCeeEEEEEEEeCCeEEEE
Q 028681 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINH-RSLRHPNIVRFKEVILTPTHLAIV 95 (205)
Q Consensus 21 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~e~~~l-~~l~h~~i~~~~~~~~~~~~~~lv 95 (205)
++|++.+.||+|+||+||+|.+..+++.||+|++.+.. ...+.+..|..++ +.++||||+++++++.+++.+++|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 68999999999999999999999999999999997532 2234455566555 478999999999999999999999
Q ss_pred EEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCCCC-
Q 028681 96 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ- 174 (205)
Q Consensus 96 ~~~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~- 174 (205)
|||+++++|.+.+.....+++..++.++.|++.||+|||+++|+||||+|+||+++.++. +||+|||+++.......
T Consensus 82 mEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~--~kl~DFG~a~~~~~~~~~ 159 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGH--IKIADFGMCKENMLGDAK 159 (320)
T ss_dssp EECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSC--EEECCCTTCBCCCCTTCC
T ss_pred EeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCc--eeccccchhhhccccccc
Confidence 999999999999998889999999999999999999999999999999999999998887 99999999976554333
Q ss_pred CCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 175 PKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 175 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
.....||+.|+|||++.+..++.+ +|||||
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~-~DiwSl 189 (320)
T d1xjda_ 160 TNTFCGTPDYIAPEILLGQKYNHS-VDWWSF 189 (320)
T ss_dssp BCCCCSCGGGCCHHHHTTCCBCTH-HHHHHH
T ss_pred ccccCCCCCcCCHHHHcCCCCCch-hhhhhh
Confidence 344579999999999999999866 999996
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=9.2e-45 Score=277.64 Aligned_cols=182 Identities=29% Similarity=0.455 Sum_probs=157.9
Q ss_pred CCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCcc----chHHHHH---HHHHHHhcCCCCeeEEEEEEEeCCeE
Q 028681 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK----IDENVQR---EIINHRSLRHPNIVRFKEVILTPTHL 92 (205)
Q Consensus 20 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~----~~~~~~~---e~~~l~~l~h~~i~~~~~~~~~~~~~ 92 (205)
.++|++.+.||+|+||.||+|.+..+|+.||+|++.+... ....+.. ++.+++.+.||||+++++++.+++.+
T Consensus 3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~ 82 (364)
T d1omwa3 3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 82 (364)
T ss_dssp STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEE
Confidence 5899999999999999999999999999999999875321 1222333 45666677899999999999999999
Q ss_pred EEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCC
Q 028681 93 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 172 (205)
Q Consensus 93 ~lv~~~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~ 172 (205)
++||||+++++|.+.+.....+++..++.++.||+.||.|||++||+||||||+||+++.++. +||+|||+|+.....
T Consensus 83 ~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~--iKl~DFGla~~~~~~ 160 (364)
T d1omwa3 83 SFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGH--VRISDLGLACDFSKK 160 (364)
T ss_dssp EEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSC--EEECCCTTCEECSSS
T ss_pred EEEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCc--EEEeeeceeeecCCC
Confidence 999999999999999988889999999999999999999999999999999999999998887 999999999765443
Q ss_pred CCCCCCCCCCCccCCceeccC-cCCCeeeEEEeC
Q 028681 173 SQPKSTVGTPAYIAPEVLLKK-EYDGKVMCVYVI 205 (205)
Q Consensus 173 ~~~~~~~~~~~~~aPE~~~~~-~~~~~~~Dvwsl 205 (205)
......||+.|+|||++.+. .++.+ +|||||
T Consensus 161 -~~~~~~GT~~y~APE~~~~~~~~~~~-~DiwSl 192 (364)
T d1omwa3 161 -KPHASVGTHGYMAPEVLQKGVAYDSS-ADWFSL 192 (364)
T ss_dssp -CCCSCCSCGGGCCHHHHSTTCCCCTH-HHHHHH
T ss_pred -cccccccccccchhHHhhcCCCCCcc-cchhHH
Confidence 34556799999999999754 46655 999996
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-44 Score=271.45 Aligned_cols=182 Identities=34% Similarity=0.513 Sum_probs=158.9
Q ss_pred cCCCeEEEe-eeccccceeEEEEEecCCCcEEEEEEeecCccchHHHHHHHHHHHhc-CCCCeeEEEEEEEe----CCeE
Q 028681 19 DSDRYELVR-DIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSL-RHPNIVRFKEVILT----PTHL 92 (205)
Q Consensus 19 ~~~~y~~~~-~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~----~~~~ 92 (205)
..++|++.. .||+|+||+||+|.+..+++.||+|+++.. +.+..|+.++.++ +||||++++++|.+ +..+
T Consensus 9 i~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~ 84 (335)
T d2ozaa1 9 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 84 (335)
T ss_dssp GGGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred cccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc----HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEE
Confidence 357899875 599999999999999999999999998743 4567788876554 89999999999976 3678
Q ss_pred EEEEEecCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCC-CCcEEEeeecccccc
Q 028681 93 AIVMEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSP-APRLKICDFGYSKSS 169 (205)
Q Consensus 93 ~lv~~~~~~~sl~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~-~~~~~l~df~~~~~~ 169 (205)
++||||+++++|.+.+... ..+++.+++.++.|++.||+|||++||+||||+|+||+++.+. ...+||+|||+|+..
T Consensus 85 ~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~ 164 (335)
T d2ozaa1 85 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKET 164 (335)
T ss_dssp EEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCTTCEEC
T ss_pred EEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccccceeeec
Confidence 9999999999999999764 3699999999999999999999999999999999999998633 335999999999887
Q ss_pred cCCCCCCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 170 VLHSQPKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 170 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
..........||+.|+|||++.+..++.+ +|||||
T Consensus 165 ~~~~~~~~~~gt~~y~aPE~~~~~~y~~~-~DiwSl 199 (335)
T d2ozaa1 165 TSHNSLTTPCYTPYYVAPEVLGPEKYDKS-CDMWSL 199 (335)
T ss_dssp CCCCCCCCCSCCCSSCCCCCCCGGGGSHH-HHHHHH
T ss_pred cCCCccccccCCcccCCcHHHcCCCCCHH-HHHHhh
Confidence 77777777889999999999999999866 999996
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=8e-45 Score=271.46 Aligned_cols=185 Identities=23% Similarity=0.339 Sum_probs=149.4
Q ss_pred ecCCCeEEEeeeccccceeEEEEEecCCCc---EEEEEEeecCc--cchHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeE
Q 028681 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEE---LVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHL 92 (205)
Q Consensus 18 ~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~---~v~iK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 92 (205)
.+.++|++.+.||+|+||+||++.+..+++ .|++|.+.... ...+.+.+|+.++++++||||++++|++..++..
T Consensus 23 i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~ 102 (299)
T d1jpaa_ 23 IDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPV 102 (299)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred hChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEE
Confidence 456889999999999999999999876554 58888876543 2345789999999999999999999999999999
Q ss_pred EEEEEecCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccC
Q 028681 93 AIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 171 (205)
Q Consensus 93 ~lv~~~~~~~sl~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~ 171 (205)
+++|||+++++|.+++.. .+.+++.++..++.|++.||.|||+++++||||||+||+++.++. +||+|||+|+....
T Consensus 103 ~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~--~Kl~DFGla~~~~~ 180 (299)
T d1jpaa_ 103 MIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLV--CKVSDFGLSRFLED 180 (299)
T ss_dssp EEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCC--EEECCC--------
T ss_pred EEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCc--EEECCcccceEccC
Confidence 999999999999998876 446999999999999999999999999999999999999998887 99999999976554
Q ss_pred CCCCCC------CCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 172 HSQPKS------TVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 172 ~~~~~~------~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
...... ..+++.|+|||.+.+..++.+ +|||||
T Consensus 181 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~-sDvwS~ 219 (299)
T d1jpaa_ 181 DTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSA-SDVWSY 219 (299)
T ss_dssp ---------------CGGGSCHHHHHSCCCCHH-HHHHHH
T ss_pred CCCcceeeecccccCCccccCHHHHhcCCCCcc-cccccc
Confidence 332221 246889999999999888766 999996
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=3.6e-44 Score=265.64 Aligned_cols=183 Identities=29% Similarity=0.413 Sum_probs=154.8
Q ss_pred CCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCcc----chHHHHHHHHHHHhcCCCCeeEEEEEEEeCC----e
Q 028681 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK----IDENVQREIINHRSLRHPNIVRFKEVILTPT----H 91 (205)
Q Consensus 20 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----~ 91 (205)
.++|++.+.||+|+||.||++.+..+++.||+|++++... ..+.+.+|+.+++.++||||+++++++...+ .
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 5789999999999999999999999999999999976432 2346889999999999999999999998653 4
Q ss_pred EEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccC
Q 028681 92 LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 171 (205)
Q Consensus 92 ~~lv~~~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~ 171 (205)
.++||||+++++|.+.+...+++++.+++.++.|++.||+|||++||+||||||+||+++.++. ++++|||.+.....
T Consensus 86 ~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~--~~l~d~~~~~~~~~ 163 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNA--VKVMDFGIARAIAD 163 (277)
T ss_dssp EEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSC--EEECCCTTCEECC-
T ss_pred EEEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCcccc--ceeehhhhhhhhcc
Confidence 8899999999999999988889999999999999999999999999999999999999998887 99999998765433
Q ss_pred CC----CCCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 172 HS----QPKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 172 ~~----~~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
.. ......||+.|+|||++.+..++.+ +|||||
T Consensus 164 ~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~-~DiwSl 200 (277)
T d1o6ya_ 164 SGNSVTQTAAVIGTAQYLSPEQARGDSVDAR-SDVYSL 200 (277)
T ss_dssp ---------------TTCCHHHHTTCCCCHH-HHHHHH
T ss_pred ccccccccccccCcccccCHHHHcCCCCCcc-eecccc
Confidence 22 2334469999999999999888766 999996
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-44 Score=265.69 Aligned_cols=183 Identities=25% Similarity=0.318 Sum_probs=155.4
Q ss_pred ecCCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCccchHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEE
Q 028681 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (205)
Q Consensus 18 ~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~ 97 (205)
.+.++|++.+.||+|+||+||++.+..+ ..||+|+++......+.+.+|+.++++++|+||++++|++.+ +..++|||
T Consensus 14 i~~~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~E 91 (285)
T d1fmka3 14 IPRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTE 91 (285)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEC
T ss_pred cCHHHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECcccCCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEE
Confidence 4578999999999999999999998765 569999998877777889999999999999999999999854 56789999
Q ss_pred ecCCCchHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCCCC-
Q 028681 98 YASGGELFERICN--AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ- 174 (205)
Q Consensus 98 ~~~~~sl~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~- 174 (205)
|+++++|...+.. .+.+++..+..++.|++.||+|||+++++||||+|+||+++.++. +||+|||+++.......
T Consensus 92 y~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~--~kl~DfGla~~~~~~~~~ 169 (285)
T d1fmka3 92 YMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLV--CKVADFGLARLIEDNEYT 169 (285)
T ss_dssp CCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC--EEECCCCTTC--------
T ss_pred ecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCc--EEEcccchhhhccCCCce
Confidence 9999999888854 456999999999999999999999999999999999999988877 99999999976543332
Q ss_pred -CCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 175 -PKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 175 -~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
.....+++.|+|||++.+..++.+ +|||||
T Consensus 170 ~~~~~~gt~~y~aPE~~~~~~~~~k-sDI~S~ 200 (285)
T d1fmka3 170 ARQGAKFPIKWTAPEAALYGRFTIK-SDVWSF 200 (285)
T ss_dssp ------CCGGGSCHHHHHHCCCCHH-HHHHHH
T ss_pred eeccccccccccChHHHhCCCCCcH-Hhhhcc
Confidence 233468999999999999998866 999996
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-44 Score=270.64 Aligned_cols=186 Identities=24% Similarity=0.338 Sum_probs=158.1
Q ss_pred eecCCCeEEEeeeccccceeEEEEEecCCCc-----EEEEEEeecCc--cchHHHHHHHHHHHhc-CCCCeeEEEEEEEe
Q 028681 17 MHDSDRYELVRDIGSGNFGVARLMRDKKTEE-----LVAVKYIERGD--KIDENVQREIINHRSL-RHPNIVRFKEVILT 88 (205)
Q Consensus 17 ~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~-----~v~iK~~~~~~--~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~ 88 (205)
..+.++|++.+.||+|+||+||++.+...++ .||+|.+.... .....+.+|+.++.++ +||||+++++++.+
T Consensus 33 ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~ 112 (325)
T d1rjba_ 33 EFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTL 112 (325)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cCCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEee
Confidence 3456899999999999999999999876543 68999886542 3346788999999998 89999999999999
Q ss_pred CCeEEEEEEecCCCchHHHHHhcC-----------------------CCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCC
Q 028681 89 PTHLAIVMEYASGGELFERICNAG-----------------------RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKL 145 (205)
Q Consensus 89 ~~~~~lv~~~~~~~sl~~~~~~~~-----------------------~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p 145 (205)
++..++||||+++++|.+++.... .+++..++.++.|++.||.|||+++|+||||||
T Consensus 113 ~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDlKp 192 (325)
T d1rjba_ 113 SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAA 192 (325)
T ss_dssp SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSG
T ss_pred CCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCch
Confidence 999999999999999999996532 488999999999999999999999999999999
Q ss_pred CCeEecCCCCCcEEEeeecccccccCCCCC---CCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 146 ENTLLDGSPAPRLKICDFGYSKSSVLHSQP---KSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 146 ~nili~~~~~~~~~l~df~~~~~~~~~~~~---~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
+||+++.++. +||+|||+|+........ ....+|+.|+|||++.+..++.+ +|||||
T Consensus 193 ~Nill~~~~~--~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~-~DiwS~ 252 (325)
T d1rjba_ 193 RNVLVTHGKV--VKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIK-SDVWSY 252 (325)
T ss_dssp GGEEEETTTE--EEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHH-HHHHHH
T ss_pred hccccccCCe--EEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcc-eeccch
Confidence 9999988877 999999999765544332 23457999999999999988866 999996
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-44 Score=265.04 Aligned_cols=185 Identities=23% Similarity=0.300 Sum_probs=152.9
Q ss_pred ecCCCeEEEeeeccccceeEEEEEecCCC----cEEEEEEeecCcc--chHHHHHHHHHHHhcCCCCeeEEEEEEEeCCe
Q 028681 18 HDSDRYELVRDIGSGNFGVARLMRDKKTE----ELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTH 91 (205)
Q Consensus 18 ~~~~~y~~~~~l~~g~~g~v~~~~~~~~~----~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 91 (205)
.+++.|++.+.||+|+||.||++....++ ..||+|.+..... ...++.+|+.++++++||||++++|++.+.+.
T Consensus 4 i~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~ 83 (283)
T d1mqba_ 4 IHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKP 83 (283)
T ss_dssp CCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred CCHHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCc
Confidence 45678999999999999999999987654 4799999875432 23568899999999999999999999999999
Q ss_pred EEEEEEecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeeccccccc
Q 028681 92 LAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 170 (205)
Q Consensus 92 ~~lv~~~~~~~sl~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~ 170 (205)
.++++|++.++++.+.+... ..+++.++..++.|++.|+.|||+++|+||||||+||+++.++. +||+|||+++...
T Consensus 84 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~--~Kl~DFGla~~~~ 161 (283)
T d1mqba_ 84 MMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLV--CKVSDFGLSRVLE 161 (283)
T ss_dssp EEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCC--EEECCCCC-----
T ss_pred eEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCe--EEEcccchhhccc
Confidence 99999999999998877654 57999999999999999999999999999999999999998887 9999999997654
Q ss_pred CCCCC----CCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 171 LHSQP----KSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 171 ~~~~~----~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
..... ....||+.|+|||++.+..++.+ +|||||
T Consensus 162 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~-sDI~S~ 199 (283)
T d1mqba_ 162 DDPEATYTTSGGKIPIRWTAPEAISYRKFTSA-SDVWSF 199 (283)
T ss_dssp ------------CCCGGGSCHHHHHSCCCCHH-HHHHHH
T ss_pred CCCccceEeccCCCCccccCHHHHccCCCCCc-cccccc
Confidence 43221 22357899999999999988866 999996
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-43 Score=264.85 Aligned_cols=183 Identities=31% Similarity=0.463 Sum_probs=157.0
Q ss_pred CCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCc---cchHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEE
Q 028681 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (205)
Q Consensus 21 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~ 97 (205)
++|++.+.||+|+||+||+|.+..+++.||+|+++... ...+.+.+|+.++++++||||+++++++.+++.+++|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 69999999999999999999999999999999996543 234678899999999999999999999999999999999
Q ss_pred ecCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCC-CCC
Q 028681 98 YASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQP 175 (205)
Q Consensus 98 ~~~~~sl~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~-~~~ 175 (205)
++.++.+...... ...+++..++.++.|++.||.|||++||+||||||+||+++.++. +||+|||.|+..... ...
T Consensus 82 ~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~--~kl~DFG~a~~~~~~~~~~ 159 (298)
T d1gz8a_ 82 FLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTY 159 (298)
T ss_dssp CCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSC--EEECSTTHHHHHCCCSBCT
T ss_pred ecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCc--ceeccCCcceeccCCcccc
Confidence 9976544433333 456999999999999999999999999999999999999988877 999999999766543 444
Q ss_pred CCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 176 KSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 176 ~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
....|++.|+|||.+....+.+.++|||||
T Consensus 160 ~~~~gt~~y~apE~~~~~~~~~~~~DiwSl 189 (298)
T d1gz8a_ 160 THEVVTLWYRAPEILLGCKYYSTAVDIWSL 189 (298)
T ss_dssp TCCBCCCTTCCHHHHTTCSSCCTHHHHHHH
T ss_pred eeecccceeeehhhhccccCCCcccccccc
Confidence 455799999999999888775566999996
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-44 Score=267.54 Aligned_cols=180 Identities=28% Similarity=0.396 Sum_probs=153.5
Q ss_pred EEEeeeccccceeEEEEEecCCCcEEEEEEeecCccc------hHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEE
Q 028681 24 ELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI------DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (205)
Q Consensus 24 ~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~ 97 (205)
+.++.||+|+||+||+|.+..+|+.||+|+++..... .+.+.+|+.++++++||||+++++++.+++..++|||
T Consensus 1 E~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE 80 (299)
T d1ua2a_ 1 EKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFD 80 (299)
T ss_dssp CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEE
T ss_pred CcceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhh
Confidence 3578999999999999999999999999998754321 2468899999999999999999999999999999999
Q ss_pred ecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCC-CCCC
Q 028681 98 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPK 176 (205)
Q Consensus 98 ~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~-~~~~ 176 (205)
|+.++++......+..+++..++.++.|++.||+|||++||+||||||+||+++.++. +||+|||+|+..... ....
T Consensus 81 ~~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~--~KL~DFG~a~~~~~~~~~~~ 158 (299)
T d1ua2a_ 81 FMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGV--LKLADFGLAKSFGSPNRAYT 158 (299)
T ss_dssp CCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCC--EEECCCGGGSTTTSCCCCCC
T ss_pred hhcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCc--cccccCccccccCCCccccc
Confidence 9988877777766778999999999999999999999999999999999999998887 999999999765443 3344
Q ss_pred CCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 177 STVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 177 ~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
...||+.|+|||++......+.++|||||
T Consensus 159 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSl 187 (299)
T d1ua2a_ 159 HQVVTRWYRAPELLFGARMYGVGVDMWAV 187 (299)
T ss_dssp CSCCCCTTCCHHHHTTCSCCCHHHHHHHH
T ss_pred ceecChhhccHHHHccCCCCChhhhhhhc
Confidence 55799999999999766543455999996
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-44 Score=264.75 Aligned_cols=181 Identities=28% Similarity=0.363 Sum_probs=150.0
Q ss_pred ecCCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCc---cchHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEE
Q 028681 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 94 (205)
Q Consensus 18 ~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 94 (205)
.+.++|++.+.||+|+||+||+++... .||+|+++... ...+.+.+|+.++++++||||+++++++.+ +..++
T Consensus 5 i~~~~~~~~~~lG~G~fg~Vy~~~~~~---~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~l 80 (276)
T d1uwha_ 5 IPDGQITVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAI 80 (276)
T ss_dssp CCTTCCCCCSEEEECSSCEEEEEESSS---EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEE
T ss_pred cccccEEEEEEEeeCCCcEEEEEEECC---EEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEE
Confidence 457899999999999999999998653 49999987543 234678899999999999999999998654 56889
Q ss_pred EEEecCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCCC
Q 028681 95 VMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 173 (205)
Q Consensus 95 v~~~~~~~sl~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~~ 173 (205)
||||+++++|.+.+.. +.++++..+..++.|++.||+|||+++|+||||||+||+++.++. +||+|||+|+......
T Consensus 81 v~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~--~Kl~DFGla~~~~~~~ 158 (276)
T d1uwha_ 81 VTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLT--VKIGDFGLATVKSRWS 158 (276)
T ss_dssp EEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSS--EEECCCCCSCC-----
T ss_pred EEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCC--EEEccccceeeccccC
Confidence 9999999999999865 456999999999999999999999999999999999999998877 9999999997654322
Q ss_pred ---CCCCCCCCCCccCCceeccC---cCCCeeeEEEeC
Q 028681 174 ---QPKSTVGTPAYIAPEVLLKK---EYDGKVMCVYVI 205 (205)
Q Consensus 174 ---~~~~~~~~~~~~aPE~~~~~---~~~~~~~Dvwsl 205 (205)
......||+.|+|||++.+. .++.+ +|||||
T Consensus 159 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~-sDiwS~ 195 (276)
T d1uwha_ 159 GSHQFEQLSGSILWMAPEVIRMQDKNPYSFQ-SDVYAF 195 (276)
T ss_dssp -------CCCCGGGCCHHHHTTCSSCCCCHH-HHHHHH
T ss_pred CcccccccccCcccCCHHHHhcccCCCCCch-hhhhhh
Confidence 23345689999999999753 35544 999996
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-44 Score=263.77 Aligned_cols=184 Identities=27% Similarity=0.426 Sum_probs=158.5
Q ss_pred CCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCccc-------hHHHHHHHHHHHhcC--CCCeeEEEEEEEeCC
Q 028681 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI-------DENVQREIINHRSLR--HPNIVRFKEVILTPT 90 (205)
Q Consensus 20 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~-------~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~ 90 (205)
.++|++.+.||+|+||+||++.+..+++.||+|++.+.... ..++..|+.++++++ ||||+++++++.+++
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~ 82 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 82 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence 47899999999999999999999999999999998754211 233668999999986 899999999999999
Q ss_pred eEEEEEEecCC-CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccc
Q 028681 91 HLAIVMEYASG-GELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 169 (205)
Q Consensus 91 ~~~lv~~~~~~-~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~ 169 (205)
..+++||++.+ +++.+.+.....+++.+++.++.|++.||.|||++||+||||||+||+++.+.. .+||+|||+|+..
T Consensus 83 ~~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~-~vkl~DFG~a~~~ 161 (273)
T d1xwsa_ 83 SFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRG-ELKLIDFGSGALL 161 (273)
T ss_dssp EEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTT-EEEECCCTTCEEC
T ss_pred eEEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCC-eEEECccccceec
Confidence 99999999965 577788888888999999999999999999999999999999999999985532 3999999999754
Q ss_pred cCCCCCCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 170 VLHSQPKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 170 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
.. .......||+.|+|||++.+..+.++++|||||
T Consensus 162 ~~-~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSl 196 (273)
T d1xwsa_ 162 KD-TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSL 196 (273)
T ss_dssp CS-SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHH
T ss_pred cc-ccccccccCCCcCCHHHHcCCCCCCcccccccc
Confidence 33 333456799999999999988876666999996
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-43 Score=261.87 Aligned_cols=183 Identities=27% Similarity=0.361 Sum_probs=155.4
Q ss_pred cCCCeEEEee-eccccceeEEEEEecC--CCcEEEEEEeecCcc--chHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEE
Q 028681 19 DSDRYELVRD-IGSGNFGVARLMRDKK--TEELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLA 93 (205)
Q Consensus 19 ~~~~y~~~~~-l~~g~~g~v~~~~~~~--~~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 93 (205)
..++|.+.+. ||+|+||.||++.+.. ++..||+|.++.... ..+++.+|+.++++++||||++++|++.. +..+
T Consensus 6 ~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~ 84 (285)
T d1u59a_ 6 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALM 84 (285)
T ss_dssp CGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEE
T ss_pred cccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEE
Confidence 4578999885 9999999999998754 355799999976532 34678999999999999999999999865 4678
Q ss_pred EEEEecCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCC
Q 028681 94 IVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 172 (205)
Q Consensus 94 lv~~~~~~~sl~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~ 172 (205)
+||||+++++|.+++.. ...+++..+..++.|++.||.|||+++|+||||+|+||+++.++. +||+|||+++.....
T Consensus 85 lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~--~Kl~DFGla~~~~~~ 162 (285)
T d1u59a_ 85 LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHY--AKISDFGLSKALGAD 162 (285)
T ss_dssp EEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTE--EEECCCTTCEECTTC
T ss_pred EEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCc--eeeccchhhhccccc
Confidence 99999999999998755 457999999999999999999999999999999999999988877 999999999765443
Q ss_pred CC----CCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 173 SQ----PKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 173 ~~----~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
.. .....|++.|+|||++....++.+ +|||||
T Consensus 163 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k-sDVwS~ 198 (285)
T d1u59a_ 163 DSYYTARSAGKWPLKWYAPECINFRKFSSR-SDVWSY 198 (285)
T ss_dssp SCEECCCCSSCCCGGGCCHHHHHHCEECHH-HHHHHH
T ss_pred ccccccccccccCccccChHHHhCCCCCcc-chhhcc
Confidence 22 223458899999999998888866 999996
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-43 Score=262.75 Aligned_cols=179 Identities=26% Similarity=0.337 Sum_probs=149.7
Q ss_pred eEEE-eeeccccceeEEEEEec--CCCcEEEEEEeecCcc---chHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEE
Q 028681 23 YELV-RDIGSGNFGVARLMRDK--KTEELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (205)
Q Consensus 23 y~~~-~~l~~g~~g~v~~~~~~--~~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 96 (205)
+.+. ++||+|+||+||++... .+++.||+|+++.... ..+++.+|+.++++++||||++++|++..+ ..++||
T Consensus 8 ~~le~k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~-~~~lvm 86 (277)
T d1xbba_ 8 LTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWMLVM 86 (277)
T ss_dssp EEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS-SEEEEE
T ss_pred CeecCCCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC-CEEEEE
Confidence 3443 47999999999999865 3457899999875432 246789999999999999999999998654 568999
Q ss_pred EecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCCCC--
Q 028681 97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-- 174 (205)
Q Consensus 97 ~~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~-- 174 (205)
||+++++|.+++....++++..+..++.|++.||.|||+++|+||||+|+||+++.++. ++|+|||+++.......
T Consensus 87 E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~--~kl~DFGla~~~~~~~~~~ 164 (277)
T d1xbba_ 87 EMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHY--AKISDFGLSKALRADENYY 164 (277)
T ss_dssp ECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTE--EEECCCTTCEECCTTCSEE
T ss_pred EcCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCc--ccccchhhhhhcccccccc
Confidence 99999999999988889999999999999999999999999999999999999988877 99999999976543322
Q ss_pred --CCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 175 --PKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 175 --~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
.....||+.|+|||.+.+..++.+ +|||||
T Consensus 165 ~~~~~~~gt~~y~APE~l~~~~~~~~-sDiwS~ 196 (277)
T d1xbba_ 165 KAQTHGKWPVKWYAPECINYYKFSSK-SDVWSF 196 (277)
T ss_dssp EC----CCCGGGCCHHHHHHCEEEHH-HHHHHH
T ss_pred ccccccCCCceecCchhhcCCCCCch-hhhccc
Confidence 223458899999999999888766 999996
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.9e-43 Score=261.42 Aligned_cols=184 Identities=25% Similarity=0.309 Sum_probs=159.0
Q ss_pred cCCCeEEEeeeccccceeEEEEEecCCCc--EEEEEEeecC--ccchHHHHHHHHHHHhc-CCCCeeEEEEEEEeCCeEE
Q 028681 19 DSDRYELVRDIGSGNFGVARLMRDKKTEE--LVAVKYIERG--DKIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLA 93 (205)
Q Consensus 19 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~--~v~iK~~~~~--~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~ 93 (205)
+.++|++.+.||+|+||.||++.+..++. .|++|.+... ....+.+.+|+.+++++ +||||++++|++.+++..+
T Consensus 8 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~ 87 (309)
T d1fvra_ 8 DWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLY 87 (309)
T ss_dssp CGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEE
T ss_pred CHHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeE
Confidence 56899999999999999999999988775 4677777543 22346789999999998 7999999999999999999
Q ss_pred EEEEecCCCchHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCc
Q 028681 94 IVMEYASGGELFERICNA----------------GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPR 157 (205)
Q Consensus 94 lv~~~~~~~sl~~~~~~~----------------~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~ 157 (205)
+||||+++++|.+++... ..+++..+..++.|++.|+.|||+++++||||+|+||+++.++.
T Consensus 88 iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~~~-- 165 (309)
T d1fvra_ 88 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYV-- 165 (309)
T ss_dssp EEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGC--
T ss_pred EEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCCCc--
Confidence 999999999999998643 46999999999999999999999999999999999999998877
Q ss_pred EEEeeecccccccCCCCCCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 158 LKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 158 ~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
+||+|||+++............++..|+|||.+.+..++.+ +|||||
T Consensus 166 ~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~-sDvwSf 212 (309)
T d1fvra_ 166 AKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTN-SDVWSY 212 (309)
T ss_dssp EEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHH-HHHHHH
T ss_pred eEEccccccccccccccccceecCCcccchHHhccCCCCcc-ceeehh
Confidence 99999999987766666666679999999999999999866 999996
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=3.3e-42 Score=256.21 Aligned_cols=183 Identities=30% Similarity=0.443 Sum_probs=155.9
Q ss_pred CCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCc---cchHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEE
Q 028681 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (205)
Q Consensus 20 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 96 (205)
.++|++++.||+|+||+||+|.+. +++.||+|+++... ...+.+.+|+.++++++||||+++++++.+++..++++
T Consensus 1 ~~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~ 79 (286)
T d1ob3a_ 1 MEKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVF 79 (286)
T ss_dssp CCSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEE
T ss_pred CCCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEE
Confidence 379999999999999999999986 67899999997643 22467899999999999999999999999999999999
Q ss_pred EecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCC-CCC
Q 028681 97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQP 175 (205)
Q Consensus 97 ~~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~-~~~ 175 (205)
+++.++.+..+....+.+++..++.++.|++.||+|||+++|+||||||+||+++.++. +||+|||.|...... ...
T Consensus 80 e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~--~kl~DfG~a~~~~~~~~~~ 157 (286)
T d1ob3a_ 80 EHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGE--LKIADFGLARAFGIPVRKY 157 (286)
T ss_dssp ECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSC--EEECCTTHHHHHCC-----
T ss_pred EeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCC--EEecccccceecccCcccc
Confidence 99988777766666778999999999999999999999999999999999999998887 999999999765433 333
Q ss_pred CCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 176 KSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 176 ~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
....+++.|+|||.+.+..+.+.++|||||
T Consensus 158 ~~~~~~~~y~~pE~~~~~~~~~~~~Diwsl 187 (286)
T d1ob3a_ 158 THEIVTLWYRAPDVLMGSKKYSTTIDIWSV 187 (286)
T ss_dssp ----CCCTTCCHHHHTTCCSCCTHHHHHHH
T ss_pred ceecccchhhhHHHHhCCCCCCcceeehhc
Confidence 445689999999999876654455999986
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-42 Score=259.18 Aligned_cols=183 Identities=21% Similarity=0.315 Sum_probs=151.5
Q ss_pred cCCCeEEEeeeccccceeEEEEEecCCCc----EEEEEEeecC--ccchHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeE
Q 028681 19 DSDRYELVRDIGSGNFGVARLMRDKKTEE----LVAVKYIERG--DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHL 92 (205)
Q Consensus 19 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~----~v~iK~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 92 (205)
+.++|++.+.||+|+||+||++.+..+|+ +||+|.++.. ....+.+.+|+.++++++||||++++|++.++ ..
T Consensus 7 k~~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~ 85 (317)
T d1xkka_ 7 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TV 85 (317)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SE
T ss_pred CHHHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-Ce
Confidence 34789999999999999999999987765 5888887653 23457799999999999999999999999875 45
Q ss_pred EEEEEecCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccC
Q 028681 93 AIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 171 (205)
Q Consensus 93 ~lv~~~~~~~sl~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~ 171 (205)
+++++++.+++|.+.+.. ...+++..+..++.|++.||.|||+++|+||||||+||+++.++. +||+|||+|+....
T Consensus 86 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~--~kl~DFGla~~~~~ 163 (317)
T d1xkka_ 86 QLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQH--VKITDFGLAKLLGA 163 (317)
T ss_dssp EEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTE--EEECCCSHHHHTTT
T ss_pred eEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCC--eEeeccccceeccc
Confidence 677888888898887765 457999999999999999999999999999999999999988877 99999999987654
Q ss_pred CCCC---CCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 172 HSQP---KSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 172 ~~~~---~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
.... ....||+.|+|||++.++.++.+ +|||||
T Consensus 164 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~-sDvwS~ 199 (317)
T d1xkka_ 164 EEKEYHAEGGKVPIKWMALESILHRIYTHQ-SDVWSY 199 (317)
T ss_dssp TCC--------CCTTTSCHHHHHHCCCCHH-HHHHHH
T ss_pred ccccccccccccCccccChHHHhcCCCChh-hhhhhH
Confidence 4332 22358999999999999988766 999996
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-42 Score=256.46 Aligned_cols=184 Identities=24% Similarity=0.332 Sum_probs=147.0
Q ss_pred ecCCCeEEEeeeccccceeEEEEEecCC---CcEEEEEEeecCcc--chHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeE
Q 028681 18 HDSDRYELVRDIGSGNFGVARLMRDKKT---EELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHL 92 (205)
Q Consensus 18 ~~~~~y~~~~~l~~g~~g~v~~~~~~~~---~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 92 (205)
.+.++|++.+.||+|+||.||++.+..+ +..|++|.++.... ..+.+.+|+.++++++||||+++++++. ++.+
T Consensus 4 i~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~ 82 (273)
T d1mp8a_ 4 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPV 82 (273)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSC
T ss_pred cCHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeE
Confidence 3467999999999999999999998654 35688888865432 2466889999999999999999999985 4678
Q ss_pred EEEEEecCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccC
Q 028681 93 AIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 171 (205)
Q Consensus 93 ~lv~~~~~~~sl~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~ 171 (205)
++||||++++++.+++.. ..++++..++.++.|++.||.|||+++++||||+|+||+++.++. +||+|||+|+....
T Consensus 83 ~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~--~Kl~DfG~a~~~~~ 160 (273)
T d1mp8a_ 83 WIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDC--VKLGDFGLSRYMED 160 (273)
T ss_dssp EEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTE--EEECC---------
T ss_pred EEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCc--EEEccchhheeccC
Confidence 999999999999988755 446999999999999999999999999999999999999988877 99999999976543
Q ss_pred CC--CCCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 172 HS--QPKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 172 ~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
.. ......+|+.|+|||++.+..++.+ +|||||
T Consensus 161 ~~~~~~~~~~gt~~y~apE~l~~~~~~~~-~DiwSl 195 (273)
T d1mp8a_ 161 STYYKASKGKLPIKWMAPESINFRRFTSA-SDVWMF 195 (273)
T ss_dssp ----------CCGGGCCHHHHHHCCCSHH-HHHHHH
T ss_pred CcceeccceecCcccchhhHhccCCCCCc-cccccc
Confidence 32 2233457899999999999888765 999996
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=6.2e-42 Score=259.29 Aligned_cols=181 Identities=24% Similarity=0.463 Sum_probs=158.0
Q ss_pred cCCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCccchHHHHHHHHHHHhcC-CCCeeEEEEEEEeC--CeEEEE
Q 028681 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLR-HPNIVRFKEVILTP--THLAIV 95 (205)
Q Consensus 19 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~--~~~~lv 95 (205)
..++|++++.||+|+||+||+|++..+++.||+|+++.. ..+++.+|+.+++.++ ||||+++++++... ...++|
T Consensus 33 ~~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~--~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v 110 (328)
T d3bqca1 33 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV--KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV 110 (328)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS--CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEE
T ss_pred CCcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH--HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEE
Confidence 457899999999999999999999999999999998754 3467889999999995 99999999999854 568999
Q ss_pred EEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCCCCC
Q 028681 96 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 175 (205)
Q Consensus 96 ~~~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~~ 175 (205)
|||+.+++|.... +.+++..++.++.|++.||.|||++||+||||||+||+++.++. .++|+|||+|+........
T Consensus 111 ~e~~~~~~L~~~~---~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~-~vkl~DFG~a~~~~~~~~~ 186 (328)
T d3bqca1 111 FEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHR-KLRLIDWGLAEFYHPGQEY 186 (328)
T ss_dssp EECCCSCBGGGTT---TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTT-EEEECCGGGCEECCTTCCC
T ss_pred EeecCCCcHHHHh---cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCC-eeeecccccceeccCCCcc
Confidence 9999999887654 45999999999999999999999999999999999999986543 3899999999887777777
Q ss_pred CCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 176 KSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 176 ~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
....+|+.|+|||.+.+....+.++|||||
T Consensus 187 ~~~~~t~~y~aPE~~~~~~~~~~~~Diwsl 216 (328)
T d3bqca1 187 NVRVASRYFKGPELLVDYQMYDYSLDMWSL 216 (328)
T ss_dssp CSCCSCGGGCCHHHHTTCCCCCTHHHHHHH
T ss_pred cccccCccccCcccccCCCCCCcccchhhh
Confidence 777899999999999876543344999985
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.2e-42 Score=260.57 Aligned_cols=181 Identities=30% Similarity=0.466 Sum_probs=152.7
Q ss_pred CCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCccchHHHHHHHHHHHhcCCCCeeEEEEEEEeC------CeEE
Q 028681 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTP------THLA 93 (205)
Q Consensus 20 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------~~~~ 93 (205)
.-+|+..+.||+|+||+||+|++..+++.||+|++...... ..+|+.+++.++|+||++++++|... .+++
T Consensus 19 ~~~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~---~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~ 95 (350)
T d1q5ka_ 19 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF---KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN 95 (350)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS---CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEE
T ss_pred cCCcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH---HHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEE
Confidence 34799999999999999999999999999999999765432 34689999999999999999998643 3578
Q ss_pred EEEEecCCCchHHHH---HhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeeccccccc
Q 028681 94 IVMEYASGGELFERI---CNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 170 (205)
Q Consensus 94 lv~~~~~~~sl~~~~---~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~ 170 (205)
+||||++++.+..+. .....+++.+++.++.|++.||+|||++||+||||||+||+++.++. .+||+|||++....
T Consensus 96 lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~-~~kl~DFG~a~~~~ 174 (350)
T d1q5ka_ 96 LVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTA-VLKLCDFGSAKQLV 174 (350)
T ss_dssp EEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTC-CEEECCCTTCEECC
T ss_pred EEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCC-ceeEecccchhhcc
Confidence 999999765433332 34557999999999999999999999999999999999999987653 29999999998777
Q ss_pred CCCCCCCCCCCCCccCCceeccC-cCCCeeeEEEeC
Q 028681 171 LHSQPKSTVGTPAYIAPEVLLKK-EYDGKVMCVYVI 205 (205)
Q Consensus 171 ~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~~Dvwsl 205 (205)
......+..|+..|+|||.+.+. .++.+ +|||||
T Consensus 175 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~-~DIwSl 209 (350)
T d1q5ka_ 175 RGEPNVSYICSRYYRAPELIFGATDYTSS-IDVWSA 209 (350)
T ss_dssp TTSCCCSCCSCTTSCCHHHHTTCSSCCTH-HHHHHH
T ss_pred CCcccccccccccccChHHhhcccCCCcc-eeeccc
Confidence 77777777899999999998765 45555 999996
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-42 Score=253.23 Aligned_cols=181 Identities=27% Similarity=0.378 Sum_probs=150.4
Q ss_pred eecCCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCccchHHHHHHHHHHHhcCCCCeeEEEEEEEeC-CeEEEE
Q 028681 17 MHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTP-THLAIV 95 (205)
Q Consensus 17 ~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~lv 95 (205)
..+.++|++.+.||+|+||.||++..+ |..||+|.++.. ...+.+.+|+.++++++||||++++|++.++ +.+++|
T Consensus 3 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~i~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv 79 (262)
T d1byga_ 3 ALNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKND-ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIV 79 (262)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCC-C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEE
T ss_pred ccCHHHeEEeEEEecCCCeEEEEEEEC--CeEEEEEEECcH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEE
Confidence 345789999999999999999999985 678999999754 3457799999999999999999999998654 568999
Q ss_pred EEecCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCCC
Q 028681 96 MEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 173 (205)
Q Consensus 96 ~~~~~~~sl~~~~~~~~--~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~~ 173 (205)
|||+++++|.+++...+ .+++..++.++.|++.||.|||+.+++||||+|+||+++.++. ++|+|||+++.....
T Consensus 80 ~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~--~kl~dfg~s~~~~~~- 156 (262)
T d1byga_ 80 TEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNV--AKVSDFGLTKEASST- 156 (262)
T ss_dssp ECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSC--EEECCCCC--------
T ss_pred EeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCC--EeecccccceecCCC-
Confidence 99999999999986543 5899999999999999999999999999999999999998887 999999999754432
Q ss_pred CCCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 174 QPKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 174 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
.....+++.|+|||++.+..++.+ +|||||
T Consensus 157 -~~~~~~~~~y~aPE~l~~~~~t~~-sDIwSf 186 (262)
T d1byga_ 157 -QDTGKLPVKWTAPEALREKKFSTK-SDVWSF 186 (262)
T ss_dssp ------CCTTTSCHHHHHHCCCCHH-HHHHHH
T ss_pred -CccccccccCCChHHHhCCCCChH-HHHHhH
Confidence 234467899999999999888766 999996
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-41 Score=251.36 Aligned_cols=183 Identities=28% Similarity=0.479 Sum_probs=161.9
Q ss_pred CCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCcc---chHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEE
Q 028681 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (205)
Q Consensus 21 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~~ 97 (205)
++|++++.||+|+||+||+|++..+++.||+|+++.... ..+++.+|+.+++.++||||+++++++.+....+++++
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 689999999999999999999999999999999975432 34678899999999999999999999999999999999
Q ss_pred ecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCCCC-CC
Q 028681 98 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-PK 176 (205)
Q Consensus 98 ~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~-~~ 176 (205)
++.++++..+....+.+++..++.++.|++.||+|||++||+||||||+||+++.++. +||+|||.++....... ..
T Consensus 82 ~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~--~kl~DFG~a~~~~~~~~~~~ 159 (292)
T d1unla_ 82 FCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGE--LKLANFGLARAFGIPVRCYS 159 (292)
T ss_dssp CCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCC--EEECCCTTCEECCSCCSCCC
T ss_pred eccccccccccccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCc--eeeeecchhhcccCCCccce
Confidence 9999888888888889999999999999999999999999999999999999988777 99999999987655443 33
Q ss_pred CCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 177 STVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 177 ~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
...++..|+|||.+....+.+.++|||||
T Consensus 160 ~~~~~~~~~~pe~~~~~~~~~~~~DiwSl 188 (292)
T d1unla_ 160 AEVVTLWYRPPDVLFGAKLYSTSIDMWSA 188 (292)
T ss_dssp SCCSCGGGCCHHHHTTCSCCCTHHHHHHH
T ss_pred eeccccchhhhhHhccCCCCCchhhcccc
Confidence 34577889999999877654455999996
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.1e-42 Score=257.23 Aligned_cols=184 Identities=26% Similarity=0.393 Sum_probs=158.0
Q ss_pred cCCCeEEEeeeccccceeEEEEEecC-----CCcEEEEEEeecCcc--chHHHHHHHHHHHhcCCCCeeEEEEEEEeCCe
Q 028681 19 DSDRYELVRDIGSGNFGVARLMRDKK-----TEELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTH 91 (205)
Q Consensus 19 ~~~~y~~~~~l~~g~~g~v~~~~~~~-----~~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 91 (205)
..++|++.+.||+|+||+||+|+... ++..||+|+++.... ..+++.+|+.++++++|||++++++++...+.
T Consensus 11 p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~ 90 (301)
T d1lufa_ 11 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKP 90 (301)
T ss_dssp CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred CHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCc
Confidence 46789999999999999999998753 457899999876433 24678999999999999999999999999999
Q ss_pred EEEEEEecCCCchHHHHHhcC------------------------CCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCC
Q 028681 92 LAIVMEYASGGELFERICNAG------------------------RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLEN 147 (205)
Q Consensus 92 ~~lv~~~~~~~sl~~~~~~~~------------------------~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~n 147 (205)
.+++++++++++|.+++.... .+++..+..++.|++.||+|||+++++||||+|+|
T Consensus 91 ~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDlKp~N 170 (301)
T d1lufa_ 91 MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRN 170 (301)
T ss_dssp CEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred eEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEEcccc
Confidence 999999999999999886422 38889999999999999999999999999999999
Q ss_pred eEecCCCCCcEEEeeecccccccCCC---CCCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 148 TLLDGSPAPRLKICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 148 ili~~~~~~~~~l~df~~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
|+++.++. +||+|||+|+...... ...+..+++.|+|||.+.+..++.+ +|||||
T Consensus 171 ILld~~~~--~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~k-sDVwS~ 228 (301)
T d1lufa_ 171 CLVGENMV--VKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTE-SDVWAY 228 (301)
T ss_dssp EEECGGGC--EEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHH-HHHHHH
T ss_pred eEECCCCc--EEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChh-hhhccc
Confidence 99998877 9999999997554332 2234468889999999999999865 999996
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-41 Score=255.33 Aligned_cols=185 Identities=30% Similarity=0.426 Sum_probs=154.5
Q ss_pred ecCCCeEEEeeeccccceeEEEEEecCC-CcEEEEEEeecCc---cchHHHHHHHHHHHhc---CCCCeeEEEEEEEe--
Q 028681 18 HDSDRYELVRDIGSGNFGVARLMRDKKT-EELVAVKYIERGD---KIDENVQREIINHRSL---RHPNIVRFKEVILT-- 88 (205)
Q Consensus 18 ~~~~~y~~~~~l~~g~~g~v~~~~~~~~-~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l---~h~~i~~~~~~~~~-- 88 (205)
...++|++++.||+|+||+||+|.+..+ ++.||+|+++... .....+.+|+.+++.+ +||||++++++|..
T Consensus 4 ~~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~ 83 (305)
T d1blxa_ 4 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR 83 (305)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred CCcCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccc
Confidence 3457999999999999999999999765 6679999986532 2233456677776665 79999999999863
Q ss_pred ---CCeEEEEEEecCCCchHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeec
Q 028681 89 ---PTHLAIVMEYASGGELFERIC-NAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFG 164 (205)
Q Consensus 89 ---~~~~~lv~~~~~~~sl~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~ 164 (205)
....++++|++.++.+..... ....+++..++.++.|++.||+|||+++|+||||||+|||++.++. +||+|||
T Consensus 84 ~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~--~kl~dfg 161 (305)
T d1blxa_ 84 TDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQ--IKLADFG 161 (305)
T ss_dssp CSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCC--EEECSCC
T ss_pred cccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCC--eeecchh
Confidence 246889999998876654443 3456999999999999999999999999999999999999988877 9999999
Q ss_pred ccccccCCCCCCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 165 YSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 165 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
+++............||+.|+|||++.+..++.+ +|||||
T Consensus 162 ~~~~~~~~~~~~~~~gT~~Y~APE~~~~~~y~~~-~DiwSl 201 (305)
T d1blxa_ 162 LARIYSFQMALTSVVVTLWYRAPEVLLQSSYATP-VDLWSV 201 (305)
T ss_dssp SCCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTH-HHHHHH
T ss_pred hhhhhcccccCCCcccChhhcCcchhcCCCCChh-ehhhch
Confidence 9987766666677789999999999999999876 999996
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-41 Score=255.17 Aligned_cols=188 Identities=27% Similarity=0.392 Sum_probs=155.8
Q ss_pred CceecCCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCc---cchHHHHHHHHHHHhcCCCCeeEEEEEEEeC--
Q 028681 15 PIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTP-- 89 (205)
Q Consensus 15 ~~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-- 89 (205)
+.+.+.++|++++.||+|+||+||+|.+..+|+.||+|++.... ....++.+|+.+++.++|+|++++++++...
T Consensus 4 ~~~~~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~ 83 (318)
T d3blha1 4 PFCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKAS 83 (318)
T ss_dssp TTSCBGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---
T ss_pred CCCCccCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccc
Confidence 44566799999999999999999999999999999999986543 2346788999999999999999999998653
Q ss_pred ------CeEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeee
Q 028681 90 ------THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDF 163 (205)
Q Consensus 90 ------~~~~lv~~~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df 163 (205)
...+++||++.++.+.........+++..++.++.|++.||.|||++||+||||+|+||+++.++. ++|+||
T Consensus 84 ~~~~~~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~--~kl~df 161 (318)
T d3blha1 84 PYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGV--LKLADF 161 (318)
T ss_dssp -------CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSC--EEECCC
T ss_pred cccccCceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCc--EEeeec
Confidence 458999999987766655556667999999999999999999999999999999999999998887 999999
Q ss_pred cccccccCC-----CCCCCCCCCCCccCCceeccCc-CCCeeeEEEeC
Q 028681 164 GYSKSSVLH-----SQPKSTVGTPAYIAPEVLLKKE-YDGKVMCVYVI 205 (205)
Q Consensus 164 ~~~~~~~~~-----~~~~~~~~~~~~~aPE~~~~~~-~~~~~~Dvwsl 205 (205)
|+++..... .......||+.|+|||++.+.. ++. ++|||||
T Consensus 162 g~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~-k~DiwSl 208 (318)
T d3blha1 162 GLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGP-PIDLWGA 208 (318)
T ss_dssp TTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCT-HHHHHHH
T ss_pred ceeeecccccccccccccceecCHHHhhHHHHcCCCCCCc-HHHcccC
Confidence 999755432 2223346899999999998764 555 4999996
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-41 Score=254.17 Aligned_cols=187 Identities=25% Similarity=0.334 Sum_probs=155.2
Q ss_pred ceecCCCeEEEeeeccccceeEEEEEecCCC-------cEEEEEEeecCcc--chHHHHHHHHHHHhc-CCCCeeEEEEE
Q 028681 16 IMHDSDRYELVRDIGSGNFGVARLMRDKKTE-------ELVAVKYIERGDK--IDENVQREIINHRSL-RHPNIVRFKEV 85 (205)
Q Consensus 16 ~~~~~~~y~~~~~l~~g~~g~v~~~~~~~~~-------~~v~iK~~~~~~~--~~~~~~~e~~~l~~l-~h~~i~~~~~~ 85 (205)
+....++|++.+.||+|+||.||+++...++ ..||+|.++.... ...++..|...+.++ +||||++++++
T Consensus 8 ~~i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~ 87 (299)
T d1fgka_ 8 WELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGA 87 (299)
T ss_dssp TBCCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred CcccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccc
Confidence 4455789999999999999999999976544 4799999876543 235677888888888 79999999999
Q ss_pred EEeCCeEEEEEEecCCCchHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeE
Q 028681 86 ILTPTHLAIVMEYASGGELFERICNA----------------GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTL 149 (205)
Q Consensus 86 ~~~~~~~~lv~~~~~~~sl~~~~~~~----------------~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nil 149 (205)
+.+++..++||||+.+++|.+.+... ..+++.++..++.|++.||.|||+++|+||||||+||+
T Consensus 88 ~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~NiL 167 (299)
T d1fgka_ 88 CTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVL 167 (299)
T ss_dssp ECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred cccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeeccccee
Confidence 99999999999999999999999654 24899999999999999999999999999999999999
Q ss_pred ecCCCCCcEEEeeecccccccCCCC---CCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 150 LDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 150 i~~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
++.++. +||+|||+++....... .....+++.|+|||.+.++.++.+ +|||||
T Consensus 168 l~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k-~DiwS~ 223 (299)
T d1fgka_ 168 VTEDNV--MKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQ-SDVWSF 223 (299)
T ss_dssp ECTTCC--EEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHH-HHHHHH
T ss_pred ecCCCC--eEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCch-hhhHHh
Confidence 998887 99999999876544332 233568899999999999999866 999996
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-41 Score=256.21 Aligned_cols=184 Identities=30% Similarity=0.457 Sum_probs=150.8
Q ss_pred cCCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCcc--chHHHHHHHHHHHhcCCCCeeEEEEEEEeCC----eE
Q 028681 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPT----HL 92 (205)
Q Consensus 19 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----~~ 92 (205)
..++|++++.||+|+||+||+|.+..+++.||+|++.+... ..+.+.+|+.++++++|||++++++++..+. ..
T Consensus 6 i~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~ 85 (345)
T d1pmea_ 6 VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 85 (345)
T ss_dssp CCTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred cCCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccce
Confidence 35789999999999999999999999999999999976432 2456889999999999999999999987653 23
Q ss_pred EEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCC
Q 028681 93 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 172 (205)
Q Consensus 93 ~lv~~~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~ 172 (205)
+++++++.+++|.+++.. ..+++..++.++.|++.||+|||++||+||||||+||+++.++. +||+|||+++.....
T Consensus 86 ~~l~~~~~~g~L~~~l~~-~~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~--~kl~DfG~a~~~~~~ 162 (345)
T d1pmea_ 86 VYLVTHLMGADLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCD--LKICDFGLARVADPD 162 (345)
T ss_dssp EEEEEECCCEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC--EEECCCTTCEECCGG
T ss_pred EEEEEeecCCchhhhhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCC--EEEcccCceeeccCC
Confidence 344455668899999865 46999999999999999999999999999999999999998877 999999999765443
Q ss_pred CC----CCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 173 SQ----PKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 173 ~~----~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
.. .....|++.|+|||++........++|||||
T Consensus 163 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSl 199 (345)
T d1pmea_ 163 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSV 199 (345)
T ss_dssp GCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHH
T ss_pred CccceeeccccccceechHHHhhcCCCCCchhhhhcc
Confidence 22 3344689999999999766554455999985
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.7e-42 Score=255.12 Aligned_cols=185 Identities=23% Similarity=0.350 Sum_probs=146.4
Q ss_pred ecCCCeEEEeeeccccceeEEEEEecC-----CCcEEEEEEeecCcc--chHHHHHHHHHHHhc-CCCCeeEEEEEEEeC
Q 028681 18 HDSDRYELVRDIGSGNFGVARLMRDKK-----TEELVAVKYIERGDK--IDENVQREIINHRSL-RHPNIVRFKEVILTP 89 (205)
Q Consensus 18 ~~~~~y~~~~~l~~g~~g~v~~~~~~~-----~~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~ 89 (205)
...++|++.+.||+|+||.||++.+.. +++.||+|.++.... ..+.+..|...+.++ +|+||+.+++++..+
T Consensus 10 i~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~ 89 (299)
T d1ywna1 10 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP 89 (299)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST
T ss_pred ccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccC
Confidence 446899999999999999999999754 346899999875432 235567777777776 689999999988765
Q ss_pred -CeEEEEEEecCCCchHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecC
Q 028681 90 -THLAIVMEYASGGELFERICNA----------------GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDG 152 (205)
Q Consensus 90 -~~~~lv~~~~~~~sl~~~~~~~----------------~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~ 152 (205)
..++++|||+++++|.+++... ..+++..+..++.|++.||.|||+++|+||||||+||+++.
T Consensus 90 ~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl~~ 169 (299)
T d1ywna1 90 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSE 169 (299)
T ss_dssp TSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECG
T ss_pred CCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccceeECC
Confidence 4689999999999999998643 24889999999999999999999999999999999999998
Q ss_pred CCCCcEEEeeecccccccCCCC---CCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 153 SPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 153 ~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
++. +||+|||+|+....... .....||+.|+|||++.+..++.+ +|||||
T Consensus 170 ~~~--~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~-sDiwS~ 222 (299)
T d1ywna1 170 KNV--VKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQ-SDVWSF 222 (299)
T ss_dssp GGC--EEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHH-HHHHHH
T ss_pred CCc--EEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcc-cceeeh
Confidence 887 99999999976543322 233468999999999999888766 999996
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-41 Score=255.86 Aligned_cols=181 Identities=27% Similarity=0.412 Sum_probs=150.1
Q ss_pred cCCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCcc---chHHHHHHHHHHHhcCCCCeeEEEEEEEeCC-----
Q 028681 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTPT----- 90 (205)
Q Consensus 19 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----- 90 (205)
..++|++++.||+|+||+||+|.+..+|+.||+|+++.... ..+.+.+|+.+++.++|||+++++++|...+
T Consensus 16 ~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~ 95 (346)
T d1cm8a_ 16 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 95 (346)
T ss_dssp CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred cCCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCcccccc
Confidence 46899999999999999999999999999999999976432 2356889999999999999999999998664
Q ss_pred -eEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccc
Q 028681 91 -HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 169 (205)
Q Consensus 91 -~~~lv~~~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~ 169 (205)
.++++|||+ +.+|.... ...++++..++.++.|++.||.|||++||+||||||+||+++.++. ++++|||+|+..
T Consensus 96 ~~~~lv~e~~-~~~l~~~~-~~~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~--~kl~Dfg~a~~~ 171 (346)
T d1cm8a_ 96 TDFYLVMPFM-GTDLGKLM-KHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCE--LKILDFGLARQA 171 (346)
T ss_dssp CCCEEEEECC-SEEHHHHH-HHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC--EEECCCTTCEEC
T ss_pred ceEEEEEecc-cccHHHHH-HhccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccc--cccccccceecc
Confidence 579999999 45666655 4567999999999999999999999999999999999999998887 999999999765
Q ss_pred cCCCCCCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 170 VLHSQPKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 170 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
.. ......+++.|+|||++.+..+.+.++|||||
T Consensus 172 ~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSl 205 (346)
T d1cm8a_ 172 DS--EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSV 205 (346)
T ss_dssp CS--SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHH
T ss_pred CC--ccccccccccccCHHHHcCCCCCCccchhhcc
Confidence 43 34556799999999999876654455999996
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-41 Score=251.66 Aligned_cols=187 Identities=23% Similarity=0.304 Sum_probs=160.3
Q ss_pred ceecCCCeEEEeeeccccceeEEEEEec-----CCCcEEEEEEeecCcc--chHHHHHHHHHHHhc-CCCCeeEEEEEEE
Q 028681 16 IMHDSDRYELVRDIGSGNFGVARLMRDK-----KTEELVAVKYIERGDK--IDENVQREIINHRSL-RHPNIVRFKEVIL 87 (205)
Q Consensus 16 ~~~~~~~y~~~~~l~~g~~g~v~~~~~~-----~~~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l-~h~~i~~~~~~~~ 87 (205)
+..+.++|++.+.||+|+||.||++... .+++.||+|+++.... ....+.+|+.+++.+ +||||+++++++.
T Consensus 18 ~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~ 97 (311)
T d1t46a_ 18 WEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACT 97 (311)
T ss_dssp GBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEe
Confidence 3445689999999999999999999863 4567899999986543 235688999999999 6999999999999
Q ss_pred eCCeEEEEEEecCCCchHHHHHhcC------------------CCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeE
Q 028681 88 TPTHLAIVMEYASGGELFERICNAG------------------RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTL 149 (205)
Q Consensus 88 ~~~~~~lv~~~~~~~sl~~~~~~~~------------------~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nil 149 (205)
++...+++|||+++++|.+++.... .+++..+..++.|++.|+.|||+++++||||||+||+
T Consensus 98 ~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~NIl 177 (311)
T d1t46a_ 98 IGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNIL 177 (311)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred eCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeeccccccccc
Confidence 9999999999999999999986533 5899999999999999999999999999999999999
Q ss_pred ecCCCCCcEEEeeecccccccCCCC---CCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 150 LDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 150 i~~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
++.++. ++++|||.++....... .....+++.|+|||++.+..++.+ +|||||
T Consensus 178 ~~~~~~--~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DIwS~ 233 (311)
T d1t46a_ 178 LTHGRI--TKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFE-SDVWSY 233 (311)
T ss_dssp EETTTE--EEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHH-HHHHHH
T ss_pred ccccCc--ccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCc-ccccch
Confidence 988776 99999999976543322 223458999999999998888766 999996
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-41 Score=249.57 Aligned_cols=184 Identities=27% Similarity=0.391 Sum_probs=145.9
Q ss_pred ecCCCeEEEeeeccccceeEEEEEecCC---CcEEEEEEeecCc----cchHHHHHHHHHHHhcCCCCeeEEEEEEEeCC
Q 028681 18 HDSDRYELVRDIGSGNFGVARLMRDKKT---EELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPT 90 (205)
Q Consensus 18 ~~~~~y~~~~~l~~g~~g~v~~~~~~~~---~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 90 (205)
.+.++|++.+.||+|+||.||++..... ...||+|.+++.. ...+++.+|+.++++++||||++++|++.+ +
T Consensus 5 i~~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~ 83 (273)
T d1u46a_ 5 IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-P 83 (273)
T ss_dssp CCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred EchHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-c
Confidence 3467899999999999999999986533 2468999887542 223578999999999999999999999975 4
Q ss_pred eEEEEEEecCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccc
Q 028681 91 HLAIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 169 (205)
Q Consensus 91 ~~~lv~~~~~~~sl~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~ 169 (205)
..++|+||++++++.+.+.. ..++++..+..++.|++.||.|||+++|+||||+|+||+++.++. +||+|||+++..
T Consensus 84 ~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~--vkl~DfGl~~~~ 161 (273)
T d1u46a_ 84 PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDL--VKIGDFGLMRAL 161 (273)
T ss_dssp SCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTE--EEECCCTTCEEC
T ss_pred chheeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccc--eeeccchhhhhc
Confidence 67899999999999887754 456999999999999999999999999999999999999998876 999999999865
Q ss_pred cCCCC----CCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 170 VLHSQ----PKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 170 ~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
..... .....++..|+|||++.+..++.+ +|||||
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~-~Di~S~ 200 (273)
T d1u46a_ 162 PQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHA-SDTWMF 200 (273)
T ss_dssp CC-CCEEEC-----CCGGGCCHHHHHHCEEEHH-HHHHHH
T ss_pred ccCCCcceecCccccCcccCCHHHHhCCCCCcc-hhhhhh
Confidence 44332 223347889999999999888766 999996
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=5.3e-40 Score=244.79 Aligned_cols=183 Identities=22% Similarity=0.255 Sum_probs=155.8
Q ss_pred CCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCccchHHHHHHHHHHHhcCC-CCeeEEEEEEEeCCeEEEEEEe
Q 028681 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRH-PNIVRFKEVILTPTHLAIVMEY 98 (205)
Q Consensus 20 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~~~ 98 (205)
.++|++.+.||+|+||+||+|++..+++.||+|++.... ..+.+..|+..++.++| +|++.+++++..+...++|||+
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~ 82 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS-DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDL 82 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT-TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEEC
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc-CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEe
Confidence 579999999999999999999999999999999886543 33456788888899875 8999999999999999999999
Q ss_pred cCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCC---CCCcEEEeeecccccccCC--
Q 028681 99 ASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGS---PAPRLKICDFGYSKSSVLH-- 172 (205)
Q Consensus 99 ~~~~sl~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~---~~~~~~l~df~~~~~~~~~-- 172 (205)
+ +++|.+.+... ..++...+..++.|++.||++||++||+||||||+||+++.+ ....++|+|||+|+.....
T Consensus 83 ~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~~~ 161 (293)
T d1csna_ 83 L-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVT 161 (293)
T ss_dssp C-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTT
T ss_pred c-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEEcccCcc
Confidence 8 57888888654 469999999999999999999999999999999999999742 2234999999999764322
Q ss_pred ------CCCCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 173 ------SQPKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 173 ------~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
.......||+.|+|||++.+..++.+ +|||||
T Consensus 162 ~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~-~DiwSl 199 (293)
T d1csna_ 162 KQHIPYREKKNLSGTARYMSINTHLGREQSRR-DDLEAL 199 (293)
T ss_dssp CCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHH-HHHHHH
T ss_pred ccceeecccCceEEchhhcCHHHhcCCCCChH-HHHHHh
Confidence 12334469999999999999988866 999996
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-40 Score=250.21 Aligned_cols=194 Identities=19% Similarity=0.254 Sum_probs=162.1
Q ss_pred ccCCCcccCceecCCCeEEEeeeccccceeEEEEEecC-----CCcEEEEEEeecCccc--hHHHHHHHHHHHhcCCCCe
Q 028681 7 TVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKK-----TEELVAVKYIERGDKI--DENVQREIINHRSLRHPNI 79 (205)
Q Consensus 7 ~~~~~~~~~~~~~~~~y~~~~~l~~g~~g~v~~~~~~~-----~~~~v~iK~~~~~~~~--~~~~~~e~~~l~~l~h~~i 79 (205)
+...+.++ ..+.++|++.+.||+|+||.||+|.+.. .+..||+|+++..... ...+.+|+.++++++||||
T Consensus 8 ~~~~~~~~--ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nI 85 (308)
T d1p4oa_ 8 DVYVPDEW--EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 85 (308)
T ss_dssp SCCCCCTT--BCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTB
T ss_pred cCcCccce--eecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCE
Confidence 34444443 3447999999999999999999998753 3568999999765432 2457899999999999999
Q ss_pred eEEEEEEEeCCeEEEEEEecCCCchHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeE
Q 028681 80 VRFKEVILTPTHLAIVMEYASGGELFERICNA----------GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTL 149 (205)
Q Consensus 80 ~~~~~~~~~~~~~~lv~~~~~~~sl~~~~~~~----------~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nil 149 (205)
+++++++..+...++||||+++++|.+++... ..++...+..++.|++.||.|||+++|+||||+|+||+
T Consensus 86 v~~~~~~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiL 165 (308)
T d1p4oa_ 86 VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCM 165 (308)
T ss_dssp CCEEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEE
T ss_pred eeeeeEEecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCcee
Confidence 99999999999999999999999999988542 24788999999999999999999999999999999999
Q ss_pred ecCCCCCcEEEeeecccccccCCCC---CCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 150 LDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 150 i~~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
++.+.. +||+|||+|+....... .....+++.|+|||.+.+..++.+ +|||||
T Consensus 166 ld~~~~--~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~-~Dv~S~ 221 (308)
T d1p4oa_ 166 VAEDFT--VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTY-SDVWSF 221 (308)
T ss_dssp ECTTCC--EEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHH-HHHHHH
T ss_pred ecCCce--EEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcc-cccccH
Confidence 998887 99999999975543322 233358899999999999988765 999996
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=7.3e-40 Score=244.90 Aligned_cols=183 Identities=26% Similarity=0.261 Sum_probs=151.0
Q ss_pred CCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCccchHHHHHHHHHHHhcCCCC-eeEEEEEEEeCCeEEEEEEe
Q 028681 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPN-IVRFKEVILTPTHLAIVMEY 98 (205)
Q Consensus 20 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~-i~~~~~~~~~~~~~~lv~~~ 98 (205)
.++|++.+.||+|+||.||+|.+..+++.||+|++.... ..+++..|+.+++.++|++ ++.+.+++.+++..++|||+
T Consensus 6 g~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~ 84 (299)
T d1ckia_ 6 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT-KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL 84 (299)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCT-TSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred CCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhc-cCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEE
Confidence 478999999999999999999999999999999887643 3455788999999998765 55666777788899999999
Q ss_pred cCCCchHHHH-HhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCC-CCCcEEEeeecccccccCCC---
Q 028681 99 ASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGS-PAPRLKICDFGYSKSSVLHS--- 173 (205)
Q Consensus 99 ~~~~sl~~~~-~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~-~~~~~~l~df~~~~~~~~~~--- 173 (205)
+++ ++...+ .....+++..+..++.|++.||+|||++||+||||||+||+++.. ....++|+|||+|+......
T Consensus 85 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~~~ 163 (299)
T d1ckia_ 85 LGP-SLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQ 163 (299)
T ss_dssp CCC-BHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTTCC
T ss_pred cCC-chhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceecccccccc
Confidence 955 555554 446679999999999999999999999999999999999998542 23349999999997654332
Q ss_pred -----CCCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 174 -----QPKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 174 -----~~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
......||+.|+|||++.+..++.+ +|||||
T Consensus 164 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwSl 199 (299)
T d1ckia_ 164 HIPYRENKNLTGTARYASINTHLGIEQSRR-DDLESL 199 (299)
T ss_dssp BCCCCBCCSCCCCSSSCCHHHHTTBCCCHH-HHHHHH
T ss_pred ceeccccCCcCCCccccCHHHHhCCCCCCh-hhEEec
Confidence 2234469999999999999988766 999996
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-40 Score=249.13 Aligned_cols=179 Identities=28% Similarity=0.323 Sum_probs=147.4
Q ss_pred CCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCccchHHHHHHHHHHHhcCCCCeeEEEEEEEeCC----eEEEEE
Q 028681 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPT----HLAIVM 96 (205)
Q Consensus 21 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----~~~lv~ 96 (205)
.+|.+.+.||+|+||.||+++. +|+.||+|.++.........+.|+..+..++||||+++++++..++ ..++||
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~ 80 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccchhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEE
Confidence 4789999999999999999986 4789999998765443334455666667889999999999998654 589999
Q ss_pred EecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh--------cCcEeecCCCCCeEecCCCCCcEEEeeeccccc
Q 028681 97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS--------MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 168 (205)
Q Consensus 97 ~~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~--------~~i~H~di~p~nili~~~~~~~~~l~df~~~~~ 168 (205)
||+++++|.+.+.+ .++++.....++.|++.|+.|||. .||+||||||+||+++.++. +||+|||+++.
T Consensus 81 Ey~~~g~L~~~l~~-~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~--~Kl~DFGl~~~ 157 (303)
T d1vjya_ 81 DYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGT--CCIADLGLAVR 157 (303)
T ss_dssp ECCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSC--EEECCCTTCEE
T ss_pred ecccCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCC--eEEEecCcccc
Confidence 99999999999966 469999999999999999999996 59999999999999988877 99999999976
Q ss_pred ccCCC-----CCCCCCCCCCccCCceeccCc------CCCeeeEEEeC
Q 028681 169 SVLHS-----QPKSTVGTPAYIAPEVLLKKE------YDGKVMCVYVI 205 (205)
Q Consensus 169 ~~~~~-----~~~~~~~~~~~~aPE~~~~~~------~~~~~~Dvwsl 205 (205)
..... ......||+.|+|||++.+.. ++ .++|||||
T Consensus 158 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~-~k~Di~S~ 204 (303)
T d1vjya_ 158 HDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESF-KRADIYAM 204 (303)
T ss_dssp EETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHH-HHHHHHHH
T ss_pred ccCCCcceeccccceecccCcCChhhccccccccCCCcC-cchhhhhh
Confidence 54433 223456999999999987643 33 34899996
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-40 Score=252.54 Aligned_cols=180 Identities=26% Similarity=0.401 Sum_probs=144.5
Q ss_pred CCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCccc---hHHHHHHHHHHHhcCCCCeeEEEEEEEeC------C
Q 028681 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI---DENVQREIINHRSLRHPNIVRFKEVILTP------T 90 (205)
Q Consensus 20 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------~ 90 (205)
.++|++++.||+|+||+||+|.+..+|..||+|++...... ..++.+|+.++++++||||++++++|... .
T Consensus 16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~ 95 (355)
T d2b1pa1 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 95 (355)
T ss_dssp ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCc
Confidence 47899999999999999999999999999999999865322 34678999999999999999999999643 6
Q ss_pred eEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeeccccccc
Q 028681 91 HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 170 (205)
Q Consensus 91 ~~~lv~~~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~ 170 (205)
..|++|||+.++.+ +.+ ...+++..++.++.|++.||.|||++||+||||||+||+++.++. ++++|||.++...
T Consensus 96 ~~~iv~Ey~~~~l~-~~~--~~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~--~kl~df~~~~~~~ 170 (355)
T d2b1pa1 96 DVYLVMELMDANLC-QVI--QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAG 170 (355)
T ss_dssp EEEEEEECCSEEHH-HHH--TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCC--EEECCCCC-----
T ss_pred eeEEEEeccchHHH-Hhh--hcCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccc--eeeechhhhhccc
Confidence 78999999976544 444 345999999999999999999999999999999999999998887 9999999988777
Q ss_pred CCCCCCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 171 LHSQPKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 171 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
.........+|+.|+|||++.+..++.+ +|||||
T Consensus 171 ~~~~~~~~~~t~~y~aPE~l~~~~~~~~-~DiwSl 204 (355)
T d2b1pa1 171 TSFMMTPYVVTRYYRAPEVILGMGYKEN-VDIWSV 204 (355)
T ss_dssp ----------CCTTCCHHHHTTCCCCTT-HHHHHH
T ss_pred cccccccccccccccChhhhcCCCCCCC-cccccc
Confidence 7676677789999999999999888766 999985
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.1e-40 Score=245.69 Aligned_cols=179 Identities=23% Similarity=0.270 Sum_probs=150.5
Q ss_pred EEEeeeccccceeEEEEEecCCC---cEEEEEEeecC--ccchHHHHHHHHHHHhcCCCCeeEEEEEEEe-CCeEEEEEE
Q 028681 24 ELVRDIGSGNFGVARLMRDKKTE---ELVAVKYIERG--DKIDENVQREIINHRSLRHPNIVRFKEVILT-PTHLAIVME 97 (205)
Q Consensus 24 ~~~~~l~~g~~g~v~~~~~~~~~---~~v~iK~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~~ 97 (205)
++.+.||+|+||+||++....++ ..||+|.++.. ....+++.+|+.++++++||||++++|++.+ ++..++|||
T Consensus 30 ~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E 109 (311)
T d1r0pa_ 30 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLP 109 (311)
T ss_dssp EEEEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEE
T ss_pred ccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEE
Confidence 44789999999999999986543 36899998753 2334679999999999999999999999876 468999999
Q ss_pred ecCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeecccccccCCCCC-
Q 028681 98 YASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP- 175 (205)
Q Consensus 98 ~~~~~sl~~~~~~~~-~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~~~~~~- 175 (205)
|+++++|.+++.... ..++..+..++.|++.||.|||+.+|+||||+|+||++++++. +||+|||+++........
T Consensus 110 ~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~--~kL~DFG~~~~~~~~~~~~ 187 (311)
T d1r0pa_ 110 YMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFT--VKVADFGLARDMYDKEFDS 187 (311)
T ss_dssp CCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCC--EEECSSGGGCCTTTTTCCC
T ss_pred EeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCC--EEEecccchhhcccccccc
Confidence 999999999887543 5778889999999999999999999999999999999998877 999999999765433222
Q ss_pred ----CCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 176 ----KSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 176 ----~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
....|++.|+|||.+.+..++.+ +|||||
T Consensus 188 ~~~~~~~~gt~~y~aPE~~~~~~~~~k-sDI~Sf 220 (311)
T d1r0pa_ 188 VHNKTGAKLPVKWMALESLQTQKFTTK-SDVWSF 220 (311)
T ss_dssp TTCTTCSSCCGGGSCHHHHHHCCCCHH-HHHHHH
T ss_pred ceecccccccccccChHHHhcCCCCCh-hHhhhh
Confidence 22358899999999999888766 999996
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-40 Score=249.37 Aligned_cols=184 Identities=28% Similarity=0.525 Sum_probs=158.7
Q ss_pred CCCeEEEeeeccccceeEEEEEe---cCCCcEEEEEEeecCc-----cchHHHHHHHHHHHhcCC-CCeeEEEEEEEeCC
Q 028681 20 SDRYELVRDIGSGNFGVARLMRD---KKTEELVAVKYIERGD-----KIDENVQREIINHRSLRH-PNIVRFKEVILTPT 90 (205)
Q Consensus 20 ~~~y~~~~~l~~g~~g~v~~~~~---~~~~~~v~iK~~~~~~-----~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~ 90 (205)
.++|++.+.||+|+||+||+|.+ +.+|+.||+|.+++.. ...+.+..|+.++++++| |||+++++++.++.
T Consensus 23 l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~ 102 (322)
T d1vzoa_ 23 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 102 (322)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred hhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCC
Confidence 48899999999999999999987 4468899999986532 234667889999999977 89999999999999
Q ss_pred eEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeeccccccc
Q 028681 91 HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 170 (205)
Q Consensus 91 ~~~lv~~~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~ 170 (205)
..++++|++.+++|.+.+...+.+++..+..++.|++.|+.|||+++++||||+|+||+++.++. ++|+|||+++...
T Consensus 103 ~~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~--vkL~DFG~a~~~~ 180 (322)
T d1vzoa_ 103 KLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGH--VVLTDFGLSKEFV 180 (322)
T ss_dssp EEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSC--EEESCSSEEEECC
T ss_pred ceeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCC--EEEeeccchhhhc
Confidence 99999999999999999998889999999999999999999999999999999999999998877 9999999997653
Q ss_pred CC--CCCCCCCCCCCccCCceeccCcC-CCeeeEEEeC
Q 028681 171 LH--SQPKSTVGTPAYIAPEVLLKKEY-DGKVMCVYVI 205 (205)
Q Consensus 171 ~~--~~~~~~~~~~~~~aPE~~~~~~~-~~~~~Dvwsl 205 (205)
.. .......|++.|+|||.+.+... ...++|||||
T Consensus 181 ~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSl 218 (322)
T d1vzoa_ 181 ADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSL 218 (322)
T ss_dssp GGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHH
T ss_pred ccccccccccccccccchhHHhhcCCcCCCchhhhHHH
Confidence 32 33345579999999999976542 2344999996
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-39 Score=247.85 Aligned_cols=182 Identities=26% Similarity=0.405 Sum_probs=151.3
Q ss_pred cCCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCcc---chHHHHHHHHHHHhcCCCCeeEEEEEEEeC-----C
Q 028681 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTP-----T 90 (205)
Q Consensus 19 ~~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~ 90 (205)
..++|++.+.||+|+||+||+|.+..+|+.||+|++.+... ..+++.+|+.++++++|+|++++++++... .
T Consensus 16 ~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~ 95 (348)
T d2gfsa1 16 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 95 (348)
T ss_dssp EETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTC
T ss_pred CCCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccC
Confidence 36889999999999999999999999999999999976533 235678999999999999999999998643 2
Q ss_pred eEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeeeccccccc
Q 028681 91 HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 170 (205)
Q Consensus 91 ~~~lv~~~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df~~~~~~~ 170 (205)
..+++++++.+++|.+++.. +++++..++.++.|++.||.|||++||+||||||+||+++.++. ++++|||.+....
T Consensus 96 ~~~~i~~~~~gg~L~~~~~~-~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~--~kl~dfg~a~~~~ 172 (348)
T d2gfsa1 96 NDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCE--LKILDFGLARHTD 172 (348)
T ss_dssp CCCEEEEECCSEEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCC--EEECCC----CCT
T ss_pred ceEEEEEeecCCchhhhccc-ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCcccccccccc--ccccccchhcccC
Confidence 34566677788999998844 57999999999999999999999999999999999999998887 9999999986543
Q ss_pred CCCCCCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 171 LHSQPKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 171 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
.......|+..|+|||.+.+..+.+.++|||||
T Consensus 173 --~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSl 205 (348)
T d2gfsa1 173 --DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSV 205 (348)
T ss_dssp --GGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHH
T ss_pred --cccccccccccccCchhhcCCccCCcccchhhh
Confidence 233445688999999998887664455999996
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=4.1e-34 Score=218.81 Aligned_cols=182 Identities=25% Similarity=0.370 Sum_probs=147.1
Q ss_pred CCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCccchHHHHHHHHHHHhcC-----------CCCeeEEEEEEEeC
Q 028681 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLR-----------HPNIVRFKEVILTP 89 (205)
Q Consensus 21 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~-----------h~~i~~~~~~~~~~ 89 (205)
++|++++.||+|+||+||+|++..+|+.||+|++++.....+.+.+|+.+++.+. |+|++++++++...
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~ 92 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHK 92 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeec
Confidence 4699999999999999999999999999999999877656677888888888774 57899999888653
Q ss_pred --CeEEEEEEecCCCc-hHHHH--HhcCCCCHHHHHHHHHHHHHHHHHHHh-cCcEeecCCCCCeEecCCCCC----cEE
Q 028681 90 --THLAIVMEYASGGE-LFERI--CNAGRFSEDEARFFFQQLISGVSYCHS-MQVCHRDLKLENTLLDGSPAP----RLK 159 (205)
Q Consensus 90 --~~~~lv~~~~~~~s-l~~~~--~~~~~~~~~~~~~i~~~i~~~l~~lh~-~~i~H~di~p~nili~~~~~~----~~~ 159 (205)
...++++.++.... ..... .....+++..++.++.|++.|+.|||+ +||+||||||+||+++.++.. .++
T Consensus 93 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~~~~k 172 (362)
T d1q8ya_ 93 GPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIK 172 (362)
T ss_dssp ETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEEEE
T ss_pred cccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCcccccceee
Confidence 45666666654332 22222 234469999999999999999999997 899999999999999755432 489
Q ss_pred EeeecccccccCCCCCCCCCCCCCccCCceeccCcCCCeeeEEEeC
Q 028681 160 ICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKVMCVYVI 205 (205)
Q Consensus 160 l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dvwsl 205 (205)
++|||.+.... .......|++.|+|||++....++.+ +|+|||
T Consensus 173 l~dfg~s~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwSl 215 (362)
T d1q8ya_ 173 IADLGNACWYD--EHYTNSIQTREYRSPEVLLGAPWGCG-ADIWST 215 (362)
T ss_dssp ECCCTTCEETT--BCCCSCCSCGGGCCHHHHHTCCCCTH-HHHHHH
T ss_pred Eeecccccccc--cccccccccccccChhhccccCCCcc-ccccch
Confidence 99999986543 33355679999999999999999866 999985
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.92 E-value=3.6e-25 Score=154.42 Aligned_cols=132 Identities=17% Similarity=0.162 Sum_probs=103.1
Q ss_pred eEEEeeeccccceeEEEEEecCCCcEEEEEEeecCcc-------------------chHHHHHHHHHHHhcCCCCeeEEE
Q 028681 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK-------------------IDENVQREIINHRSLRHPNIVRFK 83 (205)
Q Consensus 23 y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~-------------------~~~~~~~e~~~l~~l~h~~i~~~~ 83 (205)
+.+.++||+|+||+||.+.+. +|+.||+|+++.+.. .......|...+.++.|.+++..+
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~ 80 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY 80 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred chhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEE
Confidence 468899999999999999885 588999998753211 012234577888889999988877
Q ss_pred EEEEeCCeEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCCeEecCCCCCcEEEeee
Q 028681 84 EVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDF 163 (205)
Q Consensus 84 ~~~~~~~~~~lv~~~~~~~sl~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~di~p~nili~~~~~~~~~l~df 163 (205)
++. . .+++|+++++..+.+ ++......++.|++.++.+||++||+||||||+||++++++ ++|+||
T Consensus 81 ~~~--~--~~lvme~~~~~~~~~-------l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~~---~~liDF 146 (191)
T d1zara2 81 AWE--G--NAVLMELIDAKELYR-------VRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEEG---IWIIDF 146 (191)
T ss_dssp EEE--T--TEEEEECCCCEEGGG-------CCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETTE---EEECCC
T ss_pred Eec--C--CEEEEEeeccccccc-------hhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCCC---EEEEEC
Confidence 643 2 368999998765532 44555678999999999999999999999999999998543 899999
Q ss_pred cccccc
Q 028681 164 GYSKSS 169 (205)
Q Consensus 164 ~~~~~~ 169 (205)
|.|+..
T Consensus 147 G~a~~~ 152 (191)
T d1zara2 147 PQSVEV 152 (191)
T ss_dssp TTCEET
T ss_pred CCcccC
Confidence 988643
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.86 E-value=2e-08 Score=71.75 Aligned_cols=85 Identities=16% Similarity=0.070 Sum_probs=58.5
Q ss_pred CCCeEEEeeeccccceeEEEEEecCCCcEEEEEEeecCcc-chHHHHHHHHHHHhcC-CCCeeEEEEEEEeCCeEEEEEE
Q 028681 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK-IDENVQREIINHRSLR-HPNIVRFKEVILTPTHLAIVME 97 (205)
Q Consensus 20 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~~ 97 (205)
...|+..+..+.++...||++.. ++..+++|+...... ....+..|...++.+. +--+.+++.+...++..+++|+
T Consensus 13 ~~~~~~~~~~~G~s~~~v~rv~~--~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~ 90 (263)
T d1j7la_ 13 IEKYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMS 90 (263)
T ss_dssp HTTSEEEECSCCCSSSEEEEEEC--SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEE
T ss_pred hhceEEEEcCCCCCCCcEEEEEe--CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEE
Confidence 35677777655555678898753 455678887765432 3345677888877764 2235667777888889999999
Q ss_pred ecCCCchHH
Q 028681 98 YASGGELFE 106 (205)
Q Consensus 98 ~~~~~sl~~ 106 (205)
++++.++.+
T Consensus 91 ~l~G~~~~~ 99 (263)
T d1j7la_ 91 EADGVLCSE 99 (263)
T ss_dssp CCSSEEHHH
T ss_pred ecccccccc
Confidence 998876644
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=98.53 E-value=4.5e-07 Score=68.55 Aligned_cols=76 Identities=17% Similarity=0.091 Sum_probs=47.5
Q ss_pred EeeeccccceeEEEEEecCCCcEEEEEEeecC--------ccchHHHHHHHHHHHhcC-C--CCeeEEEEEEEeCCeEEE
Q 028681 26 VRDIGSGNFGVARLMRDKKTEELVAVKYIERG--------DKIDENVQREIINHRSLR-H--PNIVRFKEVILTPTHLAI 94 (205)
Q Consensus 26 ~~~l~~g~~g~v~~~~~~~~~~~v~iK~~~~~--------~~~~~~~~~e~~~l~~l~-h--~~i~~~~~~~~~~~~~~l 94 (205)
.+.||.|....||++.+..+++.+++|.-.+. +...++...|...++.+. + ..+++++.+ ++...++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence 55689899999999998887888999964321 112344556777776663 2 335555543 4555678
Q ss_pred EEEecCCCc
Q 028681 95 VMEYASGGE 103 (205)
Q Consensus 95 v~~~~~~~s 103 (205)
+||++++..
T Consensus 109 vmE~L~~~~ 117 (392)
T d2pula1 109 VMEDLSHLK 117 (392)
T ss_dssp EECCCTTSE
T ss_pred EEeccCCcc
Confidence 999997644
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.46 E-value=8.7e-07 Score=62.65 Aligned_cols=74 Identities=14% Similarity=0.066 Sum_probs=49.8
Q ss_pred eecccc-ceeEEEEEecCCCcEEEEEEeecCccchHHHHHHHHHHHhcCCC--CeeEEEEEEEeCCeEEEEEEecCCCch
Q 028681 28 DIGSGN-FGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHP--NIVRFKEVILTPTHLAIVMEYASGGEL 104 (205)
Q Consensus 28 ~l~~g~-~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~--~i~~~~~~~~~~~~~~lv~~~~~~~sl 104 (205)
.+..|. ...||++.... +..+++|...... ...+..|...++.+... .+.+++.+..+++..+++|+++++.++
T Consensus 17 ~~~~G~s~~~v~r~~~~~-~~~~vlK~~~~~~--~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQG-RPVLFVKTDLSGA--LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 93 (255)
T ss_dssp ECSCTTSSCEEEEEECTT-SCCEEEEEECSCT--TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred EcCCcccCCeEEEEEeCC-CCEEEEEeCCccC--HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence 344454 36788887654 5557888765443 34467777777776432 356677777888889999999987554
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=98.09 E-value=9.4e-06 Score=59.53 Aligned_cols=67 Identities=13% Similarity=0.137 Sum_probs=44.9
Q ss_pred ceeEEEEEecCCCcEEEEEEeecCccchHHHHHHHHHHHhcCCCCe-----eEE--EEEEEeCCeEEEEEEecCC
Q 028681 34 FGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNI-----VRF--KEVILTPTHLAIVMEYASG 101 (205)
Q Consensus 34 ~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i-----~~~--~~~~~~~~~~~lv~~~~~~ 101 (205)
.-.||++... +|..+++|+..++....+++.+|...+..|....+ +.. -..+..++..+.++++++|
T Consensus 35 EN~vy~v~~~-dg~~~VlK~~rp~~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G 108 (325)
T d1zyla1 35 ENRVYQFQDE-DRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGG 108 (325)
T ss_dssp SSEEEEECCT-TCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCC
T ss_pred cceeEEEEcC-CCCEEEEEEeCCCCCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCC
Confidence 3578998764 46779999888776667788889888887742221 111 1122345677888898865
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=97.62 E-value=0.00022 Score=51.58 Aligned_cols=30 Identities=27% Similarity=0.349 Sum_probs=25.8
Q ss_pred cCcEeecCCCCCeEecCCCCCcEEEeeecccc
Q 028681 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 167 (205)
Q Consensus 136 ~~i~H~di~p~nili~~~~~~~~~l~df~~~~ 167 (205)
.|+||+|+.++|++++++.. .-++||+.+.
T Consensus 183 ~giIHgDl~~dNvl~~~~~v--~gvIDF~~~~ 212 (316)
T d2ppqa1 183 AGVIHADLFQDNVFFLGDEL--SGLIDFYFAC 212 (316)
T ss_dssp EEEECSCCCGGGEEEETTEE--EEECCCTTCE
T ss_pred cccccCCcchhhhhcccccc--eeEecccccc
Confidence 48999999999999986654 6899999875
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=97.59 E-value=0.00026 Score=52.99 Aligned_cols=77 Identities=12% Similarity=0.143 Sum_probs=49.2
Q ss_pred CCeEEEeeeccccceeEEEEEecC-------CCcEEEEEEeecCccchHHHHHHHHHHHhcCCCCe-eEEEEEEEeCCeE
Q 028681 21 DRYELVRDIGSGNFGVARLMRDKK-------TEELVAVKYIERGDKIDENVQREIINHRSLRHPNI-VRFKEVILTPTHL 92 (205)
Q Consensus 21 ~~y~~~~~l~~g~~g~v~~~~~~~-------~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i-~~~~~~~~~~~~~ 92 (205)
+.+++ +.|+.|-.-.+|++.... .+..|++++.. +.........|..+++.+.-.++ .++++++.+
T Consensus 43 ~~l~v-~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~---- 116 (395)
T d1nw1a_ 43 EHLRI-SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-NPETESHLVAESVIFTLLSERHLGPKLYGIFSG---- 116 (395)
T ss_dssp GGEEE-EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-SCCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----
T ss_pred cceEE-EEcCCccccceEEEEeCCCCccccCCCCcEEEEecC-CcchhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----
Confidence 44555 466667777889887653 34567788766 33334456678888887754444 466666532
Q ss_pred EEEEEecCCCc
Q 028681 93 AIVMEYASGGE 103 (205)
Q Consensus 93 ~lv~~~~~~~s 103 (205)
+.|++|+++.+
T Consensus 117 g~I~efi~g~~ 127 (395)
T d1nw1a_ 117 GRLEEYIPSRP 127 (395)
T ss_dssp EEEECCCCEEE
T ss_pred ceEEEEecccc
Confidence 57888887643
|